PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Zeiler, FA; Cabeleira, M; Hutchinson, PJ; Stocchetti, N; Czosnyka, M; Smielewski, P; Ercole, A				Zeiler, Frederick A.; Cabeleira, Manuel; Hutchinson, Peter J.; Stocchetti, Nino; Czosnyka, Marek; Smielewski, Peter; Ercole, Ari		CENTER-TBI High-Resolution Icu Hr	Evaluation of the relationship between slow-waves of intracranial pressure, mean arterial pressure and brain tissue oxygen in TBI: a CENTER-TBI exploratory analysis	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Autoregulation; Brain tissue oxygen; Cerebrovascular reactivity; Traumatic brain injury; TBI	CEREBROVASCULAR REACTIVITY; CEREBRAL AUTOREGULATION; CONSENSUS CONFERENCE; LOWER LIMIT; PART II; INJURY; MANAGEMENT; INDEXES; FLOW; CLASSIFICATION	Brain tissue oxygen (PbtO(2)) monitoring in traumatic brain injury (TBI) has demonstrated strong associations with global outcome. Additionally, PbtO(2) signals have been used to derive indices thought to be associated with cerebrovascular reactivity in TBI. However, their true relationship to slow-wave vasogenic fluctuations associated with cerebral autoregulation remains unclear. The goal of this study was to investigate the relationship between slow-wave fluctuations of intracranial pressure (ICP), mean arterial pressure (MAP) and PbtO(2) over time. Using the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) high resolution ICU sub-study cohort, we evaluated those patients with recorded high-frequency digital intra-parenchymal ICP and PbtO(2) monitoring data of a minimum of 6 h in duration. Digital physiologic signals were processed for ICP, MAP, and PbtO(2) slow-waves using a moving average filter to decimate the high-frequency signal. The first 5 days of recording were analyzed. The relationship between ICP, MAP and PbtO(2) slow-waves over time were assessed using autoregressive integrative moving average (ARIMA) and vector autoregressive integrative moving average (VARIMA) modelling, as well as Granger causality testing. A total of 47 patients were included. The ARIMA structure of ICP and MAP were similar in time, where PbtO(2) displayed different optimal structure. VARIMA modelling and IRF plots confirmed the strong directional relationship between MAP and ICP, demonstrating an ICP response to MAP impulse. PbtO(2) slow-waves, however, failed to demonstrate a definite response to ICP and MAP slow-wave impulses. These results raise questions as to the utility of PbtO(2) in the derivation of cerebrovascular reactivity measures in TBI. There is a reproducible relationship between slow-wave fluctuations of ICP and MAP, as demonstrated across various time-series analytic techniques. PbtO(2) does not appear to reliably respond in time to slow-wave fluctuations in MAP, as demonstrated on various VARIMA models across all patients. These findings suggest that PbtO(2) should not be utilized in the derivation of cerebrovascular reactivity metrics in TBI, as it does not appear to be responsive to changes in MAP in the slow-waves. These findings corroborate previous results regarding PbtO(2) based cerebrovascular reactivity indices.	[Zeiler, Frederick A.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Brain Phys Lab, Cambridge CB2 0QQ, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca; mc916@cam.ac.uk; pjah2@cam.ac.uk; nino.stocchetti@policlinico.mi.it; mc141@medschl.cam.ac.uk; ps10011@cam.ac.uk; ae105@cam.ac.uk	Sahuquillo, Juan/B-3577-2008; Ercole, Ari/B-6288-2009; Raj, Rahul/K-7693-2012; Stocchetti, Nino/O-7444-2017; Moller, Kirsten/A-4751-2009	Sahuquillo, Juan/0000-0003-0713-5875; Ercole, Ari/0000-0001-8350-8093; Raj, Rahul/0000-0003-4243-9591; Stocchetti, Nino/0000-0003-3250-6834; Radoi, Andreea/0000-0002-0677-3544; Kondziella, Daniel/0000-0001-5562-9808; Moller, Kirsten/0000-0003-3058-1072; Sakowitz, Oliver/0000-0003-3248-6335; Zeiler, Frederick/0000-0003-1737-0510	Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation (CFI)Canada Foundation for Innovation; University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation Winnipeg; NIHR Cambridge BRC; NIHR (Research Professorship, Cambridge BRC, Global Health Research Group on Neurotrauma); Royal College of Surgeons of England	FAZ receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the University of Manitoba Centre on Aging, the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Rudy Falk Clinician-Scientist Professorship, and the Health Sciences Centre Foundation Winnipeg. MC is supported by NIHR Cambridge BRC. PH is supported by the NIHR (Research Professorship, Cambridge BRC, Global Health Research Group on Neurotrauma) and the Royal College of Surgeons of England.	Andresen M, 2018, NEUROCRIT CARE, V28, P162, DOI 10.1007/s12028-017-0438-z; Bernard F, 2020, CAN J NEUROL SCI, V47, P551, DOI 10.1017/cjn.2020.54; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatfield C., 2016, ANAL TIME SERIES INT; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dellazizzo L, 2019, J NEUROSURG, V131, P1639, DOI 10.3171/2018.5.JNS18651; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Douc R., 2014, NONLINEAR TIME SERIE, V1st edn; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2013, NEUROCRIT CARE, V19, P69, DOI 10.1007/s12028-013-9857-7; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Kohler K, 2019, J NEUROTRAUM, V36, P2109, DOI 10.1089/neu.2018.6187; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lutkepohl H, 2010, NEW INTRO MULTIPLE T; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Thelin EP, 2020, J CLIN MONIT COMPUT, V34, P971, DOI 10.1007/s10877-019-00392-y; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2019, J NEUROTRAUM, V36, P713, DOI 10.1089/neu.2018.5987; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129	44	1	1	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2021	35	4					711	722		10.1007/s10877-020-00527-6		MAY 2020	12	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	TM5FL	WOS:000533183900001	32418148	Green Published, hybrid, Green Submitted			2022-02-06	
J	Lubetzky, AV; Kelly, J; Wang, Z; Gospodarek, M; Fu, G; Sutera, J; Hujsak, BD				Lubetzky, Anat, V; Kelly, Jennifer; Wang, Zhu; Gospodarek, Marta; Fu, Gene; Sutera, John; Hujsak, Bryan D.			Contextual sensory integration training via head mounted display for individuals with vestibular disorders: a feasibility study	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article; Early Access						Vestibular rehabilitation; HMD; HTC Vive; virtual reality; sensory integration; balance	VIRTUAL-REALITY; POSTURAL COMPENSATION; VISUAL VERTIGO; REHABILITATION; QUESTIONNAIRE; COMMUNITY; VALIDITY; PEOPLE; FALLS; SCALE	Purpose: Virtual reality (VR) interventions can simulate real-world sensory environments. The purpose of this study was to test the feasibility of a novel VR application (app) developed for a Head Mounted Display (HMD) to target dizziness, imbalance and sensory integration in a functional context for patients with vestibular disorders. Here we describe the design of the app as well as self-reported and functional outcomes in vestibular patients before and after participating in vestibular rehabilitation using the app. Material and methods: Our app includes a virtual street, airport, subway or a park. The clinician controls the visual and auditory load including several levels of direction, amount and speed of virtual pedestrians. Clinicians enrolled 28 patients with central (mild-traumatic brain injury [mTBI] or vestibular migraine) and peripheral vestibular disorders. We recorded the Simulator Sickness Questionnaire, Visual Vertigo Analogue Scale (VVAS), Dizziness Handicap Inventory (DHI), Activities-Specific Balance Confidence Scale (ABC), 8-foot up and go (8FUG) and Four-Step Square Test (FSST) before and after the intervention. Results: Within the 15 patients who completed the study, 12 with peripheral hypofunction showed significant improvements on the VVAS (p = 0.02), DHI (p = 0.008) and ABC (p = 0.02) and a small significant improvement on the FSST (p = 0.015). Within-session changes in symptoms were minimal. Two patients with mTBI showed important improvements, but one patient with vestibular migraine, did not. Conclusion: HMD training within increasingly complex immersive environments appears to be a promising adjunct modality for vestibular rehabilitation. Future controlled studies are needed to establish effectiveness.	[Lubetzky, Anat, V; Sutera, John] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Phys Therapy, 380 2nd Ave,4t Floor, New York, NY 10010 USA; [Kelly, Jennifer; Fu, Gene; Sutera, John; Hujsak, Bryan D.] New York Eye & Ear Infirm Mt Sinai, Vestibular Rehabil, New York, NY USA; [Wang, Zhu] NYU, Courant Inst Math Sci, Dept Comp Sci, Future Real Lab, New York, NY 10012 USA; [Gospodarek, Marta] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Mus & Performing Arts Profess, New York, NY USA		Lubetzky, AV (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Phys Therapy, 380 2nd Ave,4t Floor, New York, NY 10010 USA.	anat@nyu.edu		Lubetzky, Anat/0000-0001-5869-025X			ALESSI SM, 1988, J COMPUT-BASE INSTR, V15, P40; Bastable S. B, 2010, HLTH PROFESSIONAL ED; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Dannenbaum E, 2019, J NEUROL PHYS THER, V43, P117, DOI 10.1097/NPT.0000000000000261; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; Dunlap PM, 2019, CURR OPIN NEUROL, V32, P137, DOI 10.1097/WCO.0000000000000632; Freyler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167557; Horak FB, 2010, RESTOR NEUROL NEUROS, V28, P57, DOI 10.3233/RNN-2010-0515; Horak FB, 2009, ANN NY ACAD SCI, V1164, P76, DOI 10.1111/j.1749-6632.2008.03708.x; Howard MC, 2017, COMPUT HUM BEHAV, V70, P317, DOI 10.1016/j.chb.2017.01.013; Hsu SY, 2017, DISABIL REHABIL, V39, P1601, DOI 10.1080/09638288.2016.1203027; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jahn K, 2018, J NEUROL, V265, P70, DOI 10.1007/s00415-018-8882-z; Kalron A, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0124-y; KENNEDY RS, 1992, AVIAT SPACE ENVIR MD, V63, P588; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Keshner EA, 2017, J VESTIBUL RES-EQUIL, V27, P1, DOI 10.3233/VES-170610; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Larsson P, 2010, HUM-COMPUT INT-SPRIN, P143, DOI 10.1007/978-1-84882-733-2_8; Levac D., 2016, BMC HEALTH SERV RES, V16, P1; Lubetzky AV, 2019, INT C VIRT REH TEL A; Massetti T, 2018, J CENT NERV SYST DIS, V10, DOI 10.1177/1179573518813541; Meldrum D, 2015, ARCH PHYS MED REHAB, V96, P1319, DOI 10.1016/j.apmr.2015.02.032; Morel M, 2015, NEUROPHYSIOL CLIN, V45, P315, DOI 10.1016/j.neucli.2015.09.007; Naumann T, 2015, GAIT POSTURE, V41, P774, DOI 10.1016/j.gaitpost.2015.02.003; Neuropt.org, 2018, VEST DIS; Nordahl R, 2014, OXFORD HDB INTERACTI; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Purves D, 2017, NEUROSCIENCE, P305; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Rose DJ, 2002, J AGING PHYS ACTIV, V10, P466, DOI 10.1123/japa.10.4.466; Sapi M, 2019, GAMES HEALTH J, V8, P41, DOI 10.1089/g4h.2018.0027; Schaufler G, 1996, C HUM FACT COMP SYST, P235; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Vitkovic J, 2016, AUDIOL NEURO-OTOL, V21, P195, DOI 10.1159/000445100; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Whitney SL, 2007, ARCH PHYS MED REHAB, V88, P99, DOI 10.1016/j.apmr.2006.10.027; Whitney SL, 2015, CURR OPIN NEUROL, V28, P61, DOI 10.1097/WCO.0000000000000162; WHO, 2001, INT CLASS FUNCT DIS; Xiang Q, 2008, ACTA HORTIC, P61, DOI 10.17660/ActaHortic.2008.799.6	41	1	1	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.												10.1080/17483107.2020.1765419		MAY 2020	11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	LR2KT	WOS:000535525300001	32421374				2022-02-06	
J	van Dijck, JTJM; Mostert, CQB; Greeven, APA; Kompanje, EJO; Peul, WC; de Ruiter, GCW; Polinder, S				van Dijck, Jeroen T. J. M.; Mostert, Cassidy Q. B.; Greeven, Alexander P. A.; Kompanje, Erwin J. O.; Peul, Wilco C.; de Ruiter, Godard C. W.; Polinder, Suzanne			Functional outcome, in-hospital healthcare consumption and in-hospital costs for hospitalised traumatic brain injury patients: a Dutch prospective multicentre study	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; In-hospital costs; Mortality; Functional outcome	GLASGOW COMA SCALE; LENGTH-OF-STAY; SUBDURAL-HEMATOMA; OLDER-ADULTS; DECOMPRESSIVE CRANIECTOMY; UNITED-STATES; CENTER-TBI; MANAGEMENT; GUIDELINES; MORTALITY	Background The high occurrence and acute and chronic sequelae of traumatic brain injury (TBI) cause major healthcare and socioeconomic challenges. This study aimed to describe outcome, in-hospital healthcare consumption and in-hospital costs of patients with TBI. Methods We used data from hospitalised TBI patients that were included in the prospective observational CENTER-TBI study in three Dutch Level I Trauma Centres from 2015 to 2017. Clinical data was completed with data on in-hospital healthcare consumption and costs. TBI severity was classified using the Glasgow Coma Score (GCS). Patient outcome was measured by in-hospital mortality and Glasgow Outcome Score-Extended (GOSE) at 6 months. In-hospital costs were calculated following the Dutch guidelines for cost calculation. Results A total of 486 TBI patients were included. Mean age was 56.1 +/- 22.4 years and mean GCS was 12.7 +/- 3.8. Six-month mortality (4.2%-66.7%), unfavourable outcome (GOSE <= 4) (14.6%-80.4%) and full recovery (GOSE = 8) (32.5%-5.9%) rates varied from patients with mild TBI (GCS13-15) to very severe TBI (GCS3-5). Length of stay (8 +/- 13 days) and in-hospital costs (euro11,920) were substantial and increased with higher TBI severity, presence of intracranial abnormalities, extracranial injury and surgical intervention. Costs were primarily driven by admission (66%) and surgery (13%). Conclusion In-hospital mortality and unfavourable outcome rates were rather high, but many patients also achieved full recovery. Hospitalised TBI patients show substantial in-hospital healthcare consumption and costs, even in patients with mild TBI. Because these costs are likely to be an underestimation of the actual total costs, more research is required to investigate the actual costs-effectiveness of TBI care.	[van Dijck, Jeroen T. J. M.; Mostert, Cassidy Q. B.; Peul, Wilco C.; de Ruiter, Godard C. W.] HMC, LUMC, Univ Neurosurg Ctr Holland, Dept Neurosurg, The Hague, Netherlands; [van Dijck, Jeroen T. J. M.; Mostert, Cassidy Q. B.; Peul, Wilco C.; de Ruiter, Godard C. W.] Haga Teaching Hosp, The Hague, Netherlands; [van Dijck, Jeroen T. J. M.] LUMC, Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands; [Greeven, Alexander P. A.] Haga Teaching Hosp, Dept Surg, The Hague, Netherlands; [Kompanje, Erwin J. O.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [Kompanje, Erwin J. O.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Eth & Philosophy Med, Rotterdam, Netherlands; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands		van Dijck, JTJM (corresponding author), HMC, LUMC, Univ Neurosurg Ctr Holland, Dept Neurosurg, The Hague, Netherlands.; van Dijck, JTJM (corresponding author), Haga Teaching Hosp, The Hague, Netherlands.; van Dijck, JTJM (corresponding author), LUMC, Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands.	dijck@lumc.nl	van Dijck, Jeroen/AAM-4123-2021; de Ruiter, Godard/ABC-4074-2020	van Dijck, Jeroen/0000-0002-9893-632X; 	European UnionEuropean Commission [602,150]; Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe)	This work was supported by the European Union seventh Framework Program (grant 602,150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) and Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe).	Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, pE45, DOI 10.1097/HTR.0000000000000297; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Becker A, 2018, CHIN J TRAUMATOL, V21, P152, DOI 10.1016/j.cjtee.2018.01.004; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Buisman LR, 2015, NEUROLOGY, V84, P2208, DOI 10.1212/WNL.0000000000001635; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; De Koning ME, 2018, BRAIN INJURY, V32, P540, DOI 10.1080/02699052.2018.1431844; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Govaert JA, 2016, J AM COLL SURGEONS, V222, P19, DOI 10.1016/j.jamcollsurg.2015.09.020; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hakkaart-van Roijen L, KOSTENHANDLEIDING ME; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Lansink-Hartgring AO, 2016, CRIT CARE MED, V44, P717, DOI 10.1097/CCM.0000000000001477; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Moore L, 2018, ANN SURG, V267, P177, DOI 10.1097/SLA.0000000000002036; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Moskowitz E, 2018, AM SURGEON, V84, P1314; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Raj R, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2151-5; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Salottolo K, 2016, INJURY, V47, P70, DOI 10.1016/j.injury.2015.10.002; Saltzherr TP, 2013, EUR RADIOL, V23, P148, DOI 10.1007/s00330-012-2593-0; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Shibahashi K, 2020, J NEUROSURG, V133, P504, DOI 10.3171/2019.4.JNS182660; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; TEASDALE G, 1974, LANCET, V2, P81; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; van der Linden N, 2016, LUNG CANCER, V91, P79, DOI 10.1016/j.lungcan.2015.10.015; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Dijck JT, 2018, J NEUROSURG SCI, V62, P153, DOI 10.23736/S0390-5616.17.04255-2; van Dijck JTJM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216743; van Dijck JTJM, 2019, ACTA NEUROCHIR, V161, P875, DOI 10.1007/s00701-019-03878-5; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Volovici V, 2019, J NEUROTRAUM, V36, P3183, DOI 10.1089/neu.2019.6474; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028; Zapata-Vazquez Rita Esther, 2017, Value Health Reg Issues, V14, P96, DOI 10.1016/j.vhri.2017.08.011; Zorgautoriteit Nederland, 2012, TAR DBC ZORGPR OV PR; Zorgautoriteit Nederland, OP DAT NED ZORG	83	1	1	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2020	162	7					1607	1618		10.1007/s00701-020-04384-9		MAY 2020	12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	LY2HG	WOS:000532883400003	32410121	Green Published, hybrid			2022-02-06	
J	Prieto-Palomino, MA; Delange-VanDerKroft, M; Rodriguez-Rubio, D; Lafuente-Baraza, J; Aguilar-Alonso, E; Rivera-Lopez, R; Arias-Verdu, MD; Pola-GallegoDeGuzman, MD; Munoz-Lopez, A; Fernandez-Ortega, JF; Curiel-Balsera, E; Quesada-Garcia, G; Rivera-Fernandez, R				Angel Prieto-Palomino, Miguel; Delange-VanDerKroft, Monica; Rodriguez-Rubio, David; Lafuente-Baraza, Jesus; Aguilar-Alonso, Eduardo; Rivera-Lopez, Ricardo; Dolores Arias-Verdu, Maria; Dolores Pola-GallegoDeGuzman, Maria; Munoz-Lopez, Alfonso; Francisco Fernandez-Ortega, Juan; Curiel-Balsera, Emilio; Quesada-Garcia, Guillermo; Rivera-Fernandez, Ricardo			Improvement of quality of life (QOL) between 1 and 3-4 years after traumatic brain injury (TBI) in ICU patients	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Marshall's tomographic classification; Quality of life; GOS; Mortality	MONTHS AFTER-DISCHARGE; CRITICAL ILLNESS; HEAD-INJURY; HEALTH; MODERATE; VALIDATION; MORTALITY; ADMISSION; CLASSIFICATION; SURVIVORS	Background Evaluation of changes in quality of life (QOL) in ICU patients several years after traumatic brain injury (TBI) is not well documented. Methods A prospective cohort study was conducted in all patients with TBI admitted between 2004 and 2008 to the ICU of Regional Hospital of Malaga (Spain). Functional status was evaluated by Glasgow Outcome Scale (GOS) and QOL by PAECC (Project for the Epidemiologic Analysis of Critical Care patients) questionnaire between 0 (normal QOL) to 29 points (worst QOL). Results A total of 531 patients. Median(Quartile1,Quartile 3) age: 35 (22, 56) years. After 3-4 years, 175 died (33%). Survivor QOL was deteriorated (median total PAECC score: 5 (0, 11) points) although 75.76% of patients who survived showed good functional situation (GOS normal or mild dysfunction). An improvement in QOL scores between 1 and 3-4 years was observed (median PAECC score differences between 3-4 years and 1 year: - 1(- 4, 0) points). QOL score improved during this interval of time: 62.6% of patients. Change in QOL was related by multivariate analysis to admission cranial-computed tomography scan (Marshall's classification), age, and Injury Severity Score (ISS), with the biggest improvement seen in younger patients and with more severe ISS. Basic physiological activities were maintained in the majority of patients. Subjective aspects and working activities improved between 1 and 3-4 years but with a high proportion still impaired in these items after 3-4 years. Conclusions ICU patients with TBI after 1 year show improvement in QOL between 1 and 3-4 years, with the biggest improvement in QOL seen in younger patients and in those with more severe ISS.	[Angel Prieto-Palomino, Miguel; Dolores Arias-Verdu, Maria; Munoz-Lopez, Alfonso; Francisco Fernandez-Ortega, Juan; Curiel-Balsera, Emilio; Quesada-Garcia, Guillermo] Hosp Reg Univ, Intens Care Unit, Malaga, Spain; [Delange-VanDerKroft, Monica] Hosp Comarcal Axarquia Velez Malaga, Intens Care Unit, Malaga, Spain; [Rodriguez-Rubio, David; Lafuente-Baraza, Jesus] Hosp Mar, Neurosurg Dept, Barcelona, Spain; [Aguilar-Alonso, Eduardo] Hosp Infanta Margarita, Intens Care Med, Ave Gongora S-N, Cordoba 14940, Spain; [Rivera-Lopez, Ricardo] Hosp Virgen de las Nieves, Cardiol Unit, Granada, Spain; [Dolores Pola-GallegoDeGuzman, Maria; Rivera-Fernandez, Ricardo] Complejo Hosp Jaen, Intens Care Unit, Jaen, Spain		Aguilar-Alonso, E (corresponding author), Hosp Infanta Margarita, Intens Care Med, Ave Gongora S-N, Cordoba 14940, Spain.	eaguia@yahoo.es	Curiel-Balsera, Emilio/None; Rivera-Fernandez, Ricardo/M-1724-2013	Curiel-Balsera, Emilio/0000-0002-9932-5053; Rivera-Fernandez, Ricardo/0000-0001-7383-4901; Rivera-Lopez, Ricardo/0000-0002-0787-9383	Instituto de Salud Carlos III, Ministerio de Sanidad, SpainInstituto de Salud Carlos IIISpanish Government [PI07/91032]	This study was founded by public grant PI07/91032 of Instituto de Salud Carlos III, Ministerio de Sanidad, Spain.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Prieto-Palomino MA, 2016, BRAIN INJURY, V30, P441, DOI 10.3109/02699052.2016.1141434; Badia X, 2001, INTENS CARE MED, V27, P1901, DOI 10.1007/s00134-001-1137-x; Capuzzo M, 2000, INTENS CARE MED, V26, P1296, DOI 10.1007/s001340000579; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Degos V, 2012, ANESTH ANALG, V114, P1026, DOI 10.1213/ANE.0b013e318249fe7a; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fernandez RR, 1996, INTENS CARE MED, V22, P1034, DOI 10.1007/s001340050209; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Iribarren-Diarasarri S, 2009, MED INTENSIVA, V33, P115, DOI 10.1016/S0210-5691(09)70944-1; Iribarren-Diarasarri S, 2009, INTENS CARE MED, V35, P833, DOI 10.1007/s00134-009-1418-3; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata GV, 1996, J TRAUMA, V41, P326, DOI 10.1097/00005373-199608000-00022; MATA GV, 1992, CRIT CARE MED, V20, P1257, DOI 10.1097/00003246-199209000-00012; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nikayin S, 2016, GEN HOSP PSYCHIAT, V43, P23, DOI 10.1016/j.genhosppsych.2016.08.005; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pavoni V, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-24; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabiee A, 2016, CRIT CARE MED, V44, P1744, DOI 10.1097/CCM.0000000000001811; Risling M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01153; Rivera-Fernandez R, 2001, CRIT CARE MED, V29, P1701, DOI 10.1097/00003246-200109000-00008; Rivera-Fernandez R, 2006, CRIT CARE MED, V34, P2317, DOI 10.1097/01.CCM.0000233859.01815.38; Rivera-Lopez R, 2017, ANAESTH INTENS CARE, V45, P351, DOI 10.1177/0310057X1704500310; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wehler M, 2001, INTENS CARE MED, V27, P154, DOI 10.1007/s001340000769; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZAREN B, 1987, CRIT CARE MED, V15, P743, DOI 10.1097/00003246-198708000-00006	42	1	1	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2020	162	7					1619	1628		10.1007/s00701-020-04337-2		MAY 2020	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY2HG	WOS:000532614600003	32405669				2022-02-06	
J	Hossain, I; Mohammadian, M; Takala, RSK; Tenovuo, O; Gil, LA; Frantzen, J; van Gils, M; Hutchinson, PJ; Katila, AJ; Maanpaa, HR; Menon, DK; Newcombe, VF; Tallus, J; Hrusovsky, K; Wilson, DH; Gill, J; Blennow, K; Sanchez, JC; Zetterberg, H; Posti, JP				Hossain, Iftakher; Mohammadian, Mehrbod; Takala, Riikka S. K.; Tenovuo, Olli; Gil, Leire Azurmendi; Frantzen, Janek; van Gils, Mark; Hutchinson, Peter J.; Katila, Ari J.; Maanpaa, Henna-Riikka; Menon, David K.; Newcombe, Virginia F.; Tallus, Jussi; Hrusovsky, Kevin; Wilson, David H.; Gill, Jessica; Blennow, Kaj; Sanchez, Jean-Charles; Zetterberg, Henrik; Posti, Jussi P.			Admission Levels of Total Tau and beta-Amyloid Isoforms 1-40 and 1-42 in Predicting the Outcome of Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; total tau; beta-amyloid 1-40; beta-amyloid 1-42; outcome	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; CEREBROSPINAL-FLUID; HEAD-INJURY; NEUROCHEMICAL AFTERMATH; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; PLASMA-LEVELS; DIAGNOSIS; TBI	Background: The purpose of this study was to investigate if admission levels of total tau (T-tau) and beta-amyloid isoforms 1-40 (A beta 40) and 1-42 (A beta 42) could predict clinical outcome in patients with mild traumatic brain injury (mTBI). Methods: A total of 105 patients with mTBI [Glasgow Coma Scale (GCS) >= 13] recruited in Turku University Hospital, Turku, Finland were included in this study. Blood samples were drawn within 24 h of admission for analysis of plasma T-tau, A beta 40, and A beta 42. Patients were divided into computed tomography (CT)-positive and CT-negative groups. The outcome was assessed 6-12 months after the injury using the Extended Glasgow Outcome Scale (GOSE). Outcomes were defined as complete (GOSE 8) or incomplete (GOSE < 8) recovery. The Rivermead Post Concussion Symptoms Questionnaire (RPCSQ) was also used to assess mTBI-related symptoms. Predictive values of the biomarkers were analyzed independently, in panels and together with clinical parameters. Results: The admission levels of plasma T-tau, A beta 40, and A beta 42 were not significantly different between patients with complete and incomplete recovery. The levels of T-tau, A beta 40, and A beta 42 could poorly predict complete recovery, with areas under the receiver operating characteristic curve 0.56, 0.52, and 0.54, respectively. For the whole cohort, there was a significant negative correlation between the levels of T-tau and ordinal GOSE score (Spearman rho = -0.231, p = 0.018). In a multivariate logistic regression model including age, GCS, duration of posttraumatic amnesia, Injury Severity Score (ISS), time from injury to sampling, and CT findings, none of the biomarkers could predict complete recovery independently or together with the other two biomarkers. Plasma levels of T-tau, A beta 40, and A beta 42 did not significantly differ between the outcome groups either within the CT-positive or CT-negative subgroups. Levels of A beta 40 and A beta 42 did not significantly correlate with outcome, but in the CT-positive subgroup, the levels of T-tau significantly correlated with ordinal GOSE score (Spearman rho = -0.288, p = 0.035). The levels of T-tau, A beta 40, and A beta 42 were not correlated with the RPCSQ scores. Conclusions: The early levels of T-tau are correlated with the outcome in patients with mTBI, but none of the biomarkers either alone or in any combinations could predict complete recovery in patients with mTBI.	[Hossain, Iftakher; Frantzen, Janek; Maanpaa, Henna-Riikka; Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Hossain, Iftakher; Mohammadian, Mehrbod; Tenovuo, Olli; Maanpaa, Henna-Riikka; Tallus, Jussi; Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Hossain, Iftakher; Mohammadian, Mehrbod; Tenovuo, Olli; Frantzen, Janek; Maanpaa, Henna-Riikka; Tallus, Jussi; Posti, Jussi P.] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Hossain, Iftakher; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Neurosurg Unit, Cambridge, England; [Takala, Riikka S. K.; Katila, Ari J.] Turku Univ Hosp, Intens Care Med & Pain Management, Perioperat Serv, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari J.] Univ Turku, Anaesthesiol, Intens Care, Emergency Care & Pain Med, Turku, Finland; [Gil, Leire Azurmendi; Sanchez, Jean-Charles] Univ Geneva, Fac Med, Dept Human Prot Sci, Geneva, Switzerland; [van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Tampere, Finland; [Menon, David K.; Newcombe, Virginia F.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Tallus, Jussi] Turku Univ Hosp, Dept Radiol, Turku, Finland; [Hrusovsky, Kevin; Wilson, David H.] Quanterix Corp, Lexington, MA USA; [Gill, Jessica] Natl Inst Nursing Res, NIH, Bethesda, MD 20892 USA; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Posti, JP (corresponding author), Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland.; Posti, JP (corresponding author), Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Dept Clin Neurosci, Turku, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Newcombe, Virginia/0000-0001-6044-9035; van Gils, Mark/0000-0002-0029-1771; Hossain, Iftakher/0000-0003-4836-1158	European Commission under the 7th Framework Programme [FP7-270259-TBIcare]; Integra EANS Research Grant; Orion Research Foundation sr; University of Turku Graduate School; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation sr; Maire Taponen Foundation; NIHR Research Fellowship; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; Swedish Research CouncilSwedish Research CouncilEuropean Commission; European Research CouncilEuropean Research Council (ERC)European Commission; Royal Swedish Academy of Sciences	This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), Integra EANS Research Grant (IH), Orion Research Foundation sr (IH), University of Turku Graduate School funding (MM), Academy of Finland (#17379, JP), Government's Special Financial Transfer tied to academic research in Health Sciences (Finland) (JP), Emil Aaltonen Foundation sr (JP), Finnish Brain Foundation sr (JP), Maire Taponen Foundation (JP), and NIHR Research Fellowship (PH). VN is funded by the Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. HZ is aWallenberg Academy Fellow and holds grants from the Swedish and European Research Councils. KB holds the Torsten Soderberg Professorship in Medicine, awarded by the Royal Swedish Academy of Sciences, and holds grants from the Swedish Research Council. The authors thank our research nurses Patricia Bertenyi and Satu Honkala for their valuable contribution to this study.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Hossain I, 2019, 13 WORLD C BRAIN INJ; Hossain I, 2019, EUR ASS NEUR SOC ANN; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Jack CR, 2019, JAMA-J AM MED ASSOC, V321, P2316, DOI 10.1001/jama.2019.7437; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lippa SM, 2019, J NEUROTRAUM, V36, P2190, DOI 10.1089/neu.2018.6269; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	55	1	1	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 13	2020	11								325	10.3389/fneur.2020.00325			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT7DR	WOS:000537227800001	32477238	Green Published, gold			2022-02-06	
J	Razaghi, R; Biglari, H; Karimi, A				Razaghi, Reza; Biglari, Hasan; Karimi, Alireza			A patient-specific fluid-structure interaction model of the cerebrovascular damage in relation to traumatic brain injury	TRAUMA-ENGLAND			English	Article						Cerebrovascular artery; arterial damage; traumatic brain injury; stress and deformation; fluid-structure interaction	MECHANICAL-PROPERTIES; PATHOPHYSIOLOGY; RISK	Background There is a lack of knowledge on the magnitudes of the biomechanical stresses and deformations occurring in the cerebral arterial wall after traumatic brain injury (TBI). Experimental techniques are unable to calculate the stresses and deformations in the cerebral arterial wall after TBI; therefore, the application of numerical simulations, such as finite element modeling, is preferred. Methods This study was aimed to calculate the stresses and deformations as well as the alteration in the pressure and velocity of the blood in the cerebrovascular artery using a fluid-structure interaction model. Results The results revealed considerable increase in the pressure and velocity of the blood which might lead to cerebrovascular damage followed by hemorrhage. The arterial wall showed the highest deformation of 0.047 mm in the X direction which was higher than that in the Y (0.035-0.050 mm) and Z (0.019-0.030 mm) directions. Conclusions These results have implications not only for the understanding of the stresses and deformations in the cerebral artery because of TBI, but also for providing a comprehensive knowledge for biomechanical and medical experts in regard to thresholds of cerebrovascular damage for use in establishing preventive and/or treatment methods.	[Razaghi, Reza; Biglari, Hasan] Univ Tabriz, Dept Mech Engn, Tabriz 51666, Iran; [Karimi, Alireza] Kyushu Univ, Dept Mech Engn, Fukuoka, Japan		Biglari, H (corresponding author), Univ Tabriz, Dept Mech Engn, Tabriz 51666, Iran.	hbiglari@tabrizu.ac.ir	Razaghi, Reza/S-7173-2019; Biglari, Hasan/ABF-6235-2021	Razaghi, Reza/0000-0002-9563-7535; Biglari, Hasan/0000-0003-4601-9762			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Aomura S, 2003, JSME INT J C-MECH SY, V46, P583, DOI 10.1299/jsmec.46.583; Badia S, 2009, COMPUT METHOD APPL M, V198, P2768, DOI 10.1016/j.cma.2009.04.004; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chua SND, 2003, J MATER PROCESS TECH, V143, P591, DOI 10.1016/S0924-0136(03)00435-7; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; Danaila L, 2013, CHIRURGIA-BUCHAREST, V108, P319; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DONEA J, 1982, COMPUT METHOD APPL M, V33, P689, DOI 10.1016/0045-7825(82)90128-1; Esnault P, 2017, J NEUROSURG, V127, P16, DOI 10.3171/2016.4.JNS152600; Faghihi S, 2014, MAT SCI ENG C-MATER, V38, P299, DOI 10.1016/j.msec.2014.02.015; Faghihi S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864153; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerbeau JF, 2005, COMPUT STRUCT, V83, P155, DOI 10.1016/j.compstruc.2004.03.083; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Jarrahi A, 2016, MATER TECHNOL, V31, P247, DOI 10.1179/1753555715Y.0000000049; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Karimi A, 2014, MATER TECHNOL, V29, P90, DOI 10.1179/1753555713Y.0000000115; Karimi A, 2016, ARTERY RES, V16, P1, DOI 10.1016/j.artres.2016.08.002; Karimi A, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5686-5; Karimi A, 2015, TISSUE CELL, V47, P152, DOI 10.1016/j.tice.2015.01.004; Karimi A, 2015, COMPUT METHOD BIOMEC, V18, P1418, DOI 10.1080/10255842.2014.910513; Karimi A, 2014, BIOMED ENG-APP BAS C, V26, DOI 10.4015/S1016237214500136; Karimi A, 2013, P I MECH ENG H, V227, P609, DOI 10.1177/0954411913476779; Lee CH, 2017, CHILD NERV SYST, V33, P125, DOI 10.1007/s00381-016-3252-6; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Melvin J., 2002, ACCIDENTAL INJURY, P277, DOI [10.1007/978-0-387-21787-1_13, DOI 10.1007/978-0-387-21787-1_13]; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Monson KL., 2001, THESIS; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Razaghi R, 2018, INT J IND ERGONOM, V66, P169, DOI 10.1016/j.ergon.2018.03.004; Shamloo A, 2017, J MECH BEHAV BIOMED, V74, P72, DOI 10.1016/j.jmbbm.2017.05.020; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; TAKAHASHI A, 1994, ARCH HISTOL CYTOL, V57, P341, DOI 10.1679/aohc.57.341; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	44	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JAN	2021	23	1					33	43	1460408620921729	10.1177/1460408620921729		MAY 2020	11	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	PS6IB	WOS:000532757300001					2022-02-06	
J	Yoshino, H; Aoki, C; Kitamura, S; Yamamuro, K; Tanaka, S; Kishimoto, T				Yoshino, Hiroki; Aoki, Chieko; Kitamura, Soichiro; Yamamuro, Kazuhiko; Tanaka, Shohei; Kishimoto, Toshifumi			A case report of mania with abnormal cerebral blood flow and cognitive impairment 24 years after head trauma	ANNALS OF GENERAL PSYCHIATRY			English	Article						Manic state; Brain injuries; traumatic; Orbitofrontal cortex; Posterior cingulate cortex		Background Mania usually occurs secondary to organic etiologies such as head trauma within a short time of the primary condition's onset; however, there have been a few cases reported in the literature of long time spans before the manifestation of mania. The orbitofrontal cortex has been reported to be associated with manic states in bipolar disorder and with mania-inducing lesions. Head trauma commonly disrupts various cognitive functions, including attention and information processing. Traumatic brain injury patients have been shown to have greater posterior cingulate cortex and precuneus functional connectivity to the rest of the default mode network. We describe a case of secondary mania after head trauma 24 years ago with low blood flow in the orbitofrontal cortex, high blood flow in the posterior cingulate cortex, and impaired cognitive functioning, including impaired attention and lowered processing speed. Case presentation We describe a 30-year-old Japanese man with secondary mania and a medical history of head trauma 24 years ago. After head trauma at 6 years of age, the patient first showed apathy as a sign of frontal lobe impairment. After recovering, he experienced no psychiatric problems during adolescence, although he did show disinhibited behavior. At the onset of mania, low blood flow in the OFC and high blood flow in the PCC were observed as well as impaired cognitive function, including inattention and lowered processing speed. Abnormal cerebral blood flow was less prominent and cognitive dysfunction was partially recovered following recovery from mania, but his processing speed remained low. Conclusions Although functional recovery from head trauma in childhood is better than that in adulthood, the brain may remain vulnerable for a long time. The risk of psychotic symptoms such as mania should be considered, even if sufficient superficial brain functional recovery is shown.	[Yoshino, Hiroki; Aoki, Chieko; Kitamura, Soichiro; Yamamuro, Kazuhiko; Tanaka, Shohei; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, 840 Shijocho, Kashihara, Nara 6348522, Japan		Yoshino, H (corresponding author), Nara Med Univ, Dept Psychiat, 840 Shijocho, Kashihara, Nara 6348522, Japan.	psyosino@naramed-u.ac.jp		Yoshino, Hiroki/0000-0002-5955-8143			Blumberg HP, 1999, AM J PSYCHIAT, V156, P1986; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Lee I, 2019, J AFFECT DISORDERS, V244, P115, DOI 10.1016/j.jad.2018.10.087; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004	5	1	1	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1744-859X		ANN GEN PSYCHIATR	Ann. Gen. Psychiatr.	MAY 12	2020	19	1							32	10.1186/s12991-020-00282-7			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	LR6SG	WOS:000535821800001	32426021	Green Published, gold			2022-02-06	
J	Donders, J; Gardner, V				Donders, Jacobus; Gardner, Victoria			Utility of abbreviated versions of the test of memory malingering in children with traumatic brain injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Effort; performance validity; processing speed; traumatic brain injury	TRIAL 1; PERFORMANCE; VALIDITY; TOMM	We evaluated the classification accuracy of two abbreviated versions of the Test of Memory Malingering (TOMM) in prediction of results on the full-length instrument in a sample of 126 children who were evaluated within 1-12 months after traumatic brain injury. Both a version based on administration of Trial 1 and a version based on administration of only the first 10 items of Trial 1 had acceptable specificity (i.e., > .90) and sensitivity (i.e., > .60) with regard to prediction of pass/fail results on the complete TOMM. Failure on the TOMM suppressed performance on measures of processing speed that were otherwise sensitive to severity of traumatic brain injury. We conclude that these abbreviated versions of the TOMM can be used in clinical practice with children with traumatic brain injury, at the discretion of the neuropsychologist.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Gardner, Victoria] Hope Coll, Dept Psychol, Holland, MI 49423 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J., 2018, TXB CLIN NEUROPSYCHO, P942; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Donders J, 2019, J INT NEUROPSYCH SOC, V25, P355, DOI 10.1017/S1355617719000109; Green P., 2004, MED SYMPTOM VALIDITY; Green P, 2021, APPL NEUROPSYCH-CHIL, V10, P65, DOI 10.1080/21622965.2019.1604342; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henderson M. C., 2012, PATIENT HIST EVIDENC, P30; Kirk JW, 2014, ASSESSMENT, V21, P562, DOI 10.1177/1073191114520626; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2015, VALIDITY TESTING CHI, P79; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Loughan AR, 2016, CHILD NEUROPSYCHOL, V22, P707, DOI 10.1080/09297049.2015.1020774; Loughan AR, 2014, APPL NEUROPSYCH-CHIL, V3, P26, DOI 10.1080/21622965.2012.670584; MacAllister W.S., 2015, VALIDITY TESTING CHI, P164; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Perna R, 2014, APPL NEUROPSYCH-CHIL, V3, P31, DOI 10.1080/21622965.2012.686339; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Ploetz DM, 2016, CHILD NEUROPSYCHOL, V22, P133, DOI 10.1080/09297049.2014.986446; Ricker, 2018, TXB CLIN NEUROPSYCHO, P141; Roebuck-Spencer T, 2018, NEUROPSYCHOLOGICAL CONDITIONS ACROSS THE LIFESPAN, P139; Schneider HE, 2014, CLIN NEUROPSYCHOL, V28, P1133, DOI 10.1080/13854046.2014.960004; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P1373, DOI 10.1080/13854046.2019.1619839; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tonks J, 2020, APPL NEUROPSYCH-CHIL, V9, P97, DOI 10.1080/21622965.2018.1524766; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Wodushek TR, 2017, J PSYCHIATR PRACT, V23, P214, DOI 10.1097/PRA.0000000000000233	33	1	1	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 1	2020	9	4			SI		355	359		10.1080/21622965.2020.1750109		MAY 2020	5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OD0AY	WOS:000533765500001	32401052				2022-02-06	
J	Koberda, JL				Koberda, J. Lucas			QEEG as a Useful Tool for the Evaluation of Early Cognitive Changes in Dementia and Traumatic Brain Injury	CLINICAL EEG AND NEUROSCIENCE			English	Article						EEG; QEEG; neurology; dementia; TBI; imaging	ALZHEIMERS-DISEASE; LEWY BODIES; EEG; NETWORK; PET; NEUROFEEDBACK; INTELLIGENCE; EFFICIENCY; DIAGNOSIS; SYSTEM	Quantitative electroencephalography (QEEG)-electrical neuroimaging has been underutilized in general neurology practice. Recent advances in computer technology have made this electrophysiological testing relatively inexpensive as well as precise in identifying brain areas with electrical dysfunction related to either traumatic injury or neurodegenerative process. In this article, the author presents 2 cases that can be frequently encountered in every general neurological practice: case of early dementia and traumatic brain injury. The clinical usefulness of QEEG is demonstrated by showing evidence of electrical abnormalities and networks dysfunctions (including an elevation of frontal/temporal delta and theta powers as well as abnormalities in functional connectivity). In addition, the correlation of QEEG and findings from structural imaging technique-magnetic resonance imaging diffusion tensor imaging and another functional imaging-positron emission tomography is presented.	[Koberda, J. Lucas] TNBC, PL Brain Enhancement Inc, Neurol, 4838 Kerry Forest Pkwy, Tallahassee, FL 32309 USA		Koberda, JL (corresponding author), TNBC, PL Brain Enhancement Inc, Neurol, 4838 Kerry Forest Pkwy, Tallahassee, FL 32309 USA.	jlkoberda@yahoo.com					Alper K, 1998, NEUROPSYCHOBIOLOGY, V38, P50, DOI 10.1159/000026516; Alper KR, 2006, PSYCHIAT RES-NEUROIM, V146, P271, DOI 10.1016/j.pscychresns.2005.06.008; Bocquillon P, 2011, CLIN NEUROPHYSIOL, V122, P1991, DOI 10.1016/j.clinph.2011.03.014; Boughariou J, 2015, IEEE T NANOBIOSCI, V14, P734, DOI 10.1109/TNB.2015.2477247; Cebolla AM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02133; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Duru AD, 2016, BRAIN IMAGING BEHAV, V10, P424, DOI 10.1007/s11682-015-9397-1; Ewald A, 2013, BIOMED ENG-BIOMED TE, V58, P165, DOI 10.1515/bmt-2012-0028; Frey LC, 2015, J NEUROL NEUROBIOL, V1, DOI [10.16966/2379-7150.102, DOI 10.16966/2379-7150.102]; Garn H, 2017, J NEURAL TRANSM, V124, P569, DOI 10.1007/s00702-017-1699-6; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Kida T, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00713; Koberda J. L., 2013, J NEUROTHERAPY, V17, P179, DOI DOI 10.1080/10874208.2013.813204; Koberda JL, 2013, CLIN EEG NEUROSCI, V44, P273, DOI 10.1177/1550059412475291; Koberda JL., 2014, J PSYCHOL CLIN PSYCH, V1, P37; Koberda JL, 2014, NEUROCONNECTION  SPR, P52; Koberda JL, 2013, NEUROCONNECTION  WIN, P30; Koberda JL, 2014, J NEUROL STROKE, V1, DOI [10.15406/jnsk.2014.01.00029, DOI 10.15406/JNSK.2014.01.00029]; Koberda JL., 2015, J NEUROL NEUROBIOL, V1, P1, DOI [10.16966/2379-7150.113., DOI 10.16966/2379-7150.113]; Koberda JL., 2012, NEUROCONNECTION  WIN, P24; Koberda JL, 2014, BIOFEEDBACK, V42, P74, DOI [10.5298/1081-5937-42.2.05, DOI 10.5298/1081-5937-42.2.05]; Langer N, 2013, CORTEX, V49, P2424, DOI 10.1016/j.cortex.2013.01.008; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Luijmes RE, 2016, NEUROPHYSIOL CLIN, V46, P179, DOI 10.1016/j.neucli.2016.05.069; Marcus C, 2014, CLIN NUCL MED, V39, pE413, DOI 10.1097/RLU.0000000000000547; Musaeus CS, 2018, J ALZHEIMERS DIS, V64, P1359, DOI 10.3233/JAD-180300; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stylianou M, 2018, CLIN NEUROPHYSIOL, V129, P1209, DOI 10.1016/j.clinph.2018.03.013; Surmeli T, 2016, CLIN EEG NEUROSCI, V47, P118, DOI 10.1177/1550059415590750; Thatcher R., 2008, INTRO QEEG NEUROFEED, Vsecond, P29; Thatcher RW, 2007, CLIN EEG NEUROSCI, V38, P35, DOI 10.1177/155005940703800109; Thatcher RW, 2005, CLIN EEG NEUROSCI, V36, P116, DOI 10.1177/155005940503600211; Thatcher R. W., 2003, Journal of Neurotherapy, V7, P87, DOI 10.1300/J184v07n03_05; Thatcher RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38890; Thatcher RW, 2012, HUM BRAIN MAPP, V33, P1062, DOI 10.1002/hbm.21271; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, FRONTIERS NEUROSCIEN, V8, P529	42	1	1	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	APR	2021	52	2			SI		119	125	1550059420914816	10.1177/1550059420914816		MAY 2020	7	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	RC0TJ	WOS:000533109400001	32391721				2022-02-06	
J	Olsen, MH; Jensen, HR; Ebdrup, SR; Topp, NH; Strange, DG; Moller, K; Kondziella, D				Olsen, Markus Harboe; Jensen, Helene Ravnholt; Ebdrup, Soren Roddik; Topp, Nina Hvid; Strange, Ditte Gry; Moller, Kirsten; Kondziella, Daniel			Automated pupillometry and the FOUR score - what is the diagnostic benefit in neurointensive care?	ACTA NEUROCHIRURGICA			English	Article						Consciousness; FOUR; GCS; Automated pupillometry; Prognostic marker	GLASGOW COMA SCALE; TRAUMATIC BRAIN-INJURY; FULL OUTLINE; UNRESPONSIVENESS SCORE; INTERRATER RELIABILITY; VALIDATION; VALIDITY; OUTCOMES	Introduction The Glasgow Coma Scale (GCS) and visual inspection of pupillary function are routine measures to monitor patients with impaired consciousness and predict their outcome in the neurointensive care unit (neuro-ICU). Our aim was to compare more recent measures, i.e. FOUR score and automated pupillometry, to standard monitoring with the GCS and visual inspection of pupils. Methods Supervised trained nursing staff examined a consecutive sample of patients admitted to the neuro-ICU of a tertiary referral centre using GCS and FOUR score and assessing pupillary function first by visual inspection and then by automated pupillometry. Clinical outcome was evaluated 6 months after admission using the Glasgow Outcome Scale-Extended. Results Fifty-six consecutive patients (median age 63 years) were assessed a total of 234 times. Of the 36 patients with at least one GCS score of 3, 13 had a favourable outcome. All seven patients with at least one FOUR score of <= 3 had an unfavourable outcome, which was best predicted by a low "brainstem" sub-score. Compared to automated pupillometry, visual assessment underestimated pupillary diameters (median difference, 0.4 mm; P = 0.006). Automated pupillometry detected a preserved pupillary light reflex in 10 patients, in whom visual inspection had missed pupillary constriction. Discussion Training of nursing staff to implement frequent monitoring of patients in the neuro-ICU with FOUR score and automated pupillometry is feasible. Both measures provide additional clinical information compared to the GCS and visual assessment of pupillary function, most importantly a more granular classification of patients with low levels of consciousness by the FOUR score.	[Olsen, Markus Harboe; Jensen, Helene Ravnholt; Ebdrup, Soren Roddik; Topp, Nina Hvid; Strange, Ditte Gry; Moller, Kirsten] Univ Copenhagen, Rigshosp, Neurosci Ctr, Dept Neuroanaesthesiol, Copenhagen, Denmark; [Moller, Kirsten; Kondziella, Daniel] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Kondziella, Daniel] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark		Olsen, MH (corresponding author), Univ Copenhagen, Rigshosp, Neurosci Ctr, Dept Neuroanaesthesiol, Copenhagen, Denmark.	oel@oelfam.com	Olsen, Markus/AAU-9570-2020; Moller, Kirsten/A-4751-2009	Olsen, Markus/0000-0003-0981-0723; Kondziella, Daniel/0000-0001-5562-9808; Moller, Kirsten/0000-0003-3058-1072			Almojuela A, 2019, NEUROCRIT CARE, V31, P162, DOI 10.1007/s12028-018-0630-9; Anestis DM, 2020, J NEUROL SCI, V409, DOI 10.1016/j.jns.2019.116600; Baratloo A, 2016, ARCH IRAN MED, V19, P215, DOI 0161903/AIM.0011; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Foo CC, 2019, J NEUROTRAUM, V36, P2469, DOI 10.1089/neu.2018.6243; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Johnson VD, 2013, DIMENS CRIT CARE NUR, V32, P180, DOI 10.1097/DCC.0b013e3182998082; Kramer CL, 2014, NEUROCRIT CARE, V21, P309, DOI 10.1007/s12028-014-9988-5; McNett MM, 2016, J NEUROSCI NURS, V48, P207, DOI 10.1097/JNN.0000000000000225; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Momenyan S, 2017, NEUROCRIT CARE, V27, P229, DOI 10.1007/s12028-016-0324-0; Nyam TTE, 2017, NEUROCRIT CARE, V26, P225, DOI 10.1007/s12028-016-0326-y; Obling L, 2019, EUR HEART J-ACUTE CA; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Peinkhofer C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00916; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Sepahvand E, 2016, TURK NEUROSURG, V26, P720, DOI 10.5137/1019-5149.JTN.13536-14.0; Singh TD, 2018, J CRIT CARE, V43, P42, DOI 10.1016/j.jcrc.2017.08.028; TEASDALE G, 1974, LANCET, V2, P81; Vassilieva A, 2019, PEERJ, V7, DOI 10.7717/peerj.6929; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	26	1	1	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2020	162	7					1639	1645		10.1007/s00701-020-04381-y		MAY 2020	7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LY2HG	WOS:000530977500001	32383011	Green Published, Bronze			2022-02-06	
J	Leijdesdorff, HA; Legue, J; Krijnen, P; Rhemrev, S; Kleinveld, S; Schipper, IB				Leijdesdorff, Henry Alexander; Legue, Juno; Krijnen, Pieta; Rhemrev, Steven; Kleinveld, Sanne; Schipper, Inger Birgitta			Traumatic brain injury and alcohol intoxication: effects on injury patterns and short-term outcome	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Alcohol intoxication; Blood alcohol concentration; Traumatic brain injury; Outcome; Mortality	ETHANOL INTOXICATION; MORTALITY; ASSOCIATION; SEVERITY; SURVIVAL; ABUSE	Purpose A significant number of patients with traumatic brain injuries (TBI) are diagnosed with elevated blood alcohol concentration (BAC). Recent literature suggests a neuroprotective effect of alcohol on TBI, possibly associated with less morbidity and mortality. Our goal is to analyze the association of different levels of BAC with TBI characteristics and outcome. Methods Adult patients with moderate to severe TBI (AIS >= 2) and measured BAC admitted to the Trauma Centre West (TCW), during the period 2010-2015, were retrospectively analyzed. Data included injury severity (AIS), length of hospitalization, admittance to the Intensive Care Unit (ICU) and in-hospital mortality. The association of BAC with ICU admittance and in-hospital mortality was analyzed using multivariable logistic regression analysis with correction for potentially confounding variables. Results BACs were available in 2,686 patients of whom 42% had high, 26% moderate, 6% low and 26% had normal levels. Patients with high BAC's were predominantly male, were younger, had lower ISS scores, lower AIS-head scores and less concomitant injuries compared to patients in the other BAC subgroups. High BACs were associated with a lower risk for in-hospital mortality (AOR 0.36, 95% CI 0.14-0.97). Also, patients with moderate and high BACs were less often admitted to the ICU (respectively, AOR 0.36, 95% CI 0.25-0.52 and AOR 0.40, 95% CI 0.29-0.57). Conclusion The current study suggests that in patients with moderate to severe TBI, increasing BACs are associated with less severe TBI, less ICU admissions and a higher survival. Further research into the pathophysiological mechanism is necessary to help explain these findings.	[Leijdesdorff, Henry Alexander; Legue, Juno; Krijnen, Pieta; Schipper, Inger Birgitta] Leiden Univ, Dept Trauma Surg, Med Ctr, K06-R,POB 9600, NL-2300 RC Leiden, Netherlands; [Leijdesdorff, Henry Alexander; Rhemrev, Steven] Haaglanden Med Ctr, Trauma Unit, The Hague, Netherlands; [Kleinveld, Sanne] HAGA Hosp, Dept Trauma Surg, The Hague, Netherlands		Leijdesdorff, HA (corresponding author), Leiden Univ, Dept Trauma Surg, Med Ctr, K06-R,POB 9600, NL-2300 RC Leiden, Netherlands.; Leijdesdorff, HA (corresponding author), Haaglanden Med Ctr, Trauma Unit, The Hague, Netherlands.	a.leijdesdorff@haaglandenmc.nl; j.legue@lumc.nl; p.krijnen@lumc.nl; s.rhemrev@haaglandenmc.nl; s.kleinveld@hagaziekenhuis.nl; i.b.schipper@lumc.nl	Schipper, Inger/ABE-7796-2021	Schipper, Inger/0000-0001-9952-3079; Leijdesdorff, Henry/0000-0001-8229-0707			Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berry C, 2011, AM SURGEON, V77, P1416; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Chandrasekar A, 2018, J NEUROTRAUM, V35, P2718, DOI 10.1089/neu.2017.5270; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Dorstyn DS, 2011, REHABIL PSYCHOL, V56, P1, DOI 10.1037/a0022249; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Firsching R, 2001, WORLD J SURG, V25, P1221; Gennarelli TA., 2008, ABBREVIATED INJURY S; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hsieh CH, 2013, AM SURGEON, V79, P1289; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; Matsukawa H, 2013, BRAIN INJURY, V27, P1409, DOI 10.3109/02699052.2013.823655; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Moore EE, 2005, J TRAUMA, V59, pS53, DOI 10.1097/01.ta.0000174868.13616.67; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; TEASDALE G, 1974, LANCET, V2, P81; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185	33	1	1	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2021	47	6			SI		2065	2072		10.1007/s00068-020-01381-6		MAY 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XE8ZQ	WOS:000530776400002	32377922	Green Published, hybrid			2022-02-06	
J	Efendioglu, M; Basaran, R; Akca, M; Ceman, D; Demirtas, C; Yildirim, M				Efendioglu, Mustafa; Basaran, Recep; Akca, Metehan; Ceman, Duygu; Demirtas, Cumaali; Yildirim, Mehmet			Combination Therapy of Gabapentin and N-Acetylcysteine Against Posttraumatic Epilepsy in Rats	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Posttraumatic epilepsy; Levetiracetam; Gabapentin; N-Acetylcysteine	TRAUMATIC BRAIN-INJURY; EPILEPTIFORM ACTIVITY; SEIZURE PROPHYLAXIS; MODEL; LEVETIRACETAM; EPIDEMIOLOGY; PERIOD; RISK	Traumatic brain injury (TBI) is a major public health problem worldwide that is associated with increased mortality and morbidity. Posttraumatic epilepsy (PTE) is one of the sequelae of TBI. The aim of this study was to investigate the role of N-acetylcysteine (NAC) as an adjuvant on the efficacy of levetiracetam (LEV) and gabapentin (GBP) in PTE model encouraged by pentylenetetrazol (PTZ) after mild-TBI in male Sprague-Dawley rats. Mild-TBI was performed by the weight-drop method in male Sprague-Dawley rats. PTE model was developed by injecting PTZ (30+15+15 mg/kg, 30 min intervals, i.p.) 7 days after head trauma. After the development of posttraumatic seizures, the rats were treated with NAC (100 mg/kg), LEV (50 mg/kg), GBP (100 mg/kg), NAC+LEV and NAC+GBP intraperitoneally for 14 days. Seizures related to PTE were scored by video-EEG recording. Motor performance of the animals was also evaluated in the rotarod test. 50 mg/kg LEV and 100 mg/kg GBP reduced seizures related to PTE. LEV alone (p = 0.009), but the administration of GBP+NAC (p = 0.015) was more effective on PTE-related seizure control. However, GBP+NAC application adversely affected the fall latency in the rotarod test. In terms of trauma-related seizure control, there was no statistically significant difference between the use of prophylactic LEV and symptomatic LEV. LEV alone or the combination of GBP with NAC provides more effective seizure control in the PTE facilitated by PTZ. On the other hand, the use of prophylactic LEV did not have any extra effect on posttraumatic seizure development and control.	[Efendioglu, Mustafa] Haydarpasa Numune Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Basaran, Recep; Ceman, Duygu] Sancaktepe Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Akca, Metehan; Demirtas, Cumaali; Yildirim, Mehmet] Univ Hlth Sci, Dept Physiol, Hamidiye Fac Med, Istanbul, Turkey		Yildirim, M (corresponding author), Univ Hlth Sci, Dept Physiol, Hamidiye Fac Med, Istanbul, Turkey.	mehmet.yildirim@sbu.edu.tr	DEMIRTAS, Cumaali/AAJ-1371-2021	DEMIRTAS, Cumaali/0000-0001-5226-6730			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Candy N, 2019, J CLIN NEUROSCI, V69, P198, DOI 10.1016/j.jocn.2019.07.066; Caudle KL, 2016, RESTOR NEUROL NEUROS, V34, P257, DOI 10.3233/RNN-150580; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; De Smedt T, 2007, CNS DRUG REV, V13, P57, DOI 10.1111/j.1527-3458.2007.00005.x; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Lu XCM, 2017, J TRAUMA ACUTE CARE, V83, pS25, DOI 10.1097/TA.0000000000001470; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mousavi-Hasanzadeh M, 2019, PHARMACOL BIOCHEM BE, V182, P7, DOI 10.1016/j.pbb.2019.04.010; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nadkarni S, 2005, NEUROLOGY, V64, pS2, DOI 10.1212/WNL.64.12_suppl_3.S2; Odaci E, 2013, NEUROQUANTOLOGY, V11, P573; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Patanwala AE, 2016, BRAIN INJURY, V30, P156, DOI 10.3109/02699052.2015.1089596; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P2064, DOI 10.2146/ajhp130439; Velioglu SK, 2018, EPILEPSY BEHAV, V87, P14, DOI 10.1016/j.yebeh.2018.08.001; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yildirim M, 2013, NEUROCHEM RES, V38, P1672, DOI 10.1007/s11064-013-1069-1; Yildirim M, 2011, ACTA NEUROBIOL EXP, V71, P208	38	1	1	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	AUG	2020	45	8					1802	1812		10.1007/s11064-020-03042-x		MAY 2020	11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MO4ZR	WOS:000530597800001	32372158				2022-02-06	
J	McCormick, BF; Connolly, EJ; Nelson, DV				McCormick, Brandon F.; Connolly, Eric J.; Nelson, David V.			Mild Traumatic Brain Injury as a Predictor of Classes of Youth Internalizing and Externalizing Psychopathology	CHILD PSYCHIATRY & HUMAN DEVELOPMENT			English	Article						Mild traumatic brain injury; Youth psychopathology; Internalizing disorders; Externalizing disorders	PARENT-CHILD CONFLICT; AGE; DISORDERS; SYMPTOMS; OUTCOMES; PATHOPHYSIOLOGY; CONSEQUENCES; EPIDEMIOLOGY; DISADVANTAGE; TRAJECTORIES	Mild traumatic brain injury (mTBI), is a developing public health problem. Evidence suggests that youth who suffer a mTBI experience worse outcomes than similar adults. However, the structure of long-term symptoms associated with mTBI is not well understood. The current study aims to determine if classes of youth psychopathology can be predicted by mTBI status. The current study analyzed a large sample of children and adolescents from the Project on Human Development in Chicago Neighborhoods (n = 2978) to examine trajectories of psychopathologies. Using data from the Achenbach Childhood Behavior Checklist, latent classes of internalizing and externalizing psychopathology were identified. Multinomial logistic regression models were used to examine if mTBI predicted class membership, while controlling for a number of variables associated with psychopathology. The results of the current study suggest that mTBI may be an important transdiagnostic risk factor associated with developmental patterns of internalizing and externalizing psychopathology.	[McCormick, Brandon F.] Univ Alabama, Dept Psychol, Ctr Youth Dev & Intervent, Tuscaloosa, AL 35401 USA; [Connolly, Eric J.] Sam Houston State Univ, Dept Criminal Justice & Criminol, Huntsville, TX 77340 USA; [Nelson, David V.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77340 USA		McCormick, BF (corresponding author), Univ Alabama, Dept Psychol, Ctr Youth Dev & Intervent, Tuscaloosa, AL 35401 USA.	bfmccormick@crimson.ua.edu					Achenbach T., 1991, ATTENTION PROBLEMS C MANUAL CHILD BEHAV C; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Ayduk O, 2007, J RES PERS, V41, P374, DOI 10.1016/j.jrp.2006.04.008; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Buckholtz JW, 2012, NEURON, V74, P990, DOI 10.1016/j.neuron.2012.06.002; Burstein M, 2012, J CONSULT CLIN PSYCH, V80, P102, DOI 10.1037/a0026069; Burt SA, 2009, PSYCHOL BULL, V135, P608, DOI 10.1037/a0015702; Burt SA, 2005, DEV PSYCHOPATHOL, V17, P145, DOI 10.1017/S095457940505008X; Burt SA, 2003, ARCH GEN PSYCHIAT, V60, P505, DOI 10.1001/archpsyc.60.5.505; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Connolly EJ, 2019, J ADOLESCENT HEALTH, V65, P79, DOI 10.1016/j.jadohealth.2018.12.023; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Earls F., 1997, PROJECT HUMAN DEV CH; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gauthier S, 2018, J COMMUN DISORD, V73, P77, DOI 10.1016/j.jcomdis.2018.04.003; Gennarelli TA, 2005, TXB TRAUMATIC BRAIN; Gerritsen H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020364; Glenn AL, 2019, INT J LAW PSYCHIAT, V65, DOI 10.1016/j.ijlp.2018.04.008; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hatoum AS, 2018, BEHAV GENET, V48, P298, DOI 10.1007/s10519-018-9900-8; Haynie DL, 2005, SOC FORCES, V84, P1109, DOI 10.1353/sof.2006.0018; Jones KM, 2018, J PRIM HEALTH CARE, V10, P81, DOI 10.1071/HC17038; KASS RE, 1995, J AM STAT ASSOC, V90, P928, DOI 10.2307/2291327; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Kenny DT, 2007, CRIME JUSTICE B, V107, P15; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Kirk DS, 2014, JUSTICE Q, V31, P539, DOI 10.1080/07418825.2012.737471; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Krueger RF, 2009, PSYCHOL MED, V39, P2061, DOI 10.1017/S0033291709990328; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Lamers F, 2012, BRIT J PSYCHIAT, V201, P143, DOI 10.1192/bjp.bp.111.098079; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Leventhal T, 2006, CHILD DEV, V77, P1359, DOI 10.1111/j.1467-8624.2006.00940.x; Leventhal T, 2011, DEV PSYCHOL, V47, P1680, DOI 10.1037/a0025314; Lumba-Brown A, 2016, REPORT PEDIAT MILD T; Martin KR, 2002, PROJECT HUMAN DEV CH; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; McLaughlin KA, 2007, J ABNORM CHILD PSYCH, V35, P801, DOI 10.1007/s10802-007-9128-1; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Hare W, 2003, GROWING NUMBER KIDS; Orr L., 2003, MOVING OPPORTUNITY I; Pacella M, 2018, J HEAD TRAUMA REHAB, V33, pE31, DOI 10.1097/HTR.0000000000000335; Peters DJ, 2009, INT REGIONAL SCI REV, V32, P19, DOI 10.1177/0160017608325795; Rand D, 2018, DEV THEORIES CRIME D, P46; Rodgers S, 2014, J AFFECT DISORDERS, V156, P92, DOI 10.1016/j.jad.2013.11.021; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304; Sampson R.J., 2012, GREAT AMERICAN CITY; Sampson RJ, 2005, AM J PUBLIC HEALTH, V95, P224, DOI 10.2105/AJPH.2004.037705; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turner HA, 2010, CHILD MALTREATMENT, V15, P76, DOI 10.1177/1077559509349444; US Census Bureau, 1995, STAT BRIEF POV AR; Van Hulle CA, 2018, BEHAV GENET, V48, P271, DOI 10.1007/s10519-018-9907-1; Wechsler D., 1974, WECHSLER INTELLIGENC; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wilson William Julius, 1987, TRULY DISADVANTAGED; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Zona K, 2011, J YOUTH ADOLESCENCE, V40, P1674, DOI 10.1007/s10964-011-9649-3	81	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0009-398X	1573-3327		CHILD PSYCHIAT HUM D	Child Psychiat. Hum. Dev.	FEB	2021	52	1					166	178		10.1007/s10578-020-00992-9		MAY 2020	13	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	QA4PL	WOS:000530590600001	32372378				2022-02-06	
J	Caravaggi, P; Leardini, A; Belvedere, C; Siegler, S				Caravaggi, Paolo; Leardini, Alberto; Belvedere, Claudio; Siegler, Sorin			A novel Cervical Spine Protection device for reducing neck injuries in contact sports: design concepts and preliminary in vivo testing*	SPORTS BIOMECHANICS			English	Article						American football; neck muscles; endurance; head; ROM	PROFESSIONAL FOOTBALL; HIGH-SCHOOL; CONCUSSION; HEAD; BIOMECHANICS; BRAIN; HYPEREXTENSION; EPIDEMIOLOGY; STINGERS; PLAYER	Head and neck injuries are common in contact sports such as American football. Different mechanisms can produce such injuries, including compressive impact forces on the crown of the helmet with the neck in a flexed chin-down position. The aim of this paper was developing and testing a novel Cervical Spine Protection Device (CSPD) designed to keep the neck within its safe physiological range. The cervical spine range of motion (ROM) of ten participants was measured under four conditions: free; wearing a football gear; wearing the CSPD; and wearing the CSPD underneath the gear. The CSPD was tested in terms of passive and active restraint of head motion, and for its capability to improve endurance time of the neck extensor muscles. Wearing the CSPD resulted in a significant 40-60% reduction in ROM across the three anatomical planes, and in increased endurance of the neck extensor muscles (FREE: 114 +/- 57 s; CSPD: 214 +/- 95 s; p = 0.004). In quasi-static loading conditions the CSPD was capable of keeping the neck within its physiological range, thus it may be used to decrease the risk of severe injuries due to dangerous chin-down positions.	[Caravaggi, Paolo; Leardini, Alberto; Belvedere, Claudio] Rizzoli Orthoped Inst, Movement Anal Lab, Bologna, Italy; [Siegler, Sorin] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA		Siegler, S (corresponding author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.	ssiegler@coe.drexel.edu	Caravaggi, Paolo/AAB-8196-2019; Leardini, Alberto/C-8189-2019; Belvedere, Claudio/S-6979-2019	Caravaggi, Paolo/0000-0002-8994-8062; Leardini, Alberto/0000-0003-3547-7370; Belvedere, Claudio/0000-0003-4258-2267			Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Banerjee R, 2004, AM J SPORT MED, V32, P1077, DOI 10.1177/0363546504265605; Bissinger Buzz, 2010, Time, V175, P44; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Bogduk N, 2001, CLIN BIOMECH, V16, P267, DOI 10.1016/S0268-0033(01)00003-1; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Cripton P, 2013, NATURE, V503, pS13, DOI 10.1038/503S13a; Cross KM, 2003, CLIN SPORT MED, V22, P639, DOI 10.1016/S0278-5919(02)00099-6; Dressler DM, 2014, AM SOC TEST MATER, V1552, P84, DOI 10.1520/STP155220120172; Gorden JA, 2003, J ATHL TRAINING, V38, P209; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; HOVIS WD, 1994, MED SCI SPORT EXER, V26, P872; Ivancevic V. G., 2004, DSTOTR1577 SYST SCI; Kawasaki T, 2015, AM J SPORT MED, V43, P2809, DOI 10.1177/0363546515597678; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Kuhlman GS, 1999, AM FAM PHYSICIAN, V60, P2035; McClure P, 1998, SPINE, V23, P216, DOI 10.1097/00007632-199801150-00013; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; Mueller F. O., 2013, ANN SURVEY CATASTROP; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Siegler S, 2015, J BIOMECH, V48, P3650, DOI 10.1016/j.jbiomech.2015.08.014; Stuber Kent, 2005, J Can Chiropr Assoc, V49, P216; Thomson V., 2015, THESIS; TORG JS, 1985, MED SCI SPORT EXER, V17, P295; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; TORG JS, 1977, J AM COLL HEALTH ASS, V25, P224; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C	37	1	1	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.	MAY 3	2020	19	3					382	394		10.1080/14763141.2018.1481222			13	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	LF0YE	WOS:000527152300009	30004295				2022-02-06	
J	Perlin, A; Kroshus, E				Perlin, Amit; Kroshus, Emily			Content analysis of concussion education for coaches of youth and high school sport	BRAIN INJURY			English	Article						Concussion; coach education; sport; youth; high school	FOOTBALL PLAYERS; KNOWLEDGE; HEADS; COMMUNICATION; BEHAVIORS	Objective: Describe the extent to which concussion education provided to coaches of US high school and youth sport is inclusive of information necessary for them to engage in target behaviors related to the prevention, identification and management of concussion. Methods: Sport organizations included in the sample were US state high school governing bodies and national governing bodies (NGBs) for youth sports with the highest concussion incidence rates. The concussion education resources made available online for coaches by these organizations were coded for content relevant to concussion prevention, identification and management. Results: All but one state high school governing body required coach concussion education, two NGBs required coach education, seven recommended it and only one did not require or recommend it. All educational materials covered at least 84% (n = 16/19) of the relevant knowledge domains. Discussion: Existing concussion education for coaches is addressing most, but not all, topics that may help coaches engage in concussion prevention, identification and management. Additional program development work is warranted to augment educational content related to coach communication about concussion safety with athletes and parents. Content appropriateness notwithstanding, further research is needed to understand the acceptability, efficacy, and implementation of concussion education for coaches.	[Perlin, Amit] Tulane Univ, Tulane Brain Inst, New Orleans, LA 70118 USA; [Perlin, Amit; Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Perlin, A (corresponding author), Tulane Univ, Tulane Brain Inst, New Orleans, LA 70118 USA.	amitperlin@gmail.com		Perlin, Amit/0000-0001-7316-4450; Kroshus, Emily/0000-0002-7484-2601			[Anonymous], 2011, COACH TRAINING; [Anonymous], 2018, ONLINE RULES CLIN; [Anonymous], 2018, HEADS UP HOCKEY; [Anonymous], 2018, CONCUSSION TRAINING; [Anonymous], 2018, CONCUSSION SPORTS; [Anonymous], 2017, HEADS YOUTH SPORTS O; [Anonymous], 2018, HEADS FOOTBALL; [Anonymous], 2017, BRAINSPACE TRAINING; [Anonymous], 2018, STATE ASS LISTING; [Anonymous], 2015, SPORTS CONCUSSION PO; [Anonymous], 2018, CONCUSSIONS CONCUSSI; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; Blake J., 1999, LOCAL ENVIRON, V4, P257, DOI DOI 10.1080/13549839908725599; Bobrovitz N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-45; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Coleman JS, 1997, REDESIGNING AM ED; Comstock RD, 2016, HIGH SCH RIO 2017; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Field B, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0172-2; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Hebert JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134621; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kim S, 2018, J AMATEUR SPORT, V4, P82, DOI DOI 10.17161/jas.v4i1.6664; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Shirley E, 2018, J AM ACAD ORTHOP SUR, V26, pE279, DOI 10.5435/JAAOS-D-16-00684; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Thomas A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-54	55	1	1	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 6	2020	34	7					905	913		10.1080/02699052.2020.1755894		MAY 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MI1BE	WOS:000532199000001	32362145				2022-02-06	
J	Bachynski, KE				Bachynski, Kathleen E.			Too Rough for Bare Heads: The Adoption of Helmets and Masks in North American Ice Hockey, 1959-79	SPORT HISTORY REVIEW			English	Article						North America; injury; professional sport; sporting equipment; youth sport	EYE INJURIES; PLAYERS	On November 1, 1959, a flying hockey puck broke the nose of goalie Jacques Plante. Thereafter, he insisted on wearing a face mask, a decision that signaled a broader introduction of safety equipment into North American ice hockey. This paper examines how head and facial protection became a standard requirement for playing hockey in North America at amateur and professional levels of the sport. During the mid-twentieth century, national governing bodies confronted growing safety concerns amid rising participation in organized hockey. Yet in the absence of league-wide mandates, players generally did not sustain helmet use. From the 1950s through the 1970s, masks for goalies and helmets and facial protection for skaters were mandated to protect against injuries. In the context of contemporary concussion concerns, the history of debates over hockey head and face protection illustrates the array of social, cultural, and organizational factors behind measures to protect athletes' health.	[Bachynski, Kathleen E.] Muhlenberg Coll, Publ Hlth, Allentown, PA 18104 USA		Bachynski, KE (corresponding author), Muhlenberg Coll, Publ Hlth, Allentown, PA 18104 USA.	kathleenbachynski@muhlenberg.edu					Abraham C.J., 1989, SAFETY ICE HOCKEY, P44; Anderson Dave, 1980, NY TIMES, P19; Anderson Dave, 2000, NY TIMES; Anderson Robert H., 1959, NY TIMES, pS15; [Anonymous], 1997, NY TIMES, pB14; [Anonymous], 1924, DAILY PRINCETON 0303, V45, P3; [Anonymous], 1938, SASKATOON STAR  0128, P13; [Anonymous], 1968, NY TIMES, P50; [Anonymous], 1959, NY TIMES, P37; [Anonymous], 1924, DAILY PRINCETON 0307, V45, P6; [Anonymous], 1969, WASHINGTON POST 1123, P42; [Anonymous], 1970, THE LEADER POST 0121, P32; [Anonymous], 1967, EDMONTON J, P43; [Anonymous], 1968, CALGARY HERALD  0118, P14; [Anonymous], 1963, HOCKEY MAGAZINE  JAN, P12; [Anonymous], 1968, THE LEADER POST 0117, P44; [Anonymous], 1968, VANCOUVER SUN, P16; [Anonymous], 1924, THE HARVARD CRIMSON; [Anonymous], 1963, SASKATOON STAR  1204, P22; [Anonymous], 1933, WASH POST, P18; [Anonymous], 1924, BOSTON DAILY GL 0308, P11; [Anonymous], 1933, BORDER CITIES S 1219, P4; [Anonymous], 1934, LIT DIGEST, P36; [Anonymous], 1959, THE LEADER POST 0520, P22; [Anonymous], 1965, CALGARY HERALD  0525, P18; [Anonymous], 1959, US AMATEUR HOCKE DEC, P19; [Anonymous], 1964, HOCKEY MAGAZINE  DEC, P6; Bachynski K., 2019, NO GAME BOYS PLAY HI; Bachynski Kathleen, 2018, LADY SCI        1002; Bachynski KE, 2012, AM J PUBLIC HEALTH, V102, P2214, DOI 10.2105/AJPH.2012.300721; Barlow John Matthew, 2009, COAST COAST HOCKEY C, P35; Bishop Patrick, 2011, COMMUNICATION   1104; Bogira Steve, 1976, CHICAGO TRIBUNE; Borenstein Larry, 1968, LITERACY TRADITIONAL, P1, DOI DOI 10.1080/00293656808628898; CASTALDI C R, 1991, Dental Clinics of North America, V35, P647; Castaldi C.R., 1989, SAFETY ICE HOCKEY, P14; Clarke Kenneth S., 1976, SPORTS SAF 2, P41; Clarke Kenneth S., 1975, AM J SPORTS MED, V3, P292; Clement L., 1989, SAFETY ICE HOCKEY, P164; Conley John A., 1977, SAFETY TEAM SPORTS, P37; Cooper-Weeks Ltd. advertisement, 1964, HOCKEY MAGAZINE  DEC, P27; Daley Arthur, 1959, NY TIMES, P45; Dixon J.L., 2009, SAFETY ICE HOCKEY, P207; Dulmage Jack, 1968, WINDSOR STAR    0119, P26; Dulmage Jack, 1969, WINDSOR STAR    1217, P34; Dulmage Jack, 1968, WINDSOR STAR    0116, P21; Fachet Robert, 1972, WASHINGTON POST 0502, pD2; Farber Michael, 2011, SPORTS ILLUSTRATED; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; Fisher Gord, 1966, EDMONTON J, P44; Gibbs R.W., 1974, PHYSICIAN SPORTSMED, V2, P39; HALE CJ, 1971, MATER RES STANDARD, V11, P8; Hawthorn Tom, 2005, TORONTO GLOBE M 0827; Hayes Don, 1971, THESIS; Hemenway D., 2009, WE WERE SLEEPING SUC; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Hoerner Earl F., 1981, SPORTS INJURIES, P373; Hoffmann Rich, 1989, WASHINGTON POST, pG6A; Hogan Lloyd, 1968, CHICAGO DAILY DEFEND, P16; Hulse William F., 1981, SPORTS INJURIES, P363; Hulse William F., 1981, SPORTS INJURIES UNTH, P378; Hunter Doug, 1995, BREED APART ILLUSTRA; Jerry Love W.G., 1962, J CANADIAN ASS HLTH, V92, P14; Kieran John, 1936, NY TIMES, P28; Kornheiser Tony, 1979, WASH POST, pD1; Lipsyte Robert, 1963, NY TIMES, pS2; Lorenz SL, 2015, INT J HIST SPORT, V32, P2044, DOI 10.1080/09523367.2016.1147431; McFarlane Brian, 1967, 50 YEARS HOCKEY 1917, P110; Mirtle James, 2013, GLOBE MAIL; Morris John, 1965, CHICAGO TRIBUNE, P8; MURRAY TM, 1995, PEDIATRICS, V95, P419; Nagobads V.G., 1971, AM J SPORTS MED; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; Nover Douglas A., 1983, GAMES THEY PLAYED SP, P191; O'Brien Andy, 1967, WINNIPEG FREE PRESS, P16; Pashby Jane, 2011, COMMUNICATION; PASHBY TJ, 1979, CAN MED ASSOC J, V121, P643; PASHBY TJ, 1975, CAN MED ASSOC J, V113, P663; Pashby Tom, 1993, ASTM STP, P159; Plante Jacques, 1963, HOCKEY MAGAZINE  NOV, P25; Preidt Robert, 1999, MED POST        1116; Rappleyea F.M., 1968, NAT C PROT EQ SPORTS, P46; Rickwood Gregory D., 1996, THESIS, P12; Rosengren John, 2016, ESPN; Ryan Allan J., 1968, NAT C PROT EQ SPORTS, P12; Schuster Dan, 2011, COMMUNICATION   1129; SIM FH, 1987, AM J SPORT MED, V15, P30, DOI 10.1177/036354658701500105; Snyder Richard E., 1965, TRENDS SPORTING GOOD; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stubbs Dave, 2008, THE GAZETTE MONTREAL, pC1; Teale Edwin, 1935, POPULAR SCI MONTHLY, P51; Thomas Tommy, 1968, OWOSSO ARGUS PR 0208, P22; Tolchin Martin, 1960, NY TIMES, P41; Trumble Hal, 1981, SPORTS INJURIES, P390; Walsh S., 1989, ASTM STP, P55; Wong John Chi-Kit, 2007, ENCY US LABOR WORKIN, P961; YOUNG S, 2019, SPORT VIOLENCE SOC, V11, DOI DOI 10.1088/1475-7516/2019/11/012	97	1	1	1	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1087-1659	1543-2947		SPORT HIST REV	Sport Hist. Rev.	MAY	2020	51	1			SI		25	45		10.1123/shr.2019-0026			21	History	Arts &amp; Humanities Citation Index (A&amp;HCI)	History	LY8PW	WOS:000540791300003					2022-02-06	
J	Bajaj, T; Trang, N; Nasrawi, F; Eppanapally, S				Bajaj, Tushar; Ngon Trang; Nasrawi, Faisal; Eppanapally, Sabitha			A Rare Case of Spontaneous Bilateral Subcapsular Renal Hematoma	JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS			English	Article						critical care; renal; kidney; subcapsular; hematoma; education	HEMORRHAGE	Spontaneous bilateral renal subcapsular hematoma is a rare condition. On literature review, only 2 case reports have elucidated possible etiologies for such a presentation; however, no definite conclusions have been made. We present a rare case of a 52-year-old female with diabetes mellitus type 2, chronic kidney disease stage 4, hypertension, hyperlipidemia, prior traumatic brain injury via motor vehicle accident, who presented to our hospital with diabetic ketoacidosis and clinical signs of pyelonephritis; subsequently, imaging demonstrated spontaneous bilateral renal subcapsular hematoma. Risk factors for the rare presentation in this patient included pyelonephritis, history of bilateral ureteral stent placement, and a remote history of a mild unilateral renal laceration secondary to a motor vehicle accident. Typically, patients with this condition achieve spontaneous resolution with conservative management. Our patient initially presented with diabetic ketoacidosis and pyelonephritis but gradually developed retroperitoneal bleeding and hemorrhagic shock. Our patient's critical condition required close monitoring in an intensive care unit and a more invasive approach including unilateral left renal artery embolization followed by a unilateral left nephrectomy. The patient ultimately recovered and continued to be followed outpatient without any serious long-term complications.	[Bajaj, Tushar; Eppanapally, Sabitha] UCLA Kern Med, Bakersfield, CA 93306 USA; [Ngon Trang; Nasrawi, Faisal] Ross Univ, Miramar, FL USA		Bajaj, T (corresponding author), UCLA Kern Med, Dept Med, Bakersfield, CA 93306 USA.	tusharbajajMD@gmail.com					Bansal U, 2010, UROL ANNALS, V2, P119, DOI 10.4103/0974-7796.68861; Cozzoli A, 2003, J NEPHROL, V16, P595; Greco Michele, 2016, Case Rep Urol, V2016, P2573476, DOI 10.1155/2016/2573476; KENDALL AR, 1988, J UROLOGY, V139, P246, DOI 10.1016/S0022-5347(17)42376-7; Lal A, 2009, CANCER IMAGING, V9, P56, DOI 10.1102/1470-7330.2009.0010; Lenk R., 1909, DTSCH Z CHIR, V102, P222, DOI 10.1007/BF02799543; McKinnon K, 2015, INT J UROL, V22, P137, DOI 10.1111/iju.12619; Zhang JQ, 2002, J UROLOGY, V167, P1593	8	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2324-7096			J INVEST MED HIGH IM	J. Invest. Med. High Impact Case Rep.	MAY	2020	8								2324709620918098	10.1177/2324709620918098			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LR9EQ	WOS:000535998800001	32401061	gold, Green Published			2022-02-06	
J	Buitendag, JJP; Ras, A; Kong, VY; Weale, RD; Blodgett, J; Bruce, JL; Clarke, DL; Laing, GL				Buitendag, J. J. P.; Ras, A.; Kong, V. Y.; Weale, R. D.; Blodgett, J.; Bruce, J. L.; Clarke, D. L.; Laing, G. L.			Hanging-related injury in Pietermaritzburg, South Africa	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article								Background. Hanging is a common form of self-harm, and emergency care physicians will not infrequently be called upon to manage a survivor. Despite the relative frequency of the injury, there is a paucity of literature on the topic and the spectrum and incidence of associated injuries are poorly described. Objectives. To review experience with management of victims of hanging at a major trauma centre in South Africa. Methods. All patients treated by the Pietermaritzburg Metropolitan Trauma Service following a hanging incident between December 2012 and December 2018 were identified from the Hybrid Electronic Medical Registry. Basic demographics were recorded, and the management and outcome of each patient were noted. Results. During the 6-year period under review, a total of 154 patients were seen following a hanging incident. The mean age was 29.4 years. There were 24 females (15.6%) and 130 males (84.4%). The vast majority (n=150; 97.5%) had attempted suicide, and only 4 hangings (2.5%) were accidental. A total of 92 patients (60.9%) had consumed alcohol prior to the incident. There were 23 patients with a Glasgow Coma Score (GCS) <9 (severe traumatic brain injury (TBI)), 14 with a GCS of 9 - 12 (moderate TBI) and 117 with a GCS >12 (mild TBI). A total of 7 patients (4.5%) required intensive care unit admission, and 25 (16.2%) required intubation. The following extracranial injuries were documented on computed tomography scans: hyoid bone fractures (n=2), cervical spine fracture (n=10), mandible fracture (n=4) and oesophageal injury (n=1). Intracranial pathology was evident on 27.0% of scans, with the most common finding being global cerebral ischaemia. The mortality rate was 2.5% (4/154). Conclusions. Hanging is a common mechanism of self-harm. It is associated with significant injuries and mortality. The acute management of hanging should focus on airway protection followed by detailed imaging of the head and neck. Further work must attempt to include mortuary data on hanging.	[Buitendag, J. J. P.] Stellenbosch Univ, Tygerberg Hosp, Dept Surg, Cape Town, South Africa; [Buitendag, J. J. P.] Stellenbosch Univ, Fac Med & Hlth Sci, Cape Town, South Africa; [Ras, A.; Bruce, J. L.; Clarke, D. L.; Laing, G. L.] Univ KwaZulu Natal, Dept Surg, Coll Hlth Sci, Pietermaritzburg Metropolitan Trauma Serv, Durban, South Africa; [Kong, V. Y.; Weale, R. D.; Clarke, D. L.] Univ Witwatersrand, Dept Surg, Fac Hlth Sci, Johannesburg, South Africa; [Blodgett, J.] Wessex Deanery, Dept Surg, Winchester, Hants, England; UCL, MRC Unit Lifelong Hlth & Ageing, London, England		Buitendag, JJP (corresponding author), Stellenbosch Univ, Tygerberg Hosp, Dept Surg, Cape Town, South Africa.; Buitendag, JJP (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Cape Town, South Africa.	johan_buitendag@yahoo.com		Blodgett, Dr Joanna M/0000-0001-7684-3571; Laing, Grant/0000-0001-8075-0386			Hanna SJ, 2004, INJURY, V35, P253, DOI 10.1016/S0020-1383(03)00110-4; Kaki A, 1997, CAN J ANAESTH, V44, P445, DOI 10.1007/BF03014468; Kao CL, 2018, CHIN J TRAUMATOL, V21, P84, DOI 10.1016/j.cjtee.2017.04.013; Martin MJ, 2005, AM J SURG, V190, P836, DOI 10.1016/j.amjsurg.2005.05.051; MCHUGH TP, 1983, ANN EMERG MED, V12, P774, DOI 10.1016/S0196-0644(83)80256-X; Salim A, 2006, INJURY, V37, P435, DOI 10.1016/j.injury.2005.12.013; SIMONSEN J, 1988, FORENSIC SCI INT, V38, P83, DOI 10.1016/0379-0738(88)90012-6; Vande Krol Laurie, 1994, Journal of Emergency Medicine, V12, P285, DOI 10.1016/0736-4679(94)90268-2	8	1	1	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	MAY	2020	110	5					400	402		10.7196/SAMJ.2020.v110i5.13381			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ4AP	WOS:000541169500024	32657725	gold, Green Submitted			2022-02-06	
J	Castano-Leon, AM; Cicuendez, M; Navarro-Main, B; Munarriz, PM; Paredes, I; Cepeda, S; Hilario, A; Ramos, A; Gomez, PA; Lagares, A				Castano-Leon, Ana M.; Cicuendez, Marta; Navarro-Main, Blanca; Munarriz, Pablo M.; Paredes, Igor; Cepeda, Santiago; Hilario, Amaya; Ramos, Ana; Gomez, Pedro A.; Lagares, Alfonso			Sixto Obrador SENEC prize 2019: Utility of diffusion tensor imaging as a prognostic tool in moderate to severe traumatic brain injury. Part I. Analysis of DTI metrics performed during the early subacute stage	NEUROCIRUGIA			Spanish	Article						Axial diffusivity; Diffusion tensor imaging; Fractional anisotropy; Longitudinal analysis; Ordinal regression analysis; Outcome measures; Radial diffusivity; Traumatic brain injury	CORPUS-CALLOSUM; AXONAL INJURY; HEAD-INJURY; MR; EPIDEMIOLOGY; MILD; COMA; CT	Background and objectives: Traumatic axonal injury (TAI) contributes significantly to mortality and morbidity after traumatic brain injury (TBI). Its identification is still a diagnostic challenge because of the limitations of conventional imaging techniques to characterized it. Diffusion tensor imaging (DTI) can indirectly identify areas of damaged white matter integrity by detecting water molecule diffusion alterations. Our main objective is to characterize the TAI using DTI at the early subacute stage in our series of moderate to severe TBI patients and to evaluate if there is a relationship between the information provided by the DTI and patient's outcome. Materials and methods: We have obtained DTI data from 217 patients with moderate to severe TBI acquired at a median of 19 days after TBI, and patient DTI metrics were compared with data obtained from 58 age-matched healthy controls. Region of interest method was applied to obtain mean fractional anisotropy (FA) value in 28 white matter fiber bundles susceptible to TAI. Results: Our main results were that when we compared patients with controls, patients, regardless of TBI severity, showed significantly reduced mean FA in almost all region of interest measured. We found statistically significant correlation between FA metrics and some clinical characteristics. Additionally, the FA values of the three portions of Corpus callosum, Cingulum and cerebral peduncles measured at the early subacute stage were highly associated with outcome assessed at hospital discharge and at 6 and 12 months after TBI. Conclusions: We conclude that DTI is a useful tool to characterize TAI and the detection of FA reduction in the subacute stage after TBI is associated with long-term unfavorable outcome. (C) 2019 Socie dad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Castano-Leon, Ana M.; Navarro-Main, Blanca; Munarriz, Pablo M.; Paredes, Igor; Gomez, Pedro A.; Lagares, Alfonso] Univ Complutense Madrid, Hosp Univ 12 Octubre, Serv Neurocirugia, Madrid, Spain; [Cicuendez, Marta] Univ Barcelona, Hosp Univ Vall dHebron, Serv Neurocirugia, Barcelona, Spain; [Cepeda, Santiago] Univ Valladolid, Hosp Univ Rio Hortega, Serv Neurocirugia, Valladolid, Spain; [Hilario, Amaya; Ramos, Ana] Univ Complutense Madrid, Hosp Univ 12 Octubre, Serv Neurorradiol, Madrid, Spain		Castano-Leon, AM (corresponding author), Univ Complutense Madrid, Hosp Univ 12 Octubre, Serv Neurocirugia, Madrid, Spain.	ana.maria.castano.leon@gmail.com	Munarriz, Pablo M/S-3398-2018; Castano-Leon, Ana M/ABF-6322-2020; Cepeda, Santiago/AAE-3200-2021; Paredes, Igor/AAW-6313-2021; Lagares, Alfonso/B-2969-2011; Gomez, Pedro/E-2411-2014	Munarriz, Pablo M/0000-0002-9888-7046; Castano-Leon, Ana M/0000-0002-7918-5049; Cepeda, Santiago/0000-0003-1667-8548; Paredes, Igor/0000-0002-3846-4164; Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1975, LANCET, V1, P480; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123	22	1	1	0	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	MAY-JUN	2020	31	3					132	145		10.1016/j.neucir.2019.11.005			14	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LK7CV	WOS:000531021100004	31948842				2022-02-06	
J	Choi, EB; Kim, JY; Jang, SH				Choi, Eun Bi; Kim, Jun Young; Jang, Sung Ho			Motor recovery of hemiparetic leg by improvement of limb-kinetic apraxia in a chronic patient with traumatic brain injury A case report	MEDICINE			English	Article						apraxia; diffusion tensor imaging; diffusion tensor tractography; limb-kinetic apraxia; motor recovery; stroke	CORTICOSPINAL TRACT; CORTICOFUGAL TRACT; LEVODOPA; AREA	Rationale: Limb-kinetic apraxia (LKA), a kind of apraxia, means the inability to perform precise and voluntary movements of extremities resulting from injury of the premotor cortex (PMC) or the corticofugal tract (CFT) from the PMC. Diagnosis of LKA is made by observation of movements without specific assessment tools. Patient concerns: A 44-year-old male underwent conservative management for traumatic intracerebral hemorrhage in the left basal ganglia and subarachnoid hemorrhage due to a pedestrian-car crash. When he was admitted to the rehabilitation department of a university hospital after 41 months after onset, he presented with right hemiparesis (Medical Research Council (MRC): shoulder abductor; 3, elbow flexor; 3, finger extensor; 0, hip flexor; 2- [range: 30 degrees], knee extensor; 1 and ankle dorsiflexor; 3-). In addition, he exhibited slow, clumsy, and mutilated movements when performing movements of his right ankle. Diagnoses: The patient was diagnosed as traumatic brain injury (TBI). Interventions: Clinical assessments and DTI were performed at 41 and 44 months after onset. During three months, rehabilitative therapy was performed including dopaminergic drugs (pramipexole 2.5 mg, ropinirole 2.5 mg, and amantadine 300 mg, and carbidopa/levodopa 75 mg/750 mg). Outcomes: The right leg weakness slowly recovered during 3 months, until 44 months after the initial injury (MRC: shoulder abductor, 3; elbow flexor, 3; finger extensor, 0; hip flexor, 3; knee extensor, 3; and ankle dorsiflexor, 3+). The fiber number of the right corticospinal tract (CST) was decreased on 44-month diffusion tensor tractography (DTT) (1319) compared with 41-month DTT (1470) and the left CST was not reconstructed on both DTTs. The fiber number of both CRTs were decreased on 44-month DTT (right: 1547, left: 698) than 41-month DTT (right: 3161, left: 1222). Lessons: A chronic patient with TBI showed motor recovery of the hemiparetic leg by improvement of LKA after rehabilitation. This results have important implications for neurorehabilitation.	[Choi, Eun Bi; Kim, Jun Young; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Daegu 705717, South Korea.	strokerehab@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Council MR, 1976, AIDS EX PER NERV SYS; Defazio G, 1999, CLIN NEUROPHARMACOL, V22, P292; Denes G, 1998, MOVEMENT DISORD, V13, P468, DOI 10.1002/mds.870130316; Foundas AL, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0989-9; Gross RG, 2008, CURR NEUROL NEUROSCI, V8, P490, DOI 10.1007/s11910-008-0078-y; Heilman Kenneth M, 2010, Continuum (Minneap Minn), V16, P86, DOI 10.1212/01.CON.0000368262.53662.08; Jang SH, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01188; Jang SH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009063; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE115, DOI 10.1097/PHM.0000000000000474; Jang SH, 2014, J REHABIL MED, V46, P193, DOI 10.2340/16501977-1782; Jang SH, 2013, NEUROREHABILITATION, V33, P195, DOI 10.3233/NRE-130945; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Pannek K, 2009, J MAGN RESON IMAGING, V29, P529, DOI 10.1002/jmri.21627; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Yamada S, 2004, NEUROLOGY, V62, P830, DOI 10.1212/01.WNL.0000113751.19247.84; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	20	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	MAY	2020	99	19							e20144	10.1097/MD.0000000000020144			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MO4NN	WOS:000551504800076	32384499	gold, Green Published			2022-02-06	
J	Clark, JM; Connor, TA; Williams, C; Clissold, J; McGoldrick, A; Hill, J; Annaidh, AN; Gilchrist, MD				Clark, J. Michio; Connor, Tomas A.; Williams, Claire; Clissold, Jonathan; McGoldrick, Adrian; Hill, Jerry; Annaidh, Aisling Ni; Gilchrist, Michael D.			Analysis of Helmet Damage and Associated Head Injuries Arising from Real-World Equestrian Fall Accidents	JOURNAL OF TESTING AND EVALUATION			English	Article						head injury; concussion; equestrian helmet; impact event; helmet standards	GREAT-BRITAIN; IMPACT; FOOTBALL; RECONSTRUCTION; PERFORMANCE; IRELAND; FRANCE	There is significant difference between the loading conditions used to certify equestrian helmets and the environment in which they are commonly used. This may affect their ability to provide adequate protection against head injury during a riding accident. The efficacy of helmet performance under real-world riding conditions can be judged by examining physical damage to the helmet during an impact, along with details of any head injury that may have been sustained by the rider. The present study considered the influence of different impact events on helmet damage sustained during real-world equestrian racing and eventing accidents. Video analysis of the accidents and assessment of the corresponding helmets allowed helmet damage to be matched to impacts. From a total of 1,119 accident videos and 218 inspected helmets, there was a total of 18 cases for which both the helmet and unobstructed video views of the accident sequence were available, along with details of any injuries sustained by the rider. All 18 cases involved the riders falling from their horses and impacting their heads against the turf. For 7 of the 18 cases, head impacts occurred in which a rider's head was also either kicked, crushed, or stomped on by a horse: those subsequent impacts led to significant helmet damage, suggesting that the helmets provided protection for the riders during those secondary and tertiary impacts. Surprisingly, 11 of the 18 cases involved only a fall for which none of the helmets had any evident damage, despite 6 of those cases involving diagnosed concussions and 1 hematoma. This indicates that traumatic brain injury can occur in equestrian sports even while the rider wears a helmet, which suggests that there is scope to further improve the ability of equestrian helmets to protect against concussion when riders fall and impact their head against turf.	[Clark, J. Michio; Connor, Tomas A.; Annaidh, Aisling Ni; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Connor, Tomas A.] Charles Owen & Co Ltd, Royal Works, Croesfoel Ind Pk, Wrexham LL14 4BJ, Wales; [Williams, Claire] British Equestrian Trade Assoc, East Wing,Stockeld Pk, Wetherby LS22 4AW, W Yorkshire, England; [Clissold, Jonathan] British Eventing, Abbey Pk, Kenilworth CV8 2RN, Warwick, England; [McGoldrick, Adrian] The Curragh, Irish Horseracing Regulatory Board, Newbridge, Kildare, Ireland; [Hill, Jerry] British Horseracing Author, 75 High Holborn, London WC1V 6LS, England		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	European UnionEuropean Commission [642662]	Funding for this research was received from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 642662.	Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; [Anonymous], 2011, 0152011 PAS BRIT STA, DOI [10.3403/30204553, DOI 10.3403/30204553]; [Anonymous], 2015, F116315 ASTM INT, DOI [10.1520/F1163-15, DOI 10.1520/F1163-15]; [Anonymous], 2017, 13842017 BS EN, DOI [10.3403/30290406, DOI 10.3403/30290406]; Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; Bier G, 2018, BRIT J NEUROSURG, V32, P37, DOI 10.1080/02688697.2017.1409874; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; BOND GR, 1995, PEDIATRICS, V95, P487; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Clark JM, 2018, J MECH BEHAV BIOMED, V80, P20, DOI 10.1016/j.jmbbm.2018.01.020; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Connor TA, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0193-0; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Fleming PRI, 2001, CLIN EXP OPHTHALMOL, V29, P208, DOI 10.1046/j.1442-9071.2001.00430.x; Foote C., 2011, RIRDC PUBLICATION, V10/067; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Harrison K, 2011, NY TIMES BK REV, P11; Holland AJA, 2001, MED J AUSTRALIA, V175, P609, DOI 10.5694/j.1326-5377.2001.tb143746.x; Hunt H., 1989, IRCOBI C STOCKH SWED; Hurt H. H., 1976, P AM ASS AUTOMOTIVE, P187; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Johnson GI, 2003, J TEST EVAL, V31, P79; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; Northey G, 2003, NZ MED J, V116, P1182; O'Sullivan D, 2018, J SPORT SCI, V36, P1256, DOI 10.1080/02640414.2017.1373196; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Yamaguchi GT, 2014, J TEST EVAL, V42, P1257, DOI 10.1520/JTE20130122	38	1	1	1	5	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959 USA	0090-3973	1945-7553		J TEST EVAL	J. Test. Eval.	MAY	2020	48	3			SI		2185	2195		10.1520/JTE20190513			11	Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	LH8JL	WOS:000529028900030					2022-02-06	
J	Colantonio, A				Colantonio, Angela			Beyond Football: Intimate Partner Violence and Concussion/Brain Injury	CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE			English	Article						traumatic brain injury; concussion; chronic traumatic encephalopathy; intimate partner violence; women	TRAUMATIC BRAIN-INJURY; HEALTH; WOMEN	Intimate partner violence (IPV) affects 1 in 4 women over their lifetime in Canada and international estimates are even higher. Up to 92% of hits are to the head or face in this context and are likely to be repetitive. While the majority of research on Chronic Traumatic Encephalopathy (CTE) has been conducted on male athletes, there has been a dearth of research on women experiencing brain injury in the IPV context. This work presents an overview of research on brain injury among women in the IPV context and its significance with respect to CTE. It highlights a new program of research on IPV and traumatic brain injury in Canada. which includes a needs assessment of frontline providers, and provides a report from the first national workshop on IPV and brain injury, which included a broad range of stakeholders. Innovative education strategies that have developed, including a toolkit for front-line providers, and future research directions are also discussed.	[Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, 500 Univ Ave,Suite 160, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Hlth Network, Acquired Brain Injury & Soc Team, KITE Toronto Rehabil Res Inst, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Rehabil Sci Inst, 500 Univ Ave,Suite 160, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Department of Justice; Women's Exchange, Women's College Hospital	This research program is supported by the Canadian Institutes of Health Research, the Canadian Department of Justice, and Women's Exchange, Women's College Hospital. I would also like to thank Andrea D'Souza, a research coordinator at the Acquired Brain Injury Lab, for her support in revising this article. The author has no known conflict of interest to disclose.	BURCZYCKA M, 2018, FAMILY VIOLENCE CANA; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Colantonio A., 2017, TRAUMATIC BRAIN INJU; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Department of Justice Canada, 2017, JUSTFACTS INT PARTN; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Fisher N., 2019, FORBES MAGAZINE; Haag H. L., 2019, ABUSED BRAIN INJURED; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Haag H, 2019, BRAIN IMPAIR, V20, P197, DOI 10.1017/BrImp.2019.16; Haag Halina Lin, 2019, Trauma Violence Abuse, p1524838019850623, DOI 10.1177/1524838019850623; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Mollayeva T, 2019, ALZH DEMENT-DADM, V11, P355, DOI 10.1016/j.dadm.2019.03.003; Mollayeva T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41916-5; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; National Institute of Neurological Disorders and Stroke, 2017, WORKSH SUMM UND TRAU; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; SciLine, 2018, CONC BRAIN HLTH MED; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; World Health Organization, 2013, GLOBAL REGIONAL ESTI; World Health Organization, 2014, VIOL WOM INT PARTN S; Zielonka A., 2018, WASHINGTON TIMES	25	1	1	0	2	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0708-5591	1878-7304		CAN PSYCHOL	Can. Psychol.-Psychol. Can.	MAY	2020	61	2			SI		163	166		10.1037/cap0000208			4	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LI2UQ	WOS:000529339500008					2022-02-06	
J	Cookinham, B; Swank, C				Cookinham, Brittani; Swank, Chad			Concussion History and Career Status Influence Performance on Baseline Assessments in Elite Football Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						head injury; mild traumatic brain injury; neurocognitive testing; sideline testing	POSTCONCUSSION-LIKE SYMPTOMS; SPORT CONCUSSION; RECURRENT CONCUSSION; HEAD IMPACTS; DIVISION-I; EPIDEMIOLOGY; ASSOCIATION; FREQUENCY; POSITION; OUTCOMES	Objective: To determine if concussion history and career status is associated with neurocognitive performance in elite football players. Methods: The study design was a cross-sectional single assessment. Fifty-seven elite football players (age 29.39 +/- 7.49 years) categorized as draft prospects, active professional players, and retired professional players were assessed on the Sport Concussion Assessment Tool - third edition (SCAT-3), in an outpatient therapy setting. Results: Common symptoms were the following: fatigue (45.6%), trouble falling asleep (35.1%), difficulty remembering (33.3%) and irritability (22.8%); 36.8% reported no symptoms. The low concussion (0-1) group reported fewer symptoms (U = 608.50, p < .001), less symptom severity (U = 598.00, p = -.001), and produced greater scores on the Standardized Assessment of Concussion (SAC) total scores compared to the multiple concussion (2+) group (U = 253.00, p = .024), but no differences were observed on modified Balance Error Scoring System (m-BESS) scores (U = 501.50, p = .066) on the Mann-Whitney U test. The Kruskal-Wallis test and post-hoc analysis indicated retired players were significantly different from draft prospects and current professional players for total symptom scores (p < .001), total symptom severity (p < .001), SAC total scores (p = .030), and m-BESS (p < .001). Conclusions: Concussion history and career status appear associated with total symptoms, symptom severity, performance on the SAC, and the m-BESS in elite football players. With this in mind, future research is recommended to determine longitudinal impact for elite football players.	[Cookinham, Brittani] Texas Womans Univ, Sch Phys Therapy, 5500 Southwestern Med Ave, Dallas, TX 75235 USA; [Swank, Chad] Baylor Scott & White Inst Rehabil, Dallas, TX USA		Cookinham, B (corresponding author), Texas Womans Univ, Sch Phys Therapy, 5500 Southwestern Med Ave, Dallas, TX 75235 USA.	bcookinham@twu.edu					[Anonymous], 2013, BRIT J SPORT MED, V47, P259; Arner JW, 2017, ANN JOINT, V2, DOI 10.21037/aoj.2017.11.05; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Centers for Disease Control and Prevention, 2017, HEADS; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Churchill TW, 2018, AM J MED, V131, P1491, DOI 10.1016/j.amjmed.2018.07.042; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Fuller GW, 2018, J SCI MED SPORT, V21, P347, DOI 10.1016/j.jsams.2017.07.025; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Miyashita TL, 2017, SPORTS HEALTH, V9, P318, DOI 10.1177/1941738116685306; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Valovich McLeod T. C., 2014, AM J SPORTS MED, V40, P927; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Willmott C, 2018, J SCI MED SPORT, V21, P442, DOI 10.1016/j.jsams.2017.09.591; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	40	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		257	264		10.1093/arclin/acz012			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800003	30927353	Bronze			2022-02-06	
J	Doron, O; Barnea, O; Stocchetti, N; Or, T; Nossek, E; Rosenthal, G				Doron, Omer; Barnea, Ofer; Stocchetti, Nino; Or, Tal; Nossek, Erez; Rosenthal, Guy			Cardiac-gated intracranial elastance in a swine model of raised intracranial pressure: a novel method to assess intracranial pressure?volume dynamics	JOURNAL OF NEUROSURGERY			English	Article						cardiac-gated elastance; cerebral edema; intracranial balloon pump; intracranial pressure; swine model; traumatic brain injury	TRAUMATIC BRAIN-INJURY; VOLUME-PRESSURE; TIME	OBJECTIVE Previous studies have demonstrated the importance of intracranial elastance; however, methodological difficulties have limited widespread clinical use. Measuring elastance may offer potential benefit in helping to identify patients at risk for untoward intracranial pressure (ICP) elevation from small rises in intracranial volume. The authors sought to develop an easily used method that accounts for the changing ICP that occurs over a cardiac cycle and to assess this method in a large-animal model over a broad range of ICPs. METHODS The authors used their previously described cardiac-gated intracranial balloon pump and swine model of cerebral edema. In the present experiment they measured elastance at 4 points along the cardiac cycle?early systole, peak systole, mid-diastole, and end diastole?by using rapid balloon inflation to 1 ml over an ICP range of 10?30 mm Hg. RESULTS The authors studied 7 swine with increasing cerebral edema. Intracranial elastance rose progressively with increasing ICP. Peak-systolic and end-diastolic elastance demonstrated the most consistent rise in elastance as ICP increased. Cardiac-gated elastance measurements had markedly lower variance within swine compared with non? cardiac-gated measures. The slope of the ICP?elastance curve differed between swine. At ICP between 20 and 25 mm Hg, elastance varied between 8.7 and 15.8 mm Hg/ml, indicating that ICP alone cannot accurately predict intracranial elastance. CONCLUSIONS Measuring intracranial elastance in a cardiac-gated manner is feasible and may offer an improved precision of measure. The authors? preliminary data suggest that because elastance values may vary at similar ICP levels, ICP alone may not necessarily best reflect the state of intracranial volume reserve capacity. Paired ICP?elastance measurements may offer benefit as an adjunct ?early warning monitor? alerting to the risk of untoward ICP elevation in brain-injured patients that is induced by small increases in intracranial volume.	[Doron, Omer; Rosenthal, Guy] Hadassah Hebrew Univ, Dept Neurosurg, Med Ctr, Jerusalem, Israel; [Doron, Omer; Barnea, Ofer; Or, Tal] Tel Aviv Univ, Dept Biomed Engn, Tel Aviv, Israel; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Nossek, Erez] NYU, Med Ctr, Dept Neurosurg, New York, NY 10016 USA		Rosenthal, G (corresponding author), Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel.	rosenthalg@hadassah.org.il			KAMIN research grant (KAMIN Grant) [56350]	This study was supported by a KAMIN research grant (KAMIN Grant #56350) issued by the Israeli Innovation Authority and awarded to Dr. Doron and Prof. Barnea.	Abdullah J, 2005, ACT NEUR S, V95, P311; ANILE C, 1987, NEUROSURGERY, V20, P389, DOI 10.1227/00006123-198703000-00006; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; de Noriega FR, 2018, J CLIN NEUROSCI, V58, P192, DOI 10.1016/j.jocn.2018.10.051; DIROCCO C, 1977, EXPERIENTIA, V33, P1470; Doron O, 2020, J NEUROSURG, V132, P1606, DOI 10.3171/2019.1.JNS182864; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Heldt T, 2019, ANNU REV BIOMED ENG, V21, P523, DOI 10.1146/annurev-bioeng-060418-052257; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1093, DOI 10.1136/jnnp.37.10.1093; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Miller J D, 1975, Clin Neurosurg, V22, P76; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; Monro A., 1783, OBSERVATIONS STRUCTU; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Stocchetti N, 1993, Minerva Anestesiol, V59, P1; SULLIVAN HG, 1979, ANN NEUROL, V5, P228, DOI 10.1002/ana.410050304; SULLIVAN HG, 1978, SURG NEUROL, V9, P47; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Yau YH, 2005, ACT NEUR S, V95, P289	30	1	1	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2020	134	5					1650	1657		10.3171/2020.3.JNS193262			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RZ6HU	WOS:000648699700001	32503002	Bronze			2022-02-06	
J	Dutysheva, EA; Mikeladze, MA; Trestsova, MA; Aksenov, ND; Utepova, IA; Mikhaylova, ER; Suezov, RV; Charushin, VN; Chupakhin, ON; Guzhova, IV; Margulis, BA; Lazarev, VF				Dutysheva, Elizaveta A.; Mikeladze, Marina A.; Trestsova, Maria A.; Aksenov, Nikolay D.; Utepova, Irina A.; Mikhaylova, Elena R.; Suezov, Roman, V; Charushin, Valery N.; Chupakhin, Oleg N.; Guzhova, Irina, V; Margulis, Boris A.; Lazarev, Vladimir F.			Pyrrolylquinoxaline-2-One Derivative as a Potent Therapeutic Factor for Brain Trauma Rehabilitation	PHARMACEUTICS			English	Article						traumatic brain injury; cerebrospinal fluid; Hsp70; small molecule; apoptosis	HEAT-SHOCK-PROTEIN; CEREBROSPINAL-FLUID; PHARMACOLOGICAL INDUCTION; SMALL MOLECULES; CHAPERONE; INJURY; DISEASE; HSP70; NEUROTOXICITY; AGGREGATION	Traumatic brain injury (TBI) often causes massive brain cell death accompanied by the accumulation of toxic factors in interstitial and cerebrospinal fluids. The persistence of the damaged brain area is not transient and may occur within days and weeks. Chaperone Hsp70 is known for its cytoprotective and antiapoptotic activity, and thus, a therapeutic approach based on chemically induced Hsp70 expression may become a promising approach to lower post-traumatic complications. To simulate the processes of secondary damage, we used an animal model of TBI and a cell model based on the cultivation of target cells in the presence of cerebrospinal fluid (CSF) from injured rats. Here we present a novel low molecular weight substance, PQ-29, which induces the synthesis of Hsp70 and empowers the resistance of rat C6 glioma cells to the cytotoxic effect of rat cerebrospinal fluid taken from rats subjected to TBI. In an animal model of TBI, PQ-29 elevated the Hsp70 level in brain cells and significantly slowed the process of the apoptosis in acceptor cells in response to cerebrospinal fluid action. The compound was also shown to rescue the motor function of traumatized rats, thus proving its potential application in rehabilitation therapy after TBI.	[Dutysheva, Elizaveta A.; Mikeladze, Marina A.; Aksenov, Nikolay D.; Mikhaylova, Elena R.; Suezov, Roman, V; Guzhova, Irina, V; Margulis, Boris A.; Lazarev, Vladimir F.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia; [Trestsova, Maria A.; Utepova, Irina A.; Charushin, Valery N.; Chupakhin, Oleg N.] Ural Fed Univ, Ekaterinburg 620002, Russia; [Utepova, Irina A.; Charushin, Valery N.; Chupakhin, Oleg N.] Russian Acad Sci, Postovsky Inst Organ Synth, Ural Branch, Ekaterinburg 620108, Russia		Lazarev, VF (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	linza.uri@mail.ru; marinamikeladze.cytspb@gmail.com; mtrescova@mail.ru; aksenovn@gmail.com; irina-utepova@yandex.ru; mikhailovaer@yandex.ru; roman.suezov@gmail.com; charushin@ios.uran.ru; chupakhin@ios.uran.ru; irina.guzh@gmail.com; margulis@incras.ru; vl.lazarev@gmail.com	Dutysheva, Elizaveta/AAA-8164-2021; Utepova, Irina/ABB-8067-2021; Mikhaylova, Elena/AAN-2169-2020; Aksenov, Nikolay D/F-1679-2017; Guzhova, Irina/AAB-2140-2021; Charushin, Valery N/C-4250-2016; Lazarev, Vladimir F/O-9813-2017	Utepova, Irina/0000-0003-4692-9176; Guzhova, Irina/0000-0002-8775-7713; Charushin, Valery N/0000-0002-9140-358X; Dutysheva, Elizaveta/0000-0003-0354-5199	Russian Science FoundationRussian Science Foundation (RSF) [18-74-10087]; Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [20-33-70102]; Ministry of Education and Science of Russian FederationMinistry of Education and Science, Russian Federation [0124-2019-002]	This research was funded by Russian Science Foundation, research project #18-74-10087 (V.F.L., E.A.D., M.A.M., E.R.M.), Russian Foundation for Basic Research, research project #20-33-70102 (I.A.U., O.N.C., V.N.C., M.A.T., I.V.G.), and by The Ministry of Education and Science of Russian Federation No 0124-2019-002 (R.V.S., N.D.A., B.A.M.).	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Beez T, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0994-z; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Chow AM, 2013, CELL STRESS CHAPERON, V18, P155, DOI 10.1007/s12192-012-0364-0; Curvello V, 2017, BRAIN RES, V1670, P118, DOI 10.1016/j.brainres.2017.06.010; De S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0777-4; Denault JB, 2007, NAT CHEM BIOL, V3, P519, DOI 10.1038/nchembio0907-519; Duncan Emma J, 2015, Subcell Biochem, V78, P243, DOI 10.1007/978-3-319-11731-7_12; Ekimova IV, 2018, EXP NEUROL, V306, P199, DOI 10.1016/j.expneurol.2018.04.012; Falchook AD, 2015, J CLIN EXP NEUROPSYC, V37, P1062, DOI 10.1080/13803395.2015.1077930; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314; Hart Tessa, 2017, Arch Phys Med Rehabil, V98, P407, DOI 10.1016/j.apmr.2016.09.112; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Kalmar B, 2009, CELL MOL BIOL LETT, V14, P319, DOI 10.2478/s11658-009-0002-8; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kawai T, 2000, J LAB CLIN MED, V136, P138, DOI 10.1067/mlc.2000.108157; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kim N, 2015, NEUROSCIENCE, V284, P912, DOI 10.1016/j.neuroscience.2014.11.010; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Komarova EY, 2004, CELL STRESS CHAPERON, V9, P265, DOI 10.1379/CSC-27R1.1; Kong P, 2015, MOL MED REP, V12, P2217, DOI 10.3892/mmr.2015.3575; Kroemer Guido, 2001, TheScientificWorldJOURNAL, V1, P590; Lasunskaia EB, 2010, APMIS, V118, P179, DOI 10.1111/j.1600-0463.2009.02576.x; Lazarev VF, 2013, ACTA NATURAE, V5, P81, DOI 10.32607/20758251-2013-5-2-81-89; Lazarev VF, 2011, BIOCHEMISTRY-MOSCOW+, V76, P590, DOI 10.1134/S0006297911050099; Lazarev VF, 2018, BIOCHEM BIOPH RES CO, V501, P1003, DOI 10.1016/j.bbrc.2018.05.099; Lazarev VF, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00277; Lazarev VF, 2016, FREE RADICAL BIO MED, V92, P29, DOI 10.1016/j.freeradbiomed.2015.12.025; Lazarev VF, 2016, BIOCHEM BIOPH RES CO, V470, P766, DOI 10.1016/j.bbrc.2015.12.076; Lin CH, 2014, ACS CHEM NEUROSCI, V5, P1063, DOI 10.1021/cn500075u; Mantri S, 2019, PARKINSONISM RELAT D, V64, P20, DOI 10.1016/j.parkreldis.2018.09.011; Mishra PS, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0698-0; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nakazono A, 2018, J BIOL CHEM, V293, P14758, DOI 10.1074/jbc.RA118.002913; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Rosen HJ, 2020, ALZHEIMERS DEMENT, V16, P71, DOI 10.1002/alz.12004; Smrcka M, 2005, ACT NEUR S, V95, P273; Tandean Steven, 2019, Open Access Maced J Med Sci, V7, P2763, DOI 10.3889/oamjms.2019.736; Utepova IA, 2015, GREEN CHEM, V17, P4401, DOI 10.1039/c5gc00753d; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Xu C, 2017, J NEUROCHEM, V141, P48, DOI 10.1111/jnc.13966; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144	48	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1999-4923		PHARMACEUTICS	Pharmaceutics	MAY	2020	12	5							414	10.3390/pharmaceutics12050414			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	MC6KQ	WOS:000543393700014	32366047	gold, Green Published			2022-02-06	
J	Glass, SM; Cone, BL; Rhea, CK; Duffy, DM; Ross, SE				Glass, Stephen M.; Cone, Brian L.; Rhea, Christopher K.; Duffy, Donna M.; Ross, Scott E.			Sex-Specific Dependence of Linear and Nonlinear Postural Control Metrics on Anthropometrics During Clinical Balance Tests in Healthy Young Adults	JOURNAL OF SPORT REHABILITATION			English	Article						sex differences; normalization; nonlinear dynamics; interaction effects	SPORTS; SWAY; INDIVIDUALS; COMPLEXITY; SYSTEM; APPROPRIATE; PERFORMANCE; CONCUSSION; PARAMETERS; STABILITY	Context: Previous work suggests that balance behavior is a sex-dependent, complex process that can be characterized by linear and nonlinear metrics. Although a certain degree of center of pressure variability may be expected based on sexual dimorphism, there is evidence to suggest that these effects are obscured by potential interactions between sex and anthropometric factors. To date, no study has accounted for such interactive effects using both linear and nonlinear measures. Objective: This investigation sought to analyze interactive models featuring sex, height, and weight as predictors of linear and nonlinear aspects of postural control. Design: Cross-sectional study. Setting: Controlled laboratory. Participants: A total of 26 males (23.80 [3.44] y, 177.87 [6.44] cm, 81.70 [10.80] kg) and 28 females (21.14 [2.03] y, 169.57 [8.80] cm, 64.48 [8.86] kg) were sampled from a healthy university population. Main Outcome Measures: Linear (range [RNG], velocity [VEL], and SD) and nonlinear (detrended fluctuation analysis scaling exponent, multivariate multiscale sample entropy [MMSECI]) summary metrics of center of pressure time series. Procedure: Participants stood on a force plate for 20 seconds in 3 conditions: double (D), single (S), and tandem (T) stance. Data for each stance condition were analyzed using regression models with interaction terms for sex x height and sex x weight. In D, weight had a positive, significant main effect on VELy, MMSECId, and MMSECIv. In men, height was observed to have a positive effect on SDy (S), RNGy (5). and RNGx (T) and a negative effect on MMSECIv (1). In women, weight was observed to have a positive effect on SDy and VELx (both T). Conclusions: Our findings suggest that men and women differ with respect to certain linear and nonlinear aspects of balance behavior, and that these differences may reflect sex-specific behavioral patterns in addition to effects related to sexual dimorphism.	[Glass, Stephen M.] Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA; [Cone, Brian L.; Rhea, Christopher K.; Duffy, Donna M.; Ross, Scott E.] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC USA		Glass, SM (corresponding author), Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA.	Stephen.glass@osumc.edu		Glass, Stephen/0000-0001-6263-527X			Ahmed MU, 2012, B POL ACAD SCI-TECH, V60, P433, DOI 10.2478/v10175-012-0055-0; Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; Arendt EA, 1999, J ATHL TRAINING, V34, P86; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Boer MC, 2015, EUR J PHYS REHAB MED, V51, P663; Breheny P, 2009, STAT INTERFACE, V2, P369; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Conley S, 2007, J AM ACAD ORTHOP SUR, V15, pS31, DOI 10.5435/00124635-200700001-00009; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; de Castro LA, 2016, RESP CARE, V61, P1488, DOI 10.4187/respcare.04749; Duarte M, 2001, PHYS LETT A, V283, P124, DOI 10.1016/S0375-9601(01)00188-8; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Emery CA, 2003, J SCI MED SPORT, V6, P492, DOI 10.1016/S1440-2440(03)80274-8; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Garcia C., 2015, NONLINEARTSERIES NON; Glass SM, 2015, INT J SPORTS PHYS TH, V10, P612; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Hertel J, 2002, J ATHL TRAINING, V37, P129; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Johnson ST, 2012, EUR J APPL PHYSIOL, V112, P3859, DOI 10.1007/s00421-012-2363-3; Kim JW, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414400089; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Kim J, 2012, INT J PRECIS ENG MAN, V13, P1897, DOI 10.1007/s12541-012-0249-2; Kim J, 2012, INT J PRECIS ENG MAN, V13, P963, DOI 10.1007/s12541-012-0125-0; Koltermann JJ, 2018, TECHNOLOGIES, V6, DOI 10.3390/technologies6020056; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; OMalley MJ, 1996, J BIOMECH, V29, P619, DOI 10.1016/0021-9290(95)00088-7; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rhine T, 2017, J HEAD TRAUMA REHAB, V32, pE18, DOI 10.1097/HTR.0000000000000192; Ross SE, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-47; Ross SE, 2004, CLIN J SPORT MED, V14, P332, DOI 10.1097/00042752-200411000-00002; Taylor JB, 2015, J ATHL TRAINING, V50, P1199, DOI 10.4085/1062-6050-50.11.10; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; 2009, OC CIRC EL NIN NEW, P1	42	1	1	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAY	2020	29	4					405	412		10.1123/jsr.2018-0197			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LX7PX	WOS:000540020400004	30860414				2022-02-06	
J	Herzog, C; Greenald, D; Larraz, J; Keatinge, M; Herrgen, L				Herzog, Chiara; Greenald, David; Larraz, Juan; Keatinge, Marcus; Herrgen, Leah			RNA-seq analysis and compound screening highlight multiple signalling pathways regulating secondary cell death after acute CNS injury in vivo	BIOLOGY OPEN			English	Article						CNS injury; Secondary cell death; RNA-seq; Compound screen; Cellular signalling; Zebrafish	FOCAL CEREBRAL-ISCHEMIA; ORNITHINE-DECARBOXYLASE ACTIVITY; TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM INJURY; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY; TNF-ALPHA; INDUCED EXCITOTOXICITY; ARTERY OCCLUSION; NEURONAL INJURY	Understanding the molecular mechanisms that regulate secondary cell death after acute central nervous system (CNS) injury is critical for the development of effective neuroprotective drugs. Previous research has shown that neurotoxic processes including excitotoxicity, oxidative stress and neuroinflammation can cause secondary cell death. Nevertheless, clinical trials targeting these processes have been largely unsuccessful, suggesting that the signalling pathways underlying secondary cell death remain incompletely understood. Due to their suitability for live imaging and their amenability to genetic and pharmacological manipulation, larval zebrafish provide an ideal platform for studying the regulation of secondary cell death in vivo. Here, we use RNA-seq gene expression profiling and compound screening to identify signalling pathways that regulate secondary cell death after acute neural injury in larval zebrafish. RNA-seq analysis of genes upregulated in cephalic mpegl macrophage-lineage cells isolated from mpegl:GFP transgenic larvae after neural injury suggested an involvement of cytokine and polyamine signalling in secondary cell death. Furthermore, screening a library of FDA approved compounds indicated roles for GABA, serotonin and dopamine signalling. Overall, our results highlight multiple signalling pathways that regulate secondary cell death in vivo, and thus provide a starting point for the development of novel neuroprotective treatments for patients with CNS injury. This article has an associated First Person interview with the two first authors of the paper.	[Herzog, Chiara; Greenald, David; Larraz, Juan; Keatinge, Marcus; Herrgen, Leah] Univ Edinburgh, Ctr Discovery Brain Sci, Biomed Sci, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland		Herrgen, L (corresponding author), Univ Edinburgh, Ctr Discovery Brain Sci, Biomed Sci, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	Leah.Herrgen@ed.ac.uk		Herzog, Chiara/0000-0002-1572-498X	University of Edinburgh Chancellor's Fellowship; Wellcome Trust/The University of Edinburgh Institutional Strategic Support Fund; Wellcome Trust Seed Award in ScienceWellcome Trust [207701/Z/17/Z]; Carnegie Trust Research Incentive Grant [70457]; Rosetrees Trust/Stoneygate Trust Seedcorn Award [M602]; Royal Society Research GrantRoyal Society of London [RG170428]; NERCUK Research & Innovation (UKRI)Natural Environment Research Council (NERC) [R8/H10/56]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K001744/1]; BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004243/1]	This work was supported by a University of Edinburgh Chancellor's Fellowship to L.H.; a Wellcome Trust/The University of Edinburgh Institutional Strategic Support Fund to L.H.; a Wellcome Trust Seed Award in Science (207701/Z/17/Z to L.H.); a Carnegie Trust Research Incentive Grant (70457 to L.H.); a Rosetrees Trust/Stoneygate Trust Seedcorn Award (M602 to L.H.); and a Royal Society Research Grant (RG170428 to L.H.). Analyses of RNA-seq data were carried out by Edinburgh Genomics at the University of Edinburgh. Edinburgh Genomics is partly supported through core grants from NERC (R8/H10/56), MRC (MR/K001744/1) and BBSRC (BB/J004243/1).	Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla RM, 2002, BRAIN RES, V938, P81, DOI 10.1016/S0006-8993(02)02447-2; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Babu GN, 2003, NEUROCHEM RES, V28, P1851, DOI 10.1023/A:1026123809033; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bremer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178854; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Carlson NG, 1999, J IMMUNOL, V163, P3963; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Coert BA, 2000, NEUROSCI LETT, V282, P5, DOI 10.1016/S0304-3940(00)00856-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dogan A, 1999, J NEUROSURG, V90, P1078, DOI 10.3171/jns.1999.90.6.1078; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Duan B, 2011, J NEUROSCI, V31, P2101, DOI 10.1523/JNEUROSCI.4351-10.2011; Early JJ, 2018, ELIFE, V7, DOI 10.7554/eLife.35136; Ellett Felix, 2011, Blood, V117, pe49, DOI 10.1182/blood-2010-10-314120; Fan JW, 2019, TOXICOL SCI, V168, P381, DOI 10.1093/toxsci/kfy300; Figiel I, 2008, ACTA NEUROBIOL EXP, V68, P526; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; Green AR, 2000, NEUROPHARMACOLOGY, V39, P1483, DOI 10.1016/S0028-3908(99)00233-6; Hanada R, 2011, J MOL MED, V89, P647, DOI 10.1007/s00109-011-0749-z; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; Herzog C, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174698; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Inglefield JR, 1995, HIPPOCAMPUS, V5, P460, DOI 10.1002/hipo.450050508; Iqbal S, 2002, BRAIN RES, V946, P162, DOI 10.1016/S0006-8993(02)02871-8; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; JOHANSEN FF, 1991, ACTA NEUROL SCAND, V84, P1; Jung JE, 2011, STROKE, V42, P3574, DOI 10.1161/STROKEAHA.111.626648; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kaengkan P, 2013, MOL CELLS, V36, P534, DOI 10.1007/s10059-013-0235-2; Kam KY, 2012, PROG NEURO-PSYCHOPH, V39, P69, DOI 10.1016/j.pnpbp.2012.05.010; Kelso ML, 2015, J NEUROIMMUNOL, V278, P162, DOI 10.1016/j.jneuroim.2014.11.002; Kim GH, 2009, CAN J NEUROL SCI, V36, P14, DOI 10.1017/S0317167100006247; Kim YH, 2017, CLIN ORTHOP SURG, V9, P1, DOI 10.4055/cios.2017.9.1.1; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; Kurinami H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38062; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; LUKKARAINEN J, 1995, EUR J NEUROSCI, V7, P1840, DOI 10.1111/j.1460-9568.1995.tb00704.x; Lukkarinen JA, 1999, BRAIN RES, V826, P325, DOI 10.1016/S0006-8993(99)01327-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mastracci TL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13269; Masuch A, 2016, GLIA, V64, P76, DOI 10.1002/glia.22904; Mautes AEM, 1999, NEUROSCI LETT, V264, P153, DOI 10.1016/S0304-3940(99)00197-4; Mazzolini J, 2020, GLIA, V68, P298, DOI 10.1002/glia.23717; Mazzolini J, 2018, JOVE-J VIS EXP, DOI 10.3791/57431; Meldrum BS, 1999, EPILEPSIA, V40, pS2, DOI 10.1111/j.1528-1157.1999.tb02087.x; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Mitchell DM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41298-8; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Morsch M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00321; Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Noristani HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00090; Ohnmacht J, 2016, DEVELOPMENT, V143, P1464, DOI 10.1242/dev.129155; Oosterhof N, 2017, GLIA, V65, P138, DOI 10.1002/glia.23083; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao AM, 1998, NEUROSCI LETT, V256, P65, DOI 10.1016/S0304-3940(98)00780-0; Rao WLR, 2001, J CEREBR BLOOD F MET, V21, P945; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1889, DOI 10.1089/ars.2010.3474; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROCK DM, 1995, ANNU REV PHARMACOL, V35, P463; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; SEEGER TF, 1995, J PHARMACOL EXP THER, V275, P101; Shimamura M, 2014, P NATL ACAD SCI USA, V111, P8191, DOI 10.1073/pnas.1400544111; Shimizu M., 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-018-35898-Z; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Tsarouchas TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07036-w; Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Xu WC, 2000, BRAIN RES, V874, P75, DOI 10.1016/S0006-8993(00)02554-3; Yang Y, 2000, NEUROREPORT, V11, P2307, DOI 10.1097/00001756-200007140-00048; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423; Zhu Y, 2017, J NEUROSCI, V37, P2362, DOI 10.1523/JNEUROSCI.2751-16.2017	99	1	1	1	1	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	2046-6390			BIOL OPEN	Biol. Open	MAY	2020	9	5							bio050260	10.1242/bio.050260			13	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	LW5NH	WOS:000539192700007	32366533	Green Published, gold			2022-02-06	
J	Ku, C; McKinlay, A; Grace, RC; Linden, M; McLellan, T				Ku, Cindy; McKinlay, Audrey; Grace, Randolph C.; Linden, Mark; McLellan, Tracey			An International Exploration of the Effect of Media Portrayals of Postconcussion Management on Concussion Identification in the General Public	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; media; public perception; return to play; sports	TRAUMATIC BRAIN-INJURY; SPORTS; EDUCATION; EPIDEMIOLOGY; ASSOCIATION; STATEMENT; KNOWLEDGE; PLAYERS; IMPACT; COACH	Background: Concussion portrayal in media broadcasts of sporting events may contribute to lack of public understanding regarding concussion. Methods: In total, 828 participants from Australia, New Zealand, and the United Kingdom completed a questionnaire assessing concussion knowledge. Participants were randomly assigned to either receive sports return-to-play (RTP) guideline information (RTP group) or not (no-RTP group). Participants viewed 12 short clips from televised rugby games and indicated whether they believed the player in each clip had sustained a concussion. Participants were then informed whether the player was removed, returned, or stayed in the game and again asked whether they thought a concussion had occurred. Results: Probability of reporting a likely concussion over all videos was 65.6%. When told a player's possible concussion was managed by removal from the game, participants were more likely to change their response from "no" (no concussion) to "yes" (concussion) than from "yes" to "no." When told the player stayed or returned to the game, participants were more likely to change their response from "yes" (concussion) to "no" (no concussion) than from "no" to "yes." There was no significant main effect for RTP guideline manipulation or interaction effect with RTP information. Conclusion: Additional player's injury management information influenced participants' judgments of concussion occurrence. Results show that information provided via sports media broadcasts influenced viewers' perceptions of concussion and appropriate concussion management.	[Ku, Cindy; McKinlay, Audrey; Grace, Randolph C.; McLellan, Tracey] Univ Canterbury, Christchurch, New Zealand; [McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia; [McKinlay, Audrey; Linden, Mark] Queens Univ, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		Linden, Mark/0000-0002-3832-4102	New Zealand Lottery Health Research grant [353091]	This study was funded by a New Zealand Lottery Health Research grant (#353091) awarded to Randolph C. Grace and Audrey McKinlay.	Ahmed Osman Hassan, 2017, Concussion, V2, pCNC27, DOI 10.2217/cnc-2016-0026; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Case RJL, 2017, NEW ZEAL J EDUC STUD, V52, P159, DOI 10.1007/s40841-017-0080-5; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Haarbauer-Krupa JK, 2018, BRAIN INJURY, V32, P1337, DOI 10.1080/02699052.2018.1482426; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kennard M, 2018, AUST PSYCHOL, V53, P97, DOI 10.1111/ap.12272; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; Messner M.A, 2002, TAKING FIELD WOMEN M, V4; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; National Rugby League, 2016, ANN REP 2016; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Powell JW, 1999, J ATHL TRAINING, V34, P277; Qualtrics, 2015, QUALTRICS COMPUTER S; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rugby Australia, 2015, MED SAF REC; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Sullivan SJ, 2012, PHYS THER SPORT, V13, P209, DOI 10.1016/j.ptsp.2011.10.004; Tong V., 2014, J MALTA COLL PHARM P, V20, P14	33	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		218	225		10.1097/HTR.0000000000000547			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200006	31834064	Green Published			2022-02-06	
J	Ressel, V; Berati, D; Raselli, C; Birrer, K; Kottke, R; van Hedel, HJA; Tuura, RO				Ressel, Volker; Berati, Daphne; Raselli, Carla; Birrer, Karin; Kottke, Raimund; van Hedel, Hubertus J. A.; Tuura, Ruth O'Gorman			Magnetic resonance imaging markers reflect cognitive outcome after rehabilitation in children with acquired brain injury	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Diffusion tensor maging; Paediatric; Acquired brain injury; Tractography; Biomarkers	FRACTIONAL ANISOTROPY; COMPUTED-TOMOGRAPHY; RECOVERY; STROKE; MRI; WEEFIM	Purpose: To test markers from conventional and diffusion Magnetic Resonance Imaging (MRI) as possible predictors of cognitive outcome following rehabilitation therapy in children with acquired brain injury (ABI). Methods: Twenty-one children (10 boys, mean age 11.6 years, range 7.1-19.4) with stroke or traumatic brain injury underwent MRI including Diffusion Tensor Imaging (DTI) before admission to the rehabilitation centre. The conventional images were scored according to a standardised injury scoring system, and mean Fractional Anisotropy (FA) was determined within the Corpus Callosum (CC), as this structure is hypothesised to play an important role in cognition. Both conventional MRI injury scores and mean FA of the CC and its sub-regions were compared with standard functional cognitive outcome scores. Relationships between MRI indices and cognitive outcome scores were assessed using multiple regression and receiver operating characteristic (ROC) analyses. Results: A backwards regression analysis revealed that the mean FA of the CC body and genu and the supra-tentorial injury score appear to represent the best predictors of outcome, together with the age at rehabilitation and time in rehabilitation. In the ROC analysis, the mean FA values of the CC body and genu and the infra-tentorial injury score provided the highest sensitivity, while the mean FA of the CC splenium showed the highest specificity for outcome. Conclusions: The conventional MRI injury scores and DTI metrics from the CC reflect cognitive outcomes following rehabilitation. Neuroimaging methods such as MRI with DTI may therefore provide important markers for cognitive recovery after brain injury.	[Ressel, Volker; Raselli, Carla; Birrer, Karin; van Hedel, Hubertus J. A.] Univ Childrens Hosp, Rehabil Ctr, Muhlebergstr 104, CH-8910 Affoltern Am Albis, Switzerland; [Ressel, Volker; Tuura, Ruth O'Gorman] Univ Childrens Hosp, Ctr MR Res, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Berati, Daphne] Univ Hosp Zurich, Dept Neuroradiol, Ramistr 100, CH-8091 Zurich, Switzerland; [Raselli, Carla; Birrer, Karin; van Hedel, Hubertus J. A.; Tuura, Ruth O'Gorman] Univ Childrens Hosp, Childrens Res Ctr, Steinwiesstr 75, CH-8032 Zurich, Switzerland; [Kottke, Raimund] Univ Childrens Hosp, Diagnost Imaging, Steinwiesstr 75, CH-8032 Zurich, Switzerland		Tuura, RO (corresponding author), Univ Childrens Hosp, Ctr MR Res, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	ruth.tuura@kispi.uzh.ch	Ressel, Volker/E-7657-2012; van Hedel, Hubertus/AAL-3818-2021	Kottke, Raimund/0000-0003-0166-2770; van Hedel, Hubertus/0000-0002-9577-5049	OPO Foundation, Anna Muller Grocholsky Foundation; Maxi Foundation; Clinical Research Priority Program Neurorehabilitation of the Medical Faculty of the University of Zurich	This research was supported by the OPO Foundation, Anna Muller Grocholsky Foundation, the Maxi Foundation, and the Clinical Research Priority Program Neurorehabilitation of the Medical Faculty of the University of Zurich. We are grateful to the children and their parents for providing informed consent to use their data.	Alexander LD, 2012, J STROKE CEREBROVASC, V21, P737, DOI 10.1016/j.jstrokecerebrovasdis.2011.03.010; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Boyd LA, 2017, NEUROREHAB NEURAL RE, V31, P864, DOI 10.1177/1545968317732680; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kim JH, 2019, KOREAN J ANESTHESIOL, V72, P558, DOI 10.4097/kja.19087; Kinoshita M, 2014, CLIN NEUROL NEUROSUR, V117, P45, DOI 10.1016/j.clineuro.2013.12.002; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Kusano Y, 2009, AM J NEURORADIOL, V30, P1561, DOI 10.3174/ajnr.A1639; Lockhart SN, 2014, NEUROPSYCHOL REV, V24, P271, DOI 10.1007/s11065-014-9268-3; Ma CC, 2014, J CLIN NEUROSCI, V21, P1388, DOI 10.1016/j.jocn.2013.11.032; McBride T, 2015, BRAIN INJURY, V29, P951, DOI 10.3109/02699052.2015.1022881; Moreau F, 2013, CEREBROVASC DIS EXTR, V3, P130, DOI 10.1159/000355024; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Ressel Volker, 2018, Eur Radiol Exp, V2, P33, DOI 10.1186/s41747-018-0066-1; Ressel V, 2017, BRAIN IMAGING BEHAV, V11, P1373, DOI 10.1007/s11682-016-9637-z; Shiran SI, 2014, AM J NEURORADIOL, V35, P2388, DOI 10.3174/ajnr.A3950; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Sztriha LK, 2012, STROKE, V43, P3124, DOI 10.1161/STROKEAHA.111.649244; Takeuchi N, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/128641; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	32	1	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	MAY	2020	126								108963	10.1016/j.ejrad.2020.108963			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	LC6SR	WOS:000525464400028	32208296	hybrid, Green Accepted			2022-02-06	
J	Rochefort, C; Legace, E; Boulay, C; Macartney, G; Goulet, K; Zemek, R; Sveistrup, H				Rochefort, Coralie; Legace, Elizabeth; Boulay, Chadwick; Macartney, Gail; Goulet, Kristian; Zemek, Roger; Sveistrup, Heidi			Balance Markers and Saccadic Eye-Movement Measures in Adolescents With Postconcussion Syndrome	JOURNAL OF ATHLETIC TRAINING			English	Article						center of pressure; eye tracking; dual task; Stroop Color and Word Test	TRAUMATIC BRAIN-INJURY; POSTURAL STABILITY; CONCUSSION; TRACKING; ACTIVATION; VALIDITY; CHILDREN	Context: Deficits in both balance and oculomotor function, including impairments in saccadic eye movements, are observed in approximately 30% of patients postconcussion. Whereas balance and saccadic eye movements are routinely assessed separately, growing evidence suggests that they should be assessed concurrently. Objective: To compare balance measures and saccades between adolescents 1 to 3 months postconcussion and healthy uninjured adolescents. Design: Case-control study. Setting: Concussion clinic and 2 private schools. Patients or other participants: Twenty-five adolescents (10 boys, 15 girls; median [interquartile range (IQR)] age = 14 years [11.5-16 years]) between 1 and 3 months postconcussion (median [IQR] time since injury = 39.5 days [30-56.75 days]) and 33 uninjured adolescents (18 boys, 15 girls; median [IQR] age = 13 years [11.5-14 years]). Main outcome measure(s): The center-of-pressure 95% ellipse area and medial-lateral and anterior-posterior velocity and the number of saccades in the dual-task balance conditions including a high cognitive load (cognitive condition), a low cognitive load and a gaze-shifting component (visual condition) or both a high cognitive load and a gaze-shifting component (combined condition). Results: Concussion-group participants swayed over larger center-of-pressure ellipse areas in the visual (P = .02; effect size = 0.73) and combined (P = .005; effect size = 0.86) conditions but not in the cognitive condition (P = .07; effect size = 0.50). No group differences were identified for anterior-posterior (F-1,F-56 = 2.57, P = .12) or medial-lateral (F-1,F-56 = 0.157, P = .69) velocity. Concussion-group participants also did not perform more saccades than the control-group participants (F-1,F-56 = 2.04, P = .16). Conclusions: Performing dual-task balance conditions for which the secondary task involved a gaze-shifting component or both a gaze-shifting component and a high cognitive load resulted in greater sway amplitude in adolescents with concussion. However, these larger amounts of postural sway were not associated with increased saccadic eye movements.	[Rochefort, Coralie; Legace, Elizabeth; Sveistrup, Heidi] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Boulay, Chadwick] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Macartney, Gail; Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Macartney, Gail; Goulet, Kristian] Childrens Hosp Eastern Ontario, Concuss Clin, Ottawa, ON, Canada; [Sveistrup, Heidi] Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada; [Sveistrup, Heidi] Univ Ottawa, Sch Rehabil Sci, Ottawa, ON, Canada		Sveistrup, H (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, 200 Lees Ave A-121, Ottawa, ON K1N 6N5, Canada.	HSveistrup@bruyere.org		Macartney, Gail/0000-0003-3288-4886	Ontario Graduate Scholarship awardOntario Graduate Scholarship	This research was supported by the Ontario Graduate Scholarship award (Dr Rochefort).	Ajrezo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081066; Audiffren J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081208; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Lions C, 2013, GRAEF ARCH CLIN EXP, V251, P2219, DOI 10.1007/s00417-013-2372-x; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Purves D, 2011, NEUROSCIENCE, P309; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Raynowska J, 2018, BRAIN INJURY, V32, P200, DOI 10.1080/02699052.2017.1374469; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Tse YYF, 2013, MED SCI MONITOR, V19, P175, DOI 10.12659/MSM.883824	25	1	1	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2020	55	5					475	481		10.4085/1062-6050-548-18			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4YN	WOS:000566738600005	32216658	Green Published, gold			2022-02-06	
J	Ryan, ME; Pruthi, S; Desai, NK; Falcone, RA; Glenn, OA; Joseph, MM; Maheshwari, M; Marin, JR; Mazzola, C; Milla, SS; Mirsky, DM; Myseros, JS; Niogi, SN; Partap, S; Radhakrishnan, R; Robertson, RL; Soares, BP; Udayasankar, UK; Whitehead, MT; Wright, JN; Karmazyn, B				Ryan, Maura E.; Pruthi, Sumit; Desai, Nilesh K.; Falcone, Richard A.; Glenn, Orit A.; Joseph, Madeline M.; Maheshwari, Mohit; Marin, Jennifer R.; Mazzola, Catherine; Milla, Sarah S.; Mirsky, David M.; Myseros, John S.; Niogi, Sumit N.; Partap, Sonia; Radhakrishnan, Rupa; Robertson, Richard L.; Soares, Bruno P.; Udayasankar, Unni K.; Whitehead, Matthew T.; Wright, Jason N.; Karmazyn, Boaz		Expert Panel Pediat Imaging	ACR Appropriateness Criteria (R) Head Trauma-Child	JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY			English	Article						Appropriateness Criteria; Appropriate Use Criteria; AUC; CT; Head trauma; MRI; Pediatric	BRAIN-INJURY; COMPUTED-TOMOGRAPHY; IMAGING FINDINGS; PEDIATRIC SKULL; DECISION RULE; INTRACRANIAL INJURY; PERSISTENT SYMPTOMS; UNIQUE FEATURES; PREDICTION; CONCUSSION	Head trauma is a frequent indication for cranial imaging in children. The majority of accidental pediatric head trauma is minor and sustained without intracranial injury. Well-validated pediatric-specific clinical decision guidelines should be used to identify very low-risk children who can safely forgo imaging. In those who require acute imaging, CT is considered the first-line imaging modality for suspected intracranial injury because of the short duration of the examination and its high sensitivity for acute hemorrhage. MRI can accurately detect traumatic complications, but often necessitates sedation in children, owing to the examination length and motion sensitivity, which limits rapid assessment. There is a paucity of literature regarding vascular injuries in pediatric blunt head trauma and imaging is typically guided by clinical suspicion. Advanced imaging techniques have the potential to identify changes that are not seen by standard imaging, but data are currently insufficient to support routine clinical use. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.	[Ryan, Maura E.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Pruthi, Sumit] Vanderbilt Childrens Hosp, Nashville, TN USA; [Desai, Nilesh K.] Texas Childrens Hosp, Houston, TX 77030 USA; [Falcone, Richard A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Falcone, Richard A.] Amer Pediat Surg Assoc, Oak Brook Terrace, IL USA; [Glenn, Orit A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Joseph, Madeline M.] Univ Florida, Coll Med Jacksonville, Jacksonville, FL USA; [Joseph, Madeline M.] Amer Coll Emergency Phys, Irving, TX USA; [Maheshwari, Mohit] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Marin, Jennifer R.] UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Marin, Jennifer R.] Soc Acad Emergency Med, Des Plaines, IL USA; [Mazzola, Catherine] Rutgers New Jersey Med Sch, Newark, NJ USA; [Milla, Sarah S.] Emory Univ, Atlanta, GA 30322 USA; [Milla, Sarah S.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Mirsky, David M.] Childrens Hosp Colorado, Aurora, CO USA; [Myseros, John S.; Whitehead, Matthew T.] Childrens Natl Hlth Syst, Washington, DC USA; [Niogi, Sumit N.] Weill Cornell Med, New York, NY USA; [Partap, Sonia] Stanford Univ, Stanford, CA 94305 USA; [Partap, Sonia] Amer Acad Pediat, Itasca, IL USA; [Radhakrishnan, Rupa] Indiana Univ Hlth, Indiana, PA USA; [Robertson, Richard L.] Boston Childrens Hosp, Boston, MA USA; [Soares, Bruno P.] Univ Vermont, Med Ctr, Burlington, VT USA; [Udayasankar, Unni K.] Univ Arizona, Coll Med, Tucson, AZ USA; [Wright, Jason N.] Seattle Childrens Hosp, Seattle, WA USA; [Karmazyn, Boaz] Indiana Univ, Riley Hosp Children, Indianapolis, IN 46204 USA		Ryan, ME (corresponding author), Ann & Robert H Lurie Childrens Hosp, Dept Med Imaging, 225 East Chicago Ave,Box 9, Chicago, IL 60611 USA.	mryan@luriechildrens.org		Marin, Jennifer/0000-0003-3090-664X; Radhakrishnan, Rupa/0000-0001-5224-1891			American College of Radiology, ACR APPR CRIT RAD DO; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Babl FE, 2019, EMERG MED J, V36, P4, DOI 10.1136/emermed-2017-207435; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Churchill NW, 2018, NEUROIMAGE-CLIN, V18, P518, DOI 10.1016/j.nicl.2018.02.011; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Guenette JP, 2018, NEUROIMAG CLIN N AM, V28, P43, DOI 10.1016/j.nic.2017.09.004; Halley Michelle K, 2004, Pediatr Crit Care Med, V5, P230, DOI 10.1097/01.PCC.0000123543.40224.73; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jones TS, 2012, AM J SURG, V204, P7, DOI 10.1016/j.amjsurg.2011.07.015; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Khandelwal S, 2002, INDIAN J RADIOL IMAG, V12, P485; Kopelman TR, 2011, J TRAUMA, V71, P559, DOI 10.1097/TA.0b013e318226eadd; Kpelao E, 2016, NEUROSURG REV, V39, P237, DOI 10.1007/s10143-015-0669-4; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langford S, 2015, NEURORADIOLOGY, V57, P1263, DOI 10.1007/s00234-015-1584-7; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Mortazavi MM, 2011, CHILD NERV SYST, V27, P2045, DOI 10.1007/s00381-011-1409-x; Nakahara K, 2011, J TRAUMA, V70, P180, DOI 10.1097/TA.0b013e3181d76737; Nakhjavan-Shahraki B, 2017, EUR J TRAUMA EMERG S, V43, P755, DOI 10.1007/s00068-017-0811-9; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Parri N, 2013, J EMERG MED, V44, P135, DOI 10.1016/j.jemermed.2012.02.038; Patel SK, 2018, J PEDIATR SURG, V53, P2048, DOI 10.1016/j.jpedsurg.2018.04.027; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Ryan ME, 2016, NEURORADIOLOGY, V58, P793, DOI 10.1007/s00234-016-1686-x; Sarioglu FC, 2018, EUR J TRAUMA EMERG S, V44, P351, DOI 10.1007/s00068-017-0838-y; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sepelyak K, 2010, EUR J PEDIATR, V169, P557, DOI 10.1007/s00431-009-1066-1; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Stence NV, 2011, CURR TREAT OPTION NE, V13, P636, DOI 10.1007/s11940-011-0149-2; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wootton-Gorges SL, 2017, J AM COLL RADIOL, V14, pS338, DOI 10.1016/j.jacr.2017.01.036	52	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1546-1440			J AM COLL RADIOL	J. Am. Coll. Radiol.	MAY	2020	17	5		S			S125	S137		10.1016/j.jacr.2020.01.026			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	LK5ET	WOS:000530889600011	32370957				2022-02-06	
J	Sheth, C; Prescot, AP; Legarreta, M; Renshaw, PF; McGlade, E; Yurgelun-Todd, D				Sheth, Chandni; Prescot, Andrew P.; Legarreta, Margaret; Renshaw, Perry F.; McGlade, Erin; Yurgelun-Todd, Deborah			Increased myoinositol in the anterior cingulate cortex of veterans with a history of traumatic brain injury: a proton magnetic resonance spectroscopy study	JOURNAL OF NEUROPHYSIOLOGY			English	Article						astrocytes; magnetic resonance spectroscopy; myoinositol; traumatic brain injury; veterans	NEUROCHEMICAL PROFILE; COGNITIVE SEQUELAE; METABOLIC-CHANGES; MR SPECTROSCOPY; ACID GABA; GLUTAMINE; STATE; NEUROPATHOLOGY; INDIVIDUALS; CONCUSSION	Traumatic brain injury (TBI) is one of the most prevalent forms of morbidity in veterans and service members, with mild traumatic brain injury (mTBI) being the most common. The diagnosis of mTBI in veterans is difficult because of mixed etiologies and high comorbidity with other disorders such as posttraumatic stress disorder (PTSD), depression, and substance use. Advanced neuroimaging techniques such as magnetic resonance spectroscopy (MRS) may be useful in identifying neurochemical alterations in TBI, which may aid the development of new targets for therapeutic intervention. Veterans with (n = 53) and without a history of TBI (n = 26) underwent single-voxel proton magnetic resonance spectroscopy (H-1 MRS) at 3 Tesla in the anterior cingulate cortex (ACC) using a two-dimensional J-resolved point spectroscopy sequence in addition to completing a clinical battery. TBI diagnosis was made using the research version of the Ohio State University TBI Identification Method. An increased myoinositol (mI)/H2O ratio was observed in the ACC of the TBI group compared with the non-TBI group during the chronic stage of TBI (average of 139.7 mo after injury), which may be reflective of astrogliosis. Several metabolites in the ACC demonstrated significant associations with TBI variables, including number of TBI with loss of consciousness (LOC) and time since most severe TBI, suggesting that changes in some metabolites may be potential diagnostic and prognostic indicators. NEW & NOTEWORTHY In this study of veterans, we used a state-of-the-art neuroimaging tool to probe the neurometabolic profile of the anterior cingulate cortex in veterans with traumatic brain injury (TBI). We report significantly elevated myoinositol levels in veterans with TBI compared with those without TBI.	[Sheth, Chandni; Renshaw, Perry F.; McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Prescot, Andrew P.] Univ Utah, Sch Med, Dept Radiol, Salt Lake City, UT USA; [Sheth, Chandni; Legarreta, Margaret; Renshaw, Perry F.; McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Diagnost Neuroimaging, Salt Lake City, UT USA; [Legarreta, Margaret; Renshaw, Perry F.; McGlade, Erin; Yurgelun-Todd, Deborah] George E Wahlen Dept Vet Affairs Med Ctr, Educ & Clin Ctr MIRECC, VA VISN 19 Mental Illness Res, Salt Lake City, UT USA; [Sheth, Chandni; Renshaw, Perry F.; McGlade, Erin; Yurgelun-Todd, Deborah] 383 Colorow Dr,Rm 325, Salt Lake City, UT 84108 USA		Sheth, C (corresponding author), 383 Colorow Dr,Rm 325, Salt Lake City, UT 84108 USA.	chandni.sheth@utah.edu	McGlade, Erin C/K-1157-2016	McGlade, Erin C/0000-0003-2234-1984; Sheth, Chandni/0000-0003-0876-1675	Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0178, 5I01CX000253-02]	This presentation is based on work supported with resources and the use of facilities at the VISN 19 MIRECC. This project is funded by the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award W81XWH-10-2-0178 and through Merit Review 5I01CX000253-02.	Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brennan BP, 2017, PSYCHIAT RES-NEUROIM, V269, P9, DOI 10.1016/j.pscychresns.2017.08.009; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Centers for Disease Control and Prevention, 2015, WEB BAS INJ STAT QUE; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Chen CS, 2009, PSYCHIAT RES-NEUROIM, V172, P210, DOI 10.1016/j.pscychresns.2009.01.003; Chen JM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0151-6; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Farace E, 2012, NEUROSURG FOCUS, V8, pe6; Faul M, 2010, TRAUMATIC BRAIN INJU; Filibian M, 2012, EPILEPSIA, V53, P1907, DOI 10.1111/j.1528-1167.2012.03685.x; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Giner L, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0742-x; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hadlaczky G, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00116; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harris JL, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00202, 10.3389/fnagi.2015.00202]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber RS, 2018, J AFFECT DISORDERS, V225, P71, DOI 10.1016/j.jad.2017.07.052; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Jollant F, 2017, PROG NEURO-PSYCHOPH, V73, P64, DOI 10.1016/j.pnpbp.2016.10.005; Jollant F, 2016, EUR NEUROPSYCHOPHARM, V26, P1255, DOI 10.1016/j.euroneuro.2016.06.005; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Komura A, 2019, J NEUROTRAUM, V36, P641, DOI 10.1089/neu.2018.5641; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Lim TS, 2012, DEMENT GERIATR COGN, V33, P149, DOI 10.1159/000338177; Lin AL, 2016, NEUROIMAGE-CLIN, V11, P728, DOI 10.1016/j.nicl.2016.06.001; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Mon A, 2012, DRUG ALCOHOL DEPEN, V125, P27, DOI 10.1016/j.drugalcdep.2012.03.012; Murray ME, 2014, J NEUROSCI, V34, P16247, DOI 10.1523/JNEUROSCI.2027-14.2014; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OGG RJ, 1994, J MAGN RESON SER B, V104, P1, DOI 10.1006/jmrb.1994.1048; Prescot AP, 2018, NEUROPSYCHOPHARMACOL, V43, P646, DOI 10.1038/npp.2017.156; Prescot AP, 2012, NMR BIOMED, V25, P1245, DOI 10.1002/nbm.2795; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schulte RF, 2006, NMR BIOMED, V19, P255, DOI 10.1002/nbm.1026; Sheth C, 2019, J AFFECT DISORDERS, V248, P166, DOI 10.1016/j.jad.2019.01.037; Sheth C, 2018, PSYCHIAT RES-NEUROIM, V276, P24, DOI 10.1016/j.pscychresns.2018.04.004; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stamatakis EA, 2002, J NUCL MED, V43, P476; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; Urosevich TG, 2018, MIL MED, V183, pE564, DOI 10.1093/milmed/usy102; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yasen AL, 2018, J NEUROPHYSIOL, V120, P1318, DOI 10.1152/jn.00896.2017; Zhang X, 2010, MAGN RESON MED, V46, P443; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	92	1	1	2	8	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAY	2020	123	5					1619	1629		10.1152/jn.00765.2019			11	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	LK8HW	WOS:000531101900005	32186438				2022-02-06	
J	Silva, MA; Calvo, D; Brennan, EM; Reljic, T; Drasher-Phillips, L; Schwartz, DJ; Kumar, A; Cotner, BA; Taylor, DJ; Nakase-Richardson, R				Silva, Marc A.; Calvo, Dayana; Brennan, Erin M.; Reljic, Tea; Drasher-Phillips, Leah; Schwartz, Daniel J.; Kumar, Ambuj; Cotner, Bridget A.; Taylor, Daniel J.; Nakase-Richardson, Risa			Incidence and predictors of adherence to sleep apnea treatment in rehabilitation inpatients with acquired brain injury	SLEEP MEDICINE			English	Article						Treatment adherence and compliance; Continuous positive airway pressure; Sleep apnea; Obstructive; Brain injuries; Veterans; Military personnel	POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; NEUROCOGNITIVE FUNCTION; DAYTIME SLEEPINESS; STROKE; MODERATE; THERAPY; CONSEQUENCES; DEPRIVATION	Objective: The purpose of this study was to describe incidence and assess predictors of adherence to Positive Airway Pressure (PAP) therapy for Obstructive Sleep Apnea (OSA) in persons with acquired brain injury (ABI). Methods: A 2012-2015 retrospective analysis of consecutive ABI patients admitted for neurorehabilitation, referred for polysomnography (PSG), and prescribed PAP for OSA. Univariable linear regressions were conducted to examine predictors of average hours of nightly PAP use. Univariable logistic regressions were conducted to examine predictors of PAP adherence using the conventional clinical definition of >= 4 h per night >= 70% of the time. Persons with traumatic etiology were separately analyzed. Results: ABI etiology was 51% traumatic, 36% stroke, and 13% other nontraumatic causes. Nearly two-thirds were nonadherent to PAP. For the overall sample, higher average nightly PAP usage was significantly predicted by positive hypertension diagnosis (beta = 0.271, p = 0.019). Likewise, greater adherence based on the conventional cutoff was predicted by poorer motor functioning at hospital admission (OR = 0.98, p = 0.001) and lower oxygen saturation nadir (OR = 0.99, p = 0.003). For those with traumatic injuries, greater adherence was predicted by poorer functional status at hospital admission (OR = 0.98, p = 0.010) and positive hypertension diagnosis (OR = 0.16, p = 0.023). Conclusions: In this study of hospitalized neurorehabilitation patients with ABI and comorbid OSA, predictors of adherence included lower oxygen saturation, poorer functional status and hypertension diagnosis, perhaps signifying the role of greater severity of illness on treatment adherence. High rates of refusal and nonadherence to frontline PAP therapy for sleep apnea is a concern for persons in recovery form ABI who are at a time of critical neural repair. Published by Elsevier B.V.	[Silva, Marc A.; Calvo, Dayana; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Sect MHBSS, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA; [Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, 3515 E Fletcher Ave, Tampa, FL 33613 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, 4202 East Fowler Ave,PCD4118G, Tampa, FL 33620 USA; [Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr DVBIC, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA; [Brennan, Erin M.] Univ S Florida, Dept Educ & Psychol Studies, 4202 E Fowler Ave Ste 105, Tampa, FL 33620 USA; [Brennan, Erin M.; Reljic, Tea; Drasher-Phillips, Leah; Kumar, Ambuj; Cotner, Bridget A.] James A Haley Vet Hosp, Res Serv, 13000 Bruce B Downs Blvd 151-R, Tampa, FL 33612 USA; [Reljic, Tea; Kumar, Ambuj] Univ S Florida, USF Hlth, Off Res, 12901 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Med Serv, 13000 Bruce B Downs Blvd,MDC 19, Tampa, FL 33612 USA; [Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Div Pulm Crit Care & Sleep Med, 12901 Bruce B Downs Blvd Ste MDC19, Tampa, FL 33612 USA; [Reljic, Tea; Kumar, Ambuj] Univ S Florida, Morsani Coll Med, Dept Internal Med, 12901 Bruce B Downs Blvd,MDC 27, Tampa, FL 33612 USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, 4202 E Fowler Ave,SOC107, Tampa, FL 33620 USA; [Taylor, Daniel J.] Univ Arizona, Dept Psychol, 1503 E Univ Blvd, Tucson, AZ 85721 USA		Silva, MA (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd 116-B, Tampa, FL 33612 USA.	marc.silva1@va.gov; dayana.calvo@va.gov; erin.brennan9@va.gov; treljic@usf.edu; leah.drasher-phillips@va.gov; daniel.schwartz3@va.gov; akumar6@usf.edu; bridget.cotner@va.gov; danieljtaylor@email.arizona.edu; risa.richardson@va.gov	KUMAR, ASHOK/AAF-4055-2021; Silva, Marc A./J-1874-2019	KUMAR, ASHOK/0000-0002-9244-0622; Silva, Marc A./0000-0002-3879-6054	Veterans Health Administration Central Office VA TBI Model Systems Program of Research and subcontract from General Dynamics Information Technology from the Defense and Veterans Brain Injury Center (DVBIC) [W91YTZ-13-C-0015, HT0014-19-C-0004]; United States Department of Veterans AffairsUS Department of Veterans Affairs [W81XWH-13-2-0095]; United States Department of Defense Congressionally Directed Medical Research ProgramsUnited States Department of DefenseDefense Threat Reduction Agency; Patient Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CER-1511-33005]	This work was supported by the Veterans Health Administration Central Office VA TBI Model Systems Program of Research and subcontract from General Dynamics Information Technology [W91YTZ-13-C-0015, HT0014-19-C-0004] from the Defense and Veterans Brain Injury Center (DVBIC); and from the United States Department of Veterans Affairs (grant number W81XWH-13-2-0095); and from the United States Department of Defense Congressionally Directed Medical Research Programs; and from the Patient Centered Outcomes Research Institute (PCORI) [grant number CER-1511-33005].	Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Bahammam A, 1999, SLEEP, V22, P740, DOI 10.1093/sleep/22.6.740; Bravata DM, 2017, SLEEP BREATH, V21, P713, DOI 10.1007/s11325-017-1494-5; Bucks RS, 2013, RESPIROLOGY, V18, P61, DOI 10.1111/j.1440-1843.2012.02255.x; Cai AP, 2016, HYPERTENS RES, V39, P391, DOI 10.1038/hr.2016.11; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; Chen YF, 2015, KAOHSIUNG J MED SCI, V31, P83, DOI 10.1016/j.kjms.2014.11.004; Colelli DR, 2020, SLEEP MED, V66, P243, DOI 10.1016/j.sleep.2018.10.009; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Galetke W, 2011, RESPIRATION, V82, P155, DOI 10.1159/000322838; Good DC, 1996, STROKE, V27, P252, DOI 10.1161/01.STR.27.2.252; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hsu CY, 2006, J NEUROL NEUROSUR PS, V77, P1143, DOI 10.1136/jnnp.2005.086686; JENNETT B, 1977, LANCET, V1, P878; Jing JY, 2008, LUNG, V186, P131, DOI 10.1007/s00408-008-9079-5; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kendzerska T, 2019, SLEEP BREATH, V23, P1233, DOI 10.1007/s11325-019-01811-9; Kohler M, 2010, THORAX, V65, P829, DOI 10.1136/thx.2010.135848; Kotzian ST, 2019, SLEEP MED, V64, P48, DOI 10.1016/j.sleep.2019.06.004; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Macey PM, 2012, SLEEP, V35, P9, DOI 10.5665/sleep.1572; Marshall NS, 2006, THORAX, V61, P430, DOI 10.1136/thx.2005.050583; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Mehrtash M, 2019, LUNG, V197, P115, DOI 10.1007/s00408-018-00193-1; Mysliwiec V, 2015, MIL MED, V180, P475, DOI 10.7205/MILMED-D-14-00197; Owen JE, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy199; Pan YY, 2015, CHINESE MED J-PEKING, V128, P2365, DOI 10.4103/0366-6999.163385; Park JG, 2011, MAYO CLIN PROC, V86, P549, DOI 10.4065/mcp.2010.0810; Patil SP, 2019, J CLIN SLEEP MED, V15, P335, DOI 10.5664/jcsm.7640; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Ryan CM, 2011, STROKE, V42, P1062, DOI 10.1161/STROKEAHA.110.597468; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Schoch OD, 2014, RESPIRATION, V87, P121, DOI 10.1159/000354186; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Silva MA, 2019, INT J REHABIL RES, V42, P285, DOI 10.1097/MRR.0000000000000364; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tregear S, 2010, SLEEP, V33, P1373, DOI 10.1093/sleep/33.10.1373; Vaughn BV, 2015, AASM MANUAL SCORING; Weaver TE, 2010, INDIAN J MED RES, V131, P245; Wessendorf TE, 2001, EUR RESPIR J, V18, P623, DOI 10.1183/09031936.01.00057201; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Zhang Y, 2017, SLEEP MED, V33, P183, DOI 10.1016/j.sleep.2016.11.028; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	57	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2020	69						159	167		10.1016/j.sleep.2020.01.016			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LN1QH	WOS:000532719600024	32088352				2022-02-06	
J	Soltani, N; Soltani, Z; Khaksari, M; Ebrahimi, G; Hajmohammmadi, M; Iranpour, M				Soltani, Nasrin; Soltani, Zahra; Khaksari, Mohammad; Ebrahimi, Ghasem; Hajmohammmadi, Mojdeh; Iranpour, Maryam			The Changes of Brain Edema and Neurological Outcome, and the Probable Mechanisms in Diffuse Traumatic Brain Injury Induced in Rats with the History of Exercise	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Brain injury; Malondialdehyde; Interleukin-1 beta; Apoptosis; Protein carbonyl; Oxidative stress; Inflammation	NEURON-SPECIFIC ENOLASE; OXIDATIVE STRESS; PHYSICAL-EXERCISE; AEROBIC EXERCISE; MOUSE MODEL; DYSFUNCTION; PROTECTS; IRISIN; NEUROPROTECTION; PROGESTERONE	Since no definitive treatment has been suggested for diffuse traumatic brain injury (TBI), and also as the effect of exercise has been proven to be beneficial in neurodegenerative diseases, the effect of endurance exercise on the complications of TBI along with its possible neuroprotective mechanism was investigated in this study. Our objective was to find out whether previous endurance exercise influences brain edema and neurological outcome in TBI. We also assessed the probable mechanism of endurance exercise effect in TBI. Rats were randomly assigned into four groups of sham, TBI, exercise + sham and exercise + TBI. Endurance exercise was carried out before TBI. Brain edema was assessed by calculating the percentage of brain water content 24 h after the surgery. Neurological outcome was evaluated by obtaining veterinary coma scale (VCS) at - 1, 1, 4 and 24 h after the surgery. Interleukin-1 beta (IL-1 beta), total antioxidant capacity (TAC), malondialdehyde (MDA), protein carbonyl and histopathological changes were evaluated 24 h after the surgery. Previous exercise prevented the increase in brain water content, MDA level, histopathological edema and apoptosis following TBI. The reduction in VCS in exercise + TBI group was lower than that of TBI group. In addition, a decrease in the level of serum IL-1 beta and the content of brain protein carbonyl was reported in exercise + TBI group in comparison with the TBI group. We suggest that the previous endurance exercise prevents brain edema and improves neurological outcome following diffuse TBI, probably by reducing apoptosis, inflammation and oxidative stress.	[Soltani, Nasrin; Hajmohammmadi, Mojdeh] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Soltani, Zahra] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Afzalipour Sch Med, Inst Basic & Clin Physiol Sci,Dept Physiol, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Ebrahimi, Ghasem] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Biochem, Kerman, Iran; [Iranpour, Maryam] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Pathol, Kerman, Iran		Soltani, Z (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Afzalipour Sch Med, Inst Basic & Clin Physiol Sci,Dept Physiol, Kerman, Iran.	Soltaniy@yahoo.com	IRANPOUR, MARYAM/AAH-7467-2019; Haddad, Mohammad Khaksari/AAB-9025-2019	IRANPOUR, MARYAM/0000-0001-8749-8080; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Soltani, Zahra/0000-0002-8423-6189			Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arrick DM, 2014, MICROCIRCULATION, V21, P516, DOI 10.1111/micc.12127; Battey TWK, 2014, STROKE, V45, P3643, DOI 10.1161/STROKEAHA.114.006884; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Bouzid MA, 2014, J AGING PHYS ACTIV, V22, P536, DOI [10.1123/japa.2013-0037, 10.1123/JAPA.2013-0037]; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Castro M. R. T., 2017, J PHYSL, V595, P6023, DOI [10.1113/JP273933, DOI 10.1113/JP273933]; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Ding YH, 2006, ACTA NEUROPATHOL, V112, P74, DOI 10.1007/s00401-006-0076-6; Dong N, 2017, EXP THER MED, V13, P3183, DOI 10.3892/etm.2017.4411; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Farshbaf MJ, 2016, NEUROMOL MED, V18, P1, DOI 10.1007/s12017-015-8370-x; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; He ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084602; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; Hindin SB, 2012, J AM GERIATR SOC, V60, P136, DOI 10.1111/j.1532-5415.2011.03761.x; Hoene M, 2010, EXERC IMMUNOL REV, V16, P163; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Jia LL, 2017, BRAIN RES, V1657, P202, DOI 10.1016/j.brainres.2016.12.015; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Khaksari M, 2018, IRAN J BASIC MED SCI, V21, P615, DOI 10.22038/IJBMS.2018.26586.6512; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kuloglu T, 2014, PEPTIDES, V55, P85, DOI 10.1016/j.peptides.2014.02.008; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Lima FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055668; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Nishioka R, 2016, EXP NEUROL, V277, P150, DOI 10.1016/j.expneurol.2015.12.016; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Packer L, 2008, FREE RADICAL BIO MED, V44, P123, DOI 10.1016/j.freeradbiomed.2007.05.031; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Shi Minyi, 2007, Environmental Health and Preventive Medicine, V12, P202, DOI 10.1265/ehpm.12.202; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Soltani Z., 2009, Iranian Journal of Endocrinology and Metabolism, V10, P629; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; STUMMER W, 1994, STROKE, V25, P1862, DOI 10.1161/01.STR.25.9.1862; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Taylor JM, 2015, BRAIN RES, V1622, P414, DOI 10.1016/j.brainres.2015.07.009; de Castro MRT, 2017, J PHYSIOL-LONDON, V595, P6023, DOI 10.1113/JP273933; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhang PY, 2013, INT J MOL SCI, V14, P6074, DOI 10.3390/ijms14036074; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	79	1	1	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2020	40	4					555	567		10.1007/s10571-019-00753-w			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	KY6DI	WOS:000522662300007	31836968				2022-02-06	
J	Venkatasubramanian, PN; Keni, P; Gastfield, R; Li, L; Aksenov, D; Sherman, SA; Bailes, J; Sindelar, B; Finan, JD; Lee, J; Bailes, JE; Wyrwicz, AM				Venkatasubramanian, Palamadai N.; Keni, Prachi; Gastfield, Roland; Li, Limin; Aksenov, Daniil; Sherman, Sydney A.; Bailes, Julian, III; Sindelar, Brian; Finan, John D.; Lee, John; Bailes, Julian E.; Wyrwicz, Alice M.			Diffusion Tensor Imaging Detects Acute and Subacute Changes in Corpus Callosum in Blast-Induced Traumatic Brain Injury	ASN NEURO			English	Article						blast injury; rat model; diffusion imaging; white matter; axonal injury; ultrastructure	WHITE-MATTER; MOUSE MODEL; UNMYELINATED AXONS; MILD; ANISOTROPY; PATHOLOGY	There is a critical need for understanding the progression of neuropathology in blast-induced traumatic brain injury using valid animal models to develop diagnostic approaches. In the present study, we used diffusion imaging and magnetic resonance (MR) morphometry to characterize axonal injury in white matter structures of the rat brain following a blast applied via blast tube to one side of the brain. Diffusion tensor imaging was performed on acute and subacute phases of pathology from which fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity were calculated for corpus callosum (CC), cingulum bundle, and fimbria. Ventricular volume and CC thickness were measured. Blast-injured rats showed temporally varying bilateral changes in diffusion metrics indicating persistent axonal pathology. Diffusion changes in the CC suggested vasogenic edema secondary to axonal injury in the acute phase. Axonal pathology persisted in the subacute phase marked by cytotoxic edema and demyelination which was confirmed by ultrastructural analysis. The evolution of pathology followed a different pattern in the cingulum bundle: axonal injury and demyelination in the acute phase followed by cytotoxic edema in the subacute phase. Spatially, structures close to midline were most affected. Changes in the genu were greater than in the body and splenium; the caudal cingulum bundle was more affected than the rostral cingulum. Thinning of CC and ventriculomegaly were greater only in the acute phase. Our results reveal the persistent nature of blast-induced axonal pathology and suggest that diffusion imaging may have potential for detecting the temporal evolution of blast injury.	[Venkatasubramanian, Palamadai N.; Gastfield, Roland; Li, Limin; Aksenov, Daniil; Wyrwicz, Alice M.] NorthShore Univ HealthSyst, Ctr Basic MR Res, Dept Radiol, Evanston, IL 60201 USA; [Keni, Prachi; Sherman, Sydney A.; Bailes, Julian, III; Sindelar, Brian; Finan, John D.; Bailes, Julian E.] NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA; [Lee, John] NorthShore Univ HealthSyst, Dept Pathol, Evanston, IL 60201 USA		Venkatasubramanian, PN (corresponding author), NorthShore Univ HealthSyst, Ctr Basic MR Res, 1033 Univ Pl,Suite 100, Evanston, IL 60201 USA.	pvenkat@northshore.org		Aksenov, Daniil/0000-0003-4599-0290; Finan, John/0000-0003-4626-9702	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098129]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work is supported in part by a grant from National Institute of Neurological Disorders and Stroke under R21NS098129 (J. D. F.).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Al Qattan D, 2019, ANAT HISTOL EMBRYOL, V48, P437, DOI 10.1111/ahe.12464; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Berman S, 2018, NEUROIMAGE, V182, P304, DOI 10.1016/j.neuroimage.2017.06.076; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kim Ho Soo, 2015, Korean J Neurotrauma, V11, P58, DOI 10.13004/kjnt.2015.11.2.58; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi E., 2012, FRONT NEUROL, V3, P1; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Lin M, 2016, MAGN RESON MED, V76, P290, DOI 10.1002/mrm.25816; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miyasaka N, 2006, J MAGN RESON IMAGING, V24, P908, DOI 10.1002/jmri.20709; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Van Ombergen A, 2019, P NATL ACAD SCI USA, V116, P10531, DOI 10.1073/pnas.1820354116; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Williams MR, 2019, EUR ARCH PSY CLIN N, V269, P387, DOI 10.1007/s00406-018-0904-4; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Xiong GX, 2014, J NEUROTRAUM, V31, P1396, DOI 10.1089/neu.2013.3110; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569	53	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	MAY	2020	12								1759091420922929	10.1177/1759091420922929			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LR9PL	WOS:000536027000001	32403948	gold, Green Published			2022-02-06	
J	Williams, K; Christenbury, J; Niemeier, JP; Newman, M; Pinto, S				Williams, Kathryn; Christenbury, Jennifer; Niemeier, Janet P.; Newman, Mark; Pinto, Shanti			Is Robotic Gait Training Feasible in Adults With Disorders of Consciousness?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disorders of consciousness; robotic-assisted gait training; traumatic brain injury	STATE PATIENTS; BRAIN-INJURY; SPINAL-CORD; STROKE	Objective: To investigate the feasibility and safety of robotic-assisted gait training (RAGT) in adults with disorders of consciousness (DoC). Setting: Inpatient rehabilitation hospital. Participants: Four adult male patients with traumatic brain injury and DoC. Design: Subjects participated in RAGT with body weight support for 5 to 20 minutes, over 1- to 2-week periods. Main Measures: Primary measures included vital signs, walking parameters, pain, arousal, and Agitation Behavior Scale scores. Additional data included Modified Ashworth Scale, Coma Recovery Scale-Revised, and Rancho Los Amigos Scale scores. Results: All participants safely completed at least one session of RAGT with body weight support with safe vital signs and low agitation levels. Two adverse events occurred (increased somnolence and pain due to harness placement), which were not considered severe. All subjects emerged out of DoC at which point research protocol was stopped. Conclusions: Findings suggest inpatient-based RAGT may be safe and feasible to consider when developing a therapy plan of care in adults with DoC.	[Williams, Kathryn; Christenbury, Jennifer; Newman, Mark; Pinto, Shanti] Atrium Hlth, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA; [Niemeier, Janet P.] Univ Alabama Birmingham, Birmingham, AL USA		Williams, K (corresponding author), Atrium Hlth, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	kathryn.williams@atriumhealth.org			Carolinas Healthcare Foundation; Carolinas Healthcare/Atrium Health administration	Funding was provided to cover the cost of 2017-2018 IRB renewal from the Carolinas Healthcare Foundation.; The authors would like to gratefully acknowledge Marybeth Whitney, Mark Hirsch, VuNguyen, Elizabeth Hartzog, Calvin Hung, Carolinas Healthcare/Atrium Health administration, and the Carolinas Healthcare Foundation for supporting this research.	Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Brannon FJ, 1998, CARDIOPULMONARY REHA, P254; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Frazzitta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158030; Freivogel S, 2008, BRAIN INJURY, V22, P625, DOI 10.1080/02699050801941771; Giacino JT, 2018, ARCH PHYS MED REHAB, V99, P1699, DOI 10.1016/j.apmr.2018.07.001; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hidler J, 2004, P ANN INT IEEE EMBS, V26, P4829; Hocoma, PRACT REC LOK THER W; Lapitskaya N, 2011, BRAIN INJURY, V25, P1070, DOI 10.3109/02699052.2011.607782; Latchem J, 2016, DISABIL REHABIL, V38, P22, DOI 10.3109/09638288.2015.1005759; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Suraseranivongse Suwannee, 2015, Journal of the Medical Association of Thailand, V98, P684; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004	15	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2020	35	3			SI		E266	E270		10.1097/HTR.0000000000000523			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LP4ZM	WOS:000534327200009	31479078				2022-02-06	
J	Yannetsos, C; Pacheco, MC; Thomas, DG				Yannetsos, Christina; Pacheco, Mario C.; Thomas, Danny G.			Perspective of United States Judo Coaches on Concussion: A National Survey	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						evaluation; martial arts; traumatic brain injury	HIGH-SCHOOL; INJURIES; HEAD; SPORTS; SYMPTOMS; PLAYERS	Concussions among athletes in contact sports are a prevalent health concern in the United States. There are few studies that have assessed concussion from the perspective of judo coaches. This is a descriptive study of a survey sent to 1,056 United States judo coaches assessing their attitudes, knowledge, and practices toward concussion. The survey had a response rate of 21%, with 215 total responses. Though most coaches could accurately identify common symptoms of concussion from a case presentation, many also misidentified nonconcussion and red flags (e.g., facial droop) as symptoms of concussion. A minority of coaches reported any formal training in concussion management. USA Judo coaches are receptive to and would benefit from a sport-specific standardized concussion training program.	[Yannetsos, Christina] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Pacheco, Mario C.; Thomas, Danny G.] Med Coll Wisconsin, Milwaukee, WI 53226 USA		Pacheco, MC (corresponding author), Med Coll Wisconsin, Sect Emergency Med, Pediat, Milwaukee, WI 53226 USA.	mpacheco@mcw.edu					Adler RH, 2011, PHYS MED REH CLIN N, V22, P721, DOI 10.1016/j.pmr.2011.08.010; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Heath CJ, 2013, RES SPORTS MED, V21, P195, DOI 10.1080/15438627.2013.792082; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Koshida S, 2017, EUR J SPORT SCI, V17, P417, DOI 10.1080/17461391.2016.1268652; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mizobuchi Yoshifumi, 2016, Korean J Neurotrauma, V12, P1, DOI 10.13004/kjnt.2016.12.1.1; Murayama H, 2014, NEUROL MED-CHIR, V54, P374, DOI 10.2176/nmc.oa.2013-0227; Murayama H, 2013, NEUROL MED-CHIR, V53, P580; Nagahiro S, 2014, NEUROL MED-CHIR, V54, P878, DOI 10.2176/nmc.ra.2014-0224; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Stephenson C, 2018, J PRIM PREV, V39, P421, DOI 10.1007/s10935-018-0518-7; United States Centers for Disease Control and Prevention, 2007, HEADS BRAIN INJ YOUR; Yard EE, 2007, J SCI MED SPORT, V10, P219, DOI 10.1016/j.jsams.2006.06.016	22	1	1	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	MAY	2020	25	3					148	151		10.1123/ijatt.2019-0026			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	LY1HR	WOS:000540273600009					2022-02-06	
J	Zurcher, S; Jackowski, C; Schon, CA				Zurcher, Severin; Jackowski, Christian; Schon, Corinna A.			Circumstances and causes of death of hikers at different altitudes: A retrospective analysis of hiking fatalities from 2003-2018	FORENSIC SCIENCE INTERNATIONAL			English	Article						Mountains; Hiking; Wilderness medicine; Fall from height; Accident; Cause of death	SUDDEN CARDIAC DEATH; CARDIOVASCULAR EVENTS; ADVENTURE SPORTS; MUSCLE DAMAGE; RISK; EXERCISE; HEIGHT; FALLS; INJURY; YOUNG	Introduction: The number of hikers and the popularity of hiking in the Alpine region is great. Inevitably linked to this, natural deaths as well as fatal and non-fatal accidents occur. Nevertheless, there is little data available on hiking accidents in particular. This study examines the circumstances of accidents and the causes of death of hikers who have suffered fatal accidents. Methods: Retrospectively, the police files and forensic medical reports of hiking fatalities in the Canton of Berne (Switzerland) from 2003 to 2018 were analyzed. In this process 25 predefined parameters were collected (e.g. manner of death, causes of death, height of fall). Subsequently, all fatal hiking accidents were evaluated and compared by altitude (<1800 m vs. >1800 m). Results: 77 fatal hiking accidents were recorded in the given period, all of which were caused by a fall. Over 1800 m significantly more traumatic brain injuries occurred than under 1800 m (85 vs. 62.2 %, p = 0.022). Besides, significantly more accidents occurred during descent in the group above 1800 m than below 1800 m (60.9 vs. 84.8 %, p = 0.041). A large share of accidents occurred off official hiking trails (45.9 vs. 32.5 %). Significantly more equipment shortages were found in the group below 1800 m (32.4 vs. 12. 5 %, p = 0.035). The accident victims with equipment shortages were on average 10.35 years younger. Conclusion: Causes and circumstances of death of hikers differ in some points significantly at different altitudes. Prevention in the form of education about the dangers of hiking off the official hiking trails and equipment shortages could prevent deaths in the future. The education should primarily be aimed at foreign, young and inexperienced hikers. (C) 2020 Elsevier B.V. All rights reserved.	[Zurcher, Severin; Jackowski, Christian; Schon, Corinna A.] Univ Bern, Inst Forens Med, Buehlstr 20, CH-3012 Bern, Switzerland		Zurcher, S (corresponding author), Univ Bern, Inst Forens Med, Buehlstr 20, CH-3012 Bern, Switzerland.	severin.zuercher@students.unibe.ch					Ansari M, 2017, CURR SPORT MED REP, V16, P404, DOI 10.1249/JSR.0000000000000429; Atanasijevic TC, 2005, J FORENSIC SCI, V50, P608; Baumbach SF, 2018, J SPORT MED PHYS FIT, V58, P1482, DOI 10.23736/S0022-4707.17.07152-3; Bentley TA, 2007, APPL ERGON, V38, P791, DOI 10.1016/j.apergo.2006.10.007; BURTSCHER M, 1993, NEW ENGL J MED, V329, P1738, DOI 10.1056/NEJM199312023292315; Burtscher M., 2009, SCI SKIING, P183; Burtscher M, 2007, ADV EXP MED BIOL, V618, P1; Burtscher M, 2010, PROG CARDIOVASC DIS, V52, P507, DOI 10.1016/j.pcad.2010.02.008; BUSKIRK ER, 1967, J APPL PHYSIOL, V23, P259, DOI 10.1152/jappl.1967.23.2.259; Byrne C, 2004, SPORTS MED, V34, P49, DOI 10.2165/00007256-200434010-00005; Chappex N, 2015, J FORENSIC LEG MED, V35, P62, DOI 10.1016/j.jflm.2015.07.004; Demirhan G, 2005, PERCEPT MOTOR SKILL, V100, P1155, DOI 10.2466/PMS.100.4.1155-1160; Dickson T. J., 2008, Journal of Sport Tourism, V13, P273, DOI 10.1080/14775080802577201; Faulhaber M., 2017, BMJ OPEN SPORT EXERC, V3, P1; Ferguson C, 2018, AM J FOREN MED PATH, V39, P192, DOI 10.1097/PAF.0000000000000386; Gatterer H, 2013, J STRENGTH COND RES, V27, P2149, DOI 10.1519/JSC.0b013e318279f817; Heijnen MJH, 2016, HUM MOVEMENT SCI, V46, P86, DOI 10.1016/j.humov.2015.12.007; Koene RJ, 2017, J ARRYTHM, V33, P533, DOI 10.1016/j.joa.2017.07.005; Kool B, 2012, INJURY PREV, V18, P200, DOI 10.1136/injuryprev-2011-040202; Mason RC, 2013, WILD ENVIRON MED, V24, P221, DOI 10.1016/j.wem.2013.02.002; Mosimann U., 2018, BERGUNDSTEIGEN, V103, P88; NEWHAM DJ, 1983, J NEUROL SCI, V61, P109, DOI 10.1016/0022-510X(83)90058-8; Perret G, 2003, J FORENSIC SCI, V48, P821; Ponchia A, 2006, J CARDIOVASC MED, V7, P129, DOI 10.2459/01.JCM.0000203853.20762.bb; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; SCALEA T, 1986, J TRAUMA, V26, P706, DOI 10.1097/00005373-198608000-00005; Semmler JG, 2014, ACTA PHYSIOL, V210, P754, DOI 10.1111/apha.12232; Senthilkumaran P, 2017, DISASTER ADV, V10, P21; SHLIM DR, 1989, JAMA-J AM MED ASSOC, V261, P1017, DOI 10.1001/jama.261.7.1017; Soule B, 2017, EUR J SPORT SCI, V17, P931, DOI 10.1080/17461391.2017.1324525; Stemberga V, 2013, SPORTS MED, V43, P1201, DOI 10.1007/s40279-013-0109-y; Swiss Federal Office for the Environment (Bundesamt fur Umwelt), 2000, STAT FAT SPORTS ACC; Turk EE, 2004, AM J FOREN MED PATH, V25, P194, DOI 10.1097/01.paf.0000136441.53868.a4; Windsor JS, 2009, POSTGRAD MED J, V85, P316, DOI 10.1136/pgmj.2009.078824	34	1	1	3	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	MAY	2020	310								110252	10.1016/j.forsciint.2020.110252			6	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	LL5CC	WOS:000531573800020	32203854	hybrid			2022-02-06	
J	Gardner, AK; Santschi, EM; Mudge, MC; Belknap, JK; Metzler, AG				Gardner, Alison K.; Santschi, Elizabeth M.; Mudge, Margaret C.; Belknap, James K.; Metzler, Anne G.			Intrasinus bolstering of traumatic maxillary sinus fractures by using Foley catheter balloons in two foals	VETERINARY SURGERY			English	Article							SKULL FRACTURES; COMPUTED-TOMOGRAPHY; LONG-TERM; HORSES; HEAD; CANALICULOSINOSTOMY; RECONSTRUCTION; FIXATION	Objective To describe the repair of unstable facial fractures by using Foley catheter balloons as intrasinus bolsters. Study design Case report Animals Two weanling foals with unilateral fractures of the sinus and orbit secondary to kick injuries. Preoperative imaging that included positive contrast dacrocystorhinography and computed tomography confirmed severe comminution of facial fractures and nasolacrimal duct disruption in both foals. Methods Small bone fragments were surgically removed, and large fragments were retained even when denuded of periosteum. Repair procedures included nasolacrimal canaliculosinusotomy and suturing fracture fragments together with polydioxanone sutures. After fixation, the fracture fragments could be depressed into the sinus with manual pressure, so two intrasinus Foley catheters were placed to bolster the sinus wall, with the tubing exiting through a frontal sinus trephine. The skin was completely closed over the fractures. Catheters and nasolacrimal stenting were maintained in place during fracture healing. Results One foal prematurely dislodged catheters and nasolacrimal stent 11 days after fixation. The catheters and stenting were removed as planned 4 weeks after surgery in the second foal. Wound, fracture healing, and overall cosmesis was good in both foals, and epiphora resolved. Surgical site infection, sinusitis, and sequestration did not occur. Both foals became high-level performance horses with acceptable cosmetic outcome and good bilateral nasal airflow. Conclusion Foley catheter balloons supported sinus fracture repair and maintained stability of the surgical reconstruction during convalescence. Clinical significance Suture repair of comminuted sinus fractures can be supported by using Foley catheters, which are readily available.	[Gardner, Alison K.; Mudge, Margaret C.; Belknap, James K.; Metzler, Anne G.] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Santschi, Elizabeth M.] Kansas State Univ, Dept Clin Sci, Manhattan, KS 66506 USA		Gardner, AK (corresponding author), 601 Vernon L Tharp Rd, Columbus, OH 43201 USA.	gardner.300@osu.edu					Auer JA, 2000, AO PRINCIPLES EQUINE, P35; Brink P, 2016, VET SURG, V45, P110, DOI 10.1111/vsu.12421; CARON JP, 1986, J AM VET MED ASSOC, V188, P280; Crijns CP, 2019, EQUINE VET EDUC, V31, P543, DOI 10.1111/eve.12863; Dowling BA, 2001, AUST VET J, V79, P324, DOI 10.1111/j.1751-0813.2001.tb12004.x; Gerding JC, 2014, VET OPHTHALMOL, V17, P97, DOI 10.1111/vop.12162; Kashimura T, 2017, J CRANIOFAC SURG, V28, pE669, DOI 10.1097/SCS.0000000000003826; LITTLE CB, 1985, AUST VET J, V62, P89, DOI 10.1111/j.1751-0813.1985.tb14146.x; McMaster M, 2016, VET SURG, V45, P529, DOI 10.1111/vsu.12477; Nykamp SG, 2004, VET RADIOL ULTRASOUN, V45, P23, DOI 10.1111/j.1740-8261.2004.04004.x; Robinson CS, 2016, VET SURG, V45, P115, DOI 10.1111/vsu.12424; Schaaf KL, 2008, AUST VET J, V86, P481, DOI 10.1111/j.1751-0813.2008.00369.x; Schumacher J, 2011, EQUINE VET EDUC, V23, P242, DOI 10.1111/j.2042-3292.2010.00183.x; Smallwood JE, 2002, VET RADIOL ULTRASOUN, V43, P99, DOI 10.1111/j.1740-8261.2002.tb01657.x; Solano M., 2004, Clinical Techniques in Equine Practice, V3, P374, DOI 10.1053/j.ctep.2005.02.016; Tietje S, 1996, EQUINE VET J, V28, P98, DOI 10.1111/j.2042-3306.1996.tb01599.x; Tremaine WH, 2001, EQUINE VET J, V33, P283, DOI 10.2746/042516401776249787; Turner AS, 1979, VET SURG, V8, P29; WILKIE DA, 1991, VET CLIN N AM-EQUINE, V7, P535, DOI 10.1016/S0749-0739(17)30485-6; WILSON DG, 1991, J EQUINE VET SCI, V11, P232, DOI 10.1016/S0737-0806(06)80985-8	20	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0161-3499	1532-950X		VET SURG	Vet. Surg.	AUG	2020	49	6					1255	1261		10.1111/vsu.13433		APR 2020	7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	MS1AW	WOS:000529271000001	32347989				2022-02-06	
J	Zheng, B; Fan, JZ; He, RH; Yin, RX; Wang, JW; Zhong, YH				Zheng, Bie; Fan, Jianzhong; He, Renhong; Yin, Ruixue; Wang, Jinwei; Zhong, Yuhua			Antioxidant status of uric acid, bilirubin, albumin and creatinine during the acute phase after traumatic brain injury: sex-specific features	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Traumatic brain injury; antioxidants; sex-specific; prognosis	OXIDATIVE STRESS; GENDER-DIFFERENCES; SERUM BILIRUBIN; NEUROPROTECTION; PEROXYNITRITE; INFLAMMATION; THERAPIES; CANCER	Background: It is known that the alteration of antioxidants can been seen in early phase after traumatic brain injury (TBI) in order to block oxidative damage, but little is known about the influence of sex on antioxidant system in patients with TBI. This study investigates whether there are sex differences in these endogenous antioxidant agents during the acute phase after TBI and their association with the disease. Methods: Serum levels of uric acid (UA), bilirubin, albumin and creatinine were measured in 421 individuals included 157 female TBI patients, 156 male TBI patients and 108 age- and sex-matched controls. Results: The statistically significant changes were found in UA, bilirubin, albumin and creatinine for both sexes with TBI, but the trend of changes in bilirubin and creatinine was opposite for gender groups. Serum levels of UA, bilirubin, albumin and creatinine were associated with the severity of TBI patients for both sexes. Male patient subgroups with elevated UA, albumin and creatinine had higher frequency of regaining consciousness in a month. Moreover, addition of UA and creatinine to the established clinical model had significantly improved the predictive performance over using clinical model alone in male patients with TBI. However, no similar findings were observed on female TBI patients. Conclusion: Our results suggest sex-based differences in the serum endogenous antioxidant response to TBI. Use of serum UA and creatinine could help in the outcome prediction of male patients with TBI in combination with other prognostic factors.	[Zheng, Bie; Fan, Jianzhong; He, Renhong; Yin, Ruixue; Zhong, Yuhua] Southern Med Univ, Nanfang Hosp, Dept Rehabil Med, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China; [Wang, Jinwei] Guangzhou Med Univ, Affiliated Brain Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China		Zhong, YH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Rehabil Med, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China.	zhongbinyue@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802250]; Presidential Foundation of Nanfang Hospital [2017C031]	This study was supported by the National Natural Science Foundation of China (Grant Nos. 81802250) and the Presidential Foundation of Nanfang Hospital (Grant No. 2017C031).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Giordano G, 2013, FREE RADICAL BIO MED, V58, P98, DOI 10.1016/j.freeradbiomed.2013.01.019; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Ihara H., 2000, J ANAL BIOSCI, V23, P425; Jansen EHJM, 2013, FREE RADICAL RES, V47, P535, DOI 10.3109/10715762.2013.797969; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0378-1; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Nyasavajjala SM, 2015, J CACHEXIA SARCOPENI, V6, P125, DOI 10.1002/jcsm.12020; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Peng FH, 2011, J CLIN NEUROSCI, V18, P1355, DOI 10.1016/j.jocn.2011.02.023; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Riphagen IJ, 2014, DIABETES, V63, P2845, DOI 10.2337/db13-1652; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Sedlak TW, 2009, P NATL ACAD SCI USA, V106, P5171, DOI 10.1073/pnas.0813132106; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Stepien KM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070071; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tan BL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01162; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wang L., 2017, BIOSCIENCE REP, V6, P37; Yang DH, 2016, INT J NEUROSCI, V126, P1120, DOI 10.3109/00207454.2015.1134526; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Ziberna L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29240	38	1	2	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	SEP 2	2021	131	9					833	842		10.1080/00207454.2020.1758697		APR 2020	10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC8OW	WOS:000532559800001	32306800				2022-02-06	
J	Wei, CZ; Luo, Y; Peng, LL; Huang, ZX; Pan, YZ				Wei, Chunzhu; Luo, Yan; Peng, Lingling; Huang, Zongxuan; Pan, Yuzheng			Expression of Notch and Wnt/beta-catenin signaling pathway in acute phase severe brain injury rats and the effect of exogenous thyroxine on those pathways	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Thyroxine; Severe traumatic brain injury; Notch and Wnt; beta-catenin signaling pathway; Neuroprotective effect	PROTEIN	Background With the rapid development of economy, transportation and industry, the incidence of severe traumatic brain injury (sTBI) is rising rapidly, which is one of the main traumatic diseases threatening human life. It is very difficult for sTBI patients to regenerate and repair the central nervous and recover the brain function. Moreover, no effective neuroprotective drug has been found in the treatment of sTBI patients. Seeking drugs to promote nerve repair has become a hot and difficult problem. It is widely accepted that thyroxine is one of the essential hormones in the human body, which not only promotes the growth and development of the nervous system, but also plays an important role in maintaining adult brain function. There are many reports of modern research on thyroxine, mainly focusing on the changes of thyroid hormone levels and their effects on the prognosis after injury. Besides, most of them are observed in clinical cases. Currently, there are few dynamic experimental studies about observing whether thyroxine can promote the repair of central nervous system at different stages after sTBI. In our previous experiment, we found that Wnt/beta-catenin signaling pathway, whose functions are opposite to Notch signaling pathway, can be further activated by exogenous thyroxine in rats with sTBI. As a result, we are interested in the expression of Notch and Wnt/beta-catenin signaling pathway in acute phase sTBI rats and the effect of thyroxine on those pathways. Objective To investigate expression of Notch and Wnt/beta-catenin signaling pathway in acute phase severe brain injury rats and the effect of thyroxine on those pathways by observing dynamically Notch and Wnt/beta-catenin signaling pathway, NSS, GFAP, S100B, Bcl-2, Bax, etc. Methods 108 rats were randomly divided into Group A (normal control group), Group B (normal-thyroxine group), Group C (TBI group), Group D (TBI+ low-dose thyroxine group), Group E (TBI + moderate-dose thyroxine) and Group F (TBI + high-dose thyroxine) with 18 rats in each group. The animal model was established according to Feeney's free-fall method, and administered with thyroxine or physiological saline at 6 h after sTBI. Six rats in each group were randomly killed on the 1st, 3rd and 7th days after intragastric administration. The changes of brain pathology and NSS were observed. The level of Wnt3a, beta-catenin, Notch1 and Hes1 mRNA was detected by RT-PCR method, and the level of GFAP and S100B protein in serum was detected by ELISA. The expression of Bcl-2 and Bax was detected by immunohistochemistry. Results (1) There was no significant change in brain pathology and NSS in groups A and B, but the changes of brain pathology and NSS in group D, E and F were significantly less than those in group C, especially in groups E and F. (2) RT-PCR showed that there was no change in the expression of Wnt3a mRNA, beta-catenin mRNA, Notch1 and Hes1 mRNA in groups A and B. Compared with group C, the expression of Wnt3a mRNA and beta-catenin mRNA in group D increased significantly on the 7th day after sTBI, especially in groups E and F; expression of Notch1 and Hes1 mRNA in groups D, E and F increased gradually with time, especially in group F. (3) ELISA showed that Compared with group C, GFAP and S100B in group D did not change significantly at 3 time points, GFAP in groups E and F decreased gradually with time and reached the lowest value on the 7th day, and S100B in groups E and F decreased gradually with time, especially in group F. (4) Compared with group C, the expression of BCL-2 in brain tissue of groups D, E and F increased gradually with time, and peaked on the 7th day, and the increase of E and F was more obvious. The expression of Bax in brain tissue of group D, E and F decreased gradually with time. Conclusion Exogenous thyroxine has no effect on Notch and Wnt/beta-catenin signaling pathway in normal rats. After TBI, exogenous thyroxine can activate Notch and Wnt/beta-catenin, and have a synergistic effect on the repair of central nervous system, which may be related to the up-regulation of Notch and Wnt/beta-catenin signaling pathway mRNA expression and the increase of BDNF and NGF, and resist apoptosis in the brain of sTBI rats.	[Wei, Chunzhu; Peng, Lingling; Huang, Zongxuan; Pan, Yuzheng] Guangxi Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Nanning 530021, Peoples R China; [Luo, Yan] Guangxi Med Univ, Coll Pharmacol, Nanning 530021, Peoples R China		Pan, YZ (corresponding author), Guangxi Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Nanning 530021, Peoples R China.	pyz79298@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81460687]; Department of Guangxi Zhuang Autonomous Region; Specialized Science and Technology of Traditional Chinese Medicine in the Health [GZLC14-29]	This work is supported by National Natural Science Foundation of China (No. 81460687), Department of Guangxi Zhuang Autonomous Region, Specialized Science and Technology of Traditional Chinese Medicine in the Health (NO.GZLC14-29).	Cho C, 2017, NEURON, V95, P1056, DOI 10.1016/j.neuron.2017.07.031; Dhanesh SB, 2017, CEREB CORTEX, V27, P3943, DOI 10.1093/cercor/bhw207; Du RS, 2017, J EMERG TRADIT CHIN, V26, P1589; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Kanavaki A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122724; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; Liang M, 2017, LAB INVEST, V97, P792, DOI 10.1038/labinvest.2017.24; Mahler J, 2010, J NEUROSCI, V30, P16621, DOI 10.1523/JNEUROSCI.4769-10.2010; Saha SK, 2019, CANCERS, V11, DOI 10.3390/cancers11010099; Singh S, 2018, MOL NEUROBIOL, V55, P6500, DOI 10.1007/s12035-017-0860-4; Tang YD, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108871; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang YC, 2016, APOPTOSIS, V21, P404, DOI 10.1007/s10495-016-1218-5; Wang ZM, 2017, EUR REV MED PHARMACO, V21, P4810; [韦春珠 Wei Chunzhu], 2019, [中华创伤杂志, Chinese Journal of Trauma], V35, P400; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Xu SY, 2008, PHARM EXPT METHODOLO, P1543; Ye YC, 2019, CANCER RES, V79, P4160, DOI 10.1158/0008-5472.CAN-18-1691; Yuan RD, 2017, J TRAUMA SURG, V19, P74; Zhang HP, 2014, NEUROMOL MED, V16, P191, DOI 10.1007/s12017-013-8273-7; Zhang HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193037; Zhang JT, 1998, MODERN PHARM EXPT, P1241	23	1	1	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2021	47	6			SI		2001	2015		10.1007/s00068-020-01359-4		APR 2020	15	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XE8ZQ	WOS:000528111100001	32318748				2022-02-06	
J	Francis, J; Francis, L				Francis, John; Francis, Leslie			Immunization and participation in amateur youth sports	JOURNAL OF THE PHILOSOPHY OF SPORT			English	Article						Immunization; amateur sports; measles; influenza; contagion; covid-19	MEASLES	Although inadequate immunization is a significant public health problem, as covid-19 is an urgent reminder, it has been largely ignored in amateur youth sports. By comparison, safety issues such as concussions have drawn extensive concern. This article examines the case for immunizing athletes who participate in amateur sports for youth. It begins with risks of transmission and current gaps in addressing immunization of amateur athletes. It then considers arguments for immunization, along with objections to immunization requirements for participation. The article concludes that amateur youth sports organizations must pay far more attention to immunization than they currently do, have published policies about immunization, inform participants of these policies, and educate athletes, coaches, and officials about contagion risks.	[Francis, John] Univ Utah, Polit Sci, Salt Lake City, UT 84112 USA; [Francis, Leslie] Univ Utah, Philosophy, Salt Lake City, UT USA		Francis, L (corresponding author), Univ Utah, Polit Sci, Salt Lake City, UT 84112 USA.	francisl@law.utah.edu					Associated Press, 2009, ESPN; Bickert M, 2019, FACEBOOK NEWSRO 0307; Bieler D., 2020, WASHINGTON POST; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Boston CD, 2018, SPORTS HEALTH, V10, P427, DOI 10.1177/1941738118788279; Californians for Vaccine Choice, 2019, I STAND MOTH; CDC (Centers for Disease Control and Prevention), 2019, METH RES STAPH AUR M; CDC (Centers for Disease Control and Prevention), 2019, HIST MEASL, V26, P2019; Centers for Disease Control and Prevention, 2019, TYP INFL VIR; Centers for Disease Control and Prevention, 2019, DIS BURD INFL; Centers for Disease Control and Prevention, 2019, CDC VACC PRIC LIST; CRHE (Coalition for Responsible Home Education), 2015, HOM IMM REQ; FIG (Federation Internationale de Gymnastique), 2019, FIG FRAM SAF ATHL OT; FIG (Federation Internationale de Gymnastique), 2019, FIG COD COND ATHL CO; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Glenza J, 2018, GUARDIAN; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Harris MD, 2011, CURR SPORT MED REP, V10, P84, DOI 10.1249/JSR.0b013e3182142381; HSLDA (Home School Legal Defense Association), 2019, SPORTS PUBL SCH CLAS; Hviid A, 2019, ANN INTERN MED, V170, P513, DOI 10.7326/M18-2101; IOC, 2019, OL CHART; ISU (International Skating Union), 2018, CONST GEN REG; ISU (International Skating Union), 2018, COD OF ETH; Jain A, 2015, JAMA-J AM MED ASSOC, V313, P1534, DOI 10.1001/jama.2015.3077; Jenco M. AAP, 2018, AAP NEWS; Karlamangla S., 2019, LOS ANGELES TIMES; Khalili D, 2007, J LAW MED ETHICS, V35, P471, DOI 10.1111/j.1748-720X.2007.00169.x; Learners H, 2019, ORGANIZED SPORTS HOM; Little League Baseball and Softball (Little League), 2019, MED REL; Little League Baseball and Softball (Little League), 2019, COMM DIS PROC; Little League Baseball and Softball (Little League), 2019, REG SEAS PITCH RUL; Malm H, 2015, KENNEDY INST ETHIC J, V25, P133, DOI 10.1353/ken.2015.0013; McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9; Mina MJ, 2019, SCIENCE, V366, P599, DOI 10.1126/science.aay6485; National Archives, 2019, DEADL VIR INFL EP 19; Ott M, 2007, PUBLIC HEALTH REP, V122, P803, DOI 10.1177/003335490712200612; Peterson AR, 2019, SPORTS HEALTH, V11, P47, DOI 10.1177/1941738118789954; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; Sarah S, 2019, I CANT HOMESCHOOL I; Spellberg B, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-3; Texans for Vaccine Choice, 2019, STAND N Y C A; Tokyo Organising Committee of the Olympic and Paralympic Games, 2019, OL GAM HEALTC GUID J; Trabacchi Valeria, 2015, Acta Biomed, V86, P181; USA Soccer, 2019, US SOCC COMPR PLAYER; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Warner P, 2019, P WARNER LITTLE SCHO; Warner P., 2019, P WARNER PLAY SAFER; WHO, 2019, MEASL; World Health Organization, 2019, MEASL KEY FACTS; Zumla A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0686-3	50	1	1	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0094-8705	1543-2939		J PHILOS SPORT	J. Philos. Sport	MAY 3	2020	47	2					151	167		10.1080/00948705.2020.1750960		APR 2020	17	Ethics; Hospitality, Leisure, Sport & Tourism; Sport Sciences	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	MT6OV	WOS:000526347600001		Bronze			2022-02-06	
J	Mioni, G; Fracasso, V; Cardullo, S; Stablum, F				Mioni, Giovanna; Fracasso, Verena; Cardullo, Stefano; Stablum, Franca			Comparing different tests to detect early manifestation of prospective memory decline in aging	CLINICAL NEUROPSYCHOLOGIST			English	Article						Prospective memory; aging; CAMPROMPT; MIST; RPA-ProMem	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; COMMUNITY LIVING SKILLS; AGE-RELATED DIFFERENCES; ONGOING TASK; RETROSPECTIVE MEMORY; FUNCTIONAL-CAPACITY; WORKING-MEMORY; RETRIEVAL CUE; SELF-REPORT	Objective: Prospective memory (PM) is the ability to remember to perform future intentions. Previous studies have demonstrated that, compared to a younger cohort, healthy older adults have impairments in PM. Considering the importance of early detection of age-related PM decline, the present study aims to compare the performance of healthy older adults using three well-known PM tests commonly used in clinical settings. Method: In the present study, we tested 70 older adults (65-95 years old) using the Cambridge Prospective Memory Test (CAMPROMPT), the Memory for Intentions Screening Test (MIST) and the Royal Prince Alfred Prospective Memory Test (RPA-ProMem). In order to compare performance across tests and the interaction between age and cues, we performed a linear mixed model with random intercept and random slopes. Moreover, additional mixed models with random intercept were run for analyzing the additional information provided by MIST and RPA-ProMem regarding delay responses, response modality effects and type of errors committed. Results: Our data showed a drop in PM performance as age increased detected by all three tests. Furthermore, CAMPROMPT was the most sensitive test to identify differences in PM for event-and time-based cues, at least for participants with 65-77 years old. When data were analyzed in term of delay responses, participants were more accurate for 2 min delay (MIST) and 30 in delay (RPA-ProMem). Participants were less accurate when response modality was "verbal" compared to "action" (MIST) and made more PM errors as age increased. Conclusions: Overall, the study provides important information regarding age-related PM decline and can help researchers as well as clinicians in deciding the preferred test to evaluate PM performance.	[Mioni, Giovanna; Fracasso, Verena; Stablum, Franca] Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy; [Cardullo, Stefano] Novella Fronda Fdn, Padua, Italy		Mioni, G (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.	giovanna.mioni@unipd.it					Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Anderson AM, 2018, J NEUROIMMUNOL, V319, P13, DOI 10.1016/j.jneuroim.2018.03.007; [Anonymous], 2013, [No title captured]; Aronov A, 2015, AGING NEUROPSYCHOL C, V22, P486, DOI 10.1080/13825585.2014.984653; Au RWC, 2014, PSYCHIAT RES, V219, P86, DOI 10.1016/j.psychres.2014.04.055; Au RWC, 2013, BIPOLAR DISORD, V15, P885, DOI 10.1111/bdi.12122; Avci G, 2016, AGING NEUROPSYCHOL C, V23, P716, DOI 10.1080/13825585.2016.1161001; Avgan N, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00086; Baayen HR, 2008, J MEM LANG, V59, P390, DOI DOI 10.1016/J.JML.2007.12.005; Ballhausen N., 2019, PROSPECTIVE MEMORY, P135, DOI DOI 10.4324/9781351000154-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bedard M, 2016, J PSYCHOSOC ONCOL, V34, P291, DOI 10.1080/07347332.2016.1181133; Bezdicek O, 2018, CLIN NEUROPSYCHOL, V32, P1019, DOI 10.1080/13854046.2017.1394493; Bhat NA, 2018, PSYCHIAT RES, V261, P124, DOI 10.1016/j.psychres.2017.12.032; Bracken MR, 2019, APPL NEUROPSYCH-ADUL, V26, P522, DOI 10.1080/23279095.2018.1460371; Burton CZ, 2019, CLIN NEUROPSYCHOL, V33, P594, DOI 10.1080/13854046.2018.1436725; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Casaletto KB, 2014, ARCH CLIN NEUROPSYCH, V29, P818, DOI 10.1093/arclin/acu061; Clark JMR, 2020, REHABIL PSYCHOL, V65, P72, DOI 10.1037/rep0000294; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; Costa A, 2012, NEUROL SCI, V33, P965, DOI 10.1007/s10072-012-0935-y; Coulehan K, 2014, J CLIN EXP NEUROPSYC, V36, P730, DOI 10.1080/13803395.2014.935705; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; Dennis M, 2010, CHILD NERV SYST, V26, P1749, DOI 10.1007/s00381-010-1140-z; Dewar BK, 2018, NEUROPSYCHOL REHABIL, V28, P614, DOI 10.1080/09602011.2016.1189342; Doyle K, 2012, AIDS BEHAV, V16, P2309, DOI 10.1007/s10461-011-0121-x; Doyle KL, 2013, J CLIN EXP NEUROPSYC, V35, P359, DOI 10.1080/13803395.2013.776010; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Einstein GO, 2000, PSYCHOL AGING, V15, P671, DOI 10.1037//0882-7974.15.4.671; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Faytell MP, 2018, NEUROPSYCHOL REHABIL, V28, P1038, DOI 10.1080/09602011.2016.1236733; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Fleming J, 2009, BRAIN IMPAIR, V10, P34, DOI 10.1375/brim.10.1.34; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox J., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; [郜肖肖 Gao Xiaoxiao], 2015, [中国心理卫生杂志, Chinese Mental Health Journal], V29, P516; Ghaleb H., 2008, COGN NEUR SOC M SAN; GOSCHKE T, 1993, J EXP PSYCHOL LEARN, V19, P1211, DOI 10.1037/0278-7393.19.5.1211; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Gupta S, 2010, J CLIN EXP NEUROPSYC, V32, P898, DOI 10.1080/13803391003596470; Hadjiefthyvoulou F, 2011, PSYCHOPHARMACOLOGY, V215, P761, DOI 10.1007/s00213-011-2174-y; Haines S. J., 2019, OXFORD RES ENCY PSYC, DOI [10.1093/acrefore/9780190236557.013.381., DOI 10.1093/ACREFORE/9780190236557.013.381]; Harris LL, 2018, CHILD NEUROPSYCHOL, V24, P938, DOI 10.1080/09297049.2017.1360854; Heffernan T. M., 2014, Irish Journal of Psychological Medicine, V31, P159, DOI 10.1017/ipm.2014.17; Heffernan T, 2012, DRUG ALCOHOL DEPEN, V123, P207, DOI 10.1016/j.drugalcdep.2011.11.014; Heffernan T, 2010, DRUG ALCOHOL DEPEN, V112, P234, DOI 10.1016/j.drugalcdep.2010.06.012; Heffernan TM, 2013, ADDICTION, V108, P420, DOI 10.1111/j.1360-0443.2012.04056.x; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Honan CA, 2015, J INT NEUROPSYCH SOC, V21, P156, DOI 10.1017/S1355617715000053; Hutchens RL, 2012, PSYCHOL AGING, V27, P768, DOI 10.1037/a0026256; Iudicello JE, 2011, CLIN NEUROPSYCHOL, V25, P269, DOI 10.1080/13854046.2010.546812; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Jeong JH, 2016, PSYCHOTHER PSYCHOSOM, V85, P198, DOI 10.1159/000442261; Kamat R, 2014, ASSESSMENT, V21, P742, DOI 10.1177/1073191114530774; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Khoyratty NB, 2015, PSYCHIAT RES, V228, P265, DOI 10.1016/j.psychres.2015.05.101; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kinsella GJ, 2018, CLIN NEUROPSYCHOL, V32, P960, DOI 10.1080/13854046.2018.1468926; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M., 2008, NEUROSCIENCE DEV APP; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Kliegel M, 2016, GERONTOLOGY, V62, P459, DOI 10.1159/000443698; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Ko H. Y., 2015, PSI CHI J PSYCHOL RE, V20, P236, DOI [10.24839/2164-8204.JN20.4.236, DOI 10.24839/2164-8204.JN20.4.236]; KORIAT A, 1990, MEM COGNITION, V18, P568, DOI 10.3758/BF03197099; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; KVAVILASHVILI L, 1992, APPL COGNITIVE PSYCH, V6, P507, DOI 10.1002/acp.2350060605; Lajeunesse A, 2019, CLIN NEUROPSYCHOL, V33, P1175, DOI 10.1080/13854046.2019.1598500; Lecouvey G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00241; Lenth R., 2021, EMMEANS ESTIMATED MA; Li XD, 2018, SLEEP MED, V47, P19, DOI 10.1016/j.sleep.2018.03.019; Li YR, 2014, ACTA PSYCHOL, V149, P18, DOI 10.1016/j.actpsy.2014.02.010; Li YR, 2013, J INT NEUROPSYCH SOC, V19, P718, DOI 10.1017/S1355617713000180; Logie R, 2004, EUR J COGN PSYCHOL, V16, P441, DOI 10.1080/09541440340000114; Lovell B, 2019, J FAM PSYCHOL, V33, P246, DOI 10.1037/fam0000496; [卢瑾 Lu Jin], 2016, [中国心理卫生杂志, Chinese Mental Health Journal], V30, P115; MahMood Z, 2018, J PSYCHIATR RES, V102, P201, DOI 10.1016/j.jpsychires.2018.04.011; Man DWK, 2018, NEUROPSYCHOL REHABIL, V28, P1197, DOI 10.1080/09602011.2016.1251949; Man DWK, 2015, NEUROPSYCHOL REHABIL, V25, P895, DOI 10.1080/09602011.2014.997253; Marshall AM, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00075; Martin EM, 2007, J CLIN EXP NEUROPSYC, V29, P496, DOI 10.1080/13803390600800970; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Martins SP, 2008, ARQ NEURO-PSIQUIAT, V66, P318, DOI 10.1590/S0004-282X2008000300006; McBride DM, 2011, MEM COGNITION, V39, P1222, DOI 10.3758/s13421-011-0105-0; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; MCKITRICK LA, 1992, J GERONTOL, V47, pP337, DOI 10.1093/geronj/47.5.P337; Miller AK, 2014, J CLIN EXP NEUROPSYC, V36, P887, DOI 10.1080/13803395.2014.953040; Mioni G., 2014, TRAUMATIC BRAIN INJU, P401, DOI [10.5772/5730, DOI 10.5772/57307]; Mitrovic A, 2016, J APPL RES MEM COGN, V5, P204, DOI 10.1016/j.jarmac.2016.03.006; Morgan EE, 2012, J CLIN EXP NEUROPSYC, V34, P416, DOI 10.1080/13803395.2012.654764; Nicoll DR, 2014, J INT NEUROPSYCH SOC, V20, P192, DOI 10.1017/S1355617713001355; Nigro G, 2000, EUR PSYCHOL, V5, P228, DOI 10.1027//1016-9040.5.3.228; Palermo L, 2020, APPL NEUROPSYCH-ADUL, V27, P158, DOI 10.1080/23279095.2018.1501374; Paquet L, 2018, PSYCHO-ONCOLOGY, V27, P171, DOI 10.1002/pon.4389; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; Pearce R., 2000, THESIS; Pennar A, 2018, AIDS CARE, V30, P59, DOI 10.1080/09540121.2019.1576851; Pirogovsky E, 2012, J INT NEUROPSYCH SOC, V18, P986, DOI 10.1017/S1355617712000781; Poquette AJ, 2013, J INT NEUROPSYCH SOC, V19, P155, DOI 10.1017/S1355617712001051; Rabin LA, 2014, NEUROPSYCHOL REHABIL, V24, P868, DOI 10.1080/09602011.2014.915855; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2018, J CLIN EXP NEUROPSYC, V40, P423, DOI 10.1080/13803395.2017.1371280; Raskin SA, 2019, NEUROPSYCHOL REHABIL, V29, P289, DOI 10.1080/09602011.2017.1294082; Raskin SA, 2014, NEUROPSYCHOLOGY, V28, P359, DOI 10.1037/neu0000040; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rosnow RL, 2000, PSYCHOL SCI, V11, P446, DOI 10.1111/1467-9280.00287; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; Sheppard DP, 2020, CLIN NEUROPSYCHOL, V34, P755, DOI 10.1080/13854046.2019.1637461; Sheppard DP, 2016, J ASSOC NURSE AIDS C, V27, P595, DOI 10.1016/j.jana.2016.03.006; Shum D., BRAIN IMPAIRMENT, V3, P1; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Sullivan KL, 2018, J CLIN EXP NEUROPSYC, V40, P733, DOI 10.1080/13803395.2018.1432571; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Tierney SM, 2016, J CLIN EXP NEUROPSYC, V38, P572, DOI 10.1080/13803395.2016.1141876; Twamley EW, 2008, SCHIZOPHR RES, V106, P42, DOI 10.1016/j.schres.2007.10.030; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2008, AM J PSYCHIATR REHAB, V11, P144, DOI 10.1080/15487760801963678; Uttl B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016618; Weber E, 2011, J CLIN EXP NEUROPSYC, V33, P1108, DOI 10.1080/13803395.2011.604027; Weinborn M, 2013, J INT NEUROPSYCH SOC, V19, P284, DOI 10.1017/S1355617712001361; Weinborn M, 2011, J CLIN EXP NEUROPSYC, V33, P1119, DOI 10.1080/13803395.2011.614595; Weinborn M, 2011, ARCH CLIN NEUROPSYCH, V26, P746, DOI 10.1093/arclin/acr071; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2008, ARCH CLIN NEUROPSYCH, V23, P257, DOI 10.1016/j.acn.2007.12.006; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Woods SP, 2007, ARCH CLIN NEUROPSYCH, V22, P187, DOI 10.1016/j.acn.2006.12.006; Woods SP, 2006, COGN BEHAV NEUROL, V19, P217, DOI 10.1097/01.wnn.0000213916.10514.57; Woods SP, 2007, SCHIZOPHR RES, V90, P344, DOI 10.1016/j.schres.2006.11.005; Woods SP, 2015, AGING NEUROPSYCHOL C, V22, P679, DOI 10.1080/13825585.2015.1027651; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; Zhou FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172114; Zhou FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111562; Zhou FC, 2012, SCHIZOPHR RES, V135, P34, DOI 10.1016/j.schres.2011.12.001; Zogg JB, 2011, ARCH CLIN NEUROPSYCH, V26, P250, DOI 10.1093/arclin/acr020; Zogg JB, 2010, CLIN NEUROPSYCHOL, V24, P945, DOI 10.1080/13854046.2010.501343	156	1	1	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2022	36	1					105	137		10.1080/13854046.2020.1749308		APR 2020	33	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	YF3OG	WOS:000527187300001	32301378				2022-02-06	
J	Saleem, GT; Slomine, BS; Suskauer, SJ				Saleem, Ghazala T.; Slomine, Beth S.; Suskauer, Stacy J.			Sleep Symptoms Predict School Attendance After Pediatric Concussion	CLINICAL PEDIATRICS			English	Article						brain concussions; mild traumatic brain injury; sleep; postconcussive symptoms; pediatrics	CHILDREN; RECOVERY; ADOLESCENTS; DISTURBANCE; INJURY	This study examined the relationship between postconcussive symptom domain and school attendance. Retrospective chart review was completed for 88 children aged 6 to 18 years who were evaluated within 30 days postinjury. Hierarchical multiple regression was used to assess the association of physical, cognitive, emotional, and sleep symptoms with extent of school attendance. A subgroup multiple regression analysis was conducted to evaluate whether age affected the relationship of symptoms to school attendance. After controlling for demographic variables and total number of symptoms, a higher number of postconcussive sleep symptoms strongly predicted less school attendance. Specifically, older children (>= 14 years old) with more sleep symptoms demonstrated less school attendance. For children presenting for specialty care after concussion, sleep symptoms are unfavorably associated with return to school. Future work aimed at optimizing sleep regulation following concussion may assist with early reengagement in school as recommended by current concussion management guidelines.	[Saleem, Ghazala T.; Slomine, Beth S.; Suskauer, Stacy J.] Kennedy Krieger Inst, 716 North Broadway, Baltimore, MD 21205 USA; [Saleem, Ghazala T.; Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Univ, Baltimore, MD USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 716 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org		Suskauer, Stacy/0000-0002-5009-5584; Saleem, Ghazala/0000-0002-6286-1282	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32HD007414-24, R01HD090266-02]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We acknowledge funding support from the National Institute of Child Health and Human Development (5T32HD007414-24, R01HD090266-02).	Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carskadon MA, 2002, SLEEP, V25, P606, DOI 10.1093/sleep/25.6.606; Committee on Sports-Related Concussions in Youth; Board on Children Youth and Families; Institute of Medicine; National Research Council, 2014, SPORTS RELATED CONCU; Craney T. A., 2002, Quality Engineering, V14, P391, DOI 10.1081/QEN-120001878; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Garcia-Perez MA, 2003, EDUC PSYCHOL MEAS, V63, P825, DOI 10.1177/0013164403251280; Gioia G, 2006, ACUTE CONCUSSION EVA; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hysing M, 2015, SCAND J PUBLIC HEALT, V43, P2, DOI 10.1177/1403494814556647; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Livumbaze AG, 2017, J MIDDLE E N AFR SCI, V3, P18, DOI [10.12816/0036069, DOI 10.12816/0036069]; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; Mosti C, 2016, NEUROL-CLIN PRACT, V6, P129, DOI 10.1212/CPJ.0000000000000225; Radmacher SA, 2001, J PSYCHOL, V135, P259, DOI 10.1080/00223980109603696; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zhou Y, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8120223	31	1	1	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2020	59	6					580	587	0009922820913960	10.1177/0009922820913960		APR 2020	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	LP9WD	WOS:000527760200001	32297793				2022-02-06	
J	Evans, E; Cook, NE; Iverson, GL; Townsend, EL; Duhaime, AC				Evans, Emily; Cook, Nathan E.; Iverson, Grant L.; Townsend, Elise L.; Duhaime, Ann-Christine		TRACK-TBI Investigators	Monitoring Outcome after Hospital-Presenting Milder Spectrum Pediatric Traumatic Brain Injury Using the Glasgow Outcome Scale-Extended, Pediatric Revision	JOURNAL OF NEUROTRAUMA			English	Article						brain concussion; brain injuries; traumatic; head injuries; closed; outcome assessment (healthcare); pediatrics	POST-CONCUSSIVE SYMPTOMS; CLINICALLY SIGNIFICANT CHANGE; SPORT-RELATED CONCUSSION; COMMON DATA ELEMENTS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; RELIABLE CHANGE; CHILDREN; RELIABILITY; SENSITIVITY	The Glasgow Outcome Scale, Pediatric Revision (GOSE-P) is an assessment of "global outcome" designed as a developmentally appropriate version of the Glasgow Outcome Scale-Extended for use in clinical trials of children with traumatic brain injury (TBI). Initial testing describes validity across a wide age and injury severity spectrum, yet the GOSE-P's utility for monitoring children with milder injuries is less clear. We examined the level of agreement between the GOSE-P and the Health and Behavior Inventory (HBI), a TBI-related symptom checklist used to assess children with mild TBI for clinical and research purposes. Participants included children and adolescents 3-16 years of age (n = 50) who presented to two level 1 trauma centers within 24 h of injury, with a GCS of 13-15, who underwent clinical neuroimaging. Outcome was assessed 2 weeks and 3 months following injury. We examined the severity of TBI-related symptoms across disability categories identified using the GOSE-P, and the level of agreement between the two measures in identifying deficits 2 weeks following injury and improvement from 2 weeks to 3 months. Using the GOSE-P, 62% had deficits at 2 weeks, and 42% improved from 2 weeks to 3 months. Agreement between the GOSE-P and HBI was fair 2 weeks after TBI (k = 0.24-0.33), and poor for identifying subsequent improvement (k = 0.10-0.16). Modest agreement between the GOSE-P and the HBI may reflect restricted participation from diverse causes, including TBI, other bodily injuries, and prescribed activity restrictions, and highlights the need for multi-dimensional outcome batteries.	[Evans, Emily; Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA; [Evans, Emily] MGH Inst Hlth Profess, Boston, MA USA; [Evans, Emily] Brown Univ, Ctr Gerontol & Healthcare Res, Box G-S121 6,121 S Main St, Providence, RI 02912 USA; [Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cook, Nathan E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Cook, Nathan E.; Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Townsend, Elise L.] MGH Inst Hlth Profess, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Charlestown, MA USA; [TRACK-TBI Investigators] Univ Calif San Francisco, San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94143 USA		Evans, E (corresponding author), Brown Univ, Ctr Gerontol & Healthcare Res, Box G-S121 6,121 S Main St, Providence, RI 02912 USA.	eevans@mghihp.edu		Hemphill, Claude/0000-0003-4019-7525; Ferguson, Adam/0000-0001-7102-1608	National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Department of Health and Human Services [U01NS086090-0]	This project was supported by the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), and Department of Health and Human Services, through grant U01NS086090-0. NIH had no role in the design or conduct of the study, including collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Altman DG, 1991, PRACTICAL STAT MED R, P403, DOI 10.1002/sim.4780101015; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Grill E, 2012, J VESTIBUL RES-EQUIL, V22, P261, DOI 10.3233/VES-120459; Hageman WJJM, 1999, BEHAV RES THER, V37, P1169; HAGEMAN WJJM, 1993, BEHAV RES THER, V31, P693, DOI 10.1016/0005-7967(93)90122-B; Hageman WJJM, 1999, BEHAV RES THER, V37, P1219; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; HSU LM, 1989, BEHAV ASSESS, V11, P459; Hsu LM, 1999, BEHAV RES THER, V37, P1195; Iverson G., 2011, ENCY CLIN NEUROPSYCH, P158; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobson NS, 1999, J CONSULT CLIN PSYCH, V67, P300, DOI 10.1037/0022-006X.67.3.300; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JENNETT B, 1975, LANCET, V1, P480; Jette AM, 2006, PHYS THER, V86, P726, DOI 10.1093/ptj/86.5.726; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P886; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Nelson L.D., 2017, J NEUROTRAUMA; Ogles B. M., 1996, ASSESSING OUTCOME CL; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SPEER DC, 1995, J CONSULT CLIN PSYCH, V63, P1044, DOI 10.1037/0022-006X.63.6.1044; SPEER DC, 1992, J CONSULT CLIN PSYCH, V60, P402, DOI 10.1037/0022-006X.60.3.402; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Streiner DL, 2015, HLTH MEASUREMENT SCA, P159; Suskauer SJ, 2018, J PEDIATR REHAB MED, V11, P7, DOI 10.3233/PRM-160424; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; World Health Organization, 2001, ICF INT CLASFUNCT; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	70	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2020	37	14					1627	1636		10.1089/neu.2019.6893		APR 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	MG9ML	WOS:000526100300001	32106753	Green Published			2022-02-06	
J	O'Brien, T; Mitra, B; Le Sage, N; Tardif, PA; Emond, M; D'Astous, M; Mercier, E				O'Brien, Toby; Mitra, Biswadev; Le Sage, Natalie; Tardif, Pier-Alexandre; Emond, Marcel; D'Astous, Myreille; Mercier, Eric			Clinically significant traumatic intracranial hemorrhage following minor head trauma in older adults: a retrospective cohort study	BRAIN INJURY			English	Article						Falls; head Injury; traumatic brain injury; Trauma; intracranial hemorrhage; computed tomography; anticoagulant; anti-platelet	EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; BRAIN-INJURIES; RISK; ANTIPLATELET	Objectives: The primary objective of this study was to determine the incidence of clinically significant traumatic intracranial hemorrhage (T-ICH) following minor head trauma in older adults. Secondary objective was to investigate the impact of anticoagulant and antiplatelet therapies on T-ICH incidence. Methods: This retrospective cohort study extracted data from electronic patient records. The cohort consisted of patients presenting after a fall and/or head injury and presented to one of five ED between 1st March 2010 and 31st July 2017. Inclusion criteria were age >= 65 years old and a minor head trauma defined as an impact to the head without fulfilling criteria for traumatic brain injury. Results: From the 1,000 electronic medical records evaluated, 311 cases were included. The mean age was 80.1 (SD 7.9) years. One hundred and eighty-nine (189) patients (60.8%) were on an anticoagulant (n = 69), antiplatelet (n = 130) or both (n = 16). Twenty patients (6.4%) developed a clinically significant T-ICH. Anticoagulation and/or antiplatelets therapies were not associated with an increased risk of clinically significant T-ICH in this cohort (Odds ratio (OR) 2.7, 95% CI 0.9-8.3). Conclusions: In this cohort of older adults presenting to the ED following minor head trauma, the incidence of clinically significant T-ICH was 6.4%.	[O'Brien, Toby; Le Sage, Natalie; Tardif, Pier-Alexandre; Emond, Marcel; Mercier, Eric] Univ Laval, Axe Sante Populat & Prat Optimales Sante, Unite Rech Traumatol Urgence Soins Intensifs, Ctr Rech,CHU Quebec, Quebec City, PQ, Canada; [Le Sage, Natalie; Emond, Marcel; Mercier, Eric] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [O'Brien, Toby; Mitra, Biswadev] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Mitra, Biswadev] Univ Laval, Canada Dept Med Familiale & Med Urgence, Fac Med, Quebec City, PQ, Canada; [Emond, Marcel; Mercier, Eric] Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [D'Astous, Myreille] Univ Laval, Serv Neurosurg, Dept Surg, CHU Quebec, Quebec City, PQ, Canada		Mercier, E (corresponding author), Univ Laval, Ctr Rech, CHU Quebec, 1401,18e Rue, Quebec City, PQ G1J 1Z4, Canada.	eric.mercier.2@ulaval.ca	Mitra, Biswadev/AAC-3724-2019; Le Sage, Natalie/G-7063-2016	Mitra, Biswadev/0000-0002-0508-2450; Le Sage, Natalie/0000-0003-4762-8156			Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; Beck B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217158; Berndtson AE, 2014, EUR J TRAUMA EMERG S, V40, P657, DOI 10.1007/s00068-014-0404-9; Brousseau AA, 2018, AGE AGEING, V47, P242, DOI 10.1093/ageing/afx168; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; de Wit K, 2020, INJURY, V51, P157, DOI 10.1016/j.injury.2019.12.036; Emond M, 2017, CAN GERIATR J, V20, P10, DOI 10.5770/cgj.20.246; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Levine M, 2014, AM J EMERG MED, V32, P71, DOI 10.1016/j.ajem.2013.08.063; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Mercier E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017848; Mercier E, 2016, INJURY, V47, P985, DOI 10.1016/j.injury.2016.04.001; Moore L, 2019, J TRAUMA ACUTE CARE, V86, P983, DOI 10.1097/TA.0000000000002246; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Vedin T, 2019, EUR J TRAUMA EMERG S, V45, P901, DOI 10.1007/s00068-018-0941-8	22	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					836	841		10.1080/02699052.2020.1753242		APR 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000526344100001	32286890				2022-02-06	
J	Aben, HP; Visser-Meily, JMA; Biessels, GJ; de Kort, PLM; Spikman, JM				Aben, Hugo P.; Visser-Meily, Johanna M. A.; Biessels, Geert Jan; de Kort, Paul L. M.; Spikman, Jacoba M.		PROCRAS Study Grp	High occurrence of impaired emotion recognition after ischemic stroke	EUROPEAN STROKE JOURNAL			English	Article						Ischemic stroke; emotion recognition; occurrence; social cognition; Montreal cognitive assessment; vascular cognitive disorder	TRAUMATIC BRAIN-INJURY; COGNITIVE DISORDERS; FACIAL EXPRESSION; SOCIAL COGNITION; PERCEPTION; REHABILITATION; METAANALYSIS; DEFICITS; LESION; NORMS	Introduction Deficits of emotion recognition after ischemic stroke are often overlooked by clinicians, and are mostly not spontaneously reported by patients. However, impaired emotion recognition after stroke negatively affects the ability to return to work and the quality of life. It is still unknown how often impairments of emotion recognition occur shortly after ischemic stroke. We aimed to estimate the occurrence of impaired emotion recognition after ischemic stroke and to characterise these patients with impaired emotion recognition. Patients and methods Two hundred thirty patients were included, derived from a prospective study of cognitive recovery. Five weeks after ischemic stroke a neuropsychological assessment was performed, including an emotion recognition task (i.e. Ekman 60-faces test). Emotion recognition was regarded as impaired if the total score was below the fifth percentile for a large independent reference sample. Results Emotion recognition was impaired in 33.5% of patients. Patients with impaired emotion recognition were more likely to have an abnormal Montreal Cognitive Assessment during hospitalisation, and 5 weeks after their stroke, a higher proportion of them had a vascular cognitive disorder (VCD). Even 20% of patients without VCD had impaired emotion recognition. Discussion: Emotion recognition was often impaired after ischemic stroke. This is clinically relevant, since impaired emotion recognition negatively impacts social functioning. Conclusion: Even when there was no cognitive disorder in traditional cognitive domains, emotion recognition was impaired in 1 out of 5 patients. Clinicians should systematically ask patients and their caregivers about deficits in emotion recognition, and, if needed, test for these deficits.	[Aben, Hugo P.; de Kort, Paul L. M.] Elisabeth Tweesteden Hosp, Dept Neurol, POB 90151, NL-5000 LC Tilburg, Netherlands; [Aben, Hugo P.; Biessels, Geert Jan] UMC Utrecht Brain Ctr, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Visser-Meily, Johanna M. A.] UMC Utrecht Brain Ctr, Dept Rehabil Phys Therapy Sci & Sports, Utrecht, Netherlands; [Spikman, Jacoba M.] Univ Groningen, Dept Clin & Expt Neuropsychol, Groningen, Netherlands		Aben, HP (corresponding author), Elisabeth Tweesteden Hosp, Dept Neurol, POB 90151, NL-5000 LC Tilburg, Netherlands.	h.aben@etz.nl		Aben, Hugo/0000-0003-3032-8843	ZonMW (Netherlands Organisation for Health research and Development)Netherlands Organization for Health Research and Development [842003011]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding was obtained through ZonMW (Netherlands Organisation for Health research and Development) as part of the "TopZorg" project in 2015 (grant #842003011).	Aben HP, 2018, JMIR RES PROTOC, V7, DOI 10.2196/resprot.9431; Adamaszek M, 2015, BRAIN RES, V1613, P1, DOI 10.1016/j.brainres.2015.01.027; Garcia-Casal JA, 2017, J ALZHEIMERS DIS, V57, P937, DOI 10.3233/JAD-160940; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Charbonneau S, 2003, NEUROPSYCHOLOGIA, V41, P605, DOI 10.1016/S0028-3932(02)00202-6; Cheung CCY, 2006, BRAIN COGNITION, V61, P262, DOI 10.1016/j.bandc.2006.01.008; Cooper CL, 2014, BRAIN INJURY, V28, P122, DOI 10.3109/02699052.2013.848379; Cotter J, 2018, NEUROSCI BIOBEHAV R, V84, P92, DOI 10.1016/j.neubiorev.2017.11.014; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Demenescu LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015058; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kootker JA, 2019, CLIN REHABIL, V33, P1056, DOI 10.1177/0269215519833013; Langer SL, 1998, J INT NEUROPSYCH SOC, V4, P447; Luker J, 2017, ARCH PHYS MED REHAB, V98, P1852, DOI 10.1016/j.apmr.2017.02.024; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nijsse B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213725; Nijsse B, 2019, ARCH PHYS MED REHAB, V100, P1300, DOI 10.1016/j.apmr.2019.01.023; Njomboro P, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/2627487; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Sachdev P, 2014, ALZ DIS ASSOC DIS, V28, P206, DOI 10.1097/WAD.0000000000000034; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Spunt RP, 2019, NEUROSCI LETT, V693, P44, DOI 10.1016/j.neulet.2017.06.018; STARKSTEIN SE, 1994, NEUROLOGY, V44, P515, DOI 10.1212/WNL.44.3_Part_1.515; Sumerall SW, 1997, J CLIN PSYCHOL, V53, P517, DOI 10.1002/(SICI)1097-4679(199708)53:5<517::AID-JCLP14>3.0.CO;2-H; Tippett DC, 2018, SEMIN SPEECH LANG, V39, P87, DOI 10.1055/s-0037-1608859; Vakil E, 1997, CLIN NEUROPSYCHOL, V11, P356, DOI 10.1080/13854049708400464; Voncken L, 2018, TIJDSCHRIFT NEUROPSY, V2, P143; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440	46	1	1	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2396-9873	2396-9881		EUR STROKE J	Eur. Stroke J.	SEP	2020	5	3					262	270	2396987320918132	10.1177/2396987320918132		APR 2020	9	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	NV8IN	WOS:000527164000001	33072880	Green Published, Bronze			2022-02-06	
J	Hung, YW; Wang, Y; Lee, SL				Hung, Yu-Wen; Wang, Yun; Lee, Sheau-Ling			DPP-4 inhibitor reduces striatal microglial deramification after sensorimotor cortex injury induced by external force impact	FASEB JOURNAL			English	Article						controlled cortical impact; dorsolateral striatum; microglial ramification; sitagliptin; traumatic brain injury; vildagliptin	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BRAIN MITOCHONDRIAL-FUNCTION; TYPE-2 DIABETES-MELLITUS; COGNITIVE DEFICITS; RAT MODEL; VILDAGLIPTIN; SITAGLIPTIN; NEURODEGENERATION; POLYPEPTIDE; RELEASE	Dipeptidyl peptidase-4 inhibitors (or gliptins), a class of antidiabetic drugs, have recently been shown to have protective actions in the central nervous system. Their cellular and molecular mechanisms responsible for these effects are largely unknown. In the present study, two structurally different gliptins, sitagliptin and vildagliptin, were examined for their therapeutic actions in a controlled cortical impact (CCI) model of moderate traumatic brain injury (TBI) in mice. Early post-CCI treatment with sitagliptin, but not vildagliptin, significantly reduced body asymmetry, locomotor hyperactivity, and brain lesion volume. Sitagliptin attenuated post-CCI microglial deramification in the ipsilateral dorsolateral (DL) striatum, while vildagliptin had no effect. Sitagliptin also reduced striatal expression of galectin-3 and monocyte chemoattractant protein 1(MCP-1), and increased the cortical and striatal levels of the anti-inflammatory cytokine IL-10 on the ipsilateral side. These data support a differential protective effect of sitagliptin against TBI, possibly mediated by an anti-inflammatory effect in striatum to preserve connective network. Both sitagliptin and vildagliptin produced similar increases of active glucagon-like peptide-1 (GLP-1) in blood and brain. Increasing active GLP-1 may not be the sole molecular mechanisms for the neurotherapeutic effect of sitagliptin in TBI.	[Hung, Yu-Wen; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan; [Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan Town, Miaoli County, Taiwan		Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes (NHRI)National Health Research Institutes - Taiwan [06A1-CSPP10-014,07A1-CSPP10-014]; Taiwan Central Govement ST [06A1-NPSP06-034,07A1-NPSP11-034]	National Health Research Institutes (NHRI), Grant/Award Number: 06A1-CSPP10-014,07A1-CSPP10-014; Taiwan Central Govement S&T, Grant/Award Number: 06A1-NPSP06-034,07A1-NPSP11-034	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Ahren B, 2005, ENDOCRINOLOGY, V146, P2055, DOI 10.1210/en.2004-1174; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Atkins S, 2007, J PERIPHER NERV SYST, V12, P269, DOI 10.1111/j.1529-8027.2007.00148.x; Berger J. P., 2018, DIAB METAB, V1, pe2; Bonsack F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00157; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Brantley EC, 2010, TRANSL ONCOL, V3, P380, DOI 10.1593/tlo.10208; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Chen DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001128; Chen SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28449-z; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; DellaValle B, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00450; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gault VA, 2015, DIABETES OBES METAB, V17, P403, DOI 10.1111/dom.12432; Gupta Vishal, 2011, Indian J Endocrinol Metab, V15, P298, DOI 10.4103/2230-8210.85583; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Ingberg E, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0189-8; Isik AT, 2017, DIABETES RES CLIN PR, V123, P192, DOI 10.1016/j.diabres.2016.12.010; Jain S, 2015, PHYSIOL BEHAV, V152, P182, DOI 10.1016/j.physbeh.2015.09.007; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kosaraju J, 2013, J PHARM PHARMACOL, V65, P1773, DOI 10.1111/jphp.12148; Kosaraju J, 2013, NEUROPHARMACOLOGY, V72, P291, DOI 10.1016/j.neuropharm.2013.04.008; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Manley NC, 2007, BRAIN RES, V1182, P138, DOI 10.1016/j.brainres.2007.08.092; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Pintana H, 2013, J ENDOCRINOL, V218, P1, DOI 10.1530/JOE-12-0521; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reichert F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00090; Russell S, 2013, INT J CLIN PHARM-NET, V35, P159, DOI 10.1007/s11096-012-9729-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Siew JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11441-0; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Tsai TH, 2015, J HYPERTENS, V33, P1001, DOI 10.1097/HJH.0000000000000529; Ewen T, 2013, CELL BIOCHEM BIOPHYS, V66, P337, DOI 10.1007/s12013-012-9453-z; Tziomalos K, 2015, DIABETES VASC DIS RE, V12, P463, DOI 10.1177/1479164115597867; Ujhelyi J, 2014, REGUL PEPTIDES, V194, P23, DOI 10.1016/j.regpep.2014.09.006; Van Waes V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00021; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Willuhn I, 2003, EUR J NEUROSCI, V17, P1053, DOI 10.1046/j.1460-9568.2003.02525.x; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Yu FPS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20052-6	62	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2020	34	5					6950	6964		10.1096/fj.201902818R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LL1OX	WOS:000523598500001	32246809				2022-02-06	
J	Covassin, T; McGowan, AL; Bretzin, AC; Anderson, M; Petit, KM; Savage, JL; Katie, SL; Elbin, RJ; Pontifex, MB				Covassin, Tracey; McGowan, Amanda L.; Bretzin, Abigail C.; Anderson, Morgan; Petit, Kyle Michael; Savage, Jennifer L.; Katie, Stephenson L.; Elbin, R. J.; Pontifex, Matthew Brian			Preliminary investigation of a multimodal enhanced brain function index among high school and collegiate concussed male and female athletes	PHYSICIAN AND SPORTSMEDICINE			English	Article						eBFI; sex differences; concussion; SCAT	SPORT-RELATED CONCUSSION; SEX-DIFFERENCES; POSTTRAUMATIC MIGRAINE; RECOVERY; OUTCOMES; ADOLESCENTS; SIDELINE; INJURY; SPECIFICITY; SENSITIVITY	Objective: The primary purpose of this study was to examine the longitudinal effects of sports-related concussion (SRC) on a multi-faceted assessment battery which included neuropsychological testing, symptom reporting, and enhanced brain function index (eBFI) among athletes with and without SRC. A secondary purpose was to explore longitudinal sex differences among these measures in athletes with and without SRC. Methods: A case-control, repeated-measures design was used for this study. A total of 186 athletes (concussed group:n = 87 controls:n = 99) participated in the study. A repeated-measures design was used in which each athlete was tested at four time points following an SRC: within 72 h of injury (Day 0; 2.0 +/- 0.9 days following injury), 5 days following injury (Day 5; 5.0 +/- 0.0), at return to play (RTP; 18.3 +/- 13.8 days following injury), and within 45 days following RTP (RTP45; 66.2 +/- 19.0 days following injury). All analyses were conducted separately using a 2 (Group: concussed, control) x 2 (Sex: male, female) x 4 (Time:Day 0, Day 5, RTP, RTP45) univariate multi-level model including the random intercept for each participant. A higher eBFI score indicates a better performance. Alpha level was set aprior at .05. This study was registered on clinicaltrials.gov (Objective Brain Function Assessment of mTBI/Concussion in College/high school Athletes NCT02477943, NCT02661633, CAS 13-25 NCT03963804). Results: Concussed athletes exhibited impaired eBFI within 72 h of SRC and at Day 5 compared to controls (p <.001). Analysis of eBFI scores between male and female athletes revealed a main effect of sex (p =.05), with female athletes exhibiting lower eBFI (33.9 +/- 30.7) relative to male athletes (40.4 +/- 33.0), however, it did not indicate interactions between sex, group, and time (p's >= 0.786). Conclusion: The eBFI appears to be a useful tool in determining concussed athletes during the acute stages of an SRC. However, this index may lack the sensitivity to detect sex-related differences between groups at various time points during recovery.	[Covassin, Tracey; McGowan, Amanda L.; Anderson, Morgan; Petit, Kyle Michael; Pontifex, Matthew Brian] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA; [Bretzin, Abigail C.] Univ Penn, Dept Biostat Epidemiol & Informat, Penn Injury Sci Ctr, Philadelphia, PA 19104 USA; [Savage, Jennifer L.] Cumberland Univ, Rudy Sch Nursing & Hlth Profess, Lebanon, TN USA; [Katie, Stephenson L.; Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA.	covassin@msu.edu		Anderson, Morgan/0000-0001-9170-6663; Bretzin, Abigail/0000-0003-3730-2849	U.S. Navy (Naval Health Research Center) [W911QY-14-C-0098]	The clinical study was funded in part by a contract to BrainScopeCompany Inc. from the U.S. Navy (Naval Health Research Center), contract #W911QY-14-C-0098. Disclaimer: The views, opinions and/orfindings contained in this report are those of the author(s) and shouldnot be construed as an official Department of the Navy position, policyor decision unless so designated by other documentation.	Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Goldstein H., 2011, MULTILEVEL STAT MODE, V922; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacquin A, 2018, COMPUT BIOL MED, V102, P95, DOI 10.1016/j.compbiomed.2018.09.011; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kirschstein T, 2009, CLIN EEG NEUROSCI, V40, P146, DOI 10.1177/155005940904000305; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Laibow R. E., 2001, Journal of Neurotherapy, V5, P45, DOI 10.1300/J184v05n04_04; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lenth R., 2021, EMMEANS ESTIMATED MA; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory, 2017, 5 INT C CONC SPORT B; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Pinto SM, 2017, PM&R, V9, P847, DOI 10.1016/j.pmrj.2016.12.009; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Satterthwaite TD, 2015, CEREB CORTEX, V25, P2383, DOI 10.1093/cercor/bhu036; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tejani AS, 2017, HEADACHE, V57, P1331; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tomescu MI, 2018, DEV COGN NEUROS-NETH, V31, P58, DOI 10.1016/j.dcn.2018.04.011; TROTMAN SCA, 1979, PSYCHOPHYSIOLOGY, V16, P429, DOI 10.1111/j.1469-8986.1979.tb01497.x; Volpert-Esmond HI, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13044; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	53	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT 1	2020	48	4					442	449		10.1080/00913847.2020.1745717		APR 2020	8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	PD4KS	WOS:000523708400001	32228157				2022-02-06	
J	Jang, SH; Kwon, YH; Lee, SJ				Jang, Sung Ho; Kwon, Young Hyeon; Lee, Sung Jun			Abdominal pain due to the spinothalamic tract injury in patients with mild traumatic brain injury: a case report	BMC NEUROLOGY			English	Article						Diffusion tensor tractography; Spinothalamic tract; Traumatic axonal injury; Head trauma; Brain injury	AXONAL INJURY; PATHOPHYSIOLOGY	Background We report on a patient with a mild traumatic brain injury (TBI) who developed abdominal pain due to spinothalamic tract (STT) injuries revealed by diffusion tensor tractography (DTT). Case presentation A 53-year-old female patient suffered head trauma resulting from a backward fall. While bathing at a public bathhouse, she fell backward and struck the occipital area of her head against the floor. After the head trauma, she experienced pain in the abdomen and in both hands and feet. She underwent evaluations including conventional brain MRI, abdominal and pelvic ultrasonography, and stomach and intestine endoscopy. No abnormality was observed in her brain or abdomen. In addition, her abdominal pain had not been relieved by medical management. When she came to our hospital 4 years after the head trauma, her pain characteristics and severity were as follows: intermittent pain without allodynia or hyperalgesia; squeezing and warm creeping-like pain in the abdomen (visual analog scale score: 7); tingling pain in both hands and feet (visual analog scale score: 7). She was prescribed pregabalin and gabapentin, and her abdominal and limb pain was well-controlled at a tolerable level. On DTT 4 years after head trauma, the upper portion of the spinothalamic tracts (STTs) in both hemispheres showed partial tearing. Discussion and conclusions Injury of the STT was demonstrated by using DTT in a patient who showed abdominal pain that was refractory to medical management following mild TBI. Our results suggest that central pain due to STT injury might be suspected in patients with abdominal pain that is refractory to medical management following TBI.	[Jang, Sung Ho; Kwon, Young Hyeon; Lee, Sung Jun] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea		Lee, SJ (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	hssj8020@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	Analysis and interpretation of data in writing the manuscript was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Dosenovic S, 2017, ANESTH ANALG, V125, P643, DOI 10.1213/ANE.0000000000001998; Hong JH, 2011, AM J NEURORADIOL, V32, P1358, DOI 10.3174/ajnr.A2497; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Jang SH, 2018, TRAUMATIC BRAIN INJU, P137, DOI DOI 10.5772/INTECHOPEN.70988; Jang SH, 2017, BRAIN INJURY, V31, P416, DOI 10.1080/02699052.2016.1239274; Jang SH, 2016, ANN REHABIL MED-ARM, V40, P1149, DOI 10.5535/arm.2016.40.6.1149; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jang SH, 2016, BRAIN INJURY, V30, P933, DOI 10.3109/02699052.2016.1146966; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Miller M D, 1993, Fam Pract Res J, V13, P15; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5	16	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	APR 2	2020	20	1							117	10.1186/s12883-020-01695-3			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LA1UI	WOS:000523739600001	32241253	Green Published, gold			2022-02-06	
J	Kaminski, TW; Weinstein, S; Wahlquist, VE				Kaminski, Thomas W.; Weinstein, Sarah; Wahlquist, Victoria E.			A comprehensive prospective examination of purposeful heading in American interscholastic and collegiate soccer players	SCIENCE AND MEDICINE IN FOOTBALL			English	Article						Repetitive head impacts; concussion; football; aerial challenges	NEUROCOGNITIVE PERFORMANCE; POSTURAL CONTROL; BRAIN-INJURY; EXPOSURE; EPIDEMIOLOGY; CONCUSSIONS; FREQUENCY; FEMALE	Purpose: The popularity of soccer worldwide is unquestionable, yet the aspect of purposeful heading in the sport has drawn increasing scrutiny over the past 10 years. The reason for this is primarily be-cause of the concern over the potential deleterious effects of repetitive head impacts (RHI) on brain structure and function. Accurate accounts of the header burden in soccer are needed to determine how frequently the activity occurs during practice and competition. Utilizing robust prospective database, this report provides a significant look into soccer heading exposure in both interscholastic (10 yr.-matches) and collegiate (15 yr.-practices & matches) cohorts in the United States.Methods: Headers/game exposure rates were 1.68 (interscholastic girls), 2.36 (collegiate women), and 3.55 (collegiate men). Results: Overall, the data suggests that in our cohorts of soccer players, the exposure to soccer heading in both practice and game settings is relatively low. Conclusions: Our soccer heading tabulation system accounted for 4 types of headers including clear, pass, shot, and unintentional deflection. Fortunately, the "unintentional deflections" (blows to the head) accounted for an extremely low number (range 2-5%) of the total soccer heading exposures. Additional research is needed to best understand the implications of these small number of RHI on long-term brain function and behavior.	[Kaminski, Thomas W.; Wahlquist, Victoria E.] Univ Delaware, Athlet Training Res Lab, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Weinstein, Sarah] Crozer Chester Med Ctr, Family Med, Springfield, PA USA		Kaminski, TW (corresponding author), Dept Kinesiol & Appl Physiol, 541 S Coll Ave, Newark, DE 19716 USA.	kaminski@udel.edu					Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Caccese JB, 2018, CLIN J SPORT MED, P1; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Faude O, 2017, SCAND J MED SCI SPOR, V27, P1986, DOI 10.1111/sms.12839; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harriss A, 2019, SCI MED FOOTBALL, V3, P109; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kerr ZY, 2019, J NEUROTRAUM, V36, P2073, DOI 10.1089/neu.2017.5319; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Manalac FJ, 2019, CLIN J SPORT MED, V29, P1, DOI 10.1097/JSM.0000000000000518; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meyer T, 2018, SCI MED FOOTBALL, V2, P1, DOI 10.1080/24733938.2017.1416950; Nevins D, 2018, ATHL TRAIN SPORT HEA; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Putukian Margot, 2004, Curr Sports Med Rep, V3, P9; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; US Soccer, 2015, JOINT STAT REG CONC; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zhang MR, 2013, PLOS ONE, V8, P8	36	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football	APR 2	2020	4	2					101	110		10.1080/24733938.2019.1696470			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OH6EN	WOS:000582682200004					2022-02-06	
J	Kontos, AP; Eagle, SR; Putukian, M; Kirkendall, D; Chiampas, G; Kaminski, T				Kontos, Anthony P.; Eagle, Shawn R.; Putukian, Margot; Kirkendall, Donald; Chiampas, George; Kaminski, Thomas			Concussions in US youth soccer players: results from the US soccer online concussion survey	SCIENCE AND MEDICINE IN FOOTBALL			English	Article						Head; injuries; pediatric sports; medicine; football (soccer); injury prevention	SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; EPIDEMIOLOGY; INJURIES	Purpose: This study aimed to describe incidence rates of concussion from alarge online survey of United States (U.S.) male and female youth soccer players; and to compare rates by age group, sex, competitive level, and practices compared to games.Methods: The survey was conducted through US Soccer consisting of three sections; demographic data, soccer heading exposure and awareness of US Soccer heading guidelines, and concussion data.Results: Respondents (n = 8,104) completed aretrospective online survey during the fall 2016 season representing 101,699 (42,048 girls; 41%) youth soccer players aged 7-14. Outcomes were concussion prevalence per 100 players and incidence per 10,000 athletic exposures (AE). Total concussion incidence for the sample was 8.48/10,000 athlete exposures (AE). Games (rather than practice) and older age (11-14) players had higher rates of concussion (Games: IRR = 5.67, Older Age: IRR = 2.68). Fewer than 1 in 5 concussions (47/253; 19%) occurred during attempted purposeful heading of the ball.Discussion: Overall, 82% (208/253) of all reported concussions received some form of clinical care. A majority of players sought care following their concussion suggesting that awareness and education efforts are having a positive effect on behavior.	[Kontos, Anthony P.; Eagle, Shawn R.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Kaminski, Thomas] Univ Delaware, Kinesiol & Appl Physiol, Newark, DE USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Kirkendall, Donald] Duke Univ, Med Ctr, Duke Sport Sci Inst, Durham, NC USA; [Chiampas, George] US Soccer, Chicago, IL USA		Kontos, AP (corresponding author), UPMC Sports Concuss Program, Dept Orthopaed Surg, Concuss Res Lab, 3850 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Beaudouin F, 2019, BRIT J SPORT MED, V53, P1418, DOI 10.1136/bjsports-2018-099062; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dick R, 2007, J ATHL TRAINING, V42, P278; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Faude O, 2017, SCAND J MED SCI SPOR, V27, P1986, DOI 10.1111/sms.12839; FIFA, 2007, BIG COUNT 2006 STAT; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kaminski TW, 2020, SCI MED FOOTBALL, V4, P93, DOI 10.1080/24733938.2019.1677937; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Moser RS, 2018, ARCH CLIN NEUROPSYCH, V33, P417, DOI 10.1093/arclin/acx070; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Rossler R, 2018, SPORTS MED, V48, P1493, DOI 10.1007/s40279-017-0834-8; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	22	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football	APR 2	2020	4	2					87	92		10.1080/24733938.2020.1736327			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	OH6EN	WOS:000582682200002					2022-02-06	
J	Bharath, S; Radhakrishnan, M; Rao, GSU				Bharath, Srinivasaiah; Radhakrishnan, Muthuchellappan; Rao, Ganne Sesha Umamaheswara			Hemodynamic Changes During Surgical Decompression in Traumatic Brain Injury Patients	WORLD NEUROSURGERY			English	Article						Cardiac index; FloTrac; Hemodynamic variables; Traumatic brain injury	CEREBRAL-BLOOD-FLOW; CARDIAC-OUTPUT; DYSFUNCTION	OBJECTIVE: To understand the hemodynamic changes that occur with surgical decompression of lesions caused by traumatic brain injury. METHODS: In this prospective, observational study, patients with traumatic brain injury requiring craniotomy within 48 hours of injury were recruited. Cardiac index (CI), stroke volume index, stroke volume variation, systemic vascular resistance index (SVRI), heart rate, and mean arterial pressure were monitored throughout surgery using a FloTrac transducer. Standard anesthetic and surgical regimens were followed. RESULTS: Hemodynamic data in 107 patients were compared before skin incision and after hematoma decompression (comparable anesthetic state). There was a significant increase in CI and stroke volume index and a decrease in SVRI and mean arterial pressure following surgical decompression. On subgroup analysis based on preincision CI, the changes were similar in patients with low and normal CI, whereas in patients with high CI, SVRI did not decrease significantly. High preincision CI with no change in SVRI with decompression was associated with poor neurologic outcome at discharge. CONCLUSIONS: In patients with TBI, surgical decompression leads to an increase in CI and a decrease in mean arterial pressure owing to a decrease in SVRI in patients with preincision low or normal cardiac output. These changes were not seen in patients with preincision high CI, and such patients had a poor neurologic outcome.	[Bharath, Srinivasaiah; Radhakrishnan, Muthuchellappan; Rao, Ganne Sesha Umamaheswara] Natl Inst Mental Hlth & Neurosci, Dept Neuroanesthesia, Bangalore, Karnataka, India		Bharath, S (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neuroanesthesia, Bangalore, Karnataka, India.	bharathvinay@gmail.com					BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; DAVIS DH, 1980, J NEUROSURG, V52, P745, DOI 10.3171/jns.1980.52.6.0745; Koch E, 2019, OPEN ACCESS EMERG M, V11, P179, DOI 10.2147/OAEM.S178358; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Nicholls TP, 2006, J AM COLL SURGEONS, V202, P120, DOI 10.1016/j.jamcollsurg.2005.09.007; Rzheutskaya RE, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/606179; Saito T, 2003, ACTA NEUROCHIR SUPPL, V86, P351; Tamaki T, 2006, NEUROL MED-CHIR, V46, P219, DOI 10.2176/nmc.46.219; Velmahos GC, 1999, WORLD J SURG, V23, P54, DOI 10.1007/s002689900564	11	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2020	136						E553	E558		10.1016/j.wneu.2020.01.066			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KW0BN	WOS:000520838600058	31954889				2022-02-06	
J	Cuevas-Ostrem, M; Roise, O; Wisborg, T; Jeppesen, E				Cuevas-Ostrem, Mathias; Roise, Olav; Wisborg, Torben; Jeppesen, Elisabeth			Geriatric Trauma - A Rising Tide. Assessing Patient Safety Challenges in a Vulnerable Population Using Norwegian Trauma Registry Data and Focus Group Interviews: Protocol for a Mixed Methods Study	JMIR RESEARCH PROTOCOLS			English	Article						major trauma; multiple trauma; aging; older adults; elderly; brain injuries; traumatic; geriatric; epidemiology; trauma registries; quality of health care; injury severity score	REDEFINING HYPOTENSION; OLDER PATIENTS; MAJOR TRAUMA; MORTALITY; OUTCOMES; AGE; UNDERTRIAGE; MANAGEMENT; IMPACT	Background: Elderly trauma patients constitute a vulnerable group, with a substantial risk of morbidity and mortality even after low-energy falls. As the world's elderly population continues to increase, the number of elderly trauma patients is expected to increase. Limited data are available about the possible patient safety challenges that elderly trauma patients face. The outcomes and characteristics of the Norwegian geriatric trauma population are not described on a national level. Objective: The aim of this project is to investigate whether patient safety challenges exist for geriatric trauma patients in Norway. An important objective of the study is to identify risk areas that will facilitate further work to safeguard and promote quality and safety in the Norwegian trauma system. Methods: This is a population-based mixed methods project divided into 4 parts: 3 quantitative retrospective cohort studies and 1 qualitative interview study. The quantitative studies will compare adult (aged 16-64 years) and elderly (aged >= 65 years) trauma patients captured in the Norwegian Trauma Registry (NTR) with a date of injury from January 1, 2015, to December 31, 2018. Descriptive statistics and relevant statistical methods to compare groups will be applied. The qualitative study will comprise focus group interviews with doctors responsible for trauma care, and data will be analyzed using a thematic analysis to identify important themes. Results: The project received funding in January 2019 and was approved by the Oslo University Hospital data protection officer (No. 19/16593). Registry data have been extracted for 33,344 patients, and the analysis of these data has begun. Focus group interviews will be conducted from spring 2020. Results from this project are expected to be ready for publication from fall 2020. Conclusions: By combining data from the NTR with interviews with doctors responsible for treatment and transfer of elderly trauma patients, we will provide increased knowledge about trauma in Norwegian geriatric patients on a national level that will form the basis for further research aiming at developing interventions that hopefully will make the trauma system better equipped to manage the rising tide of geriatric trauma.	[Cuevas-Ostrem, Mathias; Jeppesen, Elisabeth] Norwegian Air Ambulance Fdn, Dept Res, Postboks 414 Sentrum, N-0103 Oslo, Norway; [Cuevas-Ostrem, Mathias; Roise, Olav; Jeppesen, Elisabeth] Oslo Univ Hosp, Div Orthopaed Surg, Norwegian Trauma Registry, Oslo, Norway; [Cuevas-Ostrem, Mathias; Roise, Olav; Jeppesen, Elisabeth] Univ Stavanger, Fac Hlth Sci, Stavanger, Norway; [Roise, Olav] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Wisborg, Torben] Oslo Univ Hosp, Div Emergencies & Crit Care, Norwegian Natl Advisory Unit Trauma, Oslo, Norway; [Wisborg, Torben] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Anaesthesia & Crit Care Res Grp, Tromso, Norway		Cuevas-Ostrem, M (corresponding author), Norwegian Air Ambulance Fdn, Dept Res, Postboks 414 Sentrum, N-0103 Oslo, Norway.	mathias.cuevas-ostrem@norskluftambulanse.no		Cuevas-Ostrem, Mathias/0000-0002-1586-3357; Roise, Olav/0000-0003-4931-7001; Jeppesen, Elisabeth/0000-0001-5949-9377; Wisborg, Torben/0000-0002-7213-8012	Norwegian Air Ambulance Foundation	The project is a collaboration among the Norwegian Air Ambulance Foundation, the NTR, Oslo University Hospital, Norwegian National Advisory Unit on Trauma, and the University of Stavanger. The project leader is Professor OR MD, PhD. The study will be performed by one PhD fellow, MCO.; The project has received funding from the Norwegian Air Ambulance Foundation from January 2019 to December 2021.	American College of Surgeons, 2012, ADV TRAUM LIF SUPP A, V9th; Banerjee J, 2017, TRAUMA AUDIT RES NET; Beck B, 2018, BJS OPEN, V2, P310, DOI 10.1002/bjs5.80; Bergeron E, 2006, J TRAUMA, V60, P268, DOI 10.1097/01.ta.0000197651.00482.c5; Boltz MM, 2015, INJURY, V46, P1765, DOI 10.1016/j.injury.2015.06.013; Braun V., 2013, SUCCESSFUL QUALITATI; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Ciesla DJ, 2013, SURGERY, V154, P291, DOI 10.1016/j.surg.2013.04.025; de Vries R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190587; Dehli T, 2015, ACTA ANAESTH SCAND, V59, P384, DOI 10.1111/aas.12467; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goodmanson NW, 2012, SURGERY, V152, P668, DOI 10.1016/j.surg.2012.08.017; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Heffernan DS, 2010, J TRAUMA, V69, P813, DOI 10.1097/TA.0b013e3181f41af8; Hildebrand F, 2016, EUR J TRAUMA EMERG S, V42, P317, DOI 10.1007/s00068-015-0557-1; Jeppesen E, 2019, ANN REPORT; Jeppesen E, 2017, NASJONALT SERVICEMIL; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Knudsen AK, 2017, RESULTS GLOBAL BURDE; Kodadek LM, 2015, J SURG RES, V199, P220, DOI 10.1016/j.jss.2015.05.017; Kojima M, 2019, ANN EMERG MED, V73, P281, DOI 10.1016/j.annemergmed.2018.09.034; Meagher AD, 2019, ACAD EMERG MED, V26, P621, DOI 10.1111/acem.13727; Oyetunji TA, 2011, ARCH SURG-CHICAGO, V146, P865, DOI 10.1001/archsurg.2011.154; Palmer Cameron, 2007, Annu Proc Assoc Adv Automot Med, V51, P13; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Ringen AH, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000282; Rogers A, 2012, AM SURGEON, V78, P711; Sammy I, 2016, INJURY, V47, P1170, DOI 10.1016/j.injury.2016.02.027; Stein DM, 2018, J TRAUMA ACUTE CARE, V85, P788, DOI 10.1097/TA.0000000000001910; Syse A, 2018, POPULATION PROJECTIO; Utter GH, 2008, J EMERG MED, V35, P415, DOI 10.1016/j.jemermed.2007.04.021; Vaage OF, 2015, STAT SENTRALBYRA SSB; Vincent G. K., 2010, NEXT 4 DECADES OLDER; Wang CY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194749; World Health Organization, 2010, INJ VIOL FACTS; World Health Organization, 2018, AG HLTH	45	1	1	1	1	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	APR	2020	9	4							e15722	10.2196/15722			10	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	LU7SX	WOS:000537951700011	32352386	gold, Green Published			2022-02-06	
J	Ding, Q; Zhang, XH; Chen, P				Ding, Qin; Zhang, Xianhe; Chen, Peng			Intraoperative Dexmedetomidine in Peripheral or Emergency Neurologic Surgeries of Patients With Mild-to-Moderate Traumatic Brain Injuries: A Retrospective Cohort Study	DOSE-RESPONSE			English	Article						brain-derived neurotrophic factor; dexmedetomidine; emergency neurologic surgeries; peripheral surgeries; superoxide dismutase; traumatic brain injuries	NEUROTROPHIC FACTOR	Background: Although animal models have demonstrated dexmedetomidine (DEX) as neuroprotective in craniocerebral and subarachnoid injuries, but its role in humans remains to be elucidated. The objectives of the study were to compare plasma brain-derived neurotrophic factor (BDNF), cytokine, and superoxide dismutase levels of patients between those who received intraoperative DEX and those who received intraoperative normal saline (NSE) during peripheral or emergency neurologic surgeries. Methods: Intra- and postoperative data of blood biomarkers and surgical outcomes of patients who underwent peripheral or emergency neurologic surgeries with mild-to-moderate traumatic brain injuries were analyzed retrospectively. Patients received intraoperative DEX group (n = 109) or NSE group (n = 116). Results: At 15 minutes after intubation and before the operation, in the DEX group, plasma BDNF concentration decreased but remained much higher than the NSE group (P < .0001, q = 15.82). After 24 hours of surgeries, levels of cytokine were higher in the NSE group than the DEX group (P < .05 for all). Dexmedetomidine increased malondialdehyde (P < .0001) and superoxide dismutase (P < .0001) levels in DEX group. Conclusions: Intraoperative infusion of DEX may have a neuroprotective, anti-inflammatory, and antioxidant effects during peripheral or emergency neurologic surgeries.	[Ding, Qin] Xuzhou Med Univ, Dept Anesthesiol, Affiliated Huaian Hosp, Huaian, Jiangsu, Peoples R China; [Zhang, Xianhe] Shandong Energy Zaozhuang Min Grp Cent Hosp, Dept Infect Management, Shandong, Peoples R China; [Chen, Peng] Shanghai Jiao Tong Univ, Suzhou Kowloon Hosp, Dept Anesthesiol, Sch Med, Suzhou 215021, Jiangsu, Peoples R China		Chen, P (corresponding author), Shanghai Jiao Tong Univ, Suzhou Kowloon Hosp, Dept Anesthesiol, Sch Med, Suzhou 215021, Jiangsu, Peoples R China.	cphust2018@163.com					Aksoy M, 2018, TURK J ANAESTHESIOL, V46, P139, DOI 10.5152/TJAR.2018.90187; Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; Bekker A, 2013, J NEUROSURG ANESTH, V25, P16, DOI 10.1097/ANA.0b013e31826318af; Cosar M, 2009, SURG NEUROL, V71, P54, DOI 10.1016/j.surneu.2007.08.020; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; Drummond JC, 2008, ANESTHESIOLOGY, V108, P225, DOI 10.1097/01.anes.0000299576.00302.4c; Jiang LX, 2017, J CLIN ANESTH, V40, P25, DOI 10.1016/j.jclinane.2017.04.003; Jiang WW, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0410-7; Li S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/186736; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Pfizer Canada ULC, PROD MON PREC; Reid SNS, 2018, NUTR RES PRACT, V12, P199, DOI [10.4162/nrp.2018.12.3.199, 10.4162/nrp.201]; Tasdogan M, 2009, J CLIN ANESTH, V21, P394, DOI 10.1016/j.jclinane.2008.10.010; Wang WJ, 2014, CLIN NEUROL NEUROSUR, V125, P194, DOI 10.1016/j.clineuro.2014.08.009; Yang L, 2013, UPSALA J MED SCI, V118, P235, DOI 10.3109/03009734.2013.808295	16	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1559-3258			DOSE-RESPONSE	Dose-Response	APR	2020	18	2							1559325820920119	10.1177/1559325820920119			9	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	LR8QP	WOS:000535961600001	32489336	Green Published, gold			2022-02-06	
J	Drury, AJ; DeLisi, M; Elbert, MJ				Drury, Alan J.; DeLisi, Matt; Elbert, Michael J.			What Becomes of Chronic Juvenile Delinquents? Multifinality at Midlife	YOUTH VIOLENCE AND JUVENILE JUSTICE			English	Article						chronic offenders; chronic delinquency; multifinality; life course; youth violence; comorbidity	LIFE-COURSE-PERSISTENT; RISK-FACTORS; ANTISOCIAL-BEHAVIOR; CONDUCT DISORDER; DYNAMIC RISK; SUBSEQUENT RECIDIVISM; MULTISYSTEMIC THERAPY; PERSONALITY-DISORDER; BRAIN-INJURY; OFFENDERS	Popular in the field of developmental psychopathology, multifinality means that an initial condition or status can manifest in diverse outcomes across life. Using a near population of federal correctional clients selected from the Midwestern United States, the current study examined the association of chronic delinquent offender status on assorted life outcomes at midlife (average age of offenders was nearly 44 years). Although just 16% of the current offenders were formerly chronic delinquents, they accounted for 13.9% of current employment, 54.6% of antisocial personality disorder (ASPD) cases, 54% of those at the 90th percentile for arrest charges, 45.8% of those at the 90th percentile for assaultive arrest charges, 53% of gang activity, 43.8% of lifetime traumatic brain injury, and 22.9% of lifetime mental illness. Logistic regression models indicated that former chronic delinquency was associated with 41% reduced odds of employment, 897% increased odds of ASPD, 81% increased odds of 90th percentile offending, 82% increased odds of 90th percentile assaultive offending, 144% increased odds of gang activity, 115% increased odds of traumatic brain injury, and 141% increased odds of lifetime mental illness. Former chronic delinquency has more consistent predictive validity among males than females and among Whites than African Americans. Multifinality is a useful concept to understand the developmental course of chronic delinquency and assess noncriminal yet nevertheless socially and societally burdensome outcomes.	[Drury, Alan J.; Elbert, Michael J.] Southern Dist Iowa, US Probat & Pretrial Serv, Des Moines, IA USA; [DeLisi, Matt] Iowa State Univ, 510 Farm House Lane,203A East Hall, Ames, IA 50011 USA		DeLisi, M (corresponding author), Iowa State Univ, 510 Farm House Lane,203A East Hall, Ames, IA 50011 USA.	delisi@iastate.edu	DeLisi, Matt/U-9128-2019	DeLisi, Matt/0000-0001-5964-5848			Amemiya J, 2017, DEV PSYCHOPATHOL, V29, P819, DOI 10.1017/S095457941600050X; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Assink M, 2015, CLIN PSYCHOL REV, V42, P47, DOI 10.1016/j.cpr.2015.08.002; Baglivio MT, 2018, J CRIM JUST, V55, P46, DOI 10.1016/j.jcrimjus.2018.02.001; Baglivio MT, 2018, JUSTICE Q, V35, P443, DOI 10.1080/07418825.2017.1317013; Baglivio MT, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020197; Baglivio MT, 2014, CRIM JUSTICE BEHAV, V41, P1033, DOI 10.1177/0093854814543272; Baglivio MT, 2014, CRIMINOL PUBLIC POL, V13, P83, DOI 10.1111/1745-9133.12064; Blumstein A., 1986, CRIMINAL CAREERS CAR, VVol. 1; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Caspi A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0005; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Caudill JW, 2017, YOUTH VIOLENCE JUV J, V15, P343, DOI 10.1177/1541204016689492; Caudill JW, 2013, YOUTH VIOLENCE JUV J, V11, P183, DOI 10.1177/1541204012472211; Caudill JW, 2010, YOUTH VIOLENCE JUV J, V8, P58, DOI 10.1177/1541204009339872; Cavanagh C, 2017, J YOUTH ADOLESCENCE, V46, P1533, DOI 10.1007/s10964-017-0679-3; Cicchetti D, 1996, DEV PSYCHOPATHOL, V8, P597, DOI 10.1017/S0954579400007318; Cicchetti D., 2006, DEV PSYCHOPATHOL, V2, P1; Cohen MA., 2010, CRIMINAL JUSTICE POL, V21, P391; Cohen M, 2009, J QUANT CRIMINOL, V25, P25, DOI 10.1007/s10940-008-9057-3; Cohen T., 2014, FED PROBAT, V78, P41, DOI 10.2139/ssrn.2463376; Cohen T. H., 2016, FEDERAL PROBATION, V80, P21; COLMAN I, 2009, BMJ BRIT MED J, V0338, DOI [DOI 10.1136/bmj.a2981, DOI 10.1136/BMJ.A2981]; Cuevas C, 2019, J CRIM JUST, V60, P154, DOI 10.1016/j.jcrimjus.2018.10.003; Daigle LE, 2018, J CRIM JUST, V58, P78, DOI 10.1016/j.jcrimjus.2018.07.005; DELISI M, 2005, CAREER CRIMINALS SOC; Delisi M., 2003, CRIM JUSTICE STUD, V16, P283, DOI [10.1080/0888431032000183489, DOI 10.1080/0888431032000183489]; Delisi M, 2018, CRIM JUSTICE BEHAV, V45, P902, DOI 10.1177/0093854818765593; DeLisi M, 2016, CHILD DEV PERSPECT, V10, P53, DOI 10.1111/cdep.12161; DeLisi M, 2014, J CRIM JUST, V42, P10, DOI 10.1016/j.jcrimjus.2013.11.001; DeLisi M, 2013, INT J OFFENDER THER, V57, P911, DOI 10.1177/0306624X13493391; DeLisi M, 2013, J CRIM JUST, V41, P12, DOI 10.1016/j.jcrimjus.2012.10.002; DeLisi M, 2011, J CRIM JUST, V39, P289, DOI 10.1016/j.jcrimjus.2011.05.001; Drury A, 2017, J CRIM PSYCHOL, V7, P105, DOI 10.1108/JCP-11-2016-0039; ELLIOTT DS, 1994, CRIMINOLOGY, V32, P1, DOI 10.1111/j.1745-9125.1994.tb01144.x; Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016; Farrington D. P, 1990, STRAIGHT DEVIOUS PAT, P62; Farrington David P., 2015, OFFENDING CHILDHOOD; Farrington DP, 2003, CRIMINOLOGY, V41, P221, DOI 10.1111/j.1745-9125.2003.tb00987.x; Gottfredson M. R., 1990, GEN THEORY CRIME; Henggeler SW, 2006, CHILD YOUTH SERV REV, V28, P447, DOI 10.1016/j.childyouth.2005.07.001; Herrenkohl TI, 2000, J ADOLESCENT HEALTH, V26, P176, DOI 10.1016/S1054-139X(99)00065-8; HOWELL JC, 1995, SOURCEBOOK SERIOUS V; Jolliffe D, 2017, AGGRESS VIOLENT BEH, V33, P4, DOI 10.1016/j.avb.2017.01.002; Kempf-Leonard K, 2001, JUSTICE Q, V18, P449, DOI 10.1080/07418820100094981; Kennedy TD, 2019, YOUTH VIOLENCE JUV J, V17, P174, DOI 10.1177/1541204018770517; Laub J.H., 2003, SHARED BEGINNINGS DI; Littell JH, 2006, CHILD YOUTH SERV REV, V28, P458, DOI 10.1016/j.childyouth.2005.07.002; LOEBER R, 1982, CHILD DEV, V53, P1431, DOI 10.2307/1130070; LOEBER R, 1990, CRIMINOLOGY, V28, P97, DOI 10.1111/j.1745-9125.1990.tb01319.x; Loeber R., 1999, SERIOUS VIOLENT JUVE; Loeber R., 2001, CHILD DELINQUENTS; Marquart J.W., 2010, CRIMINAL JUSTICE REV, V35, P200, DOI [10.1177/0734016809360326, DOI 10.1177/0734016809360326]; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moffitt TE, 2018, NAT HUM BEHAV, V2, P177, DOI 10.1038/s41562-018-0309-4; Mowen TJ, 2018, YOUTH VIOLENCE JUV J, V16, P358, DOI 10.1177/1541204017712560; Nolen-Hoeksema S, 2011, PERSPECT PSYCHOL SCI, V6, P589, DOI 10.1177/1745691611419672; OLWEUS D, 1979, PSYCHOL BULL, V86, P852, DOI 10.1037/0033-2909.86.4.852; Piquero AR, 2008, LONG VIEW OF CRIME: A SYNTHESIS OF LONGITUDINAL RESEARCH, P23, DOI 10.1007/978-0-387-71165-2_2; Piquero AR, 2014, JUSTICE Q, V31, P445, DOI 10.1080/07418825.2011.641027; Piquero AR, 2011, CRIM BEHAV MENT HEAL, V21, P189, DOI 10.1002/cbm.810; Piquero AR, 2010, J RES CRIME DELINQ, V47, P151, DOI 10.1177/0022427809357713; Reising K., 2018, J CRIM JUST, V62, P3, DOI 10.1016/j.jcrimjus.2018.05.002; Remschmidt H, 2010, J NEURAL TRANSM, V117, P663, DOI 10.1007/s00702-010-0393-8; Rivenbark JG, 2018, J CHILD PSYCHOL PSYC, V59, P703, DOI 10.1111/jcpp.12850; ROBINS LN, 1978, PSYCHOL MED, V8, P611, DOI 10.1017/S0033291700018821; Schulenberg J, 1996, DEV PSYCHOL, V32, P659, DOI 10.1037/0012-1649.32.4.659; Schwartz JA, 2019, CURR OPIN PSYCHOL, V27, P67, DOI 10.1016/j.copsyc.2018.09.006; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Sroufe LA, 1997, DEV PSYCHOPATHOL, V9, P251, DOI 10.1017/S0954579497002046; Trulson C.R., 2016, LOST CAUSES BLENDED; Trulson C. R., 2005, YOUTH VIOLENCE JUV J, V3, P355, DOI DOI 10.1177/1541204005278802; Trulson C.R, 2012, CRIMINAL JUSTICE REV, V37, P174; Trulson CR, 2007, YOUTH VIOLENCE JUV J, V5, P17; Vaughn M., 2005, YOUTH VIOLENCE JUV J, V3, P235, DOI DOI 10.1177/1541204005276320; Vaughn MG, 2008, J CRIM JUST, V36, P33, DOI 10.1016/j.jcrimjus.2007.12.008; Vaughn MG, 2014, YOUTH VIOLENCE JUV J, V12, P3, DOI 10.1177/1541204013478973; Vaughn MG, 2011, J CRIM JUST, V39, P75, DOI 10.1016/j.jcrimjus.2010.12.001; Veeh CA, 2018, PSYCHOL CRIME LAW, V24, P1016, DOI 10.1080/1068316X.2018.1497632; Walters GD, 2016, LAW HUMAN BEHAV, V40, P411, DOI 10.1037/lhb0000185; Whitten T, 2017, J CRIM JUST, V52, P22, DOI 10.1016/j.jcrimjus.2017.07.001; Wolfgang M.E., 1972, DELINQUENCY BIRTH CO; Yoerger K, 1999, CRIM BEHAV MENT HEAL, V9, P24, DOI DOI 10.1002/CBM.289; ZOCCOLILLO M, 1992, PSYCHOL MED, V22, P971, DOI 10.1017/S003329170003854X; [No title captured]	87	1	1	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1541-2040	1556-9330		YOUTH VIOLENCE JUV J	Youth Violence Juv. Justice	APR	2020	18	2					119	134		10.1177/1541204019858741			16	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	KR0PV	WOS:000517323700001					2022-02-06	
J	Gallagher, MJ; Lopez, DM; Sheen, HV; Hogg, FRA; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Gallagher, Mathew J.; Lopez, David Martin; Sheen, Helen, V; Hogg, Florence R. A.; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Heterogeneous effect of increasing spinal cord perfusion pressure on sensory evoked potentials recorded from acutely injured human spinal cord	JOURNAL OF CRITICAL CARE			English	Article						Blood pressure; Critical care; Microdialysis; Monitoring; Somatosensoly evoked potential; Subdural electrode; Spinal cord injury	INTRASPINAL PRESSURE; MANAGEMENT; EVOLUTION; PROFILE; BRAIN	Purpose: To investigate the effect of increasing spinal cord perfusion pressure (SCPP) on sensory evoked potentials (SEPs) and injury site metabolism in patients with severe traumatic spinal cord injury TSCI. Materials and methods: In 12 TSCI patients we placed a pressure probe, a microdialysis catheter and a strip electrode with 8 contacts on the surface of the injured cord. We monitored SCPP, lactate-to-pyruvate ratio (LPR) and SEPs (after median or posterior tibial nerve stimulation). Results: Increase in SCPP by -20 mmHg produced a heterogeneous response in SEPs and injury site metabolism. In some patients, SEP amplitudes increased and the LPR decreased indicating improved tissue metab olism. In others, SEP amplitudes decreased and the LPR increased indicating more impaired metabolism. Compared with patients who did not improve at follow-up, those who improved had significantly more electrode contacts with SEP amplitude increase in response to increasing SCPP. Conclusions: Increasing SCPP after acute, severe TSCI may be beneficial (if associated with increase in SEP amplitude) or detrimental (if associated with decrease in SEP amplitude). Our findings support individualized management of patients with acute, severe TSCI guided by monitoring from the injury site rather than applying universal blood pressure targets as is current clinical practice. (C) 2019 Elsevier inc. All rights reserved.	[Gallagher, Mathew J.; Hogg, Florence R. A.; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England; [Lopez, David Martin; Sheen, Helen, V] St George Hosp, Dept Neurophysiol, Blackshaw Rd, London SW17 0QT, England; [Zoumprouli, Argyro] St George Hosp, Dept Anaesthesia Neuroanaesthesia, Blackshaw Rd, London SW17 0QT, England		Saadoun, S (corresponding author), St Georges Univ London, MCS Inst, Acad Neurosurg Unit, Neurosci, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Zoumprouli, Argyro/0000-0003-0890-690X	Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation (Fletcher Fund)	This work was supported by the Wings for Life Spinal Cord Research Foundation and the Neurosciences Research Foundation (Fletcher Fund).	Ahuja CS, 2017, J ORTHOP TRAUMA, V31, pS7, DOI 10.1097/BOT.0000000000000943; Bazley FA, 2014, IEEE T NEUR SYS REH, V22, P953, DOI 10.1109/TNSRE.2014.2319313; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHABOT R, 1985, J NEUROSURG, V63, P544, DOI 10.3171/jns.1985.63.4.0544; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Cheng XH, 2019, BRAIN RES BULL, V146, P7, DOI 10.1016/j.brainresbull.2018.12.003; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; Fehlings MG, 2017, GLOB SPINE J, V7, p84S, DOI 10.1177/2192568217703387; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; Gallagher MJ, 2018, J NEUROTRAUMA; Hogg FRA, 2018, NEUROCRIT CARE; Kuhn F, 2012, J NEUROTRAUM, V29, P1829, DOI 10.1089/neu.2011.2277; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; SEDGWICK EM, 1980, J NEUROL NEUROSUR PS, V43, P823, DOI 10.1136/jnnp.43.9.823; Spiess M, 2008, CLIN NEUROPHYSIOL, V119, P1051, DOI 10.1016/j.clinph.2008.01.021; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206; Xie CZ, 2014, NEUROREHABILITATION, V35, P835, DOI 10.3233/NRE-141158	27	1	1	2	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2020	56						145	151		10.1016/j.jcrc.2019.12.019			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2RN	WOS:000519555700023	31901650	Green Accepted			2022-02-06	
J	Gallant, C; Barry, N; Good, D				Gallant, Caitlyn; Barry, Nicole; Good, Dawn			Physiological arousal in athletes following repeated subconcussive impact exposure	CURRENT PSYCHOLOGY			English	Article						Subconcussion; Subconcussive impact exposure; Concussion; Repetitive head impacts; Physiological arousal	DEFAULT-MODE NETWORK; HEAD IMPACTS; NEUROPSYCHOLOGICAL PERFORMANCE; DECISION-MAKING; SOCCER PLAYERS; FOOTBALL; SCHOOL; CONCUSSION; CONTACT; INJURY	The aim of this study was to investigate the relationship between a novel measure of subconcussive impact exposure (SIE) in sports and physiological arousal. In particular, baseline arousal was examined as a potential mechanism of impairment. This research was conducted in the Jack and Nora Walker Lifespan Development Centre testing facilities at Brock University in St. Catharines, Ontario, Canada. Using a two-part longitudinal design, 77 university students (M age = 21.01, SD = 2.752, 40.3% male) of varying athletic status (25 high-risk, 28 low-risk, and 24 non-athletes) were tested individually at pre- and post-season. Electrodermal activation (EDA) was measured as an index of physiological arousal. Participants completed the Everyday Living Demographic Questionnaire (ELQ), from which a composite index of SIE was created consisting of athletic history questions. SIE significantly predicted pre- and post-season EDA. Additionally, high-risk and low-risk athletes had greater SIE than non-athletes, while low-risk and high-risk athletes did not differ in terms of SIE. These results are consistent with research demonstrating reduced physiological arousal after concussion, further illustrating the continuum of head injury severity, and indicating that EDA may be a non-invasive biomarker of SIE.	[Gallant, Caitlyn; Barry, Nicole; Good, Dawn] Brock Univ, Dept Psychol, Mackenzie Chown B326,1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada; [Good, Dawn] Brock Univ, Ctr Neurosci, St Catharines, ON L2S 3A1, Canada		Gallant, C (corresponding author), Brock Univ, Dept Psychol, Mackenzie Chown B326,1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada.	cg14xx@brocku.ca	Gallegos, Carlos/AAE-8526-2019; Valdez, Pablo/ABD-3880-2020; Azevedo, Carolina/AAJ-8385-2020	Gallegos, Carlos/0000-0002-1513-0321; Valdez, Pablo/0000-0003-1226-3054; Azevedo, Carolina/0000-0003-4985-4755; Borrani, Jorge/0000-0002-1637-3720; Garcia, Aida/0000-0002-0574-4135; Gallant, Caitlyn/0000-0003-4305-1425; Ramirez, Candelaria/0000-0001-9847-8843			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Barratt E. S, 1985, MOTIVATION EMOTION P, V5, P137; Barth JT, 1989, MILD HEAD INJURY, P257; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Canadian Fitness and Lifestyle Research Institute, 2013, PART SPORT CHILDR YO; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Fowles D.C., 1974, BIOELECTRIC RECORDIN, P231; Good D, 2008, EVERYDAY LIVING QUES; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; LAZARUS RS, 1963, PSYCHOSOM MED, V25, P19, DOI 10.1097/00006842-196301000-00004; Limestone Technologies, 2008, POLYGR PROF SUIT; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Morales D., 2007, BRAIN CONTUSION; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Paulhus D.L., 2007, HDB RES METHODS PERS, P224; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; SPSS I, 2012, STAT PACK SOC SCI; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	46	1	2	1	12	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1046-1310	1936-4733		CURR PSYCHOL	Curr. Psychol.	APR	2020	39	2					640	647		10.1007/s12144-018-9780-3			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LK7EW	WOS:000531026400026	30488723				2022-02-06	
J	Idowu, OE; Oshinaike, O; Ogun, SA; Arabambi, B; Orungbeja, TO; Malomo, OO; Aisudo, CK; Oyeleye, OO				Idowu, Olufemi Emmanuel; Oshinaike, Olajumoke; Ogun, Shamsideen Abayomi; Arabambi, Babawale; Orungbeja, Toluwani Opeyerni; Malomo, Oluwabusayomi Oghenerume; Aisudo, Charles Kolawole; Oyeleye, Olarinmoye Oluwole			Predicting outcome in traumatic brain injury using a new outcome assessment scale - The Lagos Brain Disability Examination Scale (LABDES)	TRAUMA-ENGLAND			English	Article						Brain injury; Helsinki score; Lagos Brain Disability Examination Scale; Modified Marshall score; Rotterdam score	CLASSIFICATION; AFRICA	Introduction Traumatic brain injury management is a leading cause of disability and death in young adults. Our objective was to develop a new multidomain, comprehensive, sensitive, objective and easily reproducible outcome scale with high predictive accuracy to assess patients with traumatic brain injury. The developed outcome assessment tool, the Lagos Brain Disability Examination Scale was then tested for any association of outcome predictability with patients' admission modified Marshall, Rotterdam and Helsinki computerized tomographic scores. Methods A prospective cohort study was carried out of patients aged 16 years and above who sustained traumatic brain injury. All recruited patients had their biodata and derived cranial computerized tomographic scores documented using the modified Marshall, Rotterdam and Helsinki computerized tomographic scale on a pro forma. Outcomes were assessed at eight weeks after traumatic brain injury with the Lagos Brain Disability Examination Scale. Statistical significance was judged at p < 0.05 level. Results Forty-one patients were included (31 males; mean age 38.6 years, median 38 years, range 16-83 years). The Helsinki score gave a better prognostic predictability compared to the other computerized tomographic scoring systems. Twenty-one (51.2%) patients had good recovery according to the Lagos Brain Disability Examination Scale grade. Conclusions Patients' outcome prediction on the Lagos Brain Disability Examination Scale is best using the initial Helsinki computerized tomographic scoring system. The Lagos Brain Disability Examination Scale appears to be a comprehensive and valid outcome measure to use in patients with traumatic brain injury.	[Idowu, Olufemi Emmanuel; Orungbeja, Toluwani Opeyerni; Malomo, Oluwabusayomi Oghenerume; Aisudo, Charles Kolawole; Oyeleye, Olarinmoye Oluwole] Lagos State Univ Teaching Hosp LASUTH, Dept Surg, Div Neurol Surg, Lagos, Nigeria; [Idowu, Olufemi Emmanuel] Lagos State Univ, Coll Med, Fac Clin Sci, Dept Surg,Div Neurol Surg, Lagos, Nigeria; [Oshinaike, Olajumoke; Ogun, Shamsideen Abayomi; Arabambi, Babawale] Lagos State Univ, Coll Med, Fac Clin Sci, Div Neurol,Dept Med, Lagos, Nigeria; [Oshinaike, Olajumoke; Ogun, Shamsideen Abayomi; Arabambi, Babawale] Lagos State Univ Teaching Hosp, Lagos, Nigeria		Idowu, OE (corresponding author), Lagos State Univ, Coll Med, Fac Clin Sci, GRA Ikeja, Ikeja Lagos 1-5,Oba Akinjobi St, Lagos 20001, Nigeria.	oeidowu412@yahoo.com		Idowu, Olufemi/0000-0001-9064-1562			Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bedard M, 2018, CLIN NEUROPSYCHOL, V32, P1002, DOI 10.1080/13854046.2017.1404644; Cardarelli R, 2007, J AM OSTEOPATH ASSOC, V107, P299; Ciesielska N, 2013, J HEALTH SCI, V3, P393; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Havill J H, 2001, Crit Care Resusc, V3, P15; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; Idowu OE, 2017, BRAIN INJURY, V31, P359, DOI 10.1080/02699052.2016.1257823; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Okyere-Dede EK, 2013, TROP DOCT, V43, P1, DOI 10.1177/0049475513480490; Opara J A, 2014, J Med Life, V7, P124; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Vissoci JRN, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1283-9; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilmowska-Pietruszynska A., 2010, ORZECZNICTWO LEKARSK, V7, P1; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	20	1	1	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	APR	2020	22	2					148	154		10.1177/1460408619855871			7	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	LA3HM	WOS:000523841500008					2022-02-06	
J	King, DJ; Seri, S; Beare, R; Catroppa, C; Anderson, VA; Wood, AG				King, Daniel J.; Seri, Stefano; Beare, Richard; Catroppa, Cathy; Anderson, Vicki A.; Wood, Amanda G.			Developmental divergence of structural brain networks as an indicator of future cognitive impairments in childhood brain injury: Executive functions	DEVELOPMENTAL COGNITIVE NEUROSCIENCE			English	Article						MRI; Traumatic brain injury; Development; Morphometry; Structural covariance networks; Executive function; Child; Paediatric	HUMAN CORTICAL DEVELOPMENT; GEOMETRICALLY ACCURATE; COVARIANCE NETWORKS; SOCIAL COMPETENCE; CHILDREN; THICKNESS; PATTERNS; PERFORMANCE; MODERATE; MRI	Brain insults during childhood can perturb the already non-linear trajectory of typical brain maturation. The diffuse effects of injury can be modelled using structural covariance networks (SCN), which change as a function of neurodevelopment. However, SCNs are estimated at the group-level, limiting applicability to predicting individual-subject outcomes. This study aimed to measure the divergence of the brain networks in paediatric traumatic brain injury (pTBI) patients and controls, and investigate relationships with executive functioning (EF) at 24 months post-injury. T1-weighted MRI acquired acutely in 78 child survivors of pTBI and 33 controls underwent 3D-tissue segmentation to estimate cortical thickness (CT) across 68 atlas-based regions-of-interest (ROIs). Using an 'add-one-patient' approach, we estimate a developmental divergence index (DDI). Our approach adopts a novel analytic framework in which age-appropriate reference networks to calculate the DDI were generated from control participants from the ABIDE dataset using a sliding-window approach. Divergence from the age-appropriate SCN was related to reduced EF performance and an increase in behaviours related to executive dysfunctions. The DDI measure showed predictive value with regard to executive functions, highlighting that early imaging can assist in prognosis for cognition.	[King, Daniel J.; Seri, Stefano; Wood, Amanda G.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [King, Daniel J.; Seri, Stefano; Wood, Amanda G.] Aston Univ, Aston Neurosci Inst, Birmingham B4 7ET, W Midlands, England; [King, Daniel J.; Seri, Stefano] Birmingham Womens & Childrens Hosp NHS Fdn Trust, Dept Clin Neurophysiol, Birmingham, W Midlands, England; [Beare, Richard; Catroppa, Cathy; Anderson, Vicki A.; Wood, Amanda G.] Murdoch Childrens Res Inst, Clin Sci, Brain & Mind Res, Melbourne, Vic, Australia; [Beare, Richard] Monash Univ, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Wood, Amanda G.] Deakin Univ, Fac Hlth, Sch Psychol, Melbourne Burwood Campus, Geelong, Vic, Australia		Wood, AG (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.; Wood, AG (corresponding author), Aston Univ, Aston Neurosci Inst, Birmingham B4 7ET, W Midlands, England.	a.wood4@aston.ac.uk	Griffiths-King, Daniel/ABE-6359-2021; Catroppa, Cathy/AAX-9458-2021; Wood, Amanda/K-9595-2013	Griffiths-King, Daniel/0000-0001-5797-9203; Catroppa, Cathy/0000-0002-9750-0436; Wood, Amanda/0000-0002-1537-6858; Beare, Richard/0000-0002-7530-5664	European Research Council (ERC) Consolidator Grant (ERC-CoG)European Research Council (ERC) [682734]; Aston University, School of Life and Health Sciences	This work was supported by a European Research Council (ERC) Consolidator Grant (ERC-CoG) to AW [grant number 682734]. DK was supported by a studentship from Aston University, School of Life and Health Sciences.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Alexander-Bloch A, 2013, J NEUROSCI, V33, P2889, DOI 10.1523/JNEUROSCI.3554-12.2013; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Batalle D, 2018, J CHILD PSYCHOL PSYC, V59, P350, DOI 10.1111/jcpp.12838; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; BELLEC P, 2012, FRONT NEUROINFORM, V6, DOI DOI 10.3389/CONF.FNINF.2013.09.00041; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bigler ED, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00228; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Casey BJ, 2018, DEV COGN NEUROS-NETH, V32, P43, DOI 10.1016/j.dcn.2018.03.001; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Chepkoech JL, 2016, HUM BRAIN MAPP, V37, P1831, DOI 10.1002/hbm.23139; Cole JH, 2017, TRENDS NEUROSCI, V40, P681, DOI 10.1016/j.tins.2017.10.001; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dennis EL, 2017, NEUROIMAGE-CLIN, V15, P125, DOI 10.1016/j.nicl.2017.03.014; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J, 2017, CHILD NEUROPSYCHOL, V23, P554, DOI 10.1080/09297049.2016.1161015; Erus G, 2015, CEREB CORTEX, V25, P1676, DOI 10.1093/cercor/bht425; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Friedman NP, 2016, DEV PSYCHOL, V52, P326, DOI 10.1037/dev0000075; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Hong SJ, 2017, BRAIN, V140, P2133, DOI 10.1093/brain/awx145; Horowitz-Kraus T., 2016, EXECUTIVE FUNCTION P; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Kassambara A, 2018, GGPUBR GGPLOT2 BASED; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Khundrakpam BS, 2017, NEUROIMAGE, V144, P227, DOI 10.1016/j.neuroimage.2016.08.041; Khundrakpam BS, 2016, NEUROIMAGE, V134, P192, DOI 10.1016/j.neuroimage.2016.03.062; Khundrakpam BS, 2013, CEREB CORTEX, V23, P2072, DOI 10.1093/cercor/bhs187; King DJ, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101844; King D.J., 2020, LESION INDUCED ERROR; Klapwijk ET, 2019, NEUROIMAGE, V189, P116, DOI 10.1016/j.neuroimage.2019.01.014; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kolb, 2018, NEUROBIOLOGY BRAIN B, P291, DOI [10.1016/b978-0-12-804036-2.00011-x., DOI 10.1016/B978-0-12-804036-2.00011-X]; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Lerch JP, 2017, NAT NEUROSCI, V20, P314, DOI 10.1038/nn.4501; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Manly T., 1999, TEST EVERYDAY ATTENT; MANTEL N, 1967, CANCER RES, V27, P209; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McKenna R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00154; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Mills KL, 2016, NEUROIMAGE, V141, P273, DOI 10.1016/j.neuroimage.2016.07.044; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Pagani M, 2016, NEUROIMAGE, V129, P55, DOI 10.1016/j.neuroimage.2016.01.025; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; R Core Team, 2016, R LANG ENV STAT COMP; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Resch C, 2019, NEUROPSYCHOLOGIA, V124, P236, DOI 10.1016/j.neuropsychologia.2018.12.004; Romero-Garcia R, 2018, NEUROIMAGE, V171, P256, DOI 10.1016/j.neuroimage.2017.12.060; Ryan NP, 2017, SOC COGN AFFECT NEUR, V12, P1414, DOI 10.1093/scan/nsx066; Saggar M, 2015, NEUROIMAGE, V120, P274, DOI 10.1016/j.neuroimage.2015.07.006; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Seidlitz J, 2018, NEURON, V97, P231, DOI 10.1016/j.neuron.2017.11.039; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sherman LE, 2014, DEV COGN NEUROS-NETH, V10, P148, DOI 10.1016/j.dcn.2014.08.002; Somerville LH, 2018, NEUROIMAGE, V183, P456, DOI 10.1016/j.neuroimage.2018.08.050; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; TEASDALE G, 1974, LANCET, V2, P81; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Vasa F., 2017, CEREB CORTEX, P1, DOI DOI 10.1093/CERCOR/BHX249; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wechler D., 1999, MANUAL WECHSLER ABBR; Wechsler D, 2003, WECHSLER INTELLIGENC; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, NEUROREHABILITATION, V31, P245, DOI 10.3233/NRE-2012-0794; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	112	1	1	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1878-9293	1878-9307		DEV COGN NEUROS-NETH	Dev. Cogn. Neurosci.	APR	2020	42								100762	10.1016/j.dcn.2020.100762			14	Psychology, Developmental; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	LR5UQ	WOS:000535760200006	32072940	Green Published, gold, Green Accepted			2022-02-06	
J	Li, MY; Chen, C; Wang, ZG; Ke, JJ; Feng, XB				Li, Meng-yun; Chen, Chao; Wang, Zheng-gang; Ke, Jian-juan; Feng, Xiao-bo			Effect of Nalmefene on Delayed Neurocognitive Recovery in Elderly Patients Undergoing Video-assisted Thoracic Surgery with One Lung Ventilation	CURRENT MEDICAL SCIENCE			English	Article						nalmefene; one lung ventilation; elderly patients; delayed neurocognitive recovery; perioperative neurocognitive disorders; thoracic surgery	POSTOPERATIVE COGNITIVE DYSFUNCTION; INFLAMMATORY RESPONSES; OXIDATIVE STRESS; INJURY; NEUROINFLAMMATION; NEURODEGENERATION; INTERLEUKIN-6; PULMONARY; DELIRIUM; BRAIN	The intravenous use of nalmefene has been found to exert neuroprotective effect in patients with severe traumatic brain injury and acute cerebral infarction; nonetheless, it is unknown whether nalmefene alleviates delayed neurocognitive recovery. Our purpose of the current research was to clarify the impact of nalmefene on delayed neurocognitive recovery in aged patients experiencing video-assisted thoracic surgery (VATS) with intraoperative use of one lung ventilation (OLV). The present study involved 120 patients undergoing selective VATS, randomized to accept low-dose nalmefene (N1 group, n=40), high-dose nalmefene (N2 group, n=40) or equal volume of physiologic saline (control group, n=40). A battery of neuropsychological tests were used to estimate cognitive function 1 day before surgery (t(0)) and 10 days after surgery or before discharge (t(1)). Regional cerebral oxygen saturation (rSO(2)) was detected 5 min before induction (t(0)), 5 min after induction (t(1)), 15 and 60 min after onset of OLV (t(2) and t(3)), and 15 min after termination of OLV (t(4)). The plasma values of interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha and adiponectin (ADP) were also detected prior to induction of anesthesia (T0), 1 h, 2 h and 6 h after surgery (T1, T2, T3). On t(1), delayed neurocognitive recovery occurred in 5/40 (12.5%) patients of N1 group, in 5/40 (12.5%) patients of N2 group and in 13/40 (32.5%) patients of control group (P0.05). There were no statistical differences in rSO(2) among three groups at different time points. At T1, T2 and T3, IL-1 beta, IL-6 and TNF-alpha values significantly increased and ADP value significantly decreased (P0.05) in control group. In contrast, at T1, T2 and T3, IL-1 beta, IL-6 and TNF-alpha values decreased and ADP value decreased less in N1 and N2 groups (P0.05). At T1, T2 and T3, IL-1 beta, IL-6 and TNF-alpha concentrations presented a trend of N2 group N1 group control group and ADP presented a trend of N2 groupN1 groupcontrol group (P0.05). The result of our present research supports the hypothesis that the perioperative intravenous treatment with nalmefene to VATS with OLV ameliorates postoperative cognitive function and decreases the incidence of delayed neurocognitive recovery, most likely by suppression of inflammatory responses.	[Li, Meng-yun; Chen, Chao; Wang, Zheng-gang; Ke, Jian-juan; Feng, Xiao-bo] Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430071, Peoples R China		Feng, XB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Anesthesiol, Wuhan 430071, Peoples R China.	283647213@qq.com					Amor S, 2014, IMMUNOLOGY, V141, P287, DOI 10.1111/imm.12134; BEDFORD PD, 1955, LANCET, V2, P259; Cape E, 2014, J PSYCHOSOM RES, V77, P219, DOI 10.1016/j.jpsychores.2014.06.014; Cheng WJ, 2014, MOL MED REP, V10, P2172, DOI 10.3892/mmr.2014.2411; Clark WM, 2000, STROKE, V31, P1234, DOI 10.1161/01.STR.31.6.1234; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crocker E, 2016, ANN THORAC SURG, V102, P1391, DOI 10.1016/j.athoracsur.2016.04.071; de la Gala F, 2017, BRIT J ANAESTH, V119, P655, DOI 10.1093/bja/aex230; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; Egawa J, 2016, CAN J ANESTH, V63, P1161, DOI 10.1007/s12630-016-0700-4; Eguchi T, 2014, ANN THORAC CARDIOVAS, V20, P276, DOI 10.5761/atcs.oa.13.02247; Evered L, 2018, BRIT J ANAESTH, V121, P1005, DOI 10.1016/j.bja.2017.11.087; FADEN AI, 1988, J PHARMACOL EXP THER, V245, P742; Feng Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1017-0; Forsberg A, 2017, ANN NEUROL, V81, P572, DOI 10.1002/ana.24909; Gao W, 2015, ANESTHESIOLOGY, V122, P1235, DOI 10.1097/ALN.0000000000000627; GLASS PSA, 1994, ANESTH ANALG, V78, P536; Grace PM, 2015, BRAIN BEHAV IMMUN, V48, P115, DOI 10.1016/j.bbi.2015.03.005; Hemmerling TM, 2008, BRIT J ANAESTH, V101, P870, DOI 10.1093/bja/aen275; Hirsch J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0681-9; Hu J, 2018, BRIT J ANAESTH, V120, P537, DOI 10.1016/j.bja.2017.11.096; Ju N Y, 2014, ANAESTHESIA, V69, P14, DOI [10.1111/anae.12479, DOI 10.1111/ANAE.12479]; Karzai W, 2009, ANESTHESIOLOGY, V110, P1402, DOI 10.1097/ALN.0b013e31819fb15d; Lases EC, 2000, CHEST, V117, P999, DOI 10.1378/chest.117.4.999; Li NN, 2017, BEHAV BRAIN RES, V322, P60, DOI 10.1016/j.bbr.2017.01.006; Li YC, 2012, ACTA ANAESTH SCAND, V56, P595, DOI 10.1111/j.1399-6576.2011.02616.x; Lohser J, 2015, ANESTH ANALG, V121, P302, DOI 10.1213/ANE.0000000000000808; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Mei HE, 2006, LINCHUANG SHENJINGBI, V19, P182; Michelet P, 2006, ANESTHESIOLOGY, V105, P911, DOI 10.1097/00000542-200611000-00011; Misthos P, 2005, EUR J CARDIO-THORAC, V27, P379, DOI 10.1016/j.ejcts.2004.12.023; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Sugasawa Y, 2011, J ANESTH, V25, P170, DOI 10.1007/s00540-011-1100-0; TACHIBANA M, 1994, CAN J ANAESTH, V41, P710, DOI 10.1007/BF03015626; Tang N, 2017, BRAIN RES, V1657, P377, DOI 10.1016/j.brainres.2016.12.027; Tremblay LN, 2005, AM J PHYSIOL-LUNG C, V288, pL596, DOI 10.1152/ajplung.00438.2004; Vacas S, 2014, ANESTHESIOLOGY, V120, P1160, DOI 10.1097/ALN.0000000000000045; Vivekanantham S, 2015, INT J NEUROSCI, V125, P717, DOI 10.3109/00207454.2014.982795; Wu CY, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2575910; Yamada T, 1998, WORLD J SURG, V22, P783, DOI 10.1007/s002689900470; Yu H, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3605350; Zhang HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113093; Zhang YH, 2015, INT J NEUROSCI, V125, P501, DOI 10.3109/00207454.2014.949341; Zheng J, 2015, INT J NEUROSCI, V125, P918, DOI 10.3109/00207454.2014.985294	46	1	1	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2096-5230	2523-899X		CURR MED SCI	Curr. Med. Sci.	APR	2020	40	2					380	388		10.1007/s11596-020-2170-8			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	LH5CL	WOS:000528803000025	32337700				2022-02-06	
J	Masson, M; Lamoureux, J; de Guise, E				Masson, Maxime; Lamoureux, Julie; de Guise, Elaine			Self-Reported Risk-Taking and Sensation-Seeking Behavior Predict Helmet Wear Amongst Canadian Ski and Snowboard Instructors	CANADIAN JOURNAL OF BEHAVIOURAL SCIENCE-REVUE CANADIENNE DES SCIENCES DU COMPORTEMENT			English	Article						risk-taking; sensation seeking; concussion; ski; snowboard	SAFETY HELMETS; HEAD-INJURIES; ALPINE SKIERS; CONCUSSION; KNOWLEDGE; ATTITUDES; COMPENSATION; SPORTS; LEGISLATION; PREVENTION	The aim of this study was to evaluate whether knowledge on concussions and self-reported risk-taking and sensation-seeking behavior are associated with helmet wear amongst certified Canadian ski and snowboard instructors. A total of 612 participants completed an online cross-sectional survey. Participants were asked about helmet use (answer options: always; most of the time; sometimes; rarely; never) and knowledge on concussion. Risk-taking behavior was self-reported (answer options: more cautious vs. more risky), and they completed the Sensation Seeking Scale Form V. Demographics (sex, age, education, nationality), certified winter sport (skiing and/or snowboarding), level of certification (4 levels, from beginner to expert), years of experience, average skiing time per season, and history of concussion were also recorded. Self-assessment of risk-taking was significantly associated with helmet wear (p = .04) but was not included in the multivariate model, which included only the variables level of p < .01. The final prediction model shows that self-assessment of sensation-seeking behavior (OR = 1.12; 95% confidence interval [CI: 1.05, 1.20]), certification level (OR = 5.75; 95% CI [1.85, 17.88]), and sex (OR = .22; 95% CI [.06,.76]) were significantly associated with helmet wear. Thus, a smaller proportion of men with a certification level of 3 (intermediate to expert level) who reported more sensation-seeking behaviors are wearing a helmet compared with others. In contrast, knowledge on concussion was not associated with the frequency of wearing a helmet. These findings may help in the development of prevention campaigns that focus on the main factors playing a role in helmet wear to more effectively convince nonwearers to adopt the safest practice. Public Significance Statement Our results show that a smaller proportion of male Canadian ski and snowboard instructors with a certification level of 3 (expert) who reported more sensation-seeking behaviors are wearing a helmet compared with others. Prevention programs currently focusing on educating the public on the signs and symptoms of concussions should be optimized to address factors such as risk-taking behavior and sensation seeking to increase frequency of helmet wear.	[Masson, Maxime] McGill Univ, Fac Med, Montreal, PQ, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [de Guise, Elaine] Univ Montreal, Dept Psychol, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada; [de Guise, Elaine] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Campus Laval,1700 Rue Jacques Tetreault,Bur 6230, Laval, PQ H7N 0B6, Canada.	elaine.de.guise@umontreal.ca		de Guise, Elaine/0000-0001-5095-7255			ARNETT J, 1994, PERS INDIV DIFFER, V16, P289, DOI 10.1016/0191-8869(94)90165-1; Beauducel A, 2003, DIAGNOSTICA, V49, P61, DOI 10.1026//0012-1924.49.2.61; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Brandenburg WE, 2016, WILD ENVIRON MED, V27, P62, DOI 10.1016/j.wem.2015.11.009; Brunner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132002; Buller DB, 2003, J TRAUMA, V55, P939, DOI 10.1097/01.TA.0000078694.53320.CA; Burns Sean T, 2015, F1000Res, V4, P114, DOI 10.12688/f1000research.4995.1; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Desrichard O, 2005, ADDICT BEHAV, V30, P1449, DOI 10.1016/j.addbeh.2005.01.011; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; Dohin B, 2008, ARCH PEDIATRIE, V15, P1717, DOI 10.1016/j.arcped.2008.08.022; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Fenerty L, 2016, INJURY PREV, V22, P176, DOI 10.1136/injuryprev-2015-041699; Fenerty L, 2013, J TRAUMA ACUTE CARE, V74, P895, DOI 10.1097/TA.0b013e31827e19ca; Field M., 2004, HDB IMPLICIT COGNITI, P151, DOI [DOI 10.4135/9781412976237.N11, 10.4135/9781412976237.n11]; Finch C F, 1996, Inj Prev, V2, P126, DOI 10.1136/ip.2.2.126; George KM, 2003, NY TIMES BK REV, P4; HACCOUN Robert R., 1987, REV QUEBECOISE PSYCH, V8, P30; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Kopp M, 2016, J SPORT SCI MED, V15, P11; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Liller KD, 1998, J SCHOOL HEALTH, V68, P325, DOI 10.1111/j.1746-1561.1998.tb00594.x; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; National Ski Areas Association Division of Risk & Regulatory Affairs, 2014, FACTS SKIING SNOWB S; Powell C, 2007, WILD ENVIRON MED, V18, P10, DOI 10.1580/1080-6032(2007)18[10:TPORAR]2.0.CO;2; Provance AJ, 2012, CLIN J SPORT MED, V22, P240, DOI 10.1097/JSM.0b013e3182410335; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Robertson DW, 2014, ACCIDENT ANAL PREV, V70, P314, DOI 10.1016/j.aap.2014.04.011; Ruedl G, 2010, SPORTVERLETZ SPORTSC, V24, P27, DOI 10.1055/s-0028-1110011; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Ruedl G, 2012, BRIT J SPORT MED, V46, P1091, DOI 10.1136/bjsports-2012-091374; Ruedl G, 2012, EPIDEMIOLOGY, V23, P936, DOI 10.1097/EDE.0b013e31826d2403; Ruedl G, 2012, ACCIDENT ANAL PREV, V48, P292, DOI 10.1016/j.aap.2012.01.031; Ruedl G, 2012, INJURY PREV, V18, P182, DOI 10.1136/injuryprev-2011-040042; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Ruzic L, 2011, WILD ENVIRON MED, V22, P291, DOI 10.1016/j.wem.2011.09.001; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Shealy JE., 2005, J ASTM INT, V2, P1, DOI [10.1520/JAI12092, DOI 10.1520/JAI12092]; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; Slanger E, 1997, J RES PERS, V31, P355, DOI 10.1006/jrpe.1997.2193; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Thomson CJ, 2015, ACCIDENT ANAL PREV, V75, P179, DOI 10.1016/j.aap.2014.11.024; VALLERAND RJ, 1989, CAN PSYCHOL, V30, P662, DOI 10.1037/h0079856; Warda LJ, 2012, PAED CHILD HEALT-CAN, V17, P38, DOI 10.1093/pch/17.1.35; WEINSTEIN ND, 1989, SCIENCE, V246, P1232, DOI 10.1126/science.2686031; Zheng Y, 2015, NEUROPSYCHOLOGIA, V71, P173, DOI 10.1016/j.neuropsychologia.2015.04.002; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	52	1	1	1	4	CANADIAN PSYCHOLOGICAL  ASSOC	OTTAWA	141 LAURIER AVE WEST, STE 702, OTTAWA, ONTARIO K1P 5J3, CANADA	0008-400X	1879-2669		CAN J BEHAV SCI	Can. J. Behav. Sci.-Rev. Can. Sci. Comport.	APR	2020	52	2					121	130		10.1037/cbs0000153			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	KX8VG	WOS:000522152100005					2022-02-06	
J	Merali, HS; Lin, LY; Li, QF; Bhalla, K				Merali, Hasan S.; Lin, Li-Yi; Li, Qingfeng; Bhalla, Kavi			Using street imagery and crowdsourcing internet marketplaces to measure motorcycle helmet use in Bangkok, Thailand	INJURY PREVENTION			English	Article						traumatic brain injury; helmet; public health; motorcycle; surveillance; low-middle income country	VIEW; PREVALENCE; INJURIES	Introduction The majority of Thailand's road traffic deaths occur on motorised two-wheeled or three-wheeled vehicles. Accurately measuring helmet use is important for the evaluation of new legislation and enforcement. Current methods for estimating helmet use involve roadside observation or surveillance of police and hospital records, both of which are time-consuming and costly. Our objective was to develop a novel method of estimating motorcycle helmet use. Methods Using Google Maps, 3000 intersections in Bangkok were selected at random. At each intersection, hyperlinks of four images 90 degrees apart were extracted. These 12 000 images were processed in Amazon Mechanical Turk using crowdsourcing to identify images containing motorcycles. The remaining images were sorted manually to determine helmet use. Results After processing, 462 unique motorcycle drivers were analysed. The overall helmet wearing rate was 66.7 % (95% CI 62.6 % to 71.0 %). Taxi drivers had higher helmet use, 88.4% (95% CI 78.4% to 94.9%), compared with non-taxi drivers, 62.8% (95% CI 57.9% to 67.6%). Helmet use on non-residential roads, 85.2% (95% CI 78.1 % to 90.7%), was higher compared with residential roads, 58.5% (95% CI 52.8% to 64.1%). Using logistic regression, the odds of a taxi driver wearing a helmet compared with a non-taxi driver was significantly increased 1.490 (p<0.01). The odds of helmet use on non-residential roads as compared with residential roads was also increased at 1.389 (p<0.01). Conclusion This novel method of estimating helmet use has produced results similar to traditional methods. Applying this technology can reduce time and monetary costs and could be used anywhere street imagery is used. Future directions include automating this process through machine learning.	[Merali, Hasan S.] McMaster Childrens Hosp, Div Pediat Emergency Med, Hamilton, ON L8S 4K1, Canada; [Lin, Li-Yi] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Li, Qingfeng] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Bhalla, Kavi] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA		Merali, HS (corresponding author), McMaster Childrens Hosp, Div Pediat Emergency Med, Hamilton, ON L8S 4K1, Canada.	meralih@mcmaster.ca	Merali, Hasan/AAT-4812-2021; Li, Qingfeng/J-9520-2016	Merali, Hasan/0000-0002-0486-0425; Li, Qingfeng/0000-0002-6390-6921	Alpha Chapter of the Delta Omega Public Health Honors Society at Johns Hopkins University	Funding for this study was provided by the Alpha Chapter of the Delta Omega Public Health Honors Society at Johns Hopkins University.	Acock AC, 2008, GENTLE INTRO STATA; Amazon, 2018, AM MECH TURK FREQ AS; Apte JS, 2017, ENVIRON SCI TECHNOL, V51, P6999, DOI 10.1021/acs.est.7b00891; Bachani AM, 2017, PUBLIC HEALTH, V144, pS23, DOI 10.1016/j.puhe.2016.12.005; Bachani AM, 2013, INJURY, V44, pS31, DOI [10.1016/S0020-1383(13)70210-9, 10.1016/S0020-1383(13)70209-2]; BBBike.org, 2017, OSM EXTR BANGK; Buckley L, 2016, ACCIDENT ANAL PREV, V95, P178, DOI 10.1016/j.aap.2016.07.009; Clews C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3115-9; Deus E, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5555-1; Gleibs IH, 2017, BEHAV RES METHODS, V49, P1333, DOI 10.3758/s13428-016-0789-y; Goel R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196521; Greene WH., 2003, ECONOMETRIC ANAL; Hipp JA, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00097; Hung DV, 2006, INJURY PREV, V12, P409, DOI 10.1136/ip.2006.012724; Jiwattanakulpaisarn P, 2013, GLOB HEALTH PROMOT, V20, P14, DOI 10.1177/1757975913499030; Kelly CM, 2013, ANN BEHAV MED, V45, pS108, DOI 10.1007/s12160-012-9419-9; Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Merali HS, 2018, INT J INJ CONTROL SA, V25, P134, DOI 10.1080/17457300.2017.1345948; Mistry J, 2017, INT CONF IMAG PROC; Mortensen K, 2018, J GEN INTERN MED, V33, P533, DOI 10.1007/s11606-017-4246-0; Nishi A, 2018, B WORLD HEALTH ORGAN, V96, P514, DOI 10.2471/BLT.18.215509; Olea PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054582; Peden MM, 2018, INJURY PREV, V24, P381, DOI 10.1136/injuryprev-2018-042873; Rzotkiewicz A, 2018, HEALTH PLACE, V52, P240, DOI 10.1016/j.healthplace.2018.07.001; Siviroj P, 2012, INT J ENV RES PUB HE, V9, P3286, DOI 10.3390/ijerph9093286; StataCorp, 2017, STATA STAT SOFTWARE; Suriyawongpaisa P, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-74; Tongklao A, 2016, TRAFFIC INJ PREV, V17, P80, DOI 10.1080/15389588.2015.1045062; Van Hung Trinh, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P405; Vecino-Ortiz AI, 2018, LANCET GLOB HEALTH, V6, pE523, DOI 10.1016/S2214-109X(18)30107-4; Wilson N, 2015, AUST NZ J PUBL HEAL, V39, P295, DOI 10.1111/1753-6405.12361; World Health Organization, 2015, GLOB STAT REP ROAD S; Wu CYH, 2016, TRAFFIC INJ PREV, V17, P170, DOI 10.1080/15389588.2015.1048336; Wu YT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1094	35	1	1	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2020	26	2					103	108		10.1136/injuryprev-2018-043061			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KZ7QD	WOS:000523453000003	30833286				2022-02-06	
J	Muller, M; Munster, JM; Hautz, WE; Gerber, JL; Schefold, JC; Exadaktylos, AK; Pfortmueller, CA				Mueller, Martin; Muenster, Julia M.; Hautz, Wolf E.; Gerber, Joel L.; Schefold, Joerg C.; Exadaktylos, Aristomenis K.; Pfortmueller, Carmen A.			Increased S-100 B levels are associated with fractures and soft tissue injury in multiple trauma patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						S100 B; Biomarker; Multiple trauma; Fractures; Diagnosis	SERUM S100B LEVELS; SEVERITY SCORE; BODY CT; PROTEIN; S100-BETA; MARKER; DAMAGE	Background: S-100 B protein was identified as a biomarker for traumatic brain injury, but studies suggest that extracranial injuries may also lead to increased S-100 B serum levels. In this study, we aim to quantify the impact of injury patterns on S-100 B levels in patients with suspected multiple trauma. Methods: Patients with suspected multiple trauma treated at a Level 1 Trauma centre in Switzerland were included in this retrospective patient chart review. Extent of injuries and severity was assessed and S-100 B levels on admission measured. Potential predictors of increased S-100 B levels (>0.2 mu g/L) were identified through uni- and multivariable analyses. Results: In total, 1,338 patients with suspected multiple trauma were included. Multivariable logistic regression showed a significant association with increased S-100 B levels in long bone fracture (OR 2.3, 95% CI: 1.3-4.1, p =0.004), non-long bone fracture (OR 3.0, 95% CI: 2.2-4.3, p<0.001), thoracic injury (OR 2.6, 95% CI: 1.6-4.2, p<0.001), and deep tissue injury/wounds (OR 1.9, 95% CI: 1.4-2.6, p<0.001). Head trauma with intracerebral bleeding was only weakly associated (OR 2.0, 95% CI 1.2-3.5, p = 0.01) and head trauma without intracranial bleeding was not associated with an increased S-100 B protein level (p =0.71). Trauma severity was also related to increased S-100 B levels (OR per ISS: 1.1, 95% CI 1.0-1.1, p<0.001). S-100 B levels <0.57 mu g/L had a high diagnostic value to rule out in-hospital mortality (negative predictive value: 1.0, 95% CI: 0.98-1.00). Conclusion: Fractures and thoracic injuries appeared as main factors associated with increased S-100 B levels. Head injury may only play a minor role in S-100 B protein elevation in multiple trauma patients. A normal S-100 B has a good negative predictive value for in-hospital mortality. S-100-B levels were associated with trauma severity and might thus be of use as a prognostic marker in trauma patients. (C) 2020 The Authors. Published by Elsevier Ltd.	[Mueller, Martin; Muenster, Julia M.; Hautz, Wolf E.; Exadaktylos, Aristomenis K.] Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, Bern, Switzerland; [Gerber, Joel L.; Schefold, Joerg C.; Pfortmueller, Carmen A.] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, Inselspital, Bern, Switzerland		Munster, JM (corresponding author), Univ Bern, Bern Univ Hosp, Dept Emergency Med, Inselspital, Bern, Switzerland.	martin.mueller2@insel.ch; julia.muenster@students.unibe.ch; wolf.hautz@insel.ch; joel.gerber@spitalzofingen.ch; joerg.schefold@insel.ch; aristomenis.exadaktylos@insel.ch; carmen.pfortmueller@insel.ch		Hautz, Wolf/0000-0002-2445-984X; Schefold, Joerg C./0000-0001-9162-5724	CTU-Grant from the Inselspital, Bern University Hospital; University of Bern, Bern, Switzerland	MM was funded by a CTU-Grant from the Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 2018, 10 THINGS PHYS PATIE; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Cohen PH, LONG BONE FRACTURE S; Firsching R, GUIDELINE TRAUMATIC, P7; Gennarelli T WE, ABBREVIATED INJURY S; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hasselblatt M, SERUM S100 INCREASES, P3; Heron Melonie, 2018, Natl Vital Stat Rep, V67, P1; KAHN HJ, 1991, MODERN PATHOL, V4, P698; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; Long B, 2017, AM J EMERG MED, V35, P1356, DOI 10.1016/j.ajem.2017.03.048; Mica Ladislav, 2013, J Trauma Manag Outcomes, V7, P6, DOI 10.1186/1752-2897-7-6; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152822; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Raja AS, 2017, WEST J EMERG MED, V18, P454, DOI 10.5811/westjem.2017.1.32677; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; Sierink JC, 2016, LANCET, V388, P673, DOI 10.1016/S0140-6736(16)30932-1; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2010, J HEAD TRAUMA REHABI, P13; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Zock M, 2011, NOTFALL RETTUNGSMED, V14, P261, DOI 10.1007/s10049-011-1425-0; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	APR	2020	51	4					812	818		10.1016/j.injury.2020.03.012			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	LK7SV	WOS:000531062800004	32192718	Green Published, hybrid			2022-02-06	
J	Muthalagappan, S; Robbins, T; Mehta, H; Murthy, N				Muthalagappan, Seethalakshmi; Robbins, Timothy; Mehta, Hiten; Murthy, Narasimha			Facial twitching: calcium or concussion conundrum? Hypocalcaemia in a young American football player masking an internal carotid artery dissection	BMJ CASE REPORTS			English	Article						stroke; calcium and bone	MANAGEMENT; STROKE; DIAGNOSIS; INJURY; RUGBY	A 30-year-old male American football player presented to the acute medical unit with left-hand and hemifacial spasms. History and examination revealed hemifacial spasms in keeping with seizure-like activity possibly due to symptomatic hypocalcaemia. Subsequent investigations revealed an adjusted calcium of 1.87mmol/L and, hence, he was managed with intravenous calcium replacement. He presented two further times in a 1-month period, with subjective limb weakness, despite normal adjusted calcium. During his third admission, he developed slurred speech and a marked facial droop, with absence of power in the right upper limb. Imaging revealed acute and old infarctions in the left middle cerebral artery territory and appearances consistent with left internal carotid artery dissection. This presentation of arterial stroke is atypical but with potentially grave consequences if missed. There is limited literature on the presentation of hemifacial spasm, and its association with ischaemic or haemorrhagic stroke represents a key learning point.	[Muthalagappan, Seethalakshmi] South Warwickshire NHS Fdn Trust, Diabet & Endocrinol, Warwick, England; [Robbins, Timothy; Murthy, Narasimha] Univ Hosp Coventry & Warwickshire NHS Trust, Diabet & Endocrinol, Coventry, W Midlands, England; [Mehta, Hiten] Univ Hosp Coventry & Warwickshire NHS Trust, Radiol, Coventry, W Midlands, England		Robbins, T (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Diabet & Endocrinol, Coventry, W Midlands, England.	drtrobbins@gmail.com					Aronov Moisey, 2014, BMJ Case Rep, V2014, DOI 10.1136/bcr-2014-203725; Baumgartner RW, 2005, FRONT NEUROL NEUROSC, V20, P70, DOI 10.1159/000088151; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cooper MS, 2008, BRIT MED J, V336, P1298, DOI 10.1136/bmj.39582.589433.BE; Cuellar TA, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-36; Debette S, 2015, LANCET NEUROL, V14, P640, DOI 10.1016/S1474-4422(15)00009-5; Fabian TC, 2013, J AM COLL SURGEONS, V216, P873, DOI 10.1016/j.jamcollsurg.2012.12.053; Her Majesty's Stationary Office, 1976, MED RES COUNC AIDS I; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; MACEFIELD G, 1991, BRAIN, V114, P527, DOI 10.1093/brain/114.1.527; Marx SJ, 2000, NEW ENGL J MED, V343, P1863, DOI 10.1056/NEJM200012213432508; Meek CL, 2011, CLIN CHEM, V57, P811, DOI 10.1373/clinchem.2010.150375; PALMER SH, 1995, INJURY, V26, P555, DOI 10.1016/0020-1383(95)00114-O; POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412; Stroke Association, 2019, STROK WARN SIGNS SYM; Turner J., 2016, EMERGENCY MANAGEMENT, V5; Yuan F, 2013, TURK NEUROSURG, V23, P282, DOI 10.5137/1019-5149.JTN.4889-11.1	17	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	APR	2020	13	4							e231506	10.1136/bcr-2019-231506			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SS1VU	WOS:000661530700007	32350051				2022-02-06	
J	Naylor, JF; Borgman, MA; April, MD; Hill, GJ; Schauer, SG				Naylor, Jason F.; Borgman, Matthew A.; April, Michael D.; Hill, Guyon J.; Schauer, Steven G.			Normobaric hyperoxia in wartime pediatric trauma casualties	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; CARDIAC-ARREST; IRAQ; SURVIVAL; ASSOCIATION; AFGHANISTAN; HYPOTENSION; PREDICTORS; OUTCOMES; CARE	Background: Mounting evidence suggests hyperoxia therapy may be harmful. We describe injury characteristics and survival outcomes for pediatric trauma casualties in Iraq and Afghanistan, stratified by partial pressure of arterial oxygen (PaO2). Secondarily, we performed subgroup analyses for severe traumatic brain injury (TBI) and massive transfusion of blood products (MT). Methods: We utilized Department of Defense Trauma Registry data. We included subjects <18 years. We excluded subjects without an arterial blood gas (ABG). We stratified subjects as hyperoxemia (PaO2 100-300 mmHg) and extreme hyperoxemia (PaO2 >300 mmHg). Results: January 2007-January 2016, 3439 pediatric encounters were in the database. Of those, 1323 had an ABG, with 291 (22%) demonstrating hyperoxemia and 43 (3.3%) extreme hyperoxemia. The median age was 8, most were male (76%) in Afghanistan (69%), and injured by explosive (42%). There were no significant differences in survival between subjects with no hyperoxemia, hyperoxemia, and extreme hyperoxemia (92% vs 87% vs 86%; p = 0.078). Also, there were no significant differences in survival between groups among TBI and MT subjects, and there were no increased odds of survival between groups on multivariable regression analyses. Conclusions: Hyperoxemia was common among hospitalized, wartime pediatric trauma casualties in Iraq and Afghanistan that underwent ABG analysis. Survival to hospital discharge rates were not significantly different between subjects with hyperoxemia and subjects without hyperoxemia.	[Naylor, Jason F.; Hill, Guyon J.] Madigan Army Med Ctr, Joint Base Lewis McChord, 9040 Jackson Ave, Washington, DC 98431 USA; [Borgman, Matthew A.; April, Michael D.; Schauer, Steven G.] Brooke Army Med Ctr, Joint Base San Antonio Ft Sam Houston, San Antonio, TX 78243 USA; [Schauer, Steven G.] US Army, Inst Surg Res, Joint Base San Antonio Ft Sam Houston, San Antonio, TX 78243 USA; [Schauer, Steven G.] 59th Med Wing, Joint Base San Antonio Lackland, Lackland AFB, TX 78236 USA		Naylor, JF (corresponding author), Madigan Army Med Ctr, Joint Base Lewis McChord, 9040 Jackson Ave, Washington, DC 98431 USA.	jason.f.naylor.mil@mail.mil	Borgman, Matthew A/L-9477-2015	Borgman, Matthew A/0000-0002-2008-7380; Naylor, Jason/0000-0001-8448-1160			Barnes J, 2009, ANN ADV AUTOMOTIVE M; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Deuber C, 2011, J PERINAT NEONAT NUR, V25, P268, DOI 10.1097/JPN.0b013e318226ee2c; Deulofeut R, 2006, J PERINATOL, V26, P700, DOI 10.1038/sj.jp.7211608; Edwards MJ, 2014, J AM COLL SURGEONS, V218, P1018, DOI 10.1016/j.jamcollsurg.2013.12.050; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Emeriaud G, 2011, CURR OPIN ANESTHESIO, V24, P307, DOI 10.1097/ACO.0b013e3283466b6b; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Flick RP, 2009, ANESTHESIOLOGY, V111, P1384, DOI 10.1097/ALN.0b013e3181c0e228; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Meier J, 2004, ANESTHESIOLOGY, V100, P70, DOI 10.1097/00000542-200401000-00014; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Naylor JF, 2018, PEDIATR RADIOL, V48, P620, DOI 10.1007/s00247-017-4065-9; Naylor JF, 2018, MIL MED; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Schauer SG, 2018, MIL MED; Schauer Stephen G, 2017, US Army Med Dep J, P92; Schauer SG, 2019, PREHOSP EMERG CARE, V23, P700, DOI 10.1080/10903127.2018.1560849; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P608, DOI 10.1080/10903127.2018.1428839; Schauer SG, 2018, AM J EMERG MED, V36, P1540, DOI 10.1016/j.ajem.2018.01.014; Schauer SG, 2019, AM J EMERG MED, V37, P94, DOI 10.1016/j.ajem.2018.04.068; Schauer SG, 2018, AM J EMERG MED, V36, P657, DOI 10.1016/j.ajem.2017.11.066; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vincent JL, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/2834956; Vincent JL, 2013, NEW ENGL J MED, V369, P1726, DOI 10.1056/NEJMra1208943; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Wepler M, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1980-6; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	41	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	APR	2020	38	4					709	714		10.1016/j.ajem.2019.06.005			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MI4KE	WOS:000547378200003	31182364				2022-02-06	
J	Peng, J; He, FJ; Qin, CG; Que, YY; Fan, R; Qin, B				Peng, Jing; He, Fujuan; Qin, Chenguang; Que, Yuanyuan; Fan, Rui; Qin, Bin			Intraoperative Dexmedetomidine Versus Midazolam in Patients Undergoing Peripheral Surgery With Mild Traumatic Brain Injuries: A Retrospective Cohort Analysis	DOSE-RESPONSE			English	Article						analgesia; anesthesia; dexmedetomidine; inflammatory response; midazolam; sedation	DOUBLE-BLIND; ANESTHESIA; SEDATION; CARE	Background: The intra- and postoperative effects of dexmedetomidine are not completely consistent and midazolam/fentanyl is most widely used in peripheral surgeries. The objectives of the study were to evaluate the sedative, analgesic, hemodynamic, anti-inflammatory, and antioxidant effects of dexmedetomidine against midazolam in patients undergoing peripheral surgeries with mild traumatic brain injuries. Methods: Medical records of patients who underwent peripheral surgeries with mild traumatic brain injury were included in the analysis. Patients received intraoperative midazolam (MDZ cohort, n = 225) or dexmedetomidine (DEX cohort, n = 231). Pre-, intra-, and postoperative characteristics of patients were collected and analyzed. Results: After administration of anesthesia, up to 40 minutes, patients of the MDZ group had lower modified observer's assessment of alertness/sedation score than those of the DEX group (P = .041), but after 40 minutes, patients of the MDZ group had a higher score than those of the DEX group throughout surgeries (P = 0.048). The DEX group has less requirements of postoperative morphine/equivalent doses than the MDZ group (4 +/- 1 vs 5 +/- 1, P < .0001, q = 18.451). Conclusions: Intraoperative DEX offers better sedation, postoperative analgesia, and clinical recovery for peripheral surgeries and suppresses inflammatory response.	[Peng, Jing; He, Fujuan; Qin, Chenguang; Que, Yuanyuan; Fan, Rui] Guizhou Prov Peoples Hosp, Dept Anesthesiol, Guiyang 550002, Guizhou, Peoples R China; [Qin, Bin] Guizhou Prov Peoples Hosp, Dept Oral & Maxillofacial Surg, Guiyang, Guizhou, Peoples R China		He, FJ (corresponding author), Guizhou Prov Peoples Hosp, Dept Anesthesiol, Guiyang 550002, Guizhou, Peoples R China.	527135063@qq.com			Youth fund of guizhou provincial people's hospital [GZSYQN[2018]13]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Youth fund of guizhou provincial people's hospital (No: GZSYQN[2018]13).	Abcejo AS, 2017, MAYO CLIN PROC, V92, P1042, DOI 10.1016/j.mayocp.2017.03.012; Barends CRM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169525; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Candiotti KA, 2010, ANESTH ANALG, V110, P47, DOI 10.1213/ane.0b013e3181ae0856; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P143, DOI 10.1111/j.1749-6632.2010.05761.x; Giovannitti Joseph A Jr, 2015, Anesth Prog, V62, P31, DOI 10.2344/0003-3006-62.1.31; Goldfarb Y, 2011, ANN SURG, V253, P798, DOI 10.1097/SLA.0b013e318211d7b5; Ilhan O, 2010, EURASIAN J MED, V42, P61, DOI 10.5152/eajm.2010.19; Jiang LX, 2017, J CLIN ANESTH, V40, P25, DOI 10.1016/j.jclinane.2017.04.003; Jo YY, 2016, MED SCI MONITOR, V22, P3544, DOI 10.12659/MSM.896461; Kashefi P, 2011, J RES MED SCI, V16, P1139; Kim TK, 2015, BRIT J ANAESTH, V115, P569, DOI 10.1093/bja/aev306; Koroglu A, 2006, ANESTH ANALG, V103, P63, DOI 10.1213/01.ane.0000219592.82598.AA; Li S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/186736; Liu JY, 2017, MOL MED REP, V15, P169, DOI 10.3892/mmr.2016.6031; Luo XH, 2016, CLIN NEUROL NEUROSUR, V146, P105, DOI 10.1016/j.clineuro.2016.05.004; MacLaren R, 2015, J INTENSIVE CARE MED, V30, P167, DOI 10.1177/0885066613510874; Park SW, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012565; Silva JM, 2019, REGION ANESTH PAIN M, V44, P319, DOI 10.1136/rapm-2018-100120; Zihl J, 2015, J CLIN MED, V4, P1051, DOI 10.3390/jcm4051051	20	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1559-3258			DOSE-RESPONSE	Dose-Response	APR	2020	18	2							1559325820916342	10.1177/1559325820916342			10	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	LC2XU	WOS:000525190600001	32284701	gold, Green Published			2022-02-06	
J	Pushchina, EV; Zharikova, EI; Varaksin, AA; Prudnikov, IM; Tsyvkin, VN				Pushchina, Evgeniya V.; Zharikova, Eva I.; Varaksin, Anatoly A.; Prudnikov, Igor M.; Tsyvkin, Vladimir N.			Proliferation, Adult Neuronal Stem Cells and Cells Migration in Pallium during Constitutive Neurogenesis and after Traumatic Injury of Telencephalon of Juvenile Masu Salmon, Oncorhynchus masou	BRAIN SCIENCES			English	Article						traumatic brain injury; adult neuronal stem cells; proliferation of cells; neuronal precursor cells; postmitotic neuroblasts; pallial part of telencephalon; masu salmon; GFAP; vimentin; doublecortin	MOLECULAR CHARACTERIZATION; NEURAL PROGENITORS; ZEBRAFISH BRAIN; TELEOST FISH; REGENERATION; EXPRESSION; VIMENTIN; MODEL; PROTEIN; IDENTIFICATION	A study of the lateral pallium in zebrafish and the visual tectum of the medaka revealed a population of adult neuroepithelial (NE) cells supported from the early stage of development to various postembryonic stages of ontogenesis. These data emphasize the importance of non-radial glial stem cells in the neurogenesis of adult animals, in particular fish. However, the distribution, cell cycle features, and molecular markers of NE cells and glial progenitors in fish are still poorly understood at the postembryonic stages of ontogenesis. Fetalization predominates in the ontogenetic development of salmon fish, which is associated with a delay in development and preservation of the features of the embryonic structure of the brain during the first year of life. In the present work, we studied the features of proliferation and the migration of neuronal precursors in the pallial proliferative zone of juvenile Oncorhynchus masou. The aim of the study is a comparative analysis of the distribution of glial-type aNSCs markers, such as vimentin and glial fibrillar acid protein GFAP, as well as the proliferation marker BrdU and migratory neuronal precursor doublecortin, in the pallial zone of the intact telencephalon in juvenile O. masou normal and after mechanical injury. The immunohistochemical IHC labeling with antibodies to vimentin, GFAP and doublecortin in the pallium of intact fish revealed single, small, round and oval immunopositive cells, that correspond to a persistent pool of neuronal and/or glial progenitors. After the injury, heterogeneous cell clusters, radial glia processes, single and small intensely labeled GFAP+ cells in the parenchyma of Dd and lateral part of pallium (Dl) appeared, corresponding to reactive neurogenic niches containing glial aNSCs. A multifold increase in the pool of Vim+ neuronal precursor cells (NPCs) resulting from the injury was observed. Vim+ cells of the neuroepithelial type in Dd and Dm and cells of the glial type were identified in Dl after the injury. Doublecortine (Dc) immunolabeling after the injury revealed the radial migration of neuroblasts into Dm from the neurogenic zone of the pallium. The appearance of intensely labeled Dc+ cells in the brain parenchyma might indicate the activation of resident aNSCs as a consequence of the traumatic process.	[Pushchina, Evgeniya V.; Zharikova, Eva I.; Varaksin, Anatoly A.] Russian Acad Sci, Far East Branch, Zhirmunsky Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia; [Pushchina, Evgeniya V.; Prudnikov, Igor M.; Tsyvkin, Vladimir N.] Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine		Pushchina, EV (corresponding author), Russian Acad Sci, Far East Branch, Zhirmunsky Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia.; Pushchina, EV (corresponding author), Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine.	puschina@mail.ru; eva_1213@mail.ru; anvaraksin@mail.ru; specification77@yahoo.com; malysh@biph.kiev.ua	Varaksin, Anatoliy/AAN-1585-2021; Prudnikov, Igor/C-2883-2016; Pushchina, Evgeniya/P-9789-2015	Prudnikov, Igor/0000-0002-1669-7450; Pushchina, Evgeniya/0000-0003-0388-3147	Russian FederationRussian Federation [MD-4318.2015.4]; Far Eastern Branch of the Russian Academy of SciencesRussian Academy of Sciences [15-I-6-116]	This work was supported by the President of the Russian Federation (grant No. MD-4318.2015.4; to E.V.P. and E.I.Z.) and by the Far Eastern Branch of the Russian Academy of Sciences within the Program for Basic Research for 2015-2017 (grant No. 15-I-6-116; section III; to A.A.V., E.I.Z. and E.V.P.).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Alunni A, 2010, DEV NEUROBIOL, V70, P693, DOI 10.1002/dneu.20799; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Arochena M, 2004, J COMP NEUROL, V469, P413, DOI 10.1002/cne.11021; Augusto-Oliveira M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020125; Ayanlaja AA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00199; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Candal E, 2005, DEV BRAIN RES, V160, P157, DOI 10.1016/j.devbrainres.2005.08.009; Rosillo JC, 2016, NEUROSCIENCE, V336, P63, DOI 10.1016/j.neuroscience.2016.08.045; Cerda J, 1998, EUR J CELL BIOL, V77, P175, DOI 10.1016/S0171-9335(98)80105-2; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Cuoghi B, 2009, CELL TISSUE RES, V338, P319, DOI 10.1007/s00441-009-0870-2; DAHL D, 1981, EUR J CELL BIOL, V24, P191; Dambroise E, 2017, STEM CELLS, V35, P1505, DOI 10.1002/stem.2588; Dirian L, 2014, DEV CELL, V30, P123, DOI 10.1016/j.devcel.2014.05.012; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Fernandez AS, 2011, NEUROSCIENCE, V189, P12, DOI 10.1016/j.neuroscience.2011.05.063; Fishell G, 2010, NAT NEUROSCI, V13, P144, DOI 10.1038/nn0210-145; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Herrmann H, 1996, J CELL SCI, V109, P569; Kalman M, 1998, ANAT EMBRYOL, V198, P409, DOI 10.1007/s004290050193; Kalman M, 2002, J EXP ZOOL, V293, P395, DOI 10.1002/jez.10134; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kimbrel EA, 2014, STEM CELLS DEV, V23, P1611, DOI 10.1089/scd.2013.0554; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Manger P., 2015, P AD NEUR EV REG FUN; Mazengenya P., 2015, P AD NEUR EV REG FUN; Merkulov G. A., 1969, KURS PATOLOGOGISTOLO; Ninkovic J, 2013, BIOESSAYS, V35, P242, DOI 10.1002/bies.201200108; Olivera-Pasilio V, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00437; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pushchina EV, 2019, RUSS J DEV BIOL+, V50, P59, DOI 10.1134/S106236041902005X; Pushchina EV, 2017, RUSS J DEV BIOL+, V48, P307, DOI 10.1134/S106236041705006X; Pushchina E.V., 2019, J R SCI, V1, P36; Pushchina EV, 2013, NEURAL REGEN RES, V8, P13, DOI 10.3969/j.issn.1673-5374.2013.01.002; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; Stigloher C, 2008, BRAIN RES BULL, V75, P266, DOI 10.1016/j.brainresbull.2007.10.032; Takeda A, 2015, NEUROSCIENCE, V284, P134, DOI 10.1016/j.neuroscience.2014.09.066; Teles MC, 2012, J COMP PHYSIOL A, V198, P427, DOI 10.1007/s00359-012-0721-6; Tozzini ET, 2012, AGING CELL, V11, P241, DOI 10.1111/j.1474-9726.2011.00781.x; Traniello IM, 2014, DEV NEUROBIOL, V74, P514, DOI 10.1002/dneu.22145; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vitalo AG, 2016, J COMP PHYSIOL A, V202, P445, DOI 10.1007/s00359-016-1089-9; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Xu L, 2015, MOL NEUROBIOL, V51, P131, DOI 10.1007/s12035-014-8692-y; Zupanc GKH, 2013, CURR TOP MICROBIOL, V367, P193, DOI 10.1007/82_2012_297; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	63	1	1	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	APR	2020	10	4							222	10.3390/brainsci10040222			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LP4EO	WOS:000534271500023	32276413	Green Published, gold			2022-02-06	
J	Sara, S; Mohammad, K; Nader, S; Maryam, I; Marzieh, S; Elham, J; Neda, S				Sara, Shirazpour; Mohammad, Khaksari; Nader, Shahrokhi; Maryam, Iranpour; Marzieh, Shahryari; Elham, Jafari; Neda, Salmani			Using the NGF/IL-6 ratio as a reliable criterion to show the beneficial effects of progesterone after experimental diffuse brain injury	HELIYON			English	Article						Neuroscience; Endocrinology; Health sciences; Physiology; Nervous system; Reproductive system; Progesterone; Traumatic brain injury; Brain edema; IL-6; NGF/IL-6	NERVE GROWTH-FACTOR; SEX STEROID-HORMONES; INFLAMMATORY RESPONSE; INTRACRANIAL-PRESSURE; BARRIER DYSFUNCTION; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; ESTROUS-CYCLE; INTERLEUKIN-6	Acute progesterone injection has been shown to reduce brain edema following traumatic brain injury (TBI) due to its neuroprotective effect. We investigated the effects of sustained release of progesterone through implantation of subcutaneous capsules on rat's brain edema and alteration of cerebrospinal fluid (CSF), and serum ratio of NGF/IL-6 after TBI. This experiment was performed on ovariectomized (OVX) rats and the brain injury was induced by Marmarou's method. A high and a low dose of progesterone (HP and LP) was injected intraperitoneally two h after the brain injury. In addition, in the capsule progesterone-treated group (CP), the intervention was implemented 6 h after the brain injury. Brain edema, NGF and IL-6 biomarkers in serum and cerebrospinal fluid (CSF) were measured 48 h after the TBI in injection groups and one week after the TBI in the CP group. No significant difference was found in the two groups or in the admonition methods. After TBI, the NGF level increased and IL-6 level decreased by injection of both doses, as well as by taking the capsule. Ratio of NGF/IL-6 in CSF increased significantly by all forms of progesterone administration. The increase in the level of NGF and IL-6 after TBI was higher in CSF than in serum. These results indicated that effects of progesterone in capsule form were better than the injection form. Progesterone probably works by increasing NGF and reducing IL-6. Future studies should investigate the ratio of these biomarkers as a variable to determine the neuroprotective effects of another drug.	[Sara, Shirazpour] Kerman Univ Med Sci, Neurosci Res Ctr, Neuropharmacol Inst, Kerman, Iran; [Mohammad, Khaksari] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Nader, Shahrokhi] Kerman Univ Med Sci, Physiol Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Maryam, Iranpour; Elham, Jafari] Kerman Univ Med Sci, Pathol & Stem Cell Res Ctr, Dept Pathol, Kerman, Iran; [Marzieh, Shahryari] Golestan Univ Med Sci, Med Fac, Neurosci Res Ctr, Dept Physiol, Gorgan, Golestan, Iran; [Neda, Salmani] Islamic Azad Univ Zarand, Genet Inst, Dept Psychol, Keman, Iran		Mohammad, K (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran.	mkhaksari@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Iranpour, Maryam/0000-0001-8749-8080	Kerman University of Medical Sciences	This work was supported by Kerman University of Medical Sciences.	Abbas AK, 1994, CELLULAR MOL IMMUNOL; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bimonte-Nelson HA, 2004, NEUROREPORT, V15, P2659, DOI 10.1097/00001756-200412030-00021; Bjorling DE, 2002, NEUROSCIENCE, V110, P155, DOI 10.1016/S0306-4522(01)00568-1; Branchi I, 2006, BIOL PSYCHIAT, V60, P690, DOI 10.1016/j.biopsych.2006.01.005; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; CHYATTE D, 1989, STROKE, V20, P1021, DOI 10.1161/01.STR.20.8.1021; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; DEPAOLO LV, 1979, BIOL REPROD, V21, P1015, DOI 10.1095/biolreprod21.4.1015; DEPAOLO LV, 1986, BIOL REPROD, V35, P320, DOI 10.1095/biolreprod35.2.320; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DINARELLO CA, 1991, BRAIN RES, V562, P199, DOI 10.1016/0006-8993(91)90622-3; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Freeman RS, 2004, PROG BRAIN RES, V146, P111, DOI 10.1016/S0079-6123(03)46008-1; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; Gotkin JL, 2006, AM J OBSTET GYNECOL, V195, P1015, DOI 10.1016/j.ajog.2006.07.002; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hajmohammadi M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01043; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Howell A, 2000, CANCER, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Jiang C, 2009, INFLAMM RES, V58, P619, DOI 10.1007/s00011-009-0032-8; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Joukar S, 2010, OPEN CARDIOVASC MED, V4, P1, DOI 10.2174/1874192401004010001; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; KAWAJA MD, 1991, NEURON, V7, P1019, DOI 10.1016/0896-6273(91)90346-2; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Koski CL, 2004, ENDOCRINOLOGY, V145, P95, DOI 10.1210/en.2003-0803; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Lariche MJ, 2020, ENERG SOURCE PART A, V42, P1247, DOI 10.1080/15567036.2019.1602233; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li XZ, 2009, NEUROSCI RES, V65, P252, DOI 10.1016/j.neures.2009.07.007; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Shahrokhi N, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.37005; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Yan PS, 2016, NEURAL REGEN RES, V11, P1851, DOI 10.4103/1673-5374.194758; Young J, 2015, BRAIN RES BULL, V115, P17, DOI 10.1016/j.brainresbull.2015.04.003	65	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	APR	2020	6	4							e03844	10.1016/j.heliyon.2020.e03844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LI9MM	WOS:000529800500171	32373743	Green Published, gold			2022-02-06	
J	Schijns, OEMG; Bisschop, J; Rijkers, K; Dings, J; Vanherle, S; Lindsey, P; Smeets, HJM; Hoogland, G				Schijns, Olaf E. M. G.; Bisschop, Jeroen; Rijkers, Kim; Dings, Jim; Vanherle, Sabina; Lindsey, Patrick; Smeets, Hubert J. M.; Hoogland, Govert			GAT-1 (rs2697153) and GAT-3 (rs2272400) polymorphisms are associated with febrile seizures and temporal lobe epilepsy	EPILEPTIC DISORDERS			English	Article; Proceedings Paper	Annual Meeting of the European-Association-of-Neurosurgical-Societies (EANS)	OCT 21-25, 2018	Brussels, BELGIUM	European Assoc Neurosurg Soc		GABA transporter; single nucleotide polymorphism; febrile seizures; temporal lobe epilepsy	HIPPOCAMPAL GABA; TRANSPORTER REVERSAL; ILAE COMMISSION; GENE-FUNCTION; GLUTAMATE; INHIBITION; SLC6A1; MECHANISMS; MUTATIONS; RECEPTORS	Aim. The purpose of this study was to determine a possible association between two GABA transporter (GAT) single-nucleotide polymorphisms (SNPs), rs2697153 G>A in SLC6A1 (GAT-1) and rs2272400 C>T in SLC6A11 (GAT-3), and drug-resistant temporal lobe epilepsy (TLE). Methods. DNA was isolated from 138 TLE patients (from the neocortex) and 94 non-epileptic controls (from blood/buccal swaps), and amplified by polymerase chain reaction and subjected to restriction fragment length polymorphism assays. A subgroup of patients with a positive history of febrile seizures (FS+) and traumatic brain injury (TBI+) were investigated in a separate analysis. P values were obtained using the Chi-Square test and Fishers exact test. Results. The GAT-1 SNP was different between patients and controls (p<0.05); the AA genotype was observed in 40% of the cases vs 23% of the controls (p<0.05). Thirty-one patients were FS+ and the GAT-3 CT genotype was observed significantly more frequently in the FS+ group (14%) than in the FS- group (1%; p<0.01). Thirteen patients were TBI+, and genotyping for GAT-1 and GAT-3 in these patients did not result in statistical differences between TBI+ and TBI- groups. Conclusions. The findings suggest that TLE is associated with GAT-1 and GAT-3 SNPs. More specifically, GAT-3 c1572T seems to be associated with TLE in patients with FS+. However, the pathophysiological consequences of these SNPs remain to be elucidated.	[Schijns, Olaf E. M. G.; Bisschop, Jeroen; Dings, Jim; Hoogland, Govert] Maastricht Univ, Med Ctr, Dept Neurosurg, Postbus 5800, NL-6202 AZ Maastricht, Netherlands; [Schijns, Olaf E. M. G.; Dings, Jim] Maastricht Univ, Med Ctr, Acad Ctr Epileptol ACE, Maastricht, Netherlands; [Schijns, Olaf E. M. G.; Rijkers, Kim; Dings, Jim; Smeets, Hubert J. M.; Hoogland, Govert] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Rijkers, Kim] Zuyderland Med Ctr, Dept Neurosurg, Heerlen, Netherlands; [Vanherle, Sabina; Lindsey, Patrick; Smeets, Hubert J. M.] Maastricht Univ, Dept Genet & Cell Biol, Maastricht, Netherlands		Bisschop, J (corresponding author), Maastricht Univ, Med Ctr, Dept Neurosurg, Postbus 5800, NL-6202 AZ Maastricht, Netherlands.	j.bisschop@student.maastrichtuniversity.nl	Lindsey, Patrick/AAD-8100-2021	Bisschop, Jeroen/0000-0001-8652-9535			Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BABB TL, 1984, EPILEPSIA, V25, P721, DOI 10.1111/j.1528-1157.1984.tb03483.x; BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x; Ben-Yona A, 2013, J BIOL CHEM, V288, P4549, DOI 10.1074/jbc.M112.430215; CAMMACK JN, 1994, NEURON, V13, P949, DOI 10.1016/0896-6273(94)90260-7; Carvill GL, 2015, AM J HUM GENET, V96, P808, DOI 10.1016/j.ajhg.2015.02.016; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; DURING MJ, 1993, LANCET, V341, P1607; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Guazzi M, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2018.12.55; Han HA., 2012, JASPERS BASIC MECH E; Hirunsatit R, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-71; Hoogland G, 2004, J NEUROSCI RES, V76, P881, DOI 10.1002/jnr.20128; Hosford DA, 1997, EPILEPSY RES, V27, P55, DOI 10.1016/S0920-1211(97)01023-1; JAY V, 1993, J NEUROSURG, V79, P53, DOI 10.3171/jns.1993.79.1.0053; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Johannesen KM, 2018, EPILEPSIA, V59, P389, DOI 10.1111/epi.13986; KAILA K, 1992, J PHYSIOL-LONDON, V453, P627, DOI 10.1113/jphysiol.1992.sp019248; Kang JQ, 2006, J NEUROSCI, V26, P2590, DOI 10.1523/JNEUROSCI.4243-05.2006; Kim DU, 2011, J HUM GENET, V56, P640, DOI 10.1038/jhg.2011.73; Kinney GA, 2005, J NEUROPHYSIOL, V94, P4533, DOI 10.1152/jn.00420.2005; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Mathern GW, 1999, NEUROLOGY, V52, P453, DOI 10.1212/WNL.52.3.453; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; RADIAN R, 1983, BIOCHEMISTRY-US, V22, P1236, DOI 10.1021/bi00274a038; Raiteri L, 2002, J NEUROCHEM, V80, P706, DOI 10.1046/j.0022-3042.2001.00750.x; Schijns O, 2015, J CHEM NEUROANAT, V68, P39, DOI 10.1016/j.jchemneu.2015.07.004; Schmeiser B, 2017, EPILEPSY RES, V136, P115, DOI 10.1016/j.eplepsyres.2017.08.002; Schousboe A, 2004, NEUROCHEM INT, V45, P521, DOI 10.1016/j.neuint.2003.11.001; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; Stogmann E, 2002, ANN NEUROL, V51, P260, DOI 10.1002/ana.10108; Tellez-Zenteno Jose F, 2012, Epilepsy Res Treat, V2012, P630853, DOI 10.1155/2012/630853; Thoeringer CK, 2009, J NEURAL TRANSM, V116, P649, DOI 10.1007/s00702-008-0075-y; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Waagepetersen HS, 2003, NEUROSCIENTIST, V9, P398, DOI 10.1177/1073858403254006; WILLIAMSON A, 1995, J NEUROPHYSIOL, V74, P378, DOI 10.1152/jn.1995.74.1.378; Wu YM, 2003, J NEUROPHYSIOL, V89, P2021, DOI 10.1152/jn.00856.2002; WYLER AR, 1992, J EPILEPSY, V5, P220, DOI 10.1016/S0896-6974(05)80120-3	42	1	1	1	4	JOHN LIBBEY EUROTEXT LTD	ARCUEIL	30, RUE BERTHOLLET, BATIMENT A, 94110 ARCUEIL, FRANCE	1294-9361	1950-6945		EPILEPTIC DISORD	Epileptic Disord.	APR	2020	22	2					176	182		10.1684/epd.2020.1154			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	LK2NB	WOS:000530695900005	32301730	Bronze			2022-02-06	
J	Schmidt, U; Oramary, D; Kamin, K; Buschmann, CT; Kleber, C				Schmidt, Uwe; Oramary, Delovan; Kamin, Konrad; Buschmann, Claas T.; Kleber, Christian			Synergistic Effects of Forensic Medicine and Traumatology: Comparison of Clinical Diagnosis Autopsy Findings in Trauma-Related Deaths	WORLD JOURNAL OF SURGERY			English	Article							COMPUTED-TOMOGRAPHY PMCT; VICTIMS; SCORE	Background Trauma is the third leading cause of death worldwide after cardiovascular and oncologic diseases. Predominant causes of trauma-related death (TD) are severe traumatic brain injury (sTBI), hemorrhagic shock, and multiple organ failure. An analysis of TD is required in order to review the quality of trauma care and grasp how well the entire trauma network functions, especially for the most severely injured patients. Furthermore, autopsies not only reveal hidden injuries, but also verify clinical assumed causes of death. Material During the study period of 3 years, a total of 517 trauma patients were admitted to our supraregional University Centre of Orthopaedics and Traumatology in Dresden. 13.7% (71/517) of the patients died after trauma, and in 25 cases (35.2%), a forensic autopsy was instructed by the federal prosecutor. The medical records, death certificates, and autopsy reports were retrospectively evaluated and the clinical findings matched to autopsy results. Results The observed mortality rates (13.7%) were 4.2% less than expected by the calculated RISC II probability of survival (mortality rate of 17.9%). The most frequent trauma victims were due to falls >3 m (n = 29), followed by traffic accidents (n = 28). The median ISS was 34, IQR 25, and the median New ISS (NISS) was 50, IQR 32. Locations of death were in emergency department (23.9%), ICU (73.2%), OR and ward (1.4%, respectively). Clinicians classified 47.9% of deaths due to sTBI (n = 34), followed by 9.9% thoracic trauma and multiple organ failure (n = 7), 8.4% multiple trauma (n = 6), and 2.8% hypoxia and exsanguination (n = 2). In 18.3%, cases were unspecific or other causes of death recorded on the death certificates. Evident differences with evident clinical consequences were ascertained in 4% (n = 1) and marginal clinical consequences in 24% (6/25). In 16% (4/25), marginal differences with minor forensic consequences were revealed. Conclusions Even in a supraregional trauma center, specialized in multiple trauma management (4.2% survival benefit), room for improvement exists in more than a quarter of all casualties. This underlines the need for higher autopsy rates to uncover missed injuries and to understand the pathomechanism in each trauma fatality. This would also help to uncover potential insufficiencies in clinical routines with regard to diagnostics. The interdisciplinary cooperation of trauma surgeons and forensic pathologists can increase the quality of trauma patient care.	[Schmidt, Uwe] Tech Univ Dresden, Inst Legal Med, Med Fac Carl Gustav Carus, Fetscherstrasse 74, DE-01307 Dresden, Germany; [Oramary, Delovan; Kamin, Konrad; Kleber, Christian] Tech Univ, Univ Ctr Orthpaed & Traumatol, Univ Med Carl Gustav Carus, AG Polytrauma, Fetscherstrasse 74, DE-01307 Dresden, Germany; [Buschmann, Claas T.] Charite Univ Med Berlin, Berlin, Germany; [Buschmann, Claas T.] Free Univ Berlin, Berlin, Turkey; [Buschmann, Claas T.] Humboldt Univ, Berlin Inst Hlth, Inst Legal Med & Forens Sci, Berlin, Germany		Schmidt, U (corresponding author), Tech Univ Dresden, Inst Legal Med, Med Fac Carl Gustav Carus, Fetscherstrasse 74, DE-01307 Dresden, Germany.	uwe.schmidt@tu-dresden.de					Ampanozi G, 2017, FORENSIC SCI MED PAT, V13, P284, DOI 10.1007/s12024-017-9878-1; Beck B, 2019, INJURY, V50, P1009, DOI 10.1016/j.injury.2019.03.003; Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Buschmann CT, 2015, FORENSIC SCI MED PAT, V11, P317, DOI 10.1007/s12024-014-9603-2; Buschmann CT, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-55; Byard RW, 2012, J FORENSIC LEG MED, V19, P419, DOI 10.1016/j.jflm.2012.02.002; David JS, 2019, ANAESTH CRIT CARE PA, V38, P161, DOI 10.1016/j.accpm.2018.01.006; Dickmann P, 2020, Z ORTHOP UNFALLCHIR, V158, P81, DOI 10.1055/a-0853-2054; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Jalalzadeh H, 2015, FORENSIC SCI INT, V257, P29, DOI 10.1016/j.forsciint.2015.07.026; Kirchhoff SM, 2016, INT J LEGAL MED, V130, P819, DOI 10.1007/s00414-015-1225-z; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lovric Z, 2015, INJURY, V46, pS24, DOI 10.1016/j.injury.2015.10.048; Martin BT, 2007, J TRAUMA, V62, P69, DOI 10.1097/TA.0b013e31802d08e5; Moskala A, 2016, LEGAL MED-TOKYO, V18, P25, DOI 10.1016/j.legalmed.2015.11.005; O'Connor AE, 2002, ACAD EMERG MED, V9, P957; Ong AW, 2007, J TRAUMA, V62, P1541, DOI 10.1097/TA.0b013e3180592ae8; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; POLLOCK DA, 1993, JAMA-J AM MED ASSOC, V269, P1525, DOI 10.1001/jama.269.12.1525; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Scantling D, 2017, J SURG RES, V215, P140, DOI 10.1016/j.jss.2017.03.068; Scaparra E, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0237-6; Sharma BR, 2005, INJURY, V36, P976, DOI 10.1016/j.injury.2004.09.025; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Steinwall D, 2012, INJURY, V43, P91, DOI 10.1016/j.injury.2010.11.004; Tavora F, 2008, AM J CLIN PATHOL, V129, P102, DOI 10.1309/9M7DFE62RTDKHH4D; Tien H, 2004, CURR ORTHOPAED, V18, P304, DOI 10.1016/j.cuor.2004.04.006; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	33	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	APR	2020	44	4					1137	1148		10.1007/s00268-019-05347-7			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KS3MN	WOS:000518215800020	31933040	hybrid			2022-02-06	
J	Stollhof, LE; Obertacke, U; Eschmann, D; Proba, S; Buhler, M; Neumeier, M; Bludau, F				Stollhof, Laura Emine; Obertacke, Udo; Eschmann, David; Proba, Sandra; Buehler, Miriam; Neumeier, Michael; Bludau, Frederic			S100B Serum Level is Independent of Moderate Alcohol Intoxication	ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE			English	Article						S100B; minor head injury (MHI); alcohol intoxication; serum brain markers	MINOR HEAD-INJURY; TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; CLINICAL UTILITY; PROTEIN; S-100B; DAMAGE; ELIMINATION; FAMILY	Objective In Germany, among patients with minor head injury (MHI), the incidence of coexisting alcohol intoxication is indicated up to 50%. The neurological symptoms of patients with MHI may be caused or altered by alcohol intoxication, this could mislead to further, potential harmful, diagnostic steps or to misinterpretation of the symptoms and to non-execution of necessary treatments. In order to decide which patients need further diagnostics by CCT, S100B has been proposed as a potential selection criterion. On the other hand, studies have hypothesized that alcohol intoxication may lead to elevated S100B serum levels. Therefore, the present study aims to investigate the relationship between the blood ethyl alcohol concentration and the S100B serum concentration in an experimental setting in young human adult volunteers. Methods In a cohort of 58 healthy volunteers, serum S100B concentration and blood ethyl alcohol concentration were measured before and after liberately drinking alcohol. The study was approved by the local Ethics Committee of the Medical Faculty Mannheim (Ethics Committee II, AZ 2012-272 N-MA). Instantaneous analysis of the samples was carried out using state-of-the art automated measuring systems. (Analyzer Cobas e411, Roche and Analyzer Dimension Vista 1500, Siemens). Results After drinking, alcohol levels ranged from 0,23 to 1,92g/l. The S100B value ranged from to 0,021 to 0,115 mu g/l after alcohol consumption (S100B standard value <0,11 mu g/l). By calculating the Pearson correlation of empirical correlation after drinking alcohol with r=0.01181, a correlation between serum S100B concentration and ethyl alcohol concentration is not probable. The S100B concentrations were independent on the alcohol intake in low to medium alcohol levels. Conclusion A relevant alcohol blood concentration (similar to 1g/l), in otherwise healthy volunteers, does not affect the serum concentration of S100B. S100B may be a useful brain injury marker in low to moderate drunken patients.	[Stollhof, Laura Emine] BG Unfallklin Tubingen, Orthopadie & Unfallchirurg, Schnarrenbergstr 95, D-72076 Tubingen, Germany; [Obertacke, Udo; Eschmann, David; Proba, Sandra; Buehler, Miriam; Bludau, Frederic] Heidelberg Univ, Univ Med Mannheim, Fak Mannheim, Orthopad Unfallchirurg Zentrum, Heidelberg, Germany; [Neumeier, Michael] Univ Mannheim, Inst Klin Chem, Mannheim, Germany		Stollhof, LE (corresponding author), BG Unfallklin Tubingen, Orthopadie & Unfallchirurg, Schnarrenbergstr 95, D-72076 Tubingen, Germany.	laura.stollhof@gmail.com					Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brin T, 2011, SHOCK, V36, P356, DOI 10.1097/SHK.0b013e31822bd07d; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; DONATO R, 1991, CELL CALCIUM, V12, P713, DOI 10.1016/0143-4160(91)90040-L; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Garbuglia M, 1996, FASEB J, V10, P317, DOI 10.1096/fasebj.10.2.8641565; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Knusli C, 2013, THER UMSCH, V70, P746, DOI 10.1024/0040-5930/a000474; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P123, DOI 10.1097/HTR.0b013e31820e6840; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Manolakis AC, 2011, DIGEST DIS SCI, V56, P1601, DOI 10.1007/s10620-010-1494-9; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; PEDROCCHI M, 1994, INT J CANCER, V57, P684, DOI 10.1002/ijc.2910570513; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pflugbeil S, 2011, RADIAT PROT DOSIM, V147, P305, DOI 10.1093/rpd/ncr344; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Stein SC, 2000, NEW ENGL J MED, V343, P1570; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	30	1	1	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1864-6697	1864-6743		Z ORTHOP UNFALLCHIR	Z. Orthop. Unfallchir.	APR	2020	158	2					201	207		10.1055/a-0929-7820			7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	LF8FG	WOS:000527650000016	31533168				2022-02-06	
J	Tang, BL				Tang, Bor Luen			Could metformin be therapeutically useful in Huntington's disease?	REVIEWS IN THE NEUROSCIENCES			English	Article						AMP-activated protein kinase (AMPK); Huntington's disease (HD); metformin; protein phosphatase 2A (PP2A)	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIDIABETIC DRUG METFORMIN; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MOUSE MODEL; MUTANT-HUNTINGTIN; NEUROTROPHIC FACTOR	Emerging evidence suggest that dimethylbiguanide (metformin), a first-line drug for type 2 diabetes mellitus, could be neuroprotective in a range of brain pathologies, which include neurodegenerative diseases and brain injury. However, there are also contraindications that associate metformin treatment with cognitive impairment as well as adverse outcomes in Alzheimer's disease and Parkinson's disease animal models. Recently, a beneficial effect of metformin in animal models of Huntington's disease (HD) has been strengthened by multiple reports. In this brief review, the findings associated with the effects of metformin in attenuating neurodegenerative diseases are discussed, focusing on I ID-associated pathology and the potential underlying mechanisms highlighted by these studies. The mechanism of action of metformin is complex, and its therapeutic efficacy is therefore expected to be dependent on the disease context. The key metabolic pathways that are effectively affected by metformin, such as AMP-activated protein kinase activation, may be altered in the later decades of the human lifespan. In this regard, metformin may nonetheless be therapeutically useful for neurological diseases with early pathological onsets, such as HD.	[Tang, Bor Luen] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore; [Tang, Bor Luen] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Med Dr, Singapore 119077, Singapore		Tang, BL (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117596, Singapore.; Tang, BL (corresponding author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Med Dr, Singapore 119077, Singapore.	bchtbl@nus.edu.sg	Tang, Bor Luen/E-4548-2012	Tang, Bor Luen/0000-0002-1925-636X	NUS Graduate School for Integrative Sciences and EngineeringNational University of Singapore	The author is supported by the NUS Graduate School for Integrative Sciences and Engineering and declares no conflict of interest. The author is grateful to the reviewers, whose constructive comments improved the manuscript.	Abd-Elrahman KS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0456-1; Abd-Elrahman KS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan6387; Abd-Elsameea AA, 2014, EUR REV MED PHARMACO, V18, P2387; Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; Ahmad W, 2017, MOL NEUROBIOL, V54, P5427, DOI 10.1007/s12035-016-0085-y; Ahmed S, 2017, J MOL NEUROSCI, V62, P88, DOI 10.1007/s12031-017-0915-z; Alagiakrishnan K, 2013, DISCOV MED, V16, P277; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Arbelaez-Quintero I, 2017, STROKE RES TREAT, V2017, DOI 10.1155/2017/9756429; Arnoux I, 2018, ELIFE, V7, DOI 10.7554/eLife.38744; Arteaga-Bracho EE, 2016, NEUROBIOL DIS, V96, P144, DOI 10.1016/j.nbd.2016.09.006; Asadbegi M, 2016, BRAIN RES BULL, V121, P178, DOI 10.1016/j.brainresbull.2016.02.005; Ashabi G, 2015, METAB BRAIN DIS, V30, P747, DOI 10.1007/s11011-014-9632-2; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481; Bar-Yosef T, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00196; Barini E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0082-7; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bayliss JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159381; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Berthier A, 2016, MOL NEUROBIOL, V53, P1296, DOI 10.1007/s12035-015-9091-8; Bharadwaj P, 2017, J ALZHEIMERS DIS, V59, P421, DOI 10.3233/JAD-161192; Bialik S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215152; Biosa A, 2018, MOL NEUROBIOL, V55, P8754, DOI 10.1007/s12035-018-1025-9; Bisulli F, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1132-3; Brakedal B, 2017, MOVEMENT DISORD, V32, P1594, DOI 10.1002/mds.27128; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Burrows DJ, 2019, MULT SCLER J, V25, P306, DOI 10.1177/1352458518805246; Byrne F, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/752481; Campbell JM, 2018, J ALZHEIMERS DIS, V65, P1225, DOI 10.3233/JAD-180263; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Caron NS, 2018, NAT REV DRUG DISCOV, V17, P729, DOI 10.1038/nrd.2018.133; Chang J, 2014, JARO-J ASSOC RES OTO, V15, P149, DOI 10.1007/s10162-013-0431-y; Chatterjee S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00383; Chen JL, 2019, EXP NEUROL, V311, P44, DOI 10.1016/j.expneurol.2018.09.008; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Cheng YY, 2014, J STROKE CEREBROVASC, V23, pE99, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.001; Chiang MC, 2016, EXP CELL RES, V347, P322, DOI 10.1016/j.yexcr.2016.08.013; Chung MM, 2017, EXP CELL RES, V352, P75, DOI 10.1016/j.yexcr.2017.01.017; Clarke JR, 2018, J ALZHEIMERS DIS, V64, pS405, DOI 10.3233/JAD-179911; Croce KR, 2019, NEUROBIOL DIS, V122, P16, DOI 10.1016/j.nbd.2018.08.010; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Curry DW, 2018, J PARKINSON DIS, V8, P161, DOI 10.3233/JPD-171296; Dadwal P, 2015, STEM CELL REP, V5, P166, DOI 10.1016/j.stemcr.2015.06.011; Demir U, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-52; Denton D, 2019, CELL DEATH DIFFER, V26, P605, DOI 10.1038/s41418-018-0252-y; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; DiTacchio KA, 2015, J ALZHEIMERS DIS, V44, P43, DOI 10.3233/JAD-141332; Domise M, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1464-x; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Dulovic M, 2014, NEUROBIOL DIS, V63, P1, DOI 10.1016/j.nbd.2013.11.002; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Dy ABC, 2018, CLIN GENET, V93, P216, DOI 10.1111/cge.13039; El-Mir MY, 2008, J MOL NEUROSCI, V34, P77, DOI 10.1007/s12031-007-9002-1; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Elbaz A, 2016, REV NEUROL-FRANCE, V172, P14, DOI 10.1016/j.neurol.2015.09.012; Ettcheto M, 2019, PHARMACOL RES, V145, DOI 10.1016/j.phrs.2019.104255; Fan J, 2019, BRIT J PHARMACOL, V176, P297, DOI 10.1111/bph.14519; Farina F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04256-w; Farr SA, 2019, J ALZHEIMERS DIS, V68, P1699, DOI 10.3233/JAD-181240; Fatt M, 2015, STEM CELL REP, V5, P988, DOI 10.1016/j.stemcr.2015.10.014; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Galimberti D, 2017, EXPERT OPIN INV DRUG, V26, P97, DOI 10.1080/13543784.2017.1265504; Gantois I, 2019, ANNU REV MED, V70, P167, DOI 10.1146/annurev-med-081117-041238; Gantois I, 2017, NAT MED, V23, P674, DOI 10.1038/nm.4335; Ge XH, 2017, PHYSIOL BEHAV, V170, P115, DOI 10.1016/j.physbeh.2016.12.021; Ghadernezhad N, 2016, PHARM BIOL, V54, P2211, DOI 10.3109/13880209.2016.1150306; Gil JM, 2009, BRAIN RES REV, V59, P410, DOI 10.1016/j.brainresrev.2008.12.001; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Griesche N, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00226; Guiney SJ, 2017, NEUROCHEM INT, V104, P34, DOI 10.1016/j.neuint.2017.01.004; Guo Y, 2018, NEUROCHEM RES, V43, P1111, DOI 10.1007/s11064-018-2525-8; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harada S, 2010, BRAIN RES, V1351, P254, DOI 10.1016/j.brainres.2010.06.052; Hersch SM, 2017, NEUROLOGY, V89, P594, DOI 10.1212/WNL.0000000000004209; Hervas D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179283; Hettich MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102420; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Hindupur SK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019141; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hsiao HY, 2013, HUM MOL GENET, V22, P1826, DOI 10.1093/hmg/ddt036; Hunter J, 2014, AM J MED GENET A, V164, P1648, DOI 10.1002/ajmg.a.36511; Hussein AM, 2019, CAN J PHYSIOL PHARM, V97, P37, DOI 10.1139/cjpp-2018-0266; Hwang IK, 2010, NEUROCHEM RES, V35, P645, DOI 10.1007/s11064-009-0115-5; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ismaiel AAK, 2016, TOXICOL APPL PHARM, V298, P19, DOI 10.1016/j.taap.2016.03.004; Jia J, 2015, CURR NEUROPHARMACOL, V13, P389, DOI 10.2174/1570159X13666150205143555; Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z; Jin Q, 2014, BRAIN BEHAV IMMUN, V40, P131, DOI 10.1016/j.bbi.2014.03.003; Joseph BK, 2015, J BIOL CHEM, V290, P10588, DOI 10.1074/jbc.M114.626259; Ju TC, 2014, BBA-MOL BASIS DIS, V1842, P1668, DOI 10.1016/j.bbadis.2014.06.012; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kang H, 2017, ONCOTARGET, V8, P48603, DOI 10.18632/oncotarget.18122; Kang SS, 2017, P NATL ACAD SCI USA, V114, P1183, DOI 10.1073/pnas.1618627114; Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y; Katila N, 2017, NEUROPHARMACOLOGY, V125, P396, DOI 10.1016/j.neuropharm.2017.08.015; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Khoshnan A, 2017, HUM MOL GENET, V26, P4267, DOI 10.1093/hmg/ddx315; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kim DH, 2015, BIOGERONTOLOGY, V16, P1, DOI 10.1007/s10522-014-9519-y; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Koenig AM, 2017, ALZ DIS ASSOC DIS, V31, P107, DOI 10.1097/WAD.0000000000000202; Krauss S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2514; Kuan YC, 2017, PROG NEURO-PSYCHOPH, V79, P77, DOI 10.1016/j.pnpbp.2017.06.002; Kuhla A, 2019, J ALZHEIMERS DIS, V68, P1415, DOI 10.3233/JAD-181017; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Labuschagne I, 2016, J INT NEUROPSYCH SOC, V22, P595, DOI 10.1017/S1355617716000321; Landwehrmeyer GB, 2017, MOV DISORD CLIN PRAC, V4, P212, DOI 10.1002/mdc3.12388; Lane DJR, 2018, J ALZHEIMERS DIS, V64, pS379, DOI 10.3233/JAD-179944; Languren G, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X17733640; Lee JH, 2015, NEURON, V85, P303, DOI 10.1016/j.neuron.2014.12.019; Leech T, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104261; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lin YF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00227; Ling YZ, 2017, EXP NEUROL, V288, P85, DOI 10.1016/j.expneurol.2016.11.009; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Liu YQ, 2014, NEUROSCI LETT, V579, P46, DOI 10.1016/j.neulet.2014.07.006; Lu M, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw047; Luchsinger JA, 2016, J ALZHEIMERS DIS, V51, P501, DOI 10.3233/JAD-150493; Ludman T, 2019, MOL PAIN, V15, DOI 10.1177/1744806919850043; Luo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00371; Ma JX, 2016, NEUROCHEM RES, V41, P1130, DOI 10.1007/s11064-015-1803-y; Ma JX, 2015, EUR J PHARMACOL, V764, P599, DOI 10.1016/j.ejphar.2015.06.010; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Manzo E, 2019, ELIFE, V8, DOI 10.7554/eLife.45114; Mao-Ying QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100701; Marinangeli C, 2016, CURR DRUG TARGETS, V17, P890, DOI 10.2174/1389450117666160201105645; Markowicz-Piasecka M, 2018, J ENZYM INHIB MED CH, V33, P1309, DOI 10.1080/14756366.2018.1499627; Markowicz-Piasecka M, 2017, PHARM RES-DORDR, V34, P2614, DOI 10.1007/s11095-017-2199-y; Marti E, 2016, BRAIN PATHOL, V26, P779, DOI 10.1111/bpa.12427; Masaldan S, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020093; Matthes F, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0003-8; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; McGarry A, 2017, NEUROLOGY, V88, P152, DOI 10.1212/WNL.0000000000003478; Mehrabi S, 2018, METAB BRAIN DIS, V33, P107, DOI 10.1007/s11011-017-0132-z; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mielke JG, 2006, NEUROSCIENCE, V143, P165, DOI 10.1016/j.neuroscience.2006.07.055; Mima Y, 2016, J STROKE CEREBROVASC, V25, P436, DOI 10.1016/j.jstrokecerebrovasdis.2015.10.016; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Moore EM, 2013, DIABETES CARE, V36, P2981, DOI 10.2337/dc13-0229; Moran C, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0973-4; Morgunova GV, 2019, CELL BIOCHEM FUNCT, V37, P169, DOI 10.1002/cbf.3384; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Morsi M, 2018, J CELL BIOCHEM, V119, P1249, DOI 10.1002/jcb.26261; Mostafa DK, 2016, PSYCHOPHARMACOLOGY, V233, P2513, DOI 10.1007/s00213-016-4301-2; Mujica-Mota MA, 2014, OTOLARYNG HEAD NECK, V150, P859, DOI 10.1177/0194599814521013; Muri L, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1549-6; Najafi M, 2018, MUTAT RES-GEN TOX EN, V827, P1, DOI 10.1016/j.mrgentox.2018.01.007; Nandini HS, 2019, LIFE SCI, V233, DOI 10.1016/j.lfs.2019.116686; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Neueder A, 2018, ADV EXP MED BIOL, V1049, P85, DOI 10.1007/978-3-319-71779-1_4; Niccoli T, 2016, CURR BIOL, V26, P2291, DOI [10.1016/j.cub.2016.07.017, 10.1016/j.cub.2016.09.018]; Nitschke F, 2018, NAT REV NEUROL, V14, P606, DOI 10.1038/s41582-018-0057-0; Ochaba J, 2019, P NATL ACAD SCI USA, V116, P10952, DOI 10.1073/pnas.1814246116; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ou ZR, 2018, BRAIN BEHAV IMMUN, V69, P351, DOI 10.1016/j.bbi.2017.12.009; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Paintlia Ajaib S, 2013, J Clin Cell Immunol, V4, DOI 10.4172/2155-9899.1000149; Paintlia AS, 2013, AM J PATHOL, V183, P526, DOI 10.1016/j.ajpath.2013.04.030; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Patil SP, 2014, NEUROSCIENCE, V277, P747, DOI 10.1016/j.neuroscience.2014.07.046; Peixoto CA, 2017, EXP NEUROL, V298, P31, DOI 10.1016/j.expneurol.2017.08.013; Peixoto LG, 2017, ACTA DIABETOL, V54, P943, DOI 10.1007/s00592-017-1027-5; Perez-Revuelta BI, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.175; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Picone P, 2016, AGING-US, V8, P1718, DOI 10.18632/aging.101004; Picone P, 2015, BBA-MOL CELL RES, V1853, P1046, DOI 10.1016/j.bbamcr.2015.01.017; Pinto RM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003930; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Porceddu PF, 2016, NEUROTOX RES, V30, P101, DOI 10.1007/s12640-016-9633-5; Porter KM, 2019, J CLIN ENDOCR METAB, V104, P4837, DOI 10.1210/jc.2018-01791; Protic D, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.745; Rabanal-Ruiz Y, 2017, ESSAYS BIOCHEM, V61, P565, DOI 10.1042/EBC20170027; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rawlins MD, 2016, NEUROEPIDEMIOLOGY, V46, P144, DOI 10.1159/000443738; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Rotermund C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00400; Osornio MDR, 2018, CELL MOL NEUROBIOL, V38, P1425, DOI 10.1007/s10571-018-0611-8; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rue L, 2016, J CLIN INVEST, V126, P4319, DOI 10.1172/JCI83185; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Russe OQ, 2013, J PAIN, V14, P1330, DOI 10.1016/j.jpain.2013.05.012; Ryu YK, 2018, MOL NEUROBIOL, V55, P5715, DOI 10.1007/s12035-017-0752-7; Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanchis A, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0264-9; Santo EE, 2018, CURR TOP DEV BIOL, V127, P105, DOI 10.1016/bs.ctdb.2017.10.002; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Saudubray JM, 2018, DIALOGUES CLIN NEURO, V20, P301, DOI 10.31887/DCNS.2018.20.4/jmsaudubray; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Son SM, 2016, J ALZHEIMERS DIS, V51, P1197, DOI 10.3233/JAD-151200; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sun YF, 2016, J NEUROIMMUNOL, V292, P58, DOI 10.1016/j.jneuroim.2016.01.014; Swarnkar S, 2015, NEUROBIOL DIS, V82, P66, DOI 10.1016/j.nbd.2015.05.011; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907; Taheri A, 2019, J NEUROL, V266, P1988, DOI 10.1007/s00415-019-09366-1; Tanokashira D, 2018, FEBS OPEN BIO, V8, P1104, DOI 10.1002/2211-5463.12436; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tayara K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00440; Templeman NM, 2018, J CELL BIOL, V217, P93, DOI 10.1083/jcb.201707168; Montojo MT, 2017, J HUNTINGTONS DIS, V6, P179, DOI 10.3233/JHD-170253; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Timmons JA, 2019, AGING CELL, V18, DOI 10.1111/acel.12970; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Ullah I, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-11; Vancura A, 2018, TRENDS PHARMACOL SCI, V39, P867, DOI 10.1016/j.tips.2018.07.006; Vazquez-Manrique RP, 2016, HUM MOL GENET, V25, P1043, DOI 10.1093/hmg/ddv513; Veldman MB, 2018, CURR OPIN NEUROBIOL, V48, P79, DOI 10.1016/j.conb.2017.10.019; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vuong K, 2018, HAND CLINIC, V159, P251, DOI 10.1016/B978-0-444-63916-5.00016-1; Wang C, 2016, BIOCHEM BIOPH RES CO, V477, P534, DOI 10.1016/j.bbrc.2016.05.148; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Wang L, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00290; Wang TR, 2010, ADVANCED MANUFACTURING TECHNOLOGY IN CHINA: A ROADMAP TO 2050, P5; Wang X, 2019, BRAIN RES, V1719, P30, DOI 10.1016/j.brainres.2019.05.023; Williams T, 2011, P NATL ACAD SCI USA, V108, P5849, DOI 10.1073/pnas.1013660108; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Wold MS, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0141-0; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Wyttenbach A, 2008, AUTOPHAGY, V4, P542, DOI 10.4161/auto.6059; Xu YJ, 2014, CELL SIGNAL, V26, P1680, DOI 10.1016/j.cellsig.2014.04.009; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yan QT, 2017, MOL PHARMACOL, V92, P640, DOI 10.1124/mol.117.109512; Yang Y, 2017, BIOCHEM BIOPH RES CO, V484, P450, DOI 10.1016/j.bbrc.2017.01.157; Yimer EM, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/6234758; Yuan R, 2019, NEUROREPORT, V30, P232, DOI 10.1097/WNR.0000000000001190; Zeitler B, 2019, NAT MED, V25, P1131, DOI 10.1038/s41591-019-0478-3; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang JH, 2018, J NEUROCHEM, V144, P691, DOI 10.1111/jnc.14308; Zhang J, 2019, FASEB J, V33, P7748, DOI 10.1096/fj.201802718R; Zhang JX, 2017, EXP GERONTOL, V89, P45, DOI 10.1016/j.exger.2017.01.010; Zhao M, 2019, MED SCI MONITOR, V25, P2186, DOI 10.12659/MSM.911250; Zhao X, 2019, J CELL PHYSIOL, V234, P16619, DOI 10.1002/jcp.28337; Zhou B, 2019, SEMIN CANC BIOL; Zhou CW, 2016, BRAIN RES BULL, V121, P241, DOI 10.1016/j.brainresbull.2016.02.009; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102863; Zhou WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151890; Zhu XC, 2015, MOL NEUROBIOL, V52, P375, DOI 10.1007/s12035-014-8866-7; Zimbron J, 2016, EUR NEUROPSYCHOPHARM, V26, P1353, DOI 10.1016/j.euroneuro.2016.07.010	276	1	1	0	11	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	APR	2020	31	3					297	317		10.1515/revneuro-2019-0072			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LC4UT	WOS:000525321900005	31751298				2022-02-06	
J	Tariq, A; Akhtar, S; Marryam, M; Umar, M				Tariq, Aroosa; Akhtar, Sundus; Marryam, Misbah; Umar, Muhammad			Analysis of gait pattern deviations among chronic post stroke patients	RAWAL MEDICAL JOURNAL			English	Article						Dynamic gait index; gait deviations; Modified Ashworth scale; stroke	IMPAIRMENTS	Objective: To determine the abnormalities of different parameters of gait and to determine the association of spasticity with them in chronic post stroke population. Methodology: It was a cross sectional descriptive study conducted over a duration of 3 months in 2017 at Pakistan Institute of Medical Sciences, Islamabad and Railway General Hospital, Rawalpindi and included 104 chronic stroke patients using non probability purposive sampling technique. Patients presenting with both ischemic and hemorrhagic stroke, both genders having age of 25 year to 75 years, patients who had suffered from stroke in past 6 months at time of data collection were included in the study. Those patients who had weakness due to any tumor, Gullian Barre Syndrome, peripheral nerve injury, multiple sclerosis or traumatic brain injury were excluded from the study. Dynamic gait index, Modified Ashworth scale, 10 meter walk test and temporospatial characteristics like, step length, stride length, step width and cadence were used as data collection tools. Data analysis was performed by SPSS version 21. Results: The mean age of patients was 55.56 +/- 13.46 years. Marked gait deviations were observed including decreased step length (12.75 +/- 2.23) inches, stride length (22.99 +/- 4.11) inches, cadence (66.92 +/- 20.31) steps/min and increased step width (8.15 +/- 1.58) inches. Increased tone in lower limb muscles was found in the patients on modified Ashworth scale and decreased gait velocity by 10 meter walk test (0.49 +/- 0.23) m/s. Greater risk of fall was observed by dynamic gait index (13.5 +/- 5.22). Conclusion: There were marked deviations of gait in post stroke population in chronic stage. These included changes in step length, stride length, step width and cadence. There were also changes in the scores of dynamic gait index and 10 meter walk test which showed an alteration in gait speed and adaptability thus limiting the independence of stroke patients.	[Marryam, Misbah] Riphah Coll Rehabil Sci, Dept Physiotherapy, Islamabad, Pakistan; Benazir Bhutto Hosp, Rawalpindi, Pakistan; Holy Family Hosp, Rawalpindi, Pakistan; Pakistan Inst Med Sci, Dept Neurol, Islamabad, Pakistan		Marryam, M (corresponding author), Riphah Coll Rehabil Sci, Dept Physiotherapy, Islamabad, Pakistan.	misbi.marry388@gmail.com					Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Baig MS, 2016, ANN PAK I MED SCI, V12, P142; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Foley N, 2010, EUR J NEUROL, V17, P1419, DOI 10.1111/j.1468-1331.2010.03084.x; Fulk George D, 2008, J Neurol Phys Ther, V32, P8, DOI 10.1097/NPT0b013e31816593c0; Khealani Bhojo A, 2008, J Pak Med Assoc, V58, P400; Kim Hyung-Sik, 2016, J Phys Ther Sci, V28, P2634; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Redon J, 2011, EUR HEART J; ROBINSON RG, 1986, BRIT J PSYCHIAT, V148, P541, DOI 10.1192/bjp.148.5.541; Roerdink M, 2011, NEUROREHAB NEURAL RE, V25, P253, DOI 10.1177/1545968310380687; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Woolley S M, 2001, Top Stroke Rehabil, V7, P1	17	1	1	0	0	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0303-5212			RAWAL MED J	Rawal Med. J.	APR-JUN	2020	45	2					310	313					4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	LM8EA	WOS:000532479600016					2022-02-06	
J	Whyte, J; Poulsen, I; Ni, PS; Eskildsen, M; Guldager, R				Whyte, John; Poulsen, Ingrid; Ni, Pengsheng; Eskildsen, Marianne; Guldager, Rikke			Development of a Measure of Nociception for Patients With Severe Brain Injury	CLINICAL JOURNAL OF PAIN			English	Article						brain injuries; consciousness disorders; nociception; pain; pain measurement	INPATIENT REHABILITATION; NATURAL-HISTORY; PAIN ASSESSMENT; SCALE; DISORDERS; COMA; CONSCIOUSNESS; AGITATION; RECOVERY; SCIENCE	Objectives: Severe brain injury is often accompanied by painful comorbidities and by concurrent limitations in the ability to report pain. Assessment of nociception aids diagnosis and helps balance reduction in suffering with avoidance of sedating medications. Existing assessment methods confound patients' level of consciousness with the intensity of nociception, complicating pain assessment as consciousness evolves. We sought to develop a measure of nociception that is independent of the level of consciousness. Materials and Methods: We identified 15 behavioral and physiological items likely to be sensitive to nociception. We rated noncommunicative patients with traumatic brain injury in 4 different activities predicted to modulate nociception, on each of 2 days, one randomly chosen for acetaminophen administration. The level of consciousness and level of agitation were also measured. Rasch Analysis: Rasch analysis was used to assess item fit to an underlying dimension of nociception. Results: Five items that demonstrated poor fit to the dimension were removed. The 10 remaining items demonstrated acceptable fit. Scores were significantly influenced by activity and analgesic treatment and were largely independent of measures of consciousness and agitation. Accurate scores could be obtained in about 10 minutes and were robust to missing data. Discussion: The results provide evidence that the Brain Injury Nociception Assessment Measure (BINAM) is reliable and feasible to administer. It can assess the intensity of nociception largely independent of the level of consciousness. Further research is warranted on the impact of BINAM use on the care of patients with severe traumatic brain injury.	[Whyte, John] Moss Rehabil Res Inst, Einstein Healthcare Network, Elkins Pk, PA 19027 USA; [Ni, Pengsheng] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA 02215 USA; [Poulsen, Ingrid; Eskildsen, Marianne] Univ Hosp Copenhagen, Dept Neurorehabil, Traumat Brain Injury Unit, Copenhagen, Denmark; [Guldager, Rikke] Univ Hosp Copenhagen, Dept Neurosurg, Copenhagen, Denmark; [Poulsen, Ingrid] Aarhus Univ, Sect Nursing Sci, Hlth, Aarhus, Denmark		Whyte, J (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	jwhyte@einstein.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, Washington, DC) [90DP0037-02]	Funding for this study was provided by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR, Washington, DC; grant #90DP0037-02, Tessa Hart, Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Elkins Park, PA). The authors declare no conflict of interest.	[Anonymous], 2002, J CLIN DENSITOM, V5, pS14; Bastuji H, 2016, HUM BRAIN MAPP, V37, P4301, DOI 10.1002/hbm.23310; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; Chatelle C, 2018, ARCH PHYS MED REHAB, V99, P1755, DOI 10.1016/j.apmr.2018.03.009; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Day KV, 2018, NEUROPSYCHOL REHABIL, V28, P1233, DOI 10.1080/09602011.2017.1309322; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Giacino JT, 2013, SEMIN NEUROL, V33, P142, DOI 10.1055/s-0033-1348960; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Herr K, 2006, J PAIN SYMPTOM MANAG, V31, P170, DOI 10.1016/j.jpainsymman.2005.07.001; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hummel P, 2006, SEMIN FETAL NEONAT M, V11, P237, DOI 10.1016/j.siny.2006.02.004; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kreiner S, 2007, STAT SOC BEHAV SC, P329, DOI 10.1007/978-0-387-49839-3_21; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li D, 2008, J PAIN, V9, P2, DOI 10.1016/j.jpain.2007.08.009; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Morone NE, 2013, CLIN THER, V35, P1728, DOI 10.1016/j.clinthera.2013.10.001; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Pistoia F, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0374-3; Poulsen I, 2019, PAIN MANAG NURS, V20, P592, DOI 10.1016/j.pmn.2019.02.003; Poulsen I, 2016, J NEUROSCI NURS, V48, P124, DOI 10.1097/JNN.0000000000000206; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Schnakers C, 2010, EXPERT REV NEUROTHER, V10, P1725, DOI 10.1586/ERN.10.148; TEASDALE G, 1974, LANCET, V2, P81; Vallath N, 2013, INDIAN J PALLIAT CAR, V19, P12, DOI 10.4103/0973-1075.110217; Vink P, 2017, EUR J PAIN, V21, P1463, DOI 10.1002/ejp.1063; Vink P, 2014, PAIN MANAG NURS, V15, P881, DOI 10.1016/j.pmn.2014.01.004; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	35	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-8047	1536-5409		CLIN J PAIN	Clin. J. Pain	APR	2020	36	4					281	288		10.1097/AJP.0000000000000811			8	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	LC6UD	WOS:000525468200007	32015255	hybrid			2022-02-06	
J	Reuvers, R; Over, EAB; Suijkerbuijk, AWM; Polder, JJ; de Wit, GA; van Gils, PF				Reuvers, Rick; Over, Eelco A. B.; Suijkerbuijk, Anita W. M.; Polder, Johan J.; de Wit, G. Ardine; van Gils, Paul F.			Cost-effectiveness of mandatory bicycle helmet use to prevent traumatic brain injuries and death	BMC PUBLIC HEALTH			English	Article						Bicycle helmet use; Cost-effectiveness; Traumatic brain injury; Economic evaluation; The Netherlands	QUALITY-OF-LIFE; PUBLIC-HEALTH; INTERVENTIONS; DISABILITY; EFFICACY; DALYS; RISK	Background Traumatic brain injury (TBI) is the main cause of mortality and severe morbidity in cyclists admitted to Dutch emergency departments (EDs). Although the use of bicycle helmets is an effective way of preventing TBI, this is uncommon in the Netherlands. An option to increase its use is through a legal enforcement. However, little is known about the cost-effectiveness of such mandatory use of helmets in the Dutch context. The current study aimed to assess the cost-effectiveness of a law that enforces helmet use to reduce TBI and TBI-related mortality. Methods The cost-effectiveness was estimated through decision tree modelling. In this study, wearing bicycle helmets enforced by law was compared with the current situation of infrequent voluntary helmet use. The total Dutch cycling population, consisting of 13.5 million people, was included in the model. Model data and parameters were obtained from Statistics Netherlands, the National Road Traffic Database, Dutch Injury Surveillance System, and literature. Effects included were numbers of TBI, death, and disability-adjusted life years (DALY). Costs included were healthcare costs, costs of productivity losses, and helmet costs. Sensitivity analysis was performed to assess which parameter had the largest influence on the incremental cost-effectiveness ratio (ICER). Results The intervention would lead to an estimated reduction of 2942 cases of TBI and 46 deaths. Overall, the incremental costs per 1) death averted, 2) per TBI averted, and 3) per DALY averted were estimated at 1) euro 2,002,766, 2) euro 31,028 and 3) euro 28,465, respectively. Most favorable were the incremental costs per DALY in the 65+ age group: euro 17,775. Conclusions The overall costs per DALY averted surpassed the Dutch willingness to pay threshold value of euro 20,000 for cost-effectiveness of preventive interventions. However, the cost per DALY averted for the elderly was below this threshold, indicating that in this age group largest effects can be reached. If the price of a helmet would reduce by 20%, which is non-hypothetical in a situation of large-scale purchases and use of these helmets, the introduction of this regulation would result in an intervention that is almost cost-effective in all age groups.	[Reuvers, Rick; Over, Eelco A. B.; Suijkerbuijk, Anita W. M.; Polder, Johan J.; de Wit, G. Ardine; van Gils, Paul F.] RIVM, Natl Inst Publ Hlth & Environm, Postbus 1, NL-3720 BA Bilthoven, Netherlands; [Polder, Johan J.] Tilburg Univ, Sch Social & Behav Sci, Tranzo, Tilburg, Netherlands; [de Wit, G. Ardine] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands		van Gils, PF (corresponding author), RIVM, Natl Inst Publ Hlth & Environm, Postbus 1, NL-3720 BA Bilthoven, Netherlands.	paul.van.gils@rivm.nl			National Institute for Public Health	Funding was received from the National Institute for Public Health.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2016, STIFTUNG WARENTEST, P78; [Anonymous], 2011, BIC HELM SWOV FACTSH; [Anonymous], 2018, LAB PART KEY FIG; [Anonymous], 2018, POP SEX AG MAR STAT; [Anonymous], 2013, SPECIAL EUROBAROMETE; [Anonymous], 2018, DEC PEOPL DEATH TRAF; [Anonymous], 2015, FACTSHEET NETHERLAND; [Anonymous], 2017, STIFTUNG WARENTEST, P65; [Anonymous], 2015, KOSTENHANDLEIDING ME; [Anonymous], 2016, TRAFF ACC 2014; [Anonymous], 2018, CONS PRIC ANN INFL A; [Anonymous], 2018, CONS PRIC PRIC IND 2; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Carr DJ, 1995, EVALUATION BICYCLE H; (CBS) SN, 2018, MOR FAT BIK CAR 2017; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dennis J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2674; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Fietsersbond, 2018, CYCL NUMB; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Haagsma JA, 2012, B WORLD HEALTH ORGAN, V90, P513, DOI 10.2471/BLT.11.095109; Hansen P, 1995, AUST J PUBLIC HEALTH, V19, P450; Hendrie D, 1999, C ROAD SAF PERTH W A; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Hutton G, 2008, ENVIRON HEALTH INSIG, V2, P137; Kemler HJ, 2009, BICYCLE HELMET CHILD; Kopjar B, 2000, PREV MED, V30, P401, DOI 10.1006/pmed.2000.0645; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Marshall J, 1994, EVALUATION COMPULSOR; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; Meer P.A.M.vander, 2014, RES REPORT BICYCLE B; Mulder S, 2002, INJURY PREV, V8, P74, DOI 10.1136/ip.8.1.74; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Olivier J, 2014, J AUSTRALAS COLL ROA, V25, P10; Olivier J, 2012, HEALTH PROMOT J AUST, V23, P76; Oostvogels AJJM, 2015, EPIDEMIOL INFECT, V143, P1791, DOI 10.1017/S0950268814001940; Organisation for Economic Co-operation and Development (OECD), 2018, MONTHL COMP PRIC LEV; People mobility in the Netherlands; transport modes and travel motives regions, 2017, PEOPL MOB NETH TRANS; People mobility; share of road users according to personal characteristics, 2018, PEOPL MOB SHAR ROAD; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2016, ACCIDENT ANAL PREV, V93, P92, DOI 10.1016/j.aap.2016.04.003; Polinder S, 2010, INJURY PREV, V16, P147, DOI 10.1136/ip.2009.022418; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; RAI/BOVAG/GfK, TOT REP MARK FIG CYC; Rissel Chris, 2011, Health Promot J Austr, V22, P178; Robinson DL, 2006, BMJ-BRIT MED J, V332, P722, DOI 10.1136/bmj.332.7543.722-a; ROBINSON R, 1993, BMJ-BRIT MED J, V307, P670, DOI 10.1136/bmj.307.6905.670; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Sieg G, 2016, TRANSPORTATION, V43, P935, DOI 10.1007/s11116-015-9632-z; Statistics Netherlands (CBS), MOR FAT BIC CAR 2017; Suijkerbuijk A W M, 2015, Tijdschr Psychiatr, V57, P498; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor M, 2002, INJ PREV, V8, P317, DOI 10.1136/ip.8.4.317; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thompson DC, 2000, COCHRANE DB SYST REV, V2; van de Ven T, 2017, MARKET CONSULTATION; van den Berg M, 2008, Ned Tijdschr Geneeskd, V152, P1329; van den Hout WB, 2010, ANN RHEUM DIS, V69, P89, DOI 10.1136/ard.2009.117150; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walker I, 2007, ACCIDENT ANAL PREV, V39, P417, DOI 10.1016/j.aap.2006.08.010; Working population; labor duration, 2018, WORK POP LAB DUR; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	67	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	MAR 30	2020	20	1							413	10.1186/s12889-020-08544-5			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	LA8RF	WOS:000524208400011	32228524	Green Published, gold			2022-02-06	
J	Wang, YD; Wen, L; You, WD; Zhu, YR; Wang, H; Sun, Y; Bao, WX; Yang, XF				Wang, Yadong; Wen, Liang; You, Wendong; Zhu, Yuanrun; Wang, Hao; Sun, Yun; Bao, Wangxiao; Yang, Xiaofeng			Predicting the outcomes of shunt implantation in patients with post-traumatic hydrocephalus and severe conscious disturbance: a scoring system based on clinical characteristics	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Post-traumatic hydrocephalus; traumatic brain injury; consciousness disturbance; ventriculoperitoneal shunt; predictive model; cerebrospinal fluid	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; CRANIAL DEFECT; PRESSURE	Post-traumatic hydrocephalus is a common complication secondary to traumatic brain injury. It can cause cerebral metabolic impairment and dysfunction. Therefore, timely treatment with shunt implantation is necessary. However, the outcomes of shunt surgery in patients with post-traumatic hydrocephalus combined with disturbance of consciousness are doubtful. The objective was to develop a predictive model that uses the information available before surgery to predict the outcome of shunt implantation in such patients. Retrospectively collected data were used to develop a clinical prediction model. The model was derived from 59 patients using logistic regression analysis, and then it was evaluated by the area under the receiver operating characteristic curve and Hosmer-Lem show test. A validation cohort verified the model. Four independent predictors were identified: age < 50 years, mild hydrocephalus, Glasgow Coma Scale scores 9-12 at the time of injury, and time interval from trauma to shunting < 3 months. We calculated the total score and defined the patients into three groups: low-probability (0-10 points), medium-probability (11-16 points), and high-probability (17-30 points). The rates of improved outcomes in the three groups were 14.3%, 52.6%, and 94.7%, respectively (P < 0.0001). The correlative rates of the validation cohort were 21.4%, 54.5%, and 85.7%. The prognostic model showed good discrimination (area under the receiver operating characteristic curve = 0.869) and calibration (Hosmer-Lemshovv test, P = 0.391). The developed predictive model can identify patients with post-traumatic hydrocephalus combined with disturbance of consciousness who can benefit from shunt implantation. Therefore, our prognostic model can predict the outcomes of patients with post-traumatic hydrocephalus and disturbance of consciousness after shunt surgery.	[Wang, Yadong; Wen, Liang; You, Wendong; Zhu, Yuanrun; Wang, Hao; Yang, Xiaofeng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Emergency & Trauma Ctr,Int Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Yun; Bao, Wangxiao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Rehabil Med, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Emergency & Trauma Ctr,Int Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	zjcswk@zju.edu.cn					Algin O, 2010, ACAD RADIOL, V17, P181, DOI 10.1016/j.acra.2009.08.011; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; DANDY WE, 1964, J NEUROSURG, V21, P588, DOI 10.3171/jns.1964.21.7.0588; Dixon GR, 2002, MAYO CLIN PROC, V77, P509, DOI 10.4065/77.6.509; Guyot LL, 2000, NEUROL RES, V22, P25; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kim Ho Soo, 2015, Korean J Neurotrauma, V11, P58, DOI 10.13004/kjnt.2015.11.2.58; Kowalski RG, 2019, J NEUROSURG, V130, P406, DOI 10.3171/2017.7.JNS17555; Licata C, 2001, J Neurosurg Sci, V45, P141; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Missori P, 2006, NEUROSURG REV, V29, P224, DOI 10.1007/s10143-006-0027-7; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Sun S, 2019, SCAND J SURG, V108, P265, DOI 10.1177/1457496918812210; Tarnaris A, 2011, J NEUROSURG, V115, P145, DOI 10.3171/2011.2.JNS101316; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tribl G, 2000, BRAIN INJURY, V14, P345; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Wen L, 2009, BRAIN INJURY, V23, P61, DOI 10.1080/02699050802635265; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Xu H, 2016, TRANSL NEUROSCI, V7, P92, DOI 10.1515/tnsci-2016-0015	25	1	1	1	1	IMR PRESS	WAN CHAI	RM 19C, LOCKHART CTR, 301-307 LOCKHART RD, WAN CHAI, 00000, HONG KONG	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	MAR 30	2020	19	1					31	37		10.31083/j.jin.2020.01.1231			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KZ3TV	WOS:000523189000004	32259884	gold			2022-02-06	
J	van Ierssel, J; O'Neil, J; Sveistrup, H; Marshall, S; Graham, I				van Ierssel, Jacquie; O'Neil, Jennifer; Sveistrup, Heidi; Marshall, Shawn; Graham, Ian			A qualitative study of persons with persistent postconcussion symptoms and clinicians with concussion expertise to inform the development of a concussion-specific questionnaire	DISABILITY AND REHABILITATION			English	Article						Concussion; qualitative research; International Classification of Functioning; Disability and Health; capacity	TRAUMATIC BRAIN-INJURY; INTERNATIONAL CLASSIFICATION; DISABILITY; HEALTH; INSTRUMENTS; UNCERTAINTY; PERSPECTIVE; PROGNOSIS; RECOVERY	Purpose:To explore the experiences of adults with persistent postconcussion symptoms and clinicians to inform the development of a concussion-specific questionnaire. Methods:Using a qualitative descriptive design, we conducted 10 focus groups with persons with persistent post-concussion symptoms (n = 35; female 66%; age range 19.0-65.1 years) and semi-structured interviews with clinicians with concussion expertise (n = 16; female 81%). Thematic analysis was used to identify themes within their narratives. The International Classification of Functioning, Disability and Health (ICF) provided a standardized language for coding. Results:Three overarching themes emerged from the data:Functioning,EnvironmentalandPersonal Factors, andCapacity.Functioningmapped closely onto Activities and Participation within the ICF. Contextual factors, bothEnvironmentalandPersonal, had a significant influence on functioning following concussion.Capacitywas a unique finding that described how long a person is able to engage in a task before the onset or worsening of symptoms. Conclusions:Capacity is fundamental to measuring limitations in functioning based on symptom threshold and time to recovery. The impact of contextual factors on functioning needs to be considered on a continuum from barrier to facilitator. These findings provide the basis for the development of a concussion-specific questionnaire.	[van Ierssel, Jacquie] Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 5B2, Canada; [O'Neil, Jennifer; Sveistrup, Heidi] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Sveistrup, Heidi] Bruyere Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Ottawa Hosp, Ottawa Hosp Res Inst, Div Phys Med & Rehabil, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Fac Med, Sch Med, Ottawa, ON, Canada; [Graham, Ian] Ottawa Hosp, Ctr Practice Changing Res, Res Inst, Ottawa, ON, Canada; [Graham, Ian] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Graham, Ian] Univ Ottawa, Fac Hlth Sci, Sch Nursing, Ottawa, ON, Canada		van Ierssel, J (corresponding author), Childrens Hosp Eastern Ontario Res Inst, 401 Smyth Rd, Ottawa, ON K1H 5B2, Canada.	jminn044@uottawa.ca	Graham, Ian D./ABD-5259-2021	Graham, Ian D./0000-0002-3669-1216; van Ierssel, Jacqueline/0000-0001-5519-8526			Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cieza A, 2019, DISABIL REHABIL, V41, P574, DOI 10.3109/09638288.2016.1145258; Creswell JW, 2017, DESIGNING CONDUCTING, V3rd; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Fadyl JK, 2019, NEUROPSYCHOL REHABIL, V29, P1095, DOI 10.1080/09602011.2017.1364653; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Laxe S, 2014, DISABIL REHABIL, V36, P82, DOI 10.3109/09638288.2013.780641; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Laxe S, 2011, NEUROREHABILITATION, V29, P99, DOI 10.3233/NRE-2011-0683; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Madden RH, 2019, DISABIL REHABIL, V41, P1450, DOI 10.1080/09638288.2018.1431812; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MISHEL MH, 1991, NURS RES, V40, P236; Moon K, 2014, CONSERV BIOL, V28, P1167, DOI 10.1111/cobi.12326; O'Brien KK, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-76; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM, P250; Ontario Neurotrauma Foundation, 2017, STAND POSTC CAR; Patrick DL, 2011, VALUE HEALTH, V14, P967, DOI 10.1016/j.jval.2011.06.014; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sikora E, 2018, ARCH PHYS MED REHAB, V99, pe178; Smith B, 2018, INT REV SPORT EXER P, V11, P101, DOI [10.1080/1750984X.2017.1317357, 10.1080/1750984x.2017.1317357, 10.1109/ACSD.2018.000-4]; Snell DL, 2020, DISABIL REHABIL, V42, P1942, DOI 10.1080/09638288.2018.1542461; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; van Ierssel J, 2018, QUAL LIFE RES, V27, P3071, DOI 10.1007/s11136-018-1939-8; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2007, ICD 10 CLASS MENT BE; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	48	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 6	2021	43	23					3365	3376		10.1080/09638288.2020.1743772		MAR 2020	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WV5FB	WOS:000557262900001	32223453				2022-02-06	
J	Ayoub, S; Smith, JG; Cary, I; Dalton, C; Pinto, A; Ward, C; Saverino, A				Ayoub, Sandy; Smith, Jared G.; Cary, Isabel; Dalton, Catherine; Pinto, Aimee; Ward, Claire; Saverino, Alessia			The positive and the negative impacts of spasticity in patients with long-term neurological conditions: an observational study	DISABILITY AND REHABILITATION			English	Article						PRISM; neurorehabilitation; stroke; multiple sclerosis; cerebral palsy; traumatic brain injury; spinal cord injury	QUALITY-OF-LIFE; MODIFIED ASHWORTH SCALE; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; REPORTED IMPACT; RELIABILITY; PEOPLE; ASSOCIATIONS; DEPRESSION; DISABILITY	Purpose: To describe the positive and negative impacts of spasticity across different neurological disorders using the Patient Reported Impact of Spasticity Measure (PRISM), deduce any associations between severity of spasticity and its impact, and assess for differences across diagnostic subgroups. Materials and methods: PRISM, a spasticity-specific quality of life questionnaire validated in patients with spinal cord injuries, was given to 97 follow-up patients attending a spasticity clinic prior to symptom assessment using the REsistance to PAssive movement Scale (REPAS). Results: Patients described a minor level of positive impact and a marked negative impact in the domains of "Psychological Agitation," "Daily Activities," "Need for Assistance/Positioning" and "Social Avoidance/Anxiety." Spasticity severity was, in general, a poor predictor of perceived impact, although severity and localisation of spasticity was modestly correlated with "Need for Assistance/Positioning" and "Social Embarrassment" levels. Despite comparable levels of spasticity severity, people with MS expressed a more substantial impact across some PRISM domains than did patients in other groups. Conclusion: PRISM can be useful to assess the impact of spasticity in various neurological conditions although further validation studies are needed.	[Ayoub, Sandy] St Georges Univ London, Med Sch Dept, London, England; [Smith, Jared G.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Cary, Isabel; Dalton, Catherine; Pinto, Aimee; Ward, Claire; Saverino, Alessia] Queen Mary Hosp, Wolfson Neuro Rehabil Ctr, Spastic Serv, London SW15 5PN, England		Saverino, A (corresponding author), Queen Mary Hosp, Wolfson Neuro Rehabil Ctr, Spastic Serv, London SW15 5PN, England.	alessia.saverino@gmail.com	Smith, Jared G/ABG-7370-2021	Smith, Jared G/0000-0001-6138-136X; Ayoub, Sandy/0000-0002-3518-3260			Adams MM, 2007, ARCH PHYS MED REHAB, V88, P1185, DOI 10.1016/j.apmr.2007.06.012; Andresen SR, 2016, SPINAL CORD, V54, P973, DOI 10.1038/sc.2016.46; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brenes GA, 2008, AGING MENT HEALTH, V12, P158, DOI 10.1080/13607860601124115; Nogueira LAC, 2009, ARQ NEURO-PSIQUIAT, V67, P812, DOI 10.1590/S0004-282X2009000500006; Cheung J, 2015, PHYSIOTHER CAN, V67, P157, DOI 10.3138/ptc.2014-07; Cook K, 2005, J NEUROL PHYS THER, V29, P204; Cook KF, 2007, J REHABIL RES DEV, V44, P363, DOI 10.1682/JRRD.2006.04.0036; Doan QV, 2012, PM&R, V4, P4, DOI 10.1016/j.pmrj.2011.10.001; Ertzgaard P, 2020, J SPINAL CORD MED, V43, P813, DOI 10.1080/10790268.2019.1575533; Flachenecker P, 2014, ACTA NEUROL SCAND, V129, P154, DOI 10.1111/ane.12202; Gillard PJ, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0340-3; Hair J.F., 1998, MULTIVARIATE DATA AN, V6; Hotter B, 2018, EUR STROKE J, V3, P237, DOI 10.1177/2396987318771174; Kargarfard M, 2012, EUR J NEUROL, V19, P431, DOI 10.1111/j.1468-1331.2011.03535.x; Knezevic T, 2015, INT J REHABIL RES, V38, P199, DOI 10.1097/MRR.0000000000000107; Martin A, 2014, NEUROPSYCH DIS TREAT, V10, P111, DOI 10.2147/NDT.S53913; McKay WB, 2018, SPINAL CORD, V56, P478, DOI 10.1038/s41393-017-0038-y; Meseguer-Henarejos AB, 2018, EUR J PHYS REHAB MED, V54, P576, DOI 10.23736/S1973-9087.17.04796-7; Milinis K, 2016, DISABIL REHABIL, V38, P1431, DOI 10.3109/09638288.2015.1106592; Milinis K, 2016, MULT SCLER RELAT DIS, V5, P34, DOI 10.1016/j.msard.2015.10.007; Mutlu A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-44; National Institute for Health and Care Excellence, 2017, CER PALS 25S ASS MAN; Platz T, 2008, DISABIL REHABIL, V30, P44, DOI 10.1080/09638280701191743; Royal College of Physicians, 2018, SPAST AD MAN US BOT; Sheean G, 2006, DRUG SAFETY, V29, P31, DOI 10.2165/00002018-200629010-00003; Shilt JS, 2012, DEGENER NEUROL NEURO, V2, P133, DOI 10.2147/DNND.S16630; Synnot A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008929.pub2; Voerman GE, 2010, DISABIL REHABIL, V32, P775, DOI 10.3109/09638280903304490; Ward AB, 2014, J REHABIL MED, V46, P504, DOI 10.2340/16501977-1817; World Health Organization, 2007, INT CLASS FUNCT DIS; Yelnik AP, 2010, J REHABIL MED, V42, P801, DOI 10.2340/16501977-0613	33	1	1	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 6	2021	43	23					3357	3364		10.1080/09638288.2020.1742803		MAR 2020	8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WV5FB	WOS:000523721000001	32223455	Green Accepted			2022-02-06	
J	Gowinnage, SS; Arambepola, C				Gowinnage, Samitha Samanmalee; Arambepola, Carukshi			Quality of life and its determinants among community re-integrated soldiers with permanent disabilities following traumatic limb injuries	QUALITY OF LIFE RESEARCH			English	Article						Permanent disability; Soldiers; Health-related quality of life	GLOBAL BURDEN; SELF-ESTEEM; HEALTH; AMPUTATION; ADULTS; WAR; REHABILITATION; PREDICTORS; VETERANS; AMPUTEES	Purpose To assess health-related-quality of life (HRQOL) after the end of war and its associated factors among soldiers with permanent limb disabilities in Sri Lanka Methods A cross-sectional study was conducted among 500 rehabilitated and socially re-integrated Army soldiers having permanent disability following traumatic limb injuries during the last year of ethnic conflict of Sri Lanka. Females, soldiers with no updated data, and soldiers having permanent deafness/total blindness/total brain or spinal cord injury were excluded. The sample was randomly selected from updated 'Disabled Category Registries'. Personal and injury data were collected through postal questionnaire. HRQOL was assessed using SF-36 tool validated for Sri Lankan soldiers. Results SF-36 scores obtained on HRQOL related to overall physical health (mean = 57.1; SD = 19) and mental health (mean = 58.8; SD = 17.2) were comparable. HRQOL was best in social functioning (mean = 73.4; SD = 24) and worst in vitality (mean = 48.4; SD = 15.5). Factors significantly associated with better HRQOL related to the overall physical and mental health were aged over 35 years, being married, being assigned duties, having only upper/lower limbs affected and absence of co-disability. Having duties assigned demonstrated better QOL in almost all domains. None were associated with income or education. Conclusions Physical and mental health components contribute equally to the HRQOL of rehabilitated soldiers with permanent limb disabilty. Their poorer HRQOL was determined by certain person- and injury-related factors. These need to be addressed during re-integration and post-rehabilitation services.	[Gowinnage, Samitha Samanmalee] Minist Hlth, Youth Elderly & Disabled Persons Unit, Colombo, Sri Lanka; [Arambepola, Carukshi] Univ Colombo, Fac Med, Dept Community Med, 25 Kynsey Rd, Colombo 00800, Sri Lanka		Arambepola, C (corresponding author), Univ Colombo, Fac Med, Dept Community Med, 25 Kynsey Rd, Colombo 00800, Sri Lanka.	samanmalisamitha@gmail.com; carukshi@commed.cmb.ac.lk		Arambepola, Carukshi/0000-0002-2981-349X			Brown I., 2003, QUALITY LIFE DISABIL; Buckman JEJ, 2011, OCCUP ENVIRON MED, V68, P69, DOI 10.1136/oem.2009.054692; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; Davie-Smith F, 2015, PHYSIOTHERAPY, V101, pe300; Demet K, 2003, DISABIL REHABIL, V25, P480, DOI 10.1080/0963828031000090434; Dias S, 2012, DAILY MIRROR, V17, P2012; Dougherty PJ, 2001, J BONE JOINT SURG AM, V83A, P383, DOI 10.2106/00004623-200103000-00010; Elliott A.C., 2007, STAT ANAL QUICK REFE; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Gunawardena NS, 2006, MIL MED, V171, P283, DOI 10.7205/MILMED.171.4.283; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; Karami GR, 2012, IRAN J PUBLIC HEALTH, V41, P53; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X; Kim WS, 2012, DISABIL REHABIL, V34, P1262, DOI 10.3109/09638288.2011.641656; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kumara AA, 2015, REHABILITATION MANAG; Langer V, 2014, SCI WORLD J, DOI 10.1155/2014/640430; Li B, 2011, AM J EPIDEMIOL, V174, P761, DOI 10.1093/aje/kwr154; Manhas C, 2014, J HEALTH PSYCHOL, V19, P1471, DOI 10.1177/1359105313493812; Mar J, 2010, CLINICOECONOMIC OUTC, V2, P97; Meinert CL, 2012, SAMPLE SIZE CALCULAT, P259; Mitra S, 2014, DISABIL REHABIL, V36, P940, DOI 10.3109/09638288.2013.825333; Pallant J.F., 2007, SPSS SURVIVAL MANUAL, P179; Peirano AH, 2012, INT J ANGIOL, V21, P47, DOI 10.1055/s-0032-1304275; Saffari M, 2015, APPL RES QUAL LIFE, V10, P63, DOI 10.1007/s11482-014-9300-z; Sazlina SG, 2012, J NUTR HEALTH AGING, V16, P498, DOI 10.1007/s12603-012-0038-8; Singleton P, 2012, J HUM RESOUR, V47, P972; Sinha R, 2011, PROSTHET ORTHOT INT, V35, P90, DOI 10.1177/0309364610397087; Sri Lanka Army, 2018, CTR ARM VOC TRAIN TU; Stagni SB, 2015, EUR J PHYS REHAB MED, V51, P331; Starnes BW, 2006, J TRAUMA, V60, P432, DOI 10.1097/01.ta.0000197628.55757.de; Taghipour H, 2009, J ORTHOP TRAUMA, V23, P525, DOI 10.1097/BOT.0b013e3181a10241; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x; van der Schans CP, 2002, J PAIN SYMPTOM MANAG, V24, P429, DOI 10.1016/S0885-3924(02)00511-0; Walters SJ, 2001, AGE AGEING, V30, P337, DOI 10.1093/ageing/30.4.337; Wang S, 2018, PM&R, V10, P951, DOI 10.1016/j.pmrj.2018.02.008; World Health Organization, 2001, ICF INT CLASFUNCT; Yelsma P, 1998, J SOC PSYCHOL, V138, P431, DOI 10.1080/00224549809600398; Zhang XN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121192; Zidarov D, 2009, ARCH PHYS MED REHAB, V90, P634, DOI 10.1016/j.apmr.2008.11.003	41	1	1	0	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	AUG	2020	29	8					2119	2127		10.1007/s11136-020-02473-x		MAR 2020	9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	MK3BX	WOS:000522008200003	32222929				2022-02-06	
J	Kuo, JR; Lim, SW; Zheng, HX; Ho, CH; Chang, CH; Chio, CC; Wee, HY				Kuo, Jinn-Rung; Lim, Sher-Wei; Zheng, Hong-Xiang; Ho, Chung-Han; Chang, Chin-Hung; Chio, Chung-Ching; Wee, Hsiao-Yue			Triglyceride is a Good Biomarker of Increased Injury Severity on a High Fat Diet Rat After Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						High fat diet; Total cholesterol; Triglycerides; Biomarker; Fluid percussion traumatic brain injury; Apoptosis; Tumor necrosis factor-alpha; Neuroinflammation	CORTICAL CONTUSION INJURY; NEUROINFLAMMATION; EXPRESSION; PROTEIN	Injury severity is correlated with poor prognosis after traumatic brain injury (TBI). It is not known whether triglycerides (TGs) or total cholesterol (TC) is good biomarker of increased injury of neuroinflammation and apoptosis in a high fat diet (HFD)-treated rat after TBI episodes. Five-week-old male Sprague-Dawley (SD) rats were fed a HFD for 8 weeks. The anesthetized male SD rats were divided into three sub-groups: sham-operated and TBI with 1.6 atm or with 2.4 atm fluid percussion injury (FPI). Cell infarction volume (triphenyltetrazolium chloride stain), tumor necrosis factor-alpha (TNF-alpha) expression in the microglia (OX42 marker) and astrocytes (Glial fibrillary acidic protein marker), TNF-alpha receptor expression in the neurons (TNFR1 and TNFR2 markers), and the extent of neuronal apoptosis (TUNEL marker) were evaluated by immunofluorescence, and the functional outcome was assessed by an inclined plane test. These tests were performed 72 h after TBI. Serum triglyceride and cholesterol levels were measured at 24, 48 and 72 h after TBI. The FPI with 2.4 atm significantly increased body weight loss, infarction volume, neuronal apoptosis and TNF-alpha expression in the microglia and astrocytes, and it decreased the maximum grasp degree and TNFR1 and TNFR2 expression in neurons at the 3rd day following TBI. The serum TG level was positively correlated with FPI force, infarction volume, Neu-N-TUNEL, GFAP-TNF alpha, and OX42-TNF alpha Simultaneously; the serum TG level was negatively correlated with Neu-N-TNFR1 and Neu-N-TNFR2. TG is a good biomarker of increased injury for neuroinflammation and apoptosis at the 3rd day after TBI in HFD rats.	[Kuo, Jinn-Rung; Lim, Sher-Wei; Zheng, Hong-Xiang; Chang, Chin-Hung; Chio, Chung-Ching; Wee, Hsiao-Yue] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Kuo, Jinn-Rung; Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Lim, Sher-Wei; Wee, Hsiao-Yue] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Kuo, Jinn-Rung; Wee, Hsiao-Yue] Chi Mei Med Ctr, 901 Chung Hwa Rd, Tainan, Taiwan		Kuo, JR; Wee, HY (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Wee, HY (corresponding author), Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan.; Kuo, JR; Wee, HY (corresponding author), Chi Mei Med Ctr, 901 Chung Hwa Rd, Tainan, Taiwan.	kuojinnrung@gmail.com; slsw0219@gamil.com; mars93410@gmail.com; cmh7520@chimei.mail.org.tw; ho.c.hank@gmail.com; chiocc@ms28.hinet.net; wilsonhywee@gmail.com					Backs WA, 2017, INT J OBESITY, V231, P381; Banks WA, 2012, ANN NY ACAD SCI, V1264, P13, DOI 10.1111/j.1749-6632.2012.06568.x; Bowman GL, 2012, CURR GERONTOL GERIAT, V2012; Chong AJ, 2020, NEUROCRIT CARE, V33, P230, DOI 10.1007/s12028-019-00891-5; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Conti AC, 1998, J NEUROSCI, V18, P5663; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Farr S, 2016, CURR OPIN LIPIDOL, V27, P1, DOI 10.1097/MOL.0000000000000254; Funakoshi T, 2016, J BIOL CHEM, V291, P25050, DOI 10.1074/jbc.M116.727404; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4; Kang DH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0202-2; Karaoglan A, 2011, ULUS TRAVMA ACIL CER, V17, P298, DOI 10.5505/tjtes.2011.69077; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; KUNIHARA M, 1983, J LIPID RES, V24, P639; Laaksonen DE, 2004, ANN MED, V36, P332, DOI 10.1080/07853890410031849; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Martinez BI, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0145-8; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Sekaran H, 2019, BRAIN RES BULL, V152, P63, DOI 10.1016/j.brainresbull.2019.07.010; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Spagnuolo MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00479; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; Wang CC, 2018, WORLD NEUROSURG, V112, pE719, DOI 10.1016/j.wneu.2018.01.140; Wang Y, 1997, J NEUROSCI, V17, P4341; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Yang WC, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-016-0401-6; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190	43	1	1	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2020	45	7					1536	1550		10.1007/s11064-020-03018-x		MAR 2020	15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LY5TU	WOS:000522011700001	32222876				2022-02-06	
J	McMullan, C; Retzer, A; Slade, A; Kyte, D; Jones, L; Belli, A; Calvert, M; Turner, GM				McMullan, Christel; Retzer, Ameeta; Slade, Anita; Kyte, Derek; Jones, Laura; Belli, Antonio; Calvert, Melanie; Turner, Grace M.			Care providers' and patients' attitudes toward using electronic-patient reported outcomes to support patients with traumatic brain injury: a qualitative study (PRiORiTy)	BRAIN INJURY			English	Article						PROMs; electronic PROMs; qualitative research; traumatic brain injury; ePROMs		Objectives: To (a) identify residual symptoms and deficits resulting from a traumatic brain injury (TBI) and impact on patients' and their families' quality of life; (b) explore views and experience of care providers, researchers, patients, and carers of using PROMs; and (c) explore their attitudes toward reporting symptoms and impacts on an electronic platform. Methods: Qualitative semi-structured interviews with people with TBI and their carers; health-care professionals, researchers, and third sector staff members working with people with TBI. Results: Symptoms and long-term impacts of TBI included cognitive problems, difficulties functioning, anxiety, and depression. PROMs were seen as improving knowledge of residual symptoms and their impact post-TBI but not always accurately reflecting patients' residual problems. Challenges to completing PROMs were cognitive impairment and lack of insight into condition. Perceived advantages of an electronic platform included easy data collection; flexibility; improving workflow; and the ability to send/ receive feedback and reminders easily. Suggested features of an electronic platform included simple layout, lay language, short questions, few items on the screen, and capability to send/receive feedback and additional information. Conclusion: There is a demand for reporting symptoms and their impact electronically, providing the layout is kept simple and feedback from clinicians is provided.	[McMullan, Christel; Retzer, Ameeta; Slade, Anita; Kyte, Derek; Jones, Laura; Calvert, Melanie; Turner, Grace M.] Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Ctr Patient Reported Outcomes Res, Vincent Rd, Birmingham B15 2TT, W Midlands, England; [McMullan, Christel; Retzer, Ameeta; Slade, Anita; Kyte, Derek; Belli, Antonio; Calvert, Melanie; Turner, Grace M.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [McMullan, Christel; Retzer, Ameeta; Slade, Anita; Kyte, Derek; Belli, Antonio; Calvert, Melanie; Turner, Grace M.] Univ Birmingham, Birmingham, W Midlands, England; [Slade, Anita; Kyte, Derek; Calvert, Melanie] Univ Hosp Birmingham NHS Fdn Trust, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England		Turner, GM (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Ctr Patient Reported Outcomes Res, Vincent Rd, Birmingham B15 2TT, W Midlands, England.	g.turner.1@bham.ac.uk	Belli, Antonio/I-3799-2015; Turner, Grace/H-3929-2019; Calvert, Melanie/F-7055-2011; Slade, Anita/M-3246-2017; McMullan, Christel/F-4948-2017; Jones, Laura/AAY-6159-2020	Belli, Antonio/0000-0002-3211-9933; Turner, Grace/0000-0002-9783-9413; Calvert, Melanie/0000-0002-1856-837X; Slade, Anita/0000-0003-2827-7741; McMullan, Christel/0000-0002-0878-1513; Jones, Laura/0000-0002-4018-3855	National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); NIHR Postdoctoral Fellowship program [PDF-2017-10-047]; NIHR SRMRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); British Heart FoundationBritish Heart Foundation; Snow Foundation; Eye Hope Foundation; Association Du Syndrome de Wolfram; NIHR Birmingham Biomedical Research Centre, NIHR SRMRC at the University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Health Data Research UK; Innovate UKUK Research & Innovation (UKRI)Innovate UK	This research was funded by The National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC). GT is funded by the NIHR Postdoctoral Fellowship program (PDF-2017-10-047) and NIHR SRMRC. DK reports grants from Macmillan Cancer Support, Innovate UK, the National Institute for Health Research (NIHR) (PDF2016-09-009), NIHR Birmingham Biomedical Research Centre and NIHR SRMRC at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust and personal fees from Merck outside the submitted work. AS receives funding from the British Heart Foundation, Snow Foundation, Eye Hope Foundation, and Association Du Syndrome de Wolfram. MC receives funding from the NIHR Birmingham Biomedical Research Centre, NIHR SRMRC at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Health Data Research UK, Innovate UK and Macmillan Cancer Support. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	Aiyegbusi OL, 2019, AM J KIDNEY DIS, V74, P167, DOI 10.1053/j.ajkd.2019.02.011; Asadi-Lari Mohsen, 2004, Health Qual Life Outcomes, V2, P32, DOI 10.1186/1477-7525-2-32; Ash JS, 2015, STUD HEALTH TECHNOL, V208, P55, DOI 10.3233/978-1-61499-488-6-55; Basch E, 2017, JAMA-J AM MED ASSOC, V318, P197, DOI 10.1001/jama.2017.7156; Basch E, 2016, J CLIN ONCOL, V34, P557, DOI 10.1200/JCO.2015.63.0830; Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Calvert M, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5267; Calvert MJ, 2003, J CLIN PHARM THER, V28, P513, DOI 10.1046/j.0269-4727.2003.00521.x; Chen J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-211; Dekkers-Sanchez PM, 2010, J REHABIL MED, V42, P544, DOI 10.2340/16501977-0544; Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; Hjollund NHI, 2014, INTERACT J MED RES, V3, P2, DOI 10.2196/ijmr.2885; Jensen RE, 2015, MED CARE, V53, P153, DOI 10.1097/MLR.0000000000000289; Kramer JM, 2017, ARCH PHYS MED REHAB, V98, P1705, DOI 10.1016/j.apmr.2017.03.011; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morel T, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0718-x; Muehlhausen W, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0362-x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Recinos PF, 2017, ADV THER, V34, P452, DOI 10.1007/s12325-016-0463-x; Retzer A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024617; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	29	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					723	731		10.1080/02699052.2020.1740944		MAR 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000524103700001	32223338				2022-02-06	
J	Borgen, IMH; Lovstad, M; Andelic, N; Hauger, S; Sigurdardottir, S; Soberg, HL; Sveen, U; Forslund, MV; Kleffelgard, I; Lindstad, MO; Winter, L; Roe, C				Borgen, Ida Maria H.; Lovstad, Marianne; Andelic, Nada; Hauger, Solveig; Sigurdardottir, Solrun; Soberg, Helene L.; Sveen, Unni; Forslund, Marit V.; Kleffelgard, Ingerid; Lindstad, Marte Orud; Winter, Laraine; Roe, Cecilie			Traumatic brain injury-needs and treatment options in the chronic phase: Study protocol for a randomized controlled community-based intervention	TRIALS			English	Article						Brain injury; In-home rehabilitation; Community-based rehabilitation; Chronic phase; Health-care services; Outcome measures	QUALITY-OF-LIFE; INCOG RECOMMENDATIONS; PARTICIPATION ASSESSMENT; REHABILITATION IMPROVE; UNITED-STATES; HEALTH-CARE; HEAD-INJURY; PART; TBI; MANAGEMENT	Background Traumatic brain injury (TBI) is often associated with life-long medical, cognitive, emotional, and behavioral changes. Although long-lasting disabilities are expected, research on effective treatment options in the chronic phase of TBI is scarce. Methods/design This study protocol describes a randomized controlled trial (RCT) aimed at evaluating the effectiveness of a goal-oriented and community-based intervention for increasing community integration, quality of life, and functional independence in the chronic phase of complicated mild to severe TBI. Participants will be recruited from Oslo University Hospital, Norway. Patients aged 18-72 years living at home with MRI/CT-verified intracranial abnormalities, a TBI diagnosis, a time since injury of >= 2 years, and who experience either current TBI-related problems or restrictions in community integration will be included. The 120 participants will be randomized 1:1 to either (a) an intervention group, which will receive an in-home intervention program over 4 months, or (b) a control group receiving standard care in the municipalities. The intervention will consist of six home visits and two telephone contacts with a rehabilitation professional. A SMART-goal approach will be adopted to target the individual's self-reported TBI difficulties in everyday life. Primary outcomes will be self-reported quality of life and participation. Secondary outcomes include symptom burden, emotional functioning, and clinician-assessed global outcome and need for rehabilitation services. Outcomes will be evaluated at baseline and 4-5 and 12 months after baseline. Caregiver burden and general health will be assessed in participating family members. Goal attainment and acceptability will be evaluated in the intervention group. A process evaluation will be carried out to evaluate protocol adherence, and a cost-effectiveness analysis will be applied if the intervention is found to be effective. Discussion The current study provides an innovative approach to rehabilitation in the chronic phase of TBI evaluated using an RCT design that may inform treatment planning, health policies, and coordination of patient care. Further, the study may demonstrate new modes of establishing collaboration and knowledge transition between specialized rehabilitation facilities and local rehabilitation services that may improve patient outcomes.	[Borgen, Ida Maria H.; Andelic, Nada; Soberg, Helene L.; Sveen, Unni; Forslund, Marit V.; Kleffelgard, Ingerid; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Borgen, Ida Maria H.; Lovstad, Marianne; Hauger, Solveig] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway; [Lovstad, Marianne; Hauger, Solveig; Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Soberg, Helene L.; Sveen, Unni] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Lindstad, Marte Orud] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Hlth Sci Gjovik, Gjovik, Norway; [Winter, Laraine] Philadelphia Res & Educ Fdn, Philadelphia, PA USA; [Winter, Laraine] Dept Vet Affairs Med Ctr, Nursing Serv, Philadelphia, PA 19104 USA; [Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway		Borgen, IMH (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Borgen, IMH (corresponding author), Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway.	idmbor@ous-hf.no		Borgen, Ida/0000-0001-9163-6941	Research Council of NorwayResearch Council of Norway [260673/H10]	The project is funded by the Research Council of Norway, project number 260673/H10.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2004, HAEMATOLOGICA, V89, P264; [Anonymous], 2012, SOCIAL CARE SERVICE; [Anonymous], 2005, REDDET LIV SKAL OGSA; Beck J.S., 1995, COGNITIVE THERAPY BA; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Borgen IMH, 2020, COGENT MED, V7; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Calvert M, 2018, JAMA-J AM MED ASSOC, V319, P483, DOI 10.1001/jama.2017.21903; Chan A-W, 2013, BMJ-BRIT MED J, V2013, P346, DOI DOI 10.1136/BMJ.E7586; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Gimigliano F, 2017, EUR J PHYS REHAB MED, V53, P155, DOI 10.23736/S1973-9087.17.04746-3; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gutenbrunner C, 2015, J REHABIL MED, V47, P809, DOI 10.2340/16501977-2002; Haskins E.C., 2012, COGNITIVE REHABILITA; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kristiansen Thomas, 2011, J Trauma Manag Outcomes, V5, P9, DOI 10.1186/1752-2897-5-9; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; Lewin K, 1935, PSYCHOL FORSCH, V9, P1; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2006, NEUROPSYCHOL REHABIL, V16, P315, DOI 10.1080/09602010500176534; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff R, 2013, NEUROREHABILITATION, V32, P771, DOI 10.3233/NRE-130901; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Siegert Richard J, 1800, Clin Rehabil, V28, P687, DOI 10.1177/0269215513513601; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2012, NEUROREHAB NEURAL RE, V26, P695; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wechsler D., 2008, WECHSLER ADULT INTEL; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	75	1	1	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	MAR 27	2020	21	1							294	10.1186/s13063-020-4195-5			14	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	KY1IU	WOS:000522326500002	32216840	Green Published, gold			2022-02-06	
J	Bosworth, C; Dodd, JN				Bosworth, Christopher; Dodd, Jonathan N.			Noncredible effort on the Nonverbal-Medical Symptom Validity Test (NV-MSVT): Impact on cognitive performance in pediatric mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						NV-MSVT; performance validity; pediatric; neuropsychology; concussion; brain injury	MEMORY MALINGERING TOMM; SUBOPTIMAL EFFORT; HIGH SPECIFICITY; RESPONSE BIAS; TEST FAILURE; CHILDREN; CONCUSSION; ADULTS; STATEMENT; RATES	This study examined failure rates on the Nonverbal-Medical Symptom Validity Test (NV-MSVT) and its impact on cognitive performance in a sample of youths with mild traumatic brain injury (mTBI). Participants were 184 children and adolescents who presented to a multidisciplinary concussion clinic for a targeted neuropsychological evaluation. Performance Validity Tests (PVTs) were a part of the standard battery, including the NV-MSVT. Twenty-eight participants (15.2%) failed the NV-MSVT, none of whom displayed a genuine memory impairment profile (GMIP). Participants who failed the NV-MSVT performed significantly worse than those who passed the NV-MSVT on measures of IQ, memory, and immediate attention/working memory. There was no significant difference between groups on processing speed, sustained attention, cognitive flexibility, or sight word reading level. Aside from a slight difference in age, NV-MSVT failure was not impacted by demographic variables (sex, race), premorbid risk factors (pre-injury ADHD, learning disabilities, psychiatric diagnoses or treatment, developmental delays, or prior special education), injury-related variables (time since injury, positive neuroimaging findings, post-traumatic amnesia, number of prior mTBIs, etc.) or post-mTBI anxiety/depression. That said, participants who failed NV-MSVT endorsed significantly more severe postconcussive symptoms. These findings support the use of the NV-MSVT in neuropsychological evaluation of children and adolescents with mTBI.	[Bosworth, Christopher] Washington Univ, St Louis Childrens Hosp, Sch Med, St Louis, MO 63110 USA; [Dodd, Jonathan N.] WellStar Med Grp, Psychol Serv, Dept Neuropsychol, Marietta, GA USA		Dodd, JN (corresponding author), WellStar Med Grp, Psychol Serv, ABPP, 3939 Roswell Rd,Ste 200, Marietta, GA 30062 USA.	drdodd@gatewayneuro.com					Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Armistead-Jehle P, 2016, ARCH CLIN NEUROPSYCH, V31, P465, DOI 10.1093/arclin/acw033; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Boone K., 2002, DOT COUNTING TEST; Boone K., 2002, THE B TEST; Boone K.B., 2007, ASSESSMENT FEIGNED C; Brooks BL, 2019, APPL NEUROPSYCH-CHIL, V8, P319, DOI 10.1080/21622965.2018.1476865; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Conners, 2004, CONNERS CONTINUOUS P; Conners K.C., 2014, CONNERS CONTINUOUS P; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Dodd J, 2019, CHILD NEUROPSYCHOL, V25, P795, DOI 10.1080/09297049.2018.1531983; Dodd JN, 2020, CHILD NEUROPSYCHOL, V26, P137, DOI 10.1080/09297049.2019.1620714; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2004, MANUAL GREENS MED SY; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2021, APPL NEUROPSYCH-CHIL, V10, P65, DOI 10.1080/21622965.2019.1604342; Green P, 2016, APPL NEUROPSYCH-CHIL, V5, P25, DOI 10.1080/21622965.2014.935378; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Gunn D, 2010, CHILD NEUROPSYCHOL, V16, P105, DOI 10.1080/09297040903352564; Harrison AG, 2015, APPL NEUROPSYCH-CHIL, V4, P197, DOI 10.1080/21622965.2013.850581; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Kirkwood, 2015, VALIDITY TESTING CHI, P207; Kirkwood M. W, 2015, VALIDITY TESTING CHI, P79; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee G. J., 2015, VALIDITY TESTING CHI, P62; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister W.S., 2015, VALIDITY TESTING CHI, P164; Martin PK, 2018, ASSESSMENT, V25, P640, DOI 10.1177/1073191116656796; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Reynolds A, 2015, TRANSPORT RES REC, P3, DOI 10.3141/2504-01; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; Schneider HE, 2014, CLIN NEUROPSYCHOL, V28, P1133, DOI 10.1080/13854046.2014.960004; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sherman EMS, 2015, MEMORY VALIDITY PROF; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Williams AR, 2017, CLIN NEUROPSYCHOL, V31, P775; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	75	1	1	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 1	2020	9	4			SI		367	374		10.1080/21622965.2020.1742717		MAR 2020	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OD0AY	WOS:000524574200001	32223424				2022-02-06	
J	Zhang, H; Peng, Y; Li, CL; Lan, H; Xing, GQ; Chen, Z; Zhang, B				Zhang, Han; Peng, Yi; Li, Chunliu; Lan, Hong; Xing, Guoqiang; Chen, Zhu; Zhang, Bo			Playing Mahjong for 12 Weeks Improved Executive Function in Elderly People With Mild Cognitive Impairment: A Study of Implications for TBI-Induced Cognitive Deficits	FRONTIERS IN NEUROLOGY			English	Article						mahjong; elderly; executive function; mild cognitive impairment; activities of daily living (ADL); TBI	OLDER-ADULTS; NEUROPSYCHIATRIC SYMPTOMS; INSTRUMENTAL ACTIVITIES; COMMUNITY; DEMENTIA; RISK	Background: Mild cognitive impairment (MCI) is common among elderly people. So far, effective treatment that can stabilize or reverse the cognitive decline associated with MCI is lacking. Recent studies suggest that playing mahjong may improve attention and memory in elderly people. However, its effect on executive function remains unknown. Methods: 56 elderly people (74.3 +/- 4.3 years of age) with MCI from the First Social Welfare the First Nursing Home of Nanchong were randomized into mahjong and control groups (N = 28, each group). Subjects in the mahjong group played mahjong three times a week for 12 weeks, while people in the control group assumed normal daily activity. Executive function was evaluated using the Montreal Cognitive Assessment-Beijing (MoCA-B), the Shape Trail Test (STT), and the Functional Activities Questionnaire (FAQ) before the study and then at 6 and 12 weeks after mahjong administration. Results: There were no baseline differences in MoCA-B, STT, and FAQ scoring between the two groups. The MoCA-B, STT, and FAQ scores, however, improved significantly in the mahjong group but not in the control group after the 12-week mahjong administration. Significant correlations were also found between STT and FAQ scores. Conclusions: Playing Mahjong for 12 weeks improved the executive function of elderly people with MCI. Because Mahjong is a simple, low-cost entertainment activity, it could be widely applied to slow down or reverse the progression of cognitive decline in people with MCI, including those with traumatic brain injury.	[Zhang, Han; Peng, Yi; Li, Chunliu; Lan, Hong; Chen, Zhu; Zhang, Bo] North Sichuan Med Univ, Dept Med Rehabil, Affiliated Hosp, Nanchong Cent Hosp, Nanchong, Peoples R China; [Zhang, Han; Peng, Yi; Li, Chunliu; Lan, Hong; Chen, Zhu; Zhang, Bo] North Sichuan Med Univ, Clin Med Coll 2, Nanchong Cent Hosp, Nanchong, Peoples R China; [Xing, Guoqiang] North Sichuan Med Univ, Affiliated Hosp, Nanchong, Peoples R China; [Xing, Guoqiang] North Sichuan Med Univ, Clin Med Coll 2, Nanchong, Peoples R China		Xing, GQ (corresponding author), North Sichuan Med Univ, Affiliated Hosp, Nanchong, Peoples R China.; Xing, GQ (corresponding author), North Sichuan Med Univ, Clin Med Coll 2, Nanchong, Peoples R China.	gxing99@yahoo.com	Xing, Guoqiang/ABA-8450-2020		Sciences & Technology Bureau of Nanchong City [KY-15A0028]	This study was sponsored, in part, by a grant from the Sciences & Technology Bureau of Nanchong City (KY-15A0028). The founder had no role in the design, performance, and interpretation of results of the study.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bezdicek O, 2016, AGING CLIN EXP RES, V28, P239, DOI 10.1007/s40520-015-0413-5; Boey K. W., 1998, CLIN GERONTOLOGIST, V19, P65, DOI DOI 10.1300/J018V19N01_06; Boey KW., 2000, CLIN GERONTOLOGIST, V21, P49, DOI [DOI 10.1300/J018V21N02_05, 10.1300/J018v21n02_05]; Bourassa KJ, 2017, AGING MENT HEALTH, V21, P133, DOI 10.1080/13607863.2015.1081152; Cacciaglia R, 2018, HUM BRAIN MAPP, V39, P4565, DOI 10.1002/hbm.24306; Cao WF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00070; Carnicelli L, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12821; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Cheng ST, 2006, INT J GERIATR PSYCH, V21, P611, DOI 10.1002/gps.1531; Cheng ST, 2014, INT PSYCHOGERIATR, V26, P637, DOI 10.1017/S1041610213002524; Cornelis E, 2019, INT J GERIATR PSYCH, V34, P889, DOI 10.1002/gps.5087; Fukuma K, 2016, CLIN CASE REP, V4, P948, DOI 10.1002/ccr3.653; Gao M, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0903-3; Garcia-Alvarez L, 2019, ALZH DEMENT-DADM, V11, P170, DOI 10.1016/j.dadm.2018.12.010; Giles GM, 2019, BRAIN INJURY, V33, P129, DOI 10.1080/02699052.2018.1539762; Ginsberg TB, 2019, J AM OSTEOPATH ASSOC, V119, P96, DOI 10.7556/jaoa.2019.015; Guarino A, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00437; Hamasaki A, 2018, TOHOKU J EXP MED, V245, P245, DOI 10.1620/tjem.245.245; Ige J, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0825-6; Jun- Chao Lu Q. - H. G., 2006, CHIN J CLIN PSYCHOL, V02, P118; Kim GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123251; Kirova AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748212; Knight MJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00539; Kobayashi-Cuya KE, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0880-6; Kumar KS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007935.pub2; Law LLF, 2014, AGEING RES REV, V15, P61, DOI 10.1016/j.arr.2014.02.008; Li XD, 2018, NEUROL SCI, V39, P1029, DOI 10.1007/s10072-018-3319-0; [李阳 Li Yang], 2014, [重庆医科大学学报, Jounral of Chongqing Medical University], V39, P488; Liao YY, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00162; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Lu CM, 2015, INT J GERIATR PSYCH, V30, P995, DOI 10.1002/gps.4307; Mansbach RAM, 2018, GERONTOLOGIST, V10, P1, DOI [10.1093/geront/gny097, DOI 10.1093/GERONT/GNY097]; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Mazzeo S, 2019, J NEUROL, V266, P487, DOI 10.1007/s00415-018-9164-5; Mikkelsen ASB, 2019, INQUIRY-J HEALTH CAR, V56, DOI 10.1177/0046958018823929; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Ratiu I, 2018, QUAL LIFE RES, V27, P2057, DOI 10.1007/s11136-018-1859-7; Rog LA, 2014, CLIN NEUROPSYCHOL, V28, P215, DOI 10.1080/13854046.2013.876101; Silva FD, 2019, MATURITAS, V126, P28, DOI 10.1016/j.maturitas.2019.04.217; Subramaniam Mythily, 2015, Addict Behav Rep, V1, P57, DOI 10.1016/j.abrep.2015.04.004; Tang FY, 2018, GERONTOL GERIATR MED, V4, DOI 10.1177/2333721418778180; Teh JKL, 2019, SSM-POPUL HLTH, V9, DOI 10.1016/j.ssmph.2019.100479; Tsang William W N, 2016, J Phys Ther Sci, V28, P2955; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Yu J, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-156; [张雪晴 Zhang Xueqing], 2014, [中国全科医学, Chinese General Practice], V17, P3046; Zhao QH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057333, 10.1371/journal.pone.0061140]; Zheng WY, 2010, J GAMBL STUD, V26, P441, DOI 10.1007/s10899-009-9159-3	51	1	1	8	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 27	2020	11								178	10.3389/fneur.2020.00178			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LC8NE	WOS:000525588800001	32292385	Green Published, gold			2022-02-06	
J	Zeitzer, JM; Hon, F; Whyte, J; Monden, KR; Bogner, J; Dahdah, M; Wittine, L; Bell, KR; Nakase-Richardson, R				Zeitzer, Jamie M.; Hon, Flora; Whyte, John; Monden, Kimberley R.; Bogner, Jennifer; Dahdah, Marie; Wittine, Lara; Bell, Kathleen R.; Nakase-Richardson, Risa			Coherence Between Sleep Detection by Actigraphy and Polysomnography in a Multi-Center, Inpatient Cohort of Individuals with Traumatic Brain Injury	PM&R			English	Article							CYCLE DISTURBANCES; CONSCIOUSNESS; VETERANS; NEED	Background Sleep is increasingly recognized as a crucial component to rapid and successful rehabilitation, especially from traumatic brain injuries (TBIs). Assessment of longitudinal patterns of sleep in a hospital setting, however, are difficult and often the expertise or equipment to conduct such studies is not available. Actigraphy (wrist-worn accelerometry) has been used for many years as a simple proxy measurement of sleep patterns, but its use has not been thoroughly validated in individuals with TBI. Objective To determine the validity of different sensitivity settings of actigraphy analysis to optimize its use as a proxy for recording sleep patterns in individuals with a TBI. Design Comparison of actigraphy to criterion standard polysomnographic (PSG)-determination of sleep on a single overnight study. Setting Six rehabilitation hospitals in the TBI Model System. Participants Two hundred twenty-seven consecutive, medically stable individuals with a TBI. Interventions Not applicable. Main Outcome Measure Concordance between PSG- and actigraphy-determined sleep using different sensitivity threshold settings (low, medium, high, automated). Results Bland-Altman plots revealed increasing error with increasing amounts of wake during the sleep episode. Precision-recall statistics indicate that with less sensitive actigraphy thresholds, episodes identified as "wake" are usually "wake," but many true episodes of "wake" are missed. With more sensitive actigraphy thresholds, more episodes of "wake" are identified, but only some of these are true episodes of "wake." Conclusions In hospitalized patients with TBI and poor sleep, actigraphy underestimates the level of sleep disruption and has poor concordance with PSG-determined sleep. Alternate methods of scoring sleep from actigraphy data are necessary in this population.	[Zeitzer, Jamie M.; Hon, Flora] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Zeitzer, Jamie M.] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, 3801 Miranda Ave 151Y, Palo Alto, CA 94304 USA; [Hon, Flora] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Monden, Kimberley R.] Craig Hosp, Englewood, CO USA; [Monden, Kimberley R.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; [Bogner, Jennifer] Ohio State Univ, Coll Med, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Dahdah, Marie] Baylor Scott & White Med Ctr Plano, Plano, TX USA; [Wittine, Lara; Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; James A Haley Vet Hosp, Tampa, FL 33612 USA; Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; Harborview Med Ctr, Seattle, WA USA; Rehabil Hosp Indiana, Indianapolis, IN USA; Baylor Scott & White Inst Rehabil, Dallas, TX USA; Moss Rehabil Res Inst, Elkins Pk, PA USA		Zeitzer, JM (corresponding author), VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, 3801 Miranda Ave 151Y, Palo Alto, CA 94304 USA.	jzeitzer@stanford.edu	Monden, Kimberley/AAE-9831-2020; Zeitzer, Jamie/AAO-2103-2020; Zeitzer, Jamie M/A-1168-2007	Monden, Kimberley/0000-0002-5207-0452; Zeitzer, Jamie/0000-0001-6174-5282; Zeitzer, Jamie M/0000-0001-6174-5282	Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [CER-1511-33 005]; VHA Central Office VATBI Model Systems Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015, HT0014-19-C-0004]; National Institute on Disability, Independent Living, and Rehabilitation Research (NSDC Grant)United States Department of Health & Human Services [90DPTB00070, 90DP0084, 90DPTB0013-01-00, 90DPTB0008, 90DPT80004-02]	Research reported in this article was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (CER-1511-33 005). This research was sponsored by VHA Central Office VATBI Model Systems Program of Research; Subcontract from General Dynamics Information Technology (W91YTZ-13-C-0015; HT0014-19-C-0004) from the Defense and Veterans Brain Injury Center and National Institute on Disability, Independent Living, and Rehabilitation Research (NSDC Grant #90DPTB00070, #90DP0084, 90DPTB0013-01-00, 90DPTB0008, 90DPT80004-02). The statements presented in this publication are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Berry RB., 2017, AASM MANUAL SCORING; Chen PY, 2015, J HEAD TRAUMA REHAB, V30, pE50, DOI 10.1097/HTR.0000000000000086; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Draganich C, 2019, BRAIN INJURY, V33, P1194, DOI 10.1080/02699052.2019.1631484; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Duclos C, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0709-x; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lichstein KL, 2006, SLEEP, V29, P232; Maneyapanda MB, 2018, NEUROREHABILITATION, V43, P319, DOI 10.3233/NRE-182533; Nakase-Richardson R, 2020, ARCH PHYS MED REHAB, V101, P283, DOI 10.1016/j.apmr.2019.09.019; Nazem S, 2016, J HEAD TRAUMA REHAB, V31, P136, DOI 10.1097/HTR.0000000000000225; O'Brien M., 2010, AIDS EX PER NERV SYS; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; TEASDALE G, 1974, LANCET, V2, P81; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Williams ET, 2019, J NEUROSCI NURS, V51, P134, DOI 10.1097/JNN.0000000000000441; Zeitzer JM, 2013, AM J GERIAT PSYCHIAT, V21, P391, DOI 10.1016/j.jagp.2012.12.012	30	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	DEC	2020	12	12					1205	1213		10.1002/pmrj.12353		MAR 2020	9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	PD9ET	WOS:000522475800001	32125095				2022-02-06	
J	Bouferguene, S; Lapierre, A; Rainville, P; Arbour, C				Bouferguene, Sabrina; Lapierre, Alexandra; Rainville, Pierre; Arbour, Caroline			The Effect of Age and Pain on Quantitative Sensory Testing Measurements After Moderate-to-Severe Traumatic Brain Injury: Preliminary Findings	BIOLOGICAL RESEARCH FOR NURSING			English	Article						traumatic brain injury; age; chronic pain; quantitative sensory testing	POSTTRAUMATIC-STRESS-DISORDER; PERCEPTION; INVENTORY; ANXIETY; METAANALYSIS; THRESHOLDS; PREVALENCE; SENSATION; PROTOCOL; NETWORK	Background: Chronic pain after moderate-to-severe traumatic brain injury (TBI) is associated with notable sensory alterations. Although the incidence of TBI is rapidly growing in older populations, elderly individuals have been largely excluded from sensory testing studies, thus limiting evidence regarding the influence of age on pain-related sensory alterations after TBI. This study aimed to investigate the effect of age on the sensory profiles of patients with and without chronic pain after moderate-to-severe TBI. Methods: Thermal and mechanical quantitative sensory testing were performed on the painful and contralateral body regions in TBI participants with pain (TBI-P) and on both forearms in TBI participants without pain (TBI-NP). Descriptive information about chronic pain and psychological comorbidities was assessed using validated questionnaires. Results: Participants included 37 young (18-59 years, 57% with chronic pain) and 22 elderly (>= 60 years, 46% with chronic pain) survivors of moderate-to-severe TBI. TBI-P participants exhibited significant alterations in heat and pressure pain sensitivity compared to TBI-NP participants, with more pronounced decreases in heat detection in the elderly group and increased warmth sensitivity in the young group. Alterations were not always associated with chronic pain, as cold hypoesthesia was found in elderly TBI-NP participants. In both age groups, chronic pain was associated with higher levels of depressive mood. Conclusions: Results suggest that young and elderly TBI survivors have both common and unique sensory properties, highlighting the need to pursue sensory testing studies in older patient groups. Depression might also be an important target for pain management after TBI.	[Bouferguene, Sabrina; Lapierre, Alexandra; Arbour, Caroline] Hop Sacre Coeur Montreal, Res Ctr, Room E-1380, Montreal, PQ H4J 1C5, Canada; [Bouferguene, Sabrina; Lapierre, Alexandra; Arbour, Caroline] Hop Sacre Coeur Montreal, Trauma Div, Room E-1380, Montreal, PQ H4J 1C5, Canada; [Rainville, Pierre] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada		Arbour, C (corresponding author), Hop Sacre Coeur Montreal, Res Ctr, Room E-1380, Montreal, PQ H4J 1C5, Canada.; Arbour, C (corresponding author), Hop Sacre Coeur Montreal, Trauma Div, Room E-1380, Montreal, PQ H4J 1C5, Canada.	caroline.arbour@umontreal.ca		Lapierre, Alexandra/0000-0002-8704-4940	Fonds de la recherche du Qu '	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by start-up funds provided by the principal investigator's (C. Arbour) institution. P. Rainville received salary support from the Fonds de la recherche du Qu ebec-Sant ce. For the remaining authors, no sources of funding were declared.	Alexander Michael P, 2003, Pain Res Manag, V8, P19; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bardhoshi G, 2016, J COUNS DEV, V94, P356, DOI 10.1002/jcad.12090; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; Bouferguene S, 2019, BIOL RES NURS, V21, P519, DOI 10.1177/1099800419859078; Bravo TP, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0552-2; Chen YW, 2018, EUR J PAIN, V22, P1718, DOI 10.1002/ejp.1258; Chiron M., 1998, DESCRIPTION GRAVITE; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Courtney CA, 2010, J ORTHOP SPORT PHYS, V40, P818, DOI 10.2519/jospt.2010.3314; Defrin R, 2017, J PAIN, V18, P1, DOI 10.1016/j.jpain.2016.09.005; Defrin R, 2015, J PAIN, V16, P961, DOI 10.1016/j.jpain.2015.06.010; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Diamond B., 2002, LEGAL ASPECTS PAIN M; Dyck PJ, 2000, DIABETES CARE, V23, P510, DOI 10.2337/diacare.23.4.510; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Guez M, 2002, ACTA ORTHOP SCAND, V73, P455, DOI 10.1080/00016470216329; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hendiani JA, 2003, J PAIN, V4, P203, DOI 10.1016/S1526-5900(03)00557-1; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Jabbour Pascal, 2008, Neurosurg Focus, V25, pE16, DOI 10.3171/FOC.2008.25.11.E16; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Lautenbacher S, 2005, PAIN, V115, P410, DOI 10.1016/j.pain.2005.03.025; Lautenbacher S, 2017, NEUROSCI BIOBEHAV R, V75, P104, DOI 10.1016/j.neubiorev.2017.01.039; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P1, DOI 10.1007/s11682-012-9179-y; Mendoza T, 2006, EUR J PAIN, V10, P353, DOI 10.1016/j.ejpain.2005.06.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merskey H, 1994, CLASSIFICATION CHRON; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nurmikko T, 2009, EUR J NEUROL, V16, pE104, DOI 10.1111/j.1468-1331.2009.02583.x; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Popescu C, 2015, J Med Life, V8, P272; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P117, DOI 10.1002/art.23241; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sheng JY, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/9724371; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Sullivan M. J., 1995, PAIN CATASTROPHIZING; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wickremaratchi MM, 2006, POSTGRAD MED J, V82, P301, DOI 10.1136/pgmj.2005.039651	58	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JUL	2020	22	3					341	353	1099800420912462	10.1177/1099800420912462		MAR 2020	13	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	LV5OA	WOS:000523928100001	32208852				2022-02-06	
J	Henderson, D; Sinha, S				Henderson, D.; Sinha, S.			OssDsign cranioplasty in children: a single-centre experience	CHILDS NERVOUS SYSTEM			English	Article						Cranioplasty; Decompressive craniectomy; Traumatic brain injury; Ventriculoperitoneal shunt	DECOMPRESSIVE CRANIECTOMY; PEDIATRIC POPULATION; RESORPTION; INFECTION	Introduction OssDsign have developed a new type of cranioplasty plate, consisting of calcium phosphate reinforced with titanium. Currently, there is little known about the cosmetic outcomes and infection rate when OssDsign cranioplasty plates are implanted into paediatric patients. Methods A retrospective case series was performed to include all paediatric patients who received an OssDsign cranioplasty at a single centre, Sheffield Children's Hospital. The cosmetic outcomes were subjectively reported by the parents of the children. Results We identified seven paediatric patients where OssDsign cranioplasty was performed. This included two bifrontal and five hemicranioplasties. However, there was failure to implant an OssDsign hemicranioplasty in one patient where a titanium plate was subsequently used. The median duration of follow-up was 15 months. The infection rate was zero. The parents of the patients who successfully received OssDsign cranioplasties were pleased with the cosmetic outcomes. There were cosmetic complaints from the parents of the one patient who received a titanium plate. Conclusion Our early experience with OssDsign cranioplasty in paediatric patients indicates that it may potentially be associated with a low rate of infection and good cosmetic outcomes.	[Henderson, D.; Sinha, S.] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England		Henderson, D (corresponding author), Sheffield Childrens Hosp, Sheffield, S Yorkshire, England.	duncanhenderson90@gmail.com		Henderson, Duncan/0000-0002-3916-8455; Sinha, Saurabh/0000-0001-7453-9576			Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2; Klieverik VM, 2019, CHILD NERV SYST, V35, P1473, DOI 10.1007/s00381-018-4024-2; Lam S, 2015, CRANIOMAX TRAUM REC, V8, P159, DOI 10.1055/s-0034-1395880; Linder LKB, 2019, WORLD NEUROSURG, V122, pE399, DOI 10.1016/j.wneu.2018.10.061; Ma IT, 2018, J CRANIOFAC SURG, V29, P99, DOI 10.1097/SCS.0000000000004045; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Salam AA, 2018, INTERDISCIP NEUROSUR, V13, P59, DOI 10.1016/j.inat.2018.03.004; Sheng HS, 2019, J CRANIO MAXILL SURG, V47, P1096, DOI 10.1016/j.jcms.2019.04.009; van de Vijfeijken SECM, 2018, WORLD NEUROSURG, V117, P443, DOI 10.1016/j.wneu.2018.05.193; Waqas M, 2017, PEDIATR NEUROSURG, V52, P77, DOI 10.1159/000452808; Williams L, 2016, J CRANIO MAXILL SURG, V44, P789, DOI 10.1016/j.jcms.2016.03.010	20	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2020	36	8					1773	1776		10.1007/s00381-020-04584-9		MAR 2020	4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	MI4WF	WOS:000521786600002	32215714				2022-02-06	
J	Rajwani, KM; Lavrador, JP; Ansaripour, A; Tolias, CM				Rajwani, Kapil Mohan; Lavrador, Jose Pedro; Ansaripour, Ali; Tolias, Christos M.			Which factors influence the decision to transfer patients with traumatic brain injury to a neurosurgery unit in a major trauma network?	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Traumatic brain injury; regional trauma network; major trauma centre; patient transfer	HEAD-INJURY; COMPUTED-TOMOGRAPHY; CARE; GUIDELINES; MANAGEMENT; HEMATOMA; REQUIRES; OLDER; AGE	Objectives: Within the pan London Major Trauma System many patients with minor or non-life threatening traumatic brain injury (TBI) remain at their local hospital and are not transferred to a major trauma centre (MTC). Our aim was to identify factors that influence the decision to transfer patients with TBI to a neurosurgical centre. Methods: This is a single centre prospective cohort study of all patients with TBI referred to our neurosurgery unit from regional acute hospitals over a 4-month period (Sept 2016-Jan 2017). Our primary outcome was transferred to a neurosurgical centre. We identified the following factors that may predict decision to transfer: patient demographics, transfer distance, antithrombotic therapy and severity of TBI based on initial Glasgow Coma Scale (GCS) and Marshall CT score. A multivariable logistic regression analysis was performed. Results: A total of 339 patients were referred from regional hospitals with TBI and of these, 53 (15.6%) were transferred to our hospital. The mean age of patients referred was 70.6 years, 62.5% were men and 43% on antithrombotic drugs. Eighty-six percent of patients had mild TBI (GCS 13-15) on initial assessment and 79% had a Marshall CT score of 2. The adjusted analysis revealed only higher age, higher Marshall Score, the presence of chronic subdural haematoma (CSDH), the presence of contusion(s) and fracture(s) predicted transfer (p<.05). Subgroup analysis consistently showed a higher Marshall score predicted transfer (p<.05). Conclusions: In our cohort higher Marshall score consistently predicted transfer to our neurosurgical centre. Presenting GCS, transfer distance and antithrombotic therapy did not influence decision to transfer.	[Rajwani, Kapil Mohan; Lavrador, Jose Pedro; Tolias, Christos M.] Kings Coll Hosp London, Dept Neurosurg, Denmak Hill, London SE5 9RS, England; [Ansaripour, Ali] Kings Coll London, London, England		Rajwani, KM (corresponding author), Kings Coll Hosp London, Dept Neurosurg, Denmak Hill, London SE5 9RS, England.	kapilrajwani@hotmail.com		Ansaripour, Ali/0000-0002-8407-7851			[Anonymous], 2015, S E LONDON TRAUMA CA; Capron GK, 2017, AM J SURG, V214, P1182, DOI 10.1016/j.amjsurg.2017.09.002; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; HODGKINSON S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G104; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041; Moran CG, 2018, ECLINICALMEDICINE, V2-3, P13, DOI 10.1016/j.eclinm.2018.07.001; Munakomi Sunil, 2016, Surg Neurol Int, V7, P23, DOI 10.4103/2152-7806.177125; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Sweeney TE, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0017-6; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030	26	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2020	34	3					271	275		10.1080/02688697.2020.1742289		MAR 2020	5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MI0UE	WOS:000527430500001	32212864				2022-02-06	
J	Salas, C; Casassus, M; Rowlands, L; Pimm, S				Salas, Christian; Casassus, Martin; Rowlands, Leanne; Pimm, Steve			Developing a model of long-term social rehabilitation after traumatic brain injury: the case of the head forward centre	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; social isolation; neuropsychological rehabilitation; social rehabilitation; identity	PARTICIPATION; PEOPLE; COMMUNITY; LEISURE; SELF; INDIVIDUALS; DISABILITY; EXPERIENCE; NETWORKS; IDENTITY	Background: Social isolation and inactivity are highly problematic long-term consequences of Traumatic Brain Injury. They are rarely addressed by rehabilitation programmes, which focus on early phases of recovery. Day centres, or "drop-in" peer support groups, have emerged as an informal solution to social rehabilitation needs. However, there is a lack of knowledge regarding the therapeutic ingredients of these services. Methods: Twelve survivors of Traumatic Brain Injury that attended a social rehabilitation service (Head Forward Centre, UK; HFC), were interviewed to explore the meanings attached to the service and its activities. Thematic analysis was used to describe emerging themes and build a model of social rehabilitation. Results: Four therapeutic functions were attached to HFC: (a) HFC as a safe and predictable milieu; (b) HFC as a space where identity can be reconstructed; (c) HFC as a place where survivors can remain cognitive and socially active; (d) HFC as a network of continuous support. Conclusion: A model of long-term social rehabilitation should consider both psychological and practical/functional ingredients. Such a model can help informal rehabilitation services reflect upon their goals and activities, as well as articulate therapeutic actions along the rehabilitation path. The conceptualization of these four therapeutic ingredients in holistic rehabilitation models is described, and contrasted with its use in long-term social rehabilitation.	[Salas, Christian] Univ Diego Portales, Fac Psicol, Unidad Neuropsicol Clin, Vergara 275, Santiago, Chile; [Salas, Christian] Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social, Santiago, Chile; [Salas, Christian; Casassus, Martin; Pimm, Steve] Head Forward Ctr, Manchester, Lancs, England; [Casassus, Martin] Univ Manchester, Fac Biol Med & Hlth, Time Percept Lab, Manchester, Lancs, England; [Rowlands, Leanne] Bangor Univ, Bangor, Gwynedd, Wales; [Pimm, Steve] Rehabil Walls, Milton Keynes, Bucks, England		Salas, C (corresponding author), Univ Diego Portales, Fac Psicol, Unidad Neuropsicol Clin, Vergara 275, Santiago, Chile.	salasriquelme@gmail.com		Rowlands, Leanne/0000-0003-1130-5072			Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; B Wilson, 2005, NEUROPSYCHOLOGICAL R; BenYishay Y, 1996, NEUROPSYCHOL REHABIL, V6, P327, DOI 10.1080/713755514; Berger R, 2015, QUAL RES, V15, P219, DOI 10.1177/1468794112468475; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Coetzer R, 2013, SA PHARM J, V80, P36; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Diller, 2011, HDB HOLISTIC NEUROPS; Douglas J, 2015, RETHINKING REHABILIT, DOI DOI 10.1201/B18118; Douglas J., 2012, SOCIAL CURE IDENTITY, P237; Douglas J, 2020, NEUROPSYCHOL REHABIL, V30, P1277, DOI 10.1080/09602011.2019.1574589; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Gerber GJ, 2015, BRAIN INJURY, V29, P722, DOI 10.3109/02699052.2015.1004745; Gill IJ, 2012, BRAIN INJURY, V26, P909, DOI 10.3109/02699052.2012.661118; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P123, DOI 10.1017/CBO9780511581083.011; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Greenwood R. J., 1993, CLIN REHABIL, V7, P248; Hagen C, 1972, RANCHO AMIGOS LEVELS; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Helliwell J, 2012, SOCIAL CURE IDENTITY, P55; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson SL, 2003, LEISURE SCI, V25, P143, DOI 10.1080/01490400306566; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Kinsella G, 1989, Int Disabil Stud, V11, P9; Klonoff P S, 1997, Appl Neuropsychol, V4, P107, DOI 10.1207/s15324826an0402_3; Klonoff P. S., 2005, BARROW Q, V21, P14; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Maguire M., 2017, IREL J HIGH ED, V9, P3351; Malley D, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P164, DOI 10.1017/CBO9780511581083.014; Martelli MF, 2012, NEUROREHABILITATION, V31, P3, DOI 10.3233/NRE-2012-0770; Matheson K, 2012, SOCIAL CURE IDENTITY, P133; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McLean AM, 2012, BRAIN INJURY, V26, P83, DOI 10.3109/02699052.2011.635353; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; McMillan TM, 2001, BRAIN DAM B, P257; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Oddy M, 2001, BRAIN DAM B, P287; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T., 2014, SELF IDENTITY BRAIN; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; Riley GA, 2015, BRAIN INJURY, V29, P1480, DOI 10.3109/02699052.2015.1071427; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Salmon N, 2013, J INTELL DISABIL RES, V57, P347, DOI 10.1111/j.1365-2788.2012.01541.x; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Select Committee on Health, 2001, REHABILITATION; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Silverman AM, 2017, REHABIL PSYCHOL, V62, P525, DOI 10.1037/rep0000128; Tate R. L., 2015, HDB VOCATIONAL REHAB, P263, DOI [10.1007/978-3-319-08825-9_12, DOI 10.1007/978-3-319-08825-9_12]; Tate R, 2014, BRAIN IMPAIR, V15, P157, DOI 10.1017/BrImp.2014.28; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tyerman A, 2008, PSYCHOL APPROACHES R; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wilson B, 2010, NEUROPSYCHOLOGICAL R; Wilson B, 2010, NEUROPSYCHOL REHABIL, P1; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; [No title captured], DOI DOI 10.1375/BRIM.7.2.107	79	1	1	2	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 6	2021	43	23					3405	3416		10.1080/09638288.2020.1741697		MAR 2020	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WV5FB	WOS:000524225200001	32212984				2022-02-06	
J	Morse, LR; Nguyen, N; Xu, Y; Jha, P; Battaglino, RA				Morse, Leslie R.; Nguyen, Nguyen; Xu, Yan; Jha, Prakash; Battaglino, Ricardo A.			Circulating PAMM, a novel antioxidant and anti-inflammatory protein, is elevated in acute SCI	JOURNAL OF TRANSLATIONAL MEDICINE			English	Article						PAMM; Biomarker; Inflammation; Reactive oxygen species; Spinal cord injury; Rehabilitation medicine	OXIDATIVE STRESS; INHIBITING MAPK; INFLAMMATION	Background Peroxiredoxin activated in M-CSF stimulated monocytes (PAMM) is a novel protein produced by adipocytes with putative redox regulatory and anti-inflammatory properties. Because acute spinal cord injury (SCI) is associated with oxidative stress and neuroinflammation and because PAMM can be detected in systemic circulation, we hypothesized that acute neuro-trauma might induce changes in circulating PAMM expression. Specifically, we hypothesized that PAMM levels might vary based on the presence or absence of acute, traumatic SCI. We therefore investigated circulating PAMM levels in adults with and without acute traumatic SCI. Methods We studied 105 men and women (54 with SCI and 51 without SCI). Participants with SCI were admitted for acute rehabilitation within 1 month after injury. Serum samples were obtained during hospitalization and stored at - 80 degrees C until batch analysis. Total PAMM was quantified by ELISA assay (MyBiosource, Cat. No: MBS9327247) with a detection limit of 0.25 ng/ml. Separate multivariate models including age, BMI, and injury severity were assessed to determine significant clinical predictors of change in PAMM levels. Results When adjusting for BMI, age, and gender, mean change in PAMM levels were greatest in participants with motor complete SCI compared to able-bodied (1.65 ng/ml versus 0.94 ng/ml, p = 0.003). This model explained 26% of the variation in change in circulating PAMM levels. Conclusions Our results suggest that PAMM may be a novel biomarker of neurological injury or of native anti-inflammatory responses to neurological injury. More work is needed to establish the role of PAMM and other adipocyte-derived factors in the acute response to neurotrauma.	[Morse, Leslie R.; Nguyen, Nguyen; Xu, Yan; Jha, Prakash; Battaglino, Ricardo A.] Univ Minnesota, Dept Rehabil Med, Sch Med, 500 Boynton Hlth Serv Bridge,410 Church St SE, Minneapolis, MN 55455 USA		Battaglino, RA (corresponding author), Univ Minnesota, Dept Rehabil Med, Sch Med, 500 Boynton Hlth Serv Bridge,410 Church St SE, Minneapolis, MN 55455 USA.	rbattagl@umn.edu	Battaglino, Ana/AAU-6234-2021; Morse, Leslie/AAU-5608-2020		National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [1R01AR059270-01]	This study received support from: the National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR059270-01].	Albayar AA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00027; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Gorgey AS, 2015, WORLD J ORTHOP, V6, P567, DOI 10.5312/wjo.v6.i8.567; Guo F, 2015, BIOCHEM J, V472, P309, DOI 10.1042/BJ20150019; Hart JE, 2016, J SPINAL CORD MED, V39, P344, DOI 10.1179/2045772315Y.0000000045; He H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38975; Jedrychowski MP, 2015, MOL METAB, V4, P758, DOI 10.1016/j.molmet.2015.09.002; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Pourkhodadad S, 2019, CELL J, V21, P220, DOI 10.22074/cellj.2019.6126; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Xu LY, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00690; Xu Y, 2015, REDOX BIOL, V6, P446, DOI 10.1016/j.redox.2015.09.008; Xu Y, 2010, ANTIOXID REDOX SIGN, V13, P27, DOI 10.1089/ars.2009.2886; Ydens E, 2017, MOL NEUROBIOL, V54, P1482, DOI 10.1007/s12035-016-9757-x; Zhu Y, 2019, EUR REV MED PHARMACO, V23, P37, DOI 10.26355/eurrev_201901_16745	15	1	1	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1479-5876		J TRANSL MED	J. Transl. Med.	MAR 24	2020	18	1							135	10.1186/s12967-020-02304-0			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KX7QH	WOS:000522071300001	32204712	Green Published, gold			2022-02-06	
J	Bottari, C; Dutil, E; Auger, C; Lamoureux, J				Bottari, Carolina; Dutil, Elisabeth; Auger, Claudine; Lamoureux, Julie			Structural validity and internal consistency of an ecological observation-based assessment, the Activities of Daily Living Profile	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						activities of daily living; brain injuries; cognition; occupational therapy; psychometrics		Introduction Direct observation of everyday task performance is considered the most accurate measure of independence for individuals with executive function impairments. However, few observation-based measures have been shown to have sound psychometric qualities and be clinically applicable. The objective of this study was to investigate the Activities of Daily Living (ADL) Profile's structural validity using exploratory factor analyses and internal consistency in order to identify the minimum set of tasks required to achieve reliable scores in each of three ADL environments (personal, home and community). Methods Ninety-one persons with a severe traumatic brain injury aged 16-40 years (convenience sample) were recruited from a university affiliated level 1 trauma hospital. The 17 observation-based tasks of the ADL Profile were administered by one of five occupational therapists, either in the hospital or in the subjects' home and community environments. This measure of independence considers goal formulation, planning, carrying out and verifying goal attainment. Results Exploratory factor analysis indicated the unidimensionality of the 17 tasks of the ADL Profile. A single factor explained more than 80% of the common variation, which in this case is the concept of independence. Internal consistency of task scores is very high (0.955), suggesting redundancy of the tasks. Approaches used to reduce the number of items, and to optimise the clinical applicability of the tool, showed that a minimum of two tasks per each of three environments (personal, home, community) is required to obtain reliable results that respect the tool's internal structure. Each assessment should contain both simple and familiar and more novel and complex tasks. Conclusions Findings show that the ADL Profile is a valid and clinically applicable observation-based measure of independence that considers four important task-related components: goal formulation, planning, carrying out and verifying goal attainment.	[Bottari, Carolina; Dutil, Elisabeth; Auger, Claudine; Lamoureux, Julie] Ctr Sud de Ile de Montreal, CIUSSS, Inst Univ Readaptat Deficience Phys Montreal, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Bottari, Carolina; Dutil, Elisabeth; Auger, Claudine] Univ Montreal, Fac Med, Sch Rehabil, Occupat Therapy Program, 7077 Ave Parc, Montreal, PQ H3N 1X7, Canada		Bottari, C (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, Occupat Therapy Program, 7077 Ave Parc, Montreal, PQ H3N 1X7, Canada.	carolina.bottari@umontreal.ca		Auger, Claudine/0000-0003-0159-2004	Fonds de la recherche du Quebec-santeFonds de la Recherche en Sante du Quebec [901383]	This study was supported by the Fonds de la recherche du Quebec-sante (Grant number 901383; Salary support Auger 32988). The funding agency had no role in the design of the study, in the collection and analysis of the data, or in the decision to publish the results.	Arnadottir G, 2012, SCAND J OCCUP THER, V19, P439, DOI 10.3109/11038128.2011.638674; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Burgess P., 1997, METHODOLOGY FRONTAL, P81; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Crocker L., 1986, INTRO CLASSICAL MODE; DUTIL E, 1990, Occupational Therapy in Health Care, V7, P7, DOI 10.1080/J003v07n01_03; Dutil E., 2005, ADL PROFILE DESCRIPT, V1; Dutil E, 2017, OCCUP THER INT, DOI 10.1155/2017/3014579; Fisher A. G., 2010, ASSESSMENT MOTOR PRO, V1; Hammond FM, 2013, BRAIN INJ PROF, V10, P6; LAWTON MP, 1983, GERONTOLOGIST, V23, P349, DOI 10.1093/geront/23.4.349; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Luria A.R., 1973, WORKING BRAIN INTRO; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pedhazur E. J., 1991, MEASUREMENTS DESIGN; Poncet F, 2017, NEUROPSYCHOL REHABIL, V27, P618, DOI 10.1080/09602011.2016.1268171; RIPPH, 2019, MOD RIPPH; Rousseau J., 1994, CANADIAN J OCCUPATIO, V61, P159, DOI DOI 10.1177/000841749406100305; Rousseau J., 1994, CANADIAN J OCCUPATIO, V61, P149; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Shun PLW, 2018, J CONTIN EDUC HEALTH, V38, P94, DOI 10.1097/CEH.0000000000000194; TEASDALE G, 1974, LANCET, V2, P81; Wesson J, 2016, NEUROSCI BIOBEHAV R, V68, P335, DOI 10.1016/j.neubiorev.2016.05.024	25	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	OCT	2020	67	5					407	416		10.1111/1440-1630.12654		MAR 2020	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	NV5KT	WOS:000563692900001	32201960				2022-02-06	
J	Al-Adawi, S; Al-Naamani, A; Jaju, S; Al-Farsi, YM; Dorvlo, ASS; Al-Maashani, A; Al-Adawi, SSH; Moustafa, AA; Al-Sibani, N; Essa, MM; Burke, DT; Qoronfleh, MW				Al-Adawi, Samir; Al-Naamani, Aziz; Jaju, Sanjay; Al-Farsi, Yahya M.; Dorvlo, Atsu S. S.; Al-Maashani, Ali; Al-Adawi, Sara S. H.; Moustafa, Ahmed A.; Al-Sibani, Nasser; Essa, Musthafa M.; Burke, David T.; Qoronfleh, M. Walid			Methylphenidate improves executive functions in patients with traumatic brain injuries: a feasibility trial via the idiographic approach	BMC NEUROLOGY			English	Article						Psychopharmacology; Executive functioning; Traumatic brain injury; TBI; Cognition; Depression; Anxiety; IQCODE; Methylphenidate; Ritalin	MILD COGNITIVE IMPAIRMENT; ROAD TRAFFIC INJURIES; HOSPITAL ANXIETY; WORKING-MEMORY; DEPRESSION; ATTENTION; PERFORMANCE; GENDER; PATHOPHYSIOLOGY; DYSFUNCTION	Background Road traffic accidents are known to be the main cause of traumatic brain injury (TBI). TBI is also a leading cause of death and disability. This study, by means of the idiographic approach (single-case experimental designs using multiple-baseline designs), has examined whether methylphenidate (MPH - trade name Ritalin) had a differential effect on cognitive measures among patients with TBI with the sequel of acute and chronic post-concussion syndromes. The effect on gender was also explored. Methods In comparison with healthy controls, patients with TBI (acute and chronic) and accompanying mild cognitive impairment (MCI) were screened for their integrity of executive functioning. Twenty-four patients exhibiting executive dysfunction (ED) were then instituted with the pharmacological intervention methylphenidate (MPH). The methylphenidate was administered using an uncontrolled, open label design. Results The administration of methylphenidate impacted ED in the TBI group but had no effect on mood. Attenuation of ED was more apparent in the chronic phases of TBI. The effect on gender was not statistically significant with regard to the observed changes. Conclusions To our knowledge, this is the first feasibility trial from the Arabian Gulf to report the performance of a TBI population with mild cognitive impairment according to the IQCODE Arabic version. This investigation confirms anecdotal observations of methylphenidate having the potential to attenuate cognitive impairment; particularly those functions that are critically involved in the integrity of executive functioning. The present feasibility trial should be followed by nomothetic studies such as those that adhere to the protocol of the randomized controlled trial. This evidence-based research is the foundation for intervention and future resource allocation by policy- or public health decision-makers.	[Al-Adawi, Samir; Al-Naamani, Aziz; Al-Sibani, Nasser] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Muscat, Oman; [Jaju, Sanjay; Al-Farsi, Yahya M.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Family Med & Publ Hlth, Muscat, Oman; [Dorvlo, Atsu S. S.] Sultan Qaboos Univ, Coll Sci, Dept Math & Stat, Muscat, Oman; [Al-Maashani, Ali] Minist Hlth, Dept Neurosurg, Khoula Hosp, Muscat, Oman; [Al-Adawi, Sara S. H.] Oman Med Specialty Board, Muscat, Oman; [Moustafa, Ahmed A.] Western Sydney Univ, Sch Social Sci & Psychol, Marcs Inst Brain & Behav, Penrith, NSW, Australia; [Essa, Musthafa M.] Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Food Sci & Nutr, Muscat, Oman; [Burke, David T.] Emory Univ, Sch Med, Dept Rehabil Med, Atlanta, GA USA; [Qoronfleh, M. Walid] Qatar Fdn, Res & Policy Dept, WISH, POB 5825, Doha, Qatar		Al-Adawi, S (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Muscat, Oman.; Essa, MM (corresponding author), Sultan Qaboos Univ, Coll Agr & Marine Sci, Dept Food Sci & Nutr, Muscat, Oman.; Qoronfleh, MW (corresponding author), Qatar Fdn, Res & Policy Dept, WISH, POB 5825, Doha, Qatar.	samir-adawi@fulbrightmail.org; drmdessa@gmail.com; wqoronfleh@qf.org.qa	Al-Adawi, Samir/A-9663-2016; Al-Sibani, Nasser/AAS-4038-2020; Moustafa, Ahmed/AAM-2836-2021; Al-Farsi, Yahya/AAM-2181-2020; Essa, Mohamed/AAX-2596-2020	Al-Adawi, Samir/0000-0002-9858-5582; Al-Farsi, Yahya/0000-0002-0302-7132; Musthafa Mohamed, Essa/0000-0001-7505-9785; Moustafa, Ahmed/0000-0001-5971-273X	Qatar National Library (QNL), Doha, Qatar	The authors thank the study staff and the staff at Sultan Qaboos University Hospital for their support. They thank the survivors of traumatic brain injury and the volunteers that offered their support by participating in this study. The authors also want to thank their respective institutions for their continued support. The Qatar National Library (QNL), Doha, Qatar, funded the publication of this article.	Al Naamani A, THESIS; Al Reesi H, 2016, TRAFFIC INJ PREV, V17, P480, DOI 10.1080/15389588.2015.1107679; Al-Adawi S, 2004, J NEUROPSYCH CLIN N, V16, P435, DOI 10.1176/appi.neuropsych.16.4.435; Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Al-Adawi S., 2016, INT J NUTR PHARM NEU, V6, P35, DOI [10.4103/2231-0738.173787, DOI 10.4103/2231-0738.173787]; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; Al-Adawi S, 2014, DEMENT GER COGN D EX, V4, P271, DOI 10.1159/000363621; Al-Adawi S, 2010, PSYCHIAT CLIN NEUROS, V64, P555, DOI 10.1111/j.1440-1819.2010.02117.x; Al-Asmi A, 2012, EPILEPSY RES, V98, P174, DOI 10.1016/j.eplepsyres.2011.09.012; Al-Moutaery, 2009, PAN ARAB J NEUROSURG, V13, P57; Al-Naamani Aziz, 2007, Sultan Qaboos Univ Med J, V7, P75; Al-Reesi H, 2013, TRAFFIC INJ PREV, V14, P322, DOI 10.1080/15389588.2012.694088; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bishop DVM, 2001, J CHILD PSYCHOL PSYC, V42, P551, DOI 10.1111/1469-7610.00749; Bou-Orm IR, 2018, AGING MENT HEALTH, V22, P844, DOI 10.1080/13607863.2017.1301879; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chen A, 2020, TRAUMATIC BRAIN INJU; Conti AC, 1998, J NEUROSCI, V18, P5663; Coull JT, 1996, PSYCHOPHARMACOLOGY, V123, P239, DOI 10.1007/BF02246578; Cristofori I, 2015, NEUROLOGY, V84, P1394, DOI 10.1212/WNL.0000000000001446; Darbar A, 2008, J NEUROSURG, V109, P108, DOI 10.3171/JNS/2008/109/7/0108; Davis C, 2012, INT J NEUROPSYCHOPH, V15, P181, DOI 10.1017/S1461145711001039; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Eshel I, 2020, TRAUMATIC BRAIN INJU, P421; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Feeney DM, 1997, ADV NEUROL, V73, P383; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; Goldfield GS, 2011, APPL PHYSIOL NUTR ME, V36, P1009, DOI [10.1139/h11-098, 10.1139/H11-098]; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Harrison JK, 2016, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD011333.PUB2; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hooper SM, 2017, HUMAN FRONTAL LOBES, P184; Huang CH, 2016, CURR NEUROPHARMACOL, V14, P272, DOI 10.2174/1570159X13666150514233033; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kazdin A., 1982, SINGLE CASE RES DESI; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Krueger CE, 2011, NEUROPSYCHOLOGY, V25, P249, DOI 10.1037/a0021681; Lecky F, 2017, DAMAGE CONTROL MANAG, P27; Mackinnon A, 1998, AM J PSYCHIAT, V155, P1529, DOI 10.1176/ajp.155.11.1529; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; McIntyre RS, 2017, J CLIN PSYCHOPHARM, V37, P412, DOI 10.1097/JCP.0000000000000723; Mehta MA, 2000, J NEUROSCI, V20; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nishimura Y, 2014, NEUROIMAGE, V85, P527, DOI 10.1016/j.neuroimage.2013.08.021; Pflibsen L, 2015, J NEUROSCI RES, DOI [10.1002/Jnr.%2023638, DOI 10.1002/JNR.%2023638]; Phung TKT, 2015, DEMENT GERIATR COGN, V40, P276, DOI 10.1159/000437092; Podet A, 2010, BRAIN RES BULL, V82, P293, DOI 10.1016/j.brainresbull.2010.05.006; Porth CM, 2007, ESSENTIALS PATHOPHYS; Rosenthal EN, 2006, ARCH CLIN NEUROPSYCH, V21, P131, DOI 10.1016/j.acn.2005.08.004; Sami MB, 2015, ACTA NEUROPSYCHIATR, V27, P317, DOI 10.1017/neu.2015.17; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sonde L, 2007, ACTA NEUROL SCAND, V115, P55, DOI 10.1111/j.1600-0404.2006.00728.x; Sun KM, 2017, PREHOSP EMERG CARE, V21, P242, DOI 10.1080/10903127.2016.1241325; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Toledo JB, 2015, NEUROLOGY, V85, P144, DOI 10.1212/WNL.0000000000001738; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wechsler D, 2003, WECHSLER INTELLIGENC; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zhang ZP, 2015, AM J EMERG MED, V33, DOI 10.1016/j.ajem.2014.10.038; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer L, 2017, TRENDS PHARMACOL SCI, V38, P608, DOI 10.1016/j.tips.2017.04.001	83	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	MAR 19	2020	20	1							103	10.1186/s12883-020-01663-x			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KX8OT	WOS:000522134900001	32192470	gold, Green Published			2022-02-06	
J	Erramouspe, PJ; Garcia-Pintos, MF; Benipal, S; Manoukian, MAC; Santamarina, JL; Shawagga, HG; Vo, LL; Galante, JM; Nishijima, D				Erramouspe, Pablo Joaquin; Garcia-Pintos, Maria Florencia; Benipal, Simranjeet; Manoukian, Martin A. C.; Santamarina, John-Lloyd; Shawagga, Hiwote G.; Vo, Linda L.; Galante, Joseph M.; Nishijima, Daniel			Mortality and Complication Rates in Adult Trauma Patients Receiving Tranexamic Acid: A Single-center Experience in the Post-CRASH-2 Era	ACADEMIC EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; COAGULOPATHY; EPIDEMIOLOGY; TRANSFUSION; CRASH-2; EVENTS; THROMBOSIS	Objectives The CRASH-2 trial demonstrated that tranexamic acid (TXA) in adults with significant traumatic hemorrhage safely reduces mortality. Given that the CRASH-2 trial did not include U.S. sites, our objective was to evaluate patient characteristics, TXA dosing strategies, and the incidence of mortality and adverse events in adult trauma patients receiving TXA at a U.S. Level I trauma center in the post-CRASH-2 era. Methods We conducted a retrospective study that included patients aged 18 years or older who received TXA after an acute injury from July 2014 to June 2017. We excluded patients who received TXA orally, patients who received TXA for elective surgical procedures or nontrauma indications, patients who received it 8 hours or longer after the time of injury, and patients with cardiac arrest at time of emergency department arrival. Trained abstractors collected data from the trauma registry and hospital electronic medical records. Our primary outcome measures were in-hospital death and acute thromboembolic events within 28 days from injury. Results We included 273 patients with a mean (+/- SD) age of 43.8 (+/- 18.7) years. The mean (+/- SD) time of administration of TXA from time of injury was 1.55 (+/- 1.2) hours with 229 patients (83.9%) receiving TXA within 3 hours. The overall mortality within 28 days from injury was 12.8% (95% confidence interval [CI] = 8.9% to 16.7%), which was similar compared to that in the CRASH-2 trial (14.5%, 95% CI = 13.9% to 15.2%). The incidence of acute thromboembolic events was 6.6% (95% CI = 3.7% to 9.5%), which was higher than that in the CRASH-2 trial (2.0%, 95% CI = 1.73% to 2.27%). Patients in our cohort also received surgery (64.8% vs. 47.9%) and blood transfusions (74.0% vs. 50.4%) more frequently than those in the CRASH-2 cohort. Conclusions Adult trauma patients receiving TXA had similar incidences of death but higher incidences of thromboembolic events compared to the CRASH-2 trial. Variation in patient characteristics, injury severity, TXA dosing, and surgery and transfusion rates could explain these observed differences. Further research is necessary to provide additional insight into the incidence and risk factors of thromboembolic events in TXA use.	[Erramouspe, Pablo Joaquin; Garcia-Pintos, Maria Florencia; Benipal, Simranjeet; Manoukian, Martin A. C.; Santamarina, John-Lloyd; Shawagga, Hiwote G.; Vo, Linda L.; Nishijima, Daniel] Queensland Univ Technol, Translat Res Inst, Dept Emergency Med, Brisbane, Qld, Australia; [Erramouspe, Pablo Joaquin] Queensland Univ Technol, Fac Hlth, Translat Res Inst, Brisbane, Qld, Australia; [Galante, Joseph M.] UC Davis Sch Med, Dept Surg, Sacramento, CA USA		Erramouspe, PJ (corresponding author), Queensland Univ Technol, Translat Res Inst, Dept Emergency Med, Brisbane, Qld, Australia.; Erramouspe, PJ (corresponding author), Queensland Univ Technol, Fac Hlth, Translat Res Inst, Brisbane, Qld, Australia.	joaquinerramouspe@hotmail.com		Erramouspe, Pablo Joaquin/0000-0002-3071-7147; Manoukian, Martin/0000-0002-3170-986X			Aziz F, 2015, ANN VASC SURG, V29, P661, DOI 10.1016/j.avsg.2014.11.025; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Centers for Disease Control and Prevention, 10 LEAD CAUS DEATH I; Chen F, 2015, PHLEBOLOGY, V30, P242, DOI 10.1177/0268355514524192; Cohen MJ, 2017, CRIT CARE CLIN, V33, P101, DOI 10.1016/j.ccc.2016.08.003; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gerecht Ryan, 2014, JEMS, V39, P56; Glass NE, 2019, J SURG RES, V235, P615, DOI 10.1016/j.jss.2018.10.021; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Gupta S, 2015, SURGERY, V157, P843, DOI 10.1016/j.surg.2014.12.020; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Jakobsson U, 2005, SCAND J CARING SCI, V19, P427, DOI 10.1111/j.1471-6712.2005.00368.x; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kumar MA, 2014, NEUROCRIT CARE, V20, P84, DOI 10.1007/s12028-013-9819-0; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; OKAMOTO SHOSUKE, 1964, KEIO J MED, V13, P177; Peng N, 2017, CHIN J TRAUMATOL, V20, P133, DOI 10.1016/j.cjtee.2017.03.002; Reske-Nielsen C, 2016, EMERG MED CLIN N AM, V34, P483, DOI 10.1016/j.emc.2016.04.004; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schietroma M, 2004, SURG ENDOSC, V18, P1090, DOI 10.1007/s00464-003-8819-0; Schuerer Douglas J E, 2011, Am J Orthop (Belle Mead NJ), V40, pE143; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shin Ha Song, 2014, Vasc Specialist Int, V30, P56, DOI 10.5758/vsi.2014.30.2.56; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; U.S. National Library of Medicine - ClinicalTrials.gov, CURR CLIN TRIALS ASS; Washington University School of Medicine in St. Louis - Barnes Jewish Hospital, TRAN AC MECH PHARM T; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	38	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2020	27	5					358	365		10.1111/acem.13883		MAR 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LL6TW	WOS:000520262100001	32189440	Green Published			2022-02-06	
J	Mathes, BM; Quick, AD; Albanese, BJ; Morabito, DM; Bedford, CE; Schmidt, NB				Mathes, Brittany M.; Quick, Allysa D.; Albanese, Brian J.; Morabito, Danielle M.; Bedford, Carter E.; Schmidt, Norman B.			Hostility and Suicide Risk Among Veterans: The Mediating Role of Perceived Burdensomeness	COGNITIVE THERAPY AND RESEARCH			English	Article						Veterans; Suicide; Hostility; Perceived burdensomeness; Interpersonal	TRAUMATIC BRAIN-INJURY; INTERPERSONAL THEORY; THWARTED BELONGINGNESS; SOCIAL SUPPORT; US VETERANS; IDEATION; DEPRESSION; ANGER; PTSD; AGGRESSION	There is a growing body of research aimed at identifying predictors of suicide risk among Veterans. One predictor may be hostility, as hostility and anger are associated with greater suicidal ideation among Veterans. The interpersonal theory of suicide suggests hostility may be associated with suicide risk through perceived burdensomeness and thwarted belongingness. The aim of the current study was to investigate associations among hostility, perceived burdensomeness, thwarted belongingness, and suicide risk among a sample of Veterans enrolled in a clinical trial. Participants (N = 90) completed self-report measures assessing the variables of interest. When accounting for previously identified risk factors, namely posttraumatic stress disorder, major depressive disorder, alcohol use disorder, traumatic brain injury, and family history of suicide, there was an indirect effect of hostility on suicide risk through perceived burdensomeness, but not thwarted belongingness. Specificity analyses assessing alternative predictors and mediators provided further support for the model. Findings suggest that hostility may require greater clinical attention among Veterans at risk for suicide.	[Mathes, Brittany M.; Quick, Allysa D.; Morabito, Danielle M.; Bedford, Carter E.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, 1107 W Call St, Tallahassee, FL 32306 USA; [Albanese, Brian J.] Auburn Univ, Dept Psychol, 226 Thach Hall, Auburn, AL 36849 USA		Schmidt, NB (corresponding author), Florida State Univ, Dept Psychol, 1107 W Call St, Tallahassee, FL 32306 USA.	schmidt@psy.fsu.edu		Morabito, Danielle/0000-0001-8363-3249; Mathes, Brittany/0000-0001-6145-715X	U.S. Department of DefenseUnited States Department of Defense [W81XWH-10-2-0181]	This study was supported by U.S. Department of Defense (W81XWH-10-2-0181).	Anestis MD, 2011, J PSYCHIATR RES, V45, P603, DOI 10.1016/j.jpsychires.2010.10.013; Beck AT., 1991, MANUAL BECK SCALE SU; Beckham JC, 1997, J CLIN PSYCHOL, V53, P859, DOI 10.1002/(SICI)1097-4679(199712)53:8<859::AID-JCLP11>3.3.CO;2-U; Berkowitz L., 1993, AGGRESSION ITS CAUSE; Bohnert KM, 2017, ADDICTION, V112, P1193, DOI 10.1111/add.13774; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Bryan CJ, 2015, SUICIDE LIFE-THREAT, V45, P633, DOI 10.1111/sltb.12163; Bryan CJ, 2010, PERS INDIV DIFFER, V48, P347, DOI 10.1016/j.paid.2009.10.023; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; Christodoulou C, 2017, PSYCHOL HEALTH MED, V22, P866, DOI 10.1080/13548506.2016.1238491; Chu C, 2017, PSYCHOL BULL, V143, P1313, DOI 10.1037/bul0000123; Collins KRL, 2016, J ABNORM PSYCHOL, V125, P704, DOI 10.1037/abn0000167; COYNE JC, 1976, J ABNORM PSYCHOL, V85, P186, DOI 10.1037/0021-843X.85.2.186; DeBeer BB, 2014, PSYCHIAT RES, V216, P357, DOI 10.1016/j.psychres.2014.02.010; Department of Defense, 2010, CHALL PROM STRENGTH; Dobscha SK, 2014, J GEN INTERN MED, V29, pS853, DOI 10.1007/s11606-014-3028-1; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; First M., 2015, STRUCTURED CLIN INTE; Glenn D Michael, 2002, Violence Vict, V17, P473, DOI 10.1891/vivi.17.4.473.33685; Gorenstein EE, 2007, COGN BEHAV PRACT, V14, P168, DOI 10.1016/j.cbpra.2006.07.004; Greitemeyer T, 2017, J SOC PSYCHOL, V157, P766, DOI 10.1080/00224545.2017.1288078; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hawkins KA, 2013, BEHAV THER, V44, P479, DOI 10.1016/j.beth.2013.04.005; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; Hirvikoski T, 2012, EUR PSYCHIAT, V27, P536, DOI 10.1016/j.eurpsy.2011.04.004; Howell D.C., 2007, STAT METHODS PSYCHOL; Jahn DR, 2018, PSYCHOL SERV, V15, P31, DOI 10.1037/ser0000127; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; JOINER TE, 1995, J PERS SOC PSYCHOL, V69, P778, DOI 10.1037/0022-3514.69.4.778; Kachadourian LK, 2018, AM J ADDICTION, V27, P124, DOI 10.1111/ajad.12688; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kim PY, 2011, MIL PSYCHOL, V23, P65, DOI 10.1080/08995605.2011.534415; Law KC, 2015, CURR OPIN PSYCHOL, V3, P30, DOI 10.1016/j.copsyc.2015.01.014; Lemogne C, 2011, ACTA PSYCHIAT SCAND, V124, P62, DOI 10.1111/j.1600-0447.2010.01658.x; Martin RL, 2019, SUICIDE LIFE-THREAT, V49, P1318, DOI 10.1111/sltb.12523; Matheny NL, 2017, COGNITIVE THER RES, V41, P170, DOI 10.1007/s10608-016-9808-7; McHugh RK, 2012, BEHAV THER, V43, P641, DOI 10.1016/j.beth.2011.12.001; McKinney JM, 2017, J AFFECT DISORDERS, V214, P100, DOI 10.1016/j.jad.2017.03.008; Monteith LL, 2013, SUICIDE LIFE-THREAT, V43, P418, DOI 10.1111/sltb.12027; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ritchie EC, 2003, MIL MED, V168, P177, DOI 10.1093/milmed/168.3.177; Rogers ML, 2017, J AFFECT DISORDERS, V208, P15, DOI 10.1016/j.jad.2016.09.038; Seidlitz L, 2001, J AFFECT DISORDERS, V66, P123, DOI 10.1016/S0165-0327(00)00300-1; Shea MT, 2013, BEHAV RES THER, V51, P607, DOI 10.1016/j.brat.2013.05.013; Short NA, 2019, BEHAV THER, V50, P886, DOI 10.1016/j.beth.2019.01.004; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Velting DM, 1999, PERS INDIV DIFFER, V27, P943, DOI 10.1016/S0191-8869(99)00046-X; WEISSMAN M, 1973, AM J PSYCHIAT, V130, P450; Wilkowski BM, 2010, J PERS, V78, P9, DOI 10.1111/j.1467-6494.2009.00607.x; Wilks CR, 2019, J PSYCHIATR RES, V109, P139, DOI 10.1016/j.jpsychires.2018.11.026; You S, 2012, SUICIDE LIFE-THREAT, V42, P244, DOI 10.1111/j.1943-278X.2012.00086.x	56	1	1	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0147-5916	1573-2819		COGNITIVE THER RES	Cogn. Ther. Res.	JUN	2020	44	3					636	644		10.1007/s10608-020-10082-8		MAR 2020	9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	LL3PE	WOS:000521011100001					2022-02-06	
J	Aarhus, L; Engdahl, B				Aarhus, Lisa; Engdahl, Bo			Occupational noise exposure and asymmetric hearing loss: Results from the HUNT population study in Norway	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						asymmetric hearing loss; asymmetry; audiometry; hearing loss; occupational medicine; occupational noise exposure; population-based study	TRAUMATIC BRAIN-INJURY; OTOACOUSTIC EMISSIONS; WORKERS	Background A large population study with adequate data on confounders is required to determine whether asymmetric hearing loss (AHL) is associated with occupational noise exposure. Methods We performed a cross-sectional population study in Norway (the Health Investigation in Nord-Trondelag: HUNT) with 24 183 participants, using pure-tone audiometry and questionnaires. AHL was defined as a difference in hearing threshold between the right and left ears of greater than or equal to 15 dB for the pure-tone average of 0.5 to 2 or 3 to 6 kHz. Results The mean age of the participants was 53 years (range, 19-99); 53% were women. The prevalence of AHL in this general Norwegian population was 6% for the 0.5 to 2 kHz range and 15% for 3 to 6 kHz. In unadjusted regression models, subjects reporting prolonged occupational noise exposure to high-level noise sources (N = 1652) had a higher risk of AHL at 3 to 6 kHz than those reporting no prior exposure (odds ratio [OR], 1.98; 95% confidence interval [CI], 1.75-2.25). After adjustment for age and sex, OR was 1.08; (95% CI, 0.95-1.24). After additional adjustment for head trauma, ear infections, blasting or shooting (all associated with AHL), smoking, and diabetes, OR was 1.00 (95% CI, 0.87-1.16). No association between occupational noise and right-ear hearing threshold advantage (left-right ear difference) was observed after adjustment for confounders. Conclusion Our study suggests that AHL is relatively common in the general population, especially at the high-frequency range in men and elderly subjects. Our study showed no relation between occupational noise exposure and AHL after confounder adjustment.	[Aarhus, Lisa] Natl Inst Occupat Hlth, Dept Occupat Med & Epidemiol, Postboks 8146 Dept, N-0033 Oslo, Norway; [Engdahl, Bo] Norwegian Inst Publ Hlth, Dept Chron Dis & Ageing, Oslo, Norway		Aarhus, L (corresponding author), Natl Inst Occupat Hlth, Dept Occupat Med & Epidemiol, Postboks 8146 Dept, N-0033 Oslo, Norway.	lisa.aarhus@stami.no	Engdahl, Bo/ABC-6923-2020	Engdahl, Bo/0000-0002-9166-5782			Aarhus L, 2020, EAR HEARING, V41, P67, DOI 10.1097/AUD.0000000000000729; Aarhus L, 2015, EAR HEARING, V36, P302, DOI 10.1097/AUD.0000000000000118; ALBERTI PW, 1979, ACTA OTO-LARYNGOL, V87, P255, DOI 10.3109/00016487909126417; AXELSSON A, 1987, SCAND AUDIOL, V16, P137, DOI 10.3109/01050398709042168; Berg RL, 2014, NOISE HEALTH, V16, P102, DOI 10.4103/1463-1741.132092; BURNS EM, 1992, J ACOUST SOC AM, V91, P1571, DOI 10.1121/1.402438; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chen JX, 2018, AM J OTOLARYNG, V39, P338, DOI 10.1016/j.amjoto.2018.01.018; CHUNG DY, 1983, AUDIOLOGY, V22, P199; CHUNG DY, 1983, J OCCUP ENVIRON MED, V25, P541; CHUNG DY, 1983, J ACOUST SOC AM, V73, P1277, DOI 10.1121/1.389276; Dobie RA, 2014, EAR HEARING, V35, P577, DOI 10.1097/AUD.0000000000000043; DUFRESNE RM, 1988, EAR HEARING, V9, P41, DOI 10.1097/00003446-198802000-00015; Engdahl B, 2005, INT J AUDIOL, V44, P213, DOI 10.1080/14992020500057731; Engdahl B, 2015, INT J AUDIOL, V54, P958, DOI 10.3109/14992027.2015.1090631; Engdahl B, 2013, INT J AUDIOL, V52, P74, DOI 10.3109/14992027.2012.733423; Fernandes SV, 2010, J LARYNGOL OTOL, V124, P1051, DOI 10.1017/S0022215110001258; Hong OS, 2005, INT ARCH OCC ENV HEA, V78, P565, DOI 10.1007/s00420-005-0623-9; Lutman ME, 2009, CLIN OTOLARYNGOL, V34, P316, DOI 10.1111/j.1749-4486.2009.01967.x; Masterson L, 2016, OTOL NEUROTOL, V37, P998, DOI 10.1097/MAO.0000000000001104; MAY JJ, 1990, AM J IND MED, V18, P333, DOI 10.1002/ajim.4700180315; Nondahl DM, 2000, ARCH FAM MED, V9, P352, DOI 10.1001/archfami.9.4.352; OSTRI B, 1989, SCAND AUDIOL, V18, P243, DOI 10.3109/01050398909042202; PIRILA T, 1991, SCAND AUDIOL, V20, P217, DOI 10.3109/01050399109045966; Pittman AL, 2003, EAR HEARING, V24, P198, DOI 10.1097/01.AUD.0000069226.22983.80; PROSSER S, 1988, British Journal of Audiology, V22, P85, DOI 10.3109/03005368809077802; Roth DAE, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516681168; Segal N, 2007, ANN OTO RHINOL LARYN, V116, P7, DOI 10.1177/000348940711600102; Sturman CJ, 2018, OTOL NEUROTOL, V39, pE627, DOI 10.1097/MAO.0000000000001908; Tak S, 2009, AM J IND MED, V52, P358, DOI 10.1002/ajim.20690; Tambs K, 2003, INT J AUDIOL, V42, P89, DOI 10.3109/14992020309078340; Wang XX, 2016, EAR HEARING, V37, P189, DOI 10.1097/AUD.0000000000000236	32	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0271-3586	1097-0274		AM J IND MED	Am. J. Ind. Med.	JUN	2020	63	6					535	542		10.1002/ajim.23105		MAR 2020	8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	LK8HT	WOS:000520283900001	32187713				2022-02-06	
J	Baltazar, GA; Kolwitz, C; Petrone, P; Stright, A; Joseph, D				Baltazar, Gerard A.; Kolwitz, Christine; Petrone, Patrizio; Stright, Adam; Joseph, D'Andrea			Osteopathic Manipulative Treatment Relieves Post-concussion Symptoms in a Case of Polytrauma	CUREUS			English	Article						trauma; concussion; osteopathic manipulative treatment	BALANCE	Optimal management of post-concussion symptoms (PCS) remains ill-defined but includes multimodal, symptom-guided plans of care. Osteopathic manipulative treatment (OMT) may be used as an adjunct treatment for PCS. We present a case of a motor vehicle collision victim whose PCS improved directly and progressively after OMT. To our knowledge, this is the first report of OMT utilized for PCS management after polytrauma and as part of an organized trauma system. Previous studies discuss potential benefits of OMT for patients with PCS after sports-related injuries, and none account for management of multiply injured patients as part of an organized trauma system. Further study of OMT for PCS is warranted and would benefit by recruiting patients from trauma centers in order to observe a range of mechanisms of injury that result in concussion.	[Baltazar, Gerard A.; Kolwitz, Christine; Petrone, Patrizio; Stright, Adam; Joseph, D'Andrea] NYU, NYU Langone Hlth, Surg, Winthrop Hosp, Mineola, NY 11501 USA		Baltazar, GA (corresponding author), NYU, NYU Langone Hlth, Surg, Winthrop Hosp, Mineola, NY 11501 USA.	gerard.baltazar@nyulangone.org	Petrone, Patrizio/AAQ-7986-2020	Stright, Adam/0000-0001-5843-8759; Baltazar, Gerard/0000-0001-6109-3843			Anderson RE, 2006, HEADACHE, V46, P1273, DOI 10.1111/j.1526-4610.2006.00535.x; [Anonymous], 2015, C TRAUM BRAIN INJ US; [Anonymous], 2020, WHAT IS OSTEOPATHIC; Carnes D, 2010, MANUAL THER, V15, P355, DOI 10.1016/j.math.2009.12.006; Castillo I, 2016, J AM OSTEOPATH ASSOC, V116, P178, DOI 10.7556/jaoa.2016.034; Chappell C, 2015, OSTEOPATH FAM PHYS, V7, P30; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Fraix M, 2013, J AM OSTEOPATH ASSOC, V113, P394; Giles PD, 2013, J ALTERN COMPLEM MED, V19, P92, DOI 10.1089/acm.2011.0031; Guernsey DT, 2016, J AM OSTEOPATH ASSOC, V116, pE13, DOI 10.7556/jaoa.2016.036; Hitscherich K, 2016, J AM OSTEOPATH ASSOC, V116, P170, DOI 10.7556/jaoa.2016.033; Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P685; Jonas Christopher, 2018, FP Essent, V470, P11; Lopez D, 2011, J AM OSTEOPATH ASSOC, V111, P382, DOI 10.7556/jaoa.2011.111.6.382; Sergueef N, 2002, ALTERN THER HEALTH M, V8, P74; Wetzler G, 2017, MED ACUPUNCT, V29, P239, DOI 10.1089/acu.2017.1222; Yao SC, 2019, AAO J, V29, P25; Zwibel H, 2018, J AM OSTEOPATH ASSOC, V118, P655, DOI 10.7556/jaoa.2018.144	18	1	1	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	MAR 18	2020	12	3							e7317	10.7759/cureus.7317			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	KU9DU	WOS:000520024400016	32313758	gold, Green Published			2022-02-06	
J	Demas, A; Tillot, D				Demas, Alexis; Tillot, David			Pathological laughing and psychotic disorder: the medical evaluation of the Joker	ACTA NEUROLOGICA BELGICA			English	Article						Pathological laughing; Psychotic disorder; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; RISK-FACTOR; SCHIZOPHRENIA	In the psychological thriller film Joker, released in 2019 and starring Joaquin Phoenix in the first role, another possible origin story for this iconic character is reported. Above all, it brings us medical elements for the understanding of the development of this complex character. Contrary to other interpretations, we discover a lonely, timid and uncharismatic man (Arthur Fleck). He seems to be suffering from psychobehavioral disorders and seems depressed. There is a strangeness in his behavior along with social withdrawal. He suffers from fits of laughter that occur at socially inappropriate times. He also suffers from psychotic symptoms with visual delusions. We learn through the film that he was a beaten child, psychologically and physically abused with severe traumatic brain injury (TBI). The uncontrollable outbursts of laughter, behavioral and psychotic disorders followed these elements. As a neurologist, I was intrigued by these symptoms. I have explored the neuropsychiatric symptoms complicating TBI from which he seems to suffer and which have been reported in the literature. We can assume that the Joker is suffering from neuropsychiatric sequelae related to childhood TBI involving the frontotemporal regions and, in particular, the lateral aspect of the left frontal lobe. The movie Joker has medical significance and covers social aspects of medicine and health care. First, it allows us to discuss whether psychotic disorder due to TBI should be considered a neurobiological syndrome. More broadly, albeit fictitious, it asks us about the management of patients with neuropsychiatric illness, which is a public health problem. It also reminds us that semiological descriptions of patients with neuropsychiatric disorders have served as inspiration for many authors.	[Demas, Alexis] Le Havre Hosp, Dept Neurol, Neurol Unit, 29 Ave Pierre Mendes, F-76290 Le Havre, France; [Tillot, David] Univ Hosp Charles Nicolles, Dept Anesthesiol, 37 Blvd Gambetta, F-76000 Rouen, France		Demas, A (corresponding author), Le Havre Hosp, Dept Neurol, Neurol Unit, 29 Ave Pierre Mendes, F-76290 Le Havre, France.	alexis.demas@yahoo.fr					ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Fleminger S., 2009, LISHMANS ORGANIC PSY, P167; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lipoff JB, 2016, JAMA DERMATOL, V152, P904, DOI 10.1001/jamadermatol.2015.5793; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Podoll K, 1999, LANCET, V353, P1366, DOI 10.1016/S0140-6736(05)74368-3; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; TODD J, 1955, Can Med Assoc J, V73, P701; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8	14	1	1	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2020	120	6					1379	1382		10.1007/s13760-020-01332-3		MAR 2020	4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OM4MW	WOS:000520797000001	32189221	Green Published, hybrid			2022-02-06	
J	Williams, V; Bansal, A; Jayashree, M; Ismail, J; Aggarwal, A; Gupta, SK; Singhi, S; Singhi, P; Baranwal, AK; Nallasamy, K				Williams, Vijai; Bansal, Arun; Jayashree, Muralidharan; Ismail, Javed; Aggarwal, Ashish; Gupta, S. K.; Singhi, Sunit; Singhi, Pratibha; Baranwal, Arun Kumar; Nallasamy, Karthi			Decompressive craniectomy in pediatric non-traumatic intracranial hypertension: a single center experience	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Decompressive craniectomy; pediatric; non-traumatic coma; intracranial hypertension; Glasgow Outcome Scale	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; SURGICAL INTERVENTION; MALIGNANT INFARCTION; CHILDREN; PRESSURE; COMA; MANAGEMENT; ETIOLOGY; PREDICTORS	Purpose: To study the clinical profile and predictors of outcome in children undergoing decompressive craniectomy (DC) for non-traumatic intracranial hypertension (ICH). Materials and methods: Mixed observational study of children, aged 1 month-12 years, who underwent DC for non-traumatic ICH in a tertiary care pediatric intensive care unit from 2012 to 2017. Data on clinical profile and outcome were retrieved retrospectively and survivors were assessed prospectively. The primary outcome was neurological outcome using Glasgow Outcome Scale-Extended (GOS-E) at minimum 6 months' post-discharge. GOS-E of 1-4 were classified as a poor and 5-8 as a good outcome. Results: Thirty children, median (IQR) age of 6.5 (2, 50) months, underwent DC; of which 26 (86.7%) were boys. Altered sensorium (n = 26, 86.7%), seizures (n = 25, 83.3%), pallor (n = 19, 63.3%) and anisocoria (n = 14, 46.7%) were common signs and symptoms. Median (IQR) Glasgow Coma Scale at admission was 9 (6,11). Commonest etiology was intracranial bleed (n = 24; 80%). Median (IQR) time to DC was 24 (24,72) h. Eight (26.7%) children died; 2 during PICU stay and 6 during follow-up. Neurological sequelae at discharge (n = 28) were seizures (n = 25; 89.2%) and hemiparesis (n = 16; 57.1%). Twenty-one children were followed-up at median (IQR) duration of 12 (6,54) months. Good neurological outcome was seen in 14/29 (48.2%) and hemiparesis in 10/21 (47.6%) patients. On regression analysis, anisocoria at admission was an independent predictor of poor outcome [OR 7.33; 95%CI: 1.38-38.87; p = 0.019]. Conclusions: DC is beneficial in children with non-traumatic ICH due to a focal pathology and midline shift. Evidence on indications and timing of DC in NTC is still evolving.	[Williams, Vijai; Bansal, Arun; Jayashree, Muralidharan; Ismail, Javed; Baranwal, Arun Kumar; Nallasamy, Karthi] Postgrad Inst Med Educ & Res PGIMER, Adv Pediat Ctr, Dept Pediat, Chandigarh 160012, India; [Aggarwal, Ashish; Gupta, S. K.] Postgrad Inst Med Educ & Res PGIMER, Dept Neurosurg, Chandigarh, India; [Singhi, Sunit] Medanta, Pediat, Gurugram, India; [Singhi, Pratibha] Medanta, Pediat Neurol, Gurugram, India		Bansal, A (corresponding author), Postgrad Inst Med Educ & Res PGIMER, Adv Pediat Ctr, Dept Pediat, Chandigarh 160012, India.	drarunbansal@gmail.com	Williams, Vijai/AAE-6439-2019; ismail, javed/ABA-4457-2020	Williams, Vijai/0000-0001-6508-9710; ismail, javed/0000-0001-6610-1865; Nallasamy, Karthi/0000-0002-6713-9846			Aaron S, 2013, J NEUROL NEUROSUR PS, V84, P995, DOI 10.1136/jnnp-2012-303356; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Aghakhani N, 2009, J NEUROS-PEDIATR, V3, P66, DOI 10.3171/2008.10.PEDS08116; Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Ahmad I, 2017, INT J CONT PEDIAT, V2, P77; Ahmed S, 2011, J PAK MED ASSOC, V61, P671; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Poca MA, 2010, J NEUROSURG, V112, P648, DOI 10.3171/2009.7.JNS081677; Appelboom G, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11177; Bansal Arun, 2005, Indian Journal of Pediatrics, V72, P467, DOI 10.1007/BF02724422; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fouad H, 2011, J CHILD NEUROL, V26, P136, DOI 10.1177/0883073810374358; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Honeybul Stephen, 2017, Evid Based Med, V22, P61, DOI 10.1136/ebmed-2016-110616; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kirkham FJ, 2001, ARCH DIS CHILD, V85, P303, DOI 10.1136/adc.85.4.303; Kumar RR, 2012, INDIAN J PEDIATR, V79, P518, DOI 10.1007/s12098-011-0648-x; Lanterna LA, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0910; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Malmivaara K, 2011, EUR J NEUROL, V18, P402, DOI 10.1111/j.1468-1331.2010.03162.x; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Nguyen Ha Son, 2011, Childs Nerv Syst, V27, P657, DOI 10.1007/s00381-010-1285-9; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prasad GL, 2015, BRAIN INJURY, V29, P1717, DOI 10.3109/02699052.2015.1075146; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; Riyaz M, 2015, CHILD NERV SYST, V31, P2117, DOI 10.1007/s00381-015-2808-1; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Singhi P, 2015, J CHILD NEUROL, V30, P1204, DOI 10.1177/0883073814546688; Singhi Sunit, 2001, Indian Journal of Pediatrics, V68, P737; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Smith SE, 2011, DEV MED CHILD NEUROL, V53, P29, DOI 10.1111/j.1469-8749.2010.03775.x; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Sundseth J, 2017, ACTA NEUROCHIR, V159, P301, DOI 10.1007/s00701-016-3049-0; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; Williams V, 2020, J PEDIATR INTENSIVE, V9, P1, DOI 10.1055/s-0039-3399581; Williams V, 2019, CHILD NERV SYST, V35, P1371, DOI 10.1007/s00381-019-04209-w; Williams V, 2018, CHILD NERV SYST, V34, P2317, DOI 10.1007/s00381-018-3825-7; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193	58	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2020	34	3					258	263		10.1080/02688697.2020.1740648		MAR 2020	6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MI0UE	WOS:000524087500001	32186205				2022-02-06	
J	Scher, IS; Stepan, LL; Hoover, RW				Scher, Irving S.; Stepan, Lenka L.; Hoover, Ryan W.			Head and neck injury potential during water sports falls: examining the effects of helmets	SPORTS ENGINEERING			English	Article						Wakeboarding; Water skiing; Head injury; Cervical spine injury; Head protection; Bucketing; Venting	UNITED-STATES	Head and neck injuries sustained during water skiing and wakeboarding occur as a result of falls in water and collisions with obstacles, equipment, or people. Though water sports helmets are designed to reduce injury likelihood from head impacts with hard objects, some believe that helmets increase head and neck injury rates for falls into water (with no impact to a solid object). The effect of water sports helmets on head kinematics and neck loads during simulated falls into water was evaluated using a custom-made pendulum system with a Hybrid-III anthropometric testing device. Two water entry configurations were evaluated: head-first and pelvis-first water impacts with a water entry speed of 8.8 +/- 0.1 m/s. Head and neck injury metrics were compared to injury assessment reference values and the likelihoods of brain injury were determined from head kinematics. Water sport helmets did not increase the likelihood of mild traumatic brain injury compared to a non-helmeted condition for both water entry configurations. Though helmets did increase injury metrics (such as head acceleration, HIC, and cervical spine compression) in some test configurations, the metrics remained below injury assessment reference values and the likelihoods of injury remained below 1%. Using the effective drag coefficients, the lowest water impact speed needed to produce cervical spine injury was estimated to be 15 m/s. The testing does not support the supposition that water sports helmets increase the likelihood of head or neck injury in a typical fall into water during water sports.	[Scher, Irving S.; Stepan, Lenka L.] Guidance Engn & Appl Res, 205 NE Northlake Way,Suite 100, Seattle, WA 98105 USA; [Hoover, Ryan W.] CAPE, 18881 IMMI Way, Westfield, IN 46074 USA		Scher, IS (corresponding author), Guidance Engn & Appl Res, 205 NE Northlake Way,Suite 100, Seattle, WA 98105 USA.	scher@guidanceengineering.com; stepan@guidanceengineering.com; rhoover@imminet.com					[Anonymous], 2014, J211 SAE INT; [Anonymous], 2017, SPORTS FITN LEIS ACT; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Baker JI, 2010, J SPORT SCI MED, V9, P92; Bandak, 1999, DEV IMPROVED INJURY; Bray-Miners J, 2015, P I MECH ENG P-J SPO, V229, P47, DOI 10.1177/1754337114547555; Bussone WR, 2010, 2010011017 SAE, DOI [10.4271/2010-01-1017, DOI 10.4271/2010-01-1017]; Carson WG, 2004, AM J SPORT MED, V32, P164, DOI 10.1177/0363546503258910; Chia JKK, 2000, PEDIATR NEUROSURG, V32, P291, DOI 10.1159/000028957; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Depreitere B, 2005, IUTAM S IMP BIOM FUN; Duma B, 2019, P ASME 2019 SUMM BIO, P031; European Standard, 2013, 10782012A12012 BS EN; European Standard, 2005, 13851998A12005 BS EN; Hostetler SG, 2005, AM J SPORT MED, V33, P1065, DOI 10.1177/0363546504271748; HUMMEL G, 1982, AM J SPORT MED, V10, P215, DOI 10.1177/036354658201000405; Kluger N, 2016, PRESSE MED, V45, P540, DOI 10.1016/j.lpm.2016.01.034; Liu K, 2020, P I MECH ENG P-J SPO, V234, P109, DOI 10.1177/1754337119882836; Liu K, 2019, P I MECH ENG P-J SPO, V233, P432, DOI 10.1177/1754337119840848; Loughlin S., 2013, INT J EXER SCI, V6, P29; Lyons J.C., 2012, OPEN SPORTS MED J, V6, P29, DOI DOI 10.2174/1874387001206010029; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Petrone N, 2019, J SCI MED SPORT, V22, pS78, DOI 10.1016/j.jsams.2019.05.015; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Runciman RJ, 2011, P I MECH ENG P-J SPO, V225, P231, DOI 10.1177/1754337111403693; Scheer D, 2015, PROCEDIA ENGINEER, V112, P485, DOI 10.1016/j.proeng.2015.07.229; Schofer MD, 2012, SCAND J MED SCI SPOR, V22, P583, DOI 10.1111/j.1600-0838.2012.01507.x; Stepan LL, 2010, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, 2010, P305; Taylor RK, 2000, P IRCOBI, V28, P479; Thom D, 2014, F0853 ASTM; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Yliniemi EM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3078151	32	1	1	1	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	MAR 16	2020	23	1							7	10.1007/s12283-020-0321-6			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	KU7MN	WOS:000519897300001		hybrid			2022-02-06	
J	Stafford, CA; Stojanoski, B; Wild, CJ; Brewer-Deluce, D; Wilson, TD; Owen, AM				Stafford, Clara Alexandra; Stojanoski, Bobby; Wild, Conor J.; Brewer-Deluce, Danielle; Wilson, Timothy D.; Owen, Adrian M.			Concussion-related deficits in the general population predict impairments in varsity footballers	JOURNAL OF NEUROLOGY			English	Article						Concussion; Neuropsychology; High-response rate survey; Inhibitory control; Varsity football	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; WORKING-MEMORY; COLLEGIATE; SYMPTOMS; RECOVERY	Objective We investigated the long-term cognitive effects of concussion in 19,261 members of the general population and a cohort of varsity American football players with a history of frequent head impacts, using tests that are known to be sensitive to small changes in performance. Methods We asked 19,261 participants to complete a demographic questionnaire and 12 cognitive tests measuring aspects of executive function, including inhibitory control. We compared the performance of those reporting a history of concussion (post-concussion) to those reporting no history of concussion (non-concussed) on the cognitive battery and four non-cognitive variables. We used the results of this population-level study to predict the profile of cognitive performance in varsity American football players, who completed the same cognitive tasks. Results Post-concussion and non-concussed participants did not differ on 11 of the 12 cognitive tasks employed. However, on a test of inhibitory control based on the classic Stroop paradigm, post-concussion participants showed accuracy-related impairments specific to the incongruent conditions of the task. Post-concussion participants reported higher levels of anxiety, depression, and trouble concentrating. An entirely independent sample of 74 varsity American football players demonstrated the same pattern of impairment: compared to healthy controls, they scored significantly lower on the test of inhibitory control but were indistinguishable from controls on the 11 other tasks. Interpretation Self-reported concussion is not associated with long-term general effects on cognitive function. Nevertheless, those who report at least one concussion and those who expose themselves to long-term frequent sport-related head impacts do have a modest, but statistically robust, deficit of inhibitory control.	[Stafford, Clara Alexandra; Stojanoski, Bobby; Wild, Conor J.; Brewer-Deluce, Danielle; Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON N6A 5B7, Canada; [Stojanoski, Bobby; Owen, Adrian M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5B7, Canada; [Stafford, Clara Alexandra; Owen, Adrian M.] Univ Western Ontario, Dept Psychol, London, ON N6A 5B7, Canada; [Brewer-Deluce, Danielle; Wilson, Timothy D.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5B7, Canada; [Stafford, Clara Alexandra] Univ Western Ontario, Western Interdisciplinary Res Bldg, London, ON N6A 3K7, Canada		Stafford, CA (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON N6A 5B7, Canada.; Stafford, CA (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5B7, Canada.; Stafford, CA (corresponding author), Univ Western Ontario, Western Interdisciplinary Res Bldg, London, ON N6A 3K7, Canada.	cstaffo2@uwo.ca	Stafford, Clara/AAQ-2967-2021; Brewer-Deluce, Danielle/AAD-6729-2022	Stafford, Clara/0000-0003-1716-7870; Brewer-Deluce, Danielle/0000-0002-8887-8074; Wild, Conor/0000-0002-4303-3537	Canada Excellence Research Chairs (CERC) program [215063]	We thank the Canada Excellence Research Chairs (CERC) program, which generously supported the research reported here (grant #215063 awarded to AMO).	Aggarwal C. C., 2015, DATA MINING TXB; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Faul M, 2010, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Maitland SB, 2000, AGING NEUROPSYCHOL C, V7, P32, DOI 10.1076/anec.7.1.32.807; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mehta MA, 2000, J NEUROSCI, V20; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Owen AM, 1996, P NATL ACAD SCI USA, V93, P9212, DOI 10.1073/pnas.93.17.9212; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; ROSSELLI M, 1990, BRAIN COGNITION, V12, P281, DOI 10.1016/0278-2626(90)90020-O; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Williams-Gray CH, 2007, J NEUROSCI, V27, P4832, DOI 10.1523/JNEUROSCI.0774-07.2007; Zwibel H, 2016, NEWSWEEK	34	1	1	2	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUL	2020	267	7					1970	1979		10.1007/s00415-020-09749-9		MAR 2020	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MD5FV	WOS:000519830600001	32172379	Green Submitted			2022-02-06	
J	Checklin, M; Fernon, D; Soumilas, J; Stephens, D				Checklin, Martin; Fernon, Deanne; Soumilas, Julia; Stephens, Delwyne			What is it like to have your loved one with a severe brain injury come to rehabilitation? The experiences of significant others	DISABILITY AND REHABILITATION			English	Article						Brain injury; sub-acute rehabilitation; significant other; drawing method; qualitative methodology	INPATIENT REHABILITATION; HOSPITAL STAY; FAMILIES; PATIENT; CARERS	Purpose: To investigate the experiences of significant others when their loved one with a severe brain injury is admitted to acquired brain injury (ABI) rehabilitation. Main measures: A qualitative approach was undertaken; using in-depth interviews and the drawing method to elicit information on the experiences of significant others who had loved ones enter an ABI unit, early in the sub-acute rehabilitation admission. Results: Nine significant others participated in interviews and completed drawings. Seven themes were identified from the two sources of data. Themes included: Trauma; Relief; Interactions; Change; Grief and loss; Journey, and Uncertainty. Conclusions: The whole experience for the significant other is traumatic as they try to understand changes to both their loved ones and their own roles. Healthcare providers have a key role in supporting significant others as their loved ones enter rehabilitation. The role of the drawing method appears to supplement and extend data received from interviews, shedding additional light into the lived experiences of significant others of those with an acquired brain injury.	[Checklin, Martin] Epworth Healthcare, Speech Pathol Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia; [Checklin, Martin; Fernon, Deanne; Soumilas, Julia; Stephens, Delwyne] Alfred Hlth, Acquired Brain Injury Unit, Melbourne, Vic, Australia; [Stephens, Delwyne] Irabina Austism Serv, Melbourne, Vic, Australia		Checklin, M (corresponding author), Epworth Healthcare, Speech Pathol Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	Martin.Checklin@epworth.org.au			Caulfield Hospital Small Grants funding	This research was facilitated by funding received from the Caulfield Hospital Small Grants funding.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bunyan M, 2017, J PSYCHIATR MENT HLT, V24, P221, DOI 10.1111/jpm.12382; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Cross K, 2006, VISUAL STUD, V21, P183, DOI [10.1080/14725860600945044, DOI 10.1080/14725860600945044]; D'Cruz K, 2016, SCAND J OCCUP THER, V23, P30, DOI 10.3109/11038128.2015.1057521; Duff Diane, 2002, Axone, V24, P14; Eggleton K, 2017, SOC CULT GEOGR, V18, P971, DOI 10.1080/14649365.2016.1228114; Fraser K. D., 2011, ARTS HEALTH, V3, P110, DOI [10.1080/17533015.2011.561357, DOI 10.1080/17533015.2011.561357, 10.1080/17533015.2011]; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guillemin M, 2004, HEALTH-LONDON, V8, P223, DOI 10.1177/1363459304041071; Hanger HC, 1998, CLIN REHABIL, V12, P45, DOI 10.1191/026921598668677675; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Locsin R C, 2003, Int Nurs Rev, V50, P156, DOI 10.1046/j.1466-7657.2003.00194.x; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Oyesanya TO, 2017, J FAM NURS, V23, P273, DOI 10.1177/1074840717697673; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Phillips J, 2015, BRIT J OCCUP THER, V78, P404, DOI 10.1177/0308022614562791; Rose G, 2001, VISUAL METHODOLOGIES; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Scott A, 2009, QUAL HEALTH RES, V19, P454, DOI 10.1177/1049732309332707; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; Sorenson C, 2016, J NURS SCHOLARSHIP, V48, P456, DOI 10.1111/jnu.12229; Westall C, 2011, MOTHERHOOD AND POSTNATAL DEPRESSION: NARRATIVES OF WOMEN AND THEIR PARTNERS, P1, DOI 10.1007/978-94-007-1694-0	25	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAR 12	2020	42	6					788	797		10.1080/09638288.2018.1510042			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	KU7LG	WOS:000519894000006	30422718				2022-02-06	
J	Ilie, G; Trenholm, M; Boak, A; Mann, RE; Adlaf, EM; Asbridge, M; Hamilton, H; Rehm, J; Rutledge, R; Cusiman, MD				Ilie, Gabriela; Trenholm, Michelle; Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Asbridge, Mark; Hamilton, Hayley; Rehm, Juergen; Rutledge, Robert; Cusiman, Michael D.			Adolescent traumatic brain injuries: Onset, mechanism and links with current academic performance and physical injuries	PLOS ONE			English	Article							SUBSTANCE USE; NEUROCOGNITIVE OUTCOMES; LIFETIME HISTORY; UNITED-STATES; RISK-FACTORS; DRUG-USE; PREVALENCE; AGE; EPIDEMIOLOGY; CONCUSSION	Background Traumatic brain injuries (TBIs) in adolescence are associated with adverse outcomes, but whether the timing of the onset of TBIs leads to greater deficits has not been determined. We evaluate the relationship between the first and most recent TBI, and current academic performance and medically treated physical injuries. Methods Data were derived from the 2015 Ontario Student Drug Use and Health Survey (OSDUHS) administered to adolescents in grades 7 to 12 (ages 12 to 18). TBI was defined as a head injury that resulted in loss of conscious for at least five minutes or at least one overnight hospitalization. Results One in five students reported having had a history of TBI in their lifetime and were more prevalent in males. Odds ratios were 2 times higher for males to have had their first (or only) and most recent TBI in grades 5 to 8, compared to females. Sports-related TBIs accounted for 41.1% of all TBIs. Hockey related TBIs were more frequent compared to soccer related TBIs. Reports of history of TBI was associated with lower academic performance and more physical injuries. First or only TBI occurring in grades 9-12 (occurring on average between 14 to 19 years of age) had higher significant odds of poorer academic performance than TBIs occurring in earlier grades (younger ages than 14 years old). Students who reported more visits for medical treatment of physical injuries in the past year had higher odds to report a history of TBIs in higher school grades. Conclusions Adverse physical and academic outcomes among young TBI survivors are associated with the onset and frequency of history of lifetime TBI. Prevention efforts to minimize TBIs during youth is critical.	[Ilie, Gabriela; Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Trenholm, Michelle] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Boak, Angela; Mann, Robert E.; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada; [Mann, Robert E.; Hamilton, Hayley; Rehm, Juergen; Cusiman, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rutledge, Robert] Dalhousie Univ, Dept Radiat Oncol, Halifax, NS, Canada; [Cusiman, Michael D.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada		Ilie, G (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.	Gabriela.Ilie@dal.ca	Ilie, Gabriela/AAM-9122-2021; Ilie, Gabriela/J-6066-2014	Ilie, Gabriela/0000-0002-1602-6374	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Dalhousie Research Medical Foundation Research in Medicine Program; Dalhousie Research Medical Foundation Soillse Research Fund	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research TIR-103946 (MC, RM,MA). Dalhousie Research Medical Foundation Research in Medicine Program (MT) and Dalhousie Research Medical Foundation Soillse Research Fund (GI).	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barrios LC, 2000, J AM COLL HEALTH, V48, P229, DOI 10.1080/07448480009599309; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Boak A., 2015, CAMH RES DOCUMENT SE; Burkart R. M., 2013, P 2013 IEEE 14 WORKS, P1; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diehl K, 2012, J SPORT SCI MED, V11, P201; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Farace E, 2000, Neurosurg Focus, V8, pe6; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamilton HA, 2013, CAN J PUBLIC HEALTH, V104, pE496, DOI 10.17269/cjph.104.3998; Howieson C, 2008, BRIT EDUC RES J, V34, P269, DOI 10.1080/01411920701532137; Ilie G, 2017, INJURY, V48, P285, DOI 10.1016/j.injury.2016.09.030; Ilie G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0385-3; Ilie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135860; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2015, ACCIDENT ANAL PREV, V81, P1, DOI 10.1016/j.aap.2015.04.021; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108167; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Institute of Medicine of the National Academies, 2013, REP BRIEF SPORTS REL; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kirkham FJ, 2017, CURR OPIN NEUROL, V30, P148, DOI 10.1097/WCO.0000000000000427; Kwan M, 2014, ADDICT BEHAV, V39, P497, DOI 10.1016/j.addbeh.2013.11.006; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Roemer A, 2017, J STUD ALCOHOL DRUGS, V78, P175, DOI 10.15288/jsad.2017.78.175; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Shi HX, 2013, 2013 NINTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION (ICNC), P200, DOI 10.1109/ICNC.2013.6817970; Somerville LH, 2016, NEURON, V92, P1164, DOI 10.1016/j.neuron.2016.10.059; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Veliz P, 2017, INT REV SOCIOL SPORT, V52, DOI 10.1177/1012690215586998; Wang Q, 2019, MEMORY, V27, P1, DOI 10.1080/09658211.2018.1537119; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Yumul JN, 2010, PHYS MED REHABIL, V8, P1097	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2020	15	3							e0229489	10.1371/journal.pone.0229489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ9AF	WOS:000535288600013	32163445	gold, Green Published			2022-02-06	
J	Schieren, M; Wappler, F; Wafaisade, A; Lefering, R; Sakka, SG; Kaufmann, J; Heiroth, HJ; Defosse, J; Bohmer, AB				Schieren, Mark; Wappler, Frank; Wafaisade, Arasch; Lefering, Rolf; Sakka, Samir G.; Kaufmann, Jost; Heiroth, Hi-Jae; Defosse, Jerome; Boehmer, Andreas B.			Impact of blunt chest trauma on outcome after traumatic brain injury- a matched-pair analysis of the TraumaRegister DGU (R)	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Thoracic injury; Glasgow Outcome Scale; Critical care; Registry	PULMONARY CONTUSION; SECONDARY INSULTS; HYPOXIA	Background Traumatic brain injury (TBI) is associated with high rates of long-term disability and mortality. Our aim was to investigate the effects of thoracic trauma on the in-hospital course and outcome of patients with TBI. Methods We performed a matched pair analysis of the multicenter trauma database TraumaRegisterDGU (R) (TR-DGU) in the 5-year period from 2012 to 2016. We included adult patients (>= 18 years of age) with moderate to severe TBI (abbreviated injury scale (AIS)= 3-5). Patients with isolated TBI (group 1) were compared to patients with TBI and varying degrees of additional blunt thoracic trauma (AIS(Thorax)= 2-5) (group 2). Matching criteria were gender, age, severity of TBI, initial GCS and presence/absence of shock. The chi(2)-test was used for comparing categorical variables and the Mann-Whitney-U-test was chosen for continuous parameters. Statistical significance was defined by a p-value < 0.05. Results A total of 5414 matched pairs (10,828 patients) were included. The presence of additional thoracic injuries in patients with TBI was associated with a longer duration of mechanical ventilation and a prolonged ICU and hospital length of stay. Additional thoracic trauma was also associated with higher mortality rates. These effects were most pronounced in thoracic AIS subgroups 4 and 5. Additional thoracic trauma, regardless of its severity (AIS(Thorax) >= 2) was associated with significantly decreased rates of good neurologic recovery (GOS = 5) after TBI. Conclusions Chest trauma in general, regardless of its initial severity (AIS(Thorax)= 2-5), is associated with decreased chance of good neurologic recovery after TBI. Affected patients should be considered "at risk" and vigilance for the maintenance of optimal neuro-protective measures should be high.	[Schieren, Mark; Wappler, Frank; Defosse, Jerome; Boehmer, Andreas B.] Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Anaesthesiol & Intens Care Med, Ostmerheimer Str 200, D-51109 Cologne, Germany; [Wafaisade, Arasch] Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Traumatol & Orthoped Surg, Cologne, Germany; [Lefering, Rolf] Univ Witten Herdecke, IFOM Inst Res Operat Med, Cologne, Germany; [Sakka, Samir G.] Johannes Gutenberg Univ Mainz, Dept Intens Care Med, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany; [Kaufmann, Jost] Univ Witten Herdecke, Children Hosp, Dept Pediat Anaesthesiol, Amsterdamer Str, Cologne, Germany; [Heiroth, Hi-Jae] Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Neurosurg, Cologne, Germany		Schieren, M (corresponding author), Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Anaesthesiol & Intens Care Med, Ostmerheimer Str 200, D-51109 Cologne, Germany.	mark.schieren@uni-wh.de	Defosse, Jerome/G-4303-2016	Defosse, Jerome/0000-0003-0345-3083; Kaufmann, Jost/0000-0002-5289-6465; Schieren, Mark/0000-0003-1168-5538			Bader A, 2018, J SURG RES, V230, P110, DOI 10.1016/j.jss.2018.04.049; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Dai DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074204; de Vries R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190587; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Leone M, 2003, CHEST, V124, P2261, DOI 10.1378/chest.124.6.2261; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wabi R, 2018, J NEUROSURG, P1; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359	18	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 12	2020	28	1							21	10.1186/s13049-020-0708-1			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KV4ZM	WOS:000520492200002	32164757	Green Published, gold			2022-02-06	
J	Creeden, S; Ding, VY; Parker, JJ; Jiang, B; Li, Y; Lanzman, B; Trinh, A; Khalaf, A; Wolman, D; Halpern, CH; Boothroyd, D; Wintermark, M				Creeden, Sean; Ding, Victoria Y.; Parker, Jonathon J.; Jiang, Bin; Li, Ying; Lanzman, Bryan; Trinh, Austin; Khalaf, Alexander; Wolman, Dylan; Halpern, Casey H.; Boothroyd, Derek; Wintermark, Max			Interobserver Agreement for the Computed Tomography Severity Grading Scales for Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						common data elements; computed tomography; scoring systems; traumatic brain injury	VARIABILITY; CLASSIFICATION; MAMMOGRAPHY; SYSTEM	The purpose of this study was to determine the interobserver variability among providers of different specialties and levels of experience across five established computed tomography (CT) scoring systems for acute traumatic brain injury (TBI). One hundred cases were selected at random from a retrospective population of adult patients transported to our emergency department and subjected to a non-contrast head CT due to suspicion of TBI. Eight neuroradiologists and neurosurgeons in trainee (residents and fellows) and attending roles independently scored each non-contrast head CT scan on the Marshall, Rotterdam, Helsinki, Stockholm, and NeuroImaging Radiological Interpretation System (NIRIS) head CT scales. Interobserver variability of scale scores-overall and by specialty and level of training-was quantified using the intraclass correlation coefficient (ICC), and agreement with respect to National Institutes of Health Common Data Elements (NIH CDEs) was assessed using Cohen's kappa. All CT severity scoring systems showed high interobserver agreement as evidenced by high ICCs, ranging from 0.75-0.89. For all scoring systems, neuroradiologists (ICC range from 0.81-0.94) tended to have higher interobserver agreement than neurosurgeons (ICC range from 0.63-0.76). For all scoring systems, attendings (ICC range from 0.76-0.89) had similar interobserver agreement to trainees (ICC range from 0.73-0.89). Agreement with respect to NIH CDEs was high for ascertaining presence/absence of hemorrhage, skull fracture, and mass effect, with estimated kappa statistics of least 0.89. Acute TBI CT scoring systems demonstrate high interobserver agreement. These results provide scientific rigor for future use of these systems for the classification of acute TBI.	[Creeden, Sean; Jiang, Bin; Li, Ying; Lanzman, Bryan; Trinh, Austin; Khalaf, Alexander; Wolman, Dylan; Wintermark, Max] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Ding, Victoria Y.; Boothroyd, Derek] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Parker, Jonathon J.; Halpern, Casey H.] Stanford Univ, Dept Med, Stanford, CA 94305 USA		Wintermark, M (corresponding author), Stanford Univ, Dept Radiol, Neuroradiol Div, 300 Pasteur Dr,Room S047, Stanford, CA 94305 USA.	Max.Wintermark@gmail.com					Armstead WM, 2020, J NEUROTRAUM, V37, P2372, DOI 10.1089/neu.2018.6119; Brady AP, 2018, INSIGHTS IMAGING, V9, P237, DOI 10.1007/s13244-018-0596-3; Center for Disease Control and Prevention, 2020, TRAUMATIC BRAIN INJU; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Grieve FM, 2010, BRIT J RADIOL, V83, P17, DOI 10.1259/bjr/16360063; Grimm LJ, 2015, AM J ROENTGENOL, V204, P1120, DOI 10.2214/AJR.14.13047; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlotz Curtis P, 2009, J Am Coll Radiol, V6, P861, DOI 10.1016/j.jacr.2009.09.015; Lazarus E, 2006, RADIOLOGY, V239, P385, DOI 10.1148/radiol.2392042127; Lee AY, 2017, ACAD RADIOL, V24, P60, DOI 10.1016/j.acra.2016.09.010; Lee B, 2017, CURR PROBL DIAGN RAD, V46, P186, DOI 10.1067/j.cpradiol.2016.11.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; R Core Team, 2019, R LANG ENV STAT COMP; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Redondo A, 2012, BRIT J RADIOL, V85, P1465, DOI 10.1259/bjr/21256379; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311	27	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1445	1451		10.1089/neu.2019.6871		MAR 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525031700001	31996087				2022-02-06	
J	Marom, BS; Sharabi, M; Carel, RS; Ratzon, NZ				Marom, Batia S.; Sharabi, Moshe; Carel, Rafael S.; Ratzon, Navah Z.			Returning to work after a hand injury: Does ethnicity matter?	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; EMPLOYMENT OUTCOMES; DISABILITY; CULTURE; REHABILITATION; PARTICIPATION; DISPARITIES; VALIDATION; ARABS; JEWS	Background Hand injuries (HI) are common and may limit participation in work. The objective of this study is to examine the effect of ethnicity and other prognostic variables on return-to-work (RTW) among male manual workers after acute HI. Methods A cohort of 178 subjects (90 Arabs, 88 Jews) aged 22 to 65 was studied. Trained bilingual occupational therapists evaluated and interviewed the subjects, using structured validated questionnaires for evaluating personal and environmental factors, body function and structure, and activity limitation and participation restrictions. Employment status 3 months post injury was assessed by a telephone interview. To establish a predictive model for RTW, ethnicity and certain variables of the four domains mentioned above were analyzed using logistic regression analysis. Results A significant difference in the rate of RTW between Jews and Arabs was found (45.5% for Jews, 28.9% for Arabs, p = 0.03) three months post HI. In the univariate regression analysis, ethnicity was associated with RTW (OR = 2.05; CI: 1.10-3.81) for Jews vs. Arabs. Using a multivariate analysis, only legal counseling, educational attainment, and the severity of disability were significantly associated with RTW. Conclusion RTW three months post HI among manual workers is directly related to variables such as education and legal counseling and only indirectly related to ethnicity. Patients with a lower level of education and those who were engaged in legal counseling need special attention and close guidance in the process of RTW.	[Marom, Batia S.] Clalit Hlth Serv, Occupat Therapy Unit, Tiberias, Israel; [Sharabi, Moshe] Max Stern Yezreel Valley Coll, Sociol & Anthropol Dept, Yezreel Valley, Israel; [Carel, Rafael S.] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Ratzon, Navah Z.] Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel		Marom, BS (corresponding author), Clalit Hlth Serv, Occupat Therapy Unit, Tiberias, Israel.	batiamarom2@clalit.org.il		Sharabi, Moshe/0000-0001-8570-8769	National Insurance Institute of Israel [12379]	The author Batia Marom was partly supported by a grant from the National Insurance Institute of Israel (Grant Number: 12379). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfassi-Henley M., 2014, ARABS ISRAEL DISABIL; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2010, PM&R, V2, P901, DOI 10.1016/j.pmrj.2010.05.009; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P37, DOI 10.3233/NRE-2009-0452; Baril R, 2003, SAFETY SCI, V41, P277, DOI 10.1016/S0925-7535(02)00039-5; Black RM, 2014, WILLARD SPACKMANS OC, P173; Bonder BR, 2004, AM J OCCUP THER, V58, P159, DOI 10.5014/ajot.58.2.159; Braveman B, 2012, WORK WORLD CULTURAL; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Chiang M., 2003, BRIT J OCCUP THER, V66, P559, DOI [10.1177/030802260306601204, DOI 10.1177/030802260306601204]; Crisp R, 2005, J REHABIL, V71, P30; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Dias JJ, 2006, INJURY, V37, P1071, DOI 10.1016/j.injury.2006.07.023; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gulam H., 2003, AUSTR NURSING J, V11, P23; Karasek R., 1992, HLTH WORK STRESS PRO; Katz J, 1999, SURG CLIN N AM, V79, P231, DOI 10.1016/S0039-6109(05)70381-9; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; MacDermid JC, 2007, J OCCUP REHABIL, V17, P47, DOI 10.1007/s10926-007-9069-0; Marom BS, 2019, ARCH PHYS MED REHAB, V100, P422, DOI 10.1016/j.apmr.2018.07.429; Marom BS, 2017, DISABIL REHABIL, V39, P1155, DOI 10.1080/09638288.2016.1189606; Meade MA, 2004, ARCH PHYS MED REHAB, V85, P1782, DOI 10.1016/j.apmr.2004.05.001; Muhsen K, 2017, LANCET, V389, P2531, DOI 10.1016/S0140-6736(17)30574-3; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; NATHAN PA, 1993, J OCCUP ENVIRON MED, V35, P1034; Ostun T. B., 2010, MEASURING HLTH DISAB; Poerbodipoero SJ, 2007, HAND THER, V12, P40; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Savitsky B, 2019, J COMMUNITY HLTH, P1; Schwartz S. H., 2013, UNDERSTANDING CULTUR, P137; SCHWARZWALD J, 1987, J CONSULT CLIN PSYCH, V55, P251, DOI 10.1037/0022-006X.55.2.251; Semonov M, 2000, MEGAMOT, V4, P706; Sharabi M, 2014, COMMIMITY WORK FAM, V17, P219, DOI 10.1080/13668803.2014.889660; Sharabi M, 2014, ISR AFF, V20, P503, DOI 10.1080/13537121.2014.955655; Sharon A., 2002, RELATIONSHIP PSYCHOS; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Swirski B., 2016, DISABILITY ALLOWANCE; Tiruneh A, 2017, ETHNIC HEALTH, V22, P49, DOI 10.1080/13557858.2016.1196647	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2020	15	3							e0229982	10.1371/journal.pone.0229982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8WI	WOS:000535278500049	32155201	gold, Green Published			2022-02-06	
J	Paniccia, M; Ippolito, C; McFarland, S; Murphy, J; Reed, N				Paniccia, M.; Ippolito, C.; McFarland, S.; Murphy, J.; Reed, N.			Health-Related Quality of Life in Non-Concussed Children: A Normative Study to Inform Concussion Management	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Health-related quality of life; stressors; pediatric; children; concussion; concussion symptoms	TRAUMATIC BRAIN-INJURY; LEARNING-DISABILITIES; SELF-EFFICACY; MENTAL-HEALTH; ADOLESCENTS; RELIABILITY; SYMPTOMS; RECOVERY; VALIDITY; SCHOOL	Purpose: There has been a shift to consider pediatric concussion recovery beyond symptom management by considering how health-related quality of life (HRQoL) affects recovery. This study investigated normative ranges of HRQoL in children and explored its relationship with common pediatric concussion variables. Methods: A cross-sectional study of 1,722 non-concussed children 8-12 years old (M = 10.52 +/- 1.23 years; 1,335 males, 387 females) was conducted by secondary analysis of clinical baseline concussion data. Demographic information, concussion-like symptoms (PCSI-C), and HRQoL (KIDSCREEN-10 Index) were self-reported. Results: The most reported concussion-like symptoms were common stress symptoms and were significantly negatively correlated with HRQoL. Premorbid histories of attention deficit hyperactivity disorder, mental health challenges, headaches/migraines, and concussion significantly lowered HRQoL. The number of diagnosed concussions and PCSI-C scores were significantly negatively correlated with HRQoL. Conclusions: The normative ranges and model can indicate HRQoL levels to inform clinicians how children may respond to concussion and streamline care beyond traditional assessment models.	[Paniccia, M.; Ippolito, C.; Reed, N.] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [McFarland, S.; Murphy, J.] Holland Bloorview Kids Rehabil Hosp, Early Concuss Care Program, Toronto, ON, Canada; [Reed, N.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON, Canada; [Reed, N.] Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada		Paniccia, M (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, East York, ON M4G 1R8, Canada.	melissa.paniccia@mail.utoronto.ca			Holland Bloorview Kids Rehabilitation HospitalUniversity of Toronto	This work was funded by the Holland Bloorview Kids Rehabilitation Hospital Acquired Brain Injury Fund, which Dr Nick Reed held during his tenure as the Acquired Brain Injury Chair within the Bloorview Research Institute in Toronto, Ontario, Canada.	[Anonymous], 2015, DOWSH S CHILDH STRES; Bastiaansen D, 2004, J AM ACAD CHILD PSY, V43, P221, DOI 10.1097/00004583-200402000-00019; Bevans KB, 2013, J PEDIATR PSYCHOL, V38, P173, DOI 10.1093/jpepsy/jss107; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Connelly M, 2006, J PEDIATR PSYCHOL, V31, P698, DOI 10.1093/jpepsy/jsj063; Connolly FR, 2014, J ADV NURS, V70, P714, DOI 10.1111/jan.12237; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; COSTELLO EJ, 1988, PEDIATRICS, V82, P415; Dahan-Oliel N, 2012, QUAL LIFE RES, V21, P427, DOI 10.1007/s11136-011-0063-9; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dey M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-73; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Ginieri-Coccossis M, 2013, CHILD CARE HLTH DEV, V39, P581, DOI 10.1111/j.1365-2214.2012.01369.x; GRONWALL D, 1975, LANCET, V2, P995; Haraldstad K, 2011, J CLIN NURS, V20, P3048, DOI 10.1111/j.1365-2702.2010.03693.x; Hubert-Dibon G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166541; Isokaanta S, 2019, PEDIATR ANESTH, V29, P218, DOI 10.1111/pan.13573; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Klassen AF, 2004, PEDIATRICS, V114, pE541, DOI 10.1542/peds.2004-0844; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lloyd K, 2013, J HAPPINESS STUD, V14, P67, DOI 10.1007/s10902-011-9316-0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lyness D, 2015, KIDSHEALTH; Marques A, 2017, J EXERC SCI FIT, V15, P8, DOI 10.1016/j.jesf.2017.03.001; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Michel G, 2009, QUAL LIFE RES, V18, P1147, DOI 10.1007/s11136-009-9538-3; Nezu S, 2016, ENVIRON HEALTH PREV, V21, P154, DOI 10.1007/s12199-016-0510-x; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ottosson C, 2007, QUAL LIFE RES, V16, P217, DOI 10.1007/s11136-006-9118-8; Paniccia M, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.027672; Paniccia MJ, 2017, CAN J OCCUP THER, V84, P111, DOI 10.1177/0008417416688302; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Ravens-Sieberer U, 2008, CLIN PSYCHOL PSYCHOT, V15, P154, DOI 10.1002/cpp.574; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rose Sean C, 2016, Concussion, V1, pCNC4, DOI 10.2217/cnc.15.4; Russell K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215900; Russell K, 2019, J NEUROSURG-PEDIATR, V23, P455, DOI 10.3171/2018.8.PEDS18356; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Tabassam W, 2002, LEARN DISABILITY Q, V25, P141, DOI 10.2307/1511280; Taylor O, 2015, BRAIN INJURY, V29, P709, DOI 10.3109/02699052.2015.1004739; The KIDSCREEN Group Europe, 2006, KIDSCREEN QUESTIONNA; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43; Varni JW, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-26; Watson SMR, 2002, MENT RETARD, V40, P304, DOI 10.1352/0047-6765(2002)040<0304:CTQOLO>2.0.CO;2; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Wise AE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01412; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	59	1	1	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	NOV 16	2020	23	8					534	541		10.1080/17518423.2020.1736683		MAR 2020	8	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	OU3HX	WOS:000519393300001	32156189				2022-02-06	
J	Wang, LL; Zhang, YS; Xing, EY; Peng, Y; Yu, DD				Wang, Linlin; Zhang, Yongsheng; Xing, Enyuan; Peng, Yuan; Yu, Dongdong			Distribution of Trace Elements, Sr-C Isotopes, and Sedimentary Characteristics as Paleoenvironmental Indicator of the Late Permian Linxi Formation in the Linxi Area, Eastern Inner Mongolia	JOURNAL OF CHEMISTRY			English	Article							RARE-EARTH-ELEMENTS; STRONTIUM ISOTOPES; HYDROTHERMAL FLUIDS; OXYGEN ISOTOPES; SEAWATER; CARBON; GEOCHEMISTRY; EVOLUTION; RECORD; SR-87/SR-86	The Late Permian on the periphery of the Songliao Basin, eastern Inner Mongolia, is an important hydrocarbon source rock system. Its sedimentary environment plays an important role in the evaluation of hydrocarbon prospects in the area. Unfortunately, until now, the interpretation of the sedimentary environment of this area has been controversial. We investigated the Late Permian sedimentary environment by studying the sedimentary characteristics and geochemistry. Based on these investigations, we conclude that the Linxi Formation is mainly composed of clastic sediments, interbedded with limestone lenses, with bioherm limestone at the top of the formation. Inner-layer marine fossils (calcium algae, bryozoans, and sponges) and freshwater and blackish water microfossils (bivalves) are all present, indicative of a typical shallow water sedimentary environment with an open and concussion background. In terms of geochemistry, the formation is relatively light rare Earth enriched, with significant positive Eu anomaly, slight positive La and Y anomaly, weak positive Gd anomaly, and lack of Ce anomaly. The average B/Ga ratio of the mudstone is greater than 3.3, and the average Sr/Ba ratio of the limestone is greater than 1.0. The range of the Sr-87/Sr-86 ratio is from 0.707285 to 0.707953. The range of delta C-13 values is from -4.0 parts per thousand to 2.4 parts per thousand. The sediment assemblages, rare Earth elements, trace elements, and Sr-87/Sr-86 and C isotopes of the formation indicate that the Linxi Formation formed in a marine sedimentary environment and occasional marine-terrestrial transitional facies. The formation can be further divided into littoral facies, neritic facies, bathyal facies, and delta front.	[Wang, Linlin] SINOPEC, Petr Explorat & Prod Res Inst, Beijing 100083, Peoples R China; [Zhang, Yongsheng; Xing, Enyuan; Peng, Yuan; Yu, Dongdong] CAGS, Inst Mineral Resources, Beijing 100037, Peoples R China		Wang, LL (corresponding author), SINOPEC, Petr Explorat & Prod Res Inst, Beijing 100083, Peoples R China.	wanglinlin.syky@sinopec.com; zys0601@126.com; xingenyuan@cags.ac.cn; cugb_pengyuan@126.com; kobeyudong@126.com		Wang, Linlin/0000-0003-2096-095X	National Key R & D Program of China [2017YFC0603103]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [41572098]	This research was partially supported by the National Key R & D Program of China under grant 2017YFC0603103 and the National Natural Science Foundation of China (no. 41572098).	Adachi N, 2014, PALAEOGEOGR PALAEOCL, V407, P45, DOI 10.1016/j.palaeo.2014.04.013; Banerjee B, 2017, PALAEOGEOGR PALAEOCL, V466, P166, DOI 10.1016/j.palaeo.2016.11.021; Bau M, 1999, CHEM GEOL, V155, P77, DOI 10.1016/S0009-2541(98)00142-9; Bolhar R, 2004, EARTH PLANET SC LETT, V222, P43, DOI 10.1016/j.epsl.2004.02.016; Bolhar R, 2007, PRECAMBRIAN RES, V155, P229, DOI 10.1016/j.precamres.2007.02.002; CHEN AJ, 1994, J STRATIGR, V18, P299; Chen HD, 2011, ACTA PETROL SIN, V27, P2213; Crowley BE, 2017, BIOL REV, V92, P43, DOI 10.1111/brv.12217; DU GC, 2017, SHIJIE DIZHI, V36, P135, DOI DOI 10.3969/j.issn.1004-5589.2017.01.011; Fang DQ, 2004, HIGH ENERG PHYS NUC, V28, P93; Frimmel HE, 2009, CHEM GEOL, V258, P338, DOI 10.1016/j.chemgeo.2008.10.033; GERMAN CR, 1991, GEOCHIM COSMOCHIM AC, V55, P3553, DOI 10.1016/0016-7037(91)90055-A; Harris M, 2015, EARTH PLANET SC LETT, V416, P56, DOI 10.1016/j.epsl.2015.01.042; He ZJ, 1997, INNER MONGOLIA REGIO, V16, P403; Huang S.J., 2001, ACTA SEDIMENTOL SIN, V19, P481; Jones CE, 2001, AM J SCI, V301, P112, DOI 10.2475/ajs.301.2.112; KAUFMAN AJ, 1993, EARTH PLANET SC LETT, V120, P409, DOI 10.1016/0012-821X(93)90254-7; Korte C, 2003, GEOCHIM COSMOCHIM AC, V67, P47, DOI 10.1016/S0016-7037(02)01035-9; Korte C, 2004, INT J EARTH SCI, V93, P565, DOI 10.1007/s00531-004-0406-7; Korte C, 2006, PALAEOGEOGR PALAEOCL, V240, P89, DOI 10.1016/j.palaeo.2006.03.047; Li XH, 2013, PALAEOGEOGR PALAEOCL, V385, P171, DOI 10.1016/j.palaeo.2013.03.011; LI YC, 1998, J STRATIGR, V22, P36; [梁涛 Liang Tao], 2005, [中国稀土学报, Journal of the Chinese Rare Earth Society], V23, P68; [马志鑫 Ma Zhixin], 2015, [地质科技情报, Geological Science and Techology Information], V34, P71; MARTIN EE, 1995, CHEM GEOL, V125, P73, DOI 10.1016/0009-2541(95)00081-V; MCARTHUR JM, 1994, TERRA NOVA, V6, P331, DOI 10.1111/j.1365-3121.1994.tb00507.x; Nozaki Y, 2000, GEOCHIM COSMOCHIM AC, V64, P3983, DOI 10.1016/S0016-7037(00)00473-7; Ojiambo SB, 2003, APPL GEOCHEM, V18, P1789, DOI 10.1016/S0883-2927(03)00104-5; POTTER PE, 1963, GEOCHIM COSMOCHIM AC, V27, P669, DOI 10.1016/0016-7037(63)90019-X; Rao N. V. N. D., 1973, MAR GEOL, V15, P43, DOI [10.1016/0025-3227(73)90061-3, DOI 10.1016/0025-3227(73)90061-3]; Reghellin D, 2015, PALEOCEANOGRAPHY, V30, P1261, DOI 10.1002/2015PA002825; Ryu J., 2016, GEOCHIMICA COSMOCHIM, V75, P6004; Shields GA, 2004, CHEM GEOL, V204, P103, DOI 10.1016/j.chemgeo.2003.09.010; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; TIAN JC, 1995, ACTA SEDIMENTOL SIN, V13, P125; [田树刚 Tian Shugang], 2016, [地质学报, Acta Geologica Sinica], V90, P688; [田树刚 Tian Shugang], 2012, [地质通报, Geological Bulletin of China], V31, P1554; Van Kranendonk MJ, 2003, GEOBIOLOGY, V1, P91, DOI 10.1046/j.1472-4669.2003.00014.x; Vieira MM, 2017, J S AM EARTH SCI, V79, P401, DOI 10.1016/j.jsames.2017.09.002; Webb GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1557, DOI 10.1016/S0016-7037(99)00400-7; Wei W., 2019, GEOCHIMICA COSMOCHIM; Yan Q., 1979, ACTA GEOL SINICA, V1, P74; Yu H Z, 2001, SEDIMENT GEOL, V21, P70; [翟大兴 Zhai Daxing], 2015, [地球学报, Acta Geoscientia Sinica], V36, P333; Zhang G. W, J CHINA COAL SOC, V42, P2081; [张国涛 Zhang Guotao], 2016, [中国地质, Geology of China], V43, P1291; Zhang J, 1996, GEOCHIM COSMOCHIM AC, V60, P4631, DOI 10.1016/S0016-7037(96)00276-1; Zhang JL, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5931-8; Zhang YS, 2014, CHINESE SCI BULL, V59, P62, DOI 10.1007/s11434-013-0036-1; [朱如凯 Zhu Rukai], 2007, [古地理学报, Journal of Palaeogeography], V9, P133; [朱兆洲 Zhu Zhaozhou], 2006, [地球化学, Geochimica], V35, P639	51	1	1	2	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-9063	2090-9071		J CHEM-NY	J. Chem.	MAR 7	2020	2020								7027631	10.1155/2020/7027631			17	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	KY2LQ	WOS:000522404400001		gold			2022-02-06	
J	Cederberg, D; Hansson, HA; Visse, E; Siesjo, P				Cederberg, David; Hansson, Hans-Arne; Visse, Edward; Siesjo, Peter			Antisecretory Factor May Reduce ICP in Severe TBI-A Case Series	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; intracranial hypertension; therapeutic agents per oral treatment; ICP reduction; anti-inflammatory therapy; novel treatments against traumatic brain edema	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; MANAGEMENT; THERAPY	Traumatic brain injury (TBI) constitutes a global epidemic. Overall outcome is poor, with mortality ranging from 10 to 70% and significant long-term morbidity. Several experimental reports have claimed effect on traumatic edema, but all clinical trials have failed. Antisecretory factor, an endogenous protein, is commercially available as Salovum (R), which is classified as a medical food by the European Union and has been proven effective in experimental trauma models. It has, however, previously not been tested in humans with severe TBI. We hereby report a case series of five adult patients with severe TBI, treated with Salovum. The objective of the intervention was to evaluate safety and, if possible, its effect on intracranial pressure and outcome. Patients received 1 g Salovum per kilo of body weight divided into six doses per 24 h. Each dose was administered through the nasogastric tube. Patients were scheduled for 5 days of treatment with Salovum. Intracranial pressure was controlled in all patients. In three of five patients, intracranial pressure could be controlled with Salovum and deep sedation (no barbiturates), except during periods of gastroparesis. Five of five patients had a favorable short-term outcome, and four of five patients had a favorable long-term outcome. No toxicity was observed. We conclude that at least three of the five treated patients experienced an effect of Salovum with signs of reduction of intracranial pressure and signs of clinical benefit. In order to validate the potential of antisecretory factor in TBI, a prospective, randomized, double-blind, placebo-controlled trial with Salovum has been initiated. Primary outcome for the trial is 30-day mortality; secondary outcomes are treatment intensity level, intracranial pressure, and number of days at the neurointensive care unit.	[Cederberg, David; Visse, Edward; Siesjo, Peter] Skane Univ Hosp, Dept Neurosurg, Lund, Sweden; [Hansson, Hans-Arne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden		Cederberg, D (corresponding author), Skane Univ Hosp, Dept Neurosurg, Lund, Sweden.	david.cederberg@me.com					Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Davidson TS, 2004, J LEUKOCYTE BIOL, V76, P835, DOI 10.1189/jlb.0204085; Hansson Hans-Arne, 2012, Acta Neurochir Suppl, V114, P377, DOI 10.1007/978-3-7091-0956-4_73; Ilkhanizadeh S, 2018, MOL CANCER RES, V16, P777, DOI 10.1158/1541-7786.MCR-17-0413; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jennische E, 2008, BRAIN RES, V1227, P189, DOI 10.1016/j.brainres.2008.05.083; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Lange S, 2001, INT REV CYTOL, V210, P39; Lange S, 2017, J NEUROVIROL, V23, P313, DOI 10.1007/s13365-016-0500-1; LONNROTH I, 1986, BIOCHIM BIOPHYS ACTA, V883, P138, DOI 10.1016/0304-4165(86)90144-3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Ulgheri C, 2010, NUTR RES REV, V23, P300, DOI 10.1017/S0954422410000193; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Zaman S, 2014, ACTA PAEDIATR, V103, P659, DOI 10.1111/apa.12581; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	19	1	1	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 6	2020	11								95	10.3389/fneur.2020.00095			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB3UR	WOS:000524562900001	32210902	gold, Green Published			2022-02-06	
J	Huijben, JA; Wiegers, EJA; Ercole, A; de Keizer, NF; Maas, AIR; Steyerberg, EW; Citerio, G; Wilson, L; Polinder, S; Nieboer, D; Menon, D; Lingsma, HF; van der Jagt, M				Huijben, Jilske A.; Wiegers, Eveline J. A.; Ercole, Ari; de Keizer, Nicolette F.; Maas, Andrew I. R.; Steyerberg, Ewout W.; Citerio, Giuseppe; Wilson, Lindsay; Polinder, Suzanne; Nieboer, Daan; Menon, David; Lingsma, Hester F.; van der Jagt, Mathieu			Quality indicators for patients with traumatic brain injury in European intensive care units: a CENTER-TBI study	CRITICAL CARE			English	Article						Quality indicators; Benchmarking; Traumatic brain injuries; Intensive care units; Quality of health care	HEAD; BENCHMARKING; MANAGEMENT; PROPOSAL; OUTCOMES	Background The aim of this study is to validate a previously published consensus-based quality indicator set for the management of patients with traumatic brain injury (TBI) at intensive care units (ICUs) in Europe and to study its potential for quality measurement and improvement. Methods Our analysis was based on 2006 adult patients admitted to 54 ICUs between 2014 and 2018, enrolled in the CENTER-TBI study. Indicator scores were calculated as percentage adherence for structure and process indicators and as event rates or median scores for outcome indicators. Feasibility was quantified by the completeness of the variables. Discriminability was determined by the between-centre variation, estimated with a random effect regression model adjusted for case-mix severity and quantified by the median odds ratio (MOR). Statistical uncertainty of outcome indicators was determined by the median number of events per centre, using a cut-off of 10. Results A total of 26/42 indicators could be calculated from the CENTER-TBI database. Most quality indicators proved feasible to obtain with more than 70% completeness. Sub-optimal adherence was found for most quality indicators, ranging from 26 to 93% and 20 to 99% for structure and process indicators. Significant (p < 0.001) between-centre variation was found in seven process and five outcome indicators with MORs ranging from 1.51 to 4.14. Statistical uncertainty of outcome indicators was generally high; five out of seven had less than 10 events per centre. Conclusions Overall, nine structures, five processes, but none of the outcome indicators showed potential for quality improvement purposes for TBI patients in the ICU. Future research should focus on implementation efforts and continuous reevaluation of quality indicators.	[Huijben, Jilske A.; Wiegers, Eveline J. A.; Steyerberg, Ewout W.; Polinder, Suzanne; Nieboer, Daan; Lingsma, Hester F.] Erasmus MC, Univ Med Ctr Rotterdam, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands; [Ercole, Ari; Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [de Keizer, Nicolette F.] Univ Amsterdam, Acad Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Med Informat, Amsterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp, Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Neurointens Care, Monza, Italy; [Wilson, Lindsay] Univ Stirling, Div Psychol, Stirling, Scotland; [van der Jagt, Mathieu] Erasmus MC, Univ Med Ctr Rotterdam, Dept Intens Care Adults, Rotterdam, Netherlands		Huijben, JA (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Ctr Med Decis Sci, Dept Publ Hlth, Rotterdam, Netherlands.	j.a.huijben@erasmusmc.nl	Cooper, D. James/G-7961-2013; Castano-Leon, Ana M/ABF-6322-2020; Wilson, Lindsay/A-3659-2009; Volovici, Victor/AAZ-8901-2020; Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Ledoux, Didier/ABA-8401-2021; Badenes, Rafael/K-6628-2019; Lagares, Alfonso/B-2969-2011; Laureys, Steven/AAN-2097-2021; Gomez, Pedro/E-2411-2014; van der Jagt, Mathieu/G-1905-2017; Raj, Rahul/K-7693-2012; Bartels, R.H.M.A./L-4184-2015	Cooper, D. James/0000-0002-5872-9051; Castano-Leon, Ana M/0000-0002-7918-5049; Wilson, Lindsay/0000-0003-4113-2328; Volovici, Victor/0000-0002-5798-5360; Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Ledoux, Didier/0000-0002-9314-6564; Badenes, Rafael/0000-0001-7017-0150; Lagares, Alfonso/0000-0003-3996-0554; Laureys, Steven/0000-0002-3096-3807; Zeiler, Frederick/0000-0003-1737-0510; Kolias, Angelos/0000-0003-3992-0587; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Gomez, Pedro/0000-0002-4185-5238; Kondziella, Daniel/0000-0001-5562-9808; Coles, Jonathan/0000-0003-4013-679X; Rossi, Sandra/0000-0002-9963-8121; Van Essen, Thomas/0000-0003-4657-5283; Radoi, Andreea/0000-0002-0677-3544; Posti, Jussi/0000-0002-5925-5193; Dark, Paul/0000-0003-3309-0164; Sakowitz, Oliver/0000-0003-3248-6335; Blaabjerg, Morten/0000-0001-6007-1861; Newcombe, Virginia/0000-0001-6044-9035; Sanchez-Porras, Renan/0000-0002-9084-8114; Della Corte, Francesco/0000-0003-1736-2318; van der Jagt, Mathieu/0000-0003-2566-8325; Raj, Rahul/0000-0003-4243-9591; Bartels, R.H.M.A./0000-0002-8638-4660	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]	This study is funded by the European Commission 7th Framework program (602150). The funder had no role in the design of the study and collection, analysis, interpretation of data, and in writing the manuscript.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Cai L, 2015, CODATA, V14, P1, DOI [DOI 10.5334/DSJ-2015-002, 10.5334/dsj-2015-002]; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; de Carvalho Alexandre Guilherme Ribeiro, 2017, BMC Res Notes, V10, P222, DOI 10.1186/s13104-017-2563-3; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Fischer C, 2015, QUALITY INDCATORS HO; Fox KAA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004425; Haider AH, 2014, WORLD J SURG, V38, P1882, DOI 10.1007/s00268-014-2629-5; Lingsma HF, 2010, QJM-INT J MED, V103, P99, DOI 10.1093/qjmed/hcp169; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Najjar-Pellet J, 2008, INTENS CARE MED, V34, P278, DOI 10.1007/s00134-007-0883-9; O'Reilly GM, 2012, INJURY, V43, P1148, DOI 10.1016/j.injury.2012.03.003; Padman R, 2007, PEDIATRICS, V119, pE531, DOI 10.1542/peds.2006-1414; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Salluh JIF, 2017, INTENS CARE MED, V43, P1703, DOI 10.1007/s00134-017-4760-x; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P651, DOI 10.1136/bmjqs.2009.035881; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P869, DOI 10.1136/bmjqs.2010.048058; van Overveld LFJ, 2018, J NATL COMPR CANC NE, V16, P1491, DOI 10.6004/jnccn.2018.7061; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002	31	1	2	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	MAR 4	2020	24	1							78	10.1186/s13054-020-2791-0			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW3MD	WOS:000521070200006	32131882	Green Published, gold			2022-02-06	
J	Chand, MR; Kanwar, S; Calvo, C; Peck, E				Chand, Manisha R.; Kanwar, Sumit; Calvo, Cecilia; Peck, Evan			Influence of Sex and Previous Concussion History on Postconcussive Recovery in Young Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						adolescent; neuropsychology; return-to-play; sport; traumatic brain injury; youth	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; NEUROPSYCHOLOGICAL FUNCTION; BASE-LINE; SYMPTOMS; INJURY; AGE; EPIDEMIOLOGY; STATEMENT	Objective: To determine whether concussed female athletes with a previous history of concussion have longer postconcussive recovery than that of male counterparts. Design: Retrospective cohort study. Setting: Outpatient sports medicine clinic in an academic practice. Participants: Male and female youth, high school, and collegiate athletes (n = 431; ages = 10-21 years) who sustained a sport-related concussion (SRC). Interventions: The clinical courses of young athletes treated for concussion by 1 provider at an outpatient sports medicine clinic were retrospectively reviewed. Main Outcome Measures: Recovery time was compared after an SRC with relationship to sex and previous concussion history. Results: When comparing male and female athletes with a previous history of concussion, there were no differences found (P= 0.820) in SRC recovery time. Regardless of previous concussion history, males recovered faster from an SRC compared with their female counterparts (P= 0.0002). Without regard to sex, those with no previous history of concussion recovered faster than those with a previous concussion history, although the difference was not statistically significant (P= 0.668). Athletes with a previous history of concussion were more likely to require neuropsychology referral than those with no previous concussion history (P= 0.021), and females, without regard to concussion history, were more likely to require neuropsychology referral than males (P= 0.001). Conclusions: A previous concussion history does not appear to significantly influence postconcussive recovery time in young athletes, although it does increase the probability of neuropsychological referral. Without regard to a previous concussion history, young female athletes recover slower than males from concussion and are also more likely to require neuropsychological referral.	[Chand, Manisha R.; Kanwar, Sumit; Calvo, Cecilia; Peck, Evan] Cleveland Clin Florida, Levitetz Dept Orthopaed Surg, Weston, FL USA; [Peck, Evan] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA		Peck, E (corresponding author), Cleveland Clin Florida, Tomsich Hlth & Med Ctr Palm Beach Cty, 525 Okeechobee Blvd Ste 1400, W Palm Beach, FL 33401 USA.	pecke@ccf.org					Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corbin-Berrigan LA, 2017, CLIN J SPORT MED, V27, P325, DOI 10.1097/JSM.0000000000000355; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Powell JW, 2001, J ATHL TRAINING, V36, P307; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	34	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S36	S41		10.1097/JSM.0000000000000554			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700004	32132475				2022-02-06	
J	Chung, HJ; Chung, WH; Do, SH; Lee, JH; Kim, HY				Chung, Hyo-Jin; Chung, Wook-Hun; Do, Sun-Hee; Lee, Jae-Hoon; Kim, Hwi-yool			Up-regulation of MicroRNAs-21 and -223 in a Sprague-Dawley Rat Model of Traumatic Spinal Cord Injury	BRAIN SCIENCES			English	Article						spinal cord; spinal cord injury; microRNA; pathophysiology	COMPRESSION INJURY; BRAIN-INJURY; PREVALENCE; EXPRESSION; MANAGEMENT; RESPONSES; MIRNAS; PCR	In this experimental animal study, we examined alterations in the degree of transcription of two microRNAs (miRs)-miR-21 and -223-in a Sprague-Dawley (SD) rat model of traumatic spinal cord injury (TSCI). Depending on the volume of the balloon catheter (V), a total of 75 male SD rats were divided into the three experimental groups: the sham group (n = 25; V = 0 mu L), the mild group (n = 25; V = 20 mu L), and the severe group (n = 25; V = 50 mu L). Successful induction of TSCI was confirmed on both locomotor rating scale at 4 h and 1, 3 and 7 days post-lesion and histopathologic examinations. Then, RNA isolation and quantitative polymerase chain reaction (PCR) were performed. No differences in the level of miR-21 expression were found at the first time point studied (4 h post-lesion) between the three experimental groups, whereas such differences were significant at all the other time points (p < 0.05). Moreover, there were significant alterations in the level of miR-223 expression at all time points studied through all the experimental groups (p < 0.05). Furthermore, locomotor rating scale scores had a linear relationship with the level of miR-21 expression (R-2 = 0.4363, Y = 1.661X + 3.096) and that of miR-223 one (R-2 = 0.9104, Y = 0.8385X + 2.328). Taken together, we conclude that up-regulation of miR-21 and -223 might be closely associated with progression and the early course of TSCI, respectively.	[Chung, Hyo-Jin; Chung, Wook-Hun; Kim, Hwi-yool] Konkuk Univ, Coll Vet Med, Dept Vet Surg, Seoul 05029, South Korea; [Do, Sun-Hee] Konkuk Univ, Coll Vet Med, Vet Clin Pathol, Seoul 05029, South Korea; [Lee, Jae-Hoon] Gyeongsang Natl Univ, Coll Vet Med, Dept Vet Surg, Jinju 52828, South Korea		Kim, HY (corresponding author), Konkuk Univ, Coll Vet Med, Dept Vet Surg, Seoul 05029, South Korea.	syouth@hanmail.net; chungwookhun@gmail.com; shdo@konkuk.ac.kr; jh1000@gnu.ac.kr; hykim@konkuk.ac.kr		Lee, Jae-Hoon/0000-0002-8340-3694; Do, Sun Hee/0000-0003-2372-5269			[Anonymous], 2014, J Spinal Cord Med, V37, P117, DOI 10.1179/1079026813Z.000000000249; Baril P, 2015, INT J MOL SCI, V16, P4947, DOI 10.3390/ijms16034947; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; Branco Fernando, 2007, Phys Med Rehabil Clin N Am, V18, P651, DOI 10.1016/j.pmr.2007.07.010; Budh CN, 2007, CLIN REHABIL, V21, P89, DOI 10.1177/0269215506070313; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Chambers C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-87; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Chung WH, 2013, J VET SCI, V14, P329, DOI 10.4142/jvs.2013.14.3.329; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Dong J, 2014, NEUROL SCI, V35, P1663, DOI 10.1007/s10072-014-1940-0; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Francis H, 2014, J BIOL CHEM, V289, P27526, DOI 10.1074/jbc.M114.602383; Garcia-Altes A, 2012, NEUROEPIDEMIOLOGY, V39, P103, DOI 10.1159/000338297; Gemmati D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010296; Genovese T, 2009, J NEUROCHEM, V108, P1360, DOI 10.1111/j.1471-4159.2009.05899.x; Gutierrez A, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10030963; Hachem LD, 2017, J SPINAL CORD MED, V40, P665, DOI 10.1080/10790268.2017.1329076; Han ZA, 2017, AM J PHYS MED REHAB, V96, pS83, DOI 10.1097/PHM.0000000000000593; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Izumi B, 2011, NEUROSCI LETT, V492, P114, DOI 10.1016/j.neulet.2011.01.068; Jurkovicova D, 2017, ONCOTARGET, V8, P77369, DOI 10.18632/oncotarget.20484; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kreth S, 2018, ANESTH ANALG, V126, P670, DOI 10.1213/ANE.0000000000002444; Laningschror P, 2013, BBA-MOL CELL RES, V1833, P1894, DOI 10.1016/j.bbamcr.2013.03.025; Lee JH, 2008, J NEUROSCI METH, V167, P310, DOI 10.1016/j.jneumeth.2007.07.020; Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025; Liao LM, 2015, INT J MOL SCI, V16, P18580, DOI 10.3390/ijms160818580; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lozano C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00375; Mari-Alexandre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010093; Martirosyan NL, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00056; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Navarro IC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003828; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Otzel DM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061701; Pal MK, 2015, CANCER BIOL MED, V12, P328, DOI 10.7497/j.issn.2095-3941.2015.0024; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; da Silva DCP, 2018, ARQ BRAS CARDIOL, V111, P738, DOI 10.5935/abc.20180215; Pereira IM, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020065; Podbielska M, 2013, BRAIN SCI, V3, P1282, DOI 10.3390/brainsci3031282; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Reis C, 2017, STEM CELLS INT, V2017, P2017, DOI DOI 10.1155/2017/6392592; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Shaik MM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040174; Shi ZJ, 2017, INT J NEUROSCI, V127, P1104, DOI 10.1080/00207454.2017.1323208; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Taneja A, 2017, EUR J CLIN PHARMACOL, V73, P1219, DOI 10.1007/s00228-017-2301-8; Urbanek MO, 2015, INT J MOL SCI, V16, P13259, DOI 10.3390/ijms160613259; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Wang HL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0901-8; Wang JQ, 2015, INT J MOL SCI, V16, P16848, DOI 10.3390/ijms160816848; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu L, 2015, MOL MED REP, V11, P4567, DOI 10.3892/mmr.2015.3298; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yunta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034534; Zhou S, 2016, NEUROSCI BULL, V32, P253, DOI 10.1007/s12264-016-0028-7; Zhou Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42680	76	1	2	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAR	2020	10	3							141	10.3390/brainsci10030141			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB0FS	WOS:000524314600006	32121653	Green Published, gold			2022-02-06	
J	de Haan, EHF; Seijdel, N; Kentridge, RW; Heywood, CA				de Haan, Edward H. F.; Seijdel, Noor; Kentridge, Robert W.; Heywood, Charles A.			Plasticity versus chronicity: Stable performance on category fluency 40 years post-onset	JOURNAL OF NEUROPSYCHOLOGY			English	Article						category specific impairment; encephalitis; long term recovery; semantic memory; structural brain damage	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; COGNITIVE-ABILITIES; ENCEPHALITIS; AMNESIA; RECOVERY; STROKE	What is the long-term trajectory of semantic memory deficits in patients who have suffered structural brain damage? Memory is, per definition, a changing faculty. The traditional view is that after an initial recovery period, the mature human brain has little capacity to repair or reorganize. More recently, it has been suggested that the central nervous system may be more plastic with the ability to change in neural structure, connectivity, and function. The latter observations are, however, largely based on normal learning in healthy subjects. Here, we report a patient who suffered bilateral ventro-medial damage after presumed herpes encephalitis in 1971. He was seen regularly in the eighties, and we recently had the opportunity to re-assess his semantic memory deficits. On semantic category fluency, he showed a very clear category-specific deficit performing better that control data on non-living categories and significantly worse on living items. Recent testing showed that his impairments have remained unchanged for more than 40 years. We suggest cautiousness when extrapolating the concept of brain plasticity, as observed during normal learning, to plasticity in the context of structural brain damage.	[de Haan, Edward H. F.; Seijdel, Noor] Univ Amsterdam, Dept Psychol, Room 0-16,G Bldg,Nieuwe Achtergracht 129-8, NL-1018 WT Amsterdam, Netherlands; [de Haan, Edward H. F.; Seijdel, Noor] Univ Amsterdam, Amsterdam Brain & Cognit ABC Ctr, Amsterdam, Netherlands; [Kentridge, Robert W.; Heywood, Charles A.] Univ Durham, Dept Psychol, Durham, England		de Haan, EHF (corresponding author), Univ Amsterdam, Dept Psychol, Room 0-16,G Bldg,Nieuwe Achtergracht 129-8, NL-1018 WT Amsterdam, Netherlands.	e.h.f.dehaan@uva.nl		Seijdel, Noor/0000-0002-8785-8135			Alexander I, 2010, CONSCIOUS COGN, V19, P520, DOI 10.1016/j.concog.2010.01.008; Brown W. P., 1978, BELFAST CATEGORY NOR; Chadwick AC, 2019, NEUROPSYCHOLOGIA, V128, P209, DOI 10.1016/j.neuropsychologia.2017.11.009; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Crichton SL, 2016, J NEUROL NEUROSUR PS, V87, P1091, DOI 10.1136/jnnp-2016-313361; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Douiri A, 2017, INT J STROKE, V12, P539, DOI 10.1177/1747493017706241; Duffau H, 2014, CORTEX, V58, P325, DOI 10.1016/j.cortex.2013.08.005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hokkanen L, 1997, J NEUROL NEUROSUR PS, V63, P222, DOI 10.1136/jnnp.63.2.222; Hoofien D, 2001, BRAIN INJURY, V15, P189; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334; KENNARD C, 1981, BRAIN, V104, P129, DOI 10.1093/brain/104.1.129; Laiacona M, 1997, CORTEX, V33, P441, DOI 10.1016/S0010-9452(08)70229-6; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mansvelder HD, 2019, CURR OPIN NEUROBIOL, V54, P186, DOI 10.1016/j.conb.2018.06.013; McCarthy RA, 2005, NEUROPSYCHOLOGIA, V43, P356, DOI 10.1016/j.neuropsychologia.2004.06.024; NEWCOMBE F, 1989, NEUROPSYCHOLOGIA, V27, P179, DOI 10.1016/0028-3932(89)90170-X; Newcombe F., 1975, CALLOSAL DISCONNECT, P317; Nys GMS, 2005, J INT NEUROPSYCH SOC, V11, P795, DOI 10.1017/S1355617705050952; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; Pavan A, 2011, EXP BRAIN RES, V214, P261, DOI 10.1007/s00221-011-2828-3; Ratcliff G., 1982, NORMALITY PATHOLOGY, P147; Stanhope N, 2000, NEUROCASE, V6, P99, DOI 10.1080/13554790008402764; Synhaeve NE, 2015, NEUROLOGY, V85, P776, DOI 10.1212/WNL.0000000000001882; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Toda T, 2018, CELL TISSUE RES, V373, P693, DOI 10.1007/s00441-017-2735-4; Ungerleider L. G., 2010, NEUROBIOLOGY LEARNIN, V78, P553; Verriest, 1980, COLOUR VISION DEFICI, P130; WILSON BA, 1995, J CLIN EXP NEUROPSYC, V17, P668, DOI 10.1080/01688639508405157; Wilson BA, 2008, NEUROPSYCHOL REHABIL, V18, P527, DOI 10.1080/09602010802141889; YOUNG AW, 1989, BRAIN COGNITION, V11, P186, DOI 10.1016/0278-2626(89)90017-1	32	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645	1748-6653		J NEUROPSYCHOL	J. Neuropsychol.	MAR	2020	14	1					20	27		10.1111/jnp.12180			8	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	KT2TC	WOS:000518867500002	30768853	Green Published, Green Accepted, hybrid			2022-02-06	
J	Delaplain, PT; Grigorian, A; Lekawa, M; Mallicote, M; Joe, V; Schubl, SD; Kuza, CM; Dolich, M; Nahmias, J				Delaplain, Patrick T.; Grigorian, Areg; Lekawa, Michael; Mallicote, Michael; Joe, Victor; Schubl, Sebastian D.; Kuza, Catherine M.; Dolich, Matthew; Nahmias, Jeffry			Intracranial pressure monitoring associated with increased mortality in pediatric brain injuries	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Pediatric trauma; Traumatic brain injury (TBI); Intracranial pressure (ICP) monitor; Intracranial hypertension	GLASGOW COMA SCALE; CHILDREN; TRAUMA; MULTICENTER; OUTCOMES; IMPACT	Background Utilization of ICP monitors for pediatric patients is low and varies between centers. We hypothesized that in more severely injured patients (GCS 3-4), there would be a decreased mortality associated with invasive monitoring devices. Methods The pediatric Trauma Quality Improvement Program (TQIP) was queried for patients aged <= 16 years meeting criteria for invasive monitors. Our primary outcome was mortality. Patients with ICP monitoring were compared to those without. A logistic regression was used to examine the risk of mortality. Results Of 3,808 patients, 685 (18.0%) underwent ICP monitoring. ICP monitors were associated with increased risk of mortality (OR 1.82, CI 1.36-2.44, p < 0.001). A secondary analysis including type of invasive ICP monitor and dividing GCS into 3 categories revealed both intraventricular drain (OR 1.89, CI 1.3-2.7, p = 0.001) and intraparenchymal pressure monitor (OR 1.86, CI 1.32-2.6, p < 0.001) to be independently associated with an increased likelihood of mortality regardless of GCS, while intraparenchymal oxygen monitoring was not (OR 0.47, CI 0.11-2.05, p = 0.316). The strongest effect was seen in those patients with a GCS of 5-6. Conclusion ICP monitors are an independent risk factor for mortality, particularly with intraventricular drains and intraparenchymal monitors in patients with a GCS 5-6.	[Delaplain, Patrick T.; Grigorian, Areg; Lekawa, Michael; Joe, Victor; Schubl, Sebastian D.; Dolich, Matthew; Nahmias, Jeffry] Univ Calif Irvine, Med Ctr, Dept Surg, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA; [Mallicote, Michael] Childrens Hosp Los Angeles, Dept Pediat Surg, 4650 Sunset Blvd,Mailstop 100, Los Angeles, CA 90027 USA; [Kuza, Catherine M.] Univ Southern Calif, Dept Anesthesiol, 1450 San Pablo St Suite 360, Los Angeles, CA 90033 USA		Delaplain, PT (corresponding author), Univ Calif Irvine, Med Ctr, Dept Surg, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	pdelapla@uci.edu	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X; Delaplain, Patrick/0000-0003-1799-6943			Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Aiolfi A, 2018, J NEUROSURG, V128, P828, DOI 10.3171/2016.11.JNS162198; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Arunkumar S, 2016, NEUROL INDIA, V64, P958, DOI 10.4103/0028-3886.190259; Balakrishnan B, 2018, PEDIATR NEUROSURG, V53, P379, DOI 10.1159/000494028; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Dixon RR, 2016, PEDIATR CRIT CARE ME, V17, P1064, DOI 10.1097/PCC.0000000000000937; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Guiza F, 2016, ACTA NEUROCHIR SUPPL, V122, P187, DOI 10.1007/978-3-319-22533-3_38; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Lo T, 2018, ACTA NEUROCHIR SUPPL, V126, P39, DOI 10.1007/978-3-319-65798-1_9; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Salim A, 2008, AM SURGEON, V74, P1088; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817	36	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	MAR	2020	36	3					391	398		10.1007/s00383-020-04618-y			8	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	KK4DU	WOS:000512695600015	31938835	Bronze, Green Published			2022-02-06	
J	DePadilla, L; Miller, GF; Jones, SE				DePadilla, Lara; Miller, Gabrielle F.; Jones, Sherry Everett			An Examination of 4 Questions Assessing Self-reported Concussions Among High School Students Participating in Team Sports	JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE			English	Article						athletes; concussion; high school	YOUTH SPORTS; INJURY	Objective: Current prevalence estimates of youth sports-related concussions are inconsistent because of variation in methodology and potentially unreported concussions. Methods: In 2013, Connecticut, Ohio, and Utah each added different questions that assessed self-reported concussions to the Youth Risk Behavior Survey. Two questions referenced recognition of a concussion by the student, 1 referenced identification by a doctor, and 1 referenced suspicion by a coach. Chi-square analyses were used to identify whether there was an association between demographic characteristics and the concussion questions among high school students who played on at least 1 sports team. Results: The percentage of students who reported concussions ranged from 17.6% to 20.1%. Conclusions: These estimates are higher than rates of concussions diagnosed in emergency departments or reported by athletic trainers but were similar across the 4 questions. The field would benefit from a better understanding of the impact of question wording and format on estimates of concussion prevalence.	[DePadilla, Lara] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,Mailstop F62, Atlanta, GA 30341 USA; [Miller, Gabrielle F.] Ctr Dis Control & Prevent, Div Anal Res & Practice Integrat, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Jones, Sherry Everett] Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA		DePadilla, L (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,Mailstop F62, Atlanta, GA 30341 USA.	lpo9@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Institute of Medicine & National Research Council, 2014, SPORTS RELATED CONCU; JOBE JB, 1993, APPL COGNITIVE PSYCH, V7, P567, DOI 10.1002/acp.2350070703; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022	15	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-4659	1550-5022		J PUBLIC HEALTH MAN	J. Public Health Manag. Pract.	MAR-APR	2020	26	2			SI		E23	E27		10.1097/PHH.0000000000000901			5	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KL0VH	WOS:000513150200003	31995550	Green Accepted			2022-02-06	
J	Franco-Jimenez, JA; Ceja-Espinosa, A; Alvarez-Vazquez, L; Vaca-Ruiz, MA				Franco-Jimenez, Jose A.; Ceja-Espinosa, Alejandro; Alvarez-Vazquez, Leonardo; Vaca-Ruiz, Miguel A.			Associated factors for Tracheostomy in adults with severe traumatic brain injury. Score proposal	CIRUGIA Y CIRUJANOS			English	Article						Traumatic brain injury; Tracheostomy; Mechanical ventilation; Prognostic factors; Glasgow coma scale	MECHANICAL VENTILATION; LATE TRACHEOTOMY; PNEUMONIA; IMPACT; ILL	Background: In patients with severe traumatic brain injury (TBI), there is a lack of consensus about the need and time to perform a tracheostomy. Nowadays, the decision is individualized to each case. It is considered that patients that will need a tracheostomy profit by performing it earlier. Patients and methods: An observational and prospective study was performed. One hundred and twenty patients in a period of 18 months between 2016 and 2018, older than 18 years, with severe TB! at the first 24 h of trauma were analyzed. Clinical, biochemical, and radiological findings at admission were measured; patients were followed up until discharge. The statistical analysis was made with Student's t-test, chi(2), and prevalence risk ratio. Results: Ten associated factors were grouped according to the prevalence risk ratio. The principal factors were CRASH score, IMPACT score, SAPS II score, APACHE II score, age, revised trauma score, Glasgow Coma Scale, subdural hematoma, uni or bilateral abnormal pupil reactivity, and collapse of basal cisterns. Conclusions: We conclude that there are multiple factors associated with the need for tracheostomy in adult patients with severe TBI and it is possible to predict according to our findings from admission which patients will profit by this procedure.	[Franco-Jimenez, Jose A.; Ceja-Espinosa, Alejandro; Alvarez-Vazquez, Leonardo; Vaca-Ruiz, Miguel A.] Inst Salud Estado Mexico, Ctr Med Lic Adolfo Lopez Mateos, Dept Neurocirugia, Toluca De Lerdo, Estado De Mexic, Mexico		Franco-Jimenez, JA (corresponding author), Avda Nicolas San Juan S-N, Toluca 50010, Estado De Mexic, Mexico.	franco-doc@hotmail.com					Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Durbin Charles G Jr, 2005, Respir Care, V50, P483; Gandia-Martinez F, 2010, NEUROCIRUGIA, V21, P211; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Groves DS, 2007, CURR OPIN CRIT CARE, V13, P90, DOI 10.1097/MCC.0b013e328011721e; Gurkin MA, 2002, AM SURGEON, V68, P324; LeBlanc J, 2010, J HEAD TRAUMA REHAB, V25, P362, DOI 10.1097/HTR.0b013e3181cd67ea; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Moller MG, 2005, AM J SURG, V189, P293, DOI 10.1016/j.amjsurg.2005.01.002; Richard I, 2005, ANN FR ANESTH, V24, P659, DOI 10.1016/j.annfar.2005.03.010; Scales DC, 2010, JAMA-J AM MED ASSOC, V303, P1537, DOI 10.1001/jama.2010.462; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	21	1	1	0	0	MEXICAN ACAD SURGERY	MEXICO D G	CENTRO MED NAC SIGLO XXI, EDIFICIO BLOQUE B, SOTANO, AVE CUAUHTEMOC NO 330, MEXICO D G, 06700, MEXICO	0009-7411			CIR CIR	Cir. Cir.	MAR-APR	2020	88	2					200	205		10.24875/CIRU.19001247			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PB5YN	WOS:000596396300012	32116326	gold			2022-02-06	
J	Fyffe, A; Bogg, T; Orr, R; Browne, GJ				Fyffe, Andrew; Bogg, Tina; Orr, Rhonda; Browne, Gary J.			Association of Simple Step Test With Readiness for Exercise in Youth After Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; mild traumatic brain injury; return to activity	VESTIBULAR REHABILITATION; PEDIATRIC CONCUSSION; CHILDREN; ADOLESCENTS; SYMPTOMS; SPORTS; RETURN	Objectives: We hypothesized that a submaximal step test would be associated with readiness to commence graded exercise in children and adolescents with concussion. Methods: Children and adolescents aged 8 to 18 years performed standard concussion clinical assessment for vestibular/ocular and balance impairment, and exercise examination utilizing the 3-minute Kasch Pulse Recovery test (KPR) and a symptom-limited graded exercise test (GXT). Outcome measures included activity readiness and symptom exacerbation. Results: Forty-five participants (mean age 13.2 +/- 2.1 years, 76% male) had a confirmed concussion (73% sports-related). Some participants required follow-up testing giving 75 clinical presentations. Sensitivity and specificity of the KPR were 100% and 95.7%, respectively. Area under the receiver operating characteristics curve was 0.979. Activity readiness to GXT and KPR was strongly associated (chi(2) = 21.672, P < .001), while symptom exacerbation showed a significant correlation between testing methods (r = 0.796, P < .001). Better exercise performance on GXT and KPR was significantly correlated with normal Vestibular/Ocular Motor Screening (r(s) = -0.380, P = .010, and r(s) = -0.281, P = .017, respectively) and Modified Balance Error Scoring System (r(s) = -0.452, P < .001, and r(s) = -0.301, P = .010, respectively). Conclusion: The KPR is a simple and practical tool to determine whether it is appropriate for a child or adolescent with concussion to commence graded exercise.	[Fyffe, Andrew; Bogg, Tina; Browne, Gary J.] Childrens Hosp Westmead, Royal Alexandra Hosp Children, Sydney Childrens Hosp Network, Childrens Hosp Inst Sports Med, Sydney, NSW, Australia; [Orr, Rhonda] Univ Sydney, Fac Hlth Sci, Discipline Exercise & Sport Sci, Sydney, NSW, Australia; [Orr, Rhonda] Univ Sydney, Sydney Med Sch, Clin Sch, Childrens Hosp Westmead, Sydney, NSW, Australia; [Browne, Gary J.] Univ Sydney, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia		Fyffe, A (corresponding author), Childrens Hosp Westmead, Royal Alexandra Hosp Children, Sydney Childrens Hosp Network, Childrens Hosp Inst Sports Med, Sydney, NSW, Australia.	Andrew.Fyffe@health.nsw.gov.au	Orr, Rhonda/C-1817-2008				Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Ahmad F, 2001, J PEDIATR-US, V139, P284, DOI 10.1067/mpd.2001.115968; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Borg G., 1998, BORGS PERCEIVED EXER; Britt Helena, 2002, Aust Fam Physician, V31, P876; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Browne GJ, 2016, AUST FAM PHYSICIAN, V45, P470; BRUCE R A, 1963, Pediatrics, V32, P742; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; CUMMING GR, 1978, AM J CARDIOL, V41, P69, DOI 10.1016/0002-9149(78)90134-0; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Gerritsen H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020364; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; IACOBUCCI G, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5172; Iyriboz Y, 1991, Br J Sports Med, V25, P162; Jankowski M, 2015, PEDIATR CARDIOL, V36, P27, DOI 10.1007/s00246-014-0960-0; KASCH F W, 1965, J Assoc Phys Ment Rehabil, V19, P84; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2014, AUST FAM PHYSICIAN, V43, P94; Master C. L, 2017, BRIT J SPORT MED, V51, pA15; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Orr R, 2021, CLIN J SPORT MED, V31, P23, DOI 10.1097/JSM.0000000000000683; Quatman-Yates C, 2018, ARCH PHYS MED REHAB, V99, P994, DOI 10.1016/j.apmr.2017.11.012; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	38	1	1	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E95	E102		10.1097/HTR.0000000000000512			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500005	31246885				2022-02-06	
J	Godfrey, DA; Kehoe, CM; Bastardas-Albero, A; Babcock, JC				Godfrey, Donald A.; Kehoe, Caitlin M.; Bastardas-Albero, Adriana; Babcock, Julia C.			Empathy Mediates the Relations between Working Memory and Perpetration of Intimate Partner Violence and Aggression	BEHAVIORAL SCIENCES			English	Article						executive functioning; working memory; interpersonal violence; empathy	TRAUMATIC BRAIN-INJURY; DOMESTIC VIOLENCE; SOCIAL COGNITION; HEAD-INJURY; DEFICITS; IMPAIRMENTS; PREVALENCE; MEN	Deficits in executive functioning have been associated with aggressive and violent behavior toward intimate partners. However, it is unclear what specific mechanisms are being affected by cognitive deficits that increase an individual's tendency to become aggressive. The current study examined empathy as a mediating factor between deficits in working memory and perpetration of intimate partner aggression and violence. Men in heterosexual relationships (N = 49) were administered a measure of visual-spatial working memory, and questionnaire measures of head injury and empathy. During a second session, men participated in a conflict discussion with their female partner that was coded for aggressive behavior. Female partners also reported on men's physical and psychological abuse. Working memory was positively related to cognitive and affective empathy, and negatively related to men's physical abuse perpetration and observed aggression during the conflict discussion. The effects of working memory on observed aggression during the conflict were fully mediated by cognitive and affective empathy. Additionally, the effects of working memory on reported physical IPV frequency were fully mediated by affective empathy. Deficits in working memory may decrease men's ability to use empathetic processes, resulting in increased aggression and violence toward their intimate partners. Clinically, incorporating empathy training in battering intervention programs may be helpful, especially among men with deficits in cognitive functioning.	[Godfrey, Donald A.; Kehoe, Caitlin M.; Bastardas-Albero, Adriana; Babcock, Julia C.] Univ Houston, Dept Psychol, Houston, TX 77204 USA		Godfrey, DA (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77204 USA.	dagodfre@central.uh.edu; ckehoe@cougarnet.uh.edu; abastardas-albero@uh.edu; jbabcock@Central.uh.edu		Godfrey, Donald/0000-0002-2444-4445	University of Houston	This research was funded by the University of Houston.	Armenti NA, 2018, INT J OFFENDER THER, V62, P3337, DOI 10.1177/0306624X17740029; Babcock JC, 2004, CLIN PSYCHOL REV, V23, P1023, DOI 10.1016/j.cpr.2002.07.001; Babcock J, 2016, PARTN ABUSE, V7, P355, DOI 10.1891/1946-6560.7.4.355; Bosco A, 2004, APPL COGNITIVE PSYCH, V18, P519, DOI 10.1002/acp.1000; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Brunetti R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00939; Bueso-Izquierdo N, 2015, AGGRESS VIOLENT BEH, V25, P243, DOI 10.1016/j.avb.2015.09.009; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Coan J. A., 2007, HDB EMOTION ELICITAT, P267; Cohen Jacob, 2002, APPL MULTIPLE REGRES, V3th; Cohen R A, 1999, Violence Vict, V14, P397; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Corsi P.M., 1973, DISSERTATOPM ABSTRAC, V85, P891; Corvo K, 2014, PARTN ABUSE, V5, P342, DOI 10.1891/1946-6560.5.3.342; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; Day A, 2010, AGGRESS VIOLENT BEH, V15, P201, DOI 10.1016/j.avb.2009.12.003; Eslinger PJ, 2011, J NEUROPSYCH CLIN N, V23, P74, DOI 10.1176/appi.neuropsych.23.1.74; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Gao ZF, 2016, PSYCHON B REV, V23, P468, DOI 10.3758/s13423-015-0896-2; Gu XS, 2015, HUM BRAIN MAPP, V36, P3323, DOI 10.1002/hbm.22840; Hildebran D., 1989, RELAPSE PREVENTION S, P236, DOI New York; Hooven C., 1996, PLAY BY PLAY INTERVI; Howard CJ, 2012, PSYCHOL TRAUMA-US, V4, P330, DOI 10.1037/a0024229; HUDSON SM, 1995, BEHAV CHANGE, V12, P69, DOI 10.1017/S0813483900004253; Johnson MD, 2002, PSYCHOL ASSESSMENT, V14, P423, DOI 10.1037//1040-3590.14.4.423; Landsberger H.A., 1958, HAWTHORNE REVISITED, DOI [10.1017/S1373971900078768, DOI 10.1017/S1373971900078768]; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McLaren V, 2019, PSYCHOL ASSESSMENT, V31, P1208, DOI 10.1037/pas0000741; National Center for Injury Prevention and Control, 2003, COSTS INTIMATE PARTN; Redick TS, 2015, INTELLIGENCE, V50, P14, DOI 10.1016/j.intell.2015.01.014; Romero-Martinez A, 2013, REV NEUROLOGIA, V57, P515, DOI 10.33588/rn.5711.2013141; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Sommer J, 2019, J INTERPERS VIOLENCE, V34, P3059, DOI 10.1177/0886260516665107; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Toussaint L, 2005, J SOC PSYCHOL, V145, P673, DOI 10.3200/SOCP.145.6.673-686; Ulloa EC, 2017, FAM J, V25, P208, DOI 10.1177/1066480717710644; Ulloa EC, 2016, PARTN ABUSE, V7, P140, DOI 10.1891/1946-6560.7.2.140; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; WHO, 2016, ETHICAL SAFETY RECOM; Xin F, 2015, SOC COGN AFFECT NEUR, V10, P1144, DOI 10.1093/scan/nsu160; Yu CL, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02212; Ze O, 2014, AGING MENT HEALTH, V18, P929, DOI 10.1080/13607863.2014.899973	48	1	1	5	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-328X		BEHAV SCI-BASEL	Behav. Sci.	MAR	2020	10	3							63	10.3390/bs10030063			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LA0SF	WOS:000523666200005	32150915	Green Published, gold			2022-02-06	
J	Graff, HJ; Siersma, V; Moller, A; Egerod, I; Rytter, HM				Graff, Heidi Jeannet; Siersma, Volkert; Moller, Anne; Egerod, Ingrid; Rytter, Hana Mala			Five-Year Trends in Marital Stability, Academic Achievement, and Socioeconomic Indicators After Concussion: A National Register Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						academic achievement; concussion; employment; marital stability; mild traumatic brain injury; socioeconomic status	TRAUMATIC BRAIN-INJURY; COLLEGE-STUDENTS; DANISH REGISTERS; HEALTH; PREDICTORS; IMPACT; TBI	Objective: To examine long-term trends in marital stability, academic achievement, income, and socioeconomic status in patients with concussion. Design and setting: Danish national register-based cohort study with 5 years of follow-up. Participants: A total of 23 549 hospital-admitted or emergency-treated patients between 18 and 60 years of age with concussion (International Classification of Diseases, Tenth Revision [ICD-10] diagnosis S06.0) and 22 228 matching controls. Main measures: Outcomes were the differences between patients with concussion and controls in the change from injury date to 5 years postinjury in the dichotomized outcomes-martial stability, academic achievement, income, and socioeconomic status. Results: Fewer patients had high education (19.43%) compared with controls (23.96%) and the adjusted odds ratio (OR) of high education beyond the difference in prevalence at baseline became even lower at 5 years of follow-up (OR: 0.93, 95% confidence interval [CI]: 0.90-0.95). Patients were to a lesser extent gainfully employed (67.05%) compared with controls (77.32%) and had lower odds of being gainfully employed (OR: 0.83, 95% CI: 0.79-0.88), self-employed, leaders, or managers (OR: 0.89, 95% CI: 0.84-0.95) at 5 years postinjury, beyond differences at baseline. Conclusions: Academic achievement and socioeconomic status are affected by concussion. There is no evidence that marital stability and income are affected. Supporting interventions should be considered those at risk of persistent symptoms.	[Graff, Heidi Jeannet] Univ Hosp Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Egerod, Ingrid] Univ Hosp Rigshosp, Ctr Canc & Organ Dis, Dept Intens Care, Copenhagen, Denmark; [Siersma, Volkert; Moller, Anne] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Siersma, Volkert; Moller, Anne] Univ Copenhagen, Sect Gen Practice, Copenhagen, Denmark; [Rytter, Hana Mala] Univ Copenhagen, Dept Psychol, Fac Social Sci, Copenhagen, Denmark; [Moller, Anne] Copenhagen Univ Hosp Holbaek, Dept Occupat Med & Social Med, Holbaek, Denmark; [Rytter, Hana Mala] Univ Hosp Bispebjerg Frederiksberg, Dept Neurol, Copenhagen, Denmark		Graff, HJ (corresponding author), Univ Hosp Rigshosp, Ctr Head & Orthopaed, Dept Anaesthesia, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	heidi.jeannet.graff@regionh.dk	Siersma, Volkert/G-6867-2016	Siersma, Volkert/0000-0003-1941-2681; Graff, Heidi/0000-0001-5726-6991; Rytter, Hana Mala/0000-0002-2910-372X	Research Foundation, Rigshospitalet [E-22260-03, E-23473-01]; Danish Health Foundation (Helsefonden) [16-B-0050]; Aase and Ejnar Danielsen Foundation [20-000054]	This study was supported by the Research Foundation, Rigshospitalet (E-22260-03) (E-23473-01), the Danish Health Foundation (Helsefonden) (16-B-0050), and the Aase and Ejnar Danielsen Foundation (20-000054).	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arciniegas DB, 2012, BRAIN INJURY MED; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; Besk<dipthong ae>ftigelsesministeriet [The Ministry of Employment], 2017, BEK EFT UDSK SKATT P; Boccuzzi SJ, 2003, CONTEMP CARDIOL, P63; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; BOOTH A, 1994, J MARRIAGE FAM, V56, P218, DOI 10.2307/352716; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Galili SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017735; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Hannerz H, 2012, INT J OCCUP MED ENV, V25, P200, DOI 10.2478/S13382-012-0017-7; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Kruithof N, 2017, INJURY, V48, P578, DOI 10.1016/j.injury.2017.01.013; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martinez S, 2016, J AM COLL HEALTH, V64, P390, DOI 10.1080/07448481.2016.1167057; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ministry for Economic Affairs and the Interior, 2007, STRUCT REF; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Noonan VK, 2013, J NEUROTRAUM, V30, P173, DOI 10.1089/neu.2012.2441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersson F, 2011, SCAND J PUBLIC HEALT, V39, P95, DOI 10.1177/1403494811408483; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Soll-Johanning H, 2004, DAN MED BULL, V51, P207; Statistics Denmark, 2017, HOUS FAM CHILDR SEC; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Styrelsen for Arbejdsmarked og Rekruttering [Danish Agency for Labour Market and Recruitment], 2018, DREAM VERS 42; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; Warren L, 1996, J REHABIL RES DEV, V33, P404; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	52	1	1	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E86	E94		10.1097/HTR.0000000000000501			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500003	31246879				2022-02-06	
J	Hoot, MR; Khokhar, B; Walker, WC				Hoot, Michelle R.; Khokhar, Bilal; Walker, William C.			Self-report Pain Scale Reliability in Veterans and Service Members With Traumatic Brain Injuries Undergoing Inpatient Rehabilitation	MILITARY MEDICINE			English	Article							VISUAL ANALOG SCALES; INITIAL VALIDATION; RESPONSIVENESS; CONSEQUENCES; INTENSITY; ADULTS	Introduction Pain in trauma patients with traumatic brain injury (TBI) may heighten cognitive-behavioral impairment and impede rehabilitation efforts. Multiple self-report pain assessment tools have been shown reliable in cognitively intact adults and children but are understudied in the cognitively impaired, particularly in persons with TBI. The objective of this study was to assess the utility and reliability of four pain assessment instruments among TBI patients during inpatient rehabilitation and the influence of cognitive impairment. Methods Participants self-completed four pain intensity measures, the Verbal Descriptor Scale, Faces Pain Scale (Faces), Numerical Rating Scale (NRS), and Color-Enhanced Visual Analog Scale (CAS), during five study visits over a 2-week period. Data were collected on time to completion and most preferred pain measure. To assess scale reliability, participants re-rated their current pain. To assess scale responsiveness, standard mean response was measured across time and a worst past pain experience was rated. Cognitive impairment was assessed with the Memory, Orientation, and Amnesia Test. Results The NRS was the most preferred measure by participants at every time point in the study. Mean pain measure completion time for all measures was under 11 seconds and did not significantly change during the study period. All scales showed very high test-retest reliability, with very strong correlations. Standard mean response from day 0 to 14 ranged from 0.387 to 0.532 across the scales. When stratified by cognitive impairment, the mean scores were consistently nominally higher for impaired participants, reaching statistical significance only for the CAS and Faces at baseline. In the cognitive impaired group, reliability for the Faces showed some weakening, as did the VAS to a milder degree. Conclusions All four pain measures demonstrated good utility, very high test-retest reliability, and satisfactory responsiveness. Greater cognitive impairment was associated with elevated pain ratings, especially in the Faces and CAS. The NRS was the most preferred by patients, regardless of cognitive impairment level.	[Hoot, Michelle R.; Walker, William C.] Hunter Holmes McGuire Vet Affairs Med Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA; [Hoot, Michelle R.; Walker, William C.] Def & Vet Brain Injury Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA; [Khokhar, Bilal] Gen Dynam Informat Technol, 8601 Georgia Ave, Silver Spring, MD 20910 USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1223 E Marshall St, Richmond, VA 23284 USA		Hoot, MR (corresponding author), Hunter Holmes McGuire Vet Affairs Med Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.; Hoot, MR (corresponding author), Def & Vet Brain Injury Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.			Hoot, Michelle/0000-0002-3273-0484	U.S. Department of DefenseUnited States Department of Defense [W91YTZ-11-C-0033]	U.S. Department of Defense, Award No. W91YTZ-11-C-0033.	BIERI D, 1990, PAIN, V41, P139, DOI 10.1016/0304-3959(90)90018-9; Carey S J, 1997, Orthop Nurs, V16, P29; Chan ACM, 2018, GAIT POSTURE, V59, P267, DOI 10.1016/j.gaitpost.2017.10.020; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Closs SJ, 2004, J PAIN SYMPTOM MANAG, V27, P196, DOI 10.1016/j.jpainsymman.2003.12.010; Els C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012509.pub2; Golub A, 2013, SUBST USE MISUSE, V48, P811, DOI 10.3109/10826084.2013.796988; GRACELY RH, 1978, PAIN, V5, P5, DOI 10.1016/0304-3959(78)90020-9; Gregory J, 2017, INT J ORTHOP TRAUMA, V24, P3, DOI 10.1016/j.ijotn.2016.08.004; Hammond FM, 2015, ARCH PHYS MED REHAB, V96; Herr KA, 1998, CLIN J PAIN, V14, P29, DOI 10.1097/00002508-199803000-00005; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Higgins DM, 2018, CLIN J PAIN, V34, P262, DOI 10.1097/AJP.0000000000000536; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; JENSEN MP, 1989, CLIN J PAIN, V5, P153, DOI 10.1097/00002508-198906000-00005; Joshi Girish P, 2005, Anesthesiol Clin North Am, V23, P21, DOI 10.1016/j.atc.2004.11.013; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lichtner V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-138; Lukas A, 2013, Z GERONTOL GERIATR, V46, P214, DOI 10.1007/s00391-013-0475-y; McGrath P, 1996, PAIN, V64, P435, DOI 10.1016/0304-3959(95)00171-9; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Scherder EJA, 2000, GERONTOLOGY, V46, P47, DOI 10.1159/000022133; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; SRIWATANAKUL K, 1983, CLIN PHARMACOL THER, V34, P234, DOI 10.1038/clpt.1983.159; Tsze DS, 2013, PEDIATRICS, V132, pE971, DOI 10.1542/peds.2013-1509; van Boekel RLM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177345; Zwakhalen Sandra M G, 2006, BMC Geriatr, V6, P3, DOI 10.1186/1471-2318-6-3	30	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					370	376		10.1093/milmed/usz272			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR7HU	WOS:000535866100045	31498391	Bronze			2022-02-06	
J	Inampudi, C; Ciccotosto, GD; Cappai, R; Crack, PJ				Inampudi, Chaitanya; Ciccotosto, Giuseppe D.; Cappai, Roberto; Crack, Peter J.			Genetic Modulators of Traumatic Brain Injury in Animal Models and the Impact of Sex-Dependent Effects	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; gender; genetic factors; traumatic brain injury	AMYLOID PRECURSOR PROTEIN; TUMOR-NECROSIS-FACTOR; CONTROLLED CORTICAL IMPACT; IMPROVES LONG-TERM; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; I INTERFERON; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE	Traumatic brain injury (TBI) is a major health problem causing disability and death worldwide. There is no effective treatment, due in part to the complexity of the injury pathology and factors affecting its outcome. The extent of brain injury depends on the type of insult, age, sex, lifestyle, genetic risk factors, socioeconomic status, other co-injuries, and underlying health problems. This review discusses the genes that have been directly tested in TBI models, and whether their effects are known to be sex-dependent. Sex differences can affect the incidence, symptom onset, pathology, and clinical outcomes following injury. Adult males are more susceptible at the acute phase and females show greater injury in the chronic phase. TBI is not restricted to a single sex; despite variations in the degree of symptom onset and severity, it is important to consider both female and male animals in TBI pre-clinical research studies.	[Inampudi, Chaitanya; Ciccotosto, Giuseppe D.; Cappai, Roberto; Crack, Peter J.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia		Crack, PJ (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia.	pcrack@unimelb.edu.au	Crack, Peter/ABE-2065-2020	Crack, Peter/0000-0002-5030-0330	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1120583]	Funding was received from the National Health and Medical Research Council of Australia (Grant No. APP1120583) to RC and PJC.	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Al-Suwailem E, 2018, J NEUROSCI RES, V96, P459, DOI 10.1002/jnr.24144; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Andzinsk L, 2016, INT J CANCER, V139, P1350, DOI 10.1002/ijc.30159; Aneja RK, 2019, J NEUROTRAUM, V36, P360, DOI 10.1089/neu.2018.5664; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Archer KA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003861; Arellano-Orden V, 2011, NEUROCRIT CARE, V14, P18, DOI 10.1007/s12028-010-9441-3; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; CASTLE DJ, 1991, PSYCHOL MED, V21, P565, DOI 10.1017/S0033291700022194; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen SY, 2016, EXP THER MED, V11, P2049, DOI 10.3892/etm.2016.3153; Chen XJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1407-6; Cheng CJ, 2017, INT J MED SCI, V14, P927, DOI 10.7150/ijms.18812; Chillingworth NL, 2006, AM J PHYSIOL-REG I, V291, pR327, DOI 10.1152/ajpregu.00901.2005; Choi BY, 2016, AMINO ACIDS, V48, P1619, DOI 10.1007/s00726-016-2221-4; Chou A., 2018, INT J MOL SCI, P19; Ciccotosto GD, 2014, METALLOMICS, V6, P1894, DOI 10.1039/c4mt00176a; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; Cordeau P, 2008, STROKE, V39, P935, DOI 10.1161/STROKEAHA.107.501460; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dixon KJ, 2016, STEM CELL RES, V17, P504, DOI 10.1016/j.scr.2016.09.029; Dorfman MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14556; Dumitrescu L, 2019, BRAIN, V142, P2581, DOI 10.1093/brain/awz206; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Finan John D, 2016, BMC Res Notes, V9, P160, DOI 10.1186/s13104-016-1968-8; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Girgis H, 2013, BRAIN RES, V1491, P78, DOI 10.1016/j.brainres.2012.10.049; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Guilbault C, 2002, IMMUNOLOGY, V107, P297, DOI 10.1046/j.1365-2567.2002.01508.x; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gurkoff GG, 2013, BRAIN RES, V1515, P98, DOI 10.1016/j.brainres.2013.03.043; Haag K, 2020, PSYCHOL MED, V50, P1755, DOI 10.1017/S0033291719001971; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hettiaratchi MH, 2019, J CONTROL RELEASE, V297, P14, DOI 10.1016/j.jconrel.2019.01.033; Hind WH, 2015, BRIT J PHARMACOL, V172, P3015, DOI 10.1111/bph.13106; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Ilmaniemi S, 2019, J EPIDEMIOL COMMUN H, V73, P451, DOI 10.1136/jech-2018-211960; Ito K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3794029; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jackson TC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25371-2; Jadid KD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00811; Jankord R, 2007, ENDOCRINOLOGY, V148, P3758, DOI 10.1210/en.2006-1650; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kaldoja ML, 2015, J CHILD NEUROL, V30, P860, DOI 10.1177/0883073814544705; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kerr N, 2019, CNS NEUROSCI THER, V25, P1308, DOI 10.1111/cns.13267; Khaksari M, 2018, IRAN J BASIC MED SCI, V21, P615, DOI 10.22038/IJBMS.2018.26586.6512; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Klofers M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2924848; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lamprecht MR, 2017, J NEUROTRAUM, V34, P97, DOI 10.1089/neu.2015.4306; Lang XE, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0346-9; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Li B, 2017, PROG NEUROBIOL, V159, P50, DOI 10.1016/j.pneurobio.2017.10.006; Li QQ, 2019, INT J BIOCHEM CELL B, V107, P154, DOI 10.1016/j.biocel.2018.12.018; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liao RJ, 2019, STEM CELL REP, V12, P532, DOI 10.1016/j.stemcr.2019.01.004; Lin Q, 2011, INT IMMUNOPHARMACOL, V11, P1422, DOI 10.1016/j.intimp.2011.04.026; Liou DZ, 2016, NEUROCRIT CARE, V25, P145, DOI 10.1007/s12028-015-0223-9; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu FD, 2009, STROKE, V40, P1842, DOI 10.1161/STROKEAHA.108.538686; Liu LL, 2019, BRAIN BEHAV IMMUN, V81, P188, DOI 10.1016/j.bbi.2019.06.012; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Liu T, 2015, AM J SURG, V210, P911, DOI 10.1016/j.amjsurg.2015.03.021; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Luu L, 2019, MOL NEUROBIOL, V56, P13, DOI 10.1007/s12035-018-1070-4; Ma MW, 2018, FREE RADICAL BIO MED, V117, P66, DOI 10.1016/j.freeradbiomed.2018.01.031; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mapplebeck JCS, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0289-8; Marcolini Evie G, 2019, Anesthesiol Clin, V37, P107, DOI 10.1016/j.anclin.2018.09.007; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Marzona I, 2018, INT J CARDIOL, V269, P182, DOI 10.1016/j.ijcard.2018.07.044; MATTSON MP, 1994, J NEUROBIOL, V25, P439, DOI 10.1002/neu.480250409; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Mirza MA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0251-6; Moieni M, 2015, NEUROPSYCHOPHARMACOL, V40, P1709, DOI 10.1038/npp.2015.17; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Namiranian K, 2011, J CEREBR BLOOD F MET, V31, pE1, DOI 10.1038/jcbfm.2010.223; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Needham BE, 2014, METALLOMICS, V6, P598, DOI 10.1039/c3mt00358b; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Pan ZY, 2019, DRUG DES DEV THER, V13, P265, DOI 10.2147/DDDT.S192633; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Park EM, 2006, J CEREBR BLOOD F MET, V26, P392, DOI 10.1038/sj.jcbfm.9600194; Pascual M, 2017, ADDICT BIOL, V22, P1829, DOI 10.1111/adb.12461; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Penkowa M, 1999, GLIA, V25, P343; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pijet B, 2018, MOL NEUROBIOL, V55, P9294, DOI 10.1007/s12035-018-1061-5; Plummer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190449; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Poritz JMP, 2019, REHABIL PSYCHOL, V64, P65, DOI 10.1037/rep0000234; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Renson A, 2018, MED CARE, V56, P1035, DOI 10.1097/MLR.0000000000000986; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMALL DH, 1994, J NEUROSCI, V14, P2117; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Soltani Z, 2017, BRAIN INJURY, V31, P16, DOI 10.1080/02699052.2016.1213421; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stifter SA, 2018, J BIOL CHEM, V293, P3168, DOI 10.1074/jbc.M117.800755; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Strauss KI, 2013, PROSTAG OTH LIPID M, V104, P18, DOI 10.1016/j.prostaglandins.2012.07.005; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sun JL, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00063, 10.3389/hsys.2015.00063]; Tan XL, 2020, BRAIN INJURY, V34, P131, DOI 10.1080/02699052.2019.1667539; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tao XG, 2017, WORLD NEUROSURG, V107, P888, DOI 10.1016/j.wneu.2017.06.076; Teng S, 2019, BRAIN INJURY, V33, P1385, DOI 10.1080/02699052.2019.1641622; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Theus MH, 2017, J IMMUNOL, V199, P3547, DOI 10.4049/jimmunol.1700251; THOMAS D G T, 1978, Lancet, V1, P113; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tonelli LH, 2008, NEUROPSYCHOPHARMACOL, V33, P1038, DOI 10.1038/sj.npp.1301488; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Trentzsch H, 2015, ANN SURG, V261, P774, DOI 10.1097/SLA.0000000000000789; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Umschweif G, 2014, NEUROTHERAPEUTICS, V11, P665, DOI 10.1007/s13311-014-0286-x; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wang L., 2017, BIOSCIENCE REP, P37; Wang MJ, 2008, CIRCULATION, V118, pS38, DOI 10.1161/CIRCULATIONAHA.107.756890; Wang WT, 2019, BIOCHEM BIOPH RES CO, V518, P657, DOI 10.1016/j.bbrc.2019.08.100; Wang XH, 2018, BIOCHEM BIOPH RES CO, V504, P805, DOI 10.1016/j.bbrc.2018.08.055; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Warner K, 2018, J ATHL TRAINING, V53, P1049, DOI 10.4085/1062-6050-312-17; Webb K, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03167; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wei HL, 2018, BIOCHEM BIOPH RES CO, V503, P467, DOI 10.1016/j.bbrc.2018.04.154; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; White AR, 1999, J NEUROSCI, V19, P9170; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xing GQ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00161; Xu K, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13148; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yakovlev AG, 2001, MOL MED, V7, P205, DOI 10.1007/BF03401955; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yang LX, 2019, NEURAL REGEN RES, V14, P632, DOI 10.4103/1673-5374.247467; Yang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10201-8; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40614; Yip PK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41689; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zeller CN, 2009, ANN THORAC SURG, V87, P812, DOI 10.1016/j.athoracsur.2008.12.033; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang HM, 2018, DRUG DES DEV THER, V12, P3847, DOI 10.2147/DDDT.S174037; Zhang M, 2017, NEUROCHEM INT, V108, P472, DOI 10.1016/j.neuint.2017.06.009; Zhang XY, 2014, GENET MOL RES, V13, P9220, DOI 10.4238/2014.November.7.9; Zhang ZB, 2017, CELL TRANSPLANT, V26, P1276, DOI 10.1177/0963689717716510; Zhang ZY, 2019, CLIN CHIM ACTA, V497, P6, DOI 10.1016/j.cca.2019.07.008; Zhao S, 2017, NEUROSCI LETT, V643, P125, DOI 10.1016/j.neulet.2016.12.006; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziegler SM, 2017, EUR J IMMUNOL, V47, P251, DOI 10.1002/eji.201646725	275	1	1	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					706	723		10.1089/neu.2019.6955			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200004	32027210				2022-02-06	
J	Jones, MB; Jeevan, S; Wang, JY; Li, RS; Agrawal, R; Sharafkaneh, A; Marsh, L; Jorge, RE				Jones, Melissa B.; Jeevan, Sangeeth; Wang, Jingyan; Li, Ruosha; Agrawal, Ritwick; Sharafkaneh, Amir; Marsh, Laura; Jorge, Ricardo E.			Clinical Correlates of Dream Enactment Behaviors in Previously Deployed OEF/OIF/OND Veterans: An Exploratory Analysis	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SLEEP QUALITY INDEX; TRAUMATIC BRAIN-INJURY; PARKINSON DISEASE; RISK	Objective: Veterans with posttraumatic stress disorder (PTSD) frequently report dream enactment behavior (DEB). Although DEBs are associated with PTSD symptoms, their relationship with other sleep disorders, including REM behavior disorder, warrants reexamination of their clinical correlates. Methods: The investigators used a cross-sectional, exploratory analysis to compare demographic and clinical characteristics of veterans endorsing regularly occurring DEB compared with those endorsing no or infrequent DEB. The participants comprised a convenience sample of service-members who were previously deployed to Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) and enrolled in an ongoing cohort study. Results: Of the 78 eligible participants, 19 (24.4%) endorsed DEBs occurring at least once per week in the past month. Compared with participants who reported no or infrequent DEBs, participants with regularly occurring DEBs had poorer sleep quality, greater PTSD severity, a higher number of reported mild traumatic brain injuries (mTBI) with loss of consciousness, and a higher likelihood of being diagnosed with sleep disorders. After adjustment for global sleep quality, a significant association persisted between DEBs and the number of mTBI with loss of consciousness but not between DEBs and the severity of PTSD symptoms. Conclusions: These results suggest that mTBI may disrupt neural circuits regulating sleep among OIF/OEF/OND veterans. Prospective, polysomnographic assessment of muscle tone and behavioral events during REM sleep is needed to characterize the physiology of DEBs in this population.	[Jones, Melissa B.] Vet Affairs VA South Cent Mental Illness Res Educ, Houston, TX 77030 USA; [Jones, Melissa B.; Jeevan, Sangeeth; Agrawal, Ritwick; Sharafkaneh, Amir; Marsh, Laura; Jorge, Ricardo E.] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Jones, Melissa B.; Marsh, Laura; Jorge, Ricardo E.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Wang, Jingyan; Li, Ruosha] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Agrawal, Ritwick; Sharafkaneh, Amir] Baylor Coll Med, Dept Med, Pulm Crit Med & Sleep Med Sect, Houston, TX 77030 USA		Jones, MB (corresponding author), Vet Affairs VA South Cent Mental Illness Res Educ, Houston, TX 77030 USA.; Jones, MB (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.; Jones, MB (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	melissa.jones2@bcm.edu		Jones, Melissa/0000-0002-3774-3356	Houston VA Health Services Research and Development Service Center for Innovations and Quality, Effectiveness, and Safety [CIN 13-413]; Mental Health Care Line of the Michael E. DeBakey Veterans Affairs Medical Center; Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine; VA South Central Mental Illness Research and Education Center	Supported by resources and facilities at the Houston VA Health Services Research and Development Service Center for Innovations and Quality, Effectiveness, and Safety (grant CIN 13-413), the Mental Health Care Line of the Michael E. DeBakey Veterans Affairs Medical Center, and the Division of Neuropsychiatry in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine. At the time of initiation of this study, Dr. Jones was a postdoctoral research fellow supported by the VA South Central Mental Illness Research and Education Center.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arnaldi D, 2017, SLEEP MED REV, V36, P82, DOI 10.1016/j.smrv.2016.11.002; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chan YLE, 2017, AM J GERIAT PSYCHIAT, V25, P917, DOI 10.1016/j.jagp.2017.03.012; DeGutis J, 2018, BEHAV SLEEP MED, V16, P38, DOI 10.1080/15402002.2016.1173550; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleetham JA, 2014, CAN MED ASSOC J, V186, pE273, DOI 10.1503/cmaj.120808; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gaig C, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw063; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Gustafsson H, 2015, NEUROLOGY, V84, P2422, DOI 10.1212/WNL.0000000000001684; Insana SP, 2013, J TRAUMA STRESS, V26, P192, DOI 10.1002/jts.21793; Iranzo A, 2005, SLEEP, V28, P203, DOI 10.1093/sleep/28.2.203; Li SX, 2010, SLEEP MED, V11, P43, DOI 10.1016/j.sleep.2009.06.008; McCarter SJ, 2015, SLEEP, V38, P907, DOI 10.5665/sleep.4738; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Mysliwiec V, 2018, SLEEP MED REV, V37, P94, DOI 10.1016/j.smrv.2017.01.004; Nielsen T, 2009, SLEEP, V32, P1629, DOI 10.1093/sleep/32.12.1629; Postuma RB, 2012, NEUROLOGY, V79, P428, DOI 10.1212/WNL.0b013e31825dd383; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Silber M, 2017, PRINCIPLES PRACTICE; Sixel-Doring F, 2014, SLEEP, V37, P431, DOI 10.5665/sleep.3468; St Louis EK, 2017, MAYO CLIN PROC, V92, P1723, DOI 10.1016/j.mayocp.2017.09.007; Suzuki K, 2013, CEPHALALGIA, V33, P868, DOI 10.1177/0333102413477742; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Zhang JH, 2018, EXP THER MED, V16, P93, DOI 10.3892/etm.2018.6146	32	1	1	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2020	32	2					147	153		10.1176/appi.neuropsych.19010009			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	MV7WG	WOS:000556562500006	31587626				2022-02-06	
J	Jung, AD; Morris, MC; Veile, R; Friend, LA; Stevens-Topie, S; Cox, DD; McGuire, JL; Foreman, B; Hartings, JA; Pritts, TA; Makley, AT; Goodman, MD				Jung, Andrew D.; Morris, Mackenzie C.; Veile, Rosalie; Friend, Lou Ann; Stevens-Topie, Sabre; Cox, Daniel D.; McGuire, Jennifer L.; Foreman, Brandon; Hartings, Jed A.; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.			Vibration Does Not Affect Short Term Outcomes Following Traumatic Brain Injury in a Porcine Model	MILITARY MEDICINE			English	Article							NEURON-SPECIFIC ENOLASE; NEUROINFLAMMATORY RESPONSE; AEROMEDICAL EVACUATION; POSTTRAUMATIC HYPOXIA; CORTICAL IMPACT; AIRCRAFT; SWINE	Introduction Traumatic brain injury (TBI) has become increasingly prevalent among the injuries sustained in the military. Many wounded warriors require emergency medical evacuation via helicopter and subsequently fixed wing transport. During aeromedical evacuation, both pilots and patients experience whole body vibration due to engine, rotor, and propeller rotation. The impact of posttraumatic vibration and hypoxia exposure characteristic of the aeromedical evacuation environment on TBI is currently unknown. Materials and Methods A swine TBI model of controlled cortical impact was utilized. The pigs first underwent TBI or sham injury and were subsequently exposed to vibration or no vibration and hypoxia or normoxia for 2 hours. They were monitored for an additional 4 hours following vibration/hypoxia and blood was drawn at hourly intervals for cytokine and serum biomarker analysis. Continuous physiologic and neurologic monitoring were utilized. Prior to the conclusion of the experiment, the animals underwent brain magnetic resonance imaging. At the end of the study, the brain was extracted for histologic analysis. Results Physiologic parameters except for peripheral capillary oxygen saturation (SpO(2)) were similar between all groups. The hypoxia groups demonstrated the expected decrease in SpO(2) and pO(2) during the hypoxic period, and this was sustained throughout the study period. The pH, pCO(2) and electrolytes were similar among all groups. Neuron specific enolase was increased over time in the TBI group, however it was similar to the sham TBI group at all time points. There were no differences in IL-1 beta, IL-6, IL-8, TNF alpha, GFAP, HIF1 alpha, syndecan-1, or S100 beta serum levels between groups. The mean ICP during cortical impact in the TBI group was 279.8 +/- 56.2 mmHg. However, the postinjury ICP was not different between groups at any subsequent time point. Brain tissue oxygenation and perfusion were similar between all groups. Conclusions In this novel study evaluating the effect of vibration on short-term outcomes following TBI, we demonstrate that the moderate vibration and hypoxia simulating aeromedical evacuation do not impact short term outcomes following TBI.	[Jung, Andrew D.; Morris, Mackenzie C.; Veile, Rosalie; Friend, Lou Ann; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Mil Inst Med, Dept Surg, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA; [McGuire, Jennifer L.; Hartings, Jed A.] Univ Cincinnati, Dept Neurosurg, 231 Albert Sabin Way,POB 670515, Cincinnati, OH 45267 USA; [Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, 260 Stetson St,Suite 2300, Cincinnati, OH 45267 USA; [Stevens-Topie, Sabre; Cox, Daniel D.] US Air Force, Dept Aerosp Med Res, En Route Care Div, Sch Aerosp Med, 2510 5th St,Bldg 840, Wright Patterson AFB, OH 45433 USA		Jung, AD (corresponding author), Univ Cincinnati, Mil Inst Med, Dept Surg, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.			Pritts, Timothy/0000-0003-2495-3255	United States Air ForceUnited States Department of Defense [FA8650-16-2-6G07]	FA8650-16-2-6G07 United States Air Force; Cleared, MSC/PA, Case #2019-0189, 8 May 2019.	Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Costine BA, 2012, J NEUROTRAUM, V29, P2689, DOI 10.1089/neu.2012.2428; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; Essebag V, 2003, CHEST, V124, P1937, DOI 10.1378/chest.124.5.1937; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Independent Review G. Rebuilding the Trust, 2007, REB TRUST REP REH CA; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Johannigman Jay, 2015, J Trauma Acute Care Surg, V79, pS216, DOI 10.1097/TA.0000000000000736; Joshi M C, 2010, Med J Armed Forces India, V66, P63, DOI 10.1016/S0377-1237(10)80097-8; Narayan RKPJ, 1999, NEUROTRAUMA, P31; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Scultetus AH, 2016, J TRAUMA ACUTE CARE, V81, P101, DOI 10.1097/TA.0000000000001048; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Smith SD, 2006, AVIAT SPACE ENVIR MD, V77, P32; Thelin EP, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00023; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan JG, 2015, J STROKE CEREBROVASC, V24, P2759, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.007	28	1	1	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					E473	E479		10.1093/milmed/usz346			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR7HU	WOS:000535866100024		Bronze			2022-02-06	
J	Kayadibi, Y; Tekerek, NU; Yesilbas, O; Tekerek, S; Ure, E; Kayadibi, T; Sanli, DET				Kayadibi, Yasemin; Tekerek, Nazan Ulgen; Yesilbas, Osman; Tekerek, Serhat; Ure, Emel; Kayadibi, Turgut; Sanli, Deniz Esin Tekcan			Correlation between optic nerve sheath diameter and Rotterdam computer tomography scoring in pediatric brain injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Brain edema; intracranial pressure; optic nerve sheath diameter; pediatric head trauma; Rotterdam computer tomography score	INCREASED INTRACRANIAL-PRESSURE; SONOGRAPHIC MEASUREMENT; ULTRASOUND MEASUREMENT; RISK STRATIFICATION; HEAD-INJURY; CT; CHILDREN; ULTRASONOGRAPHY; HYPERTENSION; MORTALITY	BACKGROUND: Pediatric head trauma is the most common presentation to emergency departments. Increased intracranial pressure (ICP) may lead to secondary brain damage in head trauma and early diagnosis of increased ICP is very important. Measurement of optic nerve sheath diameter (ONSD) is a method that can be used for determining increased ICP. In this study, we aimed to evaluate the relationship between optic nerve sheath diameter (ONSD) and Rotterdam computer tomography scores (RCTS) in pediatric patients for severe head trauma. METHODS: During January 2017-April 2018, medical records and imaging findings of children aged 0-18 years who underwent computed tomography (CT) imaging for head trauma (n=401) and non-traumatic (convulsions, respiratory disorders, headache) (n=255) complaints, totally 656 patient were evaluated retrospectively. Patients' age, sex, presentation and trauma type (high energy-low energy) were identified. Non-traumatic patients with normal cranial CT findings were considered as the control group. CT findings of traumatic brain injury were scored according to Rotterdam criteria. Patients were divided into groups according to their age as follows: 0-3 years, 3-6 years, 6-12 years and 12-18 years. RESULTS: In our study, tomographic reference measurements of the ONSD in pediatric cases were presented according to age. There was a statistically significant difference between ONSD of severe traumatic patients and the control group. Correlation between RCTS and ONSD was determined and age-specific cut-off values of ONSD for severe traumatic scores (score 4-5-6) were presented. CONCLUSION: In our study, reference ONSDs of the pediatric population for CT imaging was indicated. Our study also showed that ONSD measurement is a parameter that can be used in addition to the RCTS to determine the prognosis of the patient in severe head trauma, by reflecting increased intracranial pressure.	[Kayadibi, Yasemin; Tekerek, Serhat] Van Training & Res Hosp, Dept Radiol, Van, Turkey; [Tekerek, Nazan Ulgen; Yesilbas, Osman] Training & Res Hosp, Dept Pediat, Intens Care Unit, Van, Turkey; [Ure, Emel] Hakkari State Hosp, Dept Radiol, Hakkari, Turkey; [Kayadibi, Turgut] Van Training & Res Hosp, Dept Plast Surg, Van, Turkey; [Sanli, Deniz Esin Tekcan] Kahramanmaras Necip Fazil City Hosp, Dept Radiol, Kahramanmaras, Turkey		Kayadibi, Y (corresponding author), Van Egitim & Arastirma Hastanesi, Radyoloji Klin, Van, Turkey.	ysmnkayadibi@gmail.com	Yesilbas, Osman/AAR-9176-2021; kayadibi, yasemin/AAL-9095-2021; kayadibi, yasemin/N-6405-2018	kayadibi, yasemin/0000-0003-1590-5382; 			Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Aduayi OS, 2015, J NEUROSCI RURAL PRA, V6, P563, DOI 10.4103/0976-3147.165347; Agrawal S, 2012, EUR J TRAUMA EMERG S, V38, P75, DOI 10.1007/s00068-011-0093-6; Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Beare NAV, 2008, TROP MED INT HEALTH, V13, P1400, DOI 10.1111/j.1365-3156.2008.02153.x; Choi SH, 2015, ANAESTHESIA, V70, P1268, DOI 10.1111/anae.13180; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Hirsch W, 2000, PEDIATR RADIOL, V30, P439, DOI 10.1007/s002470000255; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Irazuzta JE, 2016, PEDIATR NEUROL, V54, P35, DOI 10.1016/j.pediatrneurol.2015.08.009; Korber F, 2005, ROFO-FORTSCHR RONTG, V177, P229, DOI 10.1055/s-2004-813936; Le A, 2009, ANN EMERG MED, V53, P785, DOI 10.1016/j.annemergmed.2008.11.025; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; Marchese RE, 2018, PEDIATR EMERG CARE, V34, P531, DOI 10.1097/PEC.0000000000001046; Min JY, 2015, ULTRASOUND MED BIOL, V41, P1241, DOI 10.1016/j.ultrasmedbio.2015.01.009; Narayan V, 2018, WORLD NEUROSURG, V114, P293, DOI 10.1016/j.wneu.2018.02.159; Padayachy LC, 2016, CHILD NERV SYST, V32, P1769, DOI 10.1007/s00381-016-3067-5; Padayachy V., 2016, TRANSORBITAL MEASURE; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Shofty B, 2012, AM J NEURORADIOL, V33, P366, DOI 10.3174/ajnr.A2779; Singh N, 2017, CHILD NERV SYST, V33, P1677, DOI 10.1007/s00381-017-3535-6; Steinborn M, 2015, ULTRASCHALL MED, V36, P54, DOI 10.1055/s-0034-1385012; Steinborn M, 2012, ULTRASCHALL MED, V33, P569, DOI 10.1055/s-0031-1273491; Tasker RC, 2014, PEDIATR CRIT CARE ME, V15, P569, DOI 10.1097/PCC.0000000000000164; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Vaiman M, 2016, J NEUROTRAUM, V33, P2147, DOI 10.1089/neu.2015.4293; Waqas M, 2016, J NEURORADIOLOGY, V43, P25, DOI 10.1016/j.neurad.2015.07.003; Yesilaras M, 2017, AM J EMERG MED, V35, P1408, DOI 10.1016/j.ajem.2017.04.022; Young AMH, 2017, PEDIATR RES, V81, P443, DOI 10.1038/pr.2016.165	35	1	1	0	1	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2020	26	2					212	221	PMID 32185780	10.14744/tjtes.2019.94994			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LG5UP	WOS:000528165700009	32185780	hybrid			2022-02-06	
J	Keino, D; Koto, Y; Inuo, C				Keino, Dai; Koto, Yuki; Inuo, Chisato			Kawasaki disease presented with status epilepticus and diffusion MRI abnormalities in the subcortical white matter	TURKISH JOURNAL OF PEDIATRICS			English	Article						incomplete; Kawasaki disease; encephalopathy; acute encephalopathy with biphasic seizures and late reduced diffusion	TRAUMATIC BRAIN-INJURY; ENCEPHALOPATHY; SEIZURES	Background. Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown etiology that occurs predominantly in infants and young children. Encephalitis/encephalopathy is an extremely rare complication of KD. Case. A previously healthy 8-month-old Japanese boy had a prolonged seizure after febrile illness for one day. On the fourth day, he had bilateral nonexudative conjunctivitis, changes in the extremities, rash and induration at the Bacillus Calmette-Guerin inoculation site. He was diagnosed with incomplete KD and treated with immunoglobulin. On the fifth day, he had duster seizures. Brain magnetic resonance imaging (MRI) showed restricted diffusion in the left subcortical white matter, which was consistent with acute encephalopathy with biphasic seizures and late reduced diffusion (AESD). He was treated with controlled normothermia, pulsed-dose methylprednisolone, continuous infusion of midazolam, and edaravone. On the tenth day, he had a recurrent fever and was treated with a second course of immunoglobulin. Subsequently, he had defervescence, and the abnormal signal detected in the MRI disappeared. At the age of 11 months, he had normal growth and development for his age by the Denver Developmental Screening Test. Conclusion. It is necessary to consider AESD as the differential diagnosis of prolonged seizure in infants with KD. Brain MRI led to early diagnosis and intervention in our patient. The neurological prognosis of our patient was relatively good, but the prognosis of KD with AESD is unknown. To clarify this, further case accumulation is warranted.	[Keino, Dai; Koto, Yuki; Inuo, Chisato] St Marianna Univ, Dept Pediat, Sch Med, Kawasaki, Kanagawa, Japan		Keino, D (corresponding author), St Marianna Univ, Dept Pediat, Sch Med, Kawasaki, Kanagawa, Japan.	d2keino@marianna-u.ac.jp	Keino, Dai/AAL-8770-2021	Keino, Dai/0000-0003-0312-1636			Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Morishima T., 2009, JPN J PEDIAT, V62, P2483; Shiba T, 2017, PEDIATR INT, V59, P1276, DOI 10.1111/ped.13431; Tabarki B, 2001, PEDIATR NEUROL, V25, P239, DOI 10.1016/S0887-8994(01)00290-9; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Takanashi J, 2012, J NEUROL SCI, V315, P167, DOI 10.1016/j.jns.2011.11.022; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012; Takase N, 2018, J NEUROL SCI, V390, P63, DOI 10.1016/j.jns.2018.04.010; Tanuma N, 2014, MEDIAT INFLAMM, P1; TERASAWA K, 1983, BRAIN DEV-JPN, V5, P371, DOI 10.1016/S0387-7604(83)80041-2; Yoshikawa H, 2004, PEDIATR INT, V46, P31, DOI 10.1111/j.1442-200X.2004.01850.x	13	1	1	0	0	TURKISH J PEDIATRICS	ANKARA	P K 66 SAMANPAZARI, 06240 ANKARA, TURKEY	0041-4301			TURKISH J PEDIATR	Turk. J. Pediatr.	MAR-APR	2020	62	2					315	319		10.24953/turkjped.2020.02.020			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	LO4QH	WOS:000533613800020	32419426	gold			2022-02-06	
J	Knoll, RM; Ishai, R; Lubner, RJ; Trakimas, DR; Brodsky, JR; Jung, DVH; Rauch, SD; Nadol, JB; Remenschneider, AK; Kozin, ED				Knoll, Renata M.; Ishai, Reuven; Lubner, Rory J.; Trakimas, Danielle R.; Brodsky, Jacob R.; Jung, David H.; Rauch, Steven D.; Nadol, Jr Joseph B.; Remenschneider, Aaron K.; Kozin, Elliott D.			Peripheral Vestibular Organ Degeneration After Temporal Bone Fracture: A Human Otopathology Study	LARYNGOSCOPE			English	Article; Proceedings Paper	Triological-Society Combined Sections Meeting	JAN 22-29, 2019	Coronado, CA	Triol Soc		Temporal bone fracture; peripheral vestibular system; histopathology; temporal bone	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; POSITIONAL VERTIGO; STEM INJURY; HEAD-INJURY; DIZZINESS; CONCUSSION; MANAGEMENT; CLASSIFICATION; SYMPTOMS	Objectives/Hypothesis Vestibular symptoms are a common sequela of temporal bone fractures (TBFs). The mechanisms of injury to the peripheral vestibular system following TBF, however, are not well described. Herein, we aimed to investigate the histopathology of the peripheral vestibular system in patients who sustained TBFs. Study Design Retrospective human specimen analysis. Methods Specimens from the National Temporal Bone Pathology Registry with (cases) and without (controls) TBFs were evaluated. Specimens were analyzed by light microscopy for vestibular hair cell and/or dendritic degeneration, presence of endolymphatic hydrops, blockage of the endolymphatic duct, and number of Scarpa ganglion cells (ScGCs) in the superior and inferior vestibular nerves. Results Seven temporal bones (TBs) from five individuals with TBFs, and seven TBs from six age-matched individuals without a history of head injury met inclusion and exclusion criteria. All fractures involved the otic capsule. Severe degeneration of the cristae was identified in the semicircular canals in all TBF cases. The utricular and saccular maculae showed mild to severe degeneration in the TBF cases. Vestibular hydrops (n = 2 TBs) and blockage of the endolymphatic duct (n = 3 TBs) were also present in the TBF cases. There was a decrease of 52.6% in the mean total ScGC count in the TBF cases (n = 3 TBs) compared to age-matched controls (n = 7 TBs, P = .015). There was a mean loss of 53% of the ScGCs in the superior vestibular nerve and a mean loss of 52.3% of the ScGCs in the inferior vestibular nerve compared to age-matched controls (P = .033 and P = .021, respectively). Conclusions In a cohort of patients with TBFs, there were distinct peripheral vestibular changes including reduction of ScGCs. Level of Evidence NA Laryngoscope, 130:752-760, 2020	[Knoll, Renata M.; Lubner, Rory J.; Trakimas, Danielle R.; Jung, David H.; Rauch, Steven D.; Nadol, Jr Joseph B.; Remenschneider, Aaron K.; Kozin, Elliott D.] Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA USA; [Ishai, Reuven; Jung, David H.; Rauch, Steven D.; Nadol, Jr Joseph B.; Kozin, Elliott D.] Massachusetts Eye & Ear, Otopathol Lab, Boston, MA USA; [Knoll, Renata M.; Lubner, Rory J.; Trakimas, Danielle R.; Brodsky, Jacob R.; Jung, David H.; Rauch, Steven D.; Nadol, Jr Joseph B.; Remenschneider, Aaron K.; Kozin, Elliott D.] Harvard Med Sch, Dept Otolaryngol, Boston, MA 02115 USA; [Lubner, Rory J.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Brodsky, Jacob R.] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA USA; [Trakimas, Danielle R.; Remenschneider, Aaron K.] Univ Massachusetts, Med Ctr, Dept Otolaryngol, Worcester, MA USA		Kozin, ED (corresponding author), 243 Charles St, Boston, MA 02114 USA.	elliott_kozin@meei.harvard.edu	; Kozin, Elliott/J-1225-2014	Trakimas, Danielle/0000-0003-1974-1880; Kozin, Elliott/0000-0002-0305-0682; Remenschneider, Aaron/0000-0003-0989-6264; Lubner, Rory/0000-0001-9884-2799; Brodsky, Jacob/0000-0001-9656-5855	Hearing Health Foundation Funding Source: Medline; American Academy of Otolaryngology-Head and Neck Surgery Foundation Centralized Otolaryngology Research Efforts Silverstein Grant Funding Source: Medline		Aron M, 2015, OTOLARYNG HEAD NECK, V153, P721, DOI 10.1177/0194599815594384; BARBER HO, 1965, CAN MED ASSOC J, V92, P974; Benitez J T, 1980, Am J Otol, V1, P163; Brodie HA, 1997, AM J OTOL, V18, P188; Brusis T, 2009, LARYNGO RHINO OTOL, V88, P191, DOI 10.1055/s-0029-1192045; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; Chew BG, 2012, J NEUROSURG, V117, P722, DOI 10.3171/2012.6.JNS111736; Chiaramonte R, 2013, NEURORADIOL J, V26, P52, DOI 10.1177/197140091302600109; COHEN H, 1992, OTOLARYNG HEAD NECK, V107, P638, DOI 10.1177/019459989210700505; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fischer J, 1943, INNER EAR; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishman SL, 2004, LARYNGOSCOPE, V114, P1734, DOI 10.1097/00005537-200410000-00011; Johnson F, 2008, OTOLARYNG CLIN N AM, V41, P597, DOI 10.1016/j.otc.2008.01.006; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Knoll RM, 2019, OTOLARYNG HEAD NECK, V160, P122, DOI 10.1177/0194599818795695; Lee D, 1998, LARYNGOSCOPE, V108, P816, DOI 10.1097/00005537-199806000-00008; LINDSAY JR, 1970, ANN OTO RHINOL LARYN, V79, P699, DOI 10.1177/000348947007900403; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P1303, DOI 10.1288/00005537-197609000-00002; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Merchant SN, 2005, OTOL NEUROTOL, V26, P74, DOI 10.1097/00129492-200501000-00013; Merchant SN, 2000, ANN OTO RHINOL LARYN, V109, P3, DOI 10.1177/00034894001090S502; Mygind SH, 1918, ACTA OTOLARYNG, VI, P515; Nager FR, 1907, Z OHRENHEILKD, V101, P217; NAGERIS B, 1995, AM J EMERG MED, V13, P211, DOI 10.1016/0735-6757(95)90096-9; Nosan DK, 1997, OTOLARYNG HEAD NECK, V117, P67, DOI 10.1016/S0194-5998(97)70209-2; Ort S, 2004, OTOLARYNG HEAD NECK, V131, P433, DOI 10.1016/j.otohns.2004.04.006; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PAPARELLA MM, 1983, LARYNGOSCOPE, V93, P1004; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Patel A, 2010, CRANIOMAX TRAUM REC, V3, P105, DOI 10.1055/s-0030-1254383; Peng KA, 2014, CASE REP OTOLARYNGOL, V2014, DOI 10.1155/2014/817291; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; RIZVI SS, 1979, ANN OTO RHINOL LARYN, V88, P741, DOI 10.1177/000348947908800601; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Saraiya PV, 2009, EMERG RADIOL, V16, P255, DOI 10.1007/s10140-008-0777-3; Sato G, 2013, ACTA OTO-LARYNGOL, V133, P1124, DOI 10.3109/00016489.2013.817681; Schlittler EV, 1936, ACTA OTO-LARYNGOL, V24, P213; SCHUKNECHT H, 1968, ARCH OTOLARYNGOL, V87, P33; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Ulrich K, 1926, ACTA OTO-LARYNGOL, V6, P1; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Velazquez-Villasenor L, 2000, ANN OTO RHINOL LARYN, V109, P14, DOI 10.1177/00034894001090S503; Villarreal IM, 2016, CASE REP OTOLARYNGOL, V2016, DOI 10.1155/2016/2123182; Virapongse CSB, 1987, RADIOLOGY DIAGNOSIS; Voss O., 1936, CHIRURG SCHADELBASIS; WARD PH, 1969, ANN OTO RHINOL LARYN, V78, P227, DOI 10.1177/000348946907800203; Wennmo C, 1989, Acta Otolaryngol Suppl, V468, P379; YARDLEY L, 1994, SOC SCI MED, V39, P573, DOI 10.1016/0277-9536(94)90100-7; Zhou D, 1994, Zhonghua Er Bi Yan Hou Ke Za Zhi, V29, P350	61	1	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	MAR	2020	130	3					752	760		10.1002/lary.28010			9	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Research & Experimental Medicine; Otorhinolaryngology	KM6CF	WOS:000514225500035	31074866				2022-02-06	
J	Kuci, O; Verlaan, D; Vicente, C; Nubret, E; Le Plenier, S; De Bandt, JP; Cynober, L				Kuci, O.; Verlaan, D.; Vicente, C.; Nubret, E.; Le Plenier, S.; De Bandt, J. P.; Cynober, L.			Citrulline and muscle protein homeostasis in three different models of hypercatabolism	CLINICAL NUTRITION			English	Article						Citrulline; Muscle; Metabolism; Hypercatabolisme; Clinical Nutrition; ICU	TRAUMATIC BRAIN-INJURY; IMMUNE-ENHANCING DIET; PLASMA AMINO-ACIDS; SKELETAL-MUSCLE; ANIMAL-MODELS; METABOLISM; ARGININE; GLUTAMINE; SEPSIS; CARE	Supplementation of enteral nutrition (EN) by specific amino acids (AAs) has been proposed to prevent muscle protein loss in intensive care unit (ICU) patients. Citrulline (Cit), which has been shown to stimulate muscle protein synthesis in other situations, may be of interest in this setting. Our aim was to assess the effect of Cit in three catabolic models relevant to critical illness: endotoxemia (LPS), traumatic brain injury (TBI), and TBI with infectious complications (TBI-Ec), which are characterized by different alterations in protein homeostasis. Fifty-eight male Sprague-Dawley rats (200-220 g) were randomized to receive a standard diet ad libitum (CON, n = 9) or to undergo catabolic injuries on day 0 (D0, n = 49), and EN (Sondalis HP energy (R) 290 kcal/kg/d) from day 1 (D1) combined with Cit (2 g/kg/d) or isonitrogenous non-essential AAs (NEAAs) until day 3 (D3). Endotoxemia was induced by IP injection of LPS from E. coli (3 mg/kg), TBI by hydraulic percussion, and infectious complications (TBI-Ec) by administration of luminescent E. coli on D1. Nitrogen balance (Delta N) and 3-methylhistidine (3-MHis) were measured daily. Muscle protein synthesis (MPS, measured by the SUnSET method) and mTORC1 activation (S6K-1 and 4E-BPI phosphorylation) were measured on D3 2 h after the arrest of enteral nutrition in soleus, extensor digitorum longus (EDL), gastrocnemius and tibialis muscles. Delta N was lower (p < 0.001) in all three models of injury compared with basal and CON from D1 to D3, and more negative in the LPS-CIT (p < 0.05) than in the LPS group. The 3-MHis/creatinine ratio was significantly increased on D1 in all groups compared with CON, and on D2 only in the LPS and TBI groups (p < 0.0001, LPS and TBI vs. CON). MPS was similar in all groups in soleus and tibialis but significantly higher in EDL in LPS-CIT [LPS-CIT: 4.5 +/- 1.7 (mean +/- SD) vs. CON: 2.3 +/- 1.2; and vs. LPS-NEAA: 3.1 +/- 2.31 and in gastrocnemius (LPS-CIT vs. CON; p = 0.05). S6K-1 phosphorylation in the EDL was also higher in LPS-CIT vs. CON (LPS-CIT: 0.94 +/- 0.51 CON: 0.42 +/- 0.28), but not in gastrocnemius. IL-6 plasma level was significantly higher in all the catabolic groups vs. CON (p < 0.005) with no difference between treatments (Cit or NEAAs). In conclusion, the TBI model showed only a rise in muscle proteolysis, whereas the LPS model displayed a rise in both protein synthesis and proteolysis. Secondly, our results show that the Cit effect varies according to the type of injury and to the muscle under study. The stimulation of MPS rate and the mTOR pathway in LPS-treated rats contrasts with degraded Delta N, suggesting that the Cit effect on protein metabolism in critically ill rats is limited at the whole-body level. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[Kuci, O.; Verlaan, D.; Vicente, C.; Nubret, E.; Le Plenier, S.; De Bandt, J. P.; Cynober, L.] Univ Paris 05, Lab Biol Nutr, Sorbonne Paris Cite, EA 4466 PRETRAM, Paris, France; [De Bandt, J. P.; Cynober, L.] Hop Cochin, AP HP, HUPC, Serv Biochim, Paris, France		Cynober, L (corresponding author), Fac Pharm, Lab Biol Nutr EA 4466, 4 Ave Observ, F-75270 Paris 06, France.	luc.cynober@parisdescartes.fr	Cynober, Luc/ABB-2368-2020; De Bandt, Jean-Pascal/ABA-4382-2020; De BANDT, Jean Pascal/C-4822-2013				Allison SP, 2003, NES NUTR WS, V8, P119, DOI 10.1159/000072751; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; Batista MA, 2012, JPEN-PARENTER ENTER, V36, P69, DOI 10.1177/0148607111414024; Besson VC, 2003, FREE RADICAL RES, V37, P1201, DOI 10.1080/10715760310001612568; Breuillard C, 2015, AMINO ACIDS, V47, P685, DOI 10.1007/s00726-015-1932-2; Breuillard C., 2014, BR J NUTR, V13, P1; Breuille D, 1998, CLIN SCI, V94, P413, DOI 10.1042/cs0940413; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; CERRA FB, 1979, ANN SURG, V190, P577, DOI 10.1097/00000658-197911000-00004; Charrueau C, 2016, CLIN NUTR, V35, P1291, DOI 10.1016/j.clnu.2016.04.018; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Cynober L, 2013, REANIMATION, V22, P350, DOI 10.1007/s13546-013-0691-x; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; Cynober L, 2014, CURR OPIN CLIN NUTR, V17, P98, DOI 10.1097/MCO.0000000000000014; De Bandt JP, 2016, TRAITE NUTR CLIN, P269; Deutz NEP, 2008, CLIN NUTR, V27, P321, DOI 10.1016/j.clnu.2008.03.010; Faure C, 2013, PROTEOMICS, V13, P2191, DOI 10.1002/pmic.201200262; FLAKOLL PJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE636, DOI 10.1152/ajpendo.1995.269.4.E636; Fremont RD, 2015, NUTR CLIN PRACT, V30, P344, DOI 10.1177/0884533615578457; Ginguay A, 2016, CURR OPIN CLIN NUTR, V19, P161, DOI 10.1097/MCO.0000000000000255; GOLDEN MHN, 1977, CLIN SCI MOL MED, V53, P473, DOI 10.1042/cs0530473; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gordon BS, 2015, J NUTR, V145, P708, DOI 10.3945/jn.114.207621; Grimaldi D, 2013, RESUSCITATION, V84, P60, DOI 10.1016/j.resuscitation.2012.06.010; Ham DJ, 2015, J NUTR, V145, P900, DOI 10.3945/jn.114.203737; Hamani D, 2007, INTENS CARE MED, V33, P1076, DOI 10.1007/s00134-007-0624-0; HASSELGREN PO, 1986, ARCH SURG-CHICAGO, V121, P918; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Holecek M, 2014, AMINO ACIDS, V46, P1377, DOI 10.1007/s00726-014-1701-7; Holecek M, 2012, INT J EXP PATHOL, V93, P157, DOI 10.1111/j.1365-2613.2012.00812.x; Jourdan M, 2015, CLIN NUTR, V34, P449, DOI 10.1016/j.clnu.2014.04.019; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Le Plenier S, 2012, AMINO ACIDS, V43, P1171, DOI 10.1007/s00726-011-1172-z; Lefrant J-Y, 2014, Ann Fr Anesth Reanim, V33, P202, DOI 10.1016/j.annfar.2014.01.008; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Luiking YC, 2009, AM J CLIN NUTR, V89, P142, DOI 10.3945/ajcn.2007.25765; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; MALTIN CA, 1989, AM J PHYSIOL, V257, pE823, DOI 10.1152/ajpendo.1989.257.6.E823; Meaney MP, 2016, NUTRIENTS, V8, P518; Moinard C, 2008, BRIT J NUTR, V99, P855, DOI 10.1017/S0007114507841110; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2013, J NEUROTRAUM, V30, P975, DOI 10.1089/neu.2012.2707; Moinard C, 2012, J NEUROTRAUM, V29, P335, DOI 10.1089/neu.2011.1862; Neveux N, 2004, METABOLIC THERAPEUTI, P18; Osowska S, 2004, GUT, V53, P1781, DOI 10.1136/gut.2004.042317; Osowska S, 2006, AM J PHYSIOL-ENDOC M, V291, pE582, DOI 10.1152/ajpendo.00398.2005; Pernet P, 2004, BRIT J NUTR, V92, P627, DOI 10.1079/BJN20041254; Plantefeve G, 2001, REANIMATION, V10, P550; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Rittig N, 2016, CLIN NUTR, V35, P322, DOI 10.1016/j.clnu.2015.03.021; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sinha B, 1998, RES IMMUNOL, V149, P139, DOI 10.1016/S0923-2494(98)80297-6; SJOLIN J, 1989, METABOLISM, V38, P23, DOI 10.1016/0026-0495(89)90175-3; Soeters P, 2016, CLIN NUTR, V35, P748, DOI 10.1016/j.clnu.2015.08.008; Suchner U, 2002, BRIT J NUTR, V87, pS121, DOI 10.1079/BJN2001465; Sureda A, 2009, FREE RADICAL RES, V43, P828, DOI 10.1080/10715760903071664; Villalpando S, 2006, AM J CLIN NUTR, V84, P197, DOI 10.1093/ajcn/84.1.197; Wakabayashi Y, 2004, METHABOLIC THERAPEUT, P135; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc11934; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0591-0; Wijnands KAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037439	62	1	1	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	MAR	2020	39	3					917	927		10.1016/j.clnu.2019.03.036			11	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	KW9NG	WOS:000521509800031	31010700				2022-02-06	
J	Kundu, B; Awad, AW; Park, MS; Grandhi, R; Enniss, T; Hawryluk, GWJ				Kundu, Bornali; Awad, Al-Wala; Park, Min S.; Grandhi, Ramesh; Enniss, Toby; Hawryluk, Gregory W. J.			Characterization of Focal Brain Tissue Water Measurements in Human Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Blood flow; Brain injury; Cerebral edema; Hemedex; Neuromonitoring; Tissue water	CEREBRAL-BLOOD-FLOW; INTRACRANIAL HYPERTENSION; CELLULAR EDEMA; TIME-COURSE; AUTOREGULATION; MANAGEMENT	BACKGROUND: Cerebral edema is a major cause of morbidity in patients with severe traumatic brain injury (TBI). Intraparenchymal thermal conductivity-based probes that measure local cerebral blood flow can measure percent brain tissue water (%BTW) content, but such measures have been insufficiently characterized in patients with TBI. METHODS: We retrospectively reviewed physiologic data from patients with severe TBI treated at our institution (2014-2016) who underwent cerebral blood flow monitoring. RESULTS: Sixteen patients underwent focal %BTW measurements at a 15-minute sampling rate. %BTW measurements showed characteristic temporal profiles, with a mean time to peak of 3.7 +/- 1.7 days. The mean minimum and maximum %BTWs were 71.0 +/- 3.9% and 82.7 +/- 7.4%, respectively (overall mean %BTW, 77.0 +/- 2.9%). Intracranial pressure (ICP) values of 22 mm Hg (the current treatment threshold for patients with trauma) corresponded to 75.8 +/- 5.4 %BTW. Repeated measures correlation showed that %BTW is negatively correlated with serum sodium concentration (r = -0.3; P< 0.001) and weakly positively correlated with ICP (r = 0.08; P = 0.01) and regional cerebral blood flow (r = 0.06; P< 0.001). These effects were consistent in a multivariable model including time from injury. In the best model, time was modeled as a quadratic term because the %BTW followed a parabolic trajectory. CONCLUSIONS: %BTW may be a clinically useful, real-time measurement of cerebral edema in patients with TBI. It is closely associated with the serum sodium concentration and follows a characteristic temporal course with characteristic trajectory and stability over time.	[Kundu, Bornali; Awad, Al-Wala; Grandhi, Ramesh; Hawryluk, Gregory W. J.] Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA; [Park, Min S.] Univ Virginia, Sch Med, Dept Neurosurg, Charlottesville, VA 22908 USA; [Enniss, Toby] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Hawryluk, Gregory W. J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada		Hawryluk, GWJ (corresponding author), Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA.; Hawryluk, GWJ (corresponding author), Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada.	ghawryluk@hsc.mb.ca	Kundu, Bornali/AAR-1705-2021	Grandhi, Ramesh/0000-0001-9000-6083			Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Barzo P, 1997, ACT NEUR S, V70, P119; BLAND JM, 1995, BRIT MED J, V310, P633, DOI 10.1136/bmj.310.6980.633; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Ko SB, 2012, ANN NEUROL, V72, P344, DOI 10.1002/ana.23619; Maegele M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614555142; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; OBRIEN JS, 1965, J LIPID RES, V6, P537; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tackla R, 2015, NEUROCRIT CARE, V23, P339, DOI 10.1007/s12028-015-0146-5; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Vlodavsky E, 2017, J CEREBR BLOOD F MET, V37, P166, DOI 10.1177/0271678X15621068; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008	24	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2020	135									10.1016/j.wneu.2019.11.132			15	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KR7GS	WOS:000517784600031	31805402				2022-02-06	
J	Laane, SA; Cook, LG				Laane, Sarah A.; Cook, Lori G.			Cognitive-Communication Interventions for Youth with Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						cognitive-communication; traumatic brain injury; intervention; pediatric	INDIVIDUAL-DIFFERENCES; CHILDREN; REHABILITATION; ATTENTION; METAANALYSIS; DISORDERS	Traumatic brain injuries (TBIs) are relatively common in the pediatric population, yielding several potential challenges across a wide range of skills and abilities. Cognitive-communication disorders are particularly prevalent, with implications for long-term academic and social outcomes. While considerable evidence exists for identifying and characterizing the effects of cognitive-communication deficits, evidence informing effective interventions is still emerging. This review includes discussion of individual factors that affect treatment needs and outcomes as well as evidence that supports cognitive-communication intervention approaches at both a fundamental/discrete and integrated level. Also addressed is the need for modifying contextual factors that may be barriers as well as augmenting facilitators of successful communication and participation, including collaboration with everyday communication partners and identification and use of appropriate accommodations. Overall, research suggests a growing trend toward interventions that are individualized, dynamic, and combine multiple approaches for cognitive-communication treatment after pediatric TBI.	[Laane, Sarah A.; Cook, Lori G.] Univ Texas Dallas, Ctr BrainHlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA; [Laane, Sarah A.; Cook, Lori G.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA		Cook, LG (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 West Mockingbird Lane, Dallas, TX 75235 USA.	Lori.Cook@utdallas.edu					[Anonymous], PED TRAUM BRAIN INJ; Brainerd CJ, 1998, J EXP CHILD PSYCHOL, V71, P81, DOI 10.1006/jecp.1998.2464; Catroppa C, 2010, TRAUMATIC BRAIN INJU, P192; Cermak CA, 2019, J HEAD TRAUMA REHAB, V34, pE13, DOI 10.1097/HTR.0000000000000419; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Cook LG, 2008, NEUROREHABILITATION, V23, P467; DePompei R., 2019, PEDIAT TRAUMATIC BRA; Dettmer J., 2018, BRAIN INJURY CHILDRE; Eve M, 2016, APPL NEUROPSYCH-CHIL, V5, P273, DOI 10.1080/21622965.2015.1055563; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Gabrieli John D E, 2004, Cerebrum, V6, P39; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Grant M, 2014, NEUROPSYCHOL REHABIL, V24, P661, DOI 10.1080/09602011.2014.901228; Haslam C, 2012, NEUROPSYCHOL REHABIL, V22, P697, DOI 10.1080/09602011.2012.686820; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Landis J, 2006, ARCH PHYS MED REHAB, V87, P799, DOI 10.1016/j.apmr.2006.02.017; Lundine JP, 2017, EBP BRIEFS, V12, P1; MacDonald S, 2012, THINKING SPEAKING UN; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; McDonald S, 2014, SOCIAL COMMUNICATION; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; Ward S, 2014, PERSPECT LANG LEARN, V21, P72; Wehmeyer M. L., 1998, TEACHING SELF DETERM; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	38	1	1	2	5	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	MAR	2020	41	2					183	194		10.1055/s-0040-1701686			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LE5NF	WOS:000526765100005	32155653	Bronze			2022-02-06	
J	Lahav, Y; Solomon, Z; Siegel, A; Tsur, N; Defrin, R				Lahav, Yael; Solomon, Zahava; Siegel, Alana; Tsur, Noga; Defrin, Ruth			Punishing the Self: Post-Traumatic Guilt Mediates the Link Between Trauma and Deficient Pain Modulation	JOURNAL OF PAIN			English	Article						Trauma; pain perception; pain modulation; post-traumatic guilt; post-traumatic stress disorder	STRESS-DISORDER; FORMER PRISONERS; INJURY; PTSD; WAR; PERCEPTION; STRATEGIES; BRAIN; SHAME; FEAR	Trauma survivors may suffer from post-traumatic stress disorder (PTSD), elevated post-traumatic guilt (PG), and alterations in the pain system. However, the association between PG and alterations in pain perception and modulation among trauma survivors has not been established, nor has the possible underlying role of PG. This longitudinal study investigated: 1) the unique contribution of PG in predicting pain perception and modulation, while controlling for PTSD symptoms; and 2) the mediating role of PG in explaining pain perception and modulation among torture survivors, above and beyond PTSD symptoms. Participants were 59 torture survivors and 44 age-matched controls. PG and PTSD symptoms were assessed in 2003 (T1). Heat-pain threshold, heat-pain tolerance, temporal summation of pain (TSP), and conditioned pain modulation (CPM) were measured 5 years later (T2). Torture survivors had elevated PG and PTSD symptoms, enhanced TSP, and reduced CPM, compared to controls. While PTSD predicted reduced pain tolerance and CPM, PG predicted increased pain tolerance. Moreover, PG mediated the associations between torture and (increased) pain threshold, pain tolerance, and TSP. It appears that PTSD and PG induce opposite effects on the pain modulation capacity of torture survivors, a dichotomy that may explain paradoxical pain responses among trauma survivors, as discussed. Perspective: This longitudinal study sheds light on the possible mechanisms underlying variations in pain perception and modulation among trauma survivors. PTSD and PG each mediated opposing pain modulation profiles, suggesting that individual responses to trauma, rather than the trauma itself, influence pain responses. (C) 2020 U.S. Association for the Study of Pain. Published by Elsevier Inc. All rights reserved.	[Lahav, Yael; Solomon, Zahava; Siegel, Alana; Tsur, Noga] Tel Aviv Univ, I Core Res Ctr Mass Trauma, POB 39040, IL-69978 Tel Aviv, Israel; [Solomon, Zahava; Siegel, Alana; Tsur, Noga] Tel Aviv Univ, Bob Shapell Sch Social Work, Tel Aviv, Israel; [Defrin, Ruth] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel; [Defrin, Ruth] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Lahav, Y (corresponding author), Tel Aviv Univ, I Core Res Ctr Mass Trauma, POB 39040, IL-69978 Tel Aviv, Israel.	lahav.yael62@gmail.com	Lahav, Yael/AAD-4245-2021	Lahav, Yael/0000-0003-1242-9042	Israel Science Foundation (ISF)Israel Science Foundation [669/08]	The study was supported by a grant from the Israel Science Foundation (ISF) grant no. 669/08.	Aakvaag HF, 2016, J AFFECT DISORDERS, V204, P16, DOI 10.1016/j.jad.2016.06.004; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Bastian B, 2011, PSYCHOL SCI, V22, P334, DOI 10.1177/0956797610397058; Bastin C, 2016, NEUROSCI BIOBEHAV R, V71, P455, DOI 10.1016/j.neubiorev.2016.09.019; Bockers E, 2016, J NERV MENT DIS, V204, P95, DOI 10.1097/NMD.0000000000000428; Bogdanov VB, 2015, BEHAV BRAIN RES, V281, P187, DOI 10.1016/j.bbr.2014.11.028; Briere J, 1998, AM J ORTHOPSYCHIAT, V68, P609, DOI 10.1037/h0080369; Carinci AJ, 2010, CURR PAIN HEADACHE R, V14, P73, DOI 10.1007/s11916-010-0101-2; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Danelius H, 1988, UN CONVENTION TORTUR; Defrin R, 2014, EUR J PAIN, V18, P548, DOI 10.1002/j.1532-2149.2013.00394.x; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Defrin R, 2017, J PAIN, V18, P1, DOI 10.1016/j.jpain.2016.09.005; Defrin R, 2015, J PAIN, V16, P961, DOI 10.1016/j.jpain.2015.06.010; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Dikel TN, 2005, J TRAUMA STRESS, V18, P69, DOI 10.1002/jts.20002; George SZ, 2006, EUR J PAIN, V10, P457, DOI 10.1016/j.ejpain.2005.06.007; Geuze E, 2007, ARCH GEN PSYCHIAT, V64, P76, DOI 10.1001/archpsyc.64.1.76; Geva N, 2018, J PAIN, V19, P360, DOI 10.1016/j.jpain.2017.11.011; Gifuni AJ, 2017, BRAIN IMAGING BEHAV, V11, P1164, DOI 10.1007/s11682-016-9606-6; Goodin BR, 2009, J PAIN, V10, P180, DOI 10.1016/j.jpain.2008.08.012; Gratz KL, 2000, MEASUREMENT FUNCTION; Hamza CA, 2018, PSYCHIAT RES, V269, P462, DOI 10.1016/j.psychres.2018.08.096; Hezel DM, 2012, J BEHAV THER EXP PSY, V43, P981, DOI 10.1016/j.jbtep.2012.03.005; Hirsh AT, 2008, J PAIN, V9, P806, DOI 10.1016/j.jpain.2008.03.012; Hooley JM, 2010, PERSONAL DISORD, V1, P170, DOI 10.1037/a0020106; Kaur G, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020303; Kong J, 2013, PAIN, V154, P459, DOI 10.1016/j.pain.2012.12.004; Kozaric-Kovacic D, 1999, NORD J PSYCHIAT, V53, P11; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; Kubany ES, 1996, PSYCHOL ASSESSMENT, V8, P428, DOI 10.1037/1040-3590.8.4.428; KUBANY ES, 1995, COGN BEHAV PRACT, V2, P27, DOI 10.1016/S1077-7229(05)80004-5; Lahav Y, 2015, PSYCHIATRY, V78, P354, DOI 10.1080/00332747.2015.1061311; Leknes S, 2013, PAIN, V154, P402, DOI 10.1016/j.pain.2012.11.018; Levi-Belz Y, 2015, ARCH SUICIDE RES, V19, P231, DOI 10.1080/13811118.2013.845123; Lloyd-Richardson EE, 2007, PSYCHOL MED, V37, P1183, DOI 10.1017/S003329170700027X; Mickleborough MJS, 2011, J PSYCHIATR NEUROSCI, V36, P6, DOI 10.1503/jpn.080188; Owens G.P., 2008, J AGGRESSION MALTREA, V17, P439, DOI [10.1080/10926770802473908, DOI 10.1080/10926770802473908]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; PRICE DD, 1992, PAIN, V49, P163, DOI 10.1016/0304-3959(92)90139-3; Prip K, 2008, CLIN J PAIN, V24, P135, DOI 10.1097/AJP.0b013e31815aac36; Pugh LR, 2015, J AFFECT DISORDERS, V182, P138, DOI 10.1016/j.jad.2015.04.026; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Rintamaki LS, 2009, J AM GERIATR SOC, V57, P2257, DOI 10.1111/j.1532-5415.2009.02608.x; Robinson Michael E, 2010, J Pain Res, V3, P25; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; Solomon Z, 2007, AM J ORTHOPSYCHIAT, V77, P182, DOI 10.1037/0002-9432.77.2.182; Solomon Z, 2012, PSYCHIAT RES, V199, P188, DOI 10.1016/j.psychres.2012.03.035; Street AE, 2005, J TRAUMA STRESS, V18, P245, DOI 10.1002/jts.20026; Strigo IA, 2018, J NEUROTRAUM, V35, P297, DOI 10.1089/neu.2017.5061; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Thomsen AB, 2000, FORENSIC SCI INT, V108, P155, DOI 10.1016/S0379-0738(99)00209-1; Tilghman-Osborne C, 2010, CLIN PSYCHOL REV, V30, P536, DOI 10.1016/j.cpr.2010.03.007; Vaegter HB, 2018, CLIN J PAIN, V34, P313, DOI 10.1097/AJP.0000000000000543; van Wijk G, 2010, J PAIN, V11, P408, DOI 10.1016/j.jpain.2009.10.009; Wang G, 2014, PAIN, V155, P755, DOI 10.1016/j.pain.2014.01.005; Williams ACD, 2013, BRIT J PAIN, V7, P101, DOI 10.1177/2049463713483596; WILLIAMS C, 1994, DEV PSYCHOL, V30, P617, DOI 10.1037/0012-1649.30.5.617; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Youssef AM, 2016, HUM BRAIN MAPP, V37, P2630, DOI 10.1002/hbm.23199	61	1	1	18	42	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	MAR-APR	2020	21	3-4					364	374		10.1016/j.jpain.2019.07.004			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MX7IM	WOS:000557894300010	31401209				2022-02-06	
J	Lindquist, NR; Appelbaum, EN; Sweeney, AD; Vrabec, JT				Lindquist, Nathan R.; Appelbaum, Eric N.; Sweeney, Alex D.; Vrabec, Jeffrey T.			The Role of Obesity in Iatrogenic Encephaloceles of the Temporal Bone	OTOLOGY & NEUROTOLOGY			English	Article						Encephaloceles; Iatrogenic; Obesity	CEREBROSPINAL-FLUID LEAK; BRAIN HERNIATION; MIDDLE-EAR; MANAGEMENT; DIAGNOSIS; EXPERIENCE; OTORRHEA	Objective: Acquired encephaloceles of the temporal bone may be traumatic, spontaneous, or from chronic ear disease or previous surgery. Iatrogenic encephaloceles arise in the setting of previous mastoidectomy and traditionally involve both bony dehiscence and dural injury. We aim to classify and analyze the pathogenesis, clinical presentation, and treatment options for patients with iatrogenic tegmen defects and encephaloceles of the temporal bone. Study Design: Retrospective chart review. Setting: Single tertiary academic center. Patients: Subjects with iatrogenic tegmen defects and encephaloceles of the temporal bone were included. Intervention: Patient demographics, history, symptoms, radiographic data, intraoperative findings, management, follow-up, and outcomes were recorded. Outcome Measures: Primary outcome measures included patient characteristics, time from primary otologic surgery to surgical repair, location of the defect, and management strategy including surgical approach, methods, and follow-up. Results: Iatrogenic tegmen injuries or encephaloceles were identified in 18 patients and divided into intentional or unintentional. The latter group presented immediately, early, or late, as determined by intraoperative identification or from delayed symptoms. Eleven patients presented late with previously unrecognized encephaloceles. Compared with patients presenting with incidentally noted tegmen dehiscence during revision mastoidectomy, a significant proportion of patients with late encephaloceles had BMI >= 30 kg/m(2) (p = 0.03). Conclusion: The majority of iatrogenic encephaloceles are unintentional, unrecognized, and may present many years after primary surgery. Similar to spontaneous encephaloceles of the temporal bone, obesity is associated with iatrogenic encephaloceles, although the rate of progression and timing is unclear. We recommend primary repair of any unintentional tegmen defect encountered during mastoid surgery, especially in obese patients.	[Lindquist, Nathan R.; Appelbaum, Eric N.; Sweeney, Alex D.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Vrabec, Jeffrey T.] Houston Methodist Hosp, Houston Methodist ENT Specialists, 6550 Fannin St Suite 1723, Houston, TX 77030 USA		Vrabec, JT (corresponding author), Houston Methodist Hosp, Houston Methodist ENT Specialists, 6550 Fannin St Suite 1723, Houston, TX 77030 USA.	jvrabec2@houstonmethodist.org					Blioskas S, 2014, CASE REP OTOLARYNGOL, V2014, DOI 10.1155/2014/271824; Brown NE, 2004, LARYNGOSCOPE, V114, P800, DOI 10.1097/00005537-200405000-00002; Carlson ML, 2013, J NEUROSURG, V119, P1314, DOI 10.3171/2013.6.JNS13322; Egilmez OK, 2014, CASE REP OTOLARYNGOL, V2014, DOI 10.1155/2014/756280; Gacek RR, 1999, AM J OTOL, V20, P770; GLASSCOCK ME, 1979, LARYNGOSCOPE, V89, P1743; Goddard JC, 2010, OTOL NEUROTOL, V31, P940, DOI 10.1097/MAO.0b013e3181e8f36c; Jackson CG, 1997, AM J OTOL, V18, P198; Kenning TJ, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.4.FOCUS1265; LALWANI AK, 1993, J NEUROSURG, V79, P596, DOI 10.3171/jns.1993.79.4.0596; Levay AJ, 2008, LARYNGOSCOPE, V118, P275, DOI 10.1097/MLG.0b013e31815937a6; Lundy LB, 1996, AM J OTOL, V17, P461; NEELY JG, 1985, LARYNGOSCOPE, V95, P1299; Prichard CN, 2006, OTOLARYNG HEAD NECK, V134, P767, DOI 10.1016/j.otohns.2006.01.002; RAMANIKANTH TV, 1990, J LARYNGOL OTOL, V104, P982, DOI 10.1017/S0022215100114550; Sanna M, 2009, LARYNGOSCOPE, V119, P1579, DOI 10.1002/lary.20510; Stucken EZ, 2012, OTOL NEUROTOL, V33, P1412, DOI 10.1097/MAO.0b013e318268d350; Wahba H, 2013, EUR ARCH OTO-RHINO-L, V270, P2427, DOI 10.1007/s00405-012-2260-8; Wootten CT, 2005, LARYNGOSCOPE, V115, P1256, DOI 10.1097/01.MLG.0000165455.20118.E3	19	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	MAR	2020	41	3					E342	E348		10.1097/MAO.0000000000002527			7	Clinical Neurology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	LC1UX	WOS:000525115300015	31851068				2022-02-06	
J	Lovrencic-Huzjan, A; Bosnar-Puretic, M; Hustic, I; Kobasic, I; Budisic, M; Coric, L; Roje-Bedekovic, M				Lovrencic-Huzjan, Arijana; Bosnar-Puretic, Marijana; Hustic, Ivana; Kobasic, Ivana; Budisic, Mislav; Coric, Lejla; Roje-Bedekovic, Marina			OPTIC NERVE SHEATH SONOGRAPHY IS A PROMISING TOOL FOR ASSESSMENT OF RAISED INTRACRANIAL PRESSURE IN PATIENTS ADMITTED TO NEUROLOGICAL INTENSIVE CARE UNIT	ACTA CLINICA CROATICA			English	Article						Optic nerve; Brain injuries; traumatic; Intracranial pressure; Ultrasonography	HYPERACUTE STAGE; ULTRASONOGRAPHY; DIAMETER	Optic nerve sheath diameter (ONSD) enlargement is detectable in traumatic brain injury patients with raised intracranial pressure (ICP). The aim was to assess its value in neurological patients suspected to have increased ICP. Patient clinical imaging data and hospitalization outcome were analyzed. Patients were divided into groups according to brain pathology and level of consciousness with Glasgow Coma Score (GCS). Poor hospitalization outcome was assessed by modified Rankin scale (mRS) >3. Data obtained by ocular sonography performed in acute setting were compared with data of 100 control subjects. Data were expressed as mean +/- SD. Intergroup comparison was performed by Student's t-test. Data of 34 patients (63 +/- 16 years) were suitable for analysis, including 8 primary intracerebral hemorrhage (PICH), 8 subarachnoid hemorrhage (SAH), 12 PICH or SAH and intraventricular hemorrhage (IVH), 4 tumors and 2 ischemic strokes. The mean ONSD was 5.86 +/- 0.69 mm in patients versus 4.38 +/- 0.41 mm in controls (p<0.01). ONSD was 6.28+0.61 mm in patients with GCS <8 and 5.77+0.55 mm in other patients (p<0.05). ONSD was 5.72 +/- 0.59 mm in PICH versus 6.20 +/- 0.65 mm in PICH/SAH with IVH (p=0.1). ONSD was 5.73 +/- 0.38 mm in SAH in comparison to PICH/SAH with IVH (p=0.05). There was no statistically significant difference in optic nerve diameter between patients and controls (2.48 +/- 0.28 mm vs. 2.39 +/- 0.33 mm; p>0.05). Pronounced enlargement of ONSD was observed in patients with ICH or SAH with IVH, and in patients with GCS <8. Enlarged ONSD was associated with poor neurological outcome (mRS >3).	[Lovrencic-Huzjan, Arijana; Bosnar-Puretic, Marijana; Hustic, Ivana; Kobasic, Ivana; Budisic, Mislav; Coric, Lejla; Roje-Bedekovic, Marina] Sestre Milosrdnice Univ Hosp Ctr, Dept Neurol, Vinogradska C 29, HR-10000 Zagreb, Croatia; [Lovrencic-Huzjan, Arijana; Bosnar-Puretic, Marijana; Hustic, Ivana; Kobasic, Ivana; Budisic, Mislav; Coric, Lejla; Roje-Bedekovic, Marina] Univ Zagreb, Sch Med, Zagreb, Croatia; [Lovrencic-Huzjan, Arijana] Univ Zagreb, Sch Dent Med, Zagreb, Croatia		Lovrencic-Huzjan, A (corresponding author), Sestre Milosrdnice Univ Hosp Ctr, Dept Neurol, Vinogradska C 29, HR-10000 Zagreb, Croatia.	arijana.huzjan@gmail.com					Bauerle J, 2016, J NEUROIMAGING, V26, P194, DOI 10.1111/jon.12287; Bauerle J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-187; Bauerle J, 2012, PERSPECT MED, V1, P404; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Fichtner J, 2016, J NEUROL NEUROSUR PS, V87, P650, DOI 10.1136/jnnp-2015-310853; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Gokcen E, 2017, AM J EMERG MED, V35, P1607, DOI 10.1016/j.ajem.2017.04.073; HASSLER W, 1988, J NEUROSURG, V68, P745; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lochner P, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0594-3; Lochner P, 2014, J ULTRASOUND, V17, P225, DOI 10.1007/s40477-014-0069-6; Lovrencic-Huzjana A., 2012, PERSPECT MED, V1, P414; Skoloudik D, 2011, BRIT J OPHTHALMOL, V95, P217, DOI 10.1136/bjo.2009.172890; Toscano M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1621428; Ueda T, 2015, J NEUROIMAGING, V25, P927, DOI 10.1111/jon.12246	17	1	1	4	7	SESTRE MILOSRDNICE UNIV HOSPITAL	ZAGREB	VINOGRADSKA C 29, ZAGREB, HR-10000, CROATIA	0353-9466	1333-9451		ACTA CLIN CROAT	Acta Clin. Croat.	MAR	2020	59	1					50	54		10.20471/acc.2020.59.01.06			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW6YG	WOS:000575161900006	32724274	gold, Green Published			2022-02-06	
J	MacMaster, FP; McLellan, Q; Harris, AD; Virani, S; Barlow, KM; Langevin, LM; Yeates, KO; Brooks, BL				MacMaster, Frank P.; McLellan, Quinn; Harris, Ashley D.; Virani, Shane; Barlow, Karen M.; Langevin, Lisa Marie; Yeates, Keith Owen; Brooks, Brian L.			N-Acetyl-Aspartate in the Dorsolateral Prefrontal Cortex Long After Concussion in Youth	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; chronic; concussion; magnetic resonance spectroscopy; youth	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; MULTIPLE PAST CONCUSSIONS; SPORTS-RELATED CONCUSSION; TEMPORAL WINDOW; POSTCONCUSSION SYNDROME; EMERGENCY-DEPARTMENT; ACETYLASPARTATE; CHILDREN; SYMPTOMS	Objective: Despite increasing interest in the neurobiological effects of concussion in youth, a paucity of information is available regarding outcomes long after injury. The objective of this study was to determine the association between a history of concussion and the putative neuronal marker N-acetyl-aspartate (NAA) in the dorsolateral prefrontal cortex (DLPFC) in youth. Setting: Outpatient clinic in a children's hospital. Participants: Youth with concussion (N = 35, mean = 2.63, SD = 1.07 years postinjury) and youth with a nonconcussive orthopedic injury (N = 17) participated. Design: A cross-sectional proton magnetic resonance spectroscopy (H-1-MRS) study. Main Measures: The primary outcome measure was NAA concentration in the right and left DLPFCs. Results: We observed lower levels of NAA in the right DLPFC in youth with past concussion (F = 3.31, df = 4,51, P = .018) than in orthopedic controls but not in the left DLPFC (F = 2.04, df = 4,51, P = .105). The effect of lower NAA concentrations in the right DLPFC was primarily driven by youth with a single prior concussion versus those with multiple concussions. NAA in the left DLPFC, but not in right DLPFC, was associated with worse emotional symptoms in youth with concussion. Conclusion: The presence of lower levels of DLPFC NAA suggests potential association of concussion in youth, although further investigation is needed, given that the result is driven by those with a single (and not multiple) concussion. Exploration of applying MRS in other brain regions is also warranted.	[MacMaster, Frank P.; Barlow, Karen M.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [MacMaster, Frank P.] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [McLellan, Quinn] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Harris, Ashley D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Langevin, Lisa Marie; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Langevin, Lisa Marie; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Harris, Ashley D.; Virani, Shane; Barlow, Karen M.; Langevin, Lisa Marie; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Harris, Ashley D.; Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [MacMaster, Frank P.] Alberta Hlth Serv, Strateg Clin Network Addict & Mental Hlth, Calgary, AB, Canada; [Virani, Shane; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neuropsychol Serv, Calgary, AB, Canada; [Barlow, Karen M.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca	Barlow, Karen/C-1323-2014; Yeates, Keith/AAJ-4223-2020	Barlow, Karen/0000-0003-2612-8507; MacMaster, Frank/0000-0002-7159-7583; McLellan, Quinn/0000-0003-3806-2218	Shaikh Family Research Award; Ronald and Irene Ward Chair in Pediatric Brain Injury; Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR); Ronald and IreneWard Chair in Pediatric Brain Injury	This study was funded by the Shaikh Family Research Award (an endowment held by the Alberta Children's Hospital Foundation and granted to Brian Brooks by theAlberta Children's Hospital Research Institute), with additional support from the Ronald and Irene Ward Chair in Pediatric Brain Injury (awarded to Keith Yeates). Brian Brooks acknowledges salary funding from the Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary Award. Keith Yeates acknowledges funding from the Ronald and IreneWard Chair in Pediatric Brain Injury.	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Best J, 2013, MAGNETIC RESONANCE S, P112; BOHNEN N, 1993, EUR NEUROL, V33, P77, DOI 10.1159/000116907; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Buonocore MH, 2015, REV NEUROSCIENCE, V26, P609, DOI 10.1515/revneuro-2015-0010; Carrey NJ, 2007, J CHILD ADOL PSYCHOP, V17, P11, DOI 10.1089/cap.2006.0008; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CNS Vital Signs, 2014, CNS VIT SIGNS TEST I; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gaines KD, 2018, APPL NEUROPSYCH-CHIL, V7, P31, DOI 10.1080/21622965.2016.1229406; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; KIRINO T, 1991, J CEREBR BLOOD F MET, V11, P299, DOI 10.1038/jcbfm.1991.62; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lin JC, 2013, I SYMP CONSUM ELECTR, P109; LIU Y, 1992, BRAIN RES, V586, P121, DOI 10.1016/0006-8993(92)91380-W; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; Olvera RL, 2007, J CHILD ADOL PSYCHOP, V17, P461, DOI 10.1089/cap.2007.0102; Olvera RL, 2010, PSYCHIAT RES-NEUROIM, V184, P71, DOI 10.1016/j.pscychresns.2010.07.008; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rackayova V, 2017, ANAL BIOCHEM, V529, P144, DOI 10.1016/j.ab.2016.11.007; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Reynolds S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-83; Rosen Y, 2007, NEUROTHERAPEUTICS, V4, P330, DOI 10.1016/j.nurt.2007.04.009; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Shen J., 2013, MAGNETIC RESONANCE S, P111; Stanley JA, 2002, CAN J PSYCHIAT, V47, P315, DOI 10.1177/070674370204700402; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Yang XR, 2016, PSYCHIAT CLIN NEUROS, V70, P269, DOI 10.1111/pcn.12392; Yang XR, 2014, J ECT, V30, P242, DOI 10.1097/YCT.0000000000000094; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	71	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E127	E135		10.1097/HTR.0000000000000535			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500010	31479085				2022-02-06	
J	Pagani, LS; Ellemberg, D; Moore, RD				Pagani, Linda S.; Ellemberg, Dave; Moore, Robert Davis			Clinically Historical and Prospective Associations Between Learning Disorders and Concussion in Young Adult Athletes	AMERICAN JOURNAL OF LIFESTYLE MEDICINE			English	Article						mild traumatic brain injury; concussion; head injury; sport injury; learning disorder; learning disability	TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; YOUTH; MILD; CHILDHOOD; SCHOOL; HYPERACTIVITY; DISABILITIES; STATEMENT; MEDICINE	Background. Athletes with specific learning disorder (LD) tend to score lower on neuropsychological tests and are at increased risk of personal injury than their counterparts without such disorders. Using a retrospective historical and prospective design, we examined whether adult athletes with LD, the most prevalent of neurodevelopmental disorders, experience greater chances of past and future concussions than their counterparts without LD. We expected to find that young athletes with LD would show greater risk of past (historical) and future (prospective) cerebral concussions. Methods. Participants (95 men and 53 women aged 18 to 25 years) were recruited from university sports teams and followed during an entire season. Of these, 38 participants had a history of LD and 101 had a history of at least 1 concussion (72 males, 29 females) at the preseason baseline. One-third experienced a new concussion. Data analytic procedures include inferential cross-tabulations. Results. Athletes with LD were twice more likely to have a concussion history at baseline and to have a history of multiple concussions than athletes without LD; 95% CI = [0.86, 4.92] and [0.77, 3.40], respectively. Athletes with LD were twice more likely to incur a new concussion than those without LD; 95% CI = [0.86, 4.92]. Conclusions. Adult athletes with LD experience greater chances of previous and future concussions compared with counterparts without LD. Preventive practices regarding individuals with neurodevelopmental disorders may not only prevent the biopsychosocial consequences of brain trauma for the individual, but also represent a cost-effective public health measure.	[Pagani, Linda S.] Univ Montreal, Ecole Psychoeduc, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Pagani, Linda S.; Ellemberg, Dave] Univ Montreal, St Justines Hosp Res Ctr, Brain Dis Div, Montreal, PQ, Canada; [Ellemberg, Dave] Univ Montreal, Lab Neuropsychol Sport & Dev, Montreal, PQ, Canada; [Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, NC USA		Pagani, LS (corresponding author), Univ Montreal, Ecole Psychoeduc, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	Linda.s.pagani@umontreal.ca					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arnold C, 2014, LANCET NEUROL, V13, P136, DOI 10.1016/S1474-4422(13)70287-4; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Bauer A, 2015, BRIT J LEARN DISABIL, V43, P66, DOI 10.1111/bld.12089; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Brenner RA, 2013, INT J INJ CONTROL SA, V20, P259, DOI 10.1080/17457300.2012.696662; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Chorozoglou M, 2015, J CHILD PSYCHOL PSYC, V56, P966, DOI 10.1111/jcpp.12437; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Doshi JA, 2012, J AM ACAD CHILD PSY, V51, P990, DOI 10.1016/j.jaac.2012.07.008; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Finlayson J, 2014, BRIT J OCCUP THER, V77, P400, DOI 10.4276/030802214X14071472109833; Gaddes William H, 2013, LEARNING DISABILITIE; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hooper SR, 2013, LEARNING DISABILITY; IVERSON G, 2014, BRAIN INJURY, V28, P667, DOI DOI 10.1089/neu.2014.3424; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Lefebvre G, 2015, BRAIN INJURY, V29, P1032, DOI 10.3109/02699052.2015.1028447; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath LM, 2016, J CHILD PSYCHOL PSYC, V57, P462, DOI 10.1111/jcpp.12463; Moll K, 2016, J LEARN DISABIL-US, V49, P272, DOI 10.1177/0022219414547221; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Penttila Jani, 2011, Duodecim, V127, P1433; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Samek DR, 2015, J ADOLESCENT HEALTH, V57, P107, DOI 10.1016/j.jadohealth.2015.03.009; Seifert T, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0513-0; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Wood H, 2015, NAT REV NEUROL, V11, P607, DOI [10.1038/nrneurol.2015.37, 10.1038/nrneurol.2015.148, 10.1038/nrneurol.2015.9, 10.1038/nrneurol.2015.105, 10.1038/nrneurol.2015.40, 10.1038/nrneurol.2015.204, 10.1038/nrneurol.2015.149, 10.1038/nrneurol.2015.205]; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	37	1	1	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1559-8276	1559-8284		AM J LIFESTYLE MED	Am. J. Lifestyle Med.	MAR	2020	14	2					187	193		10.1177/1559827618793350			7	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	LA7RQ	WOS:000524141400014	32231484	Green Published			2022-02-06	
J	Park, S; Kim, HJ; Kim, DK; Kim, TH				Park, Seunghun; Kim, Hyun-Jun; Kim, Dong Kyu; Kim, Tae Hee			Use of Oral Prednisolone and a 3-Phase Bone Scintigraphy in Patients with Complex Regional Pain Syndrome Type I	HEALTHCARE			English	Article						complex regional pain syndromes; steroids; radionuclide imaging; high dose; low dose	REFLEX SYMPATHETIC DYSTROPHY; DIAGNOSTIC-CRITERIA; EFFICACY; STROKE	To compare the treatment effects of a high-dose and low-dose oral steroid regimen based on changes in the radioisotope uptake ratio (RUR) observed from three-phase bone scintigraphy (TPBS) in patients with complex regional pain syndrome type I (CRPS I), we retrospectively analyzed data of 34 patients with CRPS I from traumatic brain injury and stroke. Depending on the dose of steroid administered, patients were divided into high-dose (n = 14) and low-dose steroid groups (n = 20). We compared the severity scores, Kozin's classification scores, and RUR observed from TPBS between the two groups. There were significant changes in the severity scores and Kozin's classification between the baseline and 2 weeks from baseline (p < 0.05), however, there were no significant differences in terms of changes in the scores, classification, or the RUR observed from TPBS at 2 weeks from baseline (p > 0.05). There were no treatment-emergent adverse events (TEAEs) such as blood pressure elevation, impaired glycemic control, or gastrointestinal disturbances. Our results indicate that the efficacy profile of a low-dose oral steroid regimen is comparable to that of a high-dose regimen in alleviating symptoms in CRPS I patients. However, additional prospective, large-scale, multi-center studies are warranted to confirm our results.	[Park, Seunghun; Kim, Dong Kyu; Kim, Tae Hee] Konkuk Univ, Dept Rehabil Med, Chungju Hosp, Chungju 27478, South Korea; [Kim, Hyun-Jun] Konkuk Univ, Sch Med, Dept Obstet & Gynecol, Chungju 27478, South Korea; [Kim, Hyun-Jun; Kim, Tae Hee] Konkuk Univ, Res Inst Med Sci, Sch Med, Seoul 05029, South Korea		Kim, TH (corresponding author), Konkuk Univ, Dept Rehabil Med, Chungju Hosp, Chungju 27478, South Korea.; Kim, TH (corresponding author), Konkuk Univ, Res Inst Med Sci, Sch Med, Seoul 05029, South Korea.	silveryluna@gmail.com; icarus@kku.ac.kr; peyous@hanmail.net; whitepoem37@naver.com		Park, Seung hun/0000-0002-3008-5768; KIM, TAEHEE/0000-0002-9141-6380	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A3B04031900]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A3B04031900).	Ackerman WE, 2006, SOUTH MED J, V99, P1084, DOI 10.1097/01.smj.0000233257.76957.b2; ATKINS RM, 1993, BRIT J RHEUMATOL, V32, P41; Birklein F, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000624; BRAUS DF, 1994, ANN NEUROL, V36, P728, DOI 10.1002/ana.410360507; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CHRISTENSEN K, 1982, ACTA CHIR SCAND, V148, P653; Dudhia J, 2015, JOVE-J VIS EXP, DOI 10.3791/52748; Fischer SGL, 2010, PAIN, V151, P251, DOI 10.1016/j.pain.2010.07.020; Goh EL, 2017, BURNS TRAUMA, V5, DOI 10.1186/s41038-016-0066-4; Goto S, 2013, STEREOT FUNCT NEUROS, V91, P386, DOI 10.1159/000350022; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Harden RN, 2010, PAIN, V150, P268, DOI 10.1016/j.pain.2010.04.030; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hong JB, 2005, ANN REHABIL MED-ARM, V29, P337; Kalita J, 2006, QJM-INT J MED, V99, P89, DOI 10.1093/qjmed/hcl004; Kalita J, 2016, PAIN PHYSICIAN, V19, P565; Kim YW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004388; KOZIN F, 1981, AM J MED, V70, P23, DOI 10.1016/0002-9343(81)90407-1; Kwon HW, 2011, NUCL MED MOLEC IMAG, V45, P261, DOI 10.1007/s13139-011-0104-x; Oray M, 2016, EXPERT OPIN DRUG SAF, V15, P457, DOI 10.1517/14740338.2016.1140743; Ozturk E, 2004, ANN NUCL MED, V18, P653, DOI 10.1007/BF02985958; Perez RS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-20; Perez RSGM, 2007, EUR J PAIN, V11, P895, DOI 10.1016/j.ejpain.2007.02.006; Reinders MF, 2002, CLIN J PAIN, V18, P207, DOI 10.1097/00002508-200207000-00001; Schleich FS, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-53; Shehab D, 2006, MED PRIN PRACT, V15, P46, DOI 10.1159/000089385; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Sung DH, 1997, J KOREAN ACAD REHAB, V21, P851; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Zyluk A, 2003, J HAND SURG-BRIT EUR, V28B, P238, DOI 10.1016/S0266-7381(02)00397-2/jhsb.2003.0902	30	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9032		HEALTHCARE-BASEL	Healthcare	MAR	2020	8	1							16	10.3390/healthcare8010016			10	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	LA1MZ	WOS:000523720400037	31936474	gold, Green Published			2022-02-06	
J	Peters, ME; Rahman, S; Coughlin, JM; Pomper, MG; Sair, HI				Peters, Matthew E.; Rahman, Saudur; Coughlin, Jennifer M.; Pomper, Martin G.; Sair, Haris I.			Characterizing the Link Between Glial Activation and Changed Functional Connectivity in National Football League Players Using Multimodal Neuroimaging	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							BRAIN; CONCUSSION; FMRI; INTEGRITY; NETWORK; HISTORY	Objective: The primary objective of this preliminary study was to examine the impact of NFL play on interregional functional connectivity between two brain regions, the supramarginal gyrus (SMG) and the thalamus, identified as having higher binding of [C-11]DPA-713 in NFL players. The authors' secondary objective was to examine the effect of years since play on the interregional connectivity. Methods: Resting-state functional MRI was used to examine functional brain changes between regions with evidence of past injury in active or recently retired NFL players (defined as <= 12 years since NFL play) and distantly retired players (defined as >12 years since NFL play). Age-comparable individuals without a history of concussion or participation in collegiate or professional collision sports were included as a control group. Results: Compared with healthy control subjects, NFL players showed a loss of anticorrelation between the left SMG and bilateral thalami (mean z score=-2.434, p=0.015). No difference was observed when examining right SMG connectivity. The pattern of connectivity in active and recently retired players mimicked the pattern observed in distantly retired players and older control subjects. Conclusions: Further study of the clinical significance of this altered pattern of interregional connectivity in active and recently retired NFL players is needed.	[Peters, Matthew E.; Rahman, Saudur; Coughlin, Jennifer M.; Pomper, Martin G.; Sair, Haris I.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA		Peters, ME (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mpeter42@jhmi.edu			GE; National Football League Head Health Challenge IGeneral Electric; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG026778]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS100847]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB024495]	Supported by the GE and National Football League Head Health Challenge I and NIH (grant T32AG026778 [to Dr. Peters]), the National Institute of Neurological Disorders and Stroke (grant R01 NS100847), and the National Institute of Biomedical Imaging and Bioengineering (grant P41 EB024495).	Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelly JP, 1997, NEUROLOGY, V48, P581; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Sair HI, 2018, RADIOLOGY, V287, P247, DOI 10.1148/radiol.2017162161; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	19	1	1	0	1	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2020	32	2					191	195		10.1176/appi.neuropsych.18110274			5	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	MV7WG	WOS:000556562500012	31394988	Bronze, Green Accepted			2022-02-06	
J	Ratiu, I; Azuma, T				Ratiu, Ileana; Azuma, Tamiko			Assessment of executive function in bilingual adults with history of mild traumatic brain injury	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; executive function; bilingualism	INDIVIDUAL-DIFFERENCES; LANGUAGE CONTROL; SPANISH-ENGLISH; TASK; ADVANTAGE; DIVERSITY; DEFICITS; UNITY	Background and objective: Adults with a history of traumatic brain injury (TBI) often show deficits in executive function (EF), including the ability to inhibit, switch, and attend to task relevant information. Although performances differences between bilinguals and monolinguals have been observed in EF tasks, there is little research on the effect of TBI on EF in bilinguals. In this study, an ecologically valid standardized measure and experimental computerized tasks of EF were administered to Spanish-English bilingual adults with and without history of mild traumatic brain injury (mTBI). Method: Twenty-two bilinguals with a history of mTBI [mean age=20.1 years,SD=3.7; education=13.4 years,SD=0.7] and 20 control bilinguals [mean age=20.8 years,SD=3.6; education=13.7 years,SD=1.1], matched for age and education, completed language proficiency questionnaires, theFunctional Assessment of Verbal Reasoning and Executive Strategies (FAVRES), English and Spanish language assessments, and a Flanker task (a test of inhibition). Results: Performance was analyzed using analyses of covariance. The results revealed that bilinguals with a history of mTBI performed worse on both the standardized assessment (FAVRES) and inhibition task. Interestingly, self-reported EF deficits were consistent with performance on these measures. Conclusion: The findings of this study provide useful information regarding assessment of EF deficits in bilinguals with a history mTBI. Computerized experimental tasks of EF may also prove useful in the assessment of EF in individuals with mTBI.	[Ratiu, Ileana; Azuma, Tamiko] Midwestern Univ, Dept Speech Language Pathol, 19555 N 59th Ave, Glendale, AZ 85308 USA; [Ratiu, Ileana] Arizona State Univ, Dept Speech & Hearing Sci, POB 870102, Tempe, AZ 85287 USA		Ratiu, I (corresponding author), Midwestern Univ, Dept Speech Language Pathol, 19555 N 59th Ave, Glendale, AZ 85308 USA.; Ratiu, I (corresponding author), Arizona State Univ, Dept Speech & Hearing Sci, POB 870102, Tempe, AZ 85287 USA.	iratiu@midwestern.edu			American Speech-Language-Hearing Foundation; Graduate and Professional Student Association of Arizona State University	This research was supported in part by the American Speech-Language-Hearing Foundation and the Graduate and Professional Student Association of Arizona State University. The authors are employed by the affiliated universities. The authors have no other financial or nonfinancial relationships to disclose.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; American Speech-Language-Hearing Association, 2004, KNOWL SKILLS NEED SP; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Bialystok E, 2006, Q J EXP PSYCHOL, V59, P1968, DOI 10.1080/17470210500482955; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cooper K. D, 1983, NEUROEPIDEMIOLOGY, V2, P79, DOI [10.1159/000110513, DOI 10.1159/000110513]; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891; Dijkstra T., 1998, BILINGUALISM LANGUAG, V1, P51, DOI 10.1017/S1366728998000121; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Emmorey K, 2008, PSYCHOL SCI, V19, P1201, DOI 10.1111/j.1467-9280.2008.02224.x; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Friesen DC, 2015, INT J BILINGUAL, V19, P693, DOI 10.1177/1367006914534331; Garner JK, 2009, J PSYCHOL, V143, P405, DOI 10.3200/JRLP.143.4.405-426; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; Gollan TH, 2008, J MEM LANG, V58, P787, DOI 10.1016/j.jml.2007.07.001; Gollan TH, 2011, PSYCHOL SCI, V22, P1155, DOI 10.1177/0956797611417002; Gollan TH, 2002, NEUROPSYCHOLOGY, V16, P562, DOI 10.1037//0894-4105.16.4.562; Green DW, 2013, J COGN PSYCHOL, V25, P515, DOI 10.1080/20445911.2013.796377; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kroll JF, 2015, ANNU REV LINGUIST, V1, P377, DOI 10.1146/annurev-linguist-030514-124937; Luk G, 2011, BILING-LANG COGN, V14, P588, DOI 10.1017/S1366728911000010; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Martin N. A., 2012, RECEPTIVE ONE WORD P; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Mueller JA, 2013, J SPEECH LANG HEAR R, V56, P1051, DOI 10.1044/1092-4388(2012/12-0147); Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Prior A, 2011, J INT NEUROPSYCH SOC, V17, P682, DOI 10.1017/S1355617711000580; Prior A, 2010, BILING-LANG COGN, V13, P253, DOI 10.1017/S1366728909990526; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ratiu I, 2017, BRAIN LANG, V166, P29, DOI 10.1016/j.bandl.2016.12.004; Ratiu I, 2015, J COGN PSYCHOL, V27, P1, DOI 10.1080/20445911.2014.976226; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Romaine S., 1995, BILINGUALISM; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Singh N, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00322; Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Valian V, 2015, BILING-LANG COGN, V18, P3, DOI 10.1017/S1366728914000522; West S. G., 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1037/0008-400X.26.2.210; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	59	1	1	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2020	21	1					32	46	PII S1443964619000172	10.1017/BrImp.2019.17			15	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	OB2QS	WOS:000578318900003					2022-02-06	
J	Roach, SP; Houston, MN; Peck, KY; Svoboda, SJ; Kelly, TF; Malvasi, SR; McGinty, GT; Campbell, DE; Cameron, KL				Roach, Sean P.; Houston, Megan N.; Peck, Karen Y.; Svoboda, Steven J.; Kelly, Tim F.; Malvasi, Steven R.; McGinty, Gerald T.; Campbell, Darren E.; Cameron, Kenneth L.			The Influence of Self-Reported Tobacco Use on Baseline Concussion Assessments	MILITARY MEDICINE			English	Article							CIGARETTE-SMOKING; PERFORMANCE; CONSEQUENCES; ASSOCIATION; DEPRIVATION; PERSONNEL; SPORT	Introduction Baseline symptom, balance, and neurocognitive scores have become an integral piece of the concussion management process. Factors such as sleep, learning disorders, fitness level, and sex have been linked to differences in performance on baseline assessments; however, it is unclear how tobacco use may affect these scores. The objective of this study was to compare baseline concussion assessment scores between service academy cadets who use and do not use tobacco. Methods Cadets completed a standard battery of concussion baseline assessments per standard of care and were classified into two groups: tobacco users (n = 1,232) and nonusers (n = 5,922). Dependent variables included scores on the Balance Error Scoring System, Standardized Assessment of Concussion, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Brief Symptom Inventory-18, and Brief Sensation Seeking Scale (BSSS). Separate Mann-Whitney U-tests were used to compare all baseline assessment scores between groups with an adjusted P-value < 0.004. Results Cadets that used tobacco performed significantly worse on the impulse control (P < 0.001) section of the ImPACT, reported greater ImPACT symptom severity scores (P < 0.001), and were more likely to take risks as measured by the BSSS (P < 0.001). No differences were detected for Balance Error Scoring System, Standardized Assessment of Concussion, Brief Symptom Inventory-18, and Sport Concussion Assessment Tool-3 symptom scores, verbal memory, visual memory, visual-motor speed, or reaction time on the ImPACT (P > 0.004). Conclusions Tobacco users performed significantly worse than tobacco nonusers on the impulse control section of the ImPACT, reported greater symptom severity scores on the ImPACT, and were more likely to take risks as measured by the BSSS. Despite statistical significance, these results should be interpreted with caution, as the overall effect sizes were very small. Future research should examine the influence of tobacco use on recovery post-concussion.	[Roach, Sean P.; Houston, Megan N.; Malvasi, Steven R.; Cameron, Kenneth L.] Keller Army Community Hosp, 900 Washington Rd, West Point, NY 10996 USA; [Peck, Karen Y.; Kelly, Tim F.] US Mil Acad, 606 Thayer Rd, West Point, NY 10996 USA; [Svoboda, Steven J.] MedStar Hlth, 1120 20th St Northwest,Suite 115, Washington, DC 20036 USA; [McGinty, Gerald T.] US Air Force Acad, 2355 Fac Dr,Suite 1N207, Colorado Springs, CO 80840 USA; [Campbell, Darren E.] Logan Reg Orthoped, 1350 N 500 E, Logan, UT 84321 USA		Roach, SP (corresponding author), Keller Army Community Hosp, 900 Washington Rd, West Point, NY 10996 USA.			Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research and Education (CARE) Consortium - National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This project was supported, in part, by the Grand Alliance Concussion Assessment, Research and Education (CARE) Consortium, funded by the National Collegiate Athletic Association and the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Barlas FM, 2013, 2011 HLTH RELATED BE; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cochrane GD, 2018, CLIN J SPORT MED, V28, P125, DOI 10.1097/JSM.0000000000000443; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Dawkins L, 2013, PSYCHOPHARMACOLOGY, V227, P377, DOI 10.1007/s00213-013-2983-2; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; FEIGELMAN W, 1994, PREV MED, V23, P235, DOI 10.1006/pmed.1994.1032; Fowles J., 2000, CHEM CONSTITUENTS CI, P65; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GROSS TM, 1993, PSYCHOPHARMACOLOGY, V110, P333, DOI 10.1007/BF02251289; Hatsukami D, 1989, J Subst Abuse, V1, P407; HEIMSTRA NW, 1980, ERGONOMICS, V23, P1047, DOI 10.1080/00140138008924813; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Hoad N A, 1992, J R Army Med Corps, V138, P115; Kansagara D., 2013, COMPLICATIONS MILD T; Klesges RC, 2001, TOB CONTROL, V10, P43, DOI 10.1136/tc.10.1.43; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Martinsen M, 2014, SCAND J MED SCI SPOR, V24, P439, DOI 10.1111/j.1600-0838.2012.01505.x; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Mundel T, 2017, SPORTS MED, V47, P2497, DOI 10.1007/s40279-017-0764-5; Olmsted KLR, 2011, NICOTINE TOB RES, V13, P691, DOI 10.1093/ntr/ntr060; Sandel NK, 2018, BRAIN INJURY, V32, P493, DOI 10.1080/02699052.2018.1429020; SNYDER FR, 1989, PSYCHOPHARMACOLOGY, V97, P17, DOI 10.1007/BF00443406; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	35	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					E431	E437		10.1093/milmed/usz352			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR7HU	WOS:000535866100019	31603220	hybrid			2022-02-06	
J	Sherrod, BA; Yoon, NK; Anzai, Y; Schmidt, RH; Couldwell, WT; Hawryluk, GWJ				Sherrod, Brandon A.; Yoon, Nam K.; Anzai, Yoshimi; Schmidt, Richard H.; Couldwell, William T.; Hawryluk, Gregory W. J.			Delayed Cerebrospinal Fluid Cleft Formation Through the Midbrain and Thalamus Following Hemicraniectomy and Cranioplasty for Acute Subdural Hematoma	OPERATIVE NEUROSURGERY			English	Article						Cerebrospinal fluid; Cleft; Traumatic brain injury; Hemicraniectomy; Hydrocephalus; Ventriculoperitoneal shunt	INFLICTED HEAD-INJURY; NEUROPATHOLOGY	BACKGROUND AND IMPORTANCE: Cerebrospinal fluid (CSF) cleft formation through brain parenchyma following nonpenetrating traumatic brain injury (TBI) is a rare phenomenon. Here we present a unique case of delayed CSF cleft formation months after initial injury. CLINICAL PRESENTATION: A 41-yr-old male presented after a fall with a right convexity acute subdural hematoma and ipsilateral frontal contusion. He underwent emergent hemicraniectomy with subsequent autologous cranioplasty 2 mo later. At 10-mo followup his neurological status had improved. His magnetic resonance imaging (MRI) at that time demonstrated encephalomalacia at the site of his prior contusion and punctate right pontine traumatic shearing injury. The patient re-presented to clinic 13 mo after initial injury with 2 mo of progressively worsening dysarthria, left hand numbness, diplopia, and dysphagia. MRI revealed a new tubular-shaped CSF cleft extending from the fourth ventricle, through the right midbrain and thalamus that was not present on prior MRI. Computed tomography cisternogram confirmed communication with the ventricular system, and there was no clinical evidence for elevated CSF pressure. One month later, the patient's symptoms had not improved, and imaging revealed progression of the CSF cleft. Following placement of a ventriculoperitoneal shunt, progression of the cleft ceased. We postulate that this cleft was a late sequela of traumatic shearing injury. We discuss our efforts to diagnose the etiology of the cleft and the rationale for our management strategy. CONCLUSION: To our knowledge, this represents the first reported delayed-onset CSF cleft through the midbrain and thalamus after closed TBI.	[Sherrod, Brandon A.; Yoon, Nam K.; Schmidt, Richard H.; Couldwell, William T.; Hawryluk, Gregory W. J.] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Anzai, Yoshimi] Univ Utah, Dept Radiol, Div Neuroradiol, Salt Lake City, UT 84132 USA; [Hawryluk, Gregory W. J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA		Hawryluk, GWJ (corresponding author), Univ Manitoba, Sect Neurosurg, GB1 Hlth Sci Ctr,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	ghawryluk@hsc.mb.ca	Anzai, Yoshimi/AAK-8428-2021	Anzai, Yoshimi/0000-0003-2988-7445			ANDERSON DC, 1988, ARCH NEUROL-CHICAGO, V45, P221, DOI 10.1001/archneur.1988.00520260113030; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; ORDIA IJ, 1981, J NEUROSURG, V54, P696, DOI 10.3171/jns.1981.54.5.0696; Shulyakov AV, 2012, NEUROSURGERY, V71, P1032, DOI 10.1227/NEU.0b013e3182690a0c; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wan Y, 2016, CLIN NEUROL NEUROSUR, V144, P44, DOI 10.1016/j.clineuro.2016.03.001	8	1	1	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	MAR	2020	18	3					E88	E94		10.1093/ons/opz124			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KY8XT	WOS:000522860100016	31218363				2022-02-06	
J	Stevens, A; Braun, L				Stevens, Andreas; Braun, Lena			Lack of steep, benzodiazepines and reaction performance	ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE			German	Article						Attention; reaction time; benzodiazepines; sleep deprivation	TRAUMATIC BRAIN-INJURY; REACTION-TIME; LORAZEPAM; ATTENTION; SEDATION; MEMORY; TESTS; SEX; AGE	Common wisdom holds that measures of attention are affected by both acute use of benzodiazepines and by lack of sleep. The published data is, however, inconclusive.The study described here tests both notions using a repeated-measures design. 30 healthy males performed a series of reaction time paradigms and Finger Tapping (as control for cooperation) under three conditions in a balanced sequence: (a) without medication and well rested, (b) after a 24hrs sleep-deprivation and (c) after 1 mg of oral Lorazepam. The same battery of tests was administered three times at one-week intervals. Neither acute use of 1 mg Lorazepam nor sleep deprivation had any effect with regard on reaction time nor accuracy (errors and omissions), nor finger tapping performance. Power estimates indicated that the study was sufficiently powered to make a type II error unlikely for effects amounting to 10% of reaction time (power > 0.95). Thus, contradicting claims from testees, lack of sleep or acute benzodiazepine use is not associated with impairment of attention or motor speed- at least not in the paradigms evaluated here.	[Stevens, Andreas; Braun, Lena] Med Begutachtungsinst Tubingen, Doblerstr 17, D-72074 Tubingen, Germany; [Stevens, Andreas] Univ Tubingen, Klin Psychiat & Psychotherapie, Tubingen, Germany; [Braun, Lena] Univ Tubingen, Math Nat Wissensch Fak, Fachbereich Psychol, Tubingen, Germany		Stevens, A (corresponding author), Med Begutachtungsinst Tubingen, Doblerstr 17, D-72074 Tubingen, Germany.	stevens@med-begutachtung.de					Andreou G., 2012, NEUROSCIENCE, P93; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A., 1974, PSYCHOL LEARNING MOT, V8; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; Bodenberg S., 2001, EINFUHRUNG KLIN NEUR; Broadbent D. E., 1971, DECISION STRESS; Chowdhury ZS, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/3730940; Cote KA, 2009, J SLEEP RES, V18, P291, DOI 10.1111/j.1365-2869.2008.00733.x; Dane S, 2003, INT J NEUROSCI, V113, P923, DOI 10.1080/00207450390220367; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fimm B, 2007, TESTBATTERIE AUFMERK; Fluck E, 1998, PHARMACOL BIOCHEM BE, V59, P909, DOI 10.1016/S0091-3057(97)00523-6; Galton F., 1890, J ANTHR I GREAT BR I, V19, P27, DOI [10.2307/2842529, DOI 10.2307/2842529]; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Incoccia C, 2004, CORTEX, V40, P111, DOI 10.1016/S0010-9452(08)70924-9; JALAVA KM, 1995, PHARMACOL BIOCHEM BE, V51, P189, DOI 10.1016/0091-3057(94)00399-4; Kopp B, 2008, AKTUEL NEUROL, V35, P16, DOI 10.1055/s-2007-986253; KUNSMAN GW, 1992, BRIT J CLIN PHARMACO, V34, P289, DOI 10.1111/j.1365-2125.1992.tb05633.x; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; PRESTON GC, 1989, PSYCHOPHARMACOLOGY, V97, P222, DOI 10.1007/BF00442254; PRESTON GC, 1988, PSYCHOPHARMACOLOGY, V95, P208; Rottgers H. O., 2003, Z NEUROPSYCHOL, V14, P89; Stevens A., 2010, GERMAN J PSYCHIAT, V13, P1; Sturm W, 1996, EUR REV APPL PSYCHOL, V46, P207; UNESCO Institute for Statistics, 2012, INT STAND CLASS ED I; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Welford A., 1980, REACTION TIMES, P73; Woodworth R. S, 1954, EXPT PSYCHOL	32	1	1	1	2	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1661-4747	1664-2929		Z PSYCHIATR PSYCH PS	Z. Psychiatr. Psychol. Psychother.	MAR	2020	68	2					113	119		10.1024/1661-4747/a000410			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	KX2SW	WOS:000521732200006					2022-02-06	
J	Stuart, CA; Brubacher, JR; Yau, L; Yip, R; Cripton, PA				Stuart, C. A.; Brubacher, J. R.; Yau, L.; Yip, R.; Cripton, P. A.			Skiing and snowboarding head injury: A retrospective centre-based study and implications for helmet test standards	CLINICAL BIOMECHANICS			English	Article						Skiing; Snowboarding; Craniocerebral trauma; Concussion; Head protective devices	SKIERS; RISK; ACCELERATIONS; MECHANISMS; IMPACTS	Background: Head injury occurs in up to 47% of skiing or snowboarding injuries and is the predominant cause of death in these sports. In most existing literature reporting injury type and prevalence, head injury mechanisms are underreported. Thus, protective equipment design relies on safety evaluation test protocols that are likely oversimplified. This study aims to characterize severity and mechanism of head injuries suffered while skiing and snowboarding in a form appropriate to supplement existing helmet evaluation methods. Methods: A 6-year, multicentre, retrospective clinical record review used emergency databases from two major trauma centres and Coroner's reports to identify relevant cases which indicated head impact. Records were investigated to understand the relationships between helmet use, injury type and severity, and injury mechanism. Descriptive statistics and odds ratios aided interpretation of the data. Findings: The snow sport head injury database included 766 cases. "Simple fall", "jump impact" and "impact with object" were the most common injury mechanisms while concussion was observed to be the most common injury type. Compared to "edge catch", moderate or serious head injury was more common for "fall from height" (OR = 4.69; 95% CI = 1.44-16.23; P = 0.05), "jump impact" (OR = 3.18; 95% CI = 1.48-7.26; P = 0.01) and "impact with object" (OR = 2.44; 95% CI = 1.14-5.56; P = 0.05). Occipital head impact was associated with increased odds of concussion (OR = 7.46; 95% CI = 4.55-12.56; P = 0.001). Interpretation: Snow sport head injury mechanisms are complex and cannot be represented through a single impact scenario. By relating clinical data to injury mechanism, improved evaluation methods for protective measures and ultimately better protection can be achieved.	[Stuart, C. A.; Cripton, P. A.] Univ British Columbia, Dept Mech Engn, 6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada; [Cripton, P. A.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Cripton, P. A.] Univ British Columbia, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Stuart, C. A.; Cripton, P. A.] Univ British Columbia, Orthopaed & Injury Biomech Grp, Vancouver, BC, Canada; [Brubacher, J. R.] Univ British Columbia, Vancouver Gen Hosp, Dept Emergency Med, Vancouver, BC, Canada; [Yau, L.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Yip, R.] Western Univ, Fac Sci, London, ON, Canada; [Stuart, C. A.; Cripton, P. A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC, Canada		Cripton, PA (corresponding author), Univ British Columbia, Dept Mech Engn, 6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada.	cripton@mech.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833; Brubacher, Jeffrey/0000-0002-4866-4231			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Adams, 1987, SAE TECHNICAL PAPER; [Anonymous], 1998, RS98 SNELL; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Canadian Heritage, 2013, SPORT PART 2010; Canadian Standards Association, 2014, RECR ALP SKIING SNOW; Cripton P., 2012, HELMET TESTING DESIG; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; Dickson TJ., 2015, SKIING TRAUMA SAFETY, P141; Dressler D, 2012, AM SOC TEST MATER, V1553, P235, DOI 10.1520/STP104525; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; F08 Committee, SPEC HELM US RECR SN, DOI [10.1520/F2040-18., DOI 10.1520/F2040-18]; Finch CF, 2011, SPORTS MED, V41, P59, DOI 10.2165/11537260-000000000-00000; Gennarelli TA, 2005, ABBREVIATED INJURY S; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; R Development Core Team, 2008, R LANG ENV STAT COMP; Richards D., 2008, SKI TRAUMA SAF; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Scher I., 2006, J ASTM INT, V3; SHEALY JE, 2005, J ASTM INT, V2, P12092; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; Sones JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.75351; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Sulheim S, 2017, BRIT J SPORT MED, V51, P44, DOI 10.1136/bjsports-2015-095798; Vanat L, 2017, 2017 INT REPORT SNOW; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Weber CD, 2016, EUR J TRAUMA EMERG S, V42, P741, DOI 10.1007/s00068-015-0596-7	39	1	1	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAR	2020	73						122	129		10.1016/j.clinbiomech.2020.01.011			8	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	LG7JO	WOS:000528272700016	31982809				2022-02-06	
J	Terry, DP; Wojtowicz, M; Cook, NE; Maxwell, BA; Zafonte, R; Seifert, T; Silverberg, ND; Berkner, PD; Iverson, GL				Terry, Douglas P.; Wojtowicz, Magdalena; Cook, Nathan E.; Maxwell, Bruce A.; Zafonte, Ross; Seifert, Tad; Silverberg, Noah D.; Berkner, Paul D.; Iverson, Grant L.			Factors Associated With Self-Reported Concussion History in Middle School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						head injuries; concussion; pediatric sports medicine; migraine	DEFICIT HYPERACTIVITY DISORDER; SPORT-RELATED CONCUSSION; STATES HIGH-SCHOOL; RISK-FACTORS; SOCCER PLAYERS; HEAD-INJURY; FOOTBALL; EPIDEMIOLOGY; COLLEGIATE; MIGRAINE	Objective: Identifying personal characteristics associated with sustaining a concussion is of great interest, yet only a few have examined this in children. The purpose of this study was to examine the association between sex, neurodevelopmental disorders, health history, and lifetime history of self-reported concussion in 12- and 13-year-old athletes. Design: Cross-sectional study. Setting: Middle schools. Participants: Participants were 1744 twelve- and thirteen-year-old student athletes who completed preseason Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) testing, including a self-report questionnaire about previous concussions, developmental diagnoses, and previous medical treatment. Independent Variables: Age, sex, attention-deficit/hyperactivity disorder (ADHD), learning disabilities (LDs), and previous treatment for migraine. Main Outcome Measures: Self-reported history of concussion. Results: A minority of athletes (13.7%) reported previous concussions (1 concussion, n = 181; 2 concussions, n = 41; and 3+ concussions, n = 17). A small proportion reported a history of ADHD (4.4%), LD (2.8%) or migraine treatment (4.0%). Higher rates of self-reported previous concussions were associated with male sex [16.9% vs 9.1%; chi(2)(1) = 21.47,P< 0.001] and previous migraine treatment [31.9% vs 13.0%; chi(2)(1) = 20.08,P< 0.001]. There were no differences in self-reported concussion history between 12- and 13-year olds (P= 0.18) and those with/without ADHD (P= 0.41) or LDs (P= 0.06). The overall logistic regression model was statistically significant [chi(2)(5) = 42.01,P< 0.001] but explained only 4.3% of the variance. Previous treatment for migraine [P< 0.001, Exp(B) = 3.30] and male sex [P< 0.001, Exp(B) = 2.06] were independently associated with a self-reported concussion history, whereas age, LD, and ADHD were not (P's > 0.05). Conclusions: Male sex and previous migraine treatment were associated with higher rates of self-reported previous concussions in both independent and multivariate models in middle school athletes, whereas age, ADHD, and LDs were not.	[Terry, Douglas P.; Cook, Nathan E.; Zafonte, Ross; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Terry, Douglas P.; Cook, Nathan E.; Zafonte, Ross; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Terry, Douglas P.; Zafonte, Ross; Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA USA; [Terry, Douglas P.; Zafonte, Ross; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Terry, Douglas P.; Cook, Nathan E.; Zafonte, Ross; Iverson, Grant L.] MassGen Hosp, Children Sport Concuss Program, Boston, MA USA; [Wojtowicz, Magdalena] York Univ, Dept Psychol, Toronto, ON, Canada; [Maxwell, Bruce A.] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Seifert, Tad] Norton Healthcare, Dept Neurol, Louisville, KY USA; [Seifert, Tad] Norton Healthcare, Dept Sports Hlth, Louisville, KY USA; [Seifert, Tad] Kentucky Boxing & Wrestling Commiss, Frankfort, KY USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Berkner, Paul D.] Colby Coll, Dept Biol & Hlth Serv, Waterville, ME 04901 USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 Thirteen St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bridges EJ, 2003, BRIT J SPORT MED, V37, P511, DOI 10.1136/bjsm.37.6.511; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Deitch JR, 2006, AM J SPORT MED, V34, P1077, DOI 10.1177/0363546505285383; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2016, CLIN J SPORT MED, V78, P1; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2013, RES SPORTS MED, V21, P367, DOI 10.1080/15438627.2013.825801; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Shilon Y, 2012, CHILD CARE HLTH DEV, V38, P366, DOI 10.1111/j.1365-2214.2011.01278.x; TAYLOR AR, 1966, LANCET, V2, P178; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	59	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S69	S74		10.1097/JSM.0000000000000594			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700009	32132480				2022-02-06	
J	Tracy, BM; Miller, K; Thompson, A; Cooke-Barber, J; Bloodworth, P; Clayton, E; Boswell, W				Tracy, Brett M.; Miller, Krista; Thompson, Ashley; Cooke-Barber, Jo; Bloodworth, Phillip; Clayton, Eric; Boswell, William			Pediatric golf cart trauma: Not par for the course	JOURNAL OF PEDIATRIC SURGERY			English	Article						Golf cart; Pediatric trauma; Traumatic brain injury; Skull fracture; Legislation	INJURIES; EJECTION	Introduction: Golf cart trauma in southeast Georgia represents a significant source of morbidity in the pediatric population. We believe these events are related to the introduction of new state legislation that allows local authorities to govern golf cart operation. Methods: We performed a retrospective review from 2010 to 2016 of children involved in golf cart traumas (n = 46). We recorded age, gender, Glasgow Coma Scale score (GCS), Injury Severity Score (ISS), location of event, and patient position during event. Outcomes included injury type and length of stay (LOS). Results: The most common position in a golf cart was a passenger (522%). Events varied regionally and correlated with stringency of local legislation. Skull fractures afflicted 48% (n 22) of children and traumatic brain injuries (TBIs) were noted in 35% (n = 17) of patients. TBIs (LOS = 4.6 days, p = 0.006) and abdominal injuries (LOS = 8.5 days, p = 0.017) lengthened mean hospital stay. Increasing ISS was associated with an increased probability of sustaining a TBI (OR 1.295, p = 0.004). Younger children were more likely to sustain a skull fracture (OR 1.170, p = 0.034) while older children incurred more orthopedic injuries (OR 1.217, p- 0.045). Conclusion: Skull fractures and TBIs are common following pediatric golf cart trauma. Georgia's varying municipality legislation likely contributes to the growing frequency of this trend. (C) 2018 Elsevier Inc. All rights reserved.	[Tracy, Brett M.; Miller, Krista; Thompson, Ashley; Cooke-Barber, Jo; Boswell, William] Mem Univ, Dept Surg, Med Ctr, 4700 Waters Ave, Savannah, GA 31404 USA; [Bloodworth, Phillip] Mercer Univ, Sch Med Savannah, Savannah, GA 31404 USA; [Clayton, Eric] Mem Univ, Dept Res, Med Ctr, Savannah, GA 31404 USA		Tracy, BM (corresponding author), Mem Univ, Dept Surg, Med Ctr, 4700 Waters Ave, Savannah, GA 31404 USA.	bmtracy06@gmail.com; millekr2@memorialhealth.com; thompas3@memorialhealth.com; jocooke-barber@memorialhealth.com; bloodworth_jp@med.mercer.edu; Clayter1@memorialhealth.com; boswewi1@memorialhealth.com	liu, ting/AAA-1112-2022	Miller, Krista/0000-0001-8411-6753; Tracy, Brett/0000-0002-1469-3608			American National Standards Institute, 2012, GOLF CARS SAF PERF S, P1; American National Standards Institute, 2012, PERS TRANSP VEH SAF, P1; [Anonymous], 2014, ORDINANCE DEALING OP, P1; Bergal J., 2016, WHAT HAPPENS GOLF CA; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; City of Bloomingdale, 2012, GOLF CART ORDINANCE, P1; Garay M, 2017, 2017 AAP NAT C EXH C; Glynn County Police, 2013, GOLF CART PTV SAF LE; International Agency for Research on Cancer, 2012, STRATEGIC COMMENTS, P1; International Light Transportation Vehicle Association, 2013, PERS TRANSP VEH MOD, P3; International Marine Contractors Association, 2013, GRAD ATTR PROF COMP, P1; Linnaus ME, 2017, J PEDIATR SURG, V52, P327, DOI 10.1016/j.jpedsurg.2016.09.003; Long TJ, 2007, 19 INT TECH C ENH SA, P1; McGwin G, 2008, J TRAUMA, V64, P1562, DOI 10.1097/TA.0b013e3181238d39; Miller B, 2016, INT J PEDIATR OTORHI, V88, P38, DOI 10.1016/j.ijporl.2016.06.041; Miller BL, 2011, OTOLARYNG HEAD NECK, V144, P883, DOI 10.1177/0194599810396790; National Department of Health, 2015, NATL STAND FOOD SAF, P1, DOI DOI 10.1016/J.ANNEMERGMED.2013.12.004; National Electronic Injury Surveillance System, NAT EL INJ SURV SYST; Poncy A, 2012, POLICY DESIGN CONSID, P1; Richman A., 2014, WHAT YOU NEED KNOW G; Sawyer JR, 1988, ORTHOPAEDIC ASPECTS, P219; Schau K, 2013, ACCIDENT ANAL PREV, V59, P574, DOI 10.1016/j.aap.2013.07.025; Sciarretta JD, 2016, AM SURGEON, V82, pE36; Seluga K, 2009, 21 INT TECHN C ENH S; Seluga KJ, 2005, ACCIDENT ANAL PREV, V37, P801, DOI 10.1016/j.aap.2005.03.022; Starnes JR, 2018, AM J EMERG MED, V36, P1049, DOI 10.1016/j.ajem.2018.03.002; Turner D., 2011, STRICTER GOLF CART S; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029	28	1	1	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAR	2020	55	3					451	455		10.1016/j.jpedsurg.2018.04.042			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	KY6DN	WOS:000522662800017	29848451				2022-02-06	
J	Van Deynse, H; Van Belleghem, G; Hubloue, I; Lauwaert, D; Moens, M; Pien, K; Devos, S; Putman, K				Van Deynse, Helena; Van Belleghem, Griet; Hubloue, Ives; Lauwaert, Door; Moens, Maarten; Pien, Karen; Devos, Stefanie; Putman, Koen			The Incremental Hospitalization Cost of Significant Transport-Related Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cost of illness; head trauma; hospital cost; neurotrauma; traffic accident	LENGTH-OF-STAY; PROPENSITY-SCORE; EPIDEMIOLOGY; COMORBIDITY; MORTALITY; OUTCOMES; SYSTEM; CARE	Aim: This study aims to determine the incremental cost of acute hospitalization for traumatic brain injury (TBI) compared with matched controls. A second purpose is to identify the factors contributing to this hospital costs. Methodology: Analyses were performed on administrative data for injured patients, hospitalized in Belgium between 2009 and 2011 following a road traffic accident. Cases were matched to a control with similar injuries but without TBI. The incremental hospitalization cost of TBI and the factors contributing to the hospital costs were determined using multivariable regression modeling with gamma distribution and log link. Results: A descriptive comparison of cases and controls shows clear differences in healthcare utilization and costs. The presence of a TBI increases the cost by a factor between 1.66 (95% confidence interval: 1.52-1.82) and 2.08 (95% confidence interval: 1.72-2.51). Regarding healthcare utilization, the most important determinants of hospital costs are surgical complexity, use of magnetic resonance imaging, intensive care unit admission, and mechanical ventilation. Discussion: To our knowledge, this is the first matched-control study calculating the incremental hospitalization cost of TBI. The insights provided by this study are relevant in the context of prospective payments and can be an incentive for investments in prevention policies and extramural care.	[Van Deynse, Helena; Van Belleghem, Griet; Devos, Stefanie; Putman, Koen] Vrije Univ Brussel, Interuniv Ctr Hlth Econ Res, Fac Med & Pharm, Laarbeeklaan 103 Bldg K, B-1090 Brussels, Belgium; [Hubloue, Ives; Lauwaert, Door] Univ Ziekenhuis Brussel, Dept Emergency Med, Emergency & Disaster Med, Brussels, Belgium; [Moens, Maarten] Univ Ziekenhuis Brussel, Dept Neurosurg, Brussels, Belgium; [Moens, Maarten] Univ Ziekenhuis Brussel, Dept Radiol, Brussels, Belgium; [Pien, Karen] Univ Ziekenhuis Brussel, Med Registrat, Brussels, Belgium		Van Deynse, H (corresponding author), Vrije Univ Brussel, Interuniv Ctr Hlth Econ Res, Fac Med & Pharm, Laarbeeklaan 103 Bldg K, B-1090 Brussels, Belgium.	Helena.van.deynse@vub.be	Putman, Koen/ABG-6361-2021	Van Deynse, Helena/0000-0001-7744-1478; Putman, Koen/0000-0002-7235-3759	Belgian Road Safety Institute (BRSI)	This study is part of the REKOVER project, supported by the Belgian Road Safety Institute (BRSI). The authors thank FPS Health (Ingrid Mertens, Eveline Depuijdt, Nathalie Terryn), the Department DataManagement and the TechnicalCell of the National Institute forHealth and Disability Insurance (Yves Parmentier), and Intermutualistic Agency (Ragna Preal and Birgit Gielen) for their cooperation and support in the data extraction, data storage, and data security. Finally, their gratitude goes to Elisabeth Versailles from SAS Belgium for the provision and assistance with the SAS software.	Akobundu E, 2006, PHARMACOECONOMICS, V24, P869, DOI 10.2165/00019053-200624090-00005; Ashley DW, 2015, J TRAUMA ACUTE CARE, V78, P706, DOI 10.1097/TA.0000000000000585; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Belgian Directorate-General Statistics and Economic Information, IND SEARCH; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Bergeron E, 2005, CAN J SURG, V48, P361; Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [10.1023/A:1012597123667, DOI 10.1023/A:1012597123667]; Bowman Sue, 2008, J AHIMA, V79, P24; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brooks MJ, 2005, BRIT J SURG, V92, P1288, DOI 10.1002/bjs.5058; Chona D, 2017, INT ORTHOP, V41, P859, DOI 10.1007/s00264-017-3425-2; Davenport DL, 2005, ANN SURG, V242, P463, DOI 10.1097/01.sla.0000183348.15117.ab; Devos S, 2017, INJURY, V48, P2132, DOI 10.1016/j.injury.2017.08.009; EUROPEAN COMMISSION, 2017, ANN ACC REP 2017; Gil LA, 2018, SURGERY, V164, P848, DOI 10.1016/j.surg.2018.04.046; Gosho M, 2014, J STAT SOFTW, V57, P1; Hassani-Mahmooei B, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1386-6; Hong J, 2013, ACCIDENT ANAL PREV, V52, P44, DOI 10.1016/j.aap.2012.12.007; Jentzsch T, 2018, SWISS MED WEEKLY, V148, pw14650; Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x; Lagoe Ronald J, 2011, BMC Res Notes, V4, P135, DOI 10.1186/1756-0500-4-135; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Norris SL, 2008, J AM GERIATR SOC, V56, P149, DOI 10.1111/j.1532-5415.2007.01530.x; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Parsons LS., 2001, SAS SUGI, V26, P214, DOI DOI 10.1016/J.MICINF.2011.07.011; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; The British United Provident Association Limited, BUP SCHED PROC; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Van Belleghem G, 2016, INJURY, V47, P141, DOI 10.1016/j.injury.2015.08.025; Yuan Q, 2012, INJURY, V43, P2094, DOI 10.1016/j.injury.2012.03.028	40	1	1	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E144	E155		10.1097/HTR.0000000000000522			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500014	31479077				2022-02-06	
J	Velikic, V; Wippel, A; Freidl, M				Velikic, Vid; Wippel, Andreas; Freidl, Marion			Relapse of obsessive-compulsive disorder after cerebral venous sinus thrombosis: a case report	NEUROPSYCHIATRIE			English	Article						OCD; Cerebrovascular Insult; Sertraline; Clomipramine; Combination therapy		Obsessive-compulsive disorder (OCD) is characterized by repetitive, persistent and unwanted thoughts and ritualistic, repetitive behaviors. The pathophysiology of OCD involves many distinct cortical and subcortical regions and it has been reported that OCD may occur as a consequence of traumatic brain injury, infections and tumors as well as cerebrovascular insult such as cerebral venous sinus thrombosis (CVST). We here describe the case of a 36-year-old woman who developed OCD at the age of 13 with almost complete remission of the symptoms after a 1 year-long treatment. Interestingly, after suffering CVST at the superior sagittal sinus at the age of 33, she experienced a relapse of OCD. The patient was successfully treated with Sertraline and Clomipramine. Previous studies revealed cases of OCD following different cerebrovascular accidents, i.e. predominantly arterial stroke. However, the present case is the first to describe OCD after venous thrombosis. Based on our clinical experience, the most effective treatment of OCD after CVST represents the combination of the selective serotonin reuptake inhibitor Sertraline and the tricyclic antidepressant Clomipramine.	[Velikic, Vid; Wippel, Andreas; Freidl, Marion] Med Univ Vienna, Dept Psychiat & Psychotherapy, Clin Div Social Psychiat, Wahringer Gurtel 18-20, A-1090 Vienna, Austria		Velikic, V (corresponding author), Med Univ Vienna, Dept Psychiat & Psychotherapy, Clin Div Social Psychiat, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	vid.velikic@meduniwien.ac.at		Wippel, Andreas/0000-0001-6188-9374			Akaho R, 2019, J STROKE CEREBROVASC, V28, pE17, DOI 10.1016/j.jstrokecerebrovasdis.2018.12.034; Choe Y, 2014, ANN REHABIL MED-ARM, V38, P698, DOI 10.5535/arm.2014.38.5.698; Cumming TB, 2016, AM J GERIAT PSYCHIAT, V24, P154, DOI 10.1016/j.jagp.2015.06.003; Goodman WK, 2014, PSYCHIAT CLIN N AM, V37, P257, DOI 10.1016/j.psc.2014.06.004; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Kordon A, 2011, NERVENARZT, V82, P319, DOI 10.1007/s00115-010-2963-2; Olatunji BO, 2015, FOCUS, V13, P222, DOI [10.1176/appi.focus.130219, DOI 10.1176/APPI.FOCUS.130219]; Simpson HB, 2006, J CLIN PSYCHIAT, V67, P269, DOI 10.4088/JCP.v67n0214; Stein DJ, 2012, CURR PSYCHIAT REP, V14, P211, DOI 10.1007/s11920-012-0268-9; Warkentin TE, 2005, NEW ENGL J MED, V353, P314	10	1	1	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0948-6259	2194-1327		NEUROPSYCHIATRIE	Neuropsychiatrie	MAR	2020	34	1					27	29		10.1007/s40211-019-00327-8			3	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	KV9ZE	WOS:000520832400005	31828741	hybrid, Green Published			2022-02-06	
J	Wauters, L; Marquardt, T; Munoz, ML				Wauters, Lisa; Marquardt, Thomas; Munoz, Maria L.			Verbal fluency in three Spanish-English bilingual speakers with TBI	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Brain injury; Bilingual; Verbal fluency; Generative naming; TBI; Spanish	TRAUMATIC BRAIN-INJURY; NORMATIVE DATA; TEST-SCORES; AGE; PERFORMANCE; EDUCATION; CATEGORY; ABNORMALITY; ALZHEIMERS; APHASIA	This study investigated differences between healthy bilingual participants and bilingual participants with traumatic brain injury (TBI) on verbal fluency tasks. The performance of three Spanish-English bilingual speakers with traumatic brain injury was compared to the performance of 30 neurotypical bilingual speakers on tasks of category and letter verbal fluency in English and Spanish. Responses were analyzed for total number of correct productions, differences in correct productions between languages, average cluster size, total number of switches, and rates of language choice errors. The data were analyzed using predicted scores from regression equations based on neurotypical data and modified t-tests. Analyses revealed significantly lower total output than predicted by the regression equations for both task types and in both languages for one TBI participant. The same participant demonstrated significantly lower total number of switches than the neurotypical group. Two participants demonstrated higher rates of language choice errors than the neurotypical group. There were no significant differences between TBI participants and the neurotypical group for average cluster size. There were no significant differences between predicted and obtained values for differences between English and Spanish total number correct in each task type. Results are discussed in the context of individual cognitive and linguistic profiles of the TBI participants.	[Wauters, Lisa; Marquardt, Thomas] Univ Texas Austin, Austin, TX 78712 USA; [Munoz, Maria L.] Univ Redlands, Redlands, CA 92373 USA		Wauters, L (corresponding author), 2504A Whitis Ave, Austin, TX 78712 USA.	ldwaut@utexas.edu			Ben F. Love Regents Professorship at the University of Texas	This research received financial support from the Ben F. Love Regents Professorship at the University of Texas.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bose A, 2017, INT J LANG COMM DIS, V52, P334, DOI 10.1111/1460-6984.12276; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Brucki SMD, 2004, BRAZ J MED BIOL RES, V37, P1771, DOI 10.1590/S0100-879X2004001200002; Capitani E, 2009, NEUROPSYCHOLOGIA, V47, P423, DOI 10.1016/j.neuropsychologia.2008.09.016; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eng N, 2002, TOP LANG DISORD, V22, P5, DOI 10.1097/00011363-200211000-00005; Epker MO, 1999, J CLIN EXP NEUROPSYC, V21, P425, DOI 10.1076/jcen.21.4.425.890; Fabbro F, 2001, BRAIN LANG, V79, P201, DOI 10.1006/brln.2001.2480; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Golden C.J., 1978, STROOP COLOR WORD TE; Gollan TH, 2004, J EXP PSYCHOL LEARN, V30, P246, DOI 10.1037/0278-7393.30.1.246; Gollan TH, 2002, NEUROPSYCHOLOGY, V16, P562, DOI 10.1037//0894-4105.16.4.562; Gordon JK, 2018, AGING NEUROPSYCHOL C, V25, P803, DOI 10.1080/13825585.2017.1374328; Grant D. A., 1993, WISCONSIN CARD SORTI; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Kaplan E., 2001, BOSTON NAMING TEST; Kave G, 2008, J CLIN EXP NEUROPSYC, V30, P349, DOI 10.1080/13803390701416197; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Kiran S., 2010, DON WORKSH NEUR; Kohnert KJ, 1998, BRAIN LANG, V65, P422, DOI 10.1006/brln.1998.2001; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Lorenzen B, 2008, AM J SPEECH-LANG PAT, V17, P299, DOI 10.1044/1058-0360(2008/026); Luo L, 2010, COGNITION, V114, P29, DOI 10.1016/j.cognition.2009.08.014; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; Marini A, 2016, BRAIN LANG, V159, P35, DOI 10.1016/j.bandl.2016.05.014; Marrero MZ, 2002, CLIN PSYCHOL REV, V22, P463, DOI 10.1016/S0272-7358(01)00109-X; Mathuranath PS, 2003, J CLIN EXP NEUROPSYC, V25, P1057, DOI 10.1076/jcen.25.8.1057.16736; Munoz ML, 1999, BRAIN LANG, V66, P249, DOI 10.1006/brln.1998.2021; Munoz ML, 2003, APHASIOLOGY, V17, P1115, DOI 10.1080/02687030344000427; Newcombe F, 1969, MISSLE WOUNDS BRAIN; Nogueira DS, 2016, FOLIA PHONIATR LOGO, V68, P124, DOI 10.1159/000450640; Paradis M., 1989, BILINGUAL APHA UNPUB; Paradis M., 2001, HDB NEUROPSYCHOLOGY, V3, P69; Paradis M., 1987, ASSESSMENT BILINGUAL; Patra A, 2020, BILING-LANG COGN, V23, P204, DOI 10.1017/S1366728918001098; Paul M., 2011, TRAUMATIC BRAIN INJU; Piolat A, 2008, EUR PSYCHOL, V13, P114, DOI 10.1027/1016-9040.13.2.114; Portocarrero JS, 2007, ARCH CLIN NEUROPSYCH, V22, P415, DOI 10.1016/j.acn.2007.01.015; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Ratiu I., 2019, BRAIN IMPAIR, P1; Ratiu I, 2017, BRAIN LANG, V166, P29, DOI 10.1016/j.bandl.2016.12.004; Reitan RM, 1992, TRAIL MAKING TEST MA; Rosselli M, 2002, INT J NEUROSCI, V112, P759, DOI 10.1080/00207450290025752; Rosselli M, 2000, ARCH CLIN NEUROPSYCH, V15, P692; Sandoval TC, 2010, BILING-LANG COGN, V13, P231, DOI 10.1017/S1366728909990514; Sebastian D., 2012, ASPECTS MULTILINGUAL, V8, P122; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Unsworth N, 2011, Q J EXP PSYCHOL, V64, P447, DOI 10.1080/17470218.2010.505292; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; Wauters L, 2018, ARCH CLIN NEUROPSYCH, V33, P444, DOI 10.1093/arclin/acx063; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P159; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zaninotto AL, 2014, NEUROPSYCH DIS TREAT, V10, P1155, DOI 10.2147/NDT.S62728; Zillmer E.A., 2001, TOWER LONDON DX TOLD	65	1	1	2	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	MAR-APR	2020	84								105971	10.1016/j.jcomdis.2019.105971			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	KX8IW	WOS:000522119600001	31935540				2022-02-06	
J	Xia, Z; Liu, WB; Zheng, F; Huang, W; Xing, ZH; Peng, WJ; Tang, T; Luo, JK; Yi, LH; Wang, Y				Xia, Zian; Liu, Wenbin; Zheng, Fei; Huang, Wei; Xing, Zhihua; Peng, Weijun; Tang, Tao; Luo, Jiekun; Yi, Lunzhao; Wang, Yang			VISSA-PLS-DA-Based Metabolomics Reveals a Multitargeted Mechanism of Traditional Chinese Medicine for Traumatic Brain Injury	ASN NEURO			English	Article						gas chromatography; mass spectrometry; metabolomics; traumatic brain injury; VISSA-PLS-DA; Xuefu Zhuyu decoction	SELECTION; IDENTIFICATION; CLEARANCE; OPTIMIZES	Metabolomics is an emerging tool to uncover the complex pathogenesis of disease, as well as the multitargets of traditional Chinese medicines, with chemometric analysis being a key step. However, conventional algorithms are not suitable for directly analyzing data at all times. The variable iterative space shrinkage approach-partial least squares-discriminant analysis, a novel algorithm for data mining, was first explored to screen metabolic varieties to reveal the multitargets of Xuefu Zhuyu decoction (XFZY) against traumatic brain injury (TBI) by the 7th day. Rat plasma from Sham, Vehicle, and XFZY groups was used for gas chromatography/mass spectrometry-based metabolomics. This method showed an improved discrimination ability (area under the curve = 93.64%). Threonine, trans-4-hydroxyproline, and creatinine were identified as the direct metabolic targets of XFZY against TBI. Five metabolic pathways affected by XFZY in TBI rats, were enriched using Metabolic Pathway Analysis web tool (i.e., phenylalanine, tyrosine, and tryptophan biosynthesis; phenylalanine metabolism; galactose metabolism; alanine, aspartate, and glutamate metabolism; and tryptophan metabolism). In conclusion, metabolomics coupled with variable iterative space shrinkage approach-partial least squares-discriminant analysis model may be a valuable tool for identifying the holistic molecular mechanisms involved in the effects of traditional Chinese medicine, such as XFZY.	[Xia, Zian; Huang, Wei; Xing, Zhihua; Tang, Tao; Luo, Jiekun; Wang, Yang] Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Changsha 410008, Peoples R China; [Liu, Wenbin; Yi, Lunzhao] Kunming Univ Sci & Technol, Yunnan Food Safety Res Inst, Kunming 650500, Yunnan, Peoples R China; [Zheng, Fei] Hunan Univ, Coll Elect & Informat Engn, Changsha, Peoples R China; [Peng, Weijun] Cent South Univ, Xiangya Hosp 2, Dept Integrated Tradit Chinese & Western Med, Changsha, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Dept Integrated Tradit Chinese & Western Med, Changsha 410008, Peoples R China.; Yi, LH (corresponding author), Kunming Univ Sci & Technol, Yunnan Food Safety Res Inst, Kunming 650500, Yunnan, Peoples R China.	wangyang_xy87@csu.edu.cn	yi, lunzhao/AAS-3256-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81803948, 81973665, 81874409, 81673719, 21465016]; Outstanding Youth Foundation of Hunan Provincial Natural Science Foundation of China [2019JJ30042]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported financially by the National Natural Science Foundation of China (Nos. 81803948, 81973665, 81874409, 81673719, and 21465016) and the Outstanding Youth Foundation of Hunan Provincial Natural Science Foundation of China (No. 2019JJ30042).	Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; Deng BC, 2015, ANALYST, V140, P1876, DOI 10.1039/c4an02123a; Deng BC, 2014, ANALYST, V139, P4836, DOI 10.1039/c4an00730a; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Dorsett CR, 2017, J NEUROTRAUM, V34, P220, DOI 10.1089/neu.2015.4372; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Feng DD, 2017, ONCOTARGET, V8, P94692, DOI 10.18632/oncotarget.21876; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Ichkova A, 2019, ASN NEURO, V11, DOI 10.1177/1759091419847090; Li QQ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3461572; Li YT, 2019, J FOOD SCI, V84, P2234, DOI 10.1111/1750-3841.14706; Li Z, 2012, CELL MOL NEUROBIOL, V32, P381, DOI 10.1007/s10571-011-9766-2; Li ZZ, 2018, BIOMED PHARMACOTHER, V106, P349, DOI 10.1016/j.biopha.2018.06.041; Lipponen A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0519-z; Lu Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-44; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Majid NA, 2020, PHYTOCHEM ANALYSIS, V31, P191, DOI 10.1002/pca.2880; Pattinson CL, 2018, NAT REV NEUROL, V14, P511, DOI 10.1038/s41582-018-0041-8; Perluigi M, 2016, BBA-MOL BASIS DIS, V1862, P1871, DOI 10.1016/j.bbadis.2016.07.005; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song XZ, 2016, ANAL CHIM ACTA, V948, P19, DOI 10.1016/j.aca.2016.10.041; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Talebi M, 2015, J CHROMATOGR A, V1424, P69, DOI 10.1016/j.chroma.2015.10.099; Tu T, 2014, CIRC J, V78, P993, DOI 10.1253/circj.CJ-13-1365; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Verissimo DM, 2015, EXP BIOL MED, V240, P175, DOI 10.1177/1535370214549518; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Wang Z.W., 2010, SHANXI ZHONG YI, V31, P850; Watanabe S, 2015, J BIOTECHNOL, V199, P9, DOI 10.1016/j.jbiotec.2015.01.026; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Xiang Z, 2011, PHYTOCHEM ANALYSIS, V22, P411, DOI 10.1002/pca.1296; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yi LZ, 2014, RSC ADV, V4, P59094, DOI 10.1039/c4ra09860a; Zhang XJ, 2015, J SEP SCI, V38, P4078, DOI 10.1002/jssc.201500730; Zheng F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182025; Zheng P, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6270195; Zhong YY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8916938; Zhu L, 2018, NEURAL REGEN RES, V13, P1417, DOI 10.4103/1673-5374.235297; Zobel K, 2016, CELL TISSUE RES, V365, P233, DOI 10.1007/s00441-016-2397-7	47	1	1	6	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	MAR	2020	12								1759091420910957	10.1177/1759091420910957			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB4IA	WOS:000524598000001	32146828	Green Published, gold			2022-02-06	
J	Yeniocak, T; Ozcan, PE				Yeniocak, Tugce; Ozcan, Perihan Ergin			Brain Death and Deceased Organ Donation in a Hospital in Istanbul, Turkey: The Effect of Early Identification of Brain Dead on Organ Donation Rates: A Retrospective Study	ISTANBUL MEDICAL JOURNAL			English	Article						Brain death; organ donation; deceased organ donation; transplantation		Introduction: The possibility of brain death (BD) among patients with a Glasgow Coma scale <7 must be considered by physicians who work in intensive care units. Deceased organ transplantation can be lifesaving so every BD patient should be seen as a potential donor. The aim of this study was to describe the causes of BD, rate of organ donation and to investigate the effect of diagnosis time on donation rates in our hospital over a 9-year period. Methods: After obtaining Institutional Ethics Committee approval, we conducted a retrospective review of patients who had sustained BD in our hospital between January 1, 2004 and January 1, 2013. Patients' age, methods used to diagnose BD, duration of survival after diagnosis, whether patients' family members gave consent to organ donation, and organ donation rates were reviewed. Results: Sixty patients were declared BD, of whom 21 (35%) were female and 39 (65%) were male. Their mean age was 28 years. Only 6 (10%) patients' families gave consent for donation. The most common cause of BD was traumatic brain injury (n=37, 62%). Internal carotid artery doppler ultrasonography was performed in 36 (60%) patients; cerebral angiography was performed in 14 (23%) patients; and electroencephalography was performed in two patients. The mean time from hospital admission to diagnosis of BD was 5.16 +/- 3.06 days overall; 5.5 +/- 0.4 days among non-donors; and 2.0 +/- 0.4 days among donors. The mean time from diagnosis of BD to death in non-donors was 2.4 +/- 0.3 days. In donors, the mean time from diagnosis of BD to harvesting of the patient's organs was 1.08 +/- 0.2 days. Conclusion: In our hospital, the rate of organ donation after BD is low. It is found that the time to confirm the diagnosis of BD was significantly shorter in donors than non-donors. It is believed that early diagnosis of BD is associated with an increased rate of family approval for organ donation.	[Yeniocak, Tugce] Metin Sabanci Baltalimani Bone & Joint Dis Traini, Clin Anesthesiol, Istanbul, Turkey; [Ozcan, Perihan Ergin] Istanbul Univ, Dept Anesthesiol, Fac Med, Istanbul, Turkey		Yeniocak, T (corresponding author), Metin Sabanci Baltalimani Bone & Joint Dis Traini, Clin Anesthesiol, Istanbul, Turkey.	tugcekusku@yahoo.com	ozcan, perihan ergin/AAU-2572-2020	YENIOCAK, TUGCE/0000-0001-9237-6424			[Anonymous], 2019, NAKIL BEKLEYEN HASTA, P10; Battal M, 2013, SUSKU ETFAL HASTANES, V47, P59; Eira Carla Sofia Lopes da, 2018, Rev Bras Ter Intensiva, V30, P201, DOI 10.5935/0103-507X.20180040; English V, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l967; George S, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0719-8; Girlanda Raffaele, 2016, World J Transplant, V6, P451, DOI 10.5500/wjt.v6.i3.451; Gunduz RC, 2014, TURKISH J PEDIATR, V56, P597; International Registry in Organ Donation and Transplantation, 2019, TURK DEC ORG DON EV; Karasu D, 2015, J MED SURG INTENSIVE, V6, P23, DOI 10.5152/dcbybd.2015.595; Kirikli C, 2011, YOGUN BAKIM DERG, V1, P8; Kocak Suren O, 2007, TBB DERGISI, V73, P174; McCallum J, 2019, CAN J EMERG MED, V21, P626, DOI 10.1017/cem.2019.365; Mutlu NM, 2019, TRANSPL P, V51, P2176, DOI 10.1016/j.transproceed.2019.01.164; Oczkowski SJW, 2019, PROG TRANSPLANT, V29, P179, DOI 10.1177/1526924819835826; Ozmert S, 2019, TURK J ANAESTHESIOL, V47, P55, DOI 10.5152/TJAR.2019.43726; Pestana AL, 2013, REV ESC ENFERM USP, V47, P254; Rithalia Amber, 2009, BMJ, V338, pa3162, DOI 10.1136/bmj.a3162; Tepehan S, 2014, J CRIT CARE NURS SOC, V18, P8; Tsai E, 2000, Pediatr Crit Care Med, V1, P156, DOI 10.1097/00130478-200010000-00012	19	1	1	1	1	ISTANBUL TRAINING & RESEARCH HOSPITAL	ISTANBUL	CERRAHPASA MAHALLESI, ORG ABDURRAHMAN NAFIZ GURMAN CD NO 21, FATIH, ISTANBUL, 00000, TURKEY	2619-9793	2148-094X		ISTANB MED J	Istanb. Med. J.	MAR	2020	21	2					115	119		10.4274/imj.galenos.2020.71463			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	KV4ZX	WOS:000520493300007		gold			2022-02-06	
J	Zafar, S; Sebestyen, K; Qureshi, Z; Schein, O; Johnson, P; Srikumaran, D; Woreta, FA				Zafar, Sidra; Sebestyen, Krisztian; Qureshi, Zaid; Schein, Oliver; Johnson, Pamela; Srikumaran, Divya; Woreta, Fasika A.			National Trends in Imaging Rates for Eye-Related Emergency Department Visits in the United States	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; EPIDEMIOLOGY; DIAGNOSIS; YIELD	PURPOSE: To identify nationwide trends and factors associated with advanced imaging (computed tomography [CT] and magnetic resonance imaging [MRI]) use for eye-related emergency department (ED) visits. DESIGN: Retrospective, trend study. METHODS: SETTING: National Hospital Ambulatory Medical Care Survey 2007-2015. PATIENT POPULATION: Eye-related ED patients who underwent CT or MRI. MAIN OUTCOME MEASURE(S): Population-based CT/MR imaging rates and independent factors associated with imaging. RESULTS: An estimated 7 million eye-related ED visits occurred between 2007 and 2015. Adjusted for annual eye-related ED visits, the rate of imaging use rose 94%, from 121.7 per 1,000 eye-related ED visits in 2007 to 236.0 per 1,000 eye-related ED visits in 2015. Visual disturbances, contusion of the eye and/or adnexa, open globes and open wounds of ocular adnexa, diplopia, superficial corneal and/or conjunctival injuries, and orbital fractures accounted for 73.2% of all visits where imaging was performed. On multivariable analysis, older patients (odds ratio [OR] = 1.02, 95% confidence interval [CI] 1.01-1.03) and females (OR = 2.07, 95% CI 1.18-3.63) were more likely to undergo imaging than younger patients and males. Imaging was also more likely to be performed for Medicare beneficiaries (OR = 2.12, 95% CI 1.08-4.15) than for privately insured patients. Patients who were admitted to the hospital were 6 times more likely (OR = 6.39, 95% CI 2.04-20.0) to undergo imaging than those who were not admitted. CONCLUSIONS: Advanced imaging for eye-related ED visits has escalated at a higher rate than ED visits for eye complaints. Future studies to develop evidencebased algorithms for use of CT/MR imaging for eye complaints that can help balance benefits against financial costs and health risk are warranted. ((C) 2019 Elsevier Inc. All rights reserved.)	[Zafar, Sidra; Schein, Oliver; Srikumaran, Divya; Woreta, Fasika A.] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Johnson, Pamela] Johns Hopkins Univ Hosp, Dept Radiol, Baltimore, MD 21287 USA; [Sebestyen, Krisztian] Johns Hopkins Univ, Sch Med, Johns Hopkins Surg Ctr Outcomes Res, Baltimore, MD USA; [Qureshi, Zaid] Aga Khan Univ Hosp, Karachi, Pakistan		Woreta, FA (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21218 USA.	fworeta1@jhmi.edu					Allon G, 2016, EUR J OPHTHALMOL, V26, P503, DOI 10.5301/ejo.5000788; Arey ML, 2007, OPHTHALMOLOGY, V114, P1448, DOI 10.1016/j.ophtha.2006.10.051; Ashurst JV, 2014, ACAD EMERG MED, V21, P1431, DOI 10.1111/acem.12537; Channa R, 2016, JAMA OPHTHALMOL, V134, P312, DOI 10.1001/jamaophthalmol.2015.5778; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Dick EA, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150819; DILLON EC, 1994, OPHTHALMOLOGY, V101, P1627; Hartholt KA, 2011, J TRAUMA, V71, P255, DOI 10.1097/TA.0b013e31821c36e7; Hendee WR, 2010, RADIOLOGY, V257, P240, DOI 10.1148/radiol.10100063; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Joseph DP, 2000, OPHTHALMOLOGY, V107, P1899, DOI 10.1016/S0161-6420(00)00335-3; Kirsch TD, 2011, J EMERG MED, V41, P302, DOI 10.1016/j.jemermed.2010.06.030; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Lang K, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-40; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Levin DC, 2014, J AM COLL RADIOL, V11, P1044, DOI 10.1016/j.jacr.2014.07.008; Levin DC, 2000, RADIOLOGY, V216, P265, DOI 10.1148/radiology.216.1.r00jl28265; Litkowski PE, 2016, AM J MED, V129, P1131, DOI 10.1016/j.amjmed.2016.06.020; Lu TJ, 2018, CURR OPIN OPHTHALMOL, V29, P503, DOI 10.1097/ICU.0000000000000519; Lyu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181970; McClelland C, 2012, OPHTHALMOLOGY, V119, P1701, DOI 10.1016/j.ophtha.2012.01.044; Mehta S, 2012, J NEURO-OPHTHALMOL, V32, P139, DOI 10.1097/WNO.0b013e31824e3753; Niles LM, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0615; Oren O, 2019, JAMA-J AM MED ASSOC, V321, P245, DOI 10.1001/jama.2018.20295; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Pradhan E, 2015, NEPAL J OPHTHALMOL, V7, P159, DOI 10.3126/nepjoph.v7i2.14966; Rao VM, 2012, ANN INTERN MED, V157, P574, DOI 10.7326/0003-4819-157-8-201210160-00535; Rao VM, 2011, J AM COLL RADIOL, V8, P706, DOI 10.1016/j.jacr.2011.04.004; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Stiell IG, 2000, CAN MED ASSOC J, V163, P1465; Tawfik HA, 2012, SAUDI J OPHTHALMOL, V26, P409, DOI 10.1016/j.sjopt.2012.07.004; Team RC, 2014, R LANG ENV STAT COMP; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	38	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	MAR	2020	211						114	122		10.1016/j.ajo.2019.11.007			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	KY8CR	WOS:000522799700014	31730840				2022-02-06	
J	Zakiei, A; Kiani, N; Morovati, F; Komasi, S				Zakiei, Ali; Kiani, Narges; Morovati, Faramarz; Komasi, Saeid			Classification of various types of disability and determining their predictive causes in western Iran	CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH			English	Article						Causations; Clustering; Disability; Epidemiology	TRAUMATIC BRAIN-INJURY; PREVALENCE; EPIDEMIOLOGY; COUNTRIES; CHILDREN; HEALTH; IMPACT	Objectives: The current study aims to clustering different types of disability in Kermanshah Province and determine its predictive causes. Methods: The statistical population of this cross-sectional study includes all the households living in rural and urban areas of Kermanshah Province in western Iran. Using multi-stage cluster sampling, 10150 households were selected from July to December of 2017 based on the population share of each city district. The required data were obtained using a 13-item questionnaire developed by the research team. The obtained data were analyzed using two-step cluster analysis, chi-square test, and multinomial logistic regression analysis. Results: This model suggested five clusters including (i) geographically scattered subjects with mental abnormalities, (ii) geographically scattered subjects with physical motor abnormalities, (iii) non-eastern subjects with multiple abnormalities, (iv) non-northern subjects with multiple abnormalities, and (v) geographically scattered subjects with visual-auditory abnormalities. Multinomial logistic regression emphasized the significance of some causes of disability, particularly head trauma and trauma caused by car accidents (P < 0.05). There was a significant difference among the clusters with regard to socio-demographic variables (P < 0.05). Conclusion: The eastern areas of Kermanshah province are facing a larger number of mental disorders caused by mother's disease during pregnancy and cousin marriages. Other major causes of disability include head trauma and trauma caused by car accidents. In western areas, physical-motor disability is more frequent, and in central areas, visual-auditory abnormalities are more prevalent.	[Zakiei, Ali] Kermanshah Univ Med Sci, Sleep Disorders Res Ctr, Kermanshah, Iran; [Kiani, Narges] Dept Welf Kermanshah Prov, Kermanshah, Iran; [Morovati, Faramarz] Razi Univ, Dept Counseling, Kermanshah, Iran; [Komasi, Saeid] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Zakarya Razi Blvd, Kermanshah, Iran		Komasi, S (corresponding author), Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Zakarya Razi Blvd, Kermanshah, Iran.	s_komasi63@yahoo.com	Zakiei, Ali/AAO-9644-2021; Komasi, Saeid/N-1007-2016	Zakiei, Ali/0000-0002-5259-6104; Komasi, Saeid/0000-0002-0198-3710	Welfare Organization of Kermanshah Province [1396]	Welfare Organization of Kermanshah Province (ID: 1396).	Bahadorimonfared A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065198; Barbotte E, 2001, B WORLD HEALTH ORGAN, V79, P1047; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bittles A. H., 2008, PEDIAT CHILD HLTH, V18, P244, DOI [10.1016/j.paed.2008.02.008, DOI 10.1016/j.paed.2008.02.008]; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bucher CO, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0966-7; Chala MB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4763-0; Duperrex O, 2002, BRIT MED J, V324, P1129, DOI 10.1136/bmj.324.7346.1129; Gladman JRF, 2008, J CHIN MED ASSOC, V71, P275, DOI 10.1016/S1726-4901(08)70122-9; Hansen N, 2007, TIJDSCHR ECON SOC GE, V98, P493, DOI 10.1111/j.1467-9663.2007.00417.x; Jacobs JB, 2003, ACCIDENT ANAL PREV, V15, P337; Khandaker G, 2014, J TROP PEDIATRICS, V60, P363, DOI 10.1093/tropej/fmu031; Kidd MP, 2000, J HEALTH ECON, V19, P961, DOI 10.1016/S0167-6296(00)00043-6; King G, 2010, CHILD CARE HLTH DEV, V36, P726, DOI 10.1111/j.1365-2214.2010.01089.x; Kotb AA, 2006, OPHTHAL EPIDEMIOL, V13, P1, DOI 10.1080/09286580500477317; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larsson B, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0591-4; Lucas-Carrasco R, 2011, RES DEV DISABIL, V32, P1212, DOI 10.1016/j.ridd.2010.12.030; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Mitra S, 2014, DISABIL REHABIL, V36, P940, DOI 10.3109/09638288.2013.825333; Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024; Nasiripour AA, 2012, J KNOWLEDGE HLTH, V7, P173; Robertson J, 2012, J APPL RES INTELLECT, V25, P99, DOI 10.1111/j.1468-3148.2011.00638.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Trevithick L, 2015, BJPSYCH BULL, V39, P119, DOI 10.1192/pb.bp.114.047043; van den Berge MJC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00115; Velayutham B, 2016, DISABIL HEALTH J, V9, P584, DOI 10.1016/j.dhjo.2016.04.003; Wong E, 2016, PREV MED, V82, P105, DOI 10.1016/j.ypmed.2015.11.003	30	1	1	0	0	ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTD	NEW DELHI	17-A/1 MAIN RING ROAD, LAJPAT NAGAR IV, NEW DELHI, 110024, INDIA	2452-0918	2213-3984		CLIN EPIDEMIOL GLOB	Clin. Epidemiol. Glob. Health	MAR	2020	8	1								10.1016/j.cegh.2018.11.003			7	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	LO2TC	WOS:000533481900001		Bronze			2022-02-06	
J	Zoccola, D; Shuttleworth-Edwards, AB; Radloff, SE				Zoccola, Diana; Shuttleworth-Edwards, Ann B.; Radloff, Sarah E.			Signs of cognitive dysfunction in adult players of club level rugby	SOUTH AFRICAN JOURNAL OF PSYCHOLOGY			English	Article						ImPACT test; mild traumatic brain injury; Purdue Pegboard; Rugby Union; sports concussion	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; PROCESSING SPEED; PURDUE PEGBOARD; IMPACT; CONCUSSION; PERFORMANCE; FOOTBALL	The objective of this study was to investigate players of club level Rugby Union (hereafter rugby) over one rugby season, for signs of residual cognitive dysfunction due to repeated concussive events incurred during long-term participation in the sport. Adult male players of club level rugby, without a diagnosis of a concussion during the season (n = 20), were compared with non-contact club level sports participants (n = 22) of equivalent sex, age, education, and estimated IQ at pre-, mid-, and post-season intervals. Measures included the ImPACT Verbal Memory, Visual Memory, Visual Motor Speed and Reaction Time composites, and the Purdue Pegboard test. Statistical group comparisons revealed consistently poorer performance for rugby players compared with controls for ImPACT Visual Motor Speed and Reaction Time composites at all test intervals, and for the Purdue Pegboard tasks at the first two test intervals. Repeat measures comparisons across the three test intervals demonstrated differential learning patterns between groups on ImPACT Visual Memory, ImPACT Reaction Time, and Purdue Both tasks, suggestive of cognitive vulnerability in the rugby group. Overall, the results reveal deleterious cognitive performance in adult club level rugby players relative to equivalent non-contact sports controls. The finding serves to endorse indications from other studies that demonstrate persistent brain injury effects in association with long-term participation in a contact sport. Recommendations for further research and management of concussion in rugby players are discussed.	[Zoccola, Diana; Shuttleworth-Edwards, Ann B.] Rhodes Univ, Dept Psychol, Grahamstown, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, Grahamstown, South Africa		Shuttleworth-Edwards, AB (corresponding author), 92 Constantiaberg Crescent,Stonehurst Mt Estate, ZA-7945 Cape Town, South Africa.	a.edwards@ru.ac.za					Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Buddenberg LA, 2000, AM J OCCUP THER, V54, P555, DOI 10.5014/ajot.54.5.555; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cumming G, 2001, EDUC PSYCHOL MEAS, V61, P532, DOI 10.1177/0013164401614002; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gallus J, 2003, AM J OCCUP THER, V57, P108, DOI 10.5014/ajot.57.1.108; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Shuttleworth-Edwards AB, 2014, PROG NEUROL SURG, V28, P213, DOI 10.1159/000358785; Shuttleworth-Edwards AB, 2014, ARCH CLIN NEUROPSYCH, V29, P86, DOI 10.1093/arclin/act061; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Suchy Y, 2011, J INT NEUROPSYCH SOC, V17, P101, DOI 10.1017/S135561771000130X; Tiffin, 1968, PURDUE PEGBOARD EXAM; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389	39	1	1	0	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0081-2463	2078-208X		S AFR J PSYCHOL	South Afr. J. Psychol.	MAR	2020	50	1					128	140		10.1177/0081246319826816			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LA3HO	WOS:000523841700012					2022-02-06	
J	Gertler, P; Tate, RL				Gertler, Paul; Tate, Robyn L.			Are single item mood scales (SIMS) valid for people with traumatic brain injury?	BRAIN INJURY			English	Article						Mood; measurement; single-item; depression; TBI	COSMIN CHECKLIST; DEPRESSION; ANXIETY; SATISFACTION; INSTRUMENTS; RELIABILITY	Objectives: Single-item mood scales (SIMS) are used in clinical practice and research as simple and convenient measures to track mood and response to interventions but have rarely been formally evaluated in neurological samples. The current study sought to evaluate the psychometric properties of SIMS in verbal and visual formats. Participants: Sixty-one people living in community settings in metropolitan and regional Australia, with a history of traumatic brain injury. Methods: SIMS were compared with measures of related constructs (depressed mood and satisfaction with life) on two occasions between one and three weeks apart. Results: The study met COSMIN method quality criteria for evaluation of validity. The SIMS showed evidence of construct validity, having moderate magnitude correlation coefficients with measures of similar constructs, and conversely low and non-significant correlation with dissimilar constructs. There was also evidence of discriminant validity, with significant differences based on diagnostic status (participants with depression rated SIMS lower). Correlation coefficients on the SIMS between Times 1 and 2 were of moderate magnitude, with a small but statistically significant increase in mean ratings. Conclusions: the data support the SIMS as a valid measure that can be administered to track changes in mood in clinical practice and research.	[Gertler, Paul; Tate, Robyn L.] Univ Sydney, John Walsh Ctr Rehabil Res, St Leonards, NSW, Australia		Gertler, P (corresponding author), Univ Sydney, John Walsh Ctr Rehabil Res, Kolling Inst, St Leonards, NSW 2065, Australia.	pger8510@uni.sydney.edu.au					Ahearn EP, 1997, J PSYCHIATR RES, V31, P569, DOI 10.1016/S0022-3956(97)00029-0; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eid M, 2004, SOC INDIC RES, V65, P245, DOI 10.1023/B:SOCI.0000003801.89195.bc; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Juengst SB, 2019, BRAIN INJURY, V33, P567, DOI 10.1080/02699052.2019.1584333; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; LURIA RE, 1975, J PSYCHIATR RES, V12, P51, DOI 10.1016/0022-3956(75)90020-5; MB F, 2015, STRUCTURED CLIN INTE; Mokkink LB, 2018, QUAL LIFE RES, V27, P1171, DOI 10.1007/s11136-017-1765-4; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Rosenkoetter U, 2018, BRAIN IMPAIR, V19, P103, DOI 10.1017/BrImp.2017.29; Schellingerhout JM, 2012, QUAL LIFE RES, V21, P659, DOI 10.1007/s11136-011-9965-9; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Stern RA, 1997, APHASIOLOGY, V11, P59, DOI 10.1080/02687039708248455; Tang WK, 2004, INT J PSYCHIAT MED, V34, P155, DOI 10.2190/9YJ9-NNXA-RJCY-2DYP; Turner-Stokes L, 2005, J NEUROL NEUROSUR PS, V76, P1273, DOI 10.1136/jnnp.2004.050096; Ustun T, 2010, MEASURING HLTH DISAB; van Dijk MJ, 2016, CLIN REHABIL, V30, P795, DOI 10.1177/0269215515599665; van Rijsbergen GD, 2014, PSYCHIAT RES, V220, P287, DOI 10.1016/j.psychres.2014.06.052	27	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 15	2020	34	5					653	664		10.1080/02699052.2020.1733087		FEB 2020	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LB9LL	WOS:000518349800001	32126846				2022-02-06	
J	Smith, S				Smith, Susan			Rehabilitating the mind: Avatar (2009), Inception (2010) and the science fiction imagining of lucid dreaming in the treatment of post-traumatic stress disorder in the US military	TRANSCULTURAL PSYCHIATRY			English	Article						lucid dreaming; media psychiatry; post-traumatic stress disorder (PTSD); science fiction; traumatic brain injury (TBI)		Transcultural psychiatry has increased awareness of alternative approaches to mental health and wellbeing, influencing developments in Western psychotherapeutic treatments. In this article, I look at the recent interest in alternative therapies by the U.S. military, which has explored the possibilities of lucid dreaming in order to help soldiers cope with the adverse mental and emotional effects of combat-commonly referred to as post-traumatic stress disorder (PTSD). In this context of concerns about effective rehabilitation and the cost of veteran care, I examine the popular science fiction films Avatar and Inception, which have been discussed in the media as illustrations of the potential use of lucid dreaming and digitally created virtual worlds to "heal" the minds of soldiers affected by modern warfare. In these media portrayals, psychology and science fiction come together to envision and promote human-machine fantasies of the endlessly salvageable and, therefore ultimately, invincible American soldier.	[Smith, Susan] Liverpool Hope Univ, Ctr Culture & Disabil Studies, Liverpool, Merseyside, England		Smith, S (corresponding author), Liverpool Hope Univ, Ctr Culture & Disabil Studies, Liverpool, Merseyside, England.	sua.smith@ntlworld.com					Alexander C., 2010, SMITHSONIAN MAGAZINE; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; [Anonymous], 2006, SCI AM; Cameron J, 1984, THE TERMINATOR; Cameron James, 2009, AVATAR; Clyman J., 2010, PSYCHOL TODAY; Crawford N. C, 2016, COSTS OF WAR; El-Solh AA, 2018, NAT SCI SLEEP, V10, P409, DOI 10.2147/NSS.S166089; Freud S., 1905, 3 ESSAYS THEORY SEXU; Freud S., 1990, INTERPRETATION DREAM; Gannon Charles, 2003, RUMORS WAR INFERNAL; Gavie J. E., 2010, INT J DREAM RES, V3, P13, DOI [10.2174/1573413713666170619092629, DOI 10.2174/1573413713666170619092629]; HARTMANN E, 1995, DREAMING, V5, P213, DOI 10.1037/h0094437; Jacob KS, 2013, INDIAN J PSYCHOL MED, V35, P323, DOI 10.4103/0253-7176.122218; Jones Duncan, 2011, SOURCE CODE; Kinder JM., 2015, PAYING THEIR BODIES; Koebler J., 2012, U S NEWS; Kuhn K, 2011, JETLAW          1026; Kukharenko S., 2017, INT J DREAM RES, V10, P10; LaBerge S., 1985, LUCID DREAMING; Lacan J., 1977, ECRITS SELECTION; Leab A, 2010, MOVIE REV INCEPTION; Lim D, 2011, WIRED; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mcleod S.A., 2018, WHAT ARE MOST INTERE, P1; Miller G, 2016, MED HUMANIT, V42, P213, DOI 10.1136/medhum-2016-011144; Nolan C., 2010, INCEPTION; Pols H, 2007, AM J PUBLIC HEALTH, V97, P2132, DOI 10.2105/AJPH.2006.090910; Reisman Miriam, 2016, P T, V41, P623; Sidel Victor, 2003, MILITARY MED ETHICS, V1, P293; Singh A, 2010, TELEGRAPH; Thacker E, 2001, LEONARDO, V34, P155, DOI 10.1162/002409401750184726; Verhoeven P., 1987, ROBOCOP; Young Allan, 1995, HARMONY ILLUSIONS IN; Young-Roberts B. V., 2012, FILM READERS GUIDE J; Zeimer M., 2014, LUCID DREAMING NEW P, P145; Zink M, 2015, EXPERT REV CLIN PHAR, V8, P335, DOI 10.1586/17512433.2015.1040393; [No title captured]	38	1	1	3	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1363-4615	1461-7471		TRANSCULT PSYCHIATRY	Transcult. Psychiatry	DEC	2020	57	6			SI		801	809	1363461520901638	10.1177/1363461520901638		FEB 2020	9	Anthropology; Psychiatry	Social Science Citation Index (SSCI)	Anthropology; Psychiatry	OV7UV	WOS:000516697900001	32098580				2022-02-06	
J	Vande Vyvere, T; De La Rosa, E; Wilms, G; Nieboer, D; Steyerberg, E; Maas, AIR; Verheyden, J; van den Hauwe, L; Parizel, PM				Vande Vyvere, Thijs; De La Rosa, Ezequiel; Wilms, Guido; Nieboer, Daan; Steyerberg, Ewout; Maas, Andrew I. R.; Verheyden, Jan; van den Hauwe, Luc; Parizel, Paul M.		CTR-TBI Participants Investigators	Prognostic Validation of the NINDS Common Data Elements for the Radiologic Reporting of Acute Traumatic Brain Injuries: A CENTER-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						Common Data Elements; computed tomography; structured reporting; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; TOMOGRAPHY; SIMULATION; SELECTION	The aim of this study is to investigate the prognostic value of using the National Institute of Neurological Disorders and Stroke (NINDS) standardized imaging-based pathoanatomic descriptors for the evaluation and reporting of acute traumatic brain injury (TBI) lesions. For a total of 3392 patients (2244 males and 1148 females, median age = 51 years) enrolled in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, we extracted 96 Common Data Elements (CDEs) from the structured reports, spanning all three levels of pathoanatomic information (i.e., 20 "basic," 60 "descriptive," and 16 "advanced" CDE variables per patient). Six-month clinical outcome scores were dichotomized into favorable (Glasgow Outcome Scale Extended [GOS-E] = 5-8) versus unfavorable (GOS-E = 1-4). Regularized logistic regression models were constructed and compared using the optimism-corrected area under the curve (AUC). An abnormality was reported for the majority of patients (64.51%). In 79.11% of those patients, there was at least one coexisting pathoanatomic lesion or associated finding. An increase in lesion severity, laterality, and volume was associated with more unfavorable outcomes. Compared with the full set of pathoanatomic descriptors (i.e., all three categories of information), reporting "basic" CDE information provides at least equal discrimination between patients with favorable versus unfavorable outcome (AUC = 0.8121 vs. 0.8155, respectively). Addition of a selected subset of "descriptive" detail to the basic CDEs could improve outcome prediction (AUC = 0.8248). Addition of "advanced" or "emerging/exploratory" information had minimal prognostic value. Our results show that the NINDS standardized-imaging based pathoanatomic descriptors can be used in large-scale studies and provide important insights into acute TBI lesion patterns. When used in clinical predictive models, they can provide excellent discrimination between patients with favorable and unfavorable 6-month outcomes. If further validated, our findings could support the development of structured and itemized templates in routine clinical radiology.	[Vande Vyvere, Thijs; van den Hauwe, Luc; Parizel, Paul M.] Antwerp Univ Hosp, Dept Radiol, Antwerp, Belgium; [Vande Vyvere, Thijs; Maas, Andrew I. R.; van den Hauwe, Luc; Parizel, Paul M.] Univ Antwerp, Wilrijkstr 10, B-2650 Antwerp, Belgium; [Vande Vyvere, Thijs; De La Rosa, Ezequiel; Wilms, Guido; Verheyden, Jan] Icometrix, Res & Dev, Leuven, Belgium; [Wilms, Guido] Univ Hosp Leuven, Dept Radiol, Leuven, Belgium; [Wilms, Guido] Katholieke Univ Leuven, Leuven, Belgium; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; [Nieboer, Daan; Steyerberg, Ewout] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Steyerberg, Ewout] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands		Vande Vyvere, T (corresponding author), Univ Antwerp, Wilrijkstr 10, B-2650 Antwerp, Belgium.; Vande Vyvere, T (corresponding author), Antwerp Univ Hosp, Neuroradiol Div, Dept Radiol, Wilrijkstr 10, B-2650 Antwerp, Belgium.	vandevyverethijs@gmail.com	Cooper, D. James/G-7961-2013; Castano-Leon, Ana M/ABF-6322-2020; Volovici, Victor/AAZ-8901-2020; Vande Vyvere, Thijs/AAB-5180-2022; Sahuquillo, Juan/B-3577-2008; Laureys, Steven/AAN-2097-2021; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012	Cooper, D. James/0000-0002-5872-9051; Castano-Leon, Ana M/0000-0002-7918-5049; Volovici, Victor/0000-0002-5798-5360; Vande Vyvere, Thijs/0000-0003-4032-5443; Sahuquillo, Juan/0000-0003-0713-5875; Laureys, Steven/0000-0002-3096-3807; Sakowitz, Oliver/0000-0003-3248-6335; Parizel, Paul M./0000-0002-0221-2854; Gomez, Pedro/0000-0002-4185-5238; Coles, Jonathan/0000-0003-4013-679X; Stewart, William/0000-0003-2199-2582; Van Essen, Thomas/0000-0003-4657-5283; Newcombe, Virginia/0000-0001-6044-9035; Rossi, Sandra/0000-0002-9963-8121; Zeiler, Frederick/0000-0003-1737-0510; Posti, Jussi/0000-0002-5925-5193; Radoi, Andreea/0000-0002-0677-3544; Sanchez-Porras, Renan/0000-0002-9084-8114; Raj, Rahul/0000-0003-4243-9591; Kolias, Angelos/0000-0003-3992-0587; Blaabjerg, Morten/0000-0001-6007-1861	Hannelore Kohl Foundation (Germany); One Mind	Funding of additional elements has been provided by the Hannelore Kohl; Foundation (Germany) and by the non-profit organization One Mind.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Barras CD, 2016, J MED IMAG RADIAT ON, V60, P720, DOI 10.1111/1754-9485.12491; Bullock M.R., 2006, NEUROSURGERY, pS21; Bullock R.M., 2006, NEUROSURGERY S2, V58, P1; Clarencon F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186641; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Harburg L, 2017, BRAIN INJURY, V31, P174, DOI 10.1080/02699052.2016.1225989; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Hu Y, 2015, BMC SURG, V15, DOI 10.1186/1471-2482-15-6; Huff JS, 2014, AM J EMERG MED, V32, P606, DOI 10.1016/j.ajem.2014.03.010; Jain S., 2019, INT J EMERGING TECHN, V10, P01; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Rubin DL, 2017, RADIOLOGY, V283, P836, DOI 10.1148/radiol.2016161553; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	30	1	1	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1269	1282		10.1089/neu.2019.6710		FEB 2020	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000517891700001	31813313	Bronze, Green Submitted			2022-02-06	
J	Keeves, J; Braaf, SC; Ekegren, CL; Beck, B; Gabbe, BJ				Keeves, Jemma; Braaf, Sandra C.; Ekegren, Christina L.; Beck, Ben; Gabbe, Belinda J.			Caring for people with serious injuries in urban and regional communities: a qualitative investigation of healthcare providers' perceptions	DISABILITY AND REHABILITATION			English	Article						Geography; trauma; injury; allied health professionals; patient outcomes; interview	TRAUMATIC BRAIN-INJURY; NEW-SOUTH-WALES; SPINAL-CORD-INJURY; PATIENTS EXPERIENCES; PHYSICAL-ACTIVITY; SUPPORT NEEDS; PATIENT; SERVICES; OUTCOMES; SATISFACTION	Purpose: To understand the factors that affect the management of people after serious injury in urban and regional settings, beyond hospital discharge from the perspectives of allied health professionals (AHPs). Materials and methods: An exploratory qualitative study of AHPs caring for people with serious injuries post-hospital discharge in urban and regional areas of Victoria, Australia was completed. Twenty-five semi-structured interviews were undertaken with AHPs and thematically analysed. Results: Allied health professionals in urban and regional settings reported the benefits of a multi-disciplinary team to deliver high-quality care. However, a number of barriers to service delivery were identified that impacted on their ability to meet the needs of patients. These included insufficient psychological services, a shortage of available carers and an unmet need for external clinical support in regional areas. Communication between AHPs and other services, and care co-ordination of post-discharge services, was also highlighted as key areas to improve for optimal patient care. Conclusions: Factors that influenced optimal patient management included the availability of psychological and carer services, communication between health professionals and coordination of post-discharge care. The experiences of AHPs can offer practical suggestions to optimise service delivery and post-discharge care for people with serious injuries.	[Keeves, Jemma; Braaf, Sandra C.; Ekegren, Christina L.; Beck, Ben; Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Keeves, Jemma] Epworth Med Fdn, Dept Physiotherapy, Melbourne, Vic, Australia		Keeves, J (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	jemma.keeves@monash.edu	Beck, Ben/ABD-5556-2020; Ekegren, Christina L./AAX-7887-2021	Beck, Ben/0000-0003-3262-5956; Ekegren, Christina L./0000-0002-7656-6209; Keeves, Jemma/0000-0003-1447-1535	Epworth Research Institute Grant; National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia [1106633]; Australian Research CouncilAustralian Research Council [FT170100048, DE180100825]	JK was supported by an Epworth Research Institute Grant. CE was supported by a National Health and Medical Research Council of Australia (NHMRC) Early Career Fellowship [1106633]. BG was supported by an Australian Research Council Future Fellowship [FT170100048]. BB was supported by an Australian Research Council Discovery Early Career Researcher Award Fellowship [DE180100825].	Analytis P, 2018, BRAIN INJURY, V32, P209, DOI 10.1080/02699052.2017.1395479; Australian Bureau of Statistics, 2019, REG POP GROWTH AUSTR; Australian Bureau of Statistics, 2018, AUSTR STAT GEOGRAPHY; Beckett K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005668; Beckett Kate, 2013, Br J Nurs, V22, P1118; Bellon M, 2015, BRAIN IMPAIR, V16, P131, DOI 10.1017/BrImp.2015.17; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; Braaf S, 2019, BRAIN INJURY, V33, P574, DOI 10.1080/02699052.2019.1566835; Braaf SC, 2018, DISABIL REHABIL, V40, P1893, DOI 10.1080/09638288.2017.1313910; Braaf S, 2020, DISABIL REHABIL, V42, P2707, DOI 10.1080/09638288.2019.1571116; Christie N, 2016, BRIT J GEN PRACT, V66, pE24, DOI 10.3399/bjgp15X688141; Chugh Amita, 2009, Front Health Serv Manage, V25, P11; Creswell JW, 2017, QUALITATIVE INQUIRY; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Davis MM, 2012, J GEN INTERN MED, V27, P1649, DOI 10.1007/s11606-012-2169-3; Deighton RM, 2007, J TRAUMA STRESS, V20, P63, DOI 10.1002/jts.20180; Department of Human Services, 2009, REV FUT DIR VICT STA; Eagar K, 2014, IMPLICATIONS NATL DI; Foster M, 2016, AUST J SOC ISSUES, V51, P27, DOI 10.1002/j.1839-4655.2016.tb00363.x; Foust JB, 2012, WESTERN J NURS RES, V34, P194, DOI 10.1177/0193945911400448; Franzen Carin, 2006, Accid Emerg Nurs, V14, P104, DOI 10.1016/j.aaen.2006.01.003; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Gabbe BJ, 2007, AUST HEALTH REV, V31, P628, DOI 10.1071/AH070628; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2013, MED J AUSTRALIA, V198, P149, DOI 10.5694/mja12.11179; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gagnon MP, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-18; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Glasberg AL, 2007, J ADV NURS, V57, P392, DOI 10.1111/j.1365-2648.2007.04111.x; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Goodridge D, 2015, DISABIL REHABIL, V37, P1401, DOI 10.3109/09638288.2014.972593; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hall WA, 2005, QUAL HEALTH RES, V15, P394, DOI 10.1177/1049732304272015; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Keeves J, 2019, INJURY, V50, P1826, DOI 10.1016/j.injury.2019.07.013; Khan F, 2012, BRIT J SURG, V99, P88, DOI 10.1002/bjs.7776; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Lennox A, 2018, TOP SPINAL CORD INJ, V24, P315, DOI 10.1310/sci17-00050; Leung ACT, 2004, J APPL GERONTOL, V23, P70, DOI 10.1177/0733464804263088; Mair F, 2000, BMJ-BRIT MED J, V320, P1517, DOI 10.1136/bmj.320.7248.1517; MAXWELL JA, 1992, HARVARD EDUC REV, V62, P279, DOI 10.17763/haer.62.3.8323320856251826; May C, 2003, J AM MED INFORM ASSN, V10, P596, DOI 10.1197/jamia.M1145; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Mitsch V, 2014, BRAIN INJURY, V28, P1504, DOI 10.3109/02699052.2014.938120; Murphy J., 2004, TOPICS EMERG MED, V26, P231; Newnham H, 2017, INT J QUAL HEALTH C, V29, P752, DOI 10.1093/intqhc/mzx121; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; Peden, 2004, GUIDELINES ESSENTIAL; Pointer S, 2015, INJURY RES STAT SERI, V95; Purcal C., 2016, SOCIAL POLICY REV, V28, P173, DOI 10.1332/policypress/9781447331797.003.0009; Ruseckaite R, 2012, INJURY, V43, P1600, DOI 10.1016/j.injury.2011.03.011; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Shahan CP, 2016, J TRAUMA ACUTE CARE, V81, P1167, DOI 10.1097/TA.0000000000001140; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Sippel LM, 2015, ECOL SOC, V20, DOI 10.5751/ES-07832-200410; Sleney J, 2014, INJURY, V45, P312, DOI 10.1016/j.injury.2012.12.025; Toien K, 2012, INJURY, V43, P1606, DOI 10.1016/j.injury.2011.03.038; Trauma C, 2014, RESOURCES OPTIMAL CA; Van Horn ER, 2013, INT J ORTHOP TRAUMA, V17, P180, DOI 10.1016/j.ijotn.2013.03.001; Victorian State Trauma Registry Outcomes and Monitoring (VSTORM) group, 2018, VICT STAT TRAUM SYST; Weinberg DB, 2007, HEALTH SERV RES, V42, P7, DOI 10.1111/j.1475-6773.2006.00653.x; Whalan J., 2014, REV CAPABILITIES NAT; Williams TL, 2018, DISABIL REHABIL, V40, P52, DOI 10.1080/09638288.2016.1242176; Williams TL, 2014, HEALTH PSYCHOL REV, V8, P404, DOI 10.1080/17437199.2014.898406	68	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 9	2021	43	21					3052	3060		10.1080/09638288.2020.1728787		FEB 2020	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WJ6GT	WOS:000517583300001	32109168				2022-02-06	
J	Povolo, CA; Reid, JN; Shariff, SZ; Welk, B; Morrow, SA				Povolo, Christopher A.; Reid, Jennifer N.; Shariff, Salimah Z.; Welk, Blayne; Morrow, Sarah A.			Concussion in adolescence and the risk of multiple sclerosis: A retrospective cohort study	MULTIPLE SCLEROSIS JOURNAL			English	Article						Multiple sclerosis; concussion; prevalence; risk factor	BLOOD-BRAIN-BARRIER; TRAUMA; CNS; INJURY; VISITS	Background: Physical trauma, specifically concussions sustained during adolescence, has been hypothesized to be a risk factor for multiple sclerosis (MS). Objective: To examine the association between adolescent concussions and future MS diagnosis. Methods: This retrospective study using linked administrative databases from Ontario, Canada, identified 97,965 adolescents (age 11-18 years) who sustained > 1 concussion and presented to an emergency department between 1992 and 2011. Cases were matched 1:3 with individuals who had not sustained a concussion based on age, sex, address, and index date. The primary outcome was MS diagnosis, using a validated MS diagnosis definition: > 1 hospitalization or > 5 physician billings within 2 years. Results: A concussion during adolescence was associated with a significantly increased risk of MS (hazard ratio (HR) = 1.29, p = 0.03). Sex-specific analysis revealed that only males who sustained a concussion in adolescence had a raised risk of MS (HR = 1.41, p = 0.04). Conclusion: This study supports an association between concussions in adolescence and future MS diagnoses, highlighting the potentially serious long-term effects of concussions.	[Povolo, Christopher A.] London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada; [Reid, Jennifer N.] Inst Clin Evaluat Sci, London, ON, Canada; [Shariff, Salimah Z.] Western Univ, Inst Clin Evaluat Sci Western, Lawson Heath Res Inst, London, ON, Canada; [Shariff, Salimah Z.] Western Univ, Arthur Labatt Sch Nursing, London, ON, Canada; [Welk, Blayne] Western Univ, Inst Clin Evaluat Sci, London, ON, Canada; [Welk, Blayne] Western Univ, Dept Surg & Epidemiol & Biostat, London, ON, Canada; [Morrow, Sarah A.] Western Univ, Dept Clin Neurol Sci, Univ Hosp, LHSC, 339 Windermere Rd, London N6A 5A5, ON, Canada		Morrow, SA (corresponding author), Western Univ, Dept Clin Neurol Sci, Univ Hosp, LHSC, 339 Windermere Rd, London N6A 5A5, ON, Canada.	Sarah.morrow@lhsc.on.ca			Roche CanadaRoche Holding; ICES - Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario; Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry, Western University; Lawson Health Research Institute	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by an unrestricted investigator-initiated trial grant from Roche Canada. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The study was completed at the ICES Western site, where core funding is provided by the Academic Medical Organization of Southwestern Ontario, the Schulich School of Medicine and Dentistry, Western University, and the Lawson Health Research Institute.	Al-Sakran LH, 2018, CAN J NEUROL SCI, V45, P295, DOI 10.1017/cjn.2017.301; Austin PC, 2008, PHARMACOEPIDEM DR S, V17, P1218, DOI 10.1002/pds.1674; Canchola AJ, 2003, W USERS SAS SOFTWARE, P1; Confavreux C, 2014, HAND CLINIC, V122, P343, DOI 10.1016/B978-0-444-52001-2.00014-5; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; GONZALEZSCARANO F, 1987, ANN NEUROL, V21, P300, DOI 10.1002/ana.410210312; Heide-Jorgensen U, 2018, CLIN EPIDEMIOL, V10, P1325, DOI 10.2147/CLEP.S164456; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Korn T, 2017, NAT REV IMMUNOL, V17, P179, DOI 10.1038/nri.2016.144; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Lunny CA, 2014, J NEUROL SCI, V336, P13, DOI 10.1016/j.jns.2013.08.011; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Marrie RA, 2018, NEUROLOGY, V91, pE1579, DOI [10.1212/WNL.0000000000006395, 10.1212/wnl.0000000000006395]; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Montgomery S, 2017, ANN NEUROL, V82, P554, DOI 10.1002/ana.25036; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1994, CLIN NEUROL NEUROSUR, V96, P103, DOI 10.1016/0303-8467(94)90042-6; Poser CM, 2000, ARCH NEUROL-CHICAGO, V57, P1074, DOI 10.1001/archneur.57.7.1074; Warren SA, 2013, CAN J NEUROL SCI, V40, P168, DOI 10.1017/S0317167100013688; Widdifield J, 2015, MULT SCLER J, V21, P1045, DOI 10.1177/1352458514556303; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	28	1	1	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	FEB	2021	27	2					180	187	1352458520908037	10.1177/1352458520908037		FEB 2020	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PU8IU	WOS:000515466200001	32091315				2022-02-06	
J	Sheehy, L; Taillon-Hobson, A; Sveistrup, H; Bilodeau, M; Yang, C; Finestone, H				Sheehy, Lisa; Taillon-Hobson, Anne; Sveistrup, Heidi; Bilodeau, Martin; Yang, Christine; Finestone, Hillel			Sitting Balance Exercise Performed Using Virtual Reality Training on a Stroke Rehabilitation Inpatient Service: A Randomized Controlled Study	PM&R			English	Article							CLINICALLY IMPORTANT DIFFERENCE; TRAUMATIC BRAIN-INJURY; TRUNK PERFORMANCE; ADULTS; VALIDATION; VALIDITY; MOBILITY; TASKS; SCALE; TIME	Background Virtual reality training (VRT) is engaging and may enhance rehabilitation intensity. Only one previous study has looked at its use to improve sitting balance after stroke. Objective To determine if supplemental sitting balance exercises, administered via VRT, improve control of sitting balance and upper extremity function in stroke rehabilitation inpatients. Design Assessor-blinded, placebo-controlled randomized controlled trial. Setting Stroke inpatient rehabilitation unit. Participants Seventy-six participants (out of 130 approached) with subacute stroke who could not stand independently were randomized to experimental and control groups. Sixty-nine completed the study. Interventions The experimental group did VRT that required leaning and reaching, whereas the control group had their trunk restrained and performed VRT that involved only small upper extremity movements to minimize trunk movement. Both groups performed 10-12 sessions of 30-45 minutes. Participants were assessed pre, post, and 1 month after the sessions by a blinded examiner. Outcome Measures Function in Sitting Test (FIST, primary outcome measure); Ottawa Sitting Scale; Reaching Performance Scale; Wolf Motor Function Test (WMFT). Results Thirty-three participants completed the experimental intervention and 36 the control. Pre/post differences for FIST were 3.4 (confidence interval [CI] 0.5;6.3) for the experimental group and 5.3 (2.9;7.7) for the control group. There was a significant improvement over time (adjusted for multiple comparisons, P < .006) on most outcome measures except the WMFT Performance Time Scale (control group; P = .007) and grip strength (P = .008); there were no differences between groups (P > .006). Conclusions Siting balance outcomes were similar for both groups; therefore, this study does not support the use of sitting balance exercises provided via VRT for the rehabilitation of sitting balance after stroke. However, because it is only the second study to investigate VRT for sitting balance and upper extremity function, more research, using more challenging exercises and a greater treatment intensity, is required before definitive conclusions are made.	[Sheehy, Lisa; Taillon-Hobson, Anne; Sveistrup, Heidi; Bilodeau, Martin] Bruyere Res Inst, Ottawa, ON, Canada; [Sheehy, Lisa; Sveistrup, Heidi; Bilodeau, Martin] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Sveistrup, Heidi; Bilodeau, Martin] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Yang, Christine; Finestone, Hillel] Bruyere Continuing Care, Stroke Rehabil, Ottawa, ON, Canada; [Yang, Christine; Finestone, Hillel] Univ Ottawa, Div Phys Med & Rehabil, Dept Med, Fac Med, Ottawa, ON, Canada		Finestone, H (corresponding author), Bruyere Continuing Care, Stroke Rehabil, Ottawa, ON, Canada.; Finestone, H (corresponding author), Univ Ottawa, Div Phys Med & Rehabil, Dept Med, Fac Med, Ottawa, ON, Canada.	hfinestone@bruyere.org	Sheehy, Lisa/AAE-3358-2020	Sheehy, Lisa/0000-0002-5844-0952; Yang, Christine/0000-0002-9059-5452			Buyukavci R, 2016, TURK FIZ TIP REHAB D, V62, P248, DOI 10.5606/tftrd.2016.84770; Cabanas-Valdes R, 2016, CLIN REHABIL, V30, P1024, DOI 10.1177/0269215515609414; Corbetta D, 2015, J PHYSIOTHER, V61, P117, DOI 10.1016/j.jphys.2015.05.017; Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; de Rooij IJM, 2016, PHYS THER, V96, P1905, DOI 10.2522/ptj.20160054; de Seze M, 2001, ARCH PHYS MED REHAB, V82, P793, DOI 10.1053/apmr.2001.0820793; Gorman SL, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/593280; Gorman SL, 2014, ARCH PHYS MED REHAB, V95, P2304, DOI 10.1016/j.apmr.2014.07.415; Gorman SL, 2010, J NEUROL PHYS THER, V34, P150, DOI 10.1097/NPT.0b013e3181f0065f; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Karthikbabu S, 2012, NEURAL REGEN RES, V7, P1974, DOI 10.3969/j.issn.1673-5374.2012.25.008; Kim JH, 2015, J PHYS THER SCI, V27, P2955, DOI 10.1589/jpts.27.2955; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Laerd Statistics, 2015, 2 WAY MIX ANOVA US S; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Lang CE, 2009, ARCH PHYS MED REHAB, V90, P1692, DOI 10.1016/j.apmr.2009.04.005; Lange B, 2009, EUR J PHYS REHAB MED, V45, P143; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Lee MM, 2018, MED SCI MONITOR, V24, P2590, DOI 10.12659/MSM.906451; Levin MF, 2004, PHYS THER, V84, P8, DOI 10.1093/ptj/84.1.8; Lewis GN, 2011, DISABIL REHABIL-ASSI, V6, P453, DOI 10.3109/17483107.2011.574310; Li Z, 2016, CLIN REHABIL, V30, P432, DOI 10.1177/0269215515593611; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P429, DOI 10.1177/1545968308331144; McEwen D, 2014, STROKE, V45, P1853, DOI 10.1161/STROKEAHA.114.005362; Peters DM, 2013, J NEUROL PHYS THER, V37, P105, DOI 10.1097/NPT.0b013e31829ee9bc; Pollock AS, 2002, CLIN REHABIL, V16, P473, DOI 10.1191/0269215502cr520oa; Saeys W, 2012, NEUROREHAB NEURAL RE, V26, P231, DOI 10.1177/1545968311416822; Sheehy L, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0563-x; Sheehy L, 2015, INT J STROKE, V10, P101; Stinear C, 2013, STROKE, V44, P2039, DOI 10.1161/STROKEAHA.113.000968; Taillon-Hobson A, 2015, CHARACTERIZATION SCO; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thornton M, 2010, DISABIL REHABIL, V32, P1568, DOI 10.3109/09638280903567893; van de Port IGL, 2006, J REHABIL MED, V38, P218, DOI 10.1080/16501970600582930; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Verheyden G, 2007, J NEUROL NEUROSUR PS, V78, P694, DOI 10.1136/jnnp.2006.101642; Verheyden G, 2009, NEUROREHAB NEURAL RE, V23, P281, DOI 10.1177/1545968308321776; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Young-Saver DF, 2018, J STROKE CEREBROVASC, V27, P3662, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.040	43	1	1	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	AUG	2020	12	8					754	765		10.1002/pmrj.12331		FEB 2020	12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	MX2AH	WOS:000515337400001	31970898				2022-02-06	
J	Fried, R; DiSalvo, M; Kelberman, C; Adler, A; McCafferty, D; Woodworth, KY; Green, A; Biederman, I; Faraone, SV; Biederman, J				Fried, Ronna; DiSalvo, Maura; Kelberman, Caroline; Adler, Amos; McCafferty, Debra; Woodworth, K. Yvonne; Green, Allison; Biederman, Itai; Faraone, Stephen, V; Biederman, Joseph			An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Pediatric ADHD; stimulant medication; medication adherence; SMS	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; TRAUMATIC BRAIN-INJURY; OROS METHYLPHENIDATE; MEDICATION ADHERENCE; UNITED-STATES; PARENT-REPORT; FOLLOW-UP; ADULTS	Background: Although large datasets document that stimulants decrease the risk for many adverse ADHD-associated outcomes, compliance with stimulants remains poor. Aims: This study examined the effectiveness of a novel ADHD-centric text messaging-based intervention aimed to improve adherence to stimulant medications in children with ADHD. Methods: Subjects were 87 children aged 6-12, who were prescribed a stimulant medication for ADHD treatment. Prescribers gave permission to contact their patients for participation in the study. Subjects were primarily from the primary care setting with a subsample of psychiatrically referred subjects for comparison. Age- and sex-matched comparators were identified (3:1) from the same pool of prescriber-approved subjects that did not participate. Timely prescription refills (within 37 days) were determined from prescription dates documented in patients' electronic medical record. Results: Eighty-five percent of SMS intervention patients refilled their prescriptions in a timely manner compared with 62% of patients receiving treatment as usual (OR = 3.46, 95% CI: 1.82, 6.58; p < 0.001). The number needed to treat statistic was computed as five, meaning for every five patients who receive the SMS intervention, we can keep one adherent to their stimulant treatment. Conclusions: These preliminary findings support the potential utility of a readily accessible technology to improve the poor rate of adherence to stimulant treatment in children with ADHD. To the best of our knowledge, this study is the first digital health intervention aimed at improving adherence to stimulant medication for children with ADHD. These results support the need for further examination of this technology through more definitive randomized clinical trials.	[Fried, Ronna; DiSalvo, Maura; Kelberman, Caroline; McCafferty, Debra; Woodworth, K. Yvonne; Green, Allison; Biederman, Itai; Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Boston, MA 02114 USA; [Fried, Ronna; Biederman, Joseph] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Adler, Amos; McCafferty, Debra] MemoText Corp, Toronto, ON, Canada; [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Faraone, Stephen, V] Univ Bergen, Dept Biomed, KG Jebsen Ctr Psychiat Disorders, Bergen, Norway		Biederman, J (corresponding author), Massachusetts Gen Hosp, Yawkey 6A, Boston, MA 02114 USA.	jbiederman@partners.org			MGH Pediatric Psychopharmacology Council Fund, a philanthropic sundry fund	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported exclusively by the MGH Pediatric Psychopharmacology Council Fund, a philanthropic sundry fund.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Adler LD, 2010, POSTGRAD MED, V122, P184, DOI 10.3810/pgm.2010.01.2112; American Hospital Association, 2013, LEADSH RES PAT FAM E; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Armstrong AW, 2009, ARCH DERMATOL, V145, P1230, DOI 10.1001/archdermatol.2009.269; Barbaresi WJ, 2007, J DEV BEHAV PEDIATR, V28, P274, DOI 10.1097/DBP.0b013e3180cabc28; Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Biederman J, 2006, BIOL PSYCHIAT, V59, P829, DOI 10.1016/j.biopsych.2005.09.011; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Biederman J, 2004, J CLIN PSYCHIAT, V65, P3; Biederman J, 2008, J CLIN PSYCHIAT, V69, P1217, DOI 10.4088/JCP.v69n0803; Biederman J, 2019, PSYCHIAT SERV, V70, P874, DOI 10.1176/appi.ps.201800515; Biederman J, 2019, J CLIN PSYCHOPHARM, V39, P351, DOI 10.1097/JCP.0000000000001055; Canadian ADHD Resource Alliance, 2008, CAN ADHD PRACT GUID; Faraone SV, 2007, PSYCHOL MED, V37, P1743, DOI 10.1017/S0033291707000335; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Gajria K, 2014, NEUROPSYCH DIS TREAT, V10, P1543, DOI 10.2147/NDT.S65721; Gau SSF, 2006, J CHILD ADOL PSYCHOP, V16, P286, DOI 10.1089/cap.2006.16.286; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; Jerome Laurence, 2006, Curr Psychiatry Rep, V8, P416, DOI 10.1007/s11920-006-0045-8; Kendall T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1239; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67; Levine D, 2008, AM J PUBLIC HEALTH, V98, P393, DOI 10.2105/AJPH.2007.110767; Mackenzie H, 2008, HLTH CARE INFORM REV, V12, P6; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Medori R, 2008, BIOL PSYCHIAT, V63, P981, DOI 10.1016/j.biopsych.2007.11.008; Miloh T, 2009, PEDIATRICS, V124, pE844, DOI 10.1542/peds.2009-0415; Moldavsky M, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0377-0; Nissen SE, 2006, NEW ENGL J MED, V354, P1445, DOI 10.1056/NEJMp068049; Olfson M, 2007, J MANAGE CARE PHARM, V13, P570, DOI 10.18553/jmcp.2007.13.7.570; Pappadopulos E, 2009, J AM ACAD CHILD PSY, V48, P501, DOI 10.1097/CHI.0b013e31819c23ed; Perwien AR, 2006, J CHILD ADOL PSYCHOP, V16, P713, DOI 10.1089/cap.2006.16.713; Rodgers A, 2005, TOB CONTROL, V14, P255, DOI 10.1136/tc.2005.011577; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; Safren Steven A, 2007, J Atten Disord, V10, P257, DOI 10.1177/1087054706292165; Sanchez RJ, 2005, PHARMACOTHERAPY, V25, P909, DOI 10.1592/phco.2005.25.7.909; Spencer AE, 2016, J CLIN PSYCHIAT, V77, P72, DOI 10.4088/JCP.14r09479; Spencer TJ, 2007, BIOL PSYCHIAT, V61, P1380, DOI 10.1016/j.biopsych.2006.07.032; Spencer TJ, 2013, J CLIN PSYCHIAT, V74, P902, DOI 10.4088/JCP.12r08287; StataCorp, 2017, STATA STAT SOFTWARE; Swanson J, 2003, CNS DRUGS, V17, P117, DOI 10.2165/00023210-200317020-00004; Swanson JM, 2017, J CHILD PSYCHOL PSYC, V58, P663, DOI 10.1111/jcpp.12684; US Census Bureau, AM COMM SURV 2011 20; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wilens E, 2004, JAMA-J AM MED ASSOC, V292, P619, DOI 10.1001/jama.292.5.619; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179	50	1	1	4	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	AUG	2020	34	8					883	890	0269881120908014	10.1177/0269881120908014		FEB 2020	8	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	MN9NN	WOS:000514770600001	32077768				2022-02-06	
J	Helmich, I; Nussbaum, N; Lausberg, H				Helmich, Ingo; Nussbaum, Nicola; Lausberg, Hedda			Hyperactive movement behaviour of athletes with post-concussion symptoms	BEHAVIOURAL BRAIN RESEARCH			English	Article						Nonverbal movement behaviour; Hand movement activity; Hand rest positions; Sport-Related Concussions (SRC); Mild traumatic brain injury (mTBI)	TRAUMATIC BRAIN-INJURY; RESPONSE-INHIBITION; HEAD-INJURY; LONG-TERM; DISORDER; ADHD	Objective: Observations of hyperactive (/restless, agitated) behaviour as a consequence of mild traumatic brain injuries (mTBI) in sports are inconclusive as reduced or slowed movement behaviour is also commonly described post-concussion. This might be grounded in the fact that the movement behaviour of athletes has not been systematically investigated during standardized settings and with objective methods of nonverbal movement analysis. Thus, we investigate whether symptoms after mTBI in sports are characterized by a hyper- or hypoactive movement behaviour experimentally. Methods: Three matched groups of 40 athletes were investigated: 14 symptomatic and 14 asymptomatic athletes with a mTBI; and 12 non-concussed athletes. Four certified raters analysed with a standard analysis system for nonverbal behaviour each athlete's hand movement activity, hand movement contacts, and resting positions that were displayed during a videotaped standardized anamnesis protocol. Results: Symptomatic athletes spend significantly more time with act apart hand movements and less time with closed rest positions when compared to non-concussed athletes. Post-concussion symptom (PCS) scores positively correlate with act apart hand movements. A linear regression analysis revealed that act apart hand movements significantly predict the PCS score. Conclusions: Athletes with increased symptoms after mTBI move their hands in a hyperactive and restless manner. Increased act apart hand movements, i.e., when both hands move simultaneously without touching each other, indicate a motoric destabilization in symptomatic athletes' behaviour that might be related to impaired inhibitory motor control systems. Future diagnoses should concern the systematic analysis of the nonverbal movement behaviour as a potential behavioural marker of symptoms after mTBI.	[Helmich, Ingo; Nussbaum, Nicola; Lausberg, Hedda] German Sport Univ GSU Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany		Helmich, I (corresponding author), German Sport Univ GSU Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	i.helmich@dshs-koeln.de; nicolanussbaum@web.de; h.lausberg@dshs-koeln.de			German Sports University, Cologne [L-11-10011-175-122000]	The study was funded by the University research funding of the German Sports University, Cologne (L-11-10011-175-122000).	Abdulle AE, 2020, INT REV PSYCHIATR, V32, P3, DOI 10.1080/09540261.2019.1664421; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barkley RA, 1999, MENT RETARD DEV D R, V5, P177, DOI 10.1002/(SICI)1098-2779(1999)5:3<177::AID-MRDD3>3.3.CO;2-7; Barr W.B., 2010, HDB SPORT NEUROPSYCH; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P93; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Holle H, 2015, BEHAV RES METHODS, V47, P837, DOI 10.3758/s13428-014-0506-7; Hutchinson E, 2001, CHILD CARE HLTH DEV, V27, P241, DOI 10.1046/j.1365-2214.2001.00214.x; Ito W, 2017, SLEEP MED, V32, P4, DOI 10.1016/j.sleep.2016.04.008; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Kurtis MM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00369; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lausberg H., 2019, NEUROGES ANAL SYSTEM; Lausberg H, 2011, PSYCHOTHER WISS, V1, P41; Lausberg H., 2013, UNDERSTANDING BODY M, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Neumann N., 2017, J MULTIMODAL COMMUNI, V4, P50; Nuckols Cardwell C., 2013, DIAGN STAT MAN MENT, V35, P1224, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596.744053]; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; PIERSON A, 1994, PROG NEURO-PSYCHOPH, V18, P1037, DOI 10.1016/0278-5846(94)90129-5; Pouw W, 2020, BEHAV RES METHODS, V52, P723, DOI 10.3758/s13428-019-01271-9; Reynolds C.R., 2013, DSM 5 DIAGNOSTIC CRI, DOI [10.1176/appi.books.9780890425596.x00DiagnosticClassification., DOI 10.1176/APPI.BOOKS.9780890425596.X00]; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Sacchetti M., 2017, EVIDENCE BASED PSYCH, V3, P1; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; ULRICH G, 1985, J AFFECT DISORDERS, V9, P63, DOI 10.1016/0165-0327(85)90011-4; Vrij A, 1996, J NONVERBAL BEHAV, V20, P65, DOI 10.1007/BF02248715; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y	44	1	1	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 17	2020	380								112443	10.1016/j.bbr.2019.112443			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	LD5IJ	WOS:000526062800013	31862468				2022-02-06	
J	Bigue, JL; Duclos, C; Dumont, M; Paquet, J; Blais, H; Menon, DK; Bernard, F; Gosselin, N				Bigue, Julien Lauzier; Duclos, Catherine; Dumont, Marie; Paquet, Jean; Blais, Helene; Menon, David K.; Bernard, Francis; Gosselin, Nadia			Validity of actigraphy for nighttime sleep monitoring in hospitalized patients with traumatic injuries	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						actigraphy; acute care; polysomnography; sleep; traumatic brain injury	BRAIN-INJURY; ACUTE-PHASE; CYCLE DISTURBANCES; WAKE; CONSCIOUSNESS; RECOVERY	Study Objectives: Sleep-wake disturbances are frequent among patients hospitalized for traumatic injuries but remain poorly documented because of the lack of tools validated for hospitalized patients. This study aimed to validate actigraphy for nighttime sleep monitoring of hospitalized patients with severe traumatic injuries, using ambulatory polysomnography (PSG). Methods: We tested 17 patients (30.4 +/- 14.7 years, 16.6 +/- 8.2 days postinjury) who had severe orthopedic injuries and/or spinal cord injury, with or without traumatic brain injury. When medically stable, patients wore an actigraph on a nonparalyzed arm and underwent ambulatory PSG at the bedside. Data were converted to 1-minute epochs. The following parameters were calculated for the nighttime period: total sleep time, total wake time, sleep efficiency, and number of awakenings. Epoch-by-epoch concordance between actigraphy and PSG was analyzed to derive sensitivity, specificity, and accuracy. PSG sleep parameters were compared to those obtained from four actigraphy scoring algorithms by Bland-Altman plots. Results: Sensitivity to detect sleep was >= 92% and accuracy was > 85% for all four actigraphy algorithms used, whereas specificity varied from 48% to 60%. The low-activity wake threshold (20 activity counts per epoch) was most closely associated with PSG on all sleep parameters. This scoring algorithm also had the highest specificity (59.9%) and strong sensitivity (92.8%). Conclusions: Actigraphy is valid for monitoring nighttime sleep and wakefulness in patients hospitalized with traumatic injuries, with sensitivity, specificity and accuracy comparable to actigraphic recordings in healthy individuals. A scoring algorithm using a low wake threshold is best suited for this population and setting.	[Bigue, Julien Lauzier; Duclos, Catherine; Dumont, Marie; Paquet, Jean; Blais, Helene; Gosselin, Nadia] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local J-5135, Montreal, PQ H4J 1C5, Canada; [Bigue, Julien Lauzier; Bernard, Francis] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Duclos, Catherine; Dumont, Marie] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Bernard, Francis] Hop Sacre Coeur Montreal, Crit Care, Montreal, PQ, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada		Gosselin, N (corresponding author), Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local J-5135, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [115172]; Fonds pour la Recherche du Quebec-Sante [24742]	All authors have seen and approved the manuscript. Work for this study was performed at Hopital du Sacre-Coeur de Montreal, Montreal, Canada. This study was supported by the Canadian Institutes of Health Research (grant no. 115172) and by the Fonds pour la Recherche du Quebec-Sante (grant no. 24742). The authors report no conflicts of interest.	Acebo Christine, 2006, Respir Care Clin N Am, V12, P23; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; AncoliIsrael S, 1997, SLEEP, V20, P24, DOI 10.1093/sleep/20.1.24; Blood ML, 1997, SLEEP, V20, P388; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Duclos C, 2019, SLEEP; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Duclos C, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0709-x; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Iber C., 2007, AASM MANUAL SCORING, P7; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lotjonen J, 2003, SLEEP, V26, P86; Maglione JE, 2013, SLEEP, V36, P1209, DOI 10.5665/sleep.2888; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Paquet J, 2007, SLEEP, V30, P1362, DOI 10.1093/sleep/30.10.1362; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Signal TL, 2005, AVIAT SPACE ENVIR MD, V76, P1058; TEASDALE G, 1974, LANCET, V2, P81; Towns SJ, 2016, PM&R, V8, P1046, DOI 10.1016/j.pmrj.2016.04.005; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697	26	1	1	1	3	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.	FEB 15	2020	16	2					185	192	PII jc-19-00155	10.5664/jcsm.8162			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ML9HH	WOS:000549771100006	31992412	Green Submitted, Green Published, Bronze			2022-02-06	
J	van der Kleij, LA; De Vis, JB; Restivo, MC; Turtzo, LC; Hendrikse, J; Latour, LL				van der Kleij, Lisa A.; De Vis, Jill B.; Restivo, Matthew C.; Turtzo, L. Christine; Hendrikse, Jeroen; Latour, Lawrence L.			Subarachnoid Hemorrhage and Cerebral Perfusion Are Associated with Brain Volume Decrease in a Cohort of Predominantly Mild Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						MRI; perfusion; subarachnoid hemorrhage; traumatic brain injury; volume loss	SPREADING DEPOLARIZATIONS; CEREBROSPINAL-FLUID; MR; INFLAMMATION; ATROPHY; BLOOD; CT; PERFORMANCE; DISABILITY; VASOSPASM	Biomarkers are needed to identify traumatic brain injury (TBI) patients at risk for accelerated brain volume loss and its associated functional impairment. Subarachnoid hemorrhage (SAH) has been shown to affect cerebral volume and perfusion, possibly by induction of inflammation and vasospasm. The purpose of this study was to assess the impact of SAH due to trauma on cerebral perfusion and brain volume. For this, magnetic resonance imaging (MRI) was performed <48 h and at 90 days after TBI. The <48-h scan was used to assess SAH presence and perfusion. Brain volume changes were assessed quantitatively over time. Differences in brain volume change and perfusion were compared between SAH and non-SAH patients. A linear regression analysis with clinical and imaging variables was used to identify predictors of brain volume change. All patients had a relatively good status on admission, and 83% presented with the maximum Glasgow Coma Scale (GCS) score. Brain volume decrease was greater in the 11 SAH patients (-3.2%, interquartile range [IQR] -4.8 to -1.3%) compared with the 46 non-SAH patients (-0.4%, IQR -1.8 to 0.9%; p < 0.001). Brain perfusion was not affected by SAH, but it was correlated with brain volume change (rho = 0.39; p < 0.01). Forty-three percent of brain volume change was explained by SAH (beta -0.40, p = 0.001), loss of consciousness (beta -0.24, p = 0.035), and peak perfusion curve signal intensity height (0.27, p = 0.012). SAH and lower perfusion in the acute phase may identity TBI patients at increased risk for accelerated brain volume loss, in addition to loss of consciousness occurrence. Future studies should determine whether the findings apply to TBI patients with worse clinical status on admission. SAH predicts brain volume decrease independent of brain perfusion. This indicates the adverse effects of SAH extend beyond vasoconstriction, and that hypoperfusion also occurs separately from SAH.	[van der Kleij, Lisa A.; Hendrikse, Jeroen] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [van der Kleij, Lisa A.; De Vis, Jill B.; Turtzo, L. Christine; Latour, Lawrence L.] NINDS, Acute Cerebrovasc Diagnost Unit, NIH, 10 Ctr Dr,Bldg 10,Room B1D733,MSC 1063, Bethesda, MD 20892 USA; [Restivo, Matthew C.] NHLBI, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Turtzo, L. Christine; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Acute Studies Core, Bethesda, MD USA		Latour, LL (corresponding author), NINDS, Acute Cerebrovasc Diagnost Unit, NIH, 10 Ctr Dr,Bldg 10,Room B1D733,MSC 1063, Bethesda, MD 20892 USA.	latourl@ninds.nih.gov	Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263			Bavbek M, 1998, STROKE, V29, P1930, DOI 10.1161/01.STR.29.9.1930; Bendinelli C, 2017, WORLD J SURG, V41, P2512, DOI 10.1007/s00268-017-4030-7; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; HANDA Y, 1991, NEUROSURGERY, V28, P542, DOI 10.1227/00006123-199104000-00010; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartkamp NS, 2018, J CEREBR BLOOD F MET, V38, P2021, DOI 10.1177/0271678X17724027; Hendrikse J, 2008, RADIOLOGY, V246, P572, DOI 10.1148/radiol.2461062100; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kramer DR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415813; Li JR, 2016, MOL NEUROBIOL, V53, P2668, DOI 10.1007/s12035-015-9318-8; Liu YJ, 2002, J NEUROIMAGING, V12, P330, DOI 10.1111/j.1552-6569.2002.tb00141.x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mangla R, 2011, RADIOGRAPHICS, V31, P1201, DOI 10.1148/rg.315105014; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Moraes L, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0970-2; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; R Core Team, 2017, R LANG ENV STAT COMP; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Schmid S, 2015, NEUROIMAGE, V123, P72, DOI 10.1016/j.neuroimage.2015.08.025; Schneider U, 2015, ACTA NEUROPATHOL, V130, P215, DOI 10.1007/s00401-015-1440-1; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Song SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185552; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; TEASDALE G, 1974, LANCET, V2, P81; The Management of Concussion/mTBI Working Group. (2009). VA/DoD clinical practice guideline for management of concussion/mild traumatic brain injury (mTBI). U.S. Department of Veterans Affairs and Department of Defense, 2019, VA DOD CLIN PRACT GU; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van der Kleij L.A., 2017, ISMRM 25 ANN M EXH H; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zaharchuk G, 2012, CEREBROVASC DIS, V34, P221, DOI 10.1159/000339682	53	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					600	607		10.1089/neu.2019.6514			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000511273800003	31642407	Green Published			2022-02-06	
J	Rozenfeld, M; Givon, A; Peleg, K; Alfici, R; Bahouth, H; Bala, M; Becker, A; Jeroukhimov, I; Karawani, I; Klein, Y; Lin, G; Merin, O; Mnouskin, Y; Kessel, B; Shaked, G; Sivak, G; Soffer, D; Stein, M; Weiss, M				Rozenfeld, Michael; Givon, Adi; Peleg, Kobi; Alfici, R.; Bahouth, H.; Bala, M.; Becker, A.; Jeroukhimov, I; Karawani, I; Klein, Y.; Lin, G.; Merin, O.; Mnouskin, Y.; Kessel, B.; Shaked, G.; Sivak, G.; Soffer, D.; Stein, M.; Weiss, M.		Israeli Trauma Grp	The reliability of the Glasgow Coma Scale in detecting traumatic brain injury: The continuous effect of age	BRAIN INJURY			English	Article						Glasgow Coma Scale; TBI; elderly; age; trauma mechanisms	CONSCIOUSNESS; SCORE	Background: Recent studies noted the limited applicability of Glasgow Coma Scale (GCS) for elderly patients with Traumatic Brain Injury (TBI). However, the dichotomic distinction between "elderly" and "non-elderly" does not cover the full span of influence of age on GCS presentation. Objective: To analyze the influence of age on GCS scores of patients with isolated TBI. Methods: A retrospective study of 18,534 patients hospitalized due to isolated TBI recorded in the Israeli National Trauma Registry in 1997-2017. The GCS scores were compared between four age-groups: 20-44, 45-64, 65-74 and 75+ years old. Additional factors included patient's sex, Abbreviated Injury Scores (AIS) and injury circumstances. Results: GCS scores increased continuously with age at all AIS levels. The trend was significant even after adjustment for patient's sex and injury circumstances. The angle of the trend was different in various injury circumstances, with GCS scores of victims of Road Traffic Accidents sharply increasing after age of 44 and that of the patients hospitalized after falling from own height surging after age of 64. Conclusions: Screening procedures for patients with TBI should give a greater weight to the actual age of adults, as well as to the circumstances of their injury.	[Rozenfeld, Michael; Givon, Adi; Peleg, Kobi] Gertner Inst, Israel Natl Ctr Trauma & Emergency Res, Tel Hashomer, Israel		Rozenfeld, M (corresponding author), Gertner Inst, Natl Ctr Trauma & Emergency Med Res, IL-52621 Tel Hashomer, Israel.	michaelr@gertner.health.gov.il					Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; Bellner J, 2003, J NEUROL NEUROSUR PS, V74, P351, DOI 10.1136/jnnp.74.3.351; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Granhed H., 2017, TRAUMA ACUTE CARE, V2, P38, DOI DOI 10.21767/2476-2105.100038; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Peleg K, 2011, DECADE TRAUMA INJURI; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111378; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; TEASDALE G, 1974, LANCET, V2, P81; VANZANTEN SJOV, 1994, J INFECT DIS, V169, P434, DOI 10.1093/infdis/169.2.434; Wong FY, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0310-3	14	1	1	2	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					515	519		10.1080/02699052.2020.1725838		FEB 2020	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000513750900001	32050793				2022-02-06	
J	Fuermaier, ABM; Tucha, O; Russ, D; Ehrenstein, JK; Stanke, M; Heindorf, R; Buggenthin, R; Aschenbrenner, S; Koerts, J; Tucha, L				Fuermaier, Anselm B. M.; Tucha, Oliver; Russ, Dorothea; Ehrenstein, Johanna K.; Stanke, Martin; Heindorf, Ralf; Buggenthin, Rieka; Aschenbrenner, Steffen; Koerts, Janneke; Tucha, Lara			Utility of an attention-based performance validity test for the detection of feigned cognitive dysfunction after acquired brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychological assessment; attention; acquired brain injury; performance validity; feigning	CLASSIFICATION ACCURACY; DIGIT SPAN; NEUROPSYCHOLOGY; INTELLIGENCE; VALIDATION	Introduction: The Groningen Effort Test (GET) is a recently developed performance validity test (PVT) for the identification of noncredible performance in a neuropsychological assessment of attention abilities. Because the majority of already established PVTs are based on memory functions, the GET has the potential to make a valuable contribution to validity testing. Method: The current study examined the utility of the GET in the detection of feigned cognitive dysfunction after acquired brain injury (ABI) and its incremental validity over already established PVTs, namely the Test of Memory Malingering (TOMM), the Dot Counting Test (DCT), and the b Test. Three hundred and forty-eight participants took part in this study, including 58 patients with ABI (stroke or traumatic brain injury), 43 healthy individuals instructed to show normal behavior, and 247 healthy individuals instructed to feign cognitive dysfunction after ABI. Results: With excellent overall classification accuracy, the GET performed close to the level of the TOMM, and superior to the b Test and DCT. Data analyses further revealed that the GET provides additional diagnostic accuracy compared to the b Test and the DCT in the detection of feigned cognitive dysfunction, but has no incremental validity over the TOMM. For each of the four PVTs in this study, diagnostic sensitivity was independent of the simulation strategy used. Conclusions: It is concluded that the GET is an attention-based PVT with promising test characteristics and high diagnostic accuracy in the detection of noncredible cognitive performance using a simulation design. Given the results can be replicated in studies using known-groups methodology, it may be a useful tool for clinical practice to complement neuropsychological assessments of patients with ABI.	[Fuermaier, Anselm B. M.; Tucha, Oliver; Russ, Dorothea; Ehrenstein, Johanna K.; Koerts, Janneke; Tucha, Lara] Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands; [Stanke, Martin; Heindorf, Ralf] Neurol Rehabil Friedehorst, Bremen, Germany; [Buggenthin, Rieka] Marcus Hosp Bad Driburg, Dept Neurol, Bad Driburg, Germany; [Aschenbrenner, Steffen] SRH Clin Karlsbad Langensteinbach, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany		Fuermaier, ABM (corresponding author), Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	a.b.m.fuermaier@rug.nl		Fuermaier, Anselm/0000-0002-2331-0840			ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Binks PG, 1997, ARCH CLIN NEUROPSYCH, V12, P41, DOI 10.1016/S0887-6177(96)00019-4; Boone K., 2002, DOT COUNTING TEST; Boone K., 2002, THE B TEST; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Fuermaier A. B. M., 2017, VIENNA TEST SYSTEM V; Fuermaier ABM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164297; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 1996, MANUAL COMPUTERISED; Green P., 2005, MED SYMPTOM VALIDITY; Green P., 2005, NONVERBAL MED SYMPTO; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Larrabee G.J., 2007, ASSESSMENT MALINGERE; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Lehrl S, 1995, MEHRFACHWAHL WORTSCH; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCaul C, 2018, CLIN NEUROPSYCHOL, V32, P1054, DOI 10.1080/13854046.2018.1425481; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Petermann F., 2012, WECHSLER ADULT INTEL; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reynolds CR, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P351, DOI 10.1007/978-1-4614-0442-2_13; Roberson CJ, 2013, CLIN NEUROPSYCHOL, V27, P495, DOI 10.1080/13854046.2012.737027; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; Rogers R., 2008, CLIN ASSESSMENT MALI; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Suslow T, 2009, NORD J PSYCHIAT, V63, P120, DOI 10.1080/08039480802316010; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Zimmermann P., 2010, TAP TEST ATTENTIONAL; [No title captured]	47	1	1	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 15	2020	42	3					285	297		10.1080/13803395.2019.1710468		FEB 2020	13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KS1TJ	WOS:000513439200001	32041477	Green Published, hybrid			2022-02-06	
J	Poulin, V; Jean, A; Lamontagne, ME; Pellerin, MA; Viau-Guay, A; Ouellet, MC				Poulin, Valerie; Jean, Alexandra; Lamontagne, Marie-Eve; Pellerin, Marc-Andre; Viau-Guay, Anabelle; Ouellet, Marie-Christine			Identifying clinicians' priorities for the implementation of best practices in cognitive rehabilitation post-acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Best practices; cognitive rehabilitation; priority setting; implementation; acquired brain injury	INTEGRATED KNOWLEDGE TRANSLATION; HEALTH-CARE; STROKE; IMPAIRMENT; OUTCOMES; NEUROPSYCHOLOGISTS; RECOMMENDATIONS; MANAGEMENT; GAPS	Purpose: To identify clinicians' perceptions of current levels of implementation of cognitive rehabilitation best practices, as well as individual and consensual group priorities for implementing cognitive rehabilitation interventions as part of a multi-site integrated knowledge translation initiative. Method: A two-step consensus-building methodology was used, that is the Technique for Research of Information by Animation of a Group of Experts (TRIAGE), including a cross-sectional electronic survey followed by consensual in-person group discussions to identify implementation priorities from a list of evidence-based practices for cognitive rehabilitation following traumatic brain injury and stroke. Thirty-eight professionals from three rehabilitation teams (n = 9, 13 and 16) participated, including neuropsychologists, occupational therapists, speech-language pathologists, educators, clinical coordinators and program managers. Descriptive statistics were used to document the perceived levels of implementation as well as individual and consensual group priorities. Results: Most of the best practices (81-100%) were perceived as at least partially implemented by a minimum of 50% of the participants but only 20-25% of the practices were considered fully implemented. Findings suggest that current practices are mostly consistent with general cognitive rehabilitation principles suggested in guidelines but that further efforts are needed to support the application of specific cognitive rehabilitation strategies and interventions. Executive function and self-awareness retraining, as well as interventions promoting the generalization of skills, were among the highest implementation priorities. Consensual in-person group discussions, included as part of the TRIAGE process, also helped to define and operationalize these best practices into more specific intervention components according to the teams' needs and priorities. Conclusions: TRIAGE consensus-building methodology can be used to engage stakeholders and support clinicians' decision-making regarding the identification of implementation priorities in cognitive rehabilitation post-ABI in order to tailor the implementation process to local needs.	[Poulin, Valerie; Jean, Alexandra] Univ Quebec Trois Rivieres, Dept Occupat Therapy, 3351 Boul Forges,POB 500, Trois Rivieres, PQ G9A 5H7, Canada; [Poulin, Valerie; Lamontagne, Marie-Eve; Pellerin, Marc-Andre; Ouellet, Marie-Christine] IRDPQ, Ctr Interdisciplinary Res Rehabil & Social Integr, CIUSSS CN, Quebec City, PQ, Canada; [Lamontagne, Marie-Eve; Pellerin, Marc-Andre] Univ Laval, Dept Rehabil, Quebec City, PQ, Canada; [Pellerin, Marc-Andre; Viau-Guay, Anabelle] Univ Laval, Fac Educ Sci, Quebec City, PQ, Canada; [Viau-Guay, Anabelle] Univ Laval, Ctr Rech & Intervent Reussite Scolaire, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] Univ Laval, Sch Psychol, Quebec City, PQ, Canada		Poulin, V (corresponding author), Univ Quebec Trois Rivieres, Dept Occupat Therapy, 3351 Boul Forges,POB 500, Trois Rivieres, PQ G9A 5H7, Canada.	valerie.poulin@uqtr.ca		Ouellet, Marie-Christine/0000-0003-3477-1893; Lamontagne, Marie-Eve/0000-0002-3301-7429; Viau-Guay, Anabelle/0000-0001-6725-090X	Fonds de recherche du Quebec - Societe et Culture	This study was carried out with financial support from the Fonds de recherche du Quebec - Societe et Culture.	Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Canadian Institutes of Health Research, 2012, GUID KNOWL TRANSL PL; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Demers L, 2004, ARCH GERONTOL GERIAT, V38, P221, DOI 10.1016/j.archger.2003.10.003; Downing M, 2019, BRAIN IMPAIR, V20, P24, DOI 10.1017/BrImp.2018.12; Duncan E, 2006, RES OCCUPATIONAL THE; Evans JJ, 2009, REHABILITATION EXECU, P59; Farley K, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-56; Gagliardi AR, 2017, J EPIDEMIOL COMMUN H, V71, P105, DOI 10.1136/jech-2016-207743; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gervais M, 2000, REV Q ERGO, V9, P11; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Guillez P., 2014, GUIDE PRATIQUE RECHE, P355; Guise JM, 2013, J CLIN EPIDEMIOL, V66, P666, DOI 10.1016/j.jclinepi.2012.12.010; Houldin A, 2018, OTJR-OCCUP PART HEAL, V38, P157, DOI 10.1177/1539449217736059; Institut national d'excellence en sante et en services sociaux (INESSS)-Ontario Neurotrauma Foundation (ONF), 2019, INESSS ONF CLIN PRAC; Kitson AL, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P97; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Korner-Bitensky N, 2011, AUST OCCUP THER J, V58, P241, DOI 10.1111/j.1440-1630.2011.00943.x; Kothari A, 2017, INT J HEALTH POLICY, V6, P299, DOI 10.15171/ijhpm.2017.15; Lamontagne ME, 2018, J HEAD TRAUMA REHAB, V33, P306, DOI 10.1097/HTR.0000000000000430; Lamontagne Marie-Eve, 2010, Int J Integr Care, V10, pe117; Lamontagne ME, 2013, AUGMENT ALTERN COMM, V29, P182, DOI 10.3109/07434618.2013.784927; Lanctot KL, 2020, INT J STROKE, V15, P668, DOI 10.1177/1747493019847334; Lesniak M, 2008, DEMENT GERIATR COGN, V26, P356, DOI 10.1159/000162262; McDowd JM, 2003, J GERONTOL B-PSYCHOL, V58, pP45, DOI 10.1093/geronb/58.1.P45; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; P?pin G., 2002, EVAL J AUST, V2, P45, DOI [10.1177/1035719X0200200212, DOI 10.1177/1035719X0200200212]; Pagan E, 2015, BRAIN IMPAIR, V16, P173, DOI 10.1017/BrImp.2015.34; Park SH, 2017, ANN REHABIL MED-ARM, V41, P734, DOI 10.5535/arm.2017.41.5.734; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ritchie J, 2003, QUALITATIVE RES PRAC, P219; Robertson~ I, 2008, COGNITIVE NEUROREHAB; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Stamenova V, 2019, NEUROPSYCHOL REHABIL, V29, P1569, DOI 10.1080/09602011.2018.1438294; Swaine BR, 2003, BRAIN INJURY, V17, P575, DOI 10.1080/0269905031000088568; Tang EYH, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2569-5; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Wensing M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1322-9; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P22, DOI 10.1017/CBO9780511581083.004; Wong D, 2014, AUST PSYCHOL, V49, P209, DOI 10.1111/ap.12061	46	1	1	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	SEP 25	2021	43	20					2952	2962		10.1080/09638288.2020.1721574		FEB 2020	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	WB7NO	WOS:000513478700001	32045534				2022-02-06	
J	Maza, A; Moliner, B; Ferri, J; Llorens, R				Maza, Anny; Moliner, Belen; Ferri, Joan; Llorens, Roberto			Visual Behavior, Pupil Dilation, and Ability to Identify Emotions From Facial Expressions After Stroke	FRONTIERS IN NEUROLOGY			English	Article						social cognition; theory of mind; facial expressions; emotion; visual behavior; gaze; pupil dilation; stroke	TRAUMATIC BRAIN-INJURY; RECOGNITION DEFICITS; FACE; IMPAIRMENTS; PERCEPTION; GAZE; METAANALYSIS; COGNITION; MODERATE; AMYGDALA	Social cognition is the innate human ability to interpret the emotional state of others from contextual verbal and non-verbal information, and to self-regulate accordingly. Facial expressions are one of the most relevant sources of non-verbal communication, and their interpretation has been extensively investigated in the literature, using both behavioral and physiological measures, such as those derived from visual activity and visual responses. The decoding of facial expressions of emotion is performed by conscious and unconscious cognitive processes that involve a complex brain network that can be damaged after cerebrovascular accidents. A diminished ability to identify facial expressions of emotion has been reported after stroke, which has traditionally been attributed to impaired emotional processing. While this can be true, an alteration in visual behavior after brain injury could also negatively contribute to this ability. This study investigated the accuracy, distribution of responses, visual behavior, and pupil dilation of individuals with stroke while identifying emotional facial expressions. Our results corroborated impaired performance after stroke and exhibited decreased attention to the eyes, evidenced by a diminished time and number of fixations made in this area in comparison to healthy subjects and comparable pupil dilation. The differences in visual behavior reached statistical significance in some emotions when comparing individuals with stroke with impaired performance with healthy subjects, but not when individuals post-stroke with comparable performance were considered. The performance dependence of visual behavior, although not determinant, might indicate that altered visual behavior could be a negatively contributing factor for emotion recognition from facial expressions.	[Maza, Anny; Llorens, Roberto] Univ Politecn Valencia, Inst Invest & Innovac Bioingn, Neurorehabilitat & Brain Res Grp, Valencia, Spain; [Moliner, Belen; Ferri, Joan; Llorens, Roberto] Serv Neurorrehabilitac Hosp Vithas, NEURORHB, Valencia, Spain		Llorens, R (corresponding author), Univ Politecn Valencia, Inst Invest & Innovac Bioingn, Neurorehabilitat & Brain Res Grp, Valencia, Spain.; Llorens, R (corresponding author), Serv Neurorrehabilitac Hosp Vithas, NEURORHB, Valencia, Spain.	rilorens@i3b.upv.es	Llorens, Roberto/AAL-2604-2021	Llorens, Roberto/0000-0002-8677-8707	Conselleria de Educacion, Cultura y Deporte of Generalitat Valenciana of Spain [SEJI/2019/017]; Universitat Politecnica de Valencia [PAID-10-18]	This study was funded by Conselleria de Educacion, Cultura y Deporte of Generalitat Valenciana of Spain (Project SEJI/2019/017), and Universitat Politecnica de Valencia (Grant PAID-10-18).	Abbott JD, 2014, BRAIN COGNITION, V86, P42, DOI 10.1016/j.bandc.2014.01.017; Abbott JD, 2013, LATERALITY, V18, P437, DOI 10.1080/1357650X.2012.703206; Aguillon-Hernandez N, 2016, MED PRIN PRACT, V25, P548, DOI 10.1159/000447971; Ariel R, 2014, EXP BRAIN RES, V232, P337, DOI 10.1007/s00221-013-3744-5; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Babiker A., 2014, P 5 INT C INT ADV SY, P1, DOI [10.1109/ICIAS.2014.6869498, DOI 10.1109/ICIAS.2014.6869498]; Babiker A, 2013, IEEE ICSIPA 2013, P7; Bortolon C, 2015, NEUROSCI BIOBEHAV R, V53, P79, DOI 10.1016/j.neubiorev.2015.03.006; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bradley MM, 2015, PSYCHOPHYSIOLOGY, V52, P1186, DOI 10.1111/psyp.12442; Burley DT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167436; DALAL N, 2005, AM PSYCHOL, P886, DOI DOI 10.1037/0003-066X.48.4.384; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; Delazer M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00359; Demenescu LR, 2014, EXP AGING RES, V40, P187, DOI 10.1080/0361073X.2014.882210; Doleal J., 2015, CLIN NEUROPHYSIOL, V126, pe44, DOI [10.1016/j.clinph.2014.10.200, DOI 10.1016/J.CLINPH.2014.10.200]; Duque A, 2014, COGNITION EMOTION, V28, P1347, DOI 10.1080/02699931.2014.881327; Eckstein MK, 2017, DEV COGN NEUROS-NETH, V25, P69, DOI 10.1016/j.dcn.2016.11.001; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; FELDMAN RS, 1982, DEV NONVERBAL BEHAVI, P259; Ferretti V, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12544; Ferro JM, 2009, CEREBROVASC DIS, V27, P197, DOI 10.1159/000200460; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Genova HM, 2017, SOC NEUROSCI-UK, V12, P303, DOI 10.1080/17470919.2016.1173584; Gotham KO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200340; Grainger SA, 2017, J GERONTOL B-PSYCHOL, V72, P622, DOI 10.1093/geronb/gbv100; Green C, 2018, COGNITION EMOTION, V32, P37, DOI 10.1080/02699931.2016.1273200; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Guo K, 2019, VISION RES, V157, P112, DOI 10.1016/j.visres.2018.02.001; Guo K, 2015, ACTA PSYCHOL, V155, P19, DOI 10.1016/j.actpsy.2014.12.001; Guo K, 2013, PERCEPTION, V42, P1027, DOI 10.1068/p7552; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Hall JE, 2011, GUYTON HALL TXB MED; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Huff T., 2019, NEUROANATOMY VISUAL; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lanata A., 2011, 2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth 2011), P78, DOI 10.4108/icst.pervasivehealth.2011.246056; Lancelot C, 2019, BRAIN INJURY, V33, P4, DOI 10.1080/02699052.2018.1531308; Larsen RS, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00021; Lech M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00006; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mathot S, 2018, BEHAV RES METHODS, V50, P94, DOI 10.3758/s13428-017-1007-2; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Nijsse B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213725; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Peinkhofer C, 2019, PEERJ, V7, DOI 10.7717/peerj.6882; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Rigon A, 2018, J CLIN EXP NEUROPSYC, V40, P805, DOI 10.1080/13803395.2018.1437120; Romero M, 2012, NEUROLOGIA, V27, P216, DOI 10.1016/j.nrl.2011.06.006; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Sirois S, 2014, WIRES COGN SCI, V5, P679, DOI 10.1002/wcs.1323; Smith ML, 2018, J VISION, V18, DOI 10.1167/18.9.10; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Srinivasan R, 2021, IEEE T AFFECT COMPUT, V12, P707, DOI 10.1109/TAFFC.2018.2887267; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Tippett DC, 2018, SEMIN SPEECH LANG, V39, P87, DOI 10.1055/s-0037-1608859; Vallat-Azouvi C, 2019, BRAIN INJURY, V33, P87, DOI 10.1080/02699052.2018.1531309; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zekveld AA, 2014, PSYCHOPHYSIOLOGY, V51, P277, DOI 10.1111/psyp.12151; Zinchenko O, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00227	68	1	1	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 6	2020	10								1415	10.3389/fneur.2019.01415			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KO8WI	WOS:000515828700001	32116988	gold, Green Published			2022-02-06	
J	Shimizu, Y; Tsuchiya, K; Fujisawa, H				Shimizu, Yu; Tsuchiya, Katsuhiro; Fujisawa, Hironori			Cerebral swelling caused by deep venous thrombosis immediately after cranioplasty	BRITISH JOURNAL OF NEUROSURGERY			English	Article; Early Access						Cranioplasty; cerebral swelling; deep venous thrombosis; MR venography; oral contraceptives	DEATH FOLLOWING CRANIOPLASTY; DECOMPRESSIVE CRANIECTOMY; SINUS THROMBOSIS; COMPLICATION; BRAIN; EDEMA	Recently, different groups have reported a rare, unexplained complication of sudden death with massive cerebral oedema immediately after cranioplasty. Case presentation: A 34-year-old woman underwent decompressive hemicraniectomy after traumatic brain injury. She was reportedly on oral contraceptives. She developed massive cerebral swelling immediately after an uneventful cranioplasty. After surgery, her pupils became fixed and dilated, and brain MRI revealed massive brain oedema. Magnetic resonance venography displayed occlusion in the deep venous sinus. The oedema was believed to be caused by venous sinus thrombosis. The patient's family declined to avail any surgical and medical treatment, and the patient died on the second postoperative day. Conclusions: Fatal massive cerebral oedema is an uncommon complication after cranioplasty in patients who had previously undergone decompressive craniectomy. Our patient was using oral contraceptives and was thus susceptible to the development of venous sinus thrombosis. Neurosurgeons must be aware of the complications associated with venous sinus thrombosis and discuss it with the patients and their families.	[Shimizu, Yu; Tsuchiya, Katsuhiro; Fujisawa, Hironori] Kanazawa Med Ctr, Dept Neurosurg, 1-1 Shimoishibikimachi, Kanazawa, Ishikawa 9208650, Japan		Shimizu, Y (corresponding author), Kanazawa Med Ctr, Dept Neurosurg, 1-1 Shimoishibikimachi, Kanazawa, Ishikawa 9208650, Japan.	bleuler3a@yahoo.co.jp		Shimizu, Yu/0000-0003-3036-6321			Agarwal D, 2008, ANN VASC SURG, V22, P293, DOI 10.1016/j.avsg.2007.09.005; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Brotman DJ, 2004, SOUTH MED J, V97, P213, DOI 10.1097/01.SMJ.0000105663.01648.25; Chitale R, 2013, NEUROLOGIST, V19, P17, DOI 10.1097/NRL.0b013e31827c6bb6; CRAWFORD SC, 1995, ARCH NEUROL-CHICAGO, V52, P1101, DOI 10.1001/archneur.1995.00540350095021; de Bruijn SFTM, 1998, BRIT MED J, V316, P589, DOI 10.1136/bmj.316.7131.589; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Hassaneen W, 2016, J CLIN NEUROSCI, V25, P130, DOI 10.1016/j.jocn.2015.06.026; Honeybul S, 2016, J CLIN NEUROSCI, V29, P3, DOI 10.1016/j.jocn.2016.01.014; Honeybul S, 2011, BRIT J NEUROSURG, V25, P343, DOI 10.3109/02688697.2011.568643; Kaneshiro Yuta, 2017, Surg Neurol Int, V8, P156, DOI 10.4103/sni.sni_137_17; Lee GS, 2015, J KOREAN NEUROSURG S, V58, P76, DOI 10.3340/jkns.2015.58.1.76; Mangubat E, 2015, NEUROLOGIST, V19, P135, DOI 10.1097/NRL.0000000000000024; Nomura Masashi, 2017, Asian J Neurosurg, V12, P794, DOI 10.4103/1793-5482.185070; Santana-Cabrera Luciano, 2012, Int J Crit Illn Inj Sci, V2, P107, DOI 10.4103/2229-5151.97277; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shimizu Y, 2019, J STROKE CEREBROVASC, V28, pE39, DOI 10.1016/j.jstrokecerebrovasdis.2019.01.023; Sviri GE, 2015, J NEUROSURG, V123, P1188, DOI 10.3171/2014.11.JNS141152; Van Roost D, 2003, NEUROSURGERY, V53, P1315, DOI 10.1227/01.NEU.0000093498.08913.9E; Wang HF, 2017, WORLD NEUROSURG, V107, DOI 10.1016/j.wneu.2017.07.125; Zebian B, 2011, BRIT J NEUROSURG, V25, P785, DOI 10.3109/02688697.2011.623801; Zhang XY, 2019, J NEUROL SURG PART A, V80, P498, DOI 10.1055/s-0039-1688726	23	1	1	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.												10.1080/02688697.2020.1716948		FEB 2020	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK2HP	WOS:000512569800001	32013625				2022-02-06	
J	Al Fauzi, A; Prihastomo, KT; Ranuh, IGMAR; Apriawan, T; Wahyuhadi, J; Parenrengi, MA; Turchan, A; Bajamal, AH; Notobroto, HB				Al Fauzi, Asra; Prihastomo, Krisna Tsaniadi; Ranuh, I. G. M. Aswin R.; Apriawan, Tedy; Wahyuhadi, Joni; Parenrengi, M. Arifin; Turchan, Agus; Bajamal, Abdul Hafid; Notobroto, Hari Basuki			Clinical Outcomes of MLC601 (NeuroAiD(TM)) in Traumatic Brain Injury: A Pilot Study	BRAIN SCIENCES			English	Article						MLC601; traumatic brain injury; nonsurgical lesion; clinical outcome	TRADITIONAL CHINESE MEDICINE; MLC901; EFFICACY; MODERATE; INFARCT	Background: MLC601 is a natural product formulation from Chinese medicine that is extensively studied in ischemic stroke. Traumatic brain injury (TBI) shares pathophysiological mechanisms with ischemic stroke, yet there are few studies on the use of MLC601 in treating TBI. This Indonesian pilot study aimed to investigate clinical outcomes of MLC601 for TBI. Methods: This randomized controlled trial included subjects with nonsurgical moderate TBI allocated into two groups: with and without MLC601 over three months in addition to standard TBI treatment. Clinical outcomes were measured by the Glasgow Outcome Scale (GOS) and Barthel Index (BI) observed upon discharge and at months (M) 3 and 6. Results: Thirty-two subjects were included. The MLC601 group (n = 16) had higher GOS than the control group (n = 16) at all observation timepoints, though these differences were not statistically significant (p = 0.151). The BI values indicated a significant improvement for the MLC601 group compared to the control group at M3 (47.5 vs. 35.0; p = 0.014) and at M6 (67.5 vs. 57.5; p = 0.055). No adverse effects were associated with MLC601 treatment. Conclusion: In this cohort of nonsurgical moderate TBI subjects, MLC601 showed potential for a positive effect on clinical outcome with no adverse effects.	[Al Fauzi, Asra; Ranuh, I. G. M. Aswin R.; Apriawan, Tedy; Wahyuhadi, Joni; Parenrengi, M. Arifin; Turchan, Agus; Bajamal, Abdul Hafid] Univ Airlangga, Surabaya Neurosci Inst, Dept Neurosurg, Fac Med,Dr Soetomo Gen Acad Hosp, Surabaya 60286, Indonesia; [Prihastomo, Krisna Tsaniadi] Diponegoro Univ, Fac Med, Dept Neurosurg, Dr Kariadi Hosp Med Ctr, Semarang 50111, Indonesia; [Notobroto, Hari Basuki] Univ Airlangga, Fac Publ Hlth, Dept Biostat & Populat Studies, Surabaya 60111, Indonesia		Al Fauzi, A (corresponding author), Univ Airlangga, Surabaya Neurosci Inst, Dept Neurosurg, Fac Med,Dr Soetomo Gen Acad Hosp, Surabaya 60286, Indonesia.	asrafauzi@yahoo.com; tsaniadi@gmail.com; aswinranuh@rocketmail.com; drtedyapri@gmail.com; joni.wahyuhadi@gmail.com; arifin_ns@yahoo.com; agusturchan@yahoo.com; hfbajamal@gmail.com; haribasuki.n@fkm.unair.ac.id		Apriawan, Tedy/0000-0003-4063-0982; Al Fauzi, Asra/0000-0002-5155-2476	MOLEAC Pte. Ltd., Singapore	This research was funded by MOLEAC Pte. Ltd., Singapore, the manufacturer of the product MLC601.	Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Ghandehari K, 2011, NEURAL REGEN RES, V6, P418, DOI 10.3969/j.issn.1673-5374.2011.06.003; Harandi AA, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/721613; Heurteaux C, 2013, CEREBROVASC DIS, V35, P1, DOI 10.1159/000346228; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Theadom A, 2018, EUR J NEUROL, V25, P1055, DOI 10.1111/ene.13653; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Venketasubramanian N, 2015, CEREBROVASC DIS, V39, P309, DOI 10.1159/000382082; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398	18	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	FEB	2020	10	2							60	10.3390/brainsci10020060			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT8DY	WOS:000519243400018	31973204	Green Accepted, gold, Green Published			2022-02-06	
J	Coxe, KA; Sullivan, L; Newton, A; Yang, JZ				Coxe, Kathryn A.; Sullivan, Lindsay; Newton, Alison; Yang, Jingzhen			Barriers to the Implementation of State Concussion Laws Within High Schools	JOURNAL OF ADOLESCENT HEALTH			English	Article						Concussion laws; Concussion; Youth sports; Policy; Implementation; Barriers to implementation	TRAUMATIC BRAIN-INJURIES; SPORT; EDUCATION; KNOWLEDGE	Purpose: All 50 U.S. states and the District of Columbia enacted concussion laws between 2009 and 2014 to mitigate the consequences of concussion among children and adolescents. In response, many high schools started to implement their respective state law that includes three main tenets: (1) concussion education, (2) removal from play, and (3) return-to-play. We aimed to identify barriers to the implementation of these tenets at the school level. Methods: We conducted 64 semistructured telephone interviews with high school athletic trainers from 26 states and the District of Columbia whose school participated in High School Reporting Information Online during the 2014-2015 and 2015-2016 academic years. Data were analyzed using thematic analysis. Results: All 64 high schools employed at least one athletic trainer, and most schools were public schools (90.6%). Implementation barriers to the concussion education tenet were (1) lack of quality education, (2) lack of buy-in to educational requirements, and (3) lack of time for and attendance at educational meetings. Implementation barriers to the removal from play tenet included (1) athletes underreporting concussion symptoms, (2) lack of communication, (3) resistance from parents and coaches, and (4) sport culture and "old school" mentality. Finally, (1) cost of and access to medical care, (2) resistance from stakeholders, and (3) lack of understanding of concussion were identified as implementation barriers to the return-to-play tenet. Conclusions: Identification of implementation barriers is key to the successful execution and application of state concussion laws at the school level. Future research should identify strategies to reduce these barriers. (C) 2019 Society for Adolescent Health and Medicine. All rights reserved.	[Coxe, Kathryn A.] Ohio State Univ, Coll Social Work, Columbus, OH 43210 USA; [Sullivan, Lindsay; Newton, Alison; Yang, Jingzhen] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	Ginger.Yang@nationwidechildrens.org	Coxe, Kathryn/AAJ-8041-2021	Coxe, Kathryn/0000-0002-7813-1081	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [30822]	This work was funded by the Robert Wood Johnson Foundation (Grant #30822). The interpretations and conclusions in this article do not necessarily represent those of the funding organization.	Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Coxe K, 2018, J ADOLESCENT HEALTH, V62, P255, DOI 10.1016/j.jadohealth.2017.07.003; Creswell JW, 2017, QUALITATIVE INQUIRY; CUSIMANO LA, 2017, PRS GLOB OPEN, V5; Davies S, 2018, J ATHL TRAINING, V53, P873, DOI 10.4085/1062-6050-529-17; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; High School RIOTM, REP INF ONL COL SCH; Kroshus E, 2019, HEALTH PROMOT PRACT, V20, P372, DOI 10.1177/1524839918790231; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; National Conference of State Legislatures, TRAUM BRAIN INJ LEG; National Council of Youth Sports, 2008, REP TRENDS PART ORG; National Federation of State High School Associations, HIGH SCH ATHL PART S; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Saldana J, 2012, CODING MANUAL QUALIT; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Theye Fred, 2004, Clin Med Res, V2, P165; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	36	1	1	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	FEB	2020	66	2					233	239		10.1016/j.jadohealth.2019.08.016			7	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	KC7TR	WOS:000507376100016	31757625				2022-02-06	
J	Gariepy, M; Gravel, J; Legare, F; Melnick, ER; Hess, EP; Wittman, HO; Lelaidier-Hould, L; Truchon, C; Sauve, L; Plante, P; Le Sage, N; Archambault, PM				Gariepy, Martin; Gravel, Jocelyn; Legare, France; Melnick, Edward R.; Hess, Erik P.; Wittman, Holly O.; Lelaidier-Hould, Lania; Truchon, Catherine; Sauve, Louise; Plante, Patrick; Le Sage, Natalie; Archambault, Patrick M.			Head CT overuse in children with a mild traumatic brain injury within two Canadian emergency departments	PAEDIATRICS & CHILD HEALTH			English	Article						Brain injury; Head CT; mTBI; Overuse; PECARN	DECISION RULE; PECARN; PREDICTION; SCANS	Background: The validated Pediatric Emergency Care Applied Network (PECARN) rule helps determine the relevance of a head computerized tomography (CT) for children with mild traumatic brain injury (mTBI). We sought to estimate the potential overuse of head CT within two Canadian emergency departments (EDs). Methods: We conducted a retrospective chart review of children seen in 2016 in a paediatric Level I (site 1) and a general Level II (site 2) trauma centre. We reviewed charts to determine the appropriateness of head CT use according to the PECARN rule in a random subset of children presenting with head trauma. Simple descriptive statistics were applied. Results: One thousand five hundred and forty-six eligible patients younger than 17 years consulted during the study period. Of the 203 randomly selected cases per setting, 16 (7.9%) and 24 (12%), respectively from sites 1 and 2 had a head CT performed. Based on the PECARN rule, we estimated the overuse for the younger group (<2 years) to be below 3% for both hospitals without significant difference between them. For the older group (>= 2 years), the overuse rate was higher at site 2 (9.3%, 95% confidence interval [CI]: 4.8 to 17% versus 1.2%, 95% CI: 0.2 to 6.5%, P=0.03). Conclusion: Both EDs demonstrated overuse rates below 10% although it was higher for the older group at site 2. Such low rates can potentially be explained by the university affiliation of both hospitals and by two Canadian organizations working to raise awareness among physicians about the overuse of diagnostic tools and dangers inherent to radiation.	[Gariepy, Martin; Legare, France; Wittman, Holly O.; Lelaidier-Hould, Lania; Le Sage, Natalie; Archambault, Patrick M.] Univ Laval, Fac Med, 1050 Av Med, Quebec City, PQ G1V 0A6, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Emergency Med, CHU St Justine, Montreal, PQ, Canada; [Gravel, Jocelyn] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Legare, France; Wittman, Holly O.; Le Sage, Natalie; Archambault, Patrick M.] Univ Laval CERSSP UL, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [Legare, France; Wittman, Holly O.; Le Sage, Natalie; Archambault, Patrick M.] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Melnick, Edward R.] Yale Univ, Dept Emergency Med, New Haven, CT USA; [Hess, Erik P.] Mayo Clin, Dept Emergency Med, Rochester, MN USA; [Truchon, Catherine] Inst Natl Excellence Sante & Serv Sociaux, Quebec City, PQ, Canada; [Sauve, Louise; Plante, Patrick] TELUQ Univ, Dept Educ Technol, Quebec City, PQ, Canada; [Le Sage, Natalie] Univ Laval, Trauma Emergency Crit Care Med, Populat Hlth & Optimal Hlth Practices Res Unit, CHU Quebec,Res Ctr, Quebec City, PQ, Canada; [Archambault, Patrick M.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Archambault, Patrick M.] Site Hotel Dieu Levis, Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Levis, PQ, Canada		Gariepy, M (corresponding author), Univ Laval, Fac Med, 1050 Av Med, Quebec City, PQ G1V 0A6, Canada.	martingariepy.polymtl@gmail.com	; Le Sage, Natalie/G-7063-2016	Gravel, Jocelyn/0000-0001-5901-4990; Le Sage, Natalie/0000-0003-4762-8156; Legare, France/0000-0002-2296-6696; Plante, Patrick/0000-0002-0860-5798	Fonds de recherche du Quebec - Sante FRQS [32978]	This project was funded by the Fonds de recherche du Quebec - Sante FRQS (reference #32978).	Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Cheng AHY, 2017, CAN J EMERG MED, V19, pS9, DOI 10.1017/cem.2017.1; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Engineer R, 2015, ANN EMERG MED, V66, pS4; Halaweish I, 2017, J PEDIAT SURG; Hess EP, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-253; Hurley T, 2016, ARCH DIS CHILD, V101, pA195; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lowry R., 2017, VASSARSTATS WEBSITE; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stein SC, 2008, PEDIATR NEUROSURG, V44, P448, DOI 10.1159/000172967; Tama M, 2020, PEDIATR EMERG CARE, V36, P359, DOI 10.1097/PEC.0000000000001364; United Nations, 2010, SOURC EFF ION RAD UN; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	26	1	1	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	FEB	2020	25	1					26	32		10.1093/pch/pxy180			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	KS8CI	WOS:000518532700008	33390737	Green Published, Green Accepted			2022-02-06	
J	Henke, RD; Kettner, SM; Jensen, SM; Greife, ACK; Durall, CJ				Henke, Ryan D.; Kettner, Savana M.; Jensen, Stephanie M.; Greife, Augustus C. K.; Durall, Christopher J.			Does Early Low-Intensity Aerobic Exercise Hasten Recovery in Adolescents With Sport-Related Concussion?	JOURNAL OF SPORT REHABILITATION			English	Article						mild traumatic brain injury; active rehabilitation; return to sport; subsymptom exacerbation		Clinical Scenario: Low-intensity aerobic exercise (LIAEX) below the threshold of symptom exacerbation has been shown to be superior to rest for resolving prolonged (>4 wk) symptoms following sport-related concussion (SRC), but the effects of LIAEX earlier than 4 weeks after SRC need to be elucidated. Focused Clinical Question: Does LIAEX within the first 4 weeks following SRC hasten symptom resolution? Summary of Key Findings: Two randomized controlled trials (RCT) and 1 nonrandomized trial involving adolescent athletes (10-19 y) were included. One RCT reported faster recovery time with LIAEX versus placebo stretching. Likewise, recovery time was faster with LIAEX versus rest in the nonrandomized trial, but not in the underpowered RCT, although effect sizes were similar between these studies (0.5 and 0.4, respectively). All 3 studies reported a reduction in concussion symptom severity with LIAEX; however, the magnitude of symptom reduction across the recovery timeline was greater in the LIAEX group than the rest group in the nonrandomized trial, but not the 2 RCTs. Importantly, no adverse effects or incidence of delayed recovery from LIAEX were reported in any of the studies. Clinical Bottom Line: LIAEX initiated within 10 days after SRC may facilitate a faster recovery time versus placebo stretching or rest, although additional clinical trials are strongly advised to verify this. Strength of Recommendation: Level 1b and 2b evidence suggests subsymptom exacerbation LIAEX may decrease Postconcussion Symptom Scale scores and hasten symptom resolution in adolescent athletes following SRC.	[Henke, Ryan D.; Kettner, Savana M.; Jensen, Stephanie M.; Greife, Augustus C. K.; Durall, Christopher J.] Univ Wisconsin, Doctor Phys Therapy Program, La Crosse, WI 54601 USA; [Durall, Christopher J.] Univ Wisconsin, Phys Therapy Unit, Student Hlth Ctr, La Crosse, WI 54601 USA		Henke, RD (corresponding author), Univ Wisconsin, Doctor Phys Therapy Program, La Crosse, WI 54601 USA.	rdhenke12@gmail.com					Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Doering TJ, 1998, AM J PHYS MED REHAB, V77, P490, DOI 10.1097/00002060-199811000-00006; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Ledoux AA, 2019, BRIT J SPORT MED, V53, P195, DOI 10.1136/bjsports-2017-097981; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Oxford Centre for Evidence-Based Medicine, 1998, OCEBM LEVELS EVIDENC; Ritter KG, 2019, J SPORT REHABIL, V28, P211, DOI 10.1123/jsr.2017-0159; Vega SR, 2006, BRAIN RES, V1121, P59, DOI 10.1016/j.brainres.2006.08.105	14	1	1	2	5	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	FEB	2020	29	2					248	252		10.1123/jsr.2019-0070			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LX7NN	WOS:000540014200018	31629334	Bronze			2022-02-06	
J	Henry, TCL; Huei, TJ; Yuzaidi, M; Safri, LS; Krishna, K; Rizal, IA; Azim, MIM; Harunarashid, H				Henry, Tan Chor Lip; Huei, Tan Jih; Yuzaidi, Mohamad; Safri, Lenny Suryani; Krishna, K.; Rizal, Imran Alwi; Azim, Md Idris Mohamad; Harunarashid, Hanafiah			Unexpected complication of arteriovenous fistula of the left common carotid to internal jugular vein following central venous catheterization	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Artery; Cannulation; Arterio-venous fistula; Ultrasound		Incidence of inadvertent arterial puncture secondary to central venous catheter insertion is not common with an arterial puncture rate of <1%. This is due to the advancements and wide availability of ultrasound to guide its insertion. Formation of arteriovenous fistula after arterial puncture is an unexpected complication. Till date, only five cases (including this case) of acquired arteriovenous fistula formation has been described due to inadvertent common carotid puncture. The present case is a 26-year-old man sustained traumatic brain injuries, chest injuries and multiple bony fractures. During resuscitative phase, attempts at left central venous catheter via left internal jugular vein under ultrasound guidance resulted in inadvertent puncture into the left common carotid artery. Surgical neck exploration revealed that the catheter had punctured through the left internal jugular vein into the common carotid artery with formation of arteriovenous fistula. The catheter was removed successfully and common carotid artery was repaired. Postoperatively, the patient recovered and clinic visits revealed no neurological deficits. From our literature review, the safest method for removal is via endovascular and open surgical removal. The pull/push technique (direct removal with compression) is not recommended due to the high risk for stroke, bleeding and hematoma formation. (C) 2020 Chinese Medical Association. Production and hosting by Elsevier B.V.	[Henry, Tan Chor Lip; Huei, Tan Jih; Yuzaidi, Mohamad; Rizal, Imran Alwi] Hosp Sultanah Aminah, Dept Surg, Trauma Surg Unit, Johor Baharu, Malaysia; [Henry, Tan Chor Lip; Huei, Tan Jih; Safri, Lenny Suryani; Krishna, K.; Azim, Md Idris Mohamad; Harunarashid, Hanafiah] Natl Univ Malaysia, Fac Med, Dept Gen Surg, Vasc Surg Unit,Med Ctr, Kuala Lumpur, Malaysia		Henry, TCL (corresponding author), Natl Univ Malaysia, Med Ctr, Dept Gen Surg, Fac Med, Kuala Lumpur, Malaysia.	relos1402@gmail.com	Lip, Henry Tan Chor/AAA-3229-2020; TAN, JIH HUEI JIH/E-5603-2017	Lip, Henry Tan Chor/0000-0003-0621-9276; TAN, JIH HUEI JIH/0000-0001-9833-5164			AUBANIAC R, 1952, PRESSE MED, V60, P1456; Bahcebasi S, 2011, HEMODIAL INT, V15, P284, DOI 10.1111/j.1542-4758.2010.00525.x; Droll KP, 2004, J CLIN ANESTH, V16, P127, DOI 10.1016/j.jclinane.2003.06.003; GOLDEN LR, 1995, J CARDIOTHOR VASC AN, V9, P425, DOI 10.1016/S1053-0770(05)80098-9; Guilbert MC, 2008, J VASC SURG, V48, P918, DOI 10.1016/j.jvs.2008.04.046; Kornbau Craig, 2015, Int J Crit Illn Inj Sci, V5, P170, DOI 10.4103/2229-5151.164940; Lopez-Quinones M, 2006, J CLIN ULTRASOUND, V34, P301, DOI 10.1002/jcu.20222; Mainland PA, 1997, LANCET, V349, P921, DOI 10.1016/S0140-6736(97)24013-4; ORTIZ J, 1976, MIL MED, V141, P171, DOI 10.1093/milmed/141.3.171	9	1	2	1	4	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	FEB	2020	23	1					29	31		10.1016/j.cjtee.2019.10.001			3	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	KS3ML	WOS:000518215500007	31744657	Green Published, gold			2022-02-06	
J	Jordan, J; Shirey, M; Ladores, S				Jordan, Jeremy; Shirey, Maria; Ladores, Sigrid			Corticosteroids in Pediatric Traumatic Brain Injury: A Principle-Based Concept Analysis	JNP-JOURNAL FOR NURSE PRACTITIONERS			English	Article						clinical management; concept analysis; corticosteroids; pediatrics; traumatic brain injury	SEVERE HEAD-INJURY; DOUBLE-BLIND; DEXAMETHASONE THERAPY; MRC CRASH; TRIAL; PREVENTION; GUIDELINES; MANAGEMENT; UPDATE; ADULTS	Over 7,400 children in the United States die from severe traumatic brain injury annually. Therefore, evidence-based clinical practice recommendations, such as the use of corticosteroids to reduce cerebral edema, are necessary to guide clinical practice to improve outcomes. However, a clearer analysis of their use in pediatrics is needed to validate its true impact on neurologic outcomes. A principle-based concept analysis revealed that the type of corticosteroid, indication for use, population, and outcome measurement are not consistent within the literature, thereby making clinical practice recommendations problematic. Further research in the pediatric population is necessary before clinical practice recommendations can be made. (C) 2019 Elsevier Inc. All rights reserved.	[Jordan, Jeremy] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL 35294 USA; [Shirey, Maria; Ladores, Sigrid] Univ Alabama Birmingham, Sch Nursing, Nursing, Birmingham, AL 35294 USA		Jordan, J (corresponding author), Univ Alabama Birmingham, Sch Nursing, Birmingham, AL 35294 USA.	jordanjd@uab.edu	Jordan, Jeremy/AAN-8938-2021	Jordan, Jeremy/0000-0002-6224-7434			Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Edwards P, 2005, LANCET, V365, P1957; FANCONI S, 1988, INTENS CARE MED, V14, P163; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Kahles T, 2013, CRIT CARE MED, V41, P1378, DOI 10.1097/CCM.0b013e318283ceb4; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; McEwen M., 2014, THEORETICAL BASIS NU, V4th; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nichols D, 2016, ROGERS TXB PEDIAT IN; Penrod J, 2005, J ADV NURS, V50, P403, DOI 10.1111/j.1365-2648.2005.03405.x; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Rakes L, 2016, BMJ QUAL IMPROV REP, V5; Reuter-Rice K, 2012, PEDIAT ACUTE CARE GU; Reuter-Rice K, 2015, ANNU REV NURS RES-SE, V33, P185, DOI 10.1891/0739-6686.33.185; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427	24	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1555-4155	1878-058X		JNP-J NURSE PRACT	JNP-J. Nurse Pract.	FEB	2020	16	2					105	110		10.1016/j.nurpra.2019.11.008			6	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	KG5JJ	WOS:000509984200018					2022-02-06	
J	Koh, JO				Koh, Jae-Ok			Effects of a greater incentive to attack the head and face region on incidence of head kicks and concussions among male youth taekwondo competitors	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Martial arts; Olympic style taekwondo; Brains; Injuries	VIDEO ANALYSIS; RISK-FACTORS; BLOWS; INJURY; SPORTS	BACKGROUND: In an attempt to improve the technical quality of sparring taekwondo, the World Taekwondo Federation has amended the competition rule for a head kick (HK), increasing the number of points awarded for this type of attack. The purpose of the current study was to: 1) evaluate the incidence of HKs and concussions; and 2) identify potential risk factors of concussions in sparring taekwondo. METHODS: A postmatch, interview-based prospective cohort study was conducted with 145 sparring taekwondo athletes (12-16 years of age) who: 1) competed at a 2018 sparring-Taekwondo tournament; and 2) received a valid HK during competition. Incidence rates of HKs and concussions were estimated; possible risk factors or prognosticators of concussions were also analyzed using the chi-square test and binary logistic analysis. RESULTS: Incidence rates of HKs and concussions were 133.5 (95% CI: 113.3-153.8) and 41.4 (95% CI: 29.6-53.3) per 1000 athlete-exposures, respectively. The binary logistic model revealed that athletes with no prior concussion history were less likely to experience a concussion (OR, 0.27; 95% CI: 0.1-0.7). CONCLUSIONS: Although the incidence rates of HKs and concussions are considerably high, they are not increased compared with the results of pre-2009 studies. Therefore, the new competition rule relating to HKs did not appear to increase the incidence rates of HKs or concussions in our research participants. To prevent adverse effects related to repetitive HKs and concussions, continuous research is needed.	[Koh, Jae-Ok] Seoul Natl Univ Sci & Technol, Coll Energy & Biotechnol, Dept Sports Sci, 232 Gongneung Ro, Seoul, South Korea		Koh, JO (corresponding author), Seoul Natl Univ Sci & Technol, Coll Energy & Biotechnol, Dept Sports Sci, 232 Gongneung Ro, Seoul, South Korea.	jok@seoultech.ac.kr					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; [Anonymous], 2018, WORLD TAEKWONDO; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Jae-Ok K, 2016, CLIN J SPORT MED, V26, P239, DOI 10.1097/JSM.0000000000000244; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; KOH JO, 2011, J KOREAN PHYS ED ASS, V25, P153; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lystad RP, 2013, J SPORT MED PHYS FIT, V53, P655; Lystad RP, 2014, J INT ASS TAEKWONDO, V1, P1; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Ok Koh Jae, 2018, [Journal of Korean Physical Education Association for Girls and Women, 한국여성체육학회지], V32, P171, DOI 10.16915/jkapesgw.2018.12.32.4.171; Ok Koh Jae, 2015, [Journal of Sport and Leisure Studies, 한국사회체육학회지], V59, P561; Ok Koh Jae, 2011, [Korean Journal of Sport Science, 체육과학연구], V22, P2088; Pieter W, 1999, J SPORT MED PHYS FIT, V39, P147; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412	19	1	1	1	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	FEB	2020	60	2					263	269		10.23736/S0022-4707.19.10031-X			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LV4VX	WOS:000538435900012	31665871				2022-02-06	
J	Leichtle, SW; Sarma, AK; Strein, M; Yajnik, V; Rivet, D; Sima, A; Brophy, GM				Leichtle, Stefan W.; Sarma, Anand K.; Strein, Micheal; Yajnik, Vishal; Rivet, Dennis; Sima, Adam; Brophy, Gretchen M.			High-Dose Intravenous Ascorbic Acid: Ready for Prime Time in Traumatic Brain Injury?	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Secondary brain injury; Oxidative stress; Antioxidant; Free radical scavenger; Vitamin C; Ascorbic acid	VITAMIN-C PHARMACOKINETICS; I CLINICAL-TRIAL; OXIDATIVE STRESS; BARRIER DISRUPTION; LIPID-PEROXIDATION; INTRACRANIAL HEMORRHAGE; DEHYDROASCORBIC ACID; HEAD-INJURY; MECHANISMS; SUPEROXIDE	Traumatic brain injury (TBI) is one of the leading public health problems in the USA and worldwide. It is the number one cause of death and disability in children and adults between ages 1-44. Despite efforts to prevent TBIs, the incidence continues to rise. Secondary brain injury occurs in the first hours and days after the initial impact and is the most effective target for intervention. Inflammatory processes and oxidative stress play an important role in the pathomechanism of TBI and are exacerbated by impaired endogenous defense mechanisms, including depletion of antioxidants. As a reducing agent, free radical scavenger, and co-factor in numerous biosynthetic reactions, ascorbic acid (AA, vitamin C) is an essential nutrient that rapidly becomes depleted in states of critical illness. The administration of high-dose intravenous (IV) AA has demonstrated benefits in numerous preclinical models in the areas of trauma, critical care, wound healing, and hematology. A safe and inexpensive treatment, high-dose IV AA administration gained recent attention in studies demonstrating an associated mortality reduction in septic shock patients. High-quality data on the effects of high-dose IV AA on TBI are lacking. Historic data in a small number of patients demonstrate acute and profound AA deficiency in patients with central nervous system pathology, particularly TBI, and a strong correlation between low AA concentrations and poor outcomes. While replenishing deficient AA stores in TBI patients should improve the brain's ability to tolerate oxidative stress, high-dose IV AA may prove an effective strategy to prevent or mitigate secondary brain injury due to its ability to impede lipid peroxidation, scavenge reactive oxygen species, suppress inflammatory mediators, stabilize the endothelium, and reduce brain edema. The existing preclinical data and limited clinical data suggest that high-dose IV AA may be effective in lowering oxidative stress and decreasing cerebral edema. Whether this translates into improved clinical outcomes will depend on identifying the ideal target patient population and possible treatment combinations, factors that need to be evaluated in future clinical studies. With its excellent safety profile and low cost, high-dose IV AA is ready to be evaluated in the early treatment of TBI patients to mitigate secondary brain injury and improve outcomes.	[Leichtle, Stefan W.] Virginia Commonwealth Univ, Sch Med, Dept Surg, Div Acute Care Surg Serv, Richmond, VA 23284 USA; [Sarma, Anand K.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Strein, Micheal; Brophy, Gretchen M.] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA; [Yajnik, Vishal] Virginia Commonwealth Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Richmond, VA 23284 USA; [Rivet, Dennis; Brophy, Gretchen M.] Virginia Commonwealth Univ, Sch Med, Dept Neurosurg, Richmond, VA 23284 USA; [Sima, Adam] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA		Leichtle, SW (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Surg, Div Acute Care Surg Serv, Richmond, VA 23284 USA.	stefan.leichtle@vcuhealth.org		Sima, Adam/0000-0001-8426-9987			Allahtavakoli M, 2015, BASIC CLIN PHARMACOL, V117, P335, DOI 10.1111/bcpt.12413; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Arun P, 2018, NEUROCHEM INT, V112, P234, DOI 10.1016/j.neuint.2017.07.014; Barbosa E, 2009, J BURN CARE RES, V30, P859, DOI 10.1097/BCR.0b013e3181b487a8; Barichello T, 2007, CRIT CARE MED, V35, P2186, DOI 10.1097/01.CCM.0000281452.60683.96; Berger MM, 2009, GASTROENTEROLOGY, V137, pS70, DOI 10.1053/j.gastro.2009.08.012; Berger MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6981; Biesalski HK, 2007, CRIT CARE MED, V35, pS577, DOI 10.1097/01.CCM.0000278598.95294.C5; BRAU RH, 1984, NEUROSURGERY, V14, P142, DOI 10.1227/00006123-198402000-00004; Buehner M, 2016, J BURN CARE RES, V37, pE374, DOI 10.1097/BCR.0000000000000233; Carr A, 2018, CRIT CARE RESUSC, V20, P180; Carr AC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1891-y; de Grooth HJ, 2018, CHEST, V153, P1368, DOI 10.1016/j.chest.2018.02.025; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; DePhillipo NN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118804544; Dubick MA, 2005, SHOCK, V24, P139, DOI 10.1097/01.shk.0000170355.26060.e6; Ellis GR, 2000, J AM COLL CARDIOL, V36, P1474, DOI 10.1016/S0735-1097(00)00916-5; Fisher BJ, 2012, AM J PHYSIOL-LUNG C, V303, pL20, DOI 10.1152/ajplung.00300.2011; Fisher BJ, 2011, CRIT CARE MED, V39, P1454, DOI 10.1097/CCM.0b013e3182120cb8; Fowler AA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-32; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Jackson TS, 1998, CIRC RES, V83, P916; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Lin JL, 2010, J CEREBR BLOOD F MET, V30, P1121, DOI 10.1038/jcbfm.2009.277; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Long CL, 2003, J SURG RES, V109, P144, DOI 10.1016/S0022-4804(02)00083-5; Luo MH, 2008, NUTRITION, V24, P37, DOI 10.1016/j.nut.2007.10.004; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Mack WJ, 2006, NEUROSURGERY, V59, P383, DOI 10.1227/01.NEU.0000223496.96945.A7; Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; May James M, 2012, Subcell Biochem, V56, P85, DOI 10.1007/978-94-007-2199-9_6; Mohammed BM, 2016, INT WOUND J, V13, P572, DOI 10.1111/iwj.12484; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Moor E, 2006, EXP GERONTOL, V41, P303, DOI 10.1016/j.exger.2005.12.006; Muhlhofer A, 2004, EUR J CLIN NUTR, V58, P1151, DOI 10.1038/sj.ejcn.1601943; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Nathens AB, 2002, ANN SURG, V236, P814, DOI 10.1097/00000658-200212000-00014; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Polidori MC, 2001, STROKE, V32, P898, DOI 10.1161/01.STR.32.4.898; Povlishock J T, 1992, Hum Cell, V5, P345; Putzu A, 2019, CRIT CARE MED, V47, P774, DOI 10.1097/CCM.0000000000003700; Razmkon Ali, 2011, Clin Neurosurg, V58, P133; Reynolds PS, 2018, J TRAUMA ACUTE CARE, V85, pS57, DOI [10.1097/TA.0000000000001844, 10.1097/ta.0000000000001844]; Sajja RK, 2017, NEUROSCI LETT, V653, P152, DOI 10.1016/j.neulet.2017.05.059; Sanford K, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030055; Siqueira IR, 2011, NEUROCHEM INT, V58, P527, DOI 10.1016/j.neuint.2011.01.011; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Stephenson CM, 2013, CANCER CHEMOTH PHARM, V72, P139, DOI 10.1007/s00280-013-2179-9; Tanaka H, 2000, ARCH SURG-CHICAGO, V135, P326, DOI 10.1001/archsurg.135.3.326; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vanek VW, 2012, NUTR CLIN PRACT, V27, P440, DOI 10.1177/0884533612446706; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Wei SY, 2018, J AM COLL SURGEONS, V227, P587, DOI 10.1016/j.jamcollsurg.2018.09.003; WILSON JX, 1990, NEUROCHEM RES, V15, P1037, DOI 10.1007/BF00965751; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yan M, 2014, SPINAL CORD, V52, P803, DOI 10.1038/sc.2014.135; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	74	1	1	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2020	32	1					333	339		10.1007/s12028-019-00829-x			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KK6PD	WOS:000512861100033	31440996	Bronze			2022-02-06	
J	Li, P; Ning, XH; Jia, L; Du, GQ; Jiang, SY; Gong, ZH; Song, KK; Wang, ZG; Zhang, K				Li, Peng; Ning, Xianghong; Jia, Long; Du, Gangqiang; Jiang, Shengyuan; Gong, Zhihao; Song, Kaikai; Wang, Zhigang; Zhang, Kai			A minimally invasive incision and loop drainage technique for the treatment of lower limb Morel-Lavallee lesions: Nose ring drainage technique	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Morel-Lavallee lesions; MLLs; Closed degloving injury; Nose ring drainage; Loop drainage	SUBCUTANEOUS ABSCESS; MANAGEMENT; KNEE; DIAGNOSIS	Morel-Lavallee lesions (MLLs) are shearing injuries resulting in separation of the skin and subcutaneous tissue from the underlying fascia. They are closed internal degloving injuries. Classical sites of the lesions are around the greater trochanter, pelvis, thigh, knee joint, and on the head, in decreasing order of frequency. This injury is often delayed or misdiagnosed when patients present with soft tissue injury alone or when more obvious injuries distract from its presence in polytrauma patients. There is currently no universally accepted treatment for these lesions. Conservative management often fails and requires surgical intervention. The purpose of this manuscript is to show that nose ring drainage, a minimally invasive incision and loop drainage technique for the treatment of lower limb Morel-Lavallee lesions, is effective and economical. (C) 2019 Elsevier Ltd. All rights reserved.	[Li, Peng; Jia, Long; Du, Gangqiang; Jiang, Shengyuan; Gong, Zhihao; Song, Kaikai; Wang, Zhigang; Zhang, Kai] Binzhou Med Univ Hosp, Dept Orthopaed Trauma, 661 Huanghe 2nd Rd, Binzhou 256603, Shandong, Peoples R China; [Ning, Xianghong] Binzhou Med Univ Hosp, Dept Ultrason Med, Binzhou 256603, Peoples R China		Wang, ZG; Zhang, K (corresponding author), Binzhou Med Univ Hosp, Dept Orthopaed Trauma, 661 Huanghe 2nd Rd, Binzhou 256603, Shandong, Peoples R China.	wangzgyh@sina.com; zhangkai@vip.163.com					Bonilla-Yoon I, 2014, EMERG RADIOL, V21, P35, DOI 10.1007/s10140-013-1151-7; Diviti Sreelatha, 2017, J Clin Diagn Res, V11, pTE01, DOI 10.7860/JCDR/2017/25479.9689; Gaszynski R, 2018, ANZ J SURG, V88, P87, DOI 10.1111/ans.13709; Greenhill D, 2016, ORTHOP CLIN N AM, V47, P115, DOI 10.1016/j.ocl.2015.08.012; Hudson DA, 1996, PLAST RECONSTR SURG, V98, P334, DOI 10.1097/00006534-199608000-00020; Kim S, 2016, INJURY, V47, P1064, DOI 10.1016/j.injury.2016.01.029; Koc BB, 2017, KNEE, V24, P144, DOI 10.1016/j.knee.2016.10.017; Kottmeier SA, 1996, CLIN ORTHOP RELAT R, P46; Ladde JG, 2015, AM J EMERG MED, V33, P271, DOI 10.1016/j.ajem.2014.10.014; Lee YJ, 2017, INT WOUND J, V14, P1258, DOI 10.1111/iwj.12793; Letournel E, 1993, FRACTURES ACETABULUM; Li H, 2014, CHINESE MED J-PEKING, V127, P1351, DOI 10.3760/cma.j.issn.0366-6999.20131943; Liu M, 2018, INJURY, V49, P1630, DOI 10.1016/j.injury.2018.06.003; Morel-Lavalle M, 1863, ARCH GEN MED, V1, P300; Morel-Lavallee M, 1863, ARCH GEN MED, V1, P172; Morel-Lavallee M., 1863, ARCH GEN MED, V1, P20; Nair Anirudh V, 2014, Indian J Radiol Imaging, V24, P288, DOI 10.4103/0971-3026.137053; Nickerson TP, 2014, J TRAUMA ACUTE CARE, V76, P493, DOI 10.1097/TA.0000000000000111; Palacio Evandro Pereira, 2015, Rev. bras. ortop., V50, P148, DOI 10.1016/j.rboe.2015.02.011; Scolaro JA, 2016, J AM ACAD ORTHOP SUR, V24, P667, DOI 10.5435/JAAOS-D-15-00181; Shen C, 2013, ARCH ORTHOP TRAUM SU, V133, P635, DOI 10.1007/s00402-013-1703-z; Singh R, 2018, J ORTHOP, V15, P917, DOI 10.1016/j.jor.2018.08.032; Takahara S., 2014, CASE REP ORTHOP, V2014; Tejwani SG, 2007, AM J SPORT MED, V35, P1162, DOI 10.1177/0363546507299448; Tsoraides SS, 2010, J PEDIATR SURG, V45, P606, DOI 10.1016/j.jpedsurg.2009.06.013; Vanhegan IS, 2012, CASE REP ORTHOP, V2012; Vassalou EE, 2018, AM J ROENTGENOL, V210, pW234, DOI 10.2214/AJR.17.18614; Walls A, 2017, BMJ CASE REP, V2017; Zhong BA, 2014, CAN J SURG, V57, P356, DOI 10.1503/cjs.034413	29	1	5	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	FEB	2020	51	2					570	573		10.1016/j.injury.2019.12.014			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	KH4KX	WOS:000510616700072	31852590				2022-02-06	
J	Lorente, L; Martin, MM; Perez-Cejas, A; Gonzalez-Rivero, AF; Abreu-Gonzalez, P; Ramos, L; Argueso, M; Sole-Violan, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Abreu-Gonzalez, Pedro; Ramos, Luis; Argueso, Monica; Sole-Violan, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Garcia-Marin, Victor			Traumatic Brain Injury Patients Mortality and Serum Total Antioxidant Capacity	BRAIN SCIENCES			English	Article						total antioxidant capacity; traumatic brain injury; patients; mortality; prognosis	OXIDATIVE STRESS; MELATONIN; SEVERITY; DAMAGE	Objective: Oxidation is involved in secondary brain injury after traumatic brain injury (TBI). Increased concentrations of total antioxidant capacity (TAC) in blood at the time of admission for TBI have been found in non-surviving patients. The main objective of this study was to determine the role of serum TAC levels at any time during the first week of TBI for the prediction of early mortality. Methods: Isolated (<10 points in non-cranial aspects of Injury Severity Score) and severe (<9 points in Glasgow Coma Scale) TBI patients were included. Serum TAC concentrations at days 1, 4, and 8 of TBI were determined. The end-point study was 30-day mortality. Results: Higher serum TAC levels at days 1 (p < 0.001), 4 (p < 0.001), and 8 (p = 0.002) of TBI were found in non-surviving (n = 34) than in surviving patients (n = 90). The area under curve (95% Confidence Interval) for prediction of 30-day mortality by serum TAC concentrations at days 1, 4, and 8 of TBI were 0.79 (0.71-0.86; p < 0.001), 0.87 (0.79-0.93; p < 0.001), and 0.76 (0.67-0.84; p = 0.006) respectively. Conclusions: The novelty of our study was the ability to predict 30-day mortality by serum TAC concentrations at any time during the first week of TBI.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38020, Spain; [Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.] Hosp Univ Canarias, Lab Dept, Ofra S-N, San Cristobal la Laguna 38320, Spain; [Abreu-Gonzalez, Pedro] Univ Laguna, Fac Med, Dept Physiol, Ofra S-N, San Cristobal la Laguna 38320, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista Arriba S-N, Santa Cruz De Tenerife 38713, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Barranco de la Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N, San Cristobal la Laguna 38320, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Ofra S-N, San Cristobal la Laguna 38320, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Spain.	lorentemartin@msn.com; mar.martinvelasco@gmail.com; aperezcejas@gmail.com; agonriv@hotmail.com; pabreu@ull.es; lramosgomez@gmail.com; moni_begasa@hotmail.com; jsolvio@gobiernodecanarias.org; juanjose.caceresagra@gobiernodecanarias.org; ajimenersosa@gmail.com; vicgarmar666@gmail.com		Jimenez-Sosa, Alejandro/0000-0001-8732-2616; Abreu-Gonzalez, Pedro/0000-0002-7553-1784; Lorente, Leonardo/0000-0003-4902-4065	Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain) [OA18/011]; Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [PI-18-00500]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported by a grant (OA18/011) from Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain) and a grant from Instituto de Salud Carlos III (PI-18-00500) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kavakli HS, 2010, SCI RES ESSAYS, V5, P2832; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lorente L, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4828-5; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0378-1; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Rehman SU, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070760; Rodriguez-Rodriguez A, 2017, CLIN CHEM LAB MED, V55, pE265, DOI 10.1515/cclm-2017-0022; Saniova B, 2006, CELL MOL NEUROBIOL, V26, P1475, DOI 10.1007/s10571-006-9033-0; TEASDALE G, 1974, LANCET, V2, P81; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022	25	1	1	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	FEB	2020	10	2							110	10.3390/brainsci10020110			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT8DY	WOS:000519243400059	32085496	Green Published, gold			2022-02-06	
J	Marsh, R; Matlock, DD; Maertens, JA; Rutebemberwa, A; Morris, MA; Hankinson, TC; Bennett, TD				Marsh, Rebekah; Matlock, Daniel D.; Maertens, Julie A.; Rutebemberwa, Alleluiah; Morris, Megan A.; Hankinson, Todd C.; Bennett, Tellen D.			Parental involvement in decision making about intracranial pressure monitor placement in children with traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatrics; traumatic brain injury; intracranial pressure; intracranial hypertension; qualitative research; clinical decision making; trauma	HEALTH-CARE; PREFERENCES; OUTCOMES; AIDS	OBJECTIVE Little is known about how parents of children with traumatic brain injury (TBI) participate or feel they should participate in decision making regarding placing an intracranial pressure (ICP) monitor. The objective of this study was to identify the perspectives and decisional or information needs of parents whose child sustained a TBI and may require an ICP monitor. METHODS This was a qualitative study at one US level I pediatric trauma center. The authors conducted in-depth semistructured interviews with 1) parents of critically injured children who have sustained a TBI and 2) clinicians who regularly care for children with TBI. RESULTS The authors interviewed 10 parents of 7 children (60% were mothers and 80% were white) and 28 clinicians (17 ICU clinicians and 11 surgeons). Overall, the authors found concordance between and among parents and clinicians about parental involvement in ICP monitor decision making. Parents and clinicians agreed that decision making about ICP monitoring in children who have suffered TBI is not and should not be shared between the parents and clinicians. The concordance was represented in 3 emergent themes. Parents wanted transparency, communication, and information (theme 2), but the life-threatening context of this decision (theme 1) created an environment where all involved reflected a clear preference for paternalism (theme 3). CONCLUSIONS The clear and concordant preference for clinician paternalistic decision making coupled with the parents' needs to be informed suggests that a decision support tool for this decision should be clinician facing and should emphasize transparency in collaborative decision making between clinicians.	[Marsh, Rebekah; Matlock, Daniel D.; Maertens, Julie A.; Morris, Megan A.; Hankinson, Todd C.; Bennett, Tellen D.] Univ Colorado, Sch Med, Dept Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA; [Matlock, Daniel D.] Univ Colorado, Dept Med, Div Geriatr Med, Sch Med, Aurora, CO USA; [Rutebemberwa, Alleluiah] Childrens Hosp, Colorado Res Inst, Denver, CO 80218 USA; [Hankinson, Todd C.] Univ Colorado, Sch Med, Pediat Neurosurg, Aurora, CO USA; [Bennett, Tellen D.] Univ Colorado, Sch Med, Pediat Crit Care, Aurora, CO USA; [Matlock, Daniel D.] VA Eastern Colorado Geriatr Res Educ & Clin Ctr, Denver, CO USA; [Hankinson, Todd C.] Childrens Hosp, Colorado Ctr Res Outcomes Childrens Surg, Aurora, CO USA		Bennett, TD (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu		Matlock, Dan/0000-0001-9597-9642; Bennett, Tellen/0000-0003-1483-4236	Mindsource Brain Injury Network of the Colorado Department of Human Services	This work was supported by the Mindsource Brain Injury Network of the Colorado Department of Human Services (grant to T. D.B.).	Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bennett TD, 2019, PEDIATR CRIT CARE ME, V20, P645, DOI 10.1097/PCC.0000000000001934; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Brom L, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-25; Cohen H, 2003, FAM PRACT, V20, P724, DOI 10.1093/fampra/cmg617; Committee on Quality of Health Care in America - Institute of Medicine, 2001, CROSSING QUALITY CHA; Crabtree B. F., 1999, DOING QUALITATIVE RE; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; DeLemos D, 2010, PEDIATR CRIT CARE ME, V11, P378, DOI 10.1097/PCC.0b013e3181b8088b; Faul M, 2010, TRAUMATIC BRAIN INJU; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; O'Connor A., OTTAWA DECISION SUPP; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; Paulsen C., 2006, NCES 2006 483; Pieterse AH, 2019, JAMA-J AM MED ASSOC, V322, P25, DOI 10.1001/jama.2019.3785; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Rosenbaum L, 2015, NEW ENGL J MED, V373, P589, DOI 10.1056/NEJMp1508418; Sepucha KR, 2016, HEALTH AFFAIR, V35, P630, DOI 10.1377/hlthaff.2015.1376; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tolley EE., 2005, QUALITATIVE METHODS, V1st; van den Berg AMA, 2019, EUR J ANAESTH, V36, P25, DOI 10.1097/EJA.0000000000000864	34	1	1	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	FEB	2020	25	2					183	191		10.3171/2019.8.PEDS19275			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	KI1LU	WOS:000511109700012	31675722				2022-02-06	
J	Moore, T; Phillips, N; Palermo, T; Lah, S				Moore, Teleri; Phillips, Natalie; Palermo, Tonya; Lah, Suncica			Acceptability, feasibility, and usability of a manualized cognitive behavioural programme for treatment of insomnia in children who sustained traumatic brain injury: A service providers' perspective.	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Child; Sleep disturbance; CBT; Treatment	RANDOMIZED CONTROLLED-TRIAL; SLEEP DISTURBANCES; ADOLESCENTS; THERAPY; INTERVENTIONS; DISORDERS; OUTCOMES; UPDATE; IMPACT	Sleep disturbances, especially insomnia, are common and associated with poor outcomes in children following traumatic brain injury (TBI). Yet, clinical treatment guidelines are lacking. Thus, we developed a manualized cognitive-behavioural programme for treatment of insomnia (CBT-I) in children who sustained TBI. The aim of this study was to determine acceptability, feasibility, and usability of the programme from the service providers' perspective. This observational study used an explanatory mixed-methods design. Fifteen clinicians experienced in working with children, patients with sleep disturbances or brain injuries participated. On review of the treatment programme, clinicians completed an online survey assessing (i) the overall format, aesthetics, and clarity of the programme, and (i) the overall quality of the intervention. Analyses involved descriptive statistics and a thematic analysis. Clinician's ratings indicated a high level of agreement in the acceptability, feasibility, and usability of the programme, ranging from 70.9% (the therapist manual) to 86.9% (the intervention approach). Thematic analysis revealed suggestions that related to the developmental appropriateness, feasibility, and usability of the programme. The findings of our study will be used to modify the CBT-I treatment programme that will be further validated in a feasibility clinical trial involving children aged 6-10 years who sustained TBI.	[Moore, Teleri; Phillips, Natalie; Palermo, Tonya; Lah, Suncica] Univ Sydney, Sch Psychol, Sydney, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Brain & Mind Ctr, Sch Psychol, Clin Psychol Unit, 94 Mallet St, Camperdown, NSW 2050, Australia.	suncica.lah@sydney.edu.au		Palermo, Tonya/0000-0001-6036-6715; Phillips, Natalie/0000-0001-7505-9670			ADAMS LA, 1989, PEDIATRICS, V84, P756; Addis ME, 2002, CLIN PSYCHOL-SCI PR, V9, P421, DOI 10.1093/clipsy/9.4.421; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Bogdanov S, 2019, J HEAD TRAUMA REHAB, V34, P122, DOI 10.1097/HTR.0000000000000426; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Boyatzis R. E., 1998, TRANSFORMING QUALITA; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Carroll KM, 2002, CLIN PSYCHOL-SCI PR, V9, P396, DOI 10.1093/clipsy/9.4.396; Clarke G, 2015, BEHAV RES THER, V69, P111, DOI 10.1016/j.brat.2015.04.009; Clarke V, 2018, COUNS PSYCHOTHER RES, V18, P107, DOI 10.1002/capr.12165; Cooney MR, 2018, SLEEP MED, V46, P98, DOI 10.1016/j.sleep.2018.03.003; de Bruin EJ, 2015, SLEEP, V38, P1913, DOI 10.5665/sleep.5240; Edinger JD, 2005, CLIN PSYCHOL REV, V25, P539, DOI 10.1016/J.CPR.2005.04.003; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Hilger T, 2009, ADV CLIN EXP MED, V18, P169; IBM, 2016, IBM SPSS STAT WIND V; Lah S, 2021, NEUROPSYCHOL REHABIL, V31, P345, DOI 10.1080/09602011.2019.1693404; Meltzer LJ, 2014, J PEDIATR PSYCHOL, V39, P932, DOI 10.1093/jpepsy/jsu041; Meltzer LJ, 2008, SLEEP MED CLIN, V3, P269, DOI 10.1016/j.jsmc.2008.01.004; Mindell JA, 2015, CLIN GUIDE PEDIAT SL; Mindell JA, 2006, SLEEP, V29, P1263; Moorin R, 2014, J NEUROL, V261, P1726, DOI 10.1007/s00415-014-7411-y; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Paine S, 2011, BEHAV RES THER, V49, P379, DOI 10.1016/j.brat.2011.03.008; Palermo TM, 2017, J CLIN SLEEP MED, V13, P401, DOI 10.5664/jcsm.6490; Ree M, 2017, SLEEP MED, V36, pS43, DOI 10.1016/j.sleep.2017.03.017; Schlarb AA, 2011, NAT SCI SLEEP, V3, P1, DOI 10.2147/NSS.S15254; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Vriend JL, 2011, J PEDIATR PSYCHOL, V36, P1017, DOI 10.1093/jpepsy/jsr044; Westen D, 2002, CLIN PSYCHOL-SCI PR, V9, P416, DOI 10.1093/clipsy/9.4.416; Weyenberg S., 2009, THESIS	39	1	1	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 21	2021	31	4					583	600		10.1080/09602011.2020.1717969		FEB 2020	18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RN0PC	WOS:000512409000001	32011212				2022-02-06	
J	Mubayed, L; Romme, A; Nguyen, HH				Mubayed, Lamya; Romme, Angela; Nguyen, Hoang H.			QT Prolongation After Minor Head Trauma in a Pediatric Patient	PEDIATRIC CARDIOLOGY			English	Article						QT prolongation; Parasympathetic nervous system; Concussion; Minor head trauma	INTERVAL VARIABILITY	We report a case of QTc prolongation associated with mild concussion in a pediatric patient. An 11-year-old male presented to the emergency department after sustaining a head injury during football practice. He complained of headache and blurry vision. Physical examination was within normal apart from an irregular heart rhythm. Electrocardiogram (ECG) showed normal sinus rhythm with QTc (Bazett formula) 460 ms. The patient was diagnosed with concussion and referred for cardiology follow-up of the QTc. ECG the next day showed QTc 462 ms (heart rate 105 bpm) supine and 494 ms after suddenly standing up (heart rate 120 bpm). Family history was negative for sudden cardiac events. Exercise stress testing 1 week later showed a baseline QTc 462 ms and 488 ms at 4 min into recovery. Holter monitoring showed evidence of increased para-sympathetic activity manifested by marked sinus arrhythmia. Repeated ECG, exercise stress testing, and Holter monitoring 3 months later showed normalized QTc values. His concussion symptoms were resolved at the time of repeat testing. Mild head trauma/concussion could be associated with prolonged QTc and abnormal cardiac repolarization. While these changes seem to be self-limiting, they remain a possible substrate for malignant arrhythmias. Recognition of these changes would lead to appropriate reassurance and/or precautions in the acute setting, especially in at-risk populations such as long QT syndrome patients.	[Mubayed, Lamya; Romme, Angela; Nguyen, Hoang H.] Rush Univ, Coll Med, Dept Pediat, Div Cardiol, Chicago, IL 60612 USA		Mubayed, L (corresponding author), Rush Univ, Coll Med, Dept Pediat, Div Cardiol, Chicago, IL 60612 USA.	Lamya_Mubayed@rush.edu	Nguyen, Hoang/AAA-7038-2020	Nguyen, Hoang/0000-0001-6891-9951; Mubayed, Lamya/0000-0002-4862-4774			Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Dash M, 2003, J NEUROSURG ANESTH, V15, P270, DOI 10.1097/00008506-200307000-00017; Gasior JS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01495; GOLDSTEIN B, 1998, AM J PHYSIOL, V275, pR128, DOI DOI 10.1152/AJPREGU.1998.275.4.R1287; Koturoglu G, 2006, Minerva Pediatr, V58, P575; La Fountaine MF, 2014, INT J CARDIOL, V172, pE511, DOI 10.1016/j.ijcard.2014.01.095; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; Ozdemir D, 2005, PEDIATR EMERG CARE, V21, P658, DOI 10.1097/01.pec.0000181427.25342.e0; Plymale J, 2010, PEDIATR CARDIOL, V31, P1064, DOI 10.1007/s00246-010-9766-x; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	10	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	FEB	2020	41	2					414	417		10.1007/s00246-019-02213-0			4	Cardiac & Cardiovascular Systems; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pediatrics	KU2ID	WOS:000519531100025	31599347				2022-02-06	
J	Murray, N; Belson, E; Szekely, B; Islas, A; Cipriani, D; Lynall, RC; Buckley, TA; Powell, DW; Munkasy, B				Murray, Nicholas; Belson, Emily; Szekely, Brian; Islas, Arthur; Cipriani, Daniel; Lynall, Robert C.; Buckley, Thomas A.; Powell, Douglas W.; Munkasy, Barry			Baseline Postural Control and Lower Extremity Injury Incidence Among Those With a History of Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; center of pressure; sport-related concussion; musculoskeletal injury	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; MUSCULOSKELETAL INJURY; BALANCE; STABILITY; RECOVERY; ASSOCIATION; COMPLEXITY; DYNAMICS; INCREASE	Context: Lower extremity musculoskeletal (LEMSK) injury may be more prevalent among those with a history of sport-related concussion (SRC). Objective: To investigate the relationship between baseline postural control metrics and the LEMSK injury incidence in National Collegiate Athletic Association Division I student-athletes with a history of SRC. Setting: National Collegiate Athletic Association Division I athletes. Design: Cohort study. Patients or Other Participants: Of 84 total athletes (62 males), 42 had been previously diagnosed with an SRC, and 42 were matched controls based on age, sex, height, weight, and sport. Main Outcome Measure(s): During the preseason baseline evaluation, all participants performed 3 trials of eyes-open and eyes-closed upright quiet stance on a force platform. Medical charts were assessed for all the LEMSK injuries that occurred from preseason baseline to 1 year later. Center-of-pressure data in the anteroposterior and mediolateral directions were filtered before we calculated root mean square and mean excursion velocity; the complexity index was calculated from the unfiltered data. Factorial analysis-of-variance models were used to examine differences between groups and across conditions for root mean square; mean excursion velocity, complexity index, and tests of association to examine between-groups LEMSK differences; and logistic regression models to predict LEMSK. Results: Concussion history and injury incidence were related in the SRC group (P = .043). The complexity index of the SRC group was lower with eyes closed (14.08 +/- 0.63 versus 15.93 +/- 0.52) and eyes open (10.25 +/- 0.52 vs 11.80 +/- 0.57) in the mediolateral direction than for the control participants (P < .05). Eyes-open root mean square in the mediolateral direction was greater for the SRC group (5.00 +/- 0.28 mm) than the control group (4.10 +/- 0.22 mm). Logistic regression models significantly predicted LEMSK only in control participants. Conclusions: These findings may suggest that LEMSK after SRC cannot be predicted from postural-control metrics at baseline.	[Murray, Nicholas] Univ Nevada, Sch Community Hlth Sci, 1664 North Virginia St M-S 0274, Reno, NV 89557 USA; [Szekely, Brian] Univ Nevada, Neurosci Inst, Reno, NV 89557 USA; [Islas, Arthur] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Belson, Emily; Munkasy, Barry] Georgia Southern Univ, Waters Sch Hlth Profess, Statesboro, GA USA; [Cipriani, Daniel] West Coast Univ, Phys Therapy Program, Ctr Grad Studies, Los Angeles, CA USA; [Lynall, Robert C.] Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA; [Powell, Douglas W.] Univ Memphis, Sch Hlth Studies, Exercise Neurosci Res Lab, Memphis, TN 38152 USA		Murray, N (corresponding author), Univ Nevada, Sch Community Hlth Sci, 1664 North Virginia St M-S 0274, Reno, NV 89557 USA.	nicholasmurray@unr.edu	Buckley, Thomas A/B-7525-2016; Lynall, Robert/M-2888-2014	Buckley, Thomas A/0000-0002-0515-0150; Lynall, Robert/0000-0002-0785-6640	University of Nevada, Reno Neuroscience Institute Pilot Study Program [COBRE P20GM103650]; Nevada IDeA Network of Biomedical Research Excellence pilot program [P20GM103440, U54GM104944]	This study was partially funded by the University of Nevada, Reno Neuroscience Institute Pilot Study Program (COBRE P20GM103650) and the Nevada IDeA Network of Biomedical Research Excellence pilot program (P20GM103440; U54GM104944).	[Anonymous], 1995, GAIT POSTURE; Bizzini M, 2013, BRIT J SPORT MED, V47, P803, DOI 10.1136/bjsports-2012-092124; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Engebretsen AH, 2011, SCAND J MED SCI SPOR, V21, P645, DOI 10.1111/j.1600-0838.2010.01095.x; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Powell DW, 2020, NEUROSCI LETT, V728, DOI 10.1016/j.neulet.2018.05.010; Powell DW, 2015, HUM MOVEMENT SCI, V44, P73, DOI 10.1016/j.humov.2015.08.013; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010	31	1	1	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2020	55	2					109	115		10.4085/1062-6050-187-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KM1GV	WOS:000513866900001	31935138	Green Published, gold			2022-02-06	
J	Patterson, LHC; Walker, JL; Rodriguez-Mesa, E; Shields, K; Foster, JS; Valentine, MT; Doyle, AM; Foster, KL				Patterson, Luke H. C.; Walker, Jennifer L.; Rodriguez-Mesa, Evelyn; Shields, Kevin; Foster, John S.; Valentine, Megan T.; Doyle, Adele M.; Foster, Kimberly L.			Investigating Cellular Response to Impact With a Microfluidic MEMS Device	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Cellular impact; connective tissue deformation; dynamic cell compression; microfluidic MEMS actuator; traumatic brain injury	FINITE-ELEMENT MODEL; MECHANICAL STIMULATION; BRAIN-INJURY; TISSUE; CELLS; STRAIN; DIFFERENTIATION; INDENTATION; CHONDROCYTE; SIMULATION	Although high strain and strain-rate impacts to the human body have been the subject of substantial research at both the systemic and tissue levels, little is known about the cell-level ramifications of such assaults. This is largely due to the lack of high throughput, dynamic compression devices capable of simulating such traumatic loading conditions on individual cells. To fill this gap, we developed and characterized a high speed, high actuation force, magnetically driven MEMS chip to apply stress to biological cells at unprecedented strain (10% to 90%), strain rate (30,000 to 200,000 s(-1)), and throughput (12,000 cells/min). To demonstrate the capabilities of the $\mu $ Hammer, we applied biologically relevant strains and strain rates to human leukemic K562 cells and then monitored their viability for up to 8 days. We observed significantly repressed proliferation of the hit cells compared to both unperturbed and sham-hit control cells, accompanied by minimal cell death. This indicates success in applying cellular damage without compromising the overall viability of the population, allowing us to conclude that this device is well suited to study the subtle effects of impact on large populations of inherently heterogeneous cells. [2019-0132]	[Patterson, Luke H. C.; Walker, Jennifer L.; Valentine, Megan T.; Doyle, Adele M.; Foster, Kimberly L.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Rodriguez-Mesa, Evelyn; Shields, Kevin; Foster, John S.] Owl Biomed, Santa Barbara, CA 93117 USA; [Valentine, Megan T.; Doyle, Adele M.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Valentine, Megan T.; Doyle, Adele M.] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA; [Foster, Kimberly L.] Tulane Univ, Sch Sci & Engn, Dept Phys & Engn, New Orleans, LA 70118 USA; [Foster, Kimberly L.] Tulane Univ, Sch Sci & Engn, Dept Biomed Engn, New Orleans, LA 70118 USA		Patterson, LHC (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	lpatterson@ucsb.edu; jenniferwalker@ucsb.edu; evelyn@owlbiomedical.com; kevin@owlbiomedical.com; john@owlbiomedical.com; mtvale@ucsb.edu; adoyle@ucsb.edu; klfoster@tulane.edu		Doyle, Adele/0000-0003-4204-3642; Valentine, Megan/0000-0003-4781-8478; Patterson, Luke/0000-0002-3835-8433	National Science FoundationNational Science Foundation (NSF) [CBET-1631656, CMMI-1254893]	This work was supported by the National Science Foundation under Grant CBET-1631656 and Grant CMMI-1254893. This article was presented in part at the Solid-State Sensors, Actuators, and Microsystems Workshop, Hilton Head, SC, USA, June 2018 [1]. Subject Editor X. Zhang.	Abusara Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147547; Aspden RM, 2002, OSTEOARTHR CARTILAGE, V10, P588, DOI 10.1053/joca.2002.0803; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bartell LR, 2015, J BIOMECH, V48, P3440, DOI 10.1016/j.jbiomech.2015.05.035; Breuls RGM, 2003, ANN BIOMED ENG, V31, P1357, DOI 10.1114/1.1624602; Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492; Brindley David, 2011, J Tissue Eng, V2011, P620247, DOI 10.4061/2011/620247; Campbell JJ, 2006, BIORHEOLOGY, V43, P455; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chan BP, 2008, ANN BIOMED ENG, V36, P1254, DOI 10.1007/s10439-008-9507-y; Cho H, 2012, LIFE SCI, V90, P591, DOI 10.1016/j.lfs.2012.02.014; Desmaele D, 2011, J BIOMECH, V44, P1433, DOI 10.1016/j.jbiomech.2011.02.085; Foster J. S., 2017, U.S. Patent, Patent No. [9 604 214 B2, 9604214]; Foster J. S., 2016, U.S. Patent, Patent No. [9 404 838 B2, 9404838]; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Loh O, 2009, EXP MECH, V49, P105, DOI 10.1007/s11340-007-9099-8; MacManus DB, 2018, J MECH BEHAV BIOMED, V87, P256, DOI 10.1016/j.jmbbm.2018.07.025; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; McGuire J, 2001, P I MECH ENG H, V215, P589, DOI 10.1243/0954411011536190; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Milan JL, 2010, BIOMECH MODEL MECHAN, V9, P583, DOI 10.1007/s10237-010-0199-5; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Patterson L. H. C., 2018, P SOL STAT SENS ACT, P167, DOI [10.31438/trf.hh2018.47, DOI 10.31438/TRF.HH2018.47]; Peeters EAG, 2005, J BIOMECH, V38, P1685, DOI 10.1016/j.jbiomech.2004.07.018; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Saari A, 2011, J BIOMECH, V44, P2565, DOI 10.1016/j.jbiomech.2011.06.015; Sanders DP, 2010, J PHOTOPOLYM SCI TEC, V23, P11, DOI 10.2494/photopolymer.23.11; Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021; Slomka N, 2009, CELL MOL BIOENG, V2, P118, DOI 10.1007/s12195-009-0046-x; Song B, 2007, J BIOMECH, V40, P2999, DOI 10.1016/j.jbiomech.2007.02.001; Stewart MP, 2012, NAT PROTOC, V7, P143, DOI 10.1038/nprot.2011.434; Takamatsu H, 2002, J BIOMECH ENG-T ASME, V124, P780, DOI 10.1115/1.1516197; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Waters NP, 2014, J BIOMECH, V47, P3185, DOI 10.1016/j.jbiomech.2014.06.015; Wu JZ, 2000, ANN BIOMED ENG, V28, P318, DOI 10.1114/1.271; Zacchia NA, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4921553; Zhong HX, 2017, RSC ADV, V7, P21837, DOI 10.1039/c7ra01868a	46	1	1	3	7	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	FEB	2020	29	1					14	24		10.1109/JMEMS.2019.2948895			11	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Physics	KO9SK	WOS:000515886300004		hybrid			2022-02-06	
J	Roup, CM; Ross, C; Whitelaw, G				Roup, Christina M.; Ross, Courtney; Whitelaw, Gail			Hearing Difficulties as a Result of Traumatic Brain Injury	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article; Proceedings Paper	American-Academy-of-Audiology Convention	2018	Nashville, TN	Amer Acad Audiol		Auditory processing; auditory rehabilitation; hearing aids; traumatic brain injury	IN-NOISE TEST; PERFORMANCE; VETERANS; SYSTEM	Background: Traumatic brain injury (TBI) has been shown to result in hearing difficulties (i.e., deficits in the processing of auditory information) without impacting pure-tone threshold detection. A missed diagnosis of hearing difficulties due to TBI because of normal hearing can lead to reductions in quality of life and missed opportunities to provide an appropriate treatment regimen. Purpose: This study presents a case report of a female patient with a history of TBI due to a motor vehicle accident that resulted in a broad range of symptoms, including self-perceived hearing difficulties and poorer-than-normal auditory processing performance. Research Design: Case report. Study Sample: A 58-year-old woman with a history of a mild TBI due to a motor vehicle accident. Data Collection: A neuro-audiology evaluation was conducted to address the patient's hearing complaints. The evaluation included standard audiometric and auditory processing test batteries. Results: The case report focuses on the patient's history of TBI and her presentation to our clinic with hearing complaints. Her clinical audiological outcomes, including an auditory processing assessment, and treatment with mild-gain hearing aids are discussed. The use of mild-gain hearing aids resulted in improved auditory processing skills and a significant improvement in quality of life. Conclusions: Patients with a history of TBI often have multiple and debilitating symptoms, including hearing difficulties. Accurate diagnosis of auditory processing deficits in the face of normal pure-tone detection abilities is essential to provide treatment options that can improve daily function and quality of life.	[Roup, Christina M.; Ross, Courtney; Whitelaw, Gail] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA		Roup, CM (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA.	roup.2@osu.edu					American National Standards Institute (ANSI), 2017, S3421992R2017 ANSI; American National Standards Institute (ANSI), 2012, S3391987R2012 ANSI; ANSI, 2010, S362010 ANSI; Barnes GR, 2008, PROG BRAIN RES, V171, P441, DOI 10.1016/S0079-6123(08)00665-1; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Bilger RC., 1984, ASHA REPORTS, V14; Murphy CFB, 2011, CLINICS, V66, P713, DOI 10.1590/S1807-59322011000400030; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2017, WHAT AR SIGNS SYMPT; COCKRELL J L, 1992, Brain Injury, V6, P261, DOI 10.3109/02699059209029667; *DEP VET AFF, 1998, SPEECH REC ID MAT DI; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Figueiredo CC, 2015, EINSTEIN-SAO PAULO, V13, P535, DOI 10.1590/S1679-45082015AO3379; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Isaki E, 2000, BRAIN INJURY, V14, P441; Keith, 2009, SCAN 3 TESTS AUDITOR; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kokx-Ryan M., 2016, INT HEAR AID RES C L; Kuk F, 2008, J AM ACAD AUDIOL, V19, P465, DOI 10.3766/jaaa.19.6.3; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; McGregor ML, 2014, PEDIATR CLIN N AM, V61, P621, DOI 10.1016/j.pcl.2014.03.010; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P79, DOI 10.1016/S0887-6177(00)00105-0; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Roup CM, 2018, J AM ACAD AUDIOL, V29, P477, DOI 10.3766/jaaa.16111; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; Saunders Gabrielle H., 2014, Seminars in Hearing, V35, P227, DOI 10.1055/s-0034-1383507; Strouse A, 1999, J Am Acad Audiol, V10, P557; Sweetow RW, 2006, J AM ACAD AUDIOL, V17, P538, DOI 10.3766/jaaa.17.8.2; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Wiley T L, 1996, J Am Acad Audiol, V7, P260; Wilson Richard H, 2003, J Am Acad Audiol, V14, P1, DOI 10.3766/jaaa.14.1.2; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613	48	1	1	0	0	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	FEB	2020	31	2					137	146		10.3766/jaaa.18084			10	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Otorhinolaryngology	KM6OB	WOS:000514256300008	31287053				2022-02-06	
J	Strandvik, G; Shaaban, A; Alsaleh, ARM; Khan, MM				Strandvik, Gustav; Shaaban, Ahmed; Alsaleh, Abdelrahman Rawhi Mahmoud; Khan, Muhammad Mohsin			Rapidly fatal pneumococcal meningitis following non-penetrating traumatic brain injury	BMJ CASE REPORTS			English	Article						meningitis; adult intensive care; neurological injury; trauma CNS; PNS	EARLY FEVER; PNEUMOCEPHALUS; VACCINATION; CEFTRIAXONE; PREVENTION	A previously healthy young man presented to hospital with severe traumatic brain injury following a motor vehicle collision. Within 24 hours of admission, and despite antibiotic coverage, he developed a fever. On the second day, the source of infection was discovered to be purulent pneumococcal meningitis. At 48 hours post-accident, he developed brain-stem death without evidence of raised intracranial pressure or trans-tentorial herniation. Initial CT scans of the head were essentially normal, but early repeat scans revealed evidence of pneumocephalus and possible frontal bone fracture. Current recommendations do not make room for targeted antibiotic prophylaxis in traumatic brain injury patients with traumatic skull fracture. We argue that our case demonstrates the need for aggressive targeted antibiotic prophylaxis in the presence of certain features such as frontal or sphenoid bone fracture and pneumocephalus.	[Strandvik, Gustav; Alsaleh, Abdelrahman Rawhi Mahmoud] Hamad Med Corp, Trauma Dept, Doha, Qatar; [Shaaban, Ahmed; Khan, Muhammad Mohsin] Hamad Med Corp, Neurosurg, Doha, Qatar; [Alsaleh, Abdelrahman Rawhi Mahmoud] Hamad Med Corp, ENT Dept, Doha, Qatar		Strandvik, G (corresponding author), Hamad Med Corp, Trauma Dept, Doha, Qatar.	gustav.strandvik@sky.com		Strandvik, Gustav/0000-0002-1519-523X			APPELBAUM E, 1960, JAMA-J AM MED ASSOC, V173, P1818, DOI 10.1001/jama.1960.03020340036010; Barry Conor, 2019, Case Rep Radiol, V2019, P7876494, DOI 10.1155/2019/7876494; CIOFFI WG, 1993, ARCH SURG-CHICAGO, V128, P1260; Cohen-Inbar O, 2017, J NEUROSURG SCI, V61, P245, DOI 10.23736/S0390-5616.16.03287-X; Dagi T F, 1983, Am J Emerg Med, V1, P295, DOI 10.1016/0735-6757(83)90109-2; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; Gdynia HJ, 2007, EUR J MED RES, V12, P181; Gergs U, 2014, J PHARM PHARMACOL, V66, P1552, DOI 10.1111/jphp.12282; Greenberg MS., 2016, HDB NEUROSURGERY, V8th, P1661; Hedberg AL, 2017, VACCINE, V35, P909, DOI 10.1016/j.vaccine.2016.12.065; Hinson HE, 2018, J TRAUMA ACUTE CARE, V84, P19, DOI 10.1097/TA.0000000000001627; Hinson HE, 2017, J HEAD TRAUMA REHAB, V32, pE50, DOI 10.1097/HTR.0000000000000271; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Ohe Y, 2012, INTERNAL MED, V51, P1129, DOI 10.2169/internalmedicine.51.6861; Ratilal BO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004884.pub4	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	FEB	2020	13	2							e232692	10.1136/bcr-2019-232692			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SS1VG	WOS:000661529200053	32071126				2022-02-06	
J	Stulce, C; Reisner, A; Kane, JM; Shin, HS; McCracken, C; Williamson, J; Walson, K; Paden, M				Stulce, Casey; Reisner, Andrew; Kane, Jason M.; Shin, H. Stella; McCracken, Courtney; Williamson, Julie; Walson, Karen; Paden, Matthew			Fluid Overload in Pediatric Severe Traumatic Brain Injury*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						fluid overload; hypertonic saline; pediatric; traumatic brain injury	CRITICALLY-ILL CHILDREN; ACUTE KIDNEY INJURY; SUCCESSFUL EXTUBATION; HEAD-INJURY; MORTALITY; MORBIDITY; THERAPY; VENTILATION; DYSFUNCTION; ACCURACY	Objective: Pediatric traumatic brain injury is a major public health problem in the United States. Hypertonic saline therapy is a well-established treatment in patients with severe traumatic brain injury (Glasgow Coma Scale <= 8) who have intracranial hypertension. In children, fluid overload is associated with increased mortality, ventilator duration, and length of PICU stay, even when controlling for severity of illness. This study reports prevalence of fluid overload in pediatric patients with severe traumatic brain injury treated with 3% hypertonic saline and effect on clinical outcomes. Design: Single-center retrospective chart review. Setting: PICUs at two tertiary children's hospitals. Patients: One hundred thirty-eight patients with traumatic brain injury with postresuscitation Glasgow Coma Scale less than or equal to 8 who received hypertonic saline from September 1, 2010, to February 28, 2016, and intracranial pressure monitoring and survived at least 24 hours from admission. Interventions: None. Measurements and Main Results: We used fluid balance percentage greater than or equal to 10% as our definition of fluid overload. Ninety-one percent of patients less than 1 year old had fluid overload on day 10 of admission compared with 47% of patients greater than 1 year. Fluid overloaded patients did not have increased mortality, acute kidney injury, PICU length of stay, or ventilator days. Hypertonic saline was not the cause of fluid overload in these patients. Conclusions: Patients with severe traumatic brain injury do have high rates of fluid overload. However, fluid overload did not contribute to mortality, longer days on the ventilator, increased risk of acute kidney injury, or increased PICU length of stay.	[Stulce, Casey; Kane, Jason M.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Reisner, Andrew; Williamson, Julie; Walson, Karen; Paden, Matthew] Childrens Healthcare Atlanta, Atlanta, GA USA; [Reisner, Andrew] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Shin, H. Stella; McCracken, Courtney; Williamson, Julie; Paden, Matthew] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA		Stulce, C (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	caseystulce@gmail.com	Shin, Hyunjung/ABC-6063-2021	Stulce, Casey/0000-0003-2551-1539			Alobaidi R, 2018, JAMA PEDIATR, V172, P257, DOI 10.1001/jamapediatrics.2017.4540; Arikan AA, 2012, PEDIATR CRIT CARE ME, V13, P253, DOI 10.1097/PCC.0b013e31822882a3; Basu RK, 2013, PEDIATR CRIT CARE ME, V14, pE218, DOI 10.1097/PCC.0b013e3182772f61; Bhaskar P, 2015, INTENS CARE MED, V41, P1445, DOI 10.1007/s00134-015-3851-9; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Chen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160093; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cortina G, 2019, PEDIATR CRIT CARE ME, V20, P314, DOI 10.1097/PCC.0000000000001806; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; FARGE D, 1995, CHEST, V107, P1095, DOI 10.1378/chest.107.4.1095; Faul M XL, 2010, TRAUMATIC BRAIN INJU; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Fletcher JJ, 2010, J TRAUMA, V68, P1506, DOI 10.1097/TA.0b013e3181dbbf1b; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Gillespie RS, 2004, PEDIATR NEPHROL, V19, P1394, DOI 10.1007/s00467-004-1655-1; Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x; Goldstein SL, 2001, PEDIATRICS, V107, P1309, DOI 10.1542/peds.107.6.1309; Gonda DD, 2013, PEDIATR CRIT CARE ME, V14, P610, DOI 10.1097/PCC.0b013e318291772b; Hassinger AB, 2018, PEDIATR CRIT CARE ME, V19, pE551, DOI 10.1097/PCC.0000000000001685; Hazle MA, 2013, PEDIATR CRIT CARE ME, V14, P44, DOI 10.1097/PCC.0b013e3182712799; HEELEY AM, 1955, AMA AM J DIS CHILD, V90, P251, DOI 10.1001/archpedi.1955.04030010253001; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kaddourah A, 2017, NEW ENGL J MED, V376, P11, DOI 10.1056/NEJMoa1611391; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kutchak FM, 2015, J BRAS PNEUMOL, V41, P358, DOI 10.1590/S1806-37132015000004453; LANE PH, 1994, BONE MARROW TRANSPL, V13, P613; Li YH, 2016, EUR J PEDIATR, V175, P39, DOI 10.1007/s00431-015-2592-7; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Selewski DT, 2018, PEDIATR NEPHROL, V33, P13, DOI 10.1007/s00467-016-3539-6; Sinitsky L, 2015, PEDIATR CRIT CARE ME, V16, P205, DOI 10.1097/PCC.0000000000000318; So TY, 2009, PEDIATRICS, V123, pE1045, DOI 10.1542/peds.2008-1968; Soler YA, 2013, PEDIATR CRIT CARE ME, V14, pE189, DOI 10.1097/PCC.0b013e3182745675; Soni N, 2008, BRIT J ANAESTH, V101, P446, DOI 10.1093/bja/aen240; Teixeira SN, 2015, RESP CARE, V60, P1527, DOI 10.4187/respcare.03915; Upadya A, 2005, INTENS CARE MED, V31, P1643, DOI 10.1007/s00134-005-2801-3; Wells M, 2017, RESUSCITATION, V121, P9, DOI 10.1016/j.resuscitation.2017.09.026; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	43	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2020	21	2					164	169		10.1097/PCC.0000000000002134			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	LH6KK	WOS:000528892100013	31568241				2022-02-06	
J	Tomczyk, CP; Shaver, G; Hunt, TN				Tomczyk, Christopher P.; Shaver, George; Hunt, Tamerah N.			Does Anxiety Affect Neuropsychological Assessment in College Athletes?	JOURNAL OF SPORT REHABILITATION			English	Article						brain concussion; baseline testing; reaction time; state anxiety; trait anxiety	REACTION-TIME; PERFORMANCE; CONCUSSION	Clinical Scenario: Anxiety is a mental disorder that affects a large portion of the population and may be problematic when evaluating brain injuries such as concussion. The reliance of cognitive testing in concussion protocols call for the examination of potential cognitive alterations commonly seen in athletes with anxiety. Focused Clinical Question: Does anxiety affect neuropsychological assessments in healthy college athletes? Summary of Key Findings: Three studies were included: 1 cross-sectional study and 2 prospective cohort studies. One study examined the effect of a range of psychological issues on concussion baseline testing in college athletes. Another study examined the effect of anxiety on reaction time both before and after sport competition in college-aged athletes. The final study examined the effects of psychosocial issues on reaction time during demanding tasks in college athletes. The first study reported slower simple and complex reaction times in athletes with anxiety. The second study found that athletes with high trait anxiety have slower reaction times both before and after competition. The third study reported that demanding tasks led to increased state anxiety which slowed reaction time. Overall, all 3 studies support the adverse effect anxiety can have on cognitive testing in athletes. Clinical Bottom Line: College athletes who present with anxiety at baseline may be susceptible to decreased performance on neuropsychological assessments. Strength of Recommendation: There is level B evidence that anxiety in healthy college athletes can impact neuropsychological assessments, and level C evidence that anxiety at baseline concussion assessment impacts neuropsychological testing in college athletes.	[Tomczyk, Christopher P.] Michigan State Univ, Dept Kinesiol, Sport Injury Res Lab, E Lansing, MI 48824 USA; [Shaver, George] Georgia Southern Univ, Dept Psychol, Regents Ctr Learning Disorders, Statesboro, GA USA; [Hunt, Tamerah N.] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA USA		Tomczyk, CP (corresponding author), Michigan State Univ, Dept Kinesiol, Sport Injury Res Lab, E Lansing, MI 48824 USA.	tomczykc@msu.edu		Tomczyk, Christopher/0000-0003-3790-2385			American College Health Association, 2017, AM COLL HLTH ASS NAT; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Ciucurel MM, 2012, PROCD SOC BEHV, V33, P885, DOI 10.1016/j.sbspro.2012.01.249; Covassin T, 2017, SPORT EXERC PERFORM, V6, P220, DOI 10.1037/spy0000105; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Guest A, 2003, SOCIOL EDUC, V76, P89, DOI 10.2307/3090271; Hixson KM, 2017, J SPORT REHABIL, V26, P588, DOI 10.1123/jsr.2016-0122; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Spielberger C.D., 1966, ANXIETY BEHAV, P3, DOI DOI 10.1016/B978-1-4832-3131-0.50006-8; Weinberg RS, 2015, FDN SPORT EXERCISE P, P75; Williams JM, 1997, BEHAV MED, V22, P160, DOI 10.1080/08964289.1997.10543549	11	1	1	2	8	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	FEB	2020	29	2					238	242		10.1123/jsr.2018-0123			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LX7NN	WOS:000540014200016	31094613	Bronze			2022-02-06	
J	Tunthanathip, T; Phuenpathom, N; Saehaeng, S; Oearsakul, T; Sakarunchai, I; Kaewborisutsakul, A				Tunthanathip, Thara; Phuenpathom, Nakornchai; Saehaeng, Sakchai; Oearsakul, Thakul; Sakarunchai, Ittichai; Kaewborisutsakul, Anukoon			Traumatic cerebrovascular injury: Prevalence and risk factors	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Traumatic cerebrovascular injury; Vascular injury; Traumatic brain injury; Penetrating brain injury	SEVERE HEAD-INJURY; BRAIN-INJURY; CAVERNOUS FISTULA; ARTERIAL INJURIES; CEREBRAL-ARTERY; MANAGEMENT; OCCLUSION; PATTERNS	Background: Traumatic cerebrovascular injury (TCVI) is uncommon in traumatic brain injury (TBI). Although TCVI is a rare condition, this complication is serious. A missed or delayed diagnosis may lead to an unexpected life-threatening hemorrhagic event or persistent neurological deficit. The object of this study was to determine the prevalence and risk factors associated with TCVI. Methods: The authors retrospectively reviewedmedical records and neuroimaging studies of 5178 patients with TBI. The association of various factors was investigated using time-to-event statistical analysis. A TCVI which resulted in an occlusion, arteriovenous fistula, pseudoaneurysm or cerebral artery transection was defined as an event. Results: Forty-two patients developed a TCVI after injuries with an overall prevalence of 0.8%. The risk factors for an intracranial arterial injury based on univariate analysis using the Cox proportional hazard regression were penetrating injury, severe head injury, orbitofacial injury, basilar skull fracture, subdural hematoma, and cerebral contusion. Inmultivariable analysis, the two variables that were independently associated with TCVI were basilar skull fracture (odds ratio [OR] 22.1, 95% confidence interval [CI] 11.5-42.2) followed by orbitofacial fracture (OR 13.6, 95% CI 6.8-27.3). Conclusions: Although TCVI is a rare complication of TBI, early investigation in high-risk patients may be necessary for early treatment before an unexpected fatal event occurs. (C) 2019 Elsevier Inc. All rights reserved.	[Tunthanathip, Thara; Phuenpathom, Nakornchai; Saehaeng, Sakchai; Oearsakul, Thakul; Sakarunchai, Ittichai; Kaewborisutsakul, Anukoon] Prince Songkla Univ, Dept Surg, Neurosurg Unit, Fac Med, Hat Yai 90110, Songkhla, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Dept Surg, Neurosurg Unit, Fac Med, Hat Yai 90110, Songkhla, Thailand.	tthara@medicine.psu.ac.th		Tunthanathip, Thara/0000-0002-6303-836X	Targeted Research Gants, Faculty of Medicine, Prince of Songkla University	Targeted Research Gants, Faculty of Medicine, Prince of Songkla University.	Aarabi Bizhan, 2001, Journal of Trauma Injury Infection and Critical Care, V51, pS1; Atar E, 2005, EMERG RADIOL, V11, P291, DOI 10.1007/s10140-004-0380-1; Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Cohen JE, 2005, SURG NEUROL, V64, P331, DOI 10.1016/j.surneu.2004.11.029; Craig J, 2015, AM J RHINOL ALLERGY, V29, P211, DOI 10.2500/ajra.2015.29.4160; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; GUHA A, 1989, CAN J NEUROL SCI, V16, P81, DOI 10.1017/S0317167100028560; Ishibashi Akira, 1995, Neurologia Medico-Chirurgica, V35, P882, DOI 10.2176/nmc.35.882; Kelly K, 2009, HEAD NECK-J SCI SPEC, V31, P1520, DOI 10.1002/hed.21032; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kobata H, 2017, NEUROL MED-CHIR, V57, P410, DOI 10.2176/nmc.oa.2017-0056; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lee TS, 2014, CRANIOMAX TRAUM REC, V7, P175, DOI 10.1055/s-0034-1372521; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Martin S, 2013, INT J SURG CASE REP, V4, P858, DOI 10.1016/j.ijscr.2013.07.002; Meaney DF, 2011, YOUMANS NEUROLOGICAL, P3277; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MENON G, 2018, CUREUS, V10, DOI DOI 10.7759/CUREUS; Miley Jefferson T, 2008, J Vasc Interv Neurol, V1, P79; Miyata Masaru, 1994, Neurological Surgery, V22, P253; Moosbrugger C., 2002, ATLAS STRESS STRAIN; Mundinger GS, 2013, J ORAL MAXIL SURG, V71, P2092, DOI 10.1016/j.joms.2013.07.005; Nakamura H, 2017, ACUTE MED SURG, V4, P131, DOI 10.1002/ams2.239; Onda H, 2013, NEUROL MED-CHIR, V53, P573; Paiva WS, 2013, WORLD J RADIOL, V5, P226, DOI 10.4329/wjr.v5.i5.226; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; Radvany Martin G, 2010, Semin Intervent Radiol, V27, P44, DOI 10.1055/s-0030-1247888; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Song Seung-Yoon, 2016, J Cerebrovasc Endovasc Neurosurg, V18, P253, DOI 10.7461/jcen.2016.18.3.253; Sun GH, 2011, OTOL NEUROTOL, V32, P882, DOI 10.1097/MAO.0b013e318218cfd6; Nguyen T, 2013, J CRANIOFAC SURG, V24, pE237, DOI 10.1097/SCS.0b013e31828609ee; Tunthanathip T, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18311; Tunthanathip T, 2017, J NEUROSCI RURAL PRA, V8, P601, DOI 10.4103/jnrp.jnrp_381_17; Van Rooij WJ, 2013, INTERV NEURORADIOL, V19, P56, DOI 10.1177/159101991301900108	38	1	2	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2020	38	2					182	186		10.1016/j.ajem.2019.01.055			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LR6PF	WOS:000535813900004	30737001				2022-02-06	
J	West, R; Silverman, MJ				West, Rebecca; Silverman, Michael J.			A music therapy feasibility study with adults on a hospital neuroscience unit: Investigating service user technique choices and immediate effects on mood and pain	ARTS IN PSYCHOTHERAPY			English	Article						Neuroscience; Music therapy; Techniques; Choice; Mood; Pain	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PROGRAM; ANXIETY; CANCER; PREFERENCES; RELAXATION; PREVALENCE; PERCEPTION; DEPRESSION	The purpose of this investigation was to study the frequency of service user MT technique choices and their resultant effects on mood and pain in adults receiving music therapy (MT) offered for the first time on a neuroscience unit. Participants (N = 29) self-selected into one of three pre-determined single-session techniques: 1) Listening to preferred music delivered live (receptive MT); 2) A guided relaxation script with pre-recorded music (guided relaxation); or 3) Playing instruments to preferred music delivered live (active MT) and completed mood and pain scales at pre- and posttest. Most participants selected receptive MT (n = 16, 55%), followed by guided relaxation (n = 11, 38%) and active MT (n = 2, 7%). Although no significant within- or between-group difference in mood or pain was found, most techniques tended to slightly improve mood and pain from pre- to posttest. Despite the temporal parameters of a single treatment session, MT tended to have positive impacts on mood and pain from pre- to posttest. Implications for clinical practice, limitations, and suggestions for future research are provided.	[West, Rebecca; Silverman, Michael J.] Univ Minnesota, Sch Mus, 2106 S 4thSt, Minneapolis, MN 55104 USA		West, R (corresponding author), Univ Minnesota, Sch Mus, 2106 S 4thSt, Minneapolis, MN 55104 USA.	westx489@umn.edu; silvermj@umn.edu					Ali E, 2010, EUR J NEUROL, V17, pe28, DOI 10.1111/j.1468-1331.2009.02901.x; American Music Therapy Association, 2019, 2018 AMTA MEMB SURV; Baker F, 2005, BRAIN INJURY, V19, P519, DOI 10.1080/02699050400005150; Burns DS, 2005, J MUSIC THER, V42, P185, DOI 10.1093/jmt/42.3.185; Chaput-McGovern J, 2012, ART PSYCHOTHER, V39, P417, DOI 10.1016/j.aip.2012.06.008; Crawford I, 2013, ART PSYCHOTHER, V40, P224, DOI 10.1016/j.aip.2013.02.005; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Douglas MR, 2011, CLIN MED, V11, P215, DOI 10.7861/clinmedicine.11-3-215; Draper K., 2016, VOICES WORLD FORUM M, V16, P1, DOI [10.15845/voices.v16i1.789, DOI 10.15845/VOICES.V16I1.789]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Jasemi M, 2016, INDIAN J PALLIAT CAR, V22, P455, DOI 10.4103/0973-1075.191823; Jeong SH, 2007, APPL NURS RES, V20, P125, DOI 10.1016/j.apnr.2007.04.005; Kanner AM, 2012, EPILEPSY BEHAV, V24, P169, DOI 10.1016/j.yebeh.2012.01.008; Kim DS, 2011, YONSEI MED J, V52, P977, DOI 10.3349/ymj.2011.52.6.977; Kim S, 2018, ART PSYCHOTHER, V60, P48, DOI 10.1016/j.aip.2018.06.002; Krebs EE, 2007, J GEN INTERN MED, V22, P1453, DOI 10.1007/s11606-007-0321-2; Kwan M, 2013, PROG PALLIAT CARE, V21, P151, DOI 10.1179/1743291X12Y.0000000042; Lee JH, 2016, J MUSIC THER, V53, P430, DOI 10.1093/jmt/thw012; Li XM, 2012, J ADV NURS, V68, P1145, DOI 10.1111/j.1365-2648.2011.05824.x; Lundy-Elcman L., 2007, NEUROSCIENCE FUNDAME, DOI [10.1037/pmu0000123, DOI 10.1037/PMU0000123]; Madson AT, 2010, J MUSIC THER, V47, P220, DOI 10.1093/jmt/47.3.220; Magee WL, 2018, NEUROPSYCHOL REHABIL, V28, P1331, DOI 10.1080/09602011.2018.1494003; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; Magee WL, 2015, ANN NY ACAD SCI, V1337, P256, DOI 10.1111/nyas.12633; Mondanaro John F, 2017, Am J Orthop (Belle Mead NJ), V46, pE13; Mondanaro JF, 2008, MUSIC THER PERSPECT, V26, P102, DOI 10.1093/mtp/26.2.102; Montori VM, 2013, JAMA-J AM MED ASSOC, V310, P2503, DOI 10.1001/jama.2013.281422; Naess H, 2010, J NEUROL, V257, P1446, DOI 10.1007/s00415-010-5539-y; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Pfeiffer C., 2015, PSYCHOMUSICOLOGY, V25, P392; Pocwierz-Marciniak I, 2017, HEALTH PSYCHOL REP, V5, P173, DOI 10.5114/hpr.2017.63936; Pool J, 2013, THESIS; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Raglio A, 2014, EPILEPSY BEHAV, V31, P7, DOI 10.1016/j.yebeh.2013.10.008; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Siegel A., 2019, ESSENTIAL NEUROSCIEN; Silverman MJ, 2016, ART PSYCHOTHER, V49, P1, DOI 10.1016/j.aip.2016.05.004; Simavli S, 2014, J AFFECT DISORDERS, V156, P194, DOI 10.1016/j.jad.2013.12.027; Spring B, 2007, J CLIN PSYCHOL, V63, P611, DOI 10.1002/jclp.20373; Street AJ, 2018, CLIN REHABIL, V32, P18, DOI 10.1177/0269215517717060; Tamplin Jeanette, 2014, Top Spinal Cord Inj Rehabil, V20, P236, DOI 10.1310/sci2003-236; Tamplin J, 2013, ARCH PHYS MED REHAB, V94, P426, DOI 10.1016/j.apmr.2012.10.006; Thaut M. H., 2014, CURR PHYS MED REHABI, V2, P106, DOI [10.1007/s40141-014-0049-y, DOI 10.1007/S40141-014-0049-Y]; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Tomaino CM, 2012, ANN NY ACAD SCI, V1252, P312, DOI 10.1111/j.1749-6632.2012.06451.x; Whitall J, 2013, MUSIC THER PERSPECT, V31, P40, DOI 10.1093/mtp/31.1.40; Woodruffe-Peacock C, 1998, HUM PSYCHOPHARM CLIN, V13, P53, DOI 10.1002/(SICI)1099-1077(199801)13:1<53::AID-HUP955>3.0.CO;2-S; Yoo J, 2009, MUSIC THER PERSPECT, V27, P16, DOI 10.1093/mtp/27.1.16	48	1	1	3	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	FEB	2020	67								101585	10.1016/j.aip.2019.101585			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	KR0ZY	WOS:000517350300005					2022-02-06	
J	Willems, SA; Kranenburg, FJ; Le Cessie, S; Marang-van de Mheen, PJ; Kesecioglu, J; van der Bom, JG; Arbous, MS				Willems, S. A.; Kranenburg, F. J.; Le Cessie, S.; Marang-van de Mheen, P. J.; Kesecioglu, J.; van der Bom, J. G.; Arbous, M. S.			Variation in red cell transfusion practice in the intensive care unit - An international survey	JOURNAL OF CRITICAL CARE			English	Article						Intensive care; Critical care; Decision-making; Red blood cell; Transfusion; Survey	CRITICALLY-ILL; BLOOD-TRANSFUSION; CLINICAL-PRACTICE; ANEMIA; GUIDELINES	Purpose: Unclear recommendations in transfusion guidelines may possibly lead to inconsistency in treatment of patients admitted to the intensive care unit. This study aimed to uncover variation in red blood cell (RBC) transfusion decisions in the ICU worldwide. Methods: Members of the European Society of Intensive Care Medicine (ESICM) were requested to complete an online questionnaire which included four different hypothetical clinical scenarios. The scenarios represented patients with acute myocardial infarction (AMI), abdominal sepsis, traumatic brain injury (TBI) and post-surgical complications. Hemoglobin level was 7.3 g/dL in all scenarios. The questionnaire explored the physicians' transfusion decision in each clinical scenario and identified patient characteristics that were most influential in the transfusion decision. Results: In total 211 members participated in the study, of whom 142 (67%) completed the entire survey. Most variation was observed in the clinical scenario of sepsis, in which 49% decided to transfuse and 51% decided not to. In the clinical scenarios of AMI, TBI and post-surgical complications this was respectively; 75/25%, 35/65% and 66/34%. Conclusions: Critical care physicians differed in outcome of RBC transfusion decisions and weighed patient characteristics differently. These findings indicate that variation in transfusion practice amongst critical care physicians exists. (C) 2019 Elsevier Inc. All rights reserved.	[Willems, S. A.; Kranenburg, F. J.; van der Bom, J. G.] Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands; [Willems, S. A.; Kranenburg, F. J.; Arbous, M. S.] Leiden Univ, Dept Intens Care Med, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [Willems, S. A.; Kranenburg, F. J.; Le Cessie, S.; van der Bom, J. G.; Arbous, M. S.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Le Cessie, S.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Marang-van de Mheen, P. J.] Leiden Univ, Dept Med Decis Making, Med Ctr, Leiden, Netherlands; [Kesecioglu, J.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands		Arbous, MS (corresponding author), Leiden Univ, Dept Intens Care Med, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	m.s.arbous@lumc.nl	Arbous, Sesmu/ABI-1083-2020				Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; Delaney M, 2016, LANCET, V388, P2825, DOI 10.1016/S0140-6736(15)01313-6; Hebert PC, 1998, CRIT CARE MED, V26, P482, DOI 10.1097/00003246-199803000-00019; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holbrook A, CAUSES CONSEQUENCES; Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354; Kranenburg FJ, 2018, VOX SANG, V113, P378, DOI 10.1111/vox.12639; Pape A, 2009, BLOOD TRANSFUS-ITALY, V7, P250, DOI 10.2450/2008.0072-08; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Sakr Y, 2015, INTENS CARE MED, V41, P1973, DOI 10.1007/s00134-015-3950-7; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Vincent JL, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2018-9; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499	15	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2020	55						140	144		10.1016/j.jcrc.2019.10.003			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JV8IS	WOS:000502604200021	31715532				2022-02-06	
J	Yun, R; Sciubba, DM; Lewin, JJ; Streiff, MB; Haut, ER; Lau, BD; Shermock, KM; Kraus, PS; Popoola, VO; Dalpoas, SE				Yun, Regina; Sciubba, Daniel M.; Lewin, John J.; Streiff, Michael B.; Haut, Elliott R.; Lau, Brandyn D.; Shermock, Kenneth M.; Kraus, Peggy S.; Popoola, Victor O.; Dalpoas, Stacy Elder			Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism	WORLD NEUROSURGERY			English	Article						Heparin; Neurosurgery; Perioperative; Venous thromboembolism; VTE algorithm; VTE prophylaxis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; MOLECULAR-WEIGHT; PREVENTION; RISK; HEPARIN; COMPLICATIONS; POPULATION; SURGERY	BACKGROUND: Venous thromboembolism (VTE) is a cause of considerable morbidity and mortality in hospitalized patients. An evidence-based algorithm was developed and implemented at our institution to guide perioperative VTE prophylaxis management. OBJECTIVE: We evaluated compliance with prescription of risk-appropriate VTE prophylaxis and administration of prescribed VTE prophylaxis in neurosurgery patients. METHODS: This was a retrospective analysis of postoperative neurosurgery patients at a single institution with subsequent diagnosis of acute VTE during their inpatient stay. Descriptive statistics were used to characterize pharmacologic VTE prophylaxis and prescribing patterns. RESULTS: The incidence of VTE in our neurosurgery population was 248/13,913 (1.8%). Of the 123 patients, the median time to VTE diagnosis was 96 hours after surgery (interquartile range [IQR], 58-188 hours). A total of 108 patients (87.8%) were prescribed risk-appropriate VTE prophylaxis, among whom 61 (56.5%) received all doses as prescribed. Fifty-three patients (43.1%) missed >= 1 dose of prescribed prophylaxis and the median missed doses was 3 (IQR, 0-3). The median time to first dose of pharmacologic VTE prophylaxis was 42 hours (IQR, 28-51). More than half (n = 63, 51.2%) of the VTE risk assessments contained >= 1 error, of which 15 (23.8%) would have resulted in a change in recommendation. CONCLUSIONS: Our evidence-based VTE prophylaxis algorithm was not accurately completed in more than half of patients. Many patients who developed VTE had a defect in their VTE prophylaxis management during their inpatient stay. Research to improve optimal VTE prevention practice in neurosurgery patients is needed.	[Yun, Regina; Lewin, John J.; Shermock, Kenneth M.; Kraus, Peggy S.; Dalpoas, Stacy Elder] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Sciubba, Daniel M.] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD USA; [Streiff, Michael B.; Haut, Elliott R.; Lau, Brandyn D.; Shermock, Kenneth M.; Kraus, Peggy S.; Popoola, Victor O.] Johns Hopkins Univ, Sch Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Surg, Div Acute Care Surg, Baltimore, MD 21205 USA; [Lewin, John J.; Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Lau, Brandyn D.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Lau, Brandyn D.] Johns Hopkins Univ, Sch Med, Div Hlth Sci Informat, Baltimore, MD USA; [Haut, Elliott R.; Lau, Brandyn D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA		Dalpoas, SE (corresponding author), Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA.	selder5@jhmi.edu		Haut, Elliott/0000-0001-7075-771X; Lewin, John/0000-0002-5480-726X	Patient-Centered Outcomes Research Institute entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology [CE-12-11-4489]; "Preventing Venous Thromboembolism (VTE): Engaging Patients to Reduce Preventable Harm from Missed/Refused Doses of VTE Prophylaxis" [DI-1603-34596]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R01HS024547]; National Institutes of Health National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R21HL129028, PCS-1511-32745]	E.R.H is/was primary investigator of contracts from Patient-Centered Outcomes Research Institute entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology" (CE-12-11-4489) and "Preventing Venous Thromboembolism (VTE): Engaging Patients to Reduce Preventable Harm from Missed/Refused Doses of VTE Prophylaxis" (DI-1603-34596); primary investigator of a grant from the Agency for Healthcare Research and Quality (1R01HS024547) entitled "Individualized Performance Feedback on Venous Thromboembolism Prevention Practice"; co-investigator on a grant from the National Institutes of Health National Heart, Lung, and Blood Institute (R21HL129028) entitled "Analysis of the Impact of Missed Doses of Venous Thromboembolism Prophylaxis"; he is supported by a contract from The PatientCentered Outcomes Research Institute "A Randomized Pragmatic Trial Comparing the Complications and Safety of Blood Clot Prevention Medicines Used in Orthopedic Trauma Patients" (PCS-1511-32745); he receives royalties from Lippincott Williams & Wilkins for the book Avoiding Common ICU Errors. He was the paid author of a paper commissioned by the National Academies of Medicine entitled "Military Trauma Care's Learning Health System: The Importance of Data Driven Decision Making," which was used to support the report titled "A National Trauma Care System: Integrating Military and Civilian Trauma Systems to Achieve Zero Preventable Deaths After Injury." Results presented in part at Society of Critical Care Medicine Annual Conference 2017, Honolulu, Hawaii, January 24, 2017 (Snapshot Platform Presentation).	ANGELI G, 1998, NEW ENGL J MED, V339, P80; Brandes AA, 1997, EUR J CANCER, V33, P1592, DOI 10.1016/S0959-8049(97)00167-6; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Cage TA, 2009, J NEURO-ONCOL, V93, P151, DOI 10.1007/s11060-009-9886-4; Collen JF, 2008, CHEST, V134, P237, DOI 10.1378/chest.08-0023; Couldwell WT., 2004, NEUROSURG FOCUS, V17, P1, DOI [10.3171/foc.2004.17.4.1, DOI 10.3171/F0C.2004.17.4.1]; DePasse JM, 2015, WORLD J ORTHOP, V6, P351, DOI 10.5312/wjo.v6.i3.351; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Elder S, 2016, J PATIENT SAF, V12, P63, DOI 10.1097/PTS.0000000000000086; Freeman AL, 2010, EXPERT REV CARDIOVAS, V8, P1711, DOI 10.1586/ERC.10.160; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Haut ER, 2015, JAMA SURG, V150, P912, DOI 10.1001/jamasurg.2015.1340; Haut ER, 2012, ARCH SURG-CHICAGO, V147, P901, DOI 10.1001/archsurg.2012.2024; Imberti D, 2009, THROMB RES, V124, P667, DOI [10.1016/j.thromres.2009.08.006, 10.1016/j.thromres.2009.04.021]; Iorio A, 2000, ARCH INTERN MED, V160, P2327, DOI 10.1001/archinte.160.15.2327; Kim JYS, 2015, JAMA SURG, V150, P110, DOI 10.1001/jamasurg.2014.1841; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kwee MM, 2015, INT SURG, V100, P292, DOI 10.9738/INTSURG-D-13-00256.1; Lau BD, 2018, CIRCULATION, V137, P1278, DOI 10.1161/CIRCULATIONAHA.116.026897; Lau BD, 2016, J SURG RES, V205, P179, DOI 10.1016/j.jss.2016.06.024; Lau BD, 2016, AM J MED QUAL, V31, P448, DOI 10.1177/1062860615583547; Lau BD, 2015, JAMA SURG, V150, P813, DOI 10.1001/jamasurg.2015.0891; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Shermock KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066311; Smith TR, 2015, J CLIN NEUROSCI, V22, P519, DOI 10.1016/j.jocn.2014.10.003; Sogaard KK, 2014, CIRCULATION, V130, P829, DOI 10.1161/CIRCULATIONAHA.114.009107; Stein PD, 2006, AM J MED, V119, P60, DOI 10.1016/j.amjmed.2005.06.058; STREIFF MB, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E3935; Streiff MB, 2016, J HOSP MED, V11, pS8, DOI 10.1002/jhm.2657; Sweetland S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4583; Tsuda Y, 2013, J ORTHOP SCI, V18, P613, DOI 10.1007/s00776-013-0401-6; Walsh D C, 2001, Curr Opin Pulm Med, V7, P326, DOI 10.1097/00063198-200109000-00013; Wang Chih-Ping, 2016, Taiwan J Ophthalmol, V6, P96, DOI 10.1016/j.tjo.2015.05.002; Zeidan AM, 2013, AM J HEMATOL, V88, P545, DOI 10.1002/ajh.23450	35	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2020	134						E664	E671		10.1016/j.wneu.2019.10.163			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK6VS	WOS:000512878200082	31698120				2022-02-06	
J	Zarchi, TB				Zarchi, Tova B.			Intent of health care providers to adopt a clinical decision support tool in the management of minor pediatric head injuries	JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS			English	Article						Clinical decision support; head CT scan; PECARN; pediatric head injury	COMPUTED-TOMOGRAPHY USE; TRAUMATIC BRAIN-INJURY; CHILDREN	Background: Radiographic neuroimaging in minor pediatric head injuries contains risks of radiation-induced malignancy. The Pediatric Emergency Care Applied Research Network (PECARN) head injury protocol identifies head-injured children who are at very low risk of clinically important traumatic brain injuries and can safely not receive a head computed tomography (CT) scan. Local problem: The identified urgent care facility had no facility-wide protocol to manage head injuries. Methods: The purpose of the evidence-based practice project was to educate health care providers on the risks of indiscriminate head CT prescription and the utility of the PECARN head injury protocol in the management of minor pediatric head injuries. Interventions: A knowledge assessment was conducted using pre- and posttests and the likelihood to adopt the PECARN head injury protocol in clinical practice was evaluated using the Evidence-Based Practice Attitude Scale. Additionally, rates of head CT scans ordered that were inappropriate according to the PECARN head injury protocol were calculated postproject and compared with preproject rates. Results: Data analysis was performed using descriptive statistics. Findings included increase in provider knowledge on the use of the PECARN head injury protocol and high likelihood of intent to adopt the PECARN head injury protocol in clinical practice. In addition, rates of head CT prescription postproject were lower than preproject rates, and 82.61% of CT scans ordered postproject were appropriate according to the PECARN head injury protocol. Conclusions: Using the PECARN head injury protocol was associated with consistency of care, reduced unnecessary health care resource utilization, and health care costs.	[Zarchi, Tova B.] St Pauls Sch Nursing, Staten Isl, NY USA		Zarchi, TB (corresponding author), St Pauls Sch Nursing, 742 Montgomery St B8, Brooklyn, NY 11213 USA.	tovazarchi@gmail.com					Aarons G.A., 2004, MENT HLTH SERV RES, V6, P61, DOI [10.1023/b:mhsr.0000024351.12294.65, DOI 10.1023/B:MHSR.0000024351.12294.65]; Bean JR, 2016, WORLD NEUROSURG, V91, P618, DOI 10.1016/j.wneu.2016.03.069; Blackmore CC, 2011, J AM COLL RADIOL, V8, P19, DOI 10.1016/j.jacr.2010.07.009; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Gokharman FD, 2017, TURK J MED SCI, V47, P1770, DOI 10.3906/sag-1703-206; Gupta A, 2014, J AM MED INFORM ASSN, V21, pE347, DOI 10.1136/amiajnl-2013-002536; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Ip IK, 2015, AM J EMERG MED, V33, P320, DOI 10.1016/j.ajem.2014.11.005; Kirkham FJ, 2016, HAND CLINIC, V136, P1275, DOI 10.1016/B978-0-444-53486-6.00065-X; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Miglioretti DL, 2011, AM FAM PHYSICIAN, V83, P1252; Parma C, 2014, AM SURGEON, V80, P664; Parri N, 2013, J EMERG MED, V44, P135, DOI 10.1016/j.jemermed.2012.02.038; Rogers E., 1995, DIFFUSION INNOVATION, V4th edn.; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stevens KR, 2012, STAR MODEL EBP KNOWL; Thomas M, 2008, PROJ MANAG J, V39, P105, DOI 10.1002/pmj.20079	22	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2327-6886	2327-6924		J AM ASSOC NURSE PRA	J. Am. Assoc. Nurs. Pract.	FEB	2020	32	2					168	175		10.1097/JXX.0000000000000208			8	Health Care Sciences & Services; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Nursing	LE4AF	WOS:000526661200011	30951010				2022-02-06	
J	Mocciaro, E; Grant, A; Esenaliev, RO; Petrov, IY; Petrov, Y; Sell, SL; Hausser, NL; Guptarak, J; Bishop, E; Parsley, MA; Bolding, IJ; Johnson, KM; Lidstone, M; Prough, DS; Micci, MA				Mocciaro, Emanuele; Grant, Auston; Esenaliev, Rinat O.; Petrov, Irene Y.; Petrov, Yuriy; Sell, Stacy L.; Hausser, Nicole L.; Guptarak, Jutatip; Bishop, Elizabeth; Parsley, Margaret A.; Bolding, Ian J.; Johnson, Kathia M.; Lidstone, Maxwell; Prough, Donald S.; Micci, Maria-Adelaide			Non-Invasive Transcranial Nano-Pulsed Laser Therapy Ameliorates Cognitive Function and Prevents Aberrant Migration of Neural Progenitor Cells in the Hippocampus of Rats Subjected to Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; hippocampus; neuronal progenitors; optoacoustic laser therapy; TBI	EMITTING DIODE THERAPY; STEM-CELLS; BLOOD OXYGENATION; NEUROGENESIS; NEURONS; PHOTOBIOMODULATION; EPILEPSY; MODEL	Traumatic brain injury (TBI) can lead to chronic diseases, including neurodegenerative disorders and epilepsy. The hippocampus, one of the most affected brain region after TBI, plays a critical role in learning and memory and is one of the only two regions in the brain in which new neurons are generated throughout life from neural stem cells (NSC) in the dentate gyrus (DG). These cells migrate into the granular layer where they integrate into the hippocampus circuitry. While increased proliferation of NSC in the hippocampus is known to occur shortly after injury, reduced neuronal maturation and aberrant migration of progenitor cells in the hilus contribute to cognitive and neurological dysfunctions, including epilepsy. Here, we tested the ability of a novel, proprietary non-invasive nano-pulsed laser therapy (NPLT), that combines near-infrared laser light (808 nm) and laser-generated, low-energy optoacoustic waves, to mitigate TBI-driven impairments in neurogenesis and cognitive function in the rat fluid percussion injury model. We show that injured rats treated with NPLT performed significantly better in a hippocampus-dependent cognitive test than did sham rats. In the DG, NPLT significantly decreased TBI-dependent impaired maturation and aberrant migration of neural progenitors, while preventing TBI-induced upregulation of specific microRNAs (miRNAs) in NSC. NPLT did not significantly reduce TBI-induced microglia activation in the hippocampus. Our data strongly suggest that NPLT has the potential to be an effective therapeutic tool for the treatment of TBI-induced cognitive dysfunction and dysregulation of neurogenesis, and point to modulation of miRNAs as a possible mechanism mediating its neuroprotective effects.	[Mocciaro, Emanuele; Grant, Auston; Sell, Stacy L.; Hausser, Nicole L.; Guptarak, Jutatip; Bishop, Elizabeth; Parsley, Margaret A.; Bolding, Ian J.; Johnson, Kathia M.; Prough, Donald S.; Micci, Maria-Adelaide] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Esenaliev, Rinat O.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Esenaliev, Rinat O.; Petrov, Irene Y.; Petrov, Yuriy] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Lidstone, Maxwell] Univ Texas Austin, Coll Nat Sci, Austin, TX 78712 USA		Micci, MA (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	mmicci@utmb.edu		Mocciaro, Emanuele/0000-0002-4287-8933	Moody Project for Translational Traumatic Brain Injury Research	These studies were completed as part of an interdisciplinary research team funded by the Moody Project for Translational Traumatic Brain Injury Research.	Bergstrom T, 2012, UPSALA J MED SCI, V117, P132, DOI 10.3109/03009734.2012.665096; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Chandel S, 2016, REV NEUROSCIENCE, V27, P329, DOI 10.1515/revneuro-2015-0050; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Englander Jeffrey, 2014, Arch Phys Med Rehabil, V95, P1223, DOI 10.1016/j.apmr.2013.06.002; Esenaliev RO, 2018, J NEUROTRAUM, V35, P1510, DOI 10.1089/neu.2017.5249; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Huijgen J, 2015, REV NEUROL-FRANCE, V171, P204, DOI 10.1016/j.neurol.2015.01.557; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jessberger S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020677; Karmacharya MB, 2015, NEUROPATH APPL NEURO, V41, pe80, DOI 10.1111/nan.12182; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Petrov IY, 2012, OPT EXPRESS, V20, P4159, DOI 10.1364/OE.20.004159; Petrov YY, 2005, ANESTHESIOLOGY, V102, P69, DOI 10.1097/00000542-200501000-00014; Pons-Espinal M, 2017, STEM CELL REP, V8, P1046, DOI 10.1016/j.stemcr.2017.02.012; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rocha JG, 2018, MED DEVICES-EVID RES, V11, P139, DOI 10.2147/MDER.S155356; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; ROSENCWAIG A, 1982, CLIN CHEM, V28, P1878; Sato K, 2015, GLIA, V63, P1394, DOI 10.1002/glia.22858; Schumann CM, 2005, J COMP NEUROL, V491, P320, DOI 10.1002/cne.20704; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Shapiro LA, 2017, CELL TRANSPLANT, V26, P1314, DOI 10.1177/0963689717714099; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Su WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15916-2; Takahata Keisuke, 2016, Brain Nerve, V68, P849, DOI 10.11477/mf.1416200517; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Uski J, 2018, NEUROLOGY, V91, pE878, DOI 10.1212/WNL.0000000000006077; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vivar C, 2015, CURR TOP MED CHEM, V15, P2175, DOI 10.2174/1568026615666150610141524; Wakabayashi T, 2014, ADV GENET, V86, P27, DOI 10.1016/B978-0-12-800222-3.00002-4; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wohlgehagen E., 2015, MOD RES INFLAMM, V4, P9, DOI DOI 10.4236/MRI.2015.42002; Yang F., 2009, J NEUROSCI RES, V88; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	60	1	1	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1108	1123		10.1089/neu.2019.6534		JAN 2020	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000510742800001	31856661				2022-02-06	
J	Orlando, A; Rubin, B; Panchal, R; Tanner, A; Hudson, J; Harken, K; Madayag, R; Berg, G; Bar-Or, D				Orlando, Alessandro; Rubin, Benjamin; Panchal, Ripul; Tanner, Allen, II; Hudson, John; Harken, Kyle; Madayag, Robert; Berg, Gina; Bar-Or, David			In Patients Over 50 Years, Increased Age Is Associated With Decreased Odds of Documented Loss of Consciousness After a Concussion	FRONTIERS IN NEUROLOGY			English	Article						concussion; loss of consciousness; age; mild; traumatic brain injury; national trauma data bank		Background: Advanced aged adults have the highest rate of traumatic brain injury (TBI) related hospital admissions, compared to younger age groups. Data were published in 2014 indicating differential injury and neurological responses to a TBI by age categories. In a recent article examining patients with mTBI and isolated subdural hematoma, it was found that older patients had a decreased risk of documented loss of consciousness (LOC). The primary objective was to determine the extent to which the odds of documented LOC changes with increasing age in a population of older adults suffering an isolated concussion and uncomplicated mTBI. Methods: This was a retrospective study utilizing 6 years (2010-2015) of National Trauma Data Bank data. This study included patients with (1) diagnosis of concussion; (2) positive or negative loss of consciousness; (3) loss of consciousness durations no longer than 59 min or undefined; (4) age >= 50 years; (5) had a "fall" mechanism of injury; and (6) a valid emergency department Glasgow coma scale 13-15. We excluded patients (1) with any intracranial hemorrhage or intracranial injury of other and unspecified nature; (2) skull fracture; (3) an injury severity scale score >17; (4) a concussion with "unspecified" LOC (ICD-9: 850.9). Results: There were 7,466 patients included in the study; the median (IQR) age was 70 (60-80) years. The risk of documented LOC was 71% (n = 5,319). An 80-year-old had 72% decreased odds of having a documented LOC, compared to a 50-year-old (OR = 0.28, 99.5%CI [0.23-0.34], P < 0.001). This association held when controlling for multiple demographic, comorbid, and clinical variables, and in sensitivity analyses. Conclusion: These nationwide data suggest that in patients aged >= 50 years, a significant inverse association exists between age and odds of documented LOC after sustaining a fall-related concussion. Additional studies are needed to validate these findings and to investigate the triad of age, documented LOC, and intracranial hemorrhage. Clinical diagnostic criteria relying on LOC might be at risk of being modified by the association between increasing age and decreasing odds of LOC.	[Orlando, Alessandro; Bar-Or, David] Swedish Med Ctr, Dept Trauma Res, Englewood, CO 80110 USA; [Orlando, Alessandro; Tanner, Allen, II; Bar-Or, David] Penrose Community Hosp, Dept Trauma Res, Colorado Springs, CO 80907 USA; [Orlando, Alessandro; Bar-Or, David] Med City Plano, Dept Trauma Res, Plano, TX 75075 USA; [Orlando, Alessandro; Bar-Or, David] St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA; [Orlando, Alessandro; Harken, Kyle; Bar-Or, David] Res Med Ctr, Dept Trauma Res, Kansas City, MO 64132 USA; [Orlando, Alessandro; Berg, Gina; Bar-Or, David] Wesley Med Ctr, Dept Trauma Res, Wichita, KS 67214 USA; [Rubin, Benjamin] Swedish Med Ctr, Dept Neurosurg, Englewood, CO 80110 USA; [Panchal, Ripul] Med City Plano, Dept Neurosurg, Plano, TX USA; [Hudson, John] St Anthony Hosp, Dept Neurosurg, Lakewood, CO USA; [Madayag, Robert] St Anthony Hosp, Dept Trauma Serv, Lakewood, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Dept Trauma Res, Englewood, CO 80110 USA.; Bar-Or, D (corresponding author), Penrose Community Hosp, Dept Trauma Res, Colorado Springs, CO 80907 USA.; Bar-Or, D (corresponding author), Med City Plano, Dept Trauma Res, Plano, TX 75075 USA.; Bar-Or, D (corresponding author), St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA.; Bar-Or, D (corresponding author), Res Med Ctr, Dept Trauma Res, Kansas City, MO 64132 USA.; Bar-Or, D (corresponding author), Wesley Med Ctr, Dept Trauma Res, Wichita, KS 67214 USA.	davidbme49@gmail.com			Swedish Medical Center; St. Anthony Hospital; Medical City Plano; Penrose-St. Francis Hospital; Research Medical Center; Wesley Medical Center	We would like to thank the following hospitals for supporting this open access publication: Swedish Medical Center, St. Anthony Hospital, Medical City Plano, Penrose-St. Francis Hospital, Research Medical Center, andWesley Medical Center.	Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Census Bureau US, 2018, OLD PEOPL PROJ OUTN; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; GRANT R, 1987, MAGN RESON IMAGING, V5, P465, DOI 10.1016/0730-725X(87)90380-8; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Orlando A, 2019, J NEUROSURG, V130, P1616, DOI 10.3171/2018.1.JNS171884; Pedersen SH, 2018, WORLD NEUROSURG, V110, pE119, DOI 10.1016/j.wneu.2017.10.086; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Teasdale G M, 1988, Acta Neurochir Suppl (Wien), V42, P230; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	25	1	1	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 31	2020	11								39	10.3389/fneur.2020.00039			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QD2JQ	WOS:000615351800001	32082248	Green Published, gold			2022-02-06	
J	Li, YQ; Wang, JC; Li, ZH; Cheng, HY; Zhang, Z; Luo, T; Zhang, XY; Gao, GD; Lu, HS; Li, LH				Li, Yuqian; Wang, Jiancai; Li, Zhihong; Cheng, Hongyu; Zhang, Zhuo; Luo, Tao; Zhang, Xingye; Gao, Guodong; Lu, Huashan; Li, Lihong			Propoxyphene Mediates Oxyhemoglobin-Induced Injury in Rat Cortical Neurons Through Up-Regulation of Active-beta-Catenin	FRONTIERS IN PHARMACOLOGY			English	Article						Propoxyphene; active-beta-catenin; apoptosis; traumatic subarachnoid hemorrhage; mitochondrial	EARLY BRAIN-INJURY; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; WITHDRAWAL; APOPTOSIS; INHIBITION; MORPHOLOGY; PROTECTS; RELEASE	Wnt/beta-catenin signaling is involved in various biological processes, including the development of the central nervous system. The dysfunction of mitochondria has been shown to participate in the progress of subarachnoid hemorrhage (SAH). Traumatic subarachnoid hemorrhage (tSAH) is a serious complication in acute craniocerebral trauma. Opioids can activate the canonical Wnt/beta-catenin signaling pathway. c-Myc, a downstream protein of Wnt/beta-catenin signaling, contributes to the fusion of mitochondria. Here, we investigated the protective roles of Propoxyphene (Pro) against Oxyhemoglobin (OxyHb)-induced primary cultured neuron apoptosis. The data indicated that Pro rescued active-beta-catenin from OxyHb-induced decline. Furthermore, Pro attenuated OxyHb-induced apoptosis and fission of mitochondria in primary cortical neurons. However, the protective effects were abrogated under active-beta-catenin-deficient conditions. Together, the data presented here showed that Pro, a weak opioid analgesic drug, attenuates OxyHb-induced mitochondria-dependent apoptosis in an active-beta-catenin-c-Myc-dependent manner.	[Li, Yuqian; Wang, Jiancai; Li, Zhihong; Luo, Tao; Zhang, Xingye; Gao, Guodong] Fourth Mil Med Univ, Dept Neurosurg, Tangdu Hosp, Xian, Peoples R China; [Cheng, Hongyu] Fourth Mil Med Univ, Dept Ultrasound Diag, Tangdu Hosp, Xian, Peoples R China; [Zhang, Zhuo] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian, Peoples R China; [Lu, Huashan] 96605 Mil Hosp, Dept Emergency, Tonghua, Peoples R China; [Li, Lihong] Fourth Mil Med Univ, Tangdu Hosp, Dept Emergency, Xian, Peoples R China		Lu, HS (corresponding author), 96605 Mil Hosp, Dept Emergency, Tonghua, Peoples R China.; Li, LH (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Emergency, Xian, Peoples R China.	lu_huashan@163.com; lihongli777@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401044, 81230043]	This work was supported by grants from the National Natural Science Foundation of China (81401044, 81230043).	Anzabi M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00019; Boettinger S, 2017, BEHAV BRAIN RES, V323, P154, DOI 10.1016/j.bbr.2017.02.004; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Chen T, 2018, BIOMED PHARMACOTHER, V107, P563, DOI 10.1016/j.biopha.2018.08.056; Chou SHY, 2017, STROKE, V48, P2231, DOI 10.1161/STROKEAHA.117.017758; Corachan A, 2019, FERTIL STERIL, V111, P397, DOI 10.1016/j.fertnstert.2018.10.008; Dunbar SA, 2006, ANESTHESIOLOGY, V105, P154, DOI 10.1097/00000542-200607000-00025; Elyasi L, 2014, REJUV RES, V17, P255, DOI 10.1089/rej.2013.1473; Fan K, 2014, CELL SIGNAL, V26, P2801, DOI 10.1016/j.cellsig.2014.08.023; Feng DY, 2016, MOL NEUROBIOL, V53, P5737, DOI 10.1007/s12035-015-9490-x; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Hayes CJ, 2015, PHARMACOEPIDEM DR S, V24, P1180, DOI 10.1002/pds.3851; Kawano S, 1995, INT REV CYTOL, V161, P49; Larochelle MR, 2015, JAMA INTERN MED, V175, P978, DOI 10.1001/jamainternmed.2015.0914; Li X, 2016, BRAIN RES BULL, V120, P34, DOI 10.1016/j.brainresbull.2015.11.006; Liu P, 2017, BIOCHEM BIOPH RES CO, V493, P1573, DOI 10.1016/j.bbrc.2017.10.027; Mattoo SK, 2013, GEN HOSP PSYCHIAT, V35, P100, DOI 10.1016/j.genhosppsych.2012.10.009; Ore CLD, 2018, J NEUROSURG-PEDIATR, V22, P559, DOI 10.3171/2018.5.PEDS18140; Park W, 2018, BIOCHEM BIOPH RES CO, V503, P3155, DOI 10.1016/j.bbrc.2018.08.109; Takadera T, 2012, NEUROTOX RES, V21, P309, DOI 10.1007/s12640-011-9284-5; Wang B, 2016, AUTOPHAGY, V12, P1215, DOI 10.1080/15548627.2016.1179401; Wang JC, 2019, BEHAV BRAIN RES, V359, P609, DOI 10.1016/j.bbr.2018.10.005; Wang JC, 2017, NEUROSCI LETT, V639, P199, DOI 10.1016/j.neulet.2017.01.005; Wang Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00500-5; Wu P, 2017, NEUROCHEM RES, V42, P1449, DOI 10.1007/s11064-017-2201-4; Ye ZN, 2018, BEHAV BRAIN RES, V339, P19, DOI 10.1016/j.bbr.2017.11.011; Zhang XS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00611	27	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	JAN 30	2020	10								1616	10.3389/fphar.2019.01616			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KO2MP	WOS:000515384200001	32082150	Green Published, gold			2022-02-06	
J	Jensen, KO; Teuben, MPJ; Lefering, R; Halvachizadeh, S; Mica, L; Simmen, HP; Pfeifer, R; Pape, HC; Sprengel, K				Jensen, Kai Oliver; Teuben, Michel Paul Johan; Lefering, Rolf; Halvachizadeh, Sascha; Mica, Ladislav; Simmen, Hans-Peter; Pfeifer, Roman; Pape, Hans-Christoph; Sprengel, Kai		TraumaRegister DGU	Pre-hospital trauma care in Switzerland and Germany: do they speak the same language?	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						International comparison; Switzerland; Germany; Trauma systems	SEVERELY INJURED PATIENTS; SOUTHERN FINLAND; MAJOR TRAUMA; MORTALITY; REGISTRY; SYSTEMS; DEATHS	Purpose Swiss and German (pre-)hospital systems, distribution and organization of trauma centres differ from each other. It is unclear if outcome in trauma patients differs as well. Therefore, this study aims to determine differences in characteristics, therapy and outcome of trauma patients between both German-speaking countries. Methods The TraumaRegister DGU (R) (TR-DGU) was used. Patients with Injury Severity Score >= 9 admitted to a level 1 trauma centre between 01/2009 and 12/2017 were included if they required ICU care or died. Trauma pattern, pre-hospital procedures and outcome were compared between Swiss (CH, n = 4768) and German (DE, n = 66,908) groups. Results Swiss patients were older than German patients (53 vs. 50 years). ISS did not differ between groups (CH 23.8 vs. DE 23.0 points). There were more low falls < 3 m (34% vs. 21%) at the expense of less traffic accidents (37% vs. 52%) in the Swiss population. In Switzerland 30% of allocations were done without physician involvement, whereas this occurred in 4% of German cases. Despite a comparable number of patients with a GCS <= 8 (CH 29.6%; DE 26.4%), differences in pre-hospital intubation rates occurred (CH 31% vs. DE 40%). Severe traumatic brain injuries were diagnosed most frequently in Switzerland (CH 62% vs. DE 49%). Admission vital signs were similar, and standardized mortality ratios were close to one in both countries. Conclusion This study demonstrates that patients' age, trauma patterns and pre-hospital care differ between Germany and Switzerland. However, adjusted mortality was almost similar. Further benchmarking studies are indicated to optimize trauma care in both German-speaking countries.	[Jensen, Kai Oliver; Teuben, Michel Paul Johan; Halvachizadeh, Sascha; Mica, Ladislav; Simmen, Hans-Peter; Pfeifer, Roman; Pape, Hans-Christoph; Sprengel, Kai] Univ Zurich, Univ Hosp Zurich, Dept Trauma, Div Trauma Surg, Raemistr 100, CH-8091 Zurich, Switzerland; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany		Jensen, KO (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Trauma, Div Trauma Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	kaioliver.jensen@usz.ch	Jensen, Kai/AAF-2316-2020	Pape, Hans-Christoph/0000-0002-2059-4980; Jensen, Kai Oliver/0000-0002-6207-8087			Ali J, 1997, J TRAUMA, V42, P1018, DOI 10.1097/00005373-199706000-00005; ALLGOWER M, 1991, AM J SURG, V161, P226, DOI 10.1016/0002-9610(91)91135-6; Bieler D, 2017, INJURY, V48, P32, DOI 10.1016/j.injury.2016.08.015; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brinck T, 2016, EUR J TRAUMA EMERG S, V42, P445, DOI 10.1007/s00068-015-0551-7; Brinck T, 2015, EUR J TRAUMA EMERG S, V41, P509, DOI 10.1007/s00068-014-0470-z; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Crewdson K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1603-7; Demetriades D, 1998, J AM COLL SURGEONS, V187, P373, DOI 10.1016/S1072-7515(98)00209-9; Driessen A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0233-4; European Commission, 2016, ROAD SAF COUNTR OV; Garnowski M, 2011, ACCIDENT ANAL PREV, V43, P1864, DOI 10.1016/j.aap.2011.04.026; Gunkel S, 2015, UNFALLCHIRURG, V118, P233, DOI 10.1007/s00113-014-2567-6; GUNDERSEN HJG, 1981, J MICROSC-OXFORD, V121, P65, DOI 10.1111/j.1365-2818.1981.tb01199.x; Haider AH, 2014, WORLD J SURG, V38, P1882, DOI 10.1007/s00268-014-2629-5; Jones A, 2018, EMERG MED J, V35, P720, DOI 10.1136/emermed-2018-207553; Kaserer A, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0463-0; Kaserer A, 2017, AM J EMERG MED, V35, P469, DOI 10.1016/j.ajem.2016.11.057; Kehoe A, 2015, EMERG MED J, V32, P911, DOI 10.1136/emermed-2015-205265; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Kudo D, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0202-z; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, NTDB ANN REPORT 2012; Osterwalder JJ, 2003, J TRAUMA, V55, P355, DOI 10.1097/01.TA.0000034231.94460.1F; Pittet V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-380; Polytrauma Guideline Update Group, 2018, Eur J Trauma Emerg Surg, V44, P3, DOI 10.1007/s00068-018-0922-y; Rossi R, 1997, ANAESTHESIST, V46, P126, DOI 10.1007/s001010050382; Seblova J, 2018, EUR J EMERG MED, V25, P446, DOI 10.1097/MEJ.0000000000000553; Spicer R, 2005, INJURY PREV, V11, P71, DOI 10.1136/ip.2004.005579; Staiger RD, 2019, BRIT J SURG, V106, P59, DOI 10.1002/bjs.10976; Stein P, 2017, ANAESTHESIA, V72, P1317, DOI 10.1111/anae.13920; Taylor P, 2013, INT J EPIDEMIOL, V42, P1882, DOI 10.1093/ije/dyt209; Timm A, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.08.017; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; Westhoff J, 2003, INJURY, V34, P674, DOI 10.1016/S0020-1383(03)00147-5	36	1	1	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2021	47	4			SI		1273	1280		10.1007/s00068-020-01306-3		JAN 2020	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TS1QF	WOS:000510074100001	31996977	Green Published, Bronze			2022-02-06	
J	Gasquoine, PG				Gasquoine, Philip Gerard			Railway spine: The advent of compensation for concussive symptoms	JOURNAL OF THE HISTORY OF THE NEUROSCIENCES			English	Article						Concussion of the spine; traumatic neurasthenia; hysteria of traumatic origin; symptom exaggeration; malingering; traumatic neuroses	INJURIES; DISORDER; STRESS	The introduction of railway transportation in Great Britain in the early-nineteenth century saw an increased frequency of trauma cases involving persisting symptoms without objective evidence of injury. In 1866, a prominent surgeon, Sir John Eric Erichsen, attributed such symptoms to concussion of the spine (popularized as "railway spine") that involved an organic pathology, inflammation of the spinal cord in the absence of spinal fracture, with potential psychological overlay. This was widely accepted within the medico-legal context throughout the 1870s, whereby passengers sought compensation for collision-related injuries. In 1883, a railway surgeon named Herbert William Page countered the assertion that many of Erichsen's cases likely had sustained direct physical injury to the spine, the cord, and/or the spinal nerves; and in cases without such injury, the symptoms were psychogenic, as in traumatic neurasthenia and/or hysteria. Similarities between Erichsen's and Page's medico-legal positions, such as conscious and unconscious forms of symptom exaggeration that would both resolve upon settlement of the case, ushered in the era of medical injury compensation.	[Gasquoine, Philip Gerard] Univ Texas Rio Grande Valley, Dept Psychol Sci, 1201 West Univ Dr, Edinburg, TX 78541 USA		Gasquoine, PG (corresponding author), Univ Texas Rio Grande Valley, Dept Psychol Sci, 1201 West Univ Dr, Edinburg, TX 78541 USA.	drgdrg13@yahoo.com					ALLAN DB, 1989, ACTA ORTHOP SCAND, V60, P1, DOI 10.3109/17453678909153916; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Beard George., 1869, BOSTON MED SURG J, VIII, P217, DOI [10.1056/nejm186904290801301, DOI 10.1056/NEJM186904290801301]; BROWN EM, 1990, BEHAV SCI LAW, V8, P421; Chaille SE, 1949, J CRIM LAW CRIM, V40, P397, DOI 10.2307/1137912; Charcot J.-M., 1889, CLIN LECT DIS NERVOU, V3; Clarke L., 1866, T PATHOLOGICAL SOC L, V17, P20; COOKE AM, 1982, MED HIST, V26, P307, DOI 10.1017/S0025727300041521; Dana C. L., 1884, MED REC, V26, P617; Dembe AE, 1998, INT J HEALTH SERV, V28, P227, DOI 10.2190/AHNQ-7D5R-4YN3-NX0F; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dundas Robert, 1825, Edinb Med Surg J, V23, P304; Erichsen, 1866, RAILWAY OTHER INJURI; Erichsen J.E., 1867, RAILWAY OTHER INJURI; Erichsen JE, 1875, CONCUSSION SPINE NER; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Ferrari Robert, 2003, Med Sci Monit, V9, pHY27; Gasquoine PG, 1998, CLIN NEUROPSYCHOL, V12, P315, DOI 10.1076/clin.12.3.315.1990; Gasquoine PG, 2017, NEUROPSYCHOL REV, V27, P147, DOI 10.1007/s11065-017-9346-4; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Harrington R., 2001, TRAUMATIC PASTS HIST, P31, DOI [10.1017/CBO9780511529252.003, DOI 10.1017/CBO9780511529252.003]; Hodges R. M., 1881, BOSTON MED SURG J, V104, P361, DOI [10.1056/NEJM188104211041601, DOI 10.1056/NEJM188104211041601]; Jellinek E H, 2001, Proc R Coll Physicians Edinb, V31, P342; Judd H., 1889, JAMA-J AM MED ASSOC, V13, P188, DOI [10.1001/jama.1889.04440040008002, DOI 10.1001/JAMA.1889.04440040008002]; Keller T, 1996, SPINE, V21, P1597, DOI 10.1097/00007632-199607010-00022; Lasiuk GC, 2006, PERSPECT PSYCHIATR C, V42, P13, DOI 10.1111/j.1744-6163.2006.00045.x; Lee C. A., 1854, AM J MED SCI, V56, P400, DOI [10.1097/00000441-185410000-00007, DOI 10.1097/00000441-185410000-00007]; Micale M S, 1995, J Hist Neurosci, V4, P101; Miles WD, 1982, HIST NATL LIB MED NA; National Association of Railroad Surgeons, 1894, RAILWAY SURG, V1, P244; Page H. W., 1891, RAILWAY INJURIES SPE; Page Herbert, 1883, INJURIES SPINE SPINA; POKORNY AD, 1953, AMA ARCH IND HYG OCC, V8, P547; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTKOW IM, 1993, ARCH SURG-CHICAGO, V128, P458; Sanders LJ, 2013, DIABETOLOGIA, V56, P1873, DOI 10.1007/s00125-013-2961-6; Schafer E., 1896, NATURE, V54, P548, DOI [10.1038/054548a0, DOI 10.1038/054548A0]; Solly Samuel, 1862, LANCET, V79, P184, DOI [10.1016/S0140-6736(02)58591-3, DOI 10.1016/S0140-6736(02)58591-3]; Sprigge S. S., 1926, LANCET, V208, P626; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Toogood J, 1843, Prov Med J Retrosp Med Sci, V6, P352; Wakley T. H., 1896, LANCET, V148, P897; Walton G. L., 1881, BOSTON MED SURG J, V109, P337, DOI 10.1056/NEJM188310111091501; Walusinski O, 2012, J NEUROL, V259, P1255, DOI 10.1007/s00415-012-6424-7; Weaver DF, 2017, NEUROLOGY, V89, P395, DOI 10.1212/WNL.0000000000004095; Wecht CH, 2005, J AM ACAD PSYCHIATRY, V33, P245	48	1	1	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0964-704X	1744-5213		J HIST NEUROSCI	J. Hist. Neurosci.	APR 2	2020	29	2					234	245		10.1080/0964704X.2019.1711350		JAN 2020	12	History & Philosophy Of Science; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	History & Philosophy of Science; Neurosciences & Neurology	ME8IB	WOS:000511300800001	31986104				2022-02-06	
J	Hirschberg, R; Sylvia, LG; Wright, EC; Gupta, CT; McCarthy, MD; Harward, LK; Goetter, EM; Boland, H; Tanev, K; Spencer, TJ				Hirschberg, Ronald; Sylvia, Louisa G.; Wright, Edward C.; Gupta, Carina T.; McCarthy, Megan D.; Harward, Laura K.; Goetter, Elizabeth M.; Boland, Heidi; Tanev, Kaloyan; Spencer, Thomas J.			Collaborative Songwriting Intervention for Veterans with Post-traumatic Stress Disorder	JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE			English	Article						PTSD; veterans; songwriting; military	STIGMA	Objectives: Given that veterans are significantly more likely to suffer from post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, and anxiety than civilians, yet current gold-standard treatments for PTSD are not effective for all patients, the present study sought to examine the feasibility and acceptability of a collaborative songwriting intervention (CSI) while exploring its potential effectiveness in improving physical and mental health outcomes for veterans with PTSD. Design: Ten veterans took part in the CSI. A variety of pre- and postintervention measures were administered, including the Measurement of Current Status (MOCS), the Coping Expectancies Scale (CES), the Post-traumatic Stress Disorder Checklist-Military (PCL-M), and the Patient Health Questionnaire-9 (PHQ-9). Participants also wore a Fitbit to track average heart rate, sleep, and step count. Intervention: The CSI consisted of each veteran meeting with a professional songwriter, trained specifically for co-writing original material with the veteran population. There were three phases of songwriting that took about an hour and 15 min total. Veterans were instructed to listen to their song daily for 5 weeks. Results: Participants reported that the intervention was helpful and relevant to them, and most participants (95%) would refer others to this treatment. We found that the CSI reduced participant's PTSD symptoms (d = 0.869), specifically the Numbing (d = 0.853) and Hyperarousal (d = 1.077) subscales. Depressive symptoms (d = 0.72) and stress reactivity (d = 0.785) also marginally decreased. There was no significant change in physiological data (i.e., sleep, no. of steps) from pre- to postintervention. Conclusion: These data suggest that a CSI is an acceptable intervention for veterans with PTSD that may also improve their PTSD symptoms.	[Hirschberg, Ronald; Sylvia, Louisa G.; Wright, Edward C.; Gupta, Carina T.; McCarthy, Megan D.; Harward, Laura K.; Goetter, Elizabeth M.; Boland, Heidi; Tanev, Kaloyan; Spencer, Thomas J.] Home Base, Dept Psychiat, Charlestown, MA USA; [Hirschberg, Ronald; Sylvia, Louisa G.; Wright, Edward C.; Goetter, Elizabeth M.; Tanev, Kaloyan; Spencer, Thomas J.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA		Sylvia, LG (corresponding author), 1 Constitut Rd, Charlestown, MA 02145 USA.	lsylvia2@mgh.harvard.edu		McCarthy, Megan/0000-0001-7625-7687			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2015, BONNY METHOD GUIDED; BAKER F, 2005, SONGWRITING METHODS; Baker FA, 2015, THERAPEUTIC SONGWRITING: DEVELOPMENTS IN THEORY, METHODS, AND PRACTICE, P1, DOI 10.1057/9781137499233; Blake R.L., 1994, MUSIC THER PERSPECT, V12, P125, DOI [10.1093/mtp/12.2.125, DOI 10.1093/MTP/12.2.125]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; Carver CS, 2006, MOTIV EMOTION, V30, P105, DOI 10.1007/s11031-006-9044-7; Cohen ML, 2017, INT J MUSIC EDUC, V35, P541, DOI 10.1177/0255761416689841; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; Foa EB, 1998, TREATING TRAUMA RAPE; Fortney JC, 2016, GEN HOSP PSYCHIAT, V38, P99, DOI 10.1016/j.genhosppsych.2015.09.007; Gradus, 2007, EPIDEMIOLOGY OF PTSD; Hembree EA, 2003, COGN BEHAV PRACT, V10, P22, DOI 10.1016/S1077-7229(03)80005-6; Hruschka D., 2004, FIELD METHOD, V16, P184, DOI DOI 10.1177/1525822X03262663; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Krysinska K, 2010, ARCH SUICIDE RES, V14, P1, DOI 10.1080/13811110903478997; Luberto CM, 2017, BMC COMPLEMENT ALTER, V17; Maack C, 2012, OUTCOMES PROCESSES B; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Weathers FW, 1993, PTSD CHECKLIST PCL R, V462; Zoteyeva V, 2016, PSYCHOL MUSIC, V44, P307, DOI 10.1177/0305735614566841	25	1	3	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1075-5535	1557-7708		J ALTERN COMPLEM MED	J. Altern. Complement Med.	MAR 1	2020	26	3					198	203		10.1089/acm.2019.0368		JAN 2020	6	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	LB8QS	WOS:000509789700001	31985263				2022-02-06	
J	Johnstone, B; Kvandal, A; Winslow, R; Kilgore, J; Guerra, M				Johnstone, Brick; Kvandal, Aimee; Winslow, Robin; Kilgore, Jocelyn; Guerra, Melissa			The behavioral presentation of an individual with a disordered sense of self	BRAIN INJURY			English	Article						Traumatic brain injury; sense of self; disorder of the self; right hemisphere parietal lobe		There is increased recognition that the brain processes a "sense of self" (best understood as a sense of "mineness") in the right hemisphere association area and which can be distorted due to neurologic injury. Although there are numerous descriptions of types of disorders of the self (e.g., asomatognosia, anosognosia, mirror misidentification disorder, Capgras syndrome, schizophrenia), there are few descriptions of the subjective experiences of individuals with traumatic brain injury (TBI) who experience a reduced sense of self. This article presents a longitudinal case study of a woman in her early 40s with a primarily right hemisphere TBI and disorder of the self who had difficulties relating her experiences from the perspective of the self. Subjective interviews, neuropsychological test scores, and objective personality testing illustrate how she reported her experiences of a diminished sense of self, and how this sense of self improved over the normal course of recovery following the TBI. This case demonstrates clinically relevant information regarding how individuals with a reduced "sense of self" (i.e., "mineness") associated with a right hemisphere TBI may report their subjective experiences and perform on objective testing.	[Johnstone, Brick; Kvandal, Aimee] Ft Belvoir Intrepid Spirit Ctr, Def & Vet Brain Injury Ctr, Ft Belvoir, VA USA; [Winslow, Robin; Kilgore, Jocelyn; Guerra, Melissa] Ft Belvoir Intrepid Spirit Ctr, Ft Belvoir, VA USA		Johnstone, B (corresponding author), Ft Belvoir Community Hosp, Intrepid Spirit Ctr, 5980 9th St, Ft Belvoir, VA 22060 USA.	brickjohnstone47@gmail.com					Abugel J, 2010, STRANGER MYSELF; ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; Barresi J., 2011, OXFORD HDB SELF, DOI DOI 10.1093/OXFORDHB/9780199548019.003.0002; Bermudez JL, 2011, OXFORD HDB SELF, P157, DOI DOI 10.1093/OXFORDHB/9780199548019.003.0007; Breen N, 2000, MIND LANG, V15, P74, DOI 10.1111/1468-0017.00124; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; Feinberg T., 2005, LOST SELF PATHOLOGIE; Feinberg TE., 2005, LOST SELF PATHOLOGIE, P100, DOI [10.1093/acprof:oso/9780195173413.003.0008, DOI 10.1093/ACPROF:OSO/9780195173413.003.0008]; Feinberg TE, 2011, CONSCIOUS COGN, V20, P2, DOI 10.1016/j.concog.2010.12.001; Galli S, 2011, P IEEE, V99, P998, DOI 10.1109/JPROC.2011.2109670; Gelech J, 2019, NEUROPSYCHOL REHABIL, V29, P456, DOI 10.1080/09602011.2017.1308872; Johnstone B, 2019, NEUROSCIENCE SELFLES; Mantovani A, 2011, PSYCHIAT RES, V186, P138, DOI 10.1016/j.psychres.2010.08.022; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Morey L.C., 2007, PERSONALITY ASSESSME; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Parnas J, 2011, OXFORD HDB SELF, P521; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RADOVIC F, 2002, PHILOS PSYCHIAT PSYC, V9, P271, DOI DOI 10.1353/PPP.2003.0048; Sass LA, 2014, SCHIZOPHR RES, V152, P5, DOI 10.1016/j.schres.2013.05.017; Thompson E, 2015, WAKING DREAMING BEIN; Tsakiris M, 2011, OXFORD HDB SELF, P180, DOI DOI 10.1093/OXFORDHB/9780199548019.003.0008	24	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					438	443		10.1080/02699052.2020.1717622		JAN 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000509171200001	31977238				2022-02-06	
J	Kolberg, K; Saleem, N; Ambrose, M; Cranford, J; Almeida, A; Ichesco, I; Schellpfeffer, N; Hashikawa, A				Kolberg, Kristen; Saleem, Noor; Ambrose, Michael; Cranford, Jim; Almeida, Andrea; Ichesco, Ingrid; Schellpfeffer, Natalie; Hashikawa, Andrew			Pediatric Head Injuries in Summer Camps	CLINICAL PEDIATRICS			English	Article						head injuries; summer camp; concussion; pediatrics; pediatric emergency medicine	UNITED-STATES; SEX-DIFFERENCES; CONCUSSION; SURVEILLANCE	Summer camps have a unique supervisory environment that may lead to increased head injury risk for children. The epidemiology of head injuries in camps is unclear. We partnered with to review head injury reports from camp nurses in 2016 from 197 camps in 36 states. A total of 4290 (92%) reports were coded as definite head injuries, 47% (n = 2002) in female campers, with median camper age of 10 years. Head injury severity was coded as mild (94%, n = 4040), moderate (6%, n = 248), or severe (<1%, n = 2). Only 3% (n = 134) were medically evaluated, and 29% (n = 1221) were sports-related. Head injuries were categorized as definite (3%, n = 137) and probable (13%, n = 572) concussions, with 39% (n = 277) being sports-related and 61% (n = 83) of definite concussions incurred by female campers. Summer camps, while an important location of head injury risk, appear to be a safe environment for youth.	[Kolberg, Kristen; Saleem, Noor; Cranford, Jim; Almeida, Andrea; Ichesco, Ingrid; Schellpfeffer, Natalie; Hashikawa, Andrew] Univ Michigan, Ann Arbor, MI 48109 USA; [Ambrose, Michael] St Joseph Mercy Hlth Syst, Ypsilanti, MI USA		Kolberg, K (corresponding author), Univ Michigan, Sch Med, 220 North Ingalls St, Ann Arbor, MI 48109 USA.	kolbergk@med.umich.edu		Kolberg, Kristen/0000-0002-1500-1220			Almeida AA, 2018, PEDIATR CLIN N AM, V65, P1151, DOI 10.1016/j.pcl.2018.07.006; American Camp Association, 2019, ACA FACTS TRENDS; American Camp Association, 2011, HLTH CAMP STUD IMP R; Belson K, NY TIMES; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, TBI REL EM DEP ED VI; Chang MG, 2017, SOUTH MED J, V110, P502, DOI 10.14423/SMJ.0000000000000678; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Elliott TB, 2003, WILD ENVIRON MED, V14, P2, DOI 10.1580/1080-6032(2003)014[0002:RFAWCA]2.0.CO;2; Goldlust E, 2009, INJURY PREV, V15, P413, DOI 10.1136/ip.2008.020487; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Olympia RP, 2015, PEDIATR EMERG CARE, V31, P178, DOI 10.1097/PEC.0000000000000379; Rauckhorst L, 1998, J Pediatr Nurs, V13, P200, DOI 10.1016/S0882-5963(98)80047-X; Robinson RL, 2019, J PARK RECREAT ADM, V37, P115, DOI 10.18666/JPRA-2019-8967; Schellpfeffer NR, 2017, J ALLER CL IMM-PRACT, V5, P358, DOI 10.1016/j.jaip.2016.10.018; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Ward J., 2017, NY TIMES; WETTERHALL SF, 1988, AM J SPORT MED, V16, P534, DOI 10.1177/036354658801600518; Yard EE, 2006, PEDIATRICS, V118, pE1342, DOI 10.1542/peds.2006-0834	21	1	1	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	MAY	2020	59	4-5					369	374	0009922819901009	10.1177/0009922819901009		JAN 2020	6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	LE8XW	WOS:000509202500001	31976762				2022-02-06	
J	Maclean, LM; McSkimming, P; McMillan, TM				Maclean, Linda M.; McSkimming, Paula; McMillan, Tom M.			The association between dual-task walking and counting responses and cognitive function and disability after severe head injury: A preliminary study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Dual-task; walking and counting; cognitive function; disability; severe head injury	TRAUMATIC BRAIN-INJURY; NORMAL HUMAN LOCOMOTION; HEALTHY OLDER-ADULTS; WORKING-MEMORY; EXECUTIVE DYSFUNCTION; DIVIDED ATTENTION; GAIT VARIABILITY; PERFORMANCE; PRIORITIZATION; IDENTIFICATION	Adverse outcomes after severe head injury (SHI) can be difficult to detect in primary care and other settings where there is not specialist expertise for interpretation. Walking and counting dual-task (DT) measures are strongly associated with cognitive impairment and dementia and this preliminary study investigates whether performance on DT walking and counting tasks are associated with cognitive function and disability in 125 participants who sustained a SHI on average 26 years before. Single Task (ST) walking (speed over 6 metres) and ST counting (Serial 3s) and DT performance of concurrent walking and Serial 3s were compared with neuropsychological, wellbeing and disability tests for strength of association. The strongest correlations were between ST Correct Cognitive Responses (CCRs) and MMSE (rho = 0.435), DT CCRs and Short-term Memory Binding Tests (STMBT) binding accuracy (rho = 0,409) and DT CCRs and STROOP (rho = 0.420), but associations were less strong with disability. Developing this test, as a cost-efficient screening tool for triage to onward referral for neuropsychological assessment, holds promise, but requires further research.	[Maclean, Linda M.; McMillan, Tom M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Admin Bldg Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland; [McSkimming, Paula] Univ Glasgow, Coll Med Vet & Life Sci, Robertson Ctr Biostat, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland		Maclean, LM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Admin Bldg Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland.	lin.maclean@yahoo.com			Sackler Fellowship Bequest funding	This work was supported by a Sackler Fellowship Bequest funding for the first author.	Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; AYYAPPA E, 1997, J PROSTHET ORTHOT, V9, P10; Ayyappa E., 1997, J PROSTHET ORTHOT, V9, P42; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Beauchet O, 2016, J AM MED DIR ASSOC, V17, P482, DOI 10.1016/j.jamda.2015.12.092; Ben A. E., 2015, STROKE, V46, P1077, DOI [10.1161/STROKEAHA.114.007346, DOI 10.1161/STROKEAHA.114.007346]; Bilgin S, 2012, NEURAL REGEN RES, V7, P1978, DOI 10.3969/j.issn.1673-5374.2012.25.009; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Callisaya ML, 2015, J GERONTOL A-BIOL, V70, P1226, DOI 10.1093/gerona/glv066; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Della Sala S, 2012, NEUROPSYCHOLOGIA, V50, P833, DOI 10.1016/j.neuropsychologia.2012.01.018; Doi T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-67; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Goldberg D., 1978, MANUAL GEN HLTH QUES; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Li KZH, 2012, AGING NEUROPSYCHOL C, V19, P150, DOI 10.1080/13825585.2011.628375; Lord S, 2010, GAIT POSTURE, V31, P169, DOI 10.1016/j.gaitpost.2009.09.019; Maclean LM, 2017, GAIT POSTURE, V53, P139, DOI 10.1016/j.gaitpost.2017.01.018; Martin KL, 2013, J GERONTOL A-BIOL, V68, P726, DOI 10.1093/gerona/gls224; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McFadyen BJ, 2017, NEUROPSYCHOL REHABIL, V27, P722, DOI 10.1080/09602011.2015.1100125; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Montero-Odasso M, 2006, J AM GERIATR SOC, V54, P1949, DOI 10.1111/j.1532-5415.2006.00952.x; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Persad CC, 2008, J GERONTOL A-BIOL, V63, P1350, DOI 10.1093/gerona/63.12.1350; Sala SD, 1995, ANN NY ACAD SCI, V769, P161, DOI 10.1111/j.1749-6632.1995.tb38137.x; Schwenk M, 2010, NEUROLOGY, V74, P1961, DOI 10.1212/WNL.0b013e3181e39696; Smith A., 1982, SYMBOL DIGITS MODALI; Smith R. L., 2010, QUANTIFICATION LOCAL; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Trennery M. R., 1989, STROOP NEUROPSYCHOLO; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wechsler D, 1987, MEMORY SCALE REVISED; Williams G, 2009, GAIT POSTURE, V29, P454, DOI 10.1016/j.gaitpost.2008.11.005; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Yogev-Seligmann G, 2012, GAIT POSTURE, V35, P641, DOI 10.1016/j.gaitpost.2011.12.016; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	1	1	3	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 21	2021	31	4					570	582		10.1080/09602011.2020.1716812		JAN 2020	13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RN0PC	WOS:000511522400001	31989869				2022-02-06	
J	Ssebakumba, MK; Lule, H; Olweny, F; Mabweijano, J; Kiryabwire, J				Ssebakumba, Mbaaga K.; Lule, Herman; Olweny, Francis; Mabweijano, Jacqueline; Kiryabwire, Joel			Thirty-day clinical outcome of traumatic brain injury patients with acute extradural and subdural hematoma: a cohort study at Mulago National Referral Hospital, Uganda	EGYPTIAN JOURNAL OF NEUROSURGERY			English	Article						Epidural-hematoma; Subdural-hematoma; Clinical outcome; Factors; Uganda	BLOOD-PRESSURE; PROGNOSIS	Background Increasing traumatic brain injury (TBI) has paralleled the need for decompression surgery for acute subdural (ASDH) and acute extradural haematoma (AEDH). Knowledge of key determinants of clinical outcomes of such patients is mandatory to guide treatment protocols. Objective To determine the 30-day clinical outcomes and predictor variables for patients with extra-axial hematomas at Mulago National Referral Hospital in Uganda. Methods Prospective observational cohort study of 109 patients with computed tomography (CT) confirmed extra-axial hematomas. Ethical clearance was obtained from the School of Medicine Research and Ethics Committee of College of Health Sciences, Makerere University (REC REF. 2018-185). Admitted patients were followed-up and reassessed for Glasgow Outcome Scale (GOS) and final disposition. Multivariate regression analysis was performed using Stata 14.0 (StataCorp. 2015) at 95% confidence interval, regarding p < 0.05 as statistically significant. Results The overall proportion of favorable outcome was 71.7% (n = 71), with 42.3% (n = 11) and 81.7% (n = 58) for ASDH and AEDH, respectively (p = 0.111). Factors associated with a favorable outcome were admission systolic BP > 90 mmHg [IRR = 0.88 (0.26-0.94) 95%CI, p = 0.032), oxygen saturation > 90% [IRR = 0.5 (0.26-0.94) 95%CI, p = 0.030] and diagnosis AEDH [IRR = 0.53 (0.30-0.92) 95%CI, p = 0.025). Moderate TBI [IRR = 4.57 (1.15-18.06) 95%CI, p = 0.03] and severe TBI [IRR = 6.79 (2.32-19.86) 95%CI, p < 0.001] were significantly associated with unfavorable outcomes. Conclusion The study revealed that post resuscitation GCS, systolic BP, oxygen circulation, and diagnosis of AEDH at admission are the most important determinants of outcome for patients with extra-axial intracranial hematomas. These findings are valuable for the triaging teams in resource-constrained settings.	[Ssebakumba, Mbaaga K.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Gen Surg, POB 7072, Kampala, Uganda; [Lule, Herman] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neural Sci, FI-20014 Turku, Finland; [Lule, Herman] Univ Turku, FI-20014 Turku, Finland; [Lule, Herman] Kampala Int Univ, Dept Surg, Western Campus,POB 71, Bushenyi, Uganda; [Olweny, Francis] Makerere Univ, Coll Hlth Sci, Sch Med, Clin Epidemiol Unit, Kampala, Uganda; [Mabweijano, Jacqueline] Mulago Natl Referral & Teaching Hosp, Dept Causal Trauma & Emergency Med, POB 7051, Kampala, Uganda; [Kiryabwire, Joel] Mulago Natl Referral & Teaching Hosp, Dept Neurosurg, POB 7051, Kampala, Uganda		Lule, H (corresponding author), Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neural Sci, FI-20014 Turku, Finland.; Lule, H (corresponding author), Univ Turku, FI-20014 Turku, Finland.; Lule, H (corresponding author), Kampala Int Univ, Dept Surg, Western Campus,POB 71, Bushenyi, Uganda.	lule.herman@gmail.com		Lule, Herman/0000-0002-0647-9716			Agrawal Deepak, 2016, Asian J Neurosurg, V11, P143, DOI 10.4103/1793-5482.145081; ANTONIADIS G, 1993, UNFALLCHIRURG, V96, P582; Atanasov VA., 2016, ROMANIAN NEUROSURGER, V30, P372, DOI [10.1515/romneu-2016-0057, DOI 10.1515/ROMNEU-2016-0057]; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Erem G., 2017, COGENT MED, V4, DOI [10.1080/2331205X.2017.1326205, DOI 10.1080/2331205X.2017.1326205]; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Gholipour C, 2016, WORLD J EMERG MED, V7, P135, DOI 10.5847/wjem.j.1920-8642.2016.02.009; Goldstein LN, 2017, AFR J EMERG MED, V7, P100, DOI 10.1016/j.afjem.2017.04.012; Hanif S, 2009, Ir Med J, V102, P255; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Kanazawa A, 2014, LEGAL MED-TOKYO, V16, P297, DOI 10.1016/j.legalmed.2014.05.004; Khachatryan TK, 2018, NEW ARMEN MED J, V12, P12; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kumar A, 2016, J NEUROLOGY STROKE, V5, DOI [10.15406/jnsk.2016.05.00168, DOI 10.15406/JNSK.2016.05.00168]; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Landes M, 2017, AFR J EMERG MED, V7, P130, DOI 10.1016/j.afjem.2017.04.001; Lule H., 2017, IOSR J DENT MED SCI, V16, P79, DOI [10.9790/0853-1608107992, DOI 10.9790/0853-1608107992]; Mabweijano J., 2015, EMERGENCY MED OPEN A, V05, P1, DOI [10.4172/2165-7548.1000270, DOI 10.4172/2165-7548.1000270]; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Niaz A., 2017, NEPAL J NEUROSCIENCE, V14, P13, DOI [10.3126/njn.v14i3.20519, DOI 10.3126/NJN.V14I3.20519]; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Pollauer E., 1999, PROGNOSIS ACUTE S156; Quach Nhung T, 2016, PM R, V8, pS156, DOI 10.1016/j.pmrj.2016.07.034; Schmidt Eric., 2012, PATHYS PRINCIPLES PR, P701, DOI [10.1002/9781119952930.ch60, DOI 10.1002/9781119952930.CH60]; Scotter J, 2015, EMERG MED J, V32, P654, DOI 10.1136/emermed-2014-204260; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tian H, 2008, CHINESE MED J-PEKING, V121; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57	32	1	1	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2520-8225		EGYPT J NEUROSURG	Egypt. J. Neurosurg.	JAN 23	2020	35	1							3	10.1186/s41984-020-0073-4			12	Clinical Neurology; Surgery	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Surgery	WD0PR	WOS:000704650300001		gold			2022-02-06	
J	Mineeja, KK; Ignatius, RP				Mineeja, K. K.; Ignatius, Rose P.			Levy noise-induced near-death spikes and phase transitions of a biological neural network	NONLINEAR DYNAMICS			English	Article						Levy noise; Spatiotemporal activity; Network of neurons; Chaotic neuron; Near-death surge; Phase transitions	MAGNETIC-FIELD STIMULATION; STOCHASTIC RESONANCE; SYNCHRONIZATION; MODEL; DYNAMICS; DRIVEN; SYSTEM	Near-death spikes or near-death surges are a sudden increase in neuron activity in the human brain before neurons end their firings. Just before a person is clinically dead, such spikes are observed in certain cases, so the name is near-death spikes. The reason for this behavior is the lack of oxygen in brain (Chawla et al. in J Palliat Med 12(12):1095-1100, 2009). In this study, it is demonstrated that a particular type of noise called Levy noise can generate such activity in the neural network of the worm Caenorhabditis elegans. The study identified different parameter regions of noise at which the network makes transitions from one synchronous state to another and the mechanism behind them. Such transitions are already reported in cortical regions of brain (Canavero et al. in Surg Neurol Int 7(Suppl 24):S623-S625, 2016). During the transition period between asynchronous and synchronous firing states, network is more susceptible to changes in firing pattern of individual neurons (Zandt et al. in PLoS ONE 6(7):e22127, 2011; Uzuntarla et al. Neural Netw 110:131-140, 2019). In this work, it is demonstrated that the recognized parameter regions can be used to control the network dynamics. The study also identified Levy noise values at which the network displays generation of waves of different frequencies. This result suggests a new method for neurostimulation in the case of traumatic brain injury. The study reveals that the characteristic exponent (alpha) of the noise has better influence on the network dynamics than the scale parameter of noise (D) and the synaptic coupling constant (Gsyn) of the network. The neuronal network even displayed Gamma oscillations for large values of alpha. If the parameters of the neurons are made chaotic, the network firing rate is diminished and it displayed Delta and Theta oscillations.	[Mineeja, K. K.; Ignatius, Rose P.] MG Univ, St Teresas Coll, Dept Phys, Ernakulam, Kerala, India; [Ignatius, Rose P.] Al Ameen Coll, Dept Phys, Edathala, Kerala, India		Mineeja, KK (corresponding author), MG Univ, St Teresas Coll, Dept Phys, Ernakulam, Kerala, India.	kkmineeja@gmail.com; rosgeo@yahoo.com			Mahatma Gandhi University [529/A6/J.R.F. 2018-19/Academic]	This work was supported by Mahatma Gandhi University Junior Research Fellowship. U.O. No. 529/A6/J.R.F. 2018-19/Academic dated 02/02/2019.	Aguila J, 2016, CEREB CORTEX, V26, P628, DOI 10.1093/cercor/bhu228; Altun Z.F., NERVOUS SYSTEM GEN D; Applebaum D, 1998, NOT AM MATH SOC, V51, P1336; Ariel G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9396; Bogaard A, 2009, J NEUROSCI, V29, P1677, DOI 10.1523/JNEUROSCI.5218-08.2009; Bordet M, 2013, CHAOS SOLITON FRACT, V54, P82, DOI 10.1016/j.chaos.2013.05.020; Buskila Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01125; Cai R, 2017, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aa727c; Canavero Sergio, 2016, Surg Neurol Int, V7, pS623, DOI 10.4103/2152-7806.190472; Chan T, 1999, ANN APPL PROBAB, V9, P504; Chawla LS, 2009, J PALLIAT MED, V12, P1095, DOI 10.1089/jpm.2009.0159; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Fink CG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002062; Gao FY, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.052142; Gonzalez-Rosa JJ, 2015, J NEUROSCI, V35, P9182, DOI 10.1523/JNEUROSCI.4232-14.2015; Guo DQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26096; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jercog D, 2017, ELIFE, V6, DOI 10.7554/eLife.22425; Jia YB, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501428; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Mineeja KK, 2018, NONLINEAR DYNAM, V92, P1881, DOI 10.1007/s11071-018-4169-2; Nobukawa S., 2015, EMERGING TRENDS COMP, V2015, P355; Oliviero A, 2011, J PHYSIOL-LONDON, V589, P4949, DOI 10.1113/jphysiol.2011.211953; Patel A, 2008, IEEE T NEURAL NETWOR, V19, P1993, DOI 10.1109/TNN.2008.2005610; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Perc M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/252; Perc M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022101; Perc M, 2007, ECON LETT, V97, P58, DOI 10.1016/j.econlet.2007.02.038; Pevzner A, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00030; Rosen A.D., 2010, PIERS ONLINE, V6, P133, DOI 10.2529/PIERS090529114533; Sahasranamam A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26029; Schroter M, 2017, NAT REV NEUROSCI, V18, P131, DOI 10.1038/nrn.2016.182; SHLESINGER MF, 1987, PHYS REV LETT, V58, P1100, DOI 10.1103/PhysRevLett.58.1100; SHLESINGER MF, 1986, PHYSICA A, V140, P212, DOI 10.1016/0378-4371(86)90224-4; Sun XJ, 2011, EUR PHYS J B, V79, P61, DOI 10.1140/epjb/e2010-10031-3; Thottil SK, 2017, NONLINEAR DYNAM, V87, P1879, DOI 10.1007/s11071-016-3160-z; Uzuntarla M, 2019, NEURAL NETWORKS, V110, P131, DOI 10.1016/j.neunet.2018.11.007; Vecer J, 2004, QUANT FINANC, V4, P170, DOI 10.1080/14697680400000021; Vinaya M, 2018, NONLINEAR DYNAM, V94, P1133, DOI 10.1007/s11071-018-4414-8; Wang HT, 2016, NONLINEAR DYNAM, V85, P881, DOI 10.1007/s11071-016-2730-4; Wang QY, 2013, CHAOS SOLITON FRACT, V56, P19, DOI 10.1016/j.chaos.2013.05.003; Wang ZQ, 2016, SCI CHINA TECHNOL SC, V59, P371, DOI 10.1007/s11431-015-6001-2; Wu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174330; Xu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31505; Yang J, 2015, NEUROCOMPUTING, V156, P231, DOI 10.1016/j.neucom.2014.12.056; Zandt BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022127; Zeng CB, 2015, CHAOS, V25, DOI 10.1063/1.4937726; Zhou CS, 2003, CHAOS, V13, P401, DOI 10.1063/1.1493096; Zhou LW, 2016, NEUROCOMPUTING, V173, P1235, DOI 10.1016/j.neucom.2015.08.081	51	1	1	3	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0924-090X	1573-269X		NONLINEAR DYNAM	Nonlinear Dyn.	MAR	2020	99	4					3265	3283		10.1007/s11071-020-05472-2		JAN 2020	19	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	LB2HQ	WOS:000508708000002					2022-02-06	
J	Babaei, P; Damirchi, A; Hoseini, Z; Hoseini, R				Babaei, Parvin; Damirchi, Arsalan; Hoseini, Zahra; Hoseini, Rastegar			Co-treatment of vitamin D supplementation and aerobic training improves memory deficit in ovariectomized rat	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Vitamin D; cognitive impairment; metabolic syndrome; ovariectomized rats; passive avoidance learning	TRAUMATIC BRAIN-INJURY; METABOLIC SYNDROME; TREADMILL EXERCISE; EXPRESSION; PERFORMANCE; BIOMARKERS; PROTECTS; DISEASE; OBESITY; CANCER	Objective: Metabolic syndrome (MetS) and insufficient vitamin D levels are globally increasing phenomena which are correlated with cognitive impairment. This study investigated the interactive effect of aerobic training with vitamin D supplementation on memory deficit in rats with metabolic syndrome induced by ovariectomy. Methods: A total of forty Wistar rats weighing 240-255 gr were randomly matched on their body weight and divided into ovariectomy (OVX, n = 32) and sham-operated (SHAM; n = 8) groups. OV group was then divided into vitamin D supplementation (OVX + Vit D; 10000 IU/kg/week, for 8 weeks, n = 8), aerobic training (OVX + AT; n = 8), aerobic training and vitamin D supplementation (OVX + AT + Vit D; 10000 IU/kg/week, for 8 weeks, n = 8), and vehicle control group receiving sesame oil (OVX + Ses Oil; n = 8). After the end of intervention, passive avoidance learning and memory were assessed in step through passive avoidance paradigm. Obtained data were analyzed by ANOVA and post hoc Tukey test. Results: After 8 weeks of aerobic training and vitamin D supplementation, step through dark compartment latency (STL) was significantly higher and total time spent in that compartment (TSD) was lower in OVX + AT + Vit D compared to the other counterpart groups. Conclusion: Vitamin D supplementation combined with 8-week aerobic training alleviates cognitive impairment metabolic syndrome induced by ovariectomy.	[Babaei, Parvin] Guilan Univ Med Sci, Cellular & Mol Res Ctr, Sch Med, Rasht, Iran; [Damirchi, Arsalan] Univ Guilan, Fac Sport Sci, Dept Sport Physiol, Rasht, Iran; [Hoseini, Zahra; Hoseini, Rastegar] Razi Univ, Dept Sport Physiol, Fac Sport Sci, Kermanshah, Iran		Hoseini, R (corresponding author), Razi Univ, Dept Sport Physiol, Fac Sport Sci, Kermanshah, Iran.	R.hoseini@razi.ac.ir	, Parvin/H-5269-2017; babaei, parvin/ABB-8760-2021; Hoseini, Rastegar/ABH-7065-2020	, Parvin/0000-0003-4870-8182; babaei, parvin/0000-0003-4870-8182; Hoseini, Rastegar/0000-0001-8685-2471; damirchi, arsalan/0000-0002-3442-0631			Ahmad M, 2005, J NEUROCHEM, V93, P94, DOI 10.1111/j.1471-4159.2005.03000.x; Ali A, 2018, J STEROID BIOCHEM, V175, P108, DOI 10.1016/j.jsbmb.2016.12.018; Annweiler C, 2016, ANN NY ACAD SCI, V1367, P57, DOI 10.1111/nyas.13058; Aspell N, 2018, P NUTR SOC, V77, P124, DOI 10.1017/S0029665117004153; Ayoub R, 2009, INT J DIABETES METAB, V17, P93; Babaei P, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0288-z; Beavers KM, 2018, J BONE MINER RES, V33, P2140, DOI 10.1002/jbmr.3555; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; Behboudi-Gandevani S, 2018, CLIN ENDOCRINOL, V88, P169, DOI 10.1111/cen.13477; Bernardo TC, 2016, BRAIN PATHOL, V26, P648, DOI 10.1111/bpa.12403; Berridge MJ, 2015, BIOCHEM BIOPH RES CO, V460, P53, DOI 10.1016/j.bbrc.2015.01.008; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Bora E, 2017, PSYCHOL MED, V47, P1030, DOI 10.1017/S0033291716003366; Brewer LD, 2006, CELL CALCIUM, V40, P277, DOI 10.1016/j.ceca.2006.04.001; Brondum-Jacobsen P, 2013, ANN NEUROL, V73, P38, DOI 10.1002/ana.23738; Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001; Dieli-Conwright CM, 2018, J CLIN ONCOL, V36, P875, DOI 10.1200/JCO.2017.75.7526; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gauthier MS, 2003, J APPL PHYSIOL, V94, P2127, DOI 10.1152/japplphysiol.01164.2002; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Harms LR, 2012, BEHAV BRAIN RES, V230, P125, DOI 10.1016/j.bbr.2012.02.007; Hishikawa N, 2016, EUR J NEUROL, V23, P339, DOI 10.1111/ene.12845; Hoseini R, 2017, NUTRITION, V36, P54, DOI 10.1016/j.nut.2016.06.010; Jee YS, 2008, NEUROSCI LETT, V443, P188, DOI 10.1016/j.neulet.2008.07.078; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landel V, 2018, J STEROID BIOCHEM, V177, P129, DOI 10.1016/j.jsbmb.2017.09.008; Lawrence DW, 2016, BRAIN INJURY, V30, P960, DOI 10.3109/02699052.2016.1147081; Lee B, 2010, PROG NEURO-PSYCHOPH, V34, P1085, DOI 10.1016/j.pnpbp.2010.05.031; McGrath J, 2007, NEUROEPIDEMIOLOGY, V29, P49, DOI 10.1159/000108918; Michos ED, 2018, CONTEMP CLIN TRIALS, V73, P111, DOI 10.1016/j.cct.2018.08.004; Nassar MF, 2012, J EGYPT SOC PARASITO, V240, P1, DOI DOI 10.12816/0006322; Pierrot-Deseilligny C, 2017, MULT SCLER RELAT DIS, V14, P35, DOI 10.1016/j.msard.2017.03.014; Pozzi F, 2013, ENDOCRINOLOGY, P1; Reczek CR, 2018, CANCER CELL, V33, P949, DOI 10.1016/j.ccell.2018.05.010; Rueda CB, 2016, BBA-BIOENERGETICS, V1857, P1158, DOI 10.1016/j.bbabio.2016.04.003; SAFHI MM, 2018, BULL ENVIRON PHARMAC, V7, P90; Salari M, 2015, J RES MED SCI, V20, P372; Tourkova IL, 2017, LAB INVEST, V97, P1072, DOI 10.1038/labinvest.2017.62; van den Driessche JJ, 2018, FOOD FUNCT, V9, P1944, DOI [10.1039/C7FO01792H, 10.1039/c7fo01792h]; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Zong L, 2017, EXP THER MED, V14, P581, DOI 10.3892/etm.2017.4523	42	1	1	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	JUN 2	2020	130	6					595	600		10.1080/00207454.2019.1699082		JAN 2020	6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LO8MF	WOS:000511741400001	31775548				2022-02-06	
J	Lui, SK; Fook-Chong, SMC; Teo, QQ				Lui, Siew Kwaon; Fook-Chong, Stephanie Man Chung; Teo, Qiao Qi			Demographics of traumatic brain injury and outcomes of continuous chain of early rehabilitation in Singapore	PROCEEDINGS OF SINGAPORE HEALTHCARE			English	Article						Traumatic brain injury; functional outcomes; gain; efficiency; early rehabilitation	LENGTH-OF-STAY; FUNCTIONAL INDEPENDENCE MEASURE; INPATIENT REHABILITATION; SARCOPENIA; CARE; ADULTS; HOSPITALIZATION; CONCUSSION; CONSENSUS; MODERATE	Background: Evidence shows that early initiation of a continuous chain of rehabilitation is associated with better functional outcomes in traumatic brain injured patients. The Department of Rehabilitation Medicine initiated early screening and review of patients with all traumatic brain injury (TBI) severity within 72 hours of acute admission, followed by direct transfer of suitable patients to acute inpatient rehabilitation (AIR). Objectives: This study aim to document the demographics and clinical characteristics of all TBI patients admitted to the local acute hospital; determine the characteristics of patients with TBI who are directly transferred to AIR following early screening and review; and determine clinical predictors affecting functional outcomes of patients of all TBI severity. Methods: A total of 491 patients were screened and reviewed; 116 patients were directly transferred to AIR. Results: The median age of the screened cohort was 67.0 years (interquartile range 50.0-77.0 years). Falls were the leading mechanism of TBI. Infection (odds ratio (OR)=2.95, 95% confidence interval (CI) 1.59-5.49) and neurosurgical intervention (OR=2.18, 95% CI 1.24-3.81) increased the odds of transfer to AIR. The Functional Independence Measure (FIM) gain after receiving AIR was significant (p<0.001). Increased age, complications, high motor admission FIM (AFIM) and long rehabilitation length of stay (RLOS) were negatively associated with FIM gain and FIM efficiency. Conclusions: Our study demonstrated that falls were the leading mechanism of TBI, with the majority of patients being older. Infection and neurosurgical intervention increased the likelihood of transfer to AIR. There was functional improvement after AIR. Age, complications, motor AFIM and RLOS were negatively associated with FIM gain and FIM efficiency. Further local research is warranted to confirm these findings.	[Lui, Siew Kwaon; Teo, Qiao Qi] Singapore Gen Hosp, Dept Rehabil Med, 20 Coll Rd,Acad Level 4, Singapore 169856, Singapore; [Fook-Chong, Stephanie Man Chung] Singapore Gen Hosp, Hlth Serv Res Unit, Div Med, Singapore, Singapore		Lui, SK (corresponding author), Singapore Gen Hosp, Dept Rehabil Med, 20 Coll Rd,Acad Level 4, Singapore 169856, Singapore.	lui.siew.kwaon@singhealth.com.sg	Lui, Siew Kwaon/AAH-7837-2020	Lui, Siew Kwaon/0000-0001-6155-7863			Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Edwards MJ, 2003, DISABIL REHABIL, V25, P405, DOI 10.1080/0963828031000062642; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Greiss C, 2016, J TRAUMA ACUTE CARE, V80, P70, DOI 10.1097/TA.0000000000000890; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Jain S., 2019, GLASGOW COMA SCALE; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lamontagne ME., 2016, INESSS ONF CLIN PRAC; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee K. K., 2006, SMJ Singapore Medical Journal, V47, P31; Liew TYS, 2019, FRONT SURG, V6, DOI 10.3389/fsurg.2019.00037; Lin K, 2019, RANCHOS AMIGOS; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Ostermann RC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0975-y; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Sharif-Alhoseini M, 2015, SPINAL CORD, V53, P893, DOI 10.1038/sc.2015.127; Sri-on J, 2016, AM J EMERG MED, V34, P582, DOI 10.1016/j.ajem.2015.12.009; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; TEASDALE G, 1974, LANCET, V2, P81; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Wee JZ, 2016, SINGAP MED J, V57, P491, DOI 10.11622/smedj.2015162; Welch C, 2018, AGING DIS, V9, P151, DOI 10.14336/AD.2017.0315; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	50	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2010-1058	2059-2329		PROC SINGAP HEALTHC	Proc. Singap. Healthc.	MAR	2020	29	1					33	41	2010105819901137	10.1177/2010105819901137		JAN 2020	9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	KQ0QA	WOS:000509039100001		gold			2022-02-06	
J	Molnar, S; Hunya, Z; Pavlik, A; Bozsik, A; Shadgan, B; Maffulli, N				Molnar, Szabolcs; Hunya, Zsolt; Pavlik, Attila; Bozsik, Attila; Shadgan, Babak; Maffulli, Nicola			SLAP Lesion and Injury of the Proximal Portion of Long Head of Biceps Tendon in Elite Amateur Wrestlers	INDIAN JOURNAL OF ORTHOPAEDICS			English	Article						SLAP; Wrestling; Biceps; Closed kinetic chain	SUPERIOR LABRUM ANTERIOR; DIAGNOSIS; BIOMECHANICS; REPAIR; TEARS	Background Injuries to the proximal portion of the tendon of the long head of the biceps are challenging, and often only diagnosed at arthroscopy. However, it is important to be able to formulate a preoperative plan based on physical examination and imaging studies, so as to inform patients correctly, plan the likely procedure, and give indication to length and modalities of rehabilitation. Materials and Methods Eleven elite wrestlers who suffered their injury between 2008 and 2018 were investigated retrospectively. We aimed to identify an association between the mechanism and the symptoms of the biceps-labral complex injury. Results The injury was sustained at a mean age of 20.63 years, and most wrestlers were middle or light weight. All injuries occurred during shoulder movements in closed kinetic chain with the elbow extended, the forearm pronated and the shoulder slightly elevated. The surgical procedures performed were tenodesis in three wrestlers, reinsertion in seven wrestlers, and one tenotomy of the tendon of the long head of the biceps. The postoperative rehabilitation was shorter (1-3 month) in case of tenodesis or tenotomy, and markedly longer after reinsertion (6-9 months). Conclusions Injuries to the proximal part of long head of biceps tendon are relatively frequent in elite wrestlers, reflecting the high functional demands imposed on the upper limb. Though necessitating surgery, in these athletes, such injuries are not career ending, and most of our elite athletes returned to high performance levels after surgery.	[Molnar, Szabolcs; Bozsik, Attila] Med Ctr Hungarian Def Forces, Dept Traumatol, Budapest, Hungary; [Molnar, Szabolcs] Univ Phys Educ, Budapest, Hungary; [Hunya, Zsolt] Univ Debrecen, Dept Orthoped, Debrecen, Hungary; [Pavlik, Attila] Natl Inst Sports Med, Dept Sports Surg, Budapest, Hungary; [Shadgan, Babak] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada; [Maffulli, Nicola] Univ Salerno, Fac Med Surg & Dent, Dept Musculoskeletal Disorder, Salerno, Italy; [Maffulli, Nicola] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Sports & Exercise Med, Mile End Hosp, 275 Bancroft Rd, London E1 4DG, England; [Maffulli, Nicola] Keele Univ, Sch Pharm & Bioengn, Sch Med, Thornburrow Dr, Stoke On Trent, Staffs, England		Maffulli, N (corresponding author), Univ Salerno, Fac Med Surg & Dent, Dept Musculoskeletal Disorder, Salerno, Italy.; Maffulli, N (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Sports & Exercise Med, Mile End Hosp, 275 Bancroft Rd, London E1 4DG, England.; Maffulli, N (corresponding author), Keele Univ, Sch Pharm & Bioengn, Sch Med, Thornburrow Dr, Stoke On Trent, Staffs, England.	szabolcsmolnardr@gmail.com; zsolt.hunya@gmail.com; pavlika@t-online.hu; bozsika@gmail.com; shadgan@gmail.com; n.maffulli@qmul.ac.uk	Maffulli, Nicola/A-1839-2014	Maffulli, Nicola/0000-0002-5327-3702			Abdul-Rassoul H, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119841892; Ahmad CS, 2018, ARTHROSCOPY, V34, P752, DOI 10.1016/j.arthro.2018.01.001; ANDREWS JR, 1985, AM J SPORT MED, V13, P337, DOI 10.1177/036354658501300508; Ben Kibler W, 2009, AM J SPORT MED, V37, P1840, DOI 10.1177/0363546509332505; Bennett WF, 1998, ARTHROSCOPY, V14, P789, DOI 10.1016/S0749-8063(98)70012-X; Burkhart SS, 1998, ARTHROSCOPY, V14, P637, DOI 10.1016/S0749-8063(98)70065-9; Connell DA, 1999, AM J SPORT MED, V27, P208, DOI 10.1177/03635465990270021601; Delle Rose Giacomo, 2012, Musculoskelet Surg, V96 Suppl 1, pS47, DOI 10.1007/s12306-012-0189-0; Dinauer PA, 2007, SKELETAL RADIOL, V36, P195, DOI 10.1007/s00256-006-0237-7; Gausden EB, 2016, AM J ORTHOPEDICS, V45, P503; Ge HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121286; Gervasi E, 2016, MLTJ-MUSCLE LIGAMENT, V6, P427, DOI 10.11138/mltj/2016.6.4.427; Gill HS, 2007, AM J SPORT MED, V35, P1334, DOI 10.1177/0363546507300058; Goodman AD, 2018, PHYSICIAN SPORTSMED, V46, P361, DOI 10.1080/00913847.2018.1425596; Holzapfel K, 2010, EUR RADIOL, V20, P666, DOI 10.1007/s00330-009-1593-1; Jlid MC, 2013, J SPORT MED PHYS FIT, V53, P620; Lepore Luciano, 1995, Bulletin Hospital for Joint Diseases, V54, P43; Li XN, 2010, ORTHOP REV, V2, P16, DOI 10.4081/or.2010.e6; LORISH TR, 1992, AM J SPORT MED, V20, P199, DOI 10.1177/036354659202000218; MAFFET MW, 1995, AM J SPORT MED, V23, P93, DOI 10.1177/036354659502300116; Maffulli N, 1992, Br J Sports Med, V26, P107; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; Morse KW, 2019, CURR REV MUSCULOSKE, V12, P72, DOI 10.1007/s12178-019-09539-5; Myers RJ, 2010, WEST J EMERG MED, V11, P442; Osti Leonardo, 2012, Muscles Ligaments Tendons J, V2, P258; Powell SE, 2012, OPER TECHN SPORT MED, V20, P46, DOI 10.1053/j.otsm.2012.03.006; Shadgan B, 2017, BRIT J SPORT MED, V51, P387, DOI DOI 10.1136/bjsports-2016-097372.262; Shadgan B, 2010, AM J SPORT MED, V38, P1870, DOI 10.1177/0363546510369291; SNYDER S J, 1990, Arthroscopy, V6, P274, DOI 10.1016/0749-8063(90)90056-J; Sodha S, 2017, AM J SPORT MED, V45, P775, DOI 10.1177/0363546517690349; Stetson WB, 2019, ARTHROSC TEC, V8, pE781, DOI 10.1016/j.eats.2019.03.013; Tangari M, 2011, J SHOULDER ELB SURG, V20, P409, DOI 10.1016/j.jse.2010.08.008; Taylor SA, 2016, CLIN SPORT MED, V35, P1, DOI 10.1016/j.csm.2015.08.005; Thomas RE, 2018, PHYSICIAN SPORTSMED, V46, P168, DOI 10.1080/00913847.2018.1445406; Weber AE, 2014, SPORTS MED ARTHROSC, V22, P72, DOI 10.1097/JSA.0000000000000019	35	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0019-5413	1998-3727		INDIAN J ORTHOP	Indian J. Orthop.	MAY	2020	54	3					310	316		10.1007/s43465-020-00041-6		JAN 2020	7	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	LN9GL	WOS:000522607300001	32399150	Green Published			2022-02-06	
J	Lee, EP; Hsia, SH; Chan, OW; Lin, CY; Lin, JJ; Wu, HP				Lee, En-Pei; Hsia, Shao-Hsuan; Chan, Oi-Wa; Lin, Chia-Ying; Lin, Jainn-Jim; Wu, Han-Ping			Clinical role of low hemoglobin ratio in poor neurologic outcomes in infants with traumatic intracranial hemorrhage	SCIENTIFIC REPORTS			English	Article							BLOOD-CELL TRANSFUSION; BRAIN-INJURY; CHILDREN; ANEMIA; OXYGENATION; GUIDELINES; MORTALITY; ADMISSION; SCORE; SHOCK	Traumatic brain injury (TBI) is the leading cause of pediatric morbidity and mortality worldwide, and half of all fatalities occur in infants aged less than 1 year. We analyzed 129 infants diagnosed with TBI complicated with intracranial hemorrhage confirmed by brain computed tomography. We defined delta hemoglobin (Delta HB) as nadir HB - age specific mean HB, and the ratio of HB (%) as Delta HB/age specific mean HB x 100. Infants with poor neurologic outcomes had a lower admission HB and Delta HB (p < 0.05). The in-hospital mortality rate was 10.1% (13 infants), and the infants who died had a significantly lower Delta HB ratio compared to the survivors. The area under the receiving operating characteristic curve (AUC) of initial Glasgow Coma Score (GCS) in predicting neurologic outcomes was higher than that of ratio of Delta HB (0.881 v.s 0.859). In multivariate logistic regression analysis with the optimal cutoff ratio of Delta HB, it remained an independent predictor for in-hospital mortality and poor neurologic outcomes at discharge and at 6 months. AUC analysis for the ratio of Delta HB for poor neurologic outcomes in infants aged from 0-6 months was 0.85 and the optimal cutoff was -30.7% (sensitivity, 69%; specificity, 92%; positive likelihood ratio (LR+), 8.24; negative likelihood ratio (LR-), 0.34); the AUC was 0.88 in infants aged from 6-12 months and the optimal cutoff was -20.6% (sensitivity, 89%; specificity, 79%; LR+, 4.13; LR-, 0.15).	[Lee, En-Pei; Hsia, Shao-Hsuan; Chan, Oi-Wa; Lin, Chia-Ying; Lin, Jainn-Jim] Chang Gung Mem Hosp Linko, Dept Pediat, Div Pediat Crit Care Med, Taoyuan, Taiwan; [Lee, En-Pei; Hsia, Shao-Hsuan; Chan, Oi-Wa; Lin, Chia-Ying; Lin, Jainn-Jim] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Han-Ping] China Med Univ, Childrens Hosp, Dept Pediat Emergency Med, Taichung, Taiwan; [Wu, Han-Ping] China Med Univ, Childrens Hosp, Dept Med Res, Taichung, Taiwan; [Wu, Han-Ping] China Med Univ, Sch Med, Dept Med, Taichung, Taiwan		Lin, JJ (corresponding author), Chang Gung Mem Hosp Linko, Dept Pediat, Div Pediat Crit Care Med, Taoyuan, Taiwan.; Lin, JJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Wu, HP (corresponding author), China Med Univ, Childrens Hosp, Dept Pediat Emergency Med, Taichung, Taiwan.; Wu, HP (corresponding author), China Med Univ, Childrens Hosp, Dept Med Res, Taichung, Taiwan.; Wu, HP (corresponding author), China Med Univ, Sch Med, Dept Med, Taichung, Taiwan.	lin0227@cgmh.org.tw; arthur1226@gmail.com					Amagasa S, 2018, CHILD NERV SYST, V34, P673, DOI 10.1007/s00381-017-3695-4; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Child Welfare Information Gateway, 2017, CHILD AB NEGL FAT 20; Corwin HL, 2003, CRIT CARE MED, V31, pS668, DOI 10.1097/01.CCM.0000099348.99451.84; CORWIN HL, 1995, CHEST, V108, P767, DOI 10.1378/chest.108.3.767; Demaret P, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0328-8; Diedler J, 2010, CRIT CARE, V14, DOI 10.1186/cc8961; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Egol A, 1999, CRIT CARE MED, V27, P633; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Faul M, 2010, TRAUMATIC BRAIN INJU; Figaji AA, 2010, PEDIATR CRIT CARE ME, V11, P325, DOI 10.1097/PCC.0b013e3181b80a8e; Frieden T., 2014, REPORT C TRAUMATIC B; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kevin F. Y., 2016, CAN RESPIR J, V2016; Lacroix J, 2012, SEMIN PERINATOL, V36, P225, DOI 10.1053/j.semperi.2012.04.002; Lee EP, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007107, 10.1097/md.0000000000007107]; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Runyan D, 2002, WORLD REPORT VIOLENC, DOI DOI 10.1136/IP.9.1.93; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Whyte RK, 2014, PAED CHILD HEALT-CAN, V19, P213, DOI 10.1093/pch/19.4.213; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	30	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 15	2020	10	1							400	10.1038/s41598-019-57334-6			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MO3QW	WOS:000551445800016	31942018	Green Published, gold			2022-02-06	
J	Mills, GN; Garbarino, JT; Raskin, SA				Mills, Ginger N.; Garbarino, Julianne T.; Raskin, Sarah A.			Assessing prospective memory in children using the Memory for Intentions Screening Test for Youth (MISTY)	CLINICAL NEUROPSYCHOLOGIST			English	Article						Prospective memory; neuropsychological assessment; executive functioning; children	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; VIRTUAL WEEK; PERFORMANCE; ATTENTION; TASK; SCHOOLCHILDREN; IMPACT; AGE	Objective: Prospective memory (PM) is defined as the ability to remember to complete an intention in the future. The first aim of this study was to address the need for clinically useful measures of PM in children, by assessing the psychometric properties of a new measure of PM in children and adolescents, the Memory for Intentions Screening Test for Youth (MISTY). The second aim was to assess the relationship between prospective memory and age, particularly the relationships between age and the impact of different PM task demands. The third aim was to examine children's performance on different aspects of PM, such as time-based versus event-based cues. Method: One-hundred twenty-four children between the ages of 4 and 15 were given the MISTY. Results: Analyses revealed good internal consistency among the eight individual MISTY trials and among the six MISTY subscales which included two different cue types (event-based and time-based), two different time delays (2 minutes and 10 minutes), and two different response types (action and verbal). Results also revealed good split-half and inter-rater reliability. Findings highlighted significant correlations between age and the MISTY total score and all subscales, consistent with PM lifespan research. On the MISTY, children overall performed better on event-based cues than on time-based cues, and on shorter time delays than longer ones; there was no effect of response type (i.e. action vs. verbal response). Conclusions: The MISTY is a promising instrument with sound psychometric properties that could be useful in both clinical and research settings. Additionally, this study highlights the age-related process of PM development in children.	[Mills, Ginger N.] Univ Hartford, Dept Psychol, Hartford, CT 06117 USA; [Garbarino, Julianne T.] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA; [Raskin, Sarah A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Raskin, Sarah A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA		Mills, GN (corresponding author), Univ Hartford, Dept Psychol, Hartford, CT 06117 USA.	gingernmills@gmail.com		Raskin, Sarah/0000-0002-4310-4278			Aberle I, 2010, EUR J DEV PSYCHOL, V7, P419, DOI 10.1080/17405620802507707; Albada N., 2019, TURNING TIDES; BRANDIMONTE MA, 1996, PROSPECTIVE MEMORY T; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Einstein, 2008, PROSPECTIVE MEMORY C, P283; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliott J, 2008, POPULAR FEMINIST FICTION AS AMERICAN ALLEGORY: REPRESENTING NATIONAL TIME, P1, DOI 10.1057/9780230612808; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Hainselin M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00325; Henry JD, 2014, J EXP CHILD PSYCHOL, V127, P110, DOI 10.1016/j.jecp.2014.01.011; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kliegel M, 2006, CHILD NEUROPSYCHOL, V12, P407, DOI 10.1080/09297040600696040; Kliegel M, 2013, J EXP CHILD PSYCHOL, V116, P792, DOI 10.1016/j.jecp.2013.07.012; Krasny-Pacini A, 2017, DEV NEUROREHABIL, V20, P53, DOI 10.3109/17518423.2015.1058298; Kretschmer A, 2014, CHILD NEUROPSYCHOL, V20, P662, DOI 10.1080/09297049.2013.841881; Kretschmer-Trendowicz A, 2016, COGNITIVE DEV, V39, P103, DOI 10.1016/j.cogdev.2016.04.005; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Kvavilashvili L., 2008, PROSPECTIVE MEMORY C, P115; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Landsiedel J, 2017, J AUTISM DEV DISORD, V47, P646, DOI 10.1007/s10803-016-2987-y; Lewis CE, 2016, ALCOHOL CLIN EXP RES, V40, P969, DOI 10.1111/acer.13045; Mahy CEV, 2015, CHILD NEUROPSYCHOL, V21, P823, DOI 10.1080/09297049.2014.967202; Mahy CEV, 2014, DEV REV, V34, P305, DOI 10.1016/j.dr.2014.08.001; Mahy CEV, 2014, J EXP CHILD PSYCHOL, V127, P1, DOI 10.1016/j.jecp.2014.04.003; Mahy CEV, 2011, COGNITIVE DEV, V26, P269, DOI 10.1016/j.cogdev.2011.06.002; Mattli F, 2014, AGING NEUROPSYCHOL C, V21, P515, DOI 10.1080/13825585.2013.837860; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Nigro G, 2002, PERCEPT MOTOR SKILL, V95, P515, DOI 10.2466/PMS.95.6.515-519; Passolunghi MC, 1995, INT J BEHAV DEV, V18, P631, DOI 10.1177/016502549501800404; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2018, CLIN NEUROPSYCHOL, V32, P741, DOI 10.1080/13854046.2018.1484519; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Sheppard DP, 2018, CLIN NEUROPSYCHOL, V32, P748, DOI 10.1080/13854046.2018.1435823; Sisco S, 2015, J GERONTOL B-PSYCHOL, V70, P557, DOI 10.1093/geronb/gbt133; Souchay C, 2018, CLIN NEUROPSYCHOL, V32, P981, DOI 10.1080/13854046.2017.1403652; Talbot KDS, 2018, CLIN NEUROPSYCHOL, V32, P783, DOI 10.1080/13854046.2017.1393563; Talbot KDS, 2014, J EXP CHILD PSYCHOL, V127, P126, DOI 10.1016/j.jecp.2014.02.011; Voigt B, 2011, Z PSYCHOL, V219, P92, DOI 10.1027/2151-2604/a000053; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Yang TX, 2011, NEUROPSYCHOLOGY, V25, P342, DOI 10.1037/a0022239	45	1	1	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAR 20	2021	35	3					643	659		10.1080/13854046.2019.1711198		JAN 2020	17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	RD0SE	WOS:000507029500001	31933412				2022-02-06	
J	Kotloski, RJ; Rutecki, PA; Sutula, TP				Kotloski, Robert J.; Rutecki, Paul A.; Sutula, Thomas P.			Genetic Background Influences Acute Response to TBI in Kindling-Susceptible, Kindling-Resistant, and Outbred Rats	FRONTIERS IN NEUROLOGY			English	Article						TBI; electroencephalography; BDNF; genetic background; rat	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR BDNF; SEVERE HEAD-INJURY; MESSENGER-RNAS; TRKB; EXPRESSION; MORTALITY; EPILEPSY; EPILEPTOGENESIS; STIMULATION	We hypothesized that the acute response to traumatic brain injury (TBI) shares mechanisms with brain plasticity in the kindling model. Utilizing two unique, complementary strains of inbred rats, selected to be either susceptible or resistant to seizure-induced plasticity evoked by kindling of the perforant path, we examined acute electrophysiological alterations and differences in brain-derived neurotrophic factor (BDNF) protein concentrations after a moderate-to-severe brain injury. At baseline, limited strain-dependent differences in acute electrophysiological activity were found, and no differences in BDNF. Following injury, pronounced strain-dependent differences in electrophysiologic activity were noted at 0.5 min. However, the divergence is transient, with diminished differences at 5 min after injury and no differences at 10 and 15 min after injury. Strain-specific differences in BDNF protein concentration were noted 4 h after injury. A simple risk score model generated by machine learning and based solely on post-injury electrophysiologic activity at the 0.5-min timepoint distinguished perforant path kindling susceptible (PPKS) rats from non-plasticity-susceptible strains. The findings demonstrate that genetic background which affects brain circuit plasticity also affects acute response to TBI. An improved understanding of the effect of genetic background on the cellular, molecular, and circuit plasticity mechanisms activated in response to TBI and their timecourse is key in developing much-needed novel therapeutic approaches.	[Kotloski, Robert J.; Rutecki, Paul A.; Sutula, Thomas P.] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kotloski, Robert J.; Rutecki, Paul A.] William S Middleton Mem Vet Adm Med Ctr, Dept Neurol, Madison, WI 53705 USA		Kotloski, RJ (corresponding author), Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Kotloski, RJ (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Dept Neurol, Madison, WI 53705 USA.	kotloski@neurology.wisc.edu			Department of Veterans Affairs CDA-2US Department of Veterans Affairs [IK2BX002986]; Citizens United for Research in Epilepsy (CURE); Veterans AffairsUS Department of Veterans Affairs [IK2BX002986] Funding Source: NIH RePORTER	This work was funded by a Department of Veterans Affairs CDA-2 (IK2BX002986) (RK) and Citizens United for Research in Epilepsy (CURE) (TS).	Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bennett E.R., 2016, TRANSLATIONAL RES TR, DOI [10.1201/b18959-10, DOI 10.1201/B18959-10]; Binder DK, 2009, ENCYCLOPEDIA OF BASIC EPILEPSY RESEARCH, VOLS 1-3, P936; Binder DK, 1999, J NEUROSCI, V19, P1424; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Guo W, 2018, DEV NEUROBIOL, V78, P647, DOI 10.1002/dneu.22592; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Houlden H, 2006, J NEUROL NEUROSUR PS, V77, P1106, DOI 10.1136/jnnp.2006.095513; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; KAPLAN HA, 1954, JAMA-J AM MED ASSOC, V156, P1138, DOI 10.1001/jama.1954.02950120012004; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kotloski R, 2010, HIPPOCAMPUS, V20, P713, DOI 10.1002/hipo.20673; Kowianski P, 2018, CELL MOL NEUROBIOL, V38, P579, DOI 10.1007/s10571-017-0510-4; Langberg T, 2016, NEUROBIOL DIS, V85, P122, DOI 10.1016/j.nbd.2015.10.008; Larsson LE, 1954, ACTA PSYCH NEUROL SC, V95, P7; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; Mannix R, 2015, EVALUATING EFFECTS A, DOI [10.1201/b18126-11, DOI 10.1201/B18126-11]; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McNamara J O, 1986, Adv Neurol, V44, P303; Merritt V, 2017, ARCH CLIN NEUROPSYCH, V32, P659, DOI 10.1093/arclin/acx075.14; Miranda M, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00363; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Simon D, 2016, BRAIN INJURY, V30, P23, DOI 10.3109/02699052.2015.1077993; Sutula TP, 2017, MODELS OF SEIZURES AND EPILEPSY, 2ND EDITION, P813, DOI 10.1016/B978-0-12-804066-9.00055-9; Ustun B, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1125, DOI 10.1145/3097983.3098161; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WARD JW, 1948, J NEUROPHYSIOL, V11, P59, DOI 10.1152/jn.1948.11.2.59; Whittemore AS, 2010, STAT MED, V29, P2438, DOI 10.1002/sim.3991; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zhao HL, 2017, BRAIN RES, V1665, P1, DOI 10.1016/j.brainres.2017.03.029; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898	60	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 10	2020	10								1286	10.3389/fneur.2019.01286			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KF5EJ	WOS:000509264800001	31998207	Green Published, gold			2022-02-06	
J	Brown, SM; Beesley, SJ; Stubben, C; Wilson, EL; Presson, AP; Grissom, C; Maguire, C; Rondina, MT; Hopkins, RO				Brown, Samuel M.; Beesley, Sarah J.; Stubben, Chris; Wilson, Emily L.; Presson, Angela P.; Grissom, Colin; Maguire, Colin; Rondina, Matthew T.; Hopkins, Ramona O.			Postseptic Cognitive Impairment and Expression of APOE in Peripheral Blood: The Cognition After SepsiS (CASS) Observational Pilot Study	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						sepsis; cognitive impairment; peripheral blood transcriptome	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; APOLIPOPROTEIN-E; CRITICAL ILLNESS; GENE-EXPRESSION; AMYLOID LOAD; SURVIVORS; OUTCOMES; DYSFUNCTION; GENOTYPE	Background: Cognitive impairment after sepsis is an important clinical problem. Determinants of postseptic cognitive impairment are not well understood. We thus undertook a systems biology approach to exploring a possible role for apolipoprotein E (APOE) in postseptic cognitive impairment. Design: Prospective, observational cohort. Setting: Intermountain Medical Center, a tertiary referral center in Utah. Patients/Participants: Patients with sepsis admitted to study intensive care units. Interventions: None. Methods: We obtained peripheral blood for deep sequencing of RNA and followed up survivors at 6 months with a battery of cognitive instruments. We defined cognitive impairment based on the 6-month Hayling test of executive function. In our primary analysis, we employed weighted network analysis. Secondarily, we compared variation in gene expression between patients with normal versus impaired cognition. Measurements and Main Results: We enrolled 40 patients, of whom 34 were follow-up eligible and 31 (91%) completed follow-up; 1 patient's RNA sample was degraded-the final analytic cohort was 30 patients. Mean Hayling test score was 5.8 (standard deviation 1.1), which represented 20% with impaired executive function. The network module containing APOE was dominated by low-expression genes, with no association on primary analysis (P = .8). Secondary analyses suggested several potential lines of future investigation, including oxidative stress. Conclusions: In this prospective pilot cohort, executive dysfunction affected 1 in 5 survivors of sepsis. The APOE gene was sparsely transcribed in peripheral leukocytes and not associated with cognitive impairment. Future lines of research are suggested.	[Brown, Samuel M.; Beesley, Sarah J.; Wilson, Emily L.; Hopkins, Ramona O.] Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA; [Brown, Samuel M.; Beesley, Sarah J.; Wilson, Emily L.; Grissom, Colin; Hopkins, Ramona O.] Intermt Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, UT USA; [Brown, Samuel M.; Beesley, Sarah J.; Grissom, Colin] Univ Utah, Sch Med, Dept Med, Pulm & Crit Care Div, Salt Lake City, UT USA; [Stubben, Chris] Univ Utah, Huntsman Canc Inst, Bioinformat Shared Resource, Salt Lake City, UT USA; [Presson, Angela P.] Univ Utah, Sch Med, Div Epidemiol, Study Design & Biostat Ctr, Salt Lake City, UT USA; [Maguire, Colin] Univ Utah, Ctr Translat & Clin Sci, Salt Lake City, UT USA; [Maguire, Colin; Rondina, Matthew T.] Univ Utah, Univ Utah Mol Med Program, Salt Lake City, UT USA; [Maguire, Colin; Rondina, Matthew T.] Univ Utah, Dept Internal Med & Pathol, Salt Lake City, UT USA; [Rondina, Matthew T.] George & Wahlen VAMC, Dept Internal Med, Salt Lake City, UT USA; [Rondina, Matthew T.] George & Wahlen VAMC, GRECC, Salt Lake City, UT USA; [Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA		Brown, SM (corresponding author), Shock Trauma Intens Care Unit, 5121 South Cottonwood St, Murray, UT 84107 USA.	samuel.brown@imail.org	Brown, Samuel/E-6846-2015	Brown, Samuel/0000-0003-1206-6261	Intermountain Research and Medical Foundation [IRMF738]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [HL142804, HL130541, AG059877, AG04802]; University of Utah Population Health Research (PHR) Foundation; National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health [5UL1TR001067-05, 8UL1TR000105, UL1RR025764]; George E. Wahlen VA Medical Center, Salt Lake City, Utah [I01CX001696]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported primarily by the Intermountain Research and Medical Foundation (IRMF738 to S.M.B.). This work was supported by the NHLBI and NIA (HL142804, HL130541, AG059877, and AG04802 to M.T.R.). This investigation was supported by the University of Utah Population Health Research (PHR) Foundation, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 5UL1TR001067-05 (formerly 8UL1TR000105 and UL1RR025764). This material is the result of work supported with resources and the use of facilities at the George E. Wahlen VA Medical Center, Salt Lake City, Utah (I01CX001696 to M.T.R.). The sponsor had no role in the design or preparation of the article. The contents do not represent the views of the US Department of Veterans Affairs or the US Government. The funders of the study had no role in protocol design, collection or analysis of the data, or interpretation or writing of the results.	Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyle PA, 2004, CLIN NEUROPSYCHOL, V18, P75, DOI 10.1080/13854040490507172; Bozza FA, 2010, J CEREBR BLOOD F MET, V30, P440, DOI 10.1038/jcbfm.2009.215; Brown SM, 2018, ANN AM THORAC SOC, V15, P1108, DOI 10.1513/AnnalsATS.201804-233OC; Calsavara AJC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22754-3; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chodosh J, 2004, J AM GERIATR SOC, V52, P1456, DOI 10.1111/j.1532-5415.2004.52407.x; Chuang KI, 2011, AM J SURG, V202, P325, DOI 10.1016/j.amjsurg.2010.10.017; Dinglas VD, 2016, THORAX, V71, P401, DOI 10.1136/thoraxjnl-2015-208017; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duggan MC, 2017, J CRIT CARE, V37, P72, DOI 10.1016/j.jcrc.2016.08.023; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fu P, 2014, J MICROBIOL IMMUNOL, V47, P122, DOI 10.1016/j.jmii.2013.05.010; Fukumoto H, 2003, EXP NEUROL, V183, P249, DOI 10.1016/S0014-4886(03)00088-8; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Honma T, 2013, J CLIN BIOCHEM NUTR, V52, P234, DOI 10.3164/jcbn.12-85; Hopkins RO, 2007, AM J RESP CRIT CARE, V176, P1001, DOI 10.1164/rccm.200702-290OC; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Joober R, 2012, J PSYCHIATR NEUROSCI, V37, P149, DOI 10.1503/jpn.120065; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kaysville UT, 2012, PASS 12; Khandaker GM, 2011, JAMA-J AM MED ASSOC, V305, P673, DOI 10.1001/jama.2011.142; Lambert JC, 2005, J NEUROL NEUROSUR PS, V76, P928, DOI 10.1136/jnnp.2004.048983; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li K, 2015, CIRC RES, V117, pe1, DOI 10.1161/CIRCRESAHA.117.305844; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Martinez-Lopez E, 2007, LIVER INT, V27, P930, DOI 10.1111/j.1478-3231.2007.01509.x; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Miller RR, 2013, AM J RESP CRIT CARE, V188, P77, DOI 10.1164/rccm.201212-2199OC; Mlinaric A, 2017, BIOCHEM MEDICA, V27, P447, DOI 10.11613/BM.2017.030201; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Morandi A, 2011, CHEST, V140, P580, DOI 10.1378/chest.10-3065; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Norman BC, 2016, CRIT CARE MED, V44, P2003, DOI 10.1097/CCM.0000000000001849; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Polito A, 2013, CRIT CARE, V17, DOI 10.1186/cc12899; Porhomayon J, 2015, J CARDIOVASC THORAC, V7, P43, DOI 10.15171/jcvtr.2015.10; R Core Team, 2017, R LANG ENV STAT COMP; Raymond SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184159; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; SALOMON RN, 1992, P NATL ACAD SCI USA, V89, P2814, DOI 10.1073/pnas.89.7.2814; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Taccone FS, 2013, CURR VASC PHARMACOL, V11, P170; Trusca VG, 2011, J BIOL CHEM, V286, P13891, DOI 10.1074/jbc.M110.179572; Wang CQ, 2012, CLIN BIOCHEM, V45, P215, DOI 10.1016/j.clinbiochem.2011.11.009; Yi D, 2014, AM J GERIAT PSYCHIAT, V22, P961, DOI 10.1016/j.jagp.2013.12.173; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	60	1	1	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	MAR	2021	36	3					262	270	0885066619897604	10.1177/0885066619897604		JAN 2020	9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QC5MU	WOS:000506973700001	31916880	Green Accepted			2022-02-06	
J	Sorbo, A; Eiving, I; Theodorsson, E; Rydenhag, B; Jonsdottir, IH				Sorbo, Ann; Eiving, Ingrid; Theodorsson, Elvar; Rydenhag, Bertil; Jonsdottir, Ingibjorg H.			Pre-traumatic conditions can influence cortisol levels before and after a brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						hair cortisol; pretraumatic conditions; severe brain injury; stress	SUBARACHNOID HEMORRHAGE; ACUTE-PHASE; ADRENAL INSUFFICIENCY; HAIR; PREDICTORS; ACTIVATION; GUIDELINES; MANAGEMENT; SEDATION; STRESS	Objective Satisfactory anabolic reactions, including the activation of the hypothalamic-pituitary-adrenal (HPA) axis, are essential following severe traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH). Many factors may influence this activation. This study aimed to investigate whether individuals who reported chronic diseases, psychosocial afflictions, or stressful events before a severe brain injury display a different pattern regarding cortisol levels retrospectively and up to three months compared with those who did not report stressful experiences. Materials and Methods Fifty-five patients aged 16-68 years who were admitted to the neurointensive care unit (NICU) were included. Hair cortisol measurements offer a unique opportunity to monitor cortisol levels retrospectively and after the trauma. Hair strands were collected as soon as possible after admission to the NICU and every month until three months after the injury/insult. The participants/relatives were asked about stressful events, psychosocial afflictions and recent and chronic diseases. Results The group who reported chronic diseases and/or stressful events before the brain injury had more than twice as high median hair cortisol levels before the brain injury compared with those who did not report stress, but the difference was not statistically significant (P = .12). Those who reported stress before the brain injury had statistically significantly lower hair cortisol values after the brain injury and they remained until three months after the injury. Conclusions Stressful events and/or chronic disease before brain injury might affect mobilization of adequate stress reactions following the trauma. However, the large variability in cortisol levels in these patients does not allow firm conclusions and more studies are needed.	[Sorbo, Ann] Sodra Alvsborg Hosp, Dept Neurol & Rehabil, SE-50182 Boras, Sweden; [Sorbo, Ann] Uddevalla Cent Hosp, Dept Neurol & Rehabil, Uddevalla, Sweden; [Sorbo, Ann; Rydenhag, Bertil] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Eiving, Ingrid] Sahlgrens Univ Hosp, Dept Anesthesiol & Intens Care, Neurointens Care Unit, Gothenburg, Sweden; [Theodorsson, Elvar] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden; [Theodorsson, Elvar] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Rydenhag, Bertil] Sahlgrens Univ Hosp, Dept Neurosurg, Gothenburg, Sweden; [Jonsdottir, Ingibjorg H.] Inst Stress Med, Gothenburg, Sweden		Sorbo, A (corresponding author), Sodra Alvsborg Hosp, Dept Neurol & Rehabil, SE-50182 Boras, Sweden.	ann.km.sorbo@vgregion.se		Sorbo, Ann/0000-0002-6744-6942	Health and Medical Care Committee of Region Vastra Gotaland; Department of Research and Development-NU Hospital Organization, Region Vastra Gotaland; Department of Research Sodra Alvsborg Hospital; Sodra Alvsborg Research Council, Region Vastra Gotaland, Sweden	This work was supported by grants from the Health and Medical Care Committee of Region Vastra Gotaland, the Department of Research and Development-NU Hospital Organization, Region Vastra Gotaland, the Department of Research Sodra Alvsborg Hospital and the Sodra Alvsborg Research Council, Region Vastra Gotaland, Sweden.	Abou El Fadl MH, 2018, NEUROSURG CLIN N AM, V29, P213, DOI 10.1016/j.nec.2017.11.002; Ben Assayag E, 2017, PSYCHONEUROENDOCRINO, V82, P133, DOI 10.1016/j.psyneuen.2017.05.013; Brorsson C, 2011, ACTA ANAESTH SCAND, V55, P944, DOI 10.1111/j.1399-6576.2011.02451.x; Brorsson C, 2014, INJURY, V45, P1149, DOI 10.1016/j.injury.2014.02.001; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Colledge F, 2017, NEUROPSYCHOBIOLOGY, V75, P12, DOI 10.1159/000477966; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2012.654479, 10.3109/10253890.2011.619239]; Feller S, 2014, PSYCHONEUROENDOCRINO, V39, P132, DOI 10.1016/j.psyneuen.2013.10.007; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Gow R, 2011, CLIN ENDOCRINOL, V74, P687, DOI 10.1111/j.1365-2265.2011.04001.x; Hutter BO, 2014, J NEUROSURG, V120, P923, DOI 10.3171/2013.11.JNS121552; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Lambert G, 2002, ACTA ANAESTH SCAND, V46, P160, DOI 10.1034/j.1399-6576.2002.460206.x; Li M, 2016, J INVEST MED, V64, P752, DOI 10.1136/jim-2015-000012; Lindgren C, 2013, ACTA ANAESTH SCAND, V57, P452, DOI 10.1111/aas.12014; Lindgren C, 2014, NEUROCRIT CARE, V21, P91, DOI 10.1007/s12028-013-9945-8; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Morelius E, 2004, SCAND J CLIN LAB INV, V64, P113, DOI 10.1080/00365510410004452; Naredi S, 2003, CRIT CARE MED, V31, P2713, DOI 10.1097/01.CCm.0000095462.89651.9C; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Naredi S, 2006, INTENS CARE MED, V32, P1955, DOI 10.1007/s00134-006-0408-y; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; SONNE NM, 1992, BRIT J NEUROSURG, V6, P125, DOI 10.3109/02688699209002914; Stalder T, 2010, BIOL PSYCHOL, V85, P357, DOI 10.1016/j.biopsycho.2010.08.005; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Tonnesen H, 1999, BMJ-BRIT MED J, V318, P1311, DOI 10.1136/bmj.318.7194.1311; Vespa P, 2011, NEUROCRIT CARE, V15, P361, DOI 10.1007/s12028-011-9587-7; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	33	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	APR	2020	141	4					342	350		10.1111/ane.13212		JAN 2020	9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KR7NO	WOS:000506255100001	31879940				2022-02-06	
J	Gillespie, CS; Mcleavy, CM; Islim, AI; Prescott, S; McMahon, CJ				Gillespie, Conor S.; Mcleavy, Christopher M.; Islim, Abdurrahman I.; Prescott, Sarah; McMahon, Catherine J.			Rationalising neurosurgical head injury referrals: development and validation of the Liverpool Head Injury Tomography Score (Liverpool HITS) for mild TBI	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Mild TBI; neurosurgery referral; head injury; scoring system	TRAUMATIC BRAIN-INJURY; MORTALITY; TRENDS; VISITS	Introduction: A radiological scoring system to define a 'surgically significant' mild Traumatic Brain Injury (TBI) could stratify neurosurgical referrals, and improve communication between referral centres and neurosurgical units, as most referrals are not accepted. Materials and methods: A computed tomography (CT) scoring system based on radiological injuries sustained in a TBI was developed and validated. All neurosurgical referrals to a major tertiary neurosurgery centre in England, UK with a mild TBI (GCS 13-15) during the period of 1st January to 30th October 2017 were scored retrospectively and stratified according to their mean score, and if they were accepted for transfer to the neurosurgical centre. A total of 1248 patients were identified during the study period, with 1144 being included in the final analysis. Results: Of the referrals to the neurosurgical centre, 17% (n = 195) were accepted for transfer and 83% (n = 946) were not accepted. The scoring system was 99% sensitive and 51.9% specific for determining a surgically significant TBI. Diagnostic power of the model was fair with an area under the curve of 0.79 (95% CI 0.76 to 0.82). The score identified 495 (52.2%) patients in ten months of referrals that could have been successfully managed locally without neurosurgical referral if the scoring system was correctly used at the time of injury. Conclusions: The Liverpool Head Injury Tomography Score (HITS) score is a CT-based scoring system that can be used to define a surgically significant mild TBI. The scoring system has high sensitivity and could be incorporated into local, regional and national head injury guidance.	[Gillespie, Conor S.; Islim, Abdurrahman I.; Prescott, Sarah; McMahon, Catherine J.] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Gillespie, Conor S.] Univ Liverpool, Sch Med, Liverpool, Merseyside, England; [Mcleavy, Christopher M.] Aintree Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Islim, Abdurrahman I.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Islim, Abdurrahman I.] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England		Gillespie, CS (corresponding author), Sch Med, Cedar House,Ashton St, Liverpool L69 3GE, Merseyside, England.	hlcgill2@liverpool.ac.uk		McLeavy, Christopher/0000-0001-7043-0266; Gillespie, Conor/0000-0002-9153-3077; Islim, Abdurrahman/0000-0001-9621-043X			Amarouche M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017495; Amoo M, 2018, BRIT J NEUROSURG, V32, P585, DOI 10.1080/02688697.2018.1522416; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Charry JD, 2017, J NEUROSCI RURAL PRA, V8, P23, DOI 10.4103/jnrp.jnrp_434_16; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Gelinne A, 2019, WORLD NEUROSURG, V126, pE564, DOI 10.1016/j.wneu.2019.02.095; Gordon WE, 2019, NEUROSURGERY, V85, P290, DOI 10.1093/neuros/nyy248; Gulsin GS, 2016, BRIT J NEUROSURG, V30, P187, DOI 10.3109/02688697.2015.1122170; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Joshi SS, 2018, BRIT J NEUROSURG, V32, P553, DOI 10.1080/02688697.2018.1490944; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Lecky F, 2015, EMERG MED J, V32, P906, DOI 10.1136/emermed-2015-205460; Lewis Paul R, 2017, J Trauma Acute Care Surg, V82, P776, DOI 10.1097/TA.0000000000001388; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022279; Matloob SA, 2016, BRIT J NEUROSURG, V30, P191, DOI 10.3109/02688697.2016.1161171; Michelson EA, 2018, WEST J EMERG MED, V19, P635, DOI 10.5811/westjem.2018.5.37293; Mohammadifard M, 2018, EUR J TRANSL MYOL, V28, P265, DOI 10.4081/ejtm.2018.7542; Mukerji N, 2013, BRIT J NEUROSURG, V27, P334, DOI 10.3109/02688697.2012.717979; Munakomi Sunil, 2016, Surg Neurol Int, V7, P23, DOI 10.4103/2152-7806.177125; Najem D, 2018, BIOCHEM CELL BIOL, V96, P391, DOI 10.1139/bcb-2016-0160; NICE, 2014, HEAD INJ ASS EARL MA; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Storey M, 2015, BMJ QUAL IMPROV REPO, V4, pu203531w2516; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z	38	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAR 3	2020	34	2					127	134		10.1080/02688697.2019.1710825		JAN 2020	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ME1RZ	WOS:000506353900001	31916459	Green Submitted			2022-02-06	
J	Sonnerqvist, C; Brus, O; Olivecrona, M				Sonnerqvist, Caroline; Brus, Ole; Olivecrona, Magnus			Validation of the scandinavian guidelines for initial management of minor and moderate head trauma in children	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Children; CT; Guidelines; Validation	CLINICAL DECISION RULE; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; MILD; SEVERITY; PECARN; S100B; RISK; CT	Background Head trauma in children is common, with a low rate of clinically important traumatic brain injury. CT scan is the reference standard for diagnosis of traumatic brain injury, of which the increasing use is alarming because of the risk of induction of lethal malignancies. Recently, the Scandinavian Neurotrauma Committee derived new guidelines for the initial management of minor and moderate head trauma. Our aim was to validate these guidelines. Methods We applied the guidelines to a population consisting of children with mild and moderate head trauma, enrolled in the study: "Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study" by Kuppermann et al. (Lancet 374(9696):1160-1170,, 2009). We calculated the negative predictive values of the guidelines to assess their ability to distinguish children without clinically-important traumatic brain injuries and traumatic brain injuries on CT scans, for whom CT could be omitted. Results We analysed a population of 43,025 children. For clinically-important brain injuries among children with minimal head injuries, the negative predictive value was 99.8% and the rate was 0.15%. For traumatic findings on CT, the negative predictive value was 96.9%. Traumatic finding on CT was detected in 3.1% of children with minimal head injuries who underwent a CT examination, which accounts for 0.45% of all children in this group. Conclusion Children with minimal head injuries can be safely discharged with oral and written instructions. Use of the SNC-G will potentially reduce the use of CT.	[Sonnerqvist, Caroline] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Brus, Ole] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Olivecrona, Magnus] Orebro Univ, Fac Med & Hlth, Dept Med Sci, Orebro, Sweden; [Olivecrona, Magnus] Orebro Univ Hosp, Dept Anaesthesiol & Intens Care, Sect Neurosurg, Orebro, Sweden		Olivecrona, M (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Med Sci, Orebro, Sweden.; Olivecrona, M (corresponding author), Orebro Univ Hosp, Dept Anaesthesiol & Intens Care, Sect Neurosurg, Orebro, Sweden.	magnus.olivecrona@oru.se		Olivecrona, Magnus/0000-0001-8457-4711	orebro University; HRSA/MCHB/EMSCUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)	Open access funding provided by orebro University. This manuscript was prepared using the Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study data set obtained from University of Utah School of Medicine. It does not necessarily reflect the opinions or views of the study investigators or the Health Resources Service Administration (HRSA) Maternal Child Health Bureau (MCHB) Emergency Medical Services for Children (EMSC). The material is made available through the Pediatric Emergency Care Applied Research Network (PECARN). The PECARN was funded by the HRSA/MCHB/EMSC	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Almen A, 2008, SWEDISH RADIOLOGISKA; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Grubenhoff JA, 2011, BRAIN INJURY, V25, P943, DOI 10.3109/02699052.2011.597043; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Mihindu E, 2014, AM SURGEON, V80, P841; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2018, CAN MED ASSOC J, V190, pE816, DOI 10.1503/cmaj.170406; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; PECARN, 2019, ID CHILDR VER LOW RI; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Sheppard John P, 2018, Brain Tumor Res Treat, V6, P1, DOI 10.14791/btrt.2018.6.e4; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Unden J, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1166-8	28	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2021	47	4			SI		1163	1173		10.1007/s00068-019-01288-x		JAN 2020	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TS1QF	WOS:000574084200001	31907552	hybrid, Green Published			2022-02-06	
J	Bocciarelli, M; Carvelli, V; Mariani, S; Tenni, M				Bocciarelli, Massimiliano; Carvelli, Valter; Mariani, Stefano; Tenni, Matteo			Assessment of the shock adsorption properties of bike helmets: a numerical/experimental approach	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						helmets; impacts; traumatic brain injury (TBI); numerical modelling	ENERGY-ABSORPTION; STRAIN-RATE; DEFORMATION MECHANISMS; POLYMERIC FOAMS; POLYSTYRENE; BEHAVIOR; INJURY; RATES; COMPRESSION	In this paper, a numerical and experimental study of the shock absorption properties of bike helmets is presented. Laboratory compression and tensile tests were carried out on samples of expanded polystyrene (EPS) and polycarbonate (PC), respectively constituting the internal shock absorption layer and the external hard shell of composite helmets. The measured responses of the two materials were then exploited to calibrate the relevant elasto-plastic constitutive models, adopted in full-scale finite element analyses of a helmet subject to standardized impacts. The simulations allowed assessing the time evolution of the acceleration measured inside the headform (according e.g., to EN 1078) and the failure mechanisms of the helmet, if any, as induced by the localization of plastic deformations.	[Bocciarelli, Massimiliano; Carvelli, Valter] Politecn Milan, Dipartimento Architettura Ingn Costruz & Ambiente, Milan, Italy; [Mariani, Stefano] Politecn Milan, Dipartimento Ingn Civile & Ambientale, Milan, Italy; [Mariani, Stefano] Politecn Milan, E4Sport Engn Sport Lab, Milan, Italy; [Tenni, Matteo] MET SpA, Talamona, Italy		Mariani, S (corresponding author), Politecn Milan, Dipartimento Ingn Civile & Ambientale, Milan, Italy.; Mariani, S (corresponding author), Politecn Milan, E4Sport Engn Sport Lab, Milan, Italy.	stefano.mariani@polimi.it		Mariani, Stefano/0000-0001-5111-9800	Met S.p.A.; project Safer Helmets by Fondazione Cariplo	Financial support to this work was provided by Met S.p.A., which is gratefully acknowledged. SM also acknowledges the funding of project Safer Helmets by Fondazione Cariplo.	Andena L, 2016, PROCEDIA ENGINEER, V147, P478, DOI 10.1016/j.proeng.2016.06.224; Andena L, 2019, J CELL PLAST, V55, P49, DOI 10.1177/0021955X18806794; Andena L, 2018, SPORTS ENG, V21, P453, DOI 10.1007/s12283-018-0292-z; Andena L, 2015, SPORTS ENG, V18, P1, DOI 10.1007/s12283-014-0162-2; [Anonymous], 2012, 1078 EN; [Anonymous], 2012, 5271 ISO; [Anonymous], 2006, 960 EN; [Anonymous], 2002, 604 ISO; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Arezoo S, 2013, INT J IMPACT ENG, V51, P50, DOI 10.1016/j.ijimpeng.2012.07.010; Bathe K.-J., 1996, FINITE ELEMENT PROCE; BAUWENSC.C, 1974, J MATER SCI, V9, P1197, DOI 10.1007/BF00552841; Bazant Z.P., 2010, STABILITY STRUCTURES; Boumbimba RM, 2018, J POLYM RES, V25, DOI 10.1007/s10965-018-1479-5; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Cao K, 2010, MAT SCI ENG A-STRUCT, V527, P4056, DOI 10.1016/j.msea.2010.03.088; Caserta G, 2010, MECH ADV MATER STRUC, V17, P366, DOI 10.1080/15376494.2010.488612; Chen WS, 2015, MATER DESIGN, V69, P170, DOI 10.1016/j.matdes.2014.12.024; Cobb BR, 2018, P I MECH ENG P-J SPO, V232, P176, DOI 10.1177/1754337117708092; Comi C, 2001, INT J SOLIDS STRUCT, V38, P6427, DOI 10.1016/S0020-7683(01)00066-X; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; D'Mello RJ, 2012, P ROY SOC A-MATH PHY, V468, P2981, DOI 10.1098/rspa.2011.0722; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Duncan O, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/5/054014; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Giustini M, 2005, OSAMPPRT267 I SUP SA; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Ikeshima D, 2018, COMP MATER SCI, V145, P306, DOI 10.1016/j.commatsci.2018.01.001; Kiernan S, 2010, INT J ENG SCI, V48, P1373, DOI 10.1016/j.ijengsci.2010.09.004; Koncan DA, 2016, PROCEDIA ENGINEER, V147, P578, DOI 10.1016/j.proeng.2016.06.243; Krundaeva A, 2016, POLYM TEST, V55, P61, DOI 10.1016/j.polymertesting.2016.08.005; Kuhn EN, 2017, SPORTS ENG, V20, P29, DOI 10.1007/s12283-016-0215-9; Ling C, 2018, INT J MECH SCI, V144, P480, DOI 10.1016/j.ijmecsci.2018.06.014; Lu YB, 2011, INT J IMPACT ENG, V38, P41, DOI 10.1016/j.ijimpeng.2010.08.001; Menges G, 1982, MECHANICS CELLULAR P, P27; Mills NJ, 2010, J MATER SCI, V45, P5831, DOI 10.1007/s10853-010-4659-1; Milne G, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P309; Mosleh Y, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700059; Mulliken AD, 2006, INT J SOLIDS STRUCT, V43, P1331, DOI 10.1016/j.ijsolstr.2005.04.016; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Pellegrino A, 2015, INT J IMPACT ENG, V75, P214, DOI 10.1016/j.ijimpeng.2014.08.005; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Scarpa F, 2004, SMART MATER STRUCT, V13, P49, DOI 10.1088/0964-1726/13/1/006; SIMO JC, 1998, INTERD APPL, V7, P1; Simulia, 2017, ABAQUS 2017 US MAN; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Song B, 2005, INT J IMPACT ENG, V31, P509, DOI 10.1016/j.ijimpeng.2004.02.003; Souza Neto EAD, 2008, COMPUTATIONAL METHOD; Srivastava V, 2010, INT J PLASTICITY, V26, P1138, DOI 10.1016/j.ijplas.2010.01.004; Tinard V, 2011, MATER DESIGN, V32, P3112, DOI 10.1016/j.matdes.2010.12.019; Tvergaard V, 2008, INT J SOLIDS STRUCT, V45, P3951, DOI 10.1016/j.ijsolstr.2008.02.024; Walter TR, 2009, J ENG MATER-T ASME, V131, DOI 10.1115/1.3026556; Wendlandt M, 2005, POLYMER, V46, P11786, DOI 10.1016/j.polymer.2005.08.079; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zhang J, 1998, INT J IMPACT ENG, V21, P369, DOI 10.1016/S0734-743X(97)00087-0; Zienkiewicz O.C., 2000, FINITE ELEMENT METHO, V2	56	1	1	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	APR 3	2020	23	5					169	181		10.1080/10255842.2019.1709451		JAN 2020	13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	KO4ZZ	WOS:000505871500001	31905291				2022-02-06	
J	Davanzo, JR; Simon, SD				Davanzo, Justin R.; Simon, Scott D.			Temporal augmentation with poly methyl methacrylate at the time of autologous cranioplasty	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Temporal augmentation; cranioplasty; hemicraniectomy; stroke; neurotrauma	MIDDLE CEREBRAL-ARTERY; DECOMPRESSIVE SURGERY; MALIGNANT INFARCTION; MULTICENTER; TRIAL	Patients undergoing decompressive hemicraniectomy often have temporal wasting. We present a technique to manage temporalis wasting at the time of cranioplasty. Using poly methyl methacrylate, a small temporal implant is placed during cranioplasty. This is both a simple and cost effective technique for temporal augmentation at the time of cranioplasty.	[Davanzo, Justin R.; Simon, Scott D.] Penn State Hershey Med Ctr, Dept Neurosurgery, Hershey, PA USA; [Davanzo, Justin R.] Med Ctr, Dept Neurosurgery,Penn State Hershey, CONTACT Justin Davanzo,30 Hope Dr, Hershey, PA USA		Davanzo, JR (corresponding author), Penn State Hershey Med Ctr, Dept Neurosurgery, Hershey, PA USA.; Davanzo, JR (corresponding author), Med Ctr, Dept Neurosurgery,Penn State Hershey, CONTACT Justin Davanzo,30 Hope Dr, Hershey, PA USA.	jdavanzo@pennstatehealth.psu.edu					Atherton DD, 2010, J PLAST RECONSTR AES, V63, P1629, DOI 10.1016/j.bjps.2009.09.022; BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; D'Urso PS, 2000, BRIT J PLAST SURG, V53, P200, DOI 10.1054/bjps.1999.3268; Gordon CR, 2011, AESTHET SURG J, V31, P827, DOI 10.1177/1090820X11417425; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; McNichols CH, 2012, J CRANIOFAC SURG, V23, pE234, DOI 10.1097/SCS.0b013e31824de5b8; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; WATANABE K, 1984, ANN PLAS SURG, V13, P309, DOI 10.1097/00000637-198410000-00006; Wirtz C R, 1997, Neurosurg Focus, V2, pE3	14	1	1	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JAN 2	2020	34	1					102	103		10.1080/02688697.2017.1418291			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS3UH	WOS:000518237500026	29256265				2022-02-06	
J	Hromas, G; Polejaeva, E; Sozda, CN; Heilman, KM; Schmalfuss, IM; Perlstein, WM				Hromas, Gabrielle; Polejaeva, Elena; Sozda, Christopher N.; Heilman, Kenneth M.; Schmalfuss, Ilona M.; Perlstein, William M.			The influence of traumatic brain injury on the allocation of vertical spatial attention	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; attention network task; altitudinal attention; vertical attention bias	PRISM ADAPTATION; NEGLECT; EFFICIENCY	Objective: Research on impairments of spatial attention has primarily investigated hemispatial neglect in brain-lesioned patients, revealing decrements in the allocation of attention to right versus left egocentric or allocentric hemispace. Whereas head trauma might injure those parts of the brain that allocate vertical attention, little is known about the influence of trauma on the allocation of visuospatial attention in vertical space. Thus, the goal of this study was to learn if chronic moderate-to-severe traumatic brain injury (m/sTBI) alters the allocation of vertical visuospatial attention as assessed by the Attention Network Task (ANT). The ANT assesses the influence of Posner-type spatial cues and distractors using an Eriksen flanker task. Methods: 12 chronic m/sTBI patients and 12 demographically-matched neurologically-healthy controls (HCs) completed a version of the ANT wherein trials were coded for cue and target locations above and below central visual fixation. Trial-wise reaction times (RT) and accuracy were subjected to mixed-model ANOVAs and planned contrasts. Results: These data were subject to secondary analyses, which revealed that across groups, median RTs were significantly faster when targets occurred above than below the central visual fixation (p < .01); however, only HCs' error rates differed as a function of target altitude. Unlike controls, m/sTBI survivors did not exhibit the anticipated upward error-rate attentional bias. Conclusions: As alteration of spatial attention can be a major cause of disability, present findings suggest that m/sTBI survivors exhibit this loss of normal upward attentional bias. Future studies are need to learn if these patients might benefit from treatment.	[Hromas, Gabrielle; Polejaeva, Elena; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Sozda, Christopher N.; Schmalfuss, Ilona M.] NF SG VAMC, Rehabil Res & Dev, Gainesville, FL USA; [Heilman, Kenneth M.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Heilman, Kenneth M.; Perlstein, William M.] NF SG VAMC, BRRC, Brain Rehabil Res Ctr, Gainesville, FL USA; [Schmalfuss, Ilona M.] Univ Florida, Dept Radiol, Gainesville, FL 32610 USA		Hromas, G (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	galtomare@ufl.edu					ADAIR JC, 1995, J NEUROL NEUROSUR PS, V58, P724, DOI 10.1136/jnnp.58.6.724; Asanowicz D, 2012, BRAIN COGNITION, V79, P117, DOI 10.1016/j.bandc.2012.02.014; Beck A., 1996, BECK DEPRESSION INVE; Benton A., 1983, JUDGEMENT LINE ORIEN; Benton A., 1976, MULTILINGUAL APHASIA; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; Blom G, 1958, STAT ESTIMATES TRANS; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Champod AS, 2018, NEUROPSYCHOL REHABIL, V28, P491, DOI 10.1080/09602011.2016.1182032; Chen P, 2016, NEUROREHAB NEURAL RE, V30, P451, DOI 10.1177/1545968315604397; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Cohen J., 2013, STAT POWER ANAL BEHA; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Drain M, 1996, J EXP PSYCHOL GEN, V125, P139, DOI 10.1037/0096-3445.125.2.139; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fink GR, 2001, NEUROIMAGE, V14, pS59, DOI 10.1006/nimg.2001.0819; Grill-Spector K, 2017, ANNU REV VIS SCI, V3, P167, DOI 10.1146/annurev-vision-102016-061214; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilman K. M., 2003, CLIN NEUROPSYCHOLOGY, P296, DOI [DOI 10.1016/B0-12-226870-9/00804-2, DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030]; Heilman K.M., 2012, CLIN NEUROPSYCHOLOGY; Heilman KM, 2000, SEMIN NEUROL, V20, P463, DOI 10.1055/s-2000-13179; Hill-Jarrett TG, 2015, BRAIN INJURY, V29, P1617, DOI 10.3109/02699052.2015.1075155; Kaplan E., 2001, BOSTON NAMING TEST; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kinsbourne M., 1970, T AM NEUROL ASSOC, V95, P43; LADAVAS E, 1994, NEUROPSYCHOLOGIA, V32, P1195, DOI 10.1016/0028-3932(94)90102-3; Lenhard W., 2014, HYPOTHESIS TESTS COM, DOI [10.13140/RG.2.1.2954.1367, DOI 10.13140/RG.2.1.2954.1367]; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McGinley, 2000, MENTAL HLTH SCREENIN; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RAPCSAK SZ, 1988, NEUROLOGY, V38, P277, DOI 10.1212/WNL.38.2.277; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reitan RM, 1992, TRAIL MAKING TEST MA; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; SHELTON PA, 1990, BRAIN, V113, P191, DOI 10.1093/brain/113.1.191; Shiraishi H, 2008, NEUROREHABILITATION, V23, P137; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Sozda C. N., 2012, THESIS; Speilberger C, 1983, MANUAL STATE TRAIT A; Spreen O, 1991, COMPENDIUM NEUROPSYC; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; TEASDALE G, 1974, LANCET, V2, P81; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Ungerleider LG., 1982, ANAL VISUAL BEHAV; Wechsler D, 1987, MEMORY SCALE REVISED; WOLFINGER R, 1994, SIAM J SCI COMPUT, V15, P1294, DOI 10.1137/0915079	58	1	1	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2020	42	1					101	110		10.1080/13803395.2019.1685650			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KA8MP	WOS:000506057000009	31665971				2022-02-06	
J	Jamwal, R; Enticott, J; Farnworth, L; Di Winkler; Callaway, L				Jamwal, Rebecca; Enticott, Joanne; Farnworth, Louise; Di Winkler; Callaway, Libby			The use of electronic assistive technology for social networking by people with disability living in shared supported accommodation	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Social networking; assistive technology; social integration; disabled persons	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; OUTCOMES; REHABILITATION; EXPERIENCES; NEEDS	Background: This study aimed to examine use of electronic assistive technology for social networking by people with disability living in shared supported accommodation (SSA), and compare participants' Electronic Social Networking (ESN) integration with Australian ESN normative data. Method: Telephone surveys and the ESN subscale of the Community Integration Questionnaire-Revised (CIQ-R) were administered with SSA managers. Surveys gathered demographic data, and data on Internet access, technology use and ESN integration, of 91 people with disability who were identified technology users and living in SSA. Participant ESN data were then matched with existing CIQ-R ESN normative data (N = 359). Relative risk of reduced ESN integration was calculated. Results: This study identified that, despite access to mainstream technologies, people with disability living in SSA experience low ESN integration, and use ESN for social contact less than other Australians. This group were 210% more likely to report reduced ESN integration than the matched normative sample when key demographic variables were held constant. Conclusions: Factors related to disability, including high care and support needs and greater time spent completing essential activities of daily living (such as personal care), may explain the low electronic social networking integration for people with disability living in SSA identified in this study. Further research that examines factors that influence ESN access and use following disability is necessary to inform practice to bridge the digital divide that exists between this group and other Australians.	[Jamwal, Rebecca; Farnworth, Louise; Callaway, Libby] Monash Univ, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Dept Occupat Therapy, Peninsula Campus, Frankston, Vic, Australia; [Jamwal, Rebecca] Austin Hlth, Royal Talbot Rehabil Ctr, Kew, Vic, Australia; [Enticott, Joanne] Monash Univ, Sch Clin Sci, Dept Psychiat, Southern Synergy,Monash Hlth, Clayton, Vic, Australia; [Di Winkler] Summer Fdn Ltd, Blackburn, Vic, Australia; [Callaway, Libby] Neuroskills Pty Ltd, Sandringham, Vic, Australia		Jamwal, R (corresponding author), Monash Univ, Dept Occupat Therapy, Peninsula Campus, Frankston, Vic, Australia.	rebecca.jamwal@gmail.com	enticott, joanne C/I-1587-2014	enticott, joanne C/0000-0002-4480-5690; Callaway, Libby/0000-0002-3127-6312; Jamwal, Rebecca/0000-0001-6777-0040; Farnworth, Louise/0000-0001-7740-4706; Winkler, Di/0000-0003-3899-6248	Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research Development Grant [H14-99]; Australian Government Research Training Program (RTP) ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science	This work was funded by the Transport Accident Commission through the Institute for Safety, Compensation and Recovery Research Development Grant H14-99. The first author would also like to acknowledge the support they received to undertake this work through an Australian Government Research Training Program (RTP) Scholarship.	Australian Bureau of Statistics, 2016, HOUS US INF TECHN AU; Australian Rehabilitation & Assistive Technology Association, 2016, STAT GOOD PRACT ASS; Barclay L, 2011, BRIT J OCCUP THER, V74, P573, DOI 10.4276/030802211X13232584581452; Baron RA, 2006, SOCIAL PSYCHOL, V11th; Bigby C, 2017, J INTELLECT DEV DIS, V42, P309, DOI 10.3109/13668250.2016.1253051; Bigby C, 2012, J INTELLECT DEV DIS, V37, P360, DOI 10.3109/13668250.2012.721878; BRESLOW R, 1980, ADV CHEM SER, P1; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Callaway L, 2013, MODELS SUPPORTED ACC; Callaway L., 2014, COMMUNITY INTEGRATIO; Callaway L, 2017, AUST OCCUP THER J, V64, P226, DOI 10.1111/1440-1630.12350; Callaway L, 2016, AUST OCCUP THER J, V63, P143, DOI 10.1111/1440-1630.12284; Commonwealth of Australia, 2009, SHUT OUT EXP PEOPL D; Commonwealth of Australia, 2011, NAT DIS STRAT 2010 2; Cummings P, 2004, STATA J, V4, P274, DOI 10.1177/1536867X0400400305; Department of Family & Community Services, 2015, GROUP ACC; Department of Social Services, 2016, NAT DIS STRAT 2 IMPL; Forester-Jones R, 2006, J INTELL DISABIL RES, V19, P285; Hall C, 2013, J PHYS THERAPY ED, V21, P77; Hall L, 2006, J APPL RES INTELLECT, V19, P204, DOI 10.1111/j.1468-3148.2005.00249.x; Hatton C, 2003, J APPL RES INTELLECT, V16, P177, DOI 10.1046/j.1468-3148.2003.00167.x; Hollier Scott, 2017, J INTERNET REGULATIO, V6, P1; Jamwal R, 2018, DISABIL REHABIL-ASSI, V13, P634, DOI 10.1080/17483107.2017.1360948; Jamwal R, 2017, BRIT J OCCUP THER, V80, P89, DOI 10.1177/0308022616678634; Johnson Kelley, 2005, DEINSTITUTIONALIZATI; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; McLachlan R., 2013, DEEP PERSISTENT DISA; Migliorini C, 2016, BRAIN INJURY, V30, P1201, DOI 10.1080/02699052.2016.1175666; Morsillo R, 2011, TELECOMMUN J AUST, V61, P1; Muller E, 2008, AUTISM, V12, P173, DOI 10.1177/1362361307086664; National Disability Insurance Agency, 2017, WHAT HELP CAN I GET; National Disability Insurance Agency, 2015, ASS TECHN STRAT; National Disability Insurance Agency, 2017, WEEKL Q A 16; NDIS Independent Advisory Council, 2013, REFL IMPL PRINC CHOI; Orsmond GI, 2011, AUTISM, V15, P579, DOI 10.1177/1362361310386503; Pearson D, 2008, ACCOMMODATION PEOPLE; Pentland W, 1999, SPINAL CORD, V37, P786, DOI 10.1038/sj.sc.3100908; Rigby AS, 2000, DISABIL REHABIL, V22, P259, DOI 10.1080/096382800296719; Rispoli M, 2014, AUT CHILD PSYCHO, P21, DOI 10.1007/978-1-4899-8029-8_2; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Sensis, 2017, SENS SOC MED REP CHA; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Tate R, 2011, MAN CAR NEEDS SCAL C; Thomas J, 2016, TRANS NORTHEAST, P164; White GW, 2017, J PREV INTERV COMMUN, V45, P81, DOI 10.1080/10852352.2017.1281041; Wild M. R., 2013, PERSPECTIVENEUROPH, V23, P49, DOI [10.1044/nnsld23.2.49, DOI 10.1044/NNSLD23.2.49]; Wilkinson RG, 2003, SOCIAL DETERMINANTS; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550	53	1	1	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.	JAN 2	2020	15	1					101	108		10.1080/17483107.2018.1534998			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	KB7FU	WOS:000506657200012	30663446				2022-02-06	
J	Stephens, JA; Davies, PL; Gavin, WJ; Mostofsky, SH; Slomine, BS; Suskauer, SJ				Stephens, Jaclyn A.; Davies, Patricia L.; Gavin, William J.; Mostofsky, Stewart H.; Slomine, Beth S.; Suskauer, Stacy J.			Evaluating Motor Control Improves Discrimination of Adolescents with and without Sports Related Concussion	JOURNAL OF MOTOR BEHAVIOR			English	Article						Discriminant analysis; ImPACT (R); motor control; physical and neurological examination of subtle signs; sports-related concussion	NEUROLOGICAL EXAMINATION; FUNCTIONAL CONNECTIVITY; CORPUS-CALLOSUM; SUBTLE SIGNS; ABNORMALITIES; RELIABILITY; INHIBITION; NETWORKS; CHILDREN; RECOVERY	Disrupted motor performance is increasingly recognized as a critical sequela of concussion which may have relevance for diagnosis and treatment. In 17 adolescents with recent concussion and 20 never-concussed controls, we evaluated the discriminant ability of a commonly used neurocognitive measure compared to a motor subtle sign exam, which evaluates gait, balance, and fine and gross motor control. We found that the motor subtle sign exam had better discriminant ability than the neurocognitive measure, but combining both measures was superior to analyses with individual measures (Wilks' = .297, p < .001). This supports that there is an added benefit of evaluating motor control along with neurocognitive capacities after suspected concussion to enhance diagnosis and treatment of injury.	[Stephens, Jaclyn A.; Davies, Patricia L.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Stephens, Jaclyn A.; Davies, Patricia L.; Gavin, William J.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Mostofsky, Stewart H.; Slomine, Beth S.; Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Mostofsky, Stewart H.; Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Mostofsky, Stewart H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Slomine, Beth S.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA		Stephens, JA (corresponding author), Colorado State Univ, 200 Occupat Therapy Bldg,1573 Campus Delivery, Ft Collins, CO 80523 USA.	jaclyn.stephens@colostate.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD080378, T32 HD007414] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [L40 NS098410] Funding Source: Medline		Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Fling BW, 2012, BEHAV BRAIN RES, V226, P211, DOI 10.1016/j.bbr.2011.09.018; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hammond-Tooke GD, 2010, J CLIN NEUROSCI, V17, P315, DOI 10.1016/j.jocn.2009.06.026; Hayward Kathryn S, 2017, NE1RA6 P6AS, V2017, P1; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Jansiewicz EM, 2006, J AUTISM DEV DISORD, V36, P613, DOI 10.1007/s10803-006-0109-y; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Klecka G.R., 1980, DISCRIMINANT ANAL; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mac Donald CL, 2019, J NEUROTRAUM, V36, P264, DOI 10.1089/neu.2018.5629; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Stephens J., 2016, J MOTOR BEHAV, V49, P1; Stephens JA, 2018, AM J PHYS MED REHAB, V97, P456, DOI 10.1097/PHM.0000000000000906; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; VITIELLO B, 1989, J AM ACAD CHILD PSY, V28, P749, DOI 10.1097/00004583-198909000-00017	33	1	1	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-2895	1940-1027		J MOTOR BEHAV	J. Mot. Behav.	JAN 2	2020	52	1					13	21		10.1080/00222895.2019.1570908			9	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	JT8OE	WOS:000501242100002	30732536	Green Accepted			2022-02-06	
J	Abecasis, F; Cardim, D; Czosnyka, M; Robba, C; Agrawal, S				Abecasis, Francisco; Cardim, Danilo; Czosnyka, Marek; Robba, Chiara; Agrawal, Shruti			Transcranial Doppler as a non-invasive method to estimate cerebral perfusion pressure in children with severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Transcranial Doppler; Traumatic brain injury; Cerebral perfusion pressure	INTRACRANIAL-PRESSURE; PULSATILITY INDEX; AUTOREGULATION	Introduction Cerebral perfusion pressure (CPP) is one of the most important parameters in preventing ischemic brain insults. Guidelines have used CPP values to guide treatment of traumatic brain injury (TBI) for many years. We tested the feasibility of a novel non-invasive method for CPP estimation (nCPP) in children with severe TBI. Methods Retrospective analysis of prospectively monitored pediatric TBI patients with invasive intracranial pressure (ICP) monitoring, arterial blood pressure, and Transcranial Doppler (TCD) studies was performed daily. A novel estimator of CPP (nCPP) was calculated using TCD-spectral accounting method. We analyzed the correlation coefficient and correlation in time domain between CPP and nCPP, prediction ability of nCPP to detect low CPP, and the confidence intervals for CPP prediction (95% CI). Results We retrospectively analyzed 69 TCD recordings from 19 children (median age 15 years, range 3-16 years). There was a good correlation between CPP and nCPP (Spearman correlation coefficient, R = 0.67 (p < 0.0001), and a good mean correlation in time domain (R = 0.55 +/- 0.42). The ability of nCPP to predict values of CPP below 70 mmHg was excellent as demonstrated by an area under the curve of 0.908 (95% CI = 0.83-0.98) using a receiver operating curve analysis. Bland-Altman analysis revealed that nCPP overestimated CPP by 19.61 mmHg with a wide 95% CI of +/- 40.4 mmHg. Conclusions nCPP monitoring with TCD appears to be a feasible method for CPP assessment in pediatric TBI. The novel spectral CPP tested in this study has a decent correlation with invasive CPP and can predict low CPP with excellent accuracy at the 70 mmHg threshold.	[Abecasis, Francisco] Univ Lisbon, Ctr Hosp Lisboa Norte, Fac Med, Pediat Intens Care Unit, Lisbon, Portugal; [Cardim, Danilo] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Robba, Chiara] Care San Martino Policlin Hosp, IRSSS Oncol, Anaesthesia & Intens Care, Genoa, Italy; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Pediat Intens Care Unit, Cambridge Biomed Campus, Cambridge, England		Abecasis, F (corresponding author), Univ Lisbon, Ctr Hosp Lisboa Norte, Fac Med, Pediat Intens Care Unit, Lisbon, Portugal.	francisco@abecasis.name	Robba, Chiara/AAS-7421-2020; Cardim, Danilo Augusto/B-8447-2012; Abecasis, Francisco/M-1875-2013	Cardim, Danilo Augusto/0000-0002-9261-1321; Abecasis, Francisco/0000-0002-1883-050X			Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Donnelly JE, 2017, CHILD NERV SYST, V33, P1735, DOI 10.1007/s00381-017-3523-x; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Flechet M, 2018, ACTA NEUROCHIR SUPPL, V126, P291, DOI 10.1007/978-3-319-65798-1_57; Hockel K, 2017, ACTA NEUROCHIR, V159, P2053, DOI 10.1007/s00701-017-3308-8; Hosmer D, 1989, APPL LOGISTIC REGRES; Kashif FM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003249; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS49, DOI 10.1097/PCC.0b013e31823f6696; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256	20	1	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2020	36	1					125	131		10.1007/s00381-019-04273-2			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	KG4WM	WOS:000509948300022	31273494				2022-02-06	
J	Agrawal, A; Bhoi, S; Galwankar, S; Pal, R; Deora, H; Ghosh, A; Moscote-Salazar, LR				Agrawal, Amit; Bhoi, Sanjeev; Galwankar, Sagar; Pal, Ranabir; Deora, Harsh; Ghosh, Amrita; Moscote-Salazar, Luis Rafael			Safer Roads to School	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Pediatric; pediatric trauma; road safety; road traffic accidents; school-aged children; traumatic brain injury	PEDIATRIC HEAD-INJURY; CERVICAL-SPINE; YOUNG-CHILDREN; BRAIN-INJURY; TRAUMA; TRENDS; INTERVENTIONS; EPIDEMIOLOGY; BIOMECHANICS; ADOLESCENTS	Any and all advances made by medical science cannot solve the problem of road traffic injuries (RTIs) in school-going children, especially if the only concerned people are those of the medical fraternity. Children are a vulnerable part of the traveling population and thus have been persistent due to the callous nature of the citizens and policy makers toward road safety and injury prevention. In our multicultural and multilingual country, there is a need for multistakeholder initiative with a countrywide presence if we are to stem the rise of mortality and morbidity due to these accidents. The first question we need to ask is how to prevent road traffic accidents and improve the condition of our roads. Pediatric RTIs are eternal problem of industrial revolution with complications and effects that may affect individual and society with increase in the number of motorized communications. Dedicated capacity building is urgently need who should be able to provide the necessary care to the injured children at the road crash spot as well as should be informed where to take the injured child and whom to contact in the dedicated injury care center while transporting the victims of situations.	[Agrawal, Amit] All India Inst Med Sci, Dept Neurosurg, Bhopal, Madhya Pradesh, India; [Bhoi, Sanjeev] All India Inst Med Sci, Dept Emergency Med, New Delhi, India; [Pal, Ranabir] MGM Med Coll, Dept Community Med, Kishanganj, Bihar, India; [Pal, Ranabir] LSK Hosp, Kishanganj, Bihar, India; [Deora, Harsh] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru, Karnataka, India; [Ghosh, Amrita] Kolkata Med Coll, Dept Biochem, Kolkata, W Bengal, India; [Galwankar, Sagar] Florida State Univ, Dept Emergency Med, Sarasota Mem Hosp, Sarasota, FL USA; [Moscote-Salazar, Luis Rafael] Org Latinoamer Trauma & Cuidado Neurointens, RED LATINO, Neurosurg Crit Care, Bogota, Colombia		Agrawal, A (corresponding author), All India Inst Med Sci, Dept Neurosurger, Bhopal 462020, Madhya Pradesh, India.	dramitagrawal@gmail.com	Pal, Ranabir/M-6693-2013; Moscote-Salazar, Luis Rafael/K-6307-2012; GHOSH, AMRITA/ABH-9085-2020; DEORA, HARSH/A-5817-2019; Agrawal, Amit/C-1511-2011	Moscote-Salazar, Luis Rafael/0000-0002-4180-6962; DEORA, HARSH/0000-0003-3247-1117; Agrawal, Amit/0000-0002-3287-5448			Adirim TA, 1999, AM J EMERG MED, V17, P499, DOI 10.1016/S0735-6757(99)90184-5; Akbarnia BA, 1999, ORTHOP CLIN N AM, V30, P521, DOI 10.1016/S0030-5898(05)70103-6; Al Kilani H, 2001, MIDDLE E J EMERG MED, V1, P18; Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Allen JP, 2008, AM J PREV MED, V35, pS289, DOI 10.1016/j.amepre.2008.06.017; Arnett JJ, 2002, INJURY PREV, V8, P17; Babu RA, 2017, NEUROL INDIA, V65, P546, DOI 10.4103/neuroindia.NI_1243_15; Bener A, 1997, Inj Prev, V3, P224, DOI 10.1136/ip.3.3.224; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Crankson SJ, 2006, PEDIATR SURG INT, V22, P641, DOI 10.1007/s00383-006-1715-7; Dandona R, 2006, NATL MED J INDIA, V19, P126; Davison C., 2014, INJURY YOUNG CANADIA; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Dunbar G, 2001, J EXP PSYCHOL-APPL, V7, P227, DOI 10.1037//1076-898X.7.3.227; Eid H. O., 2007, SMJ Singapore Medical Journal, V48, P693; Embree TE, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0282; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; Grivna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068636; HADLEY MN, 1988, J NEUROSURG, V68, P18, DOI 10.3171/jns.1988.68.1.0018; Honavar SG, 2019, INDIAN J OPHTHALMOL, V67, P193, DOI 10.4103/ijo.IJO_150_19; Kapapa T, 2016, J BEHAV BRAIN SCI, V6, P254; Kundal Vijay Kumar, 2017, J Indian Assoc Pediatr Surg, V22, P33, DOI 10.4103/0971-9261.194618; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LALLY KP, 1989, AM J SURG, V158, P540, DOI 10.1016/0002-9610(89)90187-6; Loprinzi PD, 2012, OBESITY FACTS, V5, P597, DOI 10.1159/000342684; Lykissas MG, 2013, J PEDIATR ORTHOPED, V33, P803, DOI 10.1097/BPO.0000000000000099; Mackett RL, 2003, TRANSPORT POLICY, V10, P179; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Martin BW, 2004, ARCH DIS CHILD, V89, P860, DOI 10.1136/adc.2003.029223; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Murphy S, 2016, CURR TRAUMA REP, V2, P222, DOI 10.1007/s40719-016-0065-8; NHS, WHAT SHOULD I KEEP M; Nuckley DJ, 2006, J BIOMECH, V39, P3045, DOI 10.1016/j.jbiomech.2005.10.014; Osifo OD, 2012, PREHOSP DISASTER MED, V27, P136, DOI 10.1017/S1049023X12000465; Pal R, 2019, J FAM MED PRIM CARE, V8, P775, DOI 10.4103/jfmpc.jfmpc_214_18; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Peden M., 2004, WORLD REPORT ROAD TR; Pitcairn TK, 2000, BRIT J PSYCHOL, V91, P391, DOI 10.1348/000712600161899; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Raina SK, 2019, J FAM MED PRIM CARE, V8, P1814, DOI 10.4103/jfmpc.jfmpc_282_19; Rasouli MR, 2011, WORLD J PEDIATR, V7, P311, DOI 10.1007/s12519-011-0327-z; Razzak JA, 2005, EMERG MED CLIN N AM, V23, P85, DOI 10.1016/j.emc.2004.09.008; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; ROUSE TM, 1992, SURG CLIN N AM, V72, P1347; Rowland D, 2003, ARCH DIS CHILD, V88, P8, DOI 10.1136/adc.88.1.8; Shrivastava Saurabh RamBihariLal, 2014, J Inj Violence Res, V6, P95; Slack SE, 2004, EMERG MED J, V21, P189, DOI 10.1136/emj.2003.012310; UNICEF, CONV RIGHTS CHILD CONV RIGHTS CHILD; Whitebread D, 2000, BRIT J EDUC PSYCHOL, V70, P539, DOI 10.1348/000709900158290; Wing R, 2013, EMERG MED CLIN N AM, V31, P653, DOI 10.1016/j.emc.2013.05.007; World Health Organization, 2004, GLOBAL BURDEN DIS; World Health Organization, CHILD INJ VIOL; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4; Zeedyk MS, 2002, ACCIDENT ANAL PREV, V34, P43, DOI 10.1016/S0001-4575(00)00101-9; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791	58	1	1	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock		2020	13	1					15	19		10.4103/JETS.JETS_71_19			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	KX8LB	WOS:000522125300004	32395044				2022-02-06	
J	Al-Mahdi, W; Ibrahim, MM; Spiegel, DA; Arkader, A; Nance, M; Baldwin, K				Al-Mahdi, Waleed; Ibrahim, Mazen M.; Spiegel, David A.; Arkader, Alexandre; Nance, Michael; Baldwin, Keith			Is Systemic Inflammatory Response Syndrome Relevant to Pulmonary Complications and Mortality in Multiply Injured Children?	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						polytrauma; orthopaedic trauma; systemic inflammatory response	ASSOCIATION; FRACTURES; FIXATION; UTILITY; TRAUMA; CARE	Background: Systemic inflammatory response syndrome (SIRS) is a well-recognized phenomenon in adult trauma populations. The "initial hit" of the traumatic event is often coupled with a systemic immune response characterized by changes in vital signs and laboratory indicators. A "second hit" from surgery during this time frame often results in acute lung injury, along with deterioration of the patient's clinical condition. We hypothesized that children and adolescents would experience SIRS physiology, but would not experience adult respiratory distress syndrome (ARDS) or "second hit" related death to the extent seen in the adult populations. Methods: We queried the trauma database of our level 1 pediatric trauma center from January 2005 to December 2015 for patients with injury severity scores of >16. We used the electronic medical record to track SIRS criteria in patients days 1 to 4 posttrauma. Trends were examined in patients with an orthopaedic injury (OI) and with no orthopaedic injury. Patients were further subcategorized and analyzed by age group based on the convention for definition of pediatric SIRS. Patients in the orthopaedic cohort were further examined for pulmonary complications and death. Logistic regression was used to identify risk factors for SIRS physiology in the first 4 days of hospitalization. Results: 81.4% (OI) and 69.1% no orthopaedic injury reached the threshold for SIRS within their first 4 days of hospitalization. Nine patients died in the hospital. Only 3 OI patients developed the criteria for ARDS, and only 3 patients with orthopaedic injuries died, 2 died within 24 hours of presentation and 1 within 48 hours, all had severe brain trauma. Increasing age groups showed increasing proportion of patients with SIRS. Increasing injury severity score and increasing age were independent predictors of SIRS during days 1 to 4. Discussion: SIRS seems to be as common in children as the reported rates for adults, and the proportion of SIRS in children increases with increasing age and injury severity. The high mortality rate and rate of ARDS observed in adults was not observed in our cohort. The presence or absence of major orthopaedic injuries was not a significant predictor. The SIRS response in polytraumatized children is poorly understood. The clinical phenomenon of acute lung injury/ARDS is observed less often in children, but the exact mechanism by which this occurs is unknown.	[Al-Mahdi, Waleed; Ibrahim, Mazen M.; Spiegel, David A.; Arkader, Alexandre; Nance, Michael; Baldwin, Keith] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA		Baldwin, K (corresponding author), Childrens Hosp Philadelphia, Div Orthopaed Surg, 2nd Floor,Wood Bldg,34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	baldwink@email.chop.edu	ibrahim, mazen/K-7224-2019	ibrahim, mazen/0000-0002-1060-8429			Baek Jong Hyun, 2014, Korean J Thorac Cardiovasc Surg, V47, P523, DOI 10.5090/kjtcs.2014.47.6.523; Balogh ZJ, 2012, LANCET, V380, P1109, DOI 10.1016/S0140-6736(12)60991-X; Bhandari M, 2005, J ORTHOP TRAUMA, V19, P140, DOI 10.1097/00005131-200502000-00012; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Carvalho Paulo R. A., 2005, J. Pediatr. (Rio J.), V81, P143, DOI 10.1590/S0021-75572005000300010; Chawla BK, 2013, J PEDIATR SURG, V48, P1936, DOI 10.1016/j.jpedsurg.2013.05.065; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Frazier SB, 2015, SOUTH MED J, V108, P665, DOI 10.14423/SMJ.0000000000000362; Giannoudis PV, 2010, INJURY, V41, pS57, DOI 10.1016/S0020-1383(10)70011-5; Giannoudis PV, 2009, INJURY, V40, pS47, DOI 10.1016/j.injury.2009.10.036; Giannoudis PV, 1999, J BONE JOINT SURG BR, V81B, P356, DOI 10.1302/0301-620X.81B2.8988; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Grover AS, 2017, PANCREAS, V46, P106, DOI 10.1097/MPA.0000000000000681; Guvener M, 2015, J CARDIAC SURG, V30, P92, DOI 10.1111/jocs.12465; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hedequist D, 1999, J ORTHOP TRAUMA, V13, P490, DOI 10.1097/00005131-199909000-00005; Kazakos Konstantinos J, 2006, Acta Orthop Belg, V72, P39; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Pallister I, 2005, J AM ACAD ORTHOP SUR, V13, P93, DOI 10.5435/00124635-200503000-00002; Pavare J, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-25; Raines A, 2013, J PEDIATR SURG, V48, P2442, DOI 10.1016/j.jpedsurg.2013.08.017; Rixen D, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1162-2; Scott HF, 2012, ACAD EMERG MED, V19, P1276, DOI 10.1111/acem.12014	23	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN	2020	40	1					1	7		10.1097/BPO.0000000000001085			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	MC0AL	WOS:000542959300002	31815855				2022-02-06	
J	Alter, SM; Mazer, BA; Solano, JJ; Shih, RD; Hughes, MJ; Clayton, LM; Greaves, SW; Trinh, NQ; Hughes, PG				Alter, Scott M.; Mazer, Benjamin A.; Solano, Joshua J.; Shih, Richard D.; Hughes, Mary J.; Clayton, Lisa M.; Greaves, Spencer W.; Trinh, Nhat Q.; Hughes, Patrick G.			Antiplatelet therapy is associated with a high rate of intracranial hemorrhage in patients with head injuries	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						platelet aggregation inhibitors; head injuries; brain injuries; traumatic	TRAUMATIC BRAIN-INJURY; PREINJURY WARFARIN; RISK; RECOMMENDATIONS; MORTALITY; ASPIRIN; AGENTS	BackgroundAntiplatelet agents are increasingly used in cardiovascular treatment. Limited research has been performed into risks of acute and delayed traumatic intracranial hemorrhage (ICH) in these patients who sustain head injuries. Our goal was to assess the overall odds and identify factors associated with ICH in patients on antiplatelet therapy.MethodsA retrospective observational study was conducted at two level I trauma centers. Adult patients with head injuries on antiplatelet agents were enrolled from the hospitals' trauma registries. Acute ICH was diagnosed by head CT. Observation and repeat CT to evaluate for delayed ICH was performed at clinicians' discretion. Patients were stratified by antiplatelet type and analyzed by ICH outcome.ResultsOf 327 patients on antiplatelets who presented with blunt head trauma, 133 (40.7%) had acute ICH. Three (0.9%) had delayed ICH on repeat CT, were asymptomatic and did not require neurosurgical intervention. One with delayed ICH was on clopidogrel and two were on both clopidogrel and aspirin. Patients with delayed ICH compared with no ICH were older (94 vs 74 years) with higher injury severity scores (15.7 vs 4.4) and trended towards lower platelet counts (141 vs 216). Patients on aspirin had a higher acute ICH rate compared with patients on P2Y12 inhibitors (48% vs 30%, 18% difference, 95%CI 4 to 33; OR 2.18, 95%CI 1.15 to 4.13). No other group comparison had significant differences in ICH rate.ConclusionsPatients on antiplatelet agents with head trauma have a high rate of ICH. Routine head CT is recommended. Patients infrequently developed delayed ICH. Routine repeat CT imaging does not appear to be necessary for all patients.Level of evidenceLevel III, prognostic.	[Alter, Scott M.; Mazer, Benjamin A.; Solano, Joshua J.; Shih, Richard D.; Clayton, Lisa M.; Greaves, Spencer W.; Hughes, Patrick G.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Div Emergency Med, Boca Raton, FL 33431 USA; [Alter, Scott M.; Solano, Joshua J.; Shih, Richard D.; Clayton, Lisa M.; Hughes, Patrick G.] Delray Med Ctr, Dept Emergency Med, Delray Beach, FL 33484 USA; [Alter, Scott M.; Solano, Joshua J.; Clayton, Lisa M.; Hughes, Patrick G.] Bethesda Hosp East, Dept Emergency Med, Boynton Beach, FL 33435 USA; [Hughes, Mary J.] Michigan State Univ, Coll Osteopath Med, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA; [Trinh, Nhat Q.] Sparrow Hosp, Emergency Med Residency Lansing, Lansing, MI USA		Alter, SM (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Div Emergency Med, Boca Raton, FL 33431 USA.; Alter, SM (corresponding author), Delray Med Ctr, Dept Emergency Med, Delray Beach, FL 33484 USA.; Alter, SM (corresponding author), Bethesda Hosp East, Dept Emergency Med, Boynton Beach, FL 33435 USA.	alters@health.fau.edu		Alter, Scott/0000-0003-3824-6308; TRINH, NHAT/0000-0001-9403-4567; Mazer, Benjamin/0000-0002-7500-5725; Clayton, Lisa/0000-0001-9729-2676; Solano, Joshua/0000-0001-8408-3189			Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; American College of Surgeons Committee on Trauma, 2014, RESOURCES OPTIMAL CA; Soriano LC, 2017, J THROMB HAEMOST, V15, P1055, DOI 10.1111/jth.13686; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Ebell MH, 2017, AM FAM PHYSICIAN, V96, P697; Galliazzo S, 2019, THROMB RES, V174, P113, DOI 10.1016/j.thromres.2018.12.015; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Hamidi M, 2019, CLIN GERIATR MED, V35, P1, DOI 10.1016/j.cger.2018.08.001; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Melville LD, 2017, ANN EMERG MED, V70, P910, DOI 10.1016/j.annemergmed.2017.05.031; National Institute for Health and Care Excellence, 2014, HEAD INJ ASS EARL MA; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ostini R, 2008, PHARMACOEPIDEM DR S, V17, P1077, DOI 10.1002/pds.1638; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Postula Marek, 2009, Recent Pat Cardiovasc Drug Discov, V4, P55; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Stuntz Mark, 2017, Prev Med Rep, V5, P183, DOI 10.1016/j.pmedr.2016.12.023; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Van Ornam J, 2019, AM J EMERG MED, V37, P1694, DOI 10.1016/j.ajem.2018.12.012	28	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2020	5	1							e000520	10.1136/tsaco-2020-000520			5	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	TI1OW	WOS:000672553900076	33294625	gold, Green Published			2022-02-06	
J	Anderson, JFI				Anderson, Jacqueline F., I			The Association Between Pain Type, Cognition and Complaint After Mild Traumatic Brain Injury in Prospectively Studied Premorbidly Healthy Adults Admitted to Hospital	NEUROPSYCHOLOGY			English	Article						mild traumatic brain injury; pain; cognition; complaint; postconcussion syndrome	POST-CONCUSSION SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; QUESTIONNAIRE; PREDICTORS; RELIABILITY; DEFICITS	Objective: Literature examining the relationship between pain, cognition, and complaint after mild traumatic brain injury (mTBI) has conceptualized and measured pain as a unitary construct. Pain is defined as being multidimensional, however, with both sensory and affective aspects. The current study aimed to determine whether the sensory and affective aspects of pain differentially relate to cognition and complaint. Method: Using a prospective observational design, 6-10 weeks after injury, we assessed 60 premorbidly healthy individuals, who were admitted to hospital after an mTBI. Participants were assessed with multidimensional and unitary pain questionnaires, as well as measures of cognition, complaint, anxiety and depression. Results: Findings showed that a univariate measure of pain did not successfully measure affective pain. Multidimensional pain assessment revealed that affective descriptors of pain were significantly and independently associated with aspects of cognitive function (p <.05). A number of sensory types of pain also significantly related to cognition (p <.05), with these relationships varying between the different sensory pain types. Continuous type sensory pain also independently predicted memory and executive function. No independent linear relationships were evident between any type of pain and level of complaint. Conclusions: These findings show for the first time that it is important to examine both affective and sensory aspects of pain in individuals after mTBI, as pain subtypes show differential relationships with cognition. The study also suggests that the relationship between pain and complaint is not an independent one. This study has implications for treatment and management of individuals experiencing cognitive difficulties after mTBI.	[Anderson, Jacqueline F., I] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F., I] Alfred Hosp, Dept Psychol, Melbourne, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	jfande@unimelb.edu.au		Anderson, Jacqueline/0000-0003-4996-8189			Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Allegri N, 2019, PAIN PRACT, V19, P328, DOI 10.1111/papr.12741; Anderson JFI, 2020, NEUROPSYCHOL REHABIL, V30, P1115, DOI 10.1080/09602011.2018.1556706; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Auvray M, 2010, NEUROSCI BIOBEHAV R, V34, P214, DOI 10.1016/j.neubiorev.2008.07.008; Aydede M, 2017, MONIST, V100, P439, DOI 10.1093/monist/onx021; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Beck AT, 1993, BECK ANXIETY INVENTO; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Boggero IA, 2015, PAIN MED, V16, P341, DOI 10.1111/pme.12598; BONICA JJ, 1979, PAIN, V6, P247, DOI 10.1016/0304-3959(79)90046-0; Boyle GJ, 2015, PSYCHOL REP, V116, P797, DOI 10.2466/03.15.PR0.116k25w7; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Dworkin RH, 2009, PAIN, V144, P35, DOI 10.1016/j.pain.2009.02.007; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gosselin N, 2012, J NEUROTRAUM, V29, P2625, DOI 10.1089/neu.2012.2312; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Helmes E., 2000, NEUROPSYCHOLOGICAL A; Iezzi T, 2004, INT J BEHAV MED, V11, P56, DOI 10.1207/s15327558ijbm1101_7; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Landro NI, 2013, PAIN, V154, P972, DOI 10.1016/j.pain.2013.01.013; Lindback Y, 2017, EUR SPINE J, V26, P2581, DOI 10.1007/s00586-017-4979-9; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; Mazza S, 2018, PROG NEURO-PSYCHOPH, V87, P183, DOI 10.1016/j.pnpbp.2017.08.006; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Moore DJ, 2017, PAIN, V158, P2035, DOI 10.1097/j.pain.0000000000001011; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Moriarty O, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00100; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Munoz M, 2005, CLIN J PAIN, V21, P287; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ojeda B, 2016, PAIN MED, V17, P1465, DOI 10.1093/pm/pnv077; Partington JE, 1949, PSYCHOL SERV CTR B, V1, P9; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rada D, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/3067426; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Schiltenwolf M, 2014, PAIN PHYSICIAN, V17, P9; Schmidt M., 1996, REY AUDITORY VERBAL; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strand LI, 2008, EUR J PAIN, V12, P917, DOI 10.1016/j.ejpain.2007.12.013; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tsushima WT, 1996, HEADACHE, V36, P613, DOI 10.1046/j.1526-4610.1996.3610613.x; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL; WILKIE DJ, 1990, NURS RES, V39, P36	58	1	1	1	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2020	34	1					53	62		10.1037/neu0000585			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JZ5TF	WOS:000505164800007	31343238				2022-02-06	
J	Llompart-Pou, JA; Barea-Mendoza, JA; Sanchez-Casado, M; Gonzalez-Robledo, J; Mayor-Garcia, DM; Montserrat-Ortiz, N; Enriquez-Giraudo, P; Cordero-Lorenzana, ML; Chico-Fernandez, M				Antonio Llompart-Pou, Juan; Abelardo Barea-Mendoza, Jesus; Sanchez-Casado, Marcelino; Gonzalez-Robledo, Javier; Mayor-Garcia, Dolores Maria; Montserrat-Ortiz, Neus; Enriquez-Giraudo, Pedro; Lourdes Cordero-Lorenzana, Maria; Chico-Fernandez, Mario		Grp Trabajo Neurointensivismo Trau	Neuromonitoring in the severe traumatic brain injury. Spanish Trauma ICU Registry (RETRAUCI)	NEUROCIRUGIA			Spanish	Article						Severe traumatic brain injury; Monitorization; Intracranial pressure; Brain tissue oxygenation	INTRACRANIAL-PRESSURE; HEAD-INJURY; MANAGEMENT; SCORE; IMPACT; TRIAL; CARE	Objectives: To analyze the use of intracranial pressure (ICP) and cerebral oximetry monitoring in patients with severe traumatic brain injury (TBI) according to the Spanish Trauma ICU Registry (RETRAUCI). Methods: We included TBI patients with Glasgow Coma Scale score <= 8. Hypotheses were tested using the Student-T or Wilcoxon tests (quantitative variables) and the Chi-square test (categorical variables). Multivariate analysis using logistic regression was performed to analyze the variables associated with the use of ICP monitoring. Results: We analyzed 1463 patients. Age 49.1 years. Males 1130 (77.3%). Mechanism of injury: falls in 350 cases (23.9%). Injury Severity Score 27.9. Uni- or bilateral mydriasis was present in 39.3% of the patients. Neurosurgical intervention within 24 hours was performed in 331 patients (22.7%). ICP was monitored in 635 patients (45.1%), pbtO2 in 122 patients (8.6%), SjVO(2) in 19 patients (1.34%) and NIRS was used in 25 cases (1.77%). In the multivariate analysis, age, bilateral mydriasis at admission and previous use of antiplatelets or anticoagulants was inversely related with ICP monitoring. Severity of injury and the need of neurosurgical intervention increased the probability of ICP monitoring. Conclusions: Our study shows a picture of ICP monitoring in severe TBI patients in our environment. Use of cerebral oximetry techniques is very limited. (C) 2019 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Antonio Llompart-Pou, Juan] Hosp Univ Son Espases, Serv Med Intens, Inst Invest Sanitaria Illes Balears IdISBa, Palma De Mallorca, Baleares, Spain; [Abelardo Barea-Mendoza, Jesus; Chico-Fernandez, Mario] Hosp Univ 12 Octubre, UCI Trauma & Emergencias, Serv Med Intens, Madrid, Spain; [Sanchez-Casado, Marcelino] Hosp Virgen Salud, Serv Med Intens, Toledo, Spain; [Gonzalez-Robledo, Javier] Complejo Asistencial Univ Salamanca, Serv Med Intens, Salamanca, Spain; [Mayor-Garcia, Dolores Maria] Complejo Hosp Torrecardenas, Serv Med Intens, Almeria, Spain; [Montserrat-Ortiz, Neus] Hosp Univ Arnau de Vilanoua, Serv Med Intens, Lleida, Spain; [Enriquez-Giraudo, Pedro] Hosp Univ Rio Hortega, Serv Med Intens, Valladolid, Spain; [Lourdes Cordero-Lorenzana, Maria] Complexo Hosp Univ A Coruna, Serv Med Intens, La Coruna, Spain		Chico-Fernandez, M (corresponding author), Hosp Univ 12 Octubre, UCI Trauma & Emergencias, Serv Med Intens, Madrid, Spain.	murgchico@yahoo.es		Barea-mendoza, Jesus A/0000-0002-1858-525X			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Dominguez-Gil B, 2017, MED INTENSIVA, V41, P162, DOI 10.1016/j.medin.2016.07.011; Dominguez-Gil B, 2017, TRANSPLANTATION, V101, pE265, DOI 10.1097/TP.0000000000001701; Gennareli TA, 2008, ABBREVIATED INJURY S; Gomez PA, 2017, NEUROCIRUGIA, V28, P1, DOI 10.1016/j.neucir.2016.11.002; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Joanes V, 2017, NEUROCIRUGIA, V28, P167, DOI 10.1016/j.neucir.2017.01.001; Egea-Guerrero JJ, 2018, J HEAD TRAUMA REHAB, V33, P46, DOI 10.1097/HTR.0000000000000292; Le Roux P, 2014, CURR OPIN CRIT CARE, V20, P141, DOI 10.1097/MCC.0000000000000078; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Penasco Y, 2017, MED INTENSIVA, V41, P394, DOI 10.1016/j.medin.2017.03.009; Perez-Barcena J, 2014, CRIT CARE CLIN, V30, P735, DOI 10.1016/j.ccc.2014.06.005; Ronning P, 2015, BRAIN INJURY, V29, P1648, DOI 10.3109/02699052.2015.1075154; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Volovici V, 2019, WORLD NEUROSURG, V125, pE515, DOI 10.1016/j.wneu.2019.01.116	23	1	1	0	3	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	JAN-FEB	2020	31	1					1	6		10.1016/j.neucir.2019.05.005			6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KH4LP	WOS:000510619100001	31466814				2022-02-06	
J	Awad, M; Bonitz, J; Pratt, A				Awad, Mark; Bonitz, Joyce; Pratt, Abimbola			Pentobarbital Induced Hypokalemia: A Worrying Sequela	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Barbiturate coma; Intracranial hypertension; Traumatic brain injury; Pentobarbital; Thiopental; Hypokalemia	INTRACRANIAL HYPERTENSION	INTRODUCTION: Intracranial hypertension that is not responsive to other therapies can be managed through the use of a barbiturate induced coma. Although potentially effective, there are known complications associated with this treatment, and as such it is typically reserved for the most severe cases. One such sequela of barbiturate induced coma therapy is refractory hypokalemia and subsequent rebound hyperkalemia. PRESENTATION OF CASE: This case report discusses a patient who experienced hypokalemia during pentobarbital induced coma for unmanageable elevations in intracranial pressure and was treated conservatively to avoid rebound hyperkalemia depicting successful deployment of permissive hypokalemia. DISCUSSION: It is vital that clinicians understand the possible adverse effects associated with barbiturate induced coma therapy, and that a careful balance be struck between hypokalemia and potassium supplementation to avoid rebound hyperkalemia. CONCLUSION: Given that the risk of rebound hyperkalemia is of significant concern in patients who experience hypokalemia on barbiturate induced coma therapy, permissive hypokalemia can be a viable treatment option achieved by lowering the potassium replacement target threshold in such patients. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of ITS Publishing Group Ltd.	[Awad, Mark; Bonitz, Joyce; Pratt, Abimbola] Hackensack Meridian Jersey Shore Univ, Med Ctr, Dept Surg, 1945 NJ-33, Neptune City, NJ 07753 USA		Awad, M (corresponding author), Hackensack Meridian Jersey Shore Univ, Med Ctr, Dept Surg, 1945 NJ-33, Neptune City, NJ 07753 USA.	Mawad2@sgu.edu					Agha RA, 2018, INT J SURG, V60, P132, DOI 10.1016/j.ijsu.2018.10.028; [Anonymous], 2000, J Neurotrauma, V17, P527; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Friederich P, 1999, ANESTHESIOLOGY, V91, P1853, DOI 10.1097/00000542-199912000-00040; Kim TK, 2015, J KOREAN NEUROSURG S, V57, P197, DOI 10.3340/jkns.2015.57.3.197; KIM Y, 2008, J KOREAN NEUROSURG S, V44; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Ng Y, 2011, INTENS CARE MED, V37, P1285, DOI 10.1007/s00134-011-2240-2	9	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2020	71						323	326		10.1016/j.ijscr.2020.05.032			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	ME6BZ	WOS:000544740200018	32492644	gold, Green Published			2022-02-06	
J	Beauchamp, MH; Degeilh, F; Yeates, K; Gagnon, I; Tang, K; Gravel, J; Stang, A; Burstein, B; Bernier, A; Lebel, C; El Jalbout, R; Lupien, S; de Beaumont, L; Zemek, R; Dehaes, M; Deschenes, S				Beauchamp, Miriam H.; Degeilh, Fanny; Yeates, Keith; Gagnon, Isabelle; Tang, Ken; Gravel, Jocelyn; Stang, Antonia; Burstein, Brett; Bernier, Annie; Lebel, Catherine; El Jalbout, Ramy; Lupien, Sonia; de Beaumont, Louis; Zemek, Roger; Dehaes, Mathieu; Deschenes, Sylvain		PERCKOALA Project	Kids' Outcomes And Long-term Abilities (KOALA): protocol for a prospective, longitudinal cohort study of mild traumatic brain injury in children 6 months to 6 years of age	BMJ OPEN			English	Article						accident & emergency medicine; neurological injury; neuroradiology; paediatric neurology; developmental neurology & neurodisability; magnetic resonance imaging	MUTUALLY RESPONSIVE ORIENTATION; YOUNG-CHILDREN; EARLY-CHILDHOOD; CONSOLABILITY SCALE; DYADIC ADJUSTMENT; SOCIAL OUTCOMES; SHORT FORMS; INFANTS; CONSTRUCTION; VALIDATION	Introduction Mild traumatic brain injury (mTBI) is highly prevalent, especially in children under 6 years. However, little research focuses on the consequences of mTBI early in development. The objective of the Kids' Outcomes And Long-term Abilities (KOALA) study is to document the impact of early mTBI on children's motor, cognitive, social and behavioural functioning, as well as on quality of life, stress, sleep and brain integrity. Methods and analyses KOALA is a prospective, multicentre, longitudinal cohort study of children aged 6 months to 6 years at the time of injury/recruitment. Children who sustain mTBI (n=150) or an orthopaedic injury (n=75) will be recruited from three paediatric emergency departments (PEDs), and compared with typically developing children (community controls, n=75). A comprehensive battery of prognostic and outcome measures will be collected in the PED, at 10 days, 1, 3 and 12 months postinjury. Biological measures, including measures of brain structure and function (magnetic resonance imaging, MRI), stress (hair cortisol), sleep (actigraphy) and genetics (saliva), will complement direct testing of function using developmental and neuropsychological measures and parent questionnaires. Group comparisons and predictive models will test the a priori hypotheses that, compared with children from the community or with orthopaedic injuries, children with mTBI will (1) display more postconcussive symptoms and exhibit poorer motor, cognitive, social and behavioural functioning; (2) show evidence of altered brain structure and function, poorer sleep and higher levels of stress hormones. A combination of child, injury, socioenvironmental and psychobiological factors are expected to predict behaviour and quality of life at 1, 3 and 12 months postinjury. Ethics and dissemination The KOALA study is approved by the Sainte-Justine University Hospital, McGill University Health Centre and University of Calgary Conjoint Health Research Ethics Boards. Parents of participants will provide written consent. Dissemination will occur through peer-reviewed journals and an integrated knowledge translation plan.	[Beauchamp, Miriam H.; Degeilh, Fanny; Dehaes, Mathieu] Univ Montreal, Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.; Degeilh, Fanny] Sainte Justine Hosp Res Ctr, Montreal, PQ, Canada; [Degeilh, Fanny] LMU Munchen, Psychiat, Munich, Bayern, Germany; [Yeates, Keith] Univ Calgary, Psychol, Calgary, AB, Canada; [Yeates, Keith; Lebel, Catherine] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith; Lebel, Catherine] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle] Montreal Childrens Hosp, Trauma, Montreal, PQ, Canada; [Tang, Ken] Childrens Hosp Eastern Ontario Res Inst, Clin Res Unit, Ottawa, ON, Canada; [Gravel, Jocelyn] CHU Sainte Justine, Pediat Emergency Med, Montreal, PQ, Canada; [Stang, Antonia] Univ Calgary, Pediat, Calgary, AB, Canada; [Stang, Antonia] Alberta Childrens Prov Gen Hosp, Pediat, Calgary, AB, Canada; [Burstein, Brett] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Pediat Emergency Med, Montreal, PQ, Canada; [Bernier, Annie] Univ Montreal, Psychol, Montreal, PQ, Canada; [Lebel, Catherine] Univ Calgary, Radiol, Calgary, AB, Canada; [El Jalbout, Ramy; Deschenes, Sylvain] CHU Sainte Justine, Radiol, Montreal, PQ, Canada; [Lupien, Sonia] Univ Montreal, Psychiat, Montreal, PQ, Canada; [de Beaumont, Louis] Univ Montreal, Surg, Montreal, PQ, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Pediat, Ottawa, ON, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Psychol, Montreal, PQ, Canada.; Beauchamp, MH (corresponding author), Sainte Justine Hosp Res Ctr, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca	Yeates, Keith/AAJ-4223-2020; Degeilh, Fanny/AAA-7445-2019	Gagnon, Isabelle/0000-0003-2043-1644; Beauchamp, Miriam/0000-0002-8637-6361; Degeilh, Fanny/0000-0002-5802-4975	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [FDN148417]	This work was supported by the Canadian Institutes of Health Research grant number FDN148417.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aksan N, 2006, DEV PSYCHOL, V42, P833, DOI 10.1037/0012-1649.42.5.833; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babl FE, 2012, PEDIATR EMERG CARE, V28, P1281, DOI 10.1097/PEC.0b013e3182767d66; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Belanger ME, 2013, J CLIN SLEEP MED, V9, P701, DOI 10.5664/jcsm.2844; Bellerose J, 2015, J INT NEUROPSYCHOL S, P1, DOI DOI 10.1902/JOP.2015.150455; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Botchway EN, 2019, J HEAD TRAUMA REHAB, V34, P241, DOI 10.1097/HTR.0000000000000446; Brigance A, 2013, BRIGANCE INVENTORY E; Brigance A.H., 2013, BRIGANCE EARLY CHILD; Briggs-Gowan MJ, 2007, INFANT MENT HEALTH J, V28, P564, DOI 10.1002/imhj.20154; Briggs-Gowan MJ, 2006, PEARSON, P17; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Chang HK, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11857; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; Connell A, 2008, J ABNORM CHILD PSYCH, V36, P1211, DOI 10.1007/s10802-008-9244-6; Crellin DJ, 2015, PAIN, V156, P2132, DOI 10.1097/j.pain.0000000000000305; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; D'Hondt F, 2017, COGN AFFECT BEHAV NE, V17, P124, DOI 10.3758/s13415-016-0467-7; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; Enders C. K., 2010, APPL MISSING DATA AN; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Gagne JR, 2011, PSYCHOL ASSESSMENT, V23, P337, DOI 10.1037/a0021746; Gagner C, 2021, J NEUROTRAUM, V38, P102, DOI 10.1089/neu.2019.6936; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gagnon I, 2018, J NEUROTRAUM, V35, P1849, DOI 10.1089/neu.2018.5887; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Geyer CJ, 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Holland SK, 2014, NEUROIMAGE-CLIN, V4, P526, DOI 10.1016/j.nicl.2014.01.013; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hutman T, 2012, INFANT BEHAV DEV, V35, P561, DOI 10.1016/j.infbeh.2012.05.007; Hutman T, 2010, J CHILD PSYCHOL PSYC, V51, P1010, DOI 10.1111/j.1469-7610.2010.02270.x; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanska G, 1996, CHILD DEV, V67, P490, DOI 10.2307/1131828; Kochanska G, 2008, CHILD DEV, V79, P30, DOI 10.1111/j.1467-8624.2007.01109.x; Korkman M., 2007, NEPSY 2 DEV NEUROPSY; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lalonde G, 2020, J NEUROPSYCHOL, V14, P98, DOI 10.1111/jnp.12179; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landry-Roy C, 2018, J INT NEUROPSYCH SOC, V24, P769, DOI 10.1017/S1355617718000401; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Laurendeau-Martin J, 2017, J INT NEUROPSYCHOL S, V25, pi; LeBuffe P.A., 2012, DEVEREUX EARLY CHILD; Lee DY, 2015, BMB REP, V48, P209, DOI 10.5483/BMBRep.2015.48.4.275; Mackrain M., 2007, DEVEREUX EARLY CHILD; Marcotte A-C, 2010, ORIENTATIONS MINISTE; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37; Mundy P., 2003, MANUAL ABRIDGED EARL; Narad ME, 2019, DEV NEUROREHABIL, V22, P437, DOI 10.1080/17518423.2018.1518350; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Oakland, 2015, ADAPTIVE BEHAV ASSES; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Plourde V, 2018, J INT NEUROPSYCH SOC, V24, P540, DOI 10.1017/S1355617718000061; Psychometrics of the Minnesota Executive Function Scale, 2017, PAP S STRENGTH MEAS; Putnam SP, 2006, J PERS ASSESS, V87, P102, DOI 10.1207/s15327752jpa8701_09; Putnam SP, 2014, J PERS ASSESS, V96, P445, DOI 10.1080/00223891.2013.841171; REED MA, 1984, MERRILL PALMER QUART, V30, P131; Rieffe C, 2010, PERS INDIV DIFFER, V49, P362, DOI 10.1016/j.paid.2010.03.046; Rogers A, 2019, BRAIN INJURY, V33, P649, DOI 10.1080/02699052.2019.1567936; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sabourin S, 2005, PSYCHOL ASSESSMENT, V17, P15, DOI 10.1037/1040-3590.17.1.15; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tahiroglu D, 2014, DEV PSYCHOL, V50, P2485, DOI 10.1037/a0037914; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Tetreault E, 2019, DEV PSYCHOBIOL, V61, P141, DOI 10.1002/dev.21805; Thieba C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00146; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Tuerk C, 2019, BRAIN INJURY, V33, P232; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Warschausky S, 2011, ENCY CLIN NEUROPSYCH, DOI [10.1007/978-0-387-79948-3_1606, DOI 10.1007/978-0-387-79948-3_1606]; Wiefferink CH, 2013, J DEAF STUD DEAF EDU, V18, P175, DOI 10.1093/deafed/ens042; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zaitsev M, 2015, J MAGN RESON IMAGING, V42, P887, DOI 10.1002/jmri.24850; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	116	1	1	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	10							e040603	10.1136/bmjopen-2020-040603			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OM0SA	WOS:000585738900008	33077571	Green Published, gold			2022-02-06	
J	Bebarta, VS; Mora, AG; Bebarta, EK; Reeves, LK; Maddry, JK; Schauer, SG; Lairet, JR				Bebarta, Vikhyat S.; Mora, Alejandra G.; Bebarta, Emma K.; Reeves, Lauren K.; Maddry, Joseph K.; Schauer, Steve G.; Lairet, Julio R.			Prehospital Use of Ketamine in the Combat Setting: A Sub-Analysis of Patients With Head Injuries Evaluated in the Prospective Life Saving Intervention Study	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				PRESSURE; MULTICENTER; ANALGESIA; MORPHINE; THEATER; CARE; PAIN	Objectives Ketamine is used as an analgesic for combat injuries. Ketamine may worsen brain injury, but new studies suggest neuroprotection. Our objective was to report the outcomes of combat casualties with traumatic brain injury (TBI) who received prehospital ketamine. Methods This was a post hoc, sub-analysis of a larger prospective, multicenter study (the Life Saving Intervention study [LSI]) evaluating prehospital interventions performed in Afghanistan. A DoD Trauma Registry query provided disposition at discharge and outcomes to be linked with the LSI data. Results For this study, we enrolled casualties that were suspected to have TBI (n = 160). Most were 26-year-old males (98%) with explosion-related injuries (66%), a median injury severity score of 12, and 5% mortality. Fifty-seven percent (n = 91) received an analgesic, 29% (n = 46) ketamine, 28% (n = 45) other analgesic (OA), and 43% (n = 69) no analgesic (NA). The ketamine group had more pelvic injuries (P = 0.0302) and tourniquets (P = 0.0041) compared to OA. In comparison to NA, the ketamine group was more severely injured and more likely to require LSI procedures, yet, had similar vital signs at admission and disposition at discharge. Conclusions We found that combat casualties with suspected TBI that received prehospital ketamine had similar outcomes to those that received OAs or NAs despite injury differences.	[Bebarta, Vikhyat S.; Mora, Alejandra G.; Maddry, Joseph K.; Schauer, Steve G.] USAF Route Care Res Ctr, MDW Chief Scientist Off 59, Jbsa Lackland, TX 78233 USA; [Bebarta, Vikhyat S.; Mora, Alejandra G.; Maddry, Joseph K.; Schauer, Steve G.] US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Bebarta, Vikhyat S.; Mora, Alejandra G.; Maddry, Joseph K.; Schauer, Steve G.] 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 USA; [Bebarta, Vikhyat S.; Reeves, Lauren K.] Univ Colorado, Dept Emergency Med, Sch Med, 12401 E 17th Ave, Aurora, CO 80045 USA; [Bebarta, Emma K.] Cherry Creek High Sch, 9300 E Union Ave, Greenwood Village, CO 80111 USA; [Lairet, Julio R.] Emory Univ, Dept Emergency Med, Sch Med, 531 Asbury Circle,Annex Bldg Suite N340, Atlanta, GA 30322 USA; [Lairet, Julio R.] Headquarters Georgia Air Natl Guard, 1000 Halsey Ave Bldg 447, Marietta, GA 30060 USA; [Schauer, Steve G.] US Army, Inst Surg Res, 3698 Chambers Pass, Jbsa Ft Sam Houston, TX USA; [Schauer, Steve G.] Brooke Army Med Ctr, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX USA		Bebarta, VS (corresponding author), USAF Route Care Res Ctr, MDW Chief Scientist Off 59, Jbsa Lackland, TX 78233 USA.; Bebarta, VS (corresponding author), US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA.; Bebarta, VS (corresponding author), 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 USA.; Bebarta, VS (corresponding author), Univ Colorado, Dept Emergency Med, Sch Med, 12401 E 17th Ave, Aurora, CO 80045 USA.		Lairet, Julio/AAE-8406-2021		 [EM-I-12-005]	This study was possible following funding support provided to the larger study-Life Saving Intervention study (Air Force Medical Support Agency, EM-I-12-005).	Bucher J, 2015, J EMERG MED, V49, P920, DOI 10.1016/j.jemermed.2015.06.078; Butler Frank K, 2014, J Spec Oper Med, V14, P13; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Fisher Andrew D, 2014, J Spec Oper Med, V14, P11; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; Gaydos SJ, 2015, J EMERG MED, V48, P313, DOI 10.1016/j.jemermed.2014.06.047; Green SM, 2015, ANN EMERG MED, V65, P52, DOI 10.1016/j.annemergmed.2014.08.025; Heitz C, 2019, ACAD EMERG MED, V26, P946, DOI 10.1111/acem.13658; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Lairet JR, 2012, J TRAUMA ACUTE CARE, V73, pS38, DOI 10.1097/TA.0b013e3182606022; Langsjo JW, 2004, ANESTHESIOLOGY, V100, P1065, DOI 10.1097/00000542-200405000-00006; Langsjo JW, 2003, ANESTHESIOLOGY, V99, P614, DOI 10.1097/00000542-200309000-00016; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Maddry JK, 2016, J TRAUMA ACUTE CARE, V81, pS104, DOI 10.1097/TA.0000000000001119; Miller JP, 2015, AM J EMERG MED, V33, P402, DOI 10.1016/j.ajem.2014.12.058; Mora AG, 2016, MIL MED, V181, P145, DOI 10.7205/MILMED-D-15-00194; Peters AJ, 2018, ANESTHESIOLOGY, V129, P278, DOI 10.1097/ALN.0000000000002197; Petz LN, 2015, MIL MED, V180, P14, DOI 10.7205/MILMED-D-14-00383; Rogers R, 2004, ANESTHESIOLOGY, V100, P292, DOI 10.1097/00000542-200402000-00018; Schauer SG, 2019, PREHOSP EMERG CARE, V23, P700, DOI 10.1080/10903127.2018.1560849; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P608, DOI 10.1080/10903127.2018.1428839; Schauer SG, 2017, PREHOSP EMERG CARE, V21, P744, DOI 10.1080/10903127.2017.1335814; Schauer Steven G, 2015, J Spec Oper Med, V15, P85; Shackelford SA, 2015, MIL MED, V180, P304, DOI 10.7205/MILMED-D-14-00257; Wang X, 2014, J ANESTH, V28, P821, DOI 10.1007/s00540-014-1845-3; WYTE SR, 1972, ANESTHESIOLOGY, V36, P174, DOI 10.1097/00000542-197202000-00021	28	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			136	142		10.1093/milmed/usz302			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600021	32074369	Bronze			2022-02-06	
J	Benko, M; Lenhartova, S; Kempova, V; Betakova, T; Kudelova, M				Benko, M.; Lenhartova, S.; Kempova, V; Betakova, T.; Kudelova, M.			Chemokine-binding proteins encoded by herpesviruses	ACTA VIROLOGICA			English	Article						herpesviruses; chemokine-binding proteins; chemokines; immunomodulation viral infection; chemokines and viral immunomodulators	SIMPLEX-VIRUS TYPE-1; MURINE GAMMAHERPESVIRUSES 68; GLYCOPROTEIN-G; CC-CHEMOKINE; GLYCOSAMINOGLYCAN BINDING; STRUCTURAL BASIS; IN-VITRO; T1/35KDA FAMILY; GAMMA RECEPTOR; IMMUNE EVASION	To establish infection, a wide variety of pathogens, including viruses, have evolved a number of strategies to avoid immune elimination. Viruses have acquired and optimized molecules that interact with the host chemokine network in order to disrupt immune surveillance and defense of vertebrates, helping to promote cell entry, facilitating dissemination of infected cells, and evasion the immune response. Viral immunomodulators include ligands, chemokine receptors and chemokine-binding proteins (vCKBPs) functioning as either cell surface receptor mimics, ligand mimics, or secreted chemokine-binding proteins. vCKBPs specifically modulate chemokine gradient formation and ligand-receptor recognition when they have a potential to even completely block chemokine-mediated responses to viral infection. Members of only two virus families (Herpesviridae and Poxviridae) encode vCKBPs capable of sequestering host chemokines through either the chemokine receptor, GAG-binding pocket, or both, which may result in the inhibition of chemotaxis in vivo. Here, we focused on vCKBPs encoded by alpha-, beta-, and gamma-herpesviruses, of which several have been experimentally used as anti-inflammatory or anti-immune reagents in animal models. Current results suggest that vCKBPs could be used to regulate the activity of both chemokines and chemokine receptors for the treatment of infections such as AIDS, diseases such as arthritis, neurotrauma, inflammatory CNS disorders, atherosclerosis, transplant rejection, and metastatic spread and angiogenesis. Better understanding of vCKBPs biology will help evaluate, which human diseases related to chemokine network dysregulation might be effectively treated with these novel promising immunomodulatory drugs to enable the manipulation of chemokine functions and leukocyte trafficking.	[Benko, M.; Lenhartova, S.; Kempova, V; Betakova, T.; Kudelova, M.] Slovak Acad Sci, Biomed Res Ctr, Inst Virol, Dubravska Cesta 9, Bratislava 84505, Slovakia		Kudelova, M (corresponding author), Slovak Acad Sci, Biomed Res Ctr, Inst Virol, Dubravska Cesta 9, Bratislava 84505, Slovakia.	virukude@savba.sk	Betakova, Tatiana/E-7576-2018; Lenhartova, Simona/ABA-6102-2021	Betakova, Tatiana/0000-0003-1095-8258; 	Slovak Ministry of Education [2/087/17]; Slovak Academy of Sciences VEGAVedecka grantova agentura MSVVaS SR a SAV (VEGA) [2/087/17]; Slovak Research and Development AgencySlovak Research and Development Agency [APVV-0621-12, APVV-15-0474]	This work was supported by the joint grant agency of the Slovak Ministry of Education and Slovak Academy of Sciences VEGA (#2/087/17) and by the Slovak Research and Development Agency (#APVV-0621-12 and APVV-15-0474).	Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; Alcami A, 2003, TRENDS MICROBIOL, V11, P191, DOI 10.1016/S0966-842X(03)00077-5; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 1998, J IMMUNOL, V160, P624; Alcami A, 2010, CURR OPIN IMMUNOL, V22, P482, DOI 10.1016/j.coi.2010.06.004; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Ali S, 2000, J BIOL CHEM, V275, P11721, DOI 10.1074/jbc.275.16.11721; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Andres G, 2009, J CELL MOL MED, V13, P2083, DOI 10.1111/j.1582-4934.2008.00415.x; Bachelerie F, 2014, NAT IMMUNOL, V15, P207, DOI 10.1038/ni.2812; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; Barrett J, 2000, J VIROL, V74, P6741, DOI [10.1128/JVI.74.15.6741-6747.2000, DOI 10.1128/JVI.74.15.6741-6747.2000]; Belperio JA, 2000, J IMMUNOL, V165, P461, DOI 10.4049/jimmunol.165.1.461; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Belvoncikova P, 2008, ACTA VIROL, V52, P91; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Bridgeman A, 2001, J EXP MED, V194, P301, DOI 10.1084/jem.194.3.301; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Campbell DJ, 2003, IMMUNOL REV, V195, P58, DOI 10.1034/j.1600-065X.2003.00067.x; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chow MT, 2014, CANCER IMMUNOL RES, V2, P1125, DOI 10.1158/2326-6066.CIR-14-0160; Costes B, 2005, J GEN VIROL, V86, P3209, DOI 10.1099/vir.0.81388-0; Dairaghi DJ, 1998, SEMIN VIROL, V8, P377, DOI 10.1006/smvy.1997.0146; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Devlin JM, 2010, VACCINE, V28, P1325, DOI 10.1016/j.vaccine.2009.11.013; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Engelhardt T, 1996, VIROLOGY, V225, P126, DOI 10.1006/viro.1996.0580; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Francois S, 2010, J GEN VIROL, V91, P2553, DOI 10.1099/vir.0.023481-0; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Gomi Y, 2002, J VIROL, V76, P11447, DOI 10.1128/JVI.76.22.11447-11459.2002; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Hajnicka V, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00458; Halasova Z, 2011, ACTA VIROL, V55, P317, DOI 10.4149/av_2011_04_317; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Hu ZT, 2014, REV MED VIROL, V24, P365, DOI 10.1002/rmv.1791; Hughes DJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001321; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Jensen KK, 2003, J VIROL, V77, P624, DOI 10.1128/JVI.77.1.624-630.2003; Johnson Z, 2004, BIOCHEM SOC T, V32, P366, DOI 10.1042/BST0320366; KIMMAN TG, 1992, VET MICROBIOL, V33, P45, DOI 10.1016/0378-1135(92)90034-Q; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Kuo NW, 2012, J BIOL CHEM, V89, P6592; Lalani AS, 2000, IMMUNOL TODAY, V21, P100, DOI 10.1016/S0167-5699(99)01556-X; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Lira SA, 2009, METHOD ENZYMOL, V460, P193, DOI 10.1016/S0076-6879(09)05209-4; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Lubman OY, 2016, STRUCTURE, V24, P57, DOI 10.1016/j.str.2015.10.018; Lubman OY, 2014, J VIROL, V88, P538, DOI 10.1128/JVI.02729-13; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; Ludwig A, 2007, THROMB HAEMOSTASIS, V97, P694; Luo X, 2016, REV NEUROSCIENCE, V27, P83, DOI 10.1515/revneuro-2015-0016; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Martin AP, 2008, DIABETES, V57, P387, DOI 10.2337/db07-1309; Martin AP, 2006, J IMMUNOL, V177, P7296, DOI 10.4049/jimmunol.177.10.7296; Martinez-Martin N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7163; Matuskova R, 2015, ACTA VIROL, V59, P360, DOI 10.4149/av_2015_04_360; McFadden G, 2000, CURR OPIN MICROBIOL, V3, P371, DOI 10.1016/S1369-5274(00)00107-7; MCGEOCH DJ, 1990, J GEN VIROL, V71, P2361, DOI 10.1099/0022-1317-71-10-2361; Millward JM, 2010, J NEUROIMMUNOL, V224, P45, DOI 10.1016/j.jneuroim.2010.05.005; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Mossman K, 1996, VIROLOGY, V215, P17, DOI 10.1006/viro.1996.0003; Murdoch C, 2000, BLOOD, V95, P3032; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Nelson CA, 2015, VIRUSES-BASEL, V7, P4873, DOI 10.3390/v7092848; Pancik P, 2013, ACTA VIROL, V57, P59, DOI 10.4149/av_2013_01_59; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Perera, 2019, TICKS TICK BORNE PAT, P113, DOI DOI 10.5772/INTECHO-PEN.81025; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Pyo R, 2004, AM J PATHOL, V164, P2289, DOI 10.1016/S0002-9440(10)63785-6; Rajani J., 2007, LATENCY STRATEGIES H, P102, DOI [10.1007/978-0-387-34127-9_5, DOI 10.1007/978-0-387-34127-9_5, DOI 10.1007/978-0-387-34127-9]; Rajcani J., 2005, Acta Microbiologica et Immunologica Hungarica, V52, P41, DOI 10.1556/AMicr.52.2005.1.2; Reading PC, 2003, J IMMUNOL, V170, P1435, DOI 10.4049/jimmunol.170.3.1435; RICHMAN DD, 1986, J VIROL, V57, P647, DOI 10.1128/JVI.57.2.647-655.1986; Roizman B., 2001, FAMILY HERPESVIRIDAE, V4th ed., P2381, DOI DOI 10.1016/B978-0-12-384684-6.00005-7; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; ROSS LJN, 1991, J GEN VIROL, V72, P949, DOI 10.1099/0022-1317-72-4-949; Cabrera JR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004571; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Sarawar SR, 2002, VIROLOGY, V293, P54, DOI 10.1006/viro.2001.1221; Sebova R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00210; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Seet BT, 2002, J LEUKOCYTE BIOL, V72, P24; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; THOMSEN DR, 1987, J VIROL, V61, P229, DOI 10.1128/JVI.61.1.229-232.1987; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; van Berkel V, 1999, J VIROL, V73, P4524, DOI 10.1128/JVI.73.5.4524-4529.1999; Van de Walle GR, 2008, J VIROL, V82, P1714, DOI 10.1128/JVI.02137-07; Van de Walle GR, 2009, J BIOL CHEM, V284, P5968, DOI 10.1074/jbc.M808127200; Viejo-Borbolla A, 2010, J GEN VIROL, V91, P23, DOI 10.1099/vir.0.011940-0; von Einem J, 2007, VIROLOGY, V362, P151, DOI 10.1016/j.virol.2006.12.008; Vossen MTM, 2002, IMMUNOGENETICS, V54, P527, DOI 10.1007/s00251-002-0493-1; Wang D, 2004, P NATL ACAD SCI USA, V101, P16642, DOI 10.1073/pnas.0407233101; Webb LMC, 2003, J VIROL, V77, P8588, DOI 10.1128/JVI.77.15.8588-8592.2003; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; WEBER PC, 1987, SCIENCE, V236, P576, DOI 10.1126/science.3033824; Wu L, 2008, HUM GENE THER, V19, P635, DOI 10.1089/hum.2007.163; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	114	1	1	3	4	AEPRESS SRO	BRATISLAVA	BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA	0001-723X	1336-2305		ACTA VIROL	Acta Virol.		2020	64	2					233	244		10.4149/av_2020_213			12	Virology	Science Citation Index Expanded (SCI-EXPANDED)	Virology	NI7XB	WOS:000565560800012	32551791	Bronze			2022-02-06	
J	Black, SE; Follmer, B; Mezzarane, RA; Pearcey, GEP; Sun, Y; Zehr, EP				Black, Stephanie E.; Follmer, Bruno; Mezzarane, Rinaldo Andre; Pearcey, Gregory E. P.; Sun, Yao; Zehr, E. Paul			Exposure to impacts across a competitive rugby season impairs balance and neuromuscular function in female rugby athletes	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						brain; concussion; rugby	HEAD IMPACTS; POSTURAL CONTROL; HOFFMANN REFLEX; HIGH-SCHOOL; SPORT; CONCUSSION; VALIDITY; IMPROVES; BOARD	ObjectivesWe used objective assessment tools to detect subtle neurological deficits that accompany repetitive and mild head impacts in contact sport across a season.MethodsFemale participants (n=13, 211.8 years old; 167.66.7 cm; 72.8 +/- 6.1 kg) completed assessments pre and post the varsity rugby season. A commercial balance board was used to assess static balance and response to dynamic postural challenge. Spinal cord excitability via the soleus H-reflex was assessed in both legs. Video analysis was used to identify head impact exposures.ResultsA total of 172 potential concussive events were verified across 11 athletes (15.6 +/- 11; 95% CI: 6.5 to 19.8). Balance performance was worse at post-season for total centre of pressure which increased by 26% in the double stance on a stable surface (t(12)=-2.33; p=0.03; d=0.6) and by 140% in the tandem stance on a foam surface (t(12)=-3.43; p<0.01; d=0.9). Despite that, dynamic postural performance was improved after the season (p<0.01). Spinal cord excitability in rugby athletes did not change across the season but deviated from normative values at baseline.ConclusionQuantitative measures revealed that exposure to impacts across a competitive rugby season impair balance in two specific stances in female rugby athletes. Tandem-leg stance on an unstable surface and double-leg stance on firm surface are useful assessment conditions when performed over a low-cost balance board, even without clinically diagnosed concussion.	[Black, Stephanie E.; Follmer, Bruno; Pearcey, Gregory E. P.; Sun, Yao; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Black, Stephanie E.; Follmer, Bruno; Sun, Yao; Zehr, E. Paul] Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC, Canada; [Follmer, Bruno; Pearcey, Gregory E. P.; Sun, Yao; Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Human Discovery Sci, Vancouver, BC, Canada; [Mezzarane, Rinaldo Andre] Univ Brasilia, Fac Phys Educ, Lab Signal Proc & Motor Control, Brasilia, DF, Brazil; [Pearcey, Gregory E. P.; Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada		Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada.; Zehr, EP (corresponding author), Univ Victoria, Sch Exercise Sci Phys & Hlth Educ, Victoria, BC, Canada.; Zehr, EP (corresponding author), Int Collaborat Repair Discoveries ICORD, Human Discovery Sci, Vancouver, BC, Canada.; Zehr, EP (corresponding author), Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada.; Zehr, EP (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC, Canada.	pzehr@uvic.ca	MEZZARANE, Rinaldo A/I-2862-2013	Follmer, Bruno/0000-0001-5052-9648; Pearcey, Gregory/0000-0002-6751-4351; Mezzarane, Rinaldo/0000-0001-9659-4015	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC)	This work was partially supported by an NSERC Discovery grant to EPZ.	Adolph KE, 2008, CURR DIR PSYCHOL SCI, V17, P213, DOI 10.1111/j.1467-8721.2008.00577.x; [Anonymous], 1995, GAIT POSTURE; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Ceballos-Villegas ME, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00530; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Forbes CR, 2016, APPL NEUROPSYCH-CHIL, V5, P14, DOI 10.1080/21622965.2014.933108; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Grospretre S, 2012, J NEUROPHYSIOL, V107, P1649, DOI 10.1152/jn.00611.2011; Holmes JD, 2013, CLIN REHABIL, V27, P361, DOI 10.1177/0269215512458684; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; KATAYAMA Y, 1985, J NEUROSURG, V63, P97, DOI 10.3171/jns.1985.63.1.0097; Kaupp C, 2018, J NEUROPHYSIOL, V119, P1095, DOI 10.1152/jn.00570.2017; Kim KM, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071037; Klarner T, 2014, BIOSYST BIOROBOT, V7, P479, DOI 10.1007/978-3-319-08072-7_71; Klimstra M, 2008, EXP BRAIN RES, V186, P93, DOI 10.1007/s00221-007-1207-6; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mezzarane RA, 2002, J NEUROPHYSIOL, V87, P2074, DOI 10.1152/jn.00129.2001; Mezzarane RA, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00355; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; Nozaki D, 1996, EXP BRAIN RES, V112, P112; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Sun Y, 2020, J MOTOR BEHAV, V52, P643, DOI 10.1080/00222895.2019.1670129; Sun Y, 2018, EXP BRAIN RES, V236, P2009, DOI 10.1007/s00221-018-5275-6; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00868; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5; Zhang XM, 2009, PERCEPT MOTOR SKILL, V109, P747, DOI 10.2466/PMS.109.3.747-756	41	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000740	10.1136/bmjsem-2020-000740			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF8FZ	WOS:000599284800001	32617174	gold, Green Published			2022-02-06	
S	Bragina, OA; Semyachkina-Glushkovskaya, OV; Nemoto, EM; Bragin, DE		Ryu, PD; LaManna, JC; Harrison, DK; Lee, SS		Bragina, Olga A.; Semyachkina-Glushkovskaya, Oxana V.; Nemoto, Edwin M.; Bragin, Denis E.			Anodal Transcranial Direct Current Stimulation Improves Impaired Cerebrovascular Reactivity in Traumatized Mouse Brain	OXYGEN TRANSPORT TO TISSUE XLI	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	46th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT)	JUL 01-05, 2018	Seoul, SOUTH KOREA	Int Soc Oxygen Transport Tissue, Coll Vet Med, OBELAB, Scitech Korea Inc, BrianKorea21Plus, Korea Mouse Phenotyping Ctr, Bio d, Kangstem Biotech, Wonkwang Univ Med Ctr, A L S Ctr, Korean Soc Primo Vasc Syst, Korean Soc Vet Sci		Traumatic brain injury (TBI); Transcranial direct current stimulation (tDCS); Cerebrovascular reactivity (CVR); Microvascular dysfunction; Hypercapnia test	NITRIC-OXIDE; NEUROMODULATION; HEALTHY; INJURY	Cerebrovascular reactivity (CVR) is a compensatory mechanism where blood vessels dilate in response to a vasodilatory stimulus, and is a biomarker of vascular reserve and microvascular health. Impaired CVR indicates microvascular hemodynamic dysfunction, which is implicated in traumatic brain injury (TBI) and associated with long-term neurological deficiency. Recently we have shown that anodal transcranial direct current stimulation (tDCS) caused prolonged dilatation of cerebral arterioles that increased brain microvascular flow and tissue oxygenation in traumatized mouse brain and was associated with neurologic improvement. Here we evaluate the effects of tDCS on impaired CVR and microvascular cerebral blood flow (mCBF) regulation after TBI. TBI was induced in mice by controlled cortical impact (CCI). Cortical microvascular tone, mCBF, and tissue oxygen supply (by nicotinamide adenine dinucleotide, NADH) were measured by two-photon laser scanning microscopy before and after anodal tDCS (0.1 mA/15 min). CVR and mCBF regulation were evaluated by measuring changes in arteriolar diameters and NADH during hypercapnia test before and after tDCS. Transient hypercapnia was induced by 60-s increase of CO 2 concentration in the inhalation mixture to 10%. As previously, anodal tDCS dilated arterioles which increased arteriolar blood flow volume that led to an increase in capillary flow velocity and the number of functioning capillaries, thereby improving tissue oxygenation in both traumatized and sham animals. In sham mice, transient hypercapnia caused transient dilatation of cerebral arterioles with constant NADH, reflecting intact CVR and mCBF regulation. In TB! animals, arteriolar dilatation response to hypercapnia was diminished while the NADH level increased (tissue oxygen supply decreased), reflecting impaired CVR and mCBF regulation. Anodal tDCS enhanced reactivity in parenchymal arterioles in both groups (especially in TBI mice) and restored CVR thereby prevented the reduction in tissue oxygen supply during hypercapnia. CVR has been shown to be related to nitric oxide elevation due to nitric oxide synthases activation, which can be sensitive to the electrical field induced by tDCS.	[Bragina, Olga A.; Nemoto, Edwin M.; Bragin, Denis E.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA; [Bragina, Olga A.; Semyachkina-Glushkovskaya, Oxana V.] Saratov NG Chernyshevskii State Univ, Dept Human & Anim Physiol, Saratov, Russia		Bragin, DE (corresponding author), Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA.	dbragin@salud.unm.edu	Glushkovskaya, Oxana V/D-5190-2013	Glushkovskaya, Oxana V/0000-0001-6753-7513	NIH-NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089]	Supported by NIH-NIGMS P20GM109089.	Balbi M, 2017, J CEREBR BLOOD F MET, V37, P3625, DOI 10.1177/0271678X16686595; Bragina OA, 2018, ADV EXP MED BIOL, V1072, P27, DOI 10.1007/978-3-319-91287-5_5; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cipolla M.J., 2009, CEREBRAL CIRCULATION; Cipolla MJ, 2014, J APPL PHYSIOL, V117, P53, DOI 10.1152/japplphysiol.00253.2014; Clayton E, 2016, BRAIN RES, V1640, P130, DOI 10.1016/j.brainres.2016.01.056; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Giorli E, 2015, J NEUROIMAGING, V25, P571, DOI 10.1111/jon.12162; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Tully H, 2018, SCI TRANSL MED, V10; Vernieri F, 2010, STROKE, V41, P2087, DOI 10.1161/STROKEAHA.110.583088; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392	14	1	1	0	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-34461-0; 978-3-030-34459-7	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2020	1232						47	53		10.1007/978-3-030-34461-0_7			7	Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	BP4YQ	WOS:000554927500007	31893393	Green Accepted			2022-02-06	
J	Brahmajothi, MV; Abou-Donia, MB				Brahmajothi, Mulugu, V; Abou-Donia, Mohamed B.			Monitoring from Battlefield to Bedside: Serum Repositories Help Identify Biomarkers, Perspectives on Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				PLATELET FACTOR-IV; VETERANS; SYSTEM; RECOMMENDATIONS; BIOREPOSITORY; TECHNOLOGIES; MECHANISMS; PLASMA; RISK	Objectives Serum repositories are foundations for seroepidemiological data, revealing targeted information about morbidities and existing heterogeneity in human populations. With the recent technological advances, we can perform high-throughput screening at an affordable cost using minimal plasma. Monitoring brain health after an injury is critical since mild Traumatic Brain Injury (mTBI) and other neurological symptoms are under-diagnosed. Our objective in this study is to present our preliminary serological data from one of our ongoing studies on mTBI. Methods In this retrospective study, we used stored plasma samples to understand biomarkers of mTBI. We compared plasma samples from five patients with mTBI following their first concussive episode to five gender and age-matched healthy controls. We assessed multiple biomarkers to show the importance of biorepositories. Results Most of the estimated plasma factors in mTBI subjects at baseline were comparable to normal healthy individuals except for the astroglial markers S100B and glial fibrillary acidic protein. Fluctuations of these biomarkers can affect the homeostasis of brain parenchyma by altering the neural network signaling, which in turn may result in intermittent behavioral symptoms. Conclusion Biorepositories are powerful resources for understanding the spectrum of morbidity. Biomarkers serve as a valuable diagnostic and therapeutic tool.	[Brahmajothi, Mulugu, V; Abou-Donia, Mohamed B.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, POB 3813, Durham, NC 27710 USA		Brahmajothi, MV (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, POB 3813, Durham, NC 27710 USA.			Brahmajothi V., Mulugu/0000-0002-6438-4854	Department of Defense (DOD)United States Department of Defense [W81XWH-15-1-0641, W81XWH-18-1-0454]; DoDUnited States Department of Defense [W81XWH-18-1-0454]	Department of Defense (DOD) Contract No. W81XWH-15-1-0641 and W81XWH-18-1-0454. Funding DoD #W81XWH-15-1-0641 was awarded to MBA and DoD#W81XWH-18-1-0454 awarded to MVB.	Abou-Donia MB, 2017, NEUROTOXICOL TERATOL, V61, P36, DOI 10.1016/j.ntt.2017.03.002; AbouDonia MB, 1996, J TOXICOL ENV HEALTH, V48, P35, DOI 10.1080/009841096161456; Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; [Anonymous], 2018, DEF MED SURV SYST TH; [Anonymous], 2016, J APPL BIOANAL, V2, P8; Baird CP, 2015, MIL MED, V180, P26, DOI 10.7205/MILMED-D-15-00065; Bendtzen K, 2013, DISCOV MED, V15, P201; Bennett AS, 2013, SUBST USE MISUSE, V48, P894, DOI 10.3109/10826084.2013.796991; Carraretto M., 2016, CRIT CARE, V20, P1; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; DeFraites RF, 2011, BMC PUBLIC HLTH S2, V11, P1; EISMAN R, 1990, BLOOD, V76, P336; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1; Hermstad Erik, 2010, J Emerg Trauma Shock, V3, P66, DOI 10.4103/0974-2700.58660; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Jannetto PJ, 2016, CLIN CHEM, V62, P92, DOI 10.1373/clinchem.2015.248146; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Karch Stephanie J, 2016, US Army Med Dep J, P52; Kaur R, 2016, J PHARMACOL PHARMACO, V7, P120, DOI 10.4103/0976-500X.189661; Lindler LE, 2015, MIL MED, V180, P90, DOI 10.7205/MILMED-D-14-00724; Munoz J, 2014, ANGEW CHEM INT EDIT, V53, P10864, DOI 10.1002/anie.201406545; Perdue CL, 2015, MIL MED, V180, P10, DOI 10.7205/MILMED-D-14-00739; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Poirier MC, 1998, CANCER EPIDEM BIOMAR, V7, P545; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Sauer UG, 2017, REGUL TOXICOL PHARM, V91, pS14, DOI 10.1016/j.yrtph.2017.09.020; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Siwek M, 2015, MIL MED, V180, P57, DOI 10.7205/MILMED-D-15-00119; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stocker RPJ, 2016, J CLIN SLEEP MED, V12, P49, DOI 10.5664/jcsm.5392; Stuart JA, 2002, MIL MED, V167, P121, DOI 10.1093/milmed/167.2.121; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Touitou Y, 2017, LIFE SCI, V173, P94, DOI 10.1016/j.lfs.2017.02.008; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Warkentin TE, 2009, BLOOD, V113, P4963, DOI 10.1182/blood-2008-10-186064; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010	41	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			197	204		10.1093/milmed/usz301			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600030	32074362	Bronze			2022-02-06	
J	Brandi, G; Schmidlin, A; Klinzing, S; Schupbach, R; Unseld, S; Pagnamenta, A				Brandi, Giovanna; Schmidlin, Adrian; Klinzing, Stephanie; Schupbach, Reto; Unseld, Simone; Pagnamenta, Alberto			Delayed prophylaxis with unfractionated heparin increases the risk of venous thromboembolic events in patients with moderate to severe traumatic brain injury: a retrospective analysis	ANAESTHESIOLOGY INTENSIVE THERAPY			English	Article						venous thromboembolism; traumatic brain injury; intracranial hemorrhage; unfractionated heparin	PHARMACOLOGICAL THROMBOPROPHYLAXIS; ENOXAPARIN PROPHYLAXIS; PULMONARY-EMBOLISM; 1602 EPISODES; SAFETY; CHEMOPROPHYLAXIS; EFFICACY; THROMBOSIS; HEMORRHAGE	Background: Venous thromboembolism (VTE) is a recognized complication in patients with traumatic brain injury (TBI) and is associated with increased morbidity and mortality. Currently, no standard exists for optimal timing or a pharmacological agent for VTE prophylaxis (pharmacological thromboprophylaxis - PTP) in patients with TBI. PTP is often delayed out of fear of causing extension of intracranial hemorrhage (ICH). The purpose of this study was to report the frequency of VTE and ICH progression after initiation of PTP with a continuous infusion of unfractionated heparin in patients with moderate to severe TBI, and to identify risk factors associated with development of VTE. Methods: In this single-center retrospective study, patients with moderate to severe TBI admitted to the ICU of a Swiss Level I Trauma Center over a three-year period were analyzed. Results: In 23 (13%) of the 177 patients included in the study a VTE episode occurred during the hospital stay. ICH progression after initiation of PTP occurred in 7 (4%) patients. In a multivariable logistic regression model, only the timing of initiation of PTP was identified as an independent predictor of VTE. Conclusions: In this study population, the risk of developing VTE increased with the delay of initiation of a pharmacological VTE prophylaxis, while ICH progression after initiation of PTP was a rare event.	[Brandi, Giovanna; Schmidlin, Adrian; Klinzing, Stephanie; Schupbach, Reto; Unseld, Simone] Univ Hosp Zurich, Zurich, Switzerland; [Pagnamenta, Alberto] Ente Osped Cantonale, Unit Clin Epidemiol, Bellinzona, Switzerland; [Pagnamenta, Alberto] Univ Hosp Geneva, Div Pneumol, Geneva, Switzerland		Brandi, G (corresponding author), Univ Hosp Zurich, Inst Intens Care, Ramistr 100, CH-8091 Zurich, Switzerland.	giovanna.brandi@usz.ch	Schuepbach, Reto/AAO-6360-2020	Schuepbach, Reto/0000-0002-7058-4377			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Dengler BA, 2016, NEUROCRIT CARE, V25, P215, DOI 10.1007/s12028-016-0280-8; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Foreman PM, 2014, CLIN NEUROL NEUROSUR, V123, P109, DOI 10.1016/j.clineuro.2014.05.017; Frisoli FA, 2017, NEUROSURGERY, V81, P1016, DOI 10.1093/neuros/nyx164; Gennarelli TA, 2008, ASS ADVANCEMENT AUTO, VVII, P167; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Owings JT, 1997, ARCH SURG-CHICAGO, V132, P862; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Rolston JD, 2014, J NEUROSURG, V121, P908, DOI 10.3171/2014.6.JNS131419; Rubin ML, 2019, J NEUROTRAUM, V36, P2417, DOI 10.1089/neu.2018.6217; Saiki Robin L, 2009, Crit Care Nurs Clin North Am, V21, P549, DOI 10.1016/j.ccell.2009.07.009; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d; Scales DC, 2010, CRIT CARE, V14, DOI 10.1186/cc8980; Schaible EV, 2013, CURR OPIN ANESTHESIO, V26, P529, DOI 10.1097/01.aco.0000432519.16586.6b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Shackford SR, 2004, ANN SURG, V240, P496; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strollo BP, 2018, J CRIT CARE, V43, P75, DOI 10.1016/j.jcrc.2017.08.012; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701	36	1	1	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1642-5758	1731-2531		ANAESTH INTENSIVE TH	Anaesth. Intensive Ther.		2020	52	1					28	33		10.5114/ait.2020.93395			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	KX2TV	WOS:000521735000006	32191827	gold, Green Accepted			2022-02-06	
J	Brocht, C; Sheldon, P; Synovec, C				Brocht, Chauna; Sheldon, Phill; Synovec, Caitlin			A clinical description of strategies to address traumatic brain injury experienced by homeless patients at Baltimore's medical respite program	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Homelessness; rehabilitation; self-management; medical respite program; homeless shelter		BACKGROUND: Medical respite programs provide a safe place for people experiencing homelessness to recover from an acute illness or injury. Many patients in respite programs have experienced a traumatic brain injury (TBI) that impedes their ability to complete the self-management tasks necessary to recover from an acute medical condition. Patients with brain injuries may also have behavioral problems that are difficult to manage in a medical respite setting. OBJECTIVE: This paper describes the experiences of one medical respite program in screening, assessing, and treating patients experiencing homelessness who have traumatic brain injuries. METHODS: Services by clinical providers were tailored to better address needs of those with a history of TBI, as well as implementation of environmental modifications. Two retrospective case studies were completed to illustrate the importance of addressing TBIs in respite programs. RESULTS: Modifications to programming can improve patient outcomes and assist in transitioning patients to appropriate community resources. CONCLUSIONS: Identifying and treating patients with TBIs in respite programs can result in long-term positive benefits for patients.	[Brocht, Chauna; Sheldon, Phill; Synovec, Caitlin] Hlth Care Homeless, 421 Fallsway, Baltimore, MD 21202 USA		Brocht, C (corresponding author), Hlth Care Homeless, 421 Fallsway, Baltimore, MD 21202 USA.	chaunabrocht@gmail.com					Allen C. K., 2007, MANUAL ALLEN COGNITI; Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; Brain Injury Association of Maryland, 2017, MAR TRAUM BRAIN INJ; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Giles GM, 2017, AM J OCCUP THER, V71, DOI 10.5014/ajot.2017.715001; Highley JL, 2008, TRAUMATIC BRAIN INJU; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Kazdin AE, 2001, BEHAV MODIFICATION A, P34; Lemsky C., 2018, ADAPTING YOUR PRACTI; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; National Health Care for the Homeless Council, 2016, STAND MED RESP PROGR; Substance Abuse and Mental Health Services Administration, 2011, CURR STAT PREV CHAR; Synovec C, 2019, ADDRESSING OCC UNPUB; Topolovec-Vranic J, 2017, J PSYCHIATR RES, V87, P53, DOI 10.1016/j.jpsychires.2016.12.004; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; World Health Organization, 2018, WHO DIS ASS SCHED 2	18	1	1	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2020	65	2					311	320		10.3233/WOR-203083			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KX1JN	WOS:000521639000011	32007975				2022-02-06	
J	Brun, SP				Brun, Shane P.			Some current challenges facing the athlete and their doctor	AUSTRALIAN JOURNAL OF GENERAL PRACTICE			English	Article							SUDDEN CARDIAC DEATH; ELECTROCARDIOGRAPHIC INTERPRETATION; NUTRITIONAL SUPPLEMENTS; SPORTS; CONCUSSION; TRACK	Background Primary care physicians are often responsible for the care of people involved in sporting and exercise activities at various competitive levels. Issues confronting the athlete and their primary care physician are the potentially serious risks, responsibilities and challenges facing those involved with sport and physical activity. Objective The aim of this article is to address three of the most important challenges currently facing the athlete and primary care physician caring for athletes. The challenges are to recognise the potential risks to the athlete of sustaining a sudden cardiac arrest, sports-related concussion or doping violation in sport, as each of these have serious implications for life, wellbeing, performance and/or reputation. Education and risk mitigation are also essential components of care that will be addressed. Discussion The primary care physician caring for athletes has a pivotal role in ensuring appropriate screening, education and ongoing surveillance to minimise the potentially serious risks facing those involved with physical activity.	[Brun, Shane P.] James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia; [Brun, Shane P.] Univ Malaysia, Sports Med Unit, Gelugor, Penang, Malaysia; [Brun, Shane P.] FIFA, Zurich, Switzerland; [Brun, Shane P.] AFC, Kuala Lumpur, Malaysia		Brun, SP (corresponding author), James Cook Univ, Coll Med & Dent, Townsville, Qld, Australia.; Brun, SP (corresponding author), Univ Malaysia, Sports Med Unit, Gelugor, Penang, Malaysia.; Brun, SP (corresponding author), FIFA, Zurich, Switzerland.; Brun, SP (corresponding author), AFC, Kuala Lumpur, Malaysia.	shane.brun@jcu.edu.au	Brun, Shane/Y-3194-2019; Brun, Shane/AAW-9854-2020	Brun, Shane/0000-0003-2897-5320; 			Araujo CGS, 2016, SCAND J MED SCI SPOR, V26, P4, DOI 10.1111/sms.12632; Bohm P, 2016, EUR J PREV CARDIOL, V23, P649, DOI 10.1177/2047487315594087; Brun SP, 2016, AUST FAM PHYSICIAN, V45, P478; Burns RD, 2004, J AM DIET ASSOC, V104, P246, DOI 10.1016/j.jada.2003.11.013; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2017, INT J CARDIOL, V237, P67, DOI 10.1016/j.ijcard.2017.03.034; Corrado D, 2011, EUR HEART J, V32, P934, DOI 10.1093/eurheartj/ehq482; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; de Noronha SV, 2009, HEART, V95, P1409, DOI 10.1136/hrt.2009.168369; Drezner JA, 2017, BRIT J SPORT MED, V51, P704, DOI 10.1136/bjsports-2016-097331; Drezner JA, 2011, BRIT J SPORT MED, V45, P947, DOI 10.1136/bjsports-2011-090077; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Harmon KG, 2011, CIRCULATION, V123, P1594, DOI 10.1161/CIRCULATIONAHA.110.004622; Hoffman JR, 2008, MED SCI SPORT EXER, V40, P15, DOI 10.1249/mss.0b013e31815a5181; KANDEL DB, 1992, J STUD ALCOHOL, V53, P447, DOI 10.15288/jsa.1992.53.447; Kandel D, 2015, ACTA PAEDIATR, V104, P130, DOI 10.1111/apa.12851; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kong MH, 2011, J AM COLL CARDIOL, V57, P794, DOI 10.1016/j.jacc.2010.09.064; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Martinez-Sanz JM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101093; Modaff DS, 2019, AM J CARDIOL, V123, P169, DOI 10.1016/j.amjcard.2018.09.012; Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842; Parr MK, 2011, TOXICOL LETT, V201, P101, DOI 10.1016/j.toxlet.2010.11.018; Petroczi A, 2008, SUBST ABUSE TREAT PR, V3, DOI 10.1186/1747-597X-3-7; Rao P, 2018, CURR CARDIOL REV, V14, P79, DOI 10.2174/1573403X14666180507160555; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sharma S, 2017, J AM COLL CARDIOL, V69, P1057, DOI 10.1016/j.jacc.2017.01.015; Travers AH, 2010, CIRCULATION, V122, pS676, DOI 10.1161/CIRCULATIONAHA.110.970913; Tscholl P, 2010, AM J SPORT MED, V38, P133, DOI 10.1177/0363546509344071; Waddington I, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012468; Yim ES, 2014, J ULTRAS MED, V33, P307, DOI 10.7863/ultra.33.2.307; Ziegler PJ, 2003, INT J SPORT NUTR EXE, V13, P266, DOI 10.1123/ijsnem.13.3.266	38	1	1	0	0	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	2208-794X	2208-7958		AUST J GEN PRACT	Aust. J. Gen. Pract.	JAN-FEB	2020	49	1-2					23	31					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KS3NG	WOS:000518218400005	32008269	Bronze			2022-02-06	
J	Campbell, J; Howland, J; Hess, C; Nelson, K; Stern, RA; Torres, A; Olshaker, J				Campbell, Julia; Howland, Jonathan; Hess, Courtney; Nelson, Kerrie; Stern, Robert A.; Torres, Alcy; Olshaker, Jonathan			Disparities in baseline neurocognitive testing for student concussion management in Massachusetts high schools	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; research; public health; injury; prevention	TRAUMATIC BRAIN-INJURY; YOUTH; SYMPTOMS; SPORT; EDUCATION; CHILDREN; ACCESS; RETURN; KNOWLEDGE; REST	PurposeThere is evidence of socioeconomic disparities with respect to the implementation of student-sports concussion laws nationally. The purpose of this study was to examine school sociodemographic characteristics associated with the provision of computerised baseline neurocognitive testing (BNT) in Massachusetts (MA) high schools, and to assess whether the scope of testing is associated with the economic status of student populations in MA.MethodsA cross-sectional secondary analysis of surveys conducted with MA athletic directors (n=270) was employed to investigate school characteristics associated with the provision of BNT. Correlation and regression analyses were used to assess whether the scope of testing is associated with the economic status of student populations in MA.ResultsThe scope of BNT was independently associated with the economic disadvantage rate (EDR) of the student population (beta=-0.02, p=0.01); whether or not the school employs an athletic trainer (AT) (beta =0.43, p=0.03); and school size (beta=-0.54, p=0.03). In a multivariable regression model, EDR was significantly associated with the scope of baseline testing, while controlling for AT and size (beta=-0.01, p=0.03, adj-R-2=0.1135).ConclusionAmong public high schools in MA, disparities in the provision of BNT for students are associated with the economic characteristics of the student body. Schools that have a greater proportion of low-income students are less likely to provide comprehensive BNT. The clinical implications of not receiving BNT prior to concussion may include diminished quality of postconcussive care, which can have short-term and long-term social, health-related and educational impacts.	[Campbell, Julia; Howland, Jonathan; Torres, Alcy; Olshaker, Jonathan] Boston Univ, Med Ctr, Dept Emergency Med, Boston, MA 02118 USA; [Campbell, Julia; Howland, Jonathan; Nelson, Kerrie; Stern, Robert A.; Torres, Alcy; Olshaker, Jonathan] Boston Univ, Med Ctr, Injury Prevent Ctr, Boston, MA 02118 USA; [Hess, Courtney] Univ Massachusetts, Dept Counseling & Sch Psychol, Boston, MA 02125 USA; [Nelson, Kerrie] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Campbell, J (corresponding author), Boston Univ, Med Ctr, Dept Emergency Med, Boston, MA 02118 USA.; Campbell, J (corresponding author), Boston Univ, Med Ctr, Injury Prevent Ctr, Boston, MA 02118 USA.	jkcampbe@bu.edu		Campbell, Julia/0000-0002-2674-1830	Massachusetts Department of Public Health through CDC [NU17CE924835]	This research was made possible through funding from the Massachusetts Department of Public Health through CDC grant NU17CE924835.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Borofsky LA, 2013, PSYCHOL VIOLENCE, V3, P381, DOI 10.1037/a0034121; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Centers for Disease Control and Prevention, 2019, TBI GET FACTS TRAUM; Centers for Disease Control and Prevention, 2016, FAQS BAS TEST; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeVoe JF, 2005, STUDENT REPORTS BULL; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Gordon, 2010, CHILDRENS FOOD SECUR; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Halstead M, 2018, SPORT RELATED CONCUS; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Holmes L, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0058-8; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kroshus E, 2019, INJURY PREV, V25, P278, DOI 10.1136/injuryprev-2017-042677; Lazar M, 2018, J COMMUN HEALTH NURS, V35, P28, DOI 10.1080/07370016.2018.1404832; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Makower, 2012, J ED DEV PSYCHOL, V2, P69, DOI DOI 10.5539/JEDP.V2N1P69; Massachuetts Department of Elementary and Secondary Education, 2014, RED LOW INC NEW METR; Massachusetts Department of Elementary and Secondary Education, 2019, CLASS SIZ GEND SEL P; Massachusetts Department of Public Health, 2018, RET SCH CONC GUID MA; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; National Center for Education Statistics, 2006, SCH LOC DEF RUR ED A; National Conference of State Legislatures, 2019, TRAUM BRAIN INJ LEG; Post E, 2019, J ATHL TRAINING, V54, P177, DOI 10.4085/1062-6050-440-17; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Russell Kelly, 2017, Concussion, V2, pCNC51, DOI 10.2217/cnc-2017-0009; Smedley BD, 2008, HEALTH AFFAIR, V27, P447, DOI 10.1377/hlthaff.27.2.447; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Zhu J, 2010, J GEN INTERN MED, V25, P1356, DOI 10.1007/s11606-010-1482-y	50	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000752	10.1136/bmjsem-2020-000752			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF8JK	WOS:000599293700001	32537243	Green Published, gold			2022-02-06	
J	Chosy, EJ; Gross, N; Meyer, M; Liu, CY; Edland, SD; Launer, LJ; White, LR				Chosy, E. Julia; Gross, Noele; Meyer, Marnie; Liu, Catherine Y.; Edland, Steven D.; Launer, Lenore J.; White, Lon R.			Brain Injury and Later-Life Cognitive Impairment and Neuropathology: The Honolulu-Asia Aging Study	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; brain lesions; cognitive dysfunction; dementia; Honolulu-Asia Aging Study; neuropathology; traumatic brain injury	ALZHEIMERS-DISEASE; RISK-FACTORS; HEAD TRAUMA; OLDER-ADULTS; EARLIER AGE; DEMENTIA; HISTORY; ONSET; ASSOCIATION; PREVALENCE	Background: Findings are inconsistent regarding the role of traumatic head injury in the subsequent development of neurologic outcomes. Objective: Examine the relationship between head injury and later cognitive impairment. Methods: A sample of 3,123 Japanese-American men was assessed for history of head injury and evaluated for cognitive impairment using the Cognitive Abilities Screening Instrument (CASI). For a subsample of 676 respondents, neuropathologic results from those with and without head injury were compared. Results: Although the crude model showed an association between history of head injury and later severe cognitive impairment, the relationship lost significance in the adjusted model (OR = 1.320, CI: 0.90-1.93), regardless of time between injury and impairment. Similar to cognitive impairment, hippocampal sclerosis was observed significantly more in the brains of respondents with a history of head injury in the crude model, but the relationship weakened in the adjusted model (OR = 1.462, CI: 0.68-3.12). After adjustment, decedents with a head injury demonstrated marginally higher brain weight (OR = 1.003, CI: 1.00-1.01). Conclusion: We did not find a relationship between head injury and subsequent cognitive decline in this cohort. The neuropathology results also displayed no strong association between history of head injury and specific brain lesions and characteristics. These results support other findings in prospective cohorts. However, they could be influenced by the demographic make-up of the sample (male Japanese-Americans) or by the observation that the majority reported only a single head injury.	[Chosy, E. Julia; Gross, Noele; Meyer, Marnie; Liu, Catherine Y.; White, Lon R.] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Edland, Steven D.] Univ Calif San Diego, San Diego, CA 92103 USA; [Launer, Lenore J.] NIA, NIH, Bethesda, MD 20892 USA		Chosy, EJ (corresponding author), 3375 Koapaka St,Suite 1-540, Honolulu, HI 96819 USA.	ejchosy@phrei.org			National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [UF1AG053983, UF1AG057707]; Intramural Research Program, NIA; Chia-Ling Chang Fund of the Hawaii Community Foundation; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0431]	This work was supported by the National Institute on Aging (NIA) grants UF1AG053983 and UF1AG057707; Intramural Research Program, NIA; the Chia-Ling Chang Fund of the Hawaii Community Foundation; and the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0431. The content in this article does not necessarily reflect the official views of the United States Government.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gelber RP, 2012, CURR ALZHEIMER RES, V9, P664; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; Latimer CS, 2017, J NEUROPATH EXP NEUR, V76, P458, DOI 10.1093/jnen/nlx030; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Maxwell CJ, 2005, DEMENT GERIATR COGN, V20, P45, DOI 10.1159/000085074; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Negash S, 2011, CURR ALZHEIMER RES, V8, P336, DOI 10.2174/156720511795745302; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rafferty LA, 2018, PSYCHOL MED, V48, P1400, DOI 10.1017/S0033291717001386; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; Yaffe K, 2019, NEUROLOGY, V92, pE205, DOI 10.1212/WNL.0000000000006778	49	1	1	1	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2020	73	1					317	325		10.3233/JAD-190053			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KB2EF	WOS:000506311500026	31771050	Green Accepted			2022-02-06	
J	Chu, TH; Cummins, K; Stys, PK				Chu, Tak-Ho; Cummins, Karen; Stys, Peter K.			Traumatic Injury Reduces Amyloid Plaque Burden in the Transgenic 5xFAD Alzheimer's Mouse Spinal Cord	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Amyloid plaque; astrocyte; microglia; spinal cord injury; neprilysin	BRAIN-INJURY; BETA-PEPTIDE; A-BETA; AXONAL INJURY; MICROGLIA; MICE; PATHOLOGY; DISEASE; ACCUMULATION; DEPOSITION	Background: Axonal injury has been implicated in the development of amyloid-beta in experimental brain injuries and clinical cases. The anatomy of the spinal cord provides a tractable model for examining the effects of trauma on amyloid deposition. Objective: Our goal was to examine the effects of axonal injury on plaque formation and clearance using wild type and 5xFAD transgenic Alzheimer's disease mice. Methods: We contused the spinal cord at the T12 spinal level at 10 weeks, an age at which no amyloid plaques spontaneously accumulate in 5xFAD mice. We then explored plaque clearance by impacting spinal cords in 27-week-old 5xFAD mice where amyloid deposition is already well established. We also examined the cellular expression of one of the most prominent amyloid-beta degradation enzymes, neprilysin, at the lesion site. Results: No plaques were found in wild type animals at any time points examined. Injury in 5xFAD prevented plaque deposition rostral and caudal to the lesion when the cords were examined at 2 and 4 months after the impact, whereas age-matched naive 5xFAD mice showed extensive amyloid plaque deposition. A massive reduction in the number of plaques around the lesion was found as early as 7 days after the impact, preceded by neprilysin upregulation in astrocytes at 3 days after injury. At 7 days after injury, the majority of amyloid was found inside microglia/macrophages. Conclusion: These observations suggest that the efficient amyloid clearance after injury in the cord may be driven by the orchestrated efforts of astroglial and immune cells.	[Chu, Tak-Ho; Cummins, Karen; Stys, Peter K.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada		Stys, PK (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, HRIC, Room 1AA22,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pstys@ucalgary.ca	Chu, Tak-Ho/AAB-4608-2021	Chu, Tak-Ho/0000-0002-3123-207X	Dr. Frank Leblanc Chair for Spinal Cord Research; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canada Research Chairs (CRC)Canada Research Chairs; Alberta Prion Research Institute (APRI) Explorations grant	This study was supported by grants from the Dr. Frank Leblanc Chair for Spinal Cord Research, Canadian Institutes of Health Research (CIHR), Canada Research Chairs (CRC) and an Alberta Prion Research Institute (APRI) Explorations grant. All experiments on animals received ethical approval from the University of Calgary.	Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bastien D, 2014, EXP NEUROL, V258, P62, DOI 10.1016/j.expneurol.2014.04.006; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Buxbaum JD, 2007, J NEUROSCI, V35, P9629; Chen PT, 2016, SCI REP-UK, V6, DOI 10.1038/srep29760; Chu TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188218; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Grimm MOW, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00098; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mawhinney LA, 2012, J NEUROPATH EXP NEUR, V71, P180, DOI 10.1097/NEN.0b013e3182479b41; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Mulder SD, 2012, EXP NEUROL, V233, P373, DOI 10.1016/j.expneurol.2011.11.001; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Nalivaeva N N, 2012, Int J Alzheimers Dis, V2012, P383796, DOI 10.1155/2012/383796; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Santos CRA, 2011, ALZHEIMER'S DISEASE PATHOGENESIS - CORE CONCEPTS, SHIFTING PARADIGMS AND THERAPEUTIC TARGETS, P53; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Selmani V, 2015, PROTEIN SCI, V24, P420, DOI 10.1002/pro.2620; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sikanyika NL, 2019, NEUROCHEM RES, V44, P1289, DOI 10.1007/s11064-019-02756-x; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Wiley CA, 2009, ARCH NEUROL-CHICAGO, V66, P60, DOI 10.1001/archneurol.2008.511; Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423	63	1	1	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2020	77	3					1315	1330		10.3233/JAD-200387			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OH6SW	WOS:000582726600002	32925040				2022-02-06	
J	Diamante, GAC; Marinho, PVT; Dal-Bo, ID; Bregadioli, T; Paes, F; do Rego, RO; Monteiro, BF; Galeazzi, VS; Macedo, AS; Ferrigno, CRA				Covino Diamante, Gabriel Antonio; Tertuliano Marinho, Paulo Vinicius; Dal-Bo, Isis dos Santos; Bregadioli, Thales; Paes, Fernanda; do Rego, Renato Otaviano; Monteiro, Bianca Fiuza; Galeazzi, Viviane Sanchez; Macedo, Aline Schafrum; Auada Ferrigno, Cassio Ricardo			Long-term clinical complications associated with the use of polymethyl methacrylate in spinal stabilization of dogs and cats: case series	SEMINA-CIENCIAS AGRARIAS			English	Article						Bone cement; Postoperative complications; Adverse effects; Spinal column	VERTEBRAL FRACTURE; INFECTION; POLYMETHYLMETHACRYLATE; MANAGEMENT; LUXATION; CEMENT	Vertebral and spinal cord trauma are common conditions in small animal practice and often result in vertebral fractures/luxation (VFL) with concomitant spinal cord laceration, concussion, compression, or ischemia. These lesions have several clinical presentations that may vary from moderate to severe pain and partial to total loss of motor, sensory, and visceral functions, which may result in death or euthanasia. Our purpose is to describe five cases (four dogs and one cat) of complications secondary to the use of bone cement for vertebral stabilization. The patients, between five months and four years of age and weighing between 1.4 and 12.2 kg, were referred to the Small Animal Orthopedics and Traumatology Service of the Veterinary Hospital of the College of Veterinary Medicine and Animal Science of the University of Sao Paulo. They had a history of post-operatory polymethyl methacrylate (PMMA) reactions (such as drainage or cement exposure due to infection or implant failure) in periods from 9 to 18 months after undergoing spinal osteosynthesis. Surgical implant removal occurred in 80% of the patients (4/5). Complete remission was not observed in the patient with residual implants. The association of pins/screws and PMMA is a versatile osteosynthesis technique and is applicable in all spinal regions. However, delayed complications can occur, which could require additional surgical procedures. Despite the small number of cases included in this study, one can infer that complications related to the use of bone cement in spinal surgery can occur in the long term and should be highlighted during the implant choosing process for vertebral osteosynthesis in small animals.	[Covino Diamante, Gabriel Antonio; Dal-Bo, Isis dos Santos; Bregadioli, Thales; Paes, Fernanda; do Rego, Renato Otaviano; Macedo, Aline Schafrum] IFSULDEMINAS, Inst Fed Sul Minas, Curso Med Vet, Muzambinho, MG, Brazil; [Monteiro, Bianca Fiuza] Univ Sao Paulo, Programa Posgrad Clin Cirurg Vet, Curso Mestrado, Sao Paulo, SP, Brazil; [Galeazzi, Viviane Sanchez] Univ Sao Paulo, Serv Ortopedia, Sao Paulo, SP, Brazil; [Auada Ferrigno, Cassio Ricardo] Univ Sao Paulo, Programa Posgrad Clin Cirurg Vet, Curso Mestrado & Doutorado, Sao Paulo, SP, Brazil		Diamante, GAC (corresponding author), IFSULDEMINAS, Inst Fed Sul Minas, Curso Med Vet, Muzambinho, MG, Brazil.	paulo.veter@gmail.com; bianca.fiuza@hotmail.com; vsgaleazzi@usp.br; cassioaf@usp.br	Macedo, Aline/ABD-1763-2020	Macedo, Aline/0000-0001-6725-7028			Bruce CW, 2008, VET COMP ORTHOPAED, V21, P280; DiFazio J, 2013, VET CLIN N AM-SMALL, V43, P915, DOI 10.1016/j.cvsm.2013.03.002; Early P, 2015, PEERJ, V3, DOI 10.7717/peerj.1094; Hettlich B., 2017, CURRENT TECHNIQUES C, V1st, P209, DOI [10.1002/9781118711545.ch25, DOI 10.1002/9781118711545.CH25]; Jeffery ND, 2010, VET CLIN N AM-SMALL, V40, P809, DOI 10.1016/j.cvsm.2010.05.004; Lewchalermwong P, 2018, VET COMP ORTHOPAED, V31, P95, DOI 10.3415/VCOT-17-03-0040; Masuda S, 2017, CLIN SPINE SURG, V30, pE1246, DOI 10.1097/BSD.0000000000000567; Mok JM, 2009, SPINE, V34, P578, DOI 10.1097/BRS.0b013e31819a827c; Nunez-Pereira S, 2013, BONE JOINT J, V95B, P1121, DOI [10.1302/0301-620X.95B8.30784, 10.1302/0301-620X.95138.30784]; PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015; Ramanathan S, 2017, SKELETAL RADIOL, V46, P715, DOI 10.1007/s00256-017-2602-0; Roberts TT, 2017, J AM ACAD ORTHOP SUR, V25, P693, DOI 10.5435/JAAOS-D-16-00007; SHORES A, 1990, VET MED-US, V85, P724; Sturges BK, 2016, VET SURG, V45, P309, DOI 10.1111/vsu.12459; Vallefuoco R, 2014, VET COMP ORTHOPAED, V27, P306, DOI 10.3415/VCOT-13-08-0098; Wu CC, 2007, EUR SPINE J, V16, pS326, DOI 10.1007/s00586-006-0237-2	16	1	1	1	1	UNIV ESTADUAL LONDRINA	LONDRINA	CAXIA POSTAL 6001, LONDRINA, PARANA 86501-990, BRAZIL	1676-546X	1679-0359		SEMIN-CIENC AGRAR	Semin.-Cienc. Agrar.		2020	41	5		1			2453	2461		10.5433/1679-0359.2020v41n5Supl1p2453			9	Agriculture, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	NT9AO	WOS:000573230300049		gold			2022-02-06	
J	D'Silva, LJ; Siengsukon, CF; Devos, H				D'Silva, Linda J.; Siengsukon, Catherine F.; Devos, Hannes			Gaze stability in young adults with previous concussion history	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article						Gaze stability; chronic concussion; sleep quality	TRAUMATIC BRAIN-INJURY; DYNAMIC VISUAL-ACUITY; SPORTS-RELATED CONCUSSION; VESTIBULOOCULAR REFLEX; NEUROCOGNITIVE PERFORMANCE; SLEEP DISORDERS; HIGH-SCHOOL; SYMPTOMS; RECOVERY; STABILIZATION	BACKGROUND: Disruption of visual-vestibular interaction after concussion can cause gaze instability with head movements. The long-term impact of concussion on gaze stability is unknown. OBJECTIVE: This cross-sectional comparative pilot study examined gaze stability in the chronic stage after concussion (greater than one year). A secondary objective was to examine the relationship between gaze stability and sleep. METHODS: Outcome measures included: 1. Gaze stability in logMAR (mean loss of dynamic visual acuity (DVA) in the yaw and pitch planes); 2. Pittsburgh Sleep Quality Index (PSQI); 3. Epworth Sleepiness Scale (ESS). Post-Concussion Symptom Scale (PCSS), time since injury, and number of concussions were collected for the people with concussion. RESULTS: The study sample included thirty-four adults (mean age 23.35 +/- 1.3 years). Seventeen had a history of 1-9 concussions, with a mean duration of 4.4 +/- 1.9 years since last concussion; and 17 were age and sex-matched controls. Mean pitch plane DVA loss was greater in the concussion group compared to the control group (p = 0.04). Participants with previous concussion had lower sleep quality based on the PSQI (p = 0.01) and increased daytime sleepiness based on the ESS (p = 0.01) compared to healthy controls. Mean DVA loss in the pitch plane was significantly correlated with the PSQI (r = 0.43, p = 0.01) and the ESS (r = 0.41, p = 0.02). CONCLUSION: Significant differences in dynamic visual acuity may be found in young adults long after a concussion, compared with those who have no concussion history. Furthermore, loss of dynamic visual acuity was associated with poorer sleep quality and higher daytime sleepiness.	[D'Silva, Linda J.] Rockhurst Univ, Dept Phys Therapy Educ, Kansas City, KS USA; [Siengsukon, Catherine F.; Devos, Hannes] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA		D'Silva, LJ (corresponding author), Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA.	ldsilva@kumc.edu					Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; Besnard S, 2018, SLEEP MED REV, V42, P220, DOI 10.1016/j.smrv.2018.09.001; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Ciriello J, 2014, BRAIN RES, V1579, P20, DOI 10.1016/j.brainres.2014.07.008; D'Silva LJ, 2017, OTOL NEUROTOL, V38, P379, DOI 10.1097/MAO.0000000000001309; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Della Santina CC, 2002, ARCH OTOLARYNGOL, V128, P1044, DOI 10.1001/archotol.128.9.1044; DEMER JL, 1995, OTOLARYNG HEAD NECK, V112, P16, DOI 10.1016/S0194-5998(95)70301-2; DEMER JL, 1994, AM J OTOL, V15, P340; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Herdman SJ, 1998, AM J OTOL, V19, P790; Herdman SJ, 2007, ARCH OTOLARYNGOL, V133, P383, DOI 10.1001/archotol.133.4.383; Hile ES, 2010, PHYS THER, V90, P1649, DOI 10.2522/ptj.20090405; Hiploylee C., 2016, J NEUROTRAUMA; Honaker JA, 2015, CLIN J SPORT MED, V25, P361, DOI 10.1097/JSM.0000000000000138; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Kim SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192705; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Larson EB, 2018, NEUROREHABILITATION, V43, P297, DOI 10.3233/NRE-182534; LEIGH RJ, 1993, NEUROLOGY, V43, P1288, DOI 10.1212/WNL.43.7.1288; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mathiasen R, 2018, J NEUROTRAUM, V35, P691, DOI 10.1089/neu.2017.5072; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Narciso FV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151609; Pandi-Perumal SR, 2016, SLEEP SCI, V9, P1, DOI 10.1016/j.slsci.2016.01.003; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pritcher MR, 2008, OTOL NEUROTOL, V29, P982, DOI 10.1097/MAO.0b013e31818457fb; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schubert MC, 2004, PHYS THER, V84, P373, DOI 10.1093/ptj/84.4.373; Schubert MC, 2010, RESTOR NEUROL NEUROS, V28, P9, DOI 10.3233/RNN-2010-0523; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607	45	1	1	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2020	30	4					259	266		10.3233/VES-200706			8	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	OH6PS	WOS:000582717000004	32675433				2022-02-06	
J	de Andrade, AF; Amorim, RL; Solla, DJF; Almeida, CC; Figueiredo, EG; Teixeira, MJ; Paiva, WS				de Andrade, Almir Ferreira; Amorim, Robson Luis; Fontoura Solla, Davi Jorge; Almeida, Cesar Cimonari; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			New technique for surgical decompression in traumatic brain injury: merging two concepts to prevent early and late complications of unilateral decompressive craniectomy with dural expansion	INTERNATIONAL JOURNAL OF BURNS AND TRAUMA			English	Article						Traumatic brain injury; subdural hematoma; decompressive craniotomy	ACUTE SUBDURAL-HEMATOMA; CRANIOTOMY; MANAGEMENT; DUROTOMY	Introduction: Decompressive craniectomy (DC) in severe traumatic brain injury (TBI) is associated with acute and late complications. To avoid these complications, we proposed a technical modification in DC. In this paper analyze a series of patients underwent to surgical treatment for acute subdural hematoma (ASDH). Methods: We perform a prospective cohort with TBI patients undergoing DC for treatment of diffuse hemispheric brain swelling and ASDH. The effect of modified craniectomy was assessed using postoperative CT. Clinical outcome was evaluated at ICU mortality in 2 weeks. Results: Comparing the CT scans before and after surgery, the midline shift decreases from median of 11 mm to 5.5 mm (P<0.001). Only one patient had presented uncontrolled intracranial hypertension after surgery. Postoperative mortality in the intensive care unit within 14 days was 48.8%. Conclusion: this is an interesting technical modification. In this pilot study, we observed ICP control, avoiding the complications of classical decompression.	[de Andrade, Almir Ferreira; Amorim, Robson Luis; Fontoura Solla, Davi Jorge; Almeida, Cesar Cimonari; Figueiredo, Eberval Gadelha; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Dept Neurol, Div Neurosurg, 255 Alves Guimaraes St,Ap 93, BR-05410000 Sao Paulo, SP, Brazil		Paiva, WS (corresponding author), Univ Sao Paulo, Hosp Clin, Dept Neurol, Div Neurosurg, 255 Alves Guimaraes St,Ap 93, BR-05410000 Sao Paulo, SP, Brazil.	wellingsonpaiva@yahoo.com.br	Amorim, Robson/AAK-1368-2021; Solla, Davi/E-6988-2013	Amorim, Robson/0000-0003-2391-7519; Solla, Davi/0000-0002-5092-6595			Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; Beer-Furlan A, 2016, WORLD NEUROSURG, V88, P569; Burger R, 2008, ACTA NEUROCHIR SUPPL, V102, P93, DOI 10.1007/978-3-211-85578-2_19; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Fen D, 2012, C NEUR SURG CHIC OCT; Gennarelli TA, 1993, HEAD INJURY, P137; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Guilburd JN, 2001, J NEUROSURG, V95, P263, DOI 10.3171/jns.2001.95.2.0263; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Kano T, 2012, NEUROL MED-CHIR, V52, P816, DOI 10.2176/nmc.52.816; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Miller JD, 1993, TRAUMATIC BRAIN SWEL; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6	18	1	1	0	1	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-2026			INT J BURNS TRAUMA	Int. J. Burns Trauma		2020	10	3					76	80					5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	MJ5YO	WOS:000548165700005	32714631				2022-02-06	
J	Derakhshanfar, H; Pourbakhtyaran, E; Rahimi, S; Sayyah, S; Soltantooyeh, Z; Karbasian, F				Derakhshanfar, Hojjat; Pourbakhtyaran, Elham; Rahimi, Samane; Sayyah, Samira; Soltantooyeh, Zahra; Karbasian, Fereshteh			Clinical guidelines for traumatic brain injuries in children and boys	EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY			English	Article						Pediatric; traumatic brain injury; TBI management; clinical guidelines	SKULL FRACTURES; HEAD-INJURY; EPIDEMIOLOGY; MANAGEMENT; HEMATOMA; OUTCOMES	The main aim of management of pediatric traumatic brain injury (TBI) is to hold normal ranges for optimizing the most proper outcomes. However, to provide physiologic requirements to an injured brain it is very important to enhance the quality of recovery and minimize secondary injuries. Within this study it is tried to identify the most proper guidelines for management of pediatric TBI. A comprehensive research was conducted on biomedical and pharmacological bibliographic database of life sciences such as PubMed, EMBASE, MEDLINE, LILACS database, global independent network of Cochrane, Science Direct and global health library of Global Index Medicus (GIM). By referencing these databases, a literature review was carried out through combining various recent studies in terms of pediatric traumatic brain injury, epidemiology, management and related clinical guidelines in accordance with articles covering this recommendations from 2000 to 2019. Main objective of this study was to provide a comprehensive review of available clinical practice guidelines for TBI. These guidelines can be administered especially for pediatric population to improve the quality of clinical practice for TBI. These guidelines of TBI could be applied worldwide despite different traditional demographic and geographic boundaries, which could affect pediatric populations in various ranges of ages. Accordingly, advances in civil foundations and reforms of health policies may hopefully decrease pediatric TBI socioeconomic burdens.	[Derakhshanfar, Hojjat; Pourbakhtyaran, Elham; Rahimi, Samane; Sayyah, Samira; Karbasian, Fereshteh] Shahid Beheshti Univ Med Sci, Dept Pediat Emergency Med, Tehran, Iran; [Soltantooyeh, Zahra] Mofid Children Hosp, Tehran, Iran		Karbasian, F (corresponding author), Shahid Beheshti Univ Med Sci, Dept Pediat Emergency Med, Tehran, Iran.	hojjatderakhshanfar@yahoo.com; pourbakhtyaran@gmail.com; Samanerahimi@yahoo.com; samirasayyah@yahoo.com; Zahrasoltantooyeh@gmail.com; Karbasian.md@gmail.com	Sayah, Samira/AAY-1277-2021	karbasian, fereshteh/0000-0003-2494-6231			Agrawal Shruti, 2016, World J Crit Care Med, V5, P36, DOI 10.5492/wjccm.v5.i1.36; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Allison KM, MED SPEECH LANGUAGE; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Aziz MM, 2019, TURK NEUROSURG, V29, P856, DOI 10.5137/1019-5149.JTN.25572-18.2; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Banik S, 2019, J PEDIATR NEUROSCI, V14, P7, DOI 10.4103/jpn.JPN_18_19; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bordbar A, 2019, PRENSA MED ARGENT, V105, P134; Bordbar A, 2018, J COMPR PED, V9; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Campbell JP, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P382, DOI 10.1109/IRPS.2009.5173283; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castellani Rudy J., 2018, J FORENSIC MED SCI L, V4, P91; Centers for Disease Control and Prevention (CDC), 2015, LEAD CAUS DEATH REP, P1999; CHEN TF, 2014, J MED SCI, V34, P238, DOI DOI 10.4103/1011-4564.143654; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; David K, 2012, J NEUROTRAUM, V29, P1; David M, 2015, AM J FOREN MED PATH, V36, P111; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; El-Hennawy HM, 2014, ANN MED HEALTH SCI R, V4, P495, DOI 10.4103/2141-9248.139279; Farrell CA, 2013, PAED CHILD HEALT-CAN, V18, P253, DOI 10.1093/pch/18.5.253; Ferrara P, 2020, J MATERN-FETAL NEO M, V33, P3900, DOI 10.1080/14767058.2019.1590330; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Hu CF, 2013, PEDIATR NEONATOL, V54, P73, DOI 10.1016/j.pedneo.2012.12.011; Karibe H, 2016, NEUROL MED-CHIR, V56, P264, DOI 10.2176/nmc.ra.2015-0308; Kashaki M, 2019, PRENSA MED ARGENT, V105, P135; Kashaki M, 2019, J PHARM RES INT, V30, DOI 10.9734/JPRI/2019/v30i230267; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kommaraju K, 2019, PEDIATR NEUROSURG, V54, P21, DOI 10.1159/000495792; Kralik SF, 2019, NEURORADIOLOGY, V61, P81, DOI 10.1007/s00234-018-2127-9; Louise M. C, 2012, PEDIATRICS, V129, P2; Mogharrabi S, 2019, ADV DENT ORAL HLTH, V11; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Patel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161554; Prasad GL, 2015, CHILD NERV SYST, V31, P269, DOI 10.1007/s00381-014-2529-x; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rebecca MJ, 2019, PEDIATRICS, V139; Rhine T, 2012, J TRAUMA ACUTE CARE, V73, pS248, DOI 10.1097/TA.0b013e31826b0062; Roneeta N, 2018, J NEUROANAESTHESIOLO, V05, P187; Rosenthal AA, 2017, AM SURGEON, V83, pE438; Roumeliotis N, 2016, CHILD NERV SYST, V32, P2363, DOI 10.1007/s00381-016-3231-y; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Saboute M, 2015, J PED, V5, P285; Saurabh J, 2015, ASIAN J NEUROSURGERY, V10, P3; Schrieff-elson L. E., 2017, TXB PEDIAT NEUROSURG; Seraj B, 2019, WORLD J DENT, V10, P93; Shankar V, 2018, 18 2 1347 INFLICTED, DOI 10.1136/injuryprevention-2018-safety.110.; Stark MJ, 2016, ARCH DIS CHILD-FETAL, V101, pF137, DOI 10.1136/archdischild-2014-306945; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stocker Reto A, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030037; Strouse PJ, 2018, PEDIATR RADIOL, V48, P1043, DOI 10.1007/s00247-018-4158-0; Sung ST, 2018, J EMERG CRIT CARE ME, V2, P18; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wan- Chao Y, 2019, J NEUROINFLAMM, V16, P36; Wei-Jun K, 2019, INT J ENV RES PUB HE, V16, P589; Welch TP, 2016, CRIT CARE MED, V44, P809, DOI 10.1097/CCM.0000000000001558; You CG, 2019, J KOREAN NEUROSURG S, V62, P225, DOI 10.3340/jkns.2016.0506.007	71	1	1	0	0	PAGEPRESS PUBL	PAVIA	MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY	2037-7452	2037-7460		EUR J TRANSL MYOL	Eur. J. Transl. Myol.		2020	30	1					159	170		10.4081/ejtm.2019.8613			12	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	NK5FU	WOS:000566757600022	32499878	Green Published, gold			2022-02-06	
J	Dumitru, I; Zorila, MV; Tolescu, RS; Racila, L; Pascu, CI; Oprica, AC; Burghila, DV; Matei, L; Vilcea, EJ; Popescu, C; Badea-Voiculescu, O; Mogoanta, L				Dumitru, Ilie; Zorila, Marian Valentin; Tolescu, Razvan Stefan; Racila, Laurentiu; Pascu, Cristina Ileana; Oprica, Alexandru Constantin; Burghila, Daniela Vasilica; Matei, Lucian; Vilcea, Elena Janina; Popescu, Cristina; Badea-Voiculescu, Oana; Mogoanta, Laurentiu			Experimental model for the study of traumatic brain injury	ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY			English	Article						traumatic brain injury; mortality; brain contusions; experimental model; pathophysiology; neurologic deficits		Traumatic brain injury (TBI) represents a public healthcare problem and a major economic burden, all over the world. It is estimated that every year, on the globe, there occur about two million severe TBI and over 42 million mild TBI. The main causes of TBI in civil population are fallings, followed by car accidents. In the last decades, the accelerated development of car industry and the poor development of traffic infrastructure in low- and average-income countries led to an increasing number of brain injuries, this becoming a major problem for medical health systems. According to some studies, approximately 1.35 million people die every year because of car accidents. In the last four decades, these types of injuries started to be studied in order to understand the lesion mechanisms for developing new safety equipment that may be installed on vehicles. The device presented by us for causing a TBI in a lab rat (mechanical pendulum) allows the performance of several major types of TBI, according to the kinetic energy, exposure area, contact surface, etc. The impact energies obtained by the device we presented may vary on a large scale, from less than 1 J up to 10 J, according to its weight, launching angle and impact head shape, thus being obtained minor, moderate or severe TBI.	[Dumitru, Ilie; Pascu, Cristina Ileana; Matei, Lucian] Univ Craiova, Fac Mech, Dept Rd Vehicles & Transportat, Craiova, Romania; [Zorila, Marian Valentin] Univ Med & Pharm Craiova, Dept Forens Med, 2 Petru Rares St, Craiova 200349, Romania; [Tolescu, Razvan Stefan] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Racila, Laurentiu] Univ Craiova, Fac Mech, Dept Appl Mech, Craiova, Romania; [Oprica, Alexandru Constantin] Univ Craiova, Dept Rd Vehicles & Transportat, Craiova, Romania; [Burghila, Daniela Vasilica] Univ Agron Sci & Vet Med Bucharest, Bucharest, Romania; [Vilcea, Elena Janina] Univ Politehn Bucuresti, Dept Mfg Engn, Bucharest, Romania; [Popescu, Cristina] Univ Med & Pharm Craiova, Depaitment Anat & Embryol, Craiova, Romania; [Badea-Voiculescu, Oana] Univ Med & Pharm Craiova, Dept Modern Languages, Craiova, Romania; [Mogoanta, Laurentiu] Univ Med & Pharm Craiova, Res Ctr Microscop Morphol & Immunol, Craiova, Romania		Zorila, MV (corresponding author), Univ Med & Pharm Craiova, Dept Forens Med, 2 Petru Rares St, Craiova 200349, Romania.	zorilavaly@yahoo.com.au	Racila, Laurentiu/ABD-7255-2021; Dumitru, Ilie/ABG-6661-2021; Matei, Lucian/ABG-5007-2021	Dumitru, Ilie/0000-0002-1049-9680; Matei, Lucian/0000-0002-2074-2410	European Social Fund within the Sectorial Operational Program Human Capital [POCU380/6/13/123990]	This work was supported by the grant POCU380/6/13/123990, co-financed by the European Social Fund within the Sectorial Operational Program Human Capital 2014-2020.	Ashraf I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223473; Bader M, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00356; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00128; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delye H, 2007, J NEUROTRAUM, V24, P1576, DOI 10.1089/neu.2007.0283; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iboaya A, 2019, NEUROREHAB NEURAL RE, V33, P975, DOI 10.1177/1545968319883879; Jalilian Marzieh Mansoori, 2019, Med Arch, V73, P169, DOI 10.5455/medarh.2019.73.169-172; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prieto R, 2009, NEUROCIRUGIA, V20, P225; Rajneesh CP, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110325; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sempere L, 2019, MED INTENSIVA, V43, P362, DOI 10.1016/j.medin.2018.04.012; Sowers JL, 2018, CURR OPIN NEUROL, V31, P709, DOI 10.1097/WCO.0000000000000613; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; World Health Organization, 2018, Global status report on alcohol and health 2018	34	1	1	1	2	EDITURA ACAD ROMANE	BUCURESTI	CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA	1220-0522	1582-4926		ROM J MORPHOL EMBRYO	Rom. J. Morphol. Embryol.		2020	61	3					729	737		10.47162/RJME.61.3.11			9	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology	RI3EU	WOS:000636791500011	33817714	gold, Green Published			2022-02-06	
J	Dwyer, B; Zasler, N				Dwyer, Brigid; Zasler, Nathan			Post-traumatic cephalalgia	NEUROREHABILITATION			English	Article						Post-traumatic headache; post-traumatic cephalalgia; headache disorders; traumatic brain injury; cervical whiplash injury; cervicalgia	TRAUMATIC BRAIN-INJURY; SPONTANEOUS INTRACRANIAL HYPOTENSION; TRANSCRANIAL MAGNETIC STIMULATION; PERIPHERAL-NERVE BLOCKS; DELAYED CEREBRAL EDEMA; MINOR HEAD; US SOLDIERS; CENTRAL SENSITIZATION; HEMIPLEGIC MIGRAINE; SPORTS CONCUSSION	After traumatic brain injury (TBI), a host of symptoms of varying severity and associated functional impairment may occur. One of the most commonly encountered and challenging to treat are the post-traumatic cephalalgias. Post-traumatic cephalalgia (PTC) or headache is often conceptualized as a single entity as currently classified using the ICHD-3. Yet, the terminology applicable to the major primary, non-traumatic, headache disorders such as migraine, tension headache, and cervicogenic headache are often used to specify the specific type of headache the patients experiences seemingly disparate from the unitary definition of post-traumatic headache adopted by ICHD-3. More complex post-traumatic presentations attributable to brain injury as well as other headache conditions are important to consider as well as other causes such as medication overuse headache and medication induced headache. Treatment of any post-traumatic cephalalgia must be optimized by understanding that there may be more than one headache pain generator, that comorbid traumatic problems may contribute to the pain presentation and that pre-existing conditions could impact both symptom complaint, clinical presentation and recovery. Any treatment for PTC must harmonize with ongoing medical and psychosocial aspects of recovery.	[Dwyer, Brigid] Boston Univ, Dept Neurol, 250 Pond St Braintree, Boston, MA 02184 USA; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA		Dwyer, B (corresponding author), Boston Univ, Dept Neurol, 250 Pond St Braintree, Boston, MA 02184 USA.	bcd@bu.edu					Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Alhilali LM, 2017, AM J NEURORADIOL, V38, P691, DOI 10.3174/ajnr.A5073; Andersen AM, 2020, HEADACHE, V60, P1066, DOI 10.1111/head.13812; Appenzeller O., 1993, WOLFFS HEADACHE OTHE, P365; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Ashkenazi A, 2010, HEADACHE, V50, P943, DOI 10.1111/j.1526-4610.2010.01675.x; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Baker VB, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0943-2; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barros J, 2013, JAMA NEUROL, V70, P235, DOI 10.1001/jamaneurol.2013.591; Bartsch T, 2003, Curr Pain Headache Rep, V7, P371, DOI 10.1007/s11916-003-0036-y; Bendtsen L, 2007, EUR J NEUROL, V14, P187, DOI 10.1111/j.1468-1331.2006.01607.x; Benoliel R, 2005, ORAL SURG ORAL MED O, V99, P657, DOI 10.1016/j.tripleo.2004.10.014; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Conidi FX, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0570-z; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Cushman DM, 2019, HEADACHE, V59, P371, DOI 10.1111/head.13451; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Delic J, 2016, RADIOLOGY, V279, P859, DOI 10.1148/radiol.2015151388; Donovan DJ, 2008, AVIAT SPACE ENVIR MD, V79, P30, DOI 10.3357/ASEM.1893.2008; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Dunning JR, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0912-3; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Elahi F, 2014, PAIN PHYSICIAN, V17, pE531; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2020, HEADACHE, V60, P318, DOI 10.1111/head.13720; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Fakhran S, 2016, AM J NEURORADIOL, V37, P1556, DOI 10.3174/ajnr.A4730; Ferrante E, 2004, HEADACHE, V44, P615, DOI 10.1111/j.1526-4610.2004.446012.x; Friedman BW, 2018, AM J EMERG MED, V36, P285, DOI 10.1016/j.ajem.2017.10.034; GAWEL MJ, 1992, CEPHALALGIA, V12, P9, DOI 10.1046/j.1468-2982.1992.1201009.x; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gurer Bora, 2016, Asian J Neurosurg, V11, P448; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Haas M, 2018, SPINE J, V18, P1741, DOI 10.1016/j.spinee.2018.02.019; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Herd Anthony, 1994, Journal of Emergency Medicine, V12, P849, DOI 10.1016/0736-4679(94)90496-0; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horn LJ, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P932; ILLINGWORTH R, 1983, J NEUROL NEUROSUR PS, V46, P558, DOI 10.1136/jnnp.46.6.558; Jacob S, 2008, CEPHALALGIA, V28, P991, DOI 10.1111/j.1468-2982.2008.01622.x; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; Katta-Charles S., 2021, BRAIN INJURY MED PRI; Kennedy Ewan, 2019, J Orthop Sports Phys Ther, V49, P845, DOI 10.2519/jospt.2019.8547; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kranz PG, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0639-3; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Lauretti GR, 2015, PAIN PRACT, V15, P654, DOI 10.1111/papr.12228; Lay CL, 1999, HEADACHE, V39, P275, DOI 10.1046/j.1526-4610.1999.3904275.x; Leroux E, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0325-z; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S., 2015, BRAIN NEUROTRAUMA; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; MCBEATH JG, 1994, HEADACHE, V34, P148, DOI 10.1111/j.1526-4610.1994.hed3403148.x; MCCRORY P, 2017, BRIT J SPORT MED, V51, P838, DOI DOI 10.1136/BJSPORTS-2017-097699; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mokri B, 2014, NEUROL CLIN, V32, P397, DOI 10.1016/j.ncl.2013.11.002; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nardone R, 2020, BRAIN RES BULL, V159, P44, DOI 10.1016/j.brainresbull.2020.03.016; Nijs J, 2016, J ORTHOP SPORT PHYS, V46, P1024, DOI 10.2519/jospt.2016.0612; Nijs J, 2014, EXPERT OPIN PHARMACO, V15, P1671, DOI 10.1517/14656566.2014.925446; Ofoghi Z, 2020, J NEUROTRAUM, V37, P907, DOI 10.1089/neu.2019.6750; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Packard Russell C, 2002, Curr Pain Headache Rep, V6, P301, DOI 10.1007/s11916-002-0051-4; Pareja Juan A, 2006, Curr Pain Headache Rep, V10, P302, DOI 10.1007/s11916-006-0036-9; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Primalani NK, 2019, WORLD NEUROSURG, V130, P550, DOI 10.1016/j.wneu.2019.05.107; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Putzki N, 2005, CEPHALALGIA, V25, P395, DOI 10.1111/j.1468-2982.2004.00860.x; Rafael B, 2016, ORAL MAXIL SURG CLIN, V28, P371, DOI 10.1016/j.coms.2016.03.002; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Samii C, 1999, J NEUROL, V246, P162, DOI 10.1007/s004150050327; Schiapparelli P, 2010, NEUROL SCI, V31, P137, DOI 10.1007/s10072-010-0307-4; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Sedighi A, 2017, J BODYW MOV THER, V21, P810, DOI 10.1016/j.jbmt.2017.01.002; Seeger TA, 2015, J CHILD NEUROL, V30, P1142, DOI 10.1177/0883073814553973; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Siavoshi S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010003; Silberstein Stephen D, 2015, Continuum (Minneap Minn), V21, P973, DOI 10.1212/CON.0000000000000199; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Stilling J, 2020, J NEUROTRAUM, V37, P312, DOI 10.1089/neu.2019.6692; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sussman WI, 2017, CLIN J SPORT MED, V27, pe6, DOI 10.1097/JSM.0000000000000325; Tanaka Y, 2016, HEADACHE, V56, P1310, DOI 10.1111/head.12887; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Tottene A, 2005, J BIOL CHEM, V280, P17678, DOI 10.1074/jbc.M501110200; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; WAN Q, 2017, BIOMED RES INT, V2017, DOI DOI 10.1155/2017/4654803; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Watson DH, 2016, HEADACHE, V56, P961, DOI 10.1111/head.12805; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495; Yorns WR, 2013, SEMIN PEDIATR NEUROL, V20, P188, DOI 10.1016/j.spen.2013.09.002; Zafonte RD, 1999, J HEAD TRAUMA REHAB, V14, P22, DOI 10.1097/00001199-199902000-00005; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zaremski JL, 2015, CURR SPORT MED REP, V14, P16, DOI 10.1249/JSR.0000000000000121; Zasler N.D., 2021, MANAGEMENT TRAUMATIC; Zasler N. D., 2020, CONCUSSION ASSESSMEN, P59; Zasler N.D., 2019, TXB TRAUMATIC BRAIN, P471; Zasler N, 2019, J HEAD TRAUMA REHAB, V34, P409, DOI 10.1097/HTR.0000000000000524; Zasler ND, 2019, CONCUSSION AND TRAUMATIC ENCEPHALOPATHY: CAUSES, DIAGNOSIS, AND MANAGEMENT, P728; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P81, DOI 10.1097/00001199-199902000-00009	134	1	1	2	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	3					327	342		10.3233/NRE-208006			16	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OW4OR	WOS:000592868600007	32986623				2022-02-06	
J	Erdogan, S; Bozkurt, TM; Iscan, H; Atay, G				Erdogan, Seher; Bozkurt, Tugce Mersin; Iscan, Husniye; Atay, Gurkan			Hemophagocytic lymphohistiocytosis after trauma	ANNALS OF CLINICAL AND ANALYTICAL MEDICINE			English	Article						Hemophagocytic lymphohistiocytosis; Head trauma		A 6-year-old female patient who had an out-of-car traffic accident, head trauma, increased fever during follow-up, splenomegaly and widespread maculopapular rashes in the whole body was evaluated as secondary hemophagocytic lymphohistiocytosis (HLH) according to laboratory findings of anemia, neutropenia, hyperferritinemia, hypertriglyceridemia and hypofibrinogenemia. Clinical improvement was achieved with intravenous immunoglobulin (IVIG) and steroid treatments. Interleukin 1 (IL-1), interleukin 6 (IL-6), tumor necrosis factor (TNF) and high concentration of cytokines originating from central nervous system after traumatic brain injury suggest that cytokines play an important role in this post-traumatic pathological process. This case is presented because it is the first pediatric patient who developed HLH after trauma.	[Erdogan, Seher; Atay, Gurkan] Hlth Sci Univ, Umraniye Res & Training Hosp, Dept Pediat Crit Care, Istanbul, Turkey; [Bozkurt, Tugce Mersin; Iscan, Husniye] Hlth Sci Univ, Umraniye Res & Training Hosp, Dept Pediat, Istanbul, Turkey		Erdogan, S (corresponding author), Umraniye Res & Training Hosp, Adem Yavuz Cad 1, TR-34764 Istanbul, Turkey.	seher70@gmail.com					Bosnak M, 2016, TRANSFUS APHER SCI, V55, P353, DOI 10.1016/j.transci.2016.09.015; Chaari A, 2011, ANN FR ANESTH, V30, P844, DOI 10.1016/j.annfar.2011.07.013; Demir H, 2012, MARMARA MED J, V25, P114, DOI 10.5472/MMJ.2012.02024.1; Hinson ARP, 2021, J PEDIAT HEMATOL ONC, V43, P24, DOI 10.1097/MPH.0000000000001652; Janka GE, 2007, EUR J PEDIATR, V166, P95, DOI 10.1007/s00431-006-0258-1; Kalmuk J, 2019, CLIN CASE REP, V7, P2076, DOI 10.1002/ccr3.2401; Lin TF, 2011, PEDIATR BLOOD CANCER, V56, P154, DOI 10.1002/pbc.22774; Oren H., 2007, TURK COCUK HEMATOLOJ, V1, P7	8	1	1	0	0	BAYRAKOL MEDICAL PUBLISHER	ANKARA	EMRAH MAHALLESI, GULGUN CADDESI, NO 62-58, KECIOREN, ANKARA, 06010, TURKEY		2667-663X		ANN CLIN ANAL MED	Ann. Clin. Anal. Med.		2020	11			2			135	137		10.4328/ACAM.20116			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NT1WJ	WOS:000572739600010		gold			2022-02-06	
J	Fallesen, P; Campos, B				Fallesen, Peter; Campos, Benito			Effect of concussion on salary and employment: a population-based event time study using a quasi-experimental design	BMJ OPEN			English	Article						health economics; neurosurgery; trauma management	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; WORK; SYMPTOMS; QUALITY; RETURN	Objective Concussions are the most frequent traumatic brain injuries. Yet, the socioeconomic impact of concussions remains unclear. Socioeconomic effects of concussions on working-age adults were studied on a population scale. Design This population-based, event time study uses administrative data as well as hospital and emergency room records for the population of Denmark. Setting We study all Danish patients, aged 20-59 years, who were treated at a public hospital or at an emergency room between 2003 and 2017 after suffering a concussion without other intracranial or extracranial injuries (n=55 424 unique individuals). None of the patients had a prior diagnosis of intracranial or extracranial injuries within the past 10 years leading up to the incident. Primary and secondary outcome measures As primary endpoint, we investigate the mean effect of concussion on annual salaried income within a 5-year period after trauma. In an exploratory analysis, we study whether the potential impact of concussion on annual salaried income is driven by patient age, education or economic cycle. Results Concussion was associated with an average change in annual salary income of -euro1223 (95% CI: -euro1540 to -905, p<0.001) corresponding to a salary change of -4.2% (95% CI: -5.2% to -3.1 %). People between 30 and 39 years and those without high school degrees suffered the largest salary decreases. Affected individuals leaving the workforce drove the main part of the decrease. Absolute annual effect sizes were countercyclical to the unemployment rate. Conclusions Concussions have a large and long-lasting impact on salary and employment of working-age adults on a nationwide scale.	[Fallesen, Peter] Stockholm Univ, Swedish Inst Social Res, Stockholm, Sweden; [Fallesen, Peter] ROCKWOOL Fdn, Copenhagen, Denmark; [Campos, Benito] Heidelberg Univ Hosp, Dept Neurosurg, Heidelberg, Germany; [Campos, Benito] Tech Univ Denmark, Dept Hlth Tech, Lyngby, Denmark		Fallesen, P (corresponding author), Stockholm Univ, Swedish Inst Social Res, Stockholm, Sweden.; Fallesen, P (corresponding author), ROCKWOOL Fdn, Copenhagen, Denmark.	peter.fallesen@sofi.su.se	Fallesen, Peter/AAO-4801-2021	Fallesen, Peter/0000-0003-0544-9977	Swedish Research Council for Health, Working Life and WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [2016-07099]; ROCKWOOL Foundation	This work was supported by the Swedish Research Council for Health (PF), Working Life and Welfare (Grant no. 2016-07099) with additional funding from the ROCKWOOL Foundation (PF). The research was carried out independently of the funders.	Buck PW, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/625621; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chu SY, 2017, BRAIN INJURY, V31, P1674, DOI 10.1080/02699052.2017.1332783; Dobkin C, 2018, AM ECON REV, V108, P308, DOI 10.1257/aer.20161038; Donker-Cools BHPM, 2016, DISABIL REHABIL, V38, P733, DOI 10.3109/09638288.2015.1061608; Fadlon I, 2015, HOUSEHOLD RESPONSES; Graff HJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026104; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ogilvie D, J EPIDEMIOL COMMUNIT; Pinner M, 2003, VIDENSCENTER HJERNES; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Statistics Denmark, 2015, DOC STAT INC STAT ST; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Vrangbaek K, 2007, HEALTH ECON POLICY L, V2, P125, DOI 10.1017/S174413310700401X; [No title captured]	21	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	10							e038161	10.1136/bmjopen-2020-038161			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OO4MP	WOS:000587355100016	33087373	gold, Green Published			2022-02-06	
J	Fellger, A; Sprint, G; Weeks, D; Crooks, E; Cook, DJ				Fellger, Allison; Sprint, Gina; Weeks, Douglas; Crooks, Elena; Cook, Diane J.			Wearable Device-Independent Next Day Activity and Next Night Sleep Prediction for Rehabilitation Populations	IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE			English	Article						Medical treatment; Machine learning; Data collection; Switching circuits; Sociology; Statistics; Biomedical monitoring; Actigraphy; activity and sleep prediction; inpatient rehabilitation; machine learning; wearable sensors	TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; ACTIVITY MONITORS; ACTIGRAPHY; VALIDATION; METAANALYSIS; RECOGNITION; VALIDITY; PHASE; WRIST	Wearable sensor-based devices are increasingly applied in free-living and clinical settings to collect fine-grained, objective data about activity and sleep behavior. The manufacturers of these devices provide proprietary software that labels the sensor data at specified time intervals with activity and sleep information. If the device wearer has a health condition affecting their movement, such as a stroke, these labels and their values can vary greatly from manufacturer to manufacturer. Consequently, generating outcome predictions based on data collected from patients attending inpatient rehabilitation wearing different sensor devices can be challenging, which hampers usefulness of these data for patient care decisions. In this article, we present a data-driven approach to combining datasets collected from different device manufacturers. With the ability to combine datasets, we merge data from three different device manufacturers to form a larger dataset of time series data collected from 44 patients receiving inpatient therapy services. To gain insights into the recovery process, we use this dataset to build models that predict a patient's next day physical activity duration and next night sleep duration. Using our data-driven approach and the combined dataset, we obtained a normalized root mean square error prediction of 9.11% for daytime physical activity and 11.18% for nighttime sleep duration. Our sleep result is comparable to the accuracy we achieved using the manufacturer's sleep labels (12.26%). Our device-independent predictions are suitable for both point-of-care and remote monitoring applications to provide information to clinicians for customizing therapy services and potentially decreasing recovery time.	[Fellger, Allison; Sprint, Gina] Gonzaga Univ, Dept Comp Sci, Spokane, WA 99258 USA; [Weeks, Douglas] St Lukes Rehabil Inst, Spokane, WA 99202 USA; [Crooks, Elena] Eastern Washington Univ, Dept Phys Therapy, Spokane, WA 99202 USA; [Cook, Diane J.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA		Sprint, G (corresponding author), Gonzaga Univ, Dept Comp Sci, Spokane, WA 99258 USA.	sprint@gonzaga.edu		Weeks, Douglas/0000-0003-0910-9064; Cook, Diane/0000-0002-4441-7508	Computing Research Association-Widening Participation (CRA-WP) CREU Grant; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25AG0146114]	This work was supported in part by the Computing Research Association-Widening Participation (CRA-WP) CREU Grant and in part by the National Institutes of Health (NIH) under Grant R25AG0146114.	Alharbi M, 2016, EUR J PREV CARDIOL, V23, P1476, DOI 10.1177/2047487316634883; Alinia P, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6321; Berger AM, 2008, J PAIN SYMPTOM MANAG, V36, P191, DOI 10.1016/j.jpainsymman.2007.10.008; Bigelow MEG, 2016, IEEE J TRANSL ENG HE, V4, DOI 10.1109/JTEHM.2016.2593920; Block VJ, 2017, J NEUROL, V264, P316, DOI 10.1007/s00415-016-8334-6; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Conci J, 2019, 2019 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI); Cook D, 2013, KNOWL INF SYST, V36, P537, DOI 10.1007/s10115-013-0665-3; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Dominick GM, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6281; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Farajtabar M, 2019, INT J DATA SCI ANAL, V8, P367, DOI 10.1007/s41060-018-0136-8; Fellger A, 2019, 2019 IEEE HEALTHCARE INNOVATIONS AND POINT OF CARE TECHNOLOGIES (HI-POCT), P41, DOI 10.1109/HI-POCT45284.2019.8962839; Floegel TA, 2017, J GERONTOL A-BIOL, V72, P229, DOI 10.1093/gerona/glw098; Hidayat W, 2018, 2018 6TH INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGY (ICOICT), P447, DOI 10.1109/ICoICT.2018.8528750; Innominato PF, 2009, CANCER RES, V69, P4700, DOI 10.1158/0008-5472.CAN-08-4747; Lee K, 2018, COMPUT ENVIRON URBAN, V67, P124, DOI 10.1016/j.compenvurbsys.2017.09.012; Leger D, 2018, SLEEP MED, V52, P88, DOI 10.1016/j.sleep.2018.07.024; Makley MJ, 2018, NEUROREHABILITATION, V43, P277, DOI 10.3233/NRE-182537; Mantua J, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050646; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Mendonca F, 2019, IEEE ACCESS, V7, P24527, DOI 10.1109/ACCESS.2019.2900345; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pasic Zejneba, 2011, Med Arh, V65, P225; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Roomkham Sirinthip, 2018, IEEE Rev Biomed Eng, V11, P53, DOI 10.1109/RBME.2018.2811735; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Saeedi R, 2020, IEEE T MOBILE COMPUT, V19, P513, DOI 10.1109/TMC.2018.2878673; Sathyanarayana A, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.6562; Skubic M, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2421499; Sprint G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102219; Thiemjarus Surapa, 2010, 2010 International Conference on Body Sensor Networks (BSN), P19, DOI 10.1109/BSN.2010.55; Treacy D, 2017, PHYS THER, V97, P581, DOI 10.1093/ptj/pzx010; Westerterp KR, 1999, INT J OBESITY, V23, pS45, DOI 10.1038/sj.ijo.0800883; Wu J, 2019, IEEE INTERNET THINGS, V6, P1427, DOI 10.1109/JIOT.2018.2856119; Y Sainath RVSN, 2018, 2018 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1900, DOI 10.1109/ICACCI.2018.8554930	38	1	1	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2372			IEEE J TRANSL ENG HE	IEEE J. Transl. Eng. Health Med.-JTEHM		2020	8									10.1109/JTEHM.2020.3014564			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	NB6RK	WOS:000560641400001	32802598	Green Published, gold			2022-02-06	
J	Fricia, M; Umana, GE; Scalia, G; Raudino, G; Passanisi, M; Spitaleri, A; Cicero, S				Fricia, Marco; Umana, Giuseppe Emmanuele; Scalia, Gianluca; Raudino, Giuseppe; Passanisi, Maurizio; Spitaleri, Angelo; Cicero, Salvatore			Posttraumatic Triple Acute Epidural Hematomas: First Report of Bilateral Synchronous Epidural Hematoma and a Third Delayed	WORLD NEUROSURGERY			English	Article						Delayed epidural hematoma; Epidural hematoma; Head injury; Skull fractures; Traumatic brain injury		BACKGROUND: Development of a delayed acute epidural hematoma (DEDH) represents a rare event, characterized by a high mortality rate. It is defined as an extradural bleeding not evident at the first brain computed tomography (CT) scan performed after traumatic brain injury but evidenced by further radiologic evaluations. CASE DESCRIPTION: A 22-year-old male was admitted to our unit after brain injury due to an assault. Immediate brain CT scan revealed a right frontal epidural hematoma (EDH) and a smaller left anterior temporal EDH with multiple, bilateral skull fractures in the frontal, parietal, and temporal bones. Both EDHs were surgically treated in the same session. Another immediate CT scan showed a third left parietal acute DEDH. The patient was retransferred to the operating room for a further left parietal craniotomy and EDH evacuation. The postoperative period was uneventful: the patient effectively improved. After 15 days, the patient left the hospital and was admitted to a rehabilitation center. CONCLUSIONS: To the best of our knowledge, this is the first report of a synchronous acute bilateral EDH with the development of a third DEDH located in a separate site. This finding is certainly related to the presence of multiple and bilateral skull fractures. In our experience, we suggest performing an intraoperative CT scan, if available, to early detect the possible development of DEDH.	[Fricia, Marco; Umana, Giuseppe Emmanuele; Passanisi, Maurizio; Spitaleri, Angelo; Cicero, Salvatore] Cannizzaro Hosp, Trauma Ctr, Gamma Knife Ctr, Dept Neurosurg, Catania, Italy; [Scalia, Gianluca] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Div Neurosurg, Messina, Italy; [Raudino, Giuseppe] Monza Gen Hosp, Dept Neurosurg, Monza, Italy		Umana, GE (corresponding author), Cannizzaro Hosp, Trauma Ctr, Gamma Knife Ctr, Dept Neurosurg, Catania, Italy.	umana.nch@gmail.com	umana, giuseppe/AAR-3533-2021	Scalia, Gianluca/0000-0002-9465-2506			Bir SC, 2015, CLIN NEUROL NEUROSUR, V138, P99, DOI 10.1016/j.clineuro.2015.07.021; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; DHARKER SR, 1991, ACTA NEUROCHIR, V110, P29, DOI 10.1007/BF01402044; Eftekhar Behzad, 2003, BMC Emerg Med, V3, P1, DOI 10.1186/1471-227X-3-1; Ferrera PC, 1997, AM J EMERG MED, V15, P76, DOI 10.1016/S0735-6757(97)90055-3; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; FUKAMACHI A, 1984, COMPUT RADIOL, V8, P197, DOI 10.1016/0730-4862(84)90123-9; Gregori F, 2019, ACTA NEUROL BELG, V119, P15, DOI 10.1007/s13760-018-1049-y; Rochat P, 2002, CLIN NEUROL NEUROSUR, V105, P39, DOI 10.1016/S0303-8467(02)00099-9; Rosenthal AA, 2017, AM SURGEON, V83, pE438; Roy GC, 1884, LANCET, V2, P319; Solomiichuk Volodymyr O, 2013, Surg Neurol Int, V4, P134, DOI 10.4103/2152-7806.119234; Yamakawa H, 2006, INJ EXTRA, V37, P38, DOI [10.1016/j.injury.2005.07.003, DOI 10.1016/J.INJURY.2005.07.003]; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	14	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						212	215		10.1016/j.wneu.2019.10.009			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700199	31605850				2022-02-06	
B	Garcia-Losarcos, N; Vuppala, A; Loparo, K		DeGeorgia, M; Loparo, K		Garcia-Losarcos, Naiara; Vuppala, Aditya; Loparo, Kenneth			Continuous EEG Monitoring and Quantitative EEG Techniques	NEUROCRITICAL CARE INFORMATICS: TRANSLATING RAW DATA INTO BEDSIDE ACTION			English	Article; Book Chapter							INTENSIVE-CARE-UNIT; NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; APPROXIMATE ENTROPY; HEMORRHAGE; INCREASE		[Garcia-Losarcos, Naiara] Univ Hosp Cleveland, Neurol Inst, Adult Epilepsy Ctr, Med Ctr, Cleveland, OH 44106 USA; [Garcia-Losarcos, Naiara] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA; [Vuppala, Aditya] Univ Nebraska Med Ctr, Dept Neurol, Comprehens Epilepsy Program, Omaha, NE USA; [Loparo, Kenneth] ISSACS Inst Smart Secure & Connected Syst, Cleveland, OH USA; [Loparo, Kenneth] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, IoT Collaborat, Cleveland, OH 44106 USA		Garcia-Losarcos, N (corresponding author), Univ Hosp Cleveland, Neurol Inst, Adult Epilepsy Ctr, Med Ctr, Cleveland, OH 44106 USA.; Garcia-Losarcos, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA.	naiara.garcialosarcos@uhhospitals.org; aditya.vuppala@unmc.edu; kal4@case.edu					Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Chatrian GE, 2003, CURRENT PRACTICE CLI, P405; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Haider HA, 2016, NEUROLOGY, V87, P935, DOI 10.1212/WNL.0000000000003034; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kaffashi F, 2008, PHYSICA D, V237, P3069, DOI 10.1016/j.physd.2008.06.005; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; LaRoche SM, 2013, HANDBOOK OF ICU EEG MONITORING, P229; McNicoll L, 2003, J AM GERIATR SOC, V51, P591, DOI 10.1034/j.1600-0579.2003.00201.x; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; SUNDT TM, 1981, MAYO CLIN PROC, V56, P533; Sutter R., 2012, EPILEPTOLOGIE, V29, P201; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vespa P, 2002, ACTA NEUROCHIR SUPPL, V81, P355; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Young GB, 2009, CAN J NEUROL SCI, V36, pS89; Young GB, 1996, NEUROLOGY, V47, P83	33	1	1	0	0	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY			978-3-662-59307-3; 978-3-662-59305-9				2020							79	109		10.1007/978-3-662-59307-3_5	10.1007/978-3-662-59307-3		31	Critical Care Medicine; Medical Informatics; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Medical Informatics; Neurosciences & Neurology	BR2EY	WOS:000637543700006					2022-02-06	
J	Giovanini, A; Bittencourt, PF; Maldonado, MU				Giovanini, Adilson; Bittencourt, Pablo F.; Maldonado, Mauricio Uriona			Innovation Ecosystem in Application Platforms: An Exploratory Study of The Role of Users	REVISTA BRASILEIRA DE INOVACAO			English	Article						App store; Assessments; Innovation; Consumer market requirement	GLOBAL COMPETITIVENESS; LOCAL DEMAND; CHALLENGES; ECONOMY	Application platforms are part of innovation ecosystems where interactions between end users and developers self-regulate the growth of the ecosystem itself. One of the most important information for this process is user reviews. This paper uses one ordinary least squares (OLS) regressions for 2016, based on 20 variables for 60 countries to measure consumer demand, using a new indicator based on end-user assessments to verify consistency of relations between quality of demand (measured by the new indicator) and the innovative performance of different countries in this productive segment. The results show the robustness and the new research possibilities that arise, given the positives characteristics presented by the new indicator built by big data and data analytics tools. This indicator shows that the quality of demand supports innovations in the productive segment, which has led to the concussion that obtaining more sophisticated demand feedback represents a potentially powerful stimulus for advancing application development.	[Giovanini, Adilson] Univ Estado Santa Catarina UDESC, Balneario, SC, Brazil; [Bittencourt, Pablo F.; Maldonado, Mauricio Uriona] Univ Fed Santa Catarina UFSC, Florianopolis, SC, Brazil		Giovanini, A (corresponding author), Univ Estado Santa Catarina UDESC, Balneario, SC, Brazil.	adilson.giovanini@udesc.br; pablofelipe.bittencourt@gmail.com; m.uriona@ufsc.br	Maldonado, Mauricio Uriona/F-4838-2013	Maldonado, Mauricio Uriona/0000-0002-1174-4828			Akpinar M, 2017, COMPET REV, V27, P161, DOI 10.1108/CR-02-2016-0014; Amaral DC, 2000, GESTAO PRODUCAO, V7, P56; ARTHUR W.B., 2017, MCKINSEY Q, V697; Autio E, 2014, OXFORD HDB INNOVATIO, P204, DOI [10.1093/oxfordhb/9780199694945.013.012, DOI 10.1093/OXFORDHB/9780199694945.013.012]; Baldwin C.Y., 2009, PLATFORMS MARKETS IN, V32; BIGGS C., 2017, BCG             0504; Blalock G, 2004, J DEV ECON, V75, P397, DOI 10.1016/j.jdeveco.2004.06.004; Blazquez D, 2018, TECHNOL FORECAST SOC, V130, P99, DOI 10.1016/j.techfore.2017.07.027; Blazquez D, 2018, TECHNOL ECON DEV ECO, V24, P406, DOI 10.3846/20294913.2016.1213193; Bonte W., 2004, INT J EC BUSINESS, V11, P259, DOI DOI 10.1080/1357151042000286393; Boon W, 2018, SCI PUBL POLICY, V45, P435, DOI 10.1093/scipol/scy014; Botsman R., 2017, WHO CAN YOU TRUST TE; Bullinger AC, 2012, HEALTH POLICY, V105, P165, DOI 10.1016/j.healthpol.2012.02.009; CAMELO G.R., 2010, SEMANA ENGENHARIA PR, V10, P1; Cardoso M., 2012, THESIS; CINICIOGLU E.N., 2013, P INT IIE C JUN 26 2; DA COSTA NETO E.C., 2019, REV GEST TECNOL, V19, P195; DAL BO G., 2017, REV ADM UNIMEP, V15, P1; DIAS P., 2014, ENCONTRO INT GESTAO, V16; Dogan E., 2016, EKONOMETRI ISTATISTI, P60; DROR I., 2015, INTRO BLENDED LEARNI; Einav L, 2014, SCIENCE, V346, P715, DOI 10.1126/science.1243089; ERKAN B.I.L., 2018, J LIFE EC, V5, P127; Evans D., 2016, MATCHMAKERS NEW EC M; Evanschitzky H, 2012, J PROD INNOVAT MANAG, V29, P21, DOI 10.1111/j.1540-5885.2012.00964.x; Fabrizio KR, 2012, STRATEGIC MANAGE J, V33, P42, DOI 10.1002/smj.942; Ganapati S., 2016, ENERGY PRICES PASS T; Ganapati S, 2018, GOV INFORM Q, V35, P77, DOI 10.1016/j.giq.2018.01.001; GOBARA C., 2010, BASE REV ADM CONTABI, V7, P252; Grobbelaar SS, 2019, LOCAL ECON, V34, P838, DOI 10.1177/0269094219897544; Irrmann, 2013, COCREATE 2013, P27; Jackson D. J, 2011, NATL SCI FDN, V1; Jacobides M., 2014, J FINANCIAL PERSPECT, V2, P1; Jin XL, 2015, BIG DATA RES, V2, P59, DOI 10.1016/j.bdr.2015.01.006; JUSTMAN M, 1994, REV ECON STAT, V76, P742, DOI 10.2307/2109775; Kontic L, 2018, CONTRIB MANAG SCI, P233, DOI 10.1007/978-3-319-77622-4_12; KORDALSKA A., 2015, I EC RES WORKING PAP, V63; Kordalska A, 2016, EQUILIBRIUM, V11, P121, DOI 10.12775/EQUIL.2016.006; Korez-Vide R., 2016, COMPETITIVENESS CEE; Kuiper C., 2015, SOCIAL SCI ELECT PUB, V70, P830; Kutschke A, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8121281; Lundvall B-A, 1988, TECHNICAL CHANGE EC, P349; Luthje C, 2005, RES POLICY, V34, P951, DOI 10.1016/j.respol.2005.05.005; Luna MMM, 2011, REV GEST ORGAN, V4, P37; MOEN O., 2018, COGENT BUSINESS MANA, V5, P1; Myers K, 2019, RAND J ECON, V50, P591, DOI 10.1111/1756-2171.12289; Neagu O., 2019, ANALELE U CONSTANTIN, P61; PORTER M.E., 2001, ESTRATEGIAS COMPETIT; Porter M. E., 1998, COMPETITIVE ADVANTAG; Porter ME, 1998, HARVARD BUS REV, V76, P77; Porter ME, 2008, GLOBAL COMPETITIVENE, V2009, P43; Vicente MR, 2015, TECHNOL FORECAST SOC, V92, P132, DOI 10.1016/j.techfore.2014.12.005; Sala-i-Martin X, 2011, GLOBAL COMPETITIVENE, P3; SALA-I-MARTIN X., 2012, GLOBAL COMPETITIVENE, P3; SALA-I-MARTIN X., 2013, GLOBAL COMPETITIVENE, P3; SAVIC N., 2018, EKONOMIKA PREDUZECA, V66, P139; Savic N, 2012, PANOECONOMICUS, V59, P105, DOI 10.2298/PAN12011055; Schmookler Jacob, 1966, INVENTION EC GROWTH; Schreieck M., 2018, DIGITAL MARKETPLACES, P527; Schwab K., 2013, GLOBAL COMPETITIVENE; Sener S, 2013, PROCD SOC BEHV, V75, P453, DOI 10.1016/j.sbspro.2013.04.049; Shaw DR, 2018, TECHNOL FORECAST SOC, V136, P88, DOI 10.1016/j.techfore.2016.11.030; SQUEFF F.H.S., 2015, RADAR TECNOLOGIA PRO, P7; Sundararajan A, 2016, SHARING ECONOMY: THE END OF EMPLOYMENT AND THE RISE OF CROWD-BASED CAPITALISM, P1; Tambade H, 2019, BENCHMARKING, V26, P922, DOI 10.1108/BIJ-09-2017-0260; Tiwana A., 2014, PLATFORM ECOSYSTEMS; Tiwana A, 2010, INFORM SYST RES, V21, P675, DOI 10.1287/isre.1100.0323; Tura N, 2018, TECHNOL ANAL STRATEG, V30, P881, DOI 10.1080/09537325.2017.1390220; Van Welsum D., 2016, WORLD DEV REPORT BAC; VANALLE R.M., 2011, EXACTA, V9, P13; Vares H., 2011, EUR J EC FINANC ADM, V31, P124; VIANNA L.G.V., 2017, MONOGRAFIA CTR U BRA; VUJICIC S., 2013, J WOMENS ENTREPRENEU, P108; Wonglimpiyarat J, 2010, FUTURES, V42, P247, DOI 10.1016/j.futures.2009.11.010; World Economic Forum (WEF), 2017, GLOBAL COMPETITIVENE; ZORZENON R., 2019, THESIS	76	1	1	3	9	UNIV ESTADUAL CAMPINAS, INST GEOCIENCIAS, DEPT POLITICA CIENTIFICA & TECN	SAO PAULO	A-C REVISTA BRASILEIRA INOVACAO, CAIXA POSTAL 6152 CAMPINAS, SAO PAULO, 13083-870, BRAZIL	1677-2504	2178-2822		REV BRAS INOV	Rev. Bras. Inov.		2020	19								e020005	10.20396/rbi.v19i0.8655371			28	Business	Emerging Sources Citation Index (ESCI)	Business & Economics	NL3JU	WOS:000567317200001		gold			2022-02-06	
J	Goker, B; Guclu, DG; Dolas, I; Ozgen, U; Altunrende, ME; Akinci, AT; Sencan, F; Aydoseli, A; Can, H; Sencer, A				Goker, Burcu; Guclu, D. Gucluhan; Dolas, Ilyas; Ozgen, Utku; Altunrende, M. Emre; Akinci, A. Tolgay; Sencan, Fahir; Aydoseli, Aydin; Can, Halil; Sencer, Altay			Clinical Study of Decompressive Craniectomy in Children	TURKISH NEUROSURGERY			English	Article						Decompressive craniectomy; Pediatric; Traumatic brain injury; Intracranial pressure; Glasgow coma scale	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL-ARTERY INFARCTION; SINGLE-CENTER EXPERIENCE; ISCHEMIC-STROKE; HEAD-INJURY; CASE SERIES; HEMICRANIECTOMY; MANAGEMENT; PRESSURE	AIM: To evaluate the clinical characteristics of children who recently underwent decompressive craniectomy (DC) due to elevated intracranial pressure (ICP) correlated to head trauma or other causes, such as ischemic insult. MATERIAL and METHODS: Twelve patients aged <= 17 years who underwent DC due to elevated ICP between 2013 and 2018 were included in the study. The clinical status of the participants, radiological characteristics, type and timing of surgery, and outcomes were recorded. RESULTS: Three female and nine male patients with a mean age of 10 years were included. The initial average Glasgow Coma Scale score was 6 (3-12). All patients presented with signs of diffuse cerebral edema and subdural hematoma of various sizes along with other intracranial pathologies. Only one patient required bilateral frontal craniectomy. In the postoperative period, three patients died, and three had severe disability. CONCLUSION: With the increasing use and success of DC in adults, this procedure can also be effective in children. Considering brain differences in children, large and well-structured clinical trials must be conducted to prevent complications and to identify the best technique, timing, and benefits of DC for children.	[Goker, Burcu] Istinye Univ, Liv Hosp Ulus, Dept Neurosurg, Sch Med, Istanbul, Turkey; [Guclu, D. Gucluhan] Univ Hlth Sci, Bakirkoy Sadi Konuk Res & Training Hosp, Dept Neurosurg, Istanbul, Turkey; [Dolas, Ilyas; Ozgen, Utku; Aydoseli, Aydin; Sencer, Altay] Istanbul Univ, Istanbul Sch Med, Dept Neurosurg, Istanbul, Turkey; [Altunrende, M. Emre] Univ Hlth Sci, Gaziosmanpasa Taksim Res & Training Hosp, Dept Neurosurg, Istanbul, Turkey; [Akinci, A. Tolgay] Trakya Univ, Dept Neurosurg, Sch Med, Edirne, Turkey; [Sencan, Fahir] Istinye Univ, Liv Hosp Bahcesehir, Dept Neurosurg, Sch Med, Istanbul, Turkey; [Can, Halil] Biruni Univ, Dept Neurosurg, Sch Med & Med Hosp, Istanbul, Turkey		Goker, B (corresponding author), Istinye Univ, Liv Hosp Ulus, Dept Neurosurg, Sch Med, Istanbul, Turkey.	burcugoker79@yahoo.com	Sencan, Fahir/AAO-3961-2020; Dolas, Ilyas/AAD-6885-2020	Sencan, Fahir/0000-0001-5519-5560; 			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Aghakhani N, 2009, J NEUROS-PEDIATR, V3, P66, DOI 10.3171/2008.10.PEDS08116; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Beez T, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2490-x; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; COOK DJ, 1992, CHEST, V102, pS305; CORDOBES F, 1987, CHILD NERV SYST, V3, P235, DOI 10.1007/BF00274055; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Csokay A, 2012, CHILD NERV SYST, V28, P441, DOI 10.1007/s00381-011-1661-0; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farooq MU, 2009, PEDIATR NEUROSURG, V45, P146, DOI 10.1159/000209654; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; FISCHER EG, 1972, J PEDIATR-US, V81, P98, DOI 10.1016/S0022-3476(72)80384-6; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; KIRKHAM FJ, 1986, DEV MED CHILD NEUROL, V28, P506; Kirton A, 2007, NAT CLIN PRACT CARD, V4, P163, DOI 10.1038/ncpcardio0825; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Lammy Simon, 2016, J Med Case Rep, V10, P368, DOI 10.1186/s13256-016-1145-7; Lane PL, 2000, CAN J SURG, V43, P442; Lee MC, 2003, PEDIATR NEUROSURG, V38, P181, DOI 10.1159/000069096; Lee SK, 2012, J KOREAN NEUROSURG S, V51, P86, DOI 10.3340/jkns.2012.51.2.86; Leetch AN, 2018, EMERG MED CLIN N AM, V36, P459, DOI 10.1016/j.emc.2017.12.012; Leonhardt G, 2002, J NEUROL, V249, P1433, DOI 10.1007/s00415-002-0875-1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Mhanna MJ, 2015, J NEUROSURG-PEDIATR, V16, P508, DOI 10.3171/2014.10.PEDS14117; Miyata Ichiro, 1994, Neurologia Medico-Chirurgica, V34, P241, DOI 10.2176/nmc.34.241; Montgomery AK, 2012, PEDIATR NEUROL, V47, P193, DOI 10.1016/j.pediatrneurol.2012.05.005; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Perez SE, 2011, J TRAUMA, V71, P133; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prasad GL, 2015, BRAIN INJURY, V29, P1717, DOI 10.3109/02699052.2015.1075146; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Rahme R, 2013, CHILD NERV SYST, V29, P99, DOI 10.1007/s00381-012-1894-6; Ramaswamy V, 2008, J CHILD NEUROL, V23, P889, DOI 10.1177/0883073808314960; Rekate Harold L., 2001, Child's Nervous System, V17, P632, DOI 10.1007/s003810100487; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Shah S, 2013, WORLD NEUROSURG, V80, P126, DOI 10.1016/j.wneu.2013.06.001; Smith SE, 2011, DEV MED CHILD NEUROL, V53, P29, DOI 10.1111/j.1469-8749.2010.03775.x; Tan MA, 2006, CHILD NERV SYST, V22, P523, DOI 10.1007/s00381-005-0001-7; Tang ZJ, 2018, WORLD NEUROSURG, V119, pE389, DOI 10.1016/j.wneu.2018.07.173; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Yamaguchi H, 2016, PEDIATR INT, V58, P622, DOI 10.1111/ped.12877; Young AMH, 2017, CHILD NERV SYST, V33, P1745, DOI 10.1007/s00381-017-3534-7	60	1	1	1	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2020	30	2					225	230		10.5137/1019-5149.JTN.27576-19.3			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KU2NS	WOS:000519545800011	31608977	Bronze			2022-02-06	
J	Gregory, H				Gregory, Hollin			Making a murderer: Media renderings of brain injury and Aaron Hernandez as a medical and sporting subject	SOCIAL SCIENCE & MEDICINE			English	Article						Chronic traumatic encephalopathy; Crime; Concussion; Dementia; Media discourse; Neuroscience; Sport; Subjectivity	GENETIC RISK; NEUROSCIENCE; MASCULINITY; CONCUSSION; RESPONSIBILITY; SCIENCE; BALANCE; DISEASE; CONTEXT	This paper examines the entanglement of medicine, brain injury, and subjectivity within newspaper discourse and through the case of ex-American footballer Aaron Hernandez. In 2017, two years after being found guilty of murder and five years after scoring in the Super Bowl, Aaron Hernandez died by suicide in his prison cell. Hernandez was posthumously diagnosed with Chronic Traumatic Encephalopathy (CTE), a neurodegenerative disease associated with violence, depression, and dementia-like symptoms. I examine newspaper coverage of the Hernandez case, focusing upon the murder, arrests, conviction, suicide, and diagnosis of CTE in order to examine understandings of Hernandez's subjectivity. I make three conclusions: First, the disease is not mentioned prior to diagnosis with family instability, friendship groups, individual psychology, and the entitlement of celebrity foregrounded. Second, CTE is foregrounded after the diagnosis and is used to explain much of Hernandez's behaviour. Third, the diagnosis of CTE goes someway to normalizing the behaviour of Hernandez, rendering his behaviours comprehensible. I conclude by considering how the specific narrative of CTE-as-acquired-dementia shapes depictions of Hernandez's subjectivity and discuss how this case troubles existing literatures on the neurologization of selfhood.	[Gregory, Hollin] Univ Leeds, Sch Sociol & Social Policy, Leeds LS2 9JT, W Yorkshire, England		Gregory, H (corresponding author), Univ Leeds, Sch Sociol & Social Policy, Leeds LS2 9JT, W Yorkshire, England.	g.hollin@leeds.ac.uk			Wellcome Trust Research Fellowship in Humanities and Social Science [212694/Z/18/Z]	This research was undertaken as part of a larger project entitled Hard Knock Life: Negotiating concussion and dementia in sport. This project has been made possible by the award of a Wellcome Trust Research Fellowship in Humanities and Social Science (212694/Z/18/Z) and I am hugely grateful for Wellcome's ongoing support. I would also like to thank Eva Haifa Giraud for providing critical comments on a draft of this manuscript, Jen Birks for advice regarding data collection, and the anonymous peer reviewers for their insightful feedback.	Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Atteveldt N.M., 2014, PLOS ONE, V9; Baez J., 2018, UNNECESSARY ROUGHNES; Biebricher T, 2011, EUR J SOC THEORY, V14, P469, DOI 10.1177/1368431011417933; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Brown HE, 2018, RSF-RUS SAGE J SOC S, V4, P118, DOI 10.7758/RSF.2018.4.5.06; Casper ST, 2019, LANCET NEUROL, V18, P522, DOI 10.1016/S1474-4422(19)30158-9; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Connell R.W., 2005, MASCULINITIES; Dimond R, 2014, NEW GENET SOC, V33, P149, DOI 10.1080/14636778.2014.910450; Dumit J., 2003, J MED HUMANITIES, V24, P35, DOI [DOI 10.1023/A:1021353631347, 10.1023/A:1021353631347]; Dumit J, 2004, PICTURING PERSONHOOD; Easter MM, 2012, SOC SCI MED, V75, P1408, DOI 10.1016/j.socscimed.2012.05.042; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Finkel AM, 2019, LANCET NEUROL, V18, P521, DOI 10.1016/S1474-4422(19)30159-0; Foucault M., 2002, ARCHAEOLOGY KNOWLEDG; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Hallin DC, 2015, MEDIA CULT SOC, V37, P85, DOI 10.1177/0163443714549090; Hallowell N, 1999, SOCIOL HEALTH ILL, V21, P597, DOI 10.1111/1467-9566.00175; Hardes J., 2017, SPORT ETHICS PHILOS, V1321, P1; Haslerig S.J., 2018, INT REV SOCIOLOGY SP; Hernandez J., 2018, TRUTH AARON MY JOURN; Hohler B., 2018, BOSTON GLOBE WONDERY; Knoblauch Austin, 2018, NFL; Landesman P., 2015, CONCUSSION; Lopez IH., 2015, DOG WHISTLE POLITICS; Malcolm D., 2016, SPORT MED HLTH MED S; Martin E, 2007, BIPOLAR EXPEDITION: MANIA AND DEPRESSION IN AMERICAN CULTURE, P1; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McFarland K., 2013, FRONTLINE LEAGUE DEN; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Michelle C, 2007, MEDIA CULT SOC, V29, P639, DOI 10.1177/0163443707078425; Novas C, 2000, ECON SOC, V29, P485; O'Connor C, 2013, PUBLIC UNDERST SCI, V22, P254, DOI 10.1177/0963662513476812; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; ORTEGA, 2017, BEING BRAINS MAKING; Page JT, 2016, HOWARD J COMMUN, V27, P270, DOI 10.1080/10646175.2016.1176969; Parker I, 1999, BRIT J MED PSYCHOL, V72, P577, DOI 10.1348/000711299160149; Patterson J., 2018, ALL AM MURDER SHOCKI; Pickersgill M, 2017, SOC SCI MED, V187, P93, DOI 10.1016/j.socscimed.2017.06.028; Pickersgill M, 2011, SUBJECTIVITY, V4, P346, DOI 10.1057/sub.2011.10; Potter J, 2005, QUAL RES PSYCHOL, V2, P281, DOI DOI 10.1191/1478088705QP045OA; Rabinow P., 1999, SCI STUDIES READER, P407; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Remnick D., 2018, FOOTBALLS LONG ECLIP; Rose N, 2004, BIOTECHNOLOGY: BETWEEN COMMERCE AND CIVIL SOCIETY, P89; Rose N, 2003, SOCIETY, V41, P46, DOI 10.1007/BF02688204; Rose N, 1996, INVENTING OUR SELVES, DOI DOI 10.1002/9780470696569.CH23; Rose N, 2010, HIST HUM SCI, V23, P79, DOI 10.1177/0952695109352415; Rugg A, 2019, COMMUN SPORT, V7, P46, DOI 10.1177/2167479517745299; Smiley C, 2016, J HUM BEHAV SOC ENVI, V26, P350, DOI 10.1080/10911359.2015.1129256; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Swallow J, 2017, SOC SCI MED, V184, P57, DOI 10.1016/j.socscimed.2017.05.017; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Vidal F, 2002, CRIT INQUIRY, V28, P930, DOI 10.1086/341240; Vidal F, 2009, HIST HUM SCI, V22, P5, DOI 10.1177/0952695108099133; Weiner K, 2017, SOCIOL HEALTH ILL, V39, P989, DOI 10.1111/1467-9566.12551; Weiner K, 2011, SOC SCI MED, V72, P1760, DOI 10.1016/j.socscimed.2010.03.053; Weiner K, 2009, HEALTH-LONDON, V13, P407, DOI 10.1177/1363459309103915	64	1	1	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	JAN	2020	244								112598	10.1016/j.socscimed.2019.112598			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	KG0FB	WOS:000509616000005	31689566	hybrid, Green Published			2022-02-06	
J	Gudziol, V; Marschke, T; Reden, J; Hummel, T				Gudziol, V; Marschke, T.; Reden, J.; Hummel, T.			Impact of anterior skull base fracture on lateralized olfactory function	RHINOLOGY			English	Article						anterior skull base fracture; olfaction; skull base; trauma; traumatic brain injury	ODOR IDENTIFICATION; HEAD-INJURY; DISCRIMINATION; DYSFUNCTION; MANAGEMENT; MR; THRESHOLDS; ANOSMIA; TRAUMA; TESTS	Background: Data on the impact of anterior skull base fractures (aSBF) on lateralized olfactory function are missing. The goal of the study was to investigate olfactory function in patients with traumatic brain injury (TBI) due to aSBF separately for each side and assess the frequency of lateralized smell impairment. Methods: Retrospective, single center study of olfactory function in 93 patients with aSBF. Olfactory function was assessed by means of the Sniffin' Sticks test battery for each side of the nose, seloarately.TBI severity was graded according to the Glasgow Coma Scale. Average time interval between olfactory test and trauma was 6.5 years. General olfactory function was defined as the best side out of both nostrils. Results: A total of 50 patients had unilateral and 43 patients bilateral aSBF.The grade of TBI was inversely correlated with olfactory function. General olfactory function was significantly worse in patients with bilateral aSBF compared to patients with unilateral aSBF. Clinically significant side by side differencesin olfactory function were found in 18 and 30% respectively for unilateral and bilateral aSBF. Grade of TBI had no significant impact on side differences. Among patients with unilateral aSBF olfactory function was not significantly different between the fractured and the non-fractured side. Conclusion: The severity of TBI and bilateral ore than unilateral aSBF results in more impaired olfactory unction. Lateralized olfactory deficits were not more frequent in any group, regardless of the fracture type and side.	[Gudziol, V; Reden, J.; Hummel, T.] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Gudziol, V] Municipal Hosp Dresden, Dept Otorhinolaryngol Head & Neck Surg, Dresden, Germany; [Marschke, T.] Tech Univ Dresden, Dept Anesthesiol, Dresden, Germany		Gudziol, V (corresponding author), Municipal Hosp, ORL, Friedrichstr 41, D-01067 Dresden, Germany.	volker.gudziol@klinikum-dresden.de					Bernal-Sprekelsen M, 2005, RHINOLOGY, V43, P277; Betchen SA, 1998, CHEM SENSES, V23, P453, DOI 10.1093/chemse/23.4.453; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; ELIES W, 1982, LARYNG RHINOL OTOL V, V61, P42, DOI 10.1055/s-2007-1008517; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Gudziol V, 2007, LARYNGOSCOPE, V117, P808, DOI 10.1097/MLG.0b013e3180330092; Gudziol V, 2006, LARYNGOSCOPE, V116, P1858, DOI 10.1097/01.mlg.0000234915.51189.cb; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Gudziol V, 2010, J NEUROL, V257, P959, DOI 10.1007/s00415-009-5445-3; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Joung YI, 2007, J KOREAN NEUROSURG S, V42, P1; Klimek L, 1998, LARYNGOSCOPE, V108, P111, DOI 10.1097/00005537-199801000-00021; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Lotsch J, 2016, NEUROIMAGE-CLIN, V11, P99, DOI 10.1016/j.nicl.2016.01.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Piccirilli M, 2012, J NEUROL SURG PART B, V73, P265, DOI 10.1055/s-0032-1312715; POWELL TPS, 1965, J ANAT, V99, P791; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Savic I, 2001, BRAIN RES BULL, V54, P307, DOI 10.1016/S0361-9230(00)00439-1; Schoentgen C, 2013, ACTA OTO-LARYNGOL, V133, P944, DOI 10.3109/00016489.2013.793821; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Swinson BD, 2004, J LARYNGOL OTOL, V118, P927, DOI 10.1258/0022215042790583; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171	33	1	1	0	2	INT RHINOLOGIC SOC	UTRECHT	UNIV MEDICAL CENTER UTRECHT, RM G05 127, DEPT OTORHINOL, HEIDELBERGLAAN 100, 3584 CX UTRECHT, NETHERLANDS	0300-0729			RHINOLOGY	Rhinology		2020	58	1					45	50		10.4193/Rhin18.092			6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	KQ2NR	WOS:000516765900007	31287451	Bronze			2022-02-06	
J	Gurcan, O; Uckun, MO; Celikmez, RC; Turkoglu, OF; Eroglu, H; Beskonakli, E; Oner, L; Taskin, Y				Gurcan, Oktay; Uckun, Merzuk Ozhan; Celikmez, Ramazan Cengiz; Turkoglu, Omer Faruk; Eroglu, Hakan; Beskonakli, Ethem; Oner, Levent; Taskin, Yamac			Neuroprotective Efficiency of Cyclosporine After Traumatic Brain Injury in Rats	TURKISH NEUROSURGERY			English	Article						Cyclosporine; Neuroprotection; Mitochondrial permeability transition pore; Traumatic brain injury; Rats	MITOCHONDRIAL DYSFUNCTION; DOSE-RESPONSE; ISCHEMIA; EDEMA; MODEL	AIM: To evaluate the possible neuroprotective effects of systemic administration of cyclosporine (Cyclosporin A) after traumatic brain injury in rats. MATERIAL and METHODS: The modified Feeney method was used as the trauma model in male Sprague Dawley rats. After the trauma, 20 mg/kg of cyclosporine was administered to the one group of the rats (n=12) intraperitoneally. Twenty-four hours after injury, the subjects were sacrificed, and brain samples were removed. The level of brain edema was evaluated through the wet-dry weight method, the lipid peroxidation ratio, and histological examination by transmission electron microscopy. RESULTS: The level of brain edema and lipid peroxidation ratio significantly decreased in the rats that received cyclosporine. Ultrastructural neurodestruction was graded, and a comparison of the scores between the experimental groups revealed significant neuroprotective effects of cyclosporine. CONCLUSION: The results demonstrated that systemic administration of cyclosporine produces a statistically significant decrease in both the level of brain edema and lipid peroxidation ratio when compared with "no treatment". Cyclosporine, which is regularly used as an immunosuppressant agent, is also known to prevent opening of the mitochondrial permeability transition pore by unbinding mitochondrial matrix cyclophilin. Regulation of transition pore for mitochondrial permeability by cyclosporine implies that mitochondrial dysfunction following traumatic brain injury is an important event in the progressive loss of neuronal tissue.	[Gurcan, Oktay; Turkoglu, Omer Faruk] Ankara Ataturk Educ & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Uckun, Merzuk Ozhan] Ankara Numune Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Celikmez, Ramazan Cengiz] Antalya Educ & Res Hosp, Dept Neurosurg, Antalya, Turkey; [Eroglu, Hakan; Oner, Levent] Hacettepe Univ, Fac Pharm, Depatment Pharmaceut Technol, Ankara, Turkey		Gurcan, O (corresponding author), Ankara Ataturk Educ & Res Hosp, Dept Neurosurg, Ankara, Turkey.	oktaygurcan@gmail.com	EROGLU, HAKAN/J-1040-2013; ONER, LEVENT/J-1032-2013; gurcan, oktay/AAW-7810-2021	ONER, LEVENT/0000-0002-6510-7680; 	Turkish Neurosurgical Society	Preparation for publication of this article is partly supported by Turkish Neurosurgical Society.	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Borlongan CV, 2005, LIFE SCI, V76, P1503, DOI 10.1016/j.lfs.2004.09.022; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Eroglu H, 2001, J MICROENCAPSUL, V18, P603; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Schinder AF, 1996, J NEUROSCI, V16, P6125; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Yamaguchi T, 2006, J PHARMACOL SCI, V100, P73, DOI 10.1254/jphs.FP0050799	22	1	1	5	5	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2020	30	4					507	512		10.5137/1019-5149.JTN.24303-18.2			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MN9PW	WOS:000551172600006	32672343	Bronze			2022-02-06	
J	Harris, SA; Chivers, PT; McIntyre, FL; Piggott, B; Bulsara, M; Farringdon, FH				Harris, Sarah Ann; Chivers, Paola T.; McIntyre, Fleur L.; Piggott, Ben; Bulsara, Max; Farringdon, Fiona H.			Exploring the association between recent concussion, subconcussive impacts and depressive symptoms in male Australian Football players	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						Australian Football; concussion; depression	HIGH-SCHOOL; CONSENSUS STATEMENT; MENTAL-HEALTH; BRAIN-INJURY; RISK; SPORT; ANXIETY; PREVALENCE; SURVEILLANCE; PERFORMANCE	ObjectivesTo explore the association between depressive symptoms and recent head-related trauma (diagnosed concussion, subconcussive impacts) in semiprofessional male Australian Football (AF) players.MethodsSixty-nine semiprofessional male players from a West Australian Football League (WAFL) club participated in the study (M-age=21.81, SD=2.91 years). Depressive symptoms were measured using the Centre for Epidemiological Studies Depression Scale. Injuries and potential confounding variables (eg, pre-existing mental health condition; alcohol or drug hangovers; experiencing a stressful event) were self-reported anonymously using the WAFL Injury Report Survey. Both tools were administered every 2-weeks over the first 22-weeks of the WAFL season. Controlling for potential confounding variables and other injuries, a repeated measures generalised estimating equations model assessed the risk of clinically relevant depressive symptoms occurring, when diagnosed concussion or subconcussive impacts were experienced.ResultsA total of 10 concussions and 183 subconcussive impacts were reported. Players who experienced a concussion were almost nine times more likely to experience clinically relevant depressive symptoms (OR 8.88, 95% CI 2.65 to 29.77, p<0.001). Although elevated, depressive symptoms following subconcussive impacts were not statistically significant (OR 1.13, 95% CI 0.67 to 1.92, p=0.641).ConclusionThese findings indicate that semiprofessional AF athletes may be at risk of experiencing depressive symptoms after concussion. Severity (concussion vs subconcussive impacts) and dose (number of impacts) appear to have an important relationship with depressive symptom outcomes in this cohort and should be considered for further research and management of player welfare.	[Harris, Sarah Ann; McIntyre, Fleur L.; Piggott, Ben; Farringdon, Fiona H.] Univ Notre Dame Australia, Sch Hlth Sci, Fremantle, WA, Australia; [Harris, Sarah Ann; Chivers, Paola T.; Bulsara, Max] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA, Australia; [Chivers, Paola T.] Edith Cowan Univ, Exercise Med Res Inst, Joondalup, WA, Australia; [Chivers, Paola T.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia		Harris, SA (corresponding author), Univ Notre Dame Australia, Sch Hlth Sci, Fremantle, WA, Australia.; Harris, SA (corresponding author), Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA, Australia.	Sarah.Harris@nd.edu.au			Australian University Postgraduate Award (UPA) scholarship	SAH was supported by an Australian University Postgraduate Award (UPA) scholarship.	Afl doctors association AFL physiotherapists association AFL football operations department, 2016, 2015 AFL INJ SURV; Andrews G, 1999, MENTAL HLTH AUSTR; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Australian Institute of Health and Welfare, 2018, AUSTR HLTH 2018; Bell ML, 2014, STAT METHODS MED RES, V23, P440, DOI 10.1177/0962280213476378; Beyond Blue, 2016, DEPR MAL; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brown DR, 2007, MED SCI SPORT EXER, V39, P2248, DOI 10.1249/mss.0b013e31815793a3; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Colby MJ, 2017, J SCI MED SPORT, V20, P1068, DOI 10.1016/j.jsams.2017.05.010; COUGHLIN SS, 2012, PUBLIC HEALTH REV, V0034; Department of Health and Ageing, 2013, NAT MENT HLTH REP 20; Dodge R. A. P., 2012, INT J WELLBEING, V2, P222, DOI [10.5502/ijw.v2i3.4, 10.5502/ijw., DOI 10.5502/IJW.V2I3.4]; Du Preez EJ, 2017, CLIN J SPORT MED, V27, P530, DOI 10.1097/JSM.0000000000000411; Ekegren CL, 2015, J SCI MED SPORT, V18, P651, DOI 10.1016/j.jsams.2014.11.390; Finch CF, 2014, BRIT J SPORT MED, V48, P718, DOI 10.1136/bjsports-2012-091797; Fisher C, 2009, CTR EPIDEMIOLOGIC ST; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GIBBS N, 2017, J SPORTS MED, V2017, P1; Gilbert F, 2012, MED J AUSTRALIA, V196, P561, DOI 10.5694/mja11.11218; Gorczynski PF, 2017, BRIT J SPORT MED, V51, P1348, DOI 10.1136/bjsports-2016-096455; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Hopwood MJ, 2016, MED J AUSTRALIA, V204, P329, DOI 10.5694/mja16.00217; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Li HM, 2017, AM J SPORT MED, V45, P2148, DOI 10.1177/0363546517702847; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Marshall S, 2015, INJURY EPIDEMIOLOGY, V2, P1; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Muller S, 2013, STAT SCI, V28, P135, DOI 10.1214/12-STS410; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Nixdorf I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00893; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Orchard J. W., 2015, 2014 AFL INJURY REPO; Orchard JW, 2012, J SCI MED SPORT, V15, P201, DOI 10.1016/j.jsams.2011.11.250; Pearce AJ, 2017, J SPORT SCI, V35, P1911, DOI 10.1080/02640414.2016.1241420; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pierce D, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-10; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Radloff, 1977, APPL PSYCH MEAS, V1, P385, DOI DOI 10.1177/014662167700100306; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Ruddock-Hudson M, 2014, J APPL SPORT PSYCHOL, V26, P377, DOI 10.1080/10413200.2014.897269; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Stares J, 2018, J SCI MED SPORT, V21, P46, DOI 10.1016/j.jsams.2017.05.012; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Valuri G, 2005, INJURY PREV, V11, P135, DOI 10.1136/ip.2003.004820; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; West Australian Football Commission Inc, 2014, WAFL PLAYER PROF; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yang JZ, 2014, J ATHL TRAINING, V49, P773, DOI 10.4085/1062-6050-49.3.65; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013	73	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000655	10.1136/bmjsem-2019-000655			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF7WL	WOS:000599260000001	32201617	Green Published, gold			2022-02-06	
J	Hart, T; Vaccaro, MJ; Fann, JR; Maiuro, RD; Neuberger, S; Sinfield, S				Hart, Tessa; Vaccaro, Monica J.; Fann, Jesse R.; Maiuro, Roland D.; Neuberger, Shira; Sinfield, Steven			Psychoeducational Interventions for Problematic Anger in Chronic Moderate to Severe Traumatic Brain Injury: A Study of Treatment Enactment	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injuries; Treatment enactment; Clinical trials; Anger management; Treatment fidelity; Treatment implementation	SELF-MANAGEMENT; TREATMENT FIDELITY; TRIALS	Objectives: Treatment enactment, a final stage of treatment implementation, refers to patients' application of skills and concepts from treatment sessions into everyday life situations. We examined treatment enactment in a two-arm, multicenter trial comparing two psychoeducational treatments for persons with chronic moderate to severe traumatic brain injury and problematic anger. Methods: Seventy-one of 90 participants from the parent trial underwent a telephone enactment interview at least 2 months (median 97 days, range 64-586 days) after cessation of treatment. Enactment, quantified as average frequency of use across seven core treatment components, was compared across treatment arms: anger self-management training (ASMT) and personal readjustment and education (PRE), a structurally equivalent control. Components were also rated for helpfulness when used. Predictors of, and barriers to, enactment were explored. Results: More than 80% of participants reported remembering all seven treatment components when queried using a recognition format. Enactment was equivalent across treatments. Most used/most helpful components concerned normalizing anger and general anger management strategies (ASMT), and normalizing traumatic brain injury-related changes while providing hope for improvement (PRE). Higher baseline executive function and IQ were predictive of better enactment, as well as better episodic memory (trend). Poor memory was cited by many participants as a barrier to enactment, as was the reaction of other people to attempted use of strategies. Conclusions: Treatment enactment is a neglected component of implementation in neuropsychological clinical trials, but is important both to measure and to help participants achieve sustained carryover of core treatment ingredients and learned material to everyday life.	[Hart, Tessa; Vaccaro, Monica J.; Neuberger, Shira] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sinfield, Steven] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD042738]; Peer Review Committee of Moss Rehabilitation Research Institute	This work was supported by the National Institutes of Health (R01HD042738) and the Peer Review Committee of Moss Rehabilitation Research Institute. The authors express deep appreciation to Jo Ann Brockway, PhD for her contributions to this work.	Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DiGiuseppe R, 2003, CLIN PSYCHOL-SCI PR, V10, P70, DOI 10.1093/clipsy/10.1.70; Dobkin BH, 2016, CURR OPIN NEUROL, V29, P693, DOI 10.1097/WCO.0000000000000380; Duffy SA, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0056-5; Faulkner MS, 2012, J SPEC PEDIATR NURS, V17, P33, DOI 10.1111/j.1744-6155.2011.00305.x; Grow JC, 2015, ADDICT BEHAV, V40, P16, DOI 10.1016/j.addbeh.2014.07.030; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2017, J HEAD TRAUMA REHAB, V32, P319, DOI 10.1097/HTR.0000000000000316; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; LICHSTEIN KL, 1994, ADV BEHAV RES THER, V16, P1, DOI 10.1016/0146-6402(94)90001-9; Maiuro R. D., 1987, J INTERPERS VIOLENCE, V2, P166, DOI [10.1177/088626087002002003, DOI 10.1177/088626087002002003]; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Olatunji, 2004, SCI REV MENTAL HLTH, V3, P2; Reitan R, 1985, HALSTEAD REITAN NEUR; Rixon L, 2016, BMC HEALTH SERV RES, V16, P1; Schmidt M., 1996, REY AUDITORY VERBAL; Spielberger CD, 2000, STATE TRAIT ANGER EX; Spillane V, 2007, J ADV NURS, V60, P343, DOI 10.1111/j.1365-2648.2007.04386.x; Taub E, 2013, STROKE, V44, P1383, DOI 10.1161/STROKEAHA.111.000559; Veenstra L, 2018, CURR OPIN PSYCHOL, V19, P98, DOI 10.1016/j.copsyc.2017.03.014; Wechsler D., 2011, WECHSLER ABBREVIATED; Whyte J, 2019, ARCH PHYS MED REHAB, V100, P156, DOI 10.1016/j.apmr.2018.09.111; Zauszniewski JA, 2016, WESTERN J NURS RES, V38, P1554, DOI 10.1177/0193945916655798	28	1	1	1	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2020	26	1			SI		119	129	PII S1355617719000833	10.1017/S1355617719000833			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	KH1RZ	WOS:000510425100012	31983369	Green Accepted			2022-02-06	
J	Hashimoto, M; Ho, G; Takamatsu, Y; Wada, R; Sugama, S; Waragai, M; Masliah, E; Takenouchi, T				Hashimoto, Makoto; Ho, Gilbert; Takamatsu, Yoshiki; Wada, Ryoko; Sugama, Shuei; Waragai, Masaaki; Masliah, Eliezer; Takenouchi, Takato			Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability	PRION			English	Article						Creutzfeldt-Jackob (CJD); sporadic CJD; genetic CJD; acquired CJD; evolvability; amyloidogenic proteins (APs); prion protein (PrP); alpha-synuclein (alpha S); antagonistic pleiotropy	CELLULAR PRION PROTEIN; JAKOB-DISEASE; ALZHEIMERS-DISEASE; BETA; COEXISTENCE; IMMUNOTHERAPY; PRECURSOR; DEPOSITS	Creutzfeldt-Jackob disease (CJD), the most common human prion disorder, is frequently accompanied by ageing-associated neurodegenerative conditions, such as Alzheimer's disease and Parkinson's disease. Although cross-seeding of amyloidogenic proteins (APs), including amyloid beta and alpha-synuclein, may be critical in the co-morbidity of neurodegenerative disorders, the direct interaction of APs with prion protein (PrP), the central molecule involved in the pathogenesis of CJD, is unlikely. Currently, the nature of this biological interaction and its significance remain obscure. In this context, the objective of the present study is to discuss such interactions from the perspective of amyloidogenic evolvability, a putative function of APs. Hypothetically, both hereditary- and sporadic CJD might be attributed to the role of PrP in evolvability against multiple stressors, such as physical stresses relevant to concussions, which might be manifest through the antagonistic pleiotropy mechanism in ageing. Furthermore, accumulating evidence suggests that PrP- and other APs evolvability may negatively regulate each other. Provided that increased APs evolvability might be beneficial for acquired CJD in young adults, a dose-reduction of alpha-synuclein, a natural inhibitor of alpha S aggregation, might be therapeutically effective in upregulating APs evolvability. Collectively, a better understanding of amyloidogenic evolvability may lead to the development of novel therapies for CJD.	[Hashimoto, Makoto; Takamatsu, Yoshiki; Wada, Ryoko; Waragai, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Parkinsons Dis, Setagaya Ku, Tokyo, Japan; [Ho, Gilbert] PCND Neurosci Res Inst, Poway, CA USA; [Sugama, Shuei] Nippon Med Sch, Dept Physiol, Tokyo, Japan; [Masliah, Eliezer] NIA, Div Neurosci, NIH, Bethesda, MD 20892 USA; [Takenouchi, Takato] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan		Hashimoto, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1560057, Japan.	hashimoto-mk@igakuken.or.jp		Reis, AlessanRSS/0000-0001-8486-7469			AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; Appleby BS, 2011, EXPERT OPIN PHARMACO, V12, P1, DOI 10.1517/14656566.2010.514903; Aulic S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10236-x; BROWN P, 1990, NEUROLOGY, V40, P226, DOI 10.1212/WNL.40.2.226; Campana V, 2009, BIOCHEM J, V418, P507, DOI 10.1042/BJ20081541; Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005; Cong X, 2013, J CHEM THEORY COMPUT, V9, P5158, DOI 10.1021/ct400534k; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Haik S, 2002, ACTA NEUROPATHOL, V103, P516; Haraguchi T, 2009, NEUROPATHOLOGY, V29, P454, DOI 10.1111/j.1440-1789.2008.00964.x; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hashimoto M, 2019, J PARKINSON DIS, V9, P793, DOI 10.3233/JPD-191675; Hashimoto M, 2018, J PARKINSON DIS, V8, P405, DOI 10.3233/JPD-181365; Hashimoto M, 2018, J ALZHEIMERS DIS, V62, P73, DOI 10.3233/JAD-170894; Iwasaki Y, 2017, NEUROPATHOLOGY, V37, P174, DOI 10.1111/neup.12355; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Maltete D, 2006, PARKINSONISM RELAT D, V12, P65, DOI 10.1016/j.parkreldis.2005.10.004; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; MURAMOTO T, 1992, ACTA NEUROPATHOL, V84, P686; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; POWERS JM, 1991, ACTA NEUROPATHOL, V83, P95, DOI 10.1007/BF00294437; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Roettger Y, 2013, NAT REV NEUROL, V9, P98, DOI 10.1038/nrneurol.2012.258; Rossi M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0706-6; Shirasaka M, 2020, BIOCHEM BIOPH RES CO, V521, P259, DOI 10.1016/j.bbrc.2019.10.120; Takamatsu Y, 2019, J ALZHEIMERS DIS, V68, P473, DOI 10.3233/JAD-180986; Takamatsu Y, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/5789424; Urrea L, 2017, PRION, V11, P226, DOI 10.1080/19336896.2017.1334748; Vital A, 2007, NEUROPATHOLOGY, V27, P273, DOI 10.1111/j.1440-1789.2007.00755.x; Zerr I, 2018, EXPERT REV NEUROTHER, V18, P761, DOI 10.1080/14737175.2018.1519397	33	1	1	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1933-6896	1933-690X		PRION	Prion	JAN 1	2020	14	1					1	8		10.1080/19336896.2020.1761514			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL7AQ	WOS:000531708400001	32375593	Green Published, gold			2022-02-06	
J	Hassan, SA; Gassoum, A; Aldeaf, SAH; Arbab, MAR; Musa, HH				Hassan, Samah Abdelrahman; Gassoum, Alsadig; Aldeaf, Sawsan Ahmed Hamed; Arbab, Mohamed Abdel Rahman; Musa, Hassan Hussein			Association Between Acute Inflammatory Cells and Mutation in ICAM-1 Gene With Injury Severity and Outcome Among Traumatic Cerebral Hemorrhagic Contusion	JOURNAL OF ACUTE MEDICINE			English	Article						cerebral contusion; inflammation; ICAM-1; neutrophils	INTERCELLULAR-ADHESION MOLECULE-1; BRAIN-INJURY; K469E POLYMORPHISM; P-SELECTIN; LEUKOCYTOSIS; EDEMA; NEUTROPHILS; EXPRESSION	Background: Acute inflammation in the brain after trauma is mediated by acute inflammatory cells (neutrophils) that contributes to ischemic brain damage, neurological deterioration, and poor outcome. Migration of neutrophils to brain is mediated by intercellular adhesion molecule-1 (ICAM- 1). The aim was to determine an association between neutrophils counts, ICAM-1 level and mutation in ICAM-1 gene with injury severity and patient's outcome. Methods: Cross- sectional study was conducted for 90 Sudanese patients presented with traumatic cerebral hemorrhagic contusion to the National Center for Neurological Sciences, Khartoum, Sudan from December 2015 to January 2018. Non-Sudanese patients and hemorrhagic contusion associated with other type of brain bleeding were excluded in this study. Moreover, 90 apparently healthy individuals were participated as control. Results: Most patients were males (93.3%), their ages ranged from 25 to 44 years, 11.1% of the patients had severe brain injury, 22.2% had brain edema and the mortality rate was 8.9%. Circulatory levels of leukocytes, neutrophil and, ICAM-1 among patients who sustained trauma were significantly elevated compared with controls (p = 0.000). The high level of leukocytes and neutrophils counts were significantly associated with ICAM-1 pg/mL circulatory level. High levels of leukocytes, neutrophils, and ICAM-1 were documented in severe brain injuries. High level of ICAM-1 was observed among patients admitted with brain edema. Leukocytes and neutrophils counts were significantly associated with patient outcome. High level of ICAM- 1 (304.88 pg/mL) was observed among patients with poor outcome compared to survivals (263.93 pg/mL). The highest circulatory level of ICAM-1 (280.75 pg/mL) was observed among patient having adenine-adenine (AA) mutant homozygous alleles, followed by (272 pg/mL) for guanineguanine (GG) homozygous alleles, then (245.12 pg/mL) for guanine-adenine (GA) heterozygous alleles. Conclusions: Mutation in ICAM-1 gene and increased levels of leukocytes, neutrophils, and ICAM-1 constitutes important markers for injury severity and patient's outcome.	[Hassan, Samah Abdelrahman] Alneelain Univ, Fac Med Lab Sci, Dept Immunol, Khartoum, Sudan; [Hassan, Samah Abdelrahman] Almugtaribeen Univ, Fac Med, Dept Med Microbiol, Khartoum, Sudan; [Gassoum, Alsadig; Aldeaf, Sawsan Ahmed Hamed; Arbab, Mohamed Abdel Rahman] Natl Ctr Neurol Sci, Khartoum, Sudan; [Arbab, Mohamed Abdel Rahman] Univ Khartoum, Fac Med, Dept Surg, Khartoum, Sudan; [Musa, Hassan Hussein] Univ Khartoum, Fac Med Lab Sci, Dept Med Microbiol, Khartoum, Sudan; [Musa, Hassan Hussein] Darfur Coll, Biomed Res Inst, Nyala, Sudan		Musa, HH (corresponding author), Univ Khartoum, Fac Med Lab Sci, Dept Med Microbiol, Khartoum, Sudan.	hassanhm@uofk.edu					Atay AE, 2017, NEFROLOGIA, V37, P381, DOI 10.1016/j.nefro.2016.11.025; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Emerich DF, 2002, EXP NEUROL, V173, P168, DOI 10.1006/exnr.2001.7835; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Gurkanlar D, 2009, TURK NEUROSURG, V19, P211; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Ji YN, 2012, MOL BIOL REP, V39, P6043, DOI 10.1007/s11033-011-1418-6; Kira S, 2005, ACTA ANAESTH SCAND, V49, P351, DOI 10.1111/j.1399-6576.2005.00593.x; Knorr R, 1997, J EXP MED, V186, P719, DOI 10.1084/jem.186.5.719; Kraus J, 2007, ACTA NEUROL SCAND, V116, P49, DOI 10.1111/j.1600-0404.2006.00790.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li H, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), P93; Lu Q, 2010, AM J PHYSIOL-LUNG C, V298, pL755, DOI 10.1152/ajplung.00330.2009; Ma QY, 2013, CNS NEUROL DISORD-DR, V12, P392, DOI 10.2174/1871527311312030012; McKeating EG, 1998, ACT NEUR S, V71, P200; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Mitsui A, 2015, CLIN IMMUNOL, V157, P43, DOI 10.1016/j.clim.2014.12.011; Morancho A, 2010, ANN NY ACAD SCI, V1207, P123, DOI 10.1111/j.1749-6632.2010.05734.x; Paladino L, 2010, WEST J EMERG MED, V11, P450; Papa A, 2004, Eur Rev Med Pharmacol Sci, V8, P187; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Ponthieux A, 2003, CLIN CHEM, V49, P1544, DOI 10.1373/49.9.1544; Popovic D, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0247-y; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Santucci CA, 2008, WEST J EMERG MED, V9, P81; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Singh A, 2014, J NEUROIMMUNOL, V276, P166, DOI 10.1016/j.jneuroim.2014.07.018; Subramanian A, 2011, BRAIN INJURY PATHOGE, DOI [10.5772/27020, DOI 10.5772/27020]; Wang KW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/910260; Wang Ming-Ying, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P1205; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; Witkowska AM, 2004, EUR CYTOKINE NETW, V15, P91; Yilmaz G, 2010, NEUROMOL MED, V12, P193, DOI 10.1007/s12017-009-8074-1; Zhang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19267-4; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170	40	1	1	0	0	TAIWAN SOC EMERGENCY MEDICINE	TAIPEI	TAIWAN SOC EMERGENCY MEDICINE, TAIPEI, 00000, TAIWAN	2211-5587	2211-5595		J ACUTE MED	J. Acute Med.		2020	10	1					1	8		10.6705/j.jacme.202003_10(1).0001			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	OC7QY	WOS:000579353500001	32995149				2022-02-06	
B	Hedges, D; Farrer, TJ; Bigler, ED; Hopkins, RO	Hedges, D; Farrer, TJ; Bigler, ED; Hopkins, RO			Hedges, Dawson; Farrer, Thomas J.; Bigler, Erin D.; Hopkins, Ramona O.	Hedges, D; Farrer, TJ; Bigler, ED; Hopkins, RO		Chronic Pain and Cognition	BRAIN AT RISK: ASSOCIATIONS BETWEEN DISEASE AND COGNITION			English	Article; Book Chapter						Chronic pain; Migraine; Traumatic injury; Disability; Back pain; Opioid medication; Fibromyalgia; Quality of life; Complex regional pain syndrome; Cognitive impact of pain	NEUROPSYCHOLOGICAL PERFORMANCE; EXECUTIVE FUNCTION; ECONOMIC COSTS; ATTENTION; BRAIN; FIBROMYALGIA; EPIDEMIOLOGY; DYSFUNCTION; INHIBITION; PREVALENCE	Chronic pain is a common clinical condition that has a high lifetime prevalence, with significant morbidity and medical cost. An often overlooked aspect of chronic pain is the cognitive consequences. Findings on chronic pain and cognitive function reveal several important factors. First, patients with chronic pain appear to have worse cognitive functioning than do healthy controls, particularly in the areas of attention, processing speed, and executive functioning. Second, the duration and intensity of chronic pain appear to be negatively correlated with cognitive function. Third, chronic pain appears to affect cognitive functioning in a multifactorial fashion. That is, there appears to be a strong overlap between neural networks devoted to attention and areas of the brain associated with pain processing. There also seem to be both general and etiology-specific focal and regional brain-volume loss associated with pain and some evidence of a reversal of these morphological changes with the cessation of pain. Finally, long-term opioid medication use may have an effect on cognition, but the actual effect is difficult to elucidate given confounding factors such as interaction effects with other medications, the type of opioid, dosage, time of dose, and length of dose.	[Hedges, Dawson; Bigler, Erin D.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Farrer, Thomas J.] Duke Univ, Med Ctr, Durham, NC USA		Hedges, D (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.						Abeare CA, 2010, CLIN J PAIN, V26, P683, DOI 10.1097/AJP.0b013e3181ed1762; [Anonymous], 1986, Pain Suppl, V3, pS1; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Attal N, 2014, BRAIN, V137, P904, DOI 10.1093/brain/awt354; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; BANNING A, 1992, ACTA ANAESTH SCAND, V36, P480, DOI 10.1111/j.1399-6576.1992.tb03501.x; Berryman C, 2014, CLIN PSYCHOL REV, V34, P563, DOI 10.1016/j.cpr.2014.08.003; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Buffington ALH, 2005, PAIN, V113, P172, DOI 10.1016/j.pain.2004.10.006; Cauda F, 2014, NEUROIMAGE-CLIN, V4, P676, DOI 10.1016/j.nicl.2014.04.007; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Glass JM, 2011, J PAIN, V12, P1219, DOI 10.1016/j.jpain.2011.06.007; Groenewald CB, 2014, J PAIN, V15, P925, DOI 10.1016/j.jpain.2014.06.002; Hardt J, 2008, PAIN MED, V9, P803, DOI 10.1111/j.1526-4637.2008.00425.x; Jain G, 2014, PAIN PHYSICIAN, V17, P109; Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x; Katz J, 2015, CAN J PSYCHIAT, V60, P160, DOI 10.1177/070674371506000402; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Kusters D, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-211; Landro NI, 2013, PAIN, V154, P972, DOI 10.1016/j.pain.2013.01.013; Lee DM, 2010, PAIN, V151, P30, DOI 10.1016/j.pain.2010.04.024; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Melkumova KA, 2011, NEUROSCIENCE BEHAV P, V41, P20, DOI DOI 10.1007/S11055-010-9376-3; Mongini F, 2005, PSYCHIAT RES, V133, P101, DOI 10.1016/j.psychres.2003.12.028; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Oosterman JM, 2012, PAIN RES MANAG, V17, P159, DOI 10.1155/2012/962786; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Pulles WLJA, 2011, PAIN MED, V12, P1769, DOI 10.1111/j.1526-4637.2011.01266.x; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Smallwood RF, 2013, J PAIN, V14, P663, DOI 10.1016/j.jpain.2013.03.001; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Tunks ER, 2008, CAN J PSYCHIAT, V53, P224, DOI 10.1177/070674370805300403; van Hecke O, 2013, BRIT J PAIN, V7, P209, DOI 10.1177/2049463713493264; Veldhuijzen DS, 2012, J PAIN, V13, P507, DOI 10.1016/j.jpain.2012.02.011; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x	38	1	1	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND			978-3-030-14260-5; 978-3-030-14258-2				2020							113	124		10.1007/978-3-030-14260-5_9	10.1007/978-3-030-14260-5		12	Medicine, Research & Experimental; Neurosciences; Psychiatry	Book Citation Index – Science (BKCI-S)	Research & Experimental Medicine; Neurosciences & Neurology; Psychiatry	BR7CA	WOS:000665522300009					2022-02-06	
B	Henne, K		Ventresca, M; McDonald, MG		Henne, Kathryn			Brain Politics Gendered Difference and Traumatic Brain Injury in Sport	SOCIOCULTURAL EXAMINATIONS OF SPORTS CONCUSSIONS	Routledge Research in Sport and Exercise Science		English	Article; Book Chapter							CONCUSSION; SEX; WOMENS; HEALTH; NEUROSCIENCE; RISK		[Henne, Kathryn] Univ Waterloo, Biogovernance Law & Soc, Balsillie Sch Int Affairs, Waterloo, ON, Canada; [Henne, Kathryn] Australian Natl Univ, Sch Regulat & Global Governance, RegNet, Canberra, ACT, Australia		Henne, K (corresponding author), Univ Waterloo, Biogovernance Law & Soc, Balsillie Sch Int Affairs, Waterloo, ON, Canada.						Canadian Institutes of Health Research, 2017, SEX GEND HLTH RES GU; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [DOI 10.2307/1229039, 10.2307/1229039]; Dussauge I, 2012, NEUROETHICS-NETH, V5, P211, DOI 10.1007/s12152-012-9165-5; Fausto-Sterling A, 2005, SIGNS, V30, P1491, DOI 10.1086/424932; Feagin J, 2014, SOC SCI MED, V103, P7, DOI 10.1016/j.socscimed.2013.09.006; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Gay Elizabeth Dawes, 2018, THE NATION      0118; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Hargreaves J., 1994, SPORTING FEMALES CRI; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henne K, 2018, SOCIOL SPORT J, V35, P216, DOI 10.1123/ssj.2017-0150; Henne K, 2014, SIGNS, V39, P787, DOI 10.1086/674208; Hokowhitu B, 2004, CONTEMP PACIFIC, V16, P259, DOI 10.1353/cp.2004.0046; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan-Young Rebecca M., 2011, BRAIN STORM FLAWS SC; Klein SL, 2015, P NATL ACAD SCI USA, V112, P5257, DOI 10.1073/pnas.1502843112; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lamke Sherece, 2011, CONCUSSION FEMALE AT; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Merry SE, 2014, AM ETHNOL, V41, P1, DOI 10.1111/amet.12055; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Mol A., 2003, BODY MULTIPLE ONTOLO; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Moore Antonio, 2015, VICE SPORTS     1224; Moore D, 2018, THEOR CRIMINOL, V22, P116, DOI 10.1177/1362480616684194; National Institutes of Health Office of Research on Women's Health, 2018, NIH POL SEX BIOL VAR; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Nixon H. L. II, 1996, Journal of Sport and Social Issues, V20, P33, DOI 10.1177/019372396020001004; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Palmer C, 2013, GLOBAL SPORTS POLICY; Pitts-Taylor V., 2016, BRAINS BODY NEUROSCI; Puar JK, 2012, PHILOSOPHIA-J CONT F, V2, P49; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Richardson SS, 2015, P NATL ACAD SCI USA, V112, P13419, DOI 10.1073/pnas.1516958112; Roy D, 2016, SIGNS, V41, P531, DOI 10.1086/684266; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; SHERWIN RK, 1994, STANFORD LAW REV, V47, P39, DOI 10.2307/1229221; Shew Ashley, 2018, Perspectives on Science, V26, P400, DOI 10.1162/posc_a_00279; Slier K, 2019, SOCIOL SPORT J, V36, P57, DOI 10.1123/ssj.2017-0125; Subramaniam B, 2009, SIGNS, V34, P951, DOI 10.1086/597147; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Theberge N, 2012, ERGONOMICS, V55, P183, DOI 10.1080/00140139.2011.592602; Theberge N, 2015, SOCIOL SPORT J, V32, P229, DOI 10.1123/ssj.2014-0023; TRUJILLO N, 1995, SOCIOL SPORT J, V12, P403, DOI 10.1123/ssj.12.4.403; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; VERTINSKY P, 1987, J SPORT HIST, V14, P7; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Women's Sports Foundation, 2015, HER LIF DEP IT; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	52	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-429-02817-5; 978-0-367-13450-1	ROUT RES SPORT EXERC			2020							151	169					19	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Sociology; Sport Sciences	BO8OT	WOS:000528901400009					2022-02-06	
J	Holmgren, AG; Juth, N; Lindblad, A; Von Vogelsang, AC				Holmgren, Amina Guenna; Juth, Niklas; Lindblad, Anna; Von Vogelsang, Ann-Christin			Restraint in a Neurosurgical Setting: A Mixed-Methods Study	WORLD NEUROSURGERY			English	Article						Autonomy; Nursing; Observational study; Physical restraint	NURSES DECISION-MAKING; INTENSIVE-CARE UNITS; PHYSICAL RESTRAINT; PERCEPTIONS; PREVALENCE; REDUCTION; AGITATION; INJURY	OBJECTIVE: To investigate the extent to which restraint is used in neurosurgical care, under what circumstances, and how it is documented. METHODS: A cross-sectional study with a mixed-methods approach was used to identify neurosurgical inpatients subjected to restraint. The data were collected in 2 phases: (1) a study-specific questionnaire was distributed to nurses in which they identified if restraints had occurred during their shifts, and if so, which restraint and to which patient; and (2) scrutinizing of electronic medical records of patients identified by the questionnaires. Numeric data were analyzed using descriptive and analytic statistical methods, and textual data were analyzed using qualitative content analysis. The findings from the different data sources were compared and merged. RESULTS: Of the 517 patients admitted to the studied department during the study period, 58 (11%) were reported to have been subjected to restraint and most of the restraining events occurred in the neurointensive care unit. Most restraint measures were not documented in the electronic medical records. The identified patients were predominantly diagnosed with traumatic brain injury or subarachnoid hemorrhage. The qualitative content analysis showed the circumstances when restraints were used: when patients were considered a danger to self or others (theme) and which symptoms and behaviors (categories) were observed in relation to the use of restraint. CONCLUSIONS: Restraint in neurosurgical care is mostly used to prevent patients from harming themselves or others. Because of the lack of documentation, restraint measures cannot be openly assessed, thus putting patients' safety at risk.	[Holmgren, Amina Guenna; Juth, Niklas; Lindblad, Anna] Karolinska Inst, Stockholm Ctr Healthcare Eth CHE, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Von Vogelsang, Ann-Christin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Holmgren, Amina Guenna; Von Vogelsang, Ann-Christin] Karolinska Univ Hosp, Neuro Theme, Stockholm, Sweden		Holmgren, AG (corresponding author), Karolinska Inst, Stockholm Ctr Healthcare Eth CHE, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.; Holmgren, AG (corresponding author), Karolinska Univ Hosp, Neuro Theme, Stockholm, Sweden.	amina.guenna.holmgren@ki.se	von Vogelsang, Ann-Christin/Y-2368-2019; Lindblad, Anna/AAC-1217-2021	von Vogelsang, Ann-Christin/0000-0002-3006-2443; 			Amato S, 2006, REHABIL NURS, V31, P235, DOI 10.1002/j.2048-7940.2006.tb00019.x; Barr J, 2010, AUSTRALAS J NEUROSCI, V20, P21; Benbenbishty Julie, 2010, Intensive Crit Care Nurs, V26, P241, DOI 10.1016/j.iccn.2010.08.003; Caeiro L, 2011, EUR J NEUROL, V18, P857, DOI 10.1111/j.1468-1331.2010.03271.x; Chang LY, 2008, AM J CRIT CARE, V17, P408; Chapman R, 2016, J CLIN NURS, V25, P1273, DOI 10.1111/jocn.13159; Cosper P, 2015, J NURS CARE QUAL, V30, P16, DOI 10.1097/NCQ.0000000000000074; Creswell JW., 2014, RES DESIGN QUALITATI, V4; de Casterle BD, 2015, NURS ETHICS, V22, P642, DOI 10.1177/0969733014543215; Evans D, 2003, J ADV NURS, V41, P274, DOI 10.1046/j.1365-2648.2003.02501.x; Evans David, 2002, Contemp Nurse, V13, P126; Gallinagh R, 2001, Br J Nurs, V10, P852; Goethals S, 2012, J ADV NURS, V68, P1198, DOI 10.1111/j.1365-2648.2011.05909.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grover Sandeep, 2017, J Anaesthesiol Clin Pharmacol, V33, P480, DOI 10.4103/0970-9185.222505; Hantikainen V, 2000, J ADV NURS, V32, P1196, DOI 10.1046/j.1365-2648.2000.01590.x; Hughes R, 2010, RIGHTS RISK RESTRAIN; Huizing AR, 2009, INT J NURS STUD, V46, P459, DOI 10.1016/j.ijnurstu.2008.03.005; Jiang H, 2015, NURS ETHICS, V22, P652, DOI 10.1177/0969733014557118; Kandeel NA, 2013, NURS HEALTH SCI, V15, P79, DOI 10.1111/nhs.12000; Karlsson S, 2000, J CLIN NURS, V9, P842, DOI 10.1046/j.1365-2702.2000.00442.x; Karlsson S, 2001, J AM GERIATR SOC, V49, P1722, DOI 10.1046/j.1532-5415.2001.49286.x; Kruger C, 2013, INT J NURS STUD, V50, P1599, DOI 10.1016/j.ijnurstu.2013.05.005; Lane C, 2011, INT J NURS PRACT, V17, P195, DOI 10.1111/j.1440-172X.2011.01925.x; Ljunggren G, 1997, AGE AGEING, V26, P43, DOI 10.1093/ageing/26.suppl_2.43; Matano F, 2017, WORLD NEUROSURG, V103, P424, DOI 10.1016/j.wneu.2017.03.139; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Minnick AF, 1998, J NURS ADMIN, V28, P19, DOI 10.1097/00005110-199811000-00007; Minnick AF, 2007, J NURS SCHOLARSHIP, V39, P30, DOI 10.1111/j.1547-5069.2007.00140.x; Mion LC, 2007, CRIT CARE MED, V35, P2714, DOI 10.1097/01.CCM.0000291651.12767.52; Morrison EF, 2000, J NURS CARE QUAL, V14, P72, DOI 10.1097/00001786-200004000-00009; Morshed RA, 2019, WORLD NEUROSURG, V126, pE930, DOI 10.1016/j.wneu.2019.03.012; Patton M., 2015, QUALITATIVE RES EVAL, V4; Plano Clark, 2018, DESIGNING CONDUCTING; Polit DF., 2012, NURSING RES GENERATI, V9th ed.; Reznik ME, 2017, NEUROCRIT CARE, V26, P428, DOI 10.1007/s12028-016-0331-1; Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2538; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Sjostrand M, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0029-5; Svensk forfattningssamling, 1991, LAG PSYK TVANGSV; Tannsjo T., 1999, COERCIVE CARE ETHICS; Tashakkori A, 2003, HDB MIXED METHODS SO; Turner O, 1940, Yale J Biol Med, V12, P459; Via-Clavero G, 2019, NURS ETHICS, V26, P1458, DOI 10.1177/0969733017752547; Woodward S., 2011, NEUROSCIENCE NURSING; Yeh Shu-Hui, 2004, J Nurs Res, V12, P246	46	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						104	111		10.1016/j.wneu.2019.09.105			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700179	31568917				2022-02-06	
J	Hosgorler, F; Koc, B; Kizildag, S; Canpolat, S; Argon, A; Karakilic, A; Kandis, S; Guvend, G; Ates, M; Arda, NM; Uysal, N				Hosgorler, Ferda; Koc, Basar; Kizildag, Servet; Canpolat, Selin; Argon, Asuman; Karakilic, Asli; Kandis, Sevim; Guvend, Guven; Ates, Mehmet; Arda, Nuri M.; Uysal, Nazan			Magnesium Acetyl Taurate Prevents Tissue Damage and Deterioration of Prosocial Behavior Related with Vasopressin Levels in Traumatic Brain Injured Rats	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Magnesium; Empathy; Vasopressin; Vasopressin v1b receptor; Rat	CLOSED-HEAD INJURY; SULFATE; MODEL; GENE; SUPPLEMENTATION; IMPAIRMENT; TRANSPORT; OUTCOMES; MICE	AIM: To investigate the effects of different magnesium forms on tissue damage, cognitive and emotional behavioural impairment after mild traumatic brain injury (TBI). MATERIAL and METHODS: Rats were divided into 5 groups (control, trauma, magnesium sulphate, magnesium citrate, magnesium acetyl taurate) and following head trauma, empathy-like behaviour, anxiety-like behaviour (elevated plus maze and open field tests), and depression (forced swim test) were measured. The rats were then sacrificed 12 days later. Oxytocin, vasopressin and receptors levels in the amygdala and prefrontal cortex regions were measured. Histopathological damage (with haematoxylin-eosin staining) and apoptosis (with caspase-3 immunohistochemistry) was evaluated. RESULTS: Following head trauma, anxiety-like behaviour and depression tests did not change; empathy-like behaviour deteriorated on the 3rd day and improved gradually on the 6th and 12th days. Oxytocin, vasopressin and vasopressin v1b receptor levels decreased in the amygdala; morphological damage and apoptosis were significant. Magnesium acetyl taurate effectively ameliorated histopathological deteriorations and improved vasopressin and v1b receptor levels in the amygdala. Transient deterioration of empathy-like behaviour was impeded only in magnesium taurate treatment. CONCLUSION: Magnesium acetyl taurate can be a promising candidate agent to prevent structural and functional damage in traumatic brain injury.	[Hosgorler, Ferda; Koc, Basar; Karakilic, Asli; Kandis, Sevim; Guvend, Guven; Uysal, Nazan] Dokuz Eylul Univ, Sch Med, Dept Physiol, Izmir, Turkey; [Kizildag, Servet; Ates, Mehmet] Dokuz Eylul Univ, Coll Vocat Sch Hlth Serv, Sch Med, Izmir, Turkey; [Canpolat, Selin; Argon, Asuman] Bozyaka Training & Res Hosp, Dept Pathol, Minist Hlth, Izmir, Turkey; [Arda, Nuri M.] Dokuz Eylul Univ, Sch Med, Dept Neurosurg, Izmir, Turkey		Hosgorler, F (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Physiol, Izmir, Turkey.	ferda.hosgorler@deu.edu.tr	ates, mehmet/P-4503-2019	ates, mehmet/0000-0002-8310-1979	Dokuz Eylul University Scientific Research Coordination UnitDokuz Eylul University [2018-KB]	This study was supported by the Dokuz Eylul University Scientific Research Coordination Unit (Project Number: 2018-KB.SAG.052).	Ahmadi S, 2018, MAGNESIUM RES, V31, P131, DOI 10.1684/mrh.2019.0446; Arjona FJ, 2018, J PHYSIOL-LONDON, V596, P747, DOI 10.1113/JP275249; Ates M, 2019, BIOL TRACE ELEM RES, V192, P244, DOI 10.1007/s12011-019-01663-0; Bac P, 1996, MAGNESIUM RES, V9, P281; Bac Pierre, 1993, Magnesium Research, V6, P11; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; BEYENBACH KW, 1990, MAGNESIUM TRACE ELEM, V9, P233; Bidri M., 2003, Annales Pharmaceutiques Francaises, V61, P385; Busingye DS, 2016, CNS NEUROSCI THER, V22, P854, DOI 10.1111/cns.12591; Corrigan F., 2011, MAGNESIUM CENTRAL NE; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Ghabriel MN, 2011, MAGNESIUM CENTRAL NE; Guo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05446-2; Han J. H., 2016, INT J NEUROPSYCHOPH, V19, P58; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Jakaria M, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101223; Jamilian M, 2017, MAGNESIUM RES, V30, P71, DOI 10.1684/mrh.2017.0425; Jiang YG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36332-0; Jonkman Kelly, 2017, F1000Res, V6, DOI 10.12688/f1000research.11372.1; Karakilic A, 2018, BEHAV BRAIN RES, V349, P31, DOI 10.1016/j.bbr.2018.04.043; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Kohler I, 1999, LAB ANIM, V33, P155, DOI 10.1258/002367799780578390; Lambuk L, 2017, NEUROTOX RES, V31, P31, DOI 10.1007/s12640-016-9658-9; Lee SW, 2019, CLIN EXP EMERG MED, V6, P125, DOI 10.15441/ceem.18.019; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKee JA, 2005, CRIT CARE MED, V33, P661, DOI 10.1097/01.ccm.0000156293.35868.b2; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; MYCHASIUK R, 2014, JOVE-J VIS EXP, V94, DOI [10.3791/51820, DOI 10.3791/51820]; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Sato N, 2015, ANIM COGN, V18, P1039, DOI 10.1007/s10071-015-0872-2; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Szczepankiewicz A, 2013, PSYCHIAT GENET, V23, P239, DOI 10.1097/YPG.0000000000000007; Tabak BA, 2015, PSYCHONEUROENDOCRINO, V51, P253, DOI 10.1016/j.psyneuen.2014.10.006; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; VINK R, 1988, J BIOL CHEM, V263, P757; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wu N, 2015, PSYCH J, V4, P160, DOI 10.1002/pchj.102; Yuksel O, 2019, BALK MED J, V36, P257, DOI 10.4274/balkanmedj.galenos.2019.2018.12.87; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	48	1	2	1	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2020	30	5					723	733		10.5137/1019-5149.JTN.29272-20.1			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NV6II	WOS:000574422300013	32865219	Bronze			2022-02-06	
J	Huang, GS; Dunham, CM; Chance, EA; Hileman, BM; DelloStritto, DJ				Huang, Gregory S.; Dunham, Carl M.; Chance, Elisha A.; Hileman, Barbara M.; DelloStritto, Daniel J.			Body mass index interaction effects with hyperglycemia and hypocholesterolemia modify blunt traumatic brain injury outcomes: a retrospective study	INTERNATIONAL JOURNAL OF BURNS AND TRAUMA			English	Article						Blunt trauma; body mass index; obesity; traumatic brain injury	LOW LIPID CONCENTRATIONS; HEMOGLOBIN A(1C) LEVELS; ORGAN DYSFUNCTION; PLASMA-GLUCOSE; SERUM-ALBUMIN; RISK-FACTORS; MORTALITY; OBESITY; CHOLESTEROL; IMPACT	Introduction: There is controversy regarding obesity or body mass index (BMI) effects on postinjury mortality and mechanical ventilation. The aim was to assess outcome associations with BMI and postinjury blood glucose and cholesterol. Method: Adult blunt traumatic brain injury patients admitted to a level I trauma center and requiring >= 3 days of intensive care were investigated. Admission blood glucose and day-4 total cholesterol were captured from the medical records. Cholesterol ratio was calculated by dividing day-4 values by published national normative levels according to sex, age, and injury date. Results: The parent cohort included 588 patients. The ventilator days >= 10 or died group, when compared to the ventilator days < 10 and lived group, had higher Injury Severity Score (ISS) (29.2 +/- 9.9 versus [vs.] 23.7 +/- 9.7, P < 0.0001), BMI (27.9 +/- 6.8 vs. 26.0 +/- 5.5, P = 0.0002), and admission glucose (182.6 +/- 79 vs. 155.4 +/- 59 mg/dl, P < 0.0001, n = 476) and lower emergency department Glasgow Coma Scale score (ED GCS) (6.9 +/- 4.7 vs. 10.3 +/- 5.0, P < 0.0001) and cholesterol ratio (0.64 +/- 0.2 vs. 0.70 +/- 0.2, P = 0.0018, n = 364). The ventilator days = 10 or died group had independent associations with increased ISS (P = 0.0709), decreased ED GCS (P = 0.0078), and increased BMI+cholesterol ratio (P = 0.0003). The ventilator days = 10 or died group had independent associations with increased ISS (P = 0.0013), decreased ED GCS (P < 0.0001), and increased BMI x glucose (P < 0.0001). Ventilator days were increased with higher ISS (P < 0.0001), BMI (P = 0.0014) and glucose (P = 0.0031) and with lower ED GCS (P < 0.0001) and cholesterol ratio (P = 0.0004). Ventilator days had independent associations with increased ISS (P < 0.0001), decreased ED GCS (P = 0.0041), and increased BMIocholesterol ratio (P = 0.0010). Ventilator days had independent associations with increased ISS (P < 0.0001), decreased ED GCS (P < 0.0001), and increased BMI x glucose (P = 0.0041). Conclusion: For TBI patients, valid risk assessment measurements include ISS (anatomic injury burden), ED GCS (brain function), BMI (preinjury weight status), admission glucose (postinjury metabolism), and day-4 cholesterol ratio (postinjury inflammation).	[Huang, Gregory S.; Dunham, Carl M.] St Elizabeth Youngstown Hosp, Trauma, Crit Care, Gen Surg, 1044 Belmont Ave, Youngstown, OH 44501 USA; [Chance, Elisha A.; Hileman, Barbara M.] St Elizabeth Youngstown Hosp, Trauma Neurosci Res, 1044 Belmont Ave, Youngstown, OH 44501 USA; [DelloStritto, Daniel J.] St Elizabeth Youngstown Hosp, Dept Surg, 1044 Belmont Ave, Youngstown, OH 44501 USA		Dunham, CM (corresponding author), St Elizabeth Youngstown Hosp, Trauma, Crit Care, Gen Surg, 1044 Belmont Ave, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Dunham, C. Michael/0000-0002-7842-9750			Albrecht RM, 2014, AM J SURG, V207, P391; Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Almahmoud K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217577; Andruszkow H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/345702; Bakalar B, 2003, WIEN KLIN WOCHENSCHR, V115, P775, DOI 10.1007/BF03040502; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Bonville Daniel A, 2004, Surg Infect (Larchmt), V5, P39, DOI 10.1089/109629604773860291; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cone JT, 2020, J NEUROSURG; Czorlich P, 2017, WORLD NEUROSURG, V107, P515, DOI 10.1016/j.wneu.2017.08.010; Delgado-Rodriguez M, 2002, ARCH SURG-CHICAGO, V137, P805, DOI 10.1001/archsurg.137.7.805; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Dunham CM, 2015, INT J BURNS TRAUMA, V5, P46; Dunham CM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-42; Dunham CM, 2003, CRIT CARE, V7, pR145, DOI 10.1186/cc2382; DUNHAM CM, 1994, CRIT CARE MED, V22, P667, DOI 10.1097/00003246-199404000-00024; Ebrahimpour A, 2018, IRAN J IMMUNOL, V15, P156, DOI IJIv15i2A8; Elliott DC, 1996, ANN SURG, V224, P672, DOI 10.1097/00000658-199611000-00011; Elliott DC, 1997, CRIT CARE MED, V25, P1437, DOI 10.1097/00003246-199708000-00038; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; Giovannini I, 1999, INTENS CARE MED, V25, P748, DOI 10.1007/s001340050940; Gordon BR, 1996, CRIT CARE MED, V24, P584, DOI 10.1097/00003246-199604000-00006; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Gui D, 1996, INTENS CARE MED, V22, P790, DOI 10.1007/s001340050168; Health United States, 2014, NAT CTR HLTH STAT PR, P205; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Honarmand A, 2008, ULUS TRAVMA ACIL CER, V14, P284; Husebye EE, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-2; Joseph B, 2017, OBES RES CLIN PRACT, V11, P72, DOI 10.1016/j.orcp.2016.03.003; Kopelman TR, 2008, J TRAUMA, V64, P30, DOI 10.1097/TA.0b013e318161b0ab; Liu T, 2013, INJURY, V44, P1145, DOI 10.1016/j.injury.2012.10.038; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Meyer AA, 2008, J TRAUMA, V64, P33; Newell MA, 2007, J AM COLL SURGEONS, V204, P1056, DOI 10.1016/j.jamcollsurg.2006.12.042; Osborne Z, 2014, AM J SURG, V207, P387, DOI 10.1016/j.amjsurg.2013.10.013; Palma S, 2007, BRIT J SURG, V94, P369, DOI 10.1002/bjs.5626; Schierend M, 2019, INJURY, V50, P96, DOI 10.1016/j.injury.2018.09.051; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Stachon A, 2000, CLIN CHEM, V46, P1114; Talmor M, 1999, ARCH SURG-CHICAGO, V134, P81, DOI 10.1001/archsurg.134.1.81; Tracy BM, 2020, J AM COLL SURGEONS, V230, P145, DOI 10.1016/j.jamcollsurg.2019.09.009; Treto K, 2017, AM SURGEON, V83, P341; Vanni HEC, 2003, J BURN CARE REHABIL, V24, P133, DOI 10.1097/01.BCR.0000066812.96811.28; Vyroubal P, 2008, BIOMED PAP, V152, P181, DOI 10.5507/bp.2008.029; Winfield RD, 2010, CRIT CARE MED, V38, P51, DOI 10.1097/CCM.0b013e3181b08089; WOLFRAM G, 1980, KLIN WOCHENSCHR, V58, P1327, DOI 10.1007/BF01477730	52	1	1	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-2026			INT J BURNS TRAUMA	Int. J. Burns Trauma		2020	10	6					314	323					10	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	PT1PM	WOS:000608391200004	33500843				2022-02-06	
J	Huibregtse, ME; Zonner, SW; Ejima, K; Bevilacqua, ZW; Newman, SD; Macy, JT; Kawata, K				Huibregtse, Megan E.; Zonner, Steven W.; Ejima, Keisuke; Bevilacqua, Zachary W.; Newman, Sharlene D.; Macy, Jonathan T.; Kawata, Keisuke			Association between Muscle Damage and Head Impacts in High School American Football	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						exercise physiology; subconcussive head impacts; creatine kinase	SERUM NEUROFILAMENT LIGHT; CREATINE-KINASE; BRAIN-INJURY; COLLEGIATE; EXERCISE; PLAYERS; EXPOSURE; SEASON	Subconcussive head impacts (SHI), defined as impacts to the cranium that do not result in concussion symptoms, are gaining traction as a major public health concern. The contribution of physiological factors such as physical exertion and muscle damage to SHI-dependent changes in neurological measures remains unknown. A prospective longitudinal study examined the association between physiological factors and SHI kinematics in 15 high school American football players over one season. Players wore a sensor-installed mouthguard for all practices and games, recording frequency and magnitude of all head impacts. Serum samples were collected at 12 time points (pre-season, pre- and post-game for five in-season games, and post-season) and were assessed for an isoenzyme of creatine kinase (CK-MM) primarily found in skeletal muscle. Physical exertion was estimated in the form of excess post-exercise oxygen consumption (EPOC) from heart rate data captured during the five games. Mixed-effect regression models indicated that head impact kinematics were significantly and positively associated with change in CK-MM but not EPOC. There was a significant and positive association between CK-MM and EPOC. These data suggest that when examining SHI, effects of skeletal muscle damage should be considered when using outcome measures that may have an interaction with muscle damage.	[Huibregtse, Megan E.; Bevilacqua, Zachary W.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, 1025 E 7th St,Ste 112, Bloomington, IN 47405 USA; [Zonner, Steven W.] Washington Township Med Fdn, Dept Sports Med, Union, NJ USA; [Ejima, Keisuke] Indiana Univ, Dept Epidemiol, Bloomington, IN 47405 USA; [Ejima, Keisuke] Indiana Univ, Dept Biostat, Bloomington, IN 47405 USA; [Newman, Sharlene D.] Indiana Univ, Dept Psychol Sci, Bloomington, IN 47405 USA; [Newman, Sharlene D.] Indiana Univ, Dept Brain Sci, Bloomington, IN 47405 USA; [Newman, Sharlene D.; Kawata, Keisuke] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Macy, Jonathan T.] Indiana Univ, Dept Appl Hlth Sci, Bloomington, IN 47405 USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, 1025 E 7th St,Ste 112, Bloomington, IN 47405 USA.	kkawata@indiana.edu					Abd-Elfattah HM, 2015, J ADV RES, V6, P351, DOI 10.1016/j.jare.2015.01.011; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Borsheim E, 2003, SPORTS MED, V33, P1037; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; GAESSER GA, 1984, MED SCI SPORT EXER, V16, P29; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gleason BH, 2017, J STRENGTH COND RES, V31, P2183, DOI 10.1519/JSC.0000000000001691; Godek SF, 2005, BRIT J SPORT MED, V39, P205, DOI 10.1136/bjsm.2004.011767; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Hoffman JR, 2005, MED SCI SPORT EXER, V37, P1237, DOI 10.1249/01.mss.0000170068.97498.26; Hoffman JR, 2002, MED SCI SPORT EXER, V34, P1845, DOI 10.1097/00005768-200211000-00023; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Iosia MF, 2008, J STRENGTH COND RES, V22, P332, DOI 10.1519/JSC.0b013e31816607b0; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kendall B, 2002, SPORTS MED, V32, P103, DOI 10.2165/00007256-200232020-00003; Khan Muzaffar Ahmad, 2016, J Phys Ther Sci, V28, P2942; Kraemer WJ, 2013, J STRENGTH COND RES, V27, P434, DOI 10.1519/JSC.0b013e318281d1b0; LANG H, 1982, CLIN CHEM, V28, P1439; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pincivero DM, 1997, SPORTS MED, V23, P247, DOI 10.2165/00007256-199723040-00004; Rhea MR, 2006, J STRENGTH COND RES, V20, P58, DOI 10.1519/00124278-200602000-00010; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHUMATE JB, 1979, NEUROLOGY, V29, P902, DOI 10.1212/WNL.29.6.902; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smolander J, 2011, CLIN PHYSIOL FUNCT I, V31, P266, DOI 10.1111/j.1475-097X.2011.01011.x; Stone JD, 2019, J STRENGTH COND RES, V33, P2481, DOI 10.1519/JSC.0000000000001920; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; WALLIMANN T, 1984, J BIOL CHEM, V259, P5238; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	51	1	1	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	JAN	2020	41	1					36	43		10.1055/a-1021-1735			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KA3OK	WOS:000505707900005	31747699				2022-02-06	
J	John, S; Dechamma, S				John, Stanley; Dechamma, Shruthi			An electronystagmographic study in post head injury vertigo patients	INDIAN JOURNAL OF OTOLOGY			English	Article						Central lesion; Claussen's butterfly chart; electronystagmography; ENG code; peripheral lesion; post head injury vertigo		Vertigo is a well-known sequelae in post head injury patients. Etiopathology is multifactorial. Vertigo is recognized in all types of head injury-mild-to-severe and is a part of the post-concussion syndrome. However, it may also present later due to degenerative process involving the vestibular system. The observations made by the analysis of the tracings of electronystagmography and by noting the corresponding code we can identify the site and side of the vestibular lesion. The present study intends to understand post head injury vertigo using electronystagmography. Objectives of the Study: To evaluate post head injury vertigo using electronystagmography, to determine the side and site of origin of vertigo, and to localize the level of lesion - peripheral, central, or combined. Methodology: Fifty patients with post head injury vertigo presenting to ENT OPD of Dr. B. R. Ambedkar Medical College and Hospital were included in the study after taking their consent. Observations and Results: Fifty patients with post head injury vertigo were subjected to electronystagmography. Young adults between the age group of 20 and 30 years were found to be the most common group involved, constituted 34% of the patients. Equal gender predisposition was observed. 1111 ENG CODE was found to be the most common type seen in 18% of the cases, followed by 0000 in 16% of patients, and 0222 seen in 16% of the patients. Bilateral peripheral lesion was the most common type seen in 36% of patients followed by unilateral peripheral lesion in 20% of patients, central lesion in 22%, and normal in 20%. Conclusion: Electronystagmography is an effective tool in the assessment of post head injury vertigo. It is useful in identifying the cause of vertigo and to localize the lesion for timely management and early vestibular rehabilitation of the patient providing better clinical outcome.	[John, Stanley; Dechamma, Shruthi] DR BRAMCH, Dept ENT, Bangalore, Karnataka, India		Dechamma, S (corresponding author), 293,4th Main,4th Cross, Bengaluru 560024, Karnataka, India.	shruthi_dechu@yahoo.co.in					Benson BE, POSTTRAUMATIC VERTIG; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kirtane MV, 1982, CLIN AUDIO VESTIBULO, P180; Moulin T, 2003, EUR NEUROL, V50, P207, DOI 10.1159/000073861; Pathak A, 2007, INDIAN J NEUROTRAUM, V4, P31, DOI 10.1016/S0973-0508(07)80008-6; Sarma AC, 2014, J NEBAO HNSI, V8, P19; Schappert SM, 1999, VITAL HLTH STAT, V142, P1; Thomson S, 2013, IEEE T SOFTWARE ENG, P1	8	1	1	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0971-7749	2249-9520		INDIAN J OTOL	Indian J. Otol.	JAN-MAR	2020	26	1					27	31		10.4103/indianjotol.INDIANJOTOL_7_19			5	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	KU5IW	WOS:000519744900006					2022-02-06	
S	Kabadi, SV; Byrnes, KR		Wright, NJD		Kabadi, Shruti V.; Byrnes, Kimberly R.			Assessment of Behavioral Dysfunction Following Experimental Traumatic Brain Injury (TBI)	BASIC NEUROBIOLOGY TECHNIQUES	Neuromethods		English	Article; Book Chapter						Fluid percussion; Controlled cortical impact; Diffuse axonal injury; Rotational acceleration; Blast injury; Beam walk; Morris water maze; Elevated plus maze; Open field; Novel object recognition; Statistical analysis	FEAR-POTENTIATED STARTLE; FOCAL CEREBRAL-ISCHEMIA; MORRIS WATER MAZE; HEAD IMPACT MODEL; PREPULSE INHIBITION; CONDITIONED INHIBITION; FUNCTIONAL RECOVERY; CDK INHIBITOR; OPEN-FIELD; MILD	Traumatic brain injury (TBI) is a major public health concern, as it is one of the leading causes of death and disability in the USA. Over the years, several attempts have been made to reconstruct the pathophysiological events that occur during a TBI and the behavioral abnormalities that are observed in TBI survivors. Such behavioral deficits lead to long-term neurological dysfunction and often demonstrate symptoms of chronic neurodegenerative disorders known to impair the quality of life of the patients. For example, TBI patients often suffer from learning disability and memory loss similar to that observed in cases of Alzheimer's disease, motor dysfunction seen in Parkinson's disease cases, and changes in mood and emotional behavior noted in patients with anxiety and depression. Although science in the field of TBI research has shown tremendous progress and advancement, more recently, trials of therapeutic agents that have shown promise in preclinical settings have consistently failed to demonstrate improvement in behavioral outcomes after clinical TBI. Therefore, there is an urgent need to develop new models while continuing to refine existing approaches used for modeling experimental TBI and related behavioral impairment. In this chapter, we describe the concept, key features, and methodology of some of the most commonly used animal models for inducing experimental TBI and evaluating behavioral dysfunction. In addition to detailing the application of different animal models, we evaluate their relevance to clinical symptoms by examining their advantages and limitations. We acknowledge that the events that occur during and after a clinical TBI are multifactorial in nature. Therefore, while developing and utilizing such animal models, it is important to focus on the diversity of the mechanisms involved in the impact during the injury, and the complexity of the secondary injury processes that lead to long-term behavioral dysfunction.	[Kabadi, Shruti V.] US FDA, Ctr Food Safety & Appl Nutr CFSAN, College Pk, MD 20740 USA; [Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA		Kabadi, SV (corresponding author), US FDA, Ctr Food Safety & Appl Nutr CFSAN, College Pk, MD 20740 USA.				Uniformed Services University Rat Behavioral Core; Uniformed Services University Center for Neuroscience and Regenerative Medicine	This work was supported by the Uniformed Services University Rat Behavioral Core and the Center for Neuroscience and Regenerative Medicine.	Acabchuk Rebecca, 2016, Concussion, V1, DOI 10.2217/cnc-2015-0001; Agoston D.V., 2015, BRAIN NEUROTRAUMA MO; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bakker J, 2002, HORM BEHAV, V42, P158, DOI 10.1006/hbeh.2002.1805; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Berkner J, 2016, METHODS MOL BIOL, V1462, P11, DOI 10.1007/978-1-4939-3816-2_2; Bevins RA, 2005, NEUROSCI BIOBEHAV R, V29, P707, DOI 10.1016/j.neubiorev.2005.03.013; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Brabazon F, 2017, J NEUROTRAUM, V34, P1074, DOI 10.1089/neu.2016.4540; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; CASTON J, 1995, NEUROBIOL LEARN MEM, V64, P195, DOI 10.1006/nlme.1995.0002; Centers for Disease Control and Prevention (CDC), 2010, NAT HOSP DISCH SURV; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chiarotti Flavia, 2005, Curr Protoc Toxicol, VChapter 13, DOI 10.1002/0471140856.tx1308s25; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00338; Du Y, 2010, BEHAV BRAIN RES, V206, P192, DOI 10.1016/j.bbr.2009.09.012; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; FERGUSON SA, 1990, NEUROTOXICOL TERATOL, V12, P91, DOI 10.1016/0892-0362(90)90118-V; Festing Michael F W, 2002, ILAR J, V43, P244; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Frieden TRH D., 2013, TRAUMATIC BRAIN INJU; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Goldstein LB, 2003, ILAR J, V44, P125, DOI 10.1093/ilar.44.2.125; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Hutter-Saunders JAL, 2012, J NEUROIMMUNE PHARM, V7, P279, DOI 10.1007/s11481-011-9269-4; Ijomone OM, 2014, ANN NEUROSCI, V21, P42, DOI 10.5214/ans.0972.7531.210203; Ishii D, 2010, PROG NEURO-PSYCHOPH, V34, P183, DOI 10.1016/j.pnpbp.2009.10.023; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kabadi SV, 2014, NEURAL REGEN RES, V9, P1578, DOI 10.4103/1673-5374.141779; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kazama AM, 2012, BEHAV NEUROSCI, V126, P392, DOI 10.1037/a0028241; Kinnavane L, 2015, BEHAV BRAIN RES, V285, P67, DOI 10.1016/j.bbr.2014.07.049; Klejbor I, 2013, FOLIA MORPHOL, V72, P300, DOI 10.5603/FM.2013.0050; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lacreuse A, 2005, NEUROBIOL AGING, V26, P543, DOI 10.1016/j.neurobiolaging.2004.05.007; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Li NX, 2008, BEHAV NEUROSCI, V122, P107, DOI 10.1037/0735-7044.122.1.107; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lucke-Wold BP, 2017, J NEUROTRAUM, V34, pS62, DOI 10.1089/neu.2016.4680; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McCabe JT, 2014, ULTRASOUND MED BIOL, V40, P965, DOI 10.1016/j.ultrasmedbio.2013.11.023; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; MURPHY MP, 1995, NEUROBIOL LEARN MEM, V64, P181, DOI 10.1006/nlme.1995.1057; Myers K, 2004, PSYCHOPHARMACOLOGY, V172, P94, DOI 10.1007/s00213-003-1633-5; Myers KM, 2004, LEARN MEMORY, V11, P464, DOI 10.1101/lm.74704; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Peissig JJ, 2007, CEREB CORTEX, V17, P1323, DOI 10.1093/cercor/bhl043; Pessiglione M, 2003, BRAIN, V126, P1392, DOI 10.1093/brain/awg139; Philippens IHCHM, 2000, BEHAV RES METH INS C, V32, P173, DOI 10.3758/BF03200799; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Prange AJ, 1999, PSYCHOSOM MED, V61, P139, DOI 10.1097/00006842-199903000-00002; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; RESCORLA RA, 1969, J COMP PHYSIOL PSYCH, V67, P504, DOI 10.1037/h0027313; Rostami E, 2016, METHODS MOL BIOL, V1462, P47, DOI 10.1007/978-1-4939-3816-2_4; Satoh Y, 2011, J NEUROSCI, V31, P11953, DOI 10.1523/JNEUROSCI.2349-11.2011; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Shoji H, 2012, JOVE-J VIS EXP, DOI 10.3791/3300; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sutcliffe JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102449; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, NEUROTOXICOL TERATOL, V45, P75, DOI 10.1016/j.ntt.2014.07.003; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Wu Y-C, 2017, FOOD TOXICOLOGY CURR, P495; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8; Yonemori F, 2000, J CEREBR BLOOD F MET, V20, P74, DOI 10.1097/00004647-200001000-00011; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	123	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	0893-2336	1940-6045	978-1-4939-9944-6; 978-1-4939-9943-9	NEUROMETHODS	Neuromethods		2020	152						315	349		10.1007/978-1-4939-9944-6_13	10.1007/978-1-4939-9944-6		35	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BP7LL	WOS:000562486700015					2022-02-06	
J	Karaca, O; Dogan, G				Karaca, Onur; Dogan, Guvenc			The effects of dexmedetomidine in increased intestinal permeability after traumatic brain injury: An experimental study	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Dexmedetomidine; intestinal mucosa damage; intestinal permeability; traumatic brain injury	ENDOTOXIN-INDUCED SHOCK; INFLAMMATORY RESPONSES; DYSFUNCTION; MORTALITY	BACKGROUND: This study aims to investigate whether or not dexmedetomidine (DEX) application affects inflammation, increased intestinal mucosa damage and intestinal permeability in traumatic brain injury (TBI). METHODS: The rats included in our study were randomized into three groups as the control group (Group 1, n= 10), trauma group (Group 2, n=10) and the trauma+dexmedetomidine group (Group 3, n=10). While trauma was not induced in the control group, head trauma was induced in all rats in Groups 2 and 3 with the same method. The rats in Group 3 additionally received the DEX application. Intestinal THE-a, serum TNF-a, IL-6, IL- 1b and D-lactate levels were measured six hours post-trauma to assess systemic and local infection. Histopathological evaluation of the terminal ileum was performed at the 6th hour to assess mucosal damage. Intestinal permeability was evaluated by measuring the level of dextran injected into the 5-cm ileum segment adhered to the proximal and distal edges at the 30th minute in the blood taken by cardiac puncture. RESULTS: Intestinal TNF-a (p=0.003), serum TNF-a (p=0.009), IL-6 (p=0.002), IL-1b (p=0.001), and D-lactate levels measured in Group 3 (p=0.046) were significantly lower than those measured in Group 2. Dextran level measured in blood in Group 3 was observed significantly lower than that of Group 2 (p<0.001). Histopathological evaluation of the intestines revealed no injuries in the ileum of the rats in Group I, injury in the ileum, villus atrophy and mucosal damage in the rats in Group 2, and a significant recovery was observed in Group 3 in comparison to Group 2. CONCLUSION: It was seen in our study that DEX reduced TBI-induced increased inflammation, intestinal mucosa damage and intestinal permeability. These results suggest that DEX may ameliorate the damage done to the intestinal tissue by modulating post-TBI inflammatory responses.	[Karaca, Onur] Aksaray Univ, Dept Anesthesiol & Reanimat, Fac Med, Aksaray, Turkey; [Dogan, Guvenc] Hitit Univ, Dept Anesthesiol & Reanimat, Fac Med, Corum, Turkey		Karaca, O (corresponding author), Aksaray Univ, Egitim & Arasurna Hastanesi, Anesteziyoloji Anabilim Dali, TR-68200 Aksaray, Turkey.	asalkaraca@gmail.com					Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Chen YQ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/918361; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Dilmen OK, 2015, TURK J ANAESTHESIOL, V43, P1, DOI 10.5152/TJAR.2014.26680; Dogan G, 2019, J PEDIATR SURG, V54, P2172, DOI 10.1016/j.jpedsurg.2019.02.011; Eser O, 2008, BRAIN RES, V1218, P250, DOI 10.1016/j.brainres.2008.04.045; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Kayhan GE, 2013, J SURG RES, V183, P733, DOI 10.1016/j.jss.2013.03.028; Kemp CD, 2008, AM SURGEON, V74, P866; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li B, 2015, SCI REP-UK, V5, DOI 10.1038/srep12342; Lin CY, 2010, BRIT J ANAESTH, V104, P44, DOI 10.1093/bja/aep336; Lorenz I, 2006, J VET MED A, V53, P490, DOI 10.1111/j.1439-0442.2006.00863.x; Brandao PGM, 2016, BRAZ J CARDIOVA SURG, V31, P213, DOI 10.5935/1678-9741.20160043; Memis D, 2007, BRIT J ANAESTH, V98, P550, DOI 10.1093/bja/aem017; Ozkan N, 2018, ULUS TRAVMA ACIL CER, V24, P1, DOI 10.5505/tjtes.2017.23539; Sun Y, 2015, EXP THER MED, V10, P647, DOI 10.3892/etm.2015.2561; Tamion F, 2002, AM J PHYSIOL-GASTR L, V283, pG408, DOI 10.1152/ajpgi.00348.2001; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Taniguchi T, 2008, J ANESTH, V22, P221, DOI 10.1007/s00540-008-0611-9; Venn RM, 1999, ANAESTHESIA, V54, P1136, DOI 10.1046/j.1365-2044.1999.01114.x	24	1	2	0	3	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JAN	2020	26	1					15	20		10.14744/tjtes.2019.49768			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KC9MN	WOS:000507495500003	31942739	hybrid			2022-02-06	
J	Keenan, RP; Lovanio, K; Lapidus, G; Chenard, D; Smith, S				Keenan, Ryan P.; Lovanio, Kathleen; Lapidus, Garry; Chenard, Danielle; Smith, Sharon			Improved Concussion Discharge Instructions in a Pediatric Emergency Department	ADVANCED EMERGENCY NURSING JOURNAL			English	Article						concussion; discharge instructions; emergency department; pediatric	KNOWLEDGE; SPORT; MANAGEMENT	Pediatric concussions are common and many children seek care in emergency departments. Providing concussion discharge instructions to patients and families is part of routine standard of care. The objective of this study was to determine whether the use of the Acute Concussion Evaluation-Emergency Department Discharge Instructions (ACE-ED DI) improves the caregiver's knowledge of injury management, specifics about returning to school and sports activities, and outpatient follow-up. This was a quasi-experimental study conducted in an urban Level 1 trauma center pediatric emergency department (PED). A convenience sample of caregivers of children aged 5-18 years who presented to the PED with a concussion was recruited and consented to participate. Caregivers completed a 16-item survey to assess overall understanding of concussion management after instructions were given. Caregivers received the standard discharge instructions (SDIs) in Phase 1 and SDIs plus the ACE-ED DI in Phase 2. Descriptive statistics were used for demographic variables and t-test to compare groups. Sixty-three of 68 (93%) caregivers participated; 30 in the SDI group and 33 in the SDI plus ACE-ED DI group. Demographic characteristics were similar between groups. Caregivers who received the ACE-ED DI reported a 24% increase in helpfulness of written materials (p < 0.001), a 25% increase in perceived understanding about concussion injury and management (p < 0.001), a 23% increase in understanding about returning to school activities (p < 0.001), and were 17% more likely to follow up with their primary care provider (p < 0.001). The ACE-ED DI used in a PED was found to be more effective at increasing caregivers' perceived knowledge of concussion management, specifics about returning to school and sports activities, and outpatient follow-up.	[Keenan, Ryan P.; Lapidus, Garry; Chenard, Danielle; Smith, Sharon] Connecticut Childrens Med Ctr, Emergency Dept, Hartford, CT 06106 USA; [Lapidus, Garry] Connecticut Childrens Med Ctr, Injury Prevent Ctr, Hartford, CT 06106 USA; [Lovanio, Kathleen] Fairfield Unin, Fairfield, CT 06824 USA		Keenan, RP (corresponding author), Connecticut Childrens Med Ctr, 282 Washington St, Hartford, CT 06106 USA.	RKeenan@Connecticutchildrens.org			Connecticut Nurses' Foundation Research Grant Award	Funding was provided by the Connecticut Nurses' Foundation Research Grant Award.	Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chew LD, 2004, FAM MED, V36, P588; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2012, PEDIATR ANN, V41, P198, DOI 10.3928/00904481-20120426-10; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Lane AD, 2017, J EMERG MED, V52, P690, DOI 10.1016/j.jemermed.2016.12.017; Lin MJ, 2015, INTERN EMERG MED, V10, P993, DOI 10.1007/s11739-015-1311-8; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	20	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1931-4485	1931-4493		ADV EMERG NURS J	Adv. Emerg. Nurs. J.	JAN-MAR	2020	42	1					63	70		10.1097/TME.0000000000000280			8	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	KL0TK	WOS:000513145300009	32000192				2022-02-06	
J	Kerr, SH; Vargas, TM; Nakajima, M; Becker, J				Kerr, Sean H.; Vargas, Tiffanye M.; Nakajima, Mimi; Becker, Jim			Examining Youth American Football Coaches' Knowledge of, and Attitudes Toward, Sport Concussions	INTERNATIONAL SPORT COACHING JOURNAL			English	Article						coaching education; youth sport safety; youth sports	HIGH-SCHOOL; COLLEGIATE; EPIDEMIOLOGY; IMPACT; HEADS	The purpose of this exploratory study was to examine youth American football coaches and their knowledge of, and attitudes toward, sport concussions. Coaches (n = 103) were recruited from a randomized sample of Pop Warner leagues within a large Western state to complete the Rosenbaum Concussion Knowledge and Attitudes Survey. Coaches ranged from 25-75 years of age and were coaching youth athletes ranging from 6-14 years of age. Coaches scored in the 80th percentile on concussion knowledge, and in the 85th percentile on concussion attitudes. However, coaches were lacking in some areas of concussion knowledge such as concussion symptomology. There was also a statistically significant positive correlation between coaches' scores on the Concussion Knowledge Index and the Concussion Attitudes Index, r= .43, p< .01. The results of this research indicate that while youth sport coaches report basic knowledge of concussions, there remain gaps in their education. This highlights the need for research to review current coaching curriculum, observe actual coaching behaviors, and to determine best practices for teaching coaches.	[Kerr, Sean H.; Vargas, Tiffanye M.; Nakajima, Mimi] Calif State Univ Long Beach, Dept Kinesiol, Long Beach, CA 90840 USA; [Becker, Jim] Montana State Univ, Bozeman, MT 59717 USA		Vargas, TM (corresponding author), Calif State Univ Long Beach, Dept Kinesiol, Long Beach, CA 90840 USA.	Tiffanye.vargas@csulb.edu					Allan V, 2018, INT REV SPORT EXER P, V11, P47, DOI [10.1080/1750984X.2017.1286514, 10.1080/1750984x.2017.1286514]; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Casebeer L, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-37; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lystad Reidar P, 2018, Inj Epidemiol, V5, P25, DOI 10.1186/s40621-018-0155-x; McCallister S.G., 2000, INT SPORTS J, V4, P9; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Shroyer J, 2016, PHYS EDUC-US, V73, P373, DOI 10.18666/TPE-2016-V73-I2-6298; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; [No title captured]	29	1	1	1	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2328-918X	2328-9198		INT SPORT COACH J	Int. Sport Coach J.	JAN	2020	7	1					31	38		10.1123/iscj.2018-0030			8	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	LY1VW	WOS:000540310500004					2022-02-06	
J	Khoshfetrat, M; Yaghoubi, MA; Hosseini, BMK; Farahmandrad, R				Khoshfetrat, Masoum; Yaghoubi, Mostafa Arab; Hosseini, Bibi Mahdie Khodadadi; Farahmandrad, Reza			The ability of GCS, FOUR, and APACHE II in predicting the outcome of patients with traumatic brain injury: A comparative study	BIOMEDICAL RESEARCH AND THERAPY			English	Article						FOUR; Glasgow Coma Scale; APACHE II; Traumatic Brain Injury; Karnofsky scale; Intensive care unit	GLASGOW COMA SCALE; INTENSIVE-CARE-UNIT; IMPAIRED CONSCIOUSNESS; FULL OUTLINE; SCORE; RELIABILITY; MORTALITY	Introduction: Assessment of the neurological condition of patients admitted to intensive care units gives healthcare professionals the necessary knowledge to attempt to improve their condition and final outcome. Such an assessment cannot be done without a highly reliable and accurate instrument. This study aimed to compare the ability of GCS and FOUR scales to assess the level of consciousness and dysfunction in patients with traumatic brain injury. Methods: This descriptive cross-sectional study was conducted on 102 patients with traumatic brain injury who were found by convenience sampling. The condition of patients during hospitalization up until determination of the final outcome was assessed using GCS, FOUR, Karnofsky, and APACHE-II scales. In the end, the ability of these scales to predict outcome and dysfunction of these patients, and their correlation in this application, was measured using one-way ANOVA and the Pearson correlation test. Results: Of the 102 patients, 80 (78.4%) were male, and 22 (21.6%) were female. The mean age of patients was 32.2 +/- 14.8. There was a significant correlation between the results of FOUR and GCS in the assessment of the patients' consciousness level (r = 0.925), which was statistically significant (p = 0.0001). The mean scores of FOUR, GCS, and Karnofsky scales were significantly higher in survivors and in patients with neurological deficits than in non-surviving patients. The patients who died also had a significantly higher APACHE-II score than those who did not. FOUR and GCS showed a strong positive correlation in the assessment of outcomes, and both of them also exhibited a high correlation with APACHE II in this respect. Conclusion: GCS and FOUR are both suitable scales for assessing consciousness level and outcome of patients with traumatic brain injury.	[Khoshfetrat, Masoum] Zahedan Univ Med Sci, Khatam Al Anbiya Hosp, Dept Anesthesiol & Crit Care, Crit Care Med FCCM, Zahedan, Iran; [Yaghoubi, Mostafa Arab] Zabol Univ Med Sci, Dept Anesthesiol & Crit Care, Zabol, Iran; [Hosseini, Bibi Mahdie Khodadadi] Mashhad Univ Med Sci, Imam Reza Hosp, Mashhad, Razavi Khorasan, Iran; [Farahmandrad, Reza] Iran Univ Med Sci, Dept Anesthesiol & Crit Care, Tehran, Iran		Khoshfetrat, M (corresponding author), Zahedan Univ Med Sci, Khatam Al Anbiya Hosp, Dept Anesthesiol & Crit Care, Crit Care Med FCCM, Zahedan, Iran.	drkhoshfetrat@yahoo.com			Zahedan University of Medical Sciences, Zahedan, Iran	The present study was financially supported by Zahedan University of Medical Sciences, Zahedan, Iran.	Akavipat P, 2011, ACTA MED OKAYAMA, V65, P205; Ayazoglu TA, 2011, ANAESTH PAIN INTENSI, V15, P7; Bakhtiari S, 2014, COMP GCS 4 SCORE PRE, V3, P85; BORN JD, 1982, NEUROCHIRURGIE, V28, P1; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Chambless LB, 2015, J NEURO-ONCOL, V121, P359, DOI 10.1007/s11060-014-1640-x; Cho DY, 1997, INTENS CARE MED, V23, P77, DOI 10.1007/s001340050294; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hosseini M, 2015, SAUDI J ANAESTH, V9, P136, DOI 10.4103/1658-354X.152839; Iyer V.N., 2009, MAYO CLIN P; Jalali R, 2014, CRITICAL CARE RES PR, V2014, P1, DOI DOI 10.1155/2014/289803; Keykha A, 2017, J CRITICAL CARE NURS, V10, DOI 10.5812/ccn.10160; Khajeh A, 2014, IRAN J PEDIATR, V24, P603; Marino P., 2014, MARINOS THE ICU BOOK; MOR V, 1984, CANCER, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Tadrisi SD, 2012, IRAN J CRIT CARE NUR, V5, P95; TEASDALE G, 1974, LANCET, V2, P81; Wagner D P, 1984, Health Care Financ Rev, VSuppl, P91; Wijdicks EFM, 1998, J NEUROL NEUROSUR PS, V64, P117, DOI 10.1136/jnnp.64.1.117; Wolf CA, 2007, MAYO CLIN P	24	1	1	1	1	BIOMEDPRESS	HO CHI MINH	BIOMEDPRESS, HO CHI MINH, 00000, VIETNAM	2198-4093			BIOMED RES THER	Biomed. Res. Ther.		2020	7	2					3614	3621		10.15419/bmrat.v7i2.588			8	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	KS6GI	WOS:000518404900002		gold			2022-02-06	
J	Kilicarslan, B; Kilicarslan, E; Kizmazoglu, C; Aydin, HE; Kaya, I; Danyeli, AE; Karabekir, HS				Kilicarslan, Bilal; Kilicarslan, Emel; Kizmazoglu, Ceren; Aydin, Hasan Emre; Kaya, Ismail; Danyeli, Ayca Ersen; Karabekir, Hamit Selim			Evaluation of the Efficacy of SiIdenafil Citrate Following Severe Head Trauma in an Experimental Rat Model	TURKISH NEUROSURGERY			English	Article; Proceedings Paper	16th World Congress of Neurosurgery of the World-Federation-of-Neurosurgical-Societies (WFNS)	AUG 20-25, 2017	Istanbul, TURKEY	World Federat Neurosurg Soc		Sildenafil citrate; Mannitol; Severe head trauma; Rat	DIFFUSE BRAIN-INJURY; CEREBRAL VASOSPASM; FUNCTIONAL RECOVERY; CYCLIC-GMP; SILDENAFIL; TERM; INHIBITION; MANNITOL; HYPOPERFUSION; TADALAFIL	AIM: To investigate the acute effects of sildenafil citrate in an experimental model of severe head trauma, and to compare it with the efficacy of mannitol, which is an osmotically active agent frequently used in clinical treatment of traumatic brain injury (TBI). MATERIAL and METHODS: Twenty-eight Wistar-derived albino strain female rats were randomized into four groups comprising seven rats each. These groups were designated as follows: Group I: sham; Group II: TBI; Group II: TBI + mannitol (20% 1 gr/kg, intraperitoneal); and Group IV: TBI + sildenafil citrate (10 mg/kg, intraperitoneal). Sections prepared following the tissue processing of samples obtained from the right prefrontal cortex and right hippocampal regions of the brains of sacrificed rats were histopathologically evaluated. Fractionator method via the Stereo Investigator software program (Micro Bright Field) was used to count the neurons. Pyknotic neuron count and pyknotic /total neuron count were compared between the groups. RESULTS: Inthe comparison of Group IIand IV,pyknotic neuron count (prefrontal; group II: 116.00 + 30.50, group IV: 80.00 +/- 19.47) and pyknotic/total neuron count (prefrontal; group I10:,30 +/- 0.08, group IV: 0.21 +/- 0.02) were significantly lower in Group IV in both regions (p<0.05). Similarly, in the comparison of Group IIand III, the values in Group III were lower in both regions (p<0.05). CONCLUSION: Sildenafil citrate decreases neuronal death in the acute phase and produces similar results with mannitol. Therefore, we believe that sildenafil citrate can be a useful adjunct or alternative agent for the clinical treatment of patients with acute TBI.	[Kilicarslan, Bilal] Bitlis Tatvan State Hosp, Dept Neurosurg, Bitlis, Turkey; [Kilicarslan, Emel] Bitlis Tatvan State Hosp, Dept Pathol, Bitlis, Turkey; [Kizmazoglu, Ceren; Karabekir, Hamit Selim] Dokuz Eylul Univ, Sch Med, Dept Neurosurg, Izmir, Turkey; [Aydin, Hasan Emre; Kaya, Ismail] Dumlupinar Univ, Evliya Celebi Training & Res Hosp, Dept Neurosurg, Kutahya, Turkey; [Danyeli, Ayca Ersen] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Pathol, Istanbul, Turkey		Kilicarslan, B (corresponding author), Bitlis Tatvan State Hosp, Dept Neurosurg, Bitlis, Turkey.	drkilicarslan@gmail.com	Aydin, Hasan Emre/AAA-4657-2021	Aydin, Hasan Emre/0000-0002-8932-1542	Turkish Neurosurgical Society	Preparation for publication of this article is partly supported by Turkish Neurosurgical Society.	Atalay B, 2006, NEUROSURGERY, V59, P1102, DOI 10.1227/01.NEU.0000245605.22817.44; Benjamins JA, 2007, NEUROCHEM RES, V32, P321, DOI 10.1007/s11064-006-9187-7; Bivalacque TJ, 2000, TRENDS PHARMACOL SCI, V21, P484, DOI 10.1016/S0165-6147(00)01587-X; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Charriaut-Marlangue C, 2014, STROKE, V45, P850, DOI 10.1161/STROKEAHA.113.003606; Chen XM, 2014, CNS NEUROSCI THER, V20, P40, DOI 10.1111/cns.12162; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DeWitt D S, 1995, New Horiz, V3, P376; Dhar R, 2016, NEUROCRIT CARE, V25, P201, DOI 10.1007/s12028-016-0243-0; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Golub VM, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00196, 10.3389/fnagi.2015.00196]; Han BH, 2012, NEUROSURGERY, V70, P178, DOI 10.1227/NEU.0b013e31822ec2b0; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kara H, 2015, BOSNIAN J BASIC MED, V15, P38, DOI 10.17305/bjbms.2015.1.119; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kramer DR, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/415813; Luvisotto TL, 1996, NEUROSURGERY, V38, P131, DOI 10.1097/00006123-199601000-00031; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Ozdegirmenci O, 2011, J MATERN-FETAL NEO M, V24, P317, DOI 10.3109/14767058.2010.492061; Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Prado J, 2013, NEUROCHEM INT, V62, P70, DOI 10.1016/j.neuint.2012.11.008; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Proietti M, 2007, J RHEUMATOL, V34, P1712; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Royl G, 2009, BRAIN RES, V1265, P148, DOI 10.1016/j.brainres.2009.01.061; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Struck MB, 2011, J AM ASSOC LAB ANIM, V50, P344; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Uthayathas S, 2007, LIFE SCI, V81, P988, DOI 10.1016/j.lfs.2007.07.018; Wakita H, 2003, BRAIN RES, V992, P53, DOI 10.1016/j.brainres.2003.08.028; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Washington CW, 2016, J NEUROSURG, V124, P318, DOI 10.3171/2015.2.JNS142752; Weimann J, 2000, ANESTHESIOLOGY, V92, P1702, DOI 10.1097/00000542-200006000-00030; Yazdani A, 2016, DEV NEUROSCI-BASEL, V38, P251, DOI 10.1159/000448327; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028	44	1	1	1	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2020	30	4					501	506		10.5137/1019-5149.JTN.23864-18.3			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Surgery	MN9PW	WOS:000551172600005	30829389	Bronze			2022-02-06	
J	Kisala, PA; Tulsky, DS; Boulton, AJ; Heinemann, AW; Victorson, D; Sherer, M; Sander, AM; Chiaravalloti, N; Carlozzi, NE; Hanks, R				Kisala, Pamela A.; Tulsky, David S.; Boulton, Aaron J.; Heinemann, Allen W.; Victorson, David; Sherer, Mark; Sander, Angelle M.; Chiaravalloti, Nancy; Carlozzi, Noelle E.; Hanks, Robin			Development and Psychometric Characteristics of the TBI-QOL Independence Item Bank and Short Form and the TBI-QOL Asking for Help Scale	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Help-seeking behavior; Independent living; Patient outcome assessment; Personal autonomy; Rehabilitation	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; OUTCOMES RESEARCH-INSTITUTE; RESPONSE THEORY; RATING-SCALE; FIT; PARTICIPATION; PERFORMANCE; VALIDATION; CRITERIA	Objective: To develop an item response theory (IRT)-calibrated, patient-reported outcome measure of subjective independence for individuals with traumatic brain injury (TBI). Design: Large-scale item calibration field testing; confirmatory factor analysis (CFA) and graded response model IRT analyses. Setting: Five TBI Model System centers across the United States. Participants: Adults with complicated mild, moderate, or severe TBI (N=556). Outcome Measures: Traumatic Brain Injury-Quality of Life (TBI-QOL) Independence item bank and the TBI-QOL Asking for Help scale. Results: A total of 556 individuals completed 44 items in the Independence item pool. Initial factor analyses indicated that items related to the idea of "asking for help" were measuring a different construct from other items in the pool. These 9 items were set aside. Twenty-two other items were removed because of bimodal distributions and/or low item-total correlations. CFA supported unidimensionality of the remaining Independence items. Graded response model IRT analysis was used to estimate slopes and thresholds for the final 13 Independence items. An 8-item fixed-length short form was also developed. The 9 Asking for Help items were analyzed separately. One misfitting item was deleted, and the final 8 items became a fixed-length IRT-calibrated scale. Reliability was high for both measures. Conclusions: The IRT-calibrated TBI-QOL Independence item bank and short form and TBI-QOL Asking for Help scale may be used to measure important issues for individuals with TBI in research and clinical applications. (C) 2019 by the American Congress of Rehabilitation Medicine	[Kisala, Pamela A.; Tulsky, David S.; Boulton, Aaron J.] Univ Delaware, Coll Hlth Sci, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Heinemann, Allen W.; Victorson, David] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Heinemann, Allen W.; Victorson, David] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Sherer, Mark; Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sherer, Mark; Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Chiaravalloti, Nancy] Kessler Fdn, E Hanover, NJ USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, Ctr Hlth Assessment Res & Translat, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Ctr Hlth Assessment Res & Translat, STAR Tower,3rd Floor,100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Chiaravalloti, Nancy/0000-0003-2943-7567; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]; NIDILRRUnited States Department of Health & Human Services [H133A120100]	Supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this manuscript was provided by NIDILRR grant #H133A120100.	Baum CM, 2017, NEUROPSYCHOL REHABIL, V27, P603, DOI 10.1080/09602011.2016.1176934; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bonikowsky S, 2012, BRIT J OCCUP THER, V75, P188, DOI 10.4276/030802212X13336366278176; Brown M.W., 1993, SOCIOL METHOD RES, P136; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Fleurence R, 2013, HEALTH AFFAIR, V32, P393, DOI 10.1377/hlthaff.2012.1176; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236; Kisala PA, 2019, HEALTH PSYCHOL, V38, P435, DOI 10.1037/hea0000685; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; Magnus BE, 2016, QUAL LIFE RES, V25, P1655, DOI 10.1007/s11136-015-1221-2; Masel B, 2009, CONCEPTUALIZING BRAI; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Messick S., 1994, VALIDITY PSYCHOL ASS; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Muthen B. O., 1998, MPLUS USERS GUIDE, V7th; Ojefors E, 2010, IEEE RAD FREQ INTEGR, P91, DOI 10.1109/RFIC.2010.5477301; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PROMIS, PROMIS INSTR DEV PSY; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reise SP, 2016, PSYCHOL MED, V46, P2025, DOI 10.1017/S0033291716000520; REISE SP, 1990, J EDUC MEAS, V27, P133, DOI 10.1111/j.1745-3984.1990.tb00738.x; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 2007, HDB REHABILITATION P, P49; Selby JV, 2013, POPUL HEALTH MANAG, V16, P69, DOI 10.1089/pop.2013.1621; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2005, PHYS MED REHABILITAT; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willis GBJRTP, 1999, COGNITIVE INTERVIEWI	62	1	1	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					33	42		10.1016/j.apmr.2019.08.469			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300004	31473207				2022-02-06	
J	Kokkinou, M; Kyprianou, TC; Kyriakides, E; Constantinidou, F				Kokkinou, M.; Kyprianou, T. C.; Kyriakides, E.; Constantinidou, F.			A population study on the epidemiology and outcome of brain injuries in intensive care	NEUROREHABILITATION			English	Article						Traumatic Brain Injury; epidemiology; cohort study; mortality; sex differences	HEAD-INJURY; SELF-AWARENESS; MODERATE; SEVERITY	BACKGROUND: Traumatic Brain Injury (TBI) is characterized by a highly heterogenous profile in terms of pathophysiology, clinical presentation and outcome. OBJECTIVE: This is the first population study investigating the epidemiology and outcomes of moderate-to-severe TBI in Cyprus. Patients treated in the Intensive Care Unit (ICU) of Nicosia General Hospital, the only Level 1 Trauma Centre in the country, were recruited between January 2013 and December 2016. METHODS: This was an observational cohort study, using longitudinal methods and six-month follow-up. Patients (N = 203) diagnosed with TBI were classified by the Glasgow Coma Scale at the Emergency Department as moderate or severe. RESULTS: Compared to international multicentre studies, the current cohort demonstrates a different case mix that includes older age, more motor vehicle collisions and lower mortality rates. There was a significantly higher proportion of injured males. Females were significantly older than males. There were no sex differences in the type, severity or place of injury. Sex did not yield differences in mortality or outcomes or on injury indices predicting outcomes. In contrast, older age was a predictor of higher mortality rates and worse outcomes. CONCLUSION: Trends as described in the study emphasize the importance of continuous evaluation of TBI epidemiology and outcome in different countries.	[Kokkinou, M.] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Kokkinou, M.; Constantinidou, F.] Univ Cyprus, Ctr Appl Neurosci, Univ Ave 1, CY-1678 Nicosia, Cyprus; [Kyprianou, T. C.] St George Univ London, London, England; [Kyprianou, T. C.] Univ Nicosia, Med Program, Med Sch, Nicosia, Cyprus; [Kyriakides, E.] Nicosia Gen Hosp, Nicosia, Cyprus; [Constantinidou, F.] Univ Cyprus, Dept Psychol, Language Disorders & Clin Neuropsychol, Nicosia, Cyprus		Constantinidou, F (corresponding author), Univ Cyprus, Ctr Appl Neurosci, Univ Ave 1, CY-1678 Nicosia, Cyprus.; Constantinidou, F (corresponding author), Univ Cyprus, Psychol, Univ Ave 1, CY-1678 Nicosia, Cyprus.	fofic@ucy.ac.cy		Kyprianou, Theodoros/0000-0001-8272-7630	European UnionEuropean Commission [602714]; Republic of Cyprus; European Regional Development FundEuropean Commission [EXCELLENCE/1216/0411]	The study was funded by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602714 (CREACTIVE) and in part by the Republic of Cyprus and the European Regional Development Fund under the Framework Programme "RESTART 2016-2020/EXCELLENCE HUBS: PILLAR II" for Research, Technological Development and Innovation (EXCELLENCE/1216/0411).	Advisory U.S. Department of State Travel, 2019, CYPR 2019 CRIM SAF R; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CARIOLOU MA, 1995, GENET EPIDEMIOL, V12, P489, DOI 10.1002/gepi.1370120506; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Constantinidou F., 2019, BEHAV NEUROL, V4, P1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; European Commission, 2017, ROAD SAF COUNTR OV C; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Frohlich S, 2011, IRISH J MED SCI, V180, P423, DOI 10.1007/s11845-011-0674-8; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; Konstantinou N, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01163; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Ministry of Finance C., 2019, DEM STAT 2018; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mollayeva Tatyana, 2017, Healthc Q, V20, P6; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Pettemeridou E, 2020, NEUROREHABILITATION, V46, P109, DOI 10.3233/NRE-192963; Raleigh V. S., 2019, NO 108 TRENDS LIFE E; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Servadei F, 1985, J Neurosurg Sci, V29, P297; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tobi KU, 2016, SOUTH AFR J ANAESTH, V22, P135, DOI 10.1080/22201181.2016.1206293; Yiannakkaras C, 2019, J INTEGR NEUROSCI, V18, P95, DOI 10.31083/j.jin.2019.02.144	46	1	1	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	2					143	152		10.3233/NRE-203111			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NW2TW	WOS:000574863700006	32741786				2022-02-06	
J	Lan, M; Dambrino, RJ; Youssef, A; Yengo-Kahn, A; Dewan, MC; Ehrenfeld, J; Bonfield, CM; Zuckerman, SL				Lan, Matthews; Dambrino, Robert J.; Youssef, Andrew; Yengo-Kahn, Aaron; Dewan, Michael C.; Ehrenfeld, Jesse; Bonfield, Christopher M.; Zuckerman, Scott L.			Repeat Surgery After Decompressive Craniectomy for Traumatic Intracranial Hemorrhage: Outcomes and Predictors	WORLD NEUROSURGERY			English	Article						Complications; Death; Decompressive craniectomy; Epidural hemorrhage; Morbidity; Subdural hemorrhage; Traumatic brain injury	ACUTE SUBDURAL-HEMATOMA; EVACUATION	INTRODUCTION: Repeat surgery (RS) after decompressive craniectomy/craniotomy (DC) for traumatic intracranial hemorrhage (TICH) is a devastating complication. In patients undergoing DC for TICH, we sought to 1) describe the population requiring RS, 2) compare outcomes of those requiring RS with those who did not, and 3) discern RS predictors. METHODS: A single-institution retrospective case-control study was conducted from 2000 to 2015. Inclusion criteria were DC for acute supratentorial TICH (subdural hemorrhage, epidural hemorrhage, and intraparenchymal hemorrhage) and day survival. Patients underwent RS within >= 7 days of DC; controls did not require RS. Outcomes and predictors of RS were evaluated with univariate and multivariate logistic regression (MLR). RESULTS: Of 201 patients requiring DC, 28 (14%) underwent RS. Common mechanisms were ground-level fall (45%) and motor vehicle collision (29%). Anticoagulation/antiplatelet medication was used by 44 patients (21%). Subdural hemorrhage was the most common hemorrhage (64%). Using MLR, those requiring RS were more likely to experience major complications (odds ratio [OR], 22.6; 95% confidence interval [CI], 5.06-101.35; P < 0.001) and in-hospital mortality (OR, 2.76; 95% CI, 1.02-7.43; P = 0.045) and he dead/dependent at 6 months (OR, 2.50; 95% CI, 1 08 - 5.82; P = 0.033) and 2 years (OR, 2.44; 95% CI, 0.99 6.00, P = 0.051). Predictors of undergoing RS identified by MLR were smaller hemorrhage (OR, 0.32; 95% CI, 0.13-0.78; P = 0.012), larger midline shift (OR, 4.40; 95% CI, 1.43-13.51; P = 0.010), and better preoperative Glasgow Coma Scale score (OR, 1.28; 95% CI, 1.13-1.46; P < 0.001). CONCLUSIONS: Patients requiring RS after DC represent a heterogenous population with worse outcomes. Although the identified risk factors for RS are not modifiable, surgeons should be aware of these factors during the initial surgery.	[Lan, Matthews] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Dambrino, Robert J.; Yengo-Kahn, Aaron; Dewan, Michael C.; Bonfield, Christopher M.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Ehrenfeld, Jesse] Vanderbilt Univ, Med Ctr, Dept Anesthesia, Nashville, TN USA; [Youssef, Andrew] Mehany Med Coll, Sch Med, Nashville, TN USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA.	scott.zuckerman@vumc.org	Ehrenfeld, Jesse/AAI-2951-2020; Yengo-Kahn, Aaron/AAV-7647-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Lan, Matthews/0000-0002-5411-0534			Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Cepeda S, 2020, J NEUROSURG, V132, P1623, DOI 10.3171/2019.2.JNS182025; Chrastina J, 2020, EUR J TRAUMA EMERG S, V46, P347, DOI 10.1007/s00068-019-01077-6; Di GF, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1179; Godlewski B, 2013, NEUROL MED-CHIR, V53, P26, DOI 10.2176/nmc.53.26; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Gutowski P, 2018, WORLD NEUROSURG, V118, pE166, DOI 10.1016/j.wneu.2018.06.147; Han Hokyun, 2016, Korean J Neurotrauma, V12, P61, DOI 10.13004/kjnt.2016.12.2.61; Kumar A, 2019, J NEUROSURG, V130, P1784, DOI 10.3171/2018.11.JNS183191; Lv JH, 2019, WORLD NEUROSURG, V122, P24, DOI 10.1016/j.wneu.2018.10.106; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Shen J, 2013, NEUROL MED-CHIR, V53, P221, DOI 10.2176/nmc.53.221; Shen J, 2013, ACTA NEUROCHIR, V155, P335, DOI 10.1007/s00701-012-1569-9; Wang Y, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.140.13982; Wu RH, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0303-1	18	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						E757	E766		10.1016/j.wneu.2019.09.148			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700143	31604134				2022-02-06	
J	Lee, SJ; Hoon, C; Seo, JP; Jang, SH				Lee, Sung Jun; Hoon, Chang; Seo, Jeong Pyo; Jang, Sung Ho			Diagnosis of Tinnitus Due to Auditory Radiation Injury Following Whiplash Injury: A Case Study	DIAGNOSTICS			English	Article						diffusion tensor tractography; tinnitus; auditory radiation; traumatic axonal injury; whiplash injury	TRAUMATIC BRAIN-INJURY; INDUCED AXONAL INJURY; TRACT; TRACTOGRAPHY; NEUROSCIENCE; PLASTICITY; PATIENT; PATHWAY	We report on a patient with tinnitus who showed injury of auditory radiation following whiplash injury, demonstrated by diffusion tensor tractography (DTT). A 48-year-old male patient suffered from a car crash resulting in flexion-hyperextension injury of his head after being hit from behind by a moving car while waiting at a signal while driving a car. Three days after the car crash, he began to feel tinnitus in both ears and his tinnitus became aggravated with the passage of time. No specific lesion was observed on a conventional brain MRI performed two weeks after the car crash. Although he visited several hospitals, the precise cause of his tinnitus was not detected. Two years after the car crash, he underwent evaluation for his tinnitus at the ear, nose and throat department of a university hospital. The pure tone audiometry was evaluated in a sound-proof room to screen his hearing status for the frequencies of 250-8000 Hz and no specific abnormality was detected. Although he was also tested for speech audiometry, there was also no specific abnormality. In order to assess his tinnitus, a tinnitogram was conducted to evaluate the frequency content and the loudness. His tinnitus was characterized at an intensity of 40 dB and a frequency of 4000 Hz. However, no abnormality was observed in either ear on physical examination. On DTT, the auditory radiation showed severe narrowing and tearing in both hemispheres. To summarize, neural injury of the auditory radiation was demonstrated in a patient with tinnitus following whiplash injury, using DTT.	[Lee, Sung Jun; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea; [Hoon, Chang] Yeungnam Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, KS002, Daegu, South Korea; [Seo, Jeong Pyo] Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, KS002, Cheonan, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	hssj8020@hanmail.net; baich@med.yu.ac.kr; raphael0905@hanmail.net; strokerehab@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	Bartels H, 2007, OTOL NEUROTOL, V28, P178, DOI 10.1097/MAO.0b013e31802b3248; Berman JI, 2013, AM J NEURORADIOL, V34, P1573, DOI 10.3174/ajnr.A3471; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Claussen, 1995, Int Tinnitus J, V1, P105; CLAUSSEN CF, 1995, ACTA OTO-LARYNGOL, P53; Coelho DH, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P769; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Jang SH, 2019, BRAIN INJURY, V33, P249, DOI 10.1080/02699052.2018.1539243; Jang SH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00057; Jang SH, 2017, AM J PHYS MED REHAB, V96, pE130, DOI 10.1097/PHM.0000000000000630; Jang SH, 2017, BRAIN INJURY, V31, P416, DOI 10.1080/02699052.2016.1239274; Jang SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005958; Jang SH, 2016, J NEUROTRAUM, V33, P1790, DOI 10.1089/neu.2015.4298; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003007; Jang SH, 2015, BRAIN INJURY, V29, P1725, DOI 10.3109/02699052.2015.1075170; Kileny PR., 2010, OTOLARYNGOLOGY HEAD, V2, P1887; Kreuzer PM, 2014, J HEAD TRAUMA REHAB, V29, P432, DOI 10.1097/HTR.0b013e31829d3129; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rowlands RG, 2009, J LARYNGOL OTOL, V123, P182, DOI 10.1017/S0022215108002569; Seroussi R, 2015, PHYS MED REH CLIN N, V26, P359, DOI 10.1016/j.pmr.2015.01.003; Shore SE, 2016, NAT REV NEUROL, V12, P150, DOI 10.1038/nrneurol.2016.12; Sterner Y, 2004, J REHABIL MED, V36, P193, DOI 10.1080/16501970410030742; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tranter RMD, 2009, J FORENSIC LEG MED, V16, P53, DOI 10.1016/j.jflm.2008.09.001; 장성호, 2016, [Brain & NeuroRehabilitation, 뇌신경재활], V9, P1	33	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	JAN	2020	10	1							19	10.3390/diagnostics10010019			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KL0NM	WOS:000513129500009	31905965	Green Published, gold			2022-02-06	
J	Lekic, N; Sheu, J; Ennis, H; Lebwohl, N; Al-Maaieh, M				Lekic, Nikola; Sheu, Jonathan; Ennis, Hayley; Lebwohl, Nathan; Al-Maaieh, Motasem			Why you should wear your seatbelt on an airplane: Burst fracture of the atlas (jefferson fracture) due to in-flight turbulence	JOURNAL OF ORTHOPAEDICS			English	Article						Jefferson fracture; Atlas; Cervical spine; Air travel; Trauma; Non-operative	UPPER CERVICAL-SPINE; HALO VEST TREATMENT; LIGAMENT; INJURIES; OSTEOSYNTHESIS; FIXATION; AXIS	The Jefferson fracture is a burst-type fracture to the atlas first described in 1919, characterized by anterior and posterior fractures of the weak C1 ring caused by a sudden axial load to the vertex of the skull. Here we report a Jefferson fracture caused by head trauma due to mid-flight turbulence in an unrestrained 56-year-old male airline passenger. Imaging revealed a comminuted burst fracture of the atlas with an avulsion fracture of the transverse atlantal ligament. The patient was treated conservatively in a Miami-J collar with close clinical and radiographic follow-up. Lateral flexion-extension radiographs demonstrated fracture stability, and clinically the patient lacked pain or neurologic symptoms at 12 weeks from injury. To our knowledge this is the first report of a Jefferson fracture caused by axial compression attributable to in-flight turbulence. Traditionally associated with automobile crashes and diving headfirst into shallow pools, the axial load results in a compressive force to the atlas and subsequent lateral separation of the two halves of the C1 vertebral ring. The purpose of this case study is to alert providers, aircraft personnel, and passengers of the inherent risk of air travel and the importance of wearing a seatbelt at all times, describe the signs and symptoms of this often-overlooked fracture, and provide general treatment guidelines based on radiographic assessments of fracture stability.	[Lekic, Nikola; Ennis, Hayley; Lebwohl, Nathan; Al-Maaieh, Motasem] Univ Miami, Jackson Mem Hosp, Dept Orthoped, 1400 NW 12th Ave 4th Floor Room 4036, Miami, FL 33136 USA; [Sheu, Jonathan] Univ Miami, Miller Sch Med, 1600 NW 10th Ave,Room 1140, Miami, FL 33136 USA		Lekic, N (corresponding author), Univ Miami, Jackson Mem Hosp, Dept Orthoped, 1400 NW 12th Ave 4th Floor Room 4036, Miami, FL 33136 USA.	nikolalekicmd@gmail.com		Sheu, Jonathan/0000-0002-1916-0755; Lekic, Nikola/0000-0002-3979-1976			Board NTS, 1995, REPORTAIRCRAFT ACC R; Board NTS, 2001, FLIGHT SEP VERT STAB; Bransford RJ, 2009, SPINE, V34, P1561, DOI 10.1097/BRS.0b013e3181a9702d; Brotak E, 2014, AEROSAFETY WORLD, V2014; Dickman CA, 1996, NEUROSURGERY, V38, P44, DOI 10.1097/00006123-199601000-00012; DICKMAN CA, 1989, J NEUROSURG, V70, P45, DOI 10.3171/jns.1989.70.1.0045; ERSMARK H, 1987, CLIN ORTHOP RELAT R, P257; ERSMARK H, 1988, J TRAUMA, V28, P407, DOI 10.1097/00005373-198803000-00020; HAN SY, 1976, J NEUROSURG, V44, P368, DOI 10.3171/jns.1976.44.3.0368; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Haus BM, 2008, CLIN ORTHOP RELAT R, V466, P1257, DOI 10.1007/s11999-008-0143-5; HELLER JG, 1993, J SPINAL DISORD, V6, P392, DOI 10.1097/00002517-199306050-00004; Jacobson ME, 2012, ORTHOP CLIN N AM, V43, P11, DOI 10.1016/j.ocl.2011.09.004; Jefferson G, 1920, BRIT J SURG, V7, P407; Kandziora F, 2017, J ORTHOP TRAUMA, V31, pS81, DOI 10.1097/BOT.0000000000000942; KESTERSON L, 1991, J NEUROSURG, V75, P213, DOI 10.3171/jns.1991.75.2.0213; KOCH R A, 1978, Spine, V3, P103, DOI 10.1097/00007632-197806000-00002; Koller H, 2010, EUR SPINE J, V19, P1288, DOI 10.1007/s00586-010-1380-3; Lee D, 2017, J CLIN NEUROSCI, V40, P27, DOI 10.1016/j.jocn.2017.01.002; Lee TT, 1998, SPINE, V23, P1963, DOI 10.1097/00007632-199809150-00008; LEVINE AM, 1991, J BONE JOINT SURG AM, V73A, P680, DOI 10.2106/00004623-199173050-00006; Li-jun L, 2014, SPINAL CORD, V52, P342, DOI 10.1038/sc.2014.8; Ma WH, 2013, EUR SPINE J, V22, P2232, DOI 10.1007/s00586-013-2870-x; Orf D, 2017, POPULAR MECH; Ross A., 2017, GUARDIAN; Shatsky J, 2016, SPINE J, V16, P372, DOI 10.1016/j.spinee.2015.11.041; SINCLAIR PC, 1991, J APPL METEOROL, V30, P3, DOI 10.1175/1520-0450(1991)030<0003:ALAWSD>2.0.CO;2; SPENCE KF, 1970, J BONE JOINT SURG AM, VA 52, P543, DOI 10.2106/00004623-197052030-00013; Vieweg U, 2001, ARCH ORTHOP TRAUM SU, V121, P50, DOI 10.1007/s004020000182	29	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0972-978X			J ORTHOP	J. Orthop.	JAN-FEB	2020	17						78	82		10.1016/j.jor.2019.06.019			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	KF9QW	WOS:000509578600017	31879479	Green Published			2022-02-06	
J	Levi, A; Theilen, TM; Rolle, U				Levi, Anna; Theilen, Till-Martin; Rolle, Udo			Injury surveillance in elite field hockey: a pilot study of three different recording techniques	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						Field hockey; Injury; Epidemiology	DATA-COLLECTION PROCEDURES; CONSENSUS STATEMENT; TEAM SPORTS; DEFINITIONS; FOOTBALL; DEBATE; FOCUS; FACE; HEAD	Objective In field hockey, injuries are assessed by various recording techniques leading to a heterogenic collection of poorly comparable injury data. Methods Injury data were prospectively collected at the 2016 Men's Hockey Junior World Cup using the match injury reports (MIRs), video injury clips provided by the Federation Internationale de Hockey, and daily medical reports (DMRs). A pilot study comparing injury type, mechanism, location on the field, injured body part and overall injury incidence among the different injury recording techniques was performed. Results MIRs and video injury clips were completely available for analysis. DMRs were returned from 11 out of 16 teams (69%). In total, MIRs yielded 28, video analysis 36, and DMRs 56 injuries. Overall injury rate varied between 24.8 and 57.9 injuries per 1000 player match hours. The majority of injuries affected the lower limbs by all three methods (41.7-61.2%) and were mainly caused by having been hit by the ball (20.4-50%) or stick (11.1-28.6%). Reports of concussions during competition were incoherent between MIR (2 cases) and DMR (no cases). The DMR was the only method to record overuse injuries (16.1%), injuries in training (12.5%), and time-loss injuries of one or two days (12.5%) or of three or more days (14.3%). Conclusion Injury data vary substantially between the MIR, DMR and injury video recording technique. Each recording technique revealed specific strengths and limitations. To further advance injury research in field hockey, the strengths of each recording technique should be brought together for a synergistic injury assessment model.	[Levi, Anna; Theilen, Till-Martin] Univ Hosp Goethe Univ, Dept Paediat Surg & Paediat Urol, Frankfurt, Germany; [Rolle, Udo] Hosp Goethe Univ Frankfurt, Dept Paediat Surg & Paediat Urol, Frankfurt, Germany		Rolle, U (corresponding author), Hosp Goethe Univ Frankfurt, Dept Paediat Surg & Paediat Urol, Frankfurt, Germany.	udo.rolle@kgu.de	Rolle, Udo/AAI-7424-2020	Rolle, Udo/0000-0002-1268-6092			Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; Barboza SD, 2018, SCAND J MED SCI SPOR, V28, P1708, DOI 10.1111/sms.13065; Barboza SD, 2018, SPORTS MED, V48, P849, DOI 10.1007/s40279-017-0839-3; Bjorneboe J, 2011, SCAND J MED SCI SPOR, V21, P713, DOI 10.1111/j.1600-0838.2009.01085.x; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Dick R, 2007, J ATHL TRAINING, V42, P211; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Furlong LAM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201834; Gardner EC, 2015, AM J SPORT MED, V43, P2027, DOI 10.1177/0363546515588175; Hodgson L, 2007, CLIN J SPORT MED, V17, P188, DOI 10.1097/JSM.0b013e3180547513; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Mukherjee S, 2013, RES SPORTS MED, V21, P318, DOI 10.1080/15438627.2013.825797; Mukherjee S, 2012, AM J SPORT MED, V40, P686, DOI 10.1177/0363546511426697; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; Murtaugh K, 2009, CURR SPORT MED REP, V8, P267, DOI 10.1249/JSR.0b013e3181b7f1f4; Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527; Theilen TM, 2021, CLIN J SPORT MED, V31, P448, DOI 10.1097/JSM.0000000000000785; Theilen TM, 2016, BRIT J SPORT MED, V50, P657, DOI 10.1136/bjsports-2015-094847	22	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000908	10.1136/bmjsem-2020-000908			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF8UR	WOS:000599323000001	33304606	gold, Green Published			2022-02-06	
S	Luo, CL; Tao, LY		Le, W		Luo, Chengliang; Tao, Luyang			The Function and Mechanisms of Autophagy in Traumatic Brain Injury	AUTOPHAGY: BIOLOGY AND DISEASES: CLINICAL SCIENCE	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Autophagy; Autophagic flux; Traumatic brain injury; Cell	CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; INDUCED CELL-DEATH; REDUCES HISTOPATHOLOGY; POLOXAMER 188; CATHEPSIN-B; DAMAGE; CONTRIBUTES; MODEL; MITOCHONDRIAL	Traumatic brain injury (TBI) is one of the most common causes of long-term disability and death worldwide. Autophagy is activated and autophagic flux is impaired following TBI. But the controversial roles and underlying mechanisms of autophagy after TBI are not clear. This chapter will update the current state of knowledge in the process of autophagy, the roles of autophagy in TBI as well as some upstream moleculars and pharmacological regulators of autophagy involved in TBI. We also discuss autophagy mechanism-based preclinical pharmacological intervention. These observations make autophagy an attractive therapeutic target for developing new therapeutic strategies to achieve better outcomes for patients suffering from TBI.	[Luo, Chengliang; Tao, Luyang] Soochow Univ, Coll Med, Dept Forens Med, Suzhou 215123, Peoples R China		Tao, LY (corresponding author), Soochow Univ, Coll Med, Dept Forens Med, Suzhou 215123, Peoples R China.	taoluyang@suda.edu.cn					Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bao HJ, 2016, NEUROSCI LETT, V634, P7, DOI 10.1016/j.neulet.2016.09.052; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ellis RC, 2005, EXP NEUROL, V193, P19, DOI 10.1016/j.expneurol.2004.11.034; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fukui K, 2012, FREE RADICAL RES, V46, P184, DOI 10.3109/10715762.2011.647689; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Klionsky DJ, 2015, AUTOPHAGY, V11, P1, DOI 10.1080/15548627.2014.996046; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lee WS, 2015, CURR MOL MED, V15, P735, DOI 10.2174/1566524015666150921105453; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu M, 2015, J SPINAL CORD MED, V38, P745, DOI 10.1179/2045772314Y.0000000224; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Wang T, 2013, NEUROSCIENCE, V231, P70, DOI 10.1016/j.neuroscience.2012.11.019; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Yi Y, 2018, MOL NEUROBIOL, V55, P2454, DOI 10.1007/s12035-017-0504-8; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang L, 2013, J NUTR BIOCHEM, V24, P903, DOI 10.1016/j.jnutbio.2012.06.008; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	40	1	1	2	3	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE	0065-2598	2214-8019	978-981-15-4272-5; 978-981-15-4271-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2020	1207						635	648		10.1007/978-981-15-4272-5_46	10.1007/978-981-15-4272-5		14	Medicine, Research & Experimental; Clinical Neurology	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	BP5KY	WOS:000556133800056	32671781				2022-02-06	
B	Malcolm, D		Ventresca, M; McDonald, MG		Malcolm, Dominic			Concussion, Chronic Traumatic Encephalopathy, and the Medicalization of Sport	SOCIOCULTURAL EXAMINATIONS OF SPORTS CONCUSSIONS	Routledge Research in Sport and Exercise Science		English	Article; Book Chapter							PLAYERS; ZURICH		[Malcolm, Dominic] Loughborough Univ, Sociol Sport, Loughborough, Leics, England		Malcolm, D (corresponding author), Loughborough Univ, Sociol Sport, Loughborough, Leics, England.						Ahmed OH, 2017, PHYS THER SPORT, V23, P7, DOI 10.1016/j.ptsp.2016.07.003; Albrecht, 2000, HDB SOCIAL STUDIES H, P409, DOI DOI 10.4135/9781848608412.N26; Bachynski K., 2019, J HIST MED ALL SCI, P1; Beamish R, 2006, ROUTL CRIT STUD SPOR, P1; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; CONRAD P, 1992, ANNU REV SOCIOL, V18, P209, DOI 10.1146/annurev.so.18.080192.001233; Conrad P, 2007, MEDICALIZATION SOC T; Conrad P, 2015, REIMAGINING BIOMEDIC; Coveney C., 2018, SOCIOLOGY HLTH ILLNE, V39, P775; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; DESWAAN A, 1989, SOC SCI MED, V28, P1165, DOI 10.1016/0277-9536(89)90009-9; Fainaru-Wada M., 2013, LEAGUE DENIAL; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Halfmann D., 2011, HEALTH, V16, P186; Hardes J, 2017, SPORT ETHICS PHILOS, V11, P281, DOI 10.1080/17511321.2017.1281344; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hillman A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002274; Hoberman John, 1992, MORTAL ENGINES SCI P; Illich, 1975, MED NEMESIS; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Malcolm, 2013, GLOBALIZING CRICKET; Malcolm D., 2017, SPORT MED HLTH MEDIC; Malcolm D., 2020, CONCUSSION CRISIS SP; Malcolm D, 2006, SOCIOL SPORT J, V23, P376, DOI 10.1123/ssj.23.4.376; Malcolm D, 2020, HEALTH-LONDON, V24, P366, DOI 10.1177/1363459318800142; Malcolm D, 2015, ROUT INT HANDB, P50; Malcolm D, 2011, SOC SCI MED, V72, P513, DOI 10.1016/j.socscimed.2010.11.016; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1999, BRIT J SPORT MED, V33, P297; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McNamee M., 2015, KINESIOL REV, V4, P190, DOI [10.1123/kr.2015-0011, DOI 10.1123/KR.2015-0011]; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; PARSONS T, 1975, MILBANK FUND Q, V53, P257, DOI 10.2307/3349493; Partridge B, 2014, J BIOETHIC INQ, V11, P65, DOI 10.1007/s11673-013-9491-2; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Sheard K., 2003, SPORT HIST FIGURATIO, P15; Sheard K. G., 1998, International Journal of the History of Sport, V15, P74, DOI 10.1080/09523369808714043; Shurley Jason P., 2012, KINESIOLOGY REV, V1, P170; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Waddington I, 1996, SOCIOL SPORT J, V13, P176, DOI 10.1123/ssj.13.2.176; Waddington I., 1992, SPORT LEISURE CIVILI, P36; Weinberg SK, 1952, AM J SOCIOL, V57, P460, DOI 10.1086/221014; Wilson J., 2019, DAILY TELEGRAPH 0116; Workewych AM, 2017, SAGE OPEN MED, V5, DOI 10.1177/2050312117720057; Zola I., 1983, SOCIOL REV, V20, P487	55	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-429-02817-5; 978-0-367-13450-1	ROUT RES SPORT EXERC			2020							23	40					18	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Sociology; Sport Sciences	BO8OT	WOS:000528901400002					2022-02-06	
J	Matuzelski, E; Harvey, TJ; Harkins, D; Nguyen, T; Ruitenberg, MJ; Piper, M				Matuzelski, Elise; Harvey, Tracey J.; Harkins, Danyon; Thuan Nguyen; Ruitenberg, Marc J.; Piper, Michael			Expression of NFIA and NFIB within the murine spinal cord	GENE EXPRESSION PATTERNS			English	Article						Nuclear factor I; NFIA; NFIB; Spinal cord injury; Neurotrauma	ONE TRANSCRIPTION FACTORS; EMBRYONIC ORIGIN; NUCLEAR; WIDESPREAD; MATURATION; REPRESSION; GENERATION; NESTIN; INJURY; ROLES	The Nuclear factor I proteins comprise a family of transcription factors that are expressed in many developing and mature cell populations, including within the central nervous system. Within the embryonic mouse spinal cord, NFIA and NFIB are expressed by neural progenitor cells lining the central canal, where they act to promote astrocytic and oligodendrocytic lineage specification. Cells lining the mature spinal cord central canal retain characteristics of neural progenitor cells, but the expression of NFIA and NFIB within the mature spinal cord at a cell-type-specific level remains undefined. Here, we investigated where these two transcription factors are expressed within the adult mouse spinal cord. We reveal that both factors are expressed in similar cohorts of mature cells, including ependymal cells, interneurons and motor neurons. We also show robust and widespread expression of NFIA and NFIB within nestin-expressing cells following injury to the spinal cord. Collectively, these data provide a basis to further define what functional role(s) NFIA and NFIB play within the adult spinal cord.	[Matuzelski, Elise; Harvey, Tracey J.; Harkins, Danyon; Thuan Nguyen; Ruitenberg, Marc J.; Piper, Michael] Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Piper, Michael] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia		Piper, M (corresponding author), Sch Biomed Sci, St Lucia, Qld 4072, Australia.	m.piper@uq.edu.au	Piper, Michael J/B-2805-2010; Harvey, Tracey/P-4305-2016	Piper, Michael J/0000-0002-6759-2560; Harvey, Tracey/0000-0001-5388-0337	Australian Research CouncilAustralian Research Council [DP180100017]; SpinalCure Australia; Wings for Life Spinal Cord Research Foundation; NHMRCNational Health and Medical Research Council of Australia [1060538, 1163835]; Australian GovernmentAustralian GovernmentCGIAR	Work in the laboratory of MP was supported by Australian Research Council grant (DP180100017). MJR's laboratory is supported by SpinalCure Australia, the Wings for Life Spinal Cord Research Foundation, and the NHMRC (1060538 and 1163835). EM and DH were supported by Research Training Program scholarships from the Australian Government. Imaging was carried out in The School of Biomedical Sciences Microscopy and Imaging Facility. We thank the facility manager, Dr. Shaun Walters, for his assistance. We would also like to thank all of the staff at the UQ Biological Resources facility for their assistance with mouse colony maintenance.	Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Chang CY, 2013, NATURE, V495, P98, DOI 10.1038/nature11847; Chen KS, 2017, CANCER LETT, V410, P124, DOI 10.1016/j.canlet.2017.09.015; Chen KS, 2017, J COMP NEUROL, V525, P2465, DOI 10.1002/cne.24206; Clark BS, 2019, NEURON, V102, P1111, DOI 10.1016/j.neuron.2019.04.010; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Denny SK, 2016, CELL, V166, P328, DOI 10.1016/j.cell.2016.05.052; Fane M, 2017, INT J CANCER, V140, P2634, DOI 10.1002/ijc.30603; Fraser J, 2020, CEREBELLUM, V19, P89, DOI 10.1007/s12311-019-01089-3; Fraser J, 2019, BRAIN STRUCT FUNCT, V224, P811, DOI 10.1007/s00429-018-1801-3; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Gotz M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018853; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Harris L., 2018, DEV 145; Harris L, 2016, DEVELOPMENT, V143, P4620, DOI 10.1242/dev.140681; Harris L, 2015, DEV DYNAM, V244, P227, DOI 10.1002/dvdy.24182; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kitada M, 2018, DEV GROWTH DIFFER, V60, P326, DOI 10.1111/dgd.12546; Klaassens M, 2015, EUR J HUM GENET, V23, P610, DOI 10.1038/ejhg.2014.162; Kumbasar A, 2009, J COMP NEUROL, V513, P98, DOI 10.1002/cne.21943; Li GN, 2013, NEURON, V78, P658, DOI 10.1016/j.neuron.2013.03.019; Li XF, 2016, EBIOMEDICINE, V13, P55, DOI 10.1016/j.ebiom.2016.10.035; Liu Y, 2015, DEVELOPMENT, V142, P3374, DOI 10.1242/dev.127068; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Mao Y, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00058; Matuzelski E, 2017, DEV BIOL, V432, P286, DOI 10.1016/j.ydbio.2017.10.019; Messina G, 2010, CELL, V140, P554, DOI 10.1016/j.cell.2010.01.027; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; Oishi S, 2019, EBIOMEDICINE, V39, P388, DOI 10.1016/j.ebiom.2018.11.044; Piper M, 2014, J NEUROSCI, V34, P2921, DOI 10.1523/JNEUROSCI.2319-13.2014; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Piper M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-43; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Rossi G, 2016, CELL REP, V14, P2238, DOI 10.1016/j.celrep.2016.02.014; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Vidovic D, 2015, BRAIN RES, V1616, P71, DOI 10.1016/j.brainres.2015.04.057; Zalucki O, 2019, CEREB CORTEX, V29, P3590, DOI 10.1093/cercor/bhy233	40	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-133X	1872-7298		GENE EXPR PATTERNS	Gene Expr. Patterns	JAN	2020	35								119098	10.1016/j.gep.2020.119098			12	Developmental Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Genetics & Heredity	LD1YZ	WOS:000525829100011	32068188				2022-02-06	
J	McDonnall, MC; Cmar, JL; Lund, EM				McDonnall, Michele C.; Cmar, Jennifer L.; Lund, Emily M.			Comorbid Traumatic Brain Injury and Visual Impairment: Vocational Rehabilitation Service Provision and Agency-Level Outcomes	JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS			English	Article						Traumatic brain injury; visual impairment; vocational rehabilitation; employment outcomes	EMPLOYMENT OUTCOMES; COMPETITIVE EMPLOYMENT; CONSUMERS; PREDICTORS; BLIND	Introduction: The purpose of this study was to investigate how services are provided to state-federal vocational rehabilitation consumers with comorbid traumatic brain injury (TBI) and visual impairment and the prevalence of and competitive employment rates for this population. Methods: We utilized a mixed-methods approach by incorporating interview data from 51 vocational rehabilitation agency administrators (to identify strategies used to serve these consumers) and case service data (to identify prevalence and competitive employment rates at the agency level). We combined the data to examine the relationship between strategies used and the prevalence of and employment outcomes for this population. A modified grounded theory approach was used for qualitative data analysis and descriptive statistics, and analyses of variance were used for quantitative data analyses. Results: Strategies used to serve these consumers included collaboration between counselors, involvement of external organizations, specialized TBI units or caseloads, staff training in TBI, and personnel with dual expertise in TBI and visual impairment. Over a third of agency administrators reported that they did not do anything special or different to serve this population. The average percentage of consumers with visual impairments who also had TBIs being served by agencies was 2.1%. Their average competitive employment rate by agency was 43.2%. Employing staff with dual expertise in TBI and visual impairment was associated with serving a greater percentage of consumers and having a higher competitive employment rate. Discussion: No agencies had a unique service delivery program or method to serve this population, perhaps due to its low prevalence. Agencies had substantial variability in the proportion of consumers with TBI and visual impairment served and their competitive employment rates. Implications for practitioners: Training vocational rehabilitation professionals to develop expertise in both TBIs and visual impairments may help agencies better serve these consumers.	[McDonnall, Michele C.; Cmar, Jennifer L.; Lund, Emily M.] Mississippi State Univ, Natl Res & Training Ctr Blindness & Low Vis, POB 6189, Mississippi State, MS 39762 USA		McDonnall, MC (corresponding author), Mississippi State Univ, Natl Res & Training Ctr Blindness & Low Vis, POB 6189, Mississippi State, MS 39762 USA.	m.mcdonnall@msstate.edu	Cmar, Jennifer/AAW-8195-2020	Cmar, Jennifer/0000-0002-7619-7773; McDonnall, Michele/0000-0002-0942-1210	U.S. Department of Health and Human Services, NIDILRR [90RT5040-01-00]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The contents of this article were developed under a grant from the U.S. Department of Health and Human Services, NIDILRR grant 90RT5040-01-00.	[Anonymous], 2015, C TRAUM BRAIN INJ US; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brain Injury Association of America, 2018, AC CERT BRAIN INJ SP; Capella-McDonnall ME, 2005, J VISUAL IMPAIR BLIN, V99, P303; Darensbourg BL, 2013, J VOCAT REHABIL, V38, P29, DOI 10.3233/JVR-120618; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Giesen JM, 2013, J VISUAL IMPAIR BLIN, V107, P453, DOI 10.1177/0145482X1310700607; Giesen JM, 2012, J VISUAL IMPAIR BLIN, V106, P475, DOI 10.1177/0145482X1210600804; Glaser B., 1998, DOING GROUNDED THEOR; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Iskow C, 2010, J VISUAL IMPAIR BLIN, V104, P597, DOI 10.1177/0145482X1010401005; Kingston J, 2010, J VISUAL IMPAIR BLIN, V104, P603, DOI 10.1177/0145482X1010401006; LeJeune BJ, 2010, J VISUAL IMPAIR BLIN, V104, P658, DOI 10.1177/0145482X1010401013; McDonnall MC, 2019, J VISUAL IMPAIR BLIN, V113, P19, DOI 10.1177/0145482X19828033; McDonnall MC, 2016, REHABIL COUNS BULL, V59, P203, DOI 10.1177/0034355215586389; Rehabilitation Services Administration, 2013, RSAPD1305; Strauss A., 1990, BASICS QUALITATIVE R; U.S. Bureau of Labor Statistics, 2018, DAT TABL SPEC UNPUB	19	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0145-482X	1559-1476		J VISUAL IMPAIR BLIN	J. Vis. Impair. Blind.	JAN-FEB	2020	114	1			SI		6	17		10.1177/0145482X19892033			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	KM4GG	WOS:000514082200002					2022-02-06	
J	McDonnall, MC; Cmar, JL; McKnight, ZS				McDonnall, Michele C.; Cmar, Jennifer L.; McKnight, Zhen Sui			Service factors and personal characteristics associated with employment and job quality for vocational rehabilitation consumers with combined traumatic brain injury and visual impairment	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury; visual impairment; employment; job quality; vocational rehabilitation	TRANSITION-AGE YOUTH; COMPETITIVE EMPLOYMENT; SSDI BENEFICIARIES; OF-LIFE; OUTCOMES; PREDICTORS; WORK; RETURN; BLIND; PATTERNS	BACKGROUND: Visual impairment following traumatic brain injury (TBI) is common, but little research has been conducted regarding employment outcomes for individuals with combined TBI and visual impairment. OBJECTIVE: The purpose of this studywas to determine whether service-related factors, including vocational rehabilitation (VR) agency service strategies, and consumer personal characteristics are associated with competitive employment and job quality for this population. METHOD: Rehabilitation Services Administration Case Service Report data from fiscal years 2013-2015 was combined with VR agency interview data about strategies utilized for providing services to these consumers. Multilevel modeling was used to determine the predictive ability of nine state/agency-level and 27 individual-level variables. RESULTS: Two service strategies were significantly associated with competitive employment: "staff with dual expertise" and "staff training on TBI." Service strategies were not associated with job quality. Ten individual-level factors were significantly associated with competitive employment and eight were significantly associated with job quality. CONCLUSIONS: Having staff with dual expertise in TBI and visual impairment was a strong predictor of competitive employment; educating staff about TBI was also important. VR agencies are encouraged to educate their staff who work with consumers with visual impairment about TBI, including developing expertise in one or more staff members.	[McDonnall, Michele C.; Cmar, Jennifer L.; McKnight, Zhen Sui] Mississippi State Univ, Natl Res & Training Ctr Blindness & Low Vis, Mississippi State, MS 39762 USA		McDonnall, MC (corresponding author), Natl Res & Training Ctr Blindness & Low Vis, CRC, POB 6189, Mississippi State, MS 39762 USA.	m.mcdonnall@msstate.edu	Cmar, Jennifer/AAW-8195-2020	Cmar, Jennifer/0000-0002-7619-7773; McDonnall, Michele/0000-0002-0942-1210	U.S. Department of Health and Human Services, NIDILRR [90RT5040-01-00]	The contents of this manuscript were developed under a grant from the U.S. Department of Health and Human Services, NIDILRR grant 90RT5040-01-00. However, these contents do not necessarily represent the policy of the Department of Health and Human Services and should not indicate endorsement by the Federal Government.	Brucker DL, 2019, J VOCAT REHABIL, V50, P121, DOI 10.3233/JVR-180994; Capella-McDonnall ME, 2005, J VISUAL IMPAIR BLIN, V99, P303; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Cavenaugh B, 2002, J VISUAL IMPAIR BLIN, V96, P655, DOI 10.1177/0145482X0209600906; Cavenaugh B. S., 2010, UPDATE SERVICES OUTC; Cavenaugh B. S., 1999, RELATIONSHIP AGENCY; Cavenaugh BS, 2000, J VISUAL IMPAIR BLIN, V94, P133, DOI 10.1177/0145482X0009400302; Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chan F, 2016, J VOCAT REHABIL, V45, P5, DOI 10.3233/JVR-160806; Cimera RE, 2015, J VOCAT REHABIL, V43, P103, DOI 10.3233/JVR-150760; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Crudden A, 2018, J VISUAL IMPAIR BLIN, V112, P461; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Darensbourg BL, 2013, J VOCAT REHABIL, V38, P29, DOI 10.3233/JVR-120618; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Gamble D, 2003, J REHABIL, V69, P31; Giesen JM, 2018, J DISABIL POLICY STU, V29, P166, DOI 10.1177/1044207318780363; Giesen JM, 2016, J VOCAT REHABIL, V44, P175, DOI 10.3233/JVR-150789; Giesen JM, 2013, J VISUAL IMPAIR BLIN, V107, P453, DOI 10.1177/0145482X1310700607; Giesen JM, 2012, J VISUAL IMPAIR BLIN, V106, P475, DOI 10.1177/0145482X1210600804; Glaser B., 1998, DOING GROUNDED THEOR; Goertz YHH, 2010, J VISUAL IMPAIR BLIN, V104, P404, DOI 10.1177/0145482X1010400704; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Iskow C, 2010, J VISUAL IMPAIR BLIN, V104, P597, DOI 10.1177/0145482X1010401005; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Kingston J, 2010, J VISUAL IMPAIR BLIN, V104, P603, DOI 10.1177/0145482X1010401006; Lorah J, 2018, LARGE-SCALE ASSESS E, V6, DOI 10.1186/s40536-018-0061-2; Lund EM, 2019, J VISUAL IMPAIR BLIN, V113, P493, DOI 10.1177/0145482X19885211; Lund EM, 2019, J VISUAL IMPAIR BLIN, V113, P518, DOI 10.1177/0145482X19885277; McDonnall M. C., 2019, ANAL RSA 911 D UNPUB; McDonnall MC, 2020, J VISUAL IMPAIR BLIN, V114, P6, DOI 10.1177/0145482X19892033; McDonnall MC, 2019, REHABIL COUNS BULL, V63, P13, DOI 10.1177/0034355218769461; McDonnall MC, 2016, REHABIL COUNS BULL, V59, P203, DOI 10.1177/0034355215586389; Nadeau C.A., 2017, LIVING WAGE CALCULAT; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Raudenbush S.W., 2011, HLM 7 FOR WINDOWS; Rumrill P, 2016, J HEAD TRAUMA REHAB, V31, P288, DOI 10.1097/HTR.0000000000000186; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; SSTI, 2016, US STATS PER CAP PER; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Steinman BA, 2013, J VISUAL IMPAIR BLIN, V107, P437, DOI 10.1177/0145482X1310700606; Strauss A., 1990, BASICS QUALITATIVE R; Tucker MS, 2017, REHABIL COUNS BULL, V60, P215, DOI 10.1177/0034355216660279; U.S. Bureau of Labor Statistics, 2019, LOC AR UN STAT; U.S. Census Bureau, 2019, TOT POP AM COMM SURV; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Warren PR, 2004, J REHABIL, V70, P16; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	52	1	1	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2020	52	3					223	238		10.3233/JVR-201073			16	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	PY0HE	WOS:000611730200001		Bronze			2022-02-06	
J	McGrath, MK; Linder, SM; Koop, MM; Zimmerman, N; Ballantyne, MAJ; Ahrendt, DM; Alberts, JL				McGrath, Morgan K.; Linder, Susan M.; Koop, Mandy Miller; Zimmerman, Nicole; Ballantyne, Maj Aaron J.; Ahrendt, Dale M.; Alberts, Jay L.			Military-Specific Normative Data for Cognitive and Motor Single- and Dual-Task Assessments for Use in Mild Traumatic Brain Injury Assessment	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				CONCUSSION; TRAIL; PERFORMANCE; AGE; PARADIGM; BALANCE; ADULTS	Introduction Military personnel and civilian athletes are both at risk for mild traumatic brain injury. However, these groups are unique in their training and typical daily activities. A fundamental gap in the evaluation of military personnel following mild traumatic brain injury is the lack of military-specific normative reference data. This project aimed to determine if a separate normative sample should be used for military personnel on their performance of the Cleveland Clinic Concussion application and a recently developed dual-task module. Methods Data were collected from healthy military personnel (n = 305) and civilians (n = 281) 18 to 30 years of age. Participants completed the following assessments: simple and choice reaction time, Trail Making tests A&B, processing speed test, single-task postural stability, single-task cognitive assessment, and dual-task assessment. Results Civilian participants outperformed military service members on all cognitive tasks under single- and dual-task conditions (P <= 0.04). The military group outperformed civilians on all postural stability tasks under single- and dual-task conditions (P <= 0.01). Conclusion Differences in cognitive performance and postural stability measures may be influenced by demographic differences between military and civilian cohorts. Thus, military-specific normative datasets must be established to optimize clinical interpretation of Cleveland Clinic Concussion assessments.	[McGrath, Morgan K.; Linder, Susan M.; Koop, Mandy Miller; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Zimmerman, Nicole] Cleveland Clin, Quantitat Hlth Sci, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Ballantyne, Maj Aaron J.; Ahrendt, Dale M.] Brooke Army Med Ctr, Div Adolescent & Young Adult Med, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA		McGrath, MK (corresponding author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44195 USA.				U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-14-1-0532]	This study was supported by the U.S. Army Medical Research and Material Command: W81XWH-14-1-0532.	Alberts J, 2019, PHYS THER; Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alberts JL, 2016, BRIDGE LINKING ENG S, V46, P23; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Amodio P, 2002, AGING CLIN EXP RES, V14, P117, DOI 10.1007/BF03324425; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Burke D, 2017, ASSESSMENT, V24, P885, DOI 10.1177/1073191116633752; Center DaVBI, 2017, DOD WORLDW NUMB TBI; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kelley AM, 2015, J HEAD TRAUMA REHAB, V30, pE11, DOI 10.1097/HTR.0000000000000060; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Linder SM, 2019, JOVE-J VIS EXP, V143; Linder SM, 2019, MIL MED, V184, P174, DOI 10.1093/milmed/usy334; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; Liston MB, 2014, GAIT POSTURE, V39, P198, DOI 10.1016/j.gaitpost.2013.07.004; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Paillard T, 2006, J ATHL TRAINING, V41, P172; Paterno MV, 2004, J ORTHOP SPORT PHYS, V34, P305, DOI 10.2519/jospt.2004.34.6.305; Rao SM, 2017, MULT SCLER J, V23, P1929, DOI 10.1177/1352458516688955; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104; Yu SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170687	32	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			176	183		10.1093/milmed/usz261			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600027	32074318	Bronze			2022-02-06	
J	Min, HW; Qu, TB; Li, ZG; Liu, KM				Min Hongwei; Qu Tiebing; Li Zhiguo; Liu Kemin			PROTEOMICS STUDY ON BIOMARKERS FOR HETEROTOPIC OSSIFICATION SECONDARY TO TRAUMATIC BRAIN INJURIES	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; heterotopic ossification; proteomics; Gc protein; RBP4; haptoglobin	D-BINDING PROTEIN; D-RECEPTOR GENE; RETINOIC ACID; BONE; PATHOPHYSIOLOGY; OSTEOGENESIS; EXPRESSION; CARTILAGE; OBESITY; CELLS	Objective: To identify differentially expressed serum proteins that could serve as sensitive biomarkers of heterotopic ossification in patients with traumatic brain injury. Methods: From August 2014 to December 2015, 18 patients with traumatic brain injury were enrolled in the study, and blood samples were collected. Patients with traumatic brain injury were divided based on the presence (n = 9 patients, heterotopic ossification group) or absence (n =9 patients, traumatic brain injury group or control group) of heterotopic ossification. Protein expression profiles were compared using 2-dimensional electrophoresis. Differentially expressed proteins were examined using matrix-assisted laser desorption/ionization and time-of-flight tandem mass spectrometry (MALDI-TOF/TOF). The differentially expressed proteins identified were further confirmed by Western blotting. Results: Seven protein spots were differentially expressed between heterotopic ossification and traumatic brain injury groups in 2-dimensional electrophoresis analysis. Vitamin D binding protein (Gc protein), retinol binding protein 4 (RBP4) and haptoglobin expression decreased significantly in the heterotopic ossification group compared with the control group (p < 0.05), and this was further confirmed by Western blotting. Conclusion: Lower levels of expression of Gc protein, RBP4 and haptoglobin may be closely related to heterotopic ossification after traumatic brain injury. These proteins may be potential biomarkers of heterotopic ossification secondary to traumatic brain injury.	[Min Hongwei; Qu Tiebing; Liu Kemin] Capital Med Univ, Sch Rehabil, Beijing, Peoples R China; [Min Hongwei; Qu Tiebing; Liu Kemin] Beijing Boai Hosp, China Rehabil Res Ctr, Dept Orthoped & Rehabil, Beijing, Peoples R China; [Li Zhiguo] North China Univ Sci & Technol, Int Sci & Technol Cooperat Base Geriatr Med, Dept Med Res Ctr, Tangshan, Peoples R China		Liu, KM (corresponding author), Beijing Boai Hosp, China Rehabil Res Ctr, Dept Orthoped & Rehabil, Beijing, Peoples R China.; Li, ZG (corresponding author), North China Univ Sci & Technol, Int Sci & Technol Cooperat Base Geriatr Med, Tangshan, Peoples R China.	lizhigao@ncst.edu.cn; keminlqliu@sina.com					Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Brown AJ, 2013, CALCIFIED TISSUE INT, V93, P163, DOI 10.1007/s00223-013-9737-3; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Chen SY, 2007, J CLIN MICROBIOL, V45, P2054, DOI 10.1128/JCM.01519-06; Choudhary S, 2013, BONE, V56, P31, DOI 10.1016/j.bone.2013.04.017; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Dilling CF, 2010, J BONE MINER RES, V25, P1147, DOI 10.1359/jbmr.091031; Eun JP, 2007, SPINE, V32, P728, DOI 10.1097/01.brs.0000259070.66805.93; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fan QM, 2009, J CELL MOL MED, V13, P2489, DOI 10.1111/j.1582-4934.2008.00606.x; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Hanash SM, 2002, PROTEOMICS, V2, P69, DOI 10.1002/1615-9861(200201)2:1<69::AID-PROT69>3.0.CO;2-8; Hisada K, 2013, J BONE MINER METAB, V31, P53, DOI 10.1007/s00774-012-0385-x; Ikeda T, 2014, J CELL MOL MED, V18, P170, DOI 10.1111/jcmm.12180; Kobashi G, 2008, SPINE, V33, pE553, DOI 10.1097/BRS.0b013e31817e9de2; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; KUSHNER I, 1972, J LAB CLIN MED, V80, P18; Lim YK, 2000, KIDNEY INT, V58, P1033, DOI 10.1046/j.1523-1755.2000.00261.x; Matsui S.M., 1996, FIELDS VIROLOGY, P811; Meyers C, 2019, JBMR PLUS, V27; Munkhtulga L, 2010, OBESITY, V18, P1006, DOI 10.1038/oby.2009.358; Murphy S, 2018, EXPERT REV PROTEOMIC, V15, P277, DOI 10.1080/14789450.2018.1429923; Rodenberg E, 2011, TISSUE ENG PT A, V17, P2487, DOI [10.1089/ten.tea.2011.0007, 10.1089/ten.TEA.2011.0007]; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schurch B, 1997, ARCH PHYS MED REHAB, V78, P687, DOI 10.1016/S0003-9993(97)90074-5; Shiigi E, 2001, J BONE MINER METAB, V19, P308, DOI 10.1007/s007740170015; Smeets MB, 2002, FEBS LETT, V529, P221, DOI 10.1016/S0014-5793(02)03343-4; Stevens AL, 2008, ARTHRITIS RHEUM-US, V58, P489, DOI 10.1002/art.23120; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Tzaphlidou M, 2000, BONE, V27, P635, DOI 10.1016/S8756-3282(00)00382-3; Vanden Bossche L, 2008, EUR J PHYS REHAB MED, V44, P423; WADA T, 1970, J RETICULOENDOTH SOC, V8, P185; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zeiser JJ, 2011, J PROTEOMICS, V75, P469, DOI 10.1016/j.jprot.2011.08.012; Zhuang Y, 2014, J TRAUMA SURG, V16, P147; Zychowicz ME, 2013, ORTHOP NURS, V32, P173, DOI 10.1097/NOR.0b013e3182920d85	41	1	1	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2020	52	1							jrm00001	10.2340/16501977-2622			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KK8MF	WOS:000512989800003	31663601	gold			2022-02-06	
S	Mishra, SK; Khushu, S; Gangenahalli, G		Turksen, K		Mishra, Sushanta Kumar; Khushu, Subash; Gangenahalli, Gurudutta			A Distinctive MRI-Based Absolute Bias Correction Protocol for the Potential Labelling and In Vivo Tracking of Stem Cells in a TBI Mice Model	IMAGING AND TRACKING STEM CELLS, 2 EDITION: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Absolute bias correction; Magnetic resonance imaging; Mesenchymal stem cells; Relaxometry; Stem cell labelling; Stem cell tracking; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONTRAST AGENT; OPTIMIZATION	Traumatic brain injury (TBI) is a leading cause of death and disability. The condition is difficult to treat owing to its heterogeneous nature and complex biological pathways. Stem cell transplantation is an emerging self-deliverable therapeutic modality which could immensely improve the invigorating management of the problem. The synergistic interaction of the stem cells with the paracrine niche molecules at the site of injury is an end point that decides the cells' effective tissue-forming regenerative response. Thus, noninvasive monitoring and tracking of the infused stem cells is quite decisive after transplantation. Here, we have designed and validated a distinctive in vivo magnetic resonance imaging protocol to monitor the transplanted mesenchymal stem cells (MSCs) longitudinally in TBI-induced mice. We have further described the synthesis of improved transverse relaxivity contrast agent, a protocol for the efficient labelling of MSCs, preparation of a TBI model system in mice, and the imaging and tracking of the implanted stem cells at the injury site through 7T MRI. MGE-T2* imaging in association with relaxometry-based quantitative assessment using absolute bias correction provided a suitable mechanism to monitor and track the infused labelled stem cells at the TBI site. High transverse relaxivity negative contrast agent synthesis, MSC labelling procedure, and quantitative T2* time measurement normalized with absolute bias correction are the key features of this protocol. This procedure has immense application potential and could therefore be extrapolated to stem cell tracking during the treatment of various diseases.	[Mishra, Sushanta Kumar; Khushu, Subash] DRDO, MRI Res Grp, Inst Nucl Med & Allied Sci INMAS, Delhi, India; [Mishra, Sushanta Kumar; Gangenahalli, Gurudutta] DRDO, Div Stem Cells & Gene Therapy Res, Inst Nucl Med & Allied Sci INMAS, Delhi, India					Mishra, Sushanta/0000-0002-3403-6891	Indian Council of Medical ResearchIndian Council of Medical Research (ICMR) [ICMR-25070/2014]; Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 323]	We wish to thank Defence Research and Development Organization (DRDO), Ministry of Defence, Govt. of India, for providing S & T project (INM-311 & 323). Sincere thanks to the Indian Council of Medical Research (ICMR-25070/2014) for providing a Research Associate fellowship to Dr. Sushanta Kumar Mishra in support of the project.	Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Mishra SK, 2018, STEM CELL REV REP, V14, P888, DOI 10.1007/s12015-018-9828-7; Mishra SK, 2018, TOXICOL IN VITRO, V50, P179, DOI 10.1016/j.tiv.2018.03.009; Mishra SK, 2017, EXP CELL RES, V351, P59, DOI 10.1016/j.yexcr.2016.12.025; Mishra SK, 2017, STEM CELL TRANSL MED, V6, P316, DOI 10.5966/sctm.2016-0087; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Mishra SK, 2016, CONTRAST MEDIA MOL I, V11, P350, DOI 10.1002/cmmi.1698; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087	17	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-0716-0627-8; 978-1-0716-0626-1	METHODS MOL BIOL	Methods Mol. Biol.		2020	2150						93	111		10.1007/7651_2019_277	10.1007/978-1-0716-0627-8		19	Biochemical Research Methods; Cell & Tissue Engineering; Cell Biology; Radiology, Nuclear Medicine & Medical Imaging	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Cell Biology; Radiology, Nuclear Medicine & Medical Imaging	BS0CK	WOS:000680871700008	31802432				2022-02-06	
J	Mohammaddoust, M; Chokan, NMJ; Farahi, SMM; Tavakolian, A; Foroughia, M				Mohammaddoust, Mohammad; Chokan, Niaz-Mohammad Jafari; Farahi, Seyedeh Maryam Moshirian; Tavakolian, Ayoub; Foroughia, Mandi			ACEP's Recommendations for Brain Computed Tomography Scan in Adult Minor Head Trauma Patients; a Diagnostic Accuracy Study	ARCHIVES OF ACADEMIC EMERGENCY MEDICINE			English	Article						Craniocerebral Trauma; Brain; Tomography; X-Ray Computed; Health Planning Guidelines	NEW-ORLEANS CRITERIA; EXTERNAL VALIDATION; DECISION INSTRUMENT; NEXUS-II; INJURY; RULE	Introduction: Some clinical decision rules have been developed to identify minor head trauma (MHT) patients in need of brain computed tomography (CT) scan for detection of possible traumatic brain injuries (TBIs). This study aimed to evaluate the performance of American College of Emergency Physicians (ACEP) recommendations in this regard. Methods: This study is a cross-sectional study of MHT (GCS: 13-15) cases who referred to emergency department of a level one trauma center, Mashhad, Iran, from October 2017 to March 2018. The screening performance characteristics of ACEP recommendations for performing brain CT scan in these patients were calculated. Results: 500 patients with a mean age of 37.97 +/- 15.96 years were evaluated. Based on level one recommendations, 73 (14.6 %) patients had to be assessed by brain CT scan. 67 (91.8%) were assessed and 6 (8.2%) were not assessed based on decision of their in-charge physician. According to level two recommendations, 125 (25.0%) patients did not need brain CT scan, 85 (68%) of whom had been assessed (all normal). Performing brain CT scan according to the level one recommendation of ACEP's clinical policy showed 29.6% sensitivity (95% CI: 13.75 to 50.18) and 86.3% specificity (95% CI: 82.68 to 89.14). The overall ACEP's clinical policy for neuroimaging of adults with MTBI showed sensitivity and specificity of 92.59% (95% CI: 75.71 to 99.09) and 26.4% (95% CI: 22.51 to 30.65), respectively. Conclusion: ACEP's clinical policy has a high-level sensitivity for using brain CT scan in detection of probable TBI in patients with MHT.	[Mohammaddoust, Mohammad] Mashhad Univ Med Sci, Dept Emergency Med, Mashhad, Razavi Khorasan, Iran; [Chokan, Niaz-Mohammad Jafari; Foroughia, Mandi] Mashhad Univ Med Sci, Dept Emergency Med, Fac Med, Mashhad, Razavi Khorasan, Iran; [Farahi, Seyedeh Maryam Moshirian] Salman Inst Higher Educ, Dept Psychol, Mashhad, Razavi Khorasan, Iran; [Tavakolian, Ayoub] Sabzevar Univ Med Sci, Fac Med, Dept Emergency Med, Sabzevar, Iran		Foroughia, M (corresponding author), Mashhad Univ Med Sci, Dept Emergency Med, Fac Med, Mashhad, Razavi Khorasan, Iran.	foroughianmh@mums.ac.ir			Mashhad University of Medical Sciences	This study was supported by Mashhad University of Medical Sciences.	Abdalla RO, 2015, ANN AFRICAN SURG, V12, P115; Anish TS, INT J CRITICAL ILLNE; [Anonymous], 2004, EMERGENCY MED NEWS, V26, P5; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Elgamal Essam A., 2006, EUR J TRAUMA, V32, P527, DOI [10.1007/s00068-006-5156-8, DOI 10.1007/S00068-006-5156-8]; Hsiao KY, 2017, HONG KONG J EMERG ME, V24, P73; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Maguen S, 2012, MIL MED, V177, P797, DOI 10.7205/MILMED-D-11-00412; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Mower WR, 2017, J EMERG MED, V53, P441; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Rosengren David, 2004, Emerg Med Australas, V16, P195, DOI 10.1111/j.1742-6723.2004.00563.x; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511	21	1	1	0	0	SHAHID BEHESHTI UNIV MEDICAL SCIENCES	TEHRAN	EMERGENCY MEDICINE DEPT, SHOHADAYE TAJRISH HOSP, SHAHRDARI ST, TAJRISH SQ, TEHRAN, 1989934148, IRAN		2645-4904		ARCH ACAD EMERG MED	Arch. Acad. Emerg. Med.		2020	8	1							e86				5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	OS2HG	WOS:000589986700001	33244521				2022-02-06	
S	Munakomi, S; Poudel, D; Shrestha, S		Pokorski, M		Munakomi, Sunil; Poudel, Deepak; Shrestha, Sangam			Reliability of Magnetic Resonance Tractography in Predicting Early Clinical Improvements in Patients with Diffuse Axonal Injury Grade III	TRENDS IN BIOMEDICAL RESEARCH	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Axonal injury; Brain; Corticospinal tracts; Dysautonomia; Magnetic resonance; Tractography	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; LONGITUDINAL MRI; WHITE-MATTER; MODERATE; DYSAUTONOMIA; PROGNOSIS; RECOVER; LESIONS	Diffuse axonal injury (DAI) grade III forms a distinct subset of traumatic brain injury wherein it is difficult to predict the outcome and the time taken for early recovery in terms of sustained eye opening and standing with minimal assistance. This study seeks to determine differences in the fractional anisotropy (FI) and diffusion-weighted image (DWI) values obtained from the seeds placed at an appropriate region of interest (ROI) within the magnetic resonance (MR) tractography of the brainstem of brain-injured patients. We found that differences in the DWI values along the corticospinal tract were associated with the days required for early recovery. Moreover, dysautonomia was an independent variable governing a delayed recovery in these patients. The lesions posterior to the corticospinal tract in the brainstem conferred increased odds for the subsequent development of dysautonomia. We conclude that MR tractography, in addition to depicting the anatomical integrity of the concerned tracts, has the potential of becoming a surrogate clinical imaging marker for effectively predicting days for early recovery among patients with DAI grade III.	[Munakomi, Sunil] Nobel Med Coll & Teaching Hosp, Dept Neurosurg, Biratnagar, Nepal; [Poudel, Deepak] Nobel Med Coll & Teaching Hosp, Dept Gen Anesthesia, Biratnagar, Nepal; [Shrestha, Sangam] Koshi Zonal Hosp, Dept Pediat, Biratnagar, Nepal		Munakomi, S (corresponding author), Nobel Med Coll & Teaching Hosp, Dept Neurosurg, Biratnagar, Nepal.	sunilmunakomi@gmail.com					Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Eum SW, 1998, J KOREAN NEUROSURG S, V27, P1668; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Gennarelli T. A., 1987, HEAD INJURY, P108; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kim CH, 1997, J KOREAN NEUROSURG S, V26, P241; Kim HJ, 2001, J KOREAN NEUROSURG S, V30, P168; Lee Hak-Jae, 2018, [Journal of Trauma and Injury, 대한외상학회지], V31, P51; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Oh KS, 2001, J KOREAN NEUROSUR S1, V30, pS20; Park SJ, 2009, J KOREAN NEUROSURG S, V46, P205, DOI 10.3340/jkns.2009.46.3.205; Park SW, 1991, J KOREAN NEUROSURG S, V20, P983; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; van Eijck M, 2018, J NEUROTRAUM, V35, P2357, DOI 10.1089/neu.2018.5650; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	34	1	2	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-41219-7; 978-3-030-41218-0	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2020	1251						19	28		10.1007/5584_2019_445	10.1007/978-3-030-41219-7		10	Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	BP4XP	WOS:000554915400002	31792809				2022-02-06	
J	Naud, R; Guinde, J; Astoul, P				Naud, Romain; Guinde, Julien; Astoul, Philippe			Pulmonary cement embolism complicating percutaneous kyphoplasty: A case report	RESPIRATORY MEDICINE CASE REPORTS			English	Article						Cement embolism; Kyphoplasty; Pulmonary embolism; Vertebroplasty; Pulmonary cement embolism	VERTEBROPLASTY	Background: Vertebral cement augmentation procedures, as kyphoplasty (KP) or percutaneous vertebroplasty (PVP), are commonly used for the management of pain of the vertebral column usually due to fractures related to traumatic injury, osteoporosis or metastatic lesion. It is a useful and safe technique with few complications. Among them, symptomatic pulmonary cement embolism (PCE) can happened, even rarely described in the literature, leading to severe cardio-respiratory manifestations depending on the location and size of the cement emboli. Case presentation: A 55 yo woman presented with atypical chest pain and presyncope three weeks after a motor vehicle accident resulting in an L1 compression fracture treated with kyphoplasty. She was hemodynamically stable. Blood tests showed D-Dimer 0.29 mu g/mL, troponin <5ng/mL, Brain Natriuretic Protein 14 ng/mL and a PaO2 of 99 mmHg on arterial blood gas analysis. A computed tomography scan of chest showed linear hyperdense foreign bodies in two segmental pulmonary arteries at the level of middle lobe and right lower lobe compatible with pulmonary cement embolism. Anticoagulation with rivaroxaban for sixth months resulted in resolution of symptoms. Conclusions: In this case, the pulmonary cement embolism occurred after kyphoplasty, which is associated with less risk of PCE than vertebroplasty. The procedure was done under biplanar fluoroscopy and no leakage of cement was noted, which would raise suspicion for CPE. Repeat imagine after this procedure is not routinely done. This case demonstrates that systematic imaging post procedure should be considered. An anticoagulation with rivaroxaban seems to be effective in our patient.	[Naud, Romain; Guinde, Julien; Astoul, Philippe] Hop Nord Marseille, Dept Thorac Oncol Pleural Dis & Intervent Pulmono, Chemin Bourrely, F-13915 Marseille 20, France; [Astoul, Philippe] Aix Marseille Univ, Marseille, France		Astoul, P (corresponding author), Hop Nord Marseille, Dept Thorac Oncol Pleural Dis & Intervent Pulmono, Chemin Bourrely, F-13915 Marseille 20, France.	pastoul@ap-hm.fr					Eck JC, 2008, SPINE J, V8, P488, DOI 10.1016/j.spinee.2007.04.004; Ignacio JMF, 2018, ASIAN SPINE J, V12, P380, DOI 10.4184/asj.2018.12.2.380; Kang HR, 2020, J THROMB THROMBOLYS, V49, P468, DOI 10.1007/s11239-019-02027-0; Luetmer MT, 2011, AM J NEURORADIOL, V32, P654, DOI 10.3174/ajnr.A2368; Venmans A, 2010, AM J NEURORADIOL, V31, P1451, DOI 10.3174/ajnr.A2127	5	1	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-0071			RESPIR MED CASE REP	Respir. Med. Case Rep.		2020	31								101188	10.1016/j.rmcr.2020.101188			3	Respiratory System	Emerging Sources Citation Index (ESCI)	Respiratory System	PH8PS	WOS:000600668000051	32923362	gold, Green Published			2022-02-06	
J	O'Donoghue, C; Meixner, C				O'Donoghue, Cynthia; Meixner, Cara			A qualitative study of providers' decision-making for cases involving neurobehavioral issues	COGENT PSYCHOLOGY			English	Article						brain injury; neurobehavioral; interprofessional team; rehabilitation; community-based care	TRAUMATIC BRAIN-INJURY; REHABILITATION	Across the continuum of care, providers representing multiple professions (i.e., rehabilitation, medical, mental health) influence post-acute care planning for persons with brain injury, yet insufficient evidence informs how decisions are made. The need to understand provider decision-making is paramount, particularly for a person with brain injury whose sequelae necessitates integrated, interprofessional care. Using vignettes drawn from authentic scenarios, this qualitative study investigated case management decisions made by providers serving individuals with varying neurobehavioral needs. Responses to three open-ended scenarios concerning neurobehavioral service provision were collected, coded, and analyzed in accordance with rigorous qualitative conventions. Participants (n = 84) represented an array of organizations serving persons with brain injury. The results revealed two courses of action: dominant and supporting. Although most respondents indicated integrated care as the ideal pathway, their concretized recommendations yielded actions focused on a single referral within the traditional medical model rather than an interdisciplinary approach. While integrated, interprofessional treatment and working across systems are considered optimal, this study suggests that in the current practice such a model is still evolving. This duel between "ideal" and "actual" highlights the need for further study, as well as resources to support best practices in rehabilitation and recovery.	[O'Donoghue, Cynthia; Meixner, Cara] James Madison Univ, Commun Sci & Disorders, Harrisonburg, VA 22807 USA; James Madison Univ, Grad Psychol, Harrisonburg, VA 22807 USA		O'Donoghue, C (corresponding author), James Madison Univ, Commun Sci & Disorders, Harrisonburg, VA 22807 USA.	odonogcr@jmu.edu			Commonwealth Neurotrauma Initiative Trust Fund	This work was supported by the Commonwealth Neurotrauma Initiative Trust Fund [NA].	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Albrecht JS, 2017, ARCH PHYS MED REHAB, V98, P2548, DOI 10.1016/j.apmr.2017.06.007; [Anonymous], 1998, NIH CONS DEV PROGR A; [Anonymous], 2015, TRAUM BRAIN INJ HOP; Baddeley A.D., 1986, WORKING MEMORY; Bouchard K, 2016, QUAL REP, V21, P59; Buchanan EA, 2000, J INFORM ETHICS, V9, P82; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Creswell JW, 2017, QUALITATIVE INQUIRY; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Evans JJ, 2001, BRAIN DAM B, P209; Gadoba D., 2009, TRAUMATIC BRIAN INJU; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Lorenz L, 2015, ISSUE BRIEF MASS HLT, V10, p[1, 1]; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Meixner C, 2013, REHABIL PSYCHOL, V58, P377, DOI 10.1037/a0033892; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; O'Donoghue CR, 2015, ACCESS NEUROBEHAVIOR; Pal R, 2020, J NEUROSCI RURAL PRA, V11, P3, DOI 10.1055/s-0040-1701540; Payne L, 2018, BRAIN INJURY, V32, P980, DOI 10.1080/02699052.2018.1468573; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Schumacher R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0801-7; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wood RL, 2001, BRAIN DAM B, P3; Zasler Nathan D, 2013, Handb Clin Neurol, V110, P377, DOI 10.1016/B978-0-444-52901-5.00032-0	33	1	1	0	1	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	2331-1908			COGENT PSYCHOL	Cogent Psychol.	JAN 1	2020	7	1							1788330	10.1080/23311908.2020.1788330			11	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	MI0UP	WOS:000547132900001		gold			2022-02-06	
J	Ondek, K; Lucero, S; Zwienenberg, M; Gurkoff, G				Ondek, Katelynn; Lucero, Steven; Zwienenberg, Marike; Gurkoff, Gene			An implantable helmet for studying repeat TBI	METHODSX			English	Article						Repeat injury; Sports injury; mTBI		An estimated 3.8 million traumatic brain injuries (TBI) occur each year, the majority classified as mild. Interest in models of mild and repeat mild TBI has grown due to reports of lasting morbidity following sports- or combat-related injury. There remains a paucity of data linking cellular or systems-related mechanisms to behavioral outcomes following repeat mild TBI, particularly in adolescent and adult rats. It is critical, therefore, to develop flexible models to evaluate which parameters of injury are associated with brain vulnerability or poor chronic outcome compared to normal recovery. While there are several existing models of repeat mild TBI in rodents, studying the effects of multiple hits has been complicated by the need for multiple survival surgeries, extensive pre-injury anesthesia time, and limitations due to animal skull thickness. We developed a chronic "helmet" implant by combining aspects of the Impact Acceleration and Controlled Cortical Impact models. Implants were performed days before injury, allowing us to decouple surgery from TBI. Critically, by pre-implanting the animals, only minimal anesthesia was required to position them under the impactor. The implant allows for flexibility in the number and severity of injuries and interval between impacts. (C) 2020 The Authors. Published by Elsevier B.V.	[Ondek, Katelynn; Zwienenberg, Marike; Gurkoff, Gene] Univ Calif Davis, Dept Neurol Surg, 1515 Newton Ct, Davis, CA 95618 USA; [Lucero, Steven] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95618 USA		Gurkoff, G (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Ct, Davis, CA 95618 USA.	kondek@ucdavis.edu; salucero@ucdavis.edu; mzwien@ucdavis.edu; gggurkoff@ucdavis.edu		Ondek, Katelynn/0000-0002-9116-0805	Children's Miracle Network grant [CMNMZ12]	University of California, Davis TEAM lab for manufacture of the plastic implant, as well as Ramesh Ragupathi, Jimmy Huh, Mayumi Prins, Kathryn Saatman, and Michelle LaPlaca for discussion related to model development and validation. We would also like to thank the Children's Miracle Network grant CMNMZ12 for financial support.	Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Ondek K, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113360; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800	3	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2215-0161		METHODSX	MethodsX		2020	7								101142	10.1016/j.mex.2020.101142			7	Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics	PS0YW	WOS:000607658900002	33318954	Green Published, gold			2022-02-06	
S	Orman, G; Rossi, A; Meoded, A; Huisman, TAGM		Hodler, J; KubikHuch, RA; VonSchulthess, GK		Orman, Gunes; Rossi, Andrea; Meoded, Avner; Huisman, Thierry A. G. M.			Children with Acute Neurological Emergency	DISEASES OF THE BRAIN, HEAD AND NECK, SPINE 2020-2023: DIAGNOSTIC IMAGING	IDKD Springer Series		English	Article; Book Chapter							ARTERIAL ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; UNIQUE FEATURES; PEDIATRIC SKULL; COMPLICATIONS; MECHANISMS; DIAGNOSIS; PATTERNS; CRITERIA		[Orman, Gunes; Meoded, Avner; Huisman, Thierry A. G. M.] Texas Childrens Hosp, Edward B Singleton Dept Radiol, Houston, TX 77030 USA; [Rossi, Andrea] IRCCS Ist Giannina Gaslini, Neuroradiol Unit, Genoa, Italy		Orman, G (corresponding author), Texas Childrens Hosp, Edward B Singleton Dept Radiol, Houston, TX 77030 USA.	gxorman@texaschildrens.org; andrearossi@gaslini.org; axmeoded@texaschildrens.org; huisman@texaschildrens.org					Bansal LR, 2019, PEDIATR NEUROL, V97, P12, DOI 10.1016/j.pediatrneurol.2019.03.018; Barrot A, 2016, NEURORADIOL J, V29, P317, DOI 10.1177/1971400916665389; Chang PT, 2016, MAGN RESON IMAGING C, V24, P449, DOI 10.1016/j.mric.2015.11.009; Filippi M, 2016, LANCET NEUROL, V15, P292, DOI 10.1016/S1474-4422(15)00393-2; Gadian DG, 2000, J CHILD NEUROL, V15, P279, DOI 10.1177/088307380001500502; Huisman TAGM, 2010, CHILD NERV SYST, V26, P1275, DOI 10.1007/s00381-010-1203-1; Jordan LC, 2011, NAT REV NEUROL, V7, P199, DOI 10.1038/nrneurol.2011.23; Kahle KT, 2016, LANCET, V387, P788, DOI 10.1016/S0140-6736(15)60694-8; Lall Neil U, 2015, Top Magn Reson Imaging, V24, P291, DOI 10.1097/RMR.0000000000000068; Langford S, 2015, NEURORADIOLOGY, V57, P1263, DOI 10.1007/s00234-015-1584-7; Lee S, 2017, PEDIATR NEUROL, V69, P37, DOI 10.1016/j.pediatrneurol.2016.12.008; Mackay MT, 2011, ANN NEUROL, V69, P130, DOI 10.1002/ana.22224; Meoded A, 2011, AM J NEURORADIOL, V32, P1806, DOI 10.3174/ajnr.A2606; Meoded A, 2014, J NEURORADIOLOGY, V41, P108, DOI 10.1016/j.neurad.2013.04.002; Meyer-Heim AD, 2003, BRAIN DEV-JPN, V25, P416, DOI 10.1016/S0387-7604(03)00029-9; Nickerson JP, 2012, J NEUROIMAGING, V22, pe52, DOI 10.1111/j.1552-6569.2011.00699.x; Nickerson JP, 2012, J NEUROIMAGING, V22, pe42, DOI 10.1111/j.1552-6569.2011.00700.x; Orman G, 2014, CHILD NERV SYST, V30, P307, DOI 10.1007/s00381-013-2288-0; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Prabhu SP, 2010, NEUROIMAG CLIN N AM, V20, P663, DOI 10.1016/j.nic.2010.07.008; Saigal G, 2018, NEUROIMAG CLIN N AM, V28, P453, DOI 10.1016/j.nic.2018.03.007; Shack M, 2017, DEV MED CHILD NEUROL, V59, P31, DOI 10.1111/dmcn.13214; Shellhaas RA, 2006, PEDIATRICS, V118, P704, DOI 10.1542/peds.2005-2676; Simonetti BG, 2015, NEUROLOGY, V84, P1941, DOI 10.1212/WNL.0000000000001555; Singh RK, 2003, ACTA RADIOL, V44, P550, DOI 10.1034/j.1600-0455.2003.00118.x; Stacey A, 2018, STROKE, V49, P842, DOI 10.1161/STROKEAHA.117.020159; Tenembaum SN, 2017, NEUROIMAG CLIN N AM, V27, P229, DOI 10.1016/j.nic.2016.12.007; Topjian AA, 2012, NEUROCRIT CARE, V17, P441, DOI 10.1007/s12028-012-9747-4; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	30	1	1	1	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2523-7829	2523-7837	978-3-030-38490-6; 978-3-030-38489-0	IDKD SPR SER			2020							179	190		10.1007/978-3-030-38490-6_14	10.1007/978-3-030-38490-6		12	Radiology, Nuclear Medicine & Medical Imaging	Book Citation Index – Science (BKCI-S)	Radiology, Nuclear Medicine & Medical Imaging	BR9AA	WOS:000674771800015		Green Published, hybrid			2022-02-06	
B	Pan, JZ; Meng, LZ		Brambrink, AM; Kirsch, JR		Pan, Jonathan Z.; Meng, Lingzhong			Traumatic Brain Injury: Risk Assessment and Perioperative Management	ESSENTIALS OF NEUROSURGICAL ANESTHESIA & CRITICAL CARE: STRATEGIES FOR PREVENTION, EARLY DETECTION, AND SUCCESSFUL MANAGEMENT OF PERIOPERATIVE COMPLICATIONS, 2ND EDITION			English	Article; Book Chapter									[Pan, Jonathan Z.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA; [Meng, Lingzhong] Yale Univ, Sch Med, Dept Anesthesiol, Div Neuro Anesthesia, New Haven, CT 06510 USA		Pan, JZ (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA.	jonathan.pan@ucsf.edu					Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dutton RP, 2010, MILLERS ANESTHESIA, P2277; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; Harris MB, 2006, SPINE, V31, pS9, DOI 10.1097/01.brs.0000217924.56853.0d; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Matjasko MJ, 2001, ANESTHESIA NEUROSURG, P693; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128	8	1	1	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND			978-3-030-17410-1; 978-3-030-17408-8				2020							67	75		10.1007/978-3-030-17410-1_10	10.1007/978-3-030-17410-1		9	Anesthesiology; Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Anesthesiology; General & Internal Medicine; Neurosciences & Neurology	BQ2UX	WOS:000582667500012					2022-02-06	
J	Perry, A; Mallah, MD; Cunningham, KW; Christmas, AB; Marrero, JJ; Gombar, MA; Davis, ML; Miles, WS; Jacobs, DG; Fischer, PE; Sing, RF; Thomas, BW				Perry, Alvin; Mallah, Mike D.; Cunningham, Kyle W.; Christmas, A. Britton; Marrero, Jennifer J.; Gombar, Meridith A.; Davis, Michael L.; Miles, William S.; Jacobs, David G.; Fischer, Peter E.; Sing, Ronald F.; Thomas, Bradley W.			PATHway to success: Implementation of a multiprofessional acute trauma health care team decreased length of stay and cost in patients with neurological injury requiring tracheostomy	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	32nd Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma (EAST)	JAN 15-19, 2019	Austin, TX	Eastern Assoc Surg Trauma		Multidisciplinary care; SCI; TBI; LEAN	IMPROVEMENT	BACKGROUND The aim of this study was to determine whether the implementation of a dedicated multiprofessional acute trauma health care (mPATH) team would decrease length of stay without adversely impacting outcomes of patients with severe traumatic brain and spinal cord injuries. The mPATH team was comprised of a physical, occupational, speech, and respiratory therapist, nurse navigator, social worker, advanced care provider, and physician who performed rounds on the subset of trauma patients with these injuries from the intensive care unit to discharge. METHODS Following the formation and implementation of the mPATH team at our Level I trauma center, a retrospective cohort study was performed comparing patients in the year immediately prior to the introduction of the mPATH team (n = 60) to those in the first full year following implementation (n = 70). Demographics were collected for both groups. Inclusion criteria were Glasgow Coma Scale score less than 8 on postinjury Day 2, all paraplegic and quadriplegic patients, and patients older than 55 years with central cord syndrome who underwent tracheostomy. The primary endpoint was length of stay; secondary endpoints were time to tracheostomy, days to evaluation by occupational, physical, and speech therapy, 30-day readmission, and 30-day mortality. RESULTS The median time to evaluation by occupational, physical, and speech therapy was universally decreased. Injury Severity Score was 27 in both cohorts. Time to tracheostomy and length of stay were both decreased. Thirty-day readmission and mortality rates remained unchanged. A cost savings of US $11,238 per index hospitalization was observed. CONCLUSION In the year following the initiation of the mPATH team, we observed earlier time to occupational, physical, and speech therapist evaluation, decreased length of stay, and cost savings in severe traumatic brain and spinal cord injury patients requiring tracheostomy compared with our historical control. These benefits were observed without adversely impacting 30-day readmission or mortality.	[Perry, Alvin; Mallah, Mike D.; Cunningham, Kyle W.; Christmas, A. Britton; Marrero, Jennifer J.; Gombar, Meridith A.; Davis, Michael L.; Miles, William S.; Jacobs, David G.; Fischer, Peter E.; Sing, Ronald F.; Thomas, Bradley W.] Carolinas Med Ctr, Div Acute Care Surg, Dept Surg, Charlotte, NC 28203 USA; [Fischer, Peter E.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA		Thomas, BW (corresponding author), POB 32861, Charlotte, NC 28232 USA.	Bradley.thomas@atriumhealth.org		Cunningham, Kyle/0000-0002-6526-183X			Borenstein JE, 2016, NURS OUTLOOK, V64, P137, DOI 10.1016/j.outlook.2015.11.014; Cameron TS, 2009, CRIT CARE RESUSC, V11, P14; de Mestral C, 2011, CAN J SURG, V54, P167, DOI 10.1503/cjs.043209; Donovan AL, 2018, CRIT CARE MED, V46, P980, DOI 10.1097/CCM.0000000000003067; Glasgow JM, 2010, JT COMM J QUAL PATIE, V36, P533, DOI 10.1016/S1553-7250(10)36081-8; LeBlanc J, 2010, J HEAD TRAUMA REHAB, V25, P362, DOI 10.1097/HTR.0b013e3181cd67ea; Niemeijer GC, 2013, J EVAL CLIN PRACT, V19, P909, DOI 10.1111/j.1365-2753.2012.01875.x; O'Mara MS, 2014, J TRAUMA ACUTE CARE, V77, P137, DOI 10.1097/TA.0000000000000261	8	1	1	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2020	88	1					176	179		10.1097/TA.0000000000002494			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	KB7JL	WOS:000506666700027	31464872				2022-02-06	
J	Raffee, L; Abuzayed, B; Al Qawasmeh, M; Alawneh, K; Abdalla, K; Aleshawi, A				Raffee, Liqaa; Abuzayed, Bashar; Al Qawasmeh, Majdi; Alawneh, Khaled; Abdalla, Khalid; Aleshawi, Abdelwahab			ISOLATED RETRODENTAL EPIDURAL HEMATOMA WITHOUT DENS FRACTURE	JOURNAL OF EMERGENCY MEDICINE			English	Article						epidural hematoma; odontoid process; retrodental; dens; trauma	RETROCLIVAL HEMATOMA	Background: Traumatic spinal epidural hematomas (TSEDH) are rare, with the reported incidence being < 1% of all spinal injuries. Causes of TSEDHs include vertebral fractures, obstetrical birth trauma, lumbar punctures, postsurgical bleeding, epidural anesthesia, and missile injuries. The retrodental location has not been reported as a location for spontaneous epidural hematoma. Case Report: A 4-year-old boy was admitted to our Emergency Department after falling down and experiencing head trauma. Glasgow Coma Scale score was 15/15 with no neurologic deficit. Brain computed tomography scan showed isolated hyperdense hematoma in the retrodental area without any fractures in the skull or cervical vertebrae. Brain and cervical magnetic resonance imaging showed a retrodental acute hematoma that was isointense in T1-weighted sequences and hypointense in T2-weighted sequences. The hematoma was in the epidural space with possible odontoid process intracapsular origin. Why Should an Emergency Physician Be Aware of This?: Isolated retrodental epidural hematoma without dens fracture is an extremely rare pathology and finding, and to the best of our knowledge, this is the first case to be reported in the literature. Emergency physicians should consider this pathology for any patients presenting for head trauma with head hematoma. (C) 2019 Elsevier Inc. All rights reserved.	[Raffee, Liqaa] Jordan Univ Sci & Technol, Dept Accid & Emergency Med, Fac Med, POB 3030, Irbid 22110, Jordan; [Abuzayed, Bashar] Specialty Hosp, Amman, Jordan; [Al Qawasmeh, Majdi] Jordan Univ Sci & Technol, Div Neurol, Dept Neurosci, Fac Med, Irbid, Jordan; [Alawneh, Khaled; Abdalla, Khalid] Jordan Univ Sci & Technol, Dept Diagnost Radiol & Nucl Med, Fac Med, Irbid, Jordan; [Aleshawi, Abdelwahab] Jordan Univ Sci & Technol, Fac Med, Irbid, Jordan		Raffee, L (corresponding author), Jordan Univ Sci & Technol, Dept Accid & Emergency Med, Fac Med, POB 3030, Irbid 22110, Jordan.		Qawasmeh, Majdi Al/ABB-8952-2020	Qawasmeh, Majdi Al/0000-0002-0990-2487			Bruyn GW, 1976, HDB CLIN NEUROLOGY, P1; Chang FC, 2005, CLIN RADIOL, V60, P762, DOI 10.1016/j.crad.2004.12.008; Cuenca PJ, 2004, J EMERG MED, V27, P37, DOI 10.1016/j.jemermed.2004.02.008; Dixon A., 2014, DENS FRACTURE EPIDUR; FOO D, 1982, NEUROSURGERY, V11, P25, DOI 10.1227/00006123-198207010-00006; Groen RJM, 2004, ACTA NEUROCHIR, V146, P103, DOI 10.1007/s00701-003-0160-9; Nguyen HS, 2016, CHILD NERV SYST, V32, P1749, DOI 10.1007/s00381-016-3098-y; Hentschel S J, 2001, Spine (Phila Pa 1976), V26, pE525, DOI 10.1097/00007632-200111150-00025; Jackson R, 1869, LANCET, V2, P5, DOI 10.1016/s0140-6736(02)67624-x; Lim JJ, 2008, J KOREAN NEUROSURG S, V44, P84, DOI 10.3340/jkns.2008.44.2.84; Meoded A, 2011, AM J NEURORADIOL, V32, P1806, DOI 10.3174/ajnr.A2606; Perez-Bovet J, 2013, SPINAL CORD, V51, P926, DOI 10.1038/sc.2013.53; Rangarajan V, 2013, J CRANIOVERTEBRAL JU, V4, P37, DOI 10.4103/0974-8237.121624; Roy AK, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14785; Runge VM, 2014, NEURORADIOLOGY ESSEN; Samanci Y, 2019, PEDIAT EMERG CARE	16	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JAN	2020	58	1					67	71		10.1016/j.jemermed.2019.09.008			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KZ0RJ	WOS:000522979000022	31740157				2022-02-06	
J	Reuter-Rice, K; Christoferson, E				Reuter-Rice, Karin; Christoferson, Elise			CRITICAL UPDATE ON THE THIRD EDITION OF THE GUIDELINES FOR MANAGING SEVERE TRAUMATIC BRAIN INJURY IN CHILDREN	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; DEXAMETHASONE THERAPY; INTRACRANIAL-PRESSURE; HYPOTHERMIA; MANAGEMENT; HOSPITALIZATIONS; HYPERTHERMIA; TIME	Background Severe traumatic brain injury (TBI) is associated with high rates of death and disability. As a result, the revised guidelines for the management of pediatric severe TBI address some of the previous gaps in pediatric TBI evidence and management strategies targeted to promote overall health outcomes. Objectives To provide highlights of the most important updates featured in the third edition of the guidelines for the management of pediatric severe TBI.These highlights can help critical care providers apply the most current and appropriate therapies for children with severe TBI. Methods and Results After a brief overview of the process behind identifying the evidence to support the third edition guidelines, both relevant and new recommendations from the guidelines are outlined to provide critical care providers with the most current management approaches needed for children with severe TBI. Recommendations for neuroimaging, hyperosmolar therapy, analgesics and sedatives, seizure prophylaxis, ventilation therapies, temperature control/hypothermia, nutrition, and corticosteroids are provided. In addition, the complete guideline document and its accompanying algorithm for recommended therapies are available electronically and are referenced within this article. Conclusions The evidence base for treating pediatric TBI is increasing and provides the basis for high-quality care. This article provides critical care providers with a quick reference to the current evidence when caring for a child with a severe TBI. In addition, it provides direct access links to the comprehensive guideline document and algorithms developed to support critical care providers.	[Reuter-Rice, Karin] Duke Univ, Dept Pediat, Sch Med, Sch Nursing, Durham, NC 27710 USA; [Christoferson, Elise] Duke Univ, Sch Nursing, Durham, NC 27710 USA		Reuter-Rice, K (corresponding author), Duke Univ, Med Ctr, 307Trent Dr,DUMC 3322, Durham, NC 27710 USA.	karin.reuter-rice@duke.edu		Reuter-Rice, Karin/0000-0003-1501-8994	US Army Contracting Command, Aberdeen Proving Ground [W911 QY-14-C-0086]; US Army Contracting Command, Natick Contracting Division [W911 QY-14-C-0086]	This work was supported, in part, by the US Army Contracting Command, Aberdeen Proving Ground, and Natick Contracting Division, through a contract awarded to Stanford University (W911 QY-14-C-0086), a subcontract awarded to Oregon Health & Science University, and by the clinical investigators of the third edition of the guidelines for the management of pediatric severe TBI.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Briassoulis G, 2006, PEDIATR CRIT CARE ME, V7, P56, DOI 10.1097/01.PCC.0000192339.44871.26; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; FANCONI S, 1988, INTENS CARE MED, V14, P163; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KLOTI J, 1987, CHILD NERV SYST, V3, P103, DOI 10.1007/BF00271134; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Minardi C, 2012, CURR DRUG TARGETS, V13, P936, DOI 10.2174/138945012800675740; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teng SS, 2018, J EMERG CRIT CARE ME, V2, P1; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	30	1	1	1	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	JAN	2020	29	1					E13	E18		10.4037/ajcc2020228			6	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	NO3HB	WOS:000569374800002	31968082	Bronze			2022-02-06	
J	Rice, VJ; Schroeder, PJ; Cassenti, DN; Boykin, GL				Rice, Valerie J.; Schroeder, Paul J.; Cassenti, Daniel N.; Boykin, Gary L.			The Effect of Traumatic Brain Injury (TBI) on Cognitive Performance in a Sample of Active Duty US Military Service Members	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				METAANALYSIS; VETERANS	Introduction Traumatic brain injury (TBI) is considered a signature injury from the fighting in Iraq and Afghanistan. Since the year 2000, over 370,000 U.S. active duty service members have been diagnosed with TBI. Although prior research has shown that even mild forms of TBI are associated with impaired cognitive performance, it is not clear which facets of cognition (computation, memory, reasoning, etc.) are impacted by injury. Method In the present study, we compared active duty military volunteers (n = 88) with and without TBI on six measures of cognition using the Automated Neuropsychological Assessment Metric software. Results Healthy volunteers exhibited significantly faster response times on the matching-to-sample, mathematical processing, and second round of simple reaction time tasks and had higher throughput scores on the mathematical processing and the second round of the simple reaction time tasks (P < 0.05). Conclusion In this population, cognitive impairments associated with TBI influenced performance requiring working memory and basic neural processing (speed/efficiency).	[Rice, Valerie J.] Army Med Dept, Army Res Lab, Real World Soldier Quantificat Branch, Field Off 3162 McIndoe Rd,Bldg 1152, San Antonio, TX 78234 USA; [Schroeder, Paul J.] DCS Corp, 6909 Metro Pk Dr,Suite 500, Alexandria, VA 22310 USA; [Cassenti, Daniel N.] Army Res Lab, Bldg 459, Aberdeen Proving Ground, MD 21005 USA		Rice, VJ (corresponding author), Army Med Dept, Army Res Lab, Real World Soldier Quantificat Branch, Field Off 3162 McIndoe Rd,Bldg 1152, San Antonio, TX 78234 USA.			Schroeder, Paul/0000-0002-3612-342X	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Army Research Laboratory-Army Combat Capabilities Development Command	This study was supported by the U.S. Army Medical Research and Materiel Command and the U.S. Army Research Laboratory-Army Combat Capabilities Development Command.	Armed Forces Health Surveillance Branch, TRAUM BRAIN INJ TBI; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Cognitive Science Research Center, 2013, ANAM TECHN MAN; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Department of Defense, 11463 DEP DEF, P200; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elliott TR, 2017, J CLIN PSYCHOL, V73, P1160, DOI 10.1002/jclp.22414; Fuchs LS, 2008, J EDUC PSYCHOL, V100, P30, DOI 10.1037/0022-0663.100.1.30; Hecht SA, 2001, J EXP CHILD PSYCHOL, V79, P192, DOI 10.1006/jecp.2000.2586; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Swanson HL, 2006, J EDUC PSYCHOL, V98, P265, DOI 10.1037/0022-0663.98.2.265; Vasterling JJ, 2017, J INT NEUROPSYCH SOC, V23, P1	22	1	1	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			184	189		10.1093/milmed/usz202			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600028	32074326	Bronze			2022-02-06	
J	Rowlands, L; Coetzer, R; Turnbull, OH				Rowlands, Leanne; Coetzer, Rudi; Turnbull, Oliver H.			Building the bond: Predictors of the alliance in neurorehabilitation	NEUROREHABILITATION			English	Article						Therapeutic alliance; working alliance; cognitive predictors; neurorehabilitation; group psycho-education; group interventions; acquired brain injury	TRAUMATIC BRAIN-INJURY; THERAPEUTIC WORKING ALLIANCE; STROKE REHABILITATION; EXECUTIVE FUNCTION; HOSPITAL ANXIETY; SELF-AWARENESS; GROUP COHESION; DEPRESSION; ENGAGEMENT; SKILLS	BACKGROUND: Neurorehabilitation services are often delivered through group psycho-education programmes. However, little is known about the therapeutic process at work during such sessions. The present study is the first to gain insight into the therapeutic alliance, during a seven-session group programme. In addition, cognitive, emotional, and demographic predictors of the alliance, and participants' feelings towards their group members, were investigated, together with predictors of patient engagement. METHODS: Forty-five participants with an acquired brain injury completed a series of questionnaires, and neuropsychological assessment, following group psycho-education. The group facilitator completed a parallel therapeutic alliance questionnaire, and rated participants' engagement. RESULTS: Results demonstrated that a strong alliance can be formed in seven group sessions. Notably, no demographic or cognitive factors appear to pose a barrier to developing a therapeutic alliance, nor to group attraction. CONCLUSION: High levels of depression, however, may be a challenge, and clinicians may need to tailor their clinical skills to ensure a good therapeutic relationship with such patients. To promote engagement, clinicians may also need to provide additional support to patients with lower levels of education, working memory, and episodic memory impairment.	[Rowlands, Leanne; Coetzer, Rudi; Turnbull, Oliver H.] Bangor Univ, Sch Psychol, Brigantia Bldg,Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales; [Rowlands, Leanne; Coetzer, Rudi] Betsi Cadwaladr Univ Hlth Board, North Wales Brain Injury Serv, Colwyn Bay, Wales		Rowlands, L (corresponding author), Bangor Univ, Sch Psychol, Brigantia Bldg,Penrallt Rd, Bangor LL57 2AS, Gwynedd, Wales.	leanne.rowlands@bangor.ac.uk		Rowlands, Leanne/0000-0003-1130-5072	EU Social Fund through the Welsh Government	This study was supported by EU Social Fund through the Welsh Government. We would like to thank all the participants and staff at the NorthWales Brain Injury Service. Our gratitude also goes to patients' friends and family, and the Welsh Ambulance Service Non-Emergency Transport, for driving the participants to the psycho-education sessions.	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bishop M, 2021, DISABIL REHABIL, V43, P1074, DOI 10.1080/09638288.2019.1651909; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Bright FAS, 2017, CLIN REHABIL, V31, P1396, DOI 10.1177/0269215517694678; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Burgess P.W., 1997, HAYLING BRIXTON TEST; Byrne C, 2017, NEUROREHABILITATION, V41, P501, DOI 10.3233/NRE-162015; Coetzer B. R., 2003, J COGNITIVE REHABILI, V21, P4; Coetzer R., 2018, NEUROPSYCHOANALYSIS, V20, P3, DOI [10.1080/15294145.2018.1478747, DOI 10.1080/15294145.2018.1478747`]; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Couchman G, 2014, NEUROPSYCHOL REHABIL, V24, P809, DOI 10.1080/09602011.2014.912957; Crowe TP, 2008, CLIN PSYCHOL PSYCHOT, V15, P239, DOI 10.1002/cpp.583; Cruwys T, 2014, PERS SOC PSYCHOL REV, V18, P215, DOI 10.1177/1088868314523839; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Health, 2005, NAT SERV FRAM LONG T; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Efron B, 2003, STAT SCI, V18, P135, DOI 10.1214/ss/1063994968; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; EVANS NJ, 1986, SMALL GROUP BEHAV, V17, P203, DOI 10.1177/104649648601700205; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Gibbon B, 2004, JARNA, V7, P8; Goldstein K., 1965, ORGANISM; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krug E, 2019, NEUROPSYCHOL REHABIL, V29, P672, DOI 10.1080/09602011.2017.1319391; Lawton M, 2016, ARCH PHYS MED REHAB, V97, P1979, DOI 10.1016/j.apmr.2016.03.031; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P89; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Lustig D., 2003, J APPL REHABIL COUS, V34, P30; Maddux JE., 1995, SELF EFFICACY, P143, DOI [10.1007/978-1-4419-6868-5_5, DOI 10.1007/978-1-4419-6868-5_5]; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Marziali E, 1997, INT J GROUP PSYCHOTH, V47, P475, DOI 10.1080/00207284.1997.11490846; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McCormack B, 2010, SCAND J CARING SCI, V24, P620, DOI 10.1111/j.1471-6712.2010.00814.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moore PA, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01418; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Peckham AD, 2010, DEPRESS ANXIETY, V27, P1135, DOI 10.1002/da.20755; Peiris CL, 2012, J PHYSIOTHER, V58, P261, DOI 10.1016/S1836-9553(12)70128-5; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Ramanathan-Elion DM, 2016, REHABIL PSYCHOL, V61, P277, DOI 10.1037/rep0000095; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Rohde A, 2012, APHASIOLOGY, V26, P1298, DOI 10.1080/02687038.2012.706799; Rosti-Otajarvi E, 2014, J NEUROL SCI, V338, P156, DOI 10.1016/j.jns.2013.12.039; Salas C. E., 2012, NEUROPSYCHOANALYSIS, V14, P77, DOI DOI 10.1080/15294145.2012.10773691; Salas CE, 2018, NEUROPSYCHOL REHABIL, V28, P1161, DOI 10.1080/09602011.2016.1247730; Salibian-Barrera M, 2008, STAT METHOD APPL, V17, P41, DOI 10.1007/s10260-007-0048-6; Schonberger M, 2007, BRAIN INJURY, V21, P825, DOI 10.1080/02699050701499433; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Smith B, 2013, PHENOMENOL COGN SCI, V12, P615, DOI 10.1007/s11097-012-9264-0; Stagg K, 2019, DISABIL REHABIL, V41, P489, DOI 10.1080/09638288.2017.1396366; Tracey T.J., 1989, J CONSULT CLIN PSYCH, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207, 10.1037/1040-3590.1.3.207.]; Tyerman A., 2016, COMMUNITY BRAIN INJU; Watkins PC, 1996, J ABNORM PSYCHOL, V105, P34, DOI 10.1037/0021-843X.105.1.34; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; WHO, 2020, WHO METHODS DATA SOU; YALOM ID, 1966, ARCH GEN PSYCHIAT, V15, P267; Zelencich L, 2020, NEUROPSYCHOL REHABIL, V30, P1682, DOI 10.1080/09602011.2019.1600554; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	89	1	1	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	3					271	285		10.3233/NRE-193005			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LZ2AH	WOS:000541030200002	32310195	Green Submitted			2022-02-06	
J	Ryan, K; Garruppo, G; Alexander, K; Hluchan, CM; Lincoln, AE				Ryan, Kelly; Garruppo, Gabrielle; Alexander, Kezia; Hluchan, Christine M.; Lincoln, Andrew E.			Injuries among Maryland jockeys during thoroughbred racing: 2015-2019	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						horse racing; epidemiology; injury	PROFESSIONAL JOCKEYS; GREAT-BRITAIN; HORSE; FALLS; IRELAND; FLAT; FRANCE	Objectives Our goal was to characterise jockey injuries at Maryland racetracks during thoroughbred racing activities over 4 years using medical records maintained by the sports medicine team. Methods Injury data were prospectively gathered by sports medicine physicians who were onsite for all thoroughbred racing activities in Maryland from 12 September 2015 to 5 May 2019 to evaluate and treat any injury to the jockeys. Descriptive statistics (frequencies, rates with corresponding 95% CIs and proportions) of injury types, body parts, mechanisms, severity and location on track were calculated. Results Over nearly 4 years of racing and 45 000 mounts, there were 204 injuries involving 184 incidents and 131 falls during those races. The vast majority of injuries (80%) was related to soft tissue, while 4% were concussions. Most injuries involved the lower extremity (31%) or upper extremity (26%) and typically resulted from a fall from the horse. Among all incidents, 79.3% (n=146) resulted in an injury, while 76.3% (n=100) of falls resulted in an injury. We identified a significant proportion of injuries (41%) in and around the starting gate. Over a quarter of incidents resulting in injury required further medical care in hospital or other medical facility, while surgery was required in 2.5% of injuries. Conclusion Access to a consistent group of sports medicine providers facilitated jockey injury reporting and tracking. The majority of jockey injuries is related to soft tissue and results from falls, while the starting gate area is associated with the greatest proportion of injuries.	[Ryan, Kelly] MedStar Franklin Sq Med Ctr, Family Med, Baltimore, MD 21237 USA; [Garruppo, Gabrielle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Alexander, Kezia; Lincoln, Andrew E.] MedStar Hlth Res Inst, MedStar Sports Med Res Ctr, Hyattsville, MD USA; [Hluchan, Christine M.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Lincoln, Andrew E.] Georgetown Univ, Med Ctr, Rehabil Med, Washington, DC 20007 USA		Ryan, K (corresponding author), MedStar Franklin Sq Med Ctr, Family Med, Baltimore, MD 21237 USA.	kelly.d.ryan@medstar.net		Lincoln, Andrew/0000-0003-2345-3320			Balendra G, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038950; Connor TA, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0193-0; Cowley S, 2007, BRIT J SPORT MED, V41, P639, DOI 10.1136/bjsm.2006.032888; Cullen S, 2015, J STRENGTH COND RES, V29, P3060, DOI 10.1519/JSC.0000000000000977; Filby M, 2012, OCCUP MED-OXFORD, V62, P343, DOI 10.1093/occmed/kqs068; Fortina M, 2019, INJURY, V50, pS56, DOI 10.1016/j.injury.2019.03.015; Hitchens PL, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113492625; Hitchens PL, 2009, MED J AUSTRALIA, V190, P83, DOI 10.5694/j.1326-5377.2009.tb02284.x; Hitchens PL, 2010, OCCUP ENVIRON MED, V67, P693, DOI 10.1136/oem.2009.050567; Madden C., 2017, NETTERS SPORTS MED; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; O'Connor S, 2018, J ATHL TRAINING, V53, P950, DOI 10.4085/1062-6050-339-17; O'Connor S, 2017, J ATHL TRAINING, V52, P1140, DOI 10.4085/1062-6050-52.12.17; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; Turner M, 2008, BRIT J SPORT MED, V42, P763, DOI 10.1136/bjsm.2007.040337; Turner M, 2012, BRIT J SPORT MED, V46, P704, DOI 10.1136/bjsports-2011-090312; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Turner M, 2019, BRIT J SPORT MED, V53, P203, DOI 10.1136/bjsports-2018-100316; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326	20	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000926	10.1136/bmjsem-2020-000926			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	OZ9MM	WOS:000595241200001	33354351	gold, Green Published			2022-02-06	
J	Sahlu, A; Getachew, K; Mekonnen, A				Sahlu, Abat; Getachew, Kaleab; Mekonnen, Abebe			Traumatic Retroclival Subdural Hematoma in a Child with Hemophilia	WORLD NEUROSURGERY			English	Article						Hemophilia; Retroclival; Subdural	CLIVAL	BACKGROUND: Retroclival hematomas are a rare entity and may occur in 3 compartments, namely the epidural, subdural, and subarachnoid spaces. They are frequently secondary to trauma. Hemophilia is a clinical syndrome affecting usually men and characterized by the inherited tendency to bleed excessively after slight injury. Hemophilia is caused by a specific defect of coagulation factor VIII. The main concern associated with the disease is bleeding, especially after trauma and surgeries. The most serious site of bleeding is the central nervous system. CASE PRESENTATION: An 11-year-old boy diagnosed with hemophilia presented after sustaining a fall. On arrival to the emergency department, his vitals where within normal range and he was fully conscious. Neurologic examination was significant for bilateral abducens nerve palsy; the rest of the examination was unremarkable. Imaging studies with computed tomography (CT) scan and brain magnetic resonance imaging showed subacute retroclival subdural hemorrhage with left cerebellar and upper cervical spine extension. Follow-up imaging with CT scan showed progressive resolution of the hematoma, and the patient had a stable clinical course while receiving factor VII replacement. CONCLUSIONS: Retroclival subdural hematomas are rare and may present either spontaneously or after trauma. Conservative treatment is the usual course of treatment. Patients with hemophilia A are under a constant threat from bleeding, either spontaneous or after trivial injury. The most common cause of death in this patient population is intracranial hemorrhage. The most important aspect of intracranial hematoma management is the early replacement therapy of deficient coagulation factors in patients with hemophilia.	[Sahlu, Abat; Getachew, Kaleab; Mekonnen, Abebe] Addis Ababa Univ, Coll Heath Sci, Addis Ababa, Ethiopia		Getachew, K (corresponding author), Addis Ababa Univ, Coll Heath Sci, Addis Ababa, Ethiopia.	kalget23@gmail.com					Ahn ES, 2005, J NEUROSURG, V103, P175, DOI 10.3171/ped.2005.103.2.0175; Amalnath SD, 2018, NEUROLOGY, V91, pE999, DOI 10.1212/WNL.0000000000006125; Azizyan A, 2015, J NEUROSURG, V123, P808, DOI 10.3171/2014.12.JNS14445; Brock S, 2010, ACTA NEUROCHIR, V152, P1543, DOI 10.1007/s00701-010-0720-8; Caramanti RL, 2019, BRAZ NEUROSURG, V38, P60, DOI 10.1055/s-0036-1593976; Casey D, 2009, J NEUROSURG, V110, P1238, DOI 10.3171/2008.9.JNS17651; Dayaratne S, 2015, CEYLON MED J, V60, P159, DOI 10.4038/cmj.v60i4.8225; Dimichele DM, 2007, HAEMOPHILIA, V13, P1, DOI 10.1111/j.1365-2516.2007.01497.x; Nguyen HS, 2016, CHILD NERV SYST, V32, P1749, DOI 10.1007/s00381-016-3098-y; Kim Myoung Soo, 2012, Surg Neurol Int, V3, P39, DOI 10.4103/2152-7806.94287; Koshy J, 2014, CHILD NERV SYST, V30, P835, DOI 10.1007/s00381-014-2369-8; Krishnan P, 2013, NEUROL INDIA, V61, P550, DOI 10.4103/0028-3886.121951; Lee IL, 2017, J NEUROL SURG REP, V78, pE46, DOI 10.1055/s-0037-1600914; Mohamed AH, 2013, BRIT J NEUROSURG, V27, P845, DOI 10.3109/02688697.2013.798855; MYERS DJ, 1995, ANN EMERG MED, V25, P249, DOI 10.1016/S0196-0644(95)70333-0; Narvid J, 2016, J NEUROSURG, V124, P716, DOI 10.3171/2015.2.JNS142221; Schievink WI, 2001, J NEUROSURG, V95, P522, DOI 10.3171/jns.2001.95.3.0522; Sever A, 2017, APPL RADIOL, V46, P38; Silvera VM, 2014, PEDIATR RADIOL, V44, P621, DOI 10.1007/s00247-014-3170-2; Sridhar K, 2010, NEUROL INDIA, V58, P131, DOI 10.4103/0028-3886.73756; van Rijn R R, 2003, JBR-BTR, V86, P174; Yadav A, 2014, PUNJAB ACAD FORENSIC, V14, P115	22	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						112	120		10.1016/j.wneu.2019.09.059			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700180	31562972				2022-02-06	
B	Samarghandian, S; Farkhondeh, T		Sarwat, M; Sumaiya, S		Samarghandian, Saeed; Farkhondeh, Tahereh			Saffron and Neurological Disorders	SAFFRON: THE AGE-OLD PANACEA IN A NEW LIGHT			English	Article; Book Chapter							CROCUS-SATIVUS-L.; TO-MODERATE DEPRESSION; POSTTRAUMATIC-STRESS-DISORDER; ETHANOL-INDUCED IMPAIRMENT; INDUCED OXIDATIVE DAMAGE; TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; ACTIVE CONSTITUENTS; AQUEOUS EXTRACT; CEREBRAL-ISCHEMIA		[Samarghandian, Saeed] Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran; [Farkhondeh, Tahereh] Birjand Univ Med Sci, Cardiovasc Dis Res Ctr, Birjand, Iran		Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Dept Basic Med Sci, Neyshabur, Iran.						Ahmad AS, 2005, PHARMACOL BIOCHEM BE, V81, P805, DOI 10.1016/j.pbb.2005.06.007; Ahmad N, 2017, ARTIF CELL NANOMED B, V45, P775, DOI 10.1080/21691401.2016.1228659; Ai JL, 1997, DRUG DEVELOP RES, V41, P99, DOI 10.1002/(SICI)1098-2299(199706)41:2<99::AID-DDR7>3.0.CO;2-M; Akhondzadeh S, 2005, PHYTOTHER RES, V19, P148, DOI 10.1002/ptr.1647; Akhondzadeh S, 2010, J CLIN PHARM THER, V35, P581, DOI 10.1111/j.1365-2710.2009.01133.x; Akhondzadeh S., 2010, PSYCHOPHARMACOLOGY, V207, P637; Akhondzadeh S, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-9; Alavi M.S., 2018, SAFRANAL ATTENUATES; Alhebshi AH, 2013, BIOCHEM BIOPH RES CO, V433, P362, DOI 10.1016/j.bbrc.2012.11.139; Alinejad S, 2018, BASIC CLIN PHARMACOL, V122, P56, DOI 10.1111/bcpt.12855; Altinoz E, 2018, BIOTECH HISTOCHEM, V93, P623, DOI 10.1080/10520295.2018.1519725; Amin B, 2012, FITOTERAPIA, V83, P888, DOI 10.1016/j.fitote.2012.03.022; Bangratz M, 2018, NEUROPSYCH DIS TREAT, V14, P1821, DOI 10.2147/NDT.S169575; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Basti AA, 2007, PROG NEURO-PSYCHOPH, V31, P439, DOI 10.1016/j.pnpbp.2006.11.010; Berger F, 2011, NEUROSCIENCE, V180, P238, DOI 10.1016/j.neuroscience.2011.02.037; Bie XD, 2011, FITOTERAPIA, V82, P997, DOI 10.1016/j.fitote.2011.06.001; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Boskabady MH, 2016, PHYTOTHER RES, V30, P1072, DOI 10.1002/ptr.5622; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bussi C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43153; Caballero-Ortega H, 2007, FOOD CHEM, V100, P1126, DOI 10.1016/j.foodchem.2005.11.020; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Cirmi S, 2016, MOLECULES, V21, DOI 10.3390/molecules21101312; Costa SL, 2016, NEUROTOX RES, V30, P41, DOI 10.1007/s12640-016-9600-1; Cryan JF, 2011, BRIT J PHARMACOL, V164, P1129, DOI 10.1111/j.1476-5381.2011.01362.x; de Oliveira L, 2009, PROG NEURO-PSYCHOPH, V33, P1003, DOI 10.1016/j.pnpbp.2009.05.010; Delkhosh-Kasmaie F, 2018, BIOMED PHARMACOTHER, V107, P203, DOI 10.1016/j.biopha.2018.07.165; Deslauriers AM, 2011, J IMMUNOL, V187, P4788, DOI 10.4049/jimmunol.1004111; Ebrahim-Habibi MB, 2010, BIOPOLYMERS, V93, P854, DOI 10.1002/bip.21477; Ettehadi H., 2013, J BEHAV BRAIN SCI, V3, P315, DOI [10.4236/jbbs.2013.33031, DOI 10.4236/JBBS.2013.33031]; Farahmand SK, 2013, BIOGERONTOLOGY, V14, P63, DOI 10.1007/s10522-012-9409-0; Farkhondeh T, 2019, J CELL PHYSIOL, V234, P14680, DOI 10.1002/jcp.28221; Farkhondeh T, 2018, CNS NEUROL DISORD-DR, V17, P361, DOI 10.2174/1871527317666180515120212; Farkhondeh T, 2016, ASIAN PAC J TROP MED, V9, P924, DOI 10.1016/j.apjtm.2016.07.027; Farokhnia M, 2014, HUM PSYCHOPHARM CLIN, V29, P351, DOI 10.1002/hup.2412; Fathimoghadam H, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01213; Forchetti Concetta M, 2005, Prim Care Companion J Clin Psychiatry, V7, P155; Georgiadou G, 2014, PSYCHOPHARMACOLOGY, V231, P717, DOI 10.1007/s00213-013-3293-4; Geromichalos GD, 2012, J AGR FOOD CHEM, V60, P6131, DOI 10.1021/jf300589c; Ghadami MR, 2009, PHYSIOL PHARMACOL, V12, P287; Ghaderi A, 2015, DARU, V23, DOI 10.1186/s40199-015-0121-x; Ghadrdoost B, 2011, EUR J PHARMACOL, V667, P222, DOI 10.1016/j.ejphar.2011.05.012; Ghajar A, 2017, PHARMACOPSYCHIATRY, V50, P152, DOI 10.1055/s-0042-116159; Ghalandari-Shamami M., 2019, NEUROCHEM RES, P1; Ghazavi A, 2009, Pak J Biol Sci, V12, P690, DOI 10.3923/pjbs.2009.690.695; Ghoshooni H, 2011, Pak J Biol Sci, V14, P939, DOI 10.3923/pjbs.2011.939.944; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Hadipour M, 2018, SYNAPSE, V72, DOI 10.1002/syn.22026; Haeri P, 2019, ANAT SCI INT, V94, P119, DOI 10.1007/s12565-018-0457-7; Haghighizad H, 2008, PHYSIOL PHARMACOL, V12, P170; Halataei BAS, 2011, PHYTOTHER RES, V25, P1833, DOI 10.1002/ptr.3495; Hamner MB, 2004, CNS SPECTRUMS, V9, P740, DOI 10.1017/S1092852900022380; Hashtjini MM, 2018, AVICENNA J PHYTOMEDI, V8, P358; Heidari S, 2018, J PHARMACOPUNCT, V21, P18, DOI 10.3831/KPI.2018.21.003; Hemmati M, 2015, EXCLI J, V14, P908, DOI 10.17179/excli2015-232; Hosseinzadeh H, 2007, PHYTOMEDICINE, V14, P256, DOI 10.1016/j.phymed.2006.03.007; Hosseinzadeh H, 2005, J PHARM PHARM SCI, V8, P394; Hosseinzadeh H, 2005, FITOTERAPIA, V76, P722, DOI 10.1016/j.fitote.2005.07.008; Hosseinzadeh H., 2002, ARCH, V5, P44; Hosseinzadeh H, 2003, 1 INT S SAFFR BIOL B, V650, DOI DOI 10.17660/ACTAH0RTIC.2004.650.54; Hosseinzadeh H, 2008, PLANTA MED, V74, P1441, DOI 10.1055/s-2008-1081335; Hosseinzadeh H, 2010, PHYTOTHER RES, V24, P726, DOI 10.1002/ptr.3011; Hosseinzadeh H, 2009, PHYTOTHER RES, V23, P768, DOI 10.1002/ptr.2597; Hsiung GYR, 2008, EXPERT OPIN PHARMACO, V9, P2575, DOI [10.1517/14656566.9.15.2575, 10.1517/14656566.9.15.2575 ]; Imenshahidi M., 2011, PHARMACOLOGYONLINE, V1, P1007; Karami M, 2013, PHYTOMEDICINE, V21, P62, DOI 10.1016/j.phymed.2013.07.013; Karimi G.R., 2001, IRAN J BASIC MED SCI, V4, P11; Kell G, 2017, COMPLEMENT THER MED, V33, P58, DOI 10.1016/j.ctim.2017.06.001; Khalili Mohsen, 2010, Iran Biomed J, V14, P59; Labak M, 2010, ACTA NEUROCHIR SUPPL, V106, P177, DOI 10.1007/978-3-211-98811-4_32; Lechtenberg M, 2008, PLANTA MED, V74, P764, DOI 10.1055/s-2008-1074535; Li DC, 2017, N-S ARCH PHARMACOL, V390, P643, DOI 10.1007/s00210-017-1363-6; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Linardaki ZI, 2013, FOOD CHEM TOXICOL, V52, P163, DOI 10.1016/j.fct.2012.11.016; Liu JZ, 2010, SEIZURE-EUR J EPILEP, V19, P165, DOI 10.1016/j.seizure.2010.01.010; Lopresti AL, 2017, J AFFECT DISORDERS, V207, P188, DOI 10.1016/j.jad.2016.09.047; Lv BC, 2016, NEUROCHEM RES, V41, P1949, DOI 10.1007/s11064-016-1905-1; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marder M, 2001, BIOORGAN MED CHEM, V9, P323, DOI 10.1016/S0968-0896(00)00250-9; Mazidi Mohsen, 2016, J Complement Integr Med, V13, P195, DOI 10.1515/jcim-2015-0043; Mehrpour O, 2012, CHRONIC LEAD POISONI; Mehrpour O, 2014, J RES MED SCI, V19, P196; Menghini L, 2018, FOOD RES INT, V109, P91, DOI 10.1016/j.foodres.2018.04.028; Milajerdi A, 2018, COMPLEMENT THER MED, V41, P196, DOI 10.1016/j.ctim.2018.09.023; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Moallem SA, 2014, TOXICOL IND HEALTH, V30, P141, DOI 10.1177/0748233712452609; Mohammadzadeh L, 2019, NUTR NEUROSCI, V21, P1; Mohammadzadeh L, 2018, ENVIRON SCI POLLUT R, V25, P4904, DOI 10.1007/s11356-017-0842-0; Motaghinejad M, 2019, MED HYPOTHESES, V124, P21, DOI 10.1016/j.mehy.2019.01.017; Mousavi B, 2015, AVICENNA J PHYTOMEDI, V5, P413; Naghibi SM, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/494367; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Nasri S., 2011, KUWAIT MED J, V15, P189; Noorbala AA, 2005, J ETHNOPHARMACOL, V97, P281, DOI 10.1016/j.jep.2004.11.004; Ochiai T, 2004, NEUROSCI LETT, V362, P61, DOI 10.1016/j.neulet.2004.02.067; Ochiai T, 2004, NEUROCHEM INT, V44, P321, DOI 10.1016/S0197-0186(03)00174-8; Papandreou MA, 2006, J AGR FOOD CHEM, V54, P8762, DOI 10.1021/jf061932a; Papandreou MA, 2011, BEHAV BRAIN RES, V219, P197, DOI 10.1016/j.bbr.2011.01.007; Pitsikas N, 2008, PHYTOMEDICINE, V15, P1135, DOI 10.1016/j.phymed.2008.06.005; Pitsikas N., 2015, EFFECT CROCUS SATIVU, V2015; Pitsikas N, 2007, BEHAV BRAIN RES, V183, P141, DOI 10.1016/j.bbr.2007.06.001; Pitsikas N, 2006, BEHAV BRAIN RES, V173, P112, DOI 10.1016/j.bbr.2006.06.005; Pitsikas N, 2017, NEUROSCI LETT, V644, P37, DOI 10.1016/j.neulet.2017.02.042; Puma SL, 2019, J CELL MOL MED, V23, P1976, DOI 10.1111/jcmm.14099; Qi Y, 2013, EXP EYE RES, V107, P44, DOI 10.1016/j.exer.2012.11.011; Rafieipour F, 2019, METAB BRAIN DIS, V34, P165, DOI 10.1007/s11011-018-0329-9; Rahiman N, 2018, MICROVASC RES, V118, P82, DOI 10.1016/j.mvr.2018.03.003; Rubin M., 2014, OVERVIEW SPINAL CORD; Sabapathy V, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/132172; Sadeghnia HR, 2008, J PHARM PHARM SCI, V11, P1; Sadeghnia HR, 2017, FOLIA NEUROPATHOL, V55, P206, DOI 10.5114/fn.2017.70485; Sadeghnia HR, 2013, IRAN J BASIC MED SCI, V16, P73; Saleem S, 2006, J MED FOOD, V9, P246, DOI 10.1089/jmf.2006.9.246; Samarghandian Saeed, 2017, Recent Pat Food Nutr Agric, V8, P183, DOI 10.2174/2212798409666170529073601; Samarghandian S, 2016, PROG NUTR, V18, P299; Samarghandian S, 2016, PHYTOTHER RES, V30, P1345, DOI 10.1002/ptr.5638; Samarghandian S, 2015, EXP ANIM TOKYO, V64, P65, DOI 10.1538/expanim.14-0027; Samarghandian S, 2014, PHARMACOGN MAG, V10, P419, DOI 10.4103/0973-1296.133296; Samarghandian S, 2014, PHARMACOGN RES, V6, P99, DOI 10.4103/0974-8490.128963; Samarghandian Saeed, 2013, Indian J Urol, V29, P177, DOI 10.4103/0970-1591.117278; Samarghandian S, 2013, J PHARM PHARM SCI, V16, P352, DOI 10.18433/J3ZS3Q; Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019; Sarnarghandian S, 2017, NEUROSCI LETT, V659, P26, DOI 10.1016/j.neulet.2017.08.065; Sarshoori JR, 2014, IRAN J BASIC MED SCI, V17, P895; Shahmansouri N, 2014, J AFFECT DISORDERS, V155, P216, DOI 10.1016/j.jad.2013.11.003; Shati AA, 2011, NEUROSCIENCE, V175, P66, DOI 10.1016/j.neuroscience.2010.11.043; Soeda S, 2001, LIFE SCI, V69, P2887, DOI 10.1016/S0024-3205(01)01357-1; Sugiura M, 1995, P JPN ACAD B-PHYS, V71, P319, DOI 10.2183/pjab.71.319; SUNANDA BPV, 2014, J PHARM PHARM SCI, V3, P1175; Tamaddonfard E, 2012, PHARMACOL REP, V64, P94, DOI 10.1016/S1734-1140(12)70735-1; Tsantarliotou MP, 2013, BLOOD COAGUL FIBRIN, V24, P305, DOI 10.1097/MBC.0b013e32835bdc8f; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vakili A, 2014, J STROKE CEREBROVASC, V23, P106, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.008; Van Ameringen M, 2004, CNS SPECTRUMS, V9, P753, DOI 10.1017/S1092852900022392; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; Wang CY, 2019, INT J MOL MED, V43, P956, DOI 10.3892/ijmm.2018.4032; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; Wang XL, 2017, J PHARMACOL SCI, V135, P141, DOI 10.1016/j.jphs.2017.08.007; Wang Xiting, 2017, Zhejiang Da Xue Xue Bao Yi Xue Ban, V46, P7; Yamauchi M, 2011, EUR J PHARMACOL, V650, P110, DOI 10.1016/j.ejphar.2010.09.081; YARIBEYGI H, 2014, AM J BIOL LIFE SCI, V2, P41; Zarrindast MR, 2006, INT J NEUROSCI, V116, P731, DOI 10.1080/00207450600675068; Zhang L, 2018, BRAIN RES BULL, V142, P352, DOI 10.1016/j.brainresbull.2018.08.021; ZHANG YX, 1994, BIOL PHARM BULL, V17, P217, DOI 10.1248/bpb.17.217; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z; Zheng YQ, 2007, BRAIN RES, V1138, P86, DOI 10.1016/j.brainres.2006.12.064	147	1	1	3	4	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-818463-9; 978-0-12-818462-2				2020							103	116		10.1016/B978-0-12-818462-2.00009-7	10.1016/C2018-0-03979-1		14	Plant Sciences; Chemistry, Medicinal	Book Citation Index – Science (BKCI-S)	Plant Sciences; Pharmacology & Pharmacy	BP8CO	WOS:000564251300011					2022-02-06	
J	Sanz-Gallen, P; de Bonet, NA; Canals, ML; Marti-Amengual, G				Sanz-Gallen, Pere; Amigo de Bonet, Narciso; Luisa Canals, Maria; Marti-Amengual, Gabriel			Fatal accident involving a welder employed by a shipping container company, associated with the use of tramadol and antidepressant agents	INTERNATIONAL MARITIME HEALTH			English	Article						fatal outcomes; occupational accidents; poisoning; opioid abuse; antidepressant agents; drug-related side effects; adverse reactions	INTOXICATION	The widespread use of opioids for the treatment of moderate or severe acute and chronic pain has become a public health problem due to the physical and psychological dependence and tolerance they produce. The increasingly higher doses that patients require may reach toxic levels or lead to accidents, including fatalities. We present the case of a welder who, while working for a shipping container company, fell from height without a safety harness and subsequently died as a result of a traumatic brain injury. Post-mortem examination revealed a cardiac blood tramadol concentration of 2.83 mg/L, which is 3-4 times higher than the maximum therapeutic dose. The combined use of synthetic opioids and antidepressants may heighten the adverse neurological and psychiatric effects. A review of the literature, identified studies, including previous reports of fatalities, supported our causal hypothesis of a serotonin syndrome. This syndrome can lead to a loss of cognitive and sensory capacity, interfere with decision-making ability, and produce mental confusion and dizziness, among other symptoms. In order to prevent harm to themselves and others, all persons who are currently taking these kinds of drugs should avoid dangerous tasks at work and must be advised by a physician regarding the type of activities that are safe for them to perform.	[Sanz-Gallen, Pere; Amigo de Bonet, Narciso; Marti-Amengual, Gabriel] Univ Barcelona, Sch Med & Hlth Sci Barcelona, Unit Occupat Med & Toxicol, Barcelona, Spain; [Luisa Canals, Maria] ISM Tarragona, Maritime Hlth Unit, Tarragona, Spain		Sanz-Gallen, P (corresponding author), Univ Barcelona, Fac Med & Hlth Sci, C Casanova 146, Barcelona 08036, Spain.	17039psg@comb.cat					Agencia Espanola de Medicamentos y Productos Sanitarios, 2019, UT MED OP ESP DUR PE; Agencia Espanola de Medicamentos y Productos Sanitarios, 2017, UOPIV113022017 AEMPS; Agencia Espanola de Medicamentos y Productos Sanitarios, 2015, UADV114012015 AEMPS; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Clarot F, 2003, FORENSIC SCI INT, V134, P57, DOI 10.1016/S0379-0738(03)00100-2; Costa I, 2013, J ANAL TOXICOL, V37, P670, DOI 10.1093/jat/bkt084; De Decker K, 2008, FORENSIC SCI INT, V175, P79, DOI 10.1016/j.forsciint.2007.07.010; DRUID, 2011, DEL 4 3 1 EST FRAM C; International Labour Office, 2013, JMS201112 ILOIMO; Marquardt KA, 2005, ANN PHARMACOTHER, V39, P1039, DOI 10.1345/aph.1E577; Randall C, 2014, J FORENSIC LEG MED, V23, P32, DOI 10.1016/j.jflm.2014.01.006; Ryan NM, 2015, CLIN TOXICOL, V53, P545, DOI 10.3109/15563650.2015.1036279; [Anonymous], 2009, Psychiatry (Edgmont), V6, P17; Sanz-Gallen P., 2020, FOMENT TREBALL BARCE; Shadnia S, 2008, HUM EXP TOXICOL, V27, P201, DOI 10.1177/0960327108090270; Simonsen KW, 2015, FORENSIC SCI INT, V248, P172, DOI 10.1016/j.forsciint.2015.01.003; Spiller HA, 1997, J TOXICOL-CLIN TOXIC, V35, P361, DOI 10.3109/15563659709043367; Teijeira R, 2006, MED CLIN-BARCELONA, V126, P787, DOI 10.1157/13089117; Tjaderborn M, 2007, FORENSIC SCI INT, V173, P107, DOI 10.1016/j.forsciint.2007.02.007	19	1	1	1	2	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1641-9251	2081-3252		INT MARIT HEALTH	Int. Marit. Health		2020	71	2					109	113	PMID 32604453	10.5603/IMH.2020.0020			5	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	MG4YZ	WOS:000546040400005	32604453	gold			2022-02-06	
J	Shavit, I; Rimon, A; Waisman, Y; Borland, ML; Phillips, N; Kochar, A; Cheek, JA; Gilhotra, Y; Furyk, J; Neutze, J; Dalziel, SR; Lyttle, MD; Bressan, S; Donath, S; Hearps, S; Oakley, E; Crowe, L; Babl, FE				Shavit, Itai; Rimon, Ayelet; Waisman, Yehezkel; Borland, Meredith L.; Phillips, Natalie; Kochar, Amit; Cheek, John A.; Gilhotra, Yuri; Furyk, Jeremy; Neutze, Jocelyn; Dalziel, Stuart R.; Lyttle, Mark D.; Bressan, Sivia; Donath, Susan; Hearps, Stephen; Oakley, Ed; Crowe, Louise; Babl, Franz E.		Paediat Res Emergency Dept Int	Performance of Two Head Injury Decision Rules Evaluated on an External Cohort of 18,913 Children	JOURNAL OF SURGICAL RESEARCH			English	Article						Head injury; Children; Accuracy; Decision rule; Computed tomography	COMPUTED-TOMOGRAPHY USE	Background: The Pediatric Emergency Care Applied Research Network (PECARN) decision rule demonstrates high sensitivity for identifying children at low risk for clinically important traumatic brain injury (ciTBI). As with the PECARN rule, the Israeli Decision Algorithm for Identifying TBI in Children (IDITBIC) recommends proceeding directly to computed tomography (CT) in children with Glasgow Coma Score (GCS) <15. The aim was to assess the diagnostic accuracy of two clinical rules that assign children with GCS <15 at presentation directly to CT. Materials and methods: Accuracy analysis for detecting ciTBI was performed on a multi-center cohort of children used in the Australasian Pediatric Head Injury Rules Study. Results: The external cohort included 18,913 children; 1691 (8.9%) had CT scan, 160 had ciTBI, and 24 (0.13%) had neurosurgery. Applying IDITBIC and PECARN rules would have missed 11 and 1 ciTBI patients; respectively. All patients with missed injuries were classified as such based on a hospital stay of >2 d. None of these patients died, needed neurosurgery, or required ventilatory support. In children aged <2 y, sensitivity, specificity, positive predictive value and negative predictive value of IDITBIC and PECARN rule were 95.2%, 79.5%, 3.8%, and 99.9% and 100.0%, 59.1%, 2.0%, and 100.0%, respectively. In children >= 2 y, sensitivity, specificity, positive predictive value and negative predictive value of IDITBIC and PECARN rule were 92.4%, 75.3%, 3.1%, and 99.9% and 99.2%, 52.9%, 1.7%, and 100.0%, respectively. Conclusions: The two decision rules demonstrated high accuracy in identifying ciTBI. As a screening tool, the PECARN rule outperformed IDITBIC. The findings suggest that clinicians should strongly consider directing children with GCS <15 at presentation to CT scan. (C) 2019 Elsevier Inc. All rights reserved.	[Shavit, Itai] Ruth Childrens Hosp, Rambam Hlth Care Campus, Emergency Dept, POB 274, IL-3080500 Haifa, Israel; [Rimon, Ayelet] Tel Aviv Univ, Dana Dwek Childrens Hosp, Tel Aviv Sourasky Med Ctr, Emergency Dept, Tel Aviv, Israel; [Waisman, Yehezkel] Tel Aviv Univ, Schneider Childrens Med Ctr, Emergency Dept, Tel Aviv, Israel; [Borland, Meredith L.] Princess Margaret Hosp Children, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Primary Aboriginal & Rural Healthcare, Crawley, WA, Australia; [Phillips, Natalie; Gilhotra, Yuri] Univ Queensland, Ctr Childrens Hlth Res, Sch Med, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Phillips, Natalie] Childrens Hlth Queensland, Lady Cilento Childrens Hosp, South Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Clayton, Vic, Australia; [Cheek, John A.; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia; [Cheek, John A.; Lyttle, Mark D.; Bressan, Sivia; Donath, Susan; Hearps, Stephen; Oakley, Ed; Crowe, Louise; Babl, Franz E.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Auckland, New Zealand; [Dalziel, Stuart R.] Starship Childrens Hosp, Childrens Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Lyttle, Mark D.] Bristol Childrens Hosp, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Bressan, Sivia] Univ Padua, Dept Womens & Child Hlth, Padua, Italy; [Donath, Susan; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia		Shavit, I (corresponding author), Ruth Childrens Hosp, Rambam Hlth Care Campus, Emergency Dept, POB 274, IL-3080500 Haifa, Israel.	itai@pem-database.org		Hearps, Stephen/0000-0003-2984-1172; Crowe, Louise/0000-0003-4619-9708; Lyttle, Mark/0000-0002-8634-7210; Donath, Susan/0000-0003-2489-3977	National Health and Medical Research Council, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727]; National Health and Medical Research Council (Center of Research Excellence for Pediatric Emergency Medicine), Canberra, Australia [GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; NHMRCNational Health and Medical Research Council of Australia; Melbourne Campus Clinician-Scientist-Fellowship; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Center of Research Excellence for Pediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. F.E.B.'s time was part funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia, an NHMRC Practitioner Fellowship and a Melbourne Campus Clinician-Scientist-Fellowship. S.R.D.'s time was part funded by the Health Research Council of New Zealand (HRC13/556).	Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Ezra V, 2014, EMERGENCY DEP MANAGE; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Homme JL, 2018, EMERG MED CLIN N AM, V36, P287, DOI 10.1016/j.emc.2017.12.015; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Medwid Kelly, 2012, Ann Emerg Med, V60, P278, DOI 10.1016/j.annemergmed.2012.01.029; Miescier MJ, 2017, PEDIATR EMERG CARE, V33, P156, DOI 10.1097/PEC.0000000000000500; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Peng P, 2018, ACAD EMERG MED; Sannuel N, 2015, BRAIN INJURY, V29, P946, DOI 10.3109/02699052.2015.1017005; Shahaf DB, 2018, BRAIN INJURY, V32, P331, DOI 10.1080/02699052.2018.1425914; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Unden J, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1166-8	19	1	1	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2020	245						426	433		10.1016/j.jss.2019.07.090			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JT4CK	WOS:000500939000057	31442746				2022-02-06	
J	Shih, CH; Thalla, PR; Elhai, JD; Mathews, J; Brickman, KR; Redfern, RE; Xie, H; Wang, X				Shih, Chia-Hao; Thalla, Palguna R.; Elhai, Jon D.; Mathews, Jeremy; Brickman, Kristopher R.; Redfern, Roberta E.; Xie, Hong; Wang, Xin			Preliminary study examining the mediational link between mild traumatic brain injury, acute stress, and post-traumatic stress symptoms following trauma	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Traumatic event; mTBI; ASD; PTSD; moderated mediation analysis	RISK-FACTORS; PSYCHOPHYSIOLOGICAL AROUSAL; DISORDER; PREVALENCE; PTSD; POPULATION; EXTINCTION; PCL-5	Background: The presence of mild traumatic brain injury (mTBI) increases post-traumatic stress disorder (PTSD) symptoms in the months following injury. However, factors that link mTBI and PTSD development are still unclear. Acute stress responses after trauma have been associated with PTSD development. mTBI may impair cognitive functions and increase anxiety immediately after trauma. Objective: This research aimed to test the possibility that mTBI increases acute stress symptoms rapidly, which in turn results in PTSD development in the subsequent months. Method: Fifty-nine patients were recruited from the emergency rooms of local hospitals. Post-mTBI, acute stress, and PTSD symptom severity were measured using the Rivermead Post-Concussion Symptoms Questionnaire (RPQ), Acute Stress Disorder Scale (ASDS), and PTSD Checklist for DSM-5 (PCL-5), respectively. Results: Moderated mediation analysis indicated that ASDS, at 2 weeks post-trauma, mediated the relationship between RPQ scores at 2 weeks and PCL-5 scores at 3 months post-trauma, only for patients who met mTBI diagnostic criteria. Conclusions: These findings present preliminary evidence suggesting that acute stress disorder symptoms may be one of the mechanisms involved in the development of PTSD among trauma survivors who have experienced mTBI, which provides a theoretical basis for early intervention of PTSD prevention after mTBI.	[Shih, Chia-Hao; Thalla, Palguna R.; Elhai, Jon D.; Mathews, Jeremy; Wang, Xin] Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA; [Elhai, Jon D.] Univ Toledo, Dept Psychol, Toledo, OH 43606 USA; [Brickman, Kristopher R.] Univ Toledo, Dept Emergency Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [Redfern, Roberta E.] ProMed Toledo Hosp, Res Dept, Toledo, OH USA; [Xie, Hong; Wang, Xin] Univ Toledo, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA		Shih, CH (corresponding author), Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA.	ChiaHao.Shih@utoledo.edu		Redfern, Roberta/0000-0001-9883-2910	National Institutes of Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH110483]	This work was supported by the National Institutes of Health (NIMH) under grant [R01MH110483].	Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 1999, AM J PSYCHIAT, V156, P360; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; BRYANT RA, 1995, AUST J PUBLIC HEALTH, V19, P185; Bryant RA, 2003, J TRAUMA STRESS, V16, P439, DOI 10.1023/A:1025750209553; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson EB, 2016, COMPR PSYCHIAT, V69, P106, DOI 10.1016/j.comppsych.2016.04.022; Cohen BE, 2009, ARCH GEN PSYCHIAT, V66, P1214, DOI 10.1001/archgenpsychiatry.2009.149; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fullana MA, 2016, MOL PSYCHIATR, V21, P500, DOI 10.1038/mp.2015.88; Garfinkel SN, 2014, J NEUROSCI, V34, P13435, DOI 10.1523/JNEUROSCI.4287-13.2014; Harnett NG, 2018, CORTEX, V109, P1, DOI 10.1016/j.cortex.2018.08.015; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hayes A.F., 2017, INTRO MEDIATION MODE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kruger-Gottschalk A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1541-6; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sareen J, 2014, CAN J PSYCHIAT, V59, P460, DOI 10.1177/070674371405900902; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; Wang X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159065; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260	43	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.		2020	11	1							1815279	10.1080/20008198.2020.1815279			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	NY5ZK	WOS:000576467000001	33133419	gold, Green Published			2022-02-06	
J	Shirvani, S; Khayyer, Z; Koleini, P; Fakharian, E; Mosavi, G; Omidi, A				Shirvani, Sheida; Khayyer, Zahra; Koleini, Peiman; Fakharian, Esmaeil; Mosavi, Gholamabas; Omidi, Abdolah			Predicting the quality of life of patients with mild traumatic brain injury: A study based on psychological variables	ARCHIVES OF TRAUMA RESEARCH			English	Article						Anxiety; depression; mental fatigue; mild traumatic brain injury; quality of life; stress	PSYCHIATRIC-DISORDERS; HEAD-INJURY; AXIS-I; EPIDEMIOLOGY; SYMPTOMS; FATIGUE; DISABILITY; POLYTRAUMA; CHILDREN; SEQUELAE	Background: Recognizing the factors related to psychological disorders such as depression, stress, anxiety, and other related problems in a mild traumatic brain injury (MTBI) can be helpful in designing more effective treatment protocols. This study aimed at examining the effect of some prevalent psychological issues on predicting the quality of life of the MTBI patients. Methods: In this descriptive correlational study, 322 MTBI patients (mean age, 38.8 +/- 10.8 years) who had admitted to the emergency and neurosurgery departments of Kashan Shahid Beheshti Hospital during April-July 2017 were selected using the convenient sampling method. Data were collected using the quality of life (WHOQOL-BREF) questionnaire (as a dependent variable), mental fatigue questionnaire, and depression, anxiety and stress scale (DASS-21). Finally, the data were analyzed in SPSS-23 by multiple regression analysis. Results: The results of the study showed that the regression model was significant (P < 0.001), in which 43% of total changes in the quality of life in MTBI patients were predicted by mental fatigue, depression, stress, anxiety, and gender. Conclusion: The findings of this study show that there is a negative relationship between psychological factors and quality of life among the MBTI patients. Thus, it is suggested to design more specific psychological-based rehabilitation programs with regard to gender differences to improve the quality of life among these patients after discharging from the hospital.	[Shirvani, Sheida] Kashan Univ Med Sci, Sch Med, Dept Clin Psychol, Kashan, Iran; [Fakharian, Esmaeil] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran; [Mosavi, Gholamabas] Kashan Univ Med Sci, Fac Hlth, Dept Biostat & Publ Hlth, Kashan, Iran; [Omidi, Abdolah] Kashan Univ Med Sci, Dept Clin Psychol, Fac Med, Kashan, Iran; [Khayyer, Zahra] Univ Isfahan, Fac Educ Psychol, Dept Psychol, Esfahan, Iran; [Koleini, Peiman] Islamic Azad Univ Isfahan, Sch Dent, Dept Dent Surg, Esfahan, Iran		Omidi, A (corresponding author), Kashan Univ Med Sci, Fac Med, Dept Clin Psychol, Kashan, Iran.	abomidi20@yahoo.com					Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Asghari A., 2008, INT J PSYCHOL, V2, P82, DOI DOI 10.1016/J.JAD.2008.01.023; Ashman TA, 2006, MT SINAI J MED, V73, P999; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barker EM, 2008, NEUROSCIENCE NURSING; Behdad A, 2008, KAUMS J FEYZ, V11, P43; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Deb S, 1999, AM J PSYCHIAT, V156, P374; Desmond DW, 1996, STROKE, V27, P1798, DOI 10.1161/01.STR.27.10.1798; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Farzandipour M, 2008, JKERMANSHAH U MED SC, V11, P58; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johansson B, 2014, INT J PHYS MED REHAB, V2, P10; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lovibond SH, MANUAL DEPRESSION AN, P42; Moradipanah F., 2017, J DENT TEHRAN, V14, P138; Nejat S, 2006, J SCH PUBLIC HLTH I, V4, P1; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rebolledo-Solleiro D, 2013, PHYSIOL BEHAV, V120, P130, DOI 10.1016/j.physbeh.2013.08.002; Rezaei S., 2012, Iranian Journal of Psychiatry and Clinical Psychology, V18, P13; Rezaei S, 2013, J IRANIAN SCI ANESTH, V82, P24; Rezaei S, 2010, THESIS; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Sameh Ghroubi SA, 2016, ANN PHYS REHABIL M S, V59, P131; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Soo C, 2007, COCHRANE DB SYST REV, V18; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Yousefzadeh S, J KERMANSHAH U MED S, V11, P288	46	1	1	1	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	JAN-MAR	2020	9	1					41	46		10.4103/atr.atr_67_18			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	LB0BG	WOS:000524303000008		gold			2022-02-06	
J	Silverberg, ND; Panenka, WJ; Lizotte, PP; Bayley, MT; Dance, D; Li, LC				Silverberg, Noah D.; Panenka, William J.; Lizotte, Pierre-Paul; Bayley, Mark T.; Dance, Derry; Li, Linda C.			Promoting early treatment for mild traumatic brain injury in primary care with a guideline implementation tool: a pilot cluster randomised trial	BMJ OPEN			English	Article						neurological injury; depression & mood disorders; clinical trials; primary care	INSOMNIA SEVERITY INDEX; PATIENT HEALTH QUESTIONNAIRE-9; GENERALIZED ANXIETY DISORDER; DEPRESSION; VALIDATION; INDICATORS; MANAGEMENT; PHYSICIANS; FRAMEWORK; SYMPTOMS	Objectives New clinical practice guidelines for the management of mild traumatic brain injury (mTBI) emphasise that family physicians should proactively screen and initiate treatment for depression/anxiety, insomnia and headaches. This study aimed to evaluate the feasibility of delivering an implementation intervention to family physicians. Design Pilot cluster randomised controlled trial. Setting Specialty outpatient clinic (recruitment) and primary care (implementation). Participants 114 primary care clinics were randomised. These clinics were associated with 137 unique family physicians caring for 148 adult patients who sustained an mTBI within the previous 3 months and were seeking care for persistent symptoms. Interventions Patients completed self-report screening measures for depression/anxiety, insomnia and headaches. A tailored letter that incorporates the patient's screening test results and associated treatment algorithms was sent to their family physician (or walk-in clinic). Physicians at clinics assigned to the control condition received a generic letter, without the screening test results. Primary outcome measures Feasibility outcomes included the frequency of primary care follow-up, retention rates and reliability of patient recall of their physicians' actions (primary mechanistic outcome). The primary efficacy outcome was the Rivermead Post-Concussion Symptom Questionnaire (RPQ). Results Most patients (97.8%; 128 of 131) followed up at the primary care clinic they planned to. Retention rates were 88% (131 of 148) and 78% (116 of 148) at the 1-month and 3-month assessments, respectively. Agreement between patient recall of their physicians' actions and medical chart audits was moderate (intraclass correlation coefficient=0.48-0.65). Patients in the experimental group reported fewer symptoms on the RPQ compared with those in the control group, whose physician received a general letter (B=-4.0, 95% CI: -7.3 to -0.7). Conclusions A larger trial will need to address minor feasibility challenges to evaluate the effectiveness of this guideline implementation tool for improving mTBI clinical outcomes and confirm the mechanism(s) of intervention benefit.	[Silverberg, Noah D.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Panenka, William J.] British Columbia Mental Hlth & Subst Use Serv Res, Vancouver, BC, Canada; [Panenka, William J.] BC Neuropsychiat Program, Vancouver, BC, Canada; [Lizotte, Pierre-Paul] Providence Hlth Care, Dept Family Med, Providence, BC, Canada; [Bayley, Mark T.] Toronto Rehabil Inst, Hull Ellis Concuss Res Ctr, Toronto, ON, Canada; [Bayley, Mark T.] Univ Toronto, Div Phys Med & Rehabil, Toronto, ON, Canada; [Dance, Derry] GF Strong Rehabil Hosp, Acquired Brain Injury Program, Vancouver, BC, Canada; [Li, Linda C.] Arthritis Res Canada, Richmond, BC, Canada; [Li, Linda C.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada.; Silverberg, ND (corresponding author), Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada.	noah.silverberg@ubc.ca	Li, Linda C./P-8485-2015	Li, Linda C./0000-0001-6280-0511; Panenka, William/0000-0001-7143-6512	VGH and UBC Hospital Foundation; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This work was supported by the VGH and UBC Hospital Foundation (an award/grant number is not available). NS also received research salary support from the Michael Smith Foundation for Health Research.	Arditi C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001175.pub3; Baker R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub3; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Flodgren G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010669.pub2; Fonhus MS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012472.pub2; Foundation ON, 2013, GUID CONC MILD TRAUM; Gagliardi AR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0389-3; Gagliardi AR, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-26; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Galili SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017735; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Grimshaw JM, 2001, MED CARE, V39, pII2; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Hunt Cindy, 2016, Concussion, V1, pCNC21, DOI 10.2217/cnc-2016-0009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS295, DOI 10.1016/j.apmr.2013.08.296; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Laws MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191940; Lawton R, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0479-2; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mercier E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017848; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Rashidian A, 2008, HEALTH POLICY, V85, P148, DOI 10.1016/j.healthpol.2007.07.011; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steiner TJ, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-3; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Terry DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198128; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Ustun T, 2010, MEASURING HLTH DISAB; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Wittkampf KA, 2007, GEN HOSP PSYCHIAT, V29, P388, DOI 10.1016/j.genhosppsych.2007.06.004	52	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	10							e035527	10.1136/bmjopen-2019-035527			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OO4MK	WOS:000587354600003	33082178	Green Published, gold			2022-02-06	
J	Strauser, DR; Rumrill, PD; Greco, C				Strauser, David R.; Rumrill, Phillip D.; Greco, Chelsea			A conceptual framework to promote career development for vocational rehabilitation consumers with traumatic brain injuries	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Traumatic brain injury; career development; well-being; employment	SUPPORT TECHNOLOGY USE; POSTSECONDARY STUDENTS; EMPLOYMENT OUTCOMES; ADULT SURVIVORS; CHILDHOOD; SERVICES; CANCER; LIFE; SUCCESS	The purpose of this article is to describe the Illinois Work and Well-being Model ((ILWM)-M-2), a multi-domain framework for conceptualizing the employment development of people with traumatic brain injuries (TBIs). The model emphasizes the interaction of contextual and career development domains to improve participation in the areas of work, society, community, and home. A brief discussion of potential implications regarding vocational rehabilitation research and service is offered with the overall goal of reinforcing employment development as the foundation of vocational rehabilitation services for adults with TBIs.	[Strauser, David R.; Greco, Chelsea] Univ Illinois, Champaign, IL 61820 USA; [Rumrill, Phillip D.] Kent State Univ, Kent, OH 44242 USA		Strauser, DR (corresponding author), Univ Illinois, Work & Disabil Lab, 213A Huff Hall,MC-588,1206 South Fourth St, Champaign, IL 61820 USA.	strauser@illinois.edu					Andrew J., 2017, DISABILITY HDB, V2017; Bishop M, 2011, SOC BEHAV EPILEPSY, P93; Blustein D.L., 2006, PSYCHOL WORKING NEW; Blustein DL, 2008, AM PSYCHOL, V63, P228, DOI 10.1037/0003-066X.63.4.228; Boman KK, 2004, J PEDIAT HEMATOL ONC, V26, P354, DOI 10.1097/00043426-200406000-00005; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; Dillahunt-Aspillaga C, 2015, BEHAV NEUROL, P1; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dolgin MJ, 1999, SOC WORK HEALTH CARE, V28, P31, DOI 10.1300/J010v28n04_03; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; Faul M, 2010, TRAUMATIC BRAIN INJU; Fong CS, 2019, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2019)015; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hendricks DJ, 2015, NEUROREHABILITATION, V37, P449, DOI 10.3233/NRE-151273; Herr EL, 1992, CAREER GUIDANCE COUN; Holland B. E., 2017, MED PSYCHOSOCIAL ASP; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Job Accommodation Network, 2017, ACCOMMODATION IDEAS; National Association of State Head Injury Administrators, 2006, TRAUM BRAIN INJ FACT; Neff W. S., 1985, WORK HUMAN BEHAV; Nissen S., 2016, PRIMER MULTIPLE SCLE, V2nd, P499; Peterson G.W., 1991, CAREER DEV SERVICES; Reardon R.C., 2004, CAREER COUNSELING SE; Roessler RT, 2017, WORK, V58, P3, DOI 10.3233/WOR-162601; Rubin S., 2016, FDN VOCATIONAL REHAB; Rumrill P, 2016, J VOCAT REHABIL, V45, P53, DOI 10.3233/JVR-160810; Saunders DE, 2000, J VOCAT BEHAV, V56, P288, DOI 10.1006/jvbe.1999.1715; Scherer MJ., 2011, ASSISTIVE TECHNOLOGI; Shepherd Center, 2018, COMM CAUS BRAIN INJ; Stam H, 2005, PSYCHO-ONCOLOGY, V14, P227, DOI 10.1002/pon.839; Stauffer M.D., 2018, CAREER COUNSELING FD; Stock S., 2006, EMPLOYMENT PERSONS B; Strauser D. R., 2013, CAREER DEV EMPLOYMEN; Strauser DR, 2015, J VOCAT REHABIL, V42, P167, DOI 10.3233/JVR-150733; Strauser D, 2015, J CANCER SURVIV, V9, P20, DOI 10.1007/s11764-014-0380-4; Strauser DR, 2018, PROFESSIONAL PRACTIC, P273; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; Turner CD, 2009, J CHILD NEUROL, V24, P1455, DOI 10.1177/0883073809341709; U. S. Department of Defense Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; U. S. Department of Health and Human Services, 2016, TRAUM BRAIN INJ CONC; Wehman P., 2013, LIFE CLASSROOM; Wehman P., 2017, NAT VA POL C MAY ORL; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; World Health Organization, 2006, NEUR DIS PUBL HLTH C	46	1	1	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2020	65	4					763	773		10.3233/WOR-203129			11	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NA3SF	WOS:000559732200007	32310207	Bronze			2022-02-06	
J	Sung, IY; Jeon, JY; Yun, KJ; Yuk, JS; Byun, E; Yoo, HW; Ko, TS; Kim, HW; Jang, DH				Sung, In Young; Jeon, Jae Yong; Yun, Ki Jeong; Yuk, Jin Sook; Byun, Eun; Yoo, Han-Wook; Ko, Tae-Sung; Kim, Hyo-Won; Jang, Dae-Hyun			Development of tablet personal computer-based cognitive training programs for children with developmental disabilities whose cognitive age is less than 4 years	MEDICINE			English	Article						cognitive impairment; cognitive therapy; computerized cognitive training program; developmental disability; early intervention	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; ATTENTIONAL CONTROL; MULTICENTER	This study was to develop tablet personal computer-based cognitive training programs for children with developmental disabilities whose cognitive age is less than 4 years. Twelve cognitive training programs (named Injini) were designed comprising cognitive domains that included attention, visual and auditory perception, memory, executive function, language, and reasoning. In addition, programs related to learning experiences, such as self-regulation, role play, learning of number, and letter/shape concepts, comparison, classification, and pattern matching, were included. Six of 12 programs comprised approximately 10 levels for each program, with different difficulty levels. Other programs consisted of universal tasks that did not have a difficulty level. To ensure that the difficulty level was appropriate, we pre-tested the pilot version of Injini among 80 children with typical development aged 18 to 41 months. After modifying the pilot version, we developed the final version and tested it among 80 children with cognitive impairment whose cognitive age was 18 to 41 months. All children were assessed using the Bayley Scales of Infant and Toddler Development to determine their development and cognitive age. The difficulty level analyses in children with typical development revealed several inappropriate results wherein the success rate did not decrease with increase in level in some programs. After adjusting the difficulty level, the analyses in children with cognitive impairment demonstrated that the success rate gradually decreased with increasing level in all programs. Cognitive training programs for children with developmental disabilities were successfully developed.	[Sung, In Young; Jeon, Jae Yong; Yun, Ki Jeong; Yuk, Jin Sook; Byun, Eun] Univ Ulsan, Coll Med, Dept Rehabil Med, Childrens Hosp,Asan Med Ctr, Ulsan, South Korea; [Yoo, Han-Wook; Ko, Tae-Sung] Univ Ulsan, Coll Med, Dept Pediat, Childrens Hosp,Asan Med Ctr, Ulsan, South Korea; [Yoo, Han-Wook] Univ Ulsan, Coll Med, Med Genet Clin & Lab, Childrens Hosp,Asan Med Ctr, Ulsan, South Korea; [Kim, Hyo-Won] Univ Ulsan, Coll Med, Dept Psychiat, Childrens Hosp,Asan Med Ctr, Ulsan, South Korea; [Jang, Dae-Hyun] Catholic Univ Korea, Coll Med, Dept Rehabil Med, Seoul, South Korea		Jang, DH (corresponding author), Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Rehabil Med, 56 Dongsu Ro, Incheon 21431, South Korea.	dhjangmd@naver.com	Jeon, Jae Yong/ABB-2910-2020	Jeon, Jae Yong/0000-0003-1534-7931	Research Fund of Asan Medical Center	This study was supported by the Research Fund of Asan Medical Center.	Campbell FA, 2012, DEV PSYCHOL, V48, P1033, DOI 10.1037/a0026644; Feuerstein Reuven, 2004, Pediatr Rehabil, V7, P20; Fisch GS, 1999, AM J MED GENET, V83, P308; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; Grunewaldt KH, 2016, DEV MED CHILD NEUROL, V58, P195, DOI 10.1111/dmcn.12841; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Kagohara DM, 2013, RES DEV DISABIL, V34, P147, DOI 10.1016/j.ridd.2012.07.027; Kaldoja ML, 2015, J PEDIATR REHAB MED, V8, P271, DOI 10.3233/PRM-150346; Karam SM, 2016, PUBLIC HEALTH GENOM, V19, P290, DOI 10.1159/000448912; Karch D, 2013, DTSCH ARZTEBL INT, V110, P643, DOI 10.3238/arztebl.2013.0643; Kirk HE, 2015, RES DEV DISABIL, V38, P145, DOI 10.1016/j.ridd.2014.12.026; Kirk HE, 2016, J CHILD PSYCHOL PSYC, V57, P1380, DOI 10.1111/jcpp.12615; Kozulin A, 2010, RES DEV DISABIL, V31, P551, DOI 10.1016/j.ridd.2009.12.001; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Lebeer J, 2016, NEUROREHABILITATION, V39, P19, DOI 10.3233/NRE-161335; Phillips NL, 2016, J NEUROTRAUM, V33, P2097, DOI 10.1089/neu.2015.4358; Shao YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130831; Sonuga-Barke E, 2014, CHILD ADOL PSYCH CL, V23, P807, DOI 10.1016/j.chc.2014.05.009; Todor O, 2015, PROCD SOC BEHV, V180, P1692, DOI 10.1016/j.sbspro.2015.05.071; Wass SV, 2012, DEV REV, V32, P360, DOI 10.1016/j.dr.2012.07.001; Wass S, 2011, CURR BIOL, V21, P1543, DOI 10.1016/j.cub.2011.08.004	21	1	1	4	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2020	99	2							e18674	10.1097/MD.0000000000018674			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LD2LL	WOS:000525864100049	31914058	Green Published, gold			2022-02-06	
S	Trofimov, A; Kopylov, A; Dobrzeniecki, M; Sheludyakov, A; Martynov, D; Trofimova, K; Agarkova, DI; Bragin, DE		Ryu, PD; LaManna, JC; Harrison, DK; Lee, SS		Trofimov, Alex; Kopylov, Artem; Dobrzeniecki, Michael; Sheludyakov, Anatoly; Martynov, Dmitry; Trofimova, Kseniia; Agarkova, Darya I.; Bragin, Denis E.			Comparative Analysis of Simultaneous Transcranial Doppler and Perfusion Computed Tomography for Cerebral Perfusion Evaluation in Patients with Traumatic Brain Injury	OXYGEN TRANSPORT TO TISSUE XLI	Advances in Experimental Medicine and Biology		English	Article; Proceedings Paper	46th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT)	JUL 01-05, 2018	Seoul, SOUTH KOREA	Int Soc Oxygen Transport Tissue, Coll Vet Med, OBELAB, Scitech Korea Inc, BrianKorea21Plus, Korea Mouse Phenotyping Ctr, Bio d, Kangstem Biotech, Wonkwang Univ Med Ctr, A L S Ctr, Korean Soc Primo Vasc Syst, Korean Soc Vet Sci		Traumatic brain injury; Perfusion computer tomography; Cerebral blood flow; Doppler; Cerebral blood flow velocity; Intracranial hematoma	BLOOD-FLOW; AUTOREGULATION; VELOCITY	The aim was to investigate the feasibility of simultaneous comparison of cerebral circulation in major vessels and microvasculature in patients suffering traumatic brain injury (TBI) with or without intracranial hematomas (IH). Methods. 170 patients were divided into two groups: Group 1 - diffuse TBI (75 patients); and Group 2 - TBI with IH (95 patients: 18 epidural, 65 subdural and 12 multiple). Perfusion computed tomography (PCT) for assessment of volumetric cerebral blood flow (CBF) was done 2-15 days after admission to hospital. Simultaneous assessment of cerebral blood flow velocity (CBFV) in both middle cerebral arteries was done by transcranial Doppler. Results. In patients with diffuse TBI, CBF had statistically valid correlations with CBFV (r = 0.28, p = 0.0149 on the left side; r = 0.382, p = 0.00075 on the right side). In patients with TBI and IH, the analysis did not reveal any reliable correlations between the CBFV and CBF velocity in the temporal lobes, either on the side of the removed IH or on the opposite side. Conclusion. The greatest linear correlation was noted in patients with diffuse TBI without the development of a coarse shift of the midline structures and dislocation syndrome. This correlation decreases with the increase in injury severity and development of secondary complications in the acute period, which probably reflects impairment of the coupling of oxygen consumption by brain tissue and cerebral microcirculation.	[Trofimov, Alex; Kopylov, Artem; Dobrzeniecki, Michael; Sheludyakov, Anatoly; Martynov, Dmitry; Trofimova, Kseniia; Agarkova, Darya I.] Privolzhsky Res Med Univ, Dept Neurosurg, Nizhnii Novgorod, Russia; [Bragin, Denis E.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA		Trofimov, A (corresponding author), Privolzhsky Res Med Univ, Dept Neurosurg, Nizhnii Novgorod, Russia.		Martynov, Dmitry/AAD-5521-2020		RFBRRussian Foundation for Basic Research (RFBR) [20-015-00110, RSF 20-15-00037]	The reported study was funded by RFBR, project number 20-015-00110 and RSF 20-15-00037.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Demolis P, 1996, STROKE, V27, P1835, DOI 10.1161/01.STR.27.10.1835; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; LASSEN NA, 1964, CIRC RES, V15, P201; Liu J, 2013, HYPERTENSION, V62, P973, DOI 10.1161/HYPERTENSIONAHA.113.01867; Mohrman DE, 2013, CARDIOVASCULAR PHYSL; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Payne S., 2016, CEREBRAL AUTOREGULAT; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826	9	1	1	1	1	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-34461-0; 978-3-030-34459-7	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2020	1232						55	62		10.1007/978-3-030-34461-0_8			8	Medicine, Research & Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	BP4YQ	WOS:000554927500008	31893394	Green Accepted			2022-02-06	
J	Tsenkina, Y; Tapanes, SA; Diaz, MM; Titus, DJ; Gajavelli, S; Bullock, R; Atkins, CM; Liebl, DJ				Tsenkina, Yanina; Tapanes, Stephen A.; Diaz, Madelen M.; Titus, David J.; Gajavelli, Shyam; Bullock, Ross; Atkins, Coleen M.; Liebl, Daniel J.			EphB3 interacts with initiator caspases and FHL-2 to activate dependence receptor cell death in oligodendrocytes after brain injury	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; dependence receptors; cell death; oligodendrocytes; EphB3	DEFICIT HYPERACTIVITY DISORDER; TRIGGERS APOPTOSIS; UNMYELINATED AXONS; CORPUS-CALLOSUM; WHITE; PATHOLOGY; VULNERABILITY; EPHRINB3	Clinical trials examining neuroprotective strategies after brain injury, including those targeting cell death mechanisms, have been underwhelming. This may be in part due to an incomplete understanding of the signalling mechanisms that induce cell death after traumatic brain injury. The recent identification of a new family of death receptors that initiate pro-cell death signals in the absence of their ligand, called dependence receptors, provides new insight into the factors that contribute to brain injury. Here, we show that blocking the dependence receptor signalling of EphB3 improves oligodendrocyte cell survival in a murine controlled cortical impact injury model, which leads to improved myelin sparing, axonal conductance and behavioural recovery. EphB3 also functions as a cysteine-aspartic protease substrate, where the recruitment of injury-dependent adaptor protein Dral/FHL-2 together with capsase-8 or -9 leads to EphB3 cleavage to initiate cell death signals in murine and human traumatic brain-injured patients, supporting a conserved mechanism of cell death. These pro-apoptotic responses can be blocked via exogenous ephrinB3 ligand administration leading to improved oligodendrocyte survival. In short, our findings identify a novel mechanism of oligodendrocyte cell death in the traumatically injured brain that may reflect an important neuroprotective strategy in patients.	[Tsenkina, Yanina; Tapanes, Stephen A.; Diaz, Madelen M.; Titus, David J.; Gajavelli, Shyam; Bullock, Ross; Atkins, Coleen M.; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Liebl, DJ (corresponding author), Univ Miami, Miami Project Cure Paralysis, Neurol Surg, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu			Miami Project to Cure Paralysis, National Institute of Health/National Institute of Neurological Disorders and Stroke [NS098740, NS069721]; Lois Pope Life Foundation	This work was supported by the Miami Project to Cure Paralysis, National Institute of Health/National Institute of Neurological Disorders and Stroke [NS098740 (D.J.L.) and NS069721 (C.M.A.)] and the Lois Pope Life Foundation.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Crawford DK, 2009, NEUROSCIENCE, V164, P1407, DOI 10.1016/j.neuroscience.2009.09.069; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Dixon KJ, 2016, STEM CELL RES, V17, P504, DOI 10.1016/j.scr.2016.09.029; Fernandez-Castaneda A, 2016, BRAIN BEHAV IMMUN, V57, P1, DOI 10.1016/j.bbi.2016.01.005; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Fombonne J, 2012, P NATL ACAD SCI USA, V109, P10510, DOI 10.1073/pnas.1200094109; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kieling C, 2008, CHILD ADOL PSYCH CL, V17, P285, DOI 10.1016/j.chc.2007.11.012; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Lee H, 2015, MOL CELLS, V38, P349, DOI 10.14348/molcells.2015.2279; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mille F, 2009, NAT CELL BIOL, V11, P739, DOI 10.1038/ncb1880; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nelersa CM, 2012, J BIOMOL SCREEN, V17, P785, DOI 10.1177/1087057112440880; Nikolov DB, 2013, BBA-PROTEINS PROTEOM, V1834, P2160, DOI 10.1016/j.bbapap.2013.04.020; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Swanson J, 1998, CURR OPIN NEUROBIOL, V8, P263, DOI 10.1016/S0959-4388(98)80150-5; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Tsenkina Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.262; Verset L, 2016, HISTOL HISTOPATHOL, V31, P469, DOI 10.14670/HH-11-709; World Health Organization, 2018, NEUROTRAUMA; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	56	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							175	10.1093/braincomms/fcaa175			16	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800113	33305261	gold, Green Published			2022-02-06	
J	Ubukata, S; Oishi, N; Higashi, T; Kagawa, S; Yamauchi, H; Okuyama, C; Watanabe, H; Ono, M; Saji, H; Aso, T; Murai, T; Ueda, K				Ubukata, Shiho; Oishi, Naoya; Higashi, Tatsuya; Kagawa, Shinya; Yamauchi, Hiroshi; Okuyama, Chio; Watanabe, Hiroyuki; Ono, Masahiro; Saji, Hideo; Aso, Toshihiko; Murai, Toshiya; Ueda, Keita			Spatial Patterns of Amyloid Deposition in Patients with Chronic Focal or Diffuse Traumatic Brain Injury Using F-18-FPYBF-2 PET	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						amyloid deposition; chronic; diffuse axonal injury; focal injury; PET	ALZHEIMERS-DISEASE; AXONAL INJURY; WHITE-MATTER; BETA; PLAQUES; ACCUMULATION; IMPAIRMENT; PATHOLOGY; PROTEINS; SINGLE	Aim: Amyloid-beta (A beta) accumulation, accelerated by traumatic brain injury (TBI), may play a crucial role in neurodegeneration in chronic-stage TBI. The injury type could influence A beta dynamics because of TBI's complex, heterogeneous nature. We, therefore, investigated spatial patterns of amyloid deposition according to injury type after TBI using 5-(5-(2-(2-(2-[F]-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-N-methylpyridin-2-amine (F-18-FPYBF-2) positron emission tomography (PET). Methods: Altogether, 20 patients with chronic TBI [12 with focal injury, 8 with diffuse axonal injury (DAI)] underwent F-18-FPYBF-2 PET, structural magnetic resonance imaging (MRI), and neuropsychological examination. Additionally, 50 healthy controls underwent either F-18-FPYBF-2 PET (n=30) or structural MRI (n=20). Results: Standardized uptake value ratio (SUVR) on PET images and regional brain volumes were measured in four cortical (frontal, parietal, occipital, temporal) and subcortical (combined caudate, putamen, pallidum, thalamus) regions. Patients with DAI showed significantly increased (compared with controls) SUVR in occipital and temporal cortices and decreased brain volume in occipital cortex (corrected p < 0.05). Although patients with focal injury showed decreased SUVR in all regions except occipital cortex, there were no significant differences (compared with controls) in the SUVR in any regions. There were no significant correlations between increased SUVR and neuropsychological impairments in patients with DAI. Conclusion: Varying spatial patterns of amyloid deposition suggest amyloid pathology diversity depending on the injury type in chronic-TBI patients.	[Ubukata, Shiho; Aso, Toshihiko; Murai, Toshiya; Ueda, Keita] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Ubukata, Shiho; Oishi, Naoya] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Higashi, Tatsuya; Kagawa, Shinya; Yamauchi, Hiroshi; Okuyama, Chio] Shiga Med Ctr Res Inst, Moriyama Ku, Shiga, Japan; [Higashi, Tatsuya] Natl Inst Quantum & Radiol Sci & Technol QST, Dept Mol Imaging & Theranost, Natl Inst Radiol Sci NIRS, Chiba, Japan; [Watanabe, Hiroyuki; Ono, Masahiro; Saji, Hideo] Kyoto Univ, Dept Pathofunct Bioanal, Grad Sch Pharmaceut Sci, Kyoto, Japan		Ubukata, S (corresponding author), Kyoto Univ, Dept Psychiat, Grad Sch Med, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	ubukata@kuhp.kyoto-u.ac.jp	Aso, Toshihiko/C-2798-2018	Aso, Toshihiko/0000-0003-4814-089X	Japan Society for the Promotion of Science, Innovative AreasMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [150502-02, 19K17110, 17K10327, 18K07712]; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [18K07712]; National Mutual Insurance Federation of Agricultural Cooperatives; ISHIZUE 2020 of Kyoto University Research Development Program	The authors thank all participants for their contribution to this project. This work was supported by an Industrial Disease Clinical Research Grants (150502-02), a Health Labor Sciences Research Grant, a Grant-in-Aid for Young Scientists (19K17110) and C (17K10327, 18K07712) from the Japan Society for the Promotion of Science, Innovative Areas (16H06402) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), a research grant from National Mutual Insurance Federation of Agricultural Cooperatives and ISHIZUE 2020 of Kyoto University Research Development Program.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ayubcha C, 2021, EUR J NUCL MED MOL I, V48, P623, DOI 10.1007/s00259-020-04926-4; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Collins JM, 2015, EXP NEUROL, V267, P219, DOI 10.1016/j.expneurol.2015.02.034; D. W, 1987, WECHSLER MEMORY SCAL; Fodero-Tavoletti MT, 2009, J NUCL MED, V50, P198, DOI 10.2967/jnumed.108.057984; Gatson JW, 2016, J NEUROSURG, V124, P1646, DOI 10.3171/2015.6.JNS15639; Harris TC, 2018, ANN BIOMED ENG, V42; Higashi T, 2018, ANN NUCL MED, V32, P206, DOI 10.1007/s12149-018-1236-1; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kemppainen NM, 2006, NEUROLOGY, V67, P1575, DOI 10.1212/01.wnl.0000240117.55680.0a; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kudo Y, 2007, J NUCL MED, V48, P553, DOI 10.2967/jnumed.106.037556; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Namiki J., 2007, J JPN SOC EMERG MED, V10, P20; Oishi N, 2007, J NEUROL SCI, V256, P52, DOI 10.1016/j.jns.2007.02.014; Ono M, 2011, J MED CHEM, V54, P2971, DOI 10.1021/jm200057u; Ota K, 2014, J NEUROSCI METH, V221, P139, DOI 10.1016/j.jneumeth.2013.10.003; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tazaki M, 2014, INT J REHABIL RES, V37, P48, DOI 10.1097/MRR.0000000000000032; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; WAIS W D., 1997, WAIS 3 ADM SCOR MAN, P25; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Wilson BA., 1997, BEHAV ASSESSMENT DYS; Yamauchi H, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101762; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032	45	1	1	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2020	16						2719	2732		10.2147/NDT.S268504			14	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	OS1QB	WOS:000589939000003	33209027	gold, Green Published			2022-02-06	
J	Venkatasubramanian, PN; Pina-Crespo, J; Mathews, K; Rigby, PH; Smith, M; Duckworth, JL; Wyrwicz, AM; Spiess, J				Venkatasubramanian, Palamadai N.; Pina-Crespo, Juan; Mathews, Kiran; Rigby, Paul H.; Smith, Matthew; Duckworth, Josh L.; Wyrwicz, Alice M.; Spiess, Joachim			Initial Biphasic Fractional Anisotropy Response to Blast-Induced Mild Traumatic Brain Injury in a Mouse Model	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				MRI; MATTER; WHITE; DTI	Introduction Blast-induced mild traumatic brain injury was generated in a mouse model using a shock tube to investigate recovery and axonal injury from single blast. Methods A supersonic helium wave hit the head of anesthetized male young adult mice with a reflected pressure of 69 psi for 0.2 ms on Day 1. Subsequently, the mice were cardioperfused on Days 2, 5, or 12. The isolated brains were subjected to diffusion tensor imaging. Reduced fractional anisotropy (FA) indicated axonal injury. Results After single blast, FA showed a biphasic response in the corpus callosum with decrease on Days 2 and 12 and increase on Day 5. Conclusions Blast-induced mild traumatic brain injury in a mouse model follows a biphasic FA response within 12 days after a single blast similar to that reported for human subjects.	[Venkatasubramanian, Palamadai N.; Smith, Matthew; Wyrwicz, Alice M.] Northshore Univ Hlth Syst, 1001 Univ Pl, Evanston, IL 60201 USA; [Pina-Crespo, Juan; Spiess, Joachim] Sanford Burnham Prebys Med Discovery Inst, 10901 N Toney Pines Rd, La Jolla, CA 92037 USA; [Mathews, Kiran; Rigby, Paul H.] L3 Appl Technol, 10180 Barnes Canyon Rd, San Diego, CA 92121 USA; [Duckworth, Josh L.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Spiess, Joachim] Cortrop Inc, 271 Cerro St, Encinitas, CA 92024 USA		Venkatasubramanian, PN (corresponding author), Northshore Univ Hlth Syst, 1001 Univ Pl, Evanston, IL 60201 USA.		Pina-Crespo, Juan C./A-5579-2009	Pina-Crespo, Juan C./0000-0003-2803-7377	Cortrop Incorporated; Max Planck Institute for Experimental Medicine; Defense Advanced Research Projects Agency funded/Uniformed Services University of the Health Sciences [HU00001-14-1-0023, HU00001-18-2-0006]	This study was supported by Cortrop Incorporated who funded most of the expenses for mice, blast, and single house animal holding and by the Max Planck Institute for Experimental Medicine that provided a small travel grant to facilitate cell-biological communication. (Spiess); Defense Advanced Research Projects Agency funded/Uniformed Services University of the Health Sciences award number HU00001-14-1-0023/Investigating the Neurologic Effects of Training Associated Blast (Duckworth); Defense Health Agency funded/Uniformed Services University of the Health Sciences award number HU00001-18-2-0006/Combat and Training Queryable Exposure/Event Repository (Duckworth).	Agoston DV, 2015, FRONTIERS NEUROENGIN; Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; DePalma RG, 2015, FRONTIERS NEUROENGIN; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hutchinson EB, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00573; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mihalik JP, 2014, J SPORT HEALTH SCI, V3, P307, DOI 10.1016/j.jshs.2014.07.005; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sarrami P, 2017, J ORTHOP TRAUMATOL, V18, P9, DOI 10.1007/s10195-016-0431-x; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713	27	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			243	247		10.1093/milmed/usz307			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600035	32074348	Green Published, hybrid			2022-02-06	
B	Ventresca, M		Ventresca, M; McDonald, MG		Ventresca, Matt			Beyond the Biopsychosocial A Case for Critical Qualitative Concussion Research	SOCIOCULTURAL EXAMINATIONS OF SPORTS CONCUSSIONS	Routledge Research in Sport and Exercise Science		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; SPORT; RISK; PSYCHOLOGY; MANAGEMENT; CLINICIAN; RECOVERY; MODEL; NEED		[Ventresca, Matt] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada		Ventresca, M (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.						Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Barth Jeffrey T, 2010, HDB SPORT NEUROPSYCH, P75; Bendelow G, 2009, HLTH EMOTION BODY; BENDELOW GA, 1995, SOCIOL HEALTH ILL, V17, P139, DOI 10.1111/1467-9566.ep10933376; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Caron JG, 2017, J LOSS TRAUMA, V22, P501, DOI 10.1080/15325024.2017.1335150; Caron Jeffrey G, 2013, J SPORT EXERCISE PSY, V35; Cassilo D, 2019, COMMUN SPORT, V7, P678, DOI 10.1177/2167479518790039; Choudhury S, 2009, BIOSOCIETIES, V4, P61, DOI 10.1017/S1745855209006437; Cochran Casey, 2016, PLAYERS TRIBUNE 0705; Cromby J, 2007, BIOSOCIETIES, V2, P149, DOI [DOI 10.1017/S1745855207005224, 10.1017/s1745855207005224]; Crossley M, 2008, SOC PERSONAL PSYCHOL, V2, P21, DOI 10.1111/j.1751-9004.2007.00041.x; Cusimano Michael, 2016, CLIN J SPORT MED, V27; Davidson J., 2005, EMOTIONAL GEOGRAPHIE, P1; Davidson J, 2016, EMOT SPACE SOC, V18, P28, DOI 10.1016/j.emospa.2016.01.002; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Frost Samantha, 2016, BIOCULTURAL CREATRES; HARAWAY D, 1988, FEMINIST STUD, V14, P575, DOI 10.2307/3178066; Harre R, 2002, THEOR CULT SOC, V19, P23, DOI 10.1177/026327640201900502; Harrits GS, 2011, J MIX METHOD RES, V5, P150, DOI 10.1177/1558689811402506; Ho RA, 2018, INT J PSYCHOPHYSIOL, V132, P62, DOI 10.1016/j.ijpsycho.2017.09.021; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson G.L., 2012, PTSD MILD TRAUMATIC; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jasanoff S., 2005, DESIGNS NATURE SCI D; Keller Evelyn Fox, 2000, CENTURY GENE; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Latour B., 1986, LAB LIFE CONSTRUCTIO, V2nd; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lima DD, 2014, PHILOS ETHICS HUM ME, V9, DOI 10.1186/1747-5341-9-2; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Liston Katie, 2016, INT REV SOCIOLOGY SP; Maguire JA, 2011, SPORT SOC, V14, P898, DOI 10.1080/17430437.2011.603547; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Malcolm D., 2017, SPORT MED HLTH MEDIC; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCuddy WT, 2018, NEUROIMAGE-CLIN, V19, P434, DOI 10.1016/j.nicl.2018.05.011; Mol A., 2002, BODY MULTIPLE ONTOLO; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; O'Rourke DJ, 2017, SPORT EXERC PERFORM, V6, P262, DOI 10.1037/spy0000097; Panczykowski DM, 2014, PROG NEUROL SURG, V28, P195, DOI 10.1159/000358780; Pitts-Taylor V., 2016, BRAINS BODY NEUROSCI; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; SCOTT JW, 1991, CRIT INQUIRY, V17, P773, DOI 10.1086/448612; Shankar S, 2018, QUAL INQ, V24, P56, DOI 10.1177/1077800417728960; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; SMITH J, 1975, PHILOS SOC SCI, V5, P33, DOI 10.1177/004839317500500103; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stam H J, 2000, J Health Psychol, V5, P273, DOI 10.1177/135910530000500309; Tjong VK, 2017, JAAOS GLOB RES REV, V1, DOI 10.5435/JAAOSGlobal-D-17-00070; Todd R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192125; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Ventresca Matt, 2020, SPORTS SOC TECHNOLOG; Vidal Fernando, 2011, NEUROCULTURES GLIMPS, P7; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Webbe Frank M., 2010, HDB SPORT NEUROPSYCH, P1; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	69	1	1	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-429-02817-5; 978-0-367-13450-1	ROUT RES SPORT EXERC			2020							170	188					19	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Sociology; Sport Sciences	BO8OT	WOS:000528901400010					2022-02-06	
J	Volovetz, J; Roach, MJ; Stampas, A; Nemunaitis, G; Kelly, ML				Volovetz, Josephine; Roach, Mary Joan; Stampas, Argyrios; Nemunaitis, Gregory; Kelly, Michael L.			Blood Alcohol Concentration Is Associated With Improved AIS Motor Score After Spinal Cord Injury	TOPICS IN SPINAL CORD INJURY REHABILITATION			English	Article						alcohol; blood alcohol concentration; neuroprotection; outcomes; spinal cord injury	TRAUMATIC BRAIN-INJURY; SUBSTANCE USE; EPIDEMIOLOGY; INTOXICATION; OUTCOMES; RISK	Objective: To investigate the relationship between blood alcohol concentration (BAC) and neurologic recovery after traumatic spinal cord injury (TSCI) using standardized outcome measures from the International Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) examination. Method: This is a retrospective review of merged, prospectively collected, multicenter data from the Spinal Cord Injury Model Systems Database and institutional trauma databases from five academic medical centers across the United States. Patients with SCI and a documented BAC were analyzed for American Spinal Injury Association Impairment Scale (AIS) motor score, FIM, sensory light touch score, and sensory proprioception score upon admission and discharge from rehabilitation. Linear regression was used for the analysis. Results: The study identified 210 patients. Mean age at injury was 47 +/- 20.5 years, 73% were male, 31% had an AIS grade A injury, 56% had >= 1 comorbidity, mean BAC was 0.42 +/- 0.9 g/dL, and the mean Glasgow Coma Score upon arrival was 13.27 +/- 4.0. ISNCSCI motor score gain positively correlated with higher BAC (4.80; confidence interval [CI], 2.39-7.22; p < .0001). FIM motor gain showed a trend toward correlation with higher BAC, although it did not reach statistical significance (3.27; CI, -0.07 to 6.61; p = .055). ISNCSCI sensory light touch score gain and sensory proprioception score gain showed no correlation with BAC (p = .44, p = .09, respectively). Conclusion: The study showed a positive association between higher BAC and neurologic recovery in patients with SCI as measured by ISNCSCI motor score gain during rehabilitation. This finding has not been previously reported in the literature and warrants further study to better understand possible protective physiological mechanisms underlying the relationship between BAC and SCI.	[Volovetz, Josephine] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Roach, Mary Joan] Case Western Reserve Univ, Ctr Healthcare Res & Policy, MetroHlth Med Ctr, Sch Med, Cleveland, OH 44109 USA; [Stampas, Argyrios] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Nemunaitis, Gregory] Cleveland Clin, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA; [Kelly, Michael L.] Case Western Reserve Univ, MetroHlth Med Ctr, Dept Neurosurg, Sch Med, Cleveland, OH 44109 USA		Kelly, ML (corresponding author), Case Western Reserve Univ, MetroHlth Med Ctr, Dept Neurosurg, Sch Med, Cleveland, OH 44109 USA.	mkelly4@metrohealth.org			National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS)	The SCI Model Systems national database is a multicenter study of the SCI Model System Centers Program and is supported by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). However, these contents do not necessarily reflect the opinions or views of the SCI Model System Centers, NIDILRR, ACL, or HHS.	Afshar M, 2016, INJURY, V47, P83, DOI 10.1016/j.injury.2015.10.063; Afshar M, 2015, J TRAUMA ACUTE CARE, V79, P643, DOI 10.1097/TA.0000000000000825; Ahmed N, 2020, INJURY, V51, P91, DOI 10.1016/j.injury.2019.10.005; American College of Surgeons Committee on Trauma, 2020, NATL TRAUMA DATA STA; Anderson T E, 1986, Cent Nerv Syst Trauma, V3, P183; BENZEL EC, 1987, NEUROSURGERY, V20, P281, DOI 10.1227/00006123-198702000-00014; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Blanksby BA, 1997, SPORTS MED, V23, P228, DOI 10.2165/00007256-199723040-00003; Brigode W, 2019, J SURG RES, V244, P196, DOI 10.1016/j.jss.2019.06.043; Burke DA, 2001, SPINAL CORD, V39, P274, DOI 10.1038/sj.sc.3101158; Chan CWL, 2016, J SPINAL CORD MED, V39, P255, DOI 10.1080/10790268.2016.1138601; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Crutcher CL, 2014, J NEUROTRAUM, V31, P798, DOI 10.1089/neu.2014.3329; DeVivo MJ, 1997, SPINAL CORD, V35, P509, DOI 10.1038/sj.sc.3100430; Eldridge LA, 2019, TOP SPINAL CORD INJ, V25, P316, DOI 10.1310/sci2504-316; Furlan JC, 2013, EUR J NEUROL, V20, P1101, DOI 10.1111/ene.12145; HALT PS, 1992, ARCH NEUROL-CHICAGO, V49, P1178, DOI 10.1001/archneur.1992.00530350096025; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Kelly ML, 2019, TOP SPINAL CORD INJ, V25, P186, DOI 10.1310/sci2502-186; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; Mohseni S, 2016, BRAIN INJURY, V30, P1256, DOI 10.1080/02699052.2016.1183823; PERRINE MW, 1994, J STUD ALCOHOL, V55, P517, DOI 10.15288/jsa.1994.55.517; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Stroud MW, 2011, J SPINAL CORD MED, V34, P461, DOI 10.1179/2045772311Y.0000000033; Tate DG, 2004, ARCH PHYS MED REHAB, V85, P1837, DOI 10.1016/j.apmr.2004.02.022; WOOLF PD, 1991, J TRAUMA, V31, P1271, DOI 10.1097/00005373-199109000-00012	30	1	1	0	0	AMER SPINAL INJURY ASSOC	RICHMOND	9702 GAYTON RD, SUITE 306, RICHMOND, VA, UNITED STATES	1082-0744	1945-5763		TOP SPINAL CORD INJ	Top. Spinal Cord Inj. Rehabil.		2020	26	4					261	267		10.46292/sci20-00014			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	SG9QU	WOS:000653775400005	33536731	Green Published			2022-02-06	
J	Wagner, MK; Berg, SK; Hassager, C; Armand, S; Moller, JE; Ekholm, O; Rasmussen, TB; Fisher, PM; Knudsen, GM; Stenbaek, DS				Wagner, Mette Kirstine; Berg, Selina Kikkenborg; Hassager, Christian; Armand, Sophia; Moller, Jacob Eifer; Ekholm, Ola; Rasmussen, Trine Bernholdt; Fisher, Patrick MacDonald; Knudsen, Gitte Moos; Stenbaek, Dea Siggaard			Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol	BMJ OPEN			English	Article						mental health; cardiology; neurology; anxiety disorders; depression and mood disorders; magnetic resonance imaging	ACUTE STRESS DISORDER; POSTTRAUMATIC-STRESS; PSYCHOMETRIC PROPERTIES; EUROPEAN RESUSCITATION; BRAIN-INJURY; RISK-FACTORS; LIFE; HEALTH; SCALE; PREVALENCE	Introduction Cognitive impairment and psychopathology caused by brain hypoxia and the traumatic impact of critical illness are common in cardiac arrest survivors and can lead to negative consequences of everyday life functioning, and further impact mental health in relatives. Most studies have dealt with the mere survival rate after cardiac arrest and not with long-term consequences to mental health in cardiac arrest survivors. Importantly, we face a gap in our knowledge about suitable screening tools in the early post-arrest phase for long-term risk prediction of mental health problems. This study aims to evaluate the efficacy of a novel screening procedure to predict risk of disabling cognitive impairment and psychopathology 3 months after cardiac arrest. Furthermore, the study aims to evaluate long-term prevalence of psychopathology in relatives. Methods and analyses In this multicentre prospective cohort study, out-of-hospital cardiac arrest survivors and their relatives will be recruited. The post-arrest screening includes the Montreal Cognitive Assessment (MoCA), the Hospital Anxiety and Depression Scale (HADS), the Impact of Event Scale-Revised (IES-R) and the Acute Stress Disorder Interview (ASDI) and is conducted during hospitalisation. In a subsample of the patients, functional MRI is done, and cortisol determination collected. At 3-month follow-up, the primary study outcomes for 200 survivors include the Danish Affective Verbal Learning Test-26 (VAMT-26), Delis-Kaplan Executive Function System tests (trail making, colour-word interference, word and design fluency), Rey's Complex Figure and Letter-number sequencing subtest of Wechsler Adult Intelligence Scale-IV, HADS and IES-R. For the relatives, they include HADS and IES-R. Ethics and dissemination The study is approved by the local regional Research Ethics Committee (H-18046155) and the Danish Data Protection Agency (RH-2017-325, j.no.05961) and follows the latest version of the Declaration of Helsinki. The results will be published in peer-reviewed journals and may impact the follow-up of cardiac arrest survivors.	[Wagner, Mette Kirstine; Berg, Selina Kikkenborg; Hassager, Christian] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Berg, Selina Kikkenborg; Hassager, Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Armand, Sophia; Fisher, Patrick MacDonald; Knudsen, Gitte Moos; Stenbaek, Dea Siggaard] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Copenhagen, Denmark; [Moller, Jacob Eifer] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Ekholm, Ola] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Syddanmark, Denmark; [Rasmussen, Trine Bernholdt] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Fisher, Patrick MacDonald; Knudsen, Gitte Moos] Copenhagen Univ Hosp, Rigshosp, Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark		Wagner, MK (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark.	mette.kirstine.wagner@regionh.dk	Wagner, Mette Kirstine/AAI-2796-2021; Fisher, Patrick MacDonald/V-8158-2017	Wagner, Mette Kirstine/0000-0001-9461-1416; Fisher, Patrick MacDonald/0000-0002-8115-0611; Rasmussen, Trine Bernholdt/0000-0002-4733-8119; Stenbaek, Dea/0000-0002-5439-4637; Hassager, Christian/0000-0002-1199-0981	Research Foundation of Copenhagen University Hospital, Rigshospitalet, Denmark [GNT 38-A2015, GNT A5638]; Danish Knowledge Centre for Rehabilitation and Palliative Care (REHPA) [GNT 34 177 058]; Helsefonden, Denmark [GNT 18-B-0235]; Danish Heart Association [GNT 18-R124-A8454-22099]; Research Committee and the Research Committee in clinical nursing, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Denmark	The REVIVAL study is funded by independent research grants from the following non-profit or governmental agencies: The Research Foundation of Copenhagen University Hospital, Rigshospitalet, Denmark (GNT 38-A2015 and GNT A5638), The Danish Knowledge Centre for Rehabilitation and Palliative Care (REHPA) (GNT 34 177 058), The Helsefonden, Denmark (GNT 18-B-0235), The Danish Heart Association (GNT 18-R124-A8454-22099, and from both The Research Committee and the Research Committee in clinical nursing, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Denmark (GNT Not Applicable).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; [Anonymous], **NON-TRADITIONAL**; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Bellelli G, 2014, AGE AGEING, V43, P496, DOI 10.1093/ageing/afu021; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Boyce LW, 2019, CURR OPIN CRIT CARE, V25, P240, DOI 10.1097/MCC.0000000000000609; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Cronberg T, 2015, JAMA NEUROL, V72, P634, DOI 10.1001/jamaneurol.2015.0169; Cronberg T, 2015, RESUSCITATION, V91, pA3, DOI 10.1016/j.resuscitation.2015.03.002; Cronberg T, 2009, RESUSCITATION, V80, P1119, DOI 10.1016/j.resuscitation.2009.06.021; Czyz-Szypenbej K, 2019, CRIT CARE MED, V47, pE531, DOI 10.1097/CCM.0000000000003726; Davies SE, 2017, RESUSCITATION, V111, P22, DOI 10.1016/j.resuscitation.2016.11.004; Delis DC., 2001, DELIS KAPLAN EXECUTI; Descatha A, 2018, RESUSCITATION, V128, P170, DOI 10.1016/j.resuscitation.2018.05.021; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Elliott VJ, 2011, RESUSCITATION, V82, P247, DOI 10.1016/j.resuscitation.2010.10.030; Gamper G, 2004, CRIT CARE MED, V32, P378, DOI 10.1097/01.CCM.0000108880.97967.C0; Green CR, 2015, ANAESTH INTENS CARE, V43, P568, DOI 10.1177/0310057X1504300504; Haywood K, 2018, RESUSCITATION, V128, pA1, DOI 10.1016/j.resuscitation.2018.04.034; Hinduja A, 2014, J FORENSIC LEG MED, V23, P84, DOI 10.1016/j.jflm.2014.02.003; Hofland JV, 2018, RESUSCITATION, V128, P198, DOI 10.1016/j.resuscitation.2018.03.016; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Jensen CG, 2016, MEMORY, V24, P1208, DOI 10.1080/09658211.2015.1087573; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kamphuis HCM, 2002, EUROPACE, V4, P417, DOI 10.1053/eupc.2002.0258; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lilja G, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003566; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Medrzycka-Dabrowska WA, 2018, POSTEP KARDIOL INTER, V14, P225, DOI 10.5114/aic.2018.78324; Moulaert VRMP, 2010, J REHABIL MED, V42, P553, DOI 10.2340/16501977-0547; Moulaert VRMP, 2009, RESUSCITATION, V80, P297, DOI 10.1016/j.resuscitation.2008.10.034; Moulaert VRMP, 2014, LIFE SURVIVAL CARDIA; Myat A, 2018, LANCET, V391, P970, DOI 10.1016/S0140-6736(18)30472-0; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perez CA, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0669-y; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Porzer M, 2017, BIOMED PAP, V161, P348, DOI 10.5507/bp.2017.054; Sakusic A, 2018, MAYO CLIN PROC, V93, P68, DOI 10.1016/j.mayocp.2017.11.005; Schaaf KPW, 2013, RESUSCITATION, V84, P873, DOI 10.1016/j.resuscitation.2012.11.021; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; van Wijnen HGFM, 2017, CLIN REHABIL, V31, P1267, DOI 10.1177/0269215516686155; Vilchinsky N, 2017, CLIN PSYCHOL REV, V55, P92, DOI 10.1016/j.cpr.2017.04.009; Visser E, 2017, J TRAUMA ACUTE CARE, V82, P1158, DOI 10.1097/TA.0000000000001447; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wachelder EM, 2009, RESUSCITATION, V80, P517, DOI 10.1016/j.resuscitation.2009.01.020; WECHSLER D, 1997, ADULT INTELLIGENCE S, V21; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiss Daniel S., 1997, P399; Wessa M, 2006, PSYCHONEUROENDOCRINO, V31, P209, DOI 10.1016/j.psyneuen.2005.06.010; Whitehead L, 2015, RESUSCITATION, V88, P150, DOI 10.1016/j.resuscitation.2014.11.013; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmerli M, 2014, RESUSCITATION, V85, P801, DOI 10.1016/j.resuscitation.2014.02.022; [No title captured]	65	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	9							e038633	10.1136/bmjopen-2020-038633			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OB4JT	WOS:000578438100010	32994252	Green Published, gold			2022-02-06	
J	Wang, YL; Wu, F; Hu, F; Wu, YJ; Zhou, J; Xu, Y; Shao, XR; Hu, T				Wang, Yali; Wu, Feng; Hu, Feng; Wu, Yunjiang; Zhou, Jun; Xu, Yan; Shao, Xiangrong; Hu, Tao			Drag -reducing polymers attenuates pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension	CLINICAL HEMORHEOLOGY AND MICROCIRCULATION			English	Article						Drag-reducing polymers; vascular remodeling; right ventricular; chronic hypoxia; pulmonary hypertension	TRAUMATIC BRAIN-INJURY; BIOFILM FORMATION; REDUCTION; OXYGENATION; FLUID	Drag-reducing polymers (DRPs) was previously demonstrated to increase blood flow, tissue perfusion, and reduce vascular resistance. The purpose of this study was to investigate the effect of DRPs on pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension (HPH). A total of forty male Wistar rats were randomly and equally assigned into four experimental groups (Group I: normoxia + saline, Group II: normoxia + PEO, Group III: hypoxia + saline, Group IV: hypoxia + PEO) and maintained in normoxia (21% O2) or hypobaric hypoxia (10% O2). After four weeks, comparisons were made of the following aspects: the mean pulmonary arterial pressure (mPAP), right ventricular systolic pressure (RVSP), right ventricular hypertrophy, wall thickness of pulmonary trunk and arteries, internal diameter of pulmonary arteries, cardiomyocyte cross-sectional area (CM CSA), and ultrastructure of right ventricular. Treatment with PEO in Group IV attenuated the increases in RVSP and mPAP (40.5 +/- 7.2 and 34.7 +/- 7.0 mmHg, respectively, both P < 0.05), compared with Group III. Distal vascular remodeling was visible as a significant increase in medial wall thickness (64.2 +/- 12.3% vs. 43.95 +/- 7.0%, P < 0.01) and a remarkable decrease in internal diameter of small pulmonary arteries (35.2 +/- 9.7 m vs. 50.4 +/- 14.7 m, P < 0.01) in Group III, to a greater extent than that detected in Group IV. Nevertheless, no significant histopathological differences in medial wall thickness was observed in pulmonary trunk between Group III and Group IV (P > 0.05), denoting that PEO chiefly attenuated the remodeling of small pulmonary arteries rather than main arteries in hypoxic environment. Infusion of DRPs (intravenous injection twice weekly) also attenuated the index of right ventricular hypertrophy, protected against the increase of cardiomyocyte cross-sectional area, and provided protection for cardiac ultrastructure. DRP treatment with intravenous injection elicited a protective effect against pulmonary vascular remodeling and right ventricular dysfunction in the rat model of HPH. DRPs may offer a new potential approach for the treatment of HPH, which may have theoretical significance and application value to society.	[Wang, Yali; Wu, Feng; Zhou, Jun; Xu, Yan; Shao, Xiangrong; Hu, Tao] Yangzhou Univ, Affiliated Hosp, Dept Resp Med, 368 Hanjiang Middle Rd, Yangzhou 225009, Jiangsu, Peoples R China; [Hu, Feng] Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Cardiac Arrhythmia Ctr, Beijing, Peoples R China; [Wu, Yunjiang] Yangzhou Univ, Affiliated Hosp, Dept Thorac Surg, Yangzhou, Jiangsu, Peoples R China		Wang, YL (corresponding author), Yangzhou Univ, Affiliated Hosp, Dept Resp Med, 368 Hanjiang Middle Rd, Yangzhou 225009, Jiangsu, Peoples R China.	wyl1586135@126.com	Hu, Feng/AAF-5173-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81800050]; Natural science fund of Yangzhou City [YZ2017119]; Science and Technology Innovation Cultivation Program of Yangzhou University [2017CXJ122]	The study was partly supported by the National Natural Science Foundation of China (81800050), and Natural science fund of Yangzhou City (YZ2017119), and Science and Technology Innovation Cultivation Program of Yangzhou University (2017CXJ122).	Abberton CL, 2016, APPL ENVIRON MICROB, V82, P5320, DOI 10.1128/AEM.01569-16; Abe H, 2017, J ATHEROSCLER THROMB, V24, P884, DOI 10.5551/jat.RV17009; Ajami NE, 2017, P NATL ACAD SCI USA, V114, P10990, DOI 10.1073/pnas.1707517114; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Booth R, 2014, LAB CHIP, V14, P1880, DOI 10.1039/c3lc51304a; Bragin DE, 2018, ADV EXP MED BIOL, V1072, P39, DOI 10.1007/978-3-319-91287-5_7; Bragin DE, 2017, J CEREBR BLOOD F MET, V37, P762, DOI 10.1177/0271678X16684153; Brands J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077252; De Rienzo MAD, 2016, APPL MICROBIOL BIOT, V100, P5773, DOI 10.1007/s00253-016-7310-5; Ding ZJ, 2017, BREAST CANCER-TARGET, V9, P61, DOI 10.2147/BCTT.S128777; Dunham-Snary KJ, 2017, CHEST, V151, P181, DOI 10.1016/j.chest.2016.09.001; Fein DG, 2016, J CLIN MED, V5, DOI 10.3390/jcm5090075; Gomez-de-Segura G, 2018, FLOW TURBUL COMBUST, V100, P995, DOI 10.1007/s10494-018-9916-4; Gyongyosi A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5786742; Hu F, 2016, CLIN HEMORHEOL MICRO, V62, P1, DOI 10.3233/CH-151925; Kim JS, 2015, AM J PHYSIOL-HEART C, V309, pH425, DOI 10.1152/ajpheart.00438.2014; Klinger JR, 2016, CARDIOL CLIN, V34, P413, DOI 10.1016/j.ccl.2016.04.003; Labrousse-Arias D, 2016, CARDIOVASC RES, V109, P115, DOI 10.1093/cvr/cvv243; Lau EMT, 2015, EUR RESPIR J, V46, P879, DOI 10.1183/13993003.01177-2015; Liu J, 2018, EBIOMEDICINE, V33, P196, DOI 10.1016/j.ebiom.2018.06.003; Marhefka JN, 2009, BIORHEOLOGY, V46, P281, DOI 10.3233/BIR-2009-0543; Mohamed HD, 2017, WATER SCI TECHNOL, V76, P739, DOI 10.2166/wst.2017.233; Moormeier DE, 2013, APPL ENVIRON MICROB, V79, P3413, DOI 10.1128/AEM.00395-13; Nathan SD, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01914-2018; Opitz I, 2018, J THORAC DIS, V10, pS2763, DOI 10.21037/jtd.2018.07.63; Pribush A, 2013, COLLOID SURFACE B, V103, P354, DOI 10.1016/j.colsurfb.2012.11.004; Rampersad SN, 2016, CELL SIGNAL, V28, P741, DOI 10.1016/j.cellsig.2015.12.001; Russell-Puleri S, 2017, AM J PHYSIOL-HEART C, V312, pH485, DOI 10.1152/ajpheart.00035.2016; Sun XZ, 2019, CLIN HEMORHEOL MICRO, V71, P3, DOI 10.3233/CH-160232; Toms B.A., 1948, P 1 INT C RHEOL AMST, P135, DOI DOI 10.1155/2011/367042; Wang YL, 2016, BIORHEOLOGY, V53, P13, DOI 10.3233/BIR-15062; Zhang Q, 2016, VASCULAR, V24, P241, DOI 10.1177/1708538115592092; Zhang XL, 2016, INT J NANOMED, V11, P6743, DOI 10.2147/IJN.S119607	33	1	1	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1386-0291	1875-8622		CLIN HEMORHEOL MICRO	Clin. Hemorheol. Microcirc.		2020	74	2					189	200		10.3233/CH-190668			12	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	LC4IE	WOS:000525287300008	31476149				2022-02-06	
J	Wermer, A; Kerwin, J; Welsh, K; Mejia-Alvarez, R; Tartis, M; Willis, A				Wermer, Anna; Kerwin, Joseph; Welsh, Kelsea; Mejia-Alvarez, Ricardo; Tartis, Michaelann; Willis, Adam			Materials Characterization of Cranial Simulants for Blast-Induced Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				MECHANICAL-PROPERTIES; TISSUE; MODEL; CAVITATION; EXPOSURE	Introduction The mechanical response of brain tissue to high-speed forces in the blast and blunt traumatic brain injury is poorly understood. Object-to-object variation and interspecies differences are current limitations in animal and cadaver studies conducted to study damage mechanisms. Biofidelic and transparent tissue simulants allow the use of high-speed optical diagnostics during a blast event, making it possible to observe deformations and damage patterns for comparison to observed injuries seen post-mortem in traumatic brain injury victims. Methods Material properties of several tissue simulants were quantified using standard mechanical characterization techniques, that is, shear rheometric, tensile, and compressive testing. Results Polyacrylamide simulants exhibited the best optical and mechanical property matching with the fewest trade-offs in the design of a cranial test object. Polyacrylamide gels yielded densities of similar to 1.04 g/cc and shear moduli ranging 1.3-14.55 kPa, allowing gray and white matter simulant tuning to a 30-35% difference in shear for biofidelity. Conclusions These materials are intended for use as layered cranial phantoms in a shock tube and open field blasts, with focus on observing phenomena occurring at the interfaces of adjacent tissue simulant types or material-fluid boundaries. Mechanistic findings from these studies may be used to inform the design of protective gear to mitigate blast injuries.	[Wermer, Anna; Welsh, Kelsea; Tartis, Michaelann] New Mexico Inst Min & Technol, Dept Chem Engn, 801 Leroy Pl, Socorro, NM 87801 USA; [Kerwin, Joseph; Mejia-Alvarez, Ricardo] Michigan State Univ, Dept Mech Engn, 1449 Engn Res Ct A117, E Lansing, MI 48824 USA; [Willis, Adam] San Antonio Mil Med Ctr, Dept Neurol, 3551 Roger Brooke Dr, San Antonio, TX 78219 USA		Wermer, A (corresponding author), New Mexico Inst Min & Technol, Dept Chem Engn, 801 Leroy Pl, Socorro, NM 87801 USA.				United States Air ForceUnited States Department of Defense [406287]	This study was supported by a grant from the United States Air Force (Contract #406287).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Bilston LE, 2001, BIORHEOLOGY, V38, P335; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Cao R, 2013, MED PHYS, V40, DOI 10.1118/1.4773315; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cronin DS, 2011, EXP MECH, V51, P1197, DOI 10.1007/s11340-010-9438-z; Cullen DK, 2011, J NEUROTRAUM, V28, P2307, DOI [10.1089/neu.2010.1718, 10.1089/neu.2011.1718]; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Duck F.A., 1990, PHYS PROPERTIES TISS; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Miller K, 1999, J BIOMECH, V32, P531, DOI 10.1016/S0021-9290(99)00010-X; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Murphy W., 2016, HDB BIOMATERIAL PROP; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Qiao YZ, 2013, ULTRASON SONOCHEM, V20, P1376, DOI 10.1016/j.ultsonch.2013.03.007; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Richler D, 2014, EXP MECH, V54, P805, DOI 10.1007/s11340-014-9848-4; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Sun MK, 2015, ULTRASON SONOCHEM, V23, P399, DOI 10.1016/j.ultsonch.2014.10.008; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Tanielian T., 2008, INVISIBLE WOUNDS WAR; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; Zell K, 2007, PHYS MED BIOL, V52, pN475, DOI 10.1088/0031-9155/52/20/N02	40	1	1	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			205	213		10.1093/milmed/usz228			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600031	32074306	Bronze			2022-02-06	
J	Whiffin, CJ; Smith, BG; Esene, IN; Karekezi, C; Bashford, T; Khan, MM; Solla, DJF; Hutchinson, PJ; Kolias, A				Whiffin, Charlotte J.; Smith, Brandon G.; Esene, Ignatius N.; Karekezi, Claire; Bashford, Tom; Khan, Muhammad Mukhtar; Solla, Davi J. Fontoura; Hutchinson, Peter J.; Kolias, Angelos			Neurosurgeons' experiences of conducting and disseminating clinical research in low- and middle-income countries: a qualitative study protocol	BMJ OPEN			English	Article						qualitative research; neurosurgery; neurological injury		Introduction Low-income and middle-income countries (LMICs) face the greatest burden of neurotrauma. However, most of the research published in scientific journals originates from high-income countries, suggesting those in LMICs are either not engaging in research or are not publishing it. Evidence originating in high-income countries may not be generalisable to LMICs; therefore, it is important to nurture research capacity in LMICs so that a relevant evidence base can be developed. However, little is published about specific challenges or contextual issues relevant to increasing research activity of neurosurgeons in LMICs. Therefore, the aim of this study was to understand neurosurgeons' experiences of, aspirations for and ability to conduct and disseminate clinical research in LMICs. Methods and analysis This is a pragmatic qualitative study situated within the naturalistic paradigm using focus groups and interviews with a purposive sample of neurosurgeons from LMICs. First, we will conduct asynchronous online focus groups with 36 neurosurgeons to broadly explore issues relevant to the study aim. Second, we will select 20 participants for follow-up semistructured interviews to explore concepts in more depth and detail than could be achieved in the focus group. Interviews will be audio-recorded and transcribed verbatim. A thematic analysis will be conducted following Braun and Clarke's six stages and will be supported by NVIVO software. Ethics and dissemination The University of Cambridge Psychology Research Ethics Committee reviewed this study and provided a favourable opinion in January 2020 (REF PRE.2020.006). Participants will provide informed consent, be able to withdraw at any time and will have their contributions kept confidential. The findings of the study will be shared with relevant stakeholders and disseminated in conference presentations and journal publications.	[Whiffin, Charlotte J.] Univ Derby, Coll Hlth & Social Care, Derby, England; [Whiffin, Charlotte J.; Smith, Brandon G.; Bashford, Tom; Hutchinson, Peter J.; Kolias, Angelos] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Whiffin, Charlotte J.; Smith, Brandon G.; Bashford, Tom; Hutchinson, Peter J.; Kolias, Angelos] Univ Cambridge, Cambridge, England; [Whiffin, Charlotte J.; Smith, Brandon G.; Esene, Ignatius N.; Bashford, Tom; Hutchinson, Peter J.; Kolias, Angelos] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Esene, Ignatius N.] Univ Bamenda, Fac Hlth Sci, Neurosurg Div, Bambili, Nw Region, Cameroon; [Karekezi, Claire] Rwanda Mil Hosp, Dept Neurosurg, Kigali City, Rwanda; [Khan, Muhammad Mukhtar] Northwest Sch Med, Neurosurg, Peshawar, Pakistan; [Khan, Muhammad Mukhtar] Northwest Gen Hosp & Res Ctr, Peshawar, Pakistan; [Solla, Davi J. Fontoura] Univ Sao Paulo, Div Neurosurg, Dept Neurol, Sao Paulo, Brazil		Whiffin, CJ (corresponding author), Univ Derby, Coll Hlth & Social Care, Derby, England.; Whiffin, CJ (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Whiffin, CJ (corresponding author), Univ Cambridge, Cambridge, England.; Whiffin, CJ (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	c.whiffin@derby.ac.uk	Karekezi, Claire/AAR-9283-2021; Bashford, Tom/H-9586-2019; ESENE, IGNATIUS/AAX-8716-2020; Solla, Davi/E-6988-2013	Karekezi, Claire/0000-0002-7183-899X; Bashford, Tom/0000-0003-0228-9779; ESENE, IGNATIUS/0000-0001-8785-8875; Whiffin, Charlotte/0000-0002-9767-2123; Smith, Brandon/0000-0001-8471-1368; Solla, Davi/0000-0002-5092-6595	National Institute for Health Research Global Health Research Group on Neurotrauma	This work was supported by the National Institute for Health Research Global Health Research Group on Neurotrauma.	Beuving J, 2015, DOING QUALITATIVE RESEARCH: THE CRAFT OF NATURALISTIC INQUIRY, P1; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; De Groot K, 2018, HEALTH SOC CARE COMM, V26, pE94, DOI 10.1111/hsc.12481; Department of Health and Social Care, 2017, GOV AW 120 MILL GLOB; Franzen SRP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012332; Griswold DP, 2020, NEUROSURGERY, V87, P476, DOI 10.1093/neuros/nyaa049; Harmsen IA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1183; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; Lincoln YS., 1985, NATURALISTIC INQUIRY, DOI 10.1016/0147-1767(85)90062-8; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375092, 10.1080/13814788.2017.1375091]; Neurotrauma. world, 2016, NIHR GLOB HLTH RES G; Peden, 2004, GUIDELINES ESSENTIAL; Polit DF., 2016, RESOURCE MANUAL NURS, V10th ed.; Servadei F, 2019, WORLD NEUROSURG, V130, pE822, DOI 10.1016/j.wneu.2019.06.230; Smith Joanna, 2011, Nurse Res, V18, P39; Sullivan-Bolyai S, 2005, NURS OUTLOOK, V53, P127, DOI 10.1016/j.outlook.2005.03.005; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Zwaanswijk Marieke, 2014, BMC Res Notes, V7, P756, DOI 10.1186/1756-0500-7-756	23	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	8							e038939	10.1136/bmjopen-2020-038939			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NH0DY	WOS:000564351500095	32792451	gold, Green Published			2022-02-06	
J	Wittrup, EM; Fox, LA; Breedlove, KM; Memmini, AK; Broglio, SP				Wittrup, Emily M.; Fox, Lucas A.; Breedlove, Katherine M.; Memmini, Allyssa K.; Broglio, Steven P.			Evaluation of Musculoskeletal Re-Injury Occurrence in Previously Concussed National Football League Athletes	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; musculoskeletal injury; return to play; NFL; professional American football	TRAUMATIC BRAIN-INJURY; RISK-FACTOR; COLLEGIATE	Introduction: Increased risk of musculoskeletal (MSK) injury post-concussion has been reported in collegiate athletes, yet it is unknown if professional football athletes are at the same risk of secondary injury. The objective of this study was to determine if the risk of MSK injury in National Football League (NFL) athletes increases after concussion. Methods: NFL injury reports from 2013 to 2017 were collected from public websites. Concussed athletes (n=91) were equally matched to a non-injured control and an athlete with an incident of musculoskeletal (MSK) injury. Results: Following their return to sport, concussed athletes were 2.35 times more likely to have a subsequent MSK injury relative to non-injured controls (95% CI: 2.35 [1.25, 4.44], P = 0.01), but were no more likely than athletes with an incident MSK injury (P = 0.55). Likewise, athletes with an incident MSK injury were no more likely to have a subsequent MSK injury than controls (P = 0.08). Discussion: Increased odds of MSK injury in the 12-week period following a concussion in professional football athletes warrants future research on the acute effects of concussion and the relationship to MSK injury risk.	[Wittrup, Emily M.; Fox, Lucas A.; Memmini, Allyssa K.; Broglio, Steven P.] Univ Michigan, Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Breedlove, Katherine M.] Brigham & Womens Hosp, Ctr Clin Spect, 75 Francis St, Boston, MA 02115 USA; [Breedlove, Katherine M.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA		Wittrup, EM (corresponding author), Univ Michigan, Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	ewittrup@umich.edu					Bahr R, 2020, ORTHOP J SPORTS MED, V8; Baker HP, 2020, PHYSICIAN SPORTSMED, V48, P124, DOI [10.1080/00913847.2019.1676137, 10.1080/00913847.2019.1587565]; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; CHOMIAK J, 2000, AM J SPORT MED, V28, pS5, DOI DOI 10.1177/28.SUPPL_5.S-5817; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Cohen J., 2013, STAT POWER ANAL BEHA; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Kawaji T, 2019, CRIT CARE MED, V47; Knight KL, 2008, J ATHL TRAINING, V43, P117, DOI 10.4085/1062-6050-43.2.117; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85	23	1	1	1	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2020	11						169	176		10.2147/OAJSM.S280841			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PL8LP	WOS:000603366500001	33364861	Green Published, gold			2022-02-06	
J	Yassa, HD; Gergis, SW; Rashed, LA; Hassan, DM; Youakim, MF				Yassa, H. D.; Gergis, S. W.; Rashed, L. A.; Hassan, D. M.; Youakim, M. F.			Therapeutic role of bone marrow mesenchymal stem cells in diabetic neuronal alternations of rat hippocampus	FOLIA MORPHOLOGICA			English	Article						diabetes; mesenchymal stem cells; hippocampus; neuronal alternations; learning and memory	MOUSE MODEL; BRAIN; APOPTOSIS; EXPRESS; DAMAGE; TRANSPLANTATION; STRESS; STROKE; MEMORY	Background: As the hippocampus is the main brain region for many forms of learning and memory functions and is acutely sensitive to blood glucose changes, diabetes mellitus, which is a serious metabolic disease, is often accompanied by learning and memory deficits. Through scientific literatures, mesenchymal stem cells (MSCs) promote functional recovery in rats with traumatic brain injury, so the present work was conducted to study MSCs as a possible treatment for the diabetic neuronal degeneration and functional impairment of rat hippocampus. Materials and methods: It was carried out using male albino rats: non-diabetic control groups (4, 8, 12 weeks) (n = 15), diabetic groups by i.v. injection of streptozotocin for (4, 8, 12 weeks) (n = 15) and MSCs treatment to diabetic groups for (8, 12 weeks) (n = 10). Hippocampal learning and memory functions were assessed by the Morris Water Maze test and its results were statistically analysed. The rat hippocampal regions (CA1 and CA3) were subjected to histological, ultrastructural examination and morphometrical analyse of pyramidal neurons. Results: Neurons of the diabetic groups showed disturbed function and architecture; shrunken hyperchromatic nuclei and vacuolated eosinophilic cytoplasm (apoptotic changes) also MSCs treatment improved hippocampal learning and memory functions plus its architectural changes; increasing populations and normal regular distribution. Conclusions: It can be concluded that diabetic hippocampal neuronal alternations and functional impairment can be ameliorated by MSCs treatment.	[Yassa, H. D.; Hassan, D. M.; Youakim, M. F.] Beni Suef Univ, Fac Med, Dept Anat, Bani Suwayf, Egypt; [Gergis, S. W.] Cairo Univ, Kasr El Aini Fac Med, Dept Anat, Giza, Egypt; [Rashed, L. A.] Cairo Univ, Kasr El Aini Fac Med, Dept Biochem, Giza, Egypt		Hassan, DM (corresponding author), Beni Suef Univ, Fac Med, Dept Anat, Bani Suwayf, Egypt.	doaa_eldary333@yahoo.com					Alexanian AR, 2008, STEM CELLS DEV, V17, P1123, DOI 10.1089/scd.2007.0212; Biessels GJ, 2002, EUR J PHARMACOL, V441, P1, DOI 10.1016/S0014-2999(02)01486-3; Bree AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE194, DOI 10.1152/ajpendo.91041.2008; Calio ML, 2014, FREE RADICAL BIO MED, V70, P141, DOI 10.1016/j.freeradbiomed.2014.01.024; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Deng J, 2006, STEM CELLS, V24, P1054, DOI 10.1634/stemcells.2005-0370; Gardoni F, 2002, J NEUROCHEM, V80, P438, DOI 10.1046/j.0022-3042.2001.00713.x; Ghaly E, 2014, ACTA MEDICA INT, V1, P57, DOI [10.5530/ami.2014.2.3., DOI 10.5530/AMI.2014.2.3]; Greco SJ, 2008, BIOL PROCED ONLINE, V10, P90, DOI 10.1251/bpo147; Jafari AI, 2014, J DIABETES RES; Jiang JJ, 2010, NEUROSCI RES, V66, P46, DOI 10.1016/j.neures.2009.09.1711; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045757; Kumar' SKS, 2014, NEURAL REGEN RES, V9, P1740, DOI 10.4103/1673-5374.143416; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lee I, 2005, NEUROBIOL LEARN MEM, V84, P138, DOI 10.1016/j.nlm.2005.06.002; Li ZG, 2002, BRAIN RES, V946, P221, DOI 10.1016/S0006-8993(02)02887-1; Liu LJ, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00035; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; Malone JI, 2008, PEDIATR DIABETES, V9, P531, DOI 10.1111/j.1399-5448.2008.00431.x; Matchynski-Franks JJ, 2016, CELL TRANSPLANT, V25, P687, DOI 10.3727/096368916X690818; McEwen BS, 2002, J PSYCHOSOM RES, V53, P883, DOI 10.1016/S0022-3999(02)00307-0; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Orlovsky MA, 2007, NEUROPHYSIOLOGY+, V39, P435, DOI 10.1007/s11062-008-9000-0; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schoenle EJ, 2002, DIABETOLOGIA, V45, P108, DOI 10.1007/s125-002-8250-6; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yang HY, 2013, MOL MED REP, V7, P431, DOI 10.3892/mmr.2012.1227; Ye M, 2007, PARKINSONISM RELAT D, V13, P44, DOI 10.1016/j.parkreldis.2006.07.013; Zhang HB, 2006, NEUROL RES, V28, P104, DOI 10.1179/016164106X91960; Zhao F, 2016, ANAT REC, V299, P1174, DOI 10.1002/ar.23344	36	1	1	0	0	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0015-5659	1644-3284		FOLIA MORPHOL	Folia Morphol.		2020	79	2					211	218	PMID 31436303	10.5603/FM.a2019.0089			8	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	LZ7TA	WOS:000541424000004	31436303	gold			2022-02-06	
J	Yu, DN; Zhu, Y; Cui, C; Long, RC; Ma, J				Yu, Dongnan; Zhu, Yi; Cui, Can; Long, Ruichun; Ma, Jue			Mechanism and antagonism of naloxone hydrochloride on neuropathic pain in rats	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Naloxone hydrochloride; TNF-alpha; IL-6	TRAUMATIC BRAIN; RECEPTOR; SYSTEM	Objective: To study the antagonistic effect of naloxone hydrochloride on neuropathic pain in rats and explore mechanisms of action. Methods: Forty-eight male SD rats were randomized into normal control (N group, n=8), sham operation (S group, n=8), pain model (M group, n=8), and naloxone hydrochloride (K group, n=24) groups. Results: There was no difference in the pre-surgery levels of paw withdrawal latency (PWL), paw withdrawal threshold (PWT), TNF-alpha and IL-6 among the four groups (all P>0.05). After surgery, the PWL of rats in the M and K groups decreased, and the levels of PWT, TNF-alpha and IL-6 increased (all P<0.05). Post-drug PWL level was higher in the K group compared to that on days 7 and 14 after surgery and was lower than the pre-surgery value (all P<0.05). The levels of post-drug PWT, TNF-alpha, and IL-6 were lower than those on days 7 and 14 after surgery and were higher than the pre-surgery values (all P<0.05). There was no difference between the post-drug levels of PWT, TNF-alpha and IL-6 and the values on day 1 post-surgery (all P>0.05). Logistical regression analysis showed that TNF-alpha and IL-6 levels were correlated with the degree of neuropathic pain in chronic constrictive injury (CCI) rats (both P<0.05). Conclusion: Naloxone hydrochloride can inhibit neuropathic pain in CCI rats and may play an antagonistic role by reducing the expression of TNF-alpha and IL-6.	[Yu, Dongnan; Zhu, Yi; Cui, Can; Long, Ruichun; Ma, Jue] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Anesthesiol, 106 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China		Ma, J (corresponding author), Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Anesthesiol, 106 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	majue53xj@163.com					Attal N, 2016, LANCET NEUROL, V15, P555, DOI 10.1016/S1474-4422(16)00017-X; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753; Chen XM, 2015, BRIT J ANAESTH, V114, P150, DOI 10.1093/bja/aeu199; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Edwards ET, 2015, PAIN THER, V4, P89, DOI 10.1007/s40122-015-0035-9; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Finnerup NB, 2015, LANCET NEUROL, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Guo W, 2011, STEM CELLS, V29, P1294, DOI 10.1002/stem.667; Hearn Jasmine Heath, 2017, Spinal Cord Ser Cases, V3, P17083, DOI 10.1038/s41394-017-0032-9; JinErLun Study Group, 2001, CHIN J NEUROSURG, V3; Mansouri MT, 2014, PHARMACOL BIOCHEM BE, V120, P43, DOI 10.1016/j.pbb.2014.02.009; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Roberto A, 2016, J PAIN SYMPTOM MANAG, V51, P1091, DOI 10.1016/j.jpainsymman.2015.12.336; SHARMA V, 2015, CLIN GASTROENTEROL H, V13, pE95; Takahashi T, 2013, J PHARMACOL SCI, V122, P51, DOI 10.1254/jphs.13029SC; Vollert J, 2016, PAIN, V157, P750, DOI 10.1097/j.pain.0000000000000433; von Banchet GS, 2013, MOL CELL NEUROSCI, V52, P152, DOI 10.1016/j.mcn.2012.11.006; Wheeler E, 2015, MMWR-MORBID MORTAL W, V64, P631; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Zhang HZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113093	21	1	1	0	1	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2020	13	1					134	140					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KS6DD	WOS:000518396500016					2022-02-06	
J	Yulug, B; Ozansoy, M; Alokten, M; Ozansoy, MB; Cankaya, S; Hanoglu, L; Kilic, U; Kilic, E				Yulug, Burak; Ozansoy, Mehmet; Alokten, Merve; Ozansoy, Muzaffer Bc; Cankaya, Seyda; Hanoglu, Lutfu; Kilic, Ulkan; Kilic, Ertugrul			Minocycline Increases in-vitro Cortical Neuronal Cell Survival after Laser Induced Axotomy	CURRENT CLINICAL PHARMACOLOGY			English	Article						Minocycline; laser-axotomy; in-vitro cortical cell culture; translational neuroscience; trauma; propidium	TRAUMATIC BRAIN-INJURY; MICROGLIAL ACTIVATION; MODEL	Background: Antibiotic therapies targeting multiple regenerative mechanisms have the potential for neuroprotective effects, but the diversity of experimental strategies and analyses of non-standardised therapeutic trials are challenging. In this respect, there are no cases of successful clinical application of such candidate molecules when it comes to human patients. Methods: After 24 hours of culturing, three different minocycline (Sigma-Aldrich, M9511, Germany) concentrations (1 mu M, 10 mu M and 100 mu M) were added to the primary cortical neurons 15 minutes before laser axotomy procedure in order to observe protective effect of minocycline in these dosages. Results: Here, we have shown that minocycline exerted a significant neuroprotective effect at 1 and 100 mu M doses. Beyond confirming the neuroprotective effect of minocycline in a more standardised and advanced in-vitro trauma model, our findings could have important implications for future studies that concentrate on the translational block between animal and human studies. Conclusion: Such sophisticated approaches might also help to conquer the influence of humanmade variabilities in critical experimental injury models. To the best of our knowledge, this is the first study showing that minocycline increases in-vitro neuronal cell survival after laser-axotomy.	[Yulug, Burak; Cankaya, Seyda] Alanya Alaaddin Keykubat Univ, Fac Med, Dept Neurol, Antalya, Turkey; [Ozansoy, Mehmet; Alokten, Merve; Ozansoy, Muzaffer Bc] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Istanbul, Turkey; [Hanoglu, Lutfu] Medipol Univ, Fac Med, Dept Neurol, Istanbul, Turkey; [Kilic, Ulkan] Univ Hlth Sci, Fac Med, Dept Med Biol, Istanbul, Turkey; [Ozansoy, Mehmet] Istanbul Medipol Univ, Dept Physiol, Int Sch Med, Istanbul, Turkey; [Ozansoy, Muzaffer Bc; Kilic, Ertugrul] Istanbul Medipol Univ, Sch Med, Dept Physiol, Istanbul, Turkey		Yulug, B (corresponding author), Alanya Alaaddin Keykubat Univ, Fac Med, Dept Neurol, Antalya, Turkey.	byulug@medipol.edu.tr	Alokten, Merve/AAB-5845-2021; Cankaya, Seyda/AAB-8862-2020; Yulug, Burak/AAD-3930-2022; Yulug, Burak/O-8322-2016; Kilic, Ertugrul/W-4563-2018	Alokten, Merve/0000-0002-5955-5356; Cankaya, Seyda/0000-0001-5309-0351; Yulug, Burak/0000-0002-9704-6173; Kilic, Ertugrul/0000-0001-6494-8923			Casha S, 2018, J NEUROTRAUM, V35, P1918, DOI 10.1089/neu.2018.5899; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Cengiz N, 2012, J NEUROTRAUM, V29, P2465, DOI 10.1089/neu.2009.0947; Czeiter E, 2008, J NEUROTRAUM, V25, P205, DOI 10.1089/neu.2007.0331; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Koliatsos VE, 1996, BRAIN PATHOL, V6, P447, DOI 10.1111/j.1750-3639.1996.tb00875.x; Lee JHT, 2010, EXP NEUROL, V225, P219, DOI 10.1016/j.expneurol.2010.06.018; Levkovitch-Verbin H, 2014, INT J NEUROSCI, V124, P755, DOI 10.3109/00207454.2013.878340; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Wu T, 2012, J R SOC INTERFACE, V9, P535, DOI 10.1098/rsif.2011.0351; Yulug B, 2018, CNS NEUROL DISORD-DR, V17, P439, DOI 10.2174/1871527317666180501110918	16	1	1	1	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-8847	2212-3938		CURR CLIN PHARMACOL	Curr. Clin. Pharmacol.		2020	15	2					105	109		10.2174/1574884714666190226093119			5	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	OD5GD	WOS:000579880000003	30813881	Green Published			2022-02-06	
J	Emelifeonwu, JA; Wiggins, AN; Andrews, PJD				Emelifeonwu, John A.; Wiggins, Anthony N.; Andrews, Peter J. D.			A national survey of clinical practice of surveillance for post-traumatic brain injury hypopituitarism in the United Kingdom and Ireland	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Posttraumatic hypopituitarism; TBI; surveillance; pituitary	ANEURYSMAL SUBARACHNOID HEMORRHAGE; PREVALENCE; PREDICTORS	Background: Traumatic brain injury (TBI) is the most common cause of death and disability in young adults in industrialised countries. Post-TBI hypopituitarism (PTHP) is thought to occur in one-third of patients, however the natural history and predictive factors are not fully understood and as such guidelines for surveillance vary. The aim of this study was to assess the variations in current surveillance practices across the Neurosurgery Centres within the United Kingdom. Methods: A questionnaire was developed following discussions with an expert panel and distributed to members of the Society of British Neurosurgeons (SBNS), by email and printed copy, to survey surveillance practices for PTHP. The questionnaire primarily aimed to determine how commonly screening was performed and the clinical parameters used to guide these surveillance practices. Results: There were 45 responders representing Neurosurgery units in regions of England, Scotland and Ireland. The majority of participants (86.7%) considered PTHP to be a problem but only 25% (11/45) routinely screened for PTHP. There was wide variation in the criteria used to determine which patients were screened. Conclusions: Our survey suggests that few Neurosurgeons routinely screen for PTHP and those that do use a wide variation of clinical parameters to guide surveillance practice. A UK-wide prospective cohort study may help identify patients at risk of developing PTHP.	[Emelifeonwu, John A.; Wiggins, Anthony N.] Univ Edinburgh, Dept Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland; [Emelifeonwu, John A.; Wiggins, Anthony N.; Andrews, Peter J. D.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland; [Emelifeonwu, John A.; Wiggins, Anthony N.; Andrews, Peter J. D.] Western Gen Hosp, NHS Lothian, Edinburgh EH4 2XU, Midlothian, Scotland		Emelifeonwu, JA (corresponding author), Univ Edinburgh, Dept Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland.; Emelifeonwu, JA (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland.; Emelifeonwu, JA (corresponding author), Western Gen Hosp, NHS Lothian, Edinburgh EH4 2XU, Midlothian, Scotland.	johnemelifeonwu@gmail.com					Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan CL, 2017, J NEUROL NEUROSUR PS, V88, P971, DOI 10.1136/jnnp-2016-315500	9	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JAN 2	2020	34	1					20	23		10.1080/02688697.2019.1699902		DEC 2019	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS3UH	WOS:000503630800001	31858834				2022-02-06	
J	Fugazzola, P; Ansaloni, L; Benni, M; Circelli, A; Coccolini, F; Gamberini, E; Nanni, A; Russo, E; Tomasoni, M; Agnoletti, V				Fugazzola, Paola; Ansaloni, Luca; Benni, Marco; Circelli, Alessandro; Coccolini, Federico; Gamberini, Emiliano; Nanni, Andrea; Russo, Emanuele; Tomasoni, Matteo; Agnoletti, Vanni			At the heart of organ donation. Case reports of organ donation after cardiac death in two patients with successfully repaired AAST grade V cardiac injuries	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Heart injury; Organ donation; Extracorporeal membrane oxygenation (ECMO); Donation after circulatory death (DCD)	PROCUREMENT	Background Trauma victims could be an important source of organs. This article presents two cases of successful organ donation and transplant, after Maastricht category III cardiac death in patients with successfully repaired AAST grade V traumatic cardiac injuries. Case presentation The first donor was an adult patient with self-inflicted heart stab wound and non-survivable burn injury. The second one was an adult patient with blunt cardiac and abdominal trauma and an anoxic brain injury due to a car accident. The cardiac injury was promptly repaired in both patients. In the first case, adequate organ perfusion ante-mortem was achieved thanks to venoarterial extracorporeal membrane oxygenation and intensive care unit support. The above procedure allowed successful organ donation and transplantation even after Maastricht category III cardiac death. This is the first case reported where, for organ donation purposes, it was made necessary first thing to avoid the immediate death of the patient, due to a rare and frequently not survivable cardiac injury. The challenge of preserving organ perfusion, due to major burn injury effects, was faced afterwards. Conclusions The outcomes of these two cases suggest that a repaired heart injury should not be considered as an absolute contraindication to organ donation, even if it is associated with non-survivable major burns. Therefore, cardiac death could provide an opportunity for these kinds of patients to contribute to the pool of potential organ donors.	[Fugazzola, Paola; Ansaloni, Luca; Tomasoni, Matteo] Bufalini Hosp, Unit Emergency & Gen Surg, Viale Ghirotti 286, I-47521 Cesena, FC, Italy; [Benni, Marco; Circelli, Alessandro; Gamberini, Emiliano; Nanni, Andrea; Russo, Emanuele; Agnoletti, Vanni] Bufalini Hosp, Intens Care Unit, Viale Ghirotti 286, Cesena, Italy; [Coccolini, Federico] Pisa Univ Hosp, Gen Emergency & Trauma Surg Dept, Pisa, Italy		Fugazzola, P (corresponding author), Bufalini Hosp, Unit Emergency & Gen Surg, Viale Ghirotti 286, I-47521 Cesena, FC, Italy.	paola.fugazzola@gmail.com	Ansaloni, Luca/AAP-9134-2020; Agnoletti, Vanni/AAC-9854-2022; Pisano, Michele/G-9348-2018; Coccolini, Federico/AAJ-6507-2020; Tomasoni, Matteo/AAC-3732-2022; Russo, Emanuele/AAP-5645-2020	Ansaloni, Luca/0000-0001-6427-0307; Agnoletti, Vanni/0000-0002-7093-2749; Pisano, Michele/0000-0001-9237-3530; Coccolini, Federico/0000-0001-6364-4186; Russo, Emanuele/0000-0002-6531-5527; Fugazzola, Paola/0000-0002-6227-9276; Gamberini, Emiliano/0000-0001-9403-5244			Ackerman A, 2019, J TRAUMA ACUTE CARE, V87, P130, DOI 10.1097/TA.0000000000002322; [Anonymous], 2015, RACC OP; Bamous M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-015-0190-3; Bellister SA, 2017, SURG CLIN N AM, V97, P1065, DOI 10.1016/j.suc.2017.06.012; Busche MN, 2011, BURNS, V37, P814, DOI 10.1016/j.burns.2011.02.002; Connelly TM, 2017, INTERACT CARDIOV TH, V24, P286, DOI 10.1093/icvts/ivw342; in't Veld MAH, 2018, CARDIOL CLIN, V36, P183, DOI 10.1016/j.ccl.2017.08.010; Isaza-Restrepo A, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0138-1; Schmauss D, 2017, BURNS, V43, P1163, DOI 10.1016/j.burns.2017.05.012; Sheridan RL, 1999, J TRAUMA, V47, P1060, DOI 10.1097/00005373-199912000-00011; SHERIDAN RL, 1995, J TRAUMA, V38, P824, DOI 10.1097/00005373-199505000-00029; Widdicombe NJ, 2013, ANAESTH INTENS CARE, V41, P380, DOI 10.1177/0310057X1304100317	12	1	1	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	DEC 19	2019	14	1							60	10.1186/s13017-019-0279-5			6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	KJ4DE	WOS:000512007600001	31889990	Green Published, gold			2022-02-06	
J	Deitcher, Y; Sachar, Y; Vakil, E				Deitcher, Yishai; Sachar, Yaron; Vakil, Eli			Effect of eye movement reactivation on visual memory among individuals with moderate-to-severe traumatic brain injury (TBI)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Visual memory; eye tracking; TBI	FUNCTIONAL-ROLE; MENTAL-IMAGERY; CONSEQUENCES; DEFICITS; ADULTS	Objective: Previous research has shown that when individuals are asked questions referring to previously seen visual stimuli, their eye movements spontaneously return to the visual area where the stimuli were first seen. This recurring eye movement phenomenon has been shown to assist the memory retrieval of visual images. Individuals with moderate-to-severe traumatic brain injury (TBI) typically suffer from visual memory deficits as well as difficulty in spontaneously initiating mnemonic strategies. Perhaps TBI patients have trouble employing the eye movement reactivation strategy, thus further contributing to the visual memory deficits so prevalent among this population. Method: In this study, 27 healthy individuals and 27 patients with moderate-to-severe TBI from the Lowenstein Rehabilitation Hospital participated in a memory task. Participants were first exposed to stimuli and were then asked questions about the displayed stimuli. The testing session was conducted for each participant under two conditions: (1) while eyes were free to move over the screen; (2) while eyes were fixated. Results: Study findings show that the control group significantly benefitted from the free viewing in comparison to the fixed viewing condition, while this effect was absent among the TBI group. This was corroborated by eye tracking data showing that participants with TBI showed a minimal tendency to reactivate eye movements effectively, as occurs among the healthy group. Conclusions: The research findings expand our comprehension of visual memory among the TBI population, presenting rehabilitation health clinicians with new directions in understanding visual memory deficits.	[Deitcher, Yishai; Vakil, Eli] Bar Ilan Univ, Psychol Dept, IL-52900 Ramat Gan, Israel; [Sachar, Yaron] Loewenstein Hosp & Rehabil Ctr, Brain Injury Rehabil, Raanana, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Psychol Dept, IL-52900 Ramat Gan, Israel.	vakile@mail.biu.ac.il			Israeli Ministry of Defense, Rehabilitation Department [203003-846]	This work was supported by the Israeli Ministry of Defense, Rehabilitation Department under Grant number [203003-846].	BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Brandt SA, 1997, J COGNITIVE NEUROSCI, V9, P27, DOI 10.1162/jocn.1997.9.1.27; Ferreira F, 2008, TRENDS COGN SCI, V12, P405, DOI 10.1016/j.tics.2008.07.007; Johansson R, 2006, COGNITIVE SCI, V30, P1053, DOI 10.1207/s15516709cog0000_86; Johansson R, 2014, PSYCHOL SCI, V25, P236, DOI 10.1177/0956797613498260; Johansson R, 2012, J EXP PSYCHOL HUMAN, V38, P1289, DOI 10.1037/a0026585; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Laeng B, 2014, COGNITION, V131, P263, DOI 10.1016/j.cognition.2014.01.003; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Martarelli CS, 2013, PSYCHOL RES-PSYCH FO, V77, P303, DOI 10.1007/s00426-012-0439-7; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Siman-Tov M, 2016, BRAIN INJURY, V30, P83, DOI 10.3109/02699052.2015.1104551; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128; Tyerman A., 2009, PSYCHOL APPROACHES R; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	20	1	1	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB 7	2020	42	2					208	221		10.1080/13803395.2019.1704223		DEC 2019	14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KH7CJ	WOS:000503508600001	31847796				2022-02-06	
J	Zhang, WJ; Qin, ZQ; Xian, KC; Tang, SH				Zhang, Wenjia; Qin, Zhongqiao; Xian, Kecong; Tang, Shuhong			Assessment of plasma homocysteine levels in patients with craniocerebral injury and prognosis	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article; Early Access						Craniocerebral injury; homocysteine; C-reactive protein; state of an illness; prognosis	TRAUMATIC BRAIN-INJURY; RESPONSES; SEVERITY	Objective To investigate the effect of plasma homocysteine (Hcy) and C-reactive protein (CRP) levels in patients with craniocerebral injury. Methods A retrospective analysis of data from patients with craniocerebral injury who underwent surgery. Patients were stratified according to the extent of the craniocerebral injury into severe, moderate and mild craniocerebral injury groups. Serum Hcy and CRP levels were determined at admission, at 7 days after treatment and at 3 months after injury. Univariate and multivariate Cox regression analyses were undertaken to identify prognostic factors. Results The study enrolled 96 patients: 29 patients with mild injury; 33 patients with moderate injury; and 34 patients with severe injury. Serum Hcy and CRP levels at admission were significantly higher in the severe craniocerebral injury group than in the other two groups; and they were significantly higher the moderate craniocerebral injury group compared with the mild craniocerebral injury group. Serum Hcy and CRP levels of the three groups of patients were significantly lower after 7 days of treatment than those before treatment. The levels of Hcy and CRP were positively correlated in all three groups. Conclusion Serum Hcy and CRP levels in patients could be used to monitor the condition and prognosis of patients with craniocerebral injury.	[Zhang, Wenjia; Qin, Zhongqiao; Xian, Kecong; Tang, Shuhong] Guigang Peoples Hosp, Dept Neurosurg, 1 Zhongshan Middle Rd, Guigang City 537100, Guangxi Zhuang, Peoples R China		Tang, SH (corresponding author), Guigang Peoples Hosp, Dept Neurosurg, 1 Zhongshan Middle Rd, Guigang City 537100, Guangxi Zhuang, Peoples R China.	sssht8@163.com			Guigang Science Research and Technology Development Programme [1701003]	This work was supported by Guigang Science Research and Technology Development Programme (No. 1701003).	Al-Bayyari N, 2018, NUTR RES, V59, P65, DOI 10.1016/j.nutres.2018.07.012; Auer Tibor, 2007, Ideggyogy Sz, V60, P480; Budzynska A, 2017, J PHYSIOL PHARMACOL, V68, P859; Cox N, 2015, P NATL ACAD SCI USA, V112, P8385, DOI 10.1073/pnas.1500956112; Curro M, 2015, J NEUROSCI RES, V93, P149, DOI 10.1002/jnr.23453; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani S, 2018, NEUROSURG REV, V41, P513, DOI 10.1007/s10143-017-0880-6; Dhandapani S, 2015, ACTA NEUROCHIR, V157, P399, DOI 10.1007/s00701-014-2297-0; Fu HJ, 2015, J MOL NEUROSCI, V56, P553, DOI 10.1007/s12031-015-0497-6; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Li JJ, 2015, INT J MOL SCI, V16, P12560, DOI 10.3390/ijms160612560; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Pan DS, 2016, CLIN CHIM ACTA, V453, P62, DOI 10.1016/j.cca.2015.11.030; Peng HY, 2015, J ZHEJIANG UNIV-SC B, V16, P78, DOI 10.1631/jzus.B1400183; Razek AAKA, 2017, POL J RADIOL, V82, P536, DOI 10.12659/PJR.902416; Rudoler N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0798-1; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Vacek TP, 2015, VASC HEALTH RISK MAN, V11, P173, DOI 10.2147/VHRM.S68415; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Wang Y, 2015, CHINESE J PRIMARY ME, V19, P2890; Zhang HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193037; Zhang YY, 2017, ARCH MED RES, V48, P449, DOI 10.1016/j.arcmed.2017.10.005	27	1	2	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.											0300060519882202	10.1177/0300060519882202		DEC 2019	10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	JX2OW	WOS:000503581400001	31852292	Green Published, gold			2022-02-06	
J	Sribnick, EA; Weber, MD; Hall, MW				Sribnick, Eric A.; Weber, Michael D.; Hall, Mark W.			Innate immune suppression after traumatic brain injury and hemorrhage in a juvenile rat model of polytrauma	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Traumatic brain injury; Hemorrhage; Rat; Juvenile; Immune suppression; Tumor necrosis factor alpha; Memory	PROGNOSTIC VALUE; SEPTIC PATIENTS; BLOOD; INFECTIONS; EXPRESSION	Traumatic injury in children is known to cause immune suppression. Polytrauma involving a traumatic brain injury (TBI) may increase this degree of immune suppression, which increases the risk of developing nosocomial infections, potentially causing secondary brain injury and worsening patient outcomes. Despite the high prevalence of polytrauma with TBI in children, mechanisms of immune suppression following such injuries remain poorly understood. Here, we used a combined animal injury model of TBI and hemorrhage to assess immune function after polytrauma. Pre-pubescent rats were injured using a prefrontal controlled cortical impact method and a controlled hemorrhage by femoral arteriotomy. Immune function was measured by whole blood ex-vivo tumor necrosis factor alpha production capacity following incubation with lipopolysaccharide, measuring the percentage of monocytes by flow cytometry, and by examining concentrations of plasma cytokines. The degree of brain injury was sufficient to produce deficits in spatial memory testing (Barnes maze). Both hemorrhage and TBI with hemorrhage (combined injury) reduced several of the measured plasma cytokines, as compared with TBI alone. The combined injury correlated with reduced concentration of monocytes and reduced tumor necrosis factor alpha production capacity at post-injury day 1. These results demonstrate that this animal model can be used to study post-injury immune suppression.	[Sribnick, Eric A.] Nationwide Childrens Hosp, Dept Surg, Div Neurosurg, Columbus, OH 43205 USA; [Sribnick, Eric A.] Ohio State Univ, Coll Med, Dept Neurosurg, Columbus, OH 43210 USA; [Sribnick, Eric A.; Weber, Michael D.; Hall, Mark W.] Nationwide Childrens Hosp, Ctr Clin & Translat Res, Res Inst, Columbus, OH 43205 USA; [Hall, Mark W.] Nationwide Childrens Hosp, Dept Pediat, Div Crit Care, Columbus, OH 43205 USA		Sribnick, EA (corresponding author), Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43205 USA.	eric.sribnick@nationwidechildrens.org; michael.weber@nationwidechildrens.org; mark.hall@nationwidechildrens.org	Sribnick, Eric/AAH-6693-2020		Research Institute at Nationwide Children's HospitalOhio State University	The Research Institute at Nationwide Children's Hospital.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Chang PP, 2019, J AM COLL SURGEONS, V228, P265, DOI 10.1016/j.jamcollsurg.2018.12.026; Cheron A, 2010, CRIT CARE, V14, DOI 10.1186/cc9331; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Dillingh MR, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0028-1; Ditschkowski M, 1999, ANN SURG, V229, P246, DOI 10.1097/00000658-199902000-00013; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Flohe S, 1999, SHOCK, V12, P17, DOI 10.1097/00024382-199907000-00003; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; Gouel-Cheron A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033095; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Kampalath B, 2003, ARCH PATHOL LAB MED, V127, P1580; Leijte GP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00663; LIVINGSTON DH, 1994, ARCH SURG-CHICAGO, V129, P172; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Muszynski JA, 2014, SHOCK, V42, P313, DOI 10.1097/SHK.0000000000000217; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Sun MJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01089; Thurm C.W, 2005, CURR PROTOC IMMUNOL, V66; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Timmermans K, 2015, CRIT CARE MED, V43, P2332, DOI 10.1097/CCM.0000000000001204; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Wang HC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/720870; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Wyen H, 2010, EUR J TRAUMA EMERG S, V36, P300, DOI 10.1007/s00068-010-1124-4	46	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	DEC 15	2019	337								577073	10.1016/j.jneuroim.2019.577073			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	JP5QK	WOS:000498318800016	31670063				2022-02-06	
J	Anwer, M; Lara-Valderrabano, L; Karttunen, J; Ndode-Ekane, XE; Puhakka, N; Pitkanen, A				Anwer, Mehwish; Lara-Valderrabano, Leonardo; Karttunen, Jenni; Ndode-Ekane, Xavier Ekolle; Puhakka, Noora; Pitkanen, Asla			Acute Downregulation of Novel Hypothalamic Protein Sushi Repeat-Containing Protein X-Linked 2 after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						hypothalamus; lateral fluid-percussion injury; sushi repeat-containing protein X-linked 2; traumatic brain injury	PITUITARY-ADRENAL AXIS; LOADING CONTROL; SRPX2; OXYTOCIN; RAT; DYSFUNCTION; DISORDERS; EPILEPSY; OUTCOMES; IMPACT	Traumatic brain injury (TBI) causes damage to the hypothalamo-hypophyseal axis, leading to endocrine dysregulation in up to 40% of TBI patients. Hence, there is an urgent need to identify non-invasive biomarkers for TBI-associated hypothalamo-hypophyseal pathology. Sushi repeat-containing protein X-linked 2 (SRPX2) is a novel hypothalamic protein expressed in both rat and human brain. Our objective was to investigate the effect of acquired brain injury on plasma SRPX2 protein levels and SRPX2 expression in the brain. We induced severe lateral fluid-percussion injury in adult male rats and investigated changes in SRPX2 expression at 2 h, 6 h, 24 h, 48 h, 72 h, 5 days, 7 days, 14 days, 1 month, and 3 months post-injury. The plasma SRPX2 level was assessed by Western blot analysis. Hypothalamic SRPX2-immunoreactive neuronal numbers were estimated from immunostained preparations. At 2 h post-TBI, plasma SRPX2 levels were markedly decreased compared with the naive group (area under the curve = 1.00, p < 0.05). Severe TBI caused a reduction in the number of hypothalamic SRPX2-immunoreactive neurons bilaterally at 2 h post-TBI compared with naive group (5032 +/- 527 vs. 9440 +/- 351, p < 0.05). At 1 month after severe TBI, however, the brain and plasma SRPX2 levels were comparable between the TBI and naive groups (p > 0.05). Unsupervised hierarchical clustering using SRPX2 expression differentiated animals into injured and uninjured clusters. Our findings indicate that TBI leads to an acute reduction in SRPX2 protein expression and reduced plasma SRPX2 level may serve as a candidate biomarker of hypothalamic injury.	[Anwer, Mehwish; Lara-Valderrabano, Leonardo; Karttunen, Jenni; Ndode-Ekane, Xavier Ekolle; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Karttunen, Jenni/0000-0002-0099-1305	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909]; European UnionEuropean Commission [602102]; National Council of Science and Technology (CONACyT)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [377269]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [642881]	The study was supported by the Medical Research Council of the Academy of Finland (Grants 272249 and 273909; A.P.), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement No 602102 (EPITARGET; A.P.), the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642881 (ECMED; A.P., M.A.), and the National Council of Science and Technology (CONACyT No 377269; L.L.).	Anwer M, 2018, J COMP NEUROL, V526, P1806, DOI 10.1002/cne.24449; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Chen LW, 2009, EARTHQ ENG ENG VIB, V8, P219, DOI 10.1007/s11803-009-9033-4; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Guaraldi F, 2015, J CLIN MED, V4, P1025, DOI 10.3390/jcm4051025; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kurosawa H, 1999, BLOOD, V93, P321, DOI 10.1182/blood.V93.1.321.401k05_321_332; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Liu KL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0548-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meidahl AC, 2018, HEADACHE, V58, P545, DOI 10.1111/head.13248; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Pfundmair M, 2016, PSYCHONEUROENDOCRINO, V73, P63, DOI 10.1016/j.psyneuen.2016.07.213; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Royer-Zemmour B, 2010, EPILEPSIES, V22, P14, DOI 10.1684/epi.2010.0288; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Szmydynger-Chodobska J, 2011, J CEREBR BLOOD F MET, V31, P47, DOI 10.1038/jcbfm.2010.188; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Theofanopoulou C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0988; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; van Vliet EA, 2017, EPILEPSIA, V58, P2013, DOI 10.1111/epi.13915; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamada T, 2014, J SURG ONCOL, V109, P836, DOI 10.1002/jso.23602; Ye Z., 2016, J COGNITIVE NEUROSCI, V29, P1; Zhang HF, 2016, NEUROSCI BULL, V32, P423, DOI 10.1007/s12264-016-0046-5; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	42	1	1	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					924	938		10.1089/neu.2019.6739		DEC 2019	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000504861000001	31650880				2022-02-06	
J	Ciszek, R; Andrade, P; Tapiala, J; Pitkanen, A; Ndode-Ekane, XE				Ciszek, Robert; Andrade, Pedro; Tapiala, Jesse; Pitkanen, Asla; Ndode-Ekane, Xavier Ekolle			Web Application for Quantification of Traumatic Brain Injury-Induced Cortical Lesions in Adult Mice	NEUROINFORMATICS			English	Article						Web applications; Visualization; Traumatic brain injury; Mouse brain		Disabilities resulting from traumatic brain injury (TBI) strongly correlate with the cytoarchitectonic part of the brain damaged, lesion area, and type of lesion. We developed a Web application to estimate the location of the lesion on mouse cerebral cortex caused by TBI induced by lateral fluid-percussion injury. The application unfolds user-determined TBI lesion measurements, e.g., from histologic sections to a reference template, and estimates the total lesion area, including the percentage of cortex damaged in different cytoarchitectural cortical regions. The resulting lesion can be visualized on a two-dimensional map of mouse cerebral cortex. The application also visualizes the development of the lesion over time when measurements from multiple time points are available. The web application was validated by comparing its performance to the manual method. The total area of the cortical lesion was similar between the manual (9.19 +/- 0.66 mm(2), range 4.25-14.93 mm(2)) and the automated analysis (9.27 +/- 0.66 mm(2), range 4.50-15.10 mm(2)) (p = 0.938). The results of the manual and automated analyses were strongly correlated (r = 0.999, p < 0.0001, Pearson correlation). The lesion localized in the same cytoarchitectonic regions when the unfolded map from the automated method was superimposed onto the map obtained using the manual method. The Web application-automated method is faster than the manual method in generating unfolded cortical lesion maps. The accuracy of the presented automated method in determining the anteroposterior level and outlining the lesion is equal to or greater than that of the manual method. Our application provides a novel tool for accurately quantifying and visualizing TBI lesions on mouse cerebral cortex.	[Ciszek, Robert; Andrade, Pedro; Tapiala, Jesse; Pitkanen, Asla; Ndode-Ekane, Xavier Ekolle] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Ndode-Ekane, XE (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	xavier.ekollendode-ekane@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341; Tapiala, Jesse/0000-0003-3338-7152; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	University of Eastern Finland (UEF) including Kuopio University Hospital	Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital.	Andrade P, 2018, J NEUROSCI METH, V308, P330, DOI 10.1016/j.jneumeth.2018.08.028; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Catmull E, 1974, COMPUT AIDED GEOM D, P31; Chen CL, 2000, ARCH PHYS MED REHAB, V81, P447, DOI 10.1053/mr.2000.3837; De Casteljau P, 1959, OUTILLAGES METHODES; Franklin K., 2007, MOUSE BRAIN STEREOTA, VThird; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; VANESSEN DC, 1980, J COMP NEUROL, V191, P255, DOI 10.1002/cne.901910208	8	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics	APR	2020	18	2					307	317		10.1007/s12021-019-09444-9		DEC 2019	11	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	KW0AF	WOS:000500642400001	31802356	Green Published, hybrid			2022-02-06	
J	Zarshenas, S; Colantonio, A; Horn, SD; Jaglal, S; Jacob, B; Cullen, N				Zarshenas, Sareh; Colantonio, Angela; Horn, Susan D.; Jaglal, Susan; Jacob, Binu; Cullen, Nora			Occupational and Physical Therapy Activities and Level of Effort in Patients With Traumatic Brain Injury: Association With Functional Outcomes	PM&R			English	Article							INPATIENT REHABILITATION; HEALTH-CARE; GUIDELINES; INTENSITY; MANAGEMENT; PREDICTORS; IMPROVE; TBI	Background Although some attention has been given to the association of functional outcomes with rehabilitation intensity, the evidence is still sparse in this field. Objective To investigate the effect of inpatient rehabilitation (IR) on discharge cognitive and motor function and the association of time spent in occupational and physical therapy and level of effort with cognitive and motor function in patients with traumatic brain injury (TBI). Design Secondary analysis of TBI-Practice Based Evidence dataset. Settings Inpatient rehabilitation. Participants One hundred forty-nine patients with TBI who were consecutively admitted for IR between 2008 and 2011 in Ontario, Canada. Interventions Not applicable. Main Outcome Measurements Admission and discharge Functional Independence Measure-Rasch Cognitive and Motor Scores. Results Patients showed significant improvement in cognitive and motor function from admission to discharge (P < .0001). After controlling for confounding factors, discharge FIM-Rasch cognitive and motor scores were not associated with either level of effort or time spent in physical therapy activities. Discharge motor, but not cognitive function, was associated with more time spent in the complex (beta = 0.20, confidence interval [CI] 0.005, 0.05) and less time spent in simple OT activities (beta = -0.13, CI -0.13, -0.01). Conclusion This study provides valuable information for clinicians about the effectiveness of IR on the improvement of motor and cognitive outcomes and the importance of considering the amount of time spent in activities based on their level of complexity rather than the total time of therapy to improve motor outcomes in this population. Level of Evidence III	[Zarshenas, Sareh; Colantonio, Angela; Jaglal, Susan; Cullen, Nora] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Zarshenas, Sareh; Colantonio, Angela; Jaglal, Susan; Jacob, Binu; Cullen, Nora] Univ Hlth Network, Univ Ctr, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada; [Colantonio, Angela] Univ Toronto, Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Horn, Susan D.] Univ Utah, Dept Populat Hlth Sci, Sch Med, Salt Lake City, UT USA		Cullen, N (corresponding author), Univ Hlth Network, Univ Ctr, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	nora.cullen@westpark.org		Cullen, Nora/0000-0001-6359-9418	Toronto Rehabilitation Institute-UHN	Thank you to all clinicians and investigators who assisted with this project in making this work a reality. We would like to gratefully acknowledge the support of the Toronto Rehabilitation Institute-UHN, which made these data available for the purpose of the study.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernat MBI, 2015, NEUROREHABILITATION, V37, P165, DOI 10.3233/NRE-151249; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Bond T. G., 2007, APPL RASCH MODEL FUN, V2; Brett CE, 2017, NEUROPSYCHOL REHABIL, V27, P959, DOI 10.1080/09602011.2015.1090459; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Chen CC, 2002, ARCH PHYS MED REHAB, V83, P1514, DOI 10.1053/apmr.2002.35107; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dahdah MN, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000270; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Marin IGGY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/257517; Hart T, 2016, ARCH PHYS MED REHAB, V97, P2045, DOI 10.1016/j.apmr.2016.07.012; Heinemann AW, 2012, J SPINAL CORD MED, V35, P578, DOI 10.1179/2045772312Y.0000000059; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; INESSS-ONF, 2016, CLIN PRACT GUID REH; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Klein AM, 2013, J NEUROTRAUM, V30, P1476, DOI 10.1089/neu.2012.2735; Konigs M, 2018, ARCH PHYS MED REHAB, V99, P1149, DOI 10.1016/j.apmr.2018.01.013; Kurokawa N, 2018, J INT MED RES, V46, P4235, DOI 10.1177/0300060518792155; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Mediware, 2014, 3 HOUR RUL DEF IRF U; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Peiris CL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-198; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TEASDALE G, 1974, LANCET, V2, P81; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Timpson M, 2019, ARCH PHYS MED REHAB, V100, P1818, DOI 10.1016/j.apmr.2018.11.015; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Zanca JM, 2014, ARCH PHYS MED REHAB, V95, pS55, DOI 10.1016/j.apmr.2013.03.034; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	47	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	APR	2020	12	4					339	348		10.1002/pmrj.12260		DEC 2019	10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LB1JA	WOS:000500520500001	31600430				2022-02-06	
J	Alcantara, A; Berenji, GR; Scherling, CS; Durcanova, B; Diaz-Aguilar, D; Silverman, DHS				Alcantara, April; Berenji, Gholam R.; Scherling, Carole S.; Durcanova, Beata; Diaz-Aguilar, Daniel; Silverman, Daniel H. S.			Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain Injury	JOURNAL OF NUCLEAR MEDICINE			English	Article						neuroimaging; cancer; chemotherapy; posttraumatic; PTSD; chronic traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; CEREBRAL GLUCOSE-METABOLISM; BREAST-CANCER; COGNITIVE IMPAIRMENT; ADJUVANT CHEMOTHERAPY; MANAGEMENT; PET; ASSOCIATION; PREVALENCE; MECHANISMS	Neuronuclear imaging has been used for several decades in the study of primary neurodegenerative conditions, such as dementia and parkinsonian syndromes, both for research and for clinical purposes. There has been a relative paucity of applications of neuro-nuclear imaging to evaluate nonneurodegenerative conditions that can also have long-term effects on cognition and function. This article summarizes clinical and imaging aspects of 3 such conditions that have garnered considerable attention in recent years: cancer- and chemotherapy-related cognitive impairment, posttraumatic stress disorder, and traumatic brain injury. Further, we describe current research using neuroimaging tools aimed to better understand the relationships between the clinical presentations and brain structure and function in these conditions.	[Alcantara, April; Berenji, Gholam R.; Durcanova, Beata; Diaz-Aguilar, Daniel; Silverman, Daniel H. S.] UCLA, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Berenji, Gholam R.] VA Greater Los Angeles Healthcare Syst, Dept Radiol, Los Angeles, CA USA; [Scherling, Carole S.] Belmont Univ, Dept Psychol Sci, Nashville, TN USA		Silverman, DHS (corresponding author), UCLA, Sch Med, AR-144,MC694215, Los Angeles, CA 90095 USA.	dsilver@ucla.edu					American Cancer Society, 2016, CANC FACTS FIG, P1, DOI DOI 10.1097/01.NNR.0000289503.22414.79; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andrewes DG, 2019, NEUROPSYCHOL REV, V29, P220, DOI 10.1007/s11065-019-09398-4; Asmundson GJG, 2019, COGN BEHAV THERAPY, V48, P1, DOI 10.1080/16506073.2018.1522371; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baudino B, 2012, Q J NUCL MED MOL IM, V56, P559; Baudino B, 2011, CHEMOTHERAPY EFFECTS; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Biegler KA, 2009, ACTA ONCOL, V48, P18, DOI 10.1080/02841860802415535; Bremner JD, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00157; Chiaravalloti A, 2013, NUCL MED COMMUN, V34, P57, DOI 10.1097/MNM.0b013e32835aa7de; Collins B, 2013, PSYCHO-ONCOLOGY, V22, P1517, DOI 10.1002/pon.3163; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; D'Agata F, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-22; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Dunlop BW, 2019, PROG NEURO-PSYCHOPH, V89, P361, DOI 10.1016/j.pnpbp.2018.10.010; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Ferguson RJ, 2012, PSYCHO-ONCOLOGY, V21, P176, DOI 10.1002/pon.1878; Forbes D, 2019, INT REV PSYCHIATR, V31, P95, DOI 10.1080/09540261.2019.1595545; Frijling JL, 2016, NEUROPSYCHOPHARMACOL, V41, P1286, DOI 10.1038/npp.2015.278; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Ganz PA, 2013, JNCI-J NATL CANCER I, V105, P791, DOI 10.1093/jnci/djt073; Gold AL, 2011, PSYCHOL MED, V41, P2563, DOI 10.1017/S0033291711000730; Gong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084391; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Gradus JL., EPIDEMIOLOGY OF PTSD; Henigsberg N, 2019, PROG NEURO-PSYCHOPH, V90, P37, DOI 10.1016/j.pnpbp.2018.11.003; Holzschneider Kathrin, 2011, Dialogues Clin Neurosci, V13, P453; Horky LL, 2014, ANN CLIN TRANSL NEUR, V1, P788, DOI 10.1002/acn3.121; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Hosomi S, 2018, NEUROIMAGE-CLIN, V20, P946, DOI 10.1016/j.nicl.2018.09.031; Hsieh TC, 2014, J NEUROIMAGING, V24, P266, DOI 10.1111/jon.12006; Hurria A, 2014, CLIN BREAST CANCER, V14, P132, DOI 10.1016/j.clbc.2013.10.010; Im JJ, 2016, EXP NEUROBIOL, V25, P277, DOI 10.5607/en.2016.25.6.277; Janelsins MC, 2014, INT REV PSYCHIATR, V26, P102, DOI 10.3109/09540261.2013.864260; Kaiser J, 2014, CORTEX, V54, P33, DOI 10.1016/j.cortex.2014.01.010; Karschnia P, 2019, LANCET ONCOL, V20, pE92, DOI 10.1016/S1470-2045(18)30938-0; Khachatryan D, 2016, GEN HOSP PSYCHIAT, V39, P46, DOI 10.1016/j.genhosppsych.2015.10.007; Kim SY, 2012, PSYCHIAT RES-NEUROIM, V201, P214, DOI 10.1016/j.pscychresns.2011.08.007; Kohli S, 2009, CANCER-AM CANCER SOC, V115, P2605, DOI 10.1002/cncr.24287; Komura A, 2019, J NEUROTRAUM, V36, P641, DOI 10.1089/neu.2018.5641; Koppelmans V, 2013, CRIT REV ONCOL HEMAT, V88, P87, DOI 10.1016/j.critrevonc.2013.04.002; Li MM, 2018, NEUROSCI BIOBEHAV R, V92, P304, DOI 10.1016/j.neubiorev.2018.05.019; Liriano F, 2019, DRUGS CONTEXT, V8; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mohamed AZ, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101829; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mohamed AZ, 2018, NEUROIMAGE-CLIN, V19, P716, DOI 10.1016/j.nicl.2018.05.016; Murray H, 2017, BRIT J CLIN PSYCHOL, V56, P474, DOI 10.1111/bjc.12150; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Patel R, 2016, NEUROBIOL LEARN MEM, V130, P170, DOI 10.1016/j.nlm.2016.02.003; Pomykala KL, 2013, BRAIN IMAGING BEHAV, V7, P511, DOI 10.1007/s11682-013-9243-2; Ponto LLB, 2015, INT J GERIATR PSYCH, V30, P587, DOI 10.1002/gps.4189; Popescu C, 2015, J Med Life, V8, P272; Raji CA, 2015, BRAIN IMAGING BEHAV, V9, P527, DOI 10.1007/s11682-015-9385-5; Ramage AE, 2016, SOC COGN AFFECT NEUR, V11, P234, DOI 10.1093/scan/nsv102; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reuveni I, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0257-9; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Scherling CS, 2013, SENSORS-BASEL, V13, P3169, DOI 10.3390/s130303169; Shrot S, 2019, PEDIATR NEUROL, V92, P37, DOI 10.1016/j.pediatrneurol.2018.10.019; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Szeszko PR, 2019, PSYCHIAT RES, V277, P52, DOI 10.1016/j.psychres.2019.02.005; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomaes K, 2014, J PSYCHIATR RES, V50, P1, DOI 10.1016/j.jpsychires.2013.11.002; Turjanski N, 1997, NEUROLOGY, V49, P183, DOI 10.1212/WNL.49.1.183; van Dam FSAM, 1998, J NATL CANCER I, V90, P210, DOI 10.1093/jnci/90.3.210; van Rooij SJH, 2016, NEUROPSYCHOPHARMACOL, V41, P1156, DOI 10.1038/npp.2015.257; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wefel JS, 2015, CA-CANCER J CLIN, V65, P123, DOI 10.3322/caac.21258; Wefel JS, 2012, CURR NEUROL NEUROSCI, V12, P267, DOI 10.1007/s11910-012-0264-9; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Zhang YX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004083	79	1	1	1	3	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC 1	2019	60	12					1682	1690		10.2967/jnumed.119.237578			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	JS8RJ	WOS:000500568800009	31601702	Bronze			2022-02-06	
J	Anghelescu, A; Deaconu, V; Axente, C; Onose, G				Anghelescu, Aurelian; Deaconu, Valentin; Axente, Catalina; Onose, Gelu			Therapeutic difficulties in recurrent, multidrug-resistant epilepsy and vagal nerve stimulation, with recent traumatic brain complications needing iterative neurosurgical interventions	BALNEO RESEARCH JOURNAL			English	Article						cerebral arteriovenous malformation; multidrug-resistant (refractory) epilepsy; vagal nerve electrostimulation (VNS); falls; traumatic brain injury		Introduction: Focal epilepsy (possible with secondary generalization) may be a secondary complication to any brain damage (traumatic, vascular, infectious), and is characterized by abnormal excessive neuronal activity with motor, cognitive and psychosocial manifestations. About one third of the patients who suffer from epilepsy have a refractory, multidrug clinical form. Falls are one of the most common medical complications in neurologic patients, occurring during paroxysmal epileptic attacks, or due to sequelary gait limitations. Physical injuries are common, and about 47% patients with epilepsy report at least one injury in the past 12 months. Case presentation: We present a 36-years-old male patient with a medical history of right frontal congenital arteriovenous malformation, ruptured and operated at the age of eight, complicated with left spastic hemiplegia and refractory epilepsy, needing three antiepileptic drugs (AED) and vagus nerve-stimulation (VNS).This presentation was approved by THEBA Bioethics Committee (No.17464/14.06.2019). During a recent epileptic seizure he suffered a severe traumatic brain injury with coma (GCS 5), needing iterative neurosurgical interventions, intensive care supervision, and orotracheal intubation. CT cerebral scan revealed right hemispheric subdural hematoma, operated (on the 2nd May 2019). Rebleeding occurred seven days later, due to an extradural hematoma, and neurosurgical intervention was performed again. The patient was transferred in our neurorehabilitation clinic with left spastic hemiplegia (global motor score was 65/100, and functional independence measure (FIM) 24/91. Neuropsychological assessment revealed an obtunded level of consciousness, depression and dysmnesia for recent events, MMSE 9/30. During hospitalization the patient has continued his previous daily AED treatment with: levetiracetamum 2000 mg + clonazepamum 1mg + carbamazepinum retard 600 mg, associated with VNS. During hospitalization emerged three new short jacksonian seizures, who gave up spontaneously. The overall evolution was favorable with rehabilitation program and psychological support, with improvement of the global motor score, FIM (44/91), and partial restoration of walking ability, but still needing human help. Discussion: The pathophysiological mechanism of relapsed seizures has complex, multiple causes: imbalance of the local brain metabolism and /or a dysfunctional VNS procedure (a possible technical issue due to an impaired electronic device or a bioelectrical one, due to local fibrosis and increased impedance at the contact level between the electrode and the vagal nerve). Specialized technical control disclosed normal electric parameters provided by the electronic device. Other neuromodulatory devices and related technologies, such as deep brain stimulation (DBS) immediately demonstrate their effect control (motor correction) of Parkinson's or dystonic movements. Unfortunately VNS has not the possibility of immediate clinical feed-back control. The AED schedule was modified, by increasing clonazepamum to 2 mg daily. Video-EEG monitoring was recommended. The quod ad vitam prognosis might be unfavorable, because seizures can relapse anytime and evolution is uncontrolled. Furthermore, new brain injures may exacerbate the severity of the epilepsy, any new seizure may worsen the neurologic evolution. The quod ad functionem rehabilitation outcome might be precarious. The family support is essential in the therapeutic efforts. This clinical case underlines the necessity to implement a fall prevention program in patients with epilepsy, the importance of therapeutically tailoring AED for different pathophysiological stages of the disease, and emphasizes the limits of the modern techniques for seizures control. A multi-/ interdisciplinary team management of a such complex clinical case is mandatory.	[Anghelescu, Aurelian; Deaconu, Valentin; Axente, Catalina; Onose, Gelu] Teaching Emergency Hosp Bagdasar Arseni TEHBA, Bucharest, Romania; [Anghelescu, Aurelian; Onose, Gelu] Univ Med & Pharm Carol Davila UMPCD, Bucharest, Romania		Anghelescu, A (corresponding author), Teaching Emergency Hosp Bagdasar Arseni TEHBA, Bucharest, Romania.; Anghelescu, A (corresponding author), Univ Med & Pharm Carol Davila UMPCD, Bucharest, Romania.	aurelian_anghelescu@yahoo.co.uk	Onose, Gelu/AAC-6786-2021	Onose, Gelu/0000-0002-6346-8941			Anghelescu A, 2017, INT J NEUROREHABILIT, V4, P2, DOI [10.4172/2376-0281.1000262, DOI 10.4172/2376-0281.1000262]; Arcand J, 2017, CAN J NEUROL SCI, V44, P532, DOI 10.1017/cjn.2017.46; Asadi-Pooya AA, 2012, SEIZURE-EUR J EPILEP, V21, P165, DOI 10.1016/j.seizure.2011.10.009; Baaj AA, 2009, ENCY LIFE SCI; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Chambers A, 2013, Ont Health Technol Assess Ser, V13, P1; Engel J, 2014, ANN INDIAN ACAD NEUR, V17, pS12, DOI 10.4103/0972-2327.128644; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Liporace J, 2001, NEUROLOGY, V57, P885, DOI 10.1212/WNL.57.5.885; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Munteanu C, 2019, BALNEO RES J, V10, P174, DOI 10.12680/balneo.2019.257; Munteanu C, 2017, BALNEO RES J, V8, P136, DOI 10.12680/balneo.2017.149; Ng WH, 2010, CHILD NERV SYST, V26, P1081, DOI 10.1007/s00381-010-1121-2; Sirven JI, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022848; Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426; Stetka BS, 2015, PAIN BRAIN MANY USES, P29; Yuan HK, 2016, HEADACHE, V56, P71, DOI 10.1111/head.12647	17	1	1	0	9	ROMANIAN ASSOC BALNEOLOGY	BUCHAREST	BUCHAREST, SECTOR 2, ALEEA DOBRINA NO 7, BL D10, SC A, AP 4, BUCHAREST, 00000, ROMANIA	2069-7597	2069-7619		BALNEO RES J	Balneo Res. J.	DEC	2019	10	4					530	534		10.12680/balneo.2019.294			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	JT3TX	WOS:000500916800017		gold			2022-02-06	
J	Berube, M				Berube, Melanie			Evidence-Based Strategies for the Prevention of Chronic Post-Intensive Care and Acute Care-Related Pain	AACN ADVANCED CRITICAL CARE			English	Article						chronic pain; critical care; intensive care units; pain; risk factors; secondary prevention	CHRONIC POSTSURGICAL PAIN; TRAUMATIC BRAIN-INJURY; NEUROPATHIC PAIN; OPIOID USE; BACK-PAIN; FOLLOW-UP; POSTOPERATIVE PAIN; UNITED-STATES; RISK-FACTORS; PROSPECTIVE-COHORT	Chronic pain is prevalent in intensive care survivors and in patients who require acute care treatments. Many adverse consequences have been associated with chronic post-intensive care and acute care-related pain. Hence, interest in interventions to prevent these pain disorders has grown. To improve the understanding of the mechanisms of action of these interventions and their potential impacts, this article outlines the pathophysiology involved in the transition from acute to chronic pain, the epidemiology and consequences of chronic post-intensive care and acute care-related pain, and risk factors for the development of chronic pain. Pharmacological, nonpharmacological, and multimodal preventive interventions specific to the targeted populations and their levels of evidence are presented. Nursing implications for preventing chronic pain in patients receiving critical and acute care are also discussed.	[Berube, Melanie] Univ Laval, CHU Quebec, Trauma Emergency & Crit Care Med, Populat Hlth & Optimal Practices Res Unit,Res Ct, Quebec City, PQ, Canada; [Berube, Melanie] Laval Univ, Fac Nursing, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada		Berube, M (corresponding author), Univ Laval, CHU Quebec, Trauma Emergency & Crit Care Med, Populat Hlth & Optimal Practices Res Unit,Res Ct, Quebec City, PQ, Canada.; Berube, M (corresponding author), Laval Univ, Fac Nursing, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.	melanie.berube@fsi.ulaval.ca					Aasvang EK, 2010, ANESTHESIOLOGY, V112, P957, DOI 10.1097/ALN.0b013e3181d31ff8; Althaus A, 2012, EUR J PAIN, V16, P901, DOI 10.1002/j.1532-2149.2011.00090.x; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Archer KR, 2012, J TRAUMA ACUTE CARE, V72, P1068, DOI 10.1097/TA.0b013e3182452df5; Azam MA, 2017, CAN J PAIN, V1, P37, DOI 10.1080/24740527.2017.1325317; Battle CE, 2013, CRIT CARE, V17, DOI 10.1186/cc12746; Baumbach P, 2018, EUR J PAIN, V22, P402, DOI 10.1002/ejp.1129; Baumbach P, 2017, CRIT CARE MED, V45, pE567, DOI 10.1097/CCM.0000000000002309; Baumbach P, 2016, CRIT CARE MED, V44, P1129, DOI 10.1097/CCM.0000000000001635; Berube M, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0444-3; Berube M, 2019, PAIN MED, V20, P2018, DOI 10.1093/pm/pnz008; Berube M, 2017, INT J ORTHOP TRAUMA, V24, P59, DOI 10.1016/j.ijotn.2016.04.001; Boyle Martin, 2004, Aust Crit Care, V17, P104, DOI 10.1016/S1036-7314(04)80012-2; Brummett CM, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.0504; Callinan CE, 2017, J PAIN, V18, P360, DOI 10.1016/j.jpain.2016.11.001; Canadian Pain Society, 2015, Pain Res Manag, V20, P287; Chanques G, 2009, INTENS CARE MED, V35, P2060, DOI 10.1007/s00134-009-1590-5; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008307.pub2; Chapman C Richard, 2017, J Pain, V18, DOI 10.1016/j.jpain.2016.11.004; Chidambaran V, 2017, EUR J PAIN, V21, P1252, DOI 10.1002/ejp.1025; Chou R, 2016, J PAIN, V17, P131, DOI 10.1016/j.jpain.2015.12.008; Clarke H, 2018, CAN J PAIN, V2, P236, DOI 10.1080/24740527.2018.1501669; Clarke H, 2015, CAN J ANESTH, V62, P294, DOI 10.1007/s12630-014-0287-6; Clay FJ, 2012, PAIN RES MANAG, V17, P35, DOI 10.1155/2012/935194; Connolly B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008632.pub2; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dahlhamer J, 2018, MMWR-MORBID MORTAL W, V67, P1001, DOI 10.15585/mmwr.mm6736a2; Daoust R, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/7203218; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI 10.1097/CCM.0000000000003259; Deyo RA, 2011, J AM BOARD FAM MED, V24, P717, DOI 10.3122/jabfm.2011.06.100232; Diatchenko L, 2013, NAT REV RHEUMATOL, V9, P340, DOI 10.1038/nrrheum.2013.43; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Doiron KA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010754.pub2; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; England JD, 1996, NEUROLOGY, V47, P272, DOI 10.1212/WNL.47.1.272; Fabricant L, 2013, AM J SURG, V205, P511, DOI 10.1016/j.amjsurg.2012.12.007; Field CA, 2014, J TRAUMA ACUTE CARE, V76, P833, DOI 10.1097/TA.0000000000000100; Foltan R, 2008, MED HYPOTHESES, V71, P572, DOI 10.1016/j.mehy.2008.05.010; Fornasari D, 2012, CLIN DRUG INVEST, V32, P45, DOI 10.2165/11630070-000000000-00000; Gangavalli Anup, 2017, J Orthop Trauma, V31, pe103, DOI 10.1097/BOT.0000000000000741; Garland EL, 2012, PRIMARY CARE, V39, P561, DOI 10.1016/j.pop.2012.06.013; Gatchel RJ, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020048; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gewandter JS, 2015, PAIN, V156, P1184, DOI 10.1097/j.pain.0000000000000191; Giummarra MJ, 2018, INJURY, V49, P1787, DOI 10.1016/j.injury.2018.08.008; Glare P, 2019, LANCET, V393, P1537, DOI 10.1016/S0140-6736(19)30352-6; Gosselin RD, 2010, NEUROSCIENTIST, V16, P519, DOI 10.1177/1073858409360822; Gottschalk A, 2008, CLIN J PAIN, V24, P708, DOI 10.1097/AJP.0b013e318174badd; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Hayhurst CJ, 2018, ANESTH ANALG, V127, P690, DOI 10.1213/ANE.0000000000003358; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hinrichs-Rocker A, 2009, EUR J PAIN, V13, P719, DOI 10.1016/j.ejpain.2008.07.015; Hogan ME, 2017, PAIN, V158, P408, DOI 10.1097/j.pain.0000000000000776; Hogan ME, 2016, PAIN, V157, P1626, DOI 10.1097/j.pain.0000000000000561; Holmes A, 2013, PAIN MED, V14, P336, DOI 10.1111/pme.12034; Hsu JR, 2019, J ORTHOP TRAUMA, V33, pE158, DOI 10.1097/BOT.0000000000001430; IOM (Institute of Medicine), 2011, REL PAIN AM BLUEPR T; Itz CJ, 2013, EUR J PAIN, V17, P5, DOI 10.1002/j.1532-2149.2012.00170.x; Jackson T, 2014, J PAIN, V15, P800, DOI 10.1016/j.jpain.2014.05.002; Jenewein J, 2009, J PSYCHOSOM RES, V66, P119, DOI 10.1016/j.jpsychores.2008.07.011; Jensen MP, 2014, AM PSYCHOL, V69, P105, DOI 10.1037/a0035641; Jonsdottir S, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2477-4; Joshi Girish P, 2005, Anesthesiol Clin North Am, V23, P21, DOI 10.1016/j.atc.2004.11.013; Katz J, 2019, CAN J PAIN, V3, P49, DOI 10.1080/24740527.2019.1574537; Katz J, 2015, J PAIN RES, V8, P695, DOI 10.2147/JPR.S91924; Katz J, 2009, EXPERT REV NEUROTHER, V9, P723, DOI [10.1586/ern.09.20, 10.1586/ERN.09.20]; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kulshrestha S, 2014, CLIN TRANSPLANT, V28, P1041, DOI 10.1111/ctr.12414; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Langerud AK, 2018, PAIN MANAG NURS, V19, P366, DOI 10.1016/j.pmn.2017.11.005; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lavandhomme P, 2018, REFR COURS 17 WORLD; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Linton SJ, 2010, SCAND J PAIN, V1, P38, DOI 10.1016/j.sjpain.2009.09.004; Low Y, 2012, SINGAP MED J, V53, P357; McCracken LA, 2008, HEALTH PSYCHOL, V27, P215, DOI 10.1037/0278-6133.27.2.215; Meyer C, 2018, ANN PHYS REHABIL MED, V61, P323, DOI 10.1016/j.rehab.2018.03.002; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Moreno P, 2018, WORLD J SURG, V42, P1358, DOI 10.1007/s00268-017-4336-5; Murgo M, 2004, AUST CRIT CARE, V17, P175; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Ochroch EA, 2006, CLIN J PAIN, V22, P491, DOI 10.1097/01.ajp.0000208246.18251.f2; Organisation for Economic Cooperation and Develop- ment, 2012, HLTH KEY TABL OECD, DOI DOI 10.1787/HLTHXP-CAP-TABLE-2012-1-EN; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Page MG, 2020, ANN SURG, V271, P845, DOI 10.1097/SLA.0000000000003403; Papaioannou M, 2009, PAIN MED, V10, P1452, DOI 10.1111/j.1526-4637.2009.00730.x; Parsons B, 2013, J PAIN RES, V6, P459, DOI 10.2147/JPR.S44939; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Peng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090014; Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Rosenbloom BN, 2017, J PAIN, V18, P956, DOI 10.1016/j.jpain.2017.03.006; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; Roy M, 2014, NAT NEUROSCI, V17, P1607, DOI 10.1038/nn.3832; Rozet I, 2014, ANESTH ANALG, V119, P454, DOI 10.1213/ANE.0000000000000292; Rushton AB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017876; Schaefer C, 2014, CLINICOECONOMIC OUTC, V6, P483, DOI 10.2147/CEOR.S63323; Schaible HG, 2004, LANGENBECK ARCH SURG, V389, P237, DOI 10.1007/s00423-004-0468-9; Schofield-Robinson OJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012701.pub2; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Stamer UM, 2019, PAIN, V160, P1856, DOI 10.1097/j.pain.0000000000001560; Steyaert A, 2018, DRUGS, V78, P339, DOI 10.1007/s40265-018-0866-x; Sullivan MJL, 2011, SPINE, V36, pS244, DOI 10.1097/BRS.0b013e3182387fed; Tiippana E, 2003, ACTA ANAESTH SCAND, V47, P433, DOI 10.1034/j.1399-6576.2003.00056.x; Tillu DV, 2008, PAIN, V136, P331, DOI 10.1016/j.pain.2007.07.011; Trevino CM, 2013, J PAIN, V14, P424, DOI 10.1016/j.jpain.2012.12.016; VanDenKerkhof EG, 2012, REGION ANESTH PAIN M, V37, P19, DOI 10.1097/AAP.0b013e318237516e; Vardeh D, 2016, J PAIN, V17, pT50, DOI 10.1016/j.jpain.2016.03.001; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Von Korff M, 2016, J PAIN, V17, P1068, DOI 10.1016/j.jpain.2016.06.009; Vowles KE, 2008, HEALTH PSYCHOL, V27, pS136, DOI 10.1037/0278-6133.27.2(Suppl.).S136; Vranceanu AM, 2019, PILOT FEASIBILITY ST, V5, DOI 10.1186/s40814-019-0416-7; Vranceanu Ana-Maria, 2014, J Bone Joint Surg Am, V96, pe20, DOI 10.2106/JBJS.L.00479; Wang L, 2018, BRIT J ANAESTH, V120, P1304, DOI 10.1016/j.bja.2017.10.026; Wasserman RA, 2014, REGION ANESTH PAIN M, V39, P13, DOI 10.1097/AAP.0000000000000024; Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yaffe PB, 2017, J INTENSIVE CARE MED, V32, P429, DOI 10.1177/0885066615618189	127	1	1	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	WIN	2019	30	4					320	334		10.4037/aacnacc2019285			15	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	NO3FX	WOS:000569371400004	31951659				2022-02-06	
J	Bounajem, MT; Samples, DC; Wallace, DJ; Tavakoli, S; Liao, L; Tarasiewicz, I				Bounajem, Michael T.; Samples, D. Clay; Wallace, David J.; Tavakoli, Samon; Liao, Lillian; Tarasiewicz, Izabela			Management of epidural hematomas in pediatric patients presenting with a GCS of 14 or better	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Epidural hematoma; Pediatric; Trauma; Management	TRAUMATIC BRAIN-INJURY; CONSERVATIVE MANAGEMENT; EXTRADURAL HEMATOMA; CHILDREN	Object: Guidelines for the management of pediatric epidural hematoma (PEDH) remain poorly defined. Here we seek to characterize the disease course of PEDH in patients with presenting Glasgow Coma Scale (GCS) of 14+, and suggest high-risk characteristics for progression to surgery. Methods: A prospectively maintained, single-institution, level-1 trauma hospital admission database was queried to identify patients ages 6 months to 18 years presenting with PEDH between 2006 and 2016. Selected charts were reviewed for clinical information and treatment. Head imaging was reviewed for hematoma size, location, fractures, and midline shift. Results: Of 210 cases reviewed, 117 presented with a GCS of 14+. Of these, 24 required surgery while 93 were managed conservatively. Factors leading to surgery included decline in GCS (40%), size alone (21%), localizing neurological deficit (20%), progression on repeat imaging (12%), and other (7%). Hematomas involving the temporal lobe plus an adjacent lobe were more likely to proceed to surgery than those involving the temporal lobe alone (OR: 24.8, 95% CI (4.74, 129.26)). Hematomas in proximity to the superior sagittal and transverse sinuses proceeded to surgery in 33.3% and 37.5% of cases, respectively. Of the 93 patients with a thickness:biparietal skull diameter ratio of <= 0.15, 89 (95.7%) were managed conservatively. Conclusion: In this single-institution experience, 21% of pediatric patients presenting with a GCS of 14+ proceeded to surgery. High-risk features include large hematoma thickness, proximity to the transverse sinus, and multilobar location. A thickness:biparietal skull diameter ratio less than 0.15 was highly unlikely to proceed to surgery. (C) 2019 Elsevier Ltd. All rights reserved.	[Bounajem, Michael T.] Univ Texas Hlth San Antonio, Long Sch Med, San Antonio, TX USA; [Samples, D. Clay; Wallace, David J.; Tavakoli, Samon; Tarasiewicz, Izabela] Univ Texas Hlth San Antonio, Dept Neurosurg, San Antonio, TX USA; [Liao, Lillian] Univ Texas Hlth San Antonio, Dept Surg, Div Trauma & Emergency Surg, San Antonio, TX USA		Bounajem, MT (corresponding author), 7701 Wurzbach Rd,Apt 1507, San Antonio, TX 78229 USA.	bounajem@livemail.uthscsa.edu		Bounajem, Michael/0000-0003-4037-0113			Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Bullock M.R., 2006, NEUROSURGERY, V58; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Cohrs G, 2018, CHILD NERV SYST, V34, P1345, DOI 10.1007/s00381-018-3771-4; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; JAMJOOM A, 1994, NEUROSURG REV, V17, P277, DOI 10.1007/BF00306818; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Khan MB, 2014, CHILD NERV SYST, V30, P1249, DOI 10.1007/s00381-014-2391-x; Pai P, 2012, IEEE SENSOR, P170; PILLAY R, 1995, S AFR MED J, V85, P672; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Xiaoyu W, 2011, TURK NEUROSURG, DOI [10.5137/1019-5149.ITN.5043-11.1, DOI 10.5137/1019-5149.ITN.5043-11.1]	17	1	1	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2019	70						118	122		10.1016/j.jocn.2019.08.056			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JS5QM	WOS:000500360600021	31421993				2022-02-06	
J	Chuang, KT; Hsieh, F; Liao, HT				Chuang, Kai-Ti; Hsieh, Frank; Liao, Han-Tsung			The Correlation of Age and Patterns of Maxillofacial Bone Fractures and Severity of Associated Injuries Caused by Motorcycle Accidents	ANNALS OF PLASTIC SURGERY			English	Article						road traffic accident; motorcycle accident; maxillofacial bone fracture; age	TRAUMATIC BRAIN-INJURY; FACIAL FRACTURES; CURRENT TRENDS; UNITED-STATES; RISK-FACTORS; EPIDEMIOLOGY; ADOLESCENTS; MANAGEMENT; FATALITIES; MORTALITY	Background Every year, there are significant numbers of motorcycle accident casualties in Taiwan. These accidents are the leading cause of maxillofacial trauma. Age should be an important factor of maxillofacial fracture patterns yet there is limited literature on the topic. Therefore, this study aims to evaluate the correlation of age with maxillofacial fracture in motorcycle accidents. Methods This is a retrospective descriptive analysis conducted over 2-year period at Linkou Chang Gung Memorial Hospital. We focused on the population of maxillofacial injury caused by motorcycle accidents. Data, including demographics, age, fracture patterns of facial bones, and other associated injuries, were collected. Results Among 881 admissions, there were 179 patients in the minor group, 644 patients in the adult group, and 58 patients in the geriatric group. With patterns of maxillofacial fracture, midface fracture was the most common type. The minor group had higher incidence of mandibular fracture. The geriatric group sustained more midface fracture. Associated injuries, such as severe head injuries and c-spine injury, were more likely to occur with the old age victims. The overall mortality rate was 3.1%. Conclusions Our study presents the different trends of fracture patterns in different age groups, which is associated with different types of treatment required. We summarized all these data in the hope of providing further assistance to trauma doctor dealing with motorcycle accidents.	[Chuang, Kai-Ti; Hsieh, Frank] Chang Gung Univ, Coll Med, Dept Surg, Taoyuan, Taiwan; [Chuang, Kai-Ti; Liao, Han-Tsung] Chang Gung Univ, Coll Med, Dept Plast & Reconstruct Surg, Div Traumat Plasty,Craniofacial Res Ctr, Taoyuan, Taiwan; [Liao, Han-Tsung] Chang Gung Univ, Coll Med, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Liao, Han-Tsung] Xiamen Changgung Hosp, Dept Plast Surg, Xiamen, Fujian, Peoples R China		Liao, HT (corresponding author), Chang Gung Univ, Coll Med, Craniofacial Res Ctr,Chang Gung Mem Hosp, Div Traumat Plast Surg,Dept Plast & Reconstruct S, 5 Fu Shing St, Taoyuan 333, Taiwan.	lia01211@gmail.com	Hsieh, Frank/AAM-6314-2021				Adeyemo WL, 2008, WORLD J SURG, V32, P2631, DOI 10.1007/s00268-008-9773-8; [Anonymous], 2015, ADOLESCENT HLTH RES; [Anonymous], 1994, AGE RELATED DISABILI; Beck LF, 2007, AM J EPIDEMIOL, V166, P212, DOI 10.1093/aje/kwm064; Camilloni L, 2008, INT J INJ CONTROL SA, V15, P25, DOI 10.1080/17457300701800118; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Chang HL, 2006, J TRANSP ENG, V132, P227, DOI 10.1061/(ASCE)0733-947X(2006)132:3(227); Chang HL, 2007, TRANSPORT RES F-TRAF, V10, P109, DOI 10.1016/j.trf.2006.08.001; Chrcanovic BR, 2010, J TRAUMA, V69, pE73, DOI 10.1097/TA.0b013e3181cc847b; Cini MA, 2014, BRIT J ORAL MAX SURG, V52, P789, DOI 10.1016/j.bjoms.2014.05.006; Delcourt T, 2015, INJURY, V46, pS24, DOI 10.1016/S0020-1383(15)70007-0; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; Dischinger Patricia C, 2006, Annu Proc Assoc Adv Automot Med, V50, P237; Evans D, 2015, AM J EMERG MED, V33, P1184, DOI 10.1016/j.ajem.2015.05.031; Gerbino G, 1999, J ORAL MAXIL SURG, V57, P777, DOI 10.1016/S0278-2391(99)90812-1; HAMPSON D, 1995, J BIOMECH, V28, P1; Jou RC, 2012, TRAFFIC INJ PREV, V13, P155, DOI 10.1080/15389588.2011.641166; Kuner EH, 1996, INJURY, V27, P185, DOI 10.1016/0020-1383(95)00211-1; Kyrychenko Sergey Y, 2006, Traffic Inj Prev, V7, P55, DOI 10.1080/15389580500377833; Liang CC, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0419-3; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MASON PN, 1990, PLASTIC SURG, P868; Mullin B, 2000, Inj Prev, V6, P32, DOI 10.1136/ip.6.1.32; Oginni FO, 2006, J ORAL MAXIL SURG, V64, P56, DOI 10.1016/j.joms.2005.09.027; Oikarinen V J, 1975, Proc Finn Dent Soc, V71, P53; Park KP, 2015, J KOR ASSOC ORAL MAX, V41, P306, DOI 10.5125/jkaoms.2015.41.6.306; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peleg K, 2005, ISR MED ASSOC J, V7, P511; Ramli R, 2008, J CRANIOFAC SURG, V19, P316, DOI 10.1097/SCS.0b013e318163f94d; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Rutter DR, 1996, ACCIDENT ANAL PREV, V28, P15, DOI 10.1016/0001-4575(95)00037-2; Talving P, 2010, J TRAUMA, V68, P441, DOI [10.1097/TA.0b013e3181cbf303, 10.1097/TA.0b013e3181bb80bf]; Toivari M, 2014, OR SURG OR MED OR PA, V118, P539, DOI 10.1016/j.oooo.2014.06.016; Weiss H, 2010, PEDIATRICS, V126, P1149, DOI 10.1542/peds.2010-0902; Zhou HH, 2013, INT J PEDIATR OTORHI, V77, P494, DOI 10.1016/j.ijporl.2012.12.017	36	1	1	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	DEC	2019	83	6					E28	E34		10.1097/SAP.0000000000001943			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JN5OU	WOS:000496948400004	31246668				2022-02-06	
J	Chung, JS; Zink, A				Chung, Jason; Zink, Amanda			What HIRTS athletes? Establishing a unified public policy understanding of Head Impact-Related Trauma in Sport	JOURNAL OF PUBLIC HEALTH POLICY			English	Article						Concussion; CTE; Public policy; Sport; Contact	BRAIN-INJURY; CONCUSSION; ENCEPHALOPATHY; EPIDEMIOLOGY; PHYSICIANS	Globally, concussions in sport now attract far greater concern than several decades ago. Yet, no international scientific consensus exists for defining 'concussion,' or for determining how many brain injuries caused by a contact sport constitute a sufficient public health threat to warrant improving policies. How can policymakers help coaches, players, and parents work with public health authorities and clinicians to identify concussions, and prevent and treat head injuries? Doing so will require language that helps distinguish among the multitude of conditions related to Head Impact-Related Trauma in Sport (HIRTS), including sport-related concussion, post-concussion syndrome, second impact syndrome, and neurodegenerative diseases such as chronic traumatic encephalopathy. We propose a 'HIRTS framework' to advance public policy pertaining to head impacts and their effects. Given the scientific ambiguities regarding the definition, diagnosis, and markers of concussion and resulting complications, we encourage international policymakers, clinicians, and public health officials to adopt the following working definitions and concomitant policy recommendations to safeguard athletes' health and optimize tracking efforts, public education, funding, and government services.	[Chung, Jason; Zink, Amanda] NYU, Sports & Soc Program, 7 E 12th St, Room 825, New York, NY 10003 USA		Chung, JS (corresponding author), NYU, Sports & Soc Program, 7 E 12th St, Room 825, New York, NY 10003 USA.	jason.chung@nyu.edu					Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Concussion Legacy Foundation, 1111, FLAG FOOTB 14; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dwyer C, 2018, BIG RULE CHANGES COU; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Kenning C., 2018, REUTERS; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Perez A. J., 2016, US TODAY; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; The Associated Press, 2015, THE OREGONIAN; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	31	1	1	3	6	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0197-5897	1745-655X		J PUBLIC HEALTH POL	J. Public Health Policy	DEC	2019	40	4					393	409		10.1057/s41271-019-00179-0			17	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	KI6XU	WOS:000511494700002	31391521				2022-02-06	
J	Culhane, J; Silverglate, B; Freeman, C				Culhane, John; Silverglate, Bret; Freeman, Carl			Alcohol is a predictor of mortality in motor vehicle collisions	JOURNAL OF SAFETY RESEARCH			English	Article						Restraint; Driver; Passenger; Risk; Mechanism; Fatality Analysis Reporting System (FARS)	TRAUMATIC BRAIN-INJURY; HOSPITAL MORTALITY; MAJOR TRAUMA; RISK; ASSOCIATION; SEVERITY; CONSUMPTION; MORBIDITY; SURVIVAL	Introduction: It is well recognized that driving while intoxicated increases the probability of a motor vehicle collision (MVC). The effect of alcohol on the chance of surviving the MVC is less clear. Method: Using data from the Fatality Analysis Reporting System (FARS) we conducted analyses for the outcome of mortality using alcohol and other variables as predictors. We also selected alcohol positive (AP) and alcohol negative (AN) persons from the same MVC and vehicle to control for confounding characteristics. Results: The odds ratio (OR) for mortality for alcohol positive drivers was 2.57, (p < 0.001 for all the following OR). Other harmful predictive factors were age OR 1.01 per year, vehicle age OR 1.05 per year, male sex OR 1.23, avoidance maneuver OR 1.09, speed related OR 2.89, rollover mechanism OR 2.75, and collision with a fixed object OR 6.70. Protective factors were proper restraint use similar to OR 0.19 and collision with another moving vehicle, OR 0.21. In the multivariate analysis the OR of mortality for AP vs AN was 1.46. Proper restraint use (OR 0.27) remained protective along with collision with another moving vehicle. When AP and AN persons from the same MVC and the same vehicle were compared, the adjusted OR's for mortality were 1.46 and 2.08, respectively. Conclusions: Alcohol is an independent predictor of mortality in an MVC. Proper restraint use is the strongest protective factor. This finding allows a more complete understanding of the risks of driving while intoxicated, not only a higher probability of an MVC, but decreased survival once the MVC occurs. Practical Applications: Identification of alcohol as an independent predictor of mortality in an accident may improve risk assessment and influence drivers to avoid driving while intoxicated. (C) 2019 National Safety Council and Elsevier Ltd. All rights reserved.	[Culhane, John; Silverglate, Bret; Freeman, Carl] St Louis Univ, Dept Trauma, 3635 Vista Ave, St Louis, MO 63110 USA		Culhane, J (corresponding author), St Louis Univ, Dept Trauma, 3635 Vista Ave, St Louis, MO 63110 USA.	johnculhane17@gmail.com; bret.silverglate@-health.slu.edu; carl.freeman@health.slu.edu					Ahmed N, 2019, EUR J TRAUMA EMERG S, V45, P151, DOI 10.1007/s00068-017-0794-6; Ahmed N, 2019, INJURY, V50, P33, DOI 10.1016/j.injury.2018.09.022; [Anonymous], 2018, FATALITY ANAL REPORT; Benson C, 2018, AM J EMERG MED, V36, P1139, DOI 10.1016/j.ajem.2017.11.028; Blomberg RD, 2009, J SAFETY RES, V40, P285, DOI 10.1016/j.jsr.2009.07.002; Borkenstein R. F., 1964, SERIES ROLE DRINKING; Calland JF, 2013, J TRAUMA ACUTE CARE, V75, P501, DOI 10.1097/TA.0b013e31829bb75c; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Compton R.P., 2015, DRUG ALCOHOL CRASH R; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P217, DOI 10.1016/0001-4575(86)90006-0; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P229, DOI 10.1016/0001-4575(86)90007-2; Fatovich DM, 2013, J TRAUMA ACUTE CARE, V74, P647, DOI 10.1097/TA.0b013e3182788065; Girasek DC, 2002, ANN EMERG MED, V39, P622, DOI 10.1067/mem.2002.122864; Grigorian A, 2019, AM J DRUG ALCOHOL AB, V45, P77, DOI 10.1080/00952990.2018.1504951; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Hsieh CH, 2013, AM SURGEON, V79, P1289; HURST PM, 1994, ACCIDENT ANAL PREV, V26, P647, DOI 10.1016/0001-4575(94)90026-4; Koval KJ, 2008, BULL HOSP JT DIS, V66, P27; Layrisse V., 2000, P R HEALTH SCI J, V37, P213; Martin JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187320; Mbarga NF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6280-1; National Highway Traffic Safety Administration, 2017, TRAFF SAF FACTS 2016; Oksanen A, 2015, ADDICTION, V110, P471, DOI 10.1111/add.12777; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Pickrell T. M., 812351 DOT HS NAT HI; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Stehman CR, 2015, J CRIT CARE, V30, P1382, DOI 10.1016/j.jcrc.2015.08.023; Subramanian R., 2002, DOTHS809403 NAT HIGH; Trentzsch H, 2014, INJURY, V45, pS20, DOI 10.1016/j.injury.2014.08.013; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461	33	1	1	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	DEC	2019	71						201	205		10.1016/j.jsr.2019.10.002			5	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	KB8FB	WOS:000506723600020	31862031				2022-02-06	
J	Damen, C; Dhaese, S; Verstraete, AG; Stove, V; De Waele, JJ				Damen, Caroline; Dhaese, Sofie; Verstraete, Alain G.; Stove, Veronique; De Waele, Jan J.			Subtherapeutic piperacillin concentrations in neurocritical patients	JOURNAL OF CRITICAL CARE			English	Article						Subtherapeutic antibiotic concentrations; Beta-lactam antibiotics; Piperacillin/tazobactam; Critically ill; Neurocritical care	AUGMENTED RENAL CLEARANCE; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY	Purpose: Increased renal elimination is the leading cause for subtherapeutic concentrations of renally cleared antibiotics and it has been hypothesized that brain damaged patients in the intensive care unit (ICU) are particularly at risk. The objective of this study is to determine the prevalence of subtherapeutic piperacillin concentrations in neurocritical patients and to investigate if having a neurocritical diagnosis is a risk factor for this. Materials and methods: Single center retrospective analysis of a prospective cohort study of adult ICU patients receiving continuous infusion piperacillin/tazobactam. Patients were categorized as either having a neurocritical diagnosis or not. An unbound piperacillin concentration > 4x the epidemiologic cut-off value (ECOFF) of Pseudomonas aeruginosa was selected as the PKPD target of choice. Multivariable logistic regression was performed to identify risk factors for subtherapeutic piperacillin concentrations. Results: 356 patients had a measured creatinine clearance (mCrCl) and matched piperacillin concentration, 52 of which had a neurocritical diagnosis. Subtherapeutic piperacillin concentrations were reported significantly more frequent in neurocritical patients. In multivariate analysis, the only risk factor identified for subtherapeutic piperacillin concentration was an increasing mCrCl. Conclusion: Subtherapeutic piperacillin concentrations are common in neurocritical patients yet having a neurocritical admission diagnosis was not identified as an independent risk factor. (C) 2019 Elsevier Inc. All rights reserved.	[Damen, Caroline; Dhaese, Sofie; De Waele, Jan J.] Ghent Univ Hosp, Dept Crit Care Med, Corneel Heymanslaan 10, B-9000 Ghent, Belgium; [Damen, Caroline] Elisabeth Tweesteden Hosp, Dept Internal Med, Doctor Deelenlaan 5, NL-5042 AD Tilburg, Netherlands; [Verstraete, Alain G.; Stove, Veronique] Ghent Univ Hosp, Dept Lab Med, Corned Heymanslaan 10, B-9000 Ghent, Belgium; [Verstraete, Alain G.; Stove, Veronique] Univ Ghent, Dept Diagnost Sci, Corned Heymanslaan 10, B-9000 Ghent, Belgium		Damen, C (corresponding author), Ghent Univ Hosp, Dept Crit Care Med, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.	cmf.damen@etz.nl	Verstraete, Alain/B-4150-2013; De Waele, Jan J/E-2704-2013; Stove, Veronique/AAG-2330-2020	Verstraete, Alain/0000-0002-0956-3315; De Waele, Jan J/0000-0003-1017-9748; Stove, Veronique/0000-0002-2447-971X	Centre of Research Excellence grant from the National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1099452]; Research Foundation Flanders (FWO)FWO [1881015N]	Sofie Dhaese is funded by a Centre of Research Excellence grant (APP1099452) from the National Health and Medical Research Council awarded to Jason A. Roberts. Jan DeWaele is senior clinical investigator funded by the Research Foundation Flanders (FWO, Ref. 1881015N).	Aardema H, 2017, INT J ANTIMICROB AG, V50, P68, DOI 10.1016/j.ijantimicag.2017.02.020; Barletta JF, 2016, J TRAUMA ACUTE CARE, V81, P1115, DOI 10.1097/TA.0000000000001211; Barnwell-Menard JL, 2015, STAT MED, V34, P936, DOI 10.1002/sim.6387; Bilbao-Meseguer I, 2018, CLIN PHARMACOKINET, V57, P1107, DOI 10.1007/s40262-018-0636-7; Carlier M, 2015, J CHROMATOGR B, V978, P89, DOI 10.1016/j.jchromb.2014.11.034; Carrie C, 2018, J CRIT CARE, V48, P66, DOI 10.1016/j.jcrc.2018.08.026; Carrie C, 2018, ANAESTH CRIT CARE PA, V37, P35, DOI 10.1016/j.accpm.2017.06.006; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; De Waele JJ, 2015, MINERVA ANESTESIOL, V81, P1079; Delattre IK, 2017, EXPERT REV ANTI-INFE, V15, P677, DOI 10.1080/14787210.2017.1338139; Dhaese SAM, 2018, INT J ANTIMICROB AG, V51, P594, DOI 10.1016/j.ijantimicag.2017.12.015; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; Goncalves-Pereira J, 2011, CRIT CARE, V15, DOI 10.1186/cc10441; Hobbs ALV, 2015, PHARMACOTHERAPY, V35, P1063, DOI 10.1002/phar.1653; Imani S, 2018, EUR J CLIN MICROBIOL, V37, P2171, DOI 10.1007/s10096-018-3357-9; Kim AJ, 2016, INT J ANTIMICROB AG, V48, P381, DOI 10.1016/j.ijantimicag.2016.06.022; Levy MM, 2018, CRIT CARE MED, V46, P997, DOI 10.1097/CCM.0000000000003119; Lord AS, 2019, NEUROCRIT CARE, V31, P196, DOI 10.1007/s12028-018-0568-y; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; Roberts JA, 2014, LANCET INFECT DIS, V14, P498, DOI 10.1016/S1473-3099(14)70036-2; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2018, BREAKPOINT TABLES IN; Timsit JF, 2019, INTENS CARE MED, V45, P172, DOI 10.1007/s00134-019-05520-5; Tsai D, 2015, CURR OPIN CRIT CARE, V21, P412, DOI 10.1097/MCC.0000000000000229; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Udy AA, 2013, INTENS CARE MED, V39, P2070, DOI 10.1007/s00134-013-3088-4	26	1	1	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2019	54						48	51		10.1016/j.jcrc.2019.07.007			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT4BE	WOS:000500935700009	31349159				2022-02-06	
J	Diora, JR; Plager, DA				Diora, Jinali R.; Plager, David A.			Sudden-onset trochlear nerve palsy: clinical characteristics and treatment implications	JOURNAL OF AAPOS			English	Article								PURPOSE To identify clinical characteristics, etiologies, and treatment implications of sudden-onset, acquired cases of superior oblique palsy. METHODS The medical records of patients diagnosed with trochlear nerve palsy between January 2010 and January 2018 were reviewed retrospectively to identify cases of acquired trochlear nerve palsy with a specific date of onset of acute symptoms or specific causative incident. Patients with congenital palsies or an uncertain date of onset, history of other strabismus, concomitant oculomotor or abducens nerve palsies, or history of strabismus surgery were excluded. RESULTS Of 214 patients with superior oblique palsy, 23 had sudden-onset, acquired palsies. There were 14 cases of unilateral palsy and 9 cases of bilateral palsy. Patients with unilateral palsy presented with vertical diplopia, while those with bilateral palsy complained of either torsional (4/9 patients) or vertical (5/9 patients) diplopia. The most common etiologies were severe trauma associated with traumatic brain injury, followed by central nervous system neoplasm and stroke. Fifteen patients underwent surgical intervention, 3 of whom required more than one surgery. CONCLUSIONS Patients with acute superior oblique palsy invariably complain of vertical and/or torsional diplopia. Neuroimaging should be considered in cases of acquired superior oblique palsy without a known traumatic cause. Bilateral cases of acquired superior oblique palsy are more challenging to manage surgically because of symptomatic torsional diplopia.	[Diora, Jinali R.] Northern Virginia Ophthalmol Associates, Falls Church, VA 22044 USA; [Plager, David A.] Indiana Univ, Indianapolis, IN 46204 USA; [Plager, David A.] IU Hlth, Riley Hosp Children, Indianapolis, IN USA		Diora, JR (corresponding author), Northern Virginia Ophthalmol Associates, Falls Church, VA 22044 USA.						Mollan SP, 2009, EYE, V23, P640, DOI 10.1038/eye.2008.24; Park UC, 2008, EYE, V22, P691, DOI 10.1038/sj.eye.6702720; VONNOORDEN GK, 1986, ARCH OPHTHALMOL-CHIC, V104, P1771, DOI 10.1001/archopht.1986.01050240045037	3	1	1	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1091-8531	1528-3933		J AAPOS	J. AAPOS	DEC	2019	23	6					321	322		10.1016/j.jaapos.2019.09.011			2	Ophthalmology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology; Pediatrics	JZ4YJ	WOS:000505109000006	31678480				2022-02-06	
J	El-Menyar, A; Asim, M; Ramzee, AF; Nabir, S; Ahmed, MN; Al-Thani, A; Al-Abdulmalek, A; Al-Thani, H				El-Menyar, Ayman; Asim, Mohammad; Ramzee, Ahmed Faidh; Nabir, Syed; Ahmed, Mohamed Nadeem; Al-Thani, Abdulaziz; Al-Abdulmalek, Abdulrahman; Al-Thani, Hassan			Bio-Shock Index: Proposal and Rationale for a New Predictive Tool for In-Hospital Mortality in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Bio-SI; HsTnT; Shock index; Traumatic brain injury	CLASSIFICATION; OUTCOMES; UTILITY	BACKGROUND: We proposed a novel prognostic tool for the prediction of in-hospital mortality based on a combination of hemodynamic parameters and biomarkers in patients with traumatic brain injury (TBI). We hypothesized that a combination of shock index (SI) with high sensitive troponin T (HsTnT), the Bio-Shock Index (Bio-SI), has better prognostic power than its individual components. METHODS: A retrospective chart review was conducted (2011-2018) for patients with TBI. Patients were categorized into 2 groups (low and high Bio-SI) based on the receiver operating characteristic curve. RESULTS: A total of 2619 patients were admitted with TBI, and 1471 fulfilled the inclusion criteria and 73% had high Bio-SI (>= 10). High Bio-SI values were associated with more intraventricular hemorrhage (P = 0.001), brain edema (P = 0.001), and had lower mean arterial pressure (P = 0.001), admission Glasgow Coma Scale score (P = 0.001), and higher SI (P = 0.001), serum lactate (P= 0.001), HsTnT values (P = 0.001), and Rotterdam score (P = 0.03). Patients with high Bio-SI had a prolonged hospital (P = 0.003) and intensive care unit stay (P = 0.001); longer ventilatory days (P = 0.001) and had higher rates of pneumonia (P = 0.001), sepsis (P = 0.001), and in-hospital mortality (P = 0.001). The Bio-SI showed high sensitivity and negative predictive value (91.4% and 94.4%, respectively) as compared with elevated SI (50.2% and 87.6%, respectively) and positive troponin (79.7% and 93.7%, respectively). CONCLUSIONS: The Bio-SI is potentially a better tool than its individual components to predict in-hospital mortality among patients with TBI; however, HsTnT alone outperforms SI. Prospective studies and multicenter trials studying troponin levels and SI in all patients with TBI with the inclusion of outcome scores will prove or disprove the predictability of the new index.	[Ramzee, Ahmed Faidh] Hamad Gen Hosp, Dept Surg, Doha, Qatar; [Nabir, Syed; Ahmed, Mohamed Nadeem] Hamad Gen Hosp, Dept Radiol, Doha, Qatar; [Al-Thani, Abdulaziz; Al-Abdulmalek, Abdulrahman] Hamad Gen Hosp, Dept Med, Doha, Qatar; [Al-Thani, Hassan] Hamad Gen Hosp, Trauma Surg Sect, Doha, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Clin Med, Doha, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Clin Res Trauma & Vasc Surg Sect, Doha, Qatar		El-Menyar, A (corresponding author), Weill Cornell Med Coll, Clin Med, Doha, Qatar.; El-Menyar, A (corresponding author), Hamad Gen Hosp, Clin Res Trauma & Vasc Surg Sect, Doha, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015; Ramzee, Ahmed Faidh/ABA-5322-2021	El-Menyar, Ayman/0000-0003-2584-953X; Ramzee, Ahmed Faidh/0000-0002-7049-6115			Acker SN, 2015, PEDIATR SURG INT, V31, P1041, DOI 10.1007/s00383-015-3789-6; Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Boyd C R, 1987, Am J Surg, V153, P514, DOI 10.1016/0002-9610(87)90790-2; Boyd CR, 1987, AM J SURG, V153, P514; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Crewdson Kate, 2019, J Intensive Care Soc, V20, P132, DOI 10.1177/1751143718767782; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675; El-Menyar A, 2019, AM J EMERG MED, V37, P133, DOI 10.1016/j.ajem.2018.10.002; El-Menyar A, 2018, J TRAUMA ACUTE CARE, V85, P646, DOI 10.1097/TA.0000000000001865; El-Menyar A, 2018, J SURG RES, V227, P52, DOI 10.1016/j.jss.2018.02.013; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0340-2; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Gerdin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144886; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Huang JF, 2019, INT J SURG, V61, P48, DOI 10.1016/j.ijsu.2018.11.030; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; Montoya KF, 2015, J ACUTE DIS, V4, P202, DOI 10.1016/j.joad.2015.04.006; Najafi Z, 2018, INT EMERG NURS, V36, P27, DOI 10.1016/j.ienj.2017.08.003; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Zarzaur BL, 2008, J SURG RES, V147, P229, DOI 10.1016/j.jss.2008.03.025	24	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2019	132						E169	E177		10.1016/j.wneu.2019.08.229			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JN5VR	WOS:000496966300021	31505291				2022-02-06	
J	Fallows, R				Fallows, Robert			Integration of Neuropsychology Into Primary Care: A Retrospective Analysis of Outcomes and Lessons Learned From a Single Provider Practice	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						primary care integration; integrated neuropsychology; neuropsychology referrals; medical home; outcomes	SURVEY PROFESSIONAL PRACTICES; SALARY SURVEY; CLINICAL NEUROPSYCHOLOGY; BELIEFS; INCOMES; CONCUSSION; MANAGEMENT; SERVICES	Neuropsychology is increasingly being integrated into different care settings. with primary care representing a newer area for integration. Although models of neuropsychology integration into primary care have been proposed. there has not yet been a study examining outcome of integration. This is a retrospective analysis of the effects of integration on neuropsychologist productivity, provider referral rates, and the impact of warm handoffs on patient's being lost to follow-up. Exploratory analysis of shifts in reason for referral was also conducted while qualitative data examining patient and provider perception of integration were gathered. Statistical analysis revealed that patients were 3.2 times more likely to complete evaluation if the neuropsychologist was integrated, whereas those referred by warm handoffs were 5.7 times more likely to complete evaluation compared to referrals received through traditional routes. Productivity significantly increased by 3.2 work relative value units (RVUs) per day, or 64.3 RVUs per month. Visual inspection of data showed increases in referral rates from primary care providers when the neuropsychologist was integrated into the clinic. Further, although the integrated neuropsychology services are valued by providers and well received by patients. there are shifts within practice model that occur when integrating into primary care. This article provides preliminary evidence for the benefit of neuropsychology's being integrated into primary care, most notably with higher utilization by primary care providers but also lower rates of patients' being lost to follow-up. Future research may focus on the factors that influence these findings, possibly including destigmatization of service.	[Fallows, Robert] Samaritan Hlth Serv, Neuropsychol Serv, Albany, OR 97321 USA; [Fallows, Robert] Samaritan Hlth Serv, Clin Training, Albany, OR 97321 USA		Fallows, R (corresponding author), Samaritan Hlth Serv, Neuropsychol Clin, 534 Northwest Pleast View Way, Albany, OR 97321 USA.	rfallows@samhealth.org					Agency for Healthcare Research and Quality, 2018, WARM HAND INT; American Academy of Clinical Neuropsychology, 2018, ABPP INT PRIM CAR SU; Benedict RHB, 2017, J INT NEUROPSYCH SOC, V23, P832, DOI 10.1017/S1355617717000959; Center for Medicare Services, 2018, US SEARCH MED PHYS F; Dux MC, 2018, ARCH CLIN NEUROPSYCH, V33, P290, DOI 10.1093/arclin/acx133; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Fallows R, 2016, 2016 OR PSYCH ASS AN; Foley FW, 2018, ARCH CLIN NEUROPSYCH, V33, P330, DOI 10.1093/arclin/acy003; Johnson-Greene D, 2018, ARCH CLIN NEUROPSYCH, V33, P310, DOI 10.1093/arclin/acx126; Kubu CS, 2018, ARCH CLIN NEUROPSYCH, V33, P365, DOI 10.1093/arclin/acx130; Kubu CS, 2016, CLIN NEUROPSYCHOL, V30, P51, DOI 10.1080/13854046.2015.1134670; Labiner DM, 2010, EPILEPSIA, V51, P2322, DOI 10.1111/j.1528-1167.2010.02648.x; Lanca M, 2018, ARCH CLIN NEUROPSYCH, V33, P269, DOI 10.1093/arclin/acx135; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDaniel SH, 2014, AM PSYCHOL, V69, P409, DOI 10.1037/a0036072; Michels TC, 2010, AM FAM PHYSICIAN, V82, P495; Morrison CE, 2018, ARCH CLIN NEUROPSYCH, V33, P354, DOI 10.1093/arclin/acx134; Noll KR, 2018, ARCH CLIN NEUROPSYCH, V33, P344, DOI 10.1093/arclin/acx131; Ott SD, 2018, ARCH CLIN NEUROPSYCH, V33, P319, DOI 10.1093/arclin/acx132; Reppeto H, 2021, J HEALTH PSYCHOL, V26, P205, DOI 10.1177/1359105318802949; Roman DD, 2018, ARCH CLIN NEUROPSYCH, V33, P339, DOI 10.1093/arclin/acx127; Ruchinskas RA, 2018, ARCH CLIN NEUROPSYCH, V33, P301, DOI 10.1093/arclin/acx128; Schoenberg M., 2017, 2017 AM AC CLIN NEUR; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165	26	1	1	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	DEC	2019	50	6					419	426		10.1037/pro0000254			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	JS0OH	WOS:000500013500007					2022-02-06	
J	Fazel, M; Ahmadi, S; Hajighanbari, MJ; Baratloo, A; Shahsavarinia, K; Hosseini, M; Yousefifard, M				Fazel, Mojtaba; Ahmadi, Sajjad; Hajighanbari, Mohammad Javad; Baratloo, Alireza; Shahsavarinia, Kavous; Hosseini, Mostafa; Yousefifard, Mahmoud			Validation of CRASH Model in Prediction of 14-Day Mortality and 6-Month Unfavourable Outcome of Pediatric Traumatic Brain Injury	INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD			English	Article						Clinical; Emergency Service; Sensitivity and Specificity; Pediatrics	EXTERNAL VALIDATION; PROGNOSTIC MODELS; ORAL MIDAZOLAM; IMPACT; CHILDREN; MODERATE; SURVIVAL	Background: Value of Corticosteroid Randomisation after Significant Head Injury (CRASH) prognostic model has not been assessed in children with traumatic brain injury (TBI). This study is designed to examine the value of CRASH model in prediction of 14-day mortality and 6-month unfavourable outcome of pediatric TBI. Materials and Methods: In a cross-sectional study. 738 children with TBI brought to the emergency ward of four hospitals were studied. For assessing the predictive value of the CRASH model discrimination power and calibration of CRASH basic model and CRASH CT model were examined. Results: The areas under the curve (AUC) of CRASH basic and CRASH CT models in prediction of 14-day mortality were 0.89 and 0.91, respectively. AUCs of the CRASH basic and CRASH CT models in predicting unfavourable outcome were 0.93 and 0.94. The value of two models in prediction of 14-day mortality (p=0.20), and 6-month unfavourable outcome (p=0.22) were equal. Both models had proper calibrations in predicting 14-day mortality and 6-month unfavourable outcome. Conclusion: As calculations of the basic model are easier than those of the CT model and it does not necessitate CT scanning, the CRASH basic model is suggested in the field of pediatrics.	[Fazel, Mojtaba] Univ Tehran Med Sci, Pediat Chron Kidney Dis Res Ctr, Tehran, Iran; [Fazel, Mojtaba] Univ Tehran Med Sci, Valiasr Hosp, Dept Pediat, Imam Khomeini Med Complex, Tehran, Iran; [Ahmadi, Sajjad] Tabriz Univ Med Sci, Dept Emergency Med, Tabriz, Iran; [Hajighanbari, Mohammad Javad] Iran Univ Med Sci, Dept Emergency Med, Haft & Tir Hosp, Tehran, Iran; [Baratloo, Alireza] Univ Tehran Med Sci, Prehosp & Hosp Emergency Res Ctr, Tehran, Iran; [Baratloo, Alireza] Univ Tehran Med Sci, Sina Hosp, Dept Emergency Med, Tehran, Iran; [Shahsavarinia, Kavous] Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Physiol Res Ctr, Tehran, Iran		Hosseini, M (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran.; Yousefifard, M (corresponding author), Imam Hossein Hosp, Physiol, Prevent Cardiovasc Dis Res Ctr, Madani Ave,POB 14665-354, Tehran, Iran.	mhossein110@yahoo.com; yousefifard20@gmail.com	Baratloo, Alireza/E-3293-2017; Yousefifard, Mahmoud/P-1621-2018; Ahmadi, Sajjad/AAY-2040-2020; Shahsavarinia, Kavous/AAZ-3411-2020	Baratloo, Alireza/0000-0002-4383-7738; Yousefifard, Mahmoud/0000-0001-5181-4985; Ahmadi, Sajjad/0000-0002-7733-5189; Shahsavarinia, Kavous/0000-0002-4049-8531	Tehran University of Medical Sciences & health Services grantTehran University of Medical Sciences [97-03-184-40748]	This research has been supported by Tehran University of Medical Sciences & health Services grant (Grant number: 97-03-184-40748). We hereby express our gratitude to the emergency department staff of studied hospitals.	Barzegari H, 2015, EMERGENCY, V3, P109; BAXT WG, 1987, J TRAUMA, V27, P602, DOI 10.1097/00005373-198706000-00003; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hashemi B, 2016, EMERGENCY, V4, P196; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kipfmueller F, 2013, KLIN PADIATR, V225, P34, DOI 10.1055/s-0032-1329945; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Loh SA, 2011, J VASC SURG, V53, P359, DOI 10.1016/j.jvs.2010.08.074; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Majidinejad S, 2015, EMERGENCY, V3, P64; Mommsen P, 2012, J SURG RES, V176, P239, DOI 10.1016/j.jss.2011.09.018; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rajasekhar A, 2011, CRIT CARE MED, V39, P1507, DOI 10.1097/CCM.0b013e31820eb517; Raux M, 2011, J TRAUMA, V71, P754, DOI 10.1097/TA.0b013e3181fd0dae; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sarcbiapone M, 2009, PSYCHIAT RES, V165, P187, DOI 10.1016/j.psychres.2008.04.026; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; von Klot CA, 2013, WORLD J UROL, P1; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	31	1	1	1	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2345-5047	2345-5055		INT J PEDIATR-MASSHA	Int. J. Pediatr.-Masshad	DEC	2019	7	12					10413	10422		10.22038/ijp.2019.42931.3596			10	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	JX7DA	WOS:000503889700002					2022-02-06	
J	Fleming, J; Goh, ATH; Lannin, NA; Ownsworth, T; Schmidt, J				Fleming, Jennifer; Goh, Amelia Tsi Hui; Lannin, Natasha A.; Ownsworth, Tamara; Schmidt, Julia			An exploratory study of verbal feedback on occupational performance for improving self-awareness in people with traumatic brain injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						awareness; feedback; occupational therapy; rehabilitation; traumatic brain injury	EXECUTIVE FUNCTION; CLINICAL UTILITY; VIDEO FEEDBACK; INTERVENTIONS; QUESTIONNAIRE; PERSPECTIVES; PROTOCOL; DEFICITS	Introduction Impaired self-awareness negatively impacts on how well persons with traumatic brain injury (TBI) learn and use strategies needed in daily life. Verbal feedback is a component of metacognitive strategy training recommended for addressing impaired self-awareness in TBI rehabilitation. Yet, it remains unknown how effectively verbal feedback on occupational performance improves self-awareness for the specific occupation involved. This study investigated the effect of verbal feedback on task-specific self-awareness for individuals with TBI. Methods A secondary analysis was conducted on selected data extracted from a randomised, assessor-blinded controlled trial in which 36 participants with impaired self-awareness post-TBI were allocated into two feedback intervention groups, verbal feedback and a control condition of experiential feedback only. All participants engaged in four sessions of meal preparation with an occupational therapist using a metacognitive strategy training approach. Participants in the verbal feedback group received feedback on their performance in a discussion with the occupational therapist following each session. Task-specific self-awareness was measured using discrepancy scores (therapist ratings minus self-ratings) on a Meal Independence Rating Scale (MIRS). Data were analysed using a mixed 2 x 2 analysis of variance. Results Positive MIRS discrepancy scores at pre-intervention reflected the propensity of participants to over-estimate their abilities There was a significant main effect of time, indicating overall gains in task-specific self-awareness at post-intervention (p = .01), but no significant group-by-time interaction. Changes in participants' self-ratings post-intervention were minimal. Instead, reduced MIRS discrepancy scores resulted largely from changes in therapists' ratings, indicating improvement in occupational performance. Conclusion Participants in both groups demonstrated improvements in occupational performance, but this did not correspond with changes in task-specific self-awareness. In this small sample, there was no statistically significant improvement in self-awareness associated with the provision of verbal feedback after occupational performance over and above the benefits of experiential feedback.	[Fleming, Jennifer; Goh, Amelia Tsi Hui] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer; Schmidt, Julia] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Lannin, Natasha A.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Lannin, Natasha A.] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia; [Lannin, Natasha A.] Univ Sydney, Fac Med, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Schmidt, Julia] Univ British Columbia, Occupat Sci & Occupat Therapy Dept, Vancouver, BC, Canada		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	j.fleming@uq.edu.au	Ownsworth, Tamara/ABB-6961-2021; Fleming, Jennifer/AAH-5108-2020; Lannin, Natasha A/A-4195-2013	Ownsworth, Tamara/0000-0003-1835-7094; Lannin, Natasha A/0000-0002-2066-8345; Fleming, Jennifer/0000-0002-5603-2410; Schmidt, Julia/0000-0003-2004-4871	Occupational Therapy Board of Queensland; Wenkart Foundation	This research was funded by the Occupational Therapy Board of Queensland and the Wenkart Foundation.	Baum CM, 2017, NEUROPSYCHOL REHABIL, V27, P603, DOI 10.1080/09602011.2016.1176934; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Bryson-Campbell M, 2016, J OCCUP SCI, V23, P208, DOI 10.1080/14427591.2015.1131188; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Cohen GL, 2014, ANNU REV PSYCHOL, V65, P333, DOI 10.1146/annurev-psych-010213-115137; Cotton GS, 2012, OCCUP THER HEALTH CA, V26, P270, DOI 10.3109/07380577.2012.726759; Doig E, 2017, NEUROREHABILITATION, V40, P519, DOI 10.3233/NRE-171439; Fleming JM, 1996, BRAIN INJURY, V10, P1; Godwin M, 2013, ISRN FAMILY MED, V2013, P1; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Hellebrekers D, 2017, BRAIN INJURY, V31, P1469, DOI 10.1080/02699052.2017.1377350; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; McPhail S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-65; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2019, J REHABIL MED, V51, P376, DOI 10.2340/16501977-2537; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Pallant J., 2010, SPSS SURVIVAL MANUAL, V4th; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Richardson C, 2015, NEUROPSYCHOL REHABIL, V25, P233, DOI 10.1080/09602011.2014.936878; Schmidt J, 2015, CAN J OCCUP THER, V82, P54, DOI 10.1177/0008417414550999; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2012, AUST OCCUP THER J, V59, P138, DOI 10.1111/j.1440-1630.2012.00998.x; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474	33	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	APR	2020	67	2					142	152		10.1111/1440-1630.12632		DEC 2019	11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	KZ7QX	WOS:000501437500001	31788819	Green Published			2022-02-06	
J	Gao, YK; Gui, CJ; Xin, WQ; Hu, D; Yang, XY				Gao, Yi-Kuan; Gui, Cheng-Jia; Xin, Wen-Qiang; Hu, Dan; Yang, Xin-Yu			Assessment of mild hypothermia combined with edaravone for the treatment of severe craniocerebral injury	TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Mild hypothermia; Edaravone; Severe craniocerebral injury; Intracranial pressure; Neurotrophic factor	TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; SCALE	Purpose: To study the clinical effect of combining mild hypothermia with edaravone in the treatment of severe craniocerebral injury. Methods: One hundred and twenty (120) patients with severe craniocerebral injury who were admitted to Tianjin Medical University General Hospital were assigned to control and study groups, respectively. Patients in the control group were given conventional treatment while those in the study group received combined treatment of mild hypothermia and edaravone, in addition to the conventional treatment received by control group. Clinical efficacy and prognosis were compared between the two groups. Results: The intracranial pressure (ICP) of both groups decreased after admission, but the decrease in ICP was more pronounced in the study group at various time points (p < 0.05). Blood lactic acid levels decreased in both groups after admission, while brain-derived neurotrophic factor (BDNF) levels increased. Improvement in blood lactic acid and BDNF was greater in the study group than in control group (p < 0.05). The treatment resulted in significant decrease in residual hematoma volume and edema range in the study group, relative to control (p < 0.05). There was a decrease in National Institutes of Health Stroke Scale (NIHSS) scores, and increase in Glasgow outcome scale (GOS) scores in both groups. However, improvement in NIHSS and GOS scores in the study group was superior to those in control group (p < 0.05). Conclusion: Mild hypothermia in combination with edaravone exerts a beneficial clinical effect in severe craniocerebral injury. The combined treatment rapidly reduces ICP and range of encephaledema, improves cerebral blood supply, promotes absorption of intracranial hematoma, and relieves nervous dysfunction.	[Gao, Yi-Kuan; Gui, Cheng-Jia; Xin, Wen-Qiang; Yang, Xin-Yu] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Gao, Yi-Kuan; Gui, Cheng-Jia; Hu, Dan] Cent Hosp Yongzhou, Dept Neurosurg, Yongzhou 425000, Hunan, Peoples R China		Yang, XY (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China.	yangxinyu@tmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571144]; Natural Science Foundation of Tianjin CityNatural Science Foundation of Tianjin [16JCZDJC35700]	Supports from National Natural Science Foundation of China (no. 81571144) and Natural Science Foundation of Tianjin City (no. 16JCZDJC35700) are gratefully acknowledged.	Ahmed AI, 2016, NEUROSURG CLIN N AM, V27, P489, DOI 10.1016/j.nec.2016.05.004; Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; [Anonymous], 2008, 59 WORLD MED C; Dinoff A, 2017, EUR J NEUROSCI, V46, P1635, DOI 10.1111/ejn.13603; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; He WX, 2012, HEIBEI MED J, V34, P1526; Hirano M, 2011, HEPATOL RES, V41, P142, DOI 10.1111/j.1872-034X.2010.00751.x; Jamal A, 2017, WORLD J EMERG MED, V8, P55, DOI 10.5847/wjem.j.1920-8642.2017.01.010; Jiang WW, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0410-7; Jing GJ, 2014, NEURAL REGEN RES, V9, P190, DOI 10.4103/1673-5374.125348; Kataria R, 2012, INDIAN J NEUROTRAUM, V9, P67, DOI 10.1016/j.ijnt.2012.04.013; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Lyden P, 2017, STROKE, V48, P513, DOI 10.1161/STROKEAHA.116.015434; Peng B, 2008, J CHIN PHYS, V36, P44; Saur J, 2008, IN VIVO, V22, P143; Shapiro H, 2016, PROSTAG LEUKOTR ESS, V111, P45, DOI 10.1016/j.plefa.2016.03.001; [宋向奇 Song Xiangqi], 2014, [中国全科医学, Chinese General Practice], V17, P2003; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Wang K, 2013, NEUROL RES, V35, P642, DOI 10.1179/1743132813Y.0000000187; Wang Y, 2011, SHANDONG MED J, V51, P64; Xu H, 2014, CHIN J GERONTOL, V5, P5099; Zhang C, 2016, J ACUTE DIS, V5, P311, DOI 10.1016/j.joad.2016.04.003; Zhao YS, 2014, P CHIN MARK INT CONF, P258; Zhu YL, 2015, CELL BIOCHEM BIOPHYS, V73, P581, DOI 10.1007/s12013-015-0584-x	25	1	1	1	4	PHARMACOTHERAPY GROUP	BENIN CITY	UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA	1596-5996			TROP J PHARM RES	Trop. J. Pharm. Res.	DEC	2019	18	12					2557	2562		10.4314/tjpr.v18i12.14			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	JZ3UO	WOS:000505027000013					2022-02-06	
J	Ghajarzadeh, M; Rahimi Foroushani, A; Nedjat, S; Sheikhrezaei, A; Saberi, H				Ghajarzadeh, Mahsa; Rahimi Foroushani, Abbas; Nedjat, Saharnaz; Sheikhrezaei, Abdolreza; Saberi, Hooshang			Survival Analysis in Patients with Chronic Traumatic Spinal Cord Injury	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Article						Survival; Traumatic spinal cord injury; Mortality; Iran	LONG-TERM SURVIVAL; MORTALITY; DEPRESSION; DEATH; MORBIDITY; COMPLICATIONS; VETERANS; SUICIDE; IMPACT; RISK	Background: The goal of this study was to determine hazard rate of death rate and the causes of death in Iranian patients with Traumatic spinal cord injury (TSCI). Methods: Overall, 1024 patients with chronic traumatic spinal cord injury referred to Brain and Spinal Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran from Jan 2013-2017 were enrolled. Epidemiological and neurological data, along with secondary complications were recorded for all participants. In the case of death, the cause, and the date of death were recorded. The Kaplan-Meier method was used for survival analysis. A log-rank test was carried out to compare survival due to different risk factors. Risk factors and relative risk estimates associated with death were assessed by means of a Cox regression model. Results: Nineteen percent were lost to follow up. During the follow-up period, 22 out of 830 remaining cases (2.6%) died. Deaths were only observed in patients with cervical injuries (59% in C1-C4 level and 41% in C5-C7 level). Kaplan-Meier Log-rank test showed that probability of survival was significantly less in females, complete injury cases, patients with cervical spine injury, depression, and ADR (Autonomic dysreflexia). Controlling for age, sex and education level, Cox regression model showed that hazard rate of death was significantly affected by the categorical variables such as level of injury (HR=0.2, 95% CI=0.12-0.39), severe ADR. Conclusion: Probability of survival is lower in female individuals, cases with complete injuries, patients with cervical spine injury, individuals wi-th depression (BDI>10), and clients who experience ADR.	[Ghajarzadeh, Mahsa; Saberi, Hooshang] Univ Tehran Med Sci, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran; [Rahimi Foroushani, Abbas] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Nedjat, Saharnaz] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Sch Publ Hlth, Dept Epidemiol & Biostatist, Tehran, Iran; [Sheikhrezaei, Abdolreza; Saberi, Hooshang] Univ Tehran Med Sci, Sch Med, Dept Neurosurg, Tehran, Iran		Saberi, H (corresponding author), Univ Tehran Med Sci, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran.; Saberi, H (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Neurosurg, Tehran, Iran.	hgsaberi@yahoo.com					Anderson CJ, 2007, J SPINAL CORD MED, V30, pS76, DOI 10.1080/10790268.2007.11754609; Anson CA, 1996, INT J REHABIL RES, V19, P55, DOI 10.1097/00004356-199603000-00006; Barman A, 2014, ARCH PHYS MED REHAB, V95, P642, DOI 10.1016/j.apmr.2013.11.003; Baron J, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0323-4; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Cragg J, 2012, CAN MED ASSOC J, V184, P66, DOI 10.1503/cmaj.110859; Cuddigan J, 1998, Adv Wound Care, V11, P294; DEVIVO MJ, 1991, PARAPLEGIA, V29, P620, DOI 10.1038/sc.1991.91; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; Elliott TR, 2004, REHABIL PSYCHOL, V49, P134, DOI 10.1037/0090-5550.49.2.134; Fann JR, 2011, ARCH PHYS MED REHAB, V92, P352, DOI 10.1016/j.apmr.2010.05.016; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Frisbie J H, 1983, J Am Paraplegia Soc, V6, P51; HACKLER RH, 1977, J UROLOGY, V117, P486, DOI 10.1016/S0022-5347(17)58506-7; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; Hartkopp A, 1997, SPINAL CORD, V35, P76, DOI 10.1038/sj.sc.3100351; Hassanpour K, 2012, J NEUROL, V259, P1142, DOI 10.1007/s00415-011-6316-2; Hatch BB, 2017, SPINAL CORD, V55, P540, DOI 10.1038/sc.2016.182; Khazaeipour Zahra, 2015, Top Spinal Cord Inj Rehabil, V21, P149, DOI 10.1310/sci2102-149; Klotz R, 2002, SPINAL CORD, V40, P457, DOI 10.1038/sj.sc.3101317; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1482, DOI 10.1016/j.apmr.2007.11.062; Krause JS, 2016, ARCH PHYS MED REHAB, V97, P1669, DOI 10.1016/j.apmr.2016.07.001; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Lidal IB, 2007, J REHABIL MED, V39, P145, DOI 10.2340/16501977-0017; Middleton JW, 2012, SPINAL CORD, V50, P803, DOI 10.1038/sc.2012.55; Mohammadi MR, 2005, SUICIDE LIFE-THREAT, V35, P309, DOI 10.1521/suli.2005.35.3.309; Munce SEP, 2016, SPINAL CORD, V54, P29, DOI 10.1038/sc.2015.91; Noe BB, 2017, SPINAL CORD, V55, P373, DOI 10.1038/sc.2016.154; Noreau Luc, 2014, Top Spinal Cord Inj Rehabil, V20, P249, DOI 10.1310/sci2004-249; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P37, DOI 10.1016/j.apmr.2004.03.018; Rabadi MH, 2016, J SPINAL CORD MED, V39, P175, DOI 10.1179/2045772315Y.0000000039; Regan MA, 2009, ARCH PHYS MED REHAB, V90, P213, DOI 10.1016/j.apmr.2008.08.212; Rish BL, 1997, MIL MED, V162, P141; Sabre L, 2013, J SPINAL CORD MED, V36, P687, DOI 10.1179/2045772313Y.0000000120; SAMSA GP, 1993, ARCH NEUROL-CHICAGO, V50, P909, DOI 10.1001/archneur.1993.00540090018005; Savic G, 2018, SPINAL CORD, V56, P2, DOI 10.1038/sc.2017.98; Savic G, 2017, SPINAL CORD, V55, P891, DOI 10.1038/sc.2017.64; Selassie Anbesaw, 2015, Top Spinal Cord Inj Rehabil, V21, P333, DOI 10.1310/sci2104-333; Sezer N, 2015, WORLD J ORTHOP, V6, P24, DOI 10.5312/wjo.v6.i1.24; Soden RJ, 2000, SPINAL CORD, V38, P604, DOI 10.1038/sj.sc.3101080; Strauss DJ, 2000, J INSURANCE MED, V32, P11; Thietje R, 2011, J SPINAL CORD MED, V34, P482, DOI 10.1179/2045772311Y.0000000022; Tulsky DS, 2015, J SPINAL CORD MED, V38, P335, DOI 10.1179/2045772315Y.0000000020; van den Berg MEL, 2010, J NEUROTRAUM, V27, P1517, DOI 10.1089/neu.2009.1138; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; WHITENECK GG, 1992, PARAPLEGIA, V30, P617, DOI 10.1038/sc.1992.124; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; Zeilig G, 2000, SPINAL CORD, V38, P563, DOI 10.1038/sj.sc.3101043	49	1	1	0	2	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	DEC	2019	48	12					2260	2269					10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JT4IH	WOS:000500954400017	31993395				2022-02-06	
J	Hammond, FM; Baker-Sparr, CA; Dahdah, MN; Dams-O'Connor, K; Dreer, LE; O'Neil-Pirozzi, TM; Novack, TA				Hammond, Flora M.; Baker-Sparr, Christina A.; Dahdah, Marie N.; Dams-O'Connor, Kristen; Dreer, Laura E.; O'Neil-Pirozzi, Therese M.; Novack, Thomas A.			Predictors of 1-Year Global Outcomes After Traumatic Brain Injury Among Older Adults: A NIDILRR Traumatic Brain Injury Model Systems Study	JOURNAL OF AGING AND HEALTH			English	Article						aging; traumatic brain injury; rehabilitation; older adults	CLOSED-HEAD INJURY; INPATIENT REHABILITATION; DRIVING CESSATION; COMMUNITY INTEGRATION; AGE; EPIDEMIOLOGY; HEALTH; SCALE; REPRESENTATIVENESS; REHOSPITALIZATION	Objective: To assess predictors of global function and driving status among older adults (50 years and older) who survived 1 year following inpatient rehabilitation for moderate-to-severe traumatic brain injury (TBI). Methods: Functional status at 1-year post-TBI was determined for 1,845 individuals. The relationship age category to function was studied using associations and predictive modeling. Results: The final model accounted for 34% variance in Glasgow Outcome Scale-Extended (GOS-E) among 60- to 69-year-olds and 70- to 79-year-olds, and 25% variance in 50- to 59-year-olds and 80+-year-olds. FIM Motor at rehabilitation discharge made the greatest contribution to GOS-E variance across all age groups. Inpatient rehabilitation discharge to nursing home or adult home and rehospitalization were associated with a one-level decrease in GOS-E. Alcohol use predicted lower GOS-E among the 70- to 79-year-olds. Gender, ethnicity, and rehospitalizations were negatively associated driving. Discussion: Rehabilitation approaches to older adults with TBI may help maximize function and, thereby, improve later outcomes and decrease rehospitlaizations. Such strategies may include longer and more intensive acute rehabilitation with greater patient engagement and enhanced transitions of care.	[Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indianapolis, Indianapolis, IN USA; [Baker-Sparr, Christina A.] Craig Hosp, Englewood, CO USA; [Dahdah, Marie N.] North Texas Traumat Brain Injury Model Syst, Dallas, TX USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Dreer, Laura E.; Novack, Thomas A.] Univ Alabama Birmingham, Birmingham, AL USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Charlestown, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Boston, MA 02115 USA		Hammond, FM (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com					[Anonymous], 2018, 2017 PROFILE OLDER A; [Anonymous], 2012, AM MED REH PROV ASS; [Anonymous], 2012, UNIFORM DATA SYSTEM; [Anonymous], 2015, TRAUM BRAIN INJ MOD; [Anonymous], 2004, INT CLASS DIS 9 REV; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Barclay L., 2004, JAMA-J AM MED ASSOC, V292, P1687; Blazer DG, 2009, AM J PSYCHIAT, V166, P1162, DOI 10.1176/appi.ajp.2009.09010016; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P994, DOI 10.1016/j.apmr.2015.02.003; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Chihuri S, 2016, J AM GERIATR SOC, V64, P332, DOI 10.1111/jgs.13931; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan J., 2003, TECHN REP PROBL SUBS; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P1290, DOI 10.1093/gerona/glp114; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Goldstein FC, 1996, NEUROPSYCHOLOGY, V10, P147; Goldstein FC., 1998, RECOVERY, V9, P28; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS293, DOI 10.1016/j.apmr.2014.08.026; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Harrison-Felix C., 2012, J HEAD TRAUMA REHAB, V27, pE1; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Kumar RG, 2019, J HEAD TRAUMA REHAB, V34, P224, DOI 10.1097/HTR.0000000000000470; Lequerica A, 2015, BRAIN INJURY, V29, P1445, DOI 10.3109/02699052.2015.1075144; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Mas MF, 2017, PHYS MED REH CLIN N, V28, P829, DOI 10.1016/j.pmr.2017.06.014; MAZZUCCHI A, 1992, J NEUROL, V239, P256; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; U.S. Department of Health and Human Services, 2018, DIET GUID AM; U.S. Department of Labor Bureau of Labor Statistics, 2014, UN RAT LEV; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Whiteneck G. G., ONE 5 YEAR OUTCOMES; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	64	1	1	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0898-2643	1552-6887		J AGING HEALTH	J. Aging Health	DEC	2019	31	10_SUPPL		10_	SI		68S	96S		10.1177/0898264318819197			29	Gerontology; Health Policy & Services	Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Health Care Sciences & Services	JM5WE	WOS:000496283500004	31718413				2022-02-06	
J	Huang, JJ; Qiu, SZ; Zheng, GR; Chen, B; Shen, J; Yin, HM; Mao, W				Huang, Jian-Jun; Qiu, Shen-Zhong; Zheng, Guan-Rong; Chen, Bin; Shen, Jia; Yin, Huai-Ming; Mao, Wei			Determination of serum tissue kallikrein levels after traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Tissue kallikrein; Outcome; Severity; Mortality; Overall survival	KININ SYSTEM; ISCHEMIC-STROKE; INHIBITION; PATHWAY; MODEL	Background: Tissue kallikrein (TK) plays an important role in the kallikrein-kinin system. Its protective role has been demonstrated in traumatic brain injury (TBI). We attempted to determine relationship between serum TK levels and trauma severity in addition to clinical outcome in TBI. Methods: We recruited 112 patients with severe TBI (Glasgow coma scale score < 9) and 112 controls. We configured 2 multivariate models to assess the relationship between serum TK levels and 30-day death. Its prognostic predictive ability was analyzed under receiver operating characteristic curve. Results: TK levels were significantly lower in patients than in controls (median 0.148 mg/l, the upper - lower quartiles 0.121-0.185 vs. median 0.258 mg/l, the upper - lower quartiles 0.207-0.342, P < 0.001). TK levels were closely and positively correlated with Glasgow coma scale score (r = 0.550). TK levels < 0.148 mg/l independently predicted 30-day mortality with odds ratio value of 4.752 (95% confidence interval (CI), 1.166-19.367) and 30-day overall survival with hazard ratio value of 3.698 (95% CI, 1.026-13.333). TK levels significantly discriminated 30-day mortality with area under curve of 0.822 (95% CI, 0.738-0.887). Conclusions: Serum TK can represent a potential predictor of clinical outcome in TBI patients.	[Huang, Jian-Jun; Qiu, Shen-Zhong; Zheng, Guan-Rong; Chen, Bin; Shen, Jia; Yin, Huai-Ming; Mao, Wei] First Peoples Hosp Fuyang Dist Hangzhou City, Dept Neurosurg, 429 Beihuan Rd, Hangzhou 311400, Zhejiang, Peoples R China		Huang, JJ (corresponding author), First Peoples Hosp Fuyang Dist Hangzhou City, Dept Neurosurg, 429 Beihuan Rd, Hangzhou 311400, Zhejiang, Peoples R China.	zjjqsz@163.com					Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; ALBERTWEISSENBERGE, 2014, FRONT CELL NEUROSCI, V8, DOI DOI 10.3389/FNCEL.2014.00345; Back N, 1970, Res Clin Stud Headache, V3, P219; Becker A, 2018, CHIN J TRAUMATOL, V21, P152, DOI 10.1016/j.cjtee.2018.01.004; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Colman R W, 1971, Prog Hematol, V7, P255; Figueroa CD, 2018, BIOL CHEM, V399, P937, DOI 10.1515/hsz-2018-0111; Filippou PS, 2017, BIOCHEM J, V474, P2417, DOI 10.1042/BCJ20170174; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Kenne E, 2019, FASEB J, V33, P2599, DOI 10.1096/fj.201801329R; Liang D, 2018, CNS NEUROSCI THER, V24, P519, DOI 10.1111/cns.12813; Liu YP, 2016, J NEUROCHEM, V139, P208, DOI 10.1111/jnc.13690; MICHAELS.G, 1969, ACTA DERM-VENEREOL, V49, P404; Mo YC, 2015, NEUROL RES, V37, P1082, DOI 10.1080/01616412.2015.1110305; Nokkari A, 2018, PROG NEUROBIOL, V165, P26, DOI 10.1016/j.pneurobio.2018.01.003; Seliga A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00156; Simoes PSR, 2019, J NEUROCHEM, V150, P296, DOI 10.1111/jnc.14793; Umer A, 2019, IEEE J BIOMED HEALTH, V23, P1261, DOI 10.1109/JBHI.2018.2842717; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; Wang Z., 2014, J NEUROSCI RES, V92; Wu F, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/5289715; Yang JW, 2017, EXP THER MED, V14, P1163, DOI 10.3892/etm.2017.4614; Zhang Q, 2011, ANN NEUROL, V70, P265, DOI 10.1002/ana.22404; Zhu J, 2018, IMMUNOPHARM IMMUNOT, V40, P134, DOI 10.1080/08923973.2017.1418883	28	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	DEC	2019	499						93	97		10.1016/j.cca.2019.09.004			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	JS5YZ	WOS:000500383600014	31499021				2022-02-06	
J	Hwang, KS; Jang, SH; Soh, MJ; Lee, HJ; Lee, SY				Hwang, Kyu-Sic; Jang, Seung-Ho; Soh, Min-Jung; Lee, Hye-Jin; Lee, Sang-Yeol			Cognitive Decline in Korean Patients with Neurocognitive Disorder due to Traumatic Brain Injury: A Control for Premorbid Intelligence	PSYCHIATRY INVESTIGATION			English	Article						Neurocognitive disorder; Traumatic brain injury; Cognitive decline; Wechsler adult intelligence scale-fourth edition; Premorbid intelligence	WAIS-IV; COMBINED PERFORMANCE; SCALE-4TH EDITION; CLINICAL UTILITY; COMPLICATED MILD; MEMORY; INDIVIDUALS	Objective Previous studies of cognitive decline in patients with neurocognitive disorder due to traumatic brain injury (NCD-TBI) have often failed to control for baseline factors such as premorbid intelligence. The purpose of the current study was to estimate and compare cognitive function among three groups (controls, complicated mild/moderate TBI, and severe TBI) after controlling for premorbid intelligence. Methods Severity of TBI was classified as complicated mild/moderate or severe based on duration of loss of consciousness and brain neuroimaging results. Premorbid intelligence quotients (IQs) were estimated with the Oklahoma Premorbid Intelligence Estimate. There were no differences in premorbid intelligence between the groups, which were also matched for age and education. Current cognitive function was evaluated with the Wechsler Adult Intelligence Scale-Fourth Edition. Results Comparison of current cognitive function among the three groups indicated significant group differences for all indexes and subtest scores. Processing speed showed the highest effect sire. However, only working memory differed significantly between the two NCD-TBI groups. Conclusion The present findings suggest that mental memory manipulation processes seem to be more sensitive to TBI severity than are perceptual-motor processes. Specifically, both auditory rehearsal/discrimination and mental alertness/manipulation will be most strongly influenced by TBI severity.	[Hwang, Kyu-Sic; Jang, Seung-Ho; Soh, Min-Jung; Lee, Sang-Yeol] Wonkwang Univ Hosp, Dept Psychiat, Iksan, South Korea; [Hwang, Kyu-Sic; Jang, Seung-Ho; Soh, Min-Jung; Lee, Sang-Yeol] Korea Brain Behav Mental Hlth Inst, Iksan, South Korea; [Jang, Seung-Ho; Lee, Sang-Yeol] Wonkwang Univ, Dept Psychiat, Sch Med, 895 Muwang Ro, Iksan 54538, South Korea; [Lee, Hye-Jin] Wonkwang Univ, Grad Sch, Dept Publ Hlth, Iksan, South Korea		Lee, SY (corresponding author), Wonkwang Univ, Dept Psychiat, Sch Med, 895 Muwang Ro, Iksan 54538, South Korea.	psysangyeol@hanmail.net		soh, minjung/0000-0003-1033-9449	Wonkwang University	This study was supported by Wonkwang University in 2019.	American Psychiatric Association, 2013, DIGAN STAT MAN MENT; BADDELEY AD, 2004, ESSENTIAL HDB MEMORY; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Cohen J., 2013, STAT POWER ANAL BEHA; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Holdnack JA, 2013, PRACT RESOUR MENT, P1; Holdnack JA, 2013, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-386934-0.00005-5; Hwang S, 2013, KOREAN WECHSLER ADUL; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kim SG, 2015, CLIN NEUROPSYCHOL, V29, P19, DOI 10.1080/13854046.2015.1072248; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; Rowley DA, 2018, J NEUROPSYCHOL, V12, P200, DOI 10.1111/jnp.12117; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Schoenberg MR, 2011, PREMORBID INTELLIGEN; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wechsler D., 2008, WECHSLER ADULT INTEL; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Zillmer E., 2008, PRINCIPLES NEUROPSYC	25	1	1	0	1	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	DEC	2019	16	12					889	895		10.30773/pi.2019.0129			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	JX4NW	WOS:000503714000003	31711280	Green Published, gold			2022-02-06	
J	Jahandideh, S; Kendall, E; Low-Choy, S; Donald, K; Jayasinghe, R; Barzegari, E				Jahandideh, Sepideh; Kendall, Elizabeth; Low-Choy, Samantha; Donald, Kenneth; Jayasinghe, Rohan; Barzegari, Ebrahim			The Process of Patient Engagement in Outpatient Cardiac Rehabilitation Programs	BEHAVIOUR CHANGE			English	Article						cardiac rehabilitation; intention to engage; cardiac rehabilitation initiation; patient engagement	TRAUMATIC BRAIN-INJURY; QUESTIONNAIRE MOT-Q; PHYSICAL-ACTIVITY; SELF-EFFICACY; BEHAVIOR; MOTIVATION; PARTICIPATION; VALIDATION; PREDICTORS; INTENTION	The primary aim of this study was to test the causal structure of the model of therapeutic engagement (MTE) for the first time, to examine whether the model assists in understanding the process of patient engagement in cardiac rehabilitation (CR) programs. This study used a prospective design, following up patients from the Gold Coast University Hospital Cardiology ward who attended Robina Cardiac Rehabilitation Clinic. A structural equation model of the interactions among the proposed variables within the three stages of the MTE (intention to engage in CR programs, CR initiation, and sustained engagement) revealed significant relationships among these variables in a dataset of 101 patients who attended a CR program. However, no relationship was discerned between outcome expectancies and patient intention to engage in CR. Patients' willingness to consider the treatment also mediated the relationship between perceived self-efficacy and patient intention to engage in CR. These findings help clarify the process proposed by Lequerica and Kortte (2010) in the context of patient engagement in CR programs. The findings also reveal information on how patients engage in CR programs. Importantly, this provides new information for healthcare providers, enabling them to more effectively engage patients according to their stage of engagement.	[Jahandideh, Sepideh] Griffith Univ, Sch Med, Human Serv & Social Work, Gold Coast Campus, Qld 4222, Australia; [Jahandideh, Sepideh] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast Campus, Qld 4222, Australia; [Kendall, Elizabeth] Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld, Australia; [Low-Choy, Samantha] Griffith Univ, Griffith Social & Behav Res Coll, Gold Coast, Qld, Australia; [Donald, Kenneth] Griffith Univ, Sch Med, Gold Coast Campus, Qld, Australia; [Jayasinghe, Rohan] Gold Coast Univ Hosp, Dept Cardiol, Gold Coast, Qld, Australia; [Barzegari, Ebrahim] Kermanshah Univ Med Sci, Hlth Technol Inst, Med Biol Res Ctr, Kermanshah, Iran		Jahandideh, S (corresponding author), Griffith Univ, Sch Med, Human Serv & Social Work, Gold Coast Campus, Qld 4222, Australia.; Jahandideh, S (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast Campus, Qld 4222, Australia.	sepideh.jahandideh@griffithuni.edu.au		Low Choy, Samantha/0000-0002-1722-4428; Kendall, Elizabeth/0000-0003-2399-1460; Barzegari, Ebrahim/0000-0002-4412-6129			Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alexander JL, 2006, REHABIL NURS, V31, P155, DOI 10.1002/j.2048-7940.2006.tb00380.x; [Anonymous], 2017, INDIAN J HEMATOL BLO, V33, pS113; Araya-Ramirez F, 2010, J CARDIOPULM REHABIL, V30, P93, DOI 10.1097/HCR.0b013e3181d0c17f; Arbuckle J., 2012, IBM SPSS AMOS 21 USE; Arbuckle J. L., 1999, AMOS 4 0 USERS GUIDE; Australian Bureau of Statistics, 2017, CAUS DEATH AUSTR 201; Bains B, 2007, NEUROPSYCHOL REHABIL, V17, P174, DOI 10.1080/09602010600562468; Bakker EC, 2015, J CARDIOVASC NURS, V30, P172, DOI 10.1097/JCN.0000000000000156; Barg CJ, 2012, PSYCHOL HEALTH, V27, P829, DOI 10.1080/08870446.2011.609595; Baumgartner H., 1996, INT J RES MARK, V13, P139, DOI DOI 10.1016/0167-8116(95)00038-0; Bennett P, 1999, BRIT J HEALTH PSYCH, V4, P247, DOI 10.1348/135910799168605; Blanchard CM, 2009, J CARDIOPULM REHABIL, V29, P188, DOI 10.1097/HCR.0b013e3181a333a3; Blasche G, 2011, INT ARCH OCC ENV HEA, V84, P859, DOI 10.1007/s00420-011-0651-6; Boosman H, 2016, NEUROPSYCHOL REHABIL, V26, P87, DOI 10.1080/09602011.2014.1001409; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Carroll DL, 2007, J CARDIOVASC NURS, V22, P313, DOI 10.1097/01.JCN.0000278955.44759.73; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Clark AM, 2014, CARDIAC REHABILITATI; Colombo M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01430; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; del Pozo-Cruz B, 2018, QUAL LIFE RES, P1; Ding L, 1995, STRUCT EQU MODELING, V2, P119, DOI 10.1080/10705519509540000; Dohnke B, 2010, RES SPORTS MED, V18, P219, DOI 10.1080/15438627.2010.510032; Doig E, 2015, SCAND J OCCUP THER, V22, P302, DOI 10.3109/11038128.2015.1017530; Dunlay SM, 2014, AM J MED, V127, P538, DOI 10.1016/j.amjmed.2014.02.008; Dutch Snapshot Research Group, 2017, COLORECTAL DIS, V19; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Gardiner FW, 2018, OUTPATIENT CARDIAC R; Gaskin J., 2016, EXCEL STATTOOLS STAT; George D, 2003, SPSS WINDOWS STEP ST, V14th, P222; Ghisi GLD, 2015, PATIENT EDUC COUNS, V98, P612, DOI 10.1016/j.pec.2015.01.006; Godlaski TM, 2009, SUBST USE MISUSE, V44, P62, DOI 10.1080/10826080802525819; Graffigna G., 2016, PATIENT ENGAGEMENT C; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hansen TB, 2018, EUR J CARDIOVASC NUR, V17, P45, DOI 10.1177/1474515117716245; Hattar A, 2016, APPL PSYCHOL-HLTH WE, V8, P127, DOI 10.1111/aphw.12065; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub3, 10.1002/14651858.CD001800.pub2]; Holliday RC, 2007, DISABIL REHABIL, V29, P389, DOI 10.1080/09638280600841117; Hutchinson P, 2015, REHABIL NURS, V40, P360, DOI 10.1002/rnj.202; Jahandideh S, 2018, BEHAV CHANGE, V35, P185, DOI 10.1017/bec.2018.20; Jolly K, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11350; Liebana-Cabanillas FJ, 2014, IND MANAGE DATA SYST, V114, P220, DOI 10.1108/IMDS-03-2013-0137; Kasila K, 2018, PERSPECTIVES PUBLIC, p1757913917751564; Kersten P, 2015, DISABIL REHABIL, V37, P1073, DOI 10.3109/09638288.2014.955137; Kjaer T, 2006, INT J TECHNOL ASSESS, V22, P211; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Law M., 2014, CANADIAN OCCUPATIONA, V5th; Lee KM, 2003, J KOREAN ACAD REHAB, V27, P309; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Marzolini S, 2010, EUR J CARDIOV PREV R, V17, P35, DOI 10.1097/HJR.0b013e32832da020; McMurray J, 2016, ARCH PHYS MED REHAB, V97, P121, DOI 10.1016/j.apmr.2015.08.408; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; O'Brien A, 2009, J MENT HEALTH, V18, P510, DOI 10.3109/09638230902968225; Ozer Mark N, 1999, Top Stroke Rehabil, V6, P43, DOI 10.1080/10749357.1999.11869235; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Rouleau CR, 2018, PATIENT EDUC COUNS, V101, P1914, DOI 10.1016/j.pec.2018.06.015; Safarnia H., 2011, INT BUSINESS MANAGEM, V2, P47, DOI 10.3968/j.ibm.1923842820110202.006; Shanks LC, 2007, REHABIL NURS, V32, P152, DOI 10.1002/j.2048-7940.2007.tb00169.x; Sniehotta FF, 2010, PSYCHOL HEALTH, V25, P839, DOI 10.1080/08870440902915915; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Soper D. S., 2018, PRIORI SAMPLE SIZE C; Sullivan KA, 2009, INT J THER REHABIL, V16, P488, DOI 10.12968/ijtr.2009.16.9.43767; Walker KC, 2018, PATIENT PREFER ADHER, V12, P145, DOI 10.2147/PPA.S150008; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Williams DM, 2010, PERS SOC PSYCHOL REV, V14, P417, DOI 10.1177/1088868310368802; Woodgate J, 2005, J APPL SOC PSYCHOL, V35, P183, DOI 10.1111/j.1559-1816.2005.tb02099.x; [No title captured]	74	1	1	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0813-4839	2049-7768		BEHAV CHANGE	Behav. Change	DEC	2019	36	4					233	251	PII S0813483919000147	10.1017/bec.2019.14			19	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	JQ7AB	WOS:000499092500004					2022-02-06	
J	Kraak, W; Coetzee, L; Kruger, A; Stewart, R; van Vuuren, H				Kraak, Wilbur; Coetzee, Lize; Kruger, Anika; Stewart, Reeco; van Vuuren, Hanno			Knowledge and Attitudes Towards Concussion in Western Province Rugby Union Senior Club Rugby Players	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						concussion knowledge; head injuries; rugby union; club league; survey	SPORT	Concussion is a frequently occurring injury in rugby which is not usually reported to coaches or medical staff. Recognition and treatment of concussion should be a priority; however, education surrounding concussion knowledge and attitudes of the players have been lacking. The aim of this study was to investigate the knowledge and attitudes toward concussion in Western Province Rugby Union (WPRU) Super League senior club rugby players. This study focused on gathering quantitative information from WPRU club rugby players, using the Rosenbaum Concussion Knowledge and Attitudes Survey-Student Version (RoCKAS-ST). The correlation between the Concussion Attitude Index (CAI) and Concussion Knowledge Index (CKI) was (r=0.14). The CKI average for the players was (16.72 +/- 2.96). The participants answered 67% (16.72 +/- 2.96) of the CKI questions and 62% (46.54 +/- 5.75) of the CAI questions correctly. The participants demonstrated sufficient knowledge of concussion, as well as safe attitudes toward concussion. A small number of players lacked knowledge of symptoms and attitudes toward concussion, which may have been influenced by the importance of games. Overall, the participants in this study demonstrated superior knowledge and safe attitudes compared to other studies. The current study found that the players had good knowledge and safe attitudes regarding the severity of concussion.	[Kraak, Wilbur; Coetzee, Lize; Kruger, Anika; Stewart, Reeco; van Vuuren, Hanno] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sports Sci, Stellenbosch, South Africa		Kraak, W (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Sports Sci, Stellenbosch, South Africa.	kjw@sun.ac.za	Kraak, Wilbur/O-7992-2014	Kraak, Wilbur/0000-0002-8233-2839			CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Griffin NG, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001735; Harriss DJ, 2017, INT J SPORTS MED, V38, P1126, DOI 10.1055/s-0043-124001; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Kraak W J, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30i1a4404; Mathema P, 2016, CLIN J SPORT MED, V26, P320, DOI 10.1097/JSM.0000000000000256; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rugby Football Union, 2018, ENGL PROF RUGB INJ S, P48; Starling Lindsay, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30ila5720; Viljoen C T, 2017, SA J. Sports Med., V29, P1, DOI 10.17159/2078-516x/2017/v29i0a1942	14	1	1	2	8	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	DEC	2019	40	13					825	830		10.1055/a-0959-2113			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JT4YE	WOS:000500996000003	31574545				2022-02-06	
J	Kroshus, E; Buth, D; Parsons, JT; Hainline, B				Kroshus, Emily; Buth, Dawn; Parsons, John T.; Hainline, Brian			Randomized Evaluation of the National Collegiate Athletic Association's Concussion Education Fact Sheet for Coaches	HEALTH EDUCATION & BEHAVIOR			English	Article						coaches; concussion; education; evaluation; sport	KNOWLEDGE; COMMUNICATION; HEADS	Background. Concussion education for coaches is being increasingly recommended by leading sports organizations, yet the effectiveness of available materials has not often been assessed. This study evaluated the impact of the National Collegiate Athletic Association's (2017) publication: "Concussion safety: What coaches need to know" (the "NCAA Fact Sheet for Coaches") on participants' concussion knowledge and safety supportive intentions. Method. NCAA head coaches (n = 779) were randomized to view the NCAA Fact Sheet for Coaches either before (intervention condition) or after (control condition) responding to questions assessing concussion knowledge and intentions to engage in three behaviors (talk to team about concussion safety; allow symptomatic athlete to continue play; encourage medical staff to return athlete as quickly as possible). Results. Knowledge scores were significantly higher among coaches in the intervention condition as compared to the control condition, largely driven by differences in knowledge about the consequences of continued play postconcussion (injury, reaction time, possible death). Fewer coaches in the intervention condition expected that they would allow an athlete with a suspected concussion continue to participate in a game or practice or that they would encourage medical staff to return athletes to play as quickly as possible. Discussion. The present study provides evidence that educational content, like that contained in the NCAA Fact Sheet for Coaches, may have a positive short-term impact on concussion knowledge and behavioral intentions of coaches. In light of these findings, sports organizations should consider providing similar educational materials to coaches, evaluating whether the information is impactful in their population.	[Kroshus, Emily] Univ Washington, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA; [Buth, Dawn; Parsons, John T.; Hainline, Brian] Natl Collegiate Athlet Assoc, Indianapolis, IN USA		Kroshus, E (corresponding author), Seattle Childrens Res Inst, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Kroshus, Emily/0000-0002-7484-2601			Adrian Molly, 2016, Psychiatr Serv, V67, P932, DOI 10.1176/appi.ps.201600099; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Basil M, 2012, HLTH COMMUNICATION M, P41; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cauberghe V, 2009, ACCIDENT ANAL PREV, V41, P276, DOI 10.1016/j.aap.2008.11.006; Cohen J., 2013, STAT POWER ANAL BEHA; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00872; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2016, CLIN J SPORT MED, V26, P391, DOI 10.1097/JSM.0000000000000272; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Lewis I, 2013, HEALTH COMMUN, V28, P84, DOI 10.1080/10410236.2013.743430; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merriam S.B., 2001, NEW DIRECTIONS ADULT, V2001, P3, DOI 10.1002/ace.3; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; National Collegiate Athletic Association, 2017, CONC MAN DIAGN BEST; National Collegiate Athletic Association, 2017, CONC FACT SHEET COAC; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; The National Collegiate Athletic Association, 2014, 2014 2015 NCAA SPORT; Wilson EAH, 2012, PATIENT EDUC COUNS, V89, P7, DOI 10.1016/j.pec.2012.06.007; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	28	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	DEC	2019	46	6					960	968		10.1177/1090198119864621			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JU0MF	WOS:000501373200008	31565969				2022-02-06	
J	Lindholm, EB; D'Cruz, R; Fajardo, R; Meckmongkol, T; Ciullo, S; Grewal, H; Prasad, R; Arthur, LG				Lindholm, Erika B.; D'Cruz, Roshan; Fajardo, Romulo; Meckmongkol, Teerin; Ciullo, Sean; Grewal, Harsh; Prasad, Rajeev; Arthur, L. Grier			Admission of Pediatric Concussion Injury Patients: Is It Necessary?	JOURNAL OF SURGICAL RESEARCH			English	Article						Pediatric; Trauma; Concussion; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MANAGEMENT; CHILDREN	Background: Currently there is no consensus on the management of patients with a concussion and negative computed tomography (CT) of the head. This study examined the necessity of admitting pediatric patients with concussive symptoms. The purpose of this study was to determine if pediatric patients evaluated in the emergency department (ED) for concussion with a negative head CT scan require routine hospital admission. Materials and methods: A retrospective chart review of pediatric trauma patients admitted to the hospital for a concussion from 2010 to 2017 was conducted after IRB approval (1709005621). Only patients with a negative head CT were included. Demographic information, ED evaluation, and hospital course were reviewed. Results: A total of 90 patients (M-age = 10 y; 72.2% male) were included in the analysis. The average Glasgow coma scale was 14.6 (range 9-15). Loss of consciousness was reported by 36.7% (n = 33) of patients. Reported symptoms included nausea/emesis in 35.5% (n = 32) and altered mental status in 40% (n = 36). Following admission, 94.4% of patients were discharged within 24 h of admission. Of the four patients (4.4%) that stayed longer than 24 h, only two hospitalizations were related to the concussion (inability to tolerate diet). One patient had a fever unrelated to the concussion and one stayed because of social issues. Average length of stay for these patients was 2.75 d (range 2-4 d). There was no difference in Glasgow coma scale in comparison to patients who were discharged within 24 h. Conclusions: Although there are a large number of pediatric patients evaluated in the ED for concussion injuries, very few of these patients require any further care. Our study suggests that patients with concussion and a negative head CT who tolerate a diet can be safely discharged home. (C) 2018 Published by Elsevier Inc.	[Lindholm, Erika B.; Meckmongkol, Teerin; Ciullo, Sean; Grewal, Harsh; Prasad, Rajeev; Arthur, L. Grier] St Christophers Hosp Children, Div Pediat Gen Thorac & Minimally Invas Surg, Philadelphia, PA 19133 USA; [D'Cruz, Roshan] Albert Einstein Coll Med, Dept Gen Surg, Philadelphia, PA USA; [Fajardo, Romulo] Temple Univ, Dept Gen Surg, Philadelphia, PA 19122 USA		Arthur, LG (corresponding author), St Christophers Hosp Children, Dept Pediat Surg, 160 East Erie Ave, Philadelphia, PA 19133 USA.	grier.arthur@americanacademic.com					Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; Collins MW, 2017, J PEDIATR SURG, V52, P16, DOI 10.1016/j.jpedsurg.2016.10.011; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Greenberg JK, 2017, JAMA PEDIATR, V171, P342, DOI 10.1001/jamapediatrics.2016.4520; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Marsh AM, 2013, J PEDIATR HEALTH CAR, V27, P499, DOI 10.1016/j.pedhc.2012.12.014; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Simma B, 2013, AM J EMERG MED, V31, P1133, DOI 10.1016/j.ajem.2013.04.007; Taylor AM, 2018, CLIN PEDIATR, V57, P806, DOI 10.1177/0009922817734363; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z	14	1	1	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2019	244						107	110		10.1016/j.jss.2018.09.040			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JG3EL	WOS:000491957000016	31279994				2022-02-06	
J	Linzey, JR; Burke, JF; Nadel, JL; Williamson, CA; Savastano, LE; Wilkinson, DA; Pandey, AS				Linzey, Joseph R.; Burke, James F.; Nadel, Jeffrey L.; Williamson, Craig A.; Savastano, Luis E.; Wilkinson, D. Andrew; Pandey, Aditya S.			Incidence of the initiation of comfort care immediately following emergent neurosurgical and endovascular procedures	JOURNAL OF NEUROSURGERY			English	Article						cerebrovascular pathology; comfort care; complications; emergent neurosurgery; end-of-life care; outcomes; surgical start time; vascular disorders	TRAUMATIC BRAIN-INJURY; OF-LIFE CARE; PALLIATIVE CARE; END; HEALTH; DEATH; NEUROONCOLOGY; STROKE; GUIDELINES; WITHDRAWAL	OBJECTIVE It is unknown what proportion of patients who undergo emergent neurosurgical procedures initiate comfort care (CC) measures shortly after the operation. The purpose of the present study was to analyze the proportion and predictive factors of patients who initiated CC measures within the same hospital admission after undergoing emergent neurosurgery. METHODS This retrospective cohort study included all adult patients who underwent emergent neurosurgical and endovascular procedures at a single center between 2009 and 2014. Primary and secondary outcomes were initiation of CC measures during the initial hospitalization and determination of predictive factors, respectively. RESULTS Of the 1295 operations, comfort care was initiated in 111 (8.6%) during the initial admission. On average, CC was initiated 9.3 +/- 10.0 days postoperatively. One-third of the patients switched to CC within 3 days. In multivariate analysis, patients > 70 years of age were significantly more likely to undergo CC than those < 50 years (70-79 years, p = 0.004; > 80 years, p = 0.0001). Two-thirds of CC patients had been admitted with a cerebrovascular pathology (p < 0.001). Admission diagnosis of cerebrovascular pathology was a significant predictor of initiating CC (p < 0.0001). A high Hunt and Hess grade of IV or V in patients with subarachnoid hemorrhage was significantly associated with initiation of CC compared to a low grade (27.1% vs 2.9%, p < 0.001). Surgery starting between 15:01 and 06:59 hours had a 1.70 times greater odds of initiating CC compared to surgery between 07:00 and 15:00. CONCLUSIONS Initiation of CC after emergent neurosurgical and endovascular procedures is relatively common, particularly when an elderly patient presents with a cerebrovascular pathology after typical operating hours.	[Linzey, Joseph R.; Nadel, Jeffrey L.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Burke, James F.; Williamson, Craig A.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Williamson, Craig A.; Savastano, Luis E.; Wilkinson, D. Andrew; Pandey, Aditya S.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI USA		Pandey, AS (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	adityap@med.umich.edu		Wilkinson, David/0000-0001-6395-7238	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1-TL1-TR-002242-01, NS-007222]	This study was supported by a TL1 Training Grant (J.R.L. and J.L.N.; 1-TL1-TR-002242-01) and an NS-007222 grant (D.A.W.), both from the National Institutes of Health.	Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Byrne RW, 2008, NEUROSURGERY, V62, P709, DOI 10.1227/01.neu.0000317320.79106.7e; Choi HA, 2015, NEUROCRIT CARE, V22, P423, DOI 10.1007/s12028-014-0073-x; Garrido MM, 2015, J PAIN SYMPTOM MANAG, V49, P828, DOI 10.1016/j.jpainsymman.2014.09.015; Geurts M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184894; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Guha R, 2017, NEUROLOGY, V89, P349, DOI 10.1212/WNL.0000000000004143; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Huynh TN, 2013, JAMA INTERN MED, V173, P1887, DOI 10.1001/jamainternmed.2013.10261; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Keehan SP, 2011, HEALTH AFFAIR, V30, P1594, DOI 10.1377/hlthaff.2011.0662; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Lewis A, 2016, NEUROCRIT CARE, V24, P481, DOI 10.1007/s12028-015-0209-7; Linzey JR, 2018, NEUROSURGERY, V83, P501, DOI 10.1093/neuros/nyx485; Miranda SP, 2018, AM J HOSP PALLIAT ME, V35, P804, DOI 10.1177/1049909117738996; Venturelli PM, 2017, AGE AGEING, V46, P329, DOI 10.1093/ageing/afw187; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Noh Thomas, 2018, Handb Clin Neurol, V149, P75, DOI 10.1016/B978-0-12-811161-1.00006-2; Pace A, 2017, LANCET ONCOL, V18, pE330, DOI 10.1016/S1470-2045(17)30345-5; Paratz ED, 2012, INTERN MED J, V42, P984, DOI 10.1111/j.1445-5994.2012.02790.x; Prabhakaran S, 2017, NEUROL-CLIN PRACT, V7, P194, DOI 10.1212/CPJ.0000000000000358; Quadri SZ, 2018, INTERN MED J, V48, P330, DOI 10.1111/imj.13619; Ramsey S, 2013, HEALTH AFFAIR, V32, P1143, DOI 10.1377/hlthaff.2012.1263; Rubin M, 2017, CURR OPIN CRIT CARE, V23, P134, DOI 10.1097/MCC.0000000000000396; Schaller C, 2006, J MED ETHICS, V32, P65, DOI 10.1136/jme.2005.011767; Sison J, 2017, CUREUS, V9, DOI 10.7759/cureus.1580; Souter M, 2010, CRIT CARE MED, V38, pS502, DOI 10.1097/CCM.0b013e3181ec5354; Tawil I, 2014, CRIT CARE MED, V42, P934, DOI 10.1097/CCM.0000000000000102; Tin M K, 1999, J Neurosci Nurs, V31, P348; Unterhofer C, 2018, NEUROSURG REV, V41, P183, DOI 10.1007/s10143-017-0833-0; Walbert T, 2016, NEURO-ONCOLOGY, V18, P7, DOI 10.1093/neuonc/nov241; Walbert T, 2014, NEURO-ONCOL PRACT, V1, P3, DOI 10.1093/nop/npt004; Walbert T, 2016, J NEURO-ONCOL, V126, P337, DOI 10.1007/s11060-015-1973-0; Walbert T, 2015, CANCER TREAT RES, V163, P171, DOI 10.1007/978-3-319-12048-5_11; Walbert T, 2014, J NEURO-ONCOL, V117, P217, DOI 10.1007/s11060-014-1393-6; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zahuranec DB, 2016, NEUROLOGY, V86, P1864, DOI 10.1212/WNL.0000000000002676	38	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2019	131	6					1725	1733		10.3171/2018.7.JNS181226			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4CC	WOS:000500253800006	30554183	Bronze			2022-02-06	
J	Powell, MR; Brown, AW; Klunk, D; Geske, JR; Krishnan, K; Green, C; Bergquist, TF				Powell, Matthew R.; Brown, Allen W.; Klunk, Danielle; Geske, Jennifer R.; Krishnan, Kamini; Green, Cassie; Bergquist, Thomas F.			Injury Severity and Depressive Symptoms in a Post-acute Brain Injury Rehabilitation Sample	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						Depression; Injury severity; Mild brain injury; Rehabilitation; Traumatic brain injury	COGNITIVE-BEHAVIORAL PREVENTION; PATIENT HEALTH QUESTIONNAIRE-9; IMPAIRED SELF-AWARENESS; OF-THE-LITERATURE; MAJOR DEPRESSION; POSTCONCUSSION SYNDROME; DIAGNOSIS THREAT; MINOR DEPRESSION; CLUSTER-ANALYSIS; HEAD-INJURY	This study explored the relationship between injury severity and depressive symptoms for treatment-seeking individuals with traumatic brain injury (TBI). The Mayo Classification System was used to classify TBI severity in 72 participants who completed the Patient Health Questionnaire at admission and at dismissal from rehabilitation. Patients with mild TBI reported more depressive symptoms than those with moderate or severe TBI at admission and at dismissal. Although injury severity groups differed by gender composition, gender had no effect on severity of depressive symptoms. All participants reported fewer depressive symptoms at dismissal from rehabilitation, including lower endorsement of dysphoria by discharge. Participants with mild TBI, however, continued to report depressive symptoms of a mild severity at dismissal, with residual problems with anhedonia. These findings underscore the benefit of interdisciplinary post-acute rehabilitation services for persons with TBI of any severity, including those with mild injury.	[Powell, Matthew R.; Krishnan, Kamini; Bergquist, Thomas F.] Mayo Clin, Dept Psychiat & Psychol, 200 First St SW, Rochester, MN 55905 USA; [Powell, Matthew R.; Brown, Allen W.; Klunk, Danielle; Bergquist, Thomas F.] Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA; [Geske, Jennifer R.] Mayo Clin, Div Biomed Stat & Informat, 200 First St SW, Rochester, MN 55905 USA; [Green, Cassie] Kirk Neurobehav Hlth, Louisville, CO USA; [Krishnan, Kamini] Cleveland Clin, Cleveland, OH 44106 USA		Powell, MR (corresponding author), Mayo Clin, Dept Psychiat & Psychol, 200 First St SW, Rochester, MN 55905 USA.; Powell, MR (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	powell.matthew@mayo.edu					Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Belanger HG, 2009, CLIN NEUROPSYCHOL, V23, P570; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Bombardier CH, 2017, J HEAD TRAUMA REHAB, V32, P343, DOI 10.1097/HTR.0000000000000288; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CLARK DC, 1984, AM J PSYCHIAT, V141, P1216; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Deary V, 2007, CLIN PSYCHOL REV, V27, P781, DOI 10.1016/j.cpr.2007.07.002; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dimaggio G, 2017, PSYCHOTHERAPY, V54, P221, DOI 10.1037/pst0000117; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Ernst J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205160; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Ferguson RJ, 1996, SOURCEBOOK PSYCHOL T, P615; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fuentes MM, 2019, J RACIAL ETHN HEALTH, V6, P335, DOI 10.1007/s40615-018-0529-3; Fuentes MM, 2017, ARCH PHYS MED REHAB, V98, P1763, DOI 10.1016/j.apmr.2016.12.013; Fuentes MM, 2016, J HEALTH CARE POOR U, V27, P1080, DOI 10.1353/hpu.2016.0143; Gauvin-Lepage J, 2019, J HEAD TRAUMA REHAB, V34, P96, DOI 10.1097/HTR.0000000000000402; Glintborg C, 2016, NEUROREHABILITATION, V38, P99, DOI 10.3233/NRE-161301; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lewis FD, 2017, NEUROREHABILITATION, V40, P401, DOI 10.3233/NRE-161427; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Fernandez EN, 2017, PSICOTHEMA, V29, P172, DOI 10.7334/psicothema2016.325; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Obermeyer Z, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5468; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2003, AM J GERIAT PSYCHIAT, V11, P365, DOI 10.1176/appi.ajgp.11.3.365; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Sacks Susan Bendersky, 2004, J Psychosoc Nurs Ment Health Serv, V42, P22; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schrader GD, 1997, COMPR PSYCHIAT, V38, P260, DOI 10.1016/S0010-440X(97)90057-2; Seidler ZE, 2018, AM J MENS HEALTH, V12, P1882, DOI 10.1177/1557988318792157; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Speicher SM, 2014, AM J OCCUP THER, V68, P412, DOI 10.5014/ajot.2014.011304; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Trontel HG, 2013, J CLIN EXP NEUROPSYC, V35, P960, DOI 10.1080/13803395.2013.844770; van Dongen CH, 2018, J OCCUP REHABIL, V28, P523, DOI 10.1007/s10926-017-9738-6; Vetter PH, 2000, PSYCHOTHER RES, V10, P159, DOI 10.1080/713663672; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563	89	1	2	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583	1573-3572		J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	DEC	2019	26	4					470	482		10.1007/s10880-019-09602-w			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	JM2CA	WOS:000496027200010	30690670				2022-02-06	
J	Pradhan, GN; Bogle, JM; Cevette, MJ; Stepanek, J				Pradhan, Gaurav N.; Bogle, Jamie M.; Cevette, Michael J.; Stepanek, Jan			Discovering Oculometric Patterns to Detect Cognitive Performance Changes in Healthy Youth Football Athletes	JOURNAL OF HEALTHCARE INFORMATICS RESEARCH			English	Article						Cognitive performance; Oculometrics; Concussion; Eye tracking; Multidimensional patterns; Pre- and post-season	KING-DEVICK TEST; EYE-MOVEMENTS; CONCUSSION; AGE; BALANCE; IMPAIRMENT; CHILDREN; HYPOXIA; VISION	In this paper, we focus on the application of oculometric patterns extracted from raw eye movements during a mental workload task to assess changes in cognitive performance in healthy youth athletes over the course of a typical sport season. Oculometric features pertaining to fixations and saccades were measured on 116 athletes in pre- and post-season testing. Participants were between 7 and 14 years of age at pre-season testing. Due to varied developmental rates, there were large interindividual performance differences during a mental workload task consisting of reading numbers. Based on different reading speeds, we classified three profiles (slow, moderate, and fast) and established their corresponding baselines for oculometric data. Within each profile, we describe changes in oculomotor function based on changes in cognitive performance during the season. To visualize these changes in multidimensional oculometric data, we also present a multidimensional visualization tool named DiViTo (diagnostic visualization tool). These experimental, computational informatics and visualization methodologies may serve to utilize oculometric information to detect changes in cognitive performance due to mild or severe cognitive impairment such as concussion/mild traumatic brain injury, as well as possibly other disorders such as attention deficit hyperactivity disorders, learning/reading disabilities, impairment of alertness, and neurocognitive function.	[Pradhan, Gaurav N.; Bogle, Jamie M.; Cevette, Michael J.; Stepanek, Jan] Mayo Clin Arizona, Aerosp Med & Vestibular Res Lab, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA		Pradhan, GN (corresponding author), Mayo Clin Arizona, Aerosp Med & Vestibular Res Lab, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	pradhan.gaurav@mayo.edu					Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Fischer TD, 2016, J NEUROTRAUM, V33, P1237, DOI 10.1089/neu.2015.3990; Fu H, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/7831469; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Pradhan GN, 2017, J HEALTHC INFORM RES, P1; Risen SR, 2017, PM&R, V9, P874, DOI 10.1016/j.pmrj.2016.12.005; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Salman MS, 2006, VISION RES, V46, P1432, DOI 10.1016/j.visres.2005.06.011; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stepanek J, 2014, AVIAT SPACE ENVIR MD, V85, P700, DOI 10.3357/ASEM.3645.2014; Stepanek J, 2013, AVIAT SPACE ENVIR MD, V84, P1017, DOI 10.3357/ASEM.3616.2013; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Weise KK., 2016, OPTOM VIS SCI, V93	36	1	1	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2509-4971	2509-498X		J HEALTHC INFORM RES	J. Healthc. Inform. Res.	DEC	2019	3	4					371	392		10.1007/s41666-019-00045-4			22	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Emerging Sources Citation Index (ESCI)	Computer Science; Health Care Sciences & Services; Medical Informatics	WE3CE	WOS:000705500200001					2022-02-06	
J	Rael, LT; Bar-Or, R; Banton, KL; Mains, CW; Madayag, RM; Marshall, GT; Tanner, IIA; Waxman, M; Acuna, DL; Bar-Or, D				Rael, Leonard T.; Bar-Or, Raphael; Banton, Kaysie L.; Mains, Charles W.; Madayag, Robert M.; Marshall, Gary T.; Tanner, I. I. Allen; Waxman, Michael; Acuna, David L.; Bar-Or, David			The presence of S-sulfonated transthyretin in commercial human serum albumin solutions: Potential contribution to neuropathy	CLINICA CHIMICA ACTA			English	Article						Albumin; Transthyretin; Amyloidosis; Proteomics; Neuropathy	PROTEIN; RESUSCITATION; OXIDATION; SULFITE	Background: Commercial solutions of human serum albumin (HSA) are administered to critically ill patients for the treatment of shock, restoration of blood volume, and the acute management of burns. Previously, conflicting results on the effects of HSA administration have been reported varying from a favorable increase in total plasma antioxidant capacity to a higher mortality rate in traumatic brain injury (TBI) patients. These results could be partially explained due to the known heterogeneity of HSA solutions. We report the discovery of S-sulfonated human transthyretin (hTTR) in HSA solutions. Methods: Proteomics was performed on commercially available solutions of 5% HSA by LC-MS analysis. The MS charge envelope for hTTR was deconvolved to the uncharged native hTTR parent mass (13,762 Da). The parent mass was then integrated, and relative proportions of the 2 major species of hTTR, native and S-sulfonated hTTR (13,842 Da), were calculated. Results: The majority of hTTR found in 5% commercial HSA solutions is in the S-sulfonated form regardless of the age of the HSA solution. S-sulfonation of hTTR at the free cysteine residue in position 10 appears to be the result of a mixed disulfide exchange possibly with S-cysteinylated hTTR or S-cysteinylated HSA. hTTR is a tetramer composed of four identical monomers each containing a reduced cysteine residue in position 10. S-sulfonation of hTTR at this cysteine residue can destabilize the hTTR tetramer, an important step in the formation of TTR-related amyloid fibrils. Conclusions: Administration of a commercial HSA solution that already contains S-sulfonated hTTR could potentially contribute to the development of amyloid-related/polyneuropathy in the critically ill.	[Rael, Leonard T.; Bar-Or, Raphael; Banton, Kaysie L.; Bar-Or, David] Swedish Med Ctr, Englewood, CO 80110 USA; [Rael, Leonard T.; Bar-Or, Raphael; Banton, Kaysie L.; Mains, Charles W.; Bar-Or, David] Rocky Vista Univ, Parker, CO USA; [Rael, Leonard T.; Bar-Or, Raphael; Mains, Charles W.; Madayag, Robert M.; Bar-Or, David] St Anthony Hosp, Lakewood, CO USA; [Rael, Leonard T.; Bar-Or, Raphael; Marshall, Gary T.; Bar-Or, David] Med City Plano, Plano, TX USA; [Rael, Leonard T.; Bar-Or, Raphael; Tanner, I. I. Allen; Bar-Or, David] Penrose Community Hosp, Colorado Springs, CO USA; [Rael, Leonard T.; Bar-Or, Raphael; Waxman, Michael; Bar-Or, David] Res Med Ctr, Kansas City, MO USA; [Acuna, David L.; Bar-Or, David] Wesley Med Ctr, Wichita, KS USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res, 501 E Hampden Ave,Rm 4-454, Englewood, CO 80113 USA.	davidbme49@gmail.com	Bar-Or, David/AAE-9328-2020				Altland K, 1999, NEUROGENETICS, V2, P183, DOI 10.1007/s100480050081; BAILEY JL, 1959, J BIOL CHEM, V234, P1733; Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Finn TE, 2012, J BIOL CHEM, V287, P21530, DOI 10.1074/jbc.M112.372961; Fong VH, 2013, NEURODEGENER DIS, V11, P42, DOI 10.1159/000338153; Gales L, 2007, BBA-PROTEINS PROTEOM, V1774, P59, DOI 10.1016/j.bbapap.2006.10.015; Gay M, 2010, PROTEOMICS, V10, P172, DOI 10.1002/pmic.200900182; Gericke B, 2007, BIOMARK INSIGHTS, V2, P299; Herl L, 2009, MOL CELL NEUROSCI, V41, P166, DOI 10.1016/j.mcn.2009.02.008; KANDA Y, 1974, J BIOL CHEM, V249, P6796; Kingsbury JS, 2008, J BIOL CHEM, V283, P11887, DOI 10.1074/jbc.M709638200; Kishikawa M, 2000, Rinsho Byori, V48, P430; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nakanishi T, 2010, BBA-PROTEINS PROTEOM, V1804, P1449, DOI 10.1016/j.bbapap.2010.03.010; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sharma M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00005; Vieira Marta, 2014, Biomol Concepts, V5, P45, DOI 10.1515/bmc-2013-0038; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Yoshioka Masanori, 2008, Rinsho Byori, V56, P425; Zhang QH, 2003, BIOCHEMISTRY-US, V42, P8756, DOI 10.1021/bi030077a	25	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	DEC	2019	499						70	74		10.1016/j.cca.2019.08.034			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	JS5YZ	WOS:000500383600010	31479652				2022-02-06	
J	Ricciardi, JN; Bouchard, SW; Luiselli, JK; Dould, T				Ricciardi, Joseph N.; Bouchard, Sonya Woelfel; Luiselli, James K.; Dould, Trudy			Integrated Behavioral Intervention and Person-Centered Therapy Within Community-Based Treatment of an Adult With Acquired Brain Injury	CLINICAL CASE STUDIES			English	Article						acquired brain injury; applied behavior analysis; behavioral neurorehabilitation; person-centered therapy; traumatic brain injury	REHABILITATION; VALIDITY	We present the case of a 30-year-old woman who had acquired brain injury (ABI) and demonstrated clinically challenging behaviors (verbally abusive outbursts toward care providers and elopement) within her community-based group home. Following a baseline phase of evaluation, she collaborated with clinicians and care providers in developing a treatment plan that included personal goal setting, differential token reinforcement, communication training, graphic performance feedback, and reinforcement fading. During 10 months of intervention, clinically challenging behaviors steadily decreased from baseline levels and low-frequency occurrence was maintained at 3-, 6-, and 9-month follow-up assessments. As the result of treatment, the woman also avoided prior psychiatric hospitalizations, enjoyed more frequent access to pleasurable activities outside her residence, and enrolled in a college course. The study illustrates an effective person-centered therapy approach combined with behavioral intervention for persons who have ABI and experience community-living adjustment difficulties.	[Ricciardi, Joseph N.; Bouchard, Sonya Woelfel; Dould, Trudy] Seven Hills Fdn, Worcester, MA 01603 USA; [Luiselli, James K.] Melmark New England, Clin Dev & Res, Andover, MA USA		Ricciardi, JN (corresponding author), Seven Hills Fdn, Seven Hills NeuroCare, Clin Serv, 81 Hope Ave, Worcester, MA 01603 USA.	jricciardi@sevenhills.org		Luiselli, James/0000-0001-6989-9155			Alderman N, 2013, NEUROREHABILITATION, V32, P761, DOI 10.3233/NRE-130900; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Call N. A., 2017, APPL BEHAV ANAL ADV, P41, DOI DOI 10.1016/B978-0-12-811122-2.00003-6; Castro EM, 2016, PATIENT EDUC COUNS, V99, P1923, DOI 10.1016/j.pec.2016.07.026; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Chambless DL, 2001, ANNU REV PSYCHOL, V52, P685, DOI 10.1146/annurev.psych.52.1.685; Clark-Wilson J, 2014, BRAIN INJURY, V28, P1646, DOI 10.3109/02699052.2014.946449; Faul M, 2010, TRAUMATIC BRAIN INJU; Field C, 2004, CLIN CASE STUD, V3, P25, DOI DOI 10.1177/1534650103258967; Flood WA, 2016, CLIN CASE STUD, V15, P476, DOI 10.1177/1534650116670512; Franklin G., 2004, CLIN PRACTICE GUIDEL; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Hagermoser Sanetti L. M., 2014, TREATMENT INTEGRITY; Haskins E.C., 2012, COGNITIVE REHABILITA; Hayes I, 2018, MOUVEMENT SOC, P3; Heinicke MR, 2014, BEHAV INTERVENT, V29, P77, DOI 10.1002/bin.1380; Heward J, 2007, APPL BEHAV ANAL; Iwata BA, 2013, J APPL BEHAV ANAL, V46, P271, DOI 10.1002/jaba.31; Kazdin AE., 2011, SINGLE CASE RES DESI; Kelly G, 2019, NEUROPSYCHOL REHABIL, V29, P704, DOI 10.1080/09602011.2017.1322523; Kolakowsky-Hayner S., 2016, ESSENTIAL BRAIN INJU, V5th; Lennox D., 2011, HDB HIGH RISK CHALLE, P271; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Parsons MB, 2012, BEHAV ANAL PRACT, V5, P2; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rahman B, 2013, NEUROPSYCHOL REHABIL, V23, P501, DOI 10.1080/09602011.2013.787938; Shogren KA, 2017, SPR SER CHILD FAM ST, P49, DOI 10.1007/978-3-319-59066-0_5; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Snodgrass MR, 2018, RES DEV DISABIL, V74, P160, DOI 10.1016/j.ridd.2018.01.007; Tursi MM, 2006, J COUNS DEV, V84, P387, DOI 10.1002/j.1556-6678.2006.tb00421.x; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Woodhead E. L., 2008, CLIN CASE STUD, V7, P301; World Health Organization [WHO], 2018, INT STAT CLASS DIS R; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	36	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-6501	1552-3802		CLIN CASE STUD	Clin. Case Stud.	APR	2020	19	2					133	144	1534650119890925	10.1177/1534650119890925		DEC 2019	12	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	KI9FF	WOS:000500125500001					2022-02-06	
J	Rosyidi, RM; Priyanto, B; Laraswati, NKP; Islam, AA; Hatta, M; Bukhari, A; Kamil, M; Wardhana, DPW				Rosyidi, Rohadi Muhammad; Priyanto, Bambang; Laraswati, Ni Komang Putri; Islam, Andi Asadul; Hatta, Mochammad; Bukhari, Agussalim; Kamil, Muhammad; Wardhana, D. P. Wisnu			Characteristics and clinical outcome of traumatic brain injury in Lombok, Indonesia	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Traumatic brain injury; Outcome prediction factors of TBI; CT Marshall classification		Background: Traumatic brain injury (TBI) has risen sharply, mainly due to increased use of motorized vehicles in countries with low and middle income. Traffic accidents are the main cause of TBI (60%) followed by falls (20%-25%) and violence (10%). Computed tomography (CT) is recommended for initial assessment in emergency services. Not only provides information and diagnosis to identify surgical needs, but also helps in evaluating patients and outcomes. Method: A retrospective study conducted using medical record data of neurosurgery patients who met the inclusion criteria in West Nusa Tenggara General Hospital in 2015 until 2017. The sample size is determined by consecutive sampling method. Result: Sample size was 209 patients. Male patients more common than female (78.95%). The highest age group at 21-30 years (21.53%) with average age was 31.66 years old. The initial median GCS was 10 points. The most common cause was motor vehicle accidents (MVA) with 176 cases (84.21%). The highest mortality rate was found in the severe brain injury group with 31 patients (14.83%). Average duration of treatment were 7.58 days. Conclusion: There was a significant relationship between age, initial GCS value, mortality rate, and length of stay for TBI patients with outcome predictions based on CT Marshall classification.	[Rosyidi, Rohadi Muhammad; Priyanto, Bambang; Islam, Andi Asadul; Hatta, Mochammad; Bukhari, Agussalim] Hasanuddin Univ, Med Fac, Makassar, Indonesia; [Rosyidi, Rohadi Muhammad; Priyanto, Bambang] Mataram Univ, West Nusa Tenggara Provience Gen Hosp, Med Fac, Dept Neurosurg, Mataram, Indonesia; [Laraswati, Ni Komang Putri] Mataram Univ, Med Fac, Mataram, Indonesia; [Kamil, Muhammad] Airlangga Univ, Med Fac, Dept Neurosurg, Surabaya, Indonesia; [Wardhana, D. P. Wisnu] Udayana Univ, Med Fac, Dept Neurosurg, Bali, Indonesia		Rosyidi, RM (corresponding author), Mataram Univ, West Nusa Tenggara Provience Gen Hosp, Med Fac, Dept Neurosurg, Mataram, Indonesia.	rha.ns2010@gmail.com	Rosyidi, Rohadi Muhammad/AAC-9249-2021; kamil, muhammad/AAT-2120-2020; Hatta, Mochammad/D-3742-2019; Wardhana, Dewa Putu Wisnu/X-6656-2019	kamil, muhammad/0000-0001-7356-5705; Hatta, Mochammad/0000-0002-8456-4203; Wardhana, Dewa Putu Wisnu/0000-0001-9934-9859; Bukhari, Agussalim/0000-0002-6340-8615			Banks Jamie L, LIT REV SYNTHESIS, V38, DOI [10.1161/01.str.0000258355.23810.c6, DOI 10.1161/01.STR.0000258355.23810.C6]; Bartlomiej Kulesza, 2015, PROGNOSTIC FACTORS T, V9; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Joni Wahyudi, 2014, GUIDELINES MANAGEMEN, P15; Kodeeswaran Marappan, 2017, FACTORS INFLUENCING, V14, P207; Kumar Verma Saurabh, 2017, EARLY INDICATORS PRO, V16; Leonidas Grigorakos, 2016, J NEUROSCI CLIN RES, V1; Maria L. Rawis, 2016, PROFILE PATIENTS MOD, V4; Miller Kelly J., J NEUROSURG, V103, P239; Randall M. Chesnut, 2000, EARLY INDICATORS PRO; Raza S, 2012, CASE-BASED NEUROLOGY, P45; Richard Winn H., 2011, YOUMANS NEUROLOGICAL, V4, P3267; Rincon-Guio Cristian, 2017, ROLE COMPUTED TOMOGR, V9; Rosyidi RM, 2019, INTERDISCIP NEUROSUR, V17, P12, DOI 10.1016/j.inat.2019.01.021; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102	16	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2019	18								100470	10.1016/j.inat.2019.04.015			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	JR2XW	WOS:000499495300042		gold			2022-02-06	
J	Sengupta, SK; Bhatoe, HS				Sengupta, Sudip Kumar; Bhatoe, Harjinder Singh			Cortical Pressure Injury: A Hypothesis to Explain the Incongruity of Clinical and Radiologic Improvement in Decompressive Craniectomy	INDIAN JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; cortical pressure injury; hypothesis	TRAUMATIC BRAIN-INJURY; ICP	It has astonished neuroscientists since the advent of decompressive craniectomy as to why a seemingly successfully achieved goal of reduction in intracranial pressure (ICP), by removing a portion of the cranial vault and the resultant intracranial volume augmentation, fails to give the desired beneficial clinical outcome in every case and in fact, at times, proves to be deleterious in some conditions with a shared problem of refractory raised ICP. The authors propose a hypothesis based on the understanding of the anatomy and physiology of the brain that can explain the fallacy.	[Sengupta, Sudip Kumar] Command Hosp Eastern Command, Dept Neurosurg, Alipore Rd, Kolkata 700061, W Bengal, India; [Bhatoe, Harjinder Singh] Fortis Hosp Noida, Dept Neurosurg, New Delhi, India		Sengupta, SK (corresponding author), Command Hosp Eastern Command, Dept Neurosurg, Alipore Rd, Kolkata 700061, W Bengal, India.	sudipkumarsengupta14@rediffmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bhat AR, 2011, INDIAN J NEUROTRAUM, V8, P105, DOI 10.1016/S0973-0508(11)80009-2; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perin A, 2008, ACTA NEUROCHIR, V150, P837, DOI 10.1007/s00701-008-1596-8; Schneider GH, 2002, ACT NEUR S, V81, P77; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zuurbier SM, 2012, J NEUROL, V259, P1099, DOI 10.1007/s00415-011-6307-3	15	1	1	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	2277-954X	2277-9167		INDIAN J NEUROSURG	Indian J. Neurosurg.	DEC	2019	8	3					188	190		10.1055/s-0039-1697727			3	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	JT3ZQ	WOS:000500931700008		gold			2022-02-06	
J	Tonetti, DA; Ares, WJ; Okonkwo, DO; Gardner, PA				Tonetti, Daniel A.; Ares, William J.; Okonkwo, David O.; Gardner, Paul A.			Management and outcomes of isolated interhemispheric subdural hematomas associated with falx syndrome	JOURNAL OF NEUROSURGERY			English	Article						interhemispheric subdural hematomas; falx syndrome; neurotrauma; trauma	HEMIPARESIS; SHIFT	OBJECTIVE Large interhemispheric subdural hematomas (iSDHs) causing falx syndrome are rare; therefore, a paucity of data exists regarding the outcomes of contemporary management of iSDH. There is a general consensus among neurosurgeons that large iSDHs with neurological deficits represent a particular treatment challenge with generally poor outcomes. Thus, radiological and clinical outcomes of surgical and nonsurgical management for iSDH bear further study, which is the aim of this report. METHODS A prospectively collected, single-institution trauma database was searched for patients with isolated traumatic iSDH causing falx syndrome in the period from January 2008 to January 2018. Information on demographic and radiological characteristics, serial neurological examinations, clinical and radiological outcomes, and posttreatment complications was collected and tallied. The authors subsequently dichotomized patients by management strategy to evaluate clinical outcome and 30-day survival. RESULTS Twenty-five patients (0.4% of those with intracranial injuries, 0.05% of those with trauma) with iSDH and falx syndrome represented the study cohort. The average age was 73.4 years, and most patients (23 [92%] of 25) were taking anticoagulants or antiplatelet medications. Six patients were managed nonoperatively, and 19 patients underwent craniotomy for iSDH evacuation; of the latter patients, 17 (89.5%) had improvement in or resolution of motor deficits postoperatively. There were no instances of venous infarction, reaccumulation, or infection after evacuation. In total, 9 (36%) of the 25 patients died within 30 days, including 6 (32%) of the 19 who had undergone craniotomy and 3 (50%) of the 6 who had been managed nonoperatively. Patients who died within 30 days were significantly more likely to experience in-hospital neurological deterioration prior to surgery (83% vs 15%, p = 0.0095) and to be comatose prior to surgery (100% vs 23%, p = 0.0031). The median modified Rankin Scale score of surgical patients who survived hospitalization (13 patients) was 1 at a mean follow-up of 22.1 months. CONCLUSIONS iSDHs associated with falx syndrome can be evacuated safely and effectively, and prompt surgical evacuation prior to neurological deterioration can improve outcomes. In this study, craniotomy for iSDH evacuation proved to be a low-risk strategy that was associated with generally good outcomes, though appropriately selected patients may fare well without evacuation.	[Tonetti, Daniel A.; Ares, William J.; Okonkwo, David O.; Gardner, Paul A.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Tonetti, DA (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.		Tonetti, Daniel/AAB-1158-2020				Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; IKEDA K, 1990, SURG NEUROL, V33, P87, DOI 10.1016/0090-3019(90)90017-J; Jukovic MF, 2015, SRP ARK CELOK LEK, V143, P386, DOI 10.2298/SARH1508386J; Moon KS, 2007, J CLIN NEUROSCI, V14, P989, DOI 10.1016/j.jocn.2006.05.016; Naqvi U, 2018, STATPEARLS; Oh SI, 2013, CAN J NEUROL SCI, V40, P601, DOI 10.1017/S031716710001475X; Sucu HK, 2006, SURG NEUROL, V66, P178, DOI 10.1016/j.surneu.2005.12.036; Tomita Y, 2018, WORLD NEUROSURG, V119, pE518, DOI 10.1016/j.wneu.2018.07.192; VanHavenbergh T, 1996, BRIT J NEUROSURG, V10, P35	9	1	1	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2019	131	6					1920	1930		10.3171/2018.8.JNS181812			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4CC	WOS:000500253800029	30641843				2022-02-06	
J	Weppner, J; Linsenmeyer, M; Ide, W				Weppner, Justin; Linsenmeyer, Mark; Ide, William			Military Blast-Related Traumatic Brain Injury	CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS			English	Article						Blast-induced neurotrauma; Blast injuries; Blast traumatic brain injury; bTBI; Post-traumatic stress disorder; Military traumatic brain injury		Purpose of ReviewThis paper aims to review and discuss the epidemiological, neuropathologic, and mechanistic characteristics of blast traumatic brain injury (bTBI) specific to the military population.Recent FindingsMilitary service members have sustained over 383,000 reported incidents of TBI since 2000. In combat, mild bTBI due to explosive attacks comprise the most common type. Identification, treatment, and reporting of bTBI are compounded by the operational demands of combat as well as frequent co-presentation with PTSD and associated injuries. Following primary injury, a secondary metabolic and inflammatory cascade in bTBI leads to an array of symptoms and impairments. Development of screening batteries, sensors, and laboratory assays has sought to advance evaluation and management.SummarybTBI is a widespread, though underreported, injury in service members with significant neurological and cognitive impacts. The highly prevalent traumatic and psychiatric comorbidities incurred in combat must be considered in the approach to management. Further research is needed to improve bTBI detection and facilitate prognosis.	[Weppner, Justin; Linsenmeyer, Mark] Univ Pittsburgh, Med Ctr, Kaufman Med Bldg,Suite 201,3471 Fifth Ave, Pittsburgh, PA 15213 USA; [Ide, William] Univ Virginia Hlth Syst, Charlottesville, VA USA		Weppner, J (corresponding author), Univ Pittsburgh, Med Ctr, Kaufman Med Bldg,Suite 201,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	cdvfdrs@gmail.com					[Anonymous], IED ATTACK FACT SHEE; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Betthauser LM, 2018, J HEAD TRAUMA REHAB, V33, P91, DOI 10.1097/HTR.0000000000000376; Brenner Lisa A, 2012, Front Neurol, V3, P31, DOI 10.3389/fneur.2012.00031; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak Ibolja, 1995, Magnesium Research, V8, P249; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; (DVBIC) DaVBIC, 2018, TOT 2000 2018 Q1 DOD TOT 2000 2018 Q1 DOD; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Finlay SE, 2012, PREHOSP DISASTER MED, V27, P385, DOI 10.1017/S1049023X12000891; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Jagade MV, 2008, INDIAN J OTOLARYNGOL, V60, P324, DOI 10.1007/s12070-008-0110-1; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; KERR AG, 1975, J LARYNGOL OTOL, V89, P131, DOI 10.1017/S002221510008018X; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu B, 2015, MIL MED, V180, P195, DOI 10.7205/MILMED-D-14-00455; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mader TH, 2006, OPHTHALMOLOGY, V113, P97, DOI 10.1016/j.ophtha.2005.07.018; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ohnishi M, 2001, EXP PHYSIOL, V86, P357, DOI 10.1113/eph8602145; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PAHOR AL, 1981, J LARYNGOL OTOL, V95, P399, DOI 10.1017/S0022215100090873; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Samson K, 2018, NEUROL TODAY, P12; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Tanielian TL, 2008, INVISIBLE WOUNDS WAR, Vxi, P52; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thach AB, 2008, OPHTHALMOLOGY, V115, P377, DOI 10.1016/j.ophtha.2007.04.032; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vaughan CA, 2014, PSYCHIAT SERV, V65, P833, DOI 10.1176/appi.ps.201300111; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Westrol MS, 2017, ANN EMERG MED, V69, pS4, DOI 10.1016/j.annemergmed.2016.09.005; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	88	1	1	7	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4833		CURR PHYS MED REHAB	Curr. Phys. Med. Rehabil. Rep.	DEC	2019	7	4					323	332		10.1007/s40141-019-00241-8			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VK2QF	WOS:000670357000004					2022-02-06	
J	Zhai, XH; Xiao, J; Yu, JK; Sun, H; Zheng, S				Zhai, Xiao-Hui; Xiao, Jian; Yu, Jie-Kai; Sun, Hong; Zheng, Shu			Novel sphingomyelin biomarkers for brain glioma and associated regulation research on the PI3K/Akt signaling pathway	ONCOLOGY LETTERS			English	Article						glioma; matrix assisted laser desorption; ionization-imaging; lipid biomarkers; sphingomyelin; PI3K; Akt signaling pathway	MASS-SPECTROMETRY; TUMOR; TISSUE; PROLIFERATION; RECEPTOR; GROWTH; CELLS	Glioma is one of the most common malignant tumor types of the central nervous system. It is necessary to identify biomarkers and novel therapeutic targets for glioma. The purpose of the present study was to distinguish lipid biomarkers with differential expression patterns in glioma tissues and normal brain tissues by matrix assisted laser desorption/ionization (MALDI)-imaging and MALDI-time of flight (TOF)-mass spectrometry (MS). Additionally, identification of lipid biomarkers was performed to describe novel therapeutic targets for glioma treatment. A total of six tissues from three patients with glioma and three control patients with traumatic brain injury were analyzed using UltrafleXtreme MALDI-TOF/TOF. The expression levels of 15 lipid peaks were higher in the TBT samples compared with in the GBT samples. The expression levels of another 16 lipid peaks were higher in the GBT samples compared with in the TBT samples. 14 peaks were identified as sphingomyelins using MS/MS. Additional results were also obtained from experiments using the glioma cell line U373-MG. These results indicated that treatment with the drug desipramine (Desi) inhibited the accumulation of ceramide on the cell membranes of glioma U373-MG cells. Treatment with Desi inhibited the activation of insulin-like growth factor-1 receptor and inhibited the activation of proteins in the PI3K/Akt signaling pathway.	[Zhai, Xiao-Hui; Xiao, Jian] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China; [Zhai, Xiao-Hui; Yu, Jie-Kai; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Sun, Hong] Univ Nevada, Dept Chem & Biochem, Las Vegas, NV 89135 USA		Zhai, XH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China.; Zheng, S (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Canc Inst, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zhaixh@zju.edu.cn; zhengshu@zju.edu.cn		Sun, Hong/0000-0003-2100-1451	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30901731]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2016A030310187]	This work was supported by the National Natural Science Foundation of China (grant no. 30901731) and the Natural Science Foundation of Guangdong Province (grant no. 2016A030310187).	Arun S, 2017, J NEURO-ONCOL, V135, P473, DOI 10.1007/s11060-017-2608-4; Buczkowicz P, 2014, ACTA NEUROPATHOL, V128, P573, DOI 10.1007/s00401-014-1319-6; Catapano ER, 2017, ADV COLLOID INTERFAC, V247, P555, DOI 10.1016/j.cis.2017.07.014; Eberlin LS, 2011, ANAL CHEM, V83, P8366, DOI 10.1021/ac202016x; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Hayashi T, 2018, NEUROPATHOLOGY, V38, P144, DOI 10.1111/neup.12446; Iwadate Y, 2004, CANCER RES, V64, P2496, DOI 10.1158/0008-5472.CAN-03-1254; Krafft C, 2004, ANALYST, V129, P921, DOI 10.1039/b408934k; Li JQ, 2017, ONCOL REP, V38, P183, DOI 10.3892/or.2017.5647; Lian HW, 2014, ASIAN PAC J CANCER P, V15, P10181, DOI 10.7314/APJCP.2014.15.23.10181; Liao YX, 2018, CELL PHYSIOL BIOCHEM, V48, P1382, DOI 10.1159/000492096; Lin ML, 2018, FEBS J, V285, P3835, DOI 10.1111/febs.14635; Miller JJ, 2016, EXPERT OPIN EMERG DR, V21, P441, DOI 10.1080/14728214.2016.1257609; Nicoletti NF, 2014, J NEURO-ONCOL, V120, P235, DOI 10.1007/s11060-014-1549-4; Ohashi R, 2014, ONCOL REP, V32, P1163, DOI 10.3892/or.2014.3283; Ribom D, 2003, TUMOR BIOL, V24, P94, DOI 10.1159/000071082; Scheidegger R, 2014, NEUROIMAGE, V99, P256, DOI 10.1016/j.neuroimage.2014.05.036; Schwartz M, 2015, ANAL BIOANAL CHEM, V407, P2255, DOI 10.1007/s00216-014-8356-9; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Shrivas K, 2010, ANAL CHEM, V82, P8800, DOI 10.1021/ac102422b; Su L, 2018, ONCOL REP, V40, P2233, DOI 10.3892/or.2018.6592; Suh CH, 2018, EUR RADIOL, V28, P3819, DOI 10.1007/s00330-018-5335-0; Tan J, 2018, J PATHOL, V245, P160, DOI 10.1002/path.5062; Wildburger NC, 2015, J PROTEOME RES, V14, P2511, DOI 10.1021/acs.jproteome.5b00076; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Yun DP, 2018, ONCOL REP, V39, P1011, DOI 10.3892/or.2018.6225; Zhang J, 2017, ONCOTARGET, V8, P36824, DOI 10.18632/oncotarget.15975; Zhou L, 2006, NEUROSCI LETT, V401, P59, DOI 10.1016/j.neulet.2006.02.080; Zhou Q, 2015, MOL MED REP, V12, P3381, DOI 10.3892/mmr.2015.3869	29	1	1	2	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	DEC	2019	18	6					6207	6213		10.3892/ol.2019.10946			7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	KA1RN	WOS:000505576300059	31788096	Green Published, gold, Green Submitted			2022-02-06	
J	Whyte, T; Kent, N; Keay, L; Coxon, K; Brown, J				Whyte, Tom; Kent, Nicholas; Keay, Lisa; Coxon, Kristy; Brown, Julie			Frontal crash seat belt restraint effectiveness and comfort accessories used by older occupants	TRAFFIC INJURY PREVENTION			English	Article						Seat belt; restraint; older occupant; comfort; accessory		Objective: Around a quarter of older occupants use some type of comfort or orthopedic aftermarket accessory on the vehicle seat while traveling in a vehicle. The aim of this study was to investigate the effect of comfort accessories on the performance of the seat belt restraint system in a frontal crash in terms of potential injury implications for older occupants. Methods: Eight frontal sled tests (43 km/h, 32 g) were carried out on a deceleration sled fitted with a three-point lap-sash seat belt and a front passenger seat from a common Australian passenger car for each test. A 5(th) percentile Hybrid III anthropometric test device (ATD) was positioned in the seat and measurements were recorded for head center of gravity acceleration, chest acceleration, neck forces and moments and sternal deflection. Tests were carried out in a baseline condition and with seven comfort accessories. Each comfort accessory was inserted between the ATD and vehicle seat as it is intended to be used, with the ATD otherwise positioned as close as possible to the baseline test position. Results: Initial distance between the seat belt anchor and ATD hip was associated with a statistically significant decrease in Head Injury Criterion and increase in sternal deflection. Submarining was related to the ATD torso recline angle and angle of the lap belt from the seat belt anchor. Conclusions: Accessories placed between the seat back and the lumbar region of an occupant have the potential to increase the risk of submarining due to a change in posture and should be avoided if such a change in posture when seated with an accessory is excessive. Sitting on seat cushions resulted in the greatest increase in seat belt anchor to hip distances and hence largest increase in sternal deflection. Given the fragility, frailty and particular importance of chest injuries among older vehicle occupants, further investigation is needed to determine whether these changes in ATD sternal deflection observed with seat cushion use results in injury threshold limits being exceeded and whether pretensioners and load limiters would ameliorate these effects without causing other negative changes in occupant response or kinematics.	[Whyte, Tom; Kent, Nicholas; Brown, Julie] Neurosci Res Australia, Margarete Ainsworth Bldg,Barker St, Randwick, NSW 2031, Australia; [Whyte, Tom; Brown, Julie] UNSW, Fac Med, Sydney, NSW, Australia; [Keay, Lisa] UNSW, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Keay, Lisa; Coxon, Kristy; Brown, Julie] George Inst Global Hlth, Newtown, NSW, Australia; [Coxon, Kristy] Western Sydney Univ, THRI, Sch Sci & Hlth, Penrith, NSW, Australia		Whyte, T (corresponding author), Neurosci Res Australia, Margarete Ainsworth Bldg,Barker St, Randwick, NSW 2031, Australia.	t.whyte@neura.edu.au		Whyte, Tom/0000-0002-3562-3844; Brown, Julie/0000-0002-7284-0127; Coxon, Kristy/0000-0003-4820-0397	Ramaciotti Health Investment Grant [2017HIG0076]	This work was supported by a Ramaciotti Health Investment Grant [2017HIG0076] and conducted at the Transurban Road Safety Center at Neuroscience Research Australia.	Beck B, 2011, TRAFFIC INJ PREV, V12, P54, DOI 10.1080/15389588.2010.523099; Coxon K, 2014, P 2014 AUSTR ROAD SA; Digges K, 2007, 51 ANN P ASS ADV AUT, P19; Digges K, 2013, 23 INT TECHN C ENH S, P11; Eby D.W., 2012, HAS TIME COME OLDER; Eppinger R., 1999, DEV IMPROVED INJURY; Fildes BN, 2008, TRAFFIC INJ PREV, V9, P387, DOI 10.1080/15389580802272435; Fong CK, 2016, TRAFFIC INJ PREV, V17, P142, DOI 10.1080/15389588.2015.1052420; Haland Y, 1991, P 13 INT TECHN C EXP; Herriotts P, 2005, APPL ERGON, V36, P255, DOI 10.1016/j.apergo.2005.01.002; Horsch J, 1989, STAPP CAR CRASH J, V98, P1847; ITARDA, 2014, INJ OLD PASS TRAFF A; Kent R, 2003, 47 ANN P ASS ADV AUT, P25; Kent R, 2009, ANN ADV AUTOMOT MED, V53, P10; Kent Richard, 2005, Stapp Car Crash J, V49, P231; Kent RW, 2007, INT J IMPACT ENG, V34, P1382, DOI 10.1016/j.ijimpeng.2006.07.002; Leung YC, 1979, COMP 572; Luet C, 2012, KINEMATICS DYNAMICS; Standards Australia Limited/Standards New Zealand, 2016, 17542013 ASNZS SAI G	19	1	1	3	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	JAN 2	2020	21	1					60	65		10.1080/15389588.2019.1690648		NOV 2019	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	KK3UL	WOS:000501433900001	31815527				2022-02-06	
J	Mucci, V; Meier, C; Bizzini, M; Romano, F; Agostino, D; Ventura, A; Bertolini, G; Feddermann-Demont, N				Mucci, Viviana; Meier, Cornelia; Bizzini, Mario; Romano, Fausto; Agostino, Daniel; Ventura, Alessandra; Bertolini, Giovanni; Feddermann-Demont, Nina			Combined Optokinetic Treatment and Vestibular Rehabilitation to Reduce Visually Induced Dizziness in a Professional Ice Hockey Player After Concussion: A Clinical Case	FRONTIERS IN NEUROLOGY			English	Article						concussion; ice hockey; optokinetic; dizziness; visually induced dizziness; vestibular rehabilitation; sport-related concussion	SPORT-RELATED CONCUSSION; POSTURAL CONTROL; VERTIGO; HEAD; CLASSIFICATION; DISORDERS; STATEMENT; INJURY	Background: The appropriate detection and therapy of concussion symptoms are of great importance to avoid long-term impairment and absence from pre-concussive activities, such as sport, school or work. Post-traumatic headache and dizziness are known as risk factors of persistent symptoms after a concussion. Dizziness has even been classified as a predictor for symptom persistence. One type of dizziness, which has never been considered is visually induced dizziness (VID) often develops as a consequence of vestibular impairment. This manuscript presents the clinical case of a 25-year-old male, professional ice hockey player, whereby a therapeutic approach to VID after concussion is demonstrated. Case: A detailed interdisciplinary clinical and laboratory-assisted neurological, neurovestibular and ocular-motor examination was performed 20 days post-concussion, which indicated VID symptoms. Thus, the player qualified for a 5-day combined vestibular, balance and optokinetic therapy, which aimed to reduce the player's increased sensitivity to visual information. Each treatment day consisted of two sessions: vestibular/ocular-motor training and exposure to optokinetic stimuli combined with postural control exercises. The optokinetic stimulus was delivered in the form of a rotating disk. VID symptoms were recorded daily via posturography and a visual analog scale prior to the optokinetic sessions. The player improved over the course of each treatment day and was able to return to ice hockey 15 days after the final treatment session. Three months later the player reported no symptoms in the follow up questionnaire. Conclusion: The combination of vestibular, balance and optokinetic therapy led to remission of VID symptoms in a professional ice hockey player after multiple concussions, within a short time frame after his last concussion. Thus, this case study highlights the significant benefit of treating post-concussive VID symptoms utilizing a multi-modal approach.	[Mucci, Viviana; Meier, Cornelia; Bizzini, Mario; Romano, Fausto; Agostino, Daniel; Ventura, Alessandra; Bertolini, Giovanni; Feddermann-Demont, Nina] Swiss Concuss Ctr, Schulthess Clin, Zurich, Switzerland; [Mucci, Viviana; Romano, Fausto; Bertolini, Giovanni; Feddermann-Demont, Nina] Univ Hosp, Dept Neurol, Zurich, Switzerland; [Mucci, Viviana; Romano, Fausto; Bertolini, Giovanni; Feddermann-Demont, Nina] Univ Zurich, Zurich, Switzerland; [Bizzini, Mario] Schulthess Clin, Human Performance Lab, Zurich, Switzerland		Mucci, V (corresponding author), Swiss Concuss Ctr, Schulthess Clin, Zurich, Switzerland.; Mucci, V (corresponding author), Univ Hosp, Dept Neurol, Zurich, Switzerland.; Mucci, V (corresponding author), Univ Zurich, Zurich, Switzerland.	viviana.mucci@swissconcussion.com	Bertolini, Giovanni/H-3510-2016	Bertolini, Giovanni/0000-0003-2428-9454			Ahmed, 2014, BRAINBLOX BRAIN BIOM; Akhand O, 2019, CURR OPIN NEUROL, V32, P68, DOI 10.1097/WCO.0000000000000654; Arshad Q, 2017, CLIN NEUROL NEUROSUR, V155, P17, DOI 10.1016/j.clineuro.2017.01.021; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Cousins S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105426; Dai MJ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00124; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Epps CT, 2017, J NEUROL NEUROPHYSIO, V8, P454, DOI [10.4172/2155-9562.1000454, DOI 10.4172/2155-9562.1000454]; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Gupta A, 2019, CURR REV MUSCULOSKE, V12, P117, DOI 10.1007/s12178-019-09545-7; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; JACOB RG, 1988, PSYCHIAT CLIN N AM, V11, P361; Kalron A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0603-6; Kamal N, 2017, EGYPT J OTOLARYNGOL, V33, P645, DOI 10.4103/ejo.ejo_69_17; Keshavarz B., 2014, HDB VIRTUAL ENV DESI, V2nd, P647, DOI DOI 10.1201/B17360-32; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mcewen BS, 2011, ANN NY ACAD SCI, V1204, P1; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MONTGOMERY DL, 1988, SPORTS MED, V5, P99, DOI 10.2165/00007256-198805020-00003; Mucci V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00887; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; de Amorim RLO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00164; Pavlou M, 2013, NEUROREHAB NEURAL RE, V27, P208, DOI 10.1177/1545968312461715; Pavlou M, 2011, GAIT POSTURE, V33, P113, DOI 10.1016/j.gaitpost.2010.10.085; Pavlou M, 2010, J NEUROL PHYS THER, V34, P105, DOI 10.1097/NPT.0b013e3181dde6bf; Pivnickova L, 2014, LATEST TRENDS CIRCUI, V8, P193; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Schneider KJ, 2019, MUSCULOSKEL SCI PRAC, V42, P151, DOI 10.1016/j.msksp.2019.01.006; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sluch IM, 2017, NEURO-OPHTHALMOLOGY, V41, P315, DOI 10.1080/01658107.2017.1326944; Staab JP, 2017, J VESTIBUL RES-EQUIL, V27, P191, DOI 10.3233/VES-170622; Van Ombergen A, 2017, NEUROIMAGE-CLIN, V14, P538, DOI 10.1016/j.nicl.2017.02.020; Van Ombergen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154528; von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351	48	1	1	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 29	2019	10								1200	10.3389/fneur.2019.01200			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV9ZP	WOS:000502719300001	31849804	Green Published, gold			2022-02-06	
J	Lovett, ME; Maa, T; Moore-Clingenpeel, M; O'Brien, NF				Lovett, Marlina E.; Maa, Tensing; Moore-Clingenpeel, Melissa; O'Brien, Nicole F.			Transcranial Doppler ultrasound findings in children with moderate-to-severe traumatic brain injury following abusive head trauma	CHILDS NERVOUS SYSTEM			English	Article						Transcranial Doppler ultrasound; Traumatic brain injury; Abusive head trauma	FLOW VELOCITIES; VASOSPASM; MORTALITY; SCALE	Purpose Abusive head trauma (AHT) is the leading cause of fatal head injuries for children under 2 years. The objective was to evaluate, using transcranial Doppler ultrasound (TCD), whether children with AHT have a similar neurovascular response to injury compared with children without AHT. Methods Retrospective sub-analysis of previously prospectively acquired data in a pediatric intensive care unit in a level 1 trauma hospital. TCD was performed daily until hospital day 8, discharge, or death. Neurologic outcome was assessed using the Glasgow Outcome Scale Extended (GOS-E Peds) at 1 month from initial injury. Results Sixty-nine children aged 1 day to 17 years with moderate-to-severe traumatic brain injury were enrolled. Fifteen children suffered AHT and 54 had no suspicion for AHT. Fifteen children with AHT underwent 80 serial TCD examinations; 54 children without AHT underwent 308 exams. After standardization for age and gender normative values, there was no statistically significant difference in mean cerebral blood flow velocity of the middle cerebral artery (V-MCA) between children with and without AHT. There was no difference in the incidence of extreme cerebral blood flow velocity (CBFV, greater or less than 2 standard deviations from normative value) between groups. Within the AHT group, there were no statistically significant differences in V-MCA between children with a favorable (GOS-E Peds 1-4) versus unfavorable neurologic outcome (GOS-E Peds 5-8). Conclusion Children with AHT have no significant differences in V-MCA or percentage of extreme CBFV in the middle cerebral artery compared to with those without AHT.	[Lovett, Marlina E.; Maa, Tensing; O'Brien, Nicole F.] Nationwide Childrens Hosp, Div Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA; [Lovett, Marlina E.; Maa, Tensing; O'Brien, Nicole F.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Moore-Clingenpeel, Melissa] Nationwide Childrens Hosp, Biostat Core, Res Inst, Columbus, OH USA		Lovett, ME (corresponding author), Nationwide Childrens Hosp, Div Crit Care Med, 700 Childrens Dr, Columbus, OH 43205 USA.; Lovett, ME (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	marlina.lovett@nationwidechildrens.org	Maa, Tensing/J-9791-2012	Maa, Tensing/0000-0001-6104-8401; Lovett, Marlina/0000-0002-9531-9481; Moore-Clingenpeel, Melissa/0000-0003-3782-0726			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; BODE H, 1988, ARCH DIS CHILD, V63, P606, DOI 10.1136/adc.63.6.606; Boop S, 2016, J NEUROSURG-PEDIATR, V18, P542, DOI 10.3171/2016.1.PEDS15583; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Greiner MV, 2015, J CHILD NEUROL, V30, P1778, DOI 10.1177/0883073815580285; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LaRovere KL, 2016, J NEUROTRAUM, V33, P2105, DOI 10.1089/neu.2015.4344; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Lovett ME, 2018, RESUSCITATION, V126, P191, DOI 10.1016/j.resuscitation.2018.02.005; Nuno M, 2018, CHILD ABUSE NEGLECT, V85, P39, DOI 10.1016/j.chiabu.2018.08.011; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2015, CHILD NERV SYST, V31, P2269, DOI 10.1007/s00381-015-2873-5; Orru' E, 2018, J NEUROIMAGING, V28, P608, DOI 10.1111/jon.12555; Parks SE., 2012, PEDIAT ABUSIVE HEAD; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Wright JN, 2017, AM J ROENTGENOL, V208, P991, DOI 10.2214/AJR.16.17602; Ziegler D, 2017, J NEUROTRAUM, V34, P121, DOI 10.1089/neu.2015.3967	25	1	1	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAY	2020	36	5					993	1000		10.1007/s00381-019-04431-6		NOV 2019	8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	LD5JM	WOS:000499245000001	31781914	Green Published, Bronze			2022-02-06	
J	Poltavski, D; Bernhardt, K; Mark, C; Biberdorf, D				Poltavski, Dmitri; Bernhardt, Kyle; Mark, Christopher; Biberdorf, David			Frontal theta-gamma ratio is a sensitive index of concussion history in athletes on tasks of visuo-motor control	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; HIGH-SCHOOL; SPORT; PERFORMANCE	Patients with mTBI often show deficits in executive function and changes in neural activity. Similar changes in those with a history of mTBI (i.e. concussion), however, have not been consistently reported. Frontal theta-to-gamma frequency ratio has shown promise in EEG research in predicting performance on working memory tasks. In the present study we explored the sensitivity of the frontal theta-togamma relative power spectral density (PSD) ratio to the history of concussion in 81 youth athletes (18 with a history of concussion, ages 13-18) during the tests of the Nike Sensory Training Station that vary in working memory and processing speed demands and motor output requirements. The results showed that the theta-to-gamma relative PSD ratio was significantly lower in the concussion history group on the tests of target capture, perception span and hand reaction time. A principle component analysis further indicated that this metric reflects an underlying dimension shared by several visuo-motor control tests of the Nike battery. The results suggested persistent deficits in psychomotor ability in the athletes with a history of concussion that may have implications for diagnosis, rehabilitation and athletic training.	[Poltavski, Dmitri; Bernhardt, Kyle] Univ North Dakota, Dept Psychol, 501 N Columbia Rd,Stop 8380, Grand Forks, ND 58202 USA; [Mark, Christopher] Salem State Univ, Dept Psychol, 352 Lafayette St, Salem, MA 01970 USA; [Biberdorf, David] Valley Vis Clin, 2200 S Washington St, Grand Forks, ND 58201 USA		Poltavski, D (corresponding author), Univ North Dakota, Dept Psychol, 501 N Columbia Rd,Stop 8380, Grand Forks, ND 58202 USA.	dmitri.poltavski@und.edu	VARRECCHIA, TIWANA/AAJ-8712-2021	Biberdorf, David/0000-0001-8915-6375	North Dakota Department of Commerce, Research ND program [15-02-G-88]	This study was funded by the North Dakota Department of Commerce, Research ND program (Grant #15-02-G-88).	[Anonymous], 2010, B AL X10 US MAN; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Buzsaki G, 2001, NEUROCHEM RES, V26, P899, DOI 10.1023/A:1012324231897; Chaiken SR, 2000, COGNITIVE PSYCHOL, V40, P198, DOI 10.1006/cogp.1999.0729; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Conley AC, 2019, J NEUROTRAUM, V36, P1, DOI 10.1089/neu.2018.5761; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Erickson GB, 2011, OPTOMETRY, V82, P528, DOI 10.1016/j.optm.2011.01.012; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Johnston K. M, 2005, THINKFIRST CONCUSSIO; Kaminski J, 2011, NEUROBIOL LEARN MEM, V95, P19, DOI 10.1016/j.nlm.2010.10.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee J.D., 2015, APA HDB HUMAN SYSTEM, P277, DOI DOI 10.1037/14528-018; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mihalik J.P., 2017, BR J SPORTS MED, V51, pA3; Munia TTK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17414-x; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Parasuraman R, 2015, APA HDB HUMAN SYSTEM, P163; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tirre WC, 1998, PERS INDIV DIFFER, V24, P603, DOI 10.1016/S0191-8869(98)80011-1; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wang LL, 2015, ACTA PSYCHOL, V157, P74, DOI 10.1016/j.actpsy.2015.02.005; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yadav NK, 2014, BRAIN INJURY, V28, P1568, DOI 10.3109/02699052.2014.939718; Yadav NK, 2014, BRAIN INJURY, V28, P922, DOI 10.3109/02699052.2014.887227	43	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 26	2019	9								17565	10.1038/s41598-019-54054-9			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JP9VX	WOS:000498605700002	31772237	Green Published, gold			2022-02-06	
J	Mallory, KD; Hickling, A; Wilson, KE; Reed, N				Mallory, Kylie D.; Hickling, Andrea; Wilson, Katherine E.; Reed, Nick			Online concussion resources for Canadian high school aged youth: A systematic search strategy	BRAIN INJURY			English	Article						Concussion; youth; brain injury; education; internet	KNOWLEDGE; READABILITY; INFORMATION	Objective: To identify online concussion resources that are suitable for Canadian youth and accurate according to the current International Consensus Statement on Concussion in Sport. Methods: A five-phased systematic search strategy was used to identify concussion resources. This included 1. searching key Canadian stakeholder websites (sport organizations, injury prevention groups, children's hospitals, governments, public health agencies, and physical and health education associations), 2. pediatric concussion expert consultation, 3. applying inclusion and exclusion criteria, 4. reviewing content for accuracy according to the consensus statement and 5. evaluating resources for readability, usability and suitability. Results: A total of 456 resources were initially identified however, only 32 met the final criteria. Across all resources, 34.6% (n=109) were excluded as they were not designed primarily for youth. Among resources reviewed for content accuracy according to the consensus statement, 53.1% (n=51) were excluded. When evaluating resources for readability, usability and suitability, 28.5% (n=13) were excluded as they were not suitable for youth.	[Mallory, Kylie D.; Reed, Nick] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Mallory, Kylie D.; Hickling, Andrea; Wilson, Katherine E.; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Hickling, Andrea; Reed, Nick] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, 500 Univ Ave, Toronto, ON M5G 1V7, Canada		Reed, N (corresponding author), Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	nick.reed@utoronto.ca		Hickling, Andrea/0000-0001-6251-6369	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [153025]	This work was supported by the Canadian Institutes of Health Research under Grant [153025].	Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1020; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Doak CC, 1996, TEACHING PATIENTS LO, P49; [EduCanada High school in Canada], 2019, HIGH SCH CAN; Gill PS, 2012, INT J GEN MED, V5, P923, DOI 10.2147/IJGM.S37110; Kollia B, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_265_17; Mao J, 2014, COMPUT HUM BEHAV, V33, P213, DOI 10.1016/j.chb.2014.01.002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Poulin V, 2018, DISABIL REHABIL, P1; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Smith S, 2008, BEGINNINGS GUIDE, P1; Statistics Canada, 2017, LIF FAST LAN AR CAN; Statistics Canada , 2016, INT DIG TECHN; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Theye Fred, 2004, Clin Med Res, V2, P165; Tonsaker T, 2014, CAN FAM PHYSICIAN, V60, P407; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	20	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					171	177		10.1080/02699052.2019.1692369		NOV 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000498111900001	31760806	hybrid			2022-02-06	
J	Chin, LMK; Chan, L; Drinkard, B; Keyser, RE				Chin, Lisa M. K.; Chan, Leighton; Drinkard, Bart; Keyser, Randall E.			Oxygen uptake on-kinetics before and after aerobic exercise training in individuals with traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Pulmonary gas exchange; brain injuries; fatigability; treadmill; physical activity	MODERATE-INTENSITY EXERCISE; PULMONARY O-2 UPTAKE; CONSTANT WORK RATE; VO2 KINETICS; CARDIORESPIRATORY FITNESS; MUSCLE DEOXYGENATION; ANAEROBIC THRESHOLD; SUBMAXIMAL EXERCISE; PHYSICAL-ACTIVITY; RESPONSES	Objective: The high prevalence of fatigue among persons with traumatic brain injury (TBI) may be related to poor cardiorespiratory fitness observed in this population. Oxygen uptake on-kinetics is a method of assessing cardiorespiratory fitness and may be used to examine performance fatigability (decline in performance during a given activity) in persons with TBI. Purpose: To examine the effect of aerobic exercise training on oxygen uptake on-kinetics during treadmill walking in individuals with TBI. Methods: Seven ambulatory adults with chronic non-penetrating TBI performed short moderate-intensity (3-6 metabolic equivalents) walking bouts on a treadmill, prior to and following an aerobic exercise training program (clinicaltrials.gov: NCT01294332). The 12-week training program consisted of vigorous-intensity exercise on a treadmill for 30 min, 3 times a week. Breath-by-breath pulmonary gas exchange was measured throughout the bouts, and oxygen uptake on-kinetics described the time taken to achieve a steady-state response. Results: Faster oxygen uptake on-kinetics was observed after exercise training, for both the absolute and relative intensity as pre-training. Conclusions: Faster oxygen uptake on-kinetics following aerobic exercise training suggests an attenuated decline in physical performance during a standardized walking bout and improved performance fatigability in these individuals with TBI.	[Chin, Lisa M. K.; Keyser, Randall E.] George Mason Univ, Dept Rehabil Sci, 4400 Univ Dr, Fairfax, VA 22030 USA; [Chin, Lisa M. K.; Chan, Leighton; Drinkard, Bart; Keyser, Randall E.] Natl Inst Hlth Clin Ctr, Rehabil Med Dept, Bethesda, MD USA; [Chin, Lisa M. K.; Chan, Leighton; Keyser, Randall E.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Chin, LMK (corresponding author), George Mason Univ, Dept Rehabil Sci, 4400 Univ Dr, Fairfax, VA 22030 USA.	lchin2@gmu.edu	Chin, Lisa MK/O-4706-2014	Chin, Lisa MK/0000-0002-0178-739X	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G192HI-H]; Intramural Research Program of the National Institutes of Health, Clinical Center (Rehabilitation Medicine Department)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was supported by the Department of Defense in the Center for Neuroscience and Regenerative Medicine [G192HI-H] and the Intramural Research Program of the National Institutes of Health, Clinical Center (Rehabilitation Medicine Department).	Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Amonette WE, 2013, J HEAD TRAUMA REHAB, V28, pE13, DOI 10.1097/HTR.0b013e31826463a1; Armeniakou E, 2015, RESP CARE, V60, P1164, DOI 10.4187/respcare.03258; Barbosa JFD, 2016, PHYSIOTHERAPY, V102, P294, DOI 10.1016/j.physio.2015.08.008; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Belardinelli R, 1997, AM J CARDIOL, V80, P1319, DOI 10.1016/S0002-9149(97)00672-3; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Berger NJA, 2006, MED SCI SPORT EXER, V38, P504, DOI 10.1249/01.mss.0000191418.37709.81; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Brandenburg SL, 1999, DIABETES CARE, V22, P1640, DOI 10.2337/diacare.22.10.1640; Buchowski MS, 2013, AGE, V35, P179, DOI 10.1007/s11357-011-9338-x; Cade WT, 2003, ARCH PHYS MED REHAB, V84, P1831, DOI 10.1016/j.apmr.2003.03.004; Chilibeck P D, 1996, Can J Appl Physiol, V21, P185; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chin LMK, 2007, J PHYSIOL-LONDON, V583, P351, DOI 10.1113/jphysiol.2007.132837; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; Department of Health and Human Services, 2012, FAT ACT LIM BIOEN AG; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Figueira TR, 2008, J SPORT SCI MED, V7, P132; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Glass S., 2007, ACSMS METABOLIC CALC; Gollie JM, 2017, EUR J APPL PHYSIOL, V117, P1989, DOI 10.1007/s00421-017-3685-y; Grassi B, 2011, EUR J APPL PHYSIOL, V111, P345, DOI 10.1007/s00421-010-1609-1; Grassi B, 2009, MED SCI SPORT EXER, V41, P2120, DOI 10.1249/MSS.0b013e3181aae96b; Gurd BJ, 2005, J APPL PHYSIOL, V98, P1371, DOI 10.1152/japplphysiol.01028.2004; Hassett L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub3; Hassett L, 2016, BRAIN IMPAIR, V17, P43, DOI 10.1017/BrImp.2015.28; Hedges L.V., 1985, STAT METHODS META AN; HICKSON RC, 1978, J APPL PHYSIOL, V44, P877, DOI 10.1152/jappl.1978.44.6.877; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Jones AM, 2009, INT J SPORT PHYSIOL, V4, P524, DOI 10.1123/ijspp.4.4.524; Keir DA, 2014, EXP PHYSIOL, V99, P1511, DOI 10.1113/expphysiol.2014.080812; Keyser RE, 2010, PM&R, V2, P347, DOI 10.1016/j.pmrj.2010.04.009; KOIKE A, 1995, CIRCULATION, V91, P1719, DOI 10.1161/01.CIR.91.6.1719; Lamotte G, 2015, JPD, V5, P941; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McKay BR, 2009, J APPL PHYSIOL, V107, P128, DOI 10.1152/japplphysiol.90828.2008; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Murias JM, 2011, EUR J APPL PHYSIOL, V111, P235, DOI 10.1007/s00421-010-1649-6; Murias JM, 2010, J APPL PHYSIOL, V108, P913, DOI 10.1152/japplphysiol.01355.2009; NERY LE, 1982, J APPL PHYSIOL, V53, P1594, DOI 10.1152/jappl.1982.53.6.1594; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Ozyener F, 2001, J PHYSIOL-LONDON, V533, P891, DOI 10.1111/j.1469-7793.2001.t01-1-00891.x; PALANGE P, 1995, J APPL PHYSIOL, V78, P2228, DOI 10.1152/jappl.1995.78.6.2228; Poole DC, 2012, COMPR PHYSIOL, V2, P933, DOI 10.1002/cphy.c100072; Puente-Maestu L, 2000, EUR RESPIR J, V15, P1026, DOI 10.1034/j.1399-3003.2000.01509.x; Roditis P, 2007, EUR J CARDIOV PREV R, V14, P304, DOI 10.1097/HJR.0b013e32808621a3; Rossiter HB, 1999, J PHYSIOL-LONDON, V518, P921, DOI 10.1111/j.1469-7793.1999.0921p.x; Spencer MD, 2011, EUR J APPL PHYSIOL, V111, P591, DOI 10.1007/s00421-010-1653-x; Stoller O, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-45; Vanderveld RA, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/11/004; Wasserman K, 1986, Adv Cardiol, V35, P1; Weinstein AA, 2017, J HEAD TRAUMA REHAB, V32, pE49, DOI 10.1097/HTR.0000000000000253; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009	59	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 20	2019	41	24					2949	2957		10.1080/09638288.2018.1483432			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	JQ9US	WOS:000499283100010	29961351	Green Accepted			2022-02-06	
J	Fernando, SM; Mok, G; Rochwerg, B; English, SW; Thavorn, K; McCredie, VA; Dowlatshahi, D; Perry, JJ; Wijdicks, EFM; Reardon, PM; Tanuseputro, P; Kyeremanteng, K				Fernando, Shannon M.; Mok, Garrick; Rochwerg, Bram; English, Shane W.; Thavorn, Kednapa; McCredie, Victoria A.; Dowlatshahi, Dar; Perry, Jeffrey J.; Wijdicks, Eelco F. M.; Reardon, Peter M.; Tanuseputro, Peter; Kyeremanteng, Kwadwo			Preadmission Antiplatelet Use and Associated Outcomes and Costs Among ICU Patients With Intracranial Hemorrhage	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						intracranial hemorrhage; antiplatelet; intensive care unit; subarachnoid hemorrhage; intracerebral hemorrhage; traumatic brain injury; health economics	INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; HOSPITAL MORTALITY; INTENSIVE-CARE; OLDER PATIENTS; THERAPY; IMPACT; PREDICTORS	Introduction: Patients with intracranial hemorrhage (including intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic hemorrhage) are commonly admitted to the intensive care unit (ICU). Although indications for oral antiplatelet agents are increasing, the impact of preadmission use on outcomes in patients with intracranial hemorrhage admitted to the ICU is unknown. We sought to evaluate the association between preadmission oral antiplatelet use, in-hospital mortality, resource utilization, and costs among ICU patients with intracranial hemorrhage. Methods: We retrospectively analyzed a prospectively collected registry (2011-2016) and included consecutive adult patients from 2 hospitals admitted to ICU with intracranial hemorrhage. Patients were categorized on the basis of preadmission oral antiplatelet use. We excluded patients with preadmission anticoagulant use. The primary outcome was in-hospital mortality and was analyzed using a multivariable logistic regression model. Contributors to total hospital cost were analyzed using a generalized linear model with log link and gamma distribution. Results: Of 720 included patients with intracranial hemorrhage, 107 (14.9%) had been using an oral antiplatelet agent at the time of ICU admission. Oral antiplatelet use was not associated with in-hospital mortality (adjusted odds ratio: 1.31 [95% confidence interval [CI]: 0.93-2.22]). Evaluation of total costs also revealed no association with oral antiplatelet use (adjusted ratio of means [aROM]: 0.92 [95% CI: 0.82-1.02, P = .10]). Total cost among patients with intracranial hemorrhage was driven by illness severity (aROM: 1.96 [95% CI: 1.94-1.98], P < .001), increasing ICU length of stay (aROM: 1.05 [95% CI: 1.05-1.06], P < .001), and use of invasive mechanical ventilation (aROM: 1.76 [95% CI: 1.68-1.86], P < .001). Conclusions: Among ICU patients admitted with intracranial hemorrhage, preadmission oral antiplatelet use was not associated with increased in-hospital mortality or hospital costs. These findings have important prognostic implications for clinicians who care for patients with intracranial hemorrhage.	[Fernando, Shannon M.; English, Shane W.; Reardon, Peter M.; Kyeremanteng, Kwadwo] Univ Ottawa, Dept Med, Div Crit Care, Ottawa, ON, Canada; [Fernando, Shannon M.; Mok, Garrick; Perry, Jeffrey J.; Reardon, Peter M.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Rochwerg, Bram] McMaster Univ, Dept Med, Div Crit Care, Hamilton, ON, Canada; [Rochwerg, Bram] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [English, Shane W.; Thavorn, Kednapa; Dowlatshahi, Dar; Perry, Jeffrey J.; Tanuseputro, Peter] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [English, Shane W.; Thavorn, Kednapa; Dowlatshahi, Dar; Perry, Jeffrey J.; Tanuseputro, Peter; Kyeremanteng, Kwadwo] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [McCredie, Victoria A.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [McCredie, Victoria A.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Dowlatshahi, Dar] Univ Ottawa, Dept Med, Div Neurol, Ottawa, ON, Canada; [Wijdicks, Eelco F. M.] Mayo Clin, Dept Neurol, Div Neurocrit Care & Hosp Neurol, Rochester, MN USA; [Tanuseputro, Peter; Kyeremanteng, Kwadwo] Univ Ottawa, Dept Med, Div Palliat Care, Ottawa, ON, Canada		Fernando, SM (corresponding author), Ottawa Hosp, Dept Crit Care Med, Civ Campus,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	sfernando@qmed.ca	English, Shane/P-9187-2019; Rochwerg, Bram/AAE-7606-2020	English, Shane/0000-0002-9477-6146; Thavorn, Kednapa/0000-0003-4738-8447; Dowlatshahi, Dar/0000-0003-1379-3612			Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [10.1023/A:1012597123667, DOI 10.1023/A:1012597123667]; Can A, 2018, NEUROLOGY, V91, pE1175, DOI 10.1212/WNL.0000000000006200; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Doble B, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1019-3; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, V17, pCd006184; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; English SW, 2016, NEUROLOGY, V87, P1557, DOI 10.1212/WNL.0000000000003204; English SW, 2016, J CLIN EPIDEMIOL, V70, P146, DOI 10.1016/j.jclinepi.2015.08.024; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fernando SM, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4225; Fernando SM, 2020, J INTENSIVE CARE MED, V35, P386, DOI 10.1177/0885066617754046; Fernando SM, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2096-8; Fernando SM, 2018, CHEST, V154, P309, DOI 10.1016/j.chest.2018.05.004; Fernando SM, 2018, CRIT CARE MED, V46, pE395, DOI 10.1097/CCM.0000000000003013; Gregori D, 2011, INT J QUAL HEALTH C, V23, P331, DOI 10.1093/intqhc/mzr010; Kramer AA, 2017, CRIT CARE MED, V45, P1457, DOI 10.1097/CCM.0000000000002563; Kyeremanteng K, 2016, J CRIT CARE, V36, P92, DOI 10.1016/j.jcrc.2016.07.004; Lawton MT, 2017, NEW ENGL J MED, V377, P257, DOI 10.1056/NEJMcp1605827; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mees SMD, 2003, STROKE, V34, P2285, DOI 10.1161/01.STR.0000083621.44269.3E; Oppenheim-Eden A, 1999, INTENS CARE MED, V25, P63, DOI 10.1007/s001340050788; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pereira AR, 2007, NEUROCRIT CARE, V7, P18, DOI 10.1007/s12028-007-0053-5; Rinkel Gabriel J E, 2009, Pract Neurol, V9, P195, DOI 10.1136/jnnp.2009.182444; Ronksley Paul E, 2015, CMAJ Open, V3, pE111, DOI 10.9778/cmajo.20140049; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Salman RAS, 2018, LANCET NEUROL, V17, P885, DOI 10.1016/S1474-4422(18)30253-9; Stuntz Mark, 2017, Prev Med Rep, V5, P183, DOI 10.1016/j.pmedr.2016.12.023; Toussaint LG, 2004, J NEUROSURG, V101, P921, DOI 10.3171/jns.2004.101.6.0921; Udy AA, 2017, CRIT CARE MED, V45, pE138, DOI 10.1097/CCM.0000000000002059; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886	38	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JAN	2021	36	1					70	79	0885066619885347	10.1177/0885066619885347		NOV 2019	10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	OZ2PS	WOS:000501185100001	31741418				2022-02-06	
J	Zhang, B; Li, ZW; Zhang, R; Hu, YL; Jiang, YD; Cao, TT; Wang, JJ; Gong, LL; Ji, L; Mu, HJ; Yang, XS; Dai, YA; Jiang, C; Yin, Y; Zou, J				Zhang, Bo; Li, Zaiwang; Zhang, Rui; Hu, Yaling; Jiang, Yingdi; Cao, Tingting; Wang, Jingjing; Gong, Lingli; Ji, Li; Mu, Huijun; Yang, Xusheng; Dai, Youai; Jiang, Cheng; Yin, Ying; Zou, Jian			PKC gamma promotes axonal remodeling in the cortico-spinal tract via GSK3 beta/beta-catenin signaling after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							PROTEIN-KINASE-C; SPINAL-CORD; FUNCTIONAL RECOVERY; NEUROPATHIC PAIN; DOWN-REGULATION; GROWTH; RAT; DIFFERENTIATION; ACTIVATION; PHOSPHORYLATION	Traumatic brain injury (TBI) is a common cause of death and disability. Enhancing the midline-crossing of the contralateral corticospinal tract (CST) to the denervated side of spinal cord facilitates functional recovery after TBI. Activation of the gamma isoform of PKC (PKC gamma) in contralateral CST implicates its roles in promoting CST remodeling after TBI. In this study, we deployed loss and gain of function strategies in N2a cells and primary cortical neurons in vitro, and demonstrated that PKC gamma is not only important but necessary for neuronal differentiation, neurite outgrowth and axonal branching but not for axonal extension. Mechanically, through the phosphorylation of GSK3 beta, PKC gamma stabilizes the expression of cytosolic beta-catenin and increase GAP43 expression, thus promoting axonal outgrowth. Further, rAAV2/9-mediated delivery of constitutive PKC gamma in the corticospinal tract after unilateral TBI in vivo additionally showed that specifically delivery of active PKC gamma mutant to cortical neuron promotes midline crossing of corticospinal fibers from the uninjured side to the denervated cervical spinal cord. This PKC gamma-mediated injury response promoted sensorimotor functional recovery. In conclusion, PKC gamma mediates stability of beta-catenin through the phosphorylation of GSK3 beta to facilitate neuronal differentiation, neurite outgrowth and axonal branching, and PKC gamma maybe a novel therapeutic target for physiological and functional recovery after TBI.	[Zhang, Bo; Zhang, Rui; Hu, Yaling; Jiang, Yingdi; Wang, Jingjing; Gong, Lingli; Ji, Li; Mu, Huijun; Yang, Xusheng; Dai, Youai; Jiang, Cheng; Yin, Ying; Zou, Jian] Nanjing Med Univ, Clin Res Ctr, Affiliated Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China; [Zhang, Bo; Hu, Yaling; Jiang, Yingdi; Wang, Jingjing; Gong, Lingli; Ji, Li; Mu, Huijun; Yang, Xusheng; Dai, Youai; Jiang, Cheng; Yin, Ying; Zou, Jian] Wuxi Inst Translat Med, Wuxi 214023, Jiangsu, Peoples R China; [Li, Zaiwang] Southern Univ Sci & Technol, Affiliated Hosp So 1, Jinan Univ,Dept Neurol, Shenzhen Peoples Hosp,Clin Med Coll 2, Shenzhen 518020, Guangdong, Peoples R China; [Li, Zaiwang; Cao, Tingting] Nanjing Med Univ, Dept Neurol, Affiliated Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China; [Zhang, Rui] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Neurosurg, Wuxi 214023, Jiangsu, Peoples R China		Yin, Y; Zou, J (corresponding author), Nanjing Med Univ, Clin Res Ctr, Affiliated Wuxi Peoples Hosp, Wuxi 214023, Jiangsu, Peoples R China.; Yin, Y; Zou, J (corresponding author), Wuxi Inst Translat Med, Wuxi 214023, Jiangsu, Peoples R China.	yinying83@njmu.edu.cn; zoujan@njmu.edu.cn		Li, Zai-Wang/0000-0003-3738-3917	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81572468, 81372710, 81671219, 81802493]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20151105, BK20151109]; "333" Engineering Project Jiangsu Province [(2016)III-0605]; Six Talent Peaks Project of Jiangsu [2015-WSN-087]; Medical Young Talents Program of Jiangsu Province [QNRC2016188, QNRC2016192]; Wuxi Key Medical Talents [ZDRC001]; Wuxi Commission of Health Precision Medicine Special Funds [J201803]	We thank Bernard Weinstein for providing the PKC gamma-WT, PKC gamma-CAT and PKC gamma-DN plasmids, Jim Woodgett for providing the HA-GSK3 beta WT and HA-GSK3 beta S9A plasmids, all these plasmids were obtained through the Addgene plasmid depository; We thank Clarity Manuscript Consultants for assistance with language editing. This work was supported by National Natural Science Foundation of China (NSFC) grants (81572468, 81372710, 81671219, 81802493), Natural Science Foundation of Jiangsu Province (BK20151105, BK20151109), "333" Engineering Project Jiangsu Province ((2016)III-0605), Six Talent Peaks Project of Jiangsu (2015-WSN-087), Medical Young Talents Program of Jiangsu Province (QNRC2016188, QNRC2016192), Wuxi Key Medical Talents (ZDRC001), Wuxi Commission of Health Precision Medicine Special Funds (J201803).	ABRAHAM I, 1991, J NEUROSCI RES, V28, P29, DOI 10.1002/jnr.490280104; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BATTAINI F, 1994, BIOCHEM BIOPH RES CO, V201, P135, DOI 10.1006/bbrc.1994.1679; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Chopra R, 2018, HUM MOL GENET, V27, P1396, DOI 10.1093/hmg/ddy050; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Garcia AL, 2018, NEURAL REGEN RES, V13, P43, DOI 10.4103/1673-5374.224359; Geddis MS, 2003, J NEUROSCI RES, V74, P210, DOI 10.1002/jnr.10741; Gobrecht P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5561; GOODE N, 1992, J BIOL CHEM, V267, P16878; Goold RG, 1999, J CELL SCI, V112, P3373; Guzman-Lenis MS, 2009, NEUROSCIENCE, V162, P31, DOI 10.1016/j.neuroscience.2009.03.067; Hamabe W, 2005, J PHARMACOL EXP THER, V313, P1027, DOI 10.1124/jpet.104.082735; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; Hirai H, 2018, CEREBELLUM, V17, P23, DOI 10.1007/s12311-017-0898-x; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jiao JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04936-9; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kerr BJ, 2007, EXP NEUROL, V206, P240, DOI 10.1016/j.expneurol.2007.04.014; Kolkova K, 2000, J NEUROSCI, V20, P2238; Lang C, 2013, EMBO REP, V14, P931, DOI 10.1038/embor.2013.117; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li HF, 2005, BRIT J PHARMACOL, V144, P301, DOI 10.1038/sj.bjp.0706033; Lieu A, 2013, J NEUROIMMUNOL, V256, P43, DOI 10.1016/j.jneuroim.2013.01.003; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Lu HZ, 2010, DIFFERENTIATION, V80, P228, DOI 10.1016/j.diff.2010.09.179; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MAO JR, 1995, BRAIN RES, V677, P257, DOI 10.1016/0006-8993(95)00161-I; Martin WJ, 1999, NEUROSCIENCE, V88, P1267, DOI 10.1016/S0306-4522(98)00314-5; Miletic G, 2015, PAIN, V156, P2514, DOI 10.1097/j.pain.0000000000000323; Miyake S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.5; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; OKAJIMA S, 1995, NEUROSCIENCE, V66, P645, DOI 10.1016/0306-4522(94)00591-R; Omoto S, 2011, NEUROSCI RES, V69, P187, DOI 10.1016/j.neures.2010.12.004; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; Pinzon-Guzman C, 2011, J NEUROSCI, V31, P18606, DOI 10.1523/JNEUROSCI.2578-11.2011; Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Saijilafu, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3690; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Tsao HK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.274; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; van Kesteren RE, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00046; Vogelaar CF, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2304; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Welniarz Q, 2017, DEV NEUROBIOL, V77, P810, DOI 10.1002/dneu.22455; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu DY, 2003, INVEST OPHTH VIS SCI, V44, P2783, DOI 10.1167/iovs.02-0715; Yin Y, 2013, NEUROBIOL DIS, V59, P165, DOI 10.1016/j.nbd.2013.07.013; Yin Y, 2013, NEUROCHEM INT, V62, P903, DOI 10.1016/j.neuint.2013.03.005; Zhang D, 2017, J CELL MOL MED, V21, P3641, DOI 10.1111/jcmm.13275; Zhang HM, 2014, NEUROL SCI, V35, P1161, DOI 10.1007/s10072-014-1716-6; Zhu LJ, 2014, NAT MED, V20, P1050, DOI 10.1038/nm.3644; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	70	1	1	5	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 19	2019	9								17078	10.1038/s41598-019-53225-y			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JO6QJ	WOS:000497701800035	31745212	Green Published, gold			2022-02-06	
J	Moneim, J; Wenlock, RD; Wells, AJ; Price, RD; Timofeev, I; Helmy, A; Hutchinson, PJ				Moneim, Joseph; Wenlock, Rhys D.; Wells, Adam J.; Price, Richard D.; Timofeev, Ivan; Helmy, Adel; Hutchinson, Peter J.			Single procedure revision cranioplasty with intra-operative autoclave following titanium plate exposure	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Complications; infection; neurotrauma; titanium cranioplasty	INFECTION	Background: Patients with titanium cranioplasties can develop skin defects and plate exposure requiring revision surgery to prevent infection. The management of these patients has historically been staged surgery to remove the exposed plate followed by re-implantation of a sterile plate at a later date. Objectives: We describe an alternative where the exposed plate is removed, sterilised by autoclaving and re-implanted, in one operation. Methods: Patients with exposed titanium cranioplasties who underwent single-stage revisions were identified over a 30-month period. All patients received antibiotics post-procedure and were followed up. Results: Between June 2015 and December 2017 four patients had five single-stage revision cranioplasties with intraoperative autoclave sterilisation (SSRC). The mean time from initial procedure to revision was 5.6years. The mean time from plate exposure to surgery was 7 days. Plate exposure recurred in 60% (3/5) of cases post-SSRC. Two of these had the plate removed. The other had a second SSRC. On average recurrent plate exposure developed 17 months after SSRC. The 2 cases who had the plate removed remained complication-free to last follow up at 25 and 52 months after SSRC. Conclusions: Single procedure revision cranioplasty with intra-operative autoclave following titanium plate exposure may be considered as an option in patients with plate exposure who do not have other evidence on infection but we found recurrent plate exposure occurred in 50%.	[Moneim, Joseph; Wenlock, Rhys D.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Wells, Adam J.; Timofeev, Ivan; Helmy, Adel; Hutchinson, Peter J.] Univ Cambridge, Dept Acad Neurosurg, Dept Clin Neurosci, Cambridge, England; [Price, Richard D.] Cambridge Univ Hosp NHS Fdn Trust, Dept Plast & Reconstruct Surg, Cambridge, England		Hutchinson, PJ (corresponding author), Addenbrookes Hosp, Acad Div Neurosurg, Neurosurg, Box 167, Cambridge CB2 2SP, England.	pjah2@cam.ac.uk	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Wenlock, Rhys/0000-0001-7510-0821; Hutchinson, Peter/0000-0002-2796-1835; Timofeev, Ivan/0000-0002-1168-0393	NIHR Research Professorship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); NIHR Global Neurotrauma Research Group; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G1002277, G0502030, G9439390, G0600986] Funding Source: UKRI	PJ Hutchinson was supported by a NIHR Research Professorship, the NIHR Cambridge Biomedical Research Centre and the NIHR Global Neurotrauma Research Group.	Kshettry VR, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822fef2c; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Oh JS, 2016, J KOREAN NEUROSURG S, V59, P492, DOI 10.3340/jkns.2016.59.5.492; Quah BL, 2016, WORLD NEUROSURG, V94, P13, DOI 10.1016/j.wneu.2016.06.081; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Vaishya R, 2017, CUREUS, V9, DOI 10.7759/cureus.1629; Wallace DJ, 2018, NEUROSURG REV, V41, P1071, DOI 10.1007/s10143-018-0955-z	7	1	1	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2020	34	3					329	332		10.1080/02688697.2019.1690129		NOV 2019	4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MI0UE	WOS:000497002600001	31736374				2022-02-06	
J	Cesar, GM; Buster, TW; Burnfield, JM				Cesar, Guilherme M.; Buster, Thad W.; Burnfield, Judith M.			Test-retest reliability and minimal detectable change of the computerized dynamic posturography PROPRIO for adults with chronic traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Balance; minimal detectable change; reliability; computerized dynamic posturography; rehabilitation; brain injury	STATIC POSTUROGRAPHY; AFTER-DISCHARGE; BALANCE; WALKING; FALLS; REHABILITATION; INDIVIDUALS; PROBABILITY; MOBILITY; STROKE	Purpose: Balance deficits after brain injury, including reactive recovery from unexpected perturbations, can persist well after rehabilitation is concluded. While traditional clinical assessments are practical, the anticipatory nature of the tasks may mask perceptible balance control. Computerized dynamic posturography can directly quantify capacity to respond to unexpected, external perturbations. This study examined the reliability of the computerized dynamic posturography assessment with the device PROPRIO (R) 4000 in adults with traumatic brain injury and created the minimal detectable change for its standardized test. Methods: Ten adults (ages 21-55 years) with chronic (average 10 +/- 6 years post-injury) severe (loss of consciousness 2-75 days) brain injury performed three trials of the Propriotest (R) on two separate days. The average of three trials and the best scores were used separately for analysis. Test-retest reliability was verified using Intraclass Correlation Coefficients with 95% confidence interval and standard error of measurement in relation to the Intraclass Correlation Coefficients at 95%. The minimal detectable change was calculated at 95% confidence level (minimal detectable change(95)) and Bland-Altman plots were created to express agreement between measurement days. Results: The results exhibited excellent reliability for both average (Intraclass Correlation Coefficient of 0.969, standard error of measurement 50.9 points) and best (Intraclass Correlation Coefficient of 0.985, standard error of measurement 31.3 points) scores, with average and best minimal detectable change(95) of 141.0 and 86.7 points, respectively. Conclusions: Clinicians and rehabilitation researchers can use these findings to determine if a Propriotest (R) change score represents a true post-treatment effect with adults with chronic brain injury.	[Cesar, Guilherme M.; Buster, Thad W.; Burnfield, Judith M.] Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, 5401 South St, Lincoln, NE 68506 USA		Cesar, GM (corresponding author), Madonna Rehabil Hosp, Inst Rehabil Sci & Engn, 5401 South St, Lincoln, NE 68506 USA.	gcesar@madonna.org		Cesar, Guilherme M/0000-0002-5596-9439; Burnfield, Judith/0000-0001-6184-5179; Buster, Thad/0000-0001-7454-1748	Bill Kubly student research scholarship	This study was funded, in part, by The Bill Kubly student research scholarship awarded to Thad W. Buster.	Agostini V, 2011, GAIT POSTURE, V34, P248, DOI 10.1016/j.gaitpost.2011.05.008; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Barclay-Goddard R., 2004, COCHRANE DB SYST REV, V18; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P268, DOI 10.1016/j.apmr.2003.06.017; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2009, ARCH PHYS MED REHAB, V90, P145, DOI 10.1016/j.apmr.2008.06.025; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Cesar GM, 2016, HUM MOVEMENT SCI, V48, P37, DOI 10.1016/j.humov.2016.03.014; De la Casa-Fages B, 2017, GAIT POSTURE, V52, P374, DOI 10.1016/j.gaitpost.2016.12.025; Fioretti S, 2010, GAIT POSTURE, V32, P317, DOI 10.1016/j.gaitpost.2010.05.017; Foster H, 2016, PHYSIOTHER THEOR PR, V32, P536, DOI 10.1080/09593985.2016.1206155; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gofrit SG, 2019, EUR ARCH OTORHINOLAR; Hagen C, 1979, LEVELS COGNITIVE FUN, P87; Hillier SL, 1997, BRAIN INJURY, V11, P661; Howcroft J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172398; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Klima D, 2019, PERCEPT MOTOR SKILL, V126, P50, DOI 10.1177/0031512518809203; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lawrence EL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/561243; Mansfield A, 2017, J STROKE CEREBROVASC, V26, P2174, DOI 10.1016/j.jstrokecerebrovasdis.2017.04.041; Marchetti GF, 2014, J NEUROL PHYS THER, V38, P119, DOI 10.1097/NPT.0000000000000015; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Myers AM, 1996, J GERONTOL A-BIOL, V51, pM37, DOI 10.1093/gerona/51A.1.M37; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Navalon N, 2014, BRAIN INJURY, V28, P1417, DOI 10.3109/02699052.2014.917200; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Peters DM, 2014, ARCH PHYS MED REHAB, V95, P1454, DOI 10.1016/j.apmr.2014.04.006; Prosperini L, 2013, NEUROREHAB NEURAL RE, V27, P45, DOI 10.1177/1545968312445638; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Tefertiller C, 2019, ARCH PHYS MED REHAB, V100, P1409, DOI 10.1016/j.apmr.2019.03.015; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yang F, 2013, J BIOMECH, V46, P2463, DOI 10.1016/j.jbiomech.2013.07.025	42	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 3	2021	43	14					2038	2044		10.1080/09638288.2019.1688872		NOV 2019	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	TD5HG	WOS:000496393100001	31724889	Green Published			2022-02-06	
J	Yu, BF; Chen, LW; Qiu, YQ; Xu, J; Yin, HW; Li, QY; Xu, WD				Yu, Bao-Fu; Chen, Li-Wen; Qiu, Yan-Qun; Xu, Jing; Yin, Hua-Wei; Li, Qin-Ying; Xu, Wen-Dong			Contralateral seventh cervical nerve transfer can affect the pennation angle of the lower limb in spastic hemiplegia patients: An observational case series study	BRAIN AND BEHAVIOR			English	Article						cervical nerve transfer; interlimb interaction; load distribution; pennation angle; spastic hemiplegia; ultrasonography	MEDIAL GASTROCNEMIUS-MUSCLE; FASCICLE LENGTH; ARM; ARCHITECTURE; RELIABILITY; ULTRASOUND; STROKE; FOOT; VALIDITY; WALKING	Introduction We previously reported transferring seventh cervical (C7) nerve from unaffected side to affected side in patients with spastic hemiplegia due to chronic cerebral injury, to improve function and reduce spasticity of paralyzed upper limb. In the clinics, some patients also reported changes of spasticity in their lower limb, which could not be detected by routine physical examinations. Pennation angle of muscle can indirectly reflect the condition of spasticity. The purpose of this study was to evaluate whether this upper limb procedure may affect spasticity of lower limb, using ultrasonography to detect changes of muscle pennation angle (PA). Methods Twelve spastic hemiplegia patients due to cerebral injury including stroke, cerebral palsy, and traumatic brain injury, who underwent C7 nerve transfer procedure, participated in this study. B-mode ultrasonography was used to measure PA of the gastrocnemius medialis (GM) muscle at rest preoperatively and postoperatively. The plantar load distribution of the lower limbs was evaluated using a Zebris FDM platform preoperatively and postoperatively. Results The PA of the GM was significantly smaller on the affected side than that of unaffected side before surgery. On the affected side, the postoperative PA was significantly larger than preoperative PA. On the unaffected side, the postoperative PA was not significantly different compared to preoperative PA. The postoperative plantar load distribution of the affected forefoot was significantly smaller than preoperative load distribution, which was consistent with ultrasonography results. Conclusions This study indicates that C7 nerve transfer surgery for improving upper limb function can also affect muscle properties of lower limb in spastic hemiplegia patients, which reveals a link between the upper and lower limbs. The interlimb interactions should be considered in rehabilitation physiotherapy, and the regular pattern and mechanism need to be further studied.	[Yu, Bao-Fu; Xu, Jing; Yin, Hua-Wei; Xu, Wen-Dong] Fudan Univ, Huashan Hosp, Dept Hand Surg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China; [Chen, Li-Wen; Qiu, Yan-Qun; Xu, Wen-Dong] Jingan Dist Ctr Hosp, Dept Hand & Upper Extrem Surg, Shanghai, Peoples R China; [Chen, Li-Wen; Qiu, Yan-Qun; Li, Qin-Ying; Xu, Wen-Dong] Shanghai Clin Med Ctr Limb Funct Reconstruct, Shanghai, Peoples R China; [Xu, Wen-Dong] Shanghai Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China; [Xu, Wen-Dong] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China		Xu, WD (corresponding author), Fudan Univ, Huashan Hosp, Dept Hand Surg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	wendongxu@fudan.edu.cn	Yu, Baofu/AAV-1361-2020; Yin, Huawei/ABC-6273-2020		National Science Fund for Distinguished Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81525009]; National Key R&D Program of China [2017YFC0840100, 2017YFC0840106]; Shanghai Top Priority Clinical Medicine Center Construction Project [2017ZZ01006]	The National Science Fund for Distinguished Young Scholars, Grant/Award Number: 81525009; National Key R&D Program of China, Grant/Award Number: 2017YFC0840100 and 2017YFC0840106; Shanghai Top Priority Clinical Medicine Center Construction Project, Grant/Award Number: 2017ZZ01006	Aggeloussis N, 2010, GAIT POSTURE, V31, P73, DOI 10.1016/j.gaitpost.2009.08.249; Aloraini SM, 2015, DISABIL REHABIL, V37, P2313, DOI 10.3109/09638288.2015.1014933; Berenpas F, 2018, RESTOR NEUROL NEUROS, V36, P547, DOI 10.3233/RNN-180822; Burridge JH, 2005, DISABIL REHABIL, V27, P69, DOI 10.1080/09638280400014592; Cho JE, 2018, TOP STROKE REHABIL, V25, P6, DOI 10.1080/10749357.2017.1383723; Cho KH, 2014, CLIN PHYSIOL FUNCT I, V34, P26, DOI 10.1111/cpf.12060; Daniilidis K, 2017, ARCH ORTHOP TRAUM SU, V137, P499, DOI 10.1007/s00402-017-2652-8; DELWAIDE PJ, 1977, J NEUROL NEUROSUR PS, V40, P616, DOI 10.1136/jnnp.40.6.616; Frigon A, 2017, J NEUROPHYSIOL, V117, P2224, DOI 10.1152/jn.00978.2016; Gao F, 2009, ARCH PHYS MED REHAB, V90, P819, DOI 10.1016/j.apmr.2008.11.004; Gao F, 2008, J APPL PHYSIOL, V105, P1802, DOI 10.1152/japplphysiol.90930.2008; Hirsch MA, 2005, MOVEMENT DISORD, V20, P1014, DOI 10.1002/mds.20499; Kalron A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0603-6; Kaupp C, 2018, J NEUROPHYSIOL, V119, P1095, DOI 10.1152/jn.00570.2017; Klarner T, 2018, J NEUROPHYSIOL, V120, P53, DOI 10.1152/jn.00554.2017; Ko DY, 2013, J PHYS THER SCI, V25, P1309, DOI 10.1589/jpts.25.1309; Kwah LK, 2013, J APPL PHYSIOL, V114, P761, DOI 10.1152/japplphysiol.01430.2011; Li L, 2007, ARCH PHYS MED REHAB, V88, P243, DOI 10.1016/j.apmr.2006.11.013; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.3.CO;2-D; Mathevon L, 2018, MUSCLE NERVE, V57, P222, DOI 10.1002/mus.25716; Minassian K, 2017, NEUROSCIENTIST, V23, P649, DOI 10.1177/1073858417699790; Morasiewicz P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34016-3; Morasiewicz P, 2018, INJURY, V49, P860, DOI 10.1016/j.injury.2018.03.016; Narici M, 1999, J ELECTROMYOGR KINES, V9, P97, DOI 10.1016/S1050-6411(98)00041-8; Ramirez-Jarquin UN, 2018, ACS CHEM NEUROSCI, V9, P211, DOI 10.1021/acschemneuro.7b00503; Pradines M, 2018, PM&R, V10, P1020, DOI 10.1016/j.pmrj.2018.02.013; Qiu YQ, 2019, WORLD NEUROSURG, V121, P12, DOI 10.1016/j.wneu.2018.09.118; Singer B, 2001, DISABIL REHABIL, V23, P749; Soltani Narjes, 2014, Asian J Sports Med, V5, P91; Takahashi K, 2011, BRAIN STIMUL, V4, P90, DOI 10.1016/j.brs.2010.07.001; Tanigor G, 2019, NEUROL SCI, V40, P193, DOI 10.1007/s10072-018-3552-6; ZAJAC FE, 1992, J HAND SURG-AM, V17A, P799, DOI 10.1016/0363-5023(92)90445-U; Zheng MX, 2018, NEW ENGL J MED, V378, P22, DOI 10.1056/NEJMoa1615208	33	1	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	DEC	2019	9	12							e01460	10.1002/brb3.1460		NOV 2019	9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	KF6ME	WOS:000496008000001	31721481	Green Published, gold			2022-02-06	
J	Ologun, GO; Pamula, A; Alegbejo-Olarinoye, M; Granet, P; Behm, R				Ologun, Gabriel O.; Pamula, Arpitha; Alegbejo-Olarinoye, Mojirola; Granet, Paul; Behm, Robert			Rethinking the Use of Routine Platelet Transfusions for Head Injured Patients on Antiplatelet Therapy	CUREUS			English	Article						head injury; antiplatelet therapy; head trauma; transfusion	BRAIN-INJURY; IMPROVE OUTCOMES; MORTALITY; ASPIRIN	Traumatic brain injury is responsible for over one million hospital visits, and thousands of deaths annually. The aging population is associated with an increased use of anticoagulation and antiplatelet agents which complicates traumatic brain injury. The use of antiplatelet agents significantly increases baseline risk of intracranial hemorrhage. However, routine platelet transfusion in an attempt to reverse the effects of antiplatelet agents may be detrimental. Here, we report a case of an elderly woman with mild traumatic brain injury, who suffered a tragic demise after platelet transfusion.	[Ologun, Gabriel O.] Robert Packer Hosp, Guthrie Clin, Gen Surg, Sayre, PA 18840 USA; [Pamula, Arpitha] St Bonaventure Univ, Robert Packer Hosp, Guthrie Clin, Med, Sayre, PA USA; [Alegbejo-Olarinoye, Mojirola] Univ Coll Hlth Sci, Gen Surg, Abuja, Nigeria; [Granet, Paul] Robert Packer Hosp, Guthrie Clin, Trauma Surg Crit Care, Sayre, PA USA; [Behm, Robert] Robert Packer Hosp, Guthrie Clin, Trauma Crit Care, Sayre, PA USA		Ologun, GO (corresponding author), Robert Packer Hosp, Guthrie Clin, Gen Surg, Sayre, PA 18840 USA.	gabe.ologun@gmail.com					Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Downey DM, 2009, AM SURGEON, V75, P1100; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e	10	1	1	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	NOV 12	2019	11	11							e6136	10.7759/cureus.6136			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JN2WQ	WOS:000496761600008	31886072	Green Published, gold			2022-02-06	
J	Lundine, JP; Peng, J; Chen, D; Lever, K; Wheeler, K; Groner, JI; Shen, JB; Lu, B; Xiang, H				Lundine, Jennifer P.; Peng, Jin; Chen, David; Lever, Kimberly; Wheeler, Krista; Groner, Jonathan I.; Shen, Jiabin; Lu, Bo; Xiang, Henry			The impact of driving time on pediatric TBI follow-up visit attendance	BRAIN INJURY			English	Article						Brain injury; child; follow-up visits; attendance; driving distance; socioeconomic status	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; SOCIOECONOMIC-STATUS; TRANSPORTATION BARRIERS; CHILDREN; NEIGHBORHOOD; OUTCOMES	Objective: Examine the effect of driving time on follow-up visit attendance for children hospitalized with a traumatic brain injury (TBI). We hypothesized that families who lived further from the hospital would show poorer follow-up attendance. Participants: 368 children admitted to the hospital with TBI. Design & Outcome Measures: Using a retrospective chart review, we calculated driving time from patients' homes. The primary outcome was attendance at the first appointment post-discharge. We used logistic regression to examine the effect of driving time on attendance, including an analysis of the effects of injury and sociodemographic covariates on the model. Results: Majority of children attended their first appointment. Patients living 30-60 min from the hospital were most likely to attend, and those living 15 min away were least likely to attend. After adjusting for patient characteristics, families with driving time of 30-60 min had significantly higher odds of returning for follow-up than those with driving time <15 min, though the significance of this relationship disappeared after specific socioeconomic (SES) factors were included. Conclusions: Distance plays a significant role on follow-up attendance for pediatric patients with TBI. However, neighborhood SES may be an additional factor that influences the significance of the distance effect.	[Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, 110 Pressey Hall,1070 Carmack Rd, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA; [Peng, Jin; Chen, David] Nationwide Childrens Hosp, Res Inst, Res Informat Solut & Innovat, Columbus, OH USA; [Lever, Kimberly; Wheeler, Krista; Groner, Jonathan I.; Shen, Jiabin; Xiang, Henry] Nationwide Childrens Hosp, Ctr Pediat Trauma Res, Columbus, OH USA; [Lever, Kimberly; Wheeler, Krista; Groner, Jonathan I.; Shen, Jiabin; Xiang, Henry] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Groner, Jonathan I.] Nationwide Childrens Hosp, Trauma Program, Columbus, OH USA; [Lu, Bo; Xiang, Henry] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA		Lundine, JP (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, 110 Pressey Hall,1070 Carmack Rd, Columbus, OH 43210 USA.	lundine.4@osu.edu	Lundine, Jennifer P/P-5184-2018; Shen, Jiabin/C-3655-2008	Lundine, Jennifer P/0000-0002-9113-7875; 	Ohio Department of Public Safety; Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [R40MC30759]	This work was funded, in part, by grants awarded to Henry Xiang from the Ohio Department of Public Safety and the Health Resources and Services Administration (grant #R40MC30759). The granting agencies had no role in study design, in the collection, analysis, or interpretation of data, or in the writing of this report and decision to submit for publication.	Agarwal S, 2015, VASC MED, V20, P439, DOI 10.1177/1358863X15592486; Alteryx, 2017, REP WORKFL SELF SERV; Auger KA, 2017, ACAD PEDIATR, V17, P79, DOI 10.1016/j.acap.2016.07.003; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Cheng TL, 2015, PEDIATRICS, V135, pE225, DOI 10.1542/peds.2014-3109; Children's Hospital Association, 2018, AB CHILDR HOSP; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; D'Agostino JA, 2015, PEDIATRICS, V136, pE794, DOI 10.1542/peds.2015-0745; Epstein D, 2014, J COMMUN HEALTH, V39, P753, DOI 10.1007/s10900-014-9823-0; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Howarth RA, 2016, J PEDIATR NEURORADIO, V5, P26, DOI 10.1055/s-0036-1584285; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Kirby JB, 2005, J HEALTH SOC BEHAV, V46, P15, DOI 10.1177/002214650504600103; Klosky James L, 2008, J Cancer Surviv, V2, P225, DOI 10.1007/s11764-008-0063-0; Kruzich JM, 2003, PSYCHIAT SERV, V54, P1513, DOI 10.1176/appi.ps.54.11.1513; Lever K, 2019, J HEAD TRAUMA REHAB, V34, pE21, DOI 10.1097/HTR.0000000000000433; Link-Gelles R, 2016, SSM-POPUL HLTH, V2, P587, DOI 10.1016/j.ssmph.2016.08.005; Lundine JP, 2019, J PEDIATR REHAB MED, V12, P21, DOI 10.3233/PRM-180568; Probst JC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-40; Robertson DB, 2013, J INJ VIOLENCE RES, V5, P51, DOI [10.5249/jivr.v5i1.205, DOI 10.5249/JIVR.V5I1.205]; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Skinner AC, 2007, J RURAL HEALTH, V23, P150, DOI 10.1111/j.1748-0361.2007.00082.x; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; University of Pittsburgh ULS, 2019, UN CENS INF PITT UND; Yang S, 2006, J HEALTH CARE POOR U, V17, P928, DOI 10.1353/hpu.2006.0137	34	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					262	268		10.1080/02699052.2019.1690679		NOV 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000495429700001	31707871				2022-02-06	
J	Xia, M; Ruan, ZY; Chen, B; Wang, YQ; Zhou, ZZ; Ren, SD; Wu, L; Tang, N				Xia, Meng; Ruan, Ziyun; Chen, Ben; Wang, Yunqiao; Zhou, Zengzi; Ren, Shiding; Wu, Lin; Tang, Nong			Wuzang Wenyang Huayu decoction regulates differentially expressed transcripts in the rats' hippocampus after cerebral hypoperfusion	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						chronic cerebral hypoperfusion; Morris water maze test; transcriptomics; vascular dementia; Wuzang Wenyang Huayu decoction	TRAUMATIC BRAIN-INJURY; VASCULAR CONTRIBUTIONS; COGNITIVE IMPAIRMENT; DEMENTIA; BIOLOGY	The modified Wenyang Huayu decoction has been widely used to treat vascular dementia in China for thousands of years. We have previously proved that a modified version, Wuzang Wenyang Huayu decoction has the potential to be a more effective clinical treatment that can attenuate cerebral ischaemic injury. However, the global transcript profile and signalling conduction pathways regulated by this recipe remains unclear. This study established a two-vessel occlusion rat model by bilateral common carotid artery occlusion. Two groups of rats were intragastrically treated Wuzang Wenyang Huayu 2.5 g/kg vs or Piracetam 0.15 g/kg for 2 weeks. Learning and memory abilities were measured with Morris water maze. Neuronal plasticity was observed by HE staining. Differentially expressed transcripts of rat hippocampus were analysed by transcriptomics with Illumina HiSeq2500 platform. Results showed that Wuzang Wenyang Huayu decoction significantly alleviated learning, memory deficits, coordination dysfunction and prevented hippocampus cellular injury; Results further revealed the increased gene expression in KEGG metabolic pathways (MT-ND2. MT-ND3, MT-ND4, MT-ND4L, MT-ND5 and MT-ATP8) and genes involved in signal transduction, carcinogenesis, immune system, endocrine system, nervous system etc (Results further revealed differential expression of genes involved in various systems, including MT-ND2) Our discovery is likely to provide new insights to molecular mechanisms of Wuzang Wenyang Huayu regarding hippocampal transcripts in a murine vascular dementia model.	[Xia, Meng; Ruan, Ziyun; Wang, Yunqiao] Guangxi Univ Chinese Med, Sch Basic Med, Nanning, Peoples R China; [Xia, Meng; Chen, Ben; Wang, Yunqiao; Ren, Shiding; Wu, Lin; Tang, Nong] Guangxi Univ Chinese Med, Guangxi Key Lab Foundat Res Chinese Med, Nanning, Peoples R China; [Zhou, Zengzi] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Ren, Shiding; Wu, Lin; Tang, Nong] Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Peoples R China		Wu, L; Tang, N (corresponding author), Guangxi Univ Chinese Med, 13 Wuhe Rd, Nanning 530200, Guangxi, Peoples R China.	15177775008@139.com; NongTangOK@163.com		Tang, Nong/0000-0003-3376-6339	Guangxi Key Lab of Chinese foundation research project [KJT1701202]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81460720, 81860805]; Guangxi University of Chinese Medicine Research Foundation [2017BS012]	Guangxi Key Lab of Chinese foundation research project, Grant/Award Number: KJT1701202; National Natural Science Foundation of China, Grant/Award Number: 81460720 and 81860805; Guangxi University of Chinese Medicine Research Foundation for introduced Ph. D, Grant/Award Number: 2017BS012	Che L, 1987, Zhonghua Yi Shi Za Zhi, V17, P79; Chen R, 1999, CHIN J MED HIST, V29, P113; Corriveau RA, 2016, CELL MOL NEUROBIOL, V36, P281, DOI 10.1007/s10571-016-0334-7; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Edison P, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00625; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Guerrini U, 2002, STROKE, V33, P825, DOI 10.1161/hs0302.104111; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kong XG, 2018, J PRACTICAL MED TECH, V25, P659; Li Jun, 2009, Zhonghua Yi Shi Za Zhi, V39, P59; Lu Z J, 1985, J Tradit Chin Med, V5, P153; Ruan WC, 2019, CELL MOL NEUROBIOL, V39, P265, DOI 10.1007/s10571-018-00646-4; Sebastian V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00038; Shin JW, 2018, AM J CHINESE MED, V46, P1203, DOI 10.1142/S0192415X18500635; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Soriano A, 2017, NAT REV RHEUMATOL, V13, P476, DOI 10.1038/nrrheum.2017.98; Tang N, 2015, J LIAONING U TRADIT, V17, P25; Varma VR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002482; Venkat P, 2019, NEUROCHEM INT, V127, P103, DOI 10.1016/j.neuint.2018.12.015; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Wang YH, 2019, NEURAL REGEN RES, V14, P470, DOI 10.4103/1673-5374.245471; Xiang J, 2016, THESIS; Yang YJ, 2016, INT J SWARM INTELL R, V7, P1, DOI 10.4018/IJSIR.2016070101; Zhai Y, 2017, THESIS; Zhang Wei-Bo, 2018, Zhen Ci Yan Jiu, V43, P424, DOI 10.13702/j.1000-0607.180185; Zhang Wei-Bo, 2013, Zhongguo Zhen Jiu, V33, P708	29	1	1	6	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	JAN	2020	24	1					294	303		10.1111/jcmm.14723		NOV 2019	10	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	JZ7TB	WOS:000495216900001	31705584	Green Published, gold			2022-02-06	
J	Tenhunen, AB; Massaro, F; Hansson, HA; Feinstein, R; Larsson, A; Perchiazzi, G				Tenhunen, Annelie Barrueta; Massaro, Fabrizia; Hansson, Hans Arne; Feinstein, Ricardo; Larsson, Anders; Perchiazzi, Gaetano			Does the antisecretory peptide AF-16 reduce lung oedema in experimental ARDS?	UPSALA JOURNAL OF MEDICAL SCIENCES			English	Article						AF-16 antisecretory factor; ARDS; extravascular lung water; pulmonary oedema	ACUTE RESPIRATORY-DISTRESS; PERMEABILITY; STRESS; STRAIN	Background: Acute respiratory distress syndrome (ARDS) is an acute inflammatory condition with pulmonary capillary leakage and lung oedema formation. There is currently no pharmacologic treatment for the condition. The antisecretory peptide AF-16 reduces oedema in experimental traumatic brain injury. In this study, we tested AF-16 in an experimental porcine model of ARDS. Methods: Under surgical anaesthesia 12 piglets were subjected to lung lavage followed by 2 hours of injurious ventilation. Every hour for 4 hours, measurements of extravascular lung water (EVLW), mechanics of the respiratory system, and hemodynamics were obtained. Results: There was a statistically significant (p = 0.006, two-way ANOVA) reduction of EVLW in the AF-16 group compared with controls. However, this was not mirrored in any improvement in the wet-to-dry ratio of lung tissue samples, histology, inflammatory markers, lung mechanics, or gas exchange. Conclusions: This pilot study suggests that AF-16 might improve oedema resolution as indicated by a reduction in EVLW in experimental ARDS.	[Tenhunen, Annelie Barrueta; Massaro, Fabrizia; Larsson, Anders; Perchiazzi, Gaetano] Uppsala Univ, Dept Surg Sci, Hedenstierna Lab, S-75185 Uppsala, Sweden; [Massaro, Fabrizia] Anthea Hosp, GVM Care & Res, Cardiac Anesthesia & Intens Care, Bari, Italy; [Hansson, Hans Arne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Feinstein, Ricardo] Natl Vet Inst, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden		Tenhunen, AB (corresponding author), Uppsala Univ, Dept Surg Sci, Hedenstierna Lab, S-75185 Uppsala, Sweden.	annelie.barrueta@surgsci.uu.se		Larsson, Anders/0000-0002-0702-8343; Perchiazzi, Gaetano/0000-0001-6834-6399	Swedish Heart and Lung FoundationSwedish Heart-Lung Foundation [20170531]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [X2015-99x-22731-01-4]; ALF grants of Uppsala University Hospital	This study was supported by the Swedish Heart and Lung Foundation (grant no. 20170531), the Swedish Research Council (grant no. X2015-99x-22731-01-4), and ALF grants of Uppsala University Hospital.	Al-Olama M, 2011, ACTA ONCOL, V50, P1098, DOI 10.3109/0284186X.2011.562240; ASHBAUGH DG, 1967, LANCET, V2, P319; BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bjorck S, 2000, GUT, V46, P824, DOI 10.1136/gut.46.6.824; Chiumello D, 2008, AM J RESP CRIT CARE, V178, P346, DOI 10.1164/rccm.200710-1589OC; Clausen F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00039; Davidson TS, 2004, J LEUKOCYTE BIOL, V76, P835, DOI 10.1189/jlb.0204085; Eriksson A, 2003, SCAND J GASTROENTERO, V38, P1045, DOI 10.1080/00365520310005064; Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907; Hanner P, 2010, ACTA OTO-LARYNGOL, V130, P223, DOI 10.3109/00016480903022842; Hansson Hans-Arne, 2012, Acta Neurochir Suppl, V114, P377, DOI 10.1007/978-3-7091-0956-4_73; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Jennische E, 2008, BRAIN RES, V1227, P189, DOI 10.1016/j.brainres.2008.05.083; Johansson E, 1997, BBA-MOL BASIS DIS, V1362, P177, DOI 10.1016/S0925-4439(97)00066-5; Johansson E, 2013, BRIT J NUTR, V109, P2247, DOI 10.1017/S0007114512004552; Johansson E, 2009, J IMMUNOL METHODS, V342, P64, DOI 10.1016/j.jim.2008.11.018; Jozwiak M, 2013, CRIT CARE MED, V41, P472, DOI 10.1097/CCM.0b013e31826ab377; Keenan JC, 2014, CURR OPIN CRIT CARE, V20, P63, DOI 10.1097/MCC.0000000000000054; Kim M, 2005, REGUL PEPTIDES, V129, P109, DOI 10.1016/j.regpep.2005.01.018; LANGE S, 1987, PFLUG ARCH EUR J PHY, V410, P648, DOI 10.1007/BF00581326; Lange S, 2001, INT REV CYTOL, V210, P39; Lonnroth I, 2003, APMIS, V111, P969, DOI 10.1034/j.1600-0463.2003.1111009.x; Lumb AB., 2000, NUNNS APPL RESP PHYS; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; MEAD R, 1990, J R STAT SOC A STAT, V153, P151, DOI 10.2307/2982800; Perchiazzi G, 2011, J APPL PHYSIOL, V110, P1374, DOI 10.1152/japplphysiol.00439.2010; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; RAPALLINO MV, 1989, INT J NEUROSCI, V46, P93, DOI 10.3109/00207458908986244; Retamal J, 2016, ACTA ANAESTH SCAND, V60, P79, DOI 10.1111/aas.12596; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; Ulgheri C, 2010, NUTR RES REV, V23, P300, DOI 10.1017/S0954422410000193	34	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0300-9734	2000-1967		UPSALA J MED SCI	Ups. J. Med. Sci.		2019	124	4					246	253		10.1080/03009734.2019.1685029		NOV 2019	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY0BE	WOS:000495161000001	31701794	Green Published, gold			2022-02-06	
J	Harbert, A; Northam, W; Elton, S; Quinsey, C				Harbert, Allie; Northam, Weston; Elton, Scott; Quinsey, Carolyn			Targeted head CT reduction for pediatric patients with hydrocephalus and traumatic brain injury: academic center institutional experience as an example of opportunities for further improvement	CHILDS NERVOUS SYSTEM			English	Article						Computed tomography; Hydrocephalus; TBI; Ionizing radiation; Rapid-sequence MRI	COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CHILDREN; CANCER; RISKS; SCANS; MRI	Purpose Recent studies aim to reduce radiation exposure associated with computed tomography (CT) using rapid-sequence magnetic resonance imaging (MRI). We evaluated imaging modalities used for hydrocephalus and traumatic brain injury (TBI) to identify opportunities for further radiation exposure reduction. Methods Pediatric (<= 18 years) patients, with either hydrocephalus or TBI receiving a head CT or head MRI from 2009 to 2017, were quantified using ICD9, ICD10, and CPT codes at a large university hospital. The odds ratios of receiving each imaging modality year-to-year and receiving a MRI or CT in a given year with each diagnosis were calculated. Results Beginning in 2015, hydrocephalus patients were more likely to receive a MRI vs CT (p < 0.0001), with likelihood increasing in the following 2 years. TBI patients were more likely to receive a CT than an MRI from 2009 to 2017. There was a smaller overall decrease in CT scans in TBI patients (p < 0.05) than hydrocephalus patients (p < 0.0001) and a larger increase in MRI use in hydrocephalus patients (p < 0.05) than TBI patients (p < 0.05) from 2009 to 2017. Conclusions Use of CT to evaluate hydrocephalus significantly decreased over the last 3-year time period. However, CT use for TBI patients was inconsistent and did not decrease proportionally, potentially representing a belief that CT is more effective than MRI for detecting hemorrhage. There was greater use of MRI as an alternate imaging method in hydrocephalus patients than TBI patients. Head injury remains an area of improvement to decrease pediatric radiation exposure at our institution and may be an area in need of attention more broadly.	[Harbert, Allie] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Northam, Weston; Elton, Scott; Quinsey, Carolyn] Univ N Carolina, Dept Neurosurg, Sch Med, Chapel Hill, NC 27515 USA		Quinsey, C (corresponding author), Univ N Carolina, Dept Neurosurg, Sch Med, Chapel Hill, NC 27515 USA.	Carolyn_Quinsey@med.unc.edu		Quinsey, Carolyn/0000-0002-5232-8492	Carolina Medial Student Research Program	This work was supported by the Carolina Medial Student Research Program. On behalf of all authors, the corresponding author states that there is no conflict of interest.	Aldrink JH, 2016, PEDIATR SURG INT, V32, P565, DOI 10.1007/s00383-016-3894-1; Antonucci MC, 2017, J PEDIATR-US, V182, P210, DOI 10.1016/j.jpeds.2016.11.051; Aw-Zoretic J, 2014, EUR J RADIOL, V83, P1920, DOI 10.1016/j.ejrad.2014.07.006; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Engineer RS, 2021, PEDIATR EMERG CARE, V37, pE1670, DOI 10.1097/PEC.0000000000001501; Florin TA, 2015, J PEDIATR-US, V167, P1382, DOI 10.1016/j.jpeds.2015.09.024; Gabriel S, 2014, AM J NEURORADIOL, V35, P2237, DOI 10.3174/ajnr.A4056; Halaweish I, 2018, J PEDIATR SURG, V53, P748, DOI 10.1016/j.jpedsurg.2017.07.008; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Iskandar BJ, 2004, J NEUROSURG, V101, P147, DOI 10.3171/ped.2004.101.2.0147; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McGrew PR, 2018, J TRAUMA ACUTE CARE, V85, P451, DOI 10.1097/TA.0000000000001974; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sheppard John P, 2018, Brain Tumor Res Treat, V6, P1, DOI 10.14791/btrt.2018.6.e4; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Yue EL, 2015, J NEUROSURG-PEDIATR, V15, P420, DOI 10.3171/2014.9.PEDS14207	22	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2020	36	3					583	589		10.1007/s00381-019-04376-w		NOV 2019	7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	KN0OG	WOS:000494778200001	31696289				2022-02-06	
J	Ceccarelli , F; Pirone, C; Mina, C; Mascolo, A; Perricone, C; Massaro, L; Spinelli, FR; Alessandri, C; Valesini, G; Conti, F				Ceccarelli, Fulvia; Pirone, Carmelo; Mina, Concetta; Mascolo, Alfredo; Perricone, Carlo; Massaro, Laura; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido; Conti, Fabrizio			Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION; DEFICITS; BRAIN; CRITERIA; INDEX	Background Cognitive impairment (CI) in systemic lupus erythematosus (SLE) is a frequent neuropsychiatric manifestation affecting several domains, even in apparently asymptomatic patients. Current research revealed that the typical CI pattern affects frontal-subcortical circuit and thus executive functions. The impairment of non-literal language or pragmatic language (PL), including metaphors, idioms, inferences or irony has been well described in several conditions such as autism disorders, Parkinson's disease, brain injury and even in earlier phases of neurodegenerative processes. Even if PL neuro-anatomy remains controversial, correlation between executive dysfunctions and non-literal language involvement has been reported both in traumatic injury and mild cognitive impairment patients. Nonetheless, no specific study has been performed to evaluate PL impairment in SLE patients so far. Objectives We aimed at assessing the PL domain in a Italian monocentric SLE cohort in comparison to healthy controls, matched to age and education, through a specific battery, the batteria sul linguaggio dell'emisfero destro (BLED). Secondly, we focused attention on possible correlations between CI and clinical and laboratory SLE-related features. Methods Forty adult patients affected by SLE, according to the American College of Rheumatology (ACR) criteria, and thirty healthy subjects were enrolled consecutively in this cross-sectional study. The protocol included complete physical examination, extensive clinical and laboratory data collection (comprehensive of demographics, past medical history, co-morbidities, disease activity, chronic damage evaluation, previous and concomitant treatments) and cognitive assessment for five different domains: memory, attention, pragmatic language, executive and visuospatial functions. Self-reported scale for anxiety and depression were performed to exclude the influence of mood disorders on cognitive dysfunction. Results We studied 40 Caucasian SLE patients [male (M)/ female (F) 3/37; mean +/- standard deviation (SD) age 45.9 +/- 10.1 years, mean +/- SD disease duration 120.8 +/- 81.2 months] and 30 healthy subjects (M/F 9/21; mean +/- SD age 41.3 +/- 13 years). According to the low level of disease activity and damage (mean +/- SD Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) of 1.3 +/- 2.3, mean +/- SD Systemic Lupus International Collaborative Clinics/American College of Rheumatology (SLICC/ACR) Damage Index (SDI) of 0.2 +/- 0.5), only 30% of patients was on glucocorticoid treatment at the study entry. PL was the most compromised domain in terms of Mean Domain Z scores. As for the Domain Cognitive Dysfunction score, a deficit of PL was observed in 45% of patients and was significantly more prevalent than memory, executive and visuospatial functions impairment (P = 0.0002, P = 0.0002 and P < 0.000001, respectively). According to Global Cognitive Dysfunction score, 25% of patients experienced a mild impairment and 7.5% a moderate one. Anti-phospholipid antibodies positivity was significantly associated with memory impairment (P < 0.0005), whereas the presence of other neuropsychiatric events was associated with executive dysfunctions (P < 0.05); no further significant association nor correlation were identified. Conclusion In this study we evaluated for the first time PL in SLE patients finding a dysfunction in almost half of patients. The dysfunction of PL was significantly more frequent than the other domains assessed.	[Ceccarelli, Fulvia; Pirone, Carmelo; Perricone, Carlo; Massaro, Laura; Spinelli, Francesca Romana; Alessandri, Cristiano; Valesini, Guido; Conti, Fabrizio] Sapienza Univ Rome, Dipartimento Med Interna & Specialita Med, Lupus Clin, Rome, Italy; [Mina, Concetta] Sapienza Univ Roma, Dipartimento Neurol & Psichiatria, Rome, Italy; [Mascolo, Alfredo] Univ Roma Tor Vergata, Dipartimento Neurosci, Clin Neurol, Rome, Italy		Conti, F (corresponding author), Sapienza Univ Rome, Dipartimento Med Interna & Specialita Med, Lupus Clin, Rome, Italy.	fabrizio.conti@uniroma1.it	Spinelli, Francesca Romana/AAM-7061-2020	Spinelli, Francesca Romana/0000-0003-1969-2097; Perricone, Carlo/0000-0003-4771-6981; Pirone, Carmelo/0000-0002-3131-3523			Alarcon GS, 2002, ARTHRIT RHEUM-ARTHR, V47, P310, DOI 10.1002/art.10457; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Brown-Schmidt S, 2009, PSYCHON B REV, V16, P893, DOI 10.3758/PBR.16.5.893; BUCHBINDER R, 1988, AUST NZ J MED, V18, P679, DOI 10.1111/j.1445-5994.1988.tb00150.x; Burns Martha S., 1996, Seminars in Speech and Language, V17, P115, DOI 10.1055/s-2008-1064092; Cardoso S, 2014, PSYCHOGERIATRICS, V14, P222, DOI 10.1111/psyg.12101; CARLESIMO GA, 1995, J CLIN EXP NEUROPSYC, V17, P691, DOI 10.1080/01688639508405159; Carotenuto A, 2018, EUR J NEUROL, V25, P205, DOI 10.1111/ene.13482; Ceccarelli F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196103; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033824; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaudreau G, 2013, NEUROPSYCHOLOGY, V27, P702, DOI 10.1037/a0034655; Gernsbacher MA, 1999, J PRAGMATICS, V31, P1619, DOI 10.1016/S0378-2166(99)00007-7; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hanly JG, 2005, J RHEUMATOL, V32, P1459; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Kozora E, 2016, ARTHRIT CARE RES, V68, P1655, DOI 10.1002/acr.22873; Kozora E, 2004, ARTHRIT RHEUM-ARTHR, V51, P810, DOI 10.1002/art.20692; Kozora E, 2008, ARTHRIT RHEUM-ARTHR, V59, P1639, DOI 10.1002/art.24189; Kramer S, 2001, INT J LANG COMM DIS, V36, P132, DOI 10.3109/13682820109177872; Leslie B, 2018, LUPUS; Leyhe T, 2011, DEMENT GER COGN D EX, V1, P51, DOI 10.1159/000323864; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; Mikdashi J, 2007, LUPUS, V16, P418, DOI 10.1177/0961203307079044; Nantes SG, 2017, J RHEUMATOL, V44, P1583, DOI 10.3899/jrheum.161125; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Rinaldi M. C., 2006, BLED SANTALUCIA BATT; Sarbu N, 2015, AUTOIMMUN REV, V14, P153, DOI 10.1016/j.autrev.2014.11.001; Spinnler H, 1987, Funct Neurol, V2, P5; Van Lier S, 2016, ACTA NEUROL BELG, V116, P163, DOI 10.1007/s13760-015-0546-5; ZUNG WWK, 1971, J CLIN PSYCHOL, V27, P247, DOI 10.1002/1097-4679(197104)27:2<247::AID-JCLP2270270230>3.0.CO;2-6	35	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0224437	10.1371/journal.pone.0224437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1AJ	WOS:000532676800016	31682630	Green Published, gold			2022-02-06	
J	Fox, B; Verona, E; Fournier, L				Fox, Bryanna; Verona, Edelyn; Fournier, Lauren			Psychological assessment of risk in a county jail: implications for reentry, recidivism and detention practices in the USA	JOURNAL OF CRIMINAL PSYCHOLOGY			English	Article							DIALECTICAL BEHAVIOR-THERAPY; TRAUMATIC BRAIN-INJURY; MENTALLY-ILL; PSYCHIATRIC-DISORDERS; UNITED-STATES; HEAD-INJURIES; LIFE-HISTORY; OFFENDERS; PRISON; AGGRESSION		[Fox, Bryanna] Univ S Florida, Dept Criminol, Sarasota, FL 34243 USA; [Verona, Edelyn; Fournier, Lauren] Univ S Florida, Dept Psychol, Sarasota, FL USA		Fox, B (corresponding author), Univ S Florida, Dept Criminol, Sarasota, FL 34243 USA.		Verona, Edelyn/AAJ-2689-2021; Fournier, Lauren F./AAB-4779-2021	Verona, Edelyn/0000-0002-3739-5283; Fournier, Lauren F./0000-0002-7354-4709			Adams K, 2008, CRIM JUSTICE BEHAV, V35, P913, DOI 10.1177/0093854808318624; Aiken Joshua, 2017, ERA MASS EXPANSION W; Andrews DA, 2010, PSYCHOL PUBLIC POL L, V16, P39, DOI 10.1037/a0018362; Andrews D.A., 2006, PSYCHOL CRIMINAL CON, V4th ed.; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Bennett T, 2008, AGGRESS VIOLENT BEH, V13, P107, DOI 10.1016/j.avb.2008.02.001; Blanco C, 2007, DRUG ALCOHOL DEPEN, V90, P252, DOI 10.1016/j.drugalcdep.2007.04.005; Bronson J., 2017, INDICATORS MENTAL HL, P1; BURGESS RL, 1966, SOC PROBL, V14, P128, DOI 10.1525/sp.1966.14.2.03a00020; Canales DD, 2014, CRIM JUSTICE BEHAV, V41, P971, DOI 10.1177/0093854814523003; Cauley CE, 2017, ANN SURG, V265, P702, DOI 10.1097/SLA.0000000000001945; Chammah Maurice, 2016, SANDRA BLAND ONE YEA; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Cloyes KG, 2010, CRIM JUSTICE BEHAV, V37, P175, DOI 10.1177/0093854809354370; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Comen E., 2018, MSN ONLINE; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Cromartie J., 2018, EIB200 USDA EC RES S; DeLisi M, 2006, J CRIM JUST, V34, P153, DOI 10.1016/j.jcrimjus.2006.01.005; Dietz EF, 2003, INT J OFFENDER THER, V47, P210, DOI 10.1177/0306624X03251088; Dimeff Linda A, 2008, Addict Sci Clin Pract, V4, P39; Dobbie W, 2018, AM ECON REV, V108, P201, DOI 10.1257/aer.20161503; Drake E. K., 2006, RECIDIVISM FINDINGS; Eslinger D., 2014, TREATMENT PERSONS ME; Evershed Sue, 2003, Crim Behav Ment Health, V13, P198, DOI 10.1002/cbm.542; Farrington D.P., 2012, VIOLENT OFFENDERS TH, P143; FEDER L, 1991, LAW HUMAN BEHAV, V15, P477, DOI 10.1007/BF01650290; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fox B, 2019, AGGRESS VIOLENT BEH, V44, P67, DOI 10.1016/j.avb.2018.11.005; Fox KA, 2010, J CRIM JUST, V38, P720, DOI 10.1016/j.jcrimjus.2010.04.046; Freudenberg N, 2005, AM J PUBLIC HEALTH, V95, P1725, DOI 10.2105/AJPH.2004.056325; Gee J, 2013, EUR J PSYCHOTHER COU, V15, P233, DOI 10.1080/13642537.2013.810659; Gladden RM, 2016, MMWR-MORBID MORTAL W, V65, P837, DOI 10.15585/mmwr.mm6533a2; Gonnerman J., 2014, The New Yorker; Gonzales Gilbert, 2006, Behav Healthc, V26, P24; Gordon RA, 2014, J RES ADOLESCENCE, V24, P235, DOI 10.1111/jora.12124; Gottfredson M. R., 1990, GEN THEORY CRIME; Grisso T, 2003, LAW HUMAN BEHAV, V27, P333, DOI 10.1023/A:1024065015717; Grisso T, 2000, MASSACHUSETTS YOUTH; Gupta A, 2016, J LEGAL STUD, V45, P471, DOI 10.1086/688907; Hare R.D., 1991, HARE PSYCHOPATHY CHE, V1st ed.; Hare R.D., 2003, HARE PSYCHOPATHY CHE; HENRICHSON C, 2017, FEDERAL SENTENCING R, V29, P85, DOI DOI 10.2307/26377039; Hofvander B, 2011, PSYCHIAT RES, V185, P280, DOI 10.1016/j.psychres.2010.05.008; Hunt K., 2016, RECIDIVISM FEDERAL O; Irwin J., 2013, JAIL MANAGING UNDERC; Ivanoff A., 2018, OXFORD HDB DIALECTIC, P1, DOI 10.1016/B978-0-12-803951-9.00001-X; James D.J., 2006, MENTAL HLTH PROBLEMS; Jones Cynthia E., 2013, NYU J LEGIS PUB POLY, V16, P919; Knight DK, 2018, J OFFENDER REHABIL, V57, P525, DOI 10.1080/10509674.2018.1549180; Levin M., 2018, OPEN ROADS OVERFLOWI; Linehan M., 2014, DBT SKILLS TRAINING; Linehan MM, 2002, DRUG ALCOHOL DEPEN, V67, P13, DOI 10.1016/S0376-8716(02)00011-X; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Linehan MM., 1993, COGNITIVE BEHAV TREA; Lowenkamp C. T., 2013, HIDDEN COSTS PRETRIA; Lutfiyya MN, 2012, DM-DIS MON, V58, P620, DOI 10.1016/j.disamonth.2012.08.005; Manuck SB, 1998, NEUROPSYCHOPHARMACOL, V19, P287, DOI 10.1038/sj.npp.1395199; McDonald DC, 2012, J PAIN, V13, P988, DOI 10.1016/j.jpain.2012.07.007; Minton T.D., 2015, JAIL INMATES MIDYEAR; Moore KE, 2018, PSYCHOL SERV, V15, P98, DOI 10.1037/ser0000105; Mulvey EP, 2017, CRIME JUSTICE, V46, P231, DOI 10.1086/688461; Nee Claire, 2005, Crim Behav Ment Health, V15, P2, DOI 10.1002/cbm.33; Palombi LC, 2018, ANN EPIDEMIOL, V28, P641, DOI 10.1016/j.annepidem.2018.05.008; Paulozzi LJ, 2006, AM J PUBLIC HEALTH, V96, P1755, DOI 10.2105/AJPH.2005.071647; Petersilia J., 2001, PRISON J, V81, P360, DOI [10.1177/0032885501081003004, DOI 10.1177/0032885501081003004]; Pinto Nick, 2015, NY TIMES; Posner K, 2008, COLUMBIA SUICIDE SEV; Rabuy B., 2016, DETAINING POOR MONEY; Reaves B., 2013, FELONY DEFENDANTS LA; Rigg KK, 2015, INT J DRUG POLICY, V26, P484, DOI 10.1016/j.drugpo.2014.10.001; Robert Wood Johnson Foundation, 2019, COUNT HLTH RANK KEY; Roscigno VJ, 2001, RURAL SOCIOL, V66, P268, DOI 10.1111/j.1549-0831.2001.tb00067.x; Rosenfeld B., 2007, INT J FORENSIC MENT, V6, P95, DOI [DOI 10.1080/14999013.2007.10471254, 10.1080/14999013.2007.10471254]; Rosenfeld R., 2017, ASSESSING RESPONDING; Sakdalan JA, 2010, J INTELL DISABIL RES, V54, P568, DOI 10.1111/j.1365-2788.2010.01274.x; Sampson R.J., 1993, CRIME MAKING PATHWAY; Sarteschi CM, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013497029; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Schwirtz M., 2015, NY TIMES; Seffrin PM, 2014, J DRUG ISSUES, V44, P394, DOI 10.1177/0022042614526994; Sheehan D. V., 2014, MINIINTERNATIONAL NE; Shelton D, 2009, BEHAV SCI LAW, V27, P787, DOI 10.1002/bsl.889; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Smith PS, 2006, CRIME JUSTICE, V34, P441, DOI 10.1086/500626; Stewart EA, 2010, CRIMINOLOGY, V48, P569, DOI 10.1111/j.1745-9125.2010.00196.x; Subramaniam Ram., 2017, OUT SIGHT GROWTH JAI; Subramanian Ram, 2015, INCARCERATIONS FRONT; Sugiea NF, 2017, AM SOCIOL REV, V82, P719, DOI 10.1177/0003122417713188; Sullivan JP, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/8/085702; Trestman RL, 2007, J AM ACAD PSYCHIATRY, V35, P490; Turney K, 2019, ANNU REV CRIMINOL, V2, P265, DOI 10.1146/annurev-criminol-011518-024601; US Census, 2017, WELC QUICK FACTS; Walden AL, 2019, J PREV INTERV COMMUN, V47, P90, DOI 10.1080/10852352.2019.1582147; Ward KC, 2016, PRISON J, V96, P27, DOI 10.1177/0032885515605473; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Zeng Z, 2018, JAIL INMATES IN 2016	98	1	1	0	11	EMERALD GROUP PUBLISHING LTD	BINGLEY	HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND	2009-3829			J CRIM PSYCHOL	J. Crim. Psychol.	NOV 4	2019	9	4					173	186		10.1108/JCP-11-2019-051			14	Criminology & Penology	Emerging Sources Citation Index (ESCI)	Criminology & Penology	JR6GQ	WOS:000499721900004					2022-02-06	
J	Udala, M; Clark, J; Miller, H; Leitner, D; Libben, M				Udala, Megan; Clark, Jeneya; Miller, Harry; Leitner, Damian; Libben, Maya			Psychological disturbance and cognitive functioning in TBI patients	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Cognition; neuropsychological tests; personality; psychological disturbance	TRAUMATIC BRAIN-INJURY; UNITED-STATES; EXECUTIVE FUNCTION; TEST-SCORES; MEMORY; DEPRESSION; ATTENTION; ANXIETY; PERFORMANCE; ABILITY	The current study examined psychopathology and neuropsychological test performance in a traumatic brain injury (TBI) patient sample. Previous research has found that the Minnesota Multiphasic Personality Inventory ? Second Edition (MMPI-2) indices of psychological disturbance were related to specific neuropsychological tests of attention and memory. Furthermore, higher scores on clinical scale 2 (Depression) and higher scores on the content scales of Fears and Bizarre Mentation of the MMPI-2 were related to poorer performance in, most notably, Attention and List Learning factors. The present study sought to extend the research by adding a neuropsychological measure of conceptual reasoning. A sample of 116 TBI patients referred for evaluation at a private practice clinic were administered a battery of neuropsychological measures of list learning, working memory, verbal memory, visuographic memory, and conceptual reasoning, as well as the MMPI-2 to assess emotional functioning. Regression analysis indicated that an overall model of MMPI-2 indices significantly predicted poorer performance on List Learning. More specifically, higher scores on the content scales of Obsessions and Fears were most robustly associated with poorer neuropsychological test performance for List Learning and Working Memory respectively. Findings suggest psychopathology is correlated with performance on neuropsychological measures for TBI patients.	[Udala, Megan; Clark, Jeneya; Miller, Harry; Leitner, Damian; Libben, Maya] Univ British Columbia Okanagan, Psychol, Kelowna, BC, Canada		Udala, M (corresponding author), Univ British Columbia Okanagan, ASC II ASC 201, 3187 Univ Way, Kelowna, BC V1V 1V7, Canada.	megan.udala@ubc.ca					Arciniegas D. B., 2013, MANAGEMENT ADULTS TR; Armitage SG, 1946, PSYCHOL MONOGR, V60, P1; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Bozikas VP, 2004, COMPR PSYCHIAT, V45, P392, DOI 10.1016/j.comppsych.2004.03.006; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Butcher J, 1989, MANUAL ADM SCORING M; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; Edmundson M, 2016, PSYCHOL INJ LAW, V9, P121, DOI 10.1007/s12207-015-9236-0; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Gass C. S., 2009, OXFORD HDB PERSONALI, P432; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Guidotti L. M., 2013, MILD TRAUMATIC BRAIN, P145; Guimond S, 2016, NEUROIMAGE-CLIN, V11, P20, DOI 10.1016/j.nicl.2015.12.010; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hill BD, 2008, ARCH CLIN NEUROPSYCH, V23, P823, DOI 10.1016/j.acn.2008.07.003; Hoelzle JB, 2011, J CLIN EXP NEUROPSYC, V33, P283, DOI 10.1080/13803395.2010.511603; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorge R., 2014, NEUROPSYCHIATRY TRAU; Kindermann SS, 1997, J CLIN EXP NEUROPSYC, V19, P625, DOI 10.1080/01688639708403749; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehto JE, 2003, BRIT J DEV PSYCHOL, V21, P59, DOI 10.1348/026151003321164627; Leitner D, 2019, APPL NEUROPSYCH-ADUL, V26, P124, DOI 10.1080/23279095.2017.1362561; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Martin PK, 2015, ARCH CLIN NEUROPSYCH, V30, P377, DOI 10.1093/arclin/acv032; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Ross SR, 2003, ARCH CLIN NEUROPSYCH, V18, P905, DOI 10.1016/S0887-6177(02)00169-5; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smitherman TA, 2007, ARCH CLIN NEUROPSYCH, V22, P647, DOI 10.1016/j.acn.2007.04.007; Thurstone L.L., 1938, PRIMARY MENTAL ABILI; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Tsushima WT, 2005, ARCH CLIN NEUROPSYCH, V20, P667, DOI 10.1016/j.acn.2005.04.003; Waldstein SR, 1997, ARCH CLIN NEUROPSYCH, V12, P567; Watari K, 2006, ARCH CLIN NEUROPSYCH, V21, P787, DOI 10.1016/j.acn.2006.06.014; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weschler D, 2008, WECHSLER ADULT INTEL; Weschler D., 2009, WECHSLER MEMORY SCAL	48	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2019	26	6					581	590		10.1080/23279095.2018.1460370			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9ER	WOS:000488884700009	30183362				2022-02-06	
J	Ballan, MS; Freyer, M				Ballan, Michelle S.; Freyer, Molly			Intimate Partner Violence and Women With Disabilities: The Role of Speech-Language Pathologists	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CHILD MALTREATMENT; MENTAL-HEALTH; SEXUAL-ABUSE; IMPAIRMENT; PREVALENCE; FREQUENCY; VICTIMS; ADULTS; GIRLS	This article is a call to action for speech-language pathologists to address the overlooked problem of intimate partner violence (IPV) among women with communication disorders (CDs). The article aims to heighten awareness of the higher rates of IPV in women with disabilities compared to those without, and to identify types of CDs that can result from IPV. The article provides background on CDs and IPV and delineates the role speech-language pathologists can play in identifying abuse and assisting patients to disclose IPV. Practice recommendations are provided, including enhanced IPV assessment for women with CDs, best practices for intervention emphasizing a trauma-informed approach, and the importance of collaboration and appropriate referrals.	[Ballan, Michelle S.; Freyer, Molly] SUNY Stony Brook, Sch Social Welf, New York, NY USA		Ballan, MS (corresponding author), SUNY Stony Brook, Sch Social Welf, New York, NY USA.	Michelle.ballan@stonybrook.edu					Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Ballan M.S., 2017, ADV SOC WORK, V18, P131, DOI [10.18060/21308, DOI 10.18060/21308]; Ballan MS, 2017, VIOLENCE AGAINST WOM, V23, P1585, DOI 10.1177/1077801216664428; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Barrett H, 2017, UNDERSTANDING SEXUAL; Barrett KA, 2009, WOMEN HEALTH ISS, V19, P94, DOI 10.1016/j.whi.2008.10.005; Black M C., 2011, NATL INTIMATE PARTNE; Black MC, 2011, AM J LIFESTYLE MED, V5, P428, DOI 10.1177/1559827611410265; Breiding MJ, 2015, ANN EPIDEMIOL, V25, P455, DOI 10.1016/j.annepidem.2015.03.017; Breiding MJ., 2015, INTIMATE PARTNER VIO; Brigham and Women's Hospital, 2013, DOM AB PROT; Brownlie EB, 2007, J ABNORM CHILD PSYCH, V35, P618, DOI 10.1007/s10802-007-9117-4; Brownlie EB, 2017, J CHILD PSYCHOL PSYC, V58, P1114, DOI 10.1111/jcpp.12723; Brownridge DA, 2006, VIOLENCE AGAINST WOM, V12, P805, DOI 10.1177/1077801206292681; Cesaro BC, 2016, DISTURBIOS COMUNICAC, V28, P462; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Collier B, 2006, AUGMENT ALTERN COMM, V22, P62, DOI 10.1080/07434610500387490; Elliott DE, 2005, J COMMUNITY PSYCHOL, V33, P461, DOI 10.1002/jcop.20063; Ferguson JE, 2010, AM J OBSTET GYNECOL, V202, P635, DOI 10.1016/j.ajog.2010.02.005; Florida State University, 2014, COND INJ REL VIOL NA; Ghandour RM, 2015, J WOMENS HEALTH, V24, P57, DOI 10.1089/jwh.2014.4885; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Harris, 2009, COMMUNITY CONNECTION, V2, P1; Jay I., 2015, THESIS; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; MacDonald S., 2015, COGNITIVE COMMUNICAT; Marshall J, 2018, INT J SPEECH-LANG PA, V20, P44, DOI 10.1080/17549507.2017.1392608; McFarlane J, 2001, J WOMEN HEALTH GEN-B, V10, P861, DOI 10.1089/152460901753285750; Mitra M, 2012, MATERN CHILD HLTH J, V16, P802, DOI 10.1007/s10995-011-0784-y; Monahan S, 2018, MINN BRAIN INJ ALL A; Noguchi Milica Satake, 2006, Pró-Fono R. Atual. Cient., V18, P41, DOI 10.1590/S0104-56872006000100006; Pollard RQ, 2014, J INTERPERS VIOLENCE, V29, P948, DOI 10.1177/0886260513505703; Royal College of Speech and Language Therapists, SAF CHILDR COMM NEED; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Snow PC, 2009, INT J SPEECH-LANG PA, V11, P95, DOI 10.1080/17549500802415712; Valera EM, 2018, J WOMENS HEALTH, V27, P735, DOI 10.1089/jwh.2017.6838; Ward KM, 2010, INTELLECT DEV DISAB, V48, P89, DOI 10.1352/1934-9556-48.2.89; Williams LM, 2015, J INTERPERS VIOLENCE, V30, P2304, DOI 10.1177/0886260514552443; World Health Organization (WHO), 2010, FRAM ACT INT ED COLL; Yehuda Na'ama, 2005, J Trauma Dissociation, V6, P9, DOI 10.1300/J229v06n01_02; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	42	1	2	1	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2019	28	4					1692	1697		10.1044/2019_AJSLP-18-0259			6	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JP0ML	WOS:000497966200022	31419158				2022-02-06	
J	Betthauser, LM; Adams, RS; Hostetter, TA; Scher, AI; Schwab, K; Brenner, LA				Betthauser, Lisa M.; Adams, Rachel Sayko; Hostetter, Trisha A.; Scher, Ann I.; Schwab, Karen; Brenner, Lisa A.			Characterization of Lifetime TBIs in a Cohort of Recently Deployed Soldiers: The Warrior Strong Study	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; lifetime history; deployment; soldiers; OEF/OIF	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MULTIPLE CONCUSSIONS; BEHAVIORAL OUTCOMES; MILITARY PERSONNEL; CHRONIC PAIN; RISK; DUTY	Objective: To describe and characterize the lifetime history of traumatic brain injury (TBI) among active duty soldiers returning from deployment to Afghanistan or Iraq. Method: Data were extracted from a larger parent study that was conducted at two large United States Army bases between 2009 and 2014 during Post-Deployment Health Assessment. The sample included 1,060 soldiers who sustained at least one TBI during their lifetime. Results: The Ohio State University TBI-Identification Method interview was administered to characterize individuals' total lifetime history of TBI. Soldiers reported sustaining a median of 2 lifetime TBIs. Slightly more than half of the sample without a most recent deployment-related TBI still reported a history of a lifetime TBI (some of which occurred during previous deployments). Most lifetime injuries reported were of mild severity; however, 6% of individuals reported a history of moderate/severe TBI. Blast was the most frequent mechanism associated with recent deployment-related mild TBIs. Conclusion: Findings suggest that soldiers who screened positive, as well as those who screened negative, for a history of TBI during their recent deployment still endorsed a lifetime history of TBI. Future research is needed to explore the functional impact of multiple TBIs over one's lifetime to help inform screening, assessment, and treatment among military personnel. Impact and Implications Although soldiers in this sample mostly reported mild traumatic brain injuries (TBIs), 6% of individuals reported lifetime moderate to severe TBIs. Moreover, a number of soldiers reported a history of nondeployment TBIs. A history of such injuries may contribute to persistent post-TBI symptoms, as well as postmilitary functional challenges. Additional research to investigate the timing, severity, and history of multiple TBIs on short- and long-term outcomes is indicated.	[Betthauser, Lisa M.; Adams, Rachel Sayko; Hostetter, Trisha A.; Brenner, Lisa A.] VA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 North Wheeling St, Aurora, CO 80045 USA; [Betthauser, Lisa M.; Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Adams, Rachel Sayko] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, Waltham, MA 02254 USA; [Scher, Ann I.; Schwab, Karen] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA		Betthauser, LM (corresponding author), VA Rocky Mt Mental Illness Res Educ & Clin Ctr, 1700 North Wheeling St, Aurora, CO 80045 USA.	lisa.betthauser@va.gov	Adams, Rachel/AAH-4653-2020; Brenner, Lisa A./AAG-2442-2019	Scher, Ann/0000-0003-4599-9834			Adams RS, 2017, J NEUROTRAUM, V34, P1457, DOI 10.1089/neu.2016.4693; Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Faul M, 2010, TRAUMATIC BRAIN INJU; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2009, GULF WAR HLTH, V7; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Yumul JN, 2016, PM&R, V8, P1097, DOI 10.1016/j.pmrj.2016.05.005	42	1	1	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2019	64	4					398	406		10.1037/rep0000286			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	JF3KC	WOS:000491284200002	31368742				2022-02-06	
J	Bobeff, EJ; Posmyk, BJ; Bobeff, KL; Fortuniak, J; Wisniewski, K; Stawiski, K; Stefanczyk, L; Jaskolski, DJ				Bobeff, Ernest J.; Posmyk, Bartlomiej J.; Bobeff, Katarzyna L.; Fortuniak, Jan; Wisniewski, Karol; Stawiski, Konrad; Stefanczyk, Ludomir; Jaskolski, Dariusz J.			Predicting Outcome and Conservative Treatment Failure in Patients with Skull Fracture after Traumatic Brain Injury: A Retrospective Cohort Study	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						skull fracture; outcome; conservative treatment failure; decision tree	CELL DISTRIBUTION WIDTH; ACUTE SUBDURAL-HEMATOMA; 28-DAY MORTALITY; OLDER-ADULTS; RISK-FACTORS; SCORE; TALK	Objective Traumatic brain injury (TBI) remains a major cause of morbidity and mortality worldwide. The prognostic value of skull fracture (SF) remains to be clearly defined. To evaluate the need for neurosurgical intervention and determine the risk factors of conservative treatment failure (CTF), we retrieved from the hospital database the records of patients with SF after TBI. Methods We analyzed 146 consecutive patients (mean age: 49.8 +/- 17.5 years) treated at the department of neurosurgery in a 5-year period. Clinical data, radiologic reports, and laboratory results were evaluated retrospectively. Results A total of 63% of patients were treated conservatively, 21.9% were operated on immediately, and 15.1% experienced CTF. Overall, 73.3% had a favorable outcome; the mortality rate was 13%. Intracranial bleeding occurred in 96.6% of cases, basilar SF in 61%, and cerebrospinal fluid (CSF) leak in 2.8%. The independent risk factors for outcome were Glasgow Coma Scale (GCS) score, age, and platelet count (PCT). The independent risk factors for CTF were epidural hematoma, subdural hematoma, mass effect, edema, international normalized ratio, PCT, mean platelet volume, and CSF leakage. The consensus decision tree algorithm used at the accident and emergency department indicated patients with no need for neurosurgical intervention with an accuracy of 91.7%, sensitivity of 88.9%, and featured the importance of mass effect, GCS, and epidural hematoma. Conclusions Tests included in the complete blood count appeared useful for predicting the course in patients with SF, although the most important factors were age and neurologic status, as well as radiologic findings. Our decision tree requires further validation before it can be used in everyday practice.	[Bobeff, Ernest J.; Posmyk, Bartlomiej J.; Fortuniak, Jan; Wisniewski, Karol; Jaskolski, Dariusz J.] Med Univ Lodz, Barlicki Mem Teaching Hosp, Dept Neurosurg & Neurooncol, Kopcinskiego St 22, PL-90153 Lodz, Poland; [Bobeff, Katarzyna L.] Med Univ Lodz, Konopnicka Mem Teaching Hosp, Dept Paediat Oncol Haematol & Diabetol, Lodz, Poland; [Stawiski, Konrad] Med Univ Lodz, Dept Biostat & Translat Med, Lodz, Poland; [Stefanczyk, Ludomir] Med Univ Lodz, Barlicki Mem Teaching Hosp, Dept Radiol, Lodz, Poland		Fortuniak, J (corresponding author), Med Univ Lodz, Barlicki Mem Teaching Hosp, Dept Neurosurg & Neurooncol, Kopcinskiego St 22, PL-90153 Lodz, Poland.	jfort@tlen.pl	Jaskolski, Dariusz J/H-8051-2013; Stawiski, Konrad/O-6006-2019; Jaskolski, Dariusz/AAA-7656-2021	Stawiski, Konrad/0000-0002-6550-3384; Posmyk, Bartlomiej/0000-0002-5590-4416; Jaskolski, Dariusz/0000-0002-9971-9677; Bobeff, Katarzyna/0000-0001-8916-683X			Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; BRAWLEY BW, 1967, J NEUROSURG, V26, P57, DOI 10.3171/jns.1967.26.1part1.0057; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Dewan M C, 2018, J NEUROSURG     0401; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Giammattei L, 2018, WORLD NEUROSURG, V109, P460, DOI 10.1016/j.wneu.2017.10.085; Greenberg M S, 2016, HDB NEUROSURGERY, P384; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Havens J M, 2018, TRAUMA SURG ACUTE CA, V3, pe000147; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ji HM, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1738-3; Kim SH, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0274-8; Kong T, 2017, AM J EMERG MED, V35, P1819, DOI 10.1016/j.ajem.2017.06.008; Lippi G, 2017, ARCH MED SCI, V13, P606, DOI 10.5114/aoms.2017.67282; Liu ZH, 2018, AM J EMERG MED, V36, P1112, DOI 10.1016/j.ajem.2017.10.028; Lv HC, 2016, J BONE MINER RES, V31, P223, DOI 10.1002/jbmr.2597; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MACPHERSON BCM, 1990, CLIN RADIOL, V42, P321, DOI 10.1016/S0009-9260(05)82145-2; Majercik S, 2013, J TRAUMA ACUTE CARE, V74, P1021, DOI 10.1097/TA.0b013e3182826f02; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Ratilal BO, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004884.pub4; REILLY PL, 1975, LANCET, V2, P375; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Stephens JR, 2016, INT J ORAL MAX SURG, V45, P275, DOI 10.1016/j.ijom.2015.10.002; Wernick B, 2017, EUR J TRAUMA EMERG S, V43, P399, DOI 10.1007/s00068-016-0679-0; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012; Yin P, 2016, OSTEOPOROSIS INT, V27, P2077, DOI 10.1007/s00198-015-3357-x; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zehir S, 2014, ACTA ORTHOP TRAUMATO, V48, P141, DOI 10.3944/AOTT.2014.2859	35	1	1	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	NOV	2019	80	6					460	469		10.1055/s-0039-1692672			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JH8DV	WOS:000492999800007	31466104				2022-02-06	
J	Budoy, D; Rodriguez-Villar, C; Pena, D; Vizcaino, F; Saavedra, S; Bohils, M; Quijada, M; de la Cruz, JM; Paredes-Zapata, D; Ruiz, A; Roque, R; Garcia, X; Bartolome, RA				Budoy, Daniel; Rodriguez-Villar, Camino; Pena, David; Vizcaino, Ferran; Saavedra, Sandra; Bohils, Marc; Quijada, Magda; de la Cruz, Jose Manuel; Paredes-Zapata, David; Ruiz, Angel; Roque, Rebeca; Garcia, Xavier; Adalia Bartolome, Ramon			Effect of Active and Early Possible Organ and Tissue Donor Detection in the Emergency Room in a University Hospital	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	33rd Spanish Congress of Transplant Coordinators	NOV 14-16, 2018	Seville, SPAIN					Purpose. The emergency room of the hospital is the gateway for patients with severe brain damage due to neurologic or cardiac conditions such as stroke or cardiac arrest. The main purpose is to design an active registry of patients, in the emergency room, to facilitate the detection and follow-up of potential donors according to their clinical evolution. Material and Methods. This is a 1-year prospective study from May 2017 to May 2018 with a register for detection of patients admitted to the emergency room with severe brain damage (Glasgow Coma Scale score <= 8), with active follow-up until hospital discharge, who might have died or otherwise become possible organ and tissue donors. Results. One hundred sixty-six (107 men and 59 women) patients met the inclusion criteria: (1) 30.7% recovered from cardiac arrest; (2) 31.3% from stroke; (3) 16.9% from traumatic brain injury and multiple trauma; (4) 10.2% had decreased level of consciousness; (5) 4.8% had other cardiac conditions; and (6) 6.0% had other diagnoses. Seventy-seven out of 166 patients (46.4%) were evaluated as possible organ and tissue donors, with 37 out of 77 (48.0%) of the possible donors becoming real donors. This means that 37 out of 166 (22.3%) of the possible donors admitted to the emergency room became real donors. Twenty-two out of 77 of the patients (28.6%) evaluated had clinical contraindications for donation and in 18 out of 77 (23.4%), there was family refusal for any kind of organ or tissue donation. This record allowed the generation of the following organs and tissues: 4 hearts, 19 livers, 14 lungs, 52 kidneys, 2 pancreata, 29 corneas, 19 donations of bone allografts, 15 donations of skin tissue, 14 donations of valvular allografts, and 11 vascular allografts. Conclusions. The early and active possible donors registry at the emergency room has facilitated early detection and allow adequate follow-up and evaluation of possible organ and tissue donors.	[Budoy, Daniel; Rodriguez-Villar, Camino; Pena, David; Vizcaino, Ferran; Saavedra, Sandra; Bohils, Marc; Quijada, Magda; de la Cruz, Jose Manuel; Paredes-Zapata, David; Ruiz, Angel; Roque, Rebeca; Garcia, Xavier; Adalia Bartolome, Ramon] Univ Barcelona, Hosp Clin, Donat & Transplant Coordinat Sect, Barcelona, Spain		Budoy, D (corresponding author), Hosp Clin Barcelona, Stair 8,Floor 4th, Barcelona 08036, Spain.	dbudoy@clinic.cat					Dominguez-Gil B, 2011, TRANSPL INT, V24, P373, DOI 10.1111/j.1432-2277.2011.01243.x; European Directorate for the Quality of Medicines and HealthCare, 2018, NEWSL TRANSPL INT FI; Martin-Delgado MC, 2019, AM J TRANSPLANT, V19, P1782, DOI 10.1111/ajt.15253; Ministry of Health Consumer Affairs and Social Welfare, 2018, PLAN ESTR DON TRASPL; Ministry of Health Social Policy and Equality, 2011, GUIA BUEN PRACT PROC; Ministry of Health Social Services and Equality, 2018, ONT PRES HOJ RUT ALC; Proyecto ACCORD Espana, 2015, PRACT CLIN FIN VID P; Rodriguez-Villar C, 2011, AVANCES DIABETOLOGIA, V27, P154	8	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	NOV	2019	51	9					3027	3029		10.1016/j.transproceed.2019.08.022			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	JP5LB	WOS:000498304900040	31629538				2022-02-06	
J	Hawley, L; Hammond, FM; Cogan, AM; Juengst, S; Mumbower, R; Pappadis, MR; Waldman, W; Dams-O'Connor, K				Hawley, Lenore; Hammond, Flora M.; Cogan, Alison M.; Juengst, Shannon; Mumbower, Rachael; Pappadis, Monique R.; Waldman, Wendy; Dams-O'Connor, Kristen			Ethical Considerations in Chronic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Brain injuries; chronic brain injury; outcome	OF-THE-LITERATURE; HEALTH-CARE; REHABILITATION; FAMILY; QUALITY; PERSPECTIVES; EXPERIENCES; COMMUNITY; CAREGIVER; OUTCOMES	A growing number of individuals are living with chronic traumatic brain injury. As these individuals and their families attempt to reintegrate into their communities, several ethical questions arise for clinicians and researchers. These include issues around alignment of perspectives and priorities, as well as responsibilities for ongoing treatment, education, community outreach, and research. An action plan for addressing these questions is outlined.	[Hawley, Lenore] Craig Hosp, 3425 S Clarkson St, Englewood, CO 80120 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp, Indianapolis, IN USA; [Cogan, Alison M.] Washington DC VA Med Ctr, Washington, DC USA; [Juengst, Shannon] UT Southwestern Med Ctr, Phys Med & Rehabil, Dallas, TX USA; [Mumbower, Rachael] Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL USA; [Pappadis, Monique R.] Univ Texas Med Branch, Galveston & Brain Injury Res Ctr, Sch Hlth Profess, Div Rehabil Sci,TIRR Mem Hermann, Houston, TX USA; [Waldman, Wendy] RHI Neuro Rehab Ctr, Resource Facilitat Program, Indianapolis, IN USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Brain Injury Res Ctr, Dept Rehabil Med, Dept Neurol, New York, NY 10029 USA		Hawley, L (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80120 USA.	lhawley@craighospital.org	Mumbower, Rachael/AAP-4635-2020; Cogan, Alison/AAS-3101-2021		American Congress of Rehabilitation Medicine Brain Injury Special Interest Group Task Force on Chronic Brain injury; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0036, 90DRTB0002, 90DPTB0009]; Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS); NIDILRRUnited States Department of Health & Human Services [90DPTB0016]; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024832, P30AG059301]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG059301, P30AG024832] Funding Source: NIH RePORTER	The contents of this publication were developed with partial support from the American Congress of Rehabilitation Medicine Brain Injury Special Interest Group Task Force on Chronic Brain injury, and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant numbers 90DP0036, 90DRTB0002, and 90DPTB0009), a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS); as well as NIDILRR: 90DPTB0016 andNational Institute on Aging (NIA):#P30AG024832; P30AG059301. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official institutional position or any other federal agency, policy, or decision unless so designated by other official documentation. The contents of this publication do not necessarily represent the policy of the NIDILRR, ACL, HHS, or NIA and you should not assume endorsement by the Federal Government.	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Biester RC, 2016, PROF CASE MANAG, V21, P22, DOI 10.1097/NCM.0000000000000121; Block CK, 2013, BRAIN INJURY, V27, P775, DOI 10.3109/02699052.2013.775487; Bogner J, 2015, ARCH PHYS MED REH S3, V96, pS274; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2018, BRAIN INJURY, V32, P431, DOI 10.1080/02699052.2018.1429024; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dams-O'Connor K, 2010, PSYCHIAT CLIN N AM, V33, P893, DOI 10.1016/j.psc.2010.08.002; Eliacin J, 2018, BRAIN INJURY, V32, P1510, DOI 10.1080/02699052.2018.1499964; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fins JJ, 2015, RIGHTS COME MIND ETH; Fins Joseph J, 2006, Palliat Support Care, V4, P169; Fins JJ, 2016, J LAW MED ETHICS, V44, P182, DOI 10.1177/1073110516644209; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Goering S, 2015, CURR REV MUSCULOSKE, V8, P134, DOI 10.1007/s12178-015-9273-z; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2018, J HEAD TRAUMA REHAB, V33, P228, DOI 10.1097/HTR.0000000000000390; McDermott GL, 2014, BRAIN INJURY, V28, P81, DOI 10.3109/02699052.2013.857790; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Paterson B, 2001, Rehabil Nurs, V26, P48; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Prigatano GP, 2013, NEUROREHABILITATION, V32, P751, DOI 10.3233/NRE-130899; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wright MS, YALE J HLTH POLICY L, V16, P233	36	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					433	436		10.1097/HTR.0000000000000538			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200015	31688380	Green Submitted, Green Accepted			2022-02-06	
J	Janatpour, ZC; Szuflita, NS; Spinelli, J; Coughlin, DJ; Rosenfeld, JV; Bell, RS				Janatpour, Zachary C.; Szuflita, Nicholas S.; Spinelli, Joseph; Coughlin, Daniel J.; Rosenfeld, Jeffrey, V; Bell, Randy S.			Inadequate Decompressive Craniectomy Following a Wartime Traumatic Brain Injury - An Illustrative Case of Why Size Matters	MILITARY MEDICINE			English	Article							BLAST; OUTCOMES; LESSONS	Traumatic brain injury has been called the "signature injury" of the wars in Iraq and Afghanistan, and the management of severe and penetrating brain injury has evolved considerably based on the experiences of military neurosurgeons. Current guidelines recommend that decompressive hemicraniectomy be performed with large, fronto-temporoparietal bone flaps, but practice patterns vary markedly. The following case is illustrative of potential clinical courses, complications, and efforts to salvage inadequately-sized decompressive craniectomies performed for combat-related severe and penetrating brain injury. The authors follow this with a review of the current literature pertaining to decompressive craniectomy, and finally provide their recommendations for some of the technical nuances of performing decompressive hemicraniectomy after severe or penetrating brain injury.	[Janatpour, Zachary C.; Rosenfeld, Jeffrey, V; Bell, Randy S.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Szuflita, Nicholas S.; Spinelli, Joseph; Bell, Randy S.] Uniformed Serv Univ Hlth Sci, Div Neurosurg, Dept Surg, Walter Reed Natl Mil Med Ctr, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Coughlin, Daniel J.] Cleveland Clin, Dept Neurosurg, Ctr Spine Hlth, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rosenfeld, Jeffrey, V] Alfred Hosp, Dept Neurosurg, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey, V] Monash Univ, Dept Surg, Australia Wellington Rd, Clayton, Vic 3800, Australia		Janatpour, ZC (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.						Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Carney N, 2016, NEUROSURGERY, DOI [DOI 10.1227/NEU.0000000000001432, 10.1227/NEU.0000000000001432, 10.1227/neu.0000000000001432]; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Fotakopoulos George, 2016, Surg Neurol Int, V7, P19, DOI 10.4103/2152-7806.176671; Girotto Dean, 2014, Coll Antropol, V38, P1255; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; McCafferty R, 2016, NEUROSURGERY SEVERE, P1; Miller K, 2016, WORLD NEUROSURG, V95, P441, DOI 10.1016/j.wneu.2016.08.061; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rosenfeld JV, 2018, EARLY DECOMPRESSIVE; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Walker P, 2018, CURR TRAUMA REP, V4, P149, DOI 10.1007/s40719-018-0133-3; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179	23	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2019	184	11-12					929	933		10.1093/milmed/usz008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KG8TE	WOS:000510223200061	30793187	Bronze			2022-02-06	
J	Kosyakovsky, J; Witthuhn, BA; Svitak, AL; Frey, WH; Hanson, LR; Fine, JM				Kosyakovsky, Jacob; Witthuhn, Bruce A.; Svitak, Aleta L.; Frey, William H., II; Hanson, Leah R.; Fine, Jared M.			Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry	ACS CHEMICAL NEUROSCIENCE			English	Article						Intranasal; deferoxamine; HPLC/ESI-MS2; pharmacokinetics; ferrioxamine; aluminoxamine	PERFORMANCE LIQUID-CHROMATOGRAPHY; COLLISION-INDUCED DISSOCIATION; SUBARACHNOID HEMORRHAGE; FERRIOXAMINE-B; MEMORY LOSS; DESFERRIOXAMINE; MODEL; SIDEROPHORES; ALUMINUM; NEUROPROTECTION	Deferoxamine, a metal chelator, has been shown to be neuroprotective in animal models of ischemic stroke, traumatic brain injury and both subarachnoid and intracerebral hemorrhage. Intranasal deferoxamine (IN DFO) has also shown promise as a potential treatment for multiple neurodegenerative diseases, including Parkinson's and Alzheimer's. However, there have been no attempts to thoroughly understand the dynamics and pharmacokinetics of IN DFO. We developed a new high-performance liquid-chromatography electrospray-tandem mass spectrometry (HPLC/ESI-MS2) method to quantify the combined total levels of DFO, ferrioxamine (FO; DFO bound to iron), and aluminoxamine (AO; aluminum-bound DFO) in brain tissue using a custom-synthesized deuterated analogue (DFO-d(7), Medical Isotopes Inc., Pelham NH) as an internal standard. We applied our method toward understanding the pharmacokinetics of IN DFO delivery to the brain and blood of rats from 15 min to 4 h after delivery. We found that IN delivery successfully targets DFO to the brain to achieve concentrations of 0.5-15 mu M in various brain regions within 15 min, and decreasing though still detectable after 4 h. Systemic exposure was minimized as assessed by concentration in blood serum. Serum concentrations were 0.02 mu M at 15 min and no more than 0.1 mu M at later time points. Compared to blood serum, brain region-specific drug exposure (as measured by area under the curve) ranged from slightly under 10 times exposure in the hippocampus to almost 200 times exposure in the olfactory bulb with IN DFO delivery. These findings represent a major step toward future method development, pharmacokinetic studies, and clinical trials for this promising therapeutic.	[Kosyakovsky, Jacob; Svitak, Aleta L.; Frey, William H., II; Hanson, Leah R.; Fine, Jared M.] HealthPartners Inst, HealthPartners Neurosci Ctr, St Paul, MN 55130 USA; [Witthuhn, Bruce A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA		Fine, JM (corresponding author), HealthPartners Inst, HealthPartners Neurosci Ctr, St Paul, MN 55130 USA.	Jared.M.Fine@HealthPartners.com			Sexton Family Foundation; Regions Hospital Foundation	Funding was provided by charitable contributions raised by Regions Hospital Foundation including a generous gift from the Sexton Family Foundation.	Febbraro F, 2013, EXP NEUROL, V247, P45, DOI 10.1016/j.expneurol.2013.03.017; Fine JM, 2017, J NEUROL SCI, V380, P164, DOI 10.1016/j.jns.2017.07.028; Fine JM, 2014, BRAIN RES, V1574, P96, DOI 10.1016/j.brainres.2014.05.048; Fine JM, 2012, EXP BRAIN RES, V219, P381, DOI 10.1007/s00221-012-3101-0; Fine JM, 2015, NEUROSCI LETT, V584, P362, DOI 10.1016/j.neulet.2014.11.013; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Gledhill M, 2001, ANALYST, V126, P1359, DOI 10.1039/b101268l; Guo C, 2016, EXP NEUROL, V280, P13, DOI 10.1016/j.expneurol.2016.03.016; Guo C, 2013, NEUROBIOL AGING, V34, P562, DOI 10.1016/j.neurobiolaging.2012.05.009; Hanson LR, 2012, DRUG DELIV TRANSL RE, V2, P160, DOI 10.1007/s13346-011-0050-2; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; HARTLEY A, 1990, FEBS LETT, V264, P145, DOI 10.1016/0014-5793(90)80786-I; Hernandez P, 1990, ANNA J, V17, P224; Hishikawa T, 2008, NEUROSURGERY, V62, P232, DOI 10.1227/01.NEU.0000311082.88766.33; Kontoghiorghe CN, 2016, DRUG DES DEV THER, V10, P465, DOI 10.2147/DDDT.S79458; KRUCK TPA, 1993, CLIN PHARMACOL THER, V53, P30, DOI 10.1038/clpt.1993.6; Mawji E, 2008, RAPID COMMUN MASS SP, V22, P2195, DOI 10.1002/rcm.3604; McCormack P, 2003, ANAL CHEM, V75, P2647, DOI 10.1021/ac0340105; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; MONZYK B, 1982, J AM CHEM SOC, V104, P4921, DOI 10.1021/ja00382a031; Porter JB, 2001, SEMIN HEMATOL, V38, P63, DOI 10.1053/shem.2001.20145; Qin Y, 2019, BEHAV BRAIN RES, V367, P194, DOI 10.1016/j.bbr.2019.04.004; Rassu G, 2015, J CONTROL RELEASE, V201, P68, DOI 10.1016/j.jconrel.2015.01.025; RICEEVANS C, 1989, FEBS LETT, V256, P17, DOI 10.1016/0014-5793(89)81709-0; Selim M, 2019, LANCET NEUROL, V18, P428, DOI 10.1016/S1474-4422(19)30069-9; Shaw CA, 2013, IMMUNOL RES, V56, P304, DOI 10.1007/s12026-013-8403-1; Sidebottom AM, 2015, J AM SOC MASS SPECTR, V26, P1899, DOI 10.1007/s13361-015-1242-7; SINGH S, 1990, ANAL BIOCHEM, V187, P212, DOI 10.1016/0003-2697(90)90446-G; Spasojevic I, 2001, INORG CHEM, V40, P49, DOI 10.1021/ic991390x; TESORO A, 1989, THER DRUG MONIT, V11, P463; VERPOOTEN GA, 1992, NEPHROL DIAL TRANSPL, V7, P931, DOI 10.1093/ndt/7.9.931; Walton JR, 2007, J INORG BIOCHEM, V101, P1275, DOI 10.1016/j.jinorgbio.2007.06.001; Walton JR, 2014, J ALZHEIMERS DIS, V40, P765, DOI 10.3233/JAD-132204; Walton JR, 2013, J ALZHEIMERS DIS, V35, P7, DOI 10.3233/JAD-121909; Wan S, 2006, ACTA NEUROCHIR SUPPL, V96, P199; Yu ZQ, 2014, NEUROPATH APPL NEURO, V40, P270, DOI 10.1111/nan.12091; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230	39	1	1	1	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	NOV	2019	10	11					4571	4578		10.1021/acschemneuro.9b00436			15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	JR6OR	WOS:000499742800014	31573798				2022-02-06	
J	Kutty, RK; Sreemathyamma, SB; Sivanandapanicker, JL; Asher, P; Peethambaran, A				Kutty, Raja K.; Sreemathyamma, Sunilkumar Balakrishnan; Sivanandapanicker, Jyothish Laila; Asher, Prasanth; Peethambaran, Anilkumar			A shunt lost in the mists of time	CHILDS NERVOUS SYSTEM			English	Article						Hydrocephalus; Ventriculo-peritoneal shunt; Migration; Asymptomatic	VENTRICULO-PERITONEAL SHUNT; BOWEL PERFORATION; INTRAVENTRICULAR MIGRATION; CATHETER; MANAGEMENT; COILING	Ventriculo peritoneal shunts offer promising results in the management of hydrocephalus. However, they are not without complications. Shunt migrations and extrusions have been reported plenty of times in the literature. Migration of both the proximal and distal catheter has been reported. However; entire shunt migrations are rare and can result in worsening of the clinical condition of the patient. We report a case of entire shunt migration in to the abdominal cavity which was diagnosed during her childhood 8 years after shunt surgery. The parents of the child were advised shunt removal and new shunt insertion but they did not agree to it and they lost follow-up. The patient attended neurosurgery outpatient clinic 24 years later for evaluation of traumatic brain injury, when this finding was incidentally detected. She remained asymptomatic for this condition during all these years. To our knowledge, such incidence of entire shunt migration being remaining asymptomatic for such a long duration has never been reported in the literature.	[Kutty, Raja K.; Sreemathyamma, Sunilkumar Balakrishnan; Sivanandapanicker, Jyothish Laila; Asher, Prasanth; Peethambaran, Anilkumar] Govt Med Coll, Dept Neurosurg, Thiruvananthapuram, Kerala, India		Kutty, RK (corresponding author), Govt Med Coll, Dept Neurosurg, Thiruvananthapuram, Kerala, India.	drrajakkutty@gmail.com; drsunilkumarbs@hotmail.com; drjyothish@gmail.com; prasanthasher@gmail.com; dranilpeethambaran@yahoo.com		K.Kutty, Raja/0000-0001-8077-9453			Acharya R, 2002, NEUROL SCI, V23, P75, DOI 10.1007/s100720200029; Al Hinai QS, 2006, J CLIN NEUROSCI, V13, P666, DOI 10.1016/j.jocn.2005.07.020; ASHPOLE R, 1995, EUR J PEDIATR SURG, V5, P280, DOI 10.1055/s-2008-1066225; Chen H S, 2000, Chang Gung Med J, V23, P180; Dominguez CJ, 2000, CHILD NERV SYST, V16, P493, DOI 10.1007/PL00007294; ELJAMEL MS, 1995, ACTA NEUROCHIR, V136, P217, DOI 10.1007/BF01410629; Gupta PK, 1999, BRIT J NEUROSURG, V13, P73, DOI 10.1080/02688699944230; Hong J, 2016, CLIN NEUROL NEUROSUR, V151, P79, DOI 10.1016/j.clineuro.2016.10.017; Huang HM, 2011, INT J SURG CASE REP, V2, P76, DOI 10.1016/j.ijscr.2011.01.009; Hurni Y, 2018, NEUROPEDIATRICS, V49, P302, DOI 10.1055/s-0038-1660854; MCLONE DG, 1993, PEDIATR NEUROSURG, V19, P101, DOI 10.1159/000120709; Nadkarni TD, 2007, J CLIN NEUROSCI, V14, P92, DOI 10.1016/j.jocn.2005.12.027; O'Donoghue G T, 2002, Ir Med J, V95, P88; Pikis S, 2015, J CLIN NEUROSCI, V22, P224, DOI 10.1016/j.jocn.2014.08.005; Riccardello GJ, 2016, J NEUROSURG-PEDIATR, V18, P325, DOI 10.3171/2016.3.PEDS15572; Rinker EK, 2013, J RADIOL CASE REP, V7, P1, DOI 10.3941/jrcr.v7i9.1243; Sengul G, 2005, PEDIATR NEUROSURG, V41, P337, DOI 10.1159/000088738; Sharma S, 2005, INDIAN PEDIATR, V42, P187; Suryadevara R, 2018, CHILD NERV SYST, V34, P787, DOI 10.1007/s00381-017-3689-2; Thipphavong S, 2004, PEDIATR RADIOL, V34, P750, DOI 10.1007/s00247-004-1195-7; VILLAREJO F, 1979, NEUROCHIRURGIA, V22, P196; Vinchon M, 2006, NEUROSURGERY, V58, P76, DOI 10.1227/01.NEU.0000192683.26584.34	22	1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2019	35	12					2427	2430		10.1007/s00381-019-04410-x		NOV 2019	4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JN5JX	WOS:000493641800001	31676943				2022-02-06	
J	Kwon, CY; Lee, B; Leem, J; Chung, SY; Kim, JW				Kwon, Chan-Young; Lee, Boram; Leem, Jungtae; Chung, Sun-Young; Kim, Jong Woo			Korean medicine treatments including blood stasis-removing therapy and auriculotherapy for persistent headache after traumatic brain injury: A case report	EXPLORE-THE JOURNAL OF SCIENCE AND HEALING			English	Article						Traumatic brain injury; Headache; Herbal medicine; Auriculotherapy		Headache after traumatic brain injury (TBI) is a common symptom which includes moderate-to-severe pain more than 5 years after the injury and severely limits the quality of life. Some guidelines have indicated that there are several cases where headaches do not respond adequately to conventional therapies. Therefore, effective alternative approaches are needed. In this case report, we present a 74-year-old woman, who had persistent headache attributed to traumatic injury to the head and subjective cognitive impairment. By using the Korean Medical (KM) treatment blood stasis-removing therapy using Dangguixu-san and auriculotherapy, her headache improved markedly. Improvements in the cognitive function and hemorrhage were also observed. This case report suggests that KM treatments using Dangguixu-san and auriculotherapy may be an alternative therapeutic approach for headache after TBI. (C) 2019 Elsevier Inc. All rights reserved.	[Kwon, Chan-Young; Chung, Sun-Young; Kim, Jong Woo] Kyung Hee Univ, Grad Sch, Dept Clin Korean Med, Seoul 02453, South Korea; [Kwon, Chan-Young] Yanggu Publ Hlth Ctr, Gangwon Do 24522, South Korea; [Lee, Boram] Korea Inst Oriental Med, Clin Res Div, Daejeon 34054, South Korea; [Leem, Jungtae] Chung Yeon Cent Inst, Gwangju 61165, South Korea; [Chung, Sun-Young; Kim, Jong Woo] Kyung Hee Univ Hosp Gangdong, Dept Oriental Neuropsychiat, Seoul 05278, South Korea		Kim, JW (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Oriental Neuropsychiat, Seoul 05278, South Korea.	beanalogue@naver.com; qhfka9357@kiom.re.kr; julcho@naver.com; lovepwr@khu.ac.kr; aromaqi@khu.ac.kr		Lee, Boram/0000-0003-1679-0644; Kwon, Chan Young/0000-0003-0068-9904			Allais G, 2011, NEUROL SCI, V32, pS173, DOI 10.1007/s10072-011-0525-4; [Anonymous], 1610, HURL TREASURED MIRRO; 정일문, 2010, [Journal of Korean Medicine Rehabilitation, 한방재활의학과학회지], V20, P13; Estores I, 2017, J SPINAL CORD MED, V40, P432, DOI 10.1080/10790268.2016.1141489; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; Kim JH, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/718302; Kim KH, 2015, EUR J INTEGR MED, V7, P628, DOI 10.1016/j.eujim.2015.09.001; Kim TH, 2010, PSYCHIAT INVEST, V7, P102, DOI 10.4306/pi.2010.7.2.102; Kwon CY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3426078; Li HQ, 2015, ACTA PHARMACOL SIN, V36, P659, DOI 10.1038/aps.2014.139; Liu Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/184503; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Murakami M, 2017, PAIN MED, V18, P551, DOI 10.1093/pm/pnw215; Nordhaug LH, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0838-2; Park B, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/316872; Park B, 2014, AM J TRANSL RES, V6, P857; Romoli M, 2014, NEUROL SCI, V35, pS189, DOI 10.1007/s10072-014-1768-7; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Wolf Jacob, 2015, Glob Adv Health Med, V4, P52, DOI 10.7453/gahmj.2014.069; Wong V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007700.pub3; YUN YJ, 2013, HERB FORMUL SCI, V21, P206; Zhong YY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8916938; Zhou J, 2017, ONCOTARGET, V8, P72069, DOI 10.18632/oncotarget.18895; 정다운, 2012, [The Journal of Oriental Obstetrics ＆ Gynecology, 대한한방부인과학회지], V25, P132; 염승철, 2009, Journal of Acupuncture Research, V26, P11	26	1	1	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1550-8307	1878-7541		EXPLORE-NY	Explore-J Sci. Heal.	NOV-DEC	2019	15	6					419	424		10.1016/j.explore.2019.06.001			6	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	JS6JK	WOS:000500411300010	31262688				2022-02-06	
J	Lee, KM; Greenhalgh, WM; Sargent, P; Chae, H; Klimp, S; Engel, S; Merritt, BP; Kretzmer, T; Bajor, L; Scott, S; Pyne, S				Lee, Katherine M.; Greenhalgh, Walter M.; Sargent, Paul; Chae, Heechin; Klimp, Scott; Engel, Scot; Merritt, Bryan P.; Kretzmer, Tracy; Bajor, Laura; Scott, Steve; Pyne, Scott			Unique Features of the US Department of Defense Multidisciplinary Concussion Clinics	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						intensive outpatient programs; multidisciplinary concussion clinics; National Intrepid Center of Excellence and Intrepid Spirit Centers; novel neuroimaging; postdeployment; posttraumatic stress disorder; Return to Forces; service members; traumatic brain injury; unique therapeutics; university model; veterans	GUA-SHA; BRAIN; EXERCISE; REHABILITATION; MINDFULNESS; SYMPTOMS; SOLDIERS	The US Department of Defense (DoD) and the Department of Veterans Affairs (VA) actively address care needs for a subset of service members (SMs) who experience prolonged symptoms and adverse sequelae interfering with their usual level of function after sustaining mild traumatic brain injury. The development of multidisciplinary concussion clinics and implementation of several reinforcing policies within the DoD and the VA address this unique patient population. A network known as the National Intrepid Center of Excellence and Intrepid Spirit Centers and the VA, primarily support these patients through intensive outpatient programs. The VA also has an inpatient program that utilizes specialized capabilities. The features unique to several of these centers are described in this article. While providing for similar patient care needs, each clinical setting implements unique evaluation and treatment modalities to target analogous goals of return to the highest functional level possible and develop life skills to enhance health, quality of life, and readiness to perform military duties. Currently, patient-reported outcomes are being collected.	[Lee, Katherine M.; Pyne, Scott] DVBIC, 1335 East West Hwy, Silver Spring, MD 20910 USA; [Greenhalgh, Walter M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Sargent, Paul] Naval Hosp Camp Pendleton, Intrepid Spirit Ctr, Camp Pendleton, CA USA; [Chae, Heechin] Ft Belvoir Community Hosp, Intrepid Spirit Ctr, Ft Belvoir, VA USA; [Klimp, Scott] Womack Army Med Ctr, Intrepid Spirit Ctr, Ft Bragg, NC USA; [Engel, Scot] Darnell Army Med Ctr, Intrepid Spirit Ctr, Ft Hood, TX USA; [Merritt, Bryan P.; Kretzmer, Tracy; Bajor, Laura; Scott, Steve] James A Haley Vet Hosp, Tampa, FL USA		Lee, KM (corresponding author), DVBIC, 1335 East West Hwy, Silver Spring, MD 20910 USA.	katherine.m.lee34.civ@mail.mil					Babakhanyan I, 2018, ANN M MIL HLTH SYST; Bergen-Cico D, 2018, J ALTERN COMPLEM MED, V24, P1166, DOI 10.1089/acm.2018.0179; Brailey K, 2007, J TRAUMA STRESS, V20, P495, DOI 10.1002/jts.20234; Burton LE, 2019, J INTEGR MED-JIM, V17, P14, DOI 10.1016/j.joim.2018.11.001; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Etnier JL, 2016, J SPORT EXERCISE PSY, V38, P331, DOI 10.1123/jsep.2015-0335; Franz Berkeley A, 2017, Perm J, V21, P17, DOI 10.7812/TPP/17-002; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Giggins OM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-60; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Liang LH, 2018, J APPL PSYCHOL, V103, P281, DOI 10.1037/apl0000283; Liu MY, 2013, CHIN J INTEGR MED, V19, P3, DOI 10.1007/s11655-013-1326-1; Martin L, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8020028; Morrissey Patrick J, 2013, Health Prog, V94, P44; Nielsen A, 2007, EXPLORE-NY, V3, P456, DOI 10.1016/j.explore.2007.06.001; Oriach C.S., 2016, CLIN NUTR EXP, V6, P25, DOI [10.1016/j.yclnex.2016.01.003, DOI 10.1016/J.YCLNEX.2016.01.003]; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Richards L. K., 2016, STIGMA AND PREJUDICE, P203, DOI DOI 10.1007/978-3-319-27580-2; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Wicklund Alissa H, 2013, Surg Neurol Int, V4, P50, DOI 10.4103/2152-7806.110150; Wolf GK, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000344; Zhuang Y, 2013, INT REV NEUROBIOL, V111, P1, DOI 10.1016/B978-0-12-411545-3.00001-8	28	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					402	408		10.1097/HTR.0000000000000526			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200011	31479081				2022-02-06	
J	Lehner, M; Deininger, S; Wendling-Keim, D				Lehner, M.; Deininger, S.; Wendling-Keim, D.			Management of traumatic brain injury in childhood	MONATSSCHRIFT KINDERHEILKUNDE			German	Article						Diagnostic imaging; Glasgow Coma Scale; Intracranial pressure; Patientmonitoring; Trauma room	CLINICAL DECISION RULES; OF-HOSPITAL HYPOTENSION; GLASGOW COMA SCALE; MINOR HEAD TRAUMA; COMPUTED-TOMOGRAPHY; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; EMERGENCY-DEPARTMENT; RADIATION-EXPOSURE; CHILDREN YOUNGER	Accidents are the leading cause of hospitalization in childhood and adolescence. Approximately 90% of fatal accidents in childhood are associated with traumatic brain injury (TBI). The classification is based on the Glasgow coma scale (GCS) adapted to children and is divided into three grades, mild, moderate and severe. The treatment of moderate and severe TBI must already start in the preclinical setting to avoid hypotension and hypoxia, as these two parameters significantly influence the outcome. In these patients, admission to a level 1 trauma center for children should be carried out by the emergency physician. 85% of patients are diagnosed as having mild TBI. Nevertheless, in this group clinically important intracranial injuries requiring surgery can also occur. It is generally necessary to diagnose the injuries of these patients within an observational period of 48 h. In childhood, inpatientmonitoring should be carried out before (primary) cranial computed tomography (CT) imaging to avoid unnecessary exposure to radiation and most probably an inconspicuous cranial CT scan. Meanwhile, well-validated algorithms have been published (PECARN rules), according to which the indications for cranial slice imaging investigations are oriented. In cases of severe TBI, in addition to a targeted and rapid patient treatment in the trauma room including neuroradiological diagnostics, monitoring of children is predominantly carried out in the intensive care unit. Children are prone to develop posttraumatic cerebral edema, which first requires medication treatment. The current recommendations of the Brain Trauma Foundation for treatment are discussed.	[Lehner, M.] Luzerner Kantonsspital, Kinderspital Luzern, Kinderchirurg Klin, Spitalstr 20, CH-6000 Luzern, Switzerland; [Deininger, S.] Univ Ulm, Neurochirurg Klin, Sekt Kinderneurochirurg, Ulm, Germany; [Wendling-Keim, D.] Ludwig Maximilians Univ Munchen, Dr von Haunersches Kinderspital, Kinderchirurg Klin, Munich, Germany		Lehner, M (corresponding author), Luzerner Kantonsspital, Kinderspital Luzern, Kinderchirurg Klin, Spitalstr 20, CH-6000 Luzern, Switzerland.	Markus.Lehner@luks.ch	Lehner, Markus/B-9955-2019	Lehner, Markus/0000-0002-8176-8067			Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bouvier D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027365; Burns ECM, 2016, ACAD EMERG MED, V23, P576, DOI 10.1111/acem.12957; Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Erlichman DB, 2010, PEDIATR RADIOL, V40, P1375, DOI 10.1007/s00247-010-1555-4; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Ferrara P, 2020, J MATERN-FETAL NEO M, V33, P3900, DOI 10.1080/14767058.2019.1590330; Guilliams K, 2016, J CHILD NEUROL, V31, P35, DOI 10.1177/0883073814562626; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Holmes JF, 2009, ACAD EMERG MED, V16, P15, DOI 10.1111/j.1553-2712.2008.00293.x; Irvine A, 2017, CAN FAM PHYSICIAN, V63, P859; Ketharanathan N, 2017, CHILD NERV SYST, V33, P1703, DOI 10.1007/s00381-017-3520-0; Klora, 2019, MED OPEN, V98, P28; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Kristman VL, 2014, ARCH PHYS MED REHAB, V95, pS265; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lehner M, 2018, ANAESTHESIST, V67, P914, DOI 10.1007/s00101-018-0500-z; Lehner M, 2018, NOTFALL RETTUNGSMED, V21, P90, DOI 10.1007/s10049-017-0385-4; Lehner M, 2013, MONATSSCHR KINDERH, V161, P49, DOI 10.1007/s00112-012-2849-4; Leitlinie, 2011, SCHAD HIRN TRAUM KIN; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mtaweh H, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0348-3; Muhm M, 2013, ANAESTHESIST, V62, P380, DOI 10.1007/s00101-013-2176-8; Murphy S, 2017, J NEUROTRAUM, V34, P2220, DOI 10.1089/neu.2016.4793; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2013, PEDIATRICS, V132, pE689, DOI 10.1542/peds.2013-0909; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; O'Brien MJ, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117732516; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pechmann A, 2015, NEUROPEDIATRICS, V46, P5, DOI 10.1055/s-0034-1393707; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Prasad GL, 2015, BRAIN INJURY, V29, P1717, DOI 10.3109/02699052.2015.1075146; Ruzas CM, 2017, NEUROCRIT CARE, V26, P256, DOI 10.1007/s12028-016-0329-8; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Spaite DW, 2017, ANN EMERG MED, V70, P522, DOI 10.1016/j.annemergmed.2017.03.027; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Vernet O, 2004, PAEDIATRICA, V15, P43; Wendling-Keim DS, 2017, PEDIATR SURG INT, V33, P249, DOI 10.1007/s00383-016-4021-z; Wyen H, 2010, EUR J TRAUMA EMERG S, V36, P300, DOI 10.1007/s00068-010-1124-4	63	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0026-9298	1433-0474		MONATSSCHR KINDERH	Mon.schr. Kinderheilkd.	NOV	2019	167	11					994	1008		10.1007/s00112-019-00770-5			15	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	JW7IJ	WOS:000503221300014					2022-02-06	
J	Lerner, A; Fost, N				Lerner, Alec; Fost, Norman			Informed Consent for Youth Tackle Football: Implications of the AAP Policy Statement	PEDIATRICS			English	Article							HIGH-SCHOOL; PHYSICAL-ACTIVITY; UNITED-STATES; CONCUSSION; SPORTS; INJURIES; CHILDREN; PARTICIPATION; EPIDEMIOLOGY; TAUOPATHY		[Lerner, Alec] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Lerner, Alec] Univ Wisconsin, Dept Med Hist & Bioeth, Madison, WI USA; [Fost, Norman] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA		Lerner, A (corresponding author), Univ Wisconsin Hosp, 600 Highland Ave,Room K4-944,Mail Code 9988, Madison, WI 53712 USA.	aplerner@wisc.edu			University of Wisconsin School of Medicine and Public Health; Herman and Gwendolyn Shapiro Foundation	Ten weeks of this project were supported by an award from the University of Wisconsin School of Medicine and Public Health and the Herman and Gwendolyn Shapiro Foundation.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Bjorklund DF, 1998, CHILD DEV, V69, P604, DOI 10.1111/j.1467-8624.1998.00604.x; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Briskin S, 2012, PEDIATRICS, V130, P774, DOI 10.1542/peds.2012-2082; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Chrisman SPD, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2402; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Concussion Legacy Foundation, 2019, ALL TIM GREAT TEAM; Concussions (be) Aware & Prepared Program, 2016, WHY DID AAP REV ITS; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Demorest RA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-3022; Diekema Douglas S, 2011, Adolesc Med State Art Rev, V22, P213; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donnelly JE, 2011, PREV MED, V52, pS36, DOI 10.1016/j.ypmed.2011.01.021; Drape J., 2018, NY TIMES; Feudtner C, 2018, JAMA PEDIATR, V172, P492, DOI 10.1001/jamapediatrics.2017.5242; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Goldstein LB, 2011, CIRCULATION, V123, P816, DOI 10.1161/CIR.0b013e31820a5528; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heck JF, 2004, J ATHL TRAINING, V39, P101; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Margolis LH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0047A; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0047B; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Miles SH, 2016, AM J BIOETHICS, V16, P6, DOI 10.1080/15265161.2016.1128751; Moore J, 2015, VICE; National Federation of State High School Associations, PART STAT; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pop Warner, 2019 PART CONTR PAR; Pope TM, 2019, AM J BIOETHICS, V19, P90, DOI [10.1080/15265161.2019.1587549, 10.1080/15265161.2018.1544309]; Purcell L, 2011, PEDIATRICS, V128, P617, DOI 10.1542/peds.2011-1165; Robeson R, 2014, J LAW MED ETHICS, V42, P334, DOI 10.1111/jlme.12150; Sabatino MJ, 2018, PEDIATRICS, V141, DOI 10.1542/peds.141.1_MeetingAbstract.203; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Schwarz A., 2016, NY TIMES; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; 2015, PLAST RECONSTR SURG, V0136	51	1	1	0	1	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2019	144	5							e20191985	10.1542/peds.2019-1985			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	JK2MP	WOS:000494681400046	31645457	Bronze			2022-02-06	
J	Melillo, C; Downs, K; Dillahunt-Aspillaga, C; Lind, J; Besterman-Dahan, K; Hahm, B; Antinori, N; Elnitsky, C; Sander, AM; Belanger, HG; Toyinbo, P; Powell-Cope, G				Melillo, Christine; Downs, Kiersten; Dillahunt-Aspillaga, Christina; Lind, Jason; Besterman-Dahan, Karen; Hahm, Bridget; Antinori, Nicole; Elnitsky, Christine; Sander, Angelle M.; Belanger, Heather G.; Toyinbo, Peter; Powell-Cope, Gail			Action Ethnography of Community Reintegration for Veterans and Military Service Members With Traumatic Brain Injury: Protocol for a Mixed Methods Study	JMIR RESEARCH PROTOCOLS			English	Article						ethnography; veteran; traumatic brain injury; community; military; social networks	ENGAGED RESEARCH; HEALTH; REHABILITATION; INTEGRATION; CHALLENGES; OUTCOMES	Background: Numerous studies of community reintegration (CR) in traumatic brain injury (TBI) have been conducted in civilian populations, but research is limited in veteran and military service member populations. Little is known about how knowledge from civilian studies translates into veterans' experiences and needs. The US Department of Veterans Health Administration (VHA) recognizes the distinctive health care needs of post-9/11 veteran and military service members, particularly with TBI, including the need to bridge health and rehabilitation-related services from acute care and inpatient settings to veteran and military service members' homes and communities to facilitate CR. Objective: The goal of this study is to better understand the experiences of veterans with complicated mild, moderate, or severe TBI; their families; and CR workers as veterans and servicemembers transition to and sustain living in communities. This paper describes the rationale, design, and methods used to reach this goal. Methods: This five-year longitudinal mixed methods study uses both a community-engaged research (CEnR) approach and an ethnographic approach. The sample includes 30 veterans and service members with TBI, 13 family caregivers, 11 CR specialists, 16 key stakeholders, and 82 community events. Interviews and observations are coded and analyzed using hierarchical coding schemes and thematic analysis. Analyses include data from surveys, interviews, and participant observations. Content analysis is used to highlight the complex social context of reintegration and to triangulate quantitative data. Egocentric (personal) social network analysis is used to examine the support system a veteran or service member has in place to facilitate reintegration. Results: Study enrollment and data collection are completed. Data analyses are underway. Conclusions: The results of this study may provide a heightened understanding of environmental factors affecting CR in complicated mild, moderate, or severe MI. Veteran, servicemember and family voices and insights provide VHA clinicians and policy makers with an ecological view of CR that is grounded in the life experiences of veterans, military service members, and families. The results of this study provide a roadmap for designing and testing interventions to maximize CR in a variety of domains The longitudinal ethnographic approach allows for capturing detailed experiences within the naturalistic context. CEnR allows collaborative assessment of the social context of reintegration with community members.	[Melillo, Christine; Downs, Kiersten; Dillahunt-Aspillaga, Christina; Lind, Jason; Besterman-Dahan, Karen; Hahm, Bridget; Antinori, Nicole; Toyinbo, Peter; Powell-Cope, Gail] Vet Hlth Adm, James A Haley Vet Hosp, Res & Dev Serv, 8900 Grand Oak Circle, Tampa, FL 33637 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Behav & Community Sci, Rehabil & Mental Hlth Counseling Program, Tampa, FL 33620 USA; [Elnitsky, Christine] Univ N Carolina, Coll Hlth & Human Serv, Sch Nursing, Charlotte, NC USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Belanger, Heather G.] US Special Operat Command, Def & Vet Brain Injury Ctr, Tampa, FL USA		Melillo, C (corresponding author), Vet Hlth Adm, James A Haley Vet Hosp, Res & Dev Serv, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	christine.melillo@va.gov		Hahm, Bridget/0000-0001-7454-4471; Lind, Jason/0000-0002-1610-0431; Besterman-Dahan, Karen/0000-0003-4829-4282; Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	Health Services Research and Development Service of the Office of Research and Development, VHA, US Department of Veterans Affairs [SDR 12-302]; Veterans AffairsUS Department of Veterans Affairs [I01HX001089] Funding Source: NIH RePORTER	This research was supported by the Award #SDR 12-302 from Health Services Research and Development Service of the Office of Research and Development, VHA, US Department of Veterans Affairs. The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the US Government. This work was also supported with resources from the James A. Haley Veterans Hospital. The authors would like to acknowledge the efforts of Lynn Dirk in the preparation of this manuscript. The authors would also like to thank the participants who generously shared their time and experiences.	Bernard H., 2016, ANAL QUALITATIVE DAT, V2nd; Besterman-Dahan K, 2018, ARCH PHYS MED REHAB, V99, pS72, DOI 10.1016/j.apmr.2017.06.035; Borgatti S., 2002, UCINET 6 WINDOWS SOF; Borgatti SP., 2006, E NETWORK SOFTWARE E; Bowen F, 2010, J BUS ETHICS, V95, P297, DOI 10.1007/s10551-009-0360-1; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Creswell J. W., 2018, DESIGNING CONDUCTING, V3nd; Crocker T, 2014, J REHABIL RES DEV, V51, pXI, DOI [10.1682/JRRD.2014.01.00111, 10.1682/JRRD.2014.01.0011]; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Elnitsky CA, 2018, ARCH PHYS MED REHAB, V99, pS58, DOI 10.1016/j.apmr.2017.10.008; Elnitsky CA, 2017, AM J ORTHOPSYCHIAT, V87, P114, DOI 10.1037/ort0000244; Fetterman D. M., 2009, ETHNOGRAPHY STEP STE; Field M, 2006, WORKSHOP DISABILITY; Friese S., 2014, QUALITATIVE DATA ANA; Krippendorff Klaus, 2018, CONTENT ANAL INTRO I; Kupersmith J, 2009, J REHABIL RES DEV, V46, pvii; Leung MW, 2004, INT J EPIDEMIOL, V33, P499, DOI 10.1093/ije/dyh010; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Michener L, 2012, ACAD MED, V87, P285, DOI 10.1097/ACM.0b013e3182441680; O'Cathain Alicia, 2010, BMJ, V341, pc4587, DOI 10.1136/bmj.c4587; Oetzel JG, 2015, AM J PUBLIC HEALTH, V105, P1161, DOI 10.2105/AJPH.2014.302457; Ottomanelli L, 2019, J HEAD TRAUMA REHAB, V34, P158, DOI 10.1097/HTR.0000000000000493; Patton mq, 2001, QUALITATIVE EVALUATI, V2nd; Perry B.L., 2018, EGOCENTRIC NETWORK A; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Qualtrics, 2019, TRY TOP RAT ONL SURV; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Savage J, 2000, BMJ-BRIT MED J, V321, P1400, DOI 10.1136/bmj.321.7273.1400; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Schensul, 1999, DESIGNING CONDUCTING; Seidel J., QUALIS RES APPENDIX; Silverman H, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-8; Smith RT, 2014, SOC MENT HEALTH, V4, P147, DOI 10.1177/2156869313512212; SPRADLEY JP, 1979, ETHNOGRAPHY CULTURE; Stern L, 2017, ADV DEV HUM RESOUR, V19, P66, DOI 10.1177/1523422316682928; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Tanaka M, VET AFFAIRS AM WOMEN; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2002, COMM LANG FUNCT DIS; World Health Organization:, WORLD REP DIS	46	1	1	0	2	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	NOV	2019	8	11							e14170	10.2196/14170			12	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	JT0RC	WOS:000500705500025	31755868	gold, Green Published			2022-02-06	
J	Noakes, MA; Schmitt, AJ; McCallum, E; Schutte, K				Noakes, Michaela A.; Schmitt, Ara J.; McCallum, Elizabeth; Schutte, Kerry			Speech-to-Text Assistive Technology for the Written Expression of Students With Traumatic Brain Injuries: A Single Case Experimental Study	SCHOOL PSYCHOLOGY			English	Article						TBI; assistive technology; written expression	RECOGNITION TECHNOLOGY; DICTATION; CHILDREN; VISITS	Traumatic brain injury in childhood (TBI) is a chronic health condition. As decreased memory, language, and rapid psychomotor impairments are known to accompany pediatric TBI (Babikian et al., 2011), students who have experienced a moderate-to-severe TBI are at particular risk for academic deficits, including writing difficulties. The purpose of this study was to measure the effects of a speech-to-text assistive technology (AT) accommodation that was implemented to bypass the impaired handwriting and spelling (i.e., transcription) skills resulting from TBI. Three African American male students (Grades 4, 8, and 9) who received formal special education services under the category of TBI participated in this study. With the application of the speech-to-text AT accommodation, all participants' total words written (TWW), words spelled correctly (WSC), and correct writing sequences (CWS) significantly increased compared to the handwriting control condition. One hundred percent nonoverlapping data points across participants and dependent variables was achieved. Implications of the findings for the school-based treatment of TBI, study limitations, and future avenues of study are discussed.	[Noakes, Michaela A.] LaRoche Coll, Dept Informat Technol, Pittsburgh, PA USA; [Schmitt, Ara J.; McCallum, Elizabeth; Schutte, Kerry] Duquesne Univ, Dept Counseling Psychol & Special Educ, Pittsburgh, PA 15219 USA		Schmitt, AJ (corresponding author), Duquesne Univ, Sch Educ, 600 Forbes Ave, Pittsburgh, PA 15282 USA.	schmitta2106@duq.edu					[Anonymous], 2016, WHAT WORKS CLEAR PRO; Filippetti VA, 2015, ACTA NEUROPSYCHOL, V13, P331, DOI 10.5604/17307503.1187493; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BARLOW DH, 1979, J APPL BEHAV ANAL, V12, P199, DOI 10.1901/jaba.1979.12-199; Berninger V. W., 2004, DEV MOTOR DISORDERS, P189; Caute A, 2016, APHASIOLOGY, V30, P245, DOI 10.1080/02687038.2015.1041095; Centers for Disease Control and Prevention, 2018, C MAN TRAUM BRAIN IN; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; De la Paz S, 1999, LEARN DISABILITY Q, V22, P173, DOI 10.2307/1511284; DelaPaz S, 1997, J EDUC PSYCHOL, V89, P203, DOI 10.1037/0022-0663.89.2.203; DENO SL, 1982, EXCEPT CHILDREN, V48, P368, DOI 10.1177/001440298204800417; Espin CA, 2005, J SPEC EDUC, V38, P208, DOI 10.1177/00224669050380040201; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gansle KA, 2006, SCHOOL PSYCHOL REV, V35, P435; Graham, 2003, HDB LEARNING DISABIL, P345; HIGGINS EL, 1995, LEARN DISABILITY Q, V18, P159, DOI 10.2307/1511202; Hooper SR, 2011, READ WRIT, V24, P221, DOI 10.1007/s11145-010-9263-x; Jones D, 1999, J EDUC PSYCHOL, V91, P44, DOI 10.1037/0022-0663.91.1.44; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; MacArthur CA, 2004, EXCEPT CHILDREN, V71, P43, DOI 10.1177/001440290407100103; MACARTHUR CA, 1987, J SPEC EDUC, V21, P22, DOI 10.1177/002246698702100304; Manasse NJ, 2000, BRAIN INJURY, V14, P1015; Marston D. B., 1981, 50 U MINN I RES LEAR; Marston DB, 1989, CURRICULUM BASED MEA, P18; Olive M. L., 2008, BEHAV ANAL TODAY, V9, P5; Peterson C, 2015, CHILD MALTREATMENT, V20, P162, DOI 10.1177/1077559515583549; Powell-Smith K. A., 2004, NCS PEARSON; Quinlan T, 2004, J EDUC PSYCHOL, V96, P337, DOI 10.1037/0022-0663.96.2.337; RASINSKI TV, 2011, HDB READING RES, V4, P286; Richards T. L., 2012, WRITING MOSAIC NEW P, P85; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Schmitt A. J., 2015, J EVIDENCE BASED PRA, V16, P46; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	38	1	1	2	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2578-4218	2578-4226		SCHOOL PSYCHOL	School Psychol.	NOV	2019	34	6					656	664		10.1037/spq0000316			9	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	KA3ES	WOS:000505682000008	31697151				2022-02-06	
J	O'Hara, NN; Mulliken, A; Joseph, K; Slobogean, GP; Johal, H; Cunningham, BP; Olaya, S; Levy, J; Pollak, AN; Klazinga, NS				O'Hara, Nathan N.; Mulliken, Alexandra; Joseph, Katherine; Slobogean, Gerard P.; Johal, Herman; Cunningham, Brian P.; Olaya, Stephan; Levy, Joseph; Pollak, Andrew N.; Klazinga, Niek S.			Valuing the Recovery Priorities of Orthopaedic Trauma Patients After Injury: Evidence From a Discrete Choice Experiment Within 6 Weeks of Injury	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						value-based health care; fracture; recovery; discrete choice experiment		Objectives: To determine the recovery priorities of extremity fracture patients during the subacute phase and the patient factors associated with variation in recovery priorities. Design: Discrete choice experiment. Setting: Academic trauma center. Patients: One hundred ninety-eight patients with a fracture to the appendicular skeleton. Patients with severe traumatic brain injuries, spinal cord injuries, and non-English-speaking patients were excluded. Main Outcome Measurement: The relative importance of clinical recovery, work-related recovery, and obtaining disability benefits after injury. Results: In the subacute period, clinical recovery was the main priority for fracture patients (mean: 62%, SD: 5.3). Work-related recovery (mean: 27%, SD: 3.9) and the receipt of other disability benefits (mean: 11%, SD: 6.4) were each of significantly less importance. Heterogeneity was observed across these estimates based on the physical demands of preinjury employment, preinjury physical health, preinjury work status, health insurance type, and the severity of the fracture. Conclusion: Clinical recovery was of paramount importance for fracture patients during the subacute recovery phase. However, patients also valued resuming work and access to disability benefits. Understanding a patient's recovery priorities early in the clinical care pathway will enable the development of multidisciplinary care plans that are responsive to these priorities and, hence, deliver value-based health care.	[O'Hara, Nathan N.; Mulliken, Alexandra; Joseph, Katherine; Slobogean, Gerard P.; Pollak, Andrew N.] Univ Maryland, Sch Med, Dept Orthopaed, 110 South Paca St, Baltimore, MD 21201 USA; [O'Hara, Nathan N.; Klazinga, Niek S.] Univ Amsterdam, Dept Publ Hlth, Amsterdam, Netherlands; [Johal, Herman] McMaster Univ, Dept Surg, Hamilton, ON, Canada; [Cunningham, Brian P.; Olaya, Stephan] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Levy, Joseph] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA		O'Hara, NN (corresponding author), Univ Maryland, Sch Med, Dept Orthopaed, 110 South Paca St, Baltimore, MD 21201 USA.	nohara@som.umaryland.edu	Johal, Herman/AAR-1935-2021	Johal, Herman/0000-0003-0643-534X; Mulliken, Alexandra/0000-0002-1694-1409			Bachrach D, 2018, ENABLING SUSTAINABLE; Coile C, 25569 NAT BUR EC RES; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Little R. J. A., 2002, STAT INFERENCE MISSI; O'Hara NN, 2019, SOCIOECONOMIC IMPACT; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Research Priorities, RES PRIOR; Ryan M., 2007, USING DISCRETE CHOIC, V11; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Scott JW, 2018, ANN SURG, V267, P1093, DOI 10.1097/SLA.0000000000002254; SOUSAPOZA A, 2000, J SOCIOECONOMICSS, V0029; Taylor LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160217; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; US Census Bureau, POV THRESH; Zarembka P, 1974, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592	16	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	NOV	2019	33			7			S16	S20		10.1097/BOT.0000000000001621			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	KH4YZ	WOS:000510656200005	31596779	Bronze			2022-02-06	
J	Oyesanya, TO; Thomas, MA				Oyesanya, Tolu O.; Thomas, Mitchell A.			Strategies nurses use when caring for patients with moderate-to-severe traumatic brain injury who have cognitive impairments	JOURNAL OF CLINICAL NURSING			English	Article						care plan; cognitive impairments; nursing; strategies; traumatic brain injury	QUALITATIVE CONTENT-ANALYSIS; PROVIDER COMMUNICATION; NURSING INTERVENTIONS; NUTRITION; REHABILITATION; AGITATION; OUTCOMES; RIGOR	Aims and objectives Adults with moderate-to-severe traumatic brain injury (TBI) may have immediate and chronic cognitive impairments that require use of specific nursing strategies. Nurses must be knowledgeable about strategies to use to accommodate these impairments. However, available clinical guidelines and research lack information to direct nonacute nursing management of cognition, limiting guidance for nurses when developing their care plans. The purpose of this study was to investigate strategies nurses use when caring for patients with moderate-to-severe TBI who have cognitive impairments. Design Cross-sectional, exploratory study. Methods A total of 692 nurses from three hospitals answered the following open-ended question via electronic survey: "Imagine you are caring for a patient with moderate-to-severe TBI who has problems with cognition (e.g., issues with memory, attention, and executive function). Please state your typical nursing routine to care for this type of patient." Data were analysed using summative content analysis. Methods are reported using COREQ guidelines (See File S1). Results Most respondents were female (89%), middle-aged (40.3 years), staff registered nurses (77%) practicing on an inpatient unit (51%) with prior experience caring for patients with moderate-to-severe TBI (95%). Nurses described 189 strategies used in their care plan when caring for patients with TBI who have cognitive impairments, including the following: (a) cognitive techniques; (b) communication techniques; (c) patient safety techniques; (d) agitation and behaviour management techniques; and (e) education techniques. Conclusions Findings have implications for education and training of nurses, direction for future research aimed at determining the effectiveness of nursing strategies with this patient population, and for development of clinical guidelines for nonacute nursing management of patients with moderate-to-severe TBI who have cognitive impairments. Relevance to clinical practice Findings provide foundational knowledge on strategies nurses use when caring for patients with TBI who have cognitive impairments, which could be used to direct evidence-based nursing care of this patient population.	[Oyesanya, Tolu O.] Duke Univ, Sch Nursing, 307 Trent Dr,Room 2029, Durham, NC 27710 USA; [Thomas, Mitchell A.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr,Room 2029, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25 GM083252] Funding Source: Medline; University of Wisconsin-Madison, School of Nursing Eckburg Research and Eckburg Dissertation Award Funding Source: Medline; NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252] Funding Source: Medline		Alverzo Joan, 2004, Rehabil Nurs, V29, P85; American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bazeley P., 2013, QUALITATIVE DATA ANA; Bistrian BR, 2011, JPEN-PARENTER ENTER, V35, P556, DOI 10.1177/0148607111416122; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Brolliar SM, 2016, J NEUROTRAUM, V33, P1554, DOI 10.1089/neu.2015.4183; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Collis J, 2012, INT J LANG COMM DIS, V47, P725, DOI 10.1111/j.1460-6984.2012.00183.x; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Department of Veterans Affairs, 2013, VHA HDB; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dondorf K., 2016, J NURS ED PRACT, V6, P17, DOI DOI 10.5430/JNEP.V6N4P17; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Ghassemi Akhtar E, 2017, Iran J Nurs Midwifery Res, V22, P497, DOI 10.4103/ijnmr.IJNMR_4_17; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hsu C.-C., 2010, ENCY RES DESIGN, P344, DOI DOI 10.4135/9781412961288; Jaglal SB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-409; Joint Trauma System, 2017, CLIN PRACT GUID NEUR; Kothari S., 2007, BRAIN INJURY MED PRI, P169; Lehman C, 2015, SPECIALTY PRACTICE R, P511; Lentz J, 2016, CONTEMP CLIN TRIALS, V49, P65, DOI 10.1016/j.cct.2016.06.005; Long AF, 2002, J ADV NURS, V37, P70, DOI 10.1046/j.1365-2648.2002.02059.x; Lor M, 2016, NURS OUTLOOK, V64, P352, DOI 10.1016/j.outlook.2016.02.006; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; McDonald S., 2016, COMMUNICATION DISORD; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; Melnyk B.M., 2011, EVIDENCE BASED PRACT; Mortimer DS, 2017, J NEUROSCI NURS, V49, P25, DOI 10.1097/JNN.0000000000000253; Oppikofer S, 2014, DEMENTIA-LONDON, V13, P306, DOI 10.1177/1471301212461110; Oyesanya TO, 2019, ASSIST TECHNOL, DOI 10.1080/10400435.2019.1612798; Oyesanya TO, 2018, J SPEC PEDIATR NURS, V23, DOI 10.1111/jspn.12209; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Patak L, 2009, J NURS ADMIN, V39, P372, DOI 10.1097/NNA.0b013e3181b414ca; Piette JD, 2003, J GEN INTERN MED, V18, P624, DOI 10.1046/j.1525-1497.2003.31968.x; Reddy RP, 2017, INDIAN J PSYCHOL MED, V39, P32, DOI 10.4103/0253-7176.198940; Rice KL, 2014, J CONTIN EDUC NURS, V45, P136, DOI 10.3928/00220124-20140219-02; SANDELOWSKI M, 1993, ADV NURS SCI, V16, P1; SANDELOWSKI M, 1986, ADV NURS SCI, V8, P27, DOI 10.1097/00012272-198604000-00005; Schmitt JAJ, 2010, NUTR REV, V68, pS2, DOI 10.1111/j.1753-4887.2010.00329.x; Secomb J, 2008, J CLIN NURS, V17, P703, DOI 10.1111/j.1365-2702.2007.01954.x; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Turkstra LS, 2013, J HEAD TRAUMA REHAB, V28, P332, DOI 10.1097/HTR.0b013e31828b4f3f; Villanueva N E, 1999, J Neurosci Nurs, V31, P216	52	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	NOV	2019	28	21-22					4098	4109		10.1111/jocn.14958			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	JD9FG	WOS:000490292100036	31190340	Green Accepted			2022-02-06	
J	Park, M; Chung, J; Kim, JK; Jeong, Y; Moon, WJ				Park, Mina; Chung, Jinyong; Kim, Jin Kook; Jeong, Yong; Moon, Won-Jin			Altered Functional Brain Networks in Patients with Traumatic Anosmia: Resting-State Functional MRI Based on Graph Theoretical Analysis	KOREAN JOURNAL OF RADIOLOGY			English	Article						Traumatic anosmia; Functional magnetic resonance imaging; Resting state; Brain networks; Functional connectivity; Graph theory	OLFACTORY LOSS; CONNECTIVITY; ORGANIZATION; DISORDERS; INJURY; FMRI	Objective: Traumatic anosmia is a common disorder following head injury; however, little is known regarding its neural basis and influence on the functional networks. Therefore, we aimed to investigate the functional connectivity changes in patients with traumatic anosmia compared to healthy controls using resting-state functional magnetic resonance imaging (rs-fMRI). Materials and Methods: Sixteen patients with traumatic anosmia and 12 healthy controls underwent rs-fMRI. Differences in the connectivity of the olfactory and whole brain networks were compared between the two groups. Graph theoretical parameters, such as modularity and global efficiency of the whole brain or olfactory networks, were calculated and compared. Correlation analyses were performed between the parameters and disease severity. Results: Patients with traumatic anosmia showed decreased intra-network connectivity in the olfactory network (false discovery rate [FDR]-corrected p < 0.05) compared with that in healthy controls. Furthermore, the inter-network connectivity was increased in both the olfactory (FDR-corrected p < 0.05) and whole brain networks (degree-based statistic-corrected p < 0.05) in the anosmia group. The whole brain networks showed decreased modularity (p < 0.001) and increased global efficiency (p = 0.019) in patients with traumatic anosmia. The modularity and global efficiency were correlated with disease severity in patients with anosmia (p < 0.001 and p = 0.002, respectively). Conclusion: Traumatic anosmia increased the inter-network connectivity observed with rs-fMRI in the olfactory and global brain functional networks. rs-fMRI parameters may serve as potential biomarkers for traumatic anosmia by revealing a more widespread functional damage than previously expected.	[Park, Mina; Moon, Won-Jin] Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, 120-1 Neungdong Ro, Seoul 05030, South Korea; [Kim, Jin Kook] Konkuk Univ, Sch Med, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Park, Mina] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Chung, Jinyong; Jeong, Yong] Korea Adv Inst Sci & Technol, Lab Cognit Neurosci & NeuroImaging, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea; [Chung, Jinyong; Jeong, Yong] Korea Adv Inst Sci & Technol, KI Hlth Sci & Technol, 291 Daehak Ro, Daejeon 34141, South Korea		Moon, WJ (corresponding author), Konkuk Univ, Sch Med, Med Ctr, Dept Radiol, 120-1 Neungdong Ro, Seoul 05030, South Korea.; Jeong, Y (corresponding author), Korea Adv Inst Sci & Technol, Lab Cognit Neurosci & NeuroImaging, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea.; Jeong, Y (corresponding author), Korea Adv Inst Sci & Technol, KI Hlth Sci & Technol, 291 Daehak Ro, Daejeon 34141, South Korea.	yong@kaist.ac.kr; mdmoonwj@naver.com	; Jeong, Yong/C-1677-2011	PARK, MINA/0000-0002-2005-7560; Jeong, Yong/0000-0002-5907-3787; Moon, Won-Jin/0000-0002-8925-7376; Kim, Jin Kook/0000-0003-4245-6252	National Research Foundation of Korea - Korean GovernmentNational Research Foundation of KoreaKorean Government [NRF-2016R1D1A1B01012705]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C1038]	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Korean Government (NRF-2016R1D1A1B01012705), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI18C1038).	Akiki TJ, 2018, NEUROIMAGE, V176, P489, DOI 10.1016/j.neuroimage.2018.05.005; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Baum GL, 2017, CURR BIOL, V27, P1561, DOI 10.1016/j.cub.2017.04.051; Bende M, 1997, PHYSIOL BEHAV, V62, P1065, DOI 10.1016/S0031-9384(97)00251-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brier MR, 2014, NEUROBIOL AGING, V35, P757, DOI 10.1016/j.neurobiolaging.2013.10.081; Cho JH, 2009, AURIS NASUS LARYNX, V36, P280, DOI 10.1016/j.anl.2008.07.005; Chung J, 2017, NEUROIMAGE, V159, P224, DOI 10.1016/j.neuroimage.2017.07.053; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Han PF, 2018, J NEUROTRAUM, V35, P2632, DOI 10.1089/neu.2017.5393; Henkin RI, 2002, J COMPUT ASSIST TOMO, V26, P39, DOI 10.1097/00004728-200201000-00008; Hohenfeld C, 2018, NEUROIMAGE-CLIN, V18, P849, DOI 10.1016/j.nicl.2018.03.013; Hong SC, 1999, KOREAN J OTOLARYNGOL, V42, P855; Hummel T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00125; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Kollndorfer K, 2015, NEUROSCIENCE, V310, P589, DOI 10.1016/j.neuroscience.2015.09.045; Kollndorfer K, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/140419; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Moon WJ, 2018, AM J NEURORADIOL, V39, P2320, DOI 10.3174/ajnr.A5873; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Pamplona GSP, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00061; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rao H, 2008, NEUROIMAGE, V42, P902, DOI 10.1016/j.neuroimage.2008.05.046; Reichert JL, 2018, HUM BRAIN MAPP, V39, P3166, DOI 10.1002/hbm.24067; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schneider F, 2007, PSYCHIAT RES-NEUROIM, V155, P103, DOI 10.1016/j.pscychresns.2006.12.004; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Shah C, 2013, HUM BRAIN MAPP, V34, P1088, DOI 10.1002/hbm.21493; Song J, 2014, BRAIN CONNECT, V4, P662, DOI 10.1089/brain.2014.0286; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Stanley ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123950; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vedaei F, 2013, BEHAV NEUROL, V27, P267, DOI [10.1155/2013/870814, 10.3233/BEN-120320]; Wang JL, 2010, BRAIN RES, V1357, P184, DOI 10.1016/j.brainres.2010.08.018; Yoo K, 2017, HUM BRAIN MAPP, V38, P165, DOI 10.1002/hbm.23352; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548	50	1	1	1	6	KOREAN RADIOLOGICAL SOC	SEOUL	121-8 YANGJAE-DONG, SEOCHO-GU, SEOUL 137-130, SOUTH KOREA	1229-6929	2005-8330		KOREAN J RADIOL	Korean J. Radiol.	NOV	2019	20	11					1536	1545		10.3348/kjr.2019.0104			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	JD1JR	WOS:000489731500006	31606958	Green Published			2022-02-06	
J	Park, YH; Ryu, DH; Lee, BK; Lee, DH				Park, Young Hoon; Ryu, Dong Hyun; Lee, Byung Kook; Lee, Dong Hun			The association between the initial lactate level and need for massive transfusion in severe trauma patients with and without traumatic brain injury	ACUTE AND CRITICAL CARE			English	Article						blood transfusion; lactate; trauma; traumatic brain injury	SYSTOLIC BLOOD-PRESSURE; VENA-CAVA; MORTALITY; SUPERIOR; OUTCOMES	Background: Exsanguination is a major cause of death in severe trauma patients. The purpose of this study was to analyze the prognostic impact of the initial lactate level for massive transfusion (MT) in severe trauma. We divided patients according to subgroups of traumatic brain injury (TBI) and non-TBI. Methods: This single-institution retrospective study was conducted on patients who were admitted to hospital for severe trauma between January 2016 and December 2017. TBI was defined by a head Abbreviated Injury Scale >= 3. Receiver operating characteristic analysis was used to analyze the prognostic impact of the lactate level. Multivariate analyses were performed to evaluate the relationship between the MT and lactate level. The primary outcome was MT. Results: Of the 553 patients, MT was performed in 62 patients (11.2%). The area under the curve (AUC) for the lactate level for predicting MT was 0.779 (95 0 /o confidence interval [CI], 0.742 to 0.813). The AUCs for lactate level in the TBI and non-TBI patients were 0.690 (95% CI, 0.627 to 0.747) and 0.842 (95% Cl, 0.796 to 0.881), respectively. In multivariate analyses, the lactate level was independently associated with the MT (odds ratio [OR], 1.179; 95% CI, 1.070 to 1.299). The lactate level was independently associated with MT in non-TBI patients (OR, 1.469; 95% CI, 1.262 to 1.710), but not in TBI patients. Conclusions: The initial lactate level may be a possible prognostic factor for MT in severe trauma. In TBI patients, however, the initial lactate level was not suitable for predicting MT.	[Park, Young Hoon; Ryu, Dong Hyun; Lee, Byung Kook; Lee, Dong Hun] Chonnam Natl Univ Hosp, Dept Emergency Med, 42 Jebong Ro, Gwangju 61469, South Korea		Lee, DH (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, 42 Jebong Ro, Gwangju 61469, South Korea.	ggodhkekf@hanmail.net	Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brooke M, 2016, J SURG RES, V204, P139, DOI 10.1016/j.jss.2016.04.015; Brown JB, 2015, J TRAUMA ACUTE CARE, V78, P352, DOI 10.1097/TA.0000000000000523; Dekker SE, 2017, EUR J TRAUMA EMERG S, V43, P841, DOI 10.1007/s00068-016-0733-y; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hagiwara A, 2016, SHOCK, V45, P495, DOI 10.1097/SHK.0000000000000536; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Johnson JJ, 2013, J TRAUMA ACUTE CARE, V74, P741, DOI 10.1097/TA.0b013e3182827270; Johnson MC, 2017, J TRAUMA ACUTE CARE, V83, P603, DOI 10.1097/TA.0000000000001595; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; Liang DJ, 2019, CORONARY ARTERY DIS, V30, P26, DOI 10.1097/MCA.0000000000000674; Lyu Xiaochun, 2015, Zhonghua Yi Xue Za Zhi, V95, P496; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Odell DD, 2011, SEMIN THORAC CARDIOV, V23, P326, DOI 10.1053/j.semtcvs.2012.01.009; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Vandromme MJ, 2010, J AM COLL SURGEONS, V210, P861, DOI 10.1016/j.jamcollsurg.2010.01.012	22	1	1	0	0	KOREAN SOC CRITICAL CARE MEDICINE	SEOUL	806 YONG SEONG BIZTEL BLDG, 109 HANGANG-DAERO, YONGSAN-GU, SEOUL, 04376, SOUTH KOREA	2586-6052	2586-6060		ACUTE CRIT CARE	Acute Crit. Care	NOV	2019	34	4					255	262		10.4266/acc.2019.00640			8	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JS8GF	WOS:000500539600003	31795623	Green Published, gold			2022-02-06	
J	Pourahmad, S; Rasouli-Emadi, S; Moayyedi, F; Khalili, H				Pourahmad, Saeedeh; Rasouli-Emadi, Soheila; Moayyedi, Fatemeh; Khalili, Hosseinali			Comparison of four variable selection methods to determine the important variables in predicting the prognosis of traumatic brain injury patients by support vector machine	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Variable selection; traumatic brain injury; support vector machine; filter; wrapper; prediction; prognosis	MODEL	Background: Large amounts of information have called for increased computational complexity. Data dimension reduction is therefore critical to preliminary analysis. In this research, four variable selection (VS) methods are compared to obtain the important variables in predicting the prognosis of traumatic brain injury (TBI) patients. Materials and Methods: In a retrospective follow-up study, 741 TBI patients who were hospitalized for at least 2 days and had a Glasgow Coma Scale score of at least one were followed. Their clinical data recorded during intensive care unit (ICU) admission and eight-category extended GOS conditions 6 months after discharge were utilized here. Two filter- and two wrapper-based VS methods were applied for comparison. A support vector machine (SVM) classifier was then used, and the sensitivity, specificity, accuracy, and the area under the receiver characteristic curve (AUC) values were calculated. Results: Theoretically, the variables selected by sequential forward selection (SFS) method would better predict the prognosis (AUC = 0.737, 95% confidence interval [0.701, 0.772], specificity = 89.2%, sensitivity = 58.9% and accuracy = 79.1%) than the others. Genetic algorithm (GA), minimum redundancy maximum relevance (MRMR), and mutual information method were in the next orders, respectively. Conclusion: The use of an SVM classifier on optimal subsets given by GA and SFS reveals that wrapper-based methods perform better than filter-based methods in our data set, although all selected subsets, except for the MRMR, were clinically accepted. In addition, for prognosis prediction of TBI patients, a small subset of clinical records during ICU admission is enough to achieve an accepted accuracy.	[Pourahmad, Saeedeh] Shiraz Univ Med Sci, Bioinformat & Computat Biol Res Ctr, Shiraz, Iran; [Pourahmad, Saeedeh; Rasouli-Emadi, Soheila] Shiraz Univ Med Sci, Med Sch, Dept Biostat, Shiraz, Iran; [Moayyedi, Fatemeh] Larestan Univ, Dept Comp Engn, Lar, Iran; [Khalili, Hosseinali] Shiraz Univ Med Sci, Shahid Rajaee Emtiaz Hosp, Trauma Res Ctr, Shiraz, Iran		Khalili, H (corresponding author), Shiraz Univ Med Sci, Shahid Rajaee Emtiaz Hosp, Trauma Res Ctr, Shiraz, Iran.	khalili_h@sums.ac.ir	Pourahmad, Saeedeh/S-9117-2017; Khalili, Hosseinali/I-1087-2016	Pourahmad, Saeedeh/0000-0002-7366-1059; Khalili, Hosseinali/0000-0002-3390-4212	Shiraz University of Medical Sciences Research Council [95-11511]	This work was supported by the grant number 95-11511 from Shiraz University of Medical Sciences Research Council. This article was extracted from Soheyla Rasouli-Emadi's Master of Science Thesis.	Babatunde O, 2014, INT J ELECT COMMUN C, V5, P2278; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Cover T. M., 2012, ELEMENTS INFORM THEO; Drotar P, 2015, COMPUT BIOL MED, V66, P1, DOI 10.1016/j.compbiomed.2015.08.010; Guney F, 2013, COMP NONLINEAR DIMEN; Jakkula V, 2006, TUTORIAL SUPPORT VEC; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Luque-Baena RM, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S7; Oh H, 2009, CRIT CARE NURSE, V29, P12, DOI 10.4037/ccn2009279; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Pourahmad S, 2016, ADV APPL STAT, V48, P369, DOI 10.17654/AS048050369; Rosati S, 2012, INT J BIOELECTROMAGN, V14, P198; Shibuya TY, 2007, J ORAL MAXIL SURG, V65, P1693, DOI 10.1016/j.joms.2006.06.309; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Terzioglu B, 2015, J RES MED SCI, V20, P1166, DOI 10.4103/1735-1995.172984; Yang Y., 1997, INT C MACH LEARN	19	1	1	1	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	NOV	2019	24								97	10.4103/jrms.JRMS_89_18			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KJ4MI	WOS:000512032100003	31850086	Green Published, gold			2022-02-06	
J	Saard, M; Bachmann, M; Sepp, K; Pertens, L; Kornet, K; Reinart, L; Koop, C; Kolk, A				Saard, Marianne; Bachmann, Madis; Sepp, Kirsi; Pertens, Lisanna; Kornet, Kai; Reinart, Liina; Koop, Christen; Kolk, Anneli			Positive outcome of visuospatial deficit rehabilitation in children with epilepsy using computer-based FORAMENRehab program	EPILEPSY & BEHAVIOR			English	Article						Children; Epilepsy; Visuospatial deficits; Cognitive rehabilitation in children; Computer-based rehabilitation; Visuospatial rehabilitation	TRAUMATIC BRAIN-INJURY; ASSISTED COGNITIVE REHABILITATION; BENIGN CHILDHOOD EPILEPSY; TEMPORAL-LOBE EPILEPSY; NEUROPSYCHOLOGICAL REHABILITATION; SPATIAL ABILITY; SEX-DIFFERENCES; MOTOR-SKILLS; SPIKES BECTS; ATTENTION	Children with epilepsy often show deficits in attention and visuospatial functions. Still, very few systematically controlled evidence-based pediatric neurorehabilitation methods exist. The aim was to assess the effectiveness of a computer-based rehabilitation program for visuospatial deficit remediation in children with epilepsy. Fifty-eight children aged 8-12 years participated: 17 children with epilepsy diagnosis in intervention group, 22 patients in waiting-list control group, and 19 healthy age equivalent controls. The intervention group received guided visuospatial functions rehabilitation with FORAMENRehab software twice a week for a 5-week period. Baseline assessments were carried out before and immediately after the intervention period, and as follow-up 1.31 years later. Intervention group showed positive immediate rehabilitation effect in 3 out of 4 visuospatial components: visual organization, visual attention, and visuospatial perception. A long-term rehabilitation effect in the study group was observed in all 4 of the trained components. Also, a positive generalized effect was confirmed by the parents' and children's qualitative feedback with some of the improved skills transferring to children's everyday life. One hundred percent compliance further confirmed the children's motivation to participate and the effectiveness of FORAMENRehab for pediatric neurorehabilitation. (C) 2019 Elsevier Inc. All rights reserved.	[Saard, Marianne; Kornet, Kai; Koop, Christen; Kolk, Anneli] Univ Tartu, Fac Med, Tartu, Estonia; [Bachmann, Madis] Cognit Psychol Lab, Tallinn, Estonia; [Sepp, Kirsi] Univ Tartu, Inst Educ, Fac Social Sci, Tartu, Estonia; [Pertens, Lisanna; Reinart, Liina; Kolk, Anneli] Tartu Univ Hosp, Childrens Clin, Dept Pediat & Neurol, Tartu, Estonia; [Reinart, Liina] Univ Tartu, Inst Psychol, Fac Social Sci, Tartu, Estonia		Saard, M (corresponding author), Lunini 6, EE-51014 Tartu, Estonia.	mariannesaard@gmail.com			Estonian Science Foundation [GARLA 9016]; Estonian Ministry of Education and ResearchMinistry of Education and Research, Estonia [TARLA 2695]	This study was supported by the Estonian Science Foundation (GARLA 9016) and by the Estonian Ministry of Education and Research TARLA 2695.	Allen K., 2019, EDUC PSYCHOL REV, V31, P1; Amonn F, 2013, NEUROREHABILITATION, V32, P555, DOI 10.3233/NRE-130877; Assel M. A., 2003, APPL DEV SCI, V7, P27, DOI [10.1207/s1532480xads0701_3, DOI 10.1207/S1532480XADS0701_3, 10.1207/S1532480XADS0701_3, DOI 10.1207/S1532480XADS0701_]; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Bender HA, 2007, PEDIATR NEUROL, V36, P312, DOI 10.1016/j.pediatrneurol.2007.01.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Carlson AG, 2013, J GENET PSYCHOL, V174, P514, DOI 10.1080/00221325.2012.717122; Cave KR, 1999, PSYCHON B REV, V6, P204, DOI 10.3758/BF03212327; Cherrier MM, 2013, LIFE SCI, V93, P617, DOI 10.1016/j.lfs.2013.08.011; Chung YT, 2014, INT J NEUROREHABIL, V1, P125; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Corti C, 2018, NEUROPSYCHOLOGIA, V120, P124, DOI 10.1016/j.neuropsychologia.2018.10.012; Crollen V, 2015, J EXP CHILD PSYCHOL, V132, P84, DOI 10.1016/j.jecp.2014.12.006; Danielsson J, 2009, EPILEPSY BEHAV, V16, P646, DOI 10.1016/j.yebeh.2009.08.012; Deonna T, 2000, DEV MED CHILD NEUROL, V42, P595, DOI 10.1017/S0012162200001122; Donnon T, 2005, CAN J SURG, V48, P387; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Farina E, 2015, EPILEPSY RES, V109, P210, DOI 10.1016/j.eplepsyres.2014.10.017; Genizi J, 2012, J CHILD NEUROL, V27, P156, DOI 10.1177/0883073811414420; Glosser G, 2003, NEUROLOGY, V61, P81, DOI 10.1212/01.WNL.0000073621.18013.E1; Hanssen KT, 2016, ACTA NEUROL SCAND, V133, P30, DOI 10.1111/ane.12420; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Holmes MD, 1996, BRAIN RES, V711, P44, DOI 10.1016/0006-8993(95)01351-2; Jokeit H, 2001, NEUROLOGY, V57, P1786, DOI 10.1212/WNL.57.10.1786; Kaldoja ML, 2015, J PEDIATR REHAB MED, V8, P271, DOI 10.3233/PRM-150346; Kanchan A, 2018, INDIAN J PSYCHIAT, V60, P38, DOI 10.4103/psychiatry.IndianJPsychiatry_118_17; Kerkhoff G, 1998, RESTOR NEUROL NEUROS, V12, P27; KOLB B, 2003, FUNDAMENTALS HUMAN N; Kolk A, 2001, BRAIN DEV-JPN, V23, P88, DOI 10.1016/S0387-7604(01)00180-2; Kolk A, 2018, APPL NEUROPSYCH-CHIL, V27, P1; Koorenhof L, 2012, SEIZURE-EUR J EPILEP, V21, P178, DOI 10.1016/j.seizure.2011.12.001; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Langenbahn DM, 2013, ARCH PHYS MED REHAB, V94, P271, DOI 10.1016/j.apmr.2012.09.011; Li Y, 2017, SOURCE CODE BIOL MED, V12, DOI 10.1186/s13029-017-0063-4; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.2307/1130467; Livelli A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00306; Lv ZX, 2014, EPILEPSY BEHAV, V35, P64, DOI 10.1016/j.yebeh.2014.04.001; Mervis CB, 1999, AM J HUM GENET, V65, P1222, DOI 10.1086/302633; Ogourtsova T, 2017, NEUROPSYCHOL REHABIL, V27, P409, DOI 10.1080/09602011.2015.1113187; Parisi P, 2012, CHILD NERV SYST, V28, P2129, DOI 10.1007/s00381-012-1867-9; Park IS, 2015, J PHYS THER SCI, V27, P773, DOI 10.1589/jpts.27.773; Pienaar AE, 2014, CHILD CARE HLTH DEV, V40, P370, DOI 10.1111/cch.12059; Radford K, 2011, EPILEPSY BEHAV, V22, P272, DOI 10.1016/j.yebeh.2011.06.021; Rathouz PJ, 2014, DEV MED CHILD NEUROL, V56, P635, DOI 10.1111/dmcn.12432; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Riccio CA, 2015, APPL NEUROPSYCH-CHIL, V4, P277, DOI 10.1080/21622965.2014.923774; Riva D, 2002, J CHILD NEUROL, V17, P661, DOI 10.1177/088307380201700902; Saard M, 2017, EPILEPSY BEHAV, V67, P111, DOI 10.1016/j.yebeh.2016.12.030; Sarajuuri JM, 2006, INT J PSYCHOL, V41, P362, DOI 10.1080/01650250500346103; Shaw DR, 2014, NEUROREHABILITATION, V34, P23, DOI 10.3233/NRE-131005; Simms V, 2016, J EXP CHILD PSYCHOL, V145, P22, DOI 10.1016/j.jecp.2015.12.004; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Tal G, 2013, PEDIATR NEUROL, V48, P424, DOI 10.1016/j.pediatrneurol.2012.11.008; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; van der Ham IJM, 2011, BRAIN COGNITION, V76, P184, DOI 10.1016/j.bandc.2011.01.008; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Veri K, 2018, J CHILD NEUROL, V33, P587, DOI 10.1177/0883073818776760; Wai J, 2009, J EDUC PSYCHOL, V101, P817, DOI 10.1037/a0016127; Witt JA, 2013, SEIZURE-EUR J EPILEP, V22, P416, DOI 10.1016/j.seizure.2013.04.004; Xiao FL, 2015, EPILEPSY BEHAV, V45, P234, DOI 10.1016/j.yebeh.2015.01.016; Zilli T, 2015, J CLIN EXP NEUROPSYC, V37, P1036, DOI 10.1080/13803395.2015.1076380	65	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	NOV	2019	100		A						106521	10.1016/j.yebeh.2019.106521			11	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	JS5MC	WOS:000500348700011	31577988				2022-02-06	
J	Schauer, SG; April, MD; Naylor, JF; Mould-Millman, NK; Bebarta, VS; Becker, TE; Maddry, JK; Ginde, AA				Schauer, Steven G.; April, Michael D.; Naylor, Jason F.; Mould-Millman, Nee-Kofi; Bebarta, Vikhyat S.; Becker, Tyson E.; Maddry, Joseph K.; Ginde, Adit A.			Incidence of Hyperoxia in Combat Wounded in Iraq and Afghanistan: A Potential Opportunity for Oxygen Conservation	MILITARY MEDICINE			English	Article							MECHANICALLY VENTILATED PATIENTS; PEDIATRIC TRAUMA PATIENTS; EMERGENCY-DEPARTMENT; THERAPY; RESUSCITATION; ASSOCIATION; MORTALITY	Introduction: Oxygen supplementation is frequently used in critically injured trauma casualties in the combat setting. Oxygen supplies in the deployed setting are limited so excessive use of oxygen may unnecessarily consume this limited resource. We describe the incidence of supraphysiologic oxygenation (hyperoxia) within casualties in the Department of Defense Trauma Registry (DoDTR). Methods: This is a subanalysis of previously published data from the DoDTR we isolated casualties with a documented arterial blood gas (ABG) and categorized hyperoxia as an arterial oxygen >100 mmHg and extreme hyperoxia > 300 mmHg (a subset of hyperoxia). We defined serious injuries as those with an Abbreviated Injury Score (AIS) of 3 or greater. We defined a probable moderate traumatic brain injury of those with an AIS of 3 or greater for the head region and at least one Glasgow Coma Scale at 8 or less. Results: Our initial search yielded 28,222 casualties, of which 10,969 had at least one ABG available. Within the 10,969, the proportion of casualties experiencing hyperoxia in this population was 20.6% (2,269) with a subset of 4.1% (452) meeting criteria for extreme hyperoxia. Among those with hyperoxia, the median age was 25 years (IQR 21-30), most were male (96.8%), most frequently US forces (41.4%), injured in Afghanistan (68.3%), injured by explosive (61.1%), with moderate injury scores (median 17, IQR 10-26), and most (93.8%) survived to hospital discharge. A total of 17.8% (1,954) of the casualties underwent endotracheal intubation: 27.5% (538 of 1,954) prior to emergency department (ED) arrival and 72.5% (1,416 of 1,954) within the ED. Among those intubated in the prehospital setting, upon ED arrival 35.1% (189) were hyperoxic, and a subset of 5.6% (30) that were extremely hyperoxic. Among those intubated in the ED, 35.4% (502) were hyperoxic, 7.9% (112) were extremely hyperoxic. Within the 1,277 with a probable TBI, 44.2% (565) experienced hyperoxia and 9.5% (122) met criteria for extreme hyperoxia. Conclusions: In our dataset, more than 1 in 5 casualties overall had documented hyperoxia on ABG measurement, 1 in 3 intubated casualties, and almost 1 in 2 TBI casualties. With limited oxygen supplies in theater and logistical challenges with oxygen resupply, efforts to avoid unnecessary oxygen supplementation may have material impact on preserving this scarce resource and avoid potential detrimental clinical effects from supraphysiologic oxygen concentrations.	[Schauer, Steven G.; Maddry, Joseph K.] US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA; [Schauer, Steven G.; April, Michael D.; Becker, Tyson E.; Maddry, Joseph K.] Brooke Army Med Ctr, Jbsa Ft Sam Houston, TX 78234 USA; [Schauer, Steven G.; Bebarta, Vikhyat S.; Maddry, Joseph K.] 59th Med Wing, Jbsa Lackland, TX 78236 USA; [Schauer, Steven G.; Maddry, Joseph K.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Naylor, Jason F.; Bebarta, Vikhyat S.] Madigan Army Med Ctr, Joint Base Lewis Mcchord, WA USA; [Mould-Millman, Nee-Kofi; Ginde, Adit A.] Univ Colorado, Sch Med, Aurora, CO USA		Schauer, SG (corresponding author), US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA.; Schauer, SG (corresponding author), Brooke Army Med Ctr, Jbsa Ft Sam Houston, TX 78234 USA.; Schauer, SG (corresponding author), 59th Med Wing, Jbsa Lackland, TX 78236 USA.; Schauer, SG (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.			Mould-Millman, Nee-Kofi/0000-0003-4303-6903			Bustillo RA, 2018, EMERGENCIAS, V30, P41; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; DONALD KW, 1947, BRIT MED J, V1, P712, DOI 10.1136/bmj.1.4507.712; DONALD KW, 1947, BRIT MED J, V1, pU672; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Joosten SA, 2007, MED J AUSTRALIA, V186, P235, DOI 10.5694/j.1326-5377.2007.tb00879.x; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Maddry JK, 2018, J TRAUMA ACUTE CARE, V84, P157, DOI 10.1097/TA.0000000000001607; Naylor JF, 2019, MIL MED, V184, pE168, DOI 10.1093/milmed/usy357; Naylor JF, 2018, PEDIATR RADIOL, V48, P620, DOI 10.1007/s00247-017-4065-9; Newth CJL, 1997, EUR RESPIR J, V10, P2174, DOI 10.1183/09031936.97.10092174; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; Rachmale S, 2012, RESP CARE, V57, P1887, DOI 10.4187/respcare.01696; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121552; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Schauer Stephen G, 2017, US Army Med Dep J, P92; Schauer SG, 2019, MIL MED, V184, pE319, DOI 10.1093/milmed/usy273; Schauer SG, 2018, PREHOSP EMERG CARE, V22, P624, DOI 10.1080/10903127.2018.1439130; Schauer SG, 2018, AM J EMERG MED, V36, P1540, DOI 10.1016/j.ajem.2018.01.014; Schauer SG, 2019, AM J EMERG MED, V37, P94, DOI 10.1016/j.ajem.2018.04.068; Suzuki S, 2014, CRIT CARE MED, V42, P1414, DOI 10.1097/CCM.0000000000000219; Vincent JL, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/2834956	26	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV-DEC	2019	184	11-12					661	667		10.1093/milmed/usz125			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KG8TE	WOS:000510223200040	31141134	hybrid			2022-02-06	
J	Siddiqui, EU; Waheed, S; Perveen, F; Daniyal, M; Khan, MAR; Siddiqui, S; Siddiqui, Z				Siddiqui, Emad Uddin; Waheed, Shahan; Perveen, Feroza; Daniyal, Muhammad; Khan, Muhammad Abdul Raffay; Siddiqui, Saif; Siddiqui, Zain			Clinical outcome of paediatric patients with traumatic brain injury (TBI) receiving 3% hypertonic saline (HTS) in the emergency room of a tertiary care hospital	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	33rd Conference of the International-Society-for-Quality-in-Health-Care (ISQua)	2016	Tokyo, JAPAN			Hypertonic saline; Traumatic Brain Injury; Head Injury; Glasgow Coma Scale; Trauma	RESUSCITATION	Objective: To determine the clinical outcome and mean length of hospital stay of paediatric patients with severe blunt traumatic head injury (THI) receiving 3% hypertonic saline (HTS) in the Emergency Department (ED). Methodology: This case series study was conducted at the Department of Emergency Medicine, Aga Khan University Hospital, Karachi, from 2014 to 2015 via chart review of 105 patients. Detailed history and clinical examination of all paediatric patients aged 2-16 years was recorded which included moderate to severe head injury as classified by the Glasgow Coma Scale (GCS) by the Brain Trauma Foundation. As per routine care after admission of such a patient, for resuscitation 3% HTS was administered. GCS was recorded at 6 hours and at the time of discharge. Results: Of the 105 patients, 76 (72.4%) were male and 29 (27.6%) were female, and the mean age was 61.6+45.9 months. Traumatic brain injury (TBI) was found moderate in 60 (57.1%) cases and severe in 45 (42.9%) of our patients as per the GCS. Six hours after resuscitation with 3% hypertonic saline, 45 (43%) patients normalised as per GCS, 39 (37%) patients had moderate TBI and 21 (20%) had severe TBI. Forty five patients had a hospital stay of 2-3 days. The GCS improved after resuscitation with 3% hypertonic saline in emergency department, with a mean length of stay of 4.6+3.9 and 12.6+10.7 days in moderate and severe head injury respectively with a P value of <0.001, and was normal in 94 (89.5%) patients at the time of discharge. Conclusion: Paediatric patients with TBI receiving 3% hypertonic saline results in improved GCS and a decrease in the length of hospital stay.	[Siddiqui, Emad Uddin; Waheed, Shahan; Perveen, Feroza; Daniyal, Muhammad; Khan, Muhammad Abdul Raffay; Siddiqui, Saif; Siddiqui, Zain] Aga Khan Univ Hosp, Dept Emergency Med, Karachi, Pakistan		Siddiqui, EU (corresponding author), Aga Khan Univ Hosp, Dept Emergency Med, Karachi, Pakistan.	emaduddin.siddiqui@aku.edu	Perveen, Feroza/AAA-1050-2021; Daniyal, Muhammad/A-1617-2015	Daniyal, Muhammad/0000-0002-5663-5211; Perveen, Feroza/0000-0002-8195-6869			Abughazaleh RD, 2012, ANN PHARMACOTHER, V46, P1441, DOI 10.1345/aph.1R019; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dubick MA, 2013, CLINICS, V68, P883, DOI 10.6061/clinics/2013(06)25; Fuhrman BP, 2011, PEDIAT CRITICAL CARE; Gerberding JL, 2003, STEPS PREVENT SERIOU; Ghani Ehtesham, 2003, J Coll Physicians Surg Pak, V13, P143; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Raja IA, 2001, WORLD J SURG, V25, P1230; Statistics NCfH, 1987, ADV REP FIN MORT STA; TEASDALE G, 1974, LANCET, V2, P81; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Weiss E, 2018, CRIT CARE MED, V46, P401, DOI 10.1097/01.ccm.0000528842.05507.37; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	24	1	1	0	3	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	NOV	2019	69	11					1741	1745		10.5455/JPMA.296439			5	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Research & Experimental Medicine	JY4XA	WOS:000504418800028	31740892				2022-02-06	
J	Spirou, A; Chiaravalloti, ND; Dobryakova, E				Spirou, Angela; Chiaravalloti, Nancy D.; Dobryakova, Ekaterina			Corticostriatal Hyperactivation to Reward Presentation in Individuals With TBI With High Depressive Symptomatology: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; fMRI; reward; striatum; TBI; VMPFC	TRAUMATIC BRAIN-INJURY; DECISION-MAKING; ABNORMALITIES; PUNISHMENT; DISORDER; ACCURATE; ROBUST; FMRI; ANHEDONIA; RESPONSES	Objective: To examine the impact of depression on neural mechanisms associated with outcome processing (rewarding and punishing outcomes) in persons with traumatic brain injury (TBI). Setting: Kessler Foundation's Rocco Ortenzio Neuroimaging Center. Participants: A total of 16 adults with moderate to severe TBI. Main Measures: Chicago Multiscale Depression Inventory (CMDI); Behavioral Inhibition/Behavioral Activation Scale (BIS/BAS); functional MRI of the head while performing a gambling task, with a reward (+$1.00) and punishment (-$0.50). Results: Individuals with TBI reporting high depressive symptomatology exhibited increased activation in the ventromedial prefrontal cortex (VMPFC) and striatum during presentation of rewarding outcomes compared with individuals with TBI reporting low depressive symptomatology. Punishing outcome presentation was not associated with any change in brain activation. No differences in volume of the striatum and VMPFC were observed between groups. Conclusions: Current findings provide the first evidence of differences in neural mechanisms underlying outcome processing between individuals with TBI with and without depression. The results suggest that depressive symptomatology might have a different effect on individuals with TBI than what is typically observed in individuals without TBI reporting with depression, with the possibility of rewards becoming more reinforcing as depressive symptomatology increases. Future studies should explore the potential implications of behavioral responses to rewards and punishments in TBI and how they can affect rehabilitation approaches and activities of daily living.	[Spirou, Angela; Chiaravalloti, Nancy D.; Dobryakova, Ekaterina] Kessler Fdn, Traumat Brain Injury Res, W Orange, NJ USA; [Chiaravalloti, Nancy D.; Dobryakova, Ekaterina] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Spirou, A (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 120 Eagle Rock,Ste 100, E Hanover, NJ 07936 USA.	edobryakova@kesslerfoundation.org	Dobryakova, Ekaterina/ABD-2853-2021	Dobryakova, Ekaterina/0000-0002-6005-2115	National Institute for Independent Living, Disability and Rehabilitation [90SF00090100]	This work was supported by the National Institute for Independent Living, Disability and Rehabilitation (Award #90SF00090100), awarded to Ekaterina Dobryakova, PhD.	Admon R, 2015, CURR OPIN PSYCHOL, V4, P114, DOI 10.1016/j.copsyc.2014.12.011; Andersson J., 2007, SD; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonatti E, 2008, COGN BEHAV NEUROL, V21, P164, DOI 10.1097/WNN.0b013e318184e688; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Clery-Melin ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023178; Cotrena C, 2014, BRAIN INJURY, V28, P1070, DOI 10.3109/02699052.2014.896943; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Dombrovski AY, 2015, PSYCHOL MED, V45, P1413, DOI 10.1017/S0033291714002517; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jenkins P, 2017, NEUROLOGY, V88; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Klauser P, 2015, J AFFECT DISORDERS, V173, P45, DOI 10.1016/j.jad.2014.10.041; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Schlund MW, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-8; Schneider W., 2002, E PRIME REFERENCE GU; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Silverman Michael E, 2009, Open Neuroimag J, V3, P58, DOI 10.2174/1874440000903010058; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Strober LB, 2015, J CLIN EXP NEUROPSYC, V37, P722, DOI 10.1080/13803395.2015.1063591; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	51	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					E19	E28		10.1097/HTR.0000000000000482			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200003	31033743				2022-02-06	
J	Steward, C				Steward, Caroline			Dialysis Disequilibrium Syndrome in the Neurointensive Care Unit: A Case Study	NEPHROLOGY NURSING JOURNAL			English	Article						Renal replacement therapy; hemodialysis; intracranial hemorrhage; traumatic brain injury; stroke; osmolarity; intracranial pressure; cerebral parenchyma; neurology; acute kidney injury	ACUTE KIDNEY INJURY; MANAGEMENT; STROKE	Renal replacement therapy, especially hemodialysis, can exacerbate brain injury. The excessive ultrafiltration and rapid changes in blood pressure directly impact cerebral perfusion pressure. Substances that are typically added or removed during hemodialysis treatments alter serum osmolarity, shifing fluids into or out of the intracranial cavity. This results in changes in the intracranial pressure due to shrinking or swelling of the cerebral parenchyma, which if left untreated, can result in death. This article describes a case of dialysis disequilibrium syndrome and is an example of how astute nephrology nurses can directly impact the care of critically ill neurological patients.	[Steward, Caroline] Capital Hlth Reg Med Ctr, Trenton, NJ 08638 USA		Steward, C (corresponding author), Capital Hlth Reg Med Ctr, Trenton, NJ 08638 USA.						Agarwal R., 2016, DIALYSIS DISEQUILIBR; Axley B., 2015, CORE CURRICULUM NEPH, P55; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Centers for Disease Control and Prevention, 2017, STROK FACTS; Davenport A, 2010, HEMODIAL INT, V14, pS27, DOI 10.1111/j.1542-4758.2010.00487.x; Davenport A, 2009, SEMIN DIALYSIS, V22, P165, DOI 10.1111/j.1525-139X.2008.00548.x; Flannery T., 2011, SPECIAL PROBLEMS HAE; Fletcher JJ, 2009, NEUROCRIT CARE, V11, P101, DOI 10.1007/s12028-009-9197-9; Nadkarni GN, 2015, STROKE, V46, P3226, DOI 10.1161/STROKEAHA.115.010985; Osgood M, 2015, NEUROCRIT CARE, V22, P176, DOI 10.1007/s12028-014-0064-y; Pagana K. D., 2014, MOSBYS MANUAL DIAGNO; Patel N, 2008, SEMIN DIALYSIS, V21, P493, DOI 10.1111/j.1525-139X.2008.00474.x; Power A, 2013, BLOOD PURIFICAT, V36, P179, DOI 10.1159/000356086; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Speranza-Reid J., 2015, CORE CURRICULUM NEPH, P146; Sterns R., 2016, MANIFESTATIONS HYPON; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Thamburaj A., 2016, INTRACRANIAL PRESSUR; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Tuazon S.A., 2019, SERUM OSMOLARITY; Wijdicks E, 2016, PRACTICE EMERGING CR	23	1	1	0	0	JANNETTI PUBLICATIONS, INC	PITMAN	EAST HOLLY AVENUE, BOX 56, PITMAN, NJ 08071-0056 USA	1526-744X	2163-5390		NEPHROL NURS J	Nephrol. Nurs. J.	NOV-DEC	2019	46	6					597	603					7	Nursing; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Urology & Nephrology	KB8CL	WOS:000506716800005	31872990				2022-02-06	
J	Sudom, KA; Nesdole, R; Zamorski, MA				Sudom, Kerry A.; Nesdole, Robert; Zamorski, Mark A.			Validation of a brief measure of combat exposure among Canadian Armed Forces personnel	HEALTH REPORTS			English	Article						deployment; combat; military; PTSD; stress disorders; Canada; Afghanistan; post-deployment screening	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; ALCOHOL-USE; AFGHANISTAN; EXPERIENCES; IRAQ; DUTY; FIT	Introduction: Exposure to military combat is associated with mental health problems, including posttraumatic stress disorder (PTSD) and depression. To understand the effects of combat on adverse health outcomes, the sound measurement of combat experiences is required; however, many scales used in past research are lengthy. A brief measure of combat exposure benefits militaries by reducing the burden on respondents as well as administration time in post-deployment settings and large population-based health surveys. Data and methods: The current study sought to describe the psychometric properties of a brief measure of combat exposure among Canadian Armed Forces (CAF) personnel. Data from post-deployment screening were used to compare the psychometric properties of an 8-item scale with the full scale that it was derived from. Results: The 8-item measure did not fit a one-factor solution well and did not offer a statistically significant improvement in model fit over the full 30-item measure. However, its association with increased odds of a number of health outcomes indicates that it could be useful as a brief measure of combat exposure in settings where using the full scale is not feasible. Interpretation: Brief measures of combat exposure are valuable for assessing events experienced during deployment among military personnel. Although the 8-item Combat Exposure Scale assessed in the current study represents a potentially useful measure for CAF personnel, further research is necessary to improve its fit.	[Sudom, Kerry A.; Nesdole, Robert] Def Res & Dev Canada, Director Gen Mil Personnel Res & Anal, Ottawa, ON, Canada; [Zamorski, Mark A.] Canadian Forces Hlth Serv Grp, Directorate Mental Hlth, Ottawa, ON, Canada; [Zamorski, Mark A.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada		Sudom, KA (corresponding author), Def Res & Dev Canada, Director Gen Mil Personnel Res & Anal, Ottawa, ON, Canada.	kerry.sudom@forces.gc.ca					BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Byrne B. M., 2006, STRUCTURAL EQUATION; Edge HJM, 2012, MIL PSYCHOL, V24, P71, DOI 10.1080/08995605.2012.642292; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Garber BG, 2012, CAN J PSYCHIAT, V57, P736, DOI 10.1177/070674371205701205; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kimbrel NA, 2014, PSYCHIAT RES, V220, P1118, DOI 10.1016/j.psychres.2014.08.053; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Office of the Surgeon General, 2006, OP IR FREED 05 07; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sudom K, 2016, MIL PSYCHOL, V28, P285, DOI 10.1037/mil0000108; Sundin J, 2014, BRIT J PSYCHIAT, V204, P202, DOI 10.1192/bjp.bp.113.129569; Watkins K., 2016, MILITARY BEHAV HLTH, V4, P285, DOI [10.1080/21635781.2016.1153538, DOI 10.1080/21635781.2016.1153538]; Watkins K, 2014, RES MILITARIS, V4, P1; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Zamorski M.A., 2011, CUMULATIVE INCIDENCE; Zamorski MA, 2016, CAN J PSYCHIAT, V61, p10S, DOI 10.1177/0706743716632731; Zamorski MA, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23822; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605	29	1	1	0	0	STATISTICS CANADA	OTTAWA	100 TUNNEYS PASTURE DRIVEWAY, OTTAWA, ONTARIO K1A 0T6, CANADA	0840-6529	1209-1367		HEALTH REP	Health Rep.	NOV	2019	30	11					11	16		10.25318/82-003-x201901100002-eng			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JP0QO	WOS:000497977800002	31747044				2022-02-06	
J	Wade, SL; Cassedy, AE; Taylor, HG; McNally, KA; Kirkwood, MW; Stancin, T; Horn, PS; Kurowski, BG				Wade, Shari L.; Cassedy, Amy E.; Taylor, H. Gerry; McNally, Kelly A.; Kirkwood, Michael W.; Stancin, Terry; Horn, Paul S.; Kurowski, Brad G.			Adolescent Quality of Life Following Family Problem-Solving Treatment for Brain Injury	JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY			English	Article						traumatic brain injury; quality of life; family problem-solving treatment; adolescence	RANDOMIZED-TRIAL; POSTCONCUSSIVE SYMPTOMS; EXECUTIVE DYSFUNCTION; BEHAVIORAL OUTCOMES; COMPLICATED MILD; CLINICAL-TRIAL; CHILDREN; THERAPY; INTERVENTION; PEDSQL(TM)-4.0	Objective: To examine changes in quality of life (QoL) in adolescents receiving family problem-solving therapy (F-PST) following traumatic brain injury (TBI). Method: Adolescents hospitalized for moderate-to-severe TBI were randomized to 1 of 3 ten-session, 6-month long treatments: face-to-face F-PST (n = 34), therapist-guided online F-PST (n = 56), and self-guided online F-PST (n = 60). Participants included 96 boys and 54 girls, of whom 124 were White and 6 were Hispanic. Outcomes were assessed pretreatment and 6 and 9 months later. Adolescents and parents rated adolescent QoL and TBI-related symptoms on the PedsQL and Health and Behavior Inventory (HBI), respectively. We used mixed modeling to examine changes over time and moderators of treatment efficacy. Results: Therapist- and self-guided online groups demonstrated improvements in parent-proxy QoL from baseline to 9 months, Cohen's d = 0.75; p = .004 and Cohen's d = 1.30;p < .001, respectively. The face-to-face group had poorer parent-proxy QoL at 6 months (M = 62, SE = 3.4) than either the therapist- (M = 70.9, SE = 2.8) or self-guided online group (M = 71.1, SE = 2.6). There were no changes or group differences in self-reported QoL over time. Similar findings were observed on the HBI. Differential treatment effects on parent-proxy outcomes were found in boys versus girls and in those from single versus 2-parent households. Improvements in parent-proxy HBI ratings mediated QoL improvements. Conclusions: Both online treatments, but not face-to-face F-PST, were associated with clinical improvements, raising questions about our current delivery paradigm. Individual and family moderators of treatment efficacy underscore the potential of personalized treatment.	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA; [Cassedy, Amy E.] Cincinnati Childrens Hosp Med Ctr, Div Epidemiol & Biostat, Cincinnati, OH 45229 USA; [Wade, Shari L.; Cassedy, Amy E.; Horn, Paul S.; Kurowski, Brad G.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Cincinnati, OH USA; [Taylor, H. Gerry; McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [McNally, Kelly A.] Nationwide Childrens Hosp, Psychiat & Behav Hlth, Columbus, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Dept Rehabil Psychol Neuropsychol, Sch Med, Boulder, CO 80309 USA; [Stancin, Terry] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Horn, Paul S.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Rehabil Med, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org					An XD, 2018, CHINESE J CHEM, V36, P1147, DOI 10.1002/cjoc.201800387; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; DeMatteo CA, 2014, BRAIN INJURY, V28, P114, DOI 10.3109/02699052.2013.848380; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fassbinder E, 2015, J CLIN PSYCHOL, V71, P764, DOI 10.1002/jclp.22204; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Haller CS, 2017, J PERS, V85, P481, DOI 10.1111/jopy.12254; Hayes Andrew F., 2012, CISC VIS NETW IND GL; Ilmer EC, 2016, EUR J PAEDIATR NEURO, V20, P131, DOI 10.1016/j.ejpn.2015.09.003; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kobak KA, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0048-0; Kurowski B., 2019, ONLINE FAMILY UNPUB; Kurowski BG, 2018, CONT CLIN TRIAL COMM, V10, P111, DOI 10.1016/j.conctc.2018.04.001; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Man DWK, 2006, NEUROREHABILITATION, V21, P205; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Office of Disease Prevention and Health Promotion, 2000, HLTH PEOPL 2020; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Sluys KP, 2015, QUAL LIFE RES, V24, P2689, DOI 10.1007/s11136-015-1002-y; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000487; Wade SL, 2019, J PEDIATR PSYCHOL, V44, P388, DOI 10.1093/jpepsy/jsy087; Wade SL, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0422; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2017, REHABIL PSYCHOL, V62, P290, DOI 10.1037/rep0000160; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wagner B, 2014, J AFFECT DISORDERS, V152, P113, DOI 10.1016/j.jad.2013.06.032; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	50	1	1	2	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0022-006X	1939-2117		J CONSULT CLIN PSYCH	J. Consult. Clin. Psychol.	NOV	2019	87	11					1043	1055		10.1037/ccp0000440			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	JD3LR	WOS:000489876400006	31556652				2022-02-06	
J	Wayment, HA; Huffman, AH; Lininger, M; Doyle, P				Wayment, Heidi A.; Huffman, Ann H.; Lininger, Monica; Doyle, Patrick			Football Team Social Structure and Perceived Support for Reporting Concussion Symptoms: Insights from a Social Network Analysis	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						concussion education; social norms; social ties; team belonging; team structure	PLAYERS; BEHAVIORS; KNOWLEDGE	Social network analysis (SNA) is a uniquely situated methodology to examine the social connections between players on a team, and how team structure may be related to self-reported team cohesion and perceived support for reporting concussion symptoms. Team belonging was positively associated with number of friendship ties (degree; r = .23, p < .05), intermediate ties between teammates (betweenness; r = .21, p < .05), and support from both teammates (r = .21, p < .05) and important others (r = .21, p < .05) for reporting concussion symptoms. Additionally, an SNA-derived measure of social influence, eigenvector centrality, was associated with football identity (r = .34, p < .01), and less support from important others (r = -.24, p < .05) regarding symptom reporting. Discussion focuses on why consideration of social influence dynamics may help improve concussion-related education efforts.	[Wayment, Heidi A.] No Arizona Univ, Dept Psychol Sci, Flagstaff, AZ 86011 USA; [Huffman, Ann H.; Lininger, Monica; Doyle, Patrick] No Arizona Univ, Flagstaff, AZ 86011 USA		Wayment, HA (corresponding author), No Arizona Univ, Dept Psychol Sci, Flagstaff, AZ 86011 USA.	Heidi.Wayment@nau.edu	Doyle, Patrick/AAC-9397-2020	Doyle, Patrick/0000-0003-1135-4800			Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Borgatti S., 2002, UCINET 6 WINDOWS SOF; Borgatti SP., 2002, NETDRAW NETWORK VISU; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; Fransen K, 2014, SPORT PSYCHOL, V28, P347, DOI 10.1123/tsp.2013-0141; Freeman L.C, 2017, ENCY SOCIAL NETWORK, P237; Gesell SB, 2016, HEALTH EDUC BEHAV, V43, P208, DOI 10.1177/1090198115599397; Johnson, 2013, ANAL SOCIAL NETWORKS; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Latkin CA, 2015, BEHAV MED, V41, P90, DOI 10.1080/08964289.2015.1034645; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Lusher D, 2010, MEAS PHYS EDUC EXERC, V14, P211, DOI 10.1080/1091367X.2010.495559; Maya-Jariego I, 2015, PSYCHOSOC INTERV, V24, P121, DOI 10.1016/j.psi.2015.10.001; McCann M, 2018, LANCET, V392, P60; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mclean S, 2019, SCI MED FOOTBALL, V3, P29, DOI 10.1080/24733938.2018.1478122; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Murdock JL, 2016, SPORT EDUC SOC, V21, P396, DOI 10.1080/13573322.2014.924920; NCAA Academic and Membership Affairs Staff, 2016, 2016 2017 NCAA DIV 1; PODSAKOFF PM, 1994, J MARKETING RES, V31, P351; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Salim M, 2018, ICEIS 2018, V1; Valente T. W., 2010, SOCIAL NETWORKS HLTH; Valente TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131712; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Wasserman S, 1994, SOCIAL NETWORK ANAL, V8, DOI 10.1017/CBO9780511815478; Wayment HA, 2019, AM J PREV MED, V56, P323, DOI 10.1016/j.amepre.2018.10.007	34	1	1	2	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	NOV	2019	24	6					256	262		10.1123/ijatt.2018-0121			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	JJ2KY	WOS:000493992100006		Bronze			2022-02-06	
J	Xu, HX; Li, X; Wu, XQ; Yang, YF; Dai, SH; Lei, T; Jing, D; Luo, P; Luo, EP				Xu, Haoxiang; Li, Xin; Wu, Xiuquan; Yang, Yuefan; Dai, Shuhui; Lei, Tao; Jing, Da; Luo, Peng; Luo, Erping			Iduna protects HT22 cells by inhibiting parthanatos: The role of the p53-MDM2 pathway	EXPERIMENTAL CELL RESEARCH			English	Article						Traumatic brain injury; Parthanatos; Iduna; PARP; AIF; p53-MDM2 pathway	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; P53; DEATH; HIPPOCAMPAL; DEGRADATION; ACTIVATION; EXPRESSION; MESSENGER; INTERACT	Traumatic brain injury (TBI) is common and often fatal in current times. The role of poly(adenosine diphosphateribose) polymerase (PARP)-induced cell death (parthanatos) in TBI has not been well studied. Our past study showed that oxidative stress-induced cell death includes parthanatos by confirming the occurrence of PARP activation and nuclear translocation of apoptosis-inducing factor (AIF). As oxidative stress plays a key role in pathological progression after TBI, we believe TBI may also be alleviated by the expression of Iduna, which is the only known endogenous regulator of parthanatos. Thus, a transection model in HT-22 cells was established for present study. Downregulation of Iduna aggravated the cell damage caused by mechanical cell injury, whereas upregulation of Iduna reduced mitochondrial dysfunction induced by mechanical cell injury but exerted no effect on apoptosis associated with mitochondrial dysfunction. By contrast, Iduna prevented parthanatos by reducing PARP activation and nuclear translocation of AIF. We also investigated 2 novel p53-MDM2 pathway inhibitors, AMG 232 and Nutlin-3, which substantially reduced the protective effects of Iduna. These findings indicate that Iduna might prevent TBI by specifically inhibiting parthanatos and promoting mitochondrial function, with the p53-MDM2 pathway playing a critical role.	[Xu, Haoxiang; Lei, Tao; Jing, Da; Luo, Erping] Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle Xi Rd, Xian 710032, Shaanxi, Peoples R China; [Wu, Xiuquan; Yang, Yuefan; Dai, Shuhui; Luo, Peng] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, 169 Changle Xi Rd, Xian 710032, Shaanxi, Peoples R China; [Li, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China; [Yang, Yuefan] 251th Hosp PLA, Zhangjiakou, Peoples R China		Luo, EP (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, 169 Changle Xi Rd, Xian 710032, Shaanxi, Peoples R China.; Luo, P (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, 169 Changle Xi Rd, Xian 710032, Shaanxi, Peoples R China.	pengluo@fmmu.edu.cn; luoerping@fmmu.edu.cn	Yang, Yuefan/AAJ-9136-2020	Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771322, 81601149, 81601077]; Military Youth talent lifting project [17-JCJQ-QT-037]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M593012]	This work was supported by the National Natural Science Foundation of China (Nos. 81771322, 81601149, 81601077), Military Youth talent lifting project (No. 17-JCJQ-QT-037), a China Postdoctoral Science Foundation funded project (2016M593012).	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Borthakur G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139254; Brockhaus K, 2018, CELL TRANSPLANT, V27, P796, DOI 10.1177/0963689718755706; Byun EB, 2018, BIOSCI BIOTECH BIOCH, V82, P1344, DOI 10.1080/09168451.2018.1460572; Clement AB, 2010, FREE RADICAL BIO MED, V48, P1236, DOI 10.1016/j.freeradbiomed.2010.02.008; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dai SH, 2017, FREE RADICAL BIO MED, V108, P345, DOI 10.1016/j.freeradbiomed.2017.04.005; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Demidenko ZN, 2004, CANCER RES, V64, P3653, DOI 10.1158/0008-5472.CAN-04-0204; Dlouhy BJ, 2012, NEW ENGL J MED, V366, P2427, DOI 10.1056/NEJMc1204669; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gero D, 2014, MOL MED, V20, P313, DOI 10.2119/molmed.2014.00102; Hong MY, 2012, CHINESE MED J-PEKING, V125, P2019, DOI 10.3760/cma.j.issn.0366-6999.2012.11.032; Huang CT, 2014, BBA-MOL CELL RES, V1843, P531, DOI 10.1016/j.bbamcr.2013.12.001; Huang S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070926; Huang ZM, 2018, ONCOTARGETS THER, V11, P6579, DOI 10.2147/OTT.S174846; Inoue K, 2016, INT J CANCER, V138, P1577, DOI 10.1002/ijc.29663; Jeong GS, 2010, INT IMMUNOPHARMACOL, V10, P1587, DOI 10.1016/j.intimp.2010.09.013; Jin MF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00322; Kaizaki A, 2006, BRAIN RES, V1108, P39, DOI 10.1016/j.brainres.2006.06.011; Karakostis K, 2016, MOL BIOL EVOL, V33, P1280, DOI 10.1093/molbev/msw012; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; Li D, 2019, NEUROCHEM RES, V44, P1903, DOI 10.1007/s11064-019-02825-1; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Rao W, 2013, BIOCHEM BIOPH RES CO, V441, P351, DOI 10.1016/j.bbrc.2013.10.054; Saito A, 2005, J CEREBR BLOOD F MET, V25, P267, DOI 10.1038/sj.jcbfm.9600028; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Tajiri N, 2016, CNS NEUROSCI THER, V22, P306, DOI 10.1111/cns.12501; Thomasova D, 2015, J AM SOC NEPHROL, V26, P1513, DOI 10.1681/ASN.2014040345; Wan CH, 2013, J MOL NEUROSCI, V51, P695, DOI 10.1007/s12031-013-0050-4; Wang BD, 2018, CELL TRANSPLANT, V27, P1731, DOI 10.1177/0963689718779364; Wang XJ, 2012, FEBS LETT, V586, P1390, DOI 10.1016/j.febslet.2012.02.049; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wei JL, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00101; Wu KM, 2013, ACS APPL MATER INTER, V5, P2733, DOI 10.1021/am400374c; Xu HX, 2013, CELL SIGNAL, V25, P1018, DOI 10.1016/j.cellsig.2013.01.006; Yang YF, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00059; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	48	1	1	1	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	NOV 1	2019	384	1							111547	10.1016/j.yexcr.2019.111547			11	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	JD5OG	WOS:000490031700003	31472117				2022-02-06	
J	Yedlinsky, NT; Neff, LA; Jordan, KM				Yedlinsky, Nicole T.; Neff, Laurel A.; Jordan, Kevin M.			Care of the Military Veteran: Selected Health Issues	AMERICAN FAMILY PHYSICIAN			English	Article							PTSD; FREEDOM/OPERATION; PAIN; PREVALENCE; DEPLOYMENT; EXPOSURE; ILLNESS; IRAQ	According to the U.S. Census Bureau, 18.2 million veterans were living in the United States in 2017, of whom 1.6 million were female. Less than one-half of all veterans receive care at a Veterans Health Administration or military treatment facility, leaving most to receive services from primary care physicians. Injuries and illnesses common among this patient population include musculoskeletal injuries and chronic pain, mental health issues such as posttraumatic stress disorder (PTSD) and moral injury, traumatic brain injury, chemical and noise exposures, and infectious disease concerns. Family physicians should ask about military service and be well informed about the range of veterans' health concerns, particularly PTSD, depression, and suicidality. Physicians should screen veterans for depression using the Patient Health Questionnaire-9 and for PTSD using the PTSD Checklist for DSM-5. Veterans with traumatic brain injury should be screened specifically for comorbid PTSD and chronic pain because the diagnosis informs treatment. Exposures to loud noise, chemicals, and infectious diseases are prevalent and can cause disability. Family physicians can use available resources and clinical practice guidelines such as those from the U.S. Department of Veterans Affairs and Department of Defense to inform care and to assist veterans. (Am Fam Physician. 2019;100(9):544-551. Copyright (C) 2019 American Academy of Family Physicians.)	[Yedlinsky, Nicole T.] Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS 66103 USA; [Neff, Laurel A.] Def Hlth Headquarters, Falls Church, VA USA; [Jordan, Kevin M.] Madigan Army Med Ctr, Dept Family Med, Tacoma, WA 98431 USA		Yedlinsky, NT (corresponding author), Univ Kansas, Sch Med, 3901 Rainbow Blvd,Mailstop 4010, Kansas City, KS 66160 USA.	nyedlinsky@kumc.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Boakye EA, 2017, MIL MED, V182, pE1691, DOI 10.7205/MILMED-D-16-00119; Bowman MA, 2019, AM FAM PHYSICIAN, V100, P523; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cameron KL, 2011, ARTHRITIS RHEUM-US, V63, P2974, DOI 10.1002/art.30498; Chandra N, 2015, BRAIN NEUROTRAUMA MO, P195; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Department of Veterans Affairs Department of Defense., 2013, VA DOD CLIN PRACT GU; Farnsworth JK, 2017, J CONTEXT BEHAV SCI, V6, P391, DOI 10.1016/j.jcbs.2017.07.003; Gatchel RJ, 2009, MIL MED, V174, P270, DOI 10.7205/MILMED-D-03-1607; Haskell SG, 2012, CLIN J PAIN, V28, P163, DOI 10.1097/AJP.0b013e318223d951; HAURET KG, 2010, AM J PREV MED, V38, pS70; Held P, 2018, COGN BEHAV PRACT, V25, P377, DOI 10.1016/j.cbpra.2017.09.003; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Johnson NL, 2015, PSYCHOL SERV, V12, P435, DOI 10.1037/ser0000061; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Konitzer LN, 2008, J HAND THER, V21, P143, DOI 10.1197/j.jht.2007.10.017; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; McAndrew LM, 2016, J REHABIL RES DEV, V53, P59, DOI 10.1682/JRRD.2014.10.0255; McAndrew LM, 2012, J OCCUP ENVIRON MED, V54, P665, DOI 10.1097/JOM.0b013e318255ba1b; McDonald JR, 2018, CLIN INFECT DIS, V67, P1205, DOI 10.1093/cid/ciy280; Mehalick ML, 2018, BRAIN INJURY, V32, P1307, DOI 10.1080/02699052.2018.1495339; Quinlan JD, 2010, AM FAM PHYSICIAN, V82, P43; Saguil A, 2019, AM FAM PHYSICIAN, V99, P577; Schnurr, 2018, PTSD CHECKLIST DSM 5; Schram B, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081605; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; U.S. Department of Veterans Affairs, INF DIS GULF WAR VET; United States Census Bureau, SEL SOC CHAR US 2013; Vest BM, 2018, FAM MED, V50, P455, DOI 10.22454/FamMed.2018.795504	35	1	1	1	4	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	NOV 1	2019	100	9					544	551					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JJ0PZ	WOS:000493865400008	31674738				2022-02-06	
J	Brady, RD; Wong, KR; Robinson, DL; Mychasiuk, R; McDonald, SJ; D'Cunha, RA; Yamakawa, GR; Sun, MJ; Wark, JD; Lee, PVS; O'Brien, TJ; Casillas-Espinosa, PM; Shultz, SR				Brady, Rhys D.; Wong, Ker Rui; Robinson, Dale L.; Mychasiuk, Richelle; McDonald, Stuart J.; D'Cunha, Ryan A.; Yamakawa, Glenn R.; Sun, Mujun; Wark, John D.; Lee, Peter Vee Sin; O'Brien, Terence J.; Casillas-Espinosa, Pablo M.; Shultz, Sandy R.			Bone Health in Rats With Temporal Lobe Epilepsy in the Absence of Anti-Epileptic Drugs	FRONTIERS IN PHARMACOLOGY			English	Article						bone; epilepsy; status epilepticus; animal model; micro-computed tomography	TRAUMATIC BRAIN-INJURY; MICRO-COMPUTED TOMOGRAPHY; MINERAL DENSITY; MODEL; SEIZURES; MASS; FRACTURE; LEPTIN; LEVETIRACETAM; THERAPY	Rationale: Epilepsy patients often exhibit reduced bone mineral density and are at an increased risk of bone fracture. Whether these bone abnormalities are due to the use of anti-epileptic drugs (AED's) or the disease itself is unknown. For example, although decreased bone health in epilepsy patients is generally attributed to the use of AED's, seizures can also trigger a number of physiological processes that have the potential to affect bone. Therefore, to assess whether bone abnormalities occur in epilepsy in the absence of AED's, the current study investigated mechanical characteristics and trabecular bone morphology in rats with chronic temporal lobe epilepsy. Methods: Ten-week old male Wistar rats underwent kainic acid-induced status epilepticus (SE; n = 7) or a sham procedure (n = 9). Rats were implanted with EEG recording electrodes at nine weeks post-SE, and video-EEG was continuously recorded for one week at 10- and 22-weeks post-SE to confirm that SE rats had spontaneous seizures. Open-field testing to assess locomotion was conducted at 23-weeks post-SE. At 24-weeks post-SE, rats were euthanized and tibia were extracted to determine trabecular morphology by micro-computed tomography (mu CT), while femurs were used to investigate mechanical properties via 3-point bending. Results: All post-SE rats had spontaneous seizures at 10- and 22-weeks post-SE, while none of the sham rats had seizures. mu CT trabecular analysis of tibia revealed no differences in total volume, bone volume, bone volume fraction, trabecular number, or trabecular separation between post-SE or sham rats, although post-SE rats did have increased trabecular thickness. There were also no group differences in total distance travelled in the open field suggesting that activity levels did not account for the increased trabecular thickness. In addition, no differences in mechanical properties of femurs were observed between the two groups. Conclusion: There was a lack of overt bone abnormalities in rats with chronic temporal lobe epilepsy in the absence of AED treatment. Although further studies are still needed, these findings may have important implications towards understanding the source (e.g., AED treatments) of bone abnormalities in epilepsy patients.	[Brady, Rhys D.; Wong, Ker Rui; Mychasiuk, Richelle; McDonald, Stuart J.; Yamakawa, Glenn R.; Sun, Mujun; O'Brien, Terence J.; Casillas-Espinosa, Pablo M.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Brady, Rhys D.; Wark, John D.; O'Brien, Terence J.; Casillas-Espinosa, Pablo M.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Robinson, Dale L.; Lee, Peter Vee Sin] Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [D'Cunha, Ryan A.] Deakin Univ, Sch Med, Geelong, Vic, Australia		Brady, RD (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.; Brady, RD (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.	rhys.brady@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Robinson, Dale/AAD-1406-2019	McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621; Sun, Mujun/0000-0002-9923-9913; Robinson, Dale/0000-0003-1486-6991; Yamakawa, Glenn/0000-0003-3079-6532	NHMRCNational Health and Medical Research Council of Australia; Monash UniversityMonash University	This work was supported by grants to SS, and T O'B, from the NHMRC, and a Monash University interdisciplinary research grant to RB.	Ahmad BS, 2017, OSTEOPOROSIS INT, V28, P2591, DOI 10.1007/s00198-017-4098-9; Aksoy D, 2016, CLIN PSYCHOPHARM NEU, V14, P74, DOI 10.9758/cpn.2016.14.1.74; Beerhorst K, 2013, J NEUROL SCI, V331, P19, DOI 10.1016/j.jns.2013.05.005; Beniczky SA, 2012, SEIZURE-EUR J EPILEP, V21, P471, DOI 10.1016/j.seizure.2012.04.002; Bhandare AM, 2017, NEUROSCIENCE, V350, P23, DOI 10.1016/j.neuroscience.2017.03.012; Bhatt R, 2005, EPILEPSY RES, V65, P169, DOI 10.1016/j.eplepsyres.2005.06.002; Bhatt R, 2004, PHYSIOL BEHAV, V82, P581, DOI 10.1016/j.physbeh.2004.05.005; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; Campbell Graeme M, 2014, Bonekey Rep, V3, P564, DOI 10.1038/bonekey.2014.59; Campbell GM, 2011, OSTEOPOROSIS INT, V22, P931, DOI 10.1007/s00198-010-1283-5; Casillas-Espinosa PM, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.04.011; Casillas-Espinosa PM, 2019, EPILEPSIA, V60, P783, DOI 10.1111/epi.14691; Ciucci T, 2015, GUT, V64, P1072, DOI 10.1136/gutjnl-2014-306947; Devinsky Orrin, 2004, Epilepsy Curr, V4, P43, DOI 10.1111/j.1535-7597.2004.42001.x; El-Hajj Fuleihan G, 2008, BONE, V43, P149, DOI 10.1016/j.bone.2008.03.002; Ensrud KE, 2004, NEUROLOGY, V62, P2051, DOI 10.1212/01.WNL.0000125185.74276.D2; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; Garip S, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.111409; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gordeladze JO, 2002, J CELL BIOCHEM, V85, P825, DOI 10.1002/jcb.10156; Hakami T, 2016, CALCIFIED TISSUE INT, V98, P556, DOI 10.1007/s00223-016-0109-7; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hum KM, 2009, EPILEPSY RES, V87, P40, DOI 10.1016/j.eplepsyres.2009.07.007; Inostroza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038959; Irie Milena Suemi, 2018, Braz Dent J, V29, P227, DOI 10.1590/0103-6440201801979; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Liu XL, 2015, CLIN ORAL IMPLAN RES, V26, P392, DOI 10.1111/clr.12360; Lyngstad-Brechan MA, 2008, SCAND J CLIN LAB INV, V68, P759, DOI 10.1080/00365510802233442; Nakken KO, 2010, EXPERT OPIN DRUG SAF, V9, P561, DOI 10.1517/14740331003636475; NILSSON OS, 1986, ARCH ORTHOP TRAUM SU, V105, P146, DOI 10.1007/BF00433931; Nishiyama KK, 2010, BONE, V46, P155, DOI 10.1016/j.bone.2009.09.023; Nissen-Meyer LSH, 2007, EPILEPSIA, V48, P1850, DOI 10.1111/j.1528-1167.2007.01176.x; Petkova Z, 2014, EPILEPSY BEHAV, V31, P198, DOI 10.1016/j.yebeh.2013.12.013; Petty SJ, 2016, CURR OSTEOPOROS REP, V14, P54, DOI 10.1007/s11914-016-0302-7; Picard RW, 2017, NEUROLOGY, V89, P633, DOI 10.1212/WNL.0000000000004208; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Poh MZ, 2012, NEUROLOGY, V78, P1868, DOI 10.1212/WNL.0b013e318258f7f1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rahimdel Abolghasem, 2016, Electron Physician, V8, P3257, DOI 10.19082/3257; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Rolvien T, 2017, BONE, V103, P136, DOI 10.1016/j.bone.2017.06.025; Santana-Gomez C, 2019, EPILEPSY RES, V156, DOI 10.1016/j.eplepsyres.2019.03.008; Sato Y, 2001, NEUROLOGY, V57, P445, DOI 10.1212/WNL.57.3.445; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Stauber Martin, 2008, V455, P273, DOI 10.1007/978-1-59745-104-8_19; Szczesniak AM, 2005, BONE, V37, P63, DOI 10.1016/j.bone.2003.10.016; Szulc P, 2009, OSTEOPOROSIS INT, V20, P1281, DOI 10.1007/s00198-009-0994-y; Ustaoglu SG, 2018, APPL SPECTROSC, V72, P689, DOI 10.1177/0003702817734617; VALIMAKI MJ, 1994, J BONE MINER RES, V9, P631; Van Nieuwenhuyse B, 2015, BRAIN RES, V1627, P1, DOI 10.1016/j.brainres.2015.08.016; van Vliet EA, 2015, SEMIN CELL DEV BIOL, V38, P26, DOI 10.1016/j.semcdb.2014.10.003; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Vestergaard P, 2015, PEDIATR DRUGS, V17, P141, DOI 10.1007/s40272-014-0115-z; Vicente-Rodriguez G, 2005, BRIT J SPORT MED, V39, P611, DOI 10.1136/bjsm.2004.014431; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Williams S, 2015, NEUROSCIENCE, V303, P160, DOI 10.1016/j.neuroscience.2015.07.005; Yu H, 2018, INT J NEUROSCI, V128, P376, DOI 10.1080/00207454.2017.1387115	70	1	1	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	OCT 29	2019	10								1278	10.3389/fphar.2019.01278			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	JM9BE	WOS:000496500800001	31749702	gold, Green Published			2022-02-06	
J	Delaney, SL; Gendreau, JL; D'Souza, M; Feng, AY; Ho, AL				Delaney, Samantha L.; Gendreau, Julian L.; D'Souza, Marissa; Feng, Austin Y.; Ho, Allen L.			Optogenetic Modulation for the Treatment of Traumatic Brain Injury	STEM CELLS AND DEVELOPMENT			English	Article						neuronal excitation; neuronal silencing; opsins; optogenetic; TBI; therapy; traumatic brain injury	DIRECT-CURRENT STIMULATION; LIGHT-INDUCED ACTIVATION; LONG-TERM; OPTICAL CONTROL; MILLISECOND-TIMESCALE; GLUTAMATE RECEPTORS; NEURAL CIRCUITRY; TRANSGENIC MICE; MAMMALIAN BRAIN; ANIMAL-MODELS	Although research involving traumatic brain injury (TBI) has traditionally focused on the acute clinical manifestations, new studies provide evidence for chronic and progressive neurological sequelae associated with TBI, highlighting the risk of persistent, and sometimes life-long, consequences for affected patients. Several treatment modalities to date have demonstrated efficacy in experimental models. However, there is currently no effective treatment to improve neural structure repair and functional recovery of TBI patients. Optogenetics represents a potential molecular tool for neuromodulation and monitoring cellular activity with unprecedented spatial resolution and millisecond temporal precision. In this review, we discuss the conceptual background and preclinical evidence of optogenetics for neuromodulation, and translational applications for TBI treatment are considered.	[Delaney, Samantha L.; Gendreau, Julian L.; D'Souza, Marissa] Mercer Univ, Sch Med, Savannah, GA USA; [Feng, Austin Y.; Ho, Allen L.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, GA USA		Ho, AL (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, 300 Pasteur Dr,R281, Stanford, CA 94305 USA.	aho5@stanford.edu		D'Souza, Marissa/0000-0001-7322-9939			Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Bamberg E, 1984, Prog Clin Biol Res, V164, P73; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Bonni S, 2013, NEUROL SCI, V34, P2053, DOI 10.1007/s10072-013-1412-y; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Chandrasekar A, 2019, CEREB CORTEX, V29, P2701, DOI 10.1093/cercor/bhy139; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Chiang CC, 2014, BRAIN STIMUL, V7, P890, DOI 10.1016/j.brs.2014.07.034; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Choy M, 2017, J NEUROSCI RES, V95, P2325, DOI 10.1002/jnr.23767; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Donthamsetti PC, 2019, J AM CHEM SOC, V141, P11522, DOI 10.1021/jacs.9b02895; Duebel J, 2015, CURR OPIN OPHTHALMOL, V26, P226, DOI 10.1097/ICU.0000000000000140; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Emiliani V, 2016, FRONT CELL NEUROSCI, V35, P13917; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Germond Arno, 2016, Biophys Rev, V8, P121, DOI 10.1007/s12551-016-0195-9; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRINVALD A, 1982, J PHYSIOL-LONDON, V333, P269, DOI 10.1113/jphysiol.1982.sp014453; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Haddad AR, 2019, NEUROMODULATION, V22, P373, DOI 10.1111/ner.12944; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2012, ACS CHEM NEUROSCI, V3, P577, DOI 10.1021/cn300065j; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hipskind SG, 2019, PHOTOBIOMODULATION P, V37, P77, DOI 10.1089/photob.2018.4489; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Hoofien D, 2001, BRAIN INJURY, V15, P189; Husson SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040937; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kawano F, 2016, NAT CHEM BIOL, V12, P1059, DOI [10.1038/NCHEMBIO.2205, 10.1038/nchembio.2205]; Koura SS, 1998, ACT NEUR S, V71, P244; Krook-Magnuson E, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0005-14.2014; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kros L, 2015, ANN NEUROL, V77, P1027, DOI 10.1002/ana.24399; Lawlor PA, 2009, MOL THER, V17, P1692, DOI 10.1038/mt.2009.170; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Li XM, 2007, EUR J NEUROSCI, V25, P391, DOI 10.1111/j.1460-9568.2006.05300.x; Lin JY, 2012, PROG BRAIN RES, V196, P29, DOI 10.1016/B978-0-444-59426-6.00002-1; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14769; Lu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10962; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Meiliana A, 2019, INDONES BIOMED J, V11, P113, DOI 10.18585/inabj.v11i2.839; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Mostany R, 2015, METHODS MOL BIOL, V1251, P25, DOI 10.1007/978-1-4939-2080-8_2; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; Navarro-Quiroga I, 2007, J NEUROSCI, V27, P5007, DOI 10.1523/JNEUROSCI.0867-07.2007; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Oh MS, 2009, GENE THER, V16, P437, DOI 10.1038/gt.2008.148; Page G, 2006, NEUROCHEM INT, V49, P413, DOI 10.1016/j.neuint.2006.01.020; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Price L., 2016, TRANSLATIONAL RES TR; Reiner A, 2014, METHODS MOL BIOL, V1148, P45, DOI 10.1007/978-1-4939-0470-9_4; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Sakmar TP, 2002, CURR OPIN CELL BIOL, V14, P189, DOI 10.1016/S0955-0674(02)00306-X; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shemesh OA, 2017, NAT NEUROSCI, V20, P1796, DOI 10.1038/s41593-017-0018-8; Shin SS, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00015; Smith KS, 2016, BEHAV NEUROSCI, V130, P137, DOI 10.1037/bne0000135; Soper C, 2016, NEUROBIOL DIS, V87, P102, DOI 10.1016/j.nbd.2015.12.012; Spangler SM, 2017, CURR OPIN PHARMACOL, V32, P56, DOI 10.1016/j.coph.2016.11.001; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tabata H, 2008, DEV GROWTH DIFFER, V50, P507, DOI [10.1111/j.1440-169x.2008.01043.x, 10.1111/j.1440-169X.2008.01043.x]; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Ung K, 2012, JOVE-J VIS EXP, V68, P50004; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan P, 2012, P NATL ACAD SCI USA, V109, P20443, DOI 10.1073/pnas.1214850109; Yang HH, 2016, J NEUROSCI, V36, P9977, DOI 10.1523/JNEUROSCI.1095-16.2016; Yu KP, 2018, ANN REHABIL MED-ARM, V42, P502, DOI 10.5535/arm.2018.42.4.502; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang J, 2018, NANO LETT, V18, P2903, DOI 10.1021/acs.nanolett.8b00087; Zhao ML, 2018, J ALZHEIMERS DIS, V63, P303, DOI 10.3233/JAD-180002; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	121	1	1	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	FEB 15	2020	29	4					187	197		10.1089/scd.2019.0187		OCT 2019	11	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	KL0GC	WOS:000492875200001	31559914	Bronze			2022-02-06	
J	Kacar, CK; Uzundere, O; Yektas, A				Kacar, Cem Kivilcum; Uzundere, Osman; Yektas, Abdulkadir			A Two Parameters for the Evaluation of Hypovolemia in Patients with Septic Shock: Inferior Vena Cava Collapsibility Index (IVCCI) Delta Cardiac Output	MEDICAL SCIENCE MONITOR			English	Article						Cardiac Output; Echocardiography; Hypovolemia; Vena Cava, Inferior	FLUID RESPONSIVENESS; VOLUME RESPONSIVENESS; ULTRASOUND; VELOCITY; CHILDREN	Background: The aim of this study was to determine the correlation between inferior vena cava collapsibility index and changes in cardiac output measured during passive leg raising test in patients with spontaneous breathing and septic shock. Material/Methods: Fifty-six patients were included in the study. All of these 56 patients were diagnosed with septic shock and had spontaneous breathing under continuous positive airway pressure. Patients exclusions included: patients with cardiac pathology, not septic shock, pregnant, spontaneous breathing, increased intra-abdominal pressure, inferior vena cava could not be visualized, arrhythmia and pulmonary hypertension. Exclusion criteria for the study were as follows: 1) left ventricular systolic dysfunction, 2) cardiomyopathy, 3) medium severe heart valve disease, 4) patients with arrhythmia; 5) pulmonary hypertension, 6) patients without spontaneous breathing (for inferior vena cava collapsibility index, it is not evaluated), 7) patients with >60 mmHg CO2 in arterial blood gas; 8) pregnant patients; 9) patients with neurogenic shock, cerebrovascular incident or traumatic brain injury, 10) patients whose inferior vena cava and parasternal long axis cannot be visualized, and 11) patients with increased intra-abdominal pressure. Patients were placed in neutral supine position, and the inferior vena cava collapsibility index and cardiac output 1 were recorded. In passive leg raising test, after which the cardiac output 2 is recorded in terms of L/min. The percentage increase between the 2 cardiac outputs was calculated and recorded. Results: A moderately positive correlation was also observed between the inferior vena cava collapsibility index and delta cardiac output (r=0.459; r2=0.21), which was statistically significant (P<0.001). The cutoff value for the delta cardiac output was 29.5. Conclusions: In conclusion, we found that the inferior vena cava collapsibility index, which is one of the dynamic parame- ters used in the diagnosis of hypovolemia in patients with septic shock, is correlated with delta cardiac output after leg raising test. We believe that, based on a clinician's experience, looking at 1 of these 2 parameters is sufficient for the identification of hypovolemia in patients diagnosed with septic shock.	[Kacar, Cem Kivilcum; Uzundere, Osman; Yektas, Abdulkadir] Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Anesthgesiol & Reanimat, Diyarbakir, Turkey		Yektas, A (corresponding author), Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Anesthgesiol & Reanimat, Diyarbakir, Turkey.	abdulkadir.yektas@saglik.gov.tr	Kacar, Cem Kivilcim/AAR-2524-2020; Uzundere, Osman/ABC-7711-2020	Kacar, Cem Kivilcim/0000-0002-0015-948X; Uzundere, Osman/0000-0002-5968-4561			Airapetian N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1100-9; Bortolotti P, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0427-1; Brennan JM, 2007, J AM SOC ECHOCARDIOG, V20, P857, DOI 10.1016/j.echo.2007.01.005; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; Desgranges FP, 2016, PEDIATR ANESTH, V26, P37, DOI 10.1111/pan.12803; Favia I, 2017, PEDIATR CARDIOL, V38, P787, DOI 10.1007/s00246-017-1582-0; Georges D, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1938-0; Jain D, 2017, ACTA ANAESTH SCAND, V61, P1105, DOI 10.1111/aas.12956; Jalil BA, 2018, AM J EMERG MED, V36, P2093, DOI 10.1016/j.ajem.2018.08.037; Kawata T, 2017, CIRC J, V81, P346, DOI 10.1253/circj.CJ-16-0916; Lamia B, 2007, INTENS CARE MED, V33, P1125, DOI 10.1007/s00134-007-0646-7; Levitov A, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/819696; Maizel J, 2007, INTENS CARE MED, V33, P1133, DOI 10.1007/s00134-007-0642-y; Mesquida J, 2017, CURR OPIN CRIT CARE, V23, P237, DOI 10.1097/MCC.0000000000000404; Monnet X, 2006, CRIT CARE MED, V34, P1402, DOI 10.1097/01.CCM.0000215453.11735.06; Muller L, 2012, CRIT CARE, V16, DOI 10.1186/cc11672; Phad N, 2018, EARLY HUM DEV, V125, P31, DOI 10.1016/j.earlhumdev.2018.08.007; Preau Sebastien, 2017, Crit Care Med, V45, pe290, DOI 10.1097/CCM.0000000000002090; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Romero-Bermejo FJ, 2011, CURR CARDIOL REV, V7, P146, DOI 10.2174/157340311798220485; Wu YF, 2014, CRIT CARE, V18, DOI 10.1186/cc13891; Zhao J, 2016, MED SCI MONITOR, V22, P3843, DOI 10.12659/MSM.897406	22	1	1	0	3	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	OCT 29	2019	25						8105	8111		10.12659/MSM.919434			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JI5WB	WOS:000493537000002	31659997	Green Published			2022-02-06	
J	Maillard, J; De Pretto, M; Delhumeau, C; Walder, B				Maillard, Julien; De Pretto, Michael; Delhumeau, Cecile; Walder, Bernhard			Prediction of long-term quality of life after severe traumatic brain injury based on variables at hospital admission	BRAIN INJURY			English	Article						Quality of life; head injury; patient-relevant outcome; prediction; Glasgow coma scale; abbreviated injury score of head region	COMMUNITY INTEGRATION; 1ST YEAR; HEALTH; MODERATE; QOLIBRI; SCALE; DISABILITY; OUTCOMES; MODELS; MILD	Objectives: Variables collected early after severe traumatic brain injury (sTBI) could predict health-related quality of life (HRQoL). Our aim was to determine the prevalence of patients with a low HRQoL 4 years after sTBI and to develop a prediction model including early variables. Methods: Adult patients with both sTBI [abbreviated injury score of the head region (HAIS) >3] and disease-specific HRQoL assessments using the 'Quality of Life after Brain Injury' (QOLIBRI) were included. The outcome was the total score (TS) of QOLIBRI; cutoff for low HRQoL: Results: One hundred-sixteen patients [median age 50.8 years (IQR 25.9-62.8; 21.6% >65 years)] were included; 68 (58.6%) with HAIS = 4, 48 (41.4%) with HAIS = 5. Median Glasgow Coma Scale (GCS) was 13 (IQR 3-15). Median TS was 77 (IQR 60-88). Low HRQoL was observed in 28 patients (24.1%). Two variables were associated with low HRQoL: GCS <13, working situation other than employed or retired. The prediction model had an AUROC of 0.765; calibration was moderate (Hosmer Lemeshow Chi2 6.82, p = .556). Conclusion: One in four patients had a low HRQoL after 4 years. A lower GCS and working situations were associated with low HRQoL.	[Maillard, Julien; De Pretto, Michael; Delhumeau, Cecile; Walder, Bernhard] Geneva Univ Hosp, Div Anaesthesiol, Geneva, Switzerland; [Maillard, Julien; Walder, Bernhard] Geneva Univ Hosp, Div Anaesthesiol, Geneva Perioperat Basic Translat & Clin Res Grp, Geneva, Switzerland; [De Pretto, Michael] Univ Fribourg, Fac Sci & Med, Fribourg, Switzerland		Maillard, J (corresponding author), Univ Hosp Geneva, Div Anaesthesiol, Dept APSI, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	julien.maillard@hcuge.ch	Maillard, Julien/AAH-7902-2020	De Pretto, Michael/0000-0003-4176-4798	Swiss Accident Insurance Fund; SUVA	This work was partially supported by the Swiss Accident Insurance Fund; SUVA.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gerber GJ, 2016, BRAIN INJURY, V30, P1552, DOI 10.1080/02699052.2016.1199896; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; GLEESON K, 1990, ARCH INTERN MED, V150, P1057, DOI 10.1001/archinte.150.5.1057; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HILDEN J, 1978, METHOD INFORM MED, V17, P227; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Hosmer DW, 1997, STAT MED, V16, P965; Howe EI, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2218-7; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin YN, 2016, J NEUROTRAUM, V33, P1363, DOI 10.1089/neu.2015.4094; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Materne M, 2018, BRAIN INJURY, V32, P1731, DOI 10.1080/02699052.2018.1517224; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ogundimu EO, 2016, J CLIN EPIDEMIOL, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Patel MB, 2015, J NEUROTRAUM, V32, P984, DOI 10.1089/neu.2014.3652; Ritchie L, 2014, ARCH PHYS MED REHAB, V95, P163, DOI 10.1016/j.apmr.2013.08.237; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; ROYSTON P, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B604; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; SPRUNG CL, 1992, CRIT CARE MED, V20, P320; Stewart K, 2016, CLIN MED, V16, P530, DOI 10.7861/clinmedicine.16-6-530; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Truelle J, 2005, ACTA NEUROPSYCHOL, V1, P6; Truelle JL, 2008, ACTA NEUROCHIR SUPPL, V101, P125; Truelle J-L, 2005, PRAT PSYCHOL, V11, P329, DOI DOI 10.1016/j.prps.2005.09.008; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	62	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					203	212		10.1080/02699052.2019.1683227		OCT 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000492497100001	31648571				2022-02-06	
J	Toomey, LM; Bartlett, CA; Gavriel, N; McGonigle, T; Majimbi, M; Gopalasingam, G; Rodger, J; Fitzgerald, M				Toomey, Lillian M.; Bartlett, Carole A.; Gavriel, Nikolas; McGonigle, Terence; Majimbi, Maimuna; Gopalasingam, Gopana; Rodger, Jennifer; Fitzgerald, Melinda			Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection	SCIENTIFIC REPORTS			English	Article							BRAIN-BARRIER PERMEABILITY; RETINAL GANGLION-CELLS; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; P2X7 RECEPTORS; CEREBRAL EDEMA; DRUG-DELIVERY; CA2+ INFLUX; HEAD-INJURY; DAMAGE	Injury to the central nervous system is exacerbated by secondary degeneration. Previous research has shown that a combination of orally and locally administered ion channel inhibitors following partial optic nerve injury protects the myelin sheath and preserves function in the ventral optic nerve, vulnerable to secondary degeneration. However, local administration is often not clinically appropriate. This study aimed to compare the efficacy of systemic and local delivery of the ion channel inhibitor combination of lomerizine, brilliant blue G (BBG) and YM872, which inhibits voltage-gated calcium channels, P2X(7) receptors and Ca2+ permeable a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors respectively. Following a partial optic nerve transection, adult female PVG rats were treated with BBG and YM872 delivered via osmotic mini pump directly to the injury site, or via intraperitoneal injection, both alongside oral administration of lomerizine. Myelin structure was preserved with both delivery modes of the ion channel inhibitor combination. However, there was no effect of treatment on inflammation, either peripherally or at the injury site, or on the density of oligodendroglial cells. Taken together, the data indicate that even at lower concentrations, the combinatorial treatment may be preserving myelin structure, and that systemic and local delivery are comparable at improving outcomes following neurotrauma.	[Toomey, Lillian M.; Bartlett, Carole A.; Gavriel, Nikolas; Gopalasingam, Gopana; Rodger, Jennifer; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia; [Toomey, Lillian M.; McGonigle, Terence; Majimbi, Maimuna; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia; [Toomey, Lillian M.; Rodger, Jennifer; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Rodger, Jennifer/H-5735-2014	Fitzgerald, Melinda/0000-0002-4823-8179; Rodger, Jennifer/0000-0003-3413-4229; Toomey, Lillian/0000-0001-9435-6128	NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia [APP1087114]; MS Research Australia Postgraduate Scholarship	M.F. was supported by an NHMRC Career Development Fellowship (APP1087114). L.T. is supported by an MS Research Australia Postgraduate Scholarship. We thank Thomas Clarke for technical assistance.	Atsumi T, 2003, ACT NEUR S, V86, P305; Bartlett CA, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3118; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Blair M, 2005, INVEST OPHTH VIS SCI, V46, P884, DOI 10.1167/iovs.04-0731; BONGARZONE ER, 1995, J NEUROSCI RES, V41, P213, DOI 10.1002/jnr.490410209; BORGES K, 1994, NEUROSCIENCE, V63, P135, DOI 10.1016/0306-4522(94)90012-4; Cervetto C, 2013, TOXICOLOGY, V311, P69, DOI 10.1016/j.tox.2013.04.004; Chang T, 2010, MED MYCOL, V48, P430, DOI 10.3109/13693780903208249; Dash AK, 1998, J PHARMACOL TOXICOL, V40, P1, DOI 10.1016/S1056-8719(98)00027-6; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Farooqui A.A., 2008, NEUROCHEMICAL ASPECT; Fitzgerald M, 2014, NEURAL REGEN RES, V9, P1096, DOI 10.4103/1673-5374.135307; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fowler JH, 2003, BRAIN RES, V991, P104, DOI 10.1016/j.brainres.2003.08.004; Frantseva M, 2002, PROG BRAIN RES, V137, P171; Frid K, 2015, ANN CLIN TRANSL NEUR, V2, P711, DOI 10.1002/acn3.207; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Guerin CJ, 2001, NEUROSCIENCE, V103, P873, DOI 10.1016/S0306-4522(01)00015-X; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hara H, 1999, CLIN EXP PHARMACOL P, V26, P870, DOI 10.1046/j.1440-1681.1999.03154.x; Diaz-Hernandez JI, 2012, NEUROBIOL AGING, V33, P1816, DOI 10.1016/j.neurobiolaging.2011.09.040; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kasinathan N, 2015, DRUG DELIV, V22, P243, DOI 10.3109/10717544.2013.878858; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; L Shahsuvaryan Marianne, 2013, Med Hypothesis Discov Innov Ophthalmol, V2, P41; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li HY, 2014, NEURAL REGEN RES, V9, P565, DOI 10.4103/1673-5374.130093; Matute C, 2008, MOL NEUROBIOL, V38, P123, DOI 10.1007/s12035-008-8028-x; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; MURGIA M, 1993, J BIOL CHEM, V268, P8199; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Sahyouni R., 2017, J CONCUSSION; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Serwer Laura, 2010, J Vis Exp, DOI 10.3791/1992; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shimada T, 2005, J PHARM PHARMACOL, V57, P177, DOI 10.1211/0022357055380; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smith NM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1227-0; Smith NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22595; Sutherland TC, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00310; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Takahashi M, 2002, CNS DRUG REV, V8, P337; Tomkins O, 2011, CARDIOVASCULAR PSYCH; Toomey LM, 2019, EXP BRAIN RES, V237, P161, DOI 10.1007/s00221-018-5414-0; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Wong HE, 2011, ACS CHEM NEUROSCI, V2, P645, DOI 10.1021/cn200056g; Wu D, 2005, ACTA MED OKAYAMA, V59, P121; Yamada C, 1997, JPN PHARMACOL THER, V25, P797; Yamaya Y, 2002, J NEUROSCI RES, V70, P588, DOI 10.1002/jnr.10425; Zhang ZS, 2016, J PHYSIOL-LONDON, V594, P39, DOI 10.1113/JP271207	61	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 25	2019	9								15297	10.1038/s41598-019-51886-3			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JH5RK	WOS:000492825800007	31653948	Green Published, gold			2022-02-06	
J	Roenn-Smidt, H; Jensen, M; Pallesen, H				Roenn-Smidt, Helle; Jensen, Marianne; Pallesen, Hanne			Body and identity in physiotherapy after stroke	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Physiotherapy; bodily approach; identity; phenomenology; stroke	TRAUMATIC BRAIN-INJURY; SELF; EXPERIENCE; MOVEMENT; CRISIS; IMAGE	Background: Stroke has been described as a rupture of current life, causing changes in the patient's identity. This has important consequences for the patient's life after stroke. Nevertheless, there is still a lack of science on the subject and also a lack of consistency in how to confront this in rehabilitation. Aim: The aim of this study is to explore how interaction between patient and physiotherapist is conducted and how an approach inspired by phenomenology might support and develop identity. Design and Methods: A qualitative study based on empirical data consisting of 146 short videos of physiotherapist and patient interactions as well as observations and interviews of physiotherapists and patients. Twelve patients were included, and data was constructed throughout their rehabilitation process (on average 2.5 years). Data was analyzed using an analytical model for multimodal interaction. Result: Four themes emerged: 1) feedback as a bodily knowledge; 2) control of the process; 3) adjustment; and 4) the bodily approach. The results revealed the importance of approaching the patient body as both an object and a subject in order to interact with the patient's bodily knowledge. Conclusion: A phenomenological approach to the patient can support the patient's embodied knowledge, and can thereby support and develop the patient's identity.	[Roenn-Smidt, Helle; Pallesen, Hanne] Univ Aarhus, Hammel Neurorehabil Ctr, RM, Voldbyvej 15, Hammel, Denmark; [Roenn-Smidt, Helle; Pallesen, Hanne] Univ Aarhus, Univ Res Clin, RM, Voldbyvej 15, Hammel, Denmark; [Jensen, Marianne] Municipal Randers, Dept Res, Hammel, Denmark		Roenn-Smidt, H (corresponding author), Univ Aarhus, Hammel Neurorehabil Ctr, RM, Voldbyvej 15, Hammel, Denmark.; Roenn-Smidt, H (corresponding author), Univ Aarhus, Univ Res Clin, RM, Voldbyvej 15, Hammel, Denmark.	helsmi@rm.dk	; Pallesen, Hanne/W-1204-2017	Roenn-Smidt, Helle/0000-0003-2987-5540; Pallesen, Hanne/0000-0001-6010-2306	Aalborg University, Hammel Neurorehabilitation and Research Centre; VIA University College, Denmark	A special thank you goes to the patients, their families, and the health professionals who took the time and trouble to participate in this research. The study was funded by Aalborg University, Hammel Neurorehabilitation and Research Centre, and VIA University College, Denmark.	Arnold P. J., 1979, MEANING MOVEMENT SPO; Boss M, 1983, EXISTENTIAL FDNS MED; Bunkan B., 2008, KROPP RESPIRASJON KR, V4; Bunkan B.H., 1991, WHAT IS PSYCHOMOTOR; Chowdhury A, 2017, PHYSIOTHER THEOR PR, V33, P550, DOI 10.1080/09593985.2017.1323360; Cumming TB, 2012, INT PSYCHOGERIATR, V24, P557, DOI 10.1017/S1041610211001980; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Damasio A., 1999, FEELING WHAT HAPPENS; Danish National Board of Health, 2011, HJERN MED TEKN; Davis JR, 2003, BRAIN INJURY, V17, P359, DOI 10.1080/0269905021000038429; Davis K. E., 1985, SOCIAL CONSTRUCTION; Dragesund T, 2012, THESIS; Ek KM, 1990, THESIS; Ekerholt K, 2004, SCAND J PUBLIC HEALT, V32, P403, DOI 10.1080/14034940410029441; Ekerholt K, 2006, EUR J PHYSIOTHER, V8, P137, DOI 10.1080/14038190600836809; Engelsrud G, 1998, DANSKE FYSIOTERAPEUT, V1998, P4; Engelsrud G, 1992, KROPPEN SOM SUBJEKT; Engelsrud G, 2019, PHYSIOTHER THEOR PR, V35, P908, DOI 10.1080/09593985.2018.1460431; Faircloth CA, 2004, SOCIOL HEALTH ILL, V26, P242, DOI 10.1111/j.1467-9566.2004.00388.x; Feinberg TE, 2011, CONSCIOUS COGN, V20, P75, DOI 10.1016/j.concog.2010.09.017; Fredens K, 2018, LAERING MED KROPPEN; Fuchs T., 2017, EMERGING SOCIALITIES, P3, DOI DOI 10.13128/Phe_Mi-20119; Gallagher S, 1995, J MIND BEHAV, V16, P369; Gallagher S, 2012, PHENOMENOLOGICAL MIND, 2ND EDITION, P1; Gallagher S., 2012, PHENOMENOLOGY; Gallagher S, 2004, PHENOMENLOGY CRITICA, V2, P139; Gallagher S, 2011, BODY SHAPES MIND; Gallagher S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00443; GERGEN KJ, 1985, AM PSYCHOL, V40, P266, DOI 10.1037/0003-066X.40.3.266; Glintborg C, 2015, GRIB MENNESKE; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Greenfield BH, 2010, PHYS THER, V90, P1185, DOI 10.2522/ptj.20090348; Guidetti S, 2007, AM J OCCUP THER, V61, P303, DOI 10.5014/ajot.61.3.303; Harman K, 2011, PHYSIOTHER CAN, V63, P212, DOI 10.3138/ptc.2009-52P; Hiromitsu K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012156; Jacobson L, 2013, FAM J, V21, P417, DOI 10.1177/1066480713488530; Johnson D, 1992, BODY RECOVERING OUR; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; Kirkengen AL, 2012, J EVAL CLIN PRACT, V18, P1095, DOI 10.1111/j.1365-2753.2012.01925.x; Merleau-Ponty M., 2012, PHENOMENOLOGY PERCEP; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Mulder T, 2002, GAIT POSTURE, V16, P198, DOI 10.1016/S0966-6362(01)00157-6; Neimeyer GJ, 1993, CONSTRUCTIVIST ASSES; Norris S, 2011, ROUTLEDGE HDB MULTIM, P78; Norris S., 2014, INTERACTIONS IMAGES; Norris S., 2004, ANAL MULTIMODAL INTE; Oberg GK, 2015, PHYSIOTHER THEOR PR, V31, P244, DOI 10.3109/09593985.2014.1002873; Ovreberg G, 1989, AADEL BULOW HANSENS; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Padgett, 2017, QUALITATIVE METHODS; Pallesen H, 2011, FEM AR EFTER APOPLEK; Pallesen H, 2014, DISABIL REHABIL, V36, P232, DOI 10.3109/09638288.2013.788217; Parry RH, 2004, SOCIOL HEALTH ILL, V26, P976, DOI 10.1111/j.0141-9889.2004.00425.x; Rosberg S, 2000, KROPP VARANDE MENING; Roscigno Cecelia I, 2008, Commun Nurs Res, V41, P77; Roxendal G, 1995, HELHEDSPERSPEKTIV FR; Schriver NB, 2003, THESIS; Shaw JA, 2012, PHYS THER REV, V17, P398, DOI 10.1179/1743288X12Y.0000000043; Sivertsen M, 2015, PHYSIOTHER THEOR PR, V31, P153, DOI 10.3109/09593985.2014.986350; Skjaerven LH, 2019, PHYSIOTHER THEOR PR, V35, P80, DOI 10.1080/09593985.2018.1434578; Skjaerven Liv H., 2008, Physiotherapy Theory and Practice, V24, P13, DOI 10.1080/01460860701378042; Stern DN, 2006, INTERPERSONAL WORLD; Timothy EK, 2016, PHYS THER, V96, P1565, DOI 10.2522/ptj.20150419; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033	67	1	1	2	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	OCT 3	2021	37	10					1067	1079		10.1080/09593985.2019.1681041		OCT 2019	13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	UP3UY	WOS:000491970800001	31642722				2022-02-06	
J	Peng, JJ; Liu, GW; Li, F; Yuan, MZ; Xiang, YL; Qin, DY				Peng, Jingjing; Liu, Guang-Wei; Li, Feng; Yuan, Meizhen; Xiang, Yanling; Qin, Deyu			The correlation between feeding intolerance and poor prognosis of patients with severe neurological conditions: a case-control study	EXPERT REVIEW OF NEUROTHERAPEUTICS			English	Article						Patients with severe neurological conditions; feeding intolerance; stroke; modified Rankin Scale assessment; poor prognosis	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; GAMMA-LINOLENIC ACID; ENTERAL NUTRITION; CLINICAL-OUTCOMES; RISK-FACTORS; THERAPY; IMPLEMENTATION; MALNUTRITION	Background: This study aims to investigate the current status of feeding intolerance (FI) among patients with severe neurological conditions and to further determine the correlation between FI and their poor prognosis. Methods: This study performed a retrospective analysis of the medical data of 58 patients from January 2017 to December 2017. Patients were divided into two groups according to modified Rankin Scale (mRS) scores. Logistic regression was used to analyze the relevant factors for the poor prognosis of these patients. Results: General data analysis showed that age and diagnosis(stroke) were significantly different between the two groups (P?<?0.05). Univariate analysis showed that APACHE II score, vomiting within 3?days of NICU admission, gastrointestinal bleeding within 3?days of NICU admission and occurrence of FI within 3?days of NICU admission were all risk factors for a poor prognosis of these patients(P?<?0.05). Multivariate logistic regression analysis showed that FI within 3?days of NICU admission(OR 8.026, 95%CI(1.550?26.039)) and diagnosis(stroke)(OR 10.654, 95%CI (1.746?21.291)) were independent factors for a poor prognosis of patients with severe neurological conditions. Conclusion: The incidence of early FI in stroke patients is correlated with a poor prognosis.	[Peng, Jingjing] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Liu, Guang-Wei; Li, Feng; Yuan, Meizhen] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Xiang, Yanling] Chongqing Med Univ, Dept Operat Anesthesia, Univ Town Hosp, Chongqing, Peoples R China; [Qin, Deyu] Chongqing Med Univ, Affiliated Hosp 1, Dept Infect, Chongqing, Peoples R China		Liu, GW (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	18523438683@163.com					Acosta Escribano J A, 2001, Nutr Hosp, V16, P262; Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Artinian V, 2006, CHEST, V129, P960, DOI 10.1378/chest.129.4.960; Barr J, 2004, CHEST, V125, P1446, DOI 10.1378/chest.125.4.1446; Binnekade JM, 2005, CRIT CARE, V9, pR218, DOI 10.1186/cc3504; Blaser AR, 2015, CLIN NUTR, V34, P956, DOI 10.1016/j.clnu.2014.10.006; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Cahill NE, 2010, CRIT CARE MED, V38, P395, DOI 10.1097/CCM.0b013e3181c0263d; Ceniccola GD, 2018, J CRIT CARE, V44, P398, DOI 10.1016/j.jcrc.2017.12.013; Chen YD, 2011, EUR NEUROL, V66, P204, DOI 10.1159/000330551; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Choi EY, 2015, JPEN-PARENTER ENTER, V39, P291, DOI 10.1177/0148607114544322; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Drescher T, 2010, EUR J CLIN NUTR, V64, P887, DOI 10.1038/ejcn.2010.64; Fraser RJL, 2010, NUTR CLIN PRACT, V25, P26, DOI 10.1177/0884533609357570; Gungabissoon U, 2015, JPEN-PARENTER ENTER, V39, P441, DOI 10.1177/0148607114526450; Heyland DK, 2011, CLIN NUTR, V30, P148, DOI 10.1016/j.clnu.2010.09.011; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P74, DOI 10.1177/014860710302700174; Kailun W, 2017, JPEN J PARENTER ENTE, V41, P959; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Li F, 2015, EXPERT REV ANTI-INFE, V13, P521, DOI 10.1586/14787210.2015.1019471; Liff JM, 2012, CLIN NEUROL NEUROSUR, V114, P789, DOI 10.1016/j.clineuro.2011.12.042; Malhotra K, 2019, J STROKE, V21, P78, DOI 10.5853/jos.2018.02369; Marls H, 2017, BRAIN BEHAV IMMUN, V66, P31; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; Neumayer LA, 2001, J SURG RES, V95, P73, DOI 10.1006/jsre.2000.6047; O'Meara D, 2008, AM J CRIT CARE, V17, P53; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; REINTAM BA, 2012, INTENS CARE MED, V38, P384, DOI DOI 10.1007/S00134-011-2459-Y; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; de Freitas MMT, 2019, REV BRAS ENFERM, V72, P73, DOI 10.1590/0034-7167-2017-0491; Thor PJ, 2003, MED SCI MONITOR, V9, P392; Tinker RJ, 2019, ACTA NEUROL BELG, V29, P112; Woo SH, 2010, NUTR CLIN PRACT, V25, P205, DOI 10.1177/0884533610361605; Xu XP, 2012, ANAT REC, V295, P307, DOI 10.1002/ar.21490; Yeh DD, 2017, NUTR CLIN PRACT, V32, P175, DOI 10.1177/0884533616686726	40	1	2	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1473-7175	1744-8360		EXPERT REV NEUROTHER	Expert Rev. Neurother.	DEC 2	2019	19	12					1265	1270		10.1080/14737175.2019.1679627		OCT 2019	6	Clinical Neurology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	JJ0HB	WOS:000491798700001	31601136				2022-02-06	
J	Armstrong, E; McAllister, M; Hersh, D; Katzenellenbogen, JM; Thompson, SC; Coffin, J; Flicker, L; Woods, D; Hayward, C; Ciccone, N				Armstrong, Elizabeth; McAllister, Meaghan; Hersh, Deborah; Katzenellenbogen, Judith M.; Thompson, Sandra C.; Coffin, Juli; Flicker, Leon; Woods, Deborah; Hayward, Colleen; Ciccone, Natalie			A screening tool for acquired communication disorders in Aboriginal Australians after brain injury: lessons learned from the pilot phase	APHASIOLOGY			English	Article						Communication disorder; screening tool; Aboriginal; indigenous	INDIGENOUS AUSTRALIANS; WESTERN-AUSTRALIA; STROKE; APHASIA; TRANSITION; KICA	Background: Screening for communication disorders in a cross-cultural context presents numerous challenges, especially when the screening tool has been designed for use in one specific cultural and linguistic context. Translation enables it to be administered to speakers of a variety of languages, but does not account for the effects of worldview nor the linguistic and cultural context that motivated the original version. Clients assessed with tools not appropriate for their culture may be at a disadvantage in completing the assessment. Furthermore, this may influence diagnostic/screening judgements and decision-making related to access to relevant services. Aims: To describe the piloting of a screening tool developed to detect acquired communication disorders in Aboriginal Australians after stroke and traumatic brain injury ? the Aboriginal Communication Assessment After Brain Injury (ACAABI). The study aims to i) assess whether a non-speech pathologist (e.g., Aboriginal Health Practitioner) can easily and accurately administer the tool, ii) determine whether the tool can identify acquired communication disorders of any type, and iii) describe a series of practical challenges encountered. Methods and procedures: Aboriginal Research Assistants (ARAs) reflected the role of the Aboriginal Health Practitioner. ARAs administered the tool to 38 Aboriginal brain injury survivors across Western Australia. A Speech Language Pathologist (SLP) observed the assessments to evaluate test administration. Another SLP undertook an independent communication assessment to provide information to an expert panel who produced a consensus diagnosis with which to compare the tool results. Sensitivity and specificity analyses were undertaken in terms of the total score and individual section scores. Field notes captured challenges encountered. Outcomes and results: Aboriginal Research Assistants could administer the tool effectively for the majority of participants, with some variations occurring. The tool appeared to be sensitive to detection of acquired communication disorders but had a high false-positive rate. However, small sample size and lack of comparative groups of non-brain-damaged individuals and those without communication disorders limits interpretation at this time. Challenges included participant recruitment, scheduling of appointments across large geographical distances, and availability of Aboriginal Research Assistants. Conclusions: The ACAABI looks promising in its ability to provide a culturally appropriate and secure way to screen for acquired communication disorders in Aboriginal people after brain injury for the purpose of referring onwards for further investigation. However, numerous challenges were encountered in the piloting and further work is needed to adjust the tool, enabling reliability, sensitivity and specificity analyses to be conclusive.	[Armstrong, Elizabeth; McAllister, Meaghan; Hersh, Deborah; Ciccone, Natalie] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Katzenellenbogen, Judith M.] Univ Western Australia, Sch Populat & Global Hlth, Perth, WA, Australia; [Katzenellenbogen, Judith M.] Telethon Inst Child Hlth Res, Perth, WA, Australia; [Thompson, Sandra C.] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, Australia; [Coffin, Juli] Telethon Inst Child Hlth Res, Broome, Australia; [Flicker, Leon] Univ Western Australia, Ctr Med Res, Perth, WA, Australia; [Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, Australia; [Hayward, Colleen] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Perth, WA, Australia		Armstrong, E (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, 270 Joondalup Dr, Joondalup, WA 6027, Australia.	b.armstrong@ecu.edu.au	; Thompson, Sandra/H-5955-2014	Flicker, Leon/0000-0002-3650-0475; Hersh, Deborah/0000-0003-2466-0225; Ciccone, Natalie/0000-0002-1822-7217; Armstrong, Elizabeth/0000-0003-4469-1117; Katzenellenbogen, Judith/0000-0001-5287-5819; Thompson, Sandra/0000-0003-0327-7155	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1046228]	This work was supported by the National Health and Medical Research Council [1046228].	Armstrong E., 2017, J CLIN PRACTICE SPEE, V19, P27; Armstrong E., 2017, SMART STROK C GOLD C; Armstrong E, 2019, BRAIN IMPAIR, V20, P120, DOI 10.1017/BrImp.2019.19; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Armstrong EM, 2017, INT J SPEECH-LANG PA, V19, P297, DOI 10.1080/17549507.2017.1290136; Australian Bureau of Statistics, 2016, PRIS AUSTR 2016; Australian Bureau of Statistics, 2016, 3238055001 AUSTR BUR; Australian Institute of Aboriginal and Torres Strait Islander Studies & Federation for Aboriginal and Torres Strait Islander Languages, 2005, NAT IND LANG SURV RE; Bagot KL, 2017, J TELEMED TELECARE, V23, P850, DOI 10.1177/1357633X17734004; Balabanski AH, 2018, INT J STROKE, V13, P811, DOI 10.1177/1747493018778113; Bessarab D., 2010, INT J CRIT INDIG STU, V3, P37; Bohanna I, 2018, BRAIN IMPAIR, V19, P246, DOI 10.1017/BrImp.2018.1; Brewer K., 2019, QUALITATIVE RES COMM, P407; Dingwall K, 2014, BMC PSYCHOL, V2, DOI [DOI 10.1186/2050-7283-2-13, 10.1186/2050-7283-2-13]; Dingwall KM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-42; Fitts MS, 2019, BRAIN IMPAIR, V20, P137, DOI 10.1017/BrImp.2019.24; Fyndanis V, 2017, CLIN LINGUIST PHONET, V31, P697, DOI 10.1080/02699206.2017.1310299; Hersh D, 2015, INT J SPEECH-LANG PA, V17, P74, DOI 10.3109/17549507.2014.923510; Hesketh A, 2011, APHASIOLOGY, V25, P291, DOI 10.1080/02687038.2010.507818; Hilari K, 2007, J NEUROL NEUROSUR PS, V78, P1072, DOI 10.1136/jnnp.2006.111476; Ivanova MV, 2013, APHASIOLOGY, V27, P891, DOI 10.1080/02687038.2013.805728; Kaplan E, 2001, BDAE 3 BOSTON DIAGNO, V3rd; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2010, CEREBROVASC DIS, V30, P57, DOI 10.1159/000314621; Kendall E, 2015, ETHNIC HEALTH, V20, P437, DOI 10.1080/13557858.2014.921897; Kertesz A., 2007, WAB R W APHASIA BATT; Kilkenny MF, 2013, INT J STROKE, V8, P164, DOI 10.1111/j.1747-4949.2011.00717.x; Kim DY, 2016, APHASIOLOGY, V30, P96, DOI 10.1080/02687038.2015.1064084; Laycock A., 2011, RES ABORIGINAL HLTH; Lewis T., 2017, J CLIN PRACTICE SPEE, V19, P14; Lin I, 2016, AUST J PRIM HEALTH, V22, P377, DOI 10.1071/PY16051; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; Malcolm I.G., 2018, AUSTR ABORIGINAL ENG; National Health and Medical Research Council, 2018, KEEP RES TRACK 2 COM; National Health and Medical Research Council, 2018, ETH COND RES AB TORR; Penn C, 2017, APHASIOLOGY, V31, P563, DOI 10.1080/02687038.2016.1213788; Simpson L, 2006, INT J HEALTH CARE Q, V19, DOI 10.1108/ijhcqa.2006.06219cae.002; Smith K, 2016, INT PSYCHOGERIATR, V28, P101, DOI 10.1017/S1041610215001283; Thommessen B, 1999, DISABIL REHABIL, V21, P110, DOI 10.1080/096382899297846; You JQ, 2015, INT J STROKE, V10, P716, DOI 10.1111/ijs.12429	42	1	1	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	NOV 1	2020	34	11					1388	1412		10.1080/02687038.2019.1678107		OCT 2019	25	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	OM5GY	WOS:000491767400001					2022-02-06	
J	Basilio, AV; Xu, P; Takahashi, Y; Yanaoka, T; Sugaya, H; Ateshian, GA; Morrison, B				Basilio, Andrew V.; Xu, Peng; Takahashi, Yukou; Yanaoka, Toshiyuki; Sugaya, Hisaki; Ateshian, Gerard A.; Morrison, Barclay, III			Simulating cerebral edema and delayed fatality after traumatic brain injury using triphasic swelling biomechanics	TRAFFIC INJURY PREVENTION			English	Article; Early Access						Cerebral edema; fixed charge density; Gibbs-Donnan swelling pressure; traumatic brain injury; triphasic biomechanics	INTRACRANIAL-PRESSURE	Objectives: Contemporary finite element (FE) models, like that from the Global Human Body Models Consortium (GHBMC), have been useful for developing safety systems to reduce the severity of injuries in motor vehicle crashes (MVCs), including traumatic brain injury (TBI). However, not all injury occurs during the MVC. Cerebral edema after TBI contributes to mortality by increasing intracranial pressure (ICP) and preventing adequate cerebral blood supply. The focus of this study was to model post-traumatic cerebral edema and subsequent mortality due to increased ICP. Methods: Brain tissue swells in a manner consistent with triphasic biomechanics, which models biological tissues as a charged deformable porous solid matrix (fixed charge density [FCD]), a solvent, and monovalent counter-ions (cerebrospinal fluid). Fluid uptake into the brain is driven by the Gibbs-Donnan osmotic pressure as the FCD is exposed when cells die. Post-TBI edema was simulated in FEBio (febio.org), which includes triphasic material formulations. The GHBMC mesh was imported into FEBio, and each element was assigned a FCD to represent impact-related cell death based on its maximum principal strain (MPS) experienced during the crash-simulation using the stock GHBMC model and LS-DYNA. The ensuing pathophysiology was simulated in FEBio in two steps. First, the brain swelled in response to exposure of FCD, causing some adjacent elements to compress as fluid was redistributed. Biologically, the compression was assumed to reduce blood flow and cause ischemic cell death, represented by additional exposure of FCD, swelling, and increased ICP. Using published prognostic models of clinical outcome, mortality was predicted based on ICP. Results: Post-traumatic volume ratio of elements ranged from less than 30% (compaction) to greater than 200% (swelling). Predicted ICP values for a fatal impact were as high as 8.55 kPa (64.1 mmHg), which is associated with a 99% probability of death. Conclusion: To the best of our knowledge, this is the first study to simulate post-traumatic brain swelling to predict outcome. By incorporating swelling, ischemia, and cell death, our novel approach may improve fidelity of predicting outcome after MVCs. A strength of our approach is relying on the validated GHBMC model to predict brain deformation in the crash-scenario. The main goal of the current study was to demonstrate feasibility of simulating post-injury swelling using triphasic biomechanics. We successfully predicted clinically relevant increases in ICP that suggest a high likelihood of death when simulating a fatal impact scenario, however, more validation of our methodology is needed.	[Basilio, Andrew V.; Xu, Peng; Ateshian, Gerard A.; Morrison, Barclay, III] Columbia Univ, Biomed Engn, 1210 Amsterdam Ave,351 Engn Terrace,MC8904, New York, NY 10027 USA; [Takahashi, Yukou; Yanaoka, Toshiyuki; Sugaya, Hisaki] Honda R&D, Haga, Tochigi, Japan; [Ateshian, Gerard A.] Columbia Univ, Mech Engn, New York, NY USA		Basilio, AV (corresponding author), Columbia Univ, Biomed Engn, 1210 Amsterdam Ave,351 Engn Terrace,MC8904, New York, NY 10027 USA.	avb2132@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	Honda RD	This study was supported by Honda R&D.	Arun MW, 2015, IRCOBI C P 2015; Ateshian GA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024823; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Czosnyka M, 2017, HAND CLINIC, V140, P67, DOI 10.1016/B978-0-444-63600-3.00005-2; Elkin BS, 2011, J NEUROTRAUM, V28, P2277, DOI 10.1089/neu.2010.1603; Ewing CL, 1978, DYNAMIC RESPONSE HUM; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; HEILIG CW, 1989, AM J PHYSIOL, V257, pF1108, DOI 10.1152/ajprenal.1989.257.6.F1108; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; OVERBEEK JTG, 1956, PROG BIOPHYS MOL BIO, V6, P58; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; Takahashi Y, 2019, TRAFFIC INJ PREV, V20, pS27, DOI 10.1080/15389588.2019.1591621; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TOMITA M, 1988, BRAIN RES, V474, P165, DOI 10.1016/0006-8993(88)90679-8; Yanaoka T, 2017, 25 INT TECHN C ENH S; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	20	1	2	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.												10.1080/15389588.2019.1663347		OCT 2019	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	JG8GB	WOS:000492315300001	31647331				2022-02-06	
J	Carney, J; Fisher, R; Augutis, M; Charlifue, S; Biering-Sorensen, F; Hofers, W; Hwang, M; New, PW; Post, M; Sadowsky, C; Vogel, L; Augustine, L; Dent, K; Mulcahey, MJ				Carney, Joan; Fisher, Rhona; Augutis, Marika; Charlifue, Susan; Biering-Sorensen, Fin; Hofers, Wiebke; Hwang, Miriam; New, Peter Wayne; Post, Marcel; Sadowsky, Cristina; Vogel, Lawrence; Augustine, Lilly; Dent, Kathryn; Mulcahey, M. J.			Development of the International Spinal Cord Injury/Dysfunction Education Basic Data Set	SPINAL CORD SERIES AND CASES			English	Article							TRAUMATIC BRAIN-INJURY; SCHOOL-AGED CHILDREN; EMPLOYMENT OUTCOMES; PARTICIPATION; PERSPECTIVES; PERFORMANCE; ILLNESS; YOUTH	Study design Consensus among international experts. Objectives The objective of this project was to develop the International Spinal Cord Injury/Dysfunction (SCI/D) Education Basic Data Set. Setting International expert working group. Methods The published guidelines for developing the International SCI Basic Data Sets were used to develop the International SCI/D Education Basic Data Set. Existing measures and literature on education and disability were reviewed to develop a preliminary draft of the basic education data set through iterative modifications via biweekly conference calls and email communication. The draft was disseminated to the larger International Workgroup for Development of Pediatric SCI/D Basic Data Sets and then to the members of the International Spinal Cord Society (ISCoS), American Spinal Injury Association (ASIA), and relevant expert groups and interested individuals for comments. All feedback received was taken into consideration before the final data set was approved by ISCoS and ASIA. Results The finalized version of the International SCI/D Education Basic Data Set Version 1.0 contains 16 items divided into three domains: school setting/therapeutic services, school participation/academic success, and barriers/attitudes. Most of the variables have been adapted from established measures. This data set is intended for children and youth up to and including high school, but not for emerging adults in higher education or postsecondary vocational training or trade schools. Conclusion The International SCI/D Education Basic Data Set has been developed for collection of a minimal amount of highly relevant information on the education experience in children and youth with SCI/D. Further validation work is needed. Sponsorship This project was funded by the Rick Hansen Institute, Research Award #G2015-27 (Mulcahey, PI).	[Carney, Joan; Sadowsky, Cristina] Kennedy Krieger Rehabil Inst, Rehabil Dept, Baltimore, MD USA; [Fisher, Rhona] Fisher Assoc, Baltimore, MD USA; [Augutis, Marika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Charlifue, Susan] Craig Hosp, Res Dept, Englewood, CO USA; [Biering-Sorensen, Fin] Univ Copenhagen, Rigshosp, Neurosci Ctr, Dept Spinal Cord Injuries, Copenhagen, Denmark; [Hofers, Wiebke] Sunnaas Hosp, Physiotherapy Dept, Bjrnemyr, Norway; [Hwang, Miriam; Vogel, Lawrence] Shriners Hosp Children, Res Dept, Chicago, IL USA; [New, Peter Wayne] Monash Univ, Sch Publ Hlth & Preventat Med, Dept Epidemil & Preventit Med, Epworth Monash Rehabil Unit, Melbourne, Vic, Australia; [Post, Marcel] Univ Utrecht, Ctr Excellence Rehabil Med, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Post, Marcel] De Hoogstr Rehabil, Utrecht, Netherlands; [Augustine, Lilly] Jonkoping Univ, Sch Educ & Psychol, Jonkoping, Sweden; [Dent, Kathryn; Mulcahey, M. J.] Thomas Jefferson Univ, Jefferson Coll Rehabil Sci, Ctr Outcomes & Measurement, Dept Occupat Therapy,Jefferson Philadelphia Univ, Philadelphia, PA 19107 USA		Mulcahey, MJ (corresponding author), Thomas Jefferson Univ, Jefferson Coll Rehabil Sci, Ctr Outcomes & Measurement, Dept Occupat Therapy,Jefferson Philadelphia Univ, Philadelphia, PA 19107 USA.	maryjane.mulcahey@jefferson.edu		New, Peter Wayne/0000-0002-5669-3286; Post, Marcel/0000-0002-2205-9404; Augutis, Marika/0000-0002-9711-1756; mulcahey, MJ/0000-0002-0837-714X; Sadowsky, Cristina/0000-0003-4028-7301			Anderson CJ, 2002, ARCH PHYS MED REHAB, V83, P791, DOI 10.1053/apmr.2002.32742; Ballert CS, 2015, ARCH PHYS MED REHAB, V96, P233, DOI 10.1016/j.apmr.2014.09.004; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Biering-Sorensen F, 2006, SPINAL CORD, V44, P530, DOI 10.1038/sj.sc.3101930; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; Biering-Sorensen F, 2011, SPINAL CORD, V49, P357, DOI 10.1038/sc.2010.153; Boonen H, 2012, CHILD CARE HLTH DEV, V38, P490, DOI 10.1111/j.1365-2214.2011.01279.x; Calhoun CL, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/854904; Carroll A, 2017, SPINAL CORD, V55, P875, DOI 10.1038/sc.2017.14; Coster W., 1998, SCH FUNCTION ASSESSM; Curie C, 2015, HBSC 2014 SURVEY SCO; Dept. of Education and Training, 2016, INCL ED ALL STUD DIS; Dumas HM, 2003, INT J REHABIL RES, V26, P303, DOI 10.1097/00004356-200312000-00008; Forrest CB, 2011, PEDIATRICS, V128, P303, DOI 10.1542/peds.2010-3347; Garcia E., 2018, STUDENT ABSENTEEISM; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V123, P174, DOI 10.1016/j.clineuro.2014.05.013; Knight A, 2008, SCH LIVES CHILDREN Y; Krause JS, 1996, ARCH PHYS MED REHAB, V77, P737; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Lum A, 2017, CHILD CARE HLTH DEV, V43, P645, DOI 10.1111/cch.12475; Lum A, 2017, CHILD CARE HLTH DEV, DOI [10.1111/cch12475, DOI 10.1111/CCH12475]; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P995, DOI 10.1016/S0003-9993(96)90058-1; Molcho M, 2014, HLTH BEHAV SCH AGED; Mulcahey MJ, 2017, SPINAL CORD, V55, P331, DOI 10.1038/sc.2016.139; Mulcahey MJ, 2016, SPINAL CORD, V54, P1183, DOI 10.1038/sc.2016.68; Mulcahey MJ, 2010, AM J OCCUP THER, V64, P605, DOI 10.5014/ajot.2010.08148; MULCAHEY MJ, 1992, AM J OCCUP THER, V46, P305, DOI 10.5014/ajot.46.4.305; Sandford PR, 1999, ARCH PHYS MED REHAB, V80, P885, DOI 10.1016/S0003-9993(99)90078-3; Sanford P., 1999, ARCH PHYS MED REHAB, V80, P855; Schnohr CW, 2015, EUR J PUBLIC HEALTH, V25, P7, DOI 10.1093/eurpub/ckv010; Sentenac M, 2013, RES DEV DISABIL, V34, P588, DOI 10.1016/j.ridd.2012.09.019; Thies KM, 1999, J SCHOOL HEALTH, V69, P392, DOI 10.1111/j.1746-1561.1999.tb06354.x; Trenaman L, 2015, J SPINAL CORD MED, V38, P422, DOI 10.1179/2045772315Y.0000000031; UNESCO Institute for Statistics, 2011, INT STAND CLASS ED; Whiteneck G, 1999, ARCH PHYS MED REHAB, V80, P1485, DOI 10.1016/S0003-9993(99)90262-9; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Zimmerman E.B., 2015, POPULATION HLTH BEHA, P347	38	1	1	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2058-6124			SPINAL CORD SER CASE	Spinal Cord Ser. Cases	OCT 21	2019	5	1							87	10.1038/s41394-019-0229-1			6	Clinical Neurology; Rehabilitation	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology; Rehabilitation	WE3WF	WOS:000705559500002		Green Published, Bronze			2022-02-06	
J	Rogers, EA; Gross, GW				Rogers, Edmond A.; Gross, Guenter W.			Simultaneous electrophysiological and morphological assessment of functional damage to neural networks in vitro after 30-300 g impacts	SCIENTIFIC REPORTS			English	Article							NUCLEAR ROTATION; CROSS-CORRELATION; CELL-CULTURE; BRAIN-INJURY; SPINAL-CORD; OSCILLATIONS; NEURONS; ABNORMALITIES; INTERNEURONS; PATTERNS	An enigma of mild traumatic brain injury are observations of substantial behavior and performance deficits in the absence of bleeding or other observable structural damage. Altered behavior and performance reflect changes in action potential (AP) patterns within neuronal networks, which could result from subtle subcellular responses that affect synaptic efficacy and AP production. The aim of this study was to investigate and quantify network activity changes after simulated concussions in vitro and therewith develop a platform for simultaneous and direct observations of morphological and electrophysiological changes in neural networks. We used spontaneously active networks grown on microelectrode arrays (MEAs) to allow long-term multisite monitoring with simultaneous optical observations before and after impacts delivered by a ballistic pendulum (30 to 300 g accelerations). The monitoring of AP waveshape templates for long periods before and after impact provided an internal control for cell death or loss of cell-electrode coupling in the observed set of neurons. Network activity patterns were linked in real-time to high power phase contrast microscopy. There was no overt loss of glial or neuronal adhesion, even at high-g impacts. All recording experiments showed repeatable spike production responses: a loss of activity with recovery to near reference in 1 hr, followed by a slow activity decay to a stable, level plateau approximately 30-40% below reference. The initial recovery occurred in two steps: a rapid return of activity to an average 24% below reference, forming a level plateau lasting from 5 to 20 min, followed by a climb to within 10% of reference where a second plateau was established for 1 to 2 hrs. Cross correlation profiles revealed changes in firing hierarchy as well as in Phase 1 in spontaneous network oscillations that were reduced by as much as 20% 6-8 min post impact with only a partial recovery at 30 min. We also observed that normally stable nuclei developed irregular rotational motion after impact in 27 out of 30 networks. The evolution of network activity deficits and recovery can be linked with microscopically observable changes in the very cells that are generating the activity. The repeatable electrophysiological impact response profiles and oscillation changes can provide a quantitative basis for systematic evaluations of pharmacological intervention strategies. Future expansion to include fluorescent microscopy should allow detailed investigations of damage mechanisms on the subcellular level.	[Rogers, Edmond A.; Gross, Guenter W.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Rogers, Edmond A.; Gross, Guenter W.] Univ North Texas, Ctr Network Neurosci, Denton, TX 76203 USA; [Rogers, Edmond A.] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Rogers, Edmond A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA		Gross, GW (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.; Gross, GW (corresponding author), Univ North Texas, Ctr Network Neurosci, Denton, TX 76203 USA.	Guenter.Gross@unt.edu			University of North Texas	This research was supported in part by a University of North Texas Research Opportunity Grant. We greatly appreciate the excellent, reliable cell culture support provided by M.S. students Nikita Suri and Stormy Durant and undergraduate volunteers Ross Hicks, Austin Moore, and Karan Bhakta. We also thank Ahmet Ors, Chris Pino, and Jake Gray, for the in-house fabrication of MEAs. Special thanks are offered to Harvey Wiggins of Plexon Inc. for equipment donation and repair, and to Dr. Joseph Pancrazio, Carole & Jay Ross, Barbara Evans, Steven Gum (TI, retired), and PTAC Direct Sales (Southlake, TX), for critical private financial support.	Alagapan S, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00015; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Bisio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107400; Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cho S, 2017, J CELL BIOL, V216, P305, DOI 10.1083/jcb.201610042; DEBONI U, 1994, INT REV CYTOL, V150, P149; Dian E., 2004, THESIS; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Espindola D, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.044024; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; FUNG LC, 1988, CELL MOTIL CYTOSKEL, V10, P363, DOI 10.1002/cm.970100303; GERSTEIN GL, 1972, BIOPHYS J, V12, P453, DOI 10.1016/S0006-3495(72)86097-1; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Gross G. W., 2011, SCHOLARPEDIA, V6, P5749, DOI DOI 10.4249/SCHOLARPEDIA.5749; Gross G.W., 2019, SMART BIOSENSOR TECH; GROSS GW, 1985, J NEUROSCI METH, V15, P243, DOI 10.1016/0165-0270(85)90105-0; GROSS GW, 1994, J NEUROSCI METH, V52, P73, DOI 10.1016/0165-0270(94)90059-0; GROSS GW, 1994, ENABLING TECHNOLOGIE, P277; GROSS GW, 2006, ADV NETWORK ELECTROP, P193; Hogberg HT, 2011, NEUROTOXICOLOGY, V32, P158, DOI 10.1016/j.neuro.2010.10.007; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Johnstone AFM, 2010, NEUROTOXICOLOGY, V31, P331, DOI 10.1016/j.neuro.2010.04.001; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; Keefer EW, 2001, J NEUROPHYSIOL, V86, P3030, DOI 10.1152/jn.2001.86.6.3030; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kumaria A, 2017, ATLA-ALTERN LAB ANIM, V45, P201, DOI 10.1177/026119291704500405; LUCAS JH, 1986, IN VITRO CELL DEV B, V22, P37; LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S; Maninova M, 2014, CELL ADHES MIGR, V8, P42, DOI 10.4161/cam.27761; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Meyer J. M., 2009, IEEE BIOMEDICAL ENG, V56, P1; Morefield SI, 2000, BIOSENS BIOELECTRON, V15, P383, DOI 10.1016/S0956-5663(00)00095-6; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; PADDOCK SW, 1988, EXP CELL RES, V175, P409, DOI 10.1016/0014-4827(88)90205-4; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1132, DOI 10.1152/jn.1977.40.5.1132; Scelfo B, 2012, TOXICOLOGY, V299, P172, DOI 10.1016/j.tox.2012.05.020; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; TSO DY, 1986, J NEUROSCI, V6, P1160; Turnbull L, 2005, J NEUROSCI METH, V145, P23, DOI 10.1016/j.jneumeth.2004.11.020; Vacher H, 2012, EPILEPSIA, V53, P21, DOI 10.1111/epi.12032; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; Vassallo A, 2017, NEUROTOXICOLOGY, V60, P280, DOI 10.1016/j.neuro.2016.03.019; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Whelan M, 2011, FRONT NEUROENG, V4, P1; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	58	1	1	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 18	2019	9								14994	10.1038/s41598-019-51541-x			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JE9DH	WOS:000490988200053	31628381	gold, Green Published			2022-02-06	
J	Clacy, A; Sharman, R; Lovell, GP				Clacy, Amanda; Sharman, Rachael; Lovell, Geoff P.			Correlates of sport-related concussion in male junior rugby union: A concurrent analysis of biopsychosocial factors	AUSTRALIAN JOURNAL OF PSYCHOLOGY			English	Article						biopsychosocial; concussion; individual differences; regression analysis; sports injuries; youth sports	DIGIT RATIO 2D/4D; SHUTTLE RUN TEST; RISK-FACTORS; HIGH-SCHOOL; DIFFICULTIES QUESTIONNAIRE; NEW-ZEALAND; INJURY; FOOTBALL; CHILDREN; LENGTH	Objective Sport-related concussion (SRC) is a multi-faceted issue that should be considered in context, with consideration for the biological, psychological, and sociocultural (i.e., biopsychosocial) factors which influence the incidence of injury in contact sports such as rugby union (rugby). Through the concurrent assessment of individual variables within a multi-measure cross-sectional research design, the current study aimed to contextualise the individual factors associated with SRC in male junior (ages 11-17 years) rugby. Method Self- and parent-report measures were used to assess athletes' psychological and behavioural functioning. Sociocultural influences were considered in terms of duration of participation, involvement of immediate family, and participation in other sports. Biological measures included athlete age, BMI, aerobic fitness, and in-utero testosterone exposure (2D:4D). Results Athlete age was positively correlated with concussion incidence, with adolescent (14-17-year-old) athletes 1.4 times more likely to report a history of SRC than pre-adolescent (11-13-year-old) athletes. Multi-sport participation and immediate family participation were found to positively predict SRC incidence. No psychological measures were identified as significant correlates to concussive injury, however, this may be due to the homogeneity of the sample scores. Conclusions The concurrent assessment of biopsychosocial factors associated with SRC presents the opportunity for a comprehensive analysis of the injury context. The findings from this study suggest that SRC in junior rugby cannot be predicted using individual variables. Future research directions are discussed.	[Clacy, Amanda] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Qld, Australia; [Sharman, Rachael; Lovell, Geoff P.] Univ Sunshine Coast, Sch Social Sci, Maroochydore, Qld, Australia		Clacy, A (corresponding author), Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Qld, Australia.	aclacy@usc.edu.au					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Austin EJ, 2002, PERS INDIV DIFFER, V33, P1115, DOI 10.1016/S0191-8869(02)00002-8; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Castanier C, 2010, RES Q EXERCISE SPORT, V81, P478, DOI 10.5641/027013610X13088600029418; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Clacy A, 2019, APPL ERGON, V80, P256, DOI 10.1016/j.apergo.2017.06.010; Clacy A, 2017, J SPORT SCI, V35, P2232, DOI 10.1080/02640414.2016.1265140; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goodman R, 2003, INT REV PSYCHIATR, V15, P173, DOI 10.1080/0954026021000046137; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Helps Y, 2008, INJURY RES STAT SERI, V45; Honekopp J, 2011, PERS INDIV DIFFER, V51, P77, DOI 10.1016/j.paid.2011.03.010; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Honekopp J, 2006, HORM BEHAV, V49, P545, DOI 10.1016/j.yhbeh.2005.11.006; IBM Corp, 2016, IBM SPSS STAT WINDOW; Junge A, 2000, AM J SPORT MED, V28, pS10; Kempel P, 2005, INTELLIGENCE, V33, P215, DOI 10.1016/j.intell.2004.11.004; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; Kremer P, 2015, J PAEDIATR CHILD H, V51, P970, DOI 10.1111/jpc.12897; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Loehlin JC, 2006, ARCH SEX BEHAV, V35, P739, DOI 10.1007/s10508-006-9039-1; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; National Health And Medical Research Council, 2013, CLIN PRACT GUID MAN; Neave N, 2003, P ROY SOC B-BIOL SCI, V270, P2167, DOI 10.1098/rspb.2003.2502; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; Olds T, 2006, J SPORT SCI, V24, P1025, DOI 10.1080/02640410500432193; Osborn Zachary H, 2009, J Inj Violence Res, V1, P15, DOI 10.5249/jivr.v1i1.8; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Schinke R, 2009, SPORTS ATHL PREP PER, P1; Steinberg L, 2013, PSYCHOL ASSESSMENT, V25, P216, DOI 10.1037/a0030550; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x	41	1	1	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-9530	1742-9536		AUST J PSYCHOL	Aust. J. Psychol.	MAR	2020	72	1					50	58		10.1111/ajpy.12266		OCT 2019	9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	LP1JS	WOS:000490671800001					2022-02-06	
J	Guberman, GI; Robitaille, MP; Larm, P; Ptito, A; Vitaro, F; Tremblay, RE; Hodgins, S				Guberman, Guido, I; Robitaille, Marie-Pier; Larm, Peter; Ptito, Alain; Vitaro, Frank; Tremblay, Richard E.; Hodgins, Sheilagh			A Prospective Study of Childhood Predictors of Traumatic Brain Injuries Sustained in Adolescence and Adulthood	CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE			English	Article						traumatic brain injuries; childhood inattention-hyperactivity; childhood externalizing problems; traumatic brain injury recurrence	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; RISK-FACTORS; HEAD-INJURY; POSTCONCUSSION SYNDROME; PSYCHIATRIC-DISORDERS; GENERAL-POPULATION; PERSONALITY-CHANGE; CRIMINAL BEHAVIOR; CONDUCT DISORDER; MENTAL-HEALTH	Objective: Traumatic brain injuries (TBIs) are sustained by approximately 17% of males in the general population, many of whom subsequently present mental disorders, cognitive, and physical problems. Little is known about predictors of TBIs and how to prevent them. The present study aimed to determine whether inattention-hyperactivity and/or all externalizing problems presented by boys at age 10 predict subsequent TBIs to age 34 after taking account of previous TBIs and family social status (FSS). Method: 742 Canadian males were followed, prospectively, from age 6 to 34. Diagnoses of TBIs were extracted from health files, parents-reported sociodemographic and family characteristics at participants' age 6, and teachers-rated participants' behaviors at age 10. Separate logistic regression models predicted TBIs sustained from age 11 to 17 and from age 18 to 34. For each age period, two models were computed, one included previous TBIs, inattention-hyperactivity, FSS, and interaction terms, the second included previous TBIs, externalizing problems, FSS, and interaction terms. Results: In models that included inattention-hyperactivity, TBIs sustained from age 11 to 17 were predicted by age 10 inattention-hyperactivity (odds ratio [OR] = 1.46, 1.05 to 2.05) and by TBIs prior to age 11 (OR = 3.50, 1.48 to 8.24); TBIs sustained from age 18 to 34 were predicted by age 10 inattention-hyperactivity (OR = 1.31, 1.01 to 170). In models that included all externalizing problems, TBIs from age 11 to 17 were predicted by prior TBIs (OR = 3.66, 1.51 to 8.39); TBIs sustained from age 18 to 34 were predicted by age 10 externalizing problems (OR = 1.45, 1.12 to 1.86). Neither FSS nor interaction terms predicted TBIs in any of the models. Conclusions: Among males, using evidence-based treatments to reduce inattention-hyperactivity and externalizing problems among boys could, potentially, decrease the risk of TBIs to age 34. Further, boys who sustain TBIs in childhood require monitoring to prevent recurrence in adolescence.	[Guberman, Guido, I; Ptito, Alain] McGill Univ, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada; [Robitaille, Marie-Pier; Vitaro, Frank; Tremblay, Richard E.; Hodgins, Sheilagh] Univ Montreal, Grp Rech Inadaptat Psychosociale, Montreal, PQ, Canada; [Larm, Peter] Malardalens Univ, Sch Hlth Care & Social Welf, Vasteras, Sweden; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth, Dublin, Ireland; [Hodgins, Sheilagh] Univ Montreal, Ctr Rech, Inst Univ Sante Mentale Montreal, Dept Psychiat & Addictol, Montreal, PQ, Canada		Guberman, GI (corresponding author), McGill Univ, Dept Neurol & Neurosurg, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	guido.guberman@mail.mcgill.ca	Guberman, Guido/AAD-2412-2019	Guberman, Guido/0000-0002-4422-2225	Fonds Quebe cois de la Recherche sur la Societe et la CultureFQRNT; Fonds de Recherche du Que bec-Sante (FRQS); Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); FRQS; McGill University; Vanier Canada Graduate Scholarship from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for the longitudinal study has been provided by the Fonds Quebe cois de la Recherche sur la Societe ' et la Culture, Fonds de Recherche du Que bec-Sante (FRQS), Social Sciences and Humanities Research Council of Canada, and Canadian Institutes of Health Research. Support for this study also comes from a Doctoral Training for Medical Students Award (to G. Guberman) from the FRQS, a Tomlinson Doctoral Fellowship (to G. Guberman) from McGill University, and a Vanier Canada Graduate Scholarship (to G. Guberman) from the Canadian Institutes of Health Research.	Amram O, 2015, INT J ENV RES PUB HE, V12, P15594, DOI 10.3390/ijerph121215009; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2011, CAN ADHD PRACT GUID; Arseneault L, 2000, AM J PSYCHIAT, V157, P917, DOI 10.1176/appi.ajp.157.6.917; Bergman LR, 2009, AGGRESSIVE BEHAV, V35, P164, DOI 10.1002/ab.20298; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Broidy LM, 2003, DEV PSYCHOL, V39, P222, DOI 10.1037/0012-1649.39.2.222; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Caye A, 2016, JAMA PSYCHIAT, V73, P705, DOI 10.1001/jamapsychiatry.2016.0383; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Cobb BK, 1995, J ADOLESCENT HEALTH, V17, P381, DOI 10.1016/1054-139X(95)00059-2; Copeland WE, 2007, AM J PSYCHIAT, V164, P1668, DOI 10.1176/appi.ajp.2007.06122026; Crowe SL, 2008, DEV PSYCHOPATHOL, V20, P1145, DOI 10.1017/S0954579408000540; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dunn DW, 2003, NEUROL CLIN, V21, P933, DOI 10.1016/S0733-8619(03)00009-4; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; FARRINGTON DP, 1993, CRIMINAL BEHAV MENTA, V0003; Farrington DP., 1999, HIST GEOGRAPHICAL IN, P299; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Green H, 2005, MENTAL HLTH CHILDREN; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; HAWKES N, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1984; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hodgins S., 1994, STUDIES CRIME CRIME, V3, P41; Jackson TL, 2017, J EPIDEMIOL COMMUN H, V71, P800, DOI 10.1136/jech-2016-208582; Kennedy E, 2017, EUR CHILD ADOLES PSY, V26, P1197, DOI 10.1007/s00787-017-0975-1; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Kratzer L., 1999, CRIM BEHAV MENT HEAL, V9, P57, DOI [DOI 10.1002/CBM.291, 10.1002/cbm.291]; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuja-Halkola R, 2015, J CHILD PSYCHOL PSYC, V56, P640, DOI 10.1111/jcpp.12340; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Livingston EM, 2017, J AM ACAD CHILD PSY, V56, P895, DOI 10.1016/j.jaac.2017.07.787; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCreary Centre Society., 2014, HASTINGS STREET HAID; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; Moffitt TE, 2015, AM J PSYCHIAT, V172, P967, DOI 10.1176/appi.ajp.2015.14101266; Monshouwer K, 2013, CLIN PSYCHOL SCI, V1, P67, DOI 10.1177/2167702612450485; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Nock MK, 2006, PSYCHOL MED, V36, P699, DOI 10.1017/S0033291706007082; Odgers CL, 2008, DEV PSYCHOPATHOL, V20, P673, DOI 10.1017/S0954579408000333; Odgers CL, 2007, ARCH GEN PSYCHIAT, V64, P476, DOI 10.1001/archpsyc.64.4.476; Olazagasti MAR, 2013, J AM ACAD CHILD PSY, V52, P153, DOI 10.1016/j.jaac.2012.11.012; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Ramtekkar UP, 2010, J AM ACAD CHILD PSY, V49, P217, DOI 10.1016/j.jaac.2009.11.011; Rommelse NNJ, 2009, J ABNORM CHILD PSYCH, V37, P793, DOI 10.1007/s10802-009-9312-6; Rotshtein P., 2018, WILEY BLACKWELL HDB, VI, P229; Rouquette A, 2014, INT J EPIDEMIOL, V43, P23, DOI 10.1093/ije/dys177; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Tefft B. C., 2017, RATES MOTOR VEHICLE; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tremblay R. E., 1995, CRIM BEHAV MENT HEAL, V5, P439; TREMBLAY RE, 1991, PSYCHIATRY, V54, P148; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Vella SA, 2017, MED SCI SPORT EXER, V49, P687, DOI [10.1249/MSS.0000000000001142, 10.1249/mss.0000000000001142]; Wertz J, 2018, J AM ACAD CHILD PSY, V57, P54, DOI 10.1016/j.jaac.2017.09.437; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Wilson DA, 2014, EPILEPSY BEHAV, V32, P42, DOI 10.1016/j.yebeh.2013.12.035; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397	85	1	1	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0706-7437	1497-0015		CAN J PSYCHIAT	Can. J. Psychiat.-Rev. Can. Psychiat.	JAN	2020	65	1					36	45	0706743719882171	10.1177/0706743719882171		OCT 2019	10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KC8CR	WOS:000491616100001	31623445	Bronze, Green Published			2022-02-06	
J	Richmond, SB; Dames, KD; Shad, JM; Sutherlin, MA; Fling, BW				Richmond, Sutton B.; Dames, Kevin D.; Shad, Joanna M.; Sutherlin, Mark A.; Fling, Brett W.			Setting boundaries: Utilization of time to boundary for objective evaluation of the balance error scoring system	JOURNAL OF SPORTS SCIENCES			English	Article						Balance Tracking Systems (BTrackS); Balance Error Scoring System (BESS); postural stability; balance; portable	POSTURAL CONTROL; CONCUSSION; INSTABILITY; STABILITY; BTRACKS; INJURY	Subjective evaluations of balance performance, like the modified Balance Error Scoring System (mBESS), are highly popular. Alternatively, quantitative measures may offer additional clarity in identifying balance dysfunction. A novel measure to define balance impairments is time to boundary (TTB), which represents the amount of time available to make corrective postural adjustments prior to the centre of pressure (CoP) reaching the edge of the base of support. The purpose of this investigation was to assess TTB and traditional measures of CoP displacement of young adults performing the mBESS on a BTrackS balance plate. Path length and TTB were calculated in anterior-posterior (AP) and medio-lateral (ML) directions, respectively. AP and ML path lengths were largest in Single stance (109.2 & 118.1 cm, respectively) and smallest in Dual stance (27.1 & 36.4 cm, respectively). The average AP and ML TTBs were higher in Dual (10.67 & 7.27?s, respectively) compared to Single (3.54 & 1.20?s, respectively) or Tandem (10.11 & 1.94?s, respectively) stances, and lower in Single stance compared to Tandem. Given the effect sizes for TTB were greater than those of path length in both directions, TTB more adequately differentiates these stance conditions than path length or subjective scores.	[Richmond, Sutton B.; Shad, Joanna M.; Fling, Brett W.] Colorado State Univ, Dept Hlth & Exercise Sci, Room B220 Moby Complex B Wing,951 Plum St, Ft Collins, CO 80523 USA; [Dames, Kevin D.; Sutherlin, Mark A.] SUNY Coll Cortland, Kinesiol Dept, Cortland, NY 13045 USA; [Fling, Brett W.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA		Richmond, SB (corresponding author), Colorado State Univ, Dept Hlth & Exercise Sci, Room B220 Moby Complex B Wing,951 Plum St, Ft Collins, CO 80523 USA.	sutton.richmond@colostate.edu		Dames, Kevin/0000-0002-5540-2424; Fling, Brett/0000-0003-1815-3681			Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alsalaheen B. A., 2015, PHYSICIAN SPORTSMED, V43, P1; Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Caccese JB, 2016, J SPORT REHABIL, V25, P133, DOI 10.1123/jsr.2014-0281; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Denke NJ, 2008, J EMERG NURS, V34, P363, DOI 10.1016/j.jen.2008.04.013; Goble DJ, 2018, J BIOMECH, V71, P277, DOI 10.1016/j.jbiomech.2018.01.040; Goble DJ, 2017, CLIN INTERV AGING, V12, DOI 10.2147/CIA.S131047; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hasson CJ, 2008, J BIOMECH, V41, P2121, DOI 10.1016/j.jbiomech.2008.04.031; Hearn MC, 2018, CLIN J SPORT MED, V28, P177, DOI 10.1097/JSM.0000000000000435; Hertel J, 2006, J APPL BIOMECH, V22, P67, DOI 10.1123/jab.22.1.67; Hertel J, 2002, J ATHL TRAINING, V37, P129; Hertel J, 2007, GAIT POSTURE, V25, P33, DOI 10.1016/j.gaitpost.2005.12.009; Horak F. B., 2009, ENCY NEUROSCIENCE, P3312; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Izenman A. J., 2013, MODERN MULTIVARIATE, P237, DOI [10.1007/978-0-387-78189-1_8, DOI 10.1007/978-0-387-78189-1_8]; Jameson E, 2016, WESTERN HIST QUART, V47, P1, DOI 10.1093/whq/whv041; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Ozinga SJ, 2018, J ATHL TRAINING, V53, P636, DOI 10.4085/1062-6050-129-17; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Portney LG, 2015, FDN CLIN RES APPL PR; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Richmond SB, 2018, J BIOMECH, V75, P102, DOI 10.1016/j.jbiomech.2018.05.008; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Slobounov SM, 1998, J GERONTOL A-BIOL, V53, pB71, DOI 10.1093/gerona/53A.1.B71; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5	35	1	1	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	JAN 2	2020	38	1					21	28		10.1080/02640414.2019.1677378		OCT 2019	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NE2WX	WOS:000490497300001	31613188				2022-02-06	
J	Gordon, EM; May, GJ; Nelson, SM				Gordon, Evan M.; May, Geoffrey J.; Nelson, Steven M.			MRI-based measures of intracortical myelin are sensitive to a history of TBI and are associated with functional connectivity	NEUROIMAGE			English	Article						Traumatic brain injury; MRI; Biomarker; Intracortical myelin; Functional connectivity	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; SURFACE-BASED ANALYSIS; DIFFUSE AXONAL INJURY; HUMAN CEREBRAL-CORTEX; GRAY-MATTER; CORPUS-CALLOSUM; MOTION ARTIFACT; UNITED-STATES	Traumatic brain injuries (TBIs) induce persistent behavioral and cognitive deficits via diffuse axonal injury. Axonal injuries are often examined in vivo using diffusion MRI, which identifies damaged and demyelinated regions in deep white matter. However, TBI patients can exhibit impairment in the absence of diffusion-measured abnormalities, suggesting that axonal injury and demyelination may occur outside the deep white matter. Importantly, myelinated axons are also present within the cortex. Cortical myelination cannot be measured using diffusion imaging, but can be mapped in-vivo using the T1-w/T2-w ratio method. Here, we conducted the first work examining effects of TBI on intracortical myelin in living humans by applying myelin mapping to 46 US Military Veterans with a history of TBI. We observed that myelin maps could be created in TBI patients that matched known distributions of cortical myelin. After controlling for age and presence of blast injury, the number of lifetime TBIs was associated with reductions in the T1-w/T2-w ratio across the cortex, most significantly in a highly-myelinated lateral occipital region corresponding with the human MT+ complex. Further, the T1-w/T2-w ratio in this MT+ region predicted resting-state functional connectivity of that region. By contrast, a history of blast TBI did not affect the T1-w/T2-w ratio in either a diffuse or focal pattern. These findings suggest that intracortical myelin, as measured using the T1-w/T2-w ratio, may be a TBI biomarker that is anatomically complementary to diffusion MRI. Thus, myelin mapping could potentially be combined with diffusion imaging to improve MRI-based diagnostic tools for TBI.	[Gordon, Evan M.; May, Geoffrey J.; Nelson, Steven M.] VISN 17 Ctr Excellence Res Returning War Vet, 4800 Mem Dr,151-C, Waco, TX 76711 USA; [Gordon, Evan M.; May, Geoffrey J.; Nelson, Steven M.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr Vital Longev, 1600 Viceroy Dr 800, Dallas, TX 75235 USA; [Gordon, Evan M.; May, Geoffrey J.; Nelson, Steven M.] Baylor Univ, Dept Psychol & Neurosci, Baylor Sci Bldg,Suite B-309, Waco, TX 76706 USA; [May, Geoffrey J.; Nelson, Steven M.] Texas A&M Hlth Sci Ctr, Dept Psychiat & Behav Sci, Coll Med, 8441 Riverside Pkwy, Bryan, TX 77807 USA		Gordon, EM (corresponding author), VISN 17 Ctr Excellence Res Returning War Vet, 4800 Mem Dr,151-C, Waco, TX 76711 USA.	evan.gordon@va.gov	Gordon, Evan/J-5672-2019	Gordon, Evan/0000-0002-2276-5237	Career Development Award from the US Department of Veterans Affairs Clinical Sciences Research and Development ServiceUS Department of Veterans Affairs [1IK2CX001680]; VA VISN17 Center of Excellence pilot funding; Veterans AffairsUS Department of Veterans Affairs [IK2CX001680] Funding Source: NIH RePORTER	This work was supported by Career Development Award #1IK2CX001680 from the US Department of Veterans Affairs Clinical Sciences Research and Development Service, and by VA VISN17 Center of Excellence pilot funding. The contents of this manuscript do not represent the views of the US Department of Veterans Affairs or the United States Government.	Agoston D.V., 2015, BRAIN NEUROTRAUMA MO; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Bruce ML, 2010, ANN NY ACAD SCI, V1208, P98, DOI 10.1111/j.1749-6632.2010.05697.x; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; Cole W. R., 2016, TRANSLATIONAL RES TR; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Fair DA, 2018, BIORXIV; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox WC, 2013, NEUROL RES, V35, P223, DOI 10.1179/1743132813Y.0000000162; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganzetti M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00671; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gordon EM, 2018, J NEUROTRAUM, V35, P767, DOI 10.1089/neu.2017.5428; Gordon EM, 2017, NEURON, V95, P791, DOI 10.1016/j.neuron.2017.07.011; Gordon EM, 2017, CEREB CORTEX, V27, P386, DOI 10.1093/cercor/bhv239; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grydeland H, 2016, CEREB CORTEX, V26, P2402, DOI 10.1093/cercor/bhv065; Grydeland H, 2013, J NEUROSCI, V33, P18618, DOI 10.1523/JNEUROSCI.2811-13.2013; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Heidemann RM, 2012, NEUROIMAGE, V60, P967, DOI 10.1016/j.neuroimage.2011.12.081; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Hirsiger S, 2016, HUM BRAIN MAPP, V37, P855, DOI 10.1002/hbm.23067; Hopf A., 1951, J HIRNFORSCH, V1, P208; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Iwatani J, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.399; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Marcus D., 2011, FRONT NEUROINF, V5; Marek S, 2018, NEURON, V100, P977, DOI 10.1016/j.neuron.2018.10.010; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Michoux N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145497; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Nieuwenhuys R, 2017, BRAIN STRUCT FUNCT, V222, P465, DOI 10.1007/s00429-016-1228-7; Nieuwenhuys R, 2013, BRAIN STRUCT FUNCT, V218, P303, DOI 10.1007/s00429-012-0460-z; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Palomero-Gallagher N, 2019, NEUROIMAGE, V197, P716, DOI 10.1016/j.neuroimage.2017.08.035; Pearce JMS, 2008, EUR NEUROL, V59, P113, DOI 10.1159/000111872; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rathi Y, 2014, HUM BRAIN MAPP, V35, P3841, DOI 10.1002/hbm.22441; Righart R, 2017, ANN NEUROL, V82, P519, DOI 10.1002/ana.25020; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Segonne F, 2005, LECT NOTES COMPUT SC, V3565, P393; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shafee R, 2015, NEUROIMAGE, V105, P473, DOI 10.1016/j.neuroimage.2014.10.054; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Sigalovsky IS, 2006, NEUROIMAGE, V32, P1524, DOI 10.1016/j.neuroimage.2006.05.023; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Song AW, 2014, BRAIN CONNECT, V4, P636, DOI 10.1089/brain.2014.0270; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strauss Sara, 2015, Top Magn Reson Imaging, V24, P353, DOI 10.1097/RMR.0000000000000071; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Tsang A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00144; Ursano RJ, 2010, ANN NY ACAD SCI, V1208, P72, DOI 10.1111/j.1749-6632.2010.05721.x; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2008, J REHABIL RES DEV, V45, P347, DOI 10.1682/JRRD.2007.05.0077; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoshiura T, 2000, RADIOLOGY, V214, P217, DOI 10.1148/radiology.214.1.r00ja17217; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	121	1	1	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	OCT 15	2019	200						199	209		10.1016/j.neuroimage.2019.06.026			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IR6VU	WOS:000481579300016	31203023	Green Accepted			2022-02-06	
J	Li, HJ; Sun, ZL; Pan, YB; Xu, MH; Feng, DF				Li, Hong-Jiang; Sun, Zhao-Liang; Pan, Yuan-Bo; Xu, Mang-Hua; Feng, Dong-Fu			Effect of alpha 7nAChR on learning and memory dysfunction in a rat model of diffuse axonal injury	EXPERIMENTAL CELL RESEARCH			English	Article						Diffuse axonal injury; alpha 7nAChR; Learning and memory function; Rat	NICOTINIC ACETYLCHOLINE-RECEPTORS; POSITIVE ALLOSTERIC MODULATORS; LONG-TERM POTENTIATION; UP-REGULATION; AGONIST; BRAIN; HIPPOCAMPUS; ACTIVATION; CALCIUM; PATHOGENESIS	Diffuse axonal injury (DAI) is the predominant effect of severe traumatic brain injury and significantly contributes to cognitive deficits. The mechanisms that underlie these cognitive deficits are often associated with complex molecular alterations. alpha 7nAChR, one of the abundant and widespread nicotinic acetylcholine receptors (nAChRs) in the brain, plays important physiological functions in the central nervous system. However, the relationship between temporospatial alterations in the alpha 7nAChR and DAI-related learning and memory dysfunction are not completely understood. Our study detected temporospatial alterations of alpha 7nAChR in vulnerable areas (hippocampus, internal capsule, corpus callosum and brain stem) of DAI rats and evaluated the development and progression of learning and memory dysfunction via the Morris water maze (MWM). We determined that alpha 7nAChR expression in vulnerable areas was mainly reduced at the recovery of DAI in rats. Moreover, the escape latency of the injured group increased significantly and the percentages of the distance travelled and time spent in the target quadrant were significantly decreased after DAL Furthermore, alpha 7nAChR expression in the vulnerable area was significantly positively correlated with MWM performance after DAI according to regression analysis. In addition, we determined that a selective alpha 7nAChR agonist significantly improved learning and memory dysfunction. Rats in the alpha 7nAChR agonist group showed better learning and memory performance than those in the antagonist group. These results demonstrate that microstructural injuryinduced alterations of alpha 7nAChR in the vulnerable area are significantly correlated with learning and memory dysfunctions after DAI and that augmentation of the alpha 7nAChR level by its agonist contributes to the improvement of learning and memory function.	[Li, Hong-Jiang; Sun, Zhao-Liang; Pan, Yuan-Bo; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurosurg, Shanghai 201999, Peoples R China; [Li, Hong-Jiang; Sun, Zhao-Liang; Xu, Mang-Hua; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai 201999, Peoples R China		Feng, DF (corresponding author), 280 Mo He Rd, Shanghai 201999, Peoples R China.	drneuro@163.com		Pan, Yuan-Bo/0000-0002-4082-9898	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372047]	This work was supported by the National Natural Science Foundation of China (Grant Number: 81372047).	Abdulla FA, 1996, PSYCHOPHARMACOLOGY, V124, P323, DOI 10.1007/BF02247437; Arevalo-Serrano J, 2008, BRAIN RES BULL, V75, P533, DOI 10.1016/j.brainresbull.2007.09.003; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Christensen DZ, 2010, J NEUROCHEM, V114, P1205, DOI 10.1111/j.1471-4159.2010.06845.x; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; Ferrarelli F, 2011, SCHIZOPHRENIA BULL, V37, P306, DOI 10.1093/schbul/sbq142; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2008, J BIOL CHEM, V283, P693, DOI 10.1074/jbc.M707330200; Gentry CL, 2002, CNS NEUROL DISORD-DR, V1, P359, DOI 10.2174/1568007023339184; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Gu ZL, 2011, NEURON, V71, P155, DOI 10.1016/j.neuron.2011.04.026; Guo LL, 2011, ACTA PHARMACOL SIN, V32, P1446, DOI 10.1038/aps.2011.115; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hashimoto K, 2008, BIOL PSYCHIAT, V63, P92, DOI 10.1016/j.biopsych.2007.04.034; Hauser TA, 2009, BIOCHEM PHARMACOL, V78, P803, DOI 10.1016/j.bcp.2009.05.030; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANDEL ER, 1981, NATURE, V293, P697, DOI 10.1038/293697a0; Kong FJ, 2015, J SURG RES, V194, P255, DOI 10.1016/j.jss.2014.09.043; Lagali PS, 2010, CLIN GENET, V78, P321, DOI 10.1111/j.1399-0004.2010.01503.x; Lagostena L, 2008, NEUROPHARMACOLOGY, V54, P676, DOI 10.1016/j.neuropharm.2007.11.016; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Levin ED, 2002, CNS NEUROL DISORD-DR, V1, P423, DOI 10.2174/1568007023339102; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Liu P, 2017, NEUROSCIENCE, V366, P162, DOI 10.1016/j.neuroscience.2017.10.017; Lotfipour S, 2017, LEARN MEMORY, V24, P231, DOI 10.1101/lm.045369.117; Lukas RJ, 2001, EUR J NEUROSCI, V13, P1849, DOI 10.1046/j.0953-816x.2001.01560.x; Mannelli LD, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/396908; Mannelli LD, 2014, NEUROPHARMACOLOGY, V79, P37, DOI 10.1016/j.neuropharm.2013.10.034; Pacini A, 2010, PAIN, V150, P542, DOI 10.1016/j.pain.2010.06.014; Patel H, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0967-6; Qi XL, 2007, NEUROCHEM INT, V51, P377, DOI 10.1016/j.neuint.2007.04.002; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Schadl K, 2018, NEUROIMAGE-CLIN, V17, P667, DOI 10.1016/j.nicl.2017.11.023; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Stevens KE, 2010, BRAIN RES, V1352, P140, DOI 10.1016/j.brainres.2010.06.063; Sun ZL, 2014, J NEURAL TRANSM, V121, P79, DOI 10.1007/s00702-013-1078-x; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Taylor JG, 2000, BIOL CYBERN, V82, P415, DOI 10.1007/s004220050595; Thomsen MS, 2012, J NEUROCHEM, V123, P73, DOI 10.1111/j.1471-4159.2012.07876.x; Udakis M, 2016, NEUROPHARMACOLOGY, V105, P618, DOI 10.1016/j.neuropharm.2016.02.028; Vicens P, 2011, BEHAV BRAIN RES, V216, P341, DOI 10.1016/j.bbr.2010.08.015; Waring JF, 2008, NEUROSCI RES, V60, P266, DOI 10.1016/j.neures.2007.11.008; Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x; Zhang W, 2015, CENT EUR J IMMUNOL, V40, P35, DOI 10.5114/ceji.2015.50831	56	1	1	3	7	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	OCT 15	2019	383	2							111546	10.1016/j.yexcr.2019.111546			13	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	JA9BQ	WOS:000488145400006	31398352				2022-02-06	
J	Bernstein, JPK; Roye, S; Weitzner, D; Calamia, M				Bernstein, John P. K.; Roye, Scott; Weitzner, Daniel; Calamia, Matthew			Evaluating the construct validity of the King?Devick test in a psychological outpatient clinical sample	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Attention; cognition; information processing	KING-DEVICK TEST; EYE-MOVEMENTS; SPECIFICITY; SENSITIVITY; CONCUSSION; SYMPTOMS; UTILITY; SCORES	The King?Devick test (K?D) has demonstrated sensitivity as a screener measure of ocular motor and cognitive problems. Despite its empirical support in the assessment of patients with certain injuries and disorders (e.g., concussion, reading disorders), less is known about the construct validity of the K?D. This study examined this topic in an outpatient, diagnostically heterogeneous clinical sample. A total of 70 individuals seen for an outpatient psychoeducational evaluation completed the K?D in addition to measures of intellectual abilities, speeded reading ability, simple and sustained attention, and executive functioning. Pearson correlation coefficients revealed that poorer K?D performance was associated with poorer processing speed, speeded reading ability and response time to target stimuli (r = .26?.31, p?<?.05). K?D performance was unrelated to other intellectual abilities, other aspects of attention, or executive functioning (all p > .05). Results suggest that the K?D demonstrates good convergent and discriminant validity in a heterogeneous outpatient clinical sample including individuals with attention-deficit hyperactivity disorder, specific learning disorders, and a number of different depressive and anxiety disorders. Findings support its wider use as a measure of reading ability and processing speed in clinical contexts.	[Bernstein, John P. K.; Roye, Scott; Weitzner, Daniel; Calamia, Matthew] Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA		Bernstein, JPK (corresponding author), Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA.	jberns3@lsu.edu		Calamia, Matthew/0000-0002-7252-7181			Baner N, 2017, NEUROLOGY, V88; Bernstein JPK, 2017, SLEEP BIOL RHYTHMS, V15, P67, DOI 10.1007/s41105-016-0081-7; Bernstein JPK, 2015, ACTA NEUROPSYCHOL, V13, P229, DOI 10.5604/17307503.1172473; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2000, ARCH CLIN NEUROPSYCH, V15, P227, DOI 10.1016/S0887-6177(99)00014-1; Bracken B. A., 2005, CLIN ASSESSMENT ATTE; Conners KC., 2000, CONNERS CONTINUOUS P; Delis DC., 2001, DELIS KAPLAN EXECUTI; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2017, ALZ DIS ASSOC DIS, V31, P152, DOI 10.1097/WAD.0000000000000157; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Jehangir N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191005; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Mrazik M, 2019, J NEUROL SCI, V399, P140, DOI 10.1016/j.jns.2019.02.020; Protopapas A, 2007, COGNITIVE PSYCHOL, V54, P251, DOI 10.1016/j.cogpsych.2006.07.003; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Silverman WK, 2001, J AM ACAD CHILD PSY, V40, P937, DOI 10.1097/00004583-200108000-00016; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Walsh DV, 2016, J NEUROL SCI, V370, P305, DOI 10.1016/j.jns.2016.09.014; Wechsler D., 2008, WECHSLER ADULT INTEL, VVol. 22, P498; Wendling B. J., 2014, WOODCOCK JOHNSON 4 T	28	1	1	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 3	2021	28	5					627	632		10.1080/23279095.2019.1678159		OCT 2019	6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TZ3RO	WOS:000490443600001	31612728				2022-02-06	
J	Shen, CC; Jiang, JF				Shen, Cui-Cui; Jiang, Jin-Feng			Auricular Electroacupuncture for Late Posttraumatic Epilepsy after Severe Brain Injury: A Retrospective Study	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article							VAGUS NERVE-STIMULATION; GLASGOW COMA SCALE; HEAD-INJURY; SEIZURES; THERAPY	Background. Posttraumatic epilepsy (PTE) is a common complication of traumatic brain injury (TBI), which seriously affects patients' survival and recovery. Vagus nerve stimulation (VNS) is a nonpharmacological therapy for epilepsy. The auricular branch of the vagus nerve (ABVN) is the only peripheral branch and has antiepileptic effects, but the efficacy of ABVN stimulation as treatment of late PTE is uncertain. We retrospectively analyzed the clinical efficacy of ABVN stimulation by auricular electroacupuncture for the treatment of late PTE, and investigated the influence of sodium valproate and edaravone on the anti-PTE effects of auricular electroacupuncture. Method. Univariate and multivariate logistic regression analyses were used to investigate the relationship of age, cause of PTE, use of auricular electroacupuncture, sodium valproate, and edaravone with the incidence of late PTE. To compare the curative effects of auricular electroacupuncture, 89 cases of late PTE were divided into an auricular electroacupuncture and a control group according to whether they were treated with auricular electroacupuncture. We further analyzed the influence of sodium valproate and edaravone on the effects of the treatment of PTE with auricular electroacupuncture. Results. Among age, cause, use of auricular electroacupuncture, sodium valproate, and edaravone, the use of auricular electroacupuncture was associated with significantly reduced incidence of late PTE (P<0.05). Compared with the control group, there were more seizure-free cases in the auricular electroacupuncture group (P<0.01). The total effective rate of the auricular electroacupuncture group was 90%. The seizure-free rate among patients treated with auricular electroacupuncture was significantly reduced, regardless of the use of sodium valproate or edaravone (P<0.05). Conclusion. Auricular electroacupuncture can reduce the incidence of late PTE and is a safe and economical therapy for late PTE.	[Shen, Cui-Cui] Nanjing Med Univ, Affiliated Wuxi 2 Peoples Hosp, Dept Acupuncture & Moxibust, Wuxi 214000, Jiangsu, Peoples R China; [Jiang, Jin-Feng] Nanjing Univ Chinese Med, Sch Acupuncture & Chinese Tuina, Nanjing 210023, Jiangsu, Peoples R China		Jiang, JF (corresponding author), Nanjing Univ Chinese Med, Sch Acupuncture & Chinese Tuina, Nanjing 210023, Jiangsu, Peoples R China.	dr.acujf@njucm.edu.cn		Shen, Cui-Cui/0000-0002-2843-0366			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ben-Menachem E, 2001, J CLIN NEUROPHYSIOL, V18, P415, DOI 10.1097/00004691-200109000-00005; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Boon P, 2001, SEIZURE-EUR J EPILEP, V10, P448, DOI 10.1053/seiz.2001.0626; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cakmak Yusuf Ozgur, 2006, Acupunct Med, V24, P164; Choi Su Jung, 2013, J Epilepsy Res, V3, P16, DOI 10.14581/jer.13003; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; De Taeye L, 2014, NEUROTHERAPEUTICS, V11, P612, DOI 10.1007/s13311-014-0272-3; Du YR, 2019, BMC PHARMACOL TOXICO, V20, DOI 10.1186/s40360-019-0285-y; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; Frangos E, 2015, BRAIN STIMUL, V8, P624, DOI 10.1016/j.brs.2014.11.018; Granata T, 2011, EPILEPSIA, V52, P5, DOI 10.1111/j.1528-1167.2011.03029.x; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786839; He W, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-85; He W, 2013, EPILEPSY BEHAV, V28, P343, DOI 10.1016/j.yebeh.2013.02.001; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/615476; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Horn CC, 2019, PHYSIOLOGY, V34, P150, DOI 10.1152/physiol.00030.2018; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mee H, 2019, ACTA NEUROCHIR, V161, P457, DOI 10.1007/s00701-018-3683-9; Mendonca GS, 2019, ARQ NEURO-PSIQUIAT, V77, P373, DOI [10.1590/0004-282x20190068, 10.1590/0004-282X20190068]; Nogier P., 1981, AURICULOTHERAPY AURI; Ogbonnaya Sunny, 2013, J Nat Sci Biol Med, V4, P8, DOI 10.4103/0976-9668.107254; Peuker ET, 2002, CLIN ANAT, V15, P35, DOI 10.1002/ca.1089; Rong PJ, 2014, CHINESE MED J-PEKING, V127, P300, DOI 10.3760/cma.j.issn.0366-6999.20131511; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Stefan H, 2012, EPILEPSIA, V53, pe115, DOI 10.1111/j.1528-1167.2012.03492.x; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; ZABARA J, 1985, ELECTROEN CLIN NEURO, V61, pS162, DOI 10.1016/0013-4694(85)90626-1; Zhang M, 2019, EXP THER MED, V18, P467, DOI 10.3892/etm.2019.7632	39	1	2	1	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.	OCT 13	2019	2019								5798912	10.1155/2019/5798912			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	JH9OI	WOS:000493097400002	31737082	Green Published, gold			2022-02-06	
J	Ferraracci, J; Anzalone, C; Bridges, RM; Moore, RD; Decker, SL				Ferraracci, Joseph; Anzalone, Christopher; Bridges, Rachel M.; Moore, R. Davis; Decker, Scott L.			QEEG correlates of cognitive processing speed in children and adolescents with traumatic brain injuries	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Assessment; child assessment; processing speed; quantitative electroencephalography; traumatic brain injury; Woodcock Johnson	WORKING-MEMORY; BAND OSCILLATIONS; VERBAL FLUENCY; MILD; EEG; ATTENTION; OUTCOMES; REHABILITATION; EPIDEMIOLOGY; CONCUSSION	Both quantitative electroencephalography (qEEG) and cognitive measures have been used to understand the underlying brain changes that occur in individuals after experiencing a traumatic brain injury, however, research exploring the relationship between qEEG patterns and cognitive test performance is scarcely studied in school-aged populations. The purpose of the present study was to explore first, the neuropsychological and academic deficits in young individuals with TBI; and second, the underlying relationship between qEEG patterns and cognitive test performance. Analyses included 21 school-aged participants whom have experienced a recent TBI and 15 school-aged participants whom have never experienced a TBI. Mean subtest and composite scores were compared and regression analyses were used to determine whether alpha band and beta band qEEG coherence values predicted processing speed measures. Results suggest that young individuals who experienced a recent TBI exhibit general deficits in cognition and academic skills beyond what would be expected in the general population. Further, beta band coherence with the frontal brain regions significantly predicted processing speed scores, providing evidence of a relationship between qEEG patterns and processing speed. This outlines a relatively inexpensive method for utilizing neural connectivity to verify cognitive deficits for school-aged individuals with a recent TBI.	[Ferraracci, Joseph; Anzalone, Christopher; Bridges, Rachel M.; Decker, Scott L.] Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA; [Moore, R. Davis] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA		Anzalone, C (corresponding author), Univ South Carolina, Barnwell Coll, Dept Psychol, 1512 Pendleton St,Suite 220, Columbia, SC 29208 USA.	anzalonc@email.sc.edu					Abu-Hamour B, 2012, PROCD SOC BEHV, V47, P665, DOI 10.1016/j.sbspro.2012.06.714; Allen DN, 2010, PSYCHOL ASSESSMENT, V22, P57, DOI 10.1037/a0016056; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell MA, 2012, J COGN DEV, V13, P281, DOI 10.1080/15248372.2012.691143; Blankenship AP, 2018, EXCEPTIONALITY, V26, P218, DOI 10.1080/09362835.2016.1238379; Bro R, 2014, ANAL METHODS-UK, V6, P2812, DOI 10.1039/c3ay41907j; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; De Luca R, 2018, NEUROPSYCHOL REHABIL, V28, P879, DOI 10.1080/09602011.2016.1211937; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; DZIUBAN CD, 1974, PSYCHOL BULL, V81, P358, DOI 10.1037/h0036316; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Elgamal SA, 2011, CAN GERIATR J, V14, P66, DOI 10.5770/cgj.v14i3.17; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Flanagan D., 2007, ESSENTIALS CROSS BAT, V2nd, P146; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Glang A, 2004, NEUROREHABILITATION, V19, P219; Gorsuch R.L., 1983, FACTOR ANAL; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P255, DOI 10.1080/09297049.2010.535654; Johansson B., 2009, BRAIN INJURY, V23, P13; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Johnstone J., 2003, Journal of Neurotherapy, V7, P31, DOI 10.1300/J184v07n03_02; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Lee TW, 2012, INTELLIGENCE, V40, P38, DOI 10.1016/j.intell.2011.11.001; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Lovell M. R., 2003, RECOVERY MILD CONCUS; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Novack T., 2011, MANAGEMENT BEHAV PRO; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Pituch K.A., 2016, APPL MULTIVARIATE ST APPL MULTIVARIATE ST; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schack B, 1999, INT J PSYCHOPHYSIOL, V31, P219, DOI 10.1016/S0167-8760(98)00052-X; Schrank F.A, 2014, WOODCOCK JOHNSON 4 T; Silberstein RB, 2004, BRAIN TOPOGR, V16, P249; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thatcher R. W., 2011, NEUROGUIDE VERSION 2; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; U.S. Department of Education Office of Special Education Programs, 39 ANN REP C IMPL IN; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vinogradov S, 2003, SCHIZOPHR RES, V59, P269, DOI 10.1016/S0920-9964(02)00200-1; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	63	1	1	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2021	10	3					247	257		10.1080/21622965.2019.1675523		OCT 2019	11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	TW4CZ	WOS:000490514100001	31613642				2022-02-06	
J	McIver, KG; Sankaran, GN; Lee, P; Bucherl, S; Leiva, N; Talavage, TM; Leverenz, L; Nauman, EA				McIver, Kevin G.; Sankaran, Goutham N.; Lee, Patrick; Bucherl, Sean; Leiva, Nicolas; Talavage, Thomas M.; Leverenz, Larry; Nauman, Eric A.			Impact attenuation of male and female lacrosse helmets using a modal impulse hammer	JOURNAL OF BIOMECHANICS			English	Article						Helmet; Lacrosse; Impact	TRAUMATIC BRAIN-INJURY; MENS LACROSSE; HEAD IMPACTS; FOOTBALL	It has been established that substantial negative changes in neurocognitive function can be observed in a large percentage of athletes who participate in contact sports such as soccer or football, motivating a need for improved safety systems. Head accelerations in men's lacrosse are similar to those in football and female lacrosse players experience high rates of concussions, necessitating better head protection in both sports. Previous studies have sought to evaluate the ability of modern football helmets to mitigate impacts both normal and oblique to the surface of the helmet using a system that quantifies both the input load and the resulting accelerations of a Hybrid III headform. This study quantifies the inputs and outputs of the helmet-Hybrid III headform system in order to compare the impact attenuation capability of two male and two female lacrosse helmets. Of those helmets tested, the better performing male helmet was the Schutt Stallion 650 and the better performing female helmet was the Hummingbird excepting device failure at the rear boss impact location, but football helmets still generally outperformed the lacrosse helmets tested here. (C) 2019 Elsevier Ltd. All rights reserved.	[McIver, Kevin G.; Sankaran, Goutham N.; Lee, Patrick; Talavage, Thomas M.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA; [Bucherl, Sean; Leiva, Nicolas; Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Leverenz, Larry] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Nauman, EA (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	enauman@purdue.edu		Talavage, Thomas/0000-0003-4977-6398	Alfred P. Sloan foundation through the Sloan Indigenous Graduate PartnershipAlfred P. Sloan Foundation [G2017-9740]; Cordier family; Chickasaw Nation Education Services Department	The authors would like to thank the Alfred P. Sloan foundation through the Sloan Indigenous Graduate Partnership under grant G2017-9740, the Cordier family, and the Chickasaw Nation Education Services Department who provided support in the form of graduate scholarships.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; [Anonymous], 2015, F313715 ASTM; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barenblatt G.I., 1996, CALING SELF SIMILARI; BERTHON B, 2015, INJ EPIDEMIOL, V2, DOI DOI 10.1186/S40658-015-0116-1; Bowman TG, 2015, J BIOMECH, V48, P3782, DOI 10.1016/j.jbiomech.2015.08.026; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM, 2018, J BIOMECH, V79, P227, DOI 10.1016/j.jbiomech.2018.08.007; Breedlove KM, 2016, J BIOMECH, V49, P2838, DOI 10.1016/j.jbiomech.2016.06.030; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Cummiskey B, 2019, P I MECH ENG P-J SPO, V233, P301, DOI 10.1177/1754337118823603; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Lacrosse U, 2010, WHY WOMENS LACROSSE; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Newman J.A., 2007, MODERN SPORTS HELMET; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE, 2018, 04115M18 NOCSAE ND; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Smith S.S, 2017, 2018 2019 NCAA WOMEN; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vollavanh LR, 2018, J APPL BIOMECH, V34, P396, DOI 10.1123/jab.2017-0231	27	1	1	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	OCT 11	2019	95								109313	10.1016/j.jbiomech.2019.08.007			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	JK5OU	WOS:000494893500028	31495519				2022-02-06	
J	Stumph, J; Young, J; Singichetti, B; Yi, HG; Valasek, A; Bowman, E; MacDonald, J; Yang, JZ; Fischer, A				Stumph, Justin; Young, Julie; Singichetti, Bhavna; Yi, Honggang; Valasek, Amy; Bowman, Eric; MacDonald, James; Yang, Jingzhen; Fischer, Anastasia			Effect of Exercise Recommendation on Adolescents With Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						adolescents; concussion; children; pediatric; traumatic brain injury; rehabilitation	SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; PHYSICAL-ACTIVITY; SYMPTOM DURATION; SEX-DIFFERENCES; CHILDREN; STATEMENT; RECOVERY; ASSOCIATION; FITNESS	We examined the effect of a noncontact, subsymptom exacerbation early exercise recommendation on recovery from sports-related concussion. Retrospective analysis of adolescents, 10-17 years old, with symptomatic concussion, within 30 days of injury was performed. Time to recovery was measured between the early exercise group and a comparison group. A total of 187 patients studied-112 in the exercise group and 75 in the comparison group; 55% were male (n = 103). The exercise group had a significantly longer duration of concussion symptoms (18.5 days vs 14, P = .002), although both groups recovered within the expected time to recovery for concussion. When analyzed separately, males experienced longer time to recovery from injury (19 days vs 14, P = .003), than females, respectively (18 days vs 14.5, P = .18). Recommendation of early exercise resulted in significantly longer recovery from concussion in male adolescents but had no significant effect in female adolescents; both groups recovered within the expected time frame.	[Stumph, Justin] Cleveland Clin Hlth Syst, Dept Family Med, Cleveland, OH USA; [Young, Julie; Valasek, Amy; MacDonald, James; Fischer, Anastasia] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH USA; [Young, Julie] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Singichetti, Bhavna] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Yi, Honggang] Nanjing Med Univ, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Valasek, Amy; MacDonald, James; Yang, Jingzhen; Fischer, Anastasia] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Bowman, Eric] Phoenix Childrens Hosp, Orthoped Surg & Sports Med, Phoenix, AZ USA; [Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA		Fischer, A (corresponding author), Nationwide Childrens Hosp, Div Sports Med, 5680 Venture Dr, Dublin, OH 43017 USA.	Anastasia.Fischer@NationwideChildrens.org		Singichetti, Bhavna/0000-0002-2188-3979; MacDonald, James/0000-0002-0432-0808			Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	40	1	1	10	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	FEB	2020	35	2					95	101	0883073819877790	10.1177/0883073819877790		OCT 2019	7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	KC1IL	WOS:000491832100001	31599706				2022-02-06	
J	Abdulle, AE; van der Naalt, J				Abdulle, Amaal Eman; van der Naalt, Joukje			The role of mood, post-traumatic stress, post-concussive symptoms and coping on outcome after MTBI in elderly patients	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Mild traumatic brain injury; outcome; elderly; coping; mood; stress; complaints	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; EMERGENCY-DEPARTMENT VISITS; PSYCHOLOGICAL DISTRESS; UNITED-STATES; HEAD-INJURY; MILD; DEPRESSION; MORTALITY; PREDICTORS	Elderly patients are at increased risk for persistent complaints after mild traumatic brain injury (MTBI). This study aimed to investigate the role of post-concussive symptoms, mood, post-traumatic stress, and coping on functional outcome in elderly with MTBI. Information on mood, post-concussive symptoms, post-traumatic stress, and coping was collected 2?weeks post-injury. Six months post-injury functional outcome was assessed with the Glasgow Outcome Scale Extended. One hundred and sixty-two patients aged ? 60 years were included, 55% male, mean age?=?71 (?6.2) years. The most frequent cause of injury was falls from standing height (75%). Two weeks post-injury anxiety, depression, and post-traumatic stress were present in 15%, 12%, and 38% of patients, respectively, with 73% reporting post-concussive symptoms. Avoidant coping was the most frequently used coping style. Six months post-injury, 44% showed incomplete recovery. Higher depression scores (OR?=?0.87, p?=?0.005) and number of post-concussive symptoms (OR?=?0.91, p?=?0.03) were associated with incomplete recovery. Half of the elderly showed incomplete recovery 6?months after MTBI, with early depression or post-concussive symptoms as important factors. Coping style was not related to outcome. These results underline the need for a different approach in elderly patients, focusing on other predicting factors and fall prevention strategies.	[Abdulle, Amaal Eman; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol AB51, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Eman Abdulle, Amaal/0000-0003-3766-2238; van der Naalt, Joukje/0000-0001-9873-2418	Brain Foundation [PS2012-06]	This work was funded by Brain Foundation [PS2012-06].	Abdulle AE, 2018, J HEAD TRAUMA REHAB, V33, pE59, DOI 10.1097/HTR.0000000000000368; Aben L, 2008, J REHABIL MED, V40, P681, DOI 10.2340/16501977-0227; Chen YW, 2018, INT J AGING HUM DEV, V86, P347, DOI 10.1177/0091415017720890; Couture M, 2005, ARCH GERONTOL GERIAT, V41, P101, DOI 10.1016/j.archger.2004.12.004; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; O'Donnell ML, 2012, J TRAUMA STRESS, V25, P125, DOI 10.1002/jts.21677; Page RL, 2010, CLIN INTERV AGING, V5, P75; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; Wylie Glenn R, 2017, Concussion, V2, pCNC50, DOI 10.2217/cnc-2017-0003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	52	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		3	11		10.1080/09540261.2019.1664421		OCT 2019	9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000489988200001	31592690	hybrid, Green Published			2022-02-06	
J	Taylor, JE; Seebeck, RF				Taylor, Joanne E.; Seebeck, Renee F.			Preinjury Psychological Factors and Case Formulation in Mild Traumatic Brain Injury Rehabilitation: A Case Report	REHABILITATION COUNSELING BULLETIN			English	Article						mild traumatic brain injury; concussion; case formulation; rehabilitation	POST-CONCUSSION SYMPTOMS; COGNITIVE-BEHAVIORAL PREVENTION; POSTCONCUSSION SYNDROME; MISERABLE MINORITY; RISK-FACTORS; HEAD-INJURY; MODERATE; THERAPY; PROGNOSIS; OUTCOMES	Mild traumatic brain injury (TBI) accounts for the majority of TBIs. Most cases recover within 3 months and usual medical advice covers physical and cognitive rest, activity and fatigue management, and education. However, in some cases, symptoms can persist and there may be ongoing postconcussion difficulties. It is well established that pre- and postinjury psychological factors can contribute to cases of persistent postconcussion symptoms. However, there are few illustrative case examples in the published literature on mild TBI. This case example demonstrates the pivotal role that preinjury psychological factors can play in recovery from mild TBI, using an example of a 35-year-old woman with persistent mild TBI symptoms who had a limited response to previous brief treatment through a Concussion Clinic. Through the process of assessment and development of a psychological case formulation, preinjury psychological factors that had been barriers to recovery and prior rehabilitation efforts were identified. Rehabilitation counselors are equipped to (1) identify and address such barriers, (2) communicate this information to other rehabilitation professionals in the treatment team to facilitate a shared understanding of how factors might affect the client's functioning and (3) contribute to team case formulation.	[Taylor, Joanne E.; Seebeck, Renee F.] Massey Univ, Palmerston North, New Zealand		Taylor, JE (corresponding author), Massey Univ, Sch Psychol, Private Bag 11-222, Palmerston North 4474, New Zealand.	j.e.taylor@massey.ac.nz	Joanne, Taylor Elizabeth/I-8418-2019	Joanne, Taylor Elizabeth/0000-0001-8502-3452			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Barros-Bailey M, 2009, REHABIL COUNS BULL, V52, P107, DOI 10.1177/0034355208324262; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan F., 2004, DIRECTIONS REHABILIT, V15, P1; Chronister JA, 2008, J REHABIL, V74, P6; Commission on Rehabilitation Counselor Certification, 2017, COD PROF ETH REH COU; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eels T. D., 2007, HDB PSYCHOTHERAPY CA; Goodheart CD, 2006, EVIDENCE BASED PSYCH; Horn SD, 2012, ARCH PHYS MED REHAB, V93, pS127, DOI 10.1016/j.apmr.2011.10.031; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnstone L., 2013, FORMULATION PSYCHOL; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KAZDIN AE, 1981, J CONSULT CLIN PSYCH, V49, P183, DOI 10.1037/0022-006X.49.2.183; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Randolph C., 1998, REPEATABLE BATTERY A; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Tarvydas V. M., 2018, PROFESSIONAL PRACTIC, P1; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Weerasekera P, 1996, MULTIPERSPECTIVE CAS; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; [No title captured]	58	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.	APR	2020	63	3					156	167	0034355219878500	10.1177/0034355219878500		OCT 2019	12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	LA4EN	WOS:000489391300001					2022-02-06	
J	Brooks, BL; Plourde, V; Fay-McClymont, TB; MacAllister, WS; Sherman, EMS				Brooks, Brian L.; Plourde, Vickie; Fay-McClymont, Taryn B.; MacAllister, William S.; Sherman, Elisabeth M. S.			Factor structure of the CNS Vital Signs computerized cognitive battery in youth with neurological diagnoses	CHILD NEUROPSYCHOLOGY			English	Article						Psychometrics; computer test; children; factor structure; neurology	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; CHILDREN; ADOLESCENTS; VALIDITY; MEMORY	Computerized cognitive batteries, such as CNS Vital Signs (CNSVS), can provide valuable information in clinical and research settings. However, psychometric properties, especially in children and adolescents, remain relatively understudied. The aim of this study was to investigate the factor structure of CNSVS in children and adolescents with neurological diagnoses. Participants with neurological diagnoses (N = 280) age 7-19 years were assessed as part of their clinical care at a tertiary hospital. All participants received the full CNSVS computerized cognitive battery, which contains seven subtests designed to measure attention, executive functioning, psychomotor speed, and memory. Principal components analyses were used to examine factor structure. Scores from CNSVS subtests loaded onto a three-component solution and accounted for 46% of the variance. The three components were deemed to best represent (1) speed, (2) memory, and (3) inhibition, with subtest scores loading differently than the original 11 primary and secondary domain scores would have suggested. Although the CNSVS program generates numerous primary and secondary domain scores, a three-component solution represents a more parsimonious approach to interpreting performance on the CNSVS in youth with neurological diagnoses. Confirmation of this factor solution in other samples is warranted.	[Brooks, Brian L.; Fay-McClymont, Taryn B.; MacAllister, William S.] Alberta Childrens Prov Gen Hosp, Neuropsychol Serv, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.; Fay-McClymont, Taryn B.; MacAllister, William S.] Univ Calgary, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada; [Plourde, Vickie] Univ Alberta, Fac St Jean, Edmonton, AB, Canada; [Fay-McClymont, Taryn B.; MacAllister, William S.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Dept Brain Hlth Program, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca		Fay-McClymont, Taryn/0000-0002-2706-6179; Plourde, Vickie/0000-0002-0098-5431	Kinsmen Chair of Pediatric Neurosciences; ACHRI Neurotrauma Fund; ACH Neurosciences Program; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	The BrainChild database, which is the centralized digital storage system for all data collected in neuropsychological assessments, was supported by funding from the Kinsmen Chair of Pediatric Neurosciences, the ACHRI Neurotrauma Fund, and the ACH Neurosciences Program (Conny Betuzzi). Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award.	Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Baytunca MB, 2018, PSYCHIAT RES, V270, P967, DOI 10.1016/j.psychres.2018.03.038; Bozkurt H, 2017, APPL NEUROPSYCH-CHIL, V6, P262, DOI 10.1080/21622965.2016.1150184; Brooks BL, 2016, J NEUROTRAUM, V33, P2091, DOI 10.1089/neu.2015.4301; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P422, DOI 10.1093/arclin/acu029; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Delis DC, 2003, J INT NEUROPSYCH SOC, V9, P936, DOI 10.1017/S1355617703960139; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Fidell, 2001, USING MULTIVARIATE S; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; GORSUCH RL, 1990, MULTIVAR BEHAV RES, V25, P33, DOI 10.1207/s15327906mbr2501_3; Gualtieri C. T, 2015, FRONTIERS, V4, P11; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; IBM Corp, 2016, IBM SPSS STAT WIND V; Ozer S, 2017, CHILD NEUROPSYCHOL, V23, P332, DOI 10.1080/09297049.2015.1108397; Parsey CM, 2013, CLIN NEUROPSYCHOL, V27, P1328, DOI 10.1080/13854046.2013.834971; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Sattler J.M., 2001, ASSESSMENT CHILDREN; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Sherman EMS, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P873, DOI 10.1007/978-0-387-76978-3_30; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Triplett RL, 2015, PEDIATR NEUROL, V52, P49, DOI 10.1016/j.pediatrneurol.2014.09.020	31	1	1	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	OCT 3	2019	25	7					980	991		10.1080/09297049.2019.1569609			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IH6IC	WOS:000474597400006	30676266				2022-02-06	
J	Hood, EA; Klima, DW; Chui, KK; Avallone, NJ				Hood, Ethan A.; Klima, Dennis W.; Chui, Kevin K.; Avallone, Nicholas J.			Pre-season concussion assessment utilizing the King-Devick Test	RESEARCH IN SPORTS MEDICINE			English	Article						Sports related concussion; King-Devick	ASSOCIATIONS	This study?s objectives were to assess the test-retest reliability and concurrent validity of the King-Devick Test (KDT) during concussion screening and to analyze potential sport-specific differences in test performance across two sports. Two hundred and sixty-six high school male American football and soccer players recruited from four area high schools participated prior to the fall sports season. Main outcome measures included the KDT and Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). KDT performance demonstrated significant correlations with the ImPACT visual motor speed composite scores, reaction time, Cognitive Efficiency Index and age. Significant baseline differences were noted on the KDT between football and soccer players. The KDT demonstrates concurrent validity with three neurocognitive domains on the ImPACT. Significant differences in baseline King-Devick Test scores were found between football and soccer players and may be related to the neurocognitive demands of the sport.	[Hood, Ethan A.] DeSales Univ, Phys Therapy Program, 2755 Stn Ave,Chappuis Hall 14, Center Valley, PA 18034 USA; [Klima, Dennis W.] Univ Maryland Eastern Shore, Dept Phys Therapy, Princess Anne, MD USA; [Chui, Kevin K.] Pacific Univ, Sch Phys Therapy & Athlet Training, Forest Grove, OR USA; [Avallone, Nicholas J.] St Lukes Univ Hlth Network, Dept Orthopaed Surg, Phillipsburg, NJ USA		Hood, EA (corresponding author), DeSales Univ, Phys Therapy Program, 2755 Stn Ave,Chappuis Hall 14, Center Valley, PA 18034 USA.	Ethan.Hood@desales.edu		Hood, Ethan/0000-0002-2171-1413			Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Caine DJ, 2018, RES SPORTS MED, V26, P5, DOI 10.1080/15438627.2018.1434041; Cuff SC, 2019, RES SPORTS MED, V27, P11, DOI 10.1080/15438627.2018.1502186; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heick JD, 2017, INT J SPORTS PHYS TH, V12, P581; Hunter LE, 2018, RES SPORTS MED, V26, P390, DOI 10.1080/15438627.2018.1492396; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Leong D, 2018, J NEURO-OPHTHALMOL, V38, P285, DOI 10.1097/WNO.0000000000000572; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Tsushima WT, 2018, APPL NEUROPSYCH-CHIL, V7, P14, DOI 10.1080/21622965.2016.1220860; Valasek AE, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P21, DOI 10.1007/978-0-387-89545-1_3; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	23	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	OCT 2	2019	27	4					467	472		10.1080/15438627.2018.1535434			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JC2LI	WOS:000489108100003	30336690				2022-02-06	
J	Ajmera, S; Motiwala, M; Lingo, R; Khan, NR; Smith, LJ; Giles, K; Vaughn, B; Klimo, P				Ajmera, Sonia; Motiwala, Mustafa; Lingo, Ryan; Khan, Nickalus R.; Smith, Lydia J.; Giles, Kim; Vaughn, Brandy; Klimo, Paul, Jr.			Emergent and Urgent Craniotomies in Pediatric Patients: Resource Utilization and Cost Analysis	PEDIATRIC NEUROSURGERY			English	Article						Emergent; urgent craniotomy; Pediatric trauma; Costs; Resources	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; CARE; AFGHANISTAN; IRAQ; OPERATION; OUTCOMES; TIME	Background: Pediatric neurosurgeons are occasionally tasked with performing surgery expeditiously to preserve a child's neurologic faculties and life. Objective: This study examines the etiologies, outcomes, and costs for urgent or emergent craniotomies at a Level I Pediatric Trauma center over a 7-year time period. Methods: A retrospective review was conducted for each patient who underwent an emergent or urgent craniotomy within 24 hours of presentation between January 2010 and April 2017. Demographic, clinical, and surgical details were recorded for a total of 48 variables. Any readmission within 90 days was analyzed. Hospital charges for each admission and readmission were collected and adjusted for inflation to October 2018 values. Results: Among the 223 children who underwent urgent or emergent craniotomies, the majority were admitted for traumatic injuries (n = 163, 73.1%). The most common traumatic mechanism was fall (n = 51, 22.9%), and the most common non-traumatic cause was tumor (n = 21, 9.4%). Overall, craniotomies were typically performed for hematoma evacuation of one type or combination (n = 115, 51.6%) during off-peak times (n = 178, 79.8%). Seventy-seven (34.5%) subjects experienced 1 or more postoperative events, 22 of whom returned to the operating room. There were 13 (5.8%) and 33 (14.8%) readmissions within 30 days and 90 days of discharge, respectively. Non-trauma patients (compared with trauma patients) and polytrauma (compared with isolated head injury) had greater healthcare needs, resulting in higher charges. Conclusion: Most urgent or emergent pediatric craniotomies were performed for the treatment of traumatic injuries involving hematoma evacuation, but non-traumatic patients were more complex requiring greater resources.	[Ajmera, Sonia; Motiwala, Mustafa] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA; [Lingo, Ryan] Neurol & Spine Inst, Savannah, GA USA; [Khan, Nickalus R.; Klimo, Paul, Jr.] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Smith, Lydia J.; Giles, Kim; Vaughn, Brandy; Klimo, Paul, Jr.] Le Bonheur Childrens Hosp, Memphis, TN USA; [Klimo, Paul, Jr.] Semmes Murphey, 6325 Humphreys Blvd, Memphis, TN 38120 USA		Klimo, P (corresponding author), Semmes Murphey, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com		Khan, M.D., Nickalus/0000-0003-4099-089X	Jackson Fogelman Pediatric Neurosurgery Research Fund	The Jackson Fogelman Pediatric Neurosurgery Research Fund supported this project.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Bishop Naomi B, 2006, Curr Probl Pediatr Adolesc Health Care, V36, P318, DOI 10.1016/j.cppeds.2006.05.004; Borgman M, 2012, J TRAUMA ACUTE CARE, V73, pS509, DOI 10.1097/TA.0b013e318275477c; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Burnett MW, 2008, PEDIATRICS, V121, P261, DOI 10.1542/peds.2006-3666; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; De Vloo P, 2018, WORLD NEUROSURG, V114, pE546, DOI 10.1016/j.wneu.2018.03.032; Desgranges FP, 2014, CHILD NERV SYST, V30, P1393, DOI 10.1007/s00381-014-2417-4; Edwards MJ, 2014, J AM COLL SURGEONS, V218, P1018, DOI 10.1016/j.jamcollsurg.2013.12.050; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Klimo P, 2010, J NEUROSURG-PEDIATR, V6, P107, DOI 10.3171/2010.3.PEDS109; Linzey JR, 2018, NEUROSURGERY, V83, P501, DOI 10.1093/neuros/nyx485; Malmivaara K, 2011, EUR J NEUROL, V18, P656, DOI 10.1111/j.1468-1331.2010.03294.x; Martin JE, 2010, J NEUROSURG-PEDIATR, V6, P250, DOI 10.3171/2010.6.PEDS1031; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Mauer UM, 2017, J NEUROL SURG PART A, V78, P20, DOI 10.1055/s-0035-1567862; McCrory MC, 2014, PEDIATRICS, V134, pE1345, DOI 10.1542/peds.2014-1071; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Suarez EP, 2011, J TRAUMA, V71, P133, DOI 10.1097/TA.0b013e318211071f; Veshchev Igor, 2002, Med Sci Monit, V8, pCS98; von Lehe M, 2013, CHILD NERV SYST, V29, P781, DOI 10.1007/s00381-012-2006-3; Wright MC, 2006, QUAL SAF HEALTH CARE, V15, P258, DOI 10.1136/qshc.2005.017566	22	1	1	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	OCT	2019	54	5					301	309		10.1159/000501042			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JF4GF	WOS:000491345100002	31401624				2022-02-06	
J	Brodbeck, K; Nuspl, E; Ertelt-Delbridge, C; Graw, M; Peldschus, S; Schick, S				Brodbeck, K.; Nuspl, E.; Ertelt-Delbridge, C.; Graw, M.; Peldschus, S.; Schick, S.			Post-mortem immunohistochemical detection of diffuse axonal injury	RECHTSMEDIZIN			German	Article						DAI; Traumatic brain injury; Immunohistochemistry; beta-APP; Axonal bulbs	AMYLOID PRECURSOR PROTEIN; ACUTE SUBDURAL-HEMATOMA; BETA-APP; HEAD-INJURY; BRAIN; DAMAGE; ACCELERATION; DIAGNOSIS; MARKER	Background A potential neuropathological consequence of traumatic brain injury (TBI), which is mainly caused by traffic accidents in Germany, is diffuse axonal injury (DAI). Inertial forces induced by rapid head acceleration can result in stretching of nerve fibers in several regions of the brain. Due to the subsequent destruction of the axonal cytoskeleton, an accumulation of proteins that are transported along the axon, e.g. beta-amyloid precursor protein (beta-APP) can occur. The main objective of this study was the post-mortem detection of DAI by immunohistochemical staining of beta-APP. Material and methods Brain tissue was prospectively and retrospectively extracted from 26 traffic accident victims and 2 fall victims, whereby samples from several brain areas were histologically examined. Immunohistochemical staining was performed with antibodies against beta-APP and axonal injury due to trauma was distinguished from axonal injury due to hypoxia by the identification of two different beta-APP staining patterns. Results In 12 traffic accident victims and 1 fall victim DAI was detected, whereby injuries due to trauma and hypoxia could be differentiated based on the distribution of stained axons. Traumatic axonal injury was mainly found within the corpus callosum, the pons and the internal capsule. The survival time of the victims ranged from 5 &#x202f;h to 34.5 days. Severe head injuries were diagnosed in all 13 cases, whereby 10 victims died due to the TBI. Conclusion Immunohistochemical staining with antibodies against beta-APP proved to be a reliable method to diagnose DAI post-mortem and to distinguish traumatic from hypoxic axonal injury. In the future, the identification of DAI in different brain areas might provide important indications for the reconstruction of the circumstances of accidents.	[Brodbeck, K.; Nuspl, E.; Graw, M.; Peldschus, S.; Schick, S.] LMU, Inst Rechtsmed, Nussbaumstr 26, D-80336 Munich, Germany; [Ertelt-Delbridge, C.] Univ Klinikum Erlangen, Neuropathol Inst, Erlangen, Germany		Brodbeck, K (corresponding author), LMU, Inst Rechtsmed, Nussbaumstr 26, D-80336 Munich, Germany.	katrin.brodbeck@med.uni-muenchen.de					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; [Anonymous], 2018, WEBPR; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Gusmao SNS, 2003, ARQ NEURO-PSIQUIAT, V61, P746, DOI 10.1590/S0004-282X2003000500008; Hayashi T, 2015, INT J LEGAL MED, V129, P1085, DOI 10.1007/s00414-015-1245-8; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Hortobagyi T, 2008, ACNR, V8, P16; Hostiuc S, 2014, ROM J LEG MED, V22, P145, DOI 10.4323/rjlm.2014.145; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Niemeyer I, 2003, THESIS; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Nuspl E, 2017, THESIS; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Stubbe H, 2012, INTENSIVE MED UP2DAT, V8, P253; [No title captured]	26	1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	OCT	2019	29	5					400	406		10.1007/s00194-019-00339-2			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	JA4OY	WOS:000487809900004					2022-02-06	
J	Burke, DT; Bell, RB; Al-Adawi, S; Burke, DP				Burke, David T.; Bell, Regina B.; Al-Adawi, Samir; Burke, Daniel P.			The Effect of Body Mass Index on the Functional Prognosis of Traumatic Brain Injury Patients	PM&R			English	Article							INPATIENT REHABILITATION OUTCOMES; OBESITY; ASSOCIATION; MORTALITY; PARADOX; DISEASE; HEALTH; RISK	Background Although many studies have demonstrated that obesity is correlated with an increased risk of chronic disease, some have reported a paradox by which those in the higher weight categories actually recover better during hospitalization. This study was designed to determine whether this obesity paradox is also reflected in the recovery of patients with traumatic brain injury (TBI) undergoing care in a rehabilitation hospital. Objective To investigate the association between body mass index (BMI) and the functional progress of patients with TBI, admitted to a rehabilitation hospital. Design Retrospective cohort study. Methods The study included all patients admitted to the brain injury unit of a rehabilitation hospital over a 6-year period. The data used for this study included patient height and weight (measured on admission) and functional independence measurements (scored on admission and discharge). Main Outcome Measures Functional independence measure (FIM) change per day, BMI category. Results For the 444 patients admitted, the overall FIM efficiency did not differ significantly by BMI (P = .93). After adjusting for age and gender, overweight and obese patients had the lowest FIM efficiency (1.04 for both groups), followed by the underweight and normal weight groups (1.11 and 1.26, respectively). Conclusion This study demonstrated that higher BMI was not significantly correlated with the rate of functional recovery among patients admitted to a rehabilitation hospital for TBI. Level of Evidence III.	[Burke, David T.; Bell, Regina B.] Emory Univ, Sch Med, Dept Rehabil Med, 12 Execut Pk NE, Atlanta, GA 30329 USA; [Al-Adawi, Samir] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Al Khoud, Oman; [Burke, Daniel P.] Georgia State Univ, Dept Biol, Atlanta, GA USA		Burke, DT (corresponding author), Emory Univ, Sch Med, Dept Rehabil Med, 12 Execut Pk NE, Atlanta, GA 30329 USA.	dburke2@emory.edu	Al-Adawi, Samir/A-9663-2016	Al-Adawi, Samir/0000-0002-9858-5582			Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Burke DT, 2014, ARCH PHYS MED REHAB, V95, P1055, DOI 10.1016/j.apmr.2014.01.019; Burke DT, 2018, ISPRM 2018 PAR FRANC; Burke DT, 2018, JPO, V30, P202; Burke DT, 2018, J CARD PULM REHAB, V2, P1; Centers for Disease Control and Prevention, AD OB FACTS; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Centers for Disease Control and Prevention, TBI GET FACTS; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Jain NB, 2008, AM J PHYS MED REHAB, V87, P21, DOI 10.1097/PHM.0b013e31815e61af; Klein S, 2007, AM J CLIN NUTR, V85, P1197, DOI 10.1093/ajcn/85.5.1197; Lavie CJ, 2016, PROG CARDIOVASC DIS, V58, P537, DOI 10.1016/j.pcad.2016.01.008; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Le D, 2015, AM J PHYS MED REHAB, V94, P627, DOI 10.1097/PHM.0000000000000222; Liao CD, 2015, ARTHRIT CARE RES, V67, P799, DOI 10.1002/acr.22474; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Poirier Paul, 2002, Curr Atheroscler Rep, V4, P448, DOI 10.1007/s11883-002-0049-8; Reuser M, 2009, OBESITY, V17, P783, DOI 10.1038/oby.2008.640; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Stenson KW, 2011, ARCH PHYS MED REHAB, V92, P384, DOI 10.1016/j.apmr.2010.07.235; Stevens-Lapsley JE, 2010, J ARTHROPLASTY, V25, P1104, DOI 10.1016/j.arth.2009.08.009; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vincent HK, 2008, OBESITY, V16, P130, DOI 10.1038/oby.2007.10; Vincent HK, 2007, OBESITY, V15, P522, DOI 10.1038/oby.2007.551; World Health Organization, 2018, BOD MASS IND BMI	27	1	2	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2019	11	10					1045	1049		10.1002/pmrj.12091			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JB4BJ	WOS:000488500300001	30689301				2022-02-06	
J	Ciocca, M				Ciocca, Mario			Attention Deficit Hyperactivity Disorder in Athletes	CLINICS IN SPORTS MEDICINE			English	Article						Attention-deficit/hyperactivity disorder; Athletes; Stimulant medication; Side effects; Banned medication	DEFICIT/HYPERACTIVITY DISORDER; STIMULANT MEDICATION; PRESCRIPTION STIMULANTS; ADHD; CHILDREN; MISUSE; METHYLPHENIDATE; CONCUSSION; RISK; AMPHETAMINES	Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that manifests in difficulties with sustaining attention in tasks and/or hyperactivity/impulsivity. Prevalence rates vary and difficulties in objectively diagnosing ADHD may lead to overdiagnosis or underdiagnosis. Assessment should include a comprehensive evaluation, including history, physical, psychological evaluation, and questionnaires for ADHD. Stimulant medications are effective for treatment, but their use, side effects, and potential for misuse and abuse are a concern, particularly in athletes. Athletes and physicians also need to be aware of the governing body's drug policy for the sport.	[Ciocca, Mario] UNC Sports Med, James A Taylor Campus Hlth Serv, Orthopead & Internal Med, CB#7470, Chapel Hill, NC 27599 USA		Ciocca, M (corresponding author), UNC Sports Med, James A Taylor Campus Hlth Serv, Orthopead & Internal Med, CB#7470, Chapel Hill, NC 27599 USA.	ciocca@email.unc.edu					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2016, Drug Ther Bull, V54, P56, DOI 10.1136/dtb.2016.5.0402; Avois L, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2006.027557; Becker SP, 2016, J DEV BEHAV PEDIATR, V37, P395, DOI 10.1097/DBP.0000000000000285; Benson K, 2015, CLIN CHILD FAM PSYCH, V18, P50, DOI 10.1007/s10567-014-0177-z; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Castells X, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007813.pub3; CHANDLER JV, 1980, MED SCI SPORT EXER, V12, P65; Clemow DB, 2014, POSTGRAD MED, V126, P64, DOI 10.3810/pgm.2014.09.2801; Cortese S, 2018, LANCET PSYCHIAT, V5, P727, DOI 10.1016/S2215-0366(18)30269-4; De Crescenzo F, 2017, EVID-BASED MENT HEAL, V20, P4, DOI 10.1136/eb-2016-102415; DuPaul GJ, 2017, HDB DSM 5 DISORDERS, P399; Fairman KA, 2020, J ATTEN DISORD, V24, P10, DOI 10.1177/1087054716688534; Fredriksen M, 2013, EUR NEUROPSYCHOPHARM, V23, P508, DOI 10.1016/j.euroneuro.2012.07.016; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Gardner RM, 2017, PHYSICIAN SPORTSMED, V45, P1, DOI 10.1080/00913847.2017.1248221; Gibbs EL, 2016, J AM COLL HEALTH, V64, P300, DOI 10.1080/07448481.2016.1138477; Hennissen L, 2017, CNS DRUGS, V31, P199, DOI 10.1007/s40263-017-0410-7; Hickey G, 1999, SPORTS MED, V27, P11, DOI 10.2165/00007256-199927010-00002; Holmskov M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178187; Howard JT, 2017, J PEDIATR ORTHOPED, V37, P348, DOI 10.1097/BPO.0000000000000651; Hoza B, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0749-3; Iverson GL, 2016, J ATTEN DISORD; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kutcher JS, 2011, CURR SPORT MED REP, V10, P32, DOI 10.1249/JSR.0b013e3182091d79; Lakhan SE, 2012, BRAIN BEHAV, V2, P661, DOI 10.1002/brb3.78; Liddle DG, 2013, PRIMARY CARE, V40, P487, DOI 10.1016/j.pop.2013.02.009; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Liu H, 2019, EUR CHILD ADOLES PSY, V28, P1283, DOI 10.1007/s00787-018-1217-x; Manderino L, 2018, CLIN J SPORT MED, V28, P111, DOI 10.1097/JSM.0000000000000433; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Naguy A, 2016, PHARMACOLOGY, V98, P87, DOI 10.1159/000446441; Nazeer A, 2014, FRONT PUBLIC HEALTH, V2, P1; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Ng QX, 2017, COMPLEMENT THER MED, V34, P123, DOI 10.1016/j.ctim.2017.08.018; Perry BA, 2016, OSTEOPOROSIS INT, V27, P2223, DOI 10.1007/s00198-016-3547-1; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Punja S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009996.pub2; Reardon CL, 2016, PHYSICIAN SPORTSMED, V44, P397, DOI 10.1080/00913847.2016.1216719; Roelands B, 2008, MED SCI SPORT EXER, V40, P879, DOI 10.1249/MSS.0b013e3181659c4d; Savill NC, 2015, CNS DRUGS, V29, P131, DOI 10.1007/s40263-014-0224-9; Schermann H, 2018, AM J SPORT MED, V46, P728, DOI 10.1177/0363546517741705; Schneider BN, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0479-3; Stewman CG, 2018, SPORTS HEALTH, V10, P40, DOI 10.1177/1941738117742906; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Verbeeck W, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009504.pub2; Vrecko S, 2015, SOC SCI MED, V131, P297, DOI 10.1016/j.socscimed.2014.10.016; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; White S., 2014, TUES ADHD WADATUEC C; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654	51	1	1	1	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	OCT	2019	38	4					545	+		10.1016/j.csm.2019.05.004			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JB6MN	WOS:000488678300007	31472765				2022-02-06	
J	Davis, AL; Hochstadter, E; Daya, T; Kulkarni, AV; Wales, P; Stephens, D; Schuh, S				Davis, Adrienne L.; Hochstadter, Elana; Daya, Tahira; Kulkarni, Abhaya V.; Wales, Paul; Stephens, Derek; Schuh, Suzanne			The Base Deficit, International Normalized Ratio, and Glasgow Coma Scale (BIG) Score, and Functional Outcome at Hospital Discharge in Children With Traumatic Brain Injury*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						BIG score; brain death; Pediatric Cerebral Performance Category; prognosis; trauma-induced coagulopathy; traumatic brain injury	PEDIATRIC HEAD-INJURY; CLINICAL-TRIALS; PERFORMANCE CATEGORY; UNIQUE CHALLENGES; COAGULOPATHY; PREDICTOR; MORTALITY; REHABILITATION; BURDEN	Objectives: To examine the association of the base deficit, international normalized ratio, and Glasgow Coma Scale (BIG) score on emergency department arrival with functional dependence at hospital discharge (Pediatric Cerebral Performance Category >= 4) in pediatric multiple trauma patients with traumatic brain injury. Design: A retrospective cohort study of a pediatric trauma database from 2001 to 2018. Setting: Level 1 trauma program at a university-affiliated pediatric institution. Patients: Two to 17 years old children sustaining major blunt trauma including a traumatic brain injury and meeting trauma team activation criteria. Interventions: None. Measurements and Main Results: Two investigators, blinded to the BIG score, determined discharge Pediatric Cerebral Performance Category scores. The BIG score was measured on emergency department arrival. The 609 study patients were 9.7 +/- 4.4 years old with a median Injury Severity Score 22 (interquartile range, 12). One-hundred seventy-one of 609 (28%) had Pediatric Cerebral Performance Category greater than or equal to 4 (primary outcome). The BIG constituted a multivariable predictor of Pediatric Cerebral Performance Category greater than or equal to 4 (odds ratio, 2.39; 95% CI, 1.81-3.15) after adjustment for neurosurgery requirement (odds ratio, 2.83; 95% CI, 1.69-4.74), pupils fixed and dilated (odds ratio, 3.1; 95% CI, 1.49-6.38), and intubation at the scene or referral hospital (odds ratio, 2.82; 95% CI, 1.35-5.87) and other postulated predictors of poor outcome. The area under the BIG receiver operating characteristic curve was 0.87 (0.84-0.90). Using an optimal BIG cutoff less than or equal to 8, sensitivity and negative predictive value for functional dependence at discharge were 93% and 96%, respectively, compared with a sensitivity of 79% and negative predictive value of 91% with Glasgow Coma Scale less than or equal to 8. In children with Glasgow Coma Scale 3, the BIG score was associated with brain death (odds ratio, 2.13; 95% CI, 1.58-2.36). The BIG also predicted disposition to inpatient rehabilitation (odds ratio, 2.26; 95% CI, 2.17-2.35). Conclusions: The BIG score is a simple, rapidly obtainable severity of illness score that constitutes an independent predictor of functional dependence at hospital discharge in pediatric trauma patients with traumatic brain injury. The BIG score may benefit Trauma and Neurocritical care programs in identifying ideal candidates for traumatic brain injury trials within the therapeutic window of treatment.	[Davis, Adrienne L.; Hochstadter, Elana; Schuh, Suzanne] Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, Toronto, ON, Canada; [Davis, Adrienne L.; Kulkarni, Abhaya V.; Wales, Paul; Stephens, Derek; Schuh, Suzanne] Hosp Sick Children, Res Inst, Toronto, ON, Canada; [Daya, Tahira] Hosp Sick Children, Dept Pediat, Div Pediat Med, Toronto, ON, Canada; [Kulkarni, Abhaya V.] Hosp Sick Children, Dept Surg, Neurosurg, Toronto, ON, Canada; [Wales, Paul] Hosp Sick Children, Dept Surg, Div Gen & Thorac Surg, Toronto, ON, Canada		Davis, AL (corresponding author), Univ Toronto, Div Pediat Emergency Med, Dept Pediat, Hosp Sick Children, Toronto, ON, Canada.	adrienne.davis@sickkids.ca					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; BOLSTRIDGE J, 2019, CRIT CARE MED S1, V47, P876; Borgman MA, 2015, J PEDIATR-US, V167, P513, DOI 10.1016/j.jpeds.2015.06.039; Borgman MA, 2011, PEDIATRICS, V127, pE892, DOI 10.1542/peds.2010-2439; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Davis AL, 2015, J PEDIATR-US, V167, P593, DOI 10.1016/j.jpeds.2015.05.041; Duhaime AC, 2007, PEDIATR CRIT CARE ME, V8, P71, DOI 10.1097/01.PCC.0000253552.60687.AC; Elkon B, 2014, PEDIATR CRIT CARE ME, V15, P623, DOI 10.1097/PCC.0000000000000170; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; Gennarelli TA., 2008, ABBREVIATED INJURY S; Ghaffarpasand Fariborz, 2013, Bull Emerg Trauma, V1, P135; Grandjean-Blanchet C, 2018, CAN J EMERG MED, V20, P592, DOI 10.1017/cem.2017.379; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Hindy-Francois C, 2009, J TRAUMA, V67, P1272, DOI 10.1097/TA.0b013e31819db828; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marr A., 2004, CENTRAL NERVOUS SYST; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; Peiniger S, 2012, PEDIATR CRIT CARE ME, V13, P455, DOI 10.1097/PCC.0b013e31823893c5; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Randolph LC, 2002, J TRAUMA, V53, P838, DOI 10.1097/00005373-200211000-00006; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Slovis J, 2017, ANN EMERG MED, V70, pS88, DOI 10.1016/j.annemergmed.2017.07.441; Stanley RM, 2017, ACAD EMERG MED, V24, P31, DOI 10.1111/acem.13085; Stewart CL, 2013, J PEDIATR SURG, V48, P2106, DOI 10.1016/j.jpedsurg.2013.05.009; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	50	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2019	20	10					970	979		10.1097/PCC.0000000000002050			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	KF6PL	WOS:000509361600014	31246737				2022-02-06	
J	Fogarty, AE; Guay, CS; Simoneau, G; Colorado, BS; Segal, GR; Werner, JK; Ellenbogen, JM				Fogarty, Alexandra E.; Guay, Christian S.; Simoneau, Gabrielle; Colorado, Berdale S.; Segal, G. Ross; Werner, J. Kent, Jr.; Ellenbogen, Jeffrey M.			Head Motion Predicts Transient Loss of Consciousness in Human Head Trauma A Case-Control Study of Mixed Martial Artists	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Brain Injuries; Traumatic; Martial Arts; Facial Injuries; Consciousness	BRAIN-INJURY; CONCUSSION; IMPACT; ENCEPHALOPATHY; HEALTH; MODEL	Objective Concussion with transient loss of consciousness is a commonly observed but poorly understood phenomenon with mounting clinical significance. This study aimed to examine the relationship between head motion in varying planes and transient loss of consciousness in athletes with brain injuries. Study Design A case-control design was used. The Ultimate Fighting Championship database was screened for events ending with knockouts from 2013 to 2016. Time of strike, striking implement, strike location, and head motion were recorded for all knockout strikes (cases) and for a subset of nonknockout strikes (controls). Characteristics of winners and losers were compared using two-tailed t tests. Multivariate logistic regression was used to determine odds ratios for strike characteristics associated with transient loss of consciousness. The Kaplan-Meier estimate was used to describe the temporal distribution of knockouts. Results One hundred thirty-six fights were identified and 110 videos were included. Head motion in the axial plane was strongly associated with transient loss of consciousness (odds ratio, 45.3; 95% confidence interval, 20.8-98.6). Other predictors of transient loss of consciousness were head motion in sagittal and coronal planes, nonfist striking implements, and strikes to the mandible or maxilla. The Kaplan-Meier survival curve demonstrated a decreasing rate of knockouts through time. Conclusions Rotational head acceleration, particularly in the axial plane, is strongly associated with transient loss of consciousness.	[Fogarty, Alexandra E.; Colorado, Berdale S.] Washington Univ, Sch Med, Dept Neurol, Div Phys Med & Rehabil, St Louis, MO 63110 USA; [Guay, Christian S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Simoneau, Gabrielle] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Colorado, Berdale S.] Washington Univ, Sch Med, Dept Orthoped Surg, Div Phys Med & Rehabil, St Louis, MO USA; [Segal, G. Ross] Segal & Lyer Orthodont, Marlton, NJ USA; [Werner, J. Kent, Jr.; Ellenbogen, Jeffrey M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Werner, J. Kent, Jr.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ellenbogen, Jeffrey M.] Walter Reed Army Inst Res, Behav Biol Branch, Silver Spring, MD USA		Fogarty, AE (corresponding author), Washington Univ, PM&R Div, 4444 Forest Pk Ave, St Louis, MO 63110 USA.		Fogarty, Alexandra/AAW-9755-2020; Werner, Kent/AAN-8594-2020	Fogarty, Alexandra/0000-0002-6495-1978; Werner, Kent/0000-0001-9858-2931; Guay, Christian/0000-0001-6744-5248			Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cox DR, 1984, ANAL SURVIVAL DATA; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gennarelli T., 2003, ANN P ASS ADV AUTOMO, V47, P624; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Lawrence DW, 2014, CLIN J SPORT MED, V24, P397, DOI 10.1097/JSM.0000000000000047; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mhuircheartaigh RN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006007; Mufson EJ, 2018, J NEUROTRAUM, V35, P1260, DOI 10.1089/neu.2017.5368; O'Sullivan DM, 2017, J NEUROSURG-PEDIATR, V19, P662, DOI 10.3171/2017.1.PEDS16432; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Phipps HW, 2016, METHODS MOL BIOL, V1462, P61, DOI 10.1007/978-1-4939-3816-2_5; Prerau MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003866; R Core Team, 2014, R LANG ENV STAT COMP; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tarnal V, 2016, J NEUROSURG ANESTH, V28, P250, DOI 10.1097/ANA.0000000000000212; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240	30	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	2019	98	10					859	865		10.1097/PHM.0000000000001205			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KA6ZZ	WOS:000505947300010	31441834				2022-02-06	
J	Fox, A; Riska, K; Tseng, CL; McCarron, K; Satcher, S; Osinubi, O; Helmer, D				Fox, Apollonia; Riska, Kristal; Tseng, Chin-Lin; McCarron, Kelly; Satcher, Serena; Osinubi, Omowunmi; Helmer, Drew			Dizziness, Vertigo, and Mental Health Comorbidity in Gulf War Veterans	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						dizziness; Gulf War Illness; posttraumatic stress disorder; vertigo; veterans	POSTTRAUMATIC-STRESS-DISORDER; MULTISYMPTOM ILLNESS; SYMPTOMS; ANXIETY; PREVALENCE; DEPLOYMENT; INJURY; PTSD	Background: Gulf War Illness (GWI) is a chronic condition involving symptoms across multiple body systems. Previous research has implicated the vestibular system as a potential underlying factor in the symptoms experienced by veterans with GWI, due in part to exposure to potentially ototoxic chemicals and events. Purpose: To characterize the presence of vertigo and dizziness symptoms in a sample of veterans with GWI using validated self-report instruments, accounting for mental health comorbidities. Research Design: This is a case series, follow-up, prospective interview of clinical veterans; results presented are purely descriptive. Study Sample: Our sample of 50 veterans was a follow-up to a case series of clinical Gulf War veterans evaluated at the War Related Illness and Injury Study Center. Data Collection and Analysis: Veterans participated in a 70-min phone interview where the following questionnaires were administered: Vertigo Symptom Scale (VSS), Patient Health Questionnaire (depression scale), Patient Health Questionnaire (somatization scale), Beck Anxiety Inventory, Posttraumatic Stress Disorder (PTSD) Checklist, Defense and Veterans Brain Injury Center Traumatic Brain Injury Questionnaire, and GWI (Kansas) Questionnaire. We used descriptive (mean/median, standard deviation, interquartile range, and percentage) statistics to describe our sample and illuminate possible relationships between measures. Results: Our primary finding is a substantial report of vertigo symptoms in our sample, according to the VSS. Ninety percent of participants scored above the VSS threshold (>12), suggesting "severe dizziness." The most commonly endorsed symptom on the VSS was "headache or pressure in the head." Conclusions: We conclude that there is significant burden of vertigo symptoms in veterans with GWI, suggesting a need for objective tests of vestibular function in this population. Furthermore, the relationship between symptoms of vertigo and dizziness, vestibular function, and PTSD warrants further exploration using objective measures.	[Fox, Apollonia; Tseng, Chin-Lin; McCarron, Kelly; Satcher, Serena; Osinubi, Omowunmi; Helmer, Drew] New Jersey Hlth Care Syst, War Related Illness & Injury Study Ctr, E Orange, NJ USA; [Riska, Kristal] Duke Univ, Sch Med, Dept Surg, Div Head & Neck Surg & Communicat Sci, Durham, NC USA; [Helmer, Drew] Rutgers New Jersey Med Sch, Newark, NJ USA		Fox, A (corresponding author), Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA.	apolloniafox@gmail.com		Gruber-Fox, Apollonia/0000-0001-5018-0909			Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Beck AT, 1993, BECK ANXIETY INVENTO; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; Black DW, 2004, EPIDEMIOLOGY, V15, P135, DOI 10.1097/01.EDE.0000103188.18059.21; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Dhingra SS, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-11; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Fiedler N, 1996, REGUL TOXICOL PHARM, V24, pS129, DOI 10.1006/rtph.1996.0089; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Fong E, 2015, ARCH PHYS MED REHAB, V96, P357, DOI 10.1016/j.apmr.2014.09.017; Fox A, 2018, MIL MED, V183, pE179, DOI 10.1093/milmed/usx052; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Gwini SM, 2016, J OCCUP ENVIRON MED, V58, P659, DOI 10.1097/JOM.0000000000000755; Harricharan S, 2017, NEUROPSYCHOLOGIA, V106, P169, DOI 10.1016/j.neuropsychologia.2017.09.010; Herdman SJ, 2012, NEUROREHAB NEURAL RE, V26, P151, DOI 10.1177/1545968311407514; Hinz A, 2017, J PSYCHOSOM RES, V96, P27, DOI 10.1016/j.jpsychores.2016.12.017; Hsu PC, 2015, J VESTIBUL RES-EQUIL, V25, P177, DOI 10.3233/VES-150559; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kahraman SS, 2017, ACTA OTO-LARYNGOL, V137, P485, DOI 10.1080/00016489.2016.1247986; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; McAndrew LM, 2017, J PSYCHOSOM RES, V98, P98, DOI 10.1016/j.jpsychores.2017.05.001; McKenzie DP, 2015, J PSYCHOSOM RES, V79, P566, DOI 10.1016/j.jpsychores.2015.08.003; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Radziej K, 2015, J PSYCHOSOM RES, V79, P123, DOI 10.1016/j.jpsychores.2015.05.005; Roland PS, 2000, OTOLARYNG HEAD NECK, V122, P319, DOI 10.1016/S0194-5998(00)70041-6; Schneiderman AI, 2006, MIL MED, V171, P577, DOI 10.7205/MILMED.171.7.577; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Steele L, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-4; Storzbach D, 2000, PSYCHOSOM MED, V62, P726, DOI 10.1097/00006842-200009000-00017; Tigno TA, 2017, MED HYPOTHESES, V106, P44, DOI 10.1016/j.mehy.2017.06.027; Weidt S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-317; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079	35	1	1	1	1	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	OCT	2019	30	9					764	771		10.3766/jaaa.17122			8	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	JB2YE	WOS:000488423800004	30424834	Bronze			2022-02-06	
J	Khajanchi, MU; Kumar, V; Gerdin, LW; Soni, KD; Saha, ML; Roy, N; Waernberg, MG				Khajanchi, Monty Uttam; Kumar, Vineet; Gerdin, Ludvig Waernberg; Soni, Kapil Dev; Saha, Makhan Lal; Roy, Nobhojit; Waernberg, Martin Gerdin			Prevalence of a definitive airway in patients with severe traumatic brain injury received at four urban public university hospitals in India: a cohort study	INJURY PREVENTION			English	Article						traumatic brain injury; trauma systems; low-middle income country	PREHOSPITAL CARE; MORTALITY; BURDEN; EPIDEMIOLOGY; INTUBATION; GUIDELINES; OUTCOMES; DISEASE	Aim To estimate the proportion of patients arriving with a Glasgow Coma Scale (GCS) less than 9 who had a definitive airway placed prior to arrival. Methods We conducted a retrospective analysis of the data from a multicentre, prospective observational research project entitled Towards Improved Trauma Care Outcomes in India. Adults aged >= 18 years with an isolated traumatic brain injury (TBI) who were transferred from another hospital to the emergency department of the participating hospital with a GCS less than 9 were included. Our outcome was a definitive airway, defined as either intubation or surgical airway, placed prior to arrival at a participating centre. Results The total number of patients eligible for this study was 1499. The median age was 40 years and 84% were male. Road traffic injuries and falls comprised 88% of the causes of isolated TBI. The number of patients with GCS<9 who had a definitive airway placed before reaching the participating centres was 229. Thus, the proportion was 0.15 (95% CI 0.13 to 0.17). The proportions of patients with a definitive airway who arrived after 24 hours (19%) were approximately double the proportion of patients who arrived within 6 hours (10%) after injury to the definitive care centre. Conclusion The rates of definitive airway placement are poor in adults with an isolated TBI who have been transferred from another health facility to tertiary care centres in India.	[Khajanchi, Monty Uttam] Seth GS Med Coll & KEM Hosp, Dept Gen Surg, Mumbai 400012, Maharashtra, India; [Kumar, Vineet] Lokmanya Tilak Municipal Med Coll & Gen Hosp, Dept Gen Surg, Mumbai, Maharashtra, India; [Gerdin, Ludvig Waernberg; Waernberg, Martin Gerdin] Karolinska Inst, Dept Publ Hlth Sci, Solna, Sweden; [Soni, Kapil Dev] AIIMS ND, JPN Apex Trauma Ctr, Dept Crit & Intens Care, New Delhi, India; [Saha, Makhan Lal] Inst Postgrad Med Educ & Res, Dept Gen Surg, Pondicherry, India; [Roy, Nobhojit] Govt India, BARC Hosp, WHO Collaborating Ctr Res Surg Care Delivery LMIC, Surg Unit, Mumbai, Maharashtra, India; [Roy, Nobhojit] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia		Khajanchi, MU (corresponding author), Seth GS Med Coll & KEM Hosp, Dept Gen Surg, Mumbai 400012, Maharashtra, India.	monta32@gmail.com	Warnberg, Martin Gerdin/D-7482-2019	Warnberg, Martin Gerdin/0000-0001-6069-4794; Roy, Nobhojit/0000-0003-2022-7416; Khajanchi, Monty/0000-0002-0898-6391; Soni, Kapil Dev/0000-0003-1214-4119	Swedish National Board of Health and Welfare; Laerdal Foundation	The data collection was funded by the Swedish National Board of Health and Welfare and the Laerdal Foundation. There is no funding to report on this submission.	Atkin C, 2005, INJURY, V36, P1277, DOI 10.1016/j.injury.2005.05.011; Ayson M, 2011, BEST EVIDENCE REV AC, P1; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Douglas RJ, 2011, WORLD J EMERG MED, V2, P85, DOI 10.5847/wjem.j.1920-8642.2011.02.001; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; Gerdin M, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0079-0; Gerdin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105606; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joshipura M, 2006, WORLD J SURG, V30, P930, DOI 10.1007/s00268-005-0765-7; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; R Development Core Team, 2008, R LANG ENV STAT COMP; Ramanujam P, 2007, J Assoc Physicians India, V55, P491; Roy N, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2085-7; Roy N, 2016, WORLD J SURG, V40, P1299, DOI 10.1007/s00268-016-3452-y; Roy N, 2010, PREHOSP DISASTER MED, V25, P145, DOI 10.1017/S1049023X00007883; Shrivastava SR, 2014, J NEUROSCI RURAL PRA, V5, pS33, DOI 10.4103/0976-3147.145198; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Stevenson M, 2017, epiR: Tools for the Analysis of Epidemiological Data. R package version 0.9-87; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Tuma M, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/135986; Vandromme MJ, 2011, J TRAUMA, V71, P1615, DOI 10.1097/TA.0b013e31822a30a1; Yeboah D, 2014, WORLD J SURG, V38, P1707, DOI 10.1007/s00268-014-2452-z	34	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	OCT	2019	25	5					428	432		10.1136/injuryprev-2018-042826			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JC5IK	WOS:000489314800013	29866716				2022-02-06	
J	Kim, T; Jung, KY; Kim, K; Yoon, H; Hwang, SY; Shin, TG; Sim, MS; Jo, IJ; Cha, WC				Kim, Taerim; Jung, Kwang Yul; Kim, Kyunga; Yoon, Hee; Hwang, Sung Yeon; Shin, Tae Gun; Sim, Min Seob; Jo, Ik Joon; Cha, Won Chul			Protective effects of helmets on bicycle-related injuries in elderly individuals	INJURY PREVENTION			English	Article						injuries; bicycling; head protective devices; aged; protective factors	PHYSICAL-ACTIVITY; RISK; HEALTH; INTERVENTIONS; ACCIDENTS; MORTALITY; HEAD; AGE	Objective The increasing frequency of bicycle-related injuries is due to the growing elderly population and their increasing physical activity. This study aimed to compare the protective effects of helmets on bicycle-related injuries in elderly individuals compared with those in younger adults. Methods Data from the Korean emergency department-based Injury In-depth Surveillance database from eight emergency departments during 2011-2016 were retrospectively analysed. The subjects sustained injuries while riding bicycles. Cases with unknown clinical outcomes were excluded. Covariates included mechanism, place and time of injury. The primary outcome was traumatic brain injury (TBI) incidence, and the secondary outcomes were in-hospital mortality and severe trauma. The effects of helmets on these outcomes were analysed and differences in effects were determined using logistic regression analysis. Subsequently, the differences in the effects of helmets use between age groups were examined by using interaction analysis Results Of 7181 adults, 1253 were aged >65 years. The injury incidents showed a bimodal pattern with peaks around ages 20 and 50 years. Meanwhile, the helmet-wearing rate showed a unimodal pattern with its peak at age 35-40 years; it decreased consistently with age. By multivariate analysis, helmet-wearing was associated with a reduced TBI incidence (OR 0.76; 95% CI 0.57 to 0.99) and severe trauma (OR 0.78; 95% CI 0.65 to 0.93). The effects of helmets increased in elderly individuals (TBI (p=0.022) and severe trauma (p=0.024)). Conclusion The protective effects of helmets on bicycle-related injuries are greater for elderly individuals, thus reducing TBI incidence.	[Kim, Taerim; Jung, Kwang Yul; Yoon, Hee; Hwang, Sung Yeon; Shin, Tae Gun; Sim, Min Seob; Jo, Ik Joon; Cha, Won Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul 440746, South Korea; [Kim, Kyunga] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea		Cha, WC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Emergency Med, Seoul 440746, South Korea.	wc.cha@samsung.com					Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; Baranowski T, 1998, AM J PREV MED, V15, P266, DOI 10.1016/S0749-3797(98)00080-4; Bin Park Won, 2016, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V27, P522; Brubacher JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153742; Chong SL, 2017, ACCIDENT ANAL PREV, V100, P59, DOI 10.1016/j.aap.2017.01.005; Chou WT, 2014, PREV MED, V59, P68, DOI 10.1016/j.ypmed.2013.11.019; Cook PA, 2001, PUBLIC HEALTH, V115, P54, DOI 10.1016/S0033-3506(01)00414-0; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; de Rome L, 2014, ACCIDENT ANAL PREV, V73, P392, DOI 10.1016/j.aap.2014.09.022; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Fong MC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2304-2; Forbes AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185367; Gaudet L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2476-9; Hillman M, 1993, CYCLE HELMETS CASE; Kett P, 2016, J COMMUN HEALTH, V41, P1160, DOI 10.1007/s10900-016-0197-3; Kim J, 2009, ACAD EMERG MED, V16, P454, DOI 10.1111/j.1553-2712.2009.00412.x; Kim YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181362; Lima SM, 2012, J ORAL MAXIL SURG, V70, P577, DOI 10.1016/j.joms.2011.03.035; Lustenberger T, 2010, J TRAUMA, V69, P1120, DOI 10.1097/TA.0b013e3181d0f68b; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Olivier J, 2017, INT J EPIDEMIOL, V46, P372, DOI 10.1093/ije/dyw360; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Prasad GL, 2018, WORLD NEUROSURG, V111, pE221, DOI 10.1016/j.wneu.2017.12.034; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; Sallis JF, 1998, AM J PREV MED, V15, P379, DOI 10.1016/S0749-3797(98)00076-2; Shin H., 2013, BICYCLE TRANSPORT PO; Stewart AL, 1997, ANN BEHAV MED, V19, P353, DOI 10.1007/BF02895154; Stier R, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.30011; The Korea Transport Institute, 2015, REP CYCL INFR LOC GO; The Korea Transport Institute, 2012, KOTI BIC TRANSP NEWS; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; World Health Organization, 2007, GUID POP BAS APPR IN; World Health Organization, 2015, GLOB STAT REP ROAD S	39	1	1	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	OCT	2019	25	5					407	413		10.1136/injuryprev-2018-042942			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JC5IK	WOS:000489314800010	30291153				2022-02-06	
J	Leno-Colorado, D; Rodriguez-Rajo, P; Ensenat, A; Pena-Casanova, J; Garcia-Molina, A				Leno-Colorado, David; Rodriguez-Rajo, Pablo; Ensenat, Antonia; Pena-Casanova, Jordi; Garcia-Molina, Alberto			The effect of traumatic brain injury on social decision making	REVISTA DE NEUROLOGIA			Spanish	Article						Assessment; Neuropsychology; Social cognition; Social decision making; Traumatic brain injury	EMOTION RECOGNITION; SEX-DIFFERENCES; COGNITION; MIND; LANGUAGE; ABILITY; FUTURE; DAMAGE; TASK	Introduction. Patients with traumatic brain injury (TBI) can present difficulties in making decisions of a social nature. Such difficulties condition complicate their personal relationships. Aims. To assess social decision-making in a sample of patients with moderate and severe TBI, and to empirically contrast if, as Ochsner's social-emotional processing model proposes, the ability to recognize and respond to socio-affective stimuli is related to the ability to regulate sensitive responses to the context based on the proposed assessment tests. Subjects and methods. Twenty-one patients with a moderate and severe TBI (experimental group) matched by gender, age and years of education with 24 healthy subjects (control group). Social decision making was measured through the Social Decision Making Test (SDMT), and the ability to recognize and respond to socio-affective stimuli through the Pictures of Facial Affect (PoFA) test. Results. Statistically significant differences in the SDMT were obtained between the experimental group and the control group. Regarding PoFA, the performance of the control group was also significantly better than that of the experimental group. However, no relationship was observed between the performance in the SDMT and the PoFA for any of the groups. Conclusions. The SDMT seems to be a sensitive test to detect alterations in social decision making in patients with moderate or severe TBI. No relationship was observed between the results in the SDMT and the PoFA.	[Leno-Colorado, David; Rodriguez-Rajo, Pablo; Ensenat, Antonia; Garcia-Molina, Alberto] UAB, Inst Univ Neurorehabil, Inst Guttmann, Barcelona, Spain; [Leno-Colorado, David; Rodriguez-Rajo, Pablo; Ensenat, Antonia; Garcia-Molina, Alberto] Fundacio Inst Invest Ciencies Salut Germans Tria, Barcelona, Spain; [Rodriguez-Rajo, Pablo] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Pena-Casanova, Jordi] FIMIM, Grp Invest Neurol Conducta, Barcelona, Spain; [Pena-Casanova, Jordi] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Barcelona, Spain; [Pena-Casanova, Jordi] Hosp Mar, Secc Neurol Conducta & Demencias, Parc Salut Mar, Barcelona, Spain; [Garcia-Molina, Alberto] Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social, Santiago, Chile		Rodriguez-Rajo, P (corresponding author), Inst Univ Neurorehabil Guttmann UAB, Cami de Can Ruti S-N, E-08916 Barcelona, Spain.	prodriguez@guttmann.com					Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Adolphs Ralph, 2009, HDB NEUROSCIENCE BEH, V2, P923; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Alted López Emilio, 2009, Med. Intensiva, V33, P16; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barker LA, 2004, NEUROCASE, V10, P233, DOI 10.1080/13554790490495096; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Ekman P., 1976, PICTURES FACIAL AFFE; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Gagnon J, 2013, BEHAV SCI-BASEL, V3, P72, DOI 10.3390/bs3010072; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Kelly M, 2014, J CLIN EXP NEUROPSYC, V36, P897, DOI 10.1080/13803395.2014.955784; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kofler MJ, 2011, J ABNORM CHILD PSYCH, V39, P805, DOI 10.1007/s10802-011-9492-8; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Llewellyn DJ, 2008, AM J PSYCHOL, V121, P363, DOI 10.2307/20445472; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; PENA M, 2008, REVI ELECT INVESTIG, V6, P400; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rios-Lago M, 2004, REV NEUROLOGIA, V38, P366, DOI 10.33588/rn.3804.2003559; Roig-Fuste JM, 2001, PRUEBA CLASIFICACION; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Schmid M, 1996, REY AUDITORY VERBAL; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; TEASDALE G, 1974, LANCET, V2, P81; Thompson AE, 2014, COGNITION EMOTION, V28, P1164, DOI 10.1080/02699931.2013.875889; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Warrier V, 2017, ENCY PERSONALITY IND; Wechsler D., 1999, ESCALA INTELIGENCIA; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	50	1	1	2	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	OCT 1	2019	69	7					280	288		10.33588/rn.6907.2019097			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JB4MB	WOS:000488530400003	31559626				2022-02-06	
J	Lin, E; Ward, I; Lequerica, A; Jasey, N; Chiaravalloti, N				Lin, Emerald; Ward, Irene; Lequerica, Anthony; Jasey, Neil; Chiaravalloti, Nancy			Understanding the Level of Concussion Knowledge in High School Sports in New Jersey	PM&R			English	Article							INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ATHLETIC-TRAINERS; MANAGEMENT; LEGISLATION; EDUCATION; PLAYERS; COACHES; ZURICH	Background Coaches, athletic trainers (ATCs), and parents/guardians (parents) are important contributors to the proper identification and management of concussions in student-athletes. However, there are limited studies on the identification of concussion knowledge gaps that will help inform educational efforts and improve concussion outcomes in these groups. Objective To identify gaps and factors influencing concussion knowledge for high school athletics. Design Survey. Setting Public, private, and recreational leagues in New Jersey. Participants 41 coaches, 34 ATCs, and 65 parents of high school student-athletes. Methods A 17-item online survey examining concussion knowledge was distributed to coaches, ATCs, and parents. Analyses included ANOVA for between-group comparisons of continuous variables and Pearson's correlations for categorical data. Main Outcome Measurements Demographics, concussion knowledge, application of knowledge, access to educational materials, and confidence in the ability to identify concussions. Results Significant between-group differences were found for overall knowledge (F[2137] = 11.0, P < .001), factual knowledge (F[2137] = 8.7, P < .001), and application of knowledge (F[2137] = 3.5, P = .03), with parents scoring lower. Coaches, ATCs, and parents had gaps in factual knowledge of baseline testing scores and identification regarding symptom severity. More coaches (73.2%) and ATCs (97.1%) felt confident in concussion knowledge compared with parents (31.3%; P < .001). All groups thought mandatory education, new law, and guidelines were positive in promoting better care of student-athletes. Conclusions Knowledge gaps were identified in all groups. Educational programs for these groups should consider including targeted techniques, including vignettes, to illustrate application of concussion knowledge. Level of Evidence III.	[Lin, Emerald] Hosp Special Surg, Dept Physiatry, New York, NY 10021 USA; [Ward, Irene; Jasey, Neil] Kessler Inst Rehabil, Brain Injury Program, W Orange, NJ USA; [Lequerica, Anthony; Chiaravalloti, Nancy] Kessler Fdn, Ctr Traumat Brain Injury Rehabil Res, E Hanover, NJ USA		Lin, E (corresponding author), Hosp Special Surg, 535 East 70th St, New York, NY 10021 USA.	line@hss.edu		Chiaravalloti, Nancy/0000-0003-2943-7567			[Anonymous], 2012, WHAT IS CONCUSSION; [Anonymous], 2011, TAKE CONCUSSIONS OUT; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guo D, 2019, CLIN J SPORT MED, V29, P486, DOI 10.1097/JSM.0000000000000542; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Naftel KG, 2014, SOUTH MED J, V107, P418, DOI 10.14423/SMJ.0000000000000136; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511	24	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2019	11	10					1107	1114		10.1002/pmrj.12120			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	JB4BJ	WOS:000488500300009	30729709				2022-02-06	
J	Mucha, A; DeWitt, J; Greenspan, AI				Mucha, Anne; DeWitt, John; Greenspan, Arlene, I			The Centers for Disease Control and Prevention (CDC) Guideline on the Diagnosis and Management of Mild Traumatic Brain Injury Among Children: What Physical Therapists Need to Know	PHYSICAL THERAPY			English	Article							SPORT-RELATED CONCUSSION; VESTIBULAR REHABILITATION; ACTIVE REHABILITATION; ADOLESCENTS; DISORDERS; EXERCISE; RECOVER; REST; SLOW		[Mucha, Anne] Univ Pittsburgh, Med Ctr, Ctr Rehab Serv, 3200 South Water St, Pittsburgh, PA 15203 USA; [DeWitt, John] Ohio State Univ, Phys Therapy Dept, Columbus, OH 43210 USA; [Greenspan, Arlene, I] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Mucha, A (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Rehab Serv, 3200 South Water St, Pittsburgh, PA 15203 USA.	muchaa@upmc.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2005, Clin J Sport Med, V15, P48; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Zemek R, 2014, GUIDELINES DIAGNOSIN	30	1	1	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	OCT	2019	99	10					1278	1280		10.1093/ptj/pzz085			3	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	JP3LJ	WOS:000498168700003	31197370				2022-02-06	
J	Munivenkatappa, A; Devi, BI; Shukla, DP; Rajeswaran, J				Munivenkatappa, Ashok; Devi, Bhagavatula Indira; Shukla, Dhaval P.; Rajeswaran, Jamuna			Three-time point view of mild brain injuries' structural alteration and their association with cognitive domains	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Attention; Memory	CEREBELLAR ATROPHY; CINGULATE CORTEX; AXONAL INJURY; HEAD-INJURY; PERFORMANCE; ATTENTION; VOLUME; MRI	BACKGROUND: Mild traumatic brain injury (mTBI) accounts for 70-80% of total neurotrauma, majority among them manifest with cognitive deficits. Till date there are few/or no 3-time-point longitudinal studies that have evidenced brain volume changes. The current study has investigated volume changes at 3-time-points and their association with cognitive sequel. METHODS: Twenty-one mTBI patients with normal imaging and 15 GCS were recruited. Initially these patients were evaluated with magnetic resonance imaging (MRI) scan <= 36 hours and neuropsychological test (NPT) during 2-3 weeks after-injury. All the patients were available for follow-up for repeat MRI and NPT on 3-4 and 6-7 months. The imaging and test scores were analyzed using repeated measures of analysis (P<0.05). The brain volumes were correlated with respective test-scores using partial-correlation. RESULTS: Left frontal lobe (P<0.029) and thalamus (P=0.049) showed significant increase in mean volume overtime, whereas corpus callosum (mid-anterior [P=0.011] and central [P=0.04]) and left cerebellum (P=0.043) showed significant decrease in mean volume overtime. Clinically cognitive scores improved with time. Eventual improvements in attention and memory scores were positively associated with increase in cingulate gyrus volume. CONCLUSIONS: The 3-time-point longitudinal study illustrates brain areas that changes with time and their association with improving cognitive scores. The study provides hint about the pattern of natural recovery.	[Munivenkatappa, Ashok] Natl Inst Epidemiol ICMR, Chennai, Tamil Nadu, India; [Devi, Bhagavatula Indira; Shukla, Dhaval P.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Rajeswaran, Jamuna] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India.	drindiradb@gmail.com	Munivenkatappa, Ashok/ABA-5952-2021		Department of Science and Technology DSTDepartment of Science & Technology (India) [SR/CSI/44/2008]	The project was funded by Department of Science and Technology DST No: SR/CSI/44/2008, Project Title: Generatively in Cognitive networks.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GEFFEN GM, 1994, BRAIN INJURY, V8, P405, DOI 10.3109/02699059409150992; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Leclercq PD, 2001, J NEUROTRAUM, V18, P1, DOI 10.1089/089771501750055721; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matschke J, 2007, PEDIATR NEUROSURG, V43, P330, DOI 10.1159/000103317; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rao SL., NIMHANS NEUROPSYCHOL; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	25	1	1	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616	1827-1855		J NEUROSURG SCI	J. Neurosurg. Sci.	OCT	2019	63	5					525	530		10.23736/S0390-5616.16.03439-1			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JC5IL	WOS:000489314900006	25501008				2022-02-06	
J	Pantazopoulos, I; Kokkoris, S; Routsi, C				Pantazopoulos, Ioannis; Kokkoris, Stelios; Routsi, Christina			Tooth Aspiration in a Patient with Traumatic Brain Injury	TURKISH THORACIC JOURNAL			English	Article						Aspiration; bronchoscopy; tooth; traumatic brain injury	FIBEROPTIC BRONCHOSCOPY; FOREIGN-BODIES	Tooth aspiration is a rare issue in the course of patients with trauma and may remain undiagnosed for a long period, resulting in delayed complications, such as atelectasis and recurrent infections. Flexible bronchoscopy is considered the preferred primary procedure for the management of airway foreign bodies in adults. However, it may cause intracranial hypertension in trauma patients with concomitant head injuries. We herein report a case of a patient with traumatic brain injury who underwent tooth aspiration using flexible bronchoscopy, with continuous monitoring of intracranial pressure (ICP). The importance of a thorough review of radiographs and chest computed tomography for foreign body aspiration in trauma patients was highlighted, particularly in a maxillofacial trauma, as tooth aspiration may remain undiagnosed for extended periods. Moreover, the difficulty in maintaining the ICP within normal limits during bronchoscopy in patients with traumatic brain injury was reinstated, and the need for continuous monitoring of the cerebral hemodynamics and harmonization was emphasized, with recommendations for bronchoscopy via an endotracheal tube.	[Pantazopoulos, Ioannis; Kokkoris, Stelios; Routsi, Christina] Univ Athens, Evangelismos Hosp, Dept Crit Care & Pulm Serv 1, Med Sch, Athens, Greece		Pantazopoulos, I (corresponding author), Univ Athens, Evangelismos Hosp, Dept Crit Care & Pulm Serv 1, Med Sch, Athens, Greece.	pantazopoulosioannis@yahoo.com		PANTAZOPOULOS, IOANNIS/0000-0002-8846-519X			Ramos MB, 2016, J THORAC DIS, V8, P3452, DOI 10.21037/jtd.2016.11.32; Casap N, 2011, J ORAL MAXIL SURG, V69, P1421, DOI 10.1016/j.joms.2010.05.076; Estella Angel, 2012, BRONCHOSCOPY MECHANI; Kerwin AJ, 2000, J TRAUMA, V48, P878, DOI 10.1097/00005373-200005000-00011; Kim Dong Wook, 2014, Respir Care, V59, pe1, DOI 10.4187/respcare.02468; Kumar N, 2014, SAUDI J ANAESTH, V8, P276, DOI 10.4103/1658-354X.130747; PEERLESS JR, 1995, CHEST, V108, P962, DOI 10.1378/chest.108.4.962; Rodrigues AJ, 2012, J BRAS PNEUMOL, V38, P315, DOI 10.1590/S1806-37132012000300006; Sehgal IS, 2015, RESP CARE, V60, P1438, DOI 10.4187/respcare.03976; Stahl David L, 2015, Int J Crit Illn Inj Sci, V5, P189, DOI 10.4103/2229-5151.164995; Xiao WL, 2009, J CRANIOFAC SURG, V20, P558, DOI 10.1097/SCS.0b013e31819ba1fe; Zhang M, 2011, CRIT CARE, V15, DOI 10.1186/cc10148	12	1	1	0	0	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY		2149-2530		TURK THORAC J	Turk. Thorac. J.	OCT	2019	20	4					262	264		10.5152/TurkThoracJ.2019.180193			3	Respiratory System	Emerging Sources Citation Index (ESCI)	Respiratory System	KB9WP	WOS:000506838600010	31584389	gold, Green Published			2022-02-06	
J	Rexrode, BL; Armstrong, JL; Hallberg, CT; Copeland, BW; Bradney, DA; Bowman, TG				Rexrode, Briana L.; Armstrong, Jennifer L.; Hallberg, Christopher T.; Copeland, Benjamin W.; Bradney, Debbie A.; Bowman, Thomas G.			The effects of socioeconomic status on baseline neurocognitive testing scores	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						ImPACT; baseline modifier; mild traumatic brain injury; examination	SPORT-RELATED CONCUSSION; PERFORMANCE; SYMPTOMS; SEX	Baseline neurocognitive testing has been recommended to provide a more accurate representation of the pre-concussion cognitive status of individual athletes. Socioeconomic status is not typically controlled for when obtaining baseline scores, which may lead to inaccurate findings if post-injury scores are compared to normative data. Understanding the role of socioeconomic status in baseline testing is important for the accurate analysis of test scores and proper evaluation of patients if individualized baseline data are not available. Our purpose was to investigate the effects of socioeconomic status, as determined by eligibility for free or reduced cost lunch on baseline neurocognitive test scores in secondary school athletes. 1,788 secondary school athletes (females = 778, males = 1,010, age = 14.96???1.11?years, height = 171.25???17.83?cm, mass = 66.82???21.63?kg) completed the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) upon starting scholastic athletics. ImPACT components (symptom severity scores and composite scores of verbal memory, visual memory, visual motor speed, and reaction time) served as the dependent variables. School administration coded free or reduced cost lunch eligibility (N?=?1255 not eligible, N?=?563 eligible) for each participant (group), which served as the independent variable. Free or reduced cost lunch eligibility significantly altered the combined dependent variables (multivariate F-5,F-1780=14.41, p?<?.001, ?(2) = .04) when sex and age were controlled. Follow up ANOVAs showed that participants eligible for free or reduced cost lunch scored significantly worse on verbal memory (F-1,F-1784 = 24.81, p?<?.001, ?(2) = .01), visual memory (F-1,F-1784 = 24.90, p?<?.001, ?(2) = .01), and visual motor speed (F-1,F-1784 = 50.54, p?<?.001, ?(2) = .03). In addition, slower reaction times (F-1,F-1784 = 35.10, p?<?.001, ?(2) = .02) and higher symptom severity scores (F-1,F-1784 = 10.37, p?<?.01, ?(2) = .01) were observed in those eligible for free or reduced cost lunch. If normative data are used instead of individual baselines, potential modifiers such as socioeconomic status should be taken into account when analyzing concussion scores to provide accurate diagnoses.	[Rexrode, Briana L.; Bradney, Debbie A.; Bowman, Thomas G.] Univ Lynchburg, Coll Hlth Sci, Lynchburg, VA 24501 USA; [Armstrong, Jennifer L.; Hallberg, Christopher T.; Copeland, Benjamin W.] Lynchburg City Sch, Lynchburg, VA USA		Bowman, TG (corresponding author), Univ Lynchburg, Coll Hlth Sci, Lynchburg, VA 24501 USA.	bowman.t@lynchburg.edu	Bowman, Tom/AAU-6473-2020; Bowman, Thomas/AAA-3036-2020	Bowman, Thomas/0000-0002-0034-2946			Broglio S. P., 2014, J ATHL TRAINING, V39, P280; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cohen J, 1998, STAT POWER ANAL BEHA; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Darling-Hammond Linda., 2004, WEB DUBOIS REV SOCIA, V1, P213, DOI DOI 10.1017/S1742058X0404202X; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Herceg M., 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097270.211; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Hunt T, 2015, J HEAD TRAUMA REHAB, V30, pE105; Koehl LM, 2019, APPL NEUROPSYCH-CHIL, V8, P253, DOI 10.1080/21622965.2018.1436440; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lomax R.G., 2013, INTRO STAT CONCEPTS; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Noble KG, 2006, COGNITIVE DEV, V21, P349, DOI 10.1016/j.cogdev.2006.01.007; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Tomczyk C. P., 2018, THESIS; United States Department of Agriculture Food and Nutrition Service, 2019, SCH MEALS INC EL GUI; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700	30	1	1	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2021	10	3					234	239		10.1080/21622965.2019.1671842		OCT 2019	6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TW4CZ	WOS:000488673200001	31578879				2022-02-06	
J	Shao, XF; Wang, QF; Shen, J; Liu, JQ; Chen, SS; Jiang, XC				Shao, Xuefei; Wang, Qifu; Shen, Jun; Liu, Jiaqiang; Chen, Sansong; Jiang, Xiaochun			Treatment of Traumatic Depressed Compound Skull Fractures	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Dural tear; dural venous sinus thrombosis; post-operative cerebrospinal fluid leakage; surgery; traumatic comminuted skull fractures	SINUS THROMBOSIS; HEAD TRAUMA; MANAGEMENT	Background: A skull fracture widely occurs in patients with traumatic brain injury, leading to intracranial hematoma, brain contusion, and intracranial infection. It also influences the prognosis and death of patients. This study aimed to discuss cases of patients with comminuted skull fractures. Methods: From October 2015 to December 2018, 38 patients with comminuted skull fractures were admitted to the hospital. All patients underwent three-dimensional reconstruction of computed tomography scan images. Digital subtraction angiography or magnetic resonance venography was performed to find out the venous sinus. The clinical findings of the patients were significant regarding gender, age, injury mechanism, location, admission Glasgow Coma Scale (GCS), combined epidural, subdural, cerebral contusion, intracranial pneumatosis, maximum depth of depression, admission to surgery, dural tear, post-operative cerebrospinal fluid leakage, post-operative infection, and Glasgow Outcome Scale (GOS) 3 months after surgery. Results: The incidence of traffic accidents, fall from a height, railway accidents, fall of an object, and chop injury was 60.5%, 18.4%, 13.2%, 5.3%, and 2.6%, respectively. Intra-operative dural trar negatively correlated with epidural hematoma, cerebral contusion, and subdural hematoma. Also, post-operative infection negatively correlated with intracranial pneumatosis, depth of fracture depression, and pre-operative cerebrospinal fluid leakage. No correlation was found between contusion, subdural hematoma, intracranial pneumatosis, depth of fracture depression, and post-operative infection. The GOS score positively correlated with age, pre-operative cerebrospinal fluid leakage, and admission GCS score. Conclusions: A perfect pre-operative examination is a key to successful surgery. Further studies should be conducted to find out more effective treatments for traumatic comminuted skull fractures.	[Shao, Xuefei; Wang, Qifu; Shen, Jun; Liu, Jiaqiang; Chen, Sansong; Jiang, Xiaochun] Yi Ji Shan Hosp, Dept Neurosurg, Wannan Med Coll, Zheshan West Rd 2nd, Wuhu, Anhui, Peoples R China		Jiang, XC (corresponding author), Yi Ji Shan Hosp, Dept Neurosurg, Wannan Med Coll, Zheshan West Rd 2nd, Wuhu, Anhui, Peoples R China.	jiangxiaochun2001@hotmail.com			Wannan Medical College, Anhui Province, China [WK2017ZF04, 2018jyxm58]; Collegiate Major Natural Science Research Projects, Anhui Province, China [KJ2018ZD027, KJ2017A267]	This study was funded by the priority of research funds of Wannan Medical College (Grant No. WK2017ZF04), the teaching quality and teaching reform project ofWannan Medical College (Grant No. 2018jyxm58) and the Collegiate Major Natural Science Research Projects (Grant Nos. KJ2018ZD027 and KJ2017A267), Anhui Province, China.	Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Behera Sanjay K, 2015, Asian J Neurosurg, V10, P17, DOI 10.4103/1793-5482.151503; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Daligic A, 2008, TURK NEUROSURG, V18, P70; Donovan DJ, 2005, SURG NEUROL, V63, P380, DOI 10.1016/j.surneu.2004.06.020; Finnie JW, 2016, VET PATHOL, V53, P962, DOI 10.1177/0300985815612155; Gazzeri R, 2015, OPER NEUROSURG, V11, P32, DOI 10.1227/NEU.0000000000000614; Grangeon L, 2017, REV NEUROL-FRANCE, V173, P411, DOI 10.1016/j.neurol.2017.03.025; Kalavrezos N, 2004, INJURY, V35, P340, DOI 10.1016/S0020-1383(03)00095-0; Kim You-Sub, 2015, Korean J Neurotrauma, V11, P118, DOI 10.13004/kjnt.2015.11.2.118; Kumar Jayendra, 2017, Asian J Neurosurg, V12, P718, DOI 10.4103/1793-5482.215758; LeFeuvre D, 2004, SURG NEUROL, V62, P121, DOI 10.1016/j.surneu.2003.10.048; Li XW, 2013, J CRANIOFAC SURG, V24, P247, DOI 10.1097/SCS.0b013e3182701226; MEIROWSKY AM, 1953, J NEUROSURG, V10, P496, DOI 10.3171/jns.1953.10.5.0496; MILLER JD, 1968, LANCET, V2, P991; Mukherjee KK, 2015, ACTA NEUROCHIR, V157, P305, DOI 10.1007/s00701-014-2296-1; Nazari Pouya, 2016, Neurointervention, V11, P42, DOI 10.5469/neuroint.2016.11.1.42; Raschka C, 1994, Sportverletz Sportschaden, V8, P46, DOI 10.1055/s-2007-993453; Salia SM, 2018, WORLD NEUROSURG, V114, pE833, DOI 10.1016/j.wneu.2018.03.095; Sheng HS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007055; Wu H, 2016, EUR RADIOL, V26, P138, DOI 10.1007/s00330-015-3804-2	21	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2019	30	7					2239	2244		10.1097/SCS.0000000000005982			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JS5VN	WOS:000500374200123	31503116				2022-02-06	
J	Taylor, MK; Hernandez, LM; Stump, J; Tschiffely, AE; Goforth, CW; Laver, DC; Ahlers, ST				Taylor, Marcus K.; Hernandez, Lisa M.; Stump, Jeremy; Tschiffely, Anna E.; Goforth, Carl W.; Laver, D. Christine; Ahlers, Stephen T.			Blast exposure interacts with genetic variant 5HTTLPR to predict posttraumatic stress symptoms in military explosives personnel	PSYCHIATRY RESEARCH			English	Article						Blast exposure; Genetics; Posttraumatic stress	DISORDER	The first of its kind, this study determined whether blast exposure interacts with genetic variant 5HTTLPR to predict posttraumatic stress (PTS) symptoms in 78 military explosives operators. In all models, blast-exposed 5HTTLPR S carriers registered definitively higher PTS symptoms in comparison to non-exposed S carriers, as well as exposed and non-exposed LL carriers (all p < 0.01). All findings were robust to confounding influences of age and traumatic brain injury diagnosis. Not only is blast exposure prevalent in EOD personnel, but it also interacts with genetic predisposition to predict trauma symptoms in this unique, at-risk military population.	[Taylor, Marcus K.; Hernandez, Lisa M.; Stump, Jeremy; Laver, D. Christine] Naval Hlth Res Ctr, Warfighter Performance Dept, Biobehav Sci Lab, 140 Sylvester Rd, San Diego, CA 92106 USA; [Hernandez, Lisa M.; Stump, Jeremy; Laver, D. Christine] Leidos Inc, San Diego, CA USA; [Tschiffely, Anna E.; Goforth, Carl W.; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Operat & Undersea Med Directorate, Silver Spring, MD USA		Hernandez, LM (corresponding author), Naval Hlth Res Ctr, Warfighter Performance Dept, Biobehav Sci Lab, 140 Sylvester Rd, San Diego, CA 92106 USA.	lisa.m.hernandez75.ctr@mail.mil		Hernandez, Lisa/0000-0003-1410-0662	Congressionally Directed Medical Programs, Joint Program Committee 5 [N1909]	This work was supported by the Congressionally Directed Medical Programs, Joint Program Committee 5, under work unit no. N1909.	Armenta RF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1590-5; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Churchman CW, 1967, MANAGE SCI, V14, pB141, DOI DOI 10.1287/MNSC.14.4.B141; Cole WR., 2016, TRANSLATIONAL RES TR, DOI DOI 10.1201/B18959-20; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Deputy Secretary of Defense, 2010, 09033 DEP SECR DEF; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Leech N.L., 2005, SPSS INTERMEDIATE ST; Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Taylor MK, 2017, PSYCHIAT RES, V249, P304, DOI 10.1016/j.psychres.2017.01.002; Taylor MK, 2016, STEROIDS, V110, P41, DOI 10.1016/j.steroids.2016.04.001; Tschiffely AE, 2015, J NEUROSCI RES, V93, P1769, DOI 10.1002/jnr.23641; Wald I, 2013, JAMA PSYCHIAT, V70, P401, DOI 10.1001/2013.jamapsychiatry.188; Walter KH, 2018, J TRAUMA STRESS, V31, P837, DOI 10.1002/jts.22337; Way BM, 2010, BIOL PSYCHIAT, V67, P487, DOI 10.1016/j.biopsych.2009.10.021; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Zhao MZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15168-0	20	1	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	OCT	2019	280								112519	10.1016/j.psychres.2019.112519			3	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	JD5TV	WOS:000490046200025	31442670	Bronze			2022-02-06	
J	Toninato, J; Healy, T; Samadani, U; Christianson, E				Toninato, Joseph; Healy, Tim; Samadani, Uzma; Christianson, Eric			Injury Rate in TackleBar Football	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						football; injury; concussion; youth	HIGH-SCHOOL; CONCUSSION; EXERCISE; OUTCOMES; YOUTH	Background: As football comes under greater scrutiny because of concussions and other injuries, many people are searching for safer alternatives, especially for youth athletes. The injury rate in TackleBar football, one such alternative, is not currently known. Purpose: To describe TackleBar football and calculate its injury rate over a single season to compare it with both traditional tackle and flag football. Study Design: Descriptive epidemiology study. Methods: TackleBar football was described, and injuries of male athletes (age range, 9-14 years) participating in TackleBar football were tracked over the course of a season (August 5 through October 27, 2018) and compared with published injury rates for traditional tackle and flag football. Results: The overall injury rate of TackleBar football was found to be 0.31 per 1000 athlete-exposures (AEs), which is lower than youth tackle (2.25-2.60/1000 AEs) and flag (5.77/1000 AEs) football. Conclusion: TackleBar football may represent a reasonable alternative to tackle and flag football with regard to injuries.	[Toninato, Joseph; Healy, Tim; Samadani, Uzma; Christianson, Eric] Univ Minnesota, Dept Bioinformat & Computat Biol, Sch Engn, Neurotrauma Res Lab, Minneapolis, MN USA; [Toninato, Joseph] UnitedHlth Grp, Res & Dev, Minnetonka, MN USA; [Healy, Tim] TackleBar, Long Lake, MN USA; [Samadani, Uzma] Univ Minnesota, Sch Med, Dept Neurosurg, Minneapolis, MN 55455 USA; [Samadani, Uzma] Univ Minnesota, Bioinformat & Computat Biol Program, Coll Sci & Engn, Minneapolis, MN USA; [Samadani, Uzma] CentraCare Hlth, St Cloud, MN USA; [Samadani, Uzma] Minneapolis VA Med Ctr, Div Neurosurg, Minneapolis, MN USA; [Christianson, Eric] Univ Minnesota, Med Ctr, Emergency Serv, Minneapolis, MN 55455 USA		Toninato, J (corresponding author), 117 Pleast St SE, Minneapolis, MN 55455 USA.	toni0015@d.umn.edu			Integra LifeSciences	One or more of the authors has declared the following potential conflict of interest or source of funding: T.H. is the chief executive officer of TackleBar as well as a shareholder in the company. TackleBar itself holds a number of patents covering its intellectual property. U.S. has received research support from Integra LifeSciences; consulting fees from Medtronic; speaking fees from Integra LifeSciences, Medtronic, and Abbott Laboratories; and hospitality payments from Globus Medical, Mazor Robotics, Medtronic, Vertex Pharmaceuticals, DePuy Synthes, St Jude Medical, Surgical Theater, NuVasive, and LDR Spine USA. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Aspen Institute, WHAT FLAG BEC STAND; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Chung J, STAR TRIBUNE; Council on Sports Medicine and Fitness of the American Academy of Pediatrics, 2015, PEDIATRICS, V136, pe1419; Davis CL, 2012, JAMA-J AM MED ASSOC, V308, P1103, DOI 10.1001/2012.jama.10762; Diamond AB, 2015, CURR SPORT MED REP, V14, P320, DOI 10.1249/JSR.0000000000000169; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Ingul CB, 2010, ARCH PEDIAT ADOL MED, V164, P852, DOI 10.1001/archpediatrics.2010.158; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115603979; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Korioth T, AAP NEWS; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; National Federation of High School Associations, 2009 10 HIGH SCH ATH; National Federation of High School Associations, 2016 17 HIGH SCH ATH; Outdoor Industry Association, OUTD PART REP; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Stop Sports Injuries, PREV FOORB INJ	23	1	1	9	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT	2019	7	10							2325967119874065	10.1177/2325967119874065			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JE5DZ	WOS:000490713300001	31637268	gold, Green Published			2022-02-06	
J	Wang, YS; Hsieh, W; Chung, JR; Lan, TH; Wang, Y				Wang, Yu-Syuan; Hsieh, Wei; Chung, Jia-Ru; Lan, Tsuo-Hung; Wang, Yun			Repetitive mild traumatic brain injury alters diurnal locomotor activity and response to the light change in mice	SCIENTIFIC REPORTS			English	Article							SLEEP; CONCUSSION; MOUSE; EXPRESSION; DEFICITS; BLAST; NEUROINFLAMMATION; INDUCTION; SEVERITY; BEHAVIOR	Mild traumatic brain injury (mTBI) is a common cause of brain damage with a high incidence of multiple mTBIs found among athletes and soldiers. The purpose of this study is to examine the diurnal behavioral changes after multiple mTBIs. Adult mice were anesthetized; mTBI was conducted by dropping a 30-g weight to the right temporal skull once (mTBI1) or three times (mTBI3) over 3-week. Open-field motor behavior was recorded for 3 days after the last mTBI. In the first 4-hour exploratory phase, mTBI1 or mTBI3 equally reduced locomotor activity. A significant reduction of locomotor activity was found in the dark cycle between 4-72 hour in mTBI1 or mTBI3 mice; higher motor activity was seen after mTBI3 compared to mTBI1. In the light cycle, mTBI3 mice demonstrated an earlier immobilization followed by hyperactivity. The response to light change significantly correlated with the number of impacts. The IBA1 and BAX protein levels were equally increased in the lesioned cortex after mTBI1 and mTBI3. mTBI3 selectively upregulated the expression of circadian clock gene Per1 in hypothalamus and hippocampus as well as iNOS expression in the lesioned side cortex. Our data suggest multiple mTBIs alter diurnal locomotor activity and response to the change of light, which may involve Per1 expression in the lesioned brain.	[Wang, Yu-Syuan; Hsieh, Wei; Chung, Jia-Ru; Lan, Tsuo-Hung; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Lan, Tsuo-Hung] Taichung Veteran Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Lan, Tsuo-Hung] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei, Taiwan		Wang, Y (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan.	ywang@nhri.edu.tw		Lan, Tsuo-Hung/0000-0002-2796-1026	National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 105-2320-B-400-012-MY3]; Taichung Veteran General Hospital, Taiwan [TCVGH-NHRI10503]; Central Government S & T grant, Taiwan [108-1901-01-19-08]	This research was supported by National Health Research Institutes and Central Government S & T grant (108-1901-01-19-08), Taiwan; Ministry of Science and Technology, Taiwan (MOST 105-2320-B-400-012-MY3), and Taichung Veteran General Hospital, Taiwan (TCVGH-NHRI10503). The authors thank Dr. William Freed for his critical suggestions/comments and Ms. Yung-Yung Yang for statistical analysis.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Clark M., 2016, TRANSLATIONAL RES TR, P17; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eun B, 2011, NEUROSCI LETT, V498, P110, DOI 10.1016/j.neulet.2011.03.039; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Ives JC, 2007, J ATHL TRAINING, V42, P431; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Numano R, 2006, P NATL ACAD SCI USA, V103, P3716, DOI 10.1073/pnas.0600060103; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shen H, 2011, BRAIN RES, V1368, P248, DOI 10.1016/j.brainres.2010.10.014; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Umschweif G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076129; Valiyaveettil M, 2013, NEUROSCI LETT, V539, P1, DOI 10.1016/j.neulet.2013.01.028; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wang B, 2018, CEREBELLUM, V17, P477, DOI 10.1007/s12311-018-0934-5; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Yu SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04048-2; Zander NE, 2016, J NEUROSCI RES, V94, P827, DOI 10.1002/jnr.23786; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	46	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 1	2019	9								14067	10.1038/s41598-019-50513-5			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB3TD	WOS:000488478700047	31575951	Green Published, gold			2022-02-06	
J	Wszalek, JA; Turkstra, LS				Wszalek, Joseph A.; Turkstra, Lyn S.			Comprehension of Social-Legal Exchanges in Adults With and Without Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						social reasoning; cognition; law; traumatic brain injury	QUALITY-OF-LIFE; COMMUNICATION ABILITY; PERCEPTION; PATHOPHYSIOLOGY; IMPAIRMENTS; PREVALENCE; PSYCHOLOGY; INFERENCE; DEFICITS; SYSTEM	Objective: To characterize comprehension of conditional social-legal rules and broader social reasoning in adults with and without traumatic brain injury (TBI). Participants: Participants were 20 adults with moderate-to-severe TBI (11 women) and 21 adults without TBI (13 women), ages 24 to 64 years. Method: Participants completed the Wason task, a test of logical reasoning of conditional rules comprising precautionary rules, social-exchange rules, and legal social-exchange rules. Dependent variables were response accuracy and response time. Results: Across rule categories, TBI group participants were significantly less accurate, F(1, 39) = 9.03, p<.01, semipartial R-2 = 0.18, and slower, F(1, 39) = 7.32, p<.01, semipartial R-2 = 0.16, than comparison peers. Rule category had no effect on accuracy, but for both groups legal social-exchange rules were associated with longer response times, F(1, 78) = 9.82, p<.01, semipartial R-2 = 0.11. Processing speed test scores correlated with accuracy, F(1, 37) = 4.62, p<.05, semipartial R-2 = 0.11, and response times, F(1, 78) = 4.45, p<.05, semipartial R-2 = 0.14, in both groups. Conclusions: Adults with TBI underperformed their uninjured peers in both accuracy and speed of comprehending on precautionary rules, social-exchange rules, and legal social-exchange rules. These differences were attributable in part to differences in processing speed both within and between groups. Results highlight the potential costs of TBI-related cognitive problems in social-legal contexts, suggest the need to better accommodate individuals with TBI who are already involved in legal systems, and identify cognitive mechanisms for future study of social-legal rule comprehension in TBI and other populations with cognitive impairments.	[Wszalek, Joseph A.; Turkstra, Lyn S.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Wszalek, Joseph A.; Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA		Wszalek, JA (corresponding author), 5172 Signe Skott Cooper Hall,701 Highland Ave, Madison, WI 53706 USA.	josephwszalek@uwalumni.com	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research Grant [R01 HD071089]; Wisconsin Alumni Research Fund Award [MSN11770800]; Walker Fund	The authors have no conflicts of interest to report. This work was supported in part by National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research Grant R01 HD071089, the Wisconsin Alumni Research Fund Award MSN11770800, and the Walker Fund. The authors thank Erica Richmond, Annelise Albers, and the other members of the Cognition and Communication Lab for their assistance with data collection and management. The authors also thank the study participants, without whose efforts the study would not have been possible.	Abelson RP, 1997, PSYCHOL METHODS, V2, P315, DOI 10.1037/1082-989X.2.4.315; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; [Anonymous], 2014, R LANG ENV STAT COMP; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Barbey AK, 2011, WIRES COGN SCI, V2, P55, DOI 10.1002/wcs.84; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COSMIDES L, 1989, ETHOL SOCIOBIOL, V10, P51, DOI 10.1016/0162-3095(89)90013-7; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Cosmides L., 2005, EVOLUTIONARY PSYCHOL, P584; Cutmore TRH, 2015, INT J PSYCHOPHYSIOL, V98, P381, DOI 10.1016/j.ijpsycho.2015.07.004; Delis D.C., 2000, CALIFORNIA VERBAL LE; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Ermer E, 2010, PSYCHOL SCI, V21, P1399, DOI 10.1177/0956797610384148; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Fiddick L, 2005, NEUROIMAGE, V28, P778, DOI 10.1016/j.neuroimage.2005.05.033; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Johnson JE, 2012, BRAIN INJURY, V26, P1118, DOI 10.3109/02699052.2012.666370; Kertesz A., 2006, W APHASIA BATTERY RE; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2013, ADDICTION, V108, P566, DOI 10.1111/add.12040; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Schrank F. A., 2014, WOODCOCK JOHNSON IV; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snijder T. A. B., 1994, SOCIOLOGICAL METHODS, V22, P3442; Sullivan R., 2009, 21 ANN HUM BEH EV SO; Togher L., 1999, COMMUNICATION DISORD, P1; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Wechsler D., 2008, WECHSLER ADULT INTEL; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Westfall J, 2014, J EXP PSYCHOL GEN, V143, P2020, DOI 10.1037/xge0000014; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; WSZALEK JA, 2015, FORDHAM INT LAW J, V29, P102; Wszalek Joseph, 2017, AJOB Neurosci, V8, P26, DOI 10.1080/21507740.2017.1285821; Wszalek JA, 2015, J HEAD TRAUMA REHAB, V30, P86, DOI 10.1097/HTR.0000000000000130; Xiang T, 2013, J NEUROSCI, V33, P1099, DOI 10.1523/JNEUROSCI.1642-12.2013	51	1	1	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2019	33	7					934	946		10.1037/neu0000567			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JA7EA	WOS:000488003100003	31192655	Bronze			2022-02-06	
J	Xie, P; Deng, M; Sun, QG; Ma, YG; Zhou, Y; Ming, JH; Chen, Q; Liu, SQ; Liu, JQ; Cai, J; Wu, F				Xie, Ping; Deng, Ming; Sun, Qin-Guo; Ma, Yong-Gang; Zhou, Yan; Ming, Jiang-Hua; Chen, Qing; Liu, Shi-Qing; Liu, Jun-Qi; Cai, Jun; Wu, Fei			Therapeutic effect of transplantation of human bone marrow-derived mesenchymal stem cells on neuron regeneration in a rat model of middle cerebral artery occlusion	MOLECULAR MEDICINE REPORTS			English	Article						human bone marrow-derived mesenchymal stromal cells; neuron regeneration; transplantation; middle cerebral artery occlusion; neuronal function	TRAUMATIC BRAIN-INJURY; STROMAL CELLS; HIPPOCAMPAL NEUROGENESIS; NUCLEAR ANTIGEN; ISCHEMIA; DIFFERENTIATION; STROKE; MECHANISMS; EXPRESSION; MARKERS	Human bone marrow-derived mesenchymal stromal cells (hBMSCs) have been revealed to be beneficial for the regeneration of tissues and cells in several diseases. The present study aimed to elucidate the mechanisms underlying the effect of hBMSC transplantation on neuron regeneration in a rat model of middle cerebral artery occlusion (MCAO). The hBMSCs were isolated, cultured and identified. A rat model of MCAO was induced via the modified Longa method. Neurological severity scores (NSS) were adopted for the evaluation of neuronal function in the model rats after cell transplantation. Next, the expression levels of nestin, beta-III-tubulin (beta-III-Tub), glial fibrillary acidic protein (GFAP), HNA and neuronal nuclear antigen (NeuN) were examined, as well as the positive expression rates of human neutrophil alloantigen (HNA), nestin, NeuN, beta-III-Tub and GFAP. The NSS, as well as the mRNA and protein expression of nestin, decreased at the 1st, 2nd, 4 and 8th weeks, while the mRNA and protein expression of NeuN, beta-III-Tub and GFAP increased with time. In addition, after treatment, the MCAO rats showed decreased NSS and mRNA and protein expression of nestin, but elevated mRNA and protein expression of NeuN, beta-III-Tub and GFAP at the 2nd, 4 and 8th weeks, and decreased positive expression of HNA and nestin with enhanced expression of NeuN, beta-III-Tub and GFAP. Therefore, the present findings demonstrated that hBMSC transplantation triggered the formation of nerve cells and enhanced neuronal function in a rat model of MCAO.	[Xie, Ping; Sun, Qin-Guo] Wuhan Univ, Wuhan Hosp 3, Tongren Hosp, Dept Chinese Tradit Med, Wuhan 430060, Hubei, Peoples R China; [Deng, Ming; Ma, Yong-Gang; Zhou, Yan; Ming, Jiang-Hua; Chen, Qing; Liu, Shi-Qing; Wu, Fei] Wuhan Univ, Renmin Hosp, Dept Orthoped, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China; [Liu, Jun-Qi] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiat Oncol, Zhengzhou 45003, Henan, Peoples R China; [Cai, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Dept Emergency & Trauma Surg, Wuhan 430014, Hubei, Peoples R China		Deng, M (corresponding author), Wuhan Univ, Renmin Hosp, Dept Orthoped, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China.	dengming1983@whu.edu.cn			Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2042017kf0139]; Innovative Seed Funds of Medical College of Wuhan University [TFZZ2018027]; Natural Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [ZRMS2019000278]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301052]	The present study was supported by the Fundamental Research Funds for the Central Universities (grant no. 2042017kf0139), Innovative Seed Funds of Medical College of Wuhan University (grant no. TFZZ2018027), Natural Science Foundation of Hubei Province (grant no. ZRMS2019000278) and the National Natural Science Foundation of China (grant no. 81301052).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Becker L, 2009, GASTROENTEROLOGY, V136, P2055, DOI 10.1053/j.gastro.2009.04.022; Cha HK, 2014, J PHYS THER SCI, V26, P981, DOI 10.1589/jpts.26.981; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen LJ, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1105-9; Cho HY, 2013, CLIN REHABIL, V27, P675, DOI 10.1177/0269215512464702; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Garbossa D, 2012, NEUROSURG REV, V35, P293, DOI 10.1007/s10143-012-0385-2; Gibson CL, 2013, J CEREBR BLOOD F MET, V33, P1355, DOI 10.1038/jcbfm.2013.102; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; He XY, 2011, CYTOTHERAPY, V13, P46, DOI 10.3109/14653249.2010.510505; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Hou M, 2007, INT J CARDIOL, V115, P220, DOI 10.1016/j.ijcard.2006.03.028; Ishiwata T, 2011, WORLD J GASTROENTERO, V17, P409, DOI 10.3748/wjg.v17.i4.409; Fiore EJ, 2018, WORLD J GASTROENTERO, V24, P2427, DOI 10.3748/wjg.v24.i23.2427; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Kucia M, 2006, LEUKEMIA, V20, P18, DOI 10.1038/sj.leu.2404011; Kulkarni S, 2012, GUT, V61, P613, DOI 10.1136/gut.2010.235614; Lavezzi AM, 2013, J NEUROL SCI, V329, P45, DOI 10.1016/j.jns.2013.03.012; Lin R, 2015, STEM CELLS, V33, P3545, DOI 10.1002/stem.2197; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Maitland G D, 1985, Aust J Physiother, V31, P215, DOI 10.1016/S0004-9514(14)60634-6; Mathivanan I, 2015, EXP CELL RES, V333, P11, DOI 10.1016/j.yexcr.2015.02.001; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; McSweeney C, 2015, JOVE-J VIS EXP, DOI 10.3791/52653; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Metrot J, 2013, NEUROREHAB NEURAL RE, V27, P251, DOI 10.1177/1545968312461072; Oh SH, 2015, CELL TRANSPLANT, V24, P1097, DOI 10.3727/096368914X679237; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Segal-Gavish H, 2016, AUTISM RES, V9, P17, DOI 10.1002/aur.1530; Shafei AE, 2017, J GENE MED, V19, DOI 10.1002/jgm.2995; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100; Vital SA, 2016, JOVE-J VIS EXP, DOI 10.3791/54302; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Xu M, 2016, STEM CELL TRANSL MED, V5, P1171, DOI 10.5966/sctm.2015-0384; Yamasaki S, 2014, CARTILAGE, V5, P196, DOI 10.1177/1947603514534681; Zhang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080139	56	1	1	3	9	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2019	20	4					3065	3074		10.3892/mmr.2019.10536			10	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	JC3IA	WOS:000489171200010	31432152	Green Published, Green Submitted, hybrid			2022-02-06	
J	You, WD; Zhu, YR; Wen, L; Sun, Y; Pan, DS; Yang, XF				You, Wendong; Zhu, Yuanrun; Wen, Liang; Sun, Yun; Pan, Desheng; Yang, Xiaofeng			Risk Factors for Anterior Hypopituitarism in Patients With Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Hypopituitarism; intracranial hypertension; prevalence; risk factors; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; LONG-TERM; PREVALENCE; PREDICTORS; INSUFFICIENCY; TBI	Background: Hypopituitarism is a common but potentially undiagnosed complication in patients who suffer traumatic brain injury (TBI). The identification of risk factors of hypopituitarism after TBI is vital to establish a rational testing approach for these patients. Methods: The authors retrospectively reviewed the case records of patients with TBI, who underwent pituitary function evaluation in our department between January 2014 and December 2016. Results: In all, 193 patients (66.3% male) hospitalized with TBI were included in this study. Anterior hypopituitarism was observed in 33 (17.1%) patients, with 4.7% of the patients having multiple pituitary axes dysfunction. Patients with hypopituitarism had a longer length of ICU stay (8.7 +/- 5.5 versus 3.3 +/- 4.6, P < 0.001), longer length of total hospital stay (28.7 +/- 20.1 versus 21.0 +/- 15.8, P = 0.011), and lower Glasgow coma scale (GCS) on admission (9.1 +/- 3.5 versus 11.8 +/- 3.6, P < 0.001) than those without the condition. Length of ICU stay (P = 0.004, OR = 1.253) and intracranial hypertension (P = 0.027, OR = 3.206) were independent risk factors for posttraumatic hypopituitarism. Conclusions: The prevalence of anterior hypopituitarism was estimated to be 17.1%. Patients with intracranial hypertension and longer length of ICU stay are at risk of hypopituitarism. Routine pituitary function evaluation is indicated for this group of patients.	[You, Wendong; Zhu, Yuanrun; Wen, Liang; Pan, Desheng; Yang, Xiaofeng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Yun] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Rehabil Med, Hangzhou, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	zjcswk@zju.edu.cn					Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cheng P, 2017, TRENDS TRAUMATIC BRA, V14; Fernandez-Rodriguez Eva, 2011, Front Endocrinol (Lausanne), V2, P25, DOI 10.3389/fendo.2011.00025; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Karamouzis I, 2016, ENDOCRINE, V52, P441, DOI 10.1007/s12020-015-0796-2; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Tan CL, 2017, J NEUROL NEUROSUR PS, V88, P971, DOI 10.1136/jnnp-2016-315500; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, J CLIN MED, V4, P847, DOI 10.3390/jcm4050847; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092	32	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2019	30	7					2119	2123		10.1097/SCS.0000000000005405			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JS5VN	WOS:000500374200094	30950947				2022-02-06	
J	Zhou, B; Dong, BZ; Fu, HT; Yang, XL; Sun, ZG; Zhao, W; Huang, SM; Nie, HH; Chen, GH				Zhou, Bin; Dong, Baizhuo; Fu, Haitao; Yang, Xiaolong; Sun, Zhigang; Zhao, Wei; Huang, Shengming; Nie, Honghua; Chen, Guohui			The Clinical Application of Nerve Injury Unit Mode in Patients with Moderate or Severe Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Daily living ability; incidence of complications; nerve injury unit; satisfaction rate; traumatic brain injury	ADMISSION	Objective: To explore the efficacy of nerve injury unit mode and conventional management mode for the treatment of patients with moderate or severe traumatic brain injury (TBI). Methods: Eighty patients with TBI in our hospital from July 2016 to December 2017 were included as observation groups (Treated with injury unit mode). Eighty-three patients with TBI from January 2015 to June 2016 were included as control group (Treated with conventional management mode). The incidence of complications, satisfaction rate, Glasgow Coma Scale (GCS) scores, Barthel index (BI), National Institutes of Health Stroke Scale (NIHSS) scores and average length of hospital stay of 2 groups were compared. Results: Observation group achieved lower incidence of complications, higher satisfaction rate, higher GCS scores, higher GOS prognosis scores, higher BI, lower NIHSS scores, and shorter average length of hospital stay compared with control group (P < 0.05). There were no significant differences in the average hospitalization cost between 2 groups (P > 0.05). Conclusion: For patients with TBI, the nerve injury unit mode can reduce the incidence of complications, improve patient satisfaction rate, shorten the hospitalization time, enhance the daily living ability, improve the patient's neurological function, improve the ability to return to society and have a significant role in promoting the rehabilitation of patients.	[Zhou, Bin; Dong, Baizhuo; Yang, Xiaolong; Huang, Shengming; Nie, Honghua; Chen, Guohui] Eighth Hosp Baotou City, Dept Neurosurg, Baotou, Peoples R China; [Fu, Haitao; Zhao, Wei] Baotou Cent Hosp, Dept Neurosurg, 1 Huancheng Rd, Baotou 014040, Inner Mongolia, Peoples R China; [Sun, Zhigang] Inner Mongolia Baotou City Hlth & Hlth Comm, Baotou, Peoples R China		Fu, HT (corresponding author), Baotou Cent Hosp, Dept Neurosurg, 1 Huancheng Rd, Baotou 014040, Inner Mongolia, Peoples R China.; Yang, XL (corresponding author), Baotou Cent Hosp, Dept Neurosurg, 22 Nanmenwai St, Baotou 014040, Inner Mongolia, Peoples R China.	abc15540241243@163.com; 578919947@qq.com					Brott T, 2000, NEW ENGL J MED, V343, P710, DOI 10.1056/NEJM200009073431007; Brouwers HB, 2012, NEUROTHERAPEUTICS, V9, P87, DOI 10.1007/s13311-011-0091-8; [但炜 Dan Wei], 2003, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V28, P516; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Fu F, 2017, CHIN J NEUROTRAUMATI, V3, P57; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langhorne P, 2004, LANCET, V363, P834, DOI 10.1016/S0140-6736(04)15771-1; Li C, 2015, CHIN J MED MANAGE SC, P17; Liu L, 2018, CLIN RES PRACT, P51; MAHONEY F I, 1965, Md State Med J, V14, P61; Matsushima K, 2016, J SURG RES, V205, P186, DOI 10.1016/j.jss.2016.06.042; Plackett TP, 2016, AM J SURG, V211, P115, DOI 10.1016/j.amjsurg.2014.12.041; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Qudah F, 1998, Top Health Inf Manage, V19, P1; Rui J, 2017, CHINESE J ORG CHEM, V37, P218, DOI 10.6023/cjoc201606038; Scott Armstrong, 2010, Mod Healthc, V40, P22; Tang X, 2017, GUIDE CHINA MED, P105; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Walker CL, 2013, FRONT BIOL, V8, P245; Wang K, 2013, INTERV NEURORADIOL, V19, P43, DOI 10.1177/159101991301900106; Yang X, 2017, WORLD LATEST MED INF, P6; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zhang J., 2013, NATL MED FRONT CHINA; Zuo J, 2016, INT CONF SMART GR C, P226, DOI 10.1109/ICSGCE.2016.7876058	27	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2019	30	7					2102	2105		10.1097/SCS.0000000000005995			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JS5VN	WOS:000500374200090	31574784				2022-02-06	
J	Menickelli, J; Cooper, CA; Withnall, C; Wonnacottc, M				Menickelli, Justin; Cooper, Christopher A.; Withnall, Chris; Wonnacottc, Michael			Analysis and comparison of lateral head impacts using various golf discs and a Hybrid III head form.	SPORTS BIOMECHANICS			English	Article; Early Access						Injury; acceleration; severity index	FOOTBALL	The potential for head injuries from discs specifically designed for the sport of disc golf has increased as more disc golf courses are constructed in municipal parks where there is an inherent risk to park users of being struck by a golf disc. This study investigated the potential for head injury of various golf discs used in the sport of disc golf at 18 m/s (40?mph) and 27 m/s (60?mph) using a Hybrid III head form. A matrix of eight modern golf discs were tested to determine if velocity, mass, disc type, or flexibility has a significant effect on the potential for head injury as indicated by peak linear acceleration, peak angular acceleration, Head Injury Criteria (HIC) and Severity Index (SI) values. Regression analyses indicated peak linear acceleration, peak rotational acceleration, HIC, and SI varied by velocity, mass, type, and flexibility. The highest mean linear and rotational acceleration results, 38.5?g and 2512?rad/s(2) respectively, both associated with a less than 10% likelihood of sustaining a concussion. The findings should be of interest to both researchers and practitioners who seek to balance use and safety of public parks.	[Menickelli, Justin] Western Carolina Univ, Sch Teaching & Learning, Cullowhee, NC 28723 USA; [Cooper, Christopher A.] Western Carolina Univ, Dept Polit Sci & Publ Affairs, Cullowhee, NC 28723 USA; [Withnall, Chris; Wonnacottc, Michael] Biokinet & Associates Ltd, Ottawa, ON, Canada		Menickelli, J (corresponding author), Western Carolina Univ, Sch Teaching & Learning, Cullowhee, NC 28723 USA.	menickelli@email.wcu.edu	liu, ting/AAA-1112-2022		Professional Disc Golf Association	This work was supported by the Professional Disc Golf Association.	DiMasi F. P., 1995, HS808282 DOT US DEP; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pickens, 2016, DEFINITIVE GUIDE DIS; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Sasakawa K, 2008, SPORT BIOMECH, V7, P311, DOI 10.1080/14763140802270936; Viano D. C., 1993, CLIN J SPORT MED, P217, DOI [DOI 10.1097/00042752-199310000-00002, 10.1097/00042752-199310000-00002]; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Yang N. H., 2014, P ASME 2014 INT MECH, V6	10	1	1	1	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2019.1656769		SEP 2019	11	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	JC8ML	WOS:000489530600001	31573407				2022-02-06	
J	Espiridion, ED; Gupta, J; Bshara, A; Danssaert, Z				Espiridion, Eduardo D.; Gupta, Jayesh; Bshara, Andre; Danssaert, Zachary			Transient Global Amnesia in a 60-year-old female with Post-traumatic Stress Disorder	CUREUS			English	Article						transient global amnesia; transient ischemic attack; traumatic brain injury; psychogenic amnesia; post traumatic stress disorder		This is a case report involving a 60-year-old female who developed transient global amnesia (TGA) after an emotional psychotherapy session in the framework of post-traumatic stress disorder (PTSD). She presented to the local emergency room, three days after her psychotherapist appointment, with complaints of memory impairment. She and her husband were worried about acute stroke since it was a sudden memory loss. The patient discussed with her psychotherapist a physical assault that occurred five years ago. Three days after that discussion, the patient developed the memory loss acutely. PTSD is associated with dissociative and retrograde amnesia. This case report demonstrates that PTSD can present with anterograde amnesia in the form of TGA.	[Espiridion, Eduardo D.] Frederick Mem Hosp, Psychiat, Frederick, MD 21701 USA; [Gupta, Jayesh; Bshara, Andre] Drexel Univ, Coll Med, Miscellaneous, Philadelphia, PA 19104 USA; [Danssaert, Zachary] Philadelphia Coll Osteopath Med, Miscellaneous, Philadelphia, PA USA		Espiridion, ED (corresponding author), Frederick Mem Hosp, Psychiat, Frederick, MD 21701 USA.	edjen19meg@gmail.com	Espiridion, Eduardo/AAB-6673-2020	Espiridion, Eduardo/0000-0001-8471-5203; Gupta, Jayesh/0000-0001-6471-035X			Arena JE, 2015, MAYO CLIN PROC, V90, P264, DOI 10.1016/j.mayocp.2014.12.001; Brown AS, 1998, PSYCHON B REV, V5, P401, DOI 10.3758/BF03208817; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Inzitari D, 1997, ARCH NEUROL-CHICAGO, V54, P866, DOI 10.1001/archneur.1997.00550190056015; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Marinella MA, 2004, NEW ENGL J MED, V350, P843, DOI 10.1056/NEJM200402193500821; Markowitsch HJ, 2013, CORTEX, V49, P1494, DOI 10.1016/j.cortex.2012.05.020; MILLER JW, 1987, NEUROLOGY, V37, P733, DOI 10.1212/WNL.37.5.733; Odagaki Yuji, 2017, Case Rep Psychiatry, V2017, P5173605, DOI 10.1155/2017/5173605; Owen D, 2007, POSTGRAD MED J, V83, P236, DOI 10.1136/pgmj.2006.052472; Portaro S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012723; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Spiegel DR, 2017, NEUROPSYCH DIS TREAT, V13, P2691, DOI 10.2147/NDT.S130710	13	1	1	1	3	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 28	2019	11	9							e5792	10.7759/cureus.5792			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JA8NX	WOS:000488109700004	31728239	Green Published, gold			2022-02-06	
J	Takeuchi, S; Planerova, A; Malmstrom, H; Saunders, R				Takeuchi, Sawako; Planerova, Adela; Malmstrom, Hans; Saunders, Ralph			Improving oral health-related quality of life for a traumatic brain injury patient: A case report	SPECIAL CARE IN DENTISTRY			English	Article						dental implants; quality of life; traumatic brain injury	VALIDATION	Aims A preliminary aim was to determine if a patient who had suffered a traumatic brain injury (TBI) could tolerate removal of his remaining teeth and replacement with partially implant-supported prosthetic replacements. The primary aim was to determine if the patient and also his main caregiver could assess a potential change in his oral health-related quality of life. Methods and results Procedures for the patient were conservative dental restorations, removal of nonrestorable teeth, placement of implants, and fabrication of new dentures. The patient and his primary caregiver, independently, completed the Oral Health Impact Profile-14 (OHIP-14) before and after placement of the implants and Locators. The scores were then compared. The results were that both successfully completed the OHIP-14 and scores showed improvement at 3 and 6 months. Conclusion This is the first report of both, a TBI patient and his primary caregiver independently self-assessing improvement in his quality of life using the OHIP-14 after fabrication of an implant-supported overdenture.	[Takeuchi, Sawako; Planerova, Adela; Malmstrom, Hans; Saunders, Ralph] Eastman Inst Oral Hlth, 625 Elmwood Ave, Rochester, NY 14620 USA		Saunders, R (corresponding author), Eastman Inst Oral Hlth, 625 Elmwood Ave, Rochester, NY 14620 USA.	ralph_saunders@urmc.rochester.edu		Saunders, Ralph/0000-0002-2010-8452			[Anonymous], 2012, AD TRAUM BRAIN INJ; Cassidy JD, 2001, J REHABIL MED, P28; Flanagan D, 2011, J ORAL IMPLANTOL, V37, P713, DOI 10.1563/AAID-JOI-D-10-00095; Kanehira Y, 2017, J ADV PROSTHODONT, V9, P476, DOI 10.4047/jap.2017.9.6.476; Locker D, 2001, COMMUNITY DENT ORAL, V29, P373, DOI 10.1034/j.1600-0528.2001.290507.x; Lueckel SN., 2018, SURGERY; Nagahisa K, 2018, INT J ORAL MAX IMPL, V33, P1141, DOI 10.11607/jomi.6496; Naik A, 2016, J PROSTHODONT RES, V60, P85, DOI 10.1016/j.jpor.2015.12.003; Parker H, 2018, REHAB PSYCHOL; Pommer B., 2013, J DENT ORAL CRANIOFA, V1, P3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Slade G, 2019, E COMMUNICATION 0730; Slade G D, 1994, Community Dent Health, V11, P3; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x; Zasler Nathan D., 1993, Brain Injury, V7, P339, DOI 10.3109/02699059309034960	15	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-1879	1754-4505		SPEC CARE DENT	Spec. Care Dent.	NOV	2019	39	6					617	623		10.1111/scd.12421		SEP 2019	7	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	JJ8UG	WOS:000487777800001	31557347				2022-02-06	
J	Wilson, HR				Wilson, Hugh R.			Voluntary Generation of Hyperchaotic Visuo-Motor Patterns	SCIENTIFIC REPORTS			English	Article							RANDOM SEQUENCES; DYNAMICS; CHAOS; EEG	Unpredictable escape behaviour is an integral part of the repertoire of many prey species. Many social species, including humans, also employ unpredictability to enhance their chances of success in social interactions with conspecifics. However, it is unclear what mechanisms provide the behavioural and neural bases of this unpredictability, which might result either from randomness or from chaotic dynamics. A novel paradigm described here demonstrates that unpredictable behaviour generated voluntarily in a simple visuomotor task represents high dimensional chaos, or hyperchaos, but not randomness. The exponential decay of predictability was also shown to be longer in older adults. As chaos has been observed among cortical neurons, this provides a plausible neural basis for hyperchaos. These results thus provide evidence that voluntary unpredictable behaviour can result from neural hyperchaos. This work has implications for the study of autism, aftereffects of concussions, early dementia, and the concept of free will.	[Wilson, Hugh R.] York Univ, Ctr Vis Res, Toronto, ON, Canada		Wilson, HR (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	hrwilson@yorku.ca			Canadian Institutes for Advanced Research	This research was supported by a grant from the Canadian Institutes for Advanced Research. L. Lillakas and F. Wilkinson provided valuable help with this project.	Anishchenko VS, 2003, PHYSICA A, V325, P199, DOI 10.1016/S0378-4371(03)00199-7; BORISYUK GN, 1995, B MATH BIOL, V57, P809, DOI 10.1007/BF02458296; GALLEZ D, 1991, BIOL CYBERN, V64, P381, DOI 10.1007/BF00224705; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Haworth Joshua, 2016, J Mot Learn Dev, V4, P219, DOI 10.1123/jmld.2015-0031; HUMPHRIE.DA, 1970, OECOLOGIA, V5, P285, DOI 10.1007/BF00815496; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Lorenz E. N., 1993, ESSENCE CHAOS; MAYERKRESS G, 1987, ANN NY ACAD SCI, V504, P62; MILLER GF, 1997, MACHIAVELLIAN INTELL, P312, DOI DOI 10.1017/CBO9780511525636.013; NEURINGER A, 1993, PSYCHOL SCI, V4, P113, DOI 10.1111/j.1467-9280.1993.tb00471.x; RAPP PE, 1985, PHYS LETT A, V110, P335, DOI 10.1016/0375-9601(85)90786-8; RICHARDS D, 1990, BEHAV SCI, V35, P219, DOI 10.1002/bs.3830350305; RICHARDS W, 1994, BIOL CYBERN, V70, P345, DOI 10.1007/s004220050037; ROSSLER OE, 1979, PHYS LETT A, V71, P155, DOI 10.1016/0375-9601(79)90150-6; ROSSLER OE, 1983, Z NATURFORSCH A, V38, P788; Skokos C, 2016, LECT NOTES PHYS, V915, P221, DOI 10.1007/978-3-662-48410-4_7; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; THOMSEN JS, 1991, NATO ADV SCI I B-PHY, V270, P397; TREISMAN M, 1987, J EXP PSYCHOL GEN, V116, P337, DOI 10.1037/0096-3445.116.4.337; vanVreeswijk C, 1996, SCIENCE, V274, P1724; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; WARD LM, 1994, PSYCHOL SCI, V5, P232, DOI 10.1111/j.1467-9280.1994.tb00506.x; Ward LM, 2002, DYNAMICAL COGNITIVE; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786	30	1	1	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 25	2019	9								13819	10.1038/s41598-019-50369-9			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JA1OP	WOS:000487586600010	31554866	gold, Green Published			2022-02-06	
J	Herrold, AA; Kletzel, SL; Mallinson, T; Pape, TLB; Weaver, JA; Guernon, A; Smith, B; Babcock-Parziale, J; High, WM; Sesso-Osburn, F; Vis, L				Herrold, Amy A.; Kletzel, Sandra L.; Mallinson, Trudy; Pape, Theresa L. Bender; Weaver, Jennifer A.; Guernon, Ann; Smith, Bridget; Babcock-Parziale, Judith; High, Walter M.; Sesso-Osburn, Francis; Vis, Lynnea			Psychometric measurement properties of the world health organization disability assessment schedule 2.0 (WHODAS) evaluated among veterans with mild traumatic brain injury and behavioral health conditions	DISABILITY AND REHABILITATION			English	Article						WHODAS; mild traumatic brain injury; veteran; mTBI; behavioral health condition; depression; anxiety; post-traumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; SPINAL-CORD-INJURY; ASSOCIATION; RELIABILITY; VALIDATION; INVENTORY; COGNITION; SYMPTOMS; VALIDITY; PTSD	Purpose: Examine the psychometric properties of the World Health Organization Disability Assessment Schedule 2.0 among U.S. Iraq/Afghanistan Veterans with a combination of mild traumatic brain injury and behavioral health conditions using Rasch analysis. Methods: 307 Veterans were classified as either combat control (n = 141), or one of three clinical groups: mild traumatic brain injury (n = 10), behavioral health conditions (n = 24), or both (n = 128). Data from the three clinical groups were used to establish step and item calibrations serving as anchors when including the control group. Results: Measurement precision was excellent (person separation reliability = 0.93). Ordering of item calibrations formed a logical hierarchy. Test items were off-target (too easy) for the clinical groups. Principal component analysis indicated unidimensionality although 4/36 items misfit the measurement model. No meaningful differential item functioning was detected. There was a moderate effect size (Hedge's g = 1.64) between the control and clinical groups. Conclusions: The World Health Organization Disability Assessment Schedule was suitable for our study sample, distinguishing 4 levels of functional ability. Although items may be easy for some Veterans with mild traumatic brain injury and/or behavioral health conditions, the World Health Organization Disability Assessment Schedule can be used to capture disability information for those with moderate to severe disability.	[Herrold, Amy A.; Kletzel, Sandra L.; Pape, Theresa L. Bender; Guernon, Ann; Smith, Bridget] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Herrold, Amy A.; Kletzel, Sandra L.; Pape, Theresa L. Bender; Guernon, Ann; Smith, Bridget] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL 60141 USA; [Herrold, Amy A.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Mallinson, Trudy; Weaver, Jennifer A.] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA; [Pape, Theresa L. Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Guernon, Ann] Marianjoy Rehabil Hosp Northwestern Med, Dept Res, Wheaton, IL USA; [Smith, Bridget] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Babcock-Parziale, Judith] Southern AZ VA Hlth Care Syst 3 124, Tucson, AZ USA; [High, Walter M.] New Mexico VA Hlth Care Syst, Albuquerque, NM USA; [Sesso-Osburn, Francis] Adler Univ, Clin Psychol Program, Chicago, IL USA; [Vis, Lynnea] US Navy, Med Serv Corps, Pentagon, AR USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, 5000 S 5th Ave,MC 151H, Hines, IL 60141 USA.	Theresa.BenderPape@va.gov	Mallinson, Trudy/S-7381-2019; Weaver, Jennifer/M-1478-2017	Mallinson, Trudy/0000-0002-4888-5579; Weaver, Jennifer/0000-0002-3964-1441	Department of Veterans Affairs Office of Research and Development, Health Services Research and DevelopmentUS Department of Veterans Affairs [08-0377]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	This work was funded by the Department of Veterans Affairs Office of Research and Development, Health Services Research and Development, Service-Directed Research 08-0377.	Association AP., 2013, DIAGN STAT MAN MENT, V5th; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1987, MANUAL REVISED BECK; Beck AT, 1988, MANUAL BECK ANXIETY; Bond T. G., 2007, APPL RASCH MODEL; Boone WJ, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-04-0148; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cadigan JM, 2017, ADDICT BEHAV, V70, P54, DOI 10.1016/j.addbeh.2017.02.009; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; De Wolf AC, 2012, J REHABIL MED, V44, P747, DOI 10.2340/16501977-1016; (DVBIC) DaVBIC, 2018, DOD NUMB TRAUM BRAIN; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Goldberg J, 2014, QUAL LIFE RES, V23, P1579, DOI 10.1007/s11136-013-0585-4; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kucukdeveci AA, 2013, DISABIL REHABIL, V35, P214, DOI 10.3109/09638288.2012.690817; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Linacre J., 2009, RASCH MEASUREMENT T, V23, P1228; Linacre JM, 2012, USERS GUIDE WINSTEPS; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Magistrale G, 2015, MULT SCLER J, V21, P448, DOI 10.1177/1352458514543732; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Marx BP, 2015, PSYCHIAT SERV, V66, P1312, DOI 10.1176/appi.ps.201400400; Monson CM, 2014, CLIN HDB PSYCHOL DIS, P62; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Schumm JA, 2017, J TRAUMA STRESS, V30, P704, DOI 10.1002/jts.22243; Smith E V Jr, 2001, J Appl Meas, V2, P281; Smith R M, 1998, J Outcome Meas, V2, P66; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tarvonen-Schroder S, 2018, J REHABIL MED, V50, P514, DOI 10.2340/16501977-2345; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun T, 2010, MEASURING HLTH DISAB; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Zakzanis KK, 2017, APPL NEUROPSYCH-ADUL, V24, P559, DOI 10.1080/23279095.2016.1225216	42	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	APR 24	2021	43	9					1313	1322		10.1080/09638288.2019.1660914		SEP 2019	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	RX0CD	WOS:000487650100001	31549869				2022-02-06	
J	Shinoda, J; Nagamine, Y; Kobayashi, S; Odaki, M; Oka, N; Kinugasa, K; Nakamura, H; Ichida, T; Miyashita, R; Shima, H; Hama, T				Shinoda, Jun; Nagamine, Yoshihide; Kobayashi, Shigeki; Odaki, Masaru; Oka, Nobuo; Kinugasa, Kazushi; Nakamura, Hirohiko; Ichida, Takafumi; Miyashita, Ritsuko; Shima, Hiroji; Hama, Takashi			Multidisciplinary attentive treatment for patients with chronic disorders of consciousness following severe traumatic brain injury in the NASVA of Japan	BRAIN INJURY			English	Article						Chronic DOC; severe TBI; NASVA; NASVA score; multidisciplinary attentive treatment (MAT)	PROLONGED DISORDERS; UNRESPONSIVE WAKEFULNESS; VEGETATIVE STATE; RECOVERY; COMA; REHABILITATION; OUTCOMES; CARE; PET	Primary Objective: The aim of this study was to demonstrate the clinical outcomes of long-term multidisciplinary attentive treatment (MAT) in patients with chronic disorders of consciousness (DOC) due to severe traumatic brain injury (TBI) following automotive accidents. Research Design: Five hundred and ten patients (mean age: 40.4 years) were enrolled in this retrospective study. Methods and Procedures: Patients were provided MAT for one to several years in the eight medical facilities of the National Agency for Automotive Safety and Victims' Aid (NASVA) in Japan. Clinical status for consciousness, communication, and activities of daily living were evaluated using the NASVA grading system. Outcomes and results: Following MAT, NASVA scores at discharge were significantly improved compared to those at admission in every patient subgroup including sex, age, NASVA score, and association with/without hypoxic encephalopathy at admission. Younger age, shorter interval between injury and admission, and better neurocognitive function at admission were found to be significant and independent factors for a good prognosis. Conclusions: MAT can partially improve the cognitive and physical abilities of patients with chronic DOC. From the perspective of not only restoring a patient's daily life, but also reducing the caregiver's burden, this type of treatment program warrants more public attention.	[Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Dysfunct, 630 Shimo Kobi,Kobi Cho, Gifu 5050034, Japan; [Shinoda, Jun] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan; [Nagamine, Yoshihide] Tohoku Ryogo Ctr, Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi, Japan; [Kobayashi, Shigeki; Odaki, Masaru; Oka, Nobuo] Natl Agcy Automot Safety & Victims Aid, Rehabil Ctr Traumat Apall Chiba, Chiba, Japan; [Kinugasa, Kazushi] NASVA Okayama Med Ctr, Okayama, Japan; [Nakamura, Hirohiko] Nakamura Mem Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Ichida, Takafumi] Shonan East Gen Hosp, NASVA Medicare Sect, Chigasaki, Kanagawa, Japan; [Miyashita, Ritsuko] Izumi Otsu Municipal Hosp, NASVA Medicare Sect, Osaka, Japan; [Shima, Hiroji] St Marys Hosp, Dept Neurosurg, Kurume, Fukuoka, Japan; [Hama, Takashi] Natl Agcy Automot Safety & Victims Aid NASVA, Tokyo, Japan		Shinoda, J (corresponding author), Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Dysfunct, 630 Shimo Kobi,Kobi Cho, Gifu 5050034, Japan.	junshino@joy.ocn.ne.jp					ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bagnato S, 2017, J NEUROTRAUM, V34, P535, DOI 10.1089/neu.2016.4418; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; de Biase S, 2014, SLEEP MED, V15, P393, DOI 10.1016/j.sleep.2013.09.026; DeFina PA, 2010, RESTOR NEUROL NEUROS, V28, P769, DOI 10.3233/RNN-2010-0548; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Eilander HJ, 2016, BRAIN INJURY, V30, P1302, DOI 10.3109/02699052.2016.1170881; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; France Ministere de la Sante de la Protection Sociale Secretariat d'Etat aux personnes handicapees, 2002, 2002288 DHOS02DGSSD5; Fujiwara S, 1997, No To Shinkei, V49, P1139; Fujiwara S, 1993, P 2 ANN M SOC TREATM, V2, P173; Fujiwara S, 2011, P 20 ANN M JAP COM S, P41; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; Godbolt AK, 2011, AM J PHYS MED REHAB, V90, P482, DOI 10.1097/PHM.0b013e31820f9768; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; Kotchoubey B, 2014, CURR PHARM DESIGN, V20, P4239; Laureys S, 2007, SCI AM, V296, P84, DOI 10.1038/scientificamerican0507-84; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; OHTA T, 1986, J NEUROSURG, V64, P420, DOI 10.3171/jns.1986.64.3.0420; Ohta T, 1974, No Shinkei Geka, V2, P623; Okumura Y, 2014, BRAIN INJURY, V28, P944, DOI 10.3109/02699052.2014.888477; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; ROSENBERG GA, 1977, ANN NEUROL, V2, P167, DOI 10.1002/ana.410020215; Royal College of Physicians, PROL DIS CONSC NAT C; SATO S, 1978, Neurologia Medico-Chirurgica, V18, P141, DOI 10.2176/nmc.18pt1.141; Sattin D, 2017, FUNCT NEUROL, V32, P159; Sazbon L, 1985, PROGR CLIN NEUROSCIE, V2, P65; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Shinoda J, 2015, INT J NEUROREHABILIT, V2, P5, DOI [10.4172/2376-0281.1000186, DOI 10.4172/2376-0281.1000186]; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; SNYDER BD, 1983, ANN NEUROL, V14, P152; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; TEASDALE G, 1974, LANCET, V2, P81; von Wild K, 2007, EUR J TRAUMA EMERG S, V33, P268, DOI 10.1007/s00068-007-6138-1; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	48	1	1	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1660	1670		10.1080/02699052.2019.1667535		SEP 2019	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000486854100001	31530028				2022-02-06	
J	Vonder Haar, C; O'Hearn, CM; Winstanley, CA				Vonder Haar, Cole; O'Hearn, Christopher M.; Winstanley, Catharine A.			Exposure to uncertainty mediates the effects of traumatic brain injury on probabilistic decision-making in rats	BRAIN INJURY			English	Article						Brain injury; rodent gambling task; impulsivity; environment; uncertainty	GAMBLING TASK; LEARNING HISTORY; IMPULSIVE ACTION; BEHAVIOR; METHYLPHENIDATE; ATOMOXETINE; PERFORMANCE; ENRICHMENT; MODULATE; CUES	Primary Objective: Traumatic brain injury (TBI) is associated with numerous psychiatric comorbidities, and subclinical psychiatric symptoms. While many symptoms have been replicated in animal models of brain injury, a vast majority of studies utilize naive rats as subjects, which fail to mimic the complex learning history of human patients. Methods and Procedures: In the current study, we evaluated the effects of a brain injury in animals with early exposure to uncertainty on post-injury decision-making in a probabilistic task, the rodent gambling task (RGT). Main Outcomes and Results: Exposure to uncertainty resulted in a heterogeneous sample relative to prior publications, and brain-injured rats showed no deficits in choice behavior compared to shams which contrasts with large, pervasive deficits in previously published work. However, TBI increased impulsivity and caused transient changes in behavioral variables indicative of initial motivational deficits (pellets earned, omitted responses). Notably, effects of amphetamine were similar on this heterogeneous sample of rats relative to a number of other published reports, suggesting consistent effects of gross monoaminergic manipulations on choice behavior, independent of experience. Conclusions: Going forward, translational studies need to consider the heterogeneity that exists at the clinical level and account for these problems when modeling diseases in animals.	[Vonder Haar, Cole; O'Hearn, Christopher M.] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV USA; [Vonder Haar, Cole] West Virginia Univ, Dept Neurosci, Morgantown, WV USA; [Vonder Haar, Cole; Winstanley, Catharine A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wvu.edu		Vonder Haar, Cole/0000-0001-7949-2068	Canadian Institutes for Health Research (Institute of Neurosciences, Mental Health and Addiction)Canadian Institutes of Health Research (CIHR) [PJT 148631]; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Southern Regional Education Board; West Virginia University	This work was supported by the Canadian Institutes for Health Research (Institute of Neurosciences, Mental Health and Addiction, PJT 148631), the Michael Smith Foundation for Health Research, Southern Regional Education Board, and West Virginia University.	Adams WK, 2017, PSYCHOPHARMACOLOGY, V234, P3091, DOI 10.1007/s00213-017-4696-4; [Anonymous], 2017, INJ PREV CONTR TRAUM; Bagur J, 2015, PEDIATR BLOOD CANCER, V62, P847, DOI 10.1002/pbc.25425; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barrus MM, 2016, J NEUROSCI, V36, P785, DOI 10.1523/JNEUROSCI.2225-15.2016; BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Ferland JMN, 2017, ADDICT BIOL, V22, P991, DOI 10.1111/adb.12388; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Kochanek PM, 2020, J NEUROTRAUM, V37, P2353, DOI 10.1089/neu.2018.6203; Lazzaretti C, 2016, J INTEGR NEUROSCI, V15, P81, DOI 10.1142/S0219635216500047; Leen-Feldner EW, 2008, BEHAV RES THER, V46, P1009, DOI 10.1016/j.brat.2008.06.002; Liu YP, 2017, PSYCHOPHARMACOLOGY, V234, P1587, DOI 10.1007/s00213-017-4579-8; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nagele C, 2014, NEUROPSYCHOBIOLOGY, V70, P67, DOI 10.1159/000364825; Olshavsky ME, 2014, J EXP ANAL BEHAV, V102, P162, DOI 10.1002/jeab.104; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Paterson NE, 2011, NEUROSCI RES, V69, P41, DOI 10.1016/j.neures.2010.10.001; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sartor CE, 2014, ADDICT BEHAV, V39, P473, DOI 10.1016/j.addbeh.2013.10.021; SCHWARTZ SM, 1994, J BEHAV THER EXP PSY, V25, P135, DOI 10.1016/0005-7916(94)90006-X; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Silveira MM, 2016, BEHAV PHARMACOL, V27, P350, DOI 10.1097/FBP.0000000000000203; Skinner B. F., 1957, SCHEDULES REINFORCEM; Tremblay M, 2019, PSYCHOPHARMACOLOGY, V236, P1901, DOI 10.1007/s00213-019-5173-z; van Enkhuizen J, 2013, PSYCHOPHARMACOLOGY, V225, P661, DOI 10.1007/s00213-012-2854-2; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wang MZ, 2017, BEHAV BRAIN RES, V327, P54, DOI 10.1016/j.bbr.2017.03.028; Zeeb FD, 2017, J PSYCHIATR NEUROSCI, V42, P404, DOI 10.1503/jpn.170003; Zeeb FD, 2013, PSYCHOPHARMACOLOGY, V225, P381, DOI 10.1007/s00213-012-2822-x; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	44	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					140	148		10.1080/02699052.2019.1669073		SEP 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000486855000001	31532706				2022-02-06	
J	Oyesanya, TO				Oyesanya, Tolu O.			Veterans Health Administration nurses' training and beliefs related to care of patients with traumatic brain injury	PLOS ONE			English	Article							KNOWLEDGE; RECOVERY; MANAGEMENT; OUTCOMES	Background Veteran patients with traumatic brain injury (TBI) and their family members regularly receive care from nurses. Understanding nurses' training and beliefs can provide direction for intervention work aimed at ensuring the best possible care is delivered to this population. Aims We examined Veterans Health Administration (VHA) nurses' training and beliefs related to care of patients with moderate-to-severe TBI. Design and methods We conducted an exploratory, cross-sectional survey with 211 VHA nurses and analyzed data using descriptive statistics. Results The average years of nursing experience was 18 years, and 90% reported ever caring for a patient with TBI. Most nurses (70%) reported only seeing patients with TBI <1-2 times per year in their current role; 20% reported seeing these patients 1-2 times per month. Even with infrequent care, almost 50% reported previously receiving TBI-related training. Beliefs items with the highest accuracy indicated nurses agreed that they need specialized training to care for patients with TBI and that TBI recovery may continue for several years (96.39% accuracy respectively). The beliefs item with the lowest accuracy indicated focus on whether nurses agreed that TBI severity was important in developing care plans (27.84% accuracy). Nurses reported the need for clarity of the nursing role in caring for patients with TBI (77.32% agreement). Conclusion VHA nurses do have accurate beliefs about caring for Veteran patients with moderate-to-severe TBI; however, there is the need for further role clarification regarding nursing care of patients with TBI. Impact These findings have implications for development of education and training interventions for nurses who care for Veteran patients with TBI.	[Oyesanya, Tolu O.] Duke Univ, Sch Nursing, Durham, NC 27706 USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27706 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510			American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; [Anonymous], 2014, CLIN PRACTICE GUIDEL; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker Mark J, 2011, Nurse Educ Pract, V11, P268, DOI 10.1016/j.nepr.2010.11.020; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Defense and Veterans Brain Injury Center, 2014, TBI MIL; Defense Medical Surveillance System (DMSS) Theater Medical Data Store (TMDS) and Armed Forces Health Surveillance Center (AFHSC), 2014, DOD WORLDW TBI; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Department of Veteran Affairs, 2016, VET INF COMP INFR; Department of Veterans Affairs, 2013, VHA HDB; Edwards Geraldine, 2006, Br J Nurs, V15, P1180; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hoge C. W., 2009, DTIC DOCUMENT; Jaimes LM, 2015, REHABIL NURS, V40, P74, DOI 10.1002/rnj.156; Lehman C, 2015, SPECIALTY PRACTICE R, P511; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Mansour A., 2015, PSYCHOLOGY, V06, P323, DOI [10.4236/psych.2015.64033, DOI 10.4236/PSYCH.2015.64033]; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maydeu-Olivares A, 2017, STRUCT EQU MODELING, V24, P495, DOI 10.1080/10705511.2017.1289816; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Melnyk Bernadette Mazurek, 2004, Worldviews Evid Based Nurs, V1, P185, DOI 10.1111/j.1524-475X.2004.04024.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Oyesanya T. O., J NURS MEAS; Oyesanya T. O., 2017, J CLIN NURS; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Sandoval WA, 2016, REV RES EDUC, V40, P457, DOI 10.3102/0091732X16669319; Scharf D.M., 2015, PUBLIC PRIVATE PARTN; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; StataCorp L. P, 2007, STATA DATA ANAL STAT, V10; Thoroddsen A, 2010, INT J NURS TERMIN CL, V21, P69, DOI 10.1111/j.1744-618X.2010.01148.x; Veterans Health Administration, 2009, VHA DIR 2010 012 MAR; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222585	10.1371/journal.pone.0222585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	WOS:000532225700040	31525241	gold, Green Published, Green Submitted			2022-02-06	
J	Osborne-Crowley, K; Wilson, E; De Blasio, F; Wearne, T; Rushby, J; McDonald, S				Osborne-Crowley, Katherine; Wilson, Emily; De Blasio, Frances; Wearne, Travis; Rushby, Jacqueline; McDonald, Skye			Empathy for people with similar experiences: Can the perception-action model explain empathy impairments after traumatic brain injury?	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Empathy; traumatic brain injury; skin conductance; perception-action model; emotion perception	SOCIAL KNOWLEDGE; HOSPITAL ANXIETY; PAIN; SYSTEMS; BEHAVIOR; DEFICITS; INSIGHT	Introduction: A significant proportion of people with traumatic brain injury (TBI) report low levels of empathy, yet there is a paucity of research investigating the mechanisms which underpin this. In this study, we investigated empathy after TBI through the lens of the perception-action model of empathy. Specifically, we looked at the effect of similarity of experience on self-reported empathy and skin conductance in participants with TBI and controls. Method: Thirty people with a traumatic brain injury and 30 matched healthy controls initially recounted three emotional events they had experienced in the past (one happy, one angry and one sad). Then, at a second visit, participants heard three stories which were written to be similar their own stories and three which were based on someone else's stories. We recorded skin conductance while participants listened and then collected self-reported levels of empathy for protagonists in the stories. Results: We found that self-reported empathy, but not skin conductance levels, was greater for similar compared to dissimilar stories. Further, participants with TBI were able to empathise with others despite having markedly reduced autonomic arousal and overall impairment in cognitive functioning. Conclusions: Our results suggest that the PAM has relevance with respect to explaining self-reported empathy for the experiences of others, but cannot explain the role of physiological responses associated with empathy. Further, our results suggest that intact cognitive functioning and physiological responses are not necessary for normal experiences of empathy after TBI.	[Osborne-Crowley, Katherine; Wilson, Emily; De Blasio, Frances; Wearne, Travis; Rushby, Jacqueline; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia		Osborne-Crowley, K (corresponding author), Huntingtons Dis Ctr, UCL Inst Neurol, Level 2,Russell Sq House, London WC1B 5EH, England.	kosbornecrowley@gmail.com	De Blasio, Frances M./D-9158-2019; McDonald, Skye/G-4118-2014	De Blasio, Frances M./0000-0003-1442-9820; McDonald, Skye/0000-0003-0723-6094; Wilson, Emily/0000-0002-1949-7657; Wearne, Travis/0000-0002-7565-9163	Australian Research CouncilAustralian Research Council [DP150100226]	This work was supported by the Australian Research Council under Grant [DP150100226].	Ardizzi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110763; Azevedo RT, 2013, HUM BRAIN MAPP, V34, P3168, DOI 10.1002/hbm.22133; BARNETT MA, 1989, J GENET PSYCHOL, V150, P417, DOI 10.1080/00221325.1989.9914607; Batson CD, 2002, PERS SOC PSYCHOL B, V28, P1656, DOI 10.1177/014616702237647; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess PW, 1997, HAYLING BRIXTON TEST, P2; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Davis M.H., 2018, EMPATHY SOCIAL PSYCH; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety J, 2003, NEUROPSYCHOLOGIA, V41, P127, DOI 10.1016/S0028-3932(02)00143-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maxwell S. E., 2003, DESIGNING EXPT ANAL; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P619, DOI 10.1080/13803395.2011.553586; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Preis MA, 2012, EUR J PAIN, V16, P1311, DOI 10.1002/j.1532-2149.2012.00119.x; Preston SD, 2007, SOC NEUROSCI-UK, V2, P254, DOI 10.1080/17470910701376902; Preston SD, 2012, EMOT REV, V4, P24, DOI 10.1177/1754073911421378; Preston SD, 2007, EMPATHY IN MENTAL ILLNESS, P428, DOI 10.1017/CBO9780511543753.024; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Shipley WC, 2009, SHIPLEY 2 MANUAL; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; Wechsler D., 2008, WECHSLER ADULT INTEL; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	1	1	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2020	42	1					28	41		10.1080/13803395.2019.1662375		SEP 2019	14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KA8MP	WOS:000486606100001	31514609				2022-02-06	
J	Ball, T; Oxford, BG; Alhourani, A; Ugiliweneza, B; Williams, BJ				Ball, Tyler; Oxford, Brent G.; Alhourani, Ahmad; Ugiliweneza, Beatrice; Williams, Brian J.			Predictors of Thirty-day Mortality and Length of Stay in Operative Subdural Hematomas	CUREUS			English	Article						subdural hematoma; traumatic brain injury; outcome prediction; head injury; coagulation; traumatic head injury; neurosurgery; national surgical quality improvement program	PROGNOSTIC-FACTORS; AMERICAN-COLLEGE; AGE	The rate of postoperative morbidity and mortality after subdural hematoma (SDH) evacuation is high. The aim of this study was to compare mortality statistics from a high-volume database to historical figures and determine the most significant preoperative predictors of mortality and length of stay (LOS). The National Surgical Quality Improvement Program registry was searched (2005-2016) for patients with operatively treated SDHs, of which 2709 were identified for univariate analysis. After exclusion for missing data, 2010 individuals were analyzed with multivariable logistic regression. Primary outcome was 30-day mortality. The average patient age was 68.8 +/- 14.9 years, and 64.1% were males. Upon multivariate analysis, nine variables were found to be associated with increased mortality: platelet count < 135,000 (OR 2.04, 95% CI 1.39-2.99), INR >1.2 (OR 1.87, 95% CI 1.34-2.6), bleeding disorder (OR 1.80, 95% CI 1.32-2.46), need for dialysis within two weeks preoperatively (OR 5.69, 95% CI 3.15-10.27), ventilator dependence in the 48 hours preceding surgery (OR 3.99, 95% CI 2.82-5.63), disseminated cancer (OR 2.95, 95% CI 1.34-6.47), WBC count >10,000 (OR 1.55, 95% CI 1.15-2.08), totally dependent functional status (OR 1.84, 95% CI 1.2-2.8), and each increasing year of age (OR 1.04, 95% CI 1.031-1.05). It is not surprising that chronic conditions and functional status were associated with increased mortality. However, specific laboratory abnormalities were also associated with increased mortality at levels generally considered within normal limits. More studies are needed to determine if correcting lab abnormalities preoperatively can improve outcomes in patients with intrinsic coagulopathy.	[Ball, Tyler] Univ Louisville, Sch Med, Neurosurg, Louisville, KY 40292 USA; [Oxford, Brent G.; Alhourani, Ahmad; Williams, Brian J.] Univ Louisville, Sch Med, Neurol Surg, Louisville, KY 40292 USA; [Ball, Tyler; Ugiliweneza, Beatrice] Univ Louisville, Dept Hlth Management & Syst Sci, Louisville, KY 40292 USA; [Oxford, Brent G.; Alhourani, Ahmad; Williams, Brian J.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Ugiliweneza, Beatrice] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA		Williams, BJ (corresponding author), Univ Louisville, Sch Med, Neurol Surg, Louisville, KY 40292 USA.; Williams, BJ (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	brian.williams@ulp.org					Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; Cohen ME, 2017, J AM COLL SURGEONS, V224, P787, DOI 10.1016/j.jamcollsurg.2016.12.057; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Guru PK, 2016, NEPHRON, V133, P175, DOI 10.1159/000447543; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Huffman KM, 2015, ANN SURG, V261, P1108, DOI 10.1097/SLA.0000000000000913; JAMJOOM A, 1992, INJURY, V23, P518, DOI 10.1016/0020-1383(92)90149-M; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wong GK, 2009, BRIT J NEUROSURG, V23, P601, DOI 10.3109/02688690902948184; Yanaka Kiyoyuki, 1993, Neurologia Medico-Chirurgica, V33, P552, DOI 10.2176/nmc.33.552; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	23	1	1	0	4	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	SEP 14	2019	11	9							e5657	10.7759/cureus.5657			17	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	IX5RN	WOS:000485741400005	31700758	Green Published, gold			2022-02-06	
J	Joseph, ALC; Lippa, SM; McNally, SM; Garcia, KM; Leary, JB; Dsurney, J; Chan, L				Joseph, Annie-Lori C.; Lippa, Sara M.; McNally, Shannon M.; Garcia, Katelyn M.; Leary, Jacob B.; Dsurney, John; Chan, Leighton			Estimating premorbid intelligence in persons with traumatic brain injury: an examination of the Test of Premorbid Functioning	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Assessment; intelligence; neuropsychology tests; rehabilitation; traumatic brain injury	ADULT READING TEST; WAIS-R IQ; COGNITIVE RESERVE; WECHSLER TEST; PERFORMANCE; ABILITY; ASSOCIATION; EQUATION; VALIDITY; MODERATE	Knowledge of intelligence is essential for interpreting cognitive performance following traumatic brain injury (TBI). The Test of Premorbid Functioning (ToPF), a word reading test co-normed with the Wechsler Adult Intelligence Scale 4(th) Edition (WAIS-IV), was examined as a tool for estimating premorbid intelligence in persons with a history of TBI. Fifty-two participants with mild, moderate, or severe TBI were administered the ToPF and WAIS-IV between two weeks and 19 months post-injury. The independent ability of the ToPF/demographic score and the Verbal Comprehension Index (VCI) to predict WAIS-IV Full Scale IQ (FSIQ) was examined, as were discrepancies between ToPF and WAIS-IV scores within and between participants. The ToPF/demographic predicted FSIQ accounted for a significant proportion of variability in actual FSIQ, above and beyond that accounted for by education or time since injury. ToPF and WAIS-IV scores did not differ by injury severity. In our sample, the ToPF/demographic predicted FSIQ underestimated intelligence in a substantial portion of our participants (31%), particularly in those with high average to superior intelligence. Finally, VCI scores were more predictive of actual FSIQ than the ToPF/demographic predicted FSIQ. The ToPF frequently underestimated post-injury intelligence and is therefore not accurately measuring premorbid intelligence in our sample, particularly in those with above average to superior intelligence. Clinicians are encouraged to administer the entire WAIS-IV, or at minimum the VCI subtests, for a more accurate measure of intelligence in those with above average intelligence and history of TBI.	[Joseph, Annie-Lori C.; Lippa, Sara M.; Leary, Jacob B.; Chan, Leighton] NIH, Ctr Clin, Rehabil Med Dept, 10 Ctr Dr, Bethesda, MD 20892 USA; [Lippa, Sara M.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lippa, Sara M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [McNally, Shannon M.; Garcia, Katelyn M.; Chan, Leighton] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Dsurney, John] Tampa Psychol Associates, Tampa, FL USA		Joseph, ALC (corresponding author), NIH, Ctr Clin, Rehabil Med Dept, 10 Ctr Dr, Bethesda, MD 20892 USA.	annielorijoseph@gmail.com	Joseph, Annie-Lori C/AAX-3221-2021	Joseph, Annie-Lori/0000-0002-6773-7934	National Institutes of Health Clinical Center Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [1ZIACL060079-09]	This work was supported by the National Institutes of Health Clinical Center Intramural Research Program and the Center for Neuroscience and Regenerative Medicine under [Grant 1ZIACL060079-09].	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beck A.T., 1996, MANUAL BECK DEPRESSI, DOI DOI 10.1037/T00742-000; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; CRAWFORD JR, 1992, BRIT J CLIN PSYCHOL, V31, P327, DOI 10.1111/j.2044-8260.1992.tb00999.x; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Delis D.C., 2000, CALIFORNIA VERBAL LE; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Green P, 2004, GREENS MED SYMPTOM V; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hinkle D.E., 2003, APPL STAT BEHAV SCI; Holdnack JA, 2013, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-386934-0.00005-5; Iverson GL, 2013, PRACT RESOUR MENT, P485, DOI 10.1016/B978-0-12-386934-0.00010-9; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; Pearson, 2009, ADV CLIN SOLUTIONS W; Pearson N. C. S., 2009, TEST PREMORBID FUNCT; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Rabinowitz AR, 2012, J INT NEUROPSYCH SOC, V18, P139, DOI 10.1017/S1355617711001275; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Schoenberg M. R., 2010, ENCY CLIN NEUROPSYCH; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shapiro ME, 2014, ARCH CLIN NEUROPSYCH, V29, P110, DOI 10.1093/arclin/act071; SHARPE K, 1991, BRIT J CLIN PSYCHOL, V30, P381, DOI 10.1111/j.2044-8260.1991.tb00962.x; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Stewart-Willis JJ, 2018, ARCH CLIN NEUROPSYCH, V33, P206, DOI 10.1093/arclin/acx053; Strauss E, 2006, COMPENDIUM NEUROPSYC, P283; The Psychological Corporation, 2009, TEST PREM FUNCT ADV; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WechslerD, 2001, WECHSLER TEST ADULT; WILLSHIRE D, 1991, J CLIN EXP NEUROPSYC, V13, P204, DOI 10.1080/01688639108401038; Zimmermann N, 2017, COGN NEUROPSYCHIATRY, V22, P346, DOI 10.1080/13546805.2017.1330191	47	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	SEP 3	2021	28	5					535	543		10.1080/23279095.2019.1661247		SEP 2019	9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TZ3RO	WOS:000486552000001	31519111				2022-02-06	
J	Kuai, L; Peng, JH; Jiang, Y; Zheng, Z; Zhou, XY				Kuai, Li; Peng, Jianhua; Jiang, Yong; Zheng, Zheng; Zhou, Xiyuan			Apolipoprotein E-Mimetic Peptide COG1410 Enhances Retinal Ganglion Cell Survival by Attenuating Inflammation and Apoptosis Following TONI	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic optic nerve injury; inflammation; apoptosis; COG1410; magnetic resonance imaging	CONTROLLED CORTICAL IMPACT; EARLY BRAIN-INJURY; GENE FAMILY; NEUROINFLAMMATION; MICROGLIA; MOUSE; MODEL; MICE; EYE	Vision loss after traumatic optic nerve injury (TONI) is considered irreversible because of the retrograde loss of retinal ganglion cells (RGCs), which undergo inflammation and apoptosis. Previous studies have shown that COG1410, a mimic peptide derived from the apolipoprotein E (apoE) receptor binding region, shows neuroprotective activity in acute brain injury. However, the detailed role and mechanisms of COG1410 in RGC survival and vision restoration after TONI are poorly understood. The current study aimed to investigate the effects of COG1410 on inflammation and apoptosis in a mouse model of TONI. The results showed that TONI-induced visual impairment was accompanied by optic nerve inflammation, apoptosis, edema, and RGC apoptosis. COG1410 significantly prevented the decrease in visual from ever occurring, attenuated inflammation and apoptosis, and reduced optic nerve edema and RGC apoptosis compared with vehicle treatment. These data identify protective roles of COG1410 in the inflammatory and apoptotic processes of TONI, as well as strategies for its treatment.	[Kuai, Li; Zheng, Zheng; Zhou, Xiyuan] Chongqing Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Chongqing, Peoples R China; [Kuai, Li] Southwest Med Univ, Affiliated Hosp, Dept Ophthalmol, Luzhou, Peoples R China; [Peng, Jianhua; Jiang, Yong] Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, Luzhou, Peoples R China; [Peng, Jianhua] Neurosurg Clin Med Res Ctr Sichuan Prov, Luzhou, Peoples R China; [Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Academician Expert Workstn, Luzhou, Peoples R China; [Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Lab Neurol Dis & Brain Funct, Luzhou, Peoples R China		Zhou, XY (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Chongqing, Peoples R China.	zhouxiyuan2002@aliyun.com		Peng, Jianhua/0000-0003-3348-9538	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771278, 81801176]; Foundation for Innovative Research Team of Sichuan Province [19CXTD0008]; Technology Innovation Talent Project of Sichuan Province [2018RZ0090, 19MZGC0003]	This work was supported by the National Natural Science Foundation of China (81771278 and 81801176), the Foundation for Innovative Research Team of Sichuan Province (19CXTD0008), and the Technology Innovation Talent Project of Sichuan Province (2018RZ0090 and 19MZGC0003).	Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Crair MC, 2016, J NEUROSCI, V36, P10707, DOI 10.1523/JNEUROSCI.1711-16.2016; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Kumar NN, 2018, J CONTROL RELEASE, V286, P467, DOI 10.1016/j.jconrel.2018.08.006; Laha B, 2017, SCIENCE, V356, P1031, DOI 10.1126/science.aal5060; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Li HJ, 2018, NEUROPHARMACOLOGY, V137, P33, DOI 10.1016/j.neuropharm.2018.04.028; Li XS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00127; Li YQ, 2017, P NATL ACAD SCI USA, V114, pE209, DOI 10.1073/pnas.1616811114; Liu C, 2018, CELL DEATH DIFFER, V25, P661, DOI 10.1038/s41418-017-0005-3; Lopez-Sanchez E, 2003, EUR J OPHTHALMOL, V13, P560, DOI 10.1177/112067210301300609; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Maes ME, 2017, PROG RETIN EYE RES, V57, P1, DOI 10.1016/j.preteyeres.2017.01.002; Manogaran P, 2018, NEUROIMAGE, V175, P327, DOI 10.1016/j.neuroimage.2018.04.004; Nadal-Nicolas FM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0982-7; Pan XD, 2009, GLIA, V57, P1227, DOI 10.1002/glia.20844; Pang JW, 2018, TRANSL STROKE RES, V9, P654, DOI 10.1007/s12975-018-0665-4; Papa S, 2019, ONCOGENE, V38, P2223, DOI 10.1038/s41388-018-0582-8; Peng JH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00150; Peng JH, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2019.101121; Pocivavsek A, 2009, GLIA, V57, P444, DOI 10.1002/glia.20772; Qin XH, 2017, J NEUROTRAUM, V34, P943, DOI 10.1089/neu.2016.4485; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Wu Y, 2016, NEUROSCI LETT, V627, P92, DOI 10.1016/j.neulet.2016.05.058; Xu ZM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00970	36	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 13	2019	13								980	10.3389/fnins.2019.00980			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX4MX	WOS:000485661400003	31607842	Green Published, gold			2022-02-06	
J	Hasjim, BJ; Grigorian, A; Kuza, CM; Schubl, S; Barrios, C; Chin, TL; Nahmias, J				Hasjim, Bima J.; Grigorian, Areg; Kuza, Catherine M.; Schubl, Sebastian; Barrios, Cristobal, Jr.; Chin, Theresa L.; Nahmias, Jeffry			Ground-Level Falls at Skilled Nursing Facilities Are Associated With More Serious Lower Extremity Injuries Compared With Home	INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS			English	Article						skilled nursing facility; lower extremity injury; traumatic brain injury; ground-level fall	MECHANICAL RESTRAINT USE; RISK-FACTORS; RESIDENTS; OUTCOMES; PREVALENCE; FRACTURE; OSTEOPOROSIS; POLYPHARMACY; METAANALYSIS; EXERCISE	Ground-level falls (GLFs) are the number one cause of injury and death in the older adult population. We compared injury profiles of GLFs at SNFs to those at homes, hypothesizing that GLFs at SNFs would lead to higher risks for serious (AIS >= 3) traumatic brain injury (TBI) and lower extremity (LE) injuries compared to GLFs at home. The 2015-2016 Trauma Quality Improvement Program was used to compare patients sustaining GLFs at home and SNFs. From 15,873 patients sustaining GLFs, 14,306 (90.1%) occurred at home while 1,567 (9.9%) at SNFs. More patients with GLFs at SNFs were female, older, and had greater incidence of congestive heart failure, end-stage renal disease, and dementia (p < 0.001) compared to those at home. Although, GLF SNF patients had lower injury severity scores (9 vs. 10, p < 0.001) and incidence for TBI (28.0% vs 33.4%, p < 0.001), they had a higher rate of femur fractures (55.1% vs. 38.9%, p < 0.001). After controlling for female, end stage renal disease, smoking, dementia, diabetes mellitus, chronic obstructive pulmonary disease, congestive heart failure, and stroke, patients falling at SNFs had an increased risk of sustaining serious LE injury AIS (OR 1.64, p < 0.001), but not serious TBI AIS (OR 0.89, p = 0.073). In conclusion, compared to GLFs at home, those at SNFs have a higher risk for serious LE injury, with femur fractures being the most common. However, GLFs at SNFs and homes had no significant difference in risk for serious TBI. Future studies are warranted to evaluate preventative measures to reduce LE injuries at SNFs.	[Hasjim, Bima J.; Grigorian, Areg; Schubl, Sebastian; Barrios, Cristobal, Jr.; Chin, Theresa L.; Nahmias, Jeffry] Univ Calif Irvine, Orange, CA 92868 USA; [Kuza, Catherine M.] Univ Southern Calif, Los Angeles, CA USA; [Kuza, Catherine M.] Los Angeles Cty USC Med Ctr, Los Angeles, CA USA		Hasjim, BJ (corresponding author), Univ Calif Irvine, Med Ctr, Dept Surg, Div Trauma Burns & Surg Crit Care, 333 City Blvd West,Suite 1600, Orange, CA 92868 USA.	bjhasjim@gmail.com	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X; Hasjim, Bima/0000-0003-4301-9011			[Anonymous], 2016, ACS SURG NEWS; Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; Bischoff-Ferrari HA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3692; Buchanan JL, 2006, J AM GERIATR SOC, V54, P458, DOI 10.1111/j.1532-5415.2005.00620.x; Capezuti E, 2002, J AM GERIATR SOC, V50, P90, DOI 10.1046/j.1532-5415.2002.50013.x; Capezuti E, 1999, J Gerontol Nurs, V25, P26; Capezuti E, 1996, J AM GERIATR SOC, V44, P627, DOI 10.1111/j.1532-5415.1996.tb01822.x; Centers for Disease Control and Prevention, 2016, 10 LEAD CAUS INJ DEA; Centre for Health Advancement and Centre for Epidemiology and Research, NEW S WAL FALLS PREV; Charles EJ, 2018, AM SURGEON, V84, P392; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Decker FH, 2008, RES NURS HEALTH, V31, P238, DOI 10.1002/nur.20249; Dwyer LL, 2010, AM J GERIATR PHARMAC, V8, P63, DOI 10.1016/j.amjopharm.2010.01.001; Elliott ME, 2003, PHARMACOTHERAPY, V23, P702, DOI 10.1592/phco.23.6.702.32182; Ghimire Ekta, 2015, Am J Prev Med, V49, pe109, DOI 10.1016/j.amepre.2015.07.004; Harrington C, 2017, NURSING FACILITIES S; Harvey LA, 2014, AUST NZ J PUBL HEAL, V38, P585, DOI 10.1111/1753-6405.12243; Hoffman GJ, 2016, MED CARE, V54, P664, DOI 10.1097/MLR.0000000000000531; Hootman JM, 2002, CLIN J SPORT MED, V12, P99, DOI 10.1097/00042752-200203000-00006; Horn SD, 2005, AM J NURS, V105, P58, DOI 10.1097/00000446-200511000-00028; Kiely DK, 1998, J AM GERIATR SOC, V46, P551, DOI 10.1111/j.1532-5415.1998.tb01069.x; Knickman JR, 2002, HEALTH SERV RES, V37, P849, DOI 10.1034/j.1600-0560.2002.56.x; KOMAR L, 1993, J AM GERIATR SOC, V41, P1057, DOI 10.1111/j.1532-5415.1993.tb06452.x; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leland NE, 2015, J AM MED DIR ASSOC, V16, P767, DOI 10.1016/j.jamda.2015.03.026; LUUKINEN H, 1995, PUBLIC HEALTH, V109, P57, DOI 10.1016/S0033-3506(95)80076-X; MYERS AH, 1991, AM J EPIDEMIOL, V133, P1179, DOI 10.1093/oxfordjournals.aje.a115830; National Center for Health Statistics, 2016, LONG TERM CAR PROV S; Oliphant SS, 2013, MATURITAS, V75, P349, DOI 10.1016/j.maturitas.2013.04.019; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Ranganathan P., 2017, CLIN RES, V8, P148, DOI DOI 10.4103/picr.PICR_87_17; Ray WA, 1997, JAMA-J AM MED ASSOC, V278, P557, DOI 10.1001/jama.278.7.557; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Thapa PB, 1996, J AM GERIATR SOC, V44, P273, DOI 10.1111/j.1532-5415.1996.tb00913.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1991, JAMA-J AM MED ASSOC, V265, P468, DOI 10.1001/jama.265.4.468; TINETTI ME, 1992, ANN INTERN MED, V116, P369, DOI 10.7326/0003-4819-116-5-369; Visschedijk JHM, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0158-1; World Bank, 2018, LIF EXP BIRTH TOT YE; Yardley L, 2002, GERONTOLOGIST, V42, P17, DOI 10.1093/geront/42.1.17; Ziere G, 2006, BRIT J CLIN PHARMACO, V61, P218, DOI 10.1111/j.1365-2125.2005.02543.x; Zimmerman SI, 1999, OSTEOPOROSIS INT, V9, P151	46	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1534-7346	1552-6941		INT J LOW EXTR WOUND	Int. J. Low. Extrem. Wounds	JUN	2020	19	2					190	196	1534734619870393	10.1177/1534734619870393		SEP 2019	7	Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dermatology; Surgery	MB2JE	WOS:000485583000001	31496322				2022-02-06	
J	Hodges, A; Ameringer, S				Hodges, Amanda; Ameringer, Suzanne			The symptom experience of adolescents with concussion	JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING			English	Article						adolescents; concussion; management; qualitative research; symptoms	SPORT-RELATED CONCUSSION; CHILDREN; MANAGEMENT; DIAGNOSIS; CARE	Purpose The incidence of concussions in adolescents has increased in recent years. Concussion causes an array of symptoms that can interfere with the daily life of an adolescent, yet the symptoms and recovery vary greatly. Concussion management is based on expert consensus guidelines but they are not specific for adolescents and it is unclear how adolescents actually manage their symptoms. This study aimed to describe the symptom experience of adolescents with a concussion and their self-management strategies. Design and Methods The study used a qualitative design to explore the symptom experiences of adolescents. Ten adolescents aged 14-17 years were recruited from a concussion clinic. Using a semi-structured interview, adolescents were asked about their concussion symptoms, the interference with their daily life, and their symptom self-management strategies. Data were analyzed using descriptive statistics and content analysis. Results Adolescents reported 17 different symptoms they experienced following their concussion. All of the adolescents reported a headache but descriptions varied. The symptoms interfered with many aspects of their daily life including school and activities. The majority of the school responses were related to difficulties attending school and learning (n = 21). The self-management strategies were organized into 11 categories. The most common strategies fell under three categories: rest (n = 20), controlling the environment (n = 20), and using motivational thoughts and activities (n = 9). Practice Implications This study indicates that adolescents experience multiple symptoms after their concussion and use a variety of strategies to manage the symptoms. Each adolescent had a unique symptom experience, highlighting the need for developing personalized concussion management plans. Nurses can coordinate the development of management plans and provide education about managing concussion symptoms and promoting recovery.	[Hodges, Amanda; Ameringer, Suzanne] Virginia Commonwealth Univ, Richmond, VA USA		Hodges, A (corresponding author), Virginia Commonwealth Univ, Sch Nursing, 1100 East Leigh St, Richmond, VA 23298 USA.; Ameringer, S (corresponding author), Virginia Commonwealth Univ, Dept Family & Community Hlth Nursing, Sch Nursing, Richmond, VA 23298 USA.	hodgesad@vcu.edu; swameringer@vcu.edu					Blume HK, 2018, CURR OPIN PEDIATR, V30, P755, DOI 10.1097/MOP.0000000000000691; Colver A, 2013, ARCH DIS CHILD, V98, P902, DOI 10.1136/archdischild-2013-303945; Creswell J. W., 2016, QUAL INQ; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Krippendorff K., 2013, CONTENT ANAL; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Pasek TA, 2015, CLIN NURSE SPEC, V29, P80, DOI 10.1097/NUR.0000000000000108; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rieger B, 2019, J INT NEUROPSYCH SOC, V25, P777, DOI 10.1017/S1355617719000468; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	25	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-0136	1744-6155		J SPEC PEDIATR NURS	J. Spec. Pediatr. Nurs.	OCT	2019	24	4							e12271	10.1111/jspn.12271		SEP 2019	8	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	JC9FV	WOS:000485474900001	31497928				2022-02-06	
J	Rozen, TD				Rozen, Todd D.			The Three T's of NDPH (How Clinical Observations Have Led to Improved Treatment Outcomes)	HEADACHE			English	Article						new daily persistent headache; Trendelenburg; thunderclap; triggers; cerebrospinal fluid pressure	DAILY PERSISTENT HEADACHE; TRAUMATIC BRAIN-INJURY		[Rozen, Todd D.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA		Rozen, TD (corresponding author), Mayo Clin Jacksonville, Dept Neurol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	rozen.todd@mayo.edu					Balaban C, 2016, J NEUROSCI METH, V272, P56, DOI 10.1016/j.jneumeth.2016.02.001; Jamali SA, 2019, HEADACHE, V59, P789, DOI 10.1111/head.13495; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Prakash S, 2010, J HEADACHE PAIN, V11, P59, DOI 10.1007/s10194-009-0171-x; Robbins MS, 2010, NEUROLOGY, V74, P1358, DOI 10.1212/WNL.0b013e3181dad5de; Rozen TD, 2006, CEPHALALGIA, V26, P1182, DOI 10.1111/j.1468-2982.2006.01187.x; Rozen T, 2008, HEADACHE, V48, P1366, DOI 10.1111/j.1526-4610.2007.01027.x; Rozen T, 2007, HEADACHE, V47, P1050, DOI 10.1111/j.1526-4610.2006.00722.x; Rozen TD, 2019, CEPHALALGIA, V39, P785, DOI 10.1177/0333102418806869; Rozen TD, 2018, J WOMENS HEALTH, V27, P203, DOI 10.1089/jwh.2017.6460; Rozen TD, 2016, HEADACHE, V56, P164, DOI 10.1111/head.12707; Rozen T, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-100; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600	13	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	SEP	2019	59	8					1401	1406		10.1111/head.13624		SEP 2019	6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IY2MD	WOS:000486738700001	31490552				2022-02-06	
J	Cook, NF; Braine, ME; Trout, R				Cook, Neal F.; Braine, Mary E.; Trout, Ruth			Nurses' understanding and experience of applying painful stimuli when assessing components of the Glasgow Coma Scale	JOURNAL OF CLINICAL NURSING			English	Article						eye-opening response; Glasgow Coma Scale; motor response; neurological assessment; noxious painful stimuli	TRAUMATIC BRAIN-INJURY; CAREGIVERS; KNOWLEDGE	Aims and objectives To evaluate nurses' application, understanding and experience of applying painful stimuli when assessing components of the Glasgow Coma Scale. Background The Glasgow Coma Scale has been subjected to much scrutiny and debate since its publication in 1974. However, criticism, confusion and misunderstandings in relation to the use of painful stimuli and its application remain. An absence of evidence-informed guidance on the use and duration of application of painful stimuli remains, with the potential to negatively impact on decision-making, delay responsiveness to neurological deterioration and result in adverse incidents. Design and Methods This international study used an online self-reported survey design to ascertain neuroscience nurses' perceptions and experiences around the application of painful stimuli as part of a GCS assessment (n = 273). The STROBE checklist was used. Results Data revealed varied practices and a sense of confusion from participants. Anatomical sites for the assessment of pain varied, but most respondents identified the trapezius grip/pinch in assessing eye-opening and motor responses. Most respondents identified they assess eye-opening and motor responses together and apply pain for Neuroscience nurses in this study clearly required evidence-informed guidelines to underpin practice both in applying painful stimuli and in managing the experience of the person in their care and the family response. A standardised approach to education is necessary to ensure greater interrater reliability of assessment not only within nursing but across professions. Relevance to practice Results of this study illustrate inconsistency and confusion when using the Glasgow Coma Scale in practice; this has the potential to compromise care. Clarity around the issues highlighted is necessary. Moreover, these results can inform future guidelines and education required for supporting nurses in practice.	[Cook, Neal F.] Ulster Univ, Sch Nursing, Coleraine, Londonderry, North Ireland; [Braine, Mary E.] Univ Salford, Sch Nursing Midwifery Social Work & Social Sci, Salford, Lancs, England; [Trout, Ruth] Buckinghamshire New Univ, Sch Healthcare & Social Work, Uxbridge, Middx, England		Cook, NF (corresponding author), Ulster Univ, Sch Nursing, Coleraine, Londonderry, North Ireland.	NF.Cook@ulster.ac.uk					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Barlow P, 2012, SURG-J R COLL SURG E, V10, P114, DOI 10.1016/j.surge.2011.12.003; Boore J. R. P., 2016, ESSENTIALS ANATOMY P; Braine ME, 2017, J CLIN NURS, V26, P280, DOI 10.1111/jocn.13390; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Chan MF, 2013, J NURS MANAGE, V21, P31, DOI 10.1111/j.1365-2834.2011.01344.x; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; Edwards S L, 2001, Br J Nurs, V10, P92; Ehwarieme T. A., 2017, AFRICAN J NURSING ST, V18, P74; Ellis A, 1992, Intensive Crit Care Nurs, V8, P94, DOI 10.1016/0964-3397(92)90037-K; Garcia-Larrea L, 2018, PROG NEURO-PSYCHOPH, V87, P193, DOI 10.1016/j.pnpbp.2017.10.007; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goksan S, 2018, ELIFE, V7, DOI 10.7554/eLife.37125; Guin P. R., 1997, THESIS; Hafsteinsdottir TB, 2011, PATIENT EDUC COUNS, V85, P14, DOI 10.1016/j.pec.2010.07.046; Hansen R, 1992, AUSTRALASIAN J NEURO, V5, P1; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heron R, 2001, Aust Crit Care, V14, P100, DOI 10.1016/S1036-7314(01)80026-6; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Iankova Andriana, 2006, Emerg Nurse, V14, P30; International Association for the Study of Pain (IASP), 2019, TERMINOLOGY; Jaddoua B. A., 2013, J KUFA NURSING SCI, V3, P133; JENNETT B, 1977, LANCET, V1, P878; Juarez V J, 1995, J Neurosci Nurs, V27, P283; LOWER J, 1992, AM J NURS, V92, P38, DOI 10.1097/00000446-199206000-00015; Manskow US, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3773-7; Mattar I, 2015, NURS CRIT CARE, V20, P98, DOI 10.1111/nicc.12077; Mattar I, 2013, J NEUROSCI NURS, V45, P272, DOI 10.1097/JNN.0b013e31829db970; McLeod Anne, 2004, Br J Nurs, V13, P354; Merskey H, 1994, CLASSIFICATION CHRON; Newell R., 2006, VITAL NOTES NURSES R; Nursing and Midwifery Council, 2018, COD PROF STAND PRACT; Okamura Kumiko, 2014, Br J Nurs, V23, P1068, DOI 10.12968/bjon.2014.23.20.1068; Reith FCM, 2016, J NEUROTRAUM, V33, P89, DOI 10.1089/neu.2014.3843; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; Rueckriegel SM, 2015, ACTA NEUROCHIR, V157, P1329, DOI 10.1007/s00701-015-2470-0; Santos WC, 2016, EINSTEIN-SAO PAULO, V14, P213, DOI 10.1590/S1679-45082016AO3618; Shoqirat N, 2006, Nurs Stand, V20, P41; Singh HKAPB, 2016, NURS RES PRACT, V2016, DOI 10.1155/2016/8056350; STARMARK JE, 1988, HUM TOXICOL, V7, P551, DOI 10.1177/096032718800700606; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Waterhouse C, 2009, BRIT J NEUROSCIENCE, V5, P209; Waterhouse C., 2008, BRIT J NEUROSCIENCE, V4, P492; Woodrow P., 2000, INTENSIVE CARE NURSI; Woodward S, 1997, NURSING TIMES S47, V93, P1	48	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	NOV	2019	28	21-22					3827	3839		10.1111/jocn.15011		SEP 2019	13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	JD9FG	WOS:000485822200001	31343105	Green Accepted, Green Submitted			2022-02-06	
J	Clement, E; Yoon, J; Sutherland, T; Tsang, B; Fawcett, V; Kim, M; Widder, S				Clement, Elizabeth; Yoon, Jenny; Sutherland, Tala; Tsang, Bonnie; Fawcett, Vanessa; Kim, Michael; Widder, Sandy			Effect of a mindfulness intervention on patients admitted after multisystem trauma	TRAUMA-ENGLAND			English	Article						Mindfulness; stress disorders; post-traumatic; trauma centers; mental health; resilience; injuries and wounds	PSYCHOLOGICAL RESILIENCE; DEPRESSION; ANXIETY; PTSD	Background The incidence of depression, anxiety, and post-traumatic stress disorders is reported to be as high as 50% in trauma patients. The perpetual negative emotions and state of mind in these disorders predisposes patients to negative mental health outcomes. Mindfulness, on the other hand, helps people to process their experience and emotions in a non-judgmental manner, and recently, there has been increased utilization of mindfulness-based therapies for the treatment of mental health conditions. This proof-of-concept study evaluates the use of a mindfulness-based online application in patients admitted to the trauma service at a Level 1 Trauma Centre. Methods Trauma patients who were English speaking, over the age of 18, and without brain injury or pre-existing neurocognitive disorder were included. Participants completed the Depression Anxiety Stress Scale (DASS)-21 to assess level of depression, anxiety, and stress, and the Connor-Davidson Resilience Scale (CD-RISC) to assess level of resiliency. Then, after 28 consecutive days of practicing mindfulness using the app 'Stop, Breathe, and Think,' the questionnaires were repeated and an exit survey conducted. Results For this study, 13 participants were enrolled, 2 withdrew, and 5 were lost to follow-up. The mean DASS-21 score at time enrollment was 16.4 and was 11.2 at follow-up (p = 0.10). There were no differences between the level of depression and stress from enrollment to follow-up, but there was significant decrease in anxiety symptoms from 7.2 to 3.0 (<0.05). CD-RISC scores at enrollment and follow-up were 77.8 and 81 (p = 0.23), respectively. At the time of exit interview, 67% of patients continued to use the application three to four times a week and 67% responded they plan to continue using the application. In addition, 83% of patients always or often felt better after practicing mindfulness and stated they would recommend the application to others. Conclusions Mindfulness shows promising potential to decrease psychological distress in trauma patients.	[Clement, Elizabeth; Yoon, Jenny; Sutherland, Tala; Tsang, Bonnie; Fawcett, Vanessa; Kim, Michael; Widder, Sandy] Univ Alberta Hosp, Dept Surg, Edmonton, AB, Canada		Clement, E (corresponding author), Univ Alberta Hosp, 2G2 DTC 2G2,8440-112st NW, Edmonton, AB T6G 2R7, Canada.	eclement@ualberta.net	Kim, Michael Joon/ABB-2067-2020	Kim, Michael Joon/0000-0001-6969-1370; Clement, Elizabeth/0000-0001-8222-4048			Averill LA, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0887-x; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; Glass O, 2019, COMPLEMENT THER CLIN, V34, P240, DOI 10.1016/j.ctcp.2018.12.005; Joy D, 2000, J TRAUMA, V48, P490, DOI 10.1097/00005373-200003000-00020; Kearney DJ, 2012, J CLIN PSYCHOL, V68, P101, DOI 10.1002/jclp.20853; Kim SH, 2013, J CLIN ENDOCR METAB, V98, P2984, DOI 10.1210/jc.2012-3742; Leskela J, 2002, J TRAUMA STRESS, V15, P223, DOI 10.1023/A:1015255311837; Nitzan-Assayag Y, 2015, J ANXIETY DISORD, V36, P25, DOI 10.1016/j.janxdis.2015.07.008; Osman A, 2012, J CLIN PSYCHOL, V68, P1322, DOI 10.1002/jclp.21908; Sakakibara BM, 2009, SPINAL CORD, V47, P841, DOI 10.1038/sc.2009.93; Thompson RW, 2011, TRAUMA VIOLENCE ABUS, V12, P220, DOI 10.1177/1524838011416375; Vincent HK, 2015, PM&R, V7, P978, DOI 10.1016/j.pmrj.2015.03.007; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wingo AP, 2017, PSYCHIAT RES, V249, P206, DOI 10.1016/j.psychres.2017.01.022; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Zhang MF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000897	16	1	1	2	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1460-4086	1477-0350		TRAUMA	Trauma	JUL	2020	22	3					208	212	1460408619872593	10.1177/1460408619872593		SEP 2019	5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	LV9RC	WOS:000485060400001					2022-02-06	
J	Bohanna, I; Fitts, M; Bird, K; Fleming, J; Gilroy, J; Clough, A; Esterman, A; Maruff, P; Potter, M				Bohanna, India; Fitts, Michelle; Bird, Katrina; Fleming, Jennifer; Gilroy, John; Clough, Alan; Esterman, Adrian; Maruff, Paul; Potter, Martin			The Potential of a Narrative and Creative Arts Approach to Enhance Transition Outcomes for Indigenous Australians Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						Traumatic brain injury; Aboriginal and Torres Strait Islander health; narrative; rehabilitation; cultural safety	MENTAL-HEALTH; PEOPLE; REHABILITATION; INDIVIDUALS; EXPERIENCES; WOMEN; SELF	Background: Increasingly, narrative and creative arts approaches are being used to enhance recovery after traumatic brain injury (TBI). Narrative and arts-based approaches congruent with Indigenous storytelling may therefore provide benefit during the transition from hospital to home for some Indigenous TBI patients. This qualitative study explored the use and impact of this approach as part of a larger, longitudinal study of TBI transition with Indigenous Australians. Method: A combined narrative and arts-based approach was used with one Indigenous Australian artist to describe his transition experiences following TBI. Together with the researchers and filmmaking team, the artist was involved in aspects of the process. The artist contributed two paintings, detailing the story of his life and TBI. Based on the artworks, a film was co-created. Following the viewing of the film, impacts of the narrative and arts-based process were examined through semi-structured interviews with the artist, a service provider and a family member. Multiple sources of data were used in the final thematic analysis including transcripts of the interviews and filming, paintings (including storylines) and researcher notes. Results: Positive impacts from the process for the artist included positive challenge; healing and identity; understanding TBI and raising awareness. Discussion: This approach may enable the individual to take ownership over their transition story and to make sense of their life following TBI at a critical point in their recovery. A combined narrative and arts-based approach has potential as a culturally responsive rehabilitation tool for use with Indigenous Australians during the transition period following TBI.	[Bohanna, India] James Cook Univ, Coll Healthcare Sci, Smithfield, Qld, Australia; [Fitts, Michelle] La Trobe Univ, Ctr Alcohol Policy Res, Melbourne, Vic 3086, Australia; [Bird, Katrina] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns Campus, Cairns, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Gilroy, John] Univ Sydney, Hlth Syst & Global Populat Fac Res Grp, Fac Hlth Sci, Sydney, NSW, Australia; [Clough, Alan] James Cook Univ, Australian Inst Trop Hlth & Med, Community Based Hlth Promot & Prevent Studies Grp, Cairns Campus, Cairns, Qld, Australia; [Esterman, Adrian] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Maruff, Paul] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Dept Med Austin Hlth, Heidelberg, Vic, Australia; [Potter, Martin] Deakin Univ, Sch Commun & Creat Arts, Burwood, Vic, Australia		Bohanna, I (corresponding author), James Cook Univ, Coll Healthcare Sci, Smithfield, Qld, Australia.	india.hohanna@jcu.edu.au	Fleming, Jennifer/AAH-5108-2020; Maruff, Paul/AAD-2454-2021; Maruff, Paul/ABA-1673-2020; Potter, Martin/N-7117-2013	Maruff, Paul/0000-0002-6947-9537; Potter, Martin/0000-0002-1681-6341; Esterman, Adrian/0000-0001-7324-9171; gilroy, john/0000-0002-7934-8485	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1081947]	This work was supported by the National Health and Medical Research Council (project grant number 1081947).	Armstrong E, 2012, INT J SPEECH-LANG PA, V14, P271, DOI 10.3109/17549507.2011.663790; Baker FA, 2017, J MUSIC THER, V54, P35, DOI 10.1093/jmt/thw018; Baker FA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00299; Barney Katelyn, 2010, MUSIC POLITICS, V4, P1, DOI [10.3998/mp.9460447.0004.202, DOI 10.3998/MP.9460447.0004.202]; Bohanna I, 2018, BRAIN IMPAIR, V19, P246, DOI 10.1017/BrImp.2018.1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cameron L, 2010, PROCD SOC BEHV, V5, P403, DOI 10.1016/j.sbspro.2010.07.112; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fitts M. S., BRAIN IMPAIRMENT; Gauld S., 2018, DISABILITY REHABILIT, V4; Geia LK, 2013, CONTEMP NURSE, V46, P13, DOI 10.5172/conu.2013.46.1.13; Hogan BA, 1999, NEUROREHABILITATION, V13, P21; Hovane V, 2014, WORKING TOGETHER ABO, p[509, 509]; Hunt J., 2013, ENGAGING INDIGENOUS; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Lakhani A, 2017, BRAIN INJURY, V31, P1718, DOI 10.1080/02699052.2017.1374468; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lund TW., 1996, NARRATIVE SOLUTIONS; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; MORRIS SD, 2004, J COGN REHABIL, V22, P15; Muirhead S., 2012, ART WELLNESS IMPORTA; Nagel T, 2007, ADV MENT HEALTH, V6, P119, DOI 10.5172/jamh.6.2.119; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Nalder E, 2012, BRAIN INJURY, V26, P1381, DOI 10.3109/02699052.2012.676225; Ownsworth T., 2014, SELF IDENTITY BRAIN; Perruzza N, 2010, BRIT J OCCUP THER, V73, P261, DOI 10.4276/030802210X12759925468943; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rasmussen MK, 2018, ADV MENT HEALTH, V16, P141, DOI 10.1080/18387357.2017.1413950; Reynolds F, 2003, DISABIL REHABIL, V25, P785, DOI 10.1080/0963828031000093486; Symons J, 2011, BRIT J OCCUP THER, V74, P44, DOI 10.4276/030802211X12947686093729; Tamplin J., 2006, NORD J MUSIC THER, V15, P177, DOI [10.1080/08098130609478164, DOI 10.1080/08098130609478164]; Tamplin J, 2016, NORD J MUSIC THER, V25, P111, DOI 10.1080/08098131.2015.1011208; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Thomas DR, 2017, QUAL RES PSYCHOL, V14, P23, DOI 10.1080/14780887.2016.1219435; Walker M, 2014, HEALTH CARE WOMEN IN, V35, P1216, DOI 10.1080/07399332.2013.815754; Willox AC, 2013, QUAL RES, V13, P127, DOI 10.1177/1468794112446105	38	1	1	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2019	20	2			SI		160	170	PII S1443964619000251	10.1017/BrImp.2019.25			11	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	IU7UQ	WOS:000483789200005					2022-02-06	
J	Bonaventure, PL; Lauzier, F; Zarychanski, R; Boutin, A; Shemilt, M; Saxena, M; Zolfagari, P; Griesdale, D; Menon, DK; Stanworth, S; English, S; Chasse, M; Fergusson, DA; Moore, L; Kramer, A; Robitaille, A; Myburgh, J; Cooper, J; Hutchinson, P; Turgeon, AF				Bonaventure, Paule Lessard; Lauzier, Francois; Zarychanski, Ryan; Boutin, Amelie; Shemilt, Michele; Saxena, Manoj; Zolfagari, Parjam; Griesdale, Donald; Menon, David K.; Stanworth, Simon; English, Shane; Chasse, Michael; Fergusson, Dean A.; Moore, Lynne; Kramer, Andreas; Robitaille, Amelie; Myburgh, John; Cooper, Jamie; Hutchinson, Peter; Turgeon, Alexis F.		Canadian Critical Care Trials Grp; Canadian Traumatic Brain Injury R	Red blood cell transfusion in critically ill patients with traumatic brain injury: an international survey of physicians' attitudes	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							HEMOGLOBIN THRESHOLDS; ANEMIA; MULTICENTER; VIGNETTES; MORTALITY; OUTCOMES	Introduction Restrictive transfusion strategies have been advocated in critically ill patients. Nevertheless, considerable uncertainty exists regarding optimal transfusion thresholds in traumatic brain injury (TBI) patients because the injured brain is susceptible to hypoxemic damage. We aimed to identify the determinants of red blood cell (RBC) transfusion and the perceived optimal transfusion thresholds in adult patients with moderate-to-severe TBI. Methods We conducted an electronic, self-administered survey targeting critical care specialists and neurosurgeons from Canada, Australia, and the United Kingdom caring for TBI patients. The questionnaire was initially developed by a panel of experts using a structured process (domains/items generation and reduction). The questionnaire was validated for clinical sensibility, reliability, and content. Results The response rate was 28.7% (218/760). When presented with the hypothetical scenario of a young adult TBI patient, a wide range of transfusion practices was observed, with 47 (95% confidence interval [CI], 41 to 54)% favouring RBC transfusion at a hemoglobin level of <= 70 g center dot L-1 in the acute phase of care, while 73 (95% CI, 67 to 79)% would use this trigger in the plateau phase of care. Multiple trauma, neuro-monitoring data, hemorrhagic shock, and planned surgery were the main factors that influenced the need for transfusion. The lack of clinical evidence and guidelines was responsible for uncertainty regarding RBC transfusion strategies in this patient population. Conclusion In our survey about critically ill TBI patients, transfusion practice was found to be mainly influenced by the acuity of care, patient characteristics, and neuro-monitoring. Clinical equipoise regarding optimal transfusion strategy is believed to be mainly attributed to the lack of clear clinical evidence and guidelines. Appropriate randomized-controlled trials are required to determine the optimal transfusion strategies in TBI patients.	[Bonaventure, Paule Lessard; Lauzier, Francois; Boutin, Amelie; Shemilt, Michele; Moore, Lynne; Robitaille, Amelie; Turgeon, Alexis F.] Univ Laval, Hop Enfant Jesus, CHU Quebec,Traumatol Emergency Crit Care Med, Res Ctr,Populat Hlth & Optimal Hlth Practices Res, 1401,18e Rue, Quebec City, PQ G1J 1Z4, Canada; [Bonaventure, Paule Lessard] Univ Laval, Dept Surg, Div Neurosurg, Quebec City, PQ, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Dept Med, Quebec City, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Fac Med, Dept Internal Med, Sect Crit Care Med,Sect Haematol, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Fac Med, Sec Med Oncol, Winnipeg, MB, Canada; [Saxena, Manoj; Myburgh, John; Cooper, Jamie] George Inst Global Hlth, Sydney, NSW, Australia; [Zolfagari, Parjam; Menon, David K.; Hutchinson, Peter] Univ Cambridge, Cambridge Univ Hosp Trust, Addenbrookes Hosp, Neurocrit Care Unit, Cambridge, England; [Griesdale, Donald] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Stanworth, Simon] Oxford Univ Hosp, Oxford Biomed Res Ctr, NIHR, Oxford, England; [English, Shane; Fergusson, Dean A.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [English, Shane] Univ Ottawa, Dept Med Crit Care, Ottawa, ON, Canada; [Chasse, Michael] Univ Montreal, CHUM Res Ctr, Montreal, PQ, Canada; [Moore, Lynne] Univ Laval, Dept Prevent & Social Med, Quebec City, PQ, Canada; [Kramer, Andreas] Foothills Med Ctr, Dept Crit Care Med, Calgary, AB, Canada; [Cooper, Jamie] Alfred Hosp, Melbourne, Vic, Australia		Turgeon, AF (corresponding author), Univ Laval, Hop Enfant Jesus, CHU Quebec,Traumatol Emergency Crit Care Med, Res Ctr,Populat Hlth & Optimal Hlth Practices Res, 1401,18e Rue, Quebec City, PQ G1J 1Z4, Canada.; Turgeon, AF (corresponding author), Univ Laval, Div Crit Care Med, Dept Anesthesiol & Crit Care Med, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	Chasse, Michael/Y-7820-2019; English, Shane/P-9187-2019; Zarychanski, Ryan/AAB-6369-2022; Cooper, D. James/G-7961-2013; Lauzier, Francois/B-9237-2015	English, Shane/0000-0002-9477-6146; Cooper, D. James/0000-0002-5872-9051; Lauzier, Francois/0000-0002-6530-5513; Chasse, Michael/0000-0001-7075-1924; Boutin, Amelie/0000-0003-1907-2920	CHU de Quebec Universite Laval Foundation (Killimanjaro Fund); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [354039]; CIHRCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec; Traumatology Research Consortium of the FRQS; Canada Research Chair in Critical Neurology and Trauma; Canadian Critical Care Trials Group - CIHR	This work was funded by the CHU de Quebec Universite Laval Foundation (Killimanjaro Fund) and by a Foundation Scheme Grant (354039) from the Canadian Institutes of Health Research (CIHR). Dr Lessard Bonaventure is the recipient of a training award from the CIHR. Drs. Lauzier, Moore, and Chasse are recipients of a research career award from the Fonds de Recherche du Quebec - Sante (FRQS). Drs. Turgeon, Lauzier, and Moore are supported by the Traumatology Research Consortium of the FRQS. Dr. Turgeon is the chairholder of the Canada Research Chair in Critical Neurology and Trauma. The Canadian Traumatic Brain Injury Research Consortium is funded by a Team Grant from the CIHR, and the Canadian Critical Care Trials Group is funded by a Community Development Grant from the CIHR.	American Association for Public Opinion Research (AAPOR), 2011, STAND DEF FIN DISP C; Badenes R, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1748-4; Boutin A, 2018, J CRIT CARE, V45, P133, DOI 10.1016/j.jcrc.2018.01.023; Boutin A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014472; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Bryson GL, 2012, CAN J ANESTH, V59, P736, DOI 10.1007/s12630-012-9727-3; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Groves R., 2004, SURVEY METHODOLOGY; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Karam O, 2014, TRANSFUSION, V54, P1125, DOI 10.1111/trf.12393; Kramer AH, 2011, CRIT CARE, V15, DOI 10.1186/cc9977; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Yamal JM, 2015, J NEUROTRAUM, V32, P1239, DOI 10.1089/neu.2014.3752; Yang Z, 2014, STAT MED, V33, P2612, DOI 10.1002/sim.6113; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	38	1	1	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	SEP	2019	66	9					1038	1048		10.1007/s12630-019-01369-w			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	IQ4UC	WOS:000480745300006	31012052	Bronze			2022-02-06	
J	Butler-Coyne, H; Shanmuganathan-Felton, V; Taylor, J				Butler-Coyne, Hannah; Shanmuganathan-Felton, Vaithehy; Taylor, Jamie			Mental Health in Equestrian Sport	JOURNAL OF CLINICAL SPORT PSYCHOLOGY			English	Article						equestrian sport; mental health; psychological wellbeing; qualitative research; sport psychology	COACH-ATHLETE ATTACHMENT; PERCEPTIONS; PREVALENCE; CONCUSSION; DEPRESSION; DISORDERS; STRESS	Equestrian media is showing an increasing interest in the impact of mental health on performance and general wellbeing of equestrian athletes. This study explores the awareness of mental health difficulties and psychological wellbeing within equestrian sport from the perspectives of equestrian athletes, instructors/coaches and parents. The exploratory nature of the research offered opportunity to use a dual approach including e-surveys and semi-structured interviews. Analysis of the qualitative data identified five key themes (Emotional Wellbeing in Balance; Emotional Wellbeing Imbalance; Wellbeing Imbalance-Impact on Equestrian Sportspeople; Impact of Equestrian Sport on Wellbeing; Regaining Balance) and 22 sub-themes. The findings determine a compelling need for education, promotion of sharing experiences, facilitation of specialist (clinical and sport) professional training and intervention as well as a review of regulations from equestrian Governing Bodies.	[Butler-Coyne, Hannah; Taylor, Jamie] Univ Cent Lancashire, Sch Psychol, Preston, Lancs, England; [Shanmuganathan-Felton, Vaithehy] Univ Roehampton, Whitelands Coll, Dept Life Sci, London, England		Butler-Coyne, H (corresponding author), Univ Cent Lancashire, Sch Psychol, Preston, Lancs, England.	hbutler-coyne@uclan.ac.uk					[Anonymous], 2015, BBC SPORT       1005; Arthur-Cameselle J, 2017, EAT DISORD, V25, P199, DOI 10.1080/10640266.2016.1258940; Bar KJ, 2013, EUR ARCH PSY CLIN N, V263, pS205, DOI 10.1007/s00406-013-0458-4; Biddle S., 2008, PSYCHOL PHYS ACTIVIT; Biggin IJR, 2017, J CLIN SPORT PSYCHOL, V11, P126, DOI [10.1123/JCSP.2016-0017, 10.1123/jcsp.2016-0017]; Bizub AL, 2003, PSYCHIATR REHABIL J, V26, P377, DOI 10.2975/26.2003.377.384; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Caulfield MJ, 2008, J SPORT SCI, V26, P877, DOI 10.1080/02640410701837349; Creswell JW., 2014, RES DESIGN QUALITATI, V4; Daley A, 2008, J CLIN PSYCHOL MED S, V15, P140, DOI 10.1007/s10880-008-9105-z; Davis L, 2014, J SPORT SCI, V32, P1454, DOI 10.1080/02640414.2014.898183; Dolan E, 2012, J BONE MINER METAB, V30, P164, DOI 10.1007/s00774-011-0297-1; Dosil J., 2008, EATING DISORDERS ATH; Felton L, 2017, J CLIN SPORT PSYCHOL, V11, P304, DOI 10.1123/jcsp.2016-0013; Funnell P., 2004, P FUNNELL AUTOBIOGRA; Gardner F., 2006, CLIN SPORT PSYCHOL; Gulliver A, 2015, J SCI MED SPORT, V18, P255, DOI 10.1016/j.jsams.2014.04.006; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-157; Gulliver Amelia, 2012, J Med Internet Res, V14, pe69, DOI 10.2196/jmir.1864; Hammond T, 2013, CLIN J SPORT MED, V23, P273, DOI 10.1097/JSM.0b013e318287b870; Hughes L, 2012, BRIT J PSYCHIAT, V200, P95, DOI 10.1192/bjp.bp.111.095976; Junge A., 2016, BMJ OPEN SPORT EXERC, V2, pE000087, DOI [10.1136/bmjsem-2015-000087, DOI 10.1136/BMJSEM-2015-000087]; Kamm RL, 2008, J CLIN SPORT PSYCHOL, V2, P178, DOI 10.1123/jcsp.2.2.178; Landolt K, 2017, QUAL RES SPORT EXERC, V9, P583, DOI [10.1080/2159676X.2017.1340329, 10.1080/2159676x.2017.1340329]; Martin SB., 2004, INT J SPORT EXERC PS, V2, P146, DOI [10.1080/1612197X.2004.9671738, DOI 10.1080/1612197X.2004.9671738]; Mathieson A, 2015, HORSE HOUND     0511; McBride SD, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-180; Milroy JJ, 2018, J CLIN SPORT PSYCHOL, V12, P268, DOI 10.1123/jcsp.2017-0029; Mind, 2014, MENT HLTH EL SPORT; Monsma E. V, 2013, J ATHLETIC ENHANCEME, V2, P2, DOI [10.4172/2324-9080.1000107, DOI 10.4172/2324-9080.1000107]; Nicholls AR, 2011, J CLIN SPORT PSYCHOL, V5, P211, DOI 10.1123/jcsp.5.3.211; Peluso Marco Aurélio Monteiro, 2005, Clinics, V60, P61, DOI 10.1590/S1807-59322005000100012; Pensguard A. M., 2000, J SPORTS SCI, V8, P183; Plateau CR, 2014, PSYCHOL SPORT EXERC, V15, P721, DOI 10.1016/j.psychsport.2013.11.004; Plymoth B, 2012, SPORT SOC, V15, P335, DOI 10.1080/17430437.2012.653204; Pummell B, 2008, PSYCHOL SPORT EXERC, V9, P427, DOI 10.1016/j.psychsport.2007.07.004; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rice SM, 2016, SPORTS MED, V46, P1333, DOI 10.1007/s40279-016-0492-2; Schultz PN, 2007, HEALTH SOC CARE COMM, V15, P265, DOI 10.1111/j.1365-2524.2006.00684.x; Shanmugam V, 2013, INT J SPORT EXERC PS, V11, P24, DOI 10.1080/1612197X.2012.724197; Shanmugam V, 2011, J CLIN SPORT PSYCHOL, V5, P166, DOI 10.1123/jcsp.5.2.166; Tenenbaum G, 2002, J SPORT EXERCISE PSY, V24, P271, DOI 10.1123/jsep.24.3.271; Thompson K, 2016, INT REV SOCIOL SPORT, V51, P97, DOI 10.1177/1012690213513266; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Torres-McGehee TM, 2011, J ATHL TRAINING, V46, P431; Vamplew W., 2012, PERMANCE ENHANCEM, V1, P51, DOI [10.1016/j.peh.2012.08.002, DOI 10.1016/J.PEH.2012.08.002]; Wolframm I., 2010, J VET BEHAV, V5, P211, DOI [10.1016/j.jveb.2009.11.012, DOI 10.1016/J.JVEB.2009.11.012]	48	1	1	5	29	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1932-9261	1932-927X		J CLIN SPORT PSYCHOL	J. Clin. Sport Psychol.	SEP	2019	13	3					405	420		10.1123/jcsp.2018-0002			16	Psychology, Applied	Social Science Citation Index (SSCI)	Psychology	IX5XX	WOS:000485758000005		Green Accepted, Green Submitted			2022-02-06	
J	Capo-Lugo, CE; Kisala, PA; Boulton, AJ; Choi, SW; Heinemann, AW; Tulsky, DS				Capo-Lugo, Carmen E.; Kisala, Pamela A.; Boulton, Aaron J.; Choi, Seung W.; Heinemann, Allen W.; Tulsky, David S.			Measuring Self-Reported Physical Function in Individuals With TBI: Development of the TBI-QOL Mobility and Upper Extremity Item Banks and Short Forms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mobility limitation; outcome assessment (healthcare); quality of life; statistical factor analysis; traumatic brain injury; upper limb	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; RESPONSE THEORY; OUTCOMES MEASUREMENT; PROMIS; RELIABILITY; VALIDITY; MODERATE; PROGRESS; IMPACT	Objectives: To describe the development and field testing of the patient-reported outcome measures of Mobility and Upper Extremity function from the Traumatic Brain Injury Quality of Life (TBI-QOL) measurement system, and to evaluate the use of computer adaptive testing. Setting: Five rehabilitation facilities funded as part of the TBI Model Systems network. Participants: Individuals with complicated mild, moderate, or severe traumatic brain injury (n = 590). Interventions: Not available. Outcome Measures: TBI-QOL Mobility and Upper Extremity item banks. Results: Item response theory and factor analyses supported the unidimensionality of the Mobility and Upper Extremity banks. Descriptive statistics showed a ceiling effect for both measures. Simulated computer adaptive tests (CATs) showed that measurement precision was maintained across administration formats for both measures. The Upper Extremity CAT showed a loss of precision for individuals without impairment and that a higher number of items were required to achieve sufficiently precise measurement, compared to the Mobility CAT. Conclusions: The TBI-QOL Upper Extremity and Mobility item banks achieved good breadth of coverage, particularly among those individuals who have experienced some degree of functional limitation. The use of CAT administration minimizes respondent burden, while allowing for the comprehensive assessment of adults with TBI. The combined use of the TBI-QOL with performance-based measures could guide the development of targeted rehabilitation treatments.	[Capo-Lugo, Carmen E.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA; [Kisala, Pamela A.; Boulton, Aaron J.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Choi, Seung W.] Univ Texas Austin, Dept Educ Psychol, Austin, TX 78712 USA; [Heinemann, Allen W.] Northwestern Univ, Ctr Rehabil Outcomes Res, Shirley Ryan AbilityLab, Feinberg Sch Med, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA		Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038, H133A120100]	This study was supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this article was provided by NIDILRR grant # H133A120100.	BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Brown M.W., 1993, SOCIOL METHOD RES, P136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2000, MED CARE, V38, P66; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Cohen J, 1977, STAT POWER ANAL BEHA; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Hays RD, 2013, ARCH PHYS MED REHAB, V94, P2291, DOI 10.1016/j.apmr.2013.05.014; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Muthen B. O., 1998, MPLUS USERS GUIDE, V7th; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Poritz JMP, 2020, ARCH PHYS MED REHAB, V101, P54, DOI 10.1016/j.apmr.2017.11.018; Quatrano LA, 2011, ARCH PHYS MED REHAB, V92, pS7, DOI 10.1016/j.apmr.2010.08.032; Rafek M, 2018, ADV SCI LETT, V24, P2362, DOI 10.1166/asl.2018.10954; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P62, DOI 10.1016/j.apmr.2017.04.016; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; STOCKING ML, 1983, APPL PSYCH MEAS, V7, P201, DOI 10.1177/014662168300700208; THISSEN D, 2003, MULTILOG VERSION 7 C; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P281, DOI 10.1097/HTR.0000000000000531; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077	41	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		340	352		10.1097/HTR.0000000000000511			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100014	31498232				2022-02-06	
J	Debus, F; Lefering, R; Lechler, P; Ruchholtz, S; Frink, M				Debus, F.; Lefering, R.; Lechler, P.; Ruchholtz, S.; Frink, M.		TraumaRegister DGU	Early clinical care strategy for severely injured patients with abdominal trauma	CHIRURG			German	Article						Polytrauma; Severely injured; Abdominal trauma; Laparoscopy; Laparotomy; Algorithm	NEUROTRAUMA PATIENTS; LAPAROSCOPY; DIAGNOSIS; MANAGEMENT; BLUNT; EMERGENCIES; GUIDELINES	Background The presence of abdominal injuries has a major impact on the mortality of severely injured patients. For injuries that require surgery, laparotomy is still the gold standard for early surgical care; however, there is increasing evidence that laparoscopy may be an alternative in the early clinical care of polytrauma patients. Objective The present registry-based study analyzed the utilization and the outcome of laparoscopy in severely injured patients with abdominal trauma in Germany. Material and methods A retrospective analysis of 12,447 patients retrieved from the TraumaRegister DGU (R) (TR-DGU) was performed. The primary inclusion criteria were an injury severity score (ISS)& x202f;>= 9 and an abbreviated injury scale (AIS) [abdomen]& x202f;>= 1. The included patients were grouped according to early treatment management: (1) laparoscopy, (2) laparotomy and (3) non-operative management (NOM). Finally, group-specific patient characteristics and outcome were analyzed. Results The majority of patients were treated by NOM (52.4%, n & x202f;= 6069), followed by laparotomy (50,6%, n & x202f;= 6295) and laparoscopy (0.7%, n & x202f;= 83). The majority of laparoscopies were performed in patients with an AIS [abdomen]& x202f;<= 3 (86.7%). The ISS of the laparoscopy group was significantly lower compared to that of the laparotomy and NOM groups (ISS 23.4 vs. 34.5 vs. 28.2, respectively, p & x202f;<= 0.001). The standardized mortality rate (SMR), defined as the ratio between observed and expected mortality, was lowest in the patients receiving laparoscopy followed by laparotomy and NOM (SMR 0.688 vs. 0.931 vs. 0.932, respectively, p-value & x202f;= 0.2128) without achieving statistical significance. Conclusion Despite being rarely employed the data indicate the effectiveness of laparoscopy for the early treatment of severely injured, hemodynamically stable patients with an AIS [abdomen]& x202f;<= 3.	[Debus, F.; Lechler, P.; Ruchholtz, S.; Frink, M.] Univ Klinikum Giessen & Marburg, Zentrum Orthopadie & Unfallchirurg, Baldingerstr, D-35043 Marburg, Germany; [Lefering, R.] Univ Witten Herdecke, Campus Koln Merheim, IFOM, Cologne, Germany; [TraumaRegister DGU] DGU, Sekt NIS, Sekt Notfall Intens Med & Schwerverletztenversorg, Berlin, Germany		Frink, M (corresponding author), Univ Klinikum Giessen & Marburg, Zentrum Orthopadie & Unfallchirurg, Baldingerstr, D-35043 Marburg, Germany.	frink@med.uni-marburg.de					Agrusa A, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-33; [Anonymous], 2011, S3 LEITL POL SCHWERV; Athanassiou L, 2002, CRIT CARE MED, V30, P2402, DOI 10.1097/00003246-200210000-00050; Cengiz H, 2014, J OBSTET GYNAECOL, V34, P616, DOI 10.3109/01443615.2014.919575; Choi YB, 2003, SURG ENDOSC, V17, P421, DOI 10.1007/s00464-002-8808-8; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Cohen A, 2013, INT J GYNECOL OBSTET, V123, P139, DOI 10.1016/j.ijgo.2013.05.014; Demetriades D, 2006, ANN SURG, V244, P620, DOI 10.1097/01.sla.0000237743.22633.01; Di Saverio S, 2014, J TRAUMA ACUTE CARE, V77, P338, DOI 10.1097/TA.0000000000000288; Galizia G, 2001, SURG ENDOSC-ULTRAS, V15, P477, DOI 10.1007/s004640000343; Groven Sigrid, 2014, J Trauma Manag Outcomes, V8, P9, DOI 10.1186/1752-2897-8-9; Hori Y, 2008, SURG ENDOSC, V22, P1353, DOI [10.1007/s00464-008-9759-5, 10.1007/s00464-008-9757-7]; Johnson JJ, 2013, AM J SURG, V205, P317, DOI 10.1016/j.amjsurg.2012.10.021; Kaban GK, 2008, SURG INNOV, V15, P26, DOI 10.1177/1553350608314664; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Khubutiya MS, 2013, SURG LAPARO ENDO PER, V23, P507, DOI 10.1097/SLE.0b013e3182937c37; Lee PC, 2014, SURG INNOV, V21, P155, DOI 10.1177/1553350612474496; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Mallat AF, 2008, AM SURGEON, V74, P1166; Prichayudh S, 2014, INJURY; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; ROTONDO MF, 1993, J TRAUMA, V35, P550, DOI 10.1097/00005373-199310000-00009; Rozycki GS, 2010, J TRAUMA, V68, P1019, DOI 10.1097/TA.0b013e3181da78de; Sauerland S, 2006, SURG ENDOSC, V20, P14, DOI 10.1007/s00464-005-0564-0; Shah M, 2014, INJURY, V45, P128, DOI 10.1016/j.injury.2013.08.015; Shapiro MB, 2000, J TRAUMA, V49, P969, DOI 10.1097/00005373-200011000-00033; SMITH RS, 1993, ARCH SURG-CHICAGO, V128, P1102; Zarour A, 2014, INT J SURG, V12, P340, DOI 10.1016/j.ijsu.2014.01.011	29	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-4722	1433-0385		CHIRURG	Chirurg	SEP	2019	90	9			SI		752	757		10.1007/s00104-019-0817-4			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IT5LE	WOS:000482903500009	30963210				2022-02-06	
J	Dooley, B; Stagnitti, K; Galvin, J				Dooley, Bridget; Stagnitti, Karen; Galvin, Jane			An investigation of the pretend play abilities of children with an acquired brain injury	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Cognitive fatigue; symbolic play; assessment; occupational therapy	COGNITIVE FATIGUE; PARTICIPATION; PREDICTORS; SKILLS; QUALITY; MIND	Introduction This study describes the self-initiated pretend play abilities of children who had sustained an acquired brain injury. Method A non-experimental study was conducted with 26 children with acquired brain injury (15 females, mean age 5.08 years, SD 1.58 years), who were out of post-traumatic amnesia, able to sit independently and engage in a play session. The children were assessed individually on one occasion using the Child-Initiated Pretend Play Assessment. Findings All children in the study presented with pretend play deficits, particularly in symbolic play. Inattention, distractibility and limited concentration were common behaviours of the children. Three quarters of the sample (76.48%) were unable to complete the time of the assessment. For many of the children the cessation of their play was sudden and abrupt, even for those who showed complex play ability. Conclusion Cognitive fatigue is argued to have impacted on the children's play ability due to the considerable amount of cognitive effort required to engage in pretend play. Implications for intervention are to offer short sessions for children with acquired brain injury and pay particular attention to a child's symbolic play within pretend play ability.	[Dooley, Bridget; Stagnitti, Karen] Deakin Univ, Sch Hlth & Social Dev, Geelong, Vic, Australia; [Galvin, Jane] Victorian Paediat Rehabil Serv, Melbourne, Vic, Australia		Dooley, B (corresponding author), Sch Hlth & Social Dev, 1 Gheringhap St, Geelong, Vic, Australia.	bridget.dooley@deakin.edu.au		Sarah, Bridget/0000-0002-0464-1417			Agresti A., 2015, FDN LINEAR GEN LINEA; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Bergen D., 2002, EARLY CHILDHOOD RES, V4, P1; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Daniel WW, 2005, BIOSTATISTICS FDN AN, V8th; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Fink N, 2012, DEV NEUROREHABIL, V15, P336, DOI 10.3109/17518423.2012.655798; Galvin J, 2010, BRAIN INJURY, V24, P1008, DOI 10.3109/02699052.2010.489793; Galvin J, 2009, DEV NEUROREHABIL, V12, P352, DOI 10.3109/17518420903087293; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; German TP, 2004, J COGNITIVE NEUROSCI, V16, P1805, DOI 10.1162/0898929042947892; Hughes C, 2004, SOC DEV, V13, P590, DOI 10.1111/j.1467-9507.2004.00285.x; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Lillard A, 2010, HDB CHILDHOOD COGNIT; Lin SK, 2017, EUR CHILD ADOLES PSY, V26, P1187, DOI 10.1007/s00787-017-0973-3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McKinlay A, 2016, BRAIN INJURY, V30, P1656, DOI 10.1080/02699052.2016.1201592; Nicolopoulou A, 2013, AM J PLAY, V6, P55; O'Sullivan, 2012, INT J PLAY, V1, P197, DOI [DOI 10.1080/21594937.2012.693384, 10.1080/21594937.2012.693384]; Parham L. D, 2008, PLAY OCCUPATIONAL TH; Perry B.D., 2006, SOCIAL WORK PRACTICE, P27; Pfeifer LI, 2011, PHYS OCCUP THER PEDI, V31, P390, DOI 10.3109/01942638.2011.572149; Rushworth N, 2008, BRAIN INJURY AUSTR P; Ryan NP, 2016, CORTEX, V83, P222, DOI 10.1016/j.cortex.2016.07.020; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P1142, DOI 10.1111/j.1467-7687.2011.01065.x; Stagnitti K, 2000, Can J Occup Ther, V67, P291; Stagnitti K, 2004, AM J OCCUP THER, V58, P93, DOI 10.5014/ajot.58.1.93; Stagnitti K, 2017, CREATIVE PSYCHOTHERA, P185; Stagnitti K., 2007, CHILD INITIATED PRET; Stagnitti K, 2015, INT J SPEECH-LANG PA, V17, P148, DOI 10.3109/17549507.2014.941934; Swindells D., 2006, AUST OCCUP THER J, V53, P314, DOI [10.1111/j.1440-1630.2006.00592.x, DOI 10.1111/J.1440-1630.2006.00592.X]; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Whitehead C, 2009, SOC COGN AFFECT NEUR, V4, P369, DOI 10.1093/scan/nsp021; World Health Organization, 2007, INT CLASS FUNCT DIS	39	1	1	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	SEP	2019	82	9					588	596		10.1177/0308022619836941			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IU3OB	WOS:000483494800008					2022-02-06	
J	Fekri, A; Jahan, A; Salimi, MM; Oskouei, AE				Fekri, Atefeh; Jahan, Ali; Salimi, Maryam Moghadam; Oskouei, Ali E.			Short-term Effects of Transcranial Near-Infrared Photobiomodulation on Motor Performance in Healthy Human Subjects: An Experimental Single-Blind Randomized Clinical Trial	JOURNAL OF LASERS IN MEDICAL SCIENCES			English	Article						Transcranial; Cytochrome-c oxidase; Laser; Motor cortex	TRAUMATIC BRAIN-INJURY; LEVEL LIGHT THERAPY; CEREBRAL-BLOOD-FLOW; CYTOCHROME-OXIDASE; LASER STIMULATION; EMBOLIC STROKES; LED THERAPY; ASYMMETRY; SPECIALIZATION; IMPROVEMENTS	Introduction: Transcranial near-infrared photobiomodulation (NIR-PBM) is a new noninvasive procedure which transcranially applies a near-infrared wavelength to the scalp with a laser or a light-emitting diode (LED) source. Improvement in the neurological or psychological symptoms has been reported following light irradiation. However, to our knowledge, there is no study to investigate the effects of transcranial NIR-PBM on motor performance directly. Therefore, the objective of this study was to investigate the short-term effects of transcranial NIR-PBM on motor performance in healthy human subjects. Methods: In this experimental single-blind randomized clinical trial study, 56 right-handed healthy participants, whose ages ranged from 18 to 30, were randomly assigned to (1) Real transcranial NIR-PBMC3 group (n=14), (2) Sham transcranial NIR-PBMC3 group (n=14), (3) Real transcranial NIR-PBMC4 group (n=14), and (4) Sham transcranial NIR-PBMC4 group (n=14). We applied the 808 nm laser with irradiation energy density of 60 J/cm(2) and power density of 200 mw/cm(2) to the C3 or C4 points of the scalp. The number of finger taps as an indicator of motor performance was assessed by the finger-tapping test (FTT) before and after irradiation of transcranial NIR-PBM on the corresponding points of the scalp for 5 minutes. Results: The results showed that the number of finger taps in both right and left hands following the use of transcranial NIR-PBM in the real transcranial NIR-PBMC3 group significantly increased (P < 0.05). Conclusion: We concluded that using transcranial NIR-PBM with a laser source on C3 point of the motor cortex in right-handed healthy people can increase the number of finger taps in both hands as an indicator of motor performance improvement.	[Fekri, Atefeh; Salimi, Maryam Moghadam] Tabriz Univ Med Sci, Fac Rehabil, Dept Physiotherapy, Tabriz, Iran; [Jahan, Ali] Tabriz Univ Med Sci, Fac Rehabil, Dept Speech Therapy, Tabriz, Iran; [Oskouei, Ali E.] Tabriz Univ Med Sci, Phys Med & Rehabil Res Ctr, Tabriz, Iran		Oskouei, AE (corresponding author), Tabriz Univ Med Sci, Phys Med & Rehabil Res Ctr, Tabriz, Iran.; Oskouei, AE (corresponding author), Tabriz Univ Med Sci, Dept Physiotherapy, Phys Med & Rehabil Res Ctr, Tabriz, Iran.	eterafoskouei@tbzmed.ac.ir	Jahan, Ali/L-8744-2017		Tabriz University of Medical Sciences	This study was supported by Tabriz University of Medical Sciences. The authors acknowledge the participants who participated in this study.	ALIPOUR A, 2006, DEV PSYCHOL J, V2, P197; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; BORNSTEIN RA, 1987, J NERV MENT DIS, V175, P229, DOI 10.1097/00005053-198704000-00007; Cavill S, 2003, BRAIN COGNITION, V53, P149, DOI 10.1016/S0278-2626(03)00098-8; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; De Gennaro L, 2004, CLIN NEUROPHYSIOL, V115, P1305, DOI 10.1016/j.clinph.2004.01.014; Duan R, 2003, LASER SURG MED, V33, P199, DOI 10.1002/lsm.10216; Elias L. J., 2006, NEUROPSYCHOLOGY CLIN; HERRON J, 1979, SCIENCE, V205, P1285, DOI 10.1126/science.472745; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Jahan A, 2019, LASER MED SCI, V34, P1193, DOI 10.1007/s10103-018-02710-3; Kawashima R, 1997, NEUROREPORT, V8, P1729, DOI 10.1097/00001756-199705060-00032; KAWASHIMA R, 1993, BRAIN RES, V623, P33, DOI 10.1016/0006-8993(93)90006-9; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lee HI, 2016, RESTOR NEUROL NEUROS, V34, P201, DOI 10.3233/RNN-150559; Lewin JS, 1996, J COMPUT ASSIST TOMO, V20, P695, DOI 10.1097/00004728-199609000-00002; Moghadam HS, 2017, IRAN RED CRESCENT ME, V19, DOI 10.5812/ircmj.44513; Moro C, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-40; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; de Sousa MVP, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.015003; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Sabate M, 2004, NEUROPSYCHOLOGIA, V42, P1041, DOI 10.1016/j.neuropsychologia.2003.12.015; Saimpont A, 2016, EUR J NEUROSCI, V43, P113, DOI 10.1111/ejn.13122; Salehpour F, 2019, BRAIN RES BULL, V144, P213, DOI 10.1016/j.brainresbull.2018.10.010; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Salehpour F, 2018, BRAIN RES, V1682, P36, DOI 10.1016/j.brainres.2017.12.040; Salgado ASI, 2015, LASER MED SCI, V30, P339, DOI 10.1007/s10103-014-1669-2; Salgado SIA, 2015, J BIOENG BIOMED SCI, V5, P1; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wang XL, 2017, J CEREBR BLOOD F MET, V37, P3789, DOI 10.1177/0271678X17691783; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013	47	1	1	0	3	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MEDICINE	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19395, TEHRAN, 4618, IRAN	2008-9783	2228-6721		J LASERS MED SCI	J. Lasers Med. Sci.	FAL	2019	10	4					317	323		10.15171/jlms.2019.51			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	JE7VU	WOS:000490899200010	31875125	gold, Green Published			2022-02-06	
J	Ferkel, RC; Hutchinson, ZT; Razors, S; True, L; Zupin, D; Jones, LM; Judge, LW				Ferkel, Rick C.; Hutchinson, Zach T.; Razors, Selen; True, Larissa; Zupin, Dagny; Jones, Lani M.; Judge, Lawrence W.			The Benefits of Health-Related Fitness Education in Secondary PE	PHYSICAL EDUCATOR-US			English	Article							SELF-DETERMINATION THEORY; SCHOOL PHYSICAL-EDUCATION; ACADEMIC MOTIVATION; EXERCISE; SPORT; BEHAVIOR; PARTICIPATION; ADOLESCENCE; CONCUSSIONS; POPULATION	The health status and physical activity levels in the United States of adolescents and adults is disheartening. Many health professionals have been using the term exercise is medicine to advocate more physically active lifestyles. Unfortunately, the focus of most PE curriculums is directed toward a sport and game model, which research indicates does not prepare students for continued PA, exercise, and fitness. This article challenges higher education and secondary PE programs to re-evaluate the curricular approach of a sport and game model and shift to a health-related fitness education model. Health-related fitness education can empower students to create and execute a plan for lifetime fitness through learning the skills (e.g., exercise modalities) and knowledge (e.g., goal setting FITT principles, planning) needed for staying fit. Health-related fitness education also helps develop self-efficacy and other affective attributes that can motivate for lifelong habitual adherence. There is no greater time than now for PE to be the leader in exercise is medicine, by equipping youth with the tools to make exercise, PA, fitness, and health a way of life today and forever.	[Ferkel, Rick C.; Hutchinson, Zach T.] Cent Michigan Univ, Dept Phys Educ & Sport, Mt Pleasant, MI 48859 USA; [Razors, Selen] West Chester Univ, Dept Kinesiol, W Chester, PA USA; [True, Larissa] SUNY Coll Cortland, Kinesiol Dept, Cortland, NY 13045 USA; [Zupin, Dagny; Jones, Lani M.; Judge, Lawrence W.] Ball State Univ, Sch Kinesiol, Muncie, IN 47306 USA		Ferkel, RC (corresponding author), Cent Michigan Univ, Dept Phys Educ & Sport, Mt Pleasant, MI 48859 USA.	rick.ferkel@cmich.edu					Bandura A., 1986, ANN CHILD DEV, P1; Barney D, 2015, PHYS EDUC-US, V72, P278; Berryman JW, 2010, CURR SPORT MED REP, V9, P195, DOI 10.1249/JSR.0b013e3181e7d86d; Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Buell JL, 2008, J ATHL TRAINING, V43, P608, DOI 10.4085/1062-6050-43.6.608; Burgeson CR, 2001, J SCHOOL HEALTH, V71, P279, DOI 10.1111/j.1746-1561.2001.tb03505.x; Caputo P, 2005, J SPORT SCI MED, V4, P58; Center for Disease Control and Prevention, 2017, CHILDH OB FACTS; Center for Disease Control and Prevention, 2017, AD OB FACTS; Centers for Disease Control and Prevention, 2017, EX PHYS ACT; Centers for Disease Control and Prevention, 2018, PHYS ACT GUID AM, V2nd; Centers for Disease Control and Prevention, 2017, HLTH EXP; Clow A., 2014, PHYS ACTIVITY MENTAL; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Dale D, 1998, PEDIATR EXERC SCI, V10, P97, DOI 10.1123/pes.10.2.97; Dale D, 2000, RES Q EXERCISE SPORT, V71, P61, DOI 10.1080/02701367.2000.10608881; Deci E.L., 1994, SCANDINAVIAN J ED RE, V38, P3, DOI [DOI 10.1080/0031383940380101, 10.1080/0031383940380101]; Deci E.L., 1985, INTRINSIC MOTIVATION; Deci E. L, 2010, SELF DETERMINATION; Duncan LR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-7; Edmunds J, 2007, PSYCHOL SPORT EXERC, V8, P722, DOI 10.1016/j.psychsport.2006.07.006; Edmunds J, 2006, J APPL SOC PSYCHOL, V36, P2240, DOI 10.1111/j.0021-9029.2006.00102.x; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Ennis CD, 2010, J PHYS EDUC RECREAT, V81, P17, DOI 10.1080/07303084.2010.10598475; Ennis CD, 2011, QUEST, V63, P5, DOI 10.1080/00336297.2011.10483659; Fairclough S., 2002, EUR PHYS EDUC REV, V8, P69, DOI DOI 10.1177/1356336X020081005; Ferkel RC, 2017, PHYS EDUC-US, V74, P255, DOI 10.18666/TPE-2017-V74-I2-7426; Gerteis J., 2014, MULTIPLE CHRONIC CON; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Green K., 2005, Leisure Studies, V24, P27, DOI 10.1080/0261436042000231637; Greenwood Parr M., 1998, Journal of Physical Education, Recreation & Dance, V69, P72; Haerens L, 2010, EUR PHYS EDUC REV, V16, P117, DOI 10.1177/1356336X10381304; Hagger M.S., 2008, INT REV SPORT EXER P, V1, P79, DOI [10.1080/17509840701827437, DOI 10.1080/17509840701827437]; Hagger MS, 2007, PSYCHOL SPORT EXERC, V8, P597, DOI 10.1016/j.psychsport.2007.06.003; HAYWOOD KM, 1991, RES Q EXERCISE SPORT, V62, P151, DOI 10.1080/02701367.1991.10608705; Hirvonen N, 2012, J AM SOC INF SCI TEC, V63, P1804, DOI 10.1002/asi.22704; Hogstrom G, 2016, INT J EPIDEMIOL, V45, P1159, DOI 10.1093/ije/dyv321; Houston J., 2014, STRATEGIES, V27, P20; Hulteen RM, 2017, PREV MED, V95, P14, DOI 10.1016/j.ypmed.2016.11.027; Judge LW, 2010, STRENGTH COND J, V32, P28, DOI 10.1519/SSC.0b013e3181df8963; Kimball J, 2009, EUR PHYS EDUC REV, V15, P249, DOI 10.1177/1356336X09345226; Lewis BA, 2017, J BEHAV MED, V40, P112, DOI 10.1007/s10865-016-9797-8; Lewis M., 2011, J SPORT BEHAV, V34, P82; Lobelo F, 2014, BRIT J SPORT MED, V48, P1627, DOI 10.1136/bjsports-2013-093080; Louw KR, 2016, MOTIV EMOTION, V40, P566, DOI 10.1007/s11031-016-9551-0; Lox C.L., 2017, PSYCHOL EXERCISE INT; McGladrey BW, 2014, J STRENGTH COND RES, V28, P1433, DOI 10.1519/JSC.0000000000000265; Mears D, 2008, PHYS EDUC-US, V65, P195; Mercier K, 2016, HIGH SCH J, V99, P179, DOI [org/10.1353/ hsj.2016.0001, DOI 10.1353/HSJ.2016.0001]; Michie S, 2011, PSYCHOL HEALTH, V26, P1479, DOI 10.1080/08870446.2010.540664; Miller A, 2017, EUR PHYS EDUC REV, V23, P171, DOI 10.1177/1356336X16642716; Misra A., 2014, COMMON SPORTS INJURI; Mohr D. J., 2001, Journal of Physical Education, Recreation & Dance, V72, P37; Mohr DJ, 2006, PHYS EDUC-US, V63, P18; Morgan C. F., 2003, J PHYS ED RECREATION, V74, P33, DOI [DOI 10.1080/07303084.2003.10609235, 10.1080/07303084.2003.10609235]; Myrick L, 1996, J PHYS ED RECREATION, V67, P6, DOI DOI 10.1080/07303084.1996.10604825; Nahas MV., 2003, PHYS EDUCATOR, V60, P42; Netz Y, 2008, INT J SPORT EXERC PS, V6, P9, DOI 10.1080/1612197X.2008.9671851; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Physical Activity Council, 2017, 2017 PART REP; Prusak K, 2011, J PHYS EDUC RECREAT, V82, P39, DOI 10.1080/07303084.2011.10598613; Rikard GL, 2006, SPORT EDUC SOC, V11, P385, DOI 10.1080/13573320600924882; Ristolainen L, 2010, SCAND J MED SCI SPOR, V20, P384, DOI 10.1111/j.1600-0838.2009.00955.x; Roberts K., 1999, LEISURE CONT SOC; Ross J.G., 1985, J PHYS ED RECREAT DA, V56, P73, DOI [10.1080/07303084.1985.10603690, DOI 10.1080/07303084.1985.10603690]; Ross M, 2016, LIBR INFORM SCI RES, V38, P2, DOI 10.1016/j.lisr.2016.01.002; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sallis J F, 1990, Exerc Sport Sci Rev, V18, P307; Sallis JF, 2012, RES Q EXERCISE SPORT, V83, P125, DOI 10.1080/02701367.2012.10599842; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Siedentop D., 1986, PHYS ED TEACHING CUR; Siedentop D., 1994, QUALITY PE POSITIVE; Song M, 2013, AM J PREV MED, V44, P216, DOI 10.1016/j.amepre.2012.11.016; Stanec A. D., 2008, INDEPENDENT SCH, V66, P112; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; U.S. Census Bureau, 2012, STAT ABSTR US, P12; Vallerand R. J., 2001, HDB SPORT PSYCHOL, V2, P389, DOI DOI 10.4135/9781483332222.N163; VALLERAND RJ, 1992, EDUC PSYCHOL MEAS, V52, P1003, DOI 10.1177/0013164492052004025; Wanless E, 2014, SCI WORLD J, DOI 10.1155/2014/370759; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wiberg C., 2016, LEARNING, V3, P3663; Woods RoseA, 2017, SPORTS AND EXERCISE	89	1	1	2	10	SAGAMORE PUBL LLC	URBANA	1807 N FEDERAL DR, URBANA, IL 61801 USA	2160-1682			PHYS EDUC-US	Phys. Educ.-US	FAL	2019	76	4					883	906		10.18666/TPE-2019-V76-I4-8724			24	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	JE1GE	WOS:000490440300001					2022-02-06	
J	Grusser, L; Blaumeiser-Debarry, R; Rossaint, R; Krings, M; Kremer, B; Hollig, A; Coburn, M				Gruesser, Linda; Blaumeiser-Debarry, Rosmarie; Rossaint, Rolf; Krings, Matthias; Kremer, Benedikt; Hoellig, Anke; Coburn, Mark			A 6-Step Approach to Gain Higher Quality Results From Organotypic Hippocampal Brain Slices in a Traumatic Brain Injury Model	BASIC AND CLINICAL NEUROSCIENCE			English	Article						Organotypic hippocampal brain slices; In vitro model; Traumatic Brain Injury (TBI); Propidium Iodide (PI); Eligibility; Framework	IN-VITRO MODEL; CULTURES; ARGON; NEUROPROTECTION; DAMAGE; XENON; DESFLURANE; HELIUM	Introduction: Organotypic Hippocampal Brain Slices (OHBS) provide a better alternative to in vivo models to scrutinize Traumatic Brain Injury (TBI). We followed a well-esciablished TBI protocol but noticed that several factors might influence the results in such a set-up. Here, we describe a structured approach to generate more comparable results and discuss why specific eligibility criteria should be applied. Methods: We defined necessary checkpoints and developed inclusion and exclusion criteria that took into consideration the observed variation in such a model. Objective measures include the identification and exclusion of pre-damaged slices and outliers. In this study, six steps were outlined. Results: A six-step approach to enhance comparability is proposed and summarized in a flowchart. We applied the suggested measures to data derived from our TBI-experiments, examining the impact of three different interventions in 1459 OHBS. Our exemplary results show that more precise findings are ensured through equal requirements set for all slices. Conclusion: Results in a TBI experiment on OHBS should be critically analyzed as inhomogeneity may occur. In other words, a structured approach to comparing the results should be followed to ensure achieving more precise findings. Further research is recommended to confirm and further develop this framework.	[Gruesser, Linda; Blaumeiser-Debarry, Rosmarie; Rossaint, Rolf; Krings, Matthias; Coburn, Mark] RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany; [Kremer, Benedikt; Hoellig, Anke] RWTH Aachen Univ Hosp, Dept Neurosurg, Aachen, Germany		Grusser, L (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Aachen, Germany.	linda.gruesser@googlemail.com					Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Grusser L, 2017, MED GAS RES, V7, P93, DOI 10.4103/2045-9912.208512; Guy Y, 2011, J NEUROSCI METH, V199, P78, DOI 10.1016/j.jneumeth.2011.03.027; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Harrison RG, 1907, ANAT REC, V1, P116, DOI 10.1002/ar.1090010503; Harrison RG, 1910, J EXP ZOOL, V9, P787, DOI 10.1002/jez.1400090405; HOGUE M J, 1952, Etudes Neonatales, V1, P1; Hughes RH, 2014, BRAIN RES, V1543, P308, DOI 10.1016/j.brainres.2013.11.020; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Krings M, 2016, MED GAS RES, V6, P3, DOI 10.4103/2045-9912.179338; Li Q, 2016, MOL NEUROBIOL, V53, P4226, DOI 10.1007/s12035-015-9362-4; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Smith M, 2016, EXP NEUROL, V286, P107, DOI 10.1016/j.expneurol.2016.10.002; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	38	1	1	1	2	IRAN UNIV MEDICAL SCIENCES	TEHRAN	COOPERATION IRAN NEUROSCIENCE SOC, NEGAH INST SCIENTIFIC COMMUNICATION, SHAHID HEMMAT HIGHWAY, TEHRAN, 1449614535, IRAN	2008-126X	2228-7442		BASIC CLIN NEUROSCI	Basic Clin. Neurosci.	SEP-OCT	2019	10	5					485	496		10.32598/bcn.9.10.235			12	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	KB0KV	WOS:000506188700009	32284838	Green Published, gold			2022-02-06	
J	Heppekcan, D; Ekin, S; Qivi, M; Tok, DA				Heppekcan, Deniz; Ekin, Serpil; Qivi, Melek; Tok, Demet Aydin			Impact of Secondary Insults in Brain Death After Traumatic Brain Injury	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	1st International Transplant Network Congress	OCT 17-21, 2018	Antalya, TURKEY				TRANSPLANTATION	In addition to primary injury in severe head trauma, secondary systemic insults that aggravate the brain injury may result in fatal neurologic outcome. We aim to evaluate the correlation between brain death and secondary systemic insults in 100 patients with severe traumatic brain injury (TBI) admitted to the intensive care unit. We collected data on hypotension and hypoxemia at the time of admission to intensive care unit and data on hypotension, hypoxemia, hypocarbia, hypercarbia, shock, anemia, hyperglycemia, and hyperthermia within the first 24 hours. In addition, we recorded the category of TBI according to computed tomography findings. Twenty-six patients (26%) who developed brain death were significantly younger than survivors. Early hypotension (odds ratio [OR], 10.24; 95% confidence interval [CI], 3.64-28.78; P = .000) and early shock (OR, 8.31; 95% CI, 2.65-26.01; P = .000) were significantly more frequent among brain-death patients. The most featured factor that independently predicted the development of brain death in patients with severe TBI was the existence of hypotension (B-2.74; 95% CI, 0.016-0.252; P = .000). The most common type of injury among brain death patients was a surgically evacuated mass lesion. Although all critical care principles are applied to prevent secondary systemic brain insults, when brain death occurs, the prevention of hypotension will become significant in preserving organs in better condition for procurement.	[Heppekcan, Deniz; Ekin, Serpil; Qivi, Melek; Tok, Demet Aydin] Manisa Celal Bayar Univ, Hafsa Sultan Hosp, Intens Care Unit, Anesthesiol & Reanimat Dept, Manisa, Turkey		Heppekcan, D (corresponding author), Manisa Celal Bayar Univ, Hafsa Sultan Hosp, TR-45030 Yunusemre, Manisa, Turkey.	denizheppekcan@yahoo.com.tr		heppekcan, deniz/0000-0002-3217-1387			Bullock R, 2007, J NEUROTRAUMA S1, V24; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R M, 1995, New Horiz, V3, P366; Dayoub JC, 2018, EXP GERONTOL, V110, P230, DOI 10.1016/j.exger.2018.06.019; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Johnson RJ, 2014, TRANSPLANTATION, V97, pS1, DOI 10.1097/01.TP.0000438215.16737.68; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Saidi RF, 2014, INT J TRANSPLANT MED, V5, P87; TEASDALE G, 1974, LANCET, V2, P81; Wong G, 2017, TRANSPLANTATION, V101, P1152, DOI 10.1097/TP.0000000000001351	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	SEP	2019	51	7					2186	2188		10.1016/j.transproceed.2019.01.176			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	IZ8JG	WOS:000487349900010	31378470				2022-02-06	
J	Herrmann, LL; Deatrick, JA				Herrmann, Linda L.; Deatrick, Janet A.			Experiences and Perceptions of Hospitalization and Recovery of Older Adults and Their Caregivers Following Traumatic Brain Injury "Not Knowing"	RESEARCH IN GERONTOLOGICAL NURSING			English	Article							PROSPECTIVE-PAYMENT SYSTEM; QUALITY-OF-LIFE; ELDERLY-PATIENTS; SUBDURAL-HEMATOMA; MAJOR DEPRESSION; MEDICARE PAYMENT; ACUTE-CARE; AGE; REHABILITATION; UNCERTAINTY	The purpose of the current study is to describe the experience and perceptions of older adults and their caregivers following hospitalization for mild or moderate traumatic brain injury (TBI). Qualitative analysis of data obtained in individual semi-structured interviews with older adults and their caregivers (N = 11, five dyads and one individual) was performed to capture the perceptions and experiences of the survivor and their caregivers about the acute injury, hospitalization, and recovery. Data were collected over a 2-month period following discharge from the hospital. Open coding and constant comparative analysis generated codes that were revised throughout the analysis and reformulated into thematic descriptions. As a result, seven interrelated themes were identified. These findings can be used to implement interventions focused on recovery, communication, teaching, patient outcomes, and satisfaction.	[Herrmann, Linda L.] NYU, Rory Myers Coll Nursing, Hartford Inst Geriatr Nursing, 433 1st Ave, New York, NY 10010 USA; [Deatrick, Janet A.] Univ Penn, Nursing, Philadelphia, PA 19104 USA		Herrmann, LL (corresponding author), NYU, Rory Myers Coll Nursing, Hartford Inst Geriatr Nursing, 433 1st Ave, New York, NY 10010 USA.	LLH8@nyu.edu		Herrmann, Linda/0000-0002-1857-6310	National Hartford Center of Gerontological Nursing Excellence	The authors have disclosed no potential conflicts of interest, financial or otherwise. The authors acknowledge the National Hartford Center of Gerontological Nursing Excellence for their generous support of this study.	Administration on Aging, 2018, PROF OLD AM 2018; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Bakas Tamilyn, 2002, J Neurosci Nurs, V34, P242; Bakas T, 2009, TOP STROKE REHABIL, V16, P105, DOI 10.1310/tsr1602-105; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Boltz M, 2013, NURS HEALTH SCI, V15, P518, DOI 10.1111/nhs.12067; Boltz Marie, 2013, Medsurg Nurs, V22, P26; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dobrez DG, 2004, ARCH PHYS MED REHAB, V85, P1909, DOI 10.1016/j.apmr.2004.06.064; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Draper K, 2007, PSYCHOSOCIAL EMOTION, DOI [10.1097/01.HTR.0000290972.63753.a7, DOI 10.1097/01.HTR.0000290972.63753.A7]; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson C, 2017, INT J STROKE, V12, P9; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Jones AL, 2000, DISABIL REHABIL, V22, P490, DOI 10.1080/096382800413970; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Li CY, 2018, ARCH PHYS MED REHAB, V99, P1279, DOI 10.1016/j.apmr.2017.12.006; Liliang PC, 2002, INJURY, V33, P345, DOI 10.1016/S0020-1383(02)00020-7; Lin WC, 2006, HEALTH SERV RES, V41, P1338, DOI 10.1111/j.1475-6773.2006.00546.x; McCall N, 2003, MILBANK Q, V81, P277, DOI 10.1111/1468-0009.t01-1-00054; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Mishel M H, 1997, Annu Rev Nurs Res, V15, P57; MISHEL MH, 1991, NURS RES, V40, P167; MISHEL MH, 1988, NURS RES, V37, P98; MISHEL MH, 1981, NURS RES, V30, P258; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray PK, 2005, MED CARE, V43, P1109, DOI 10.1097/01.mlr.0000182490.09539.1e; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Paddock SM, 2007, MED CARE, V45, P123, DOI 10.1097/01.mlr.0000250863.65686.bc; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Richmond TS, 2000, J ADV NURS, V32, P1341, DOI 10.1046/j.1365-2648.2000.01629.x; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; van den Heuvel ETP, 2001, CLIN REHABIL, V15, P669, DOI 10.1191/0269215501cr446oa; Whittemore R, 2001, QUAL HEALTH RES, V11, P522, DOI 10.1177/104973201129119299; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wu YP, 2016, J PEDIATR PSYCHOL, V41, P493, DOI 10.1093/jpepsy/jsw032; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	63	1	1	0	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	1940-4921	1938-2464		RES GERONTOL NURS	Res. Gerontol. Nurs.	SEP-OCT	2019	12	5					227	+		10.3928/19404921-20190610-01			14	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	JA1OA	WOS:000487585100003	31283828				2022-02-06	
J	Jones, KM; Theadom, A; Barker-Collo, S; Broadbent, E; Feigin, VL; McPherson, K; Jones, A; Te Ao, B; Kydd, R; Barber, PA; Parag, V; Ameratunga, S; Starkey, N; Dowell, A; Kahan, M; Christey, G; Hardakar, N; Brown, P				Jones, Kelly M.; Theadom, Alice; Barker-Collo, Suzanne; Broadbent, Elizabeth; Feigin, Valery L.; McPherson, K.; Jones, A.; Te Ao, B.; Kydd, R.; Barber, P. Alan; Parag, V.; Ameratunga, S.; Starkey, N.; Dowell, A.; Kahan, M.; Christey, G.; Hardakar, N.; Brown, P.		BIONIC Study Grp	Associations between brain drawings following mild traumatic brain injury and negative illness perceptions and post-concussion symptoms at 4 years	JOURNAL OF HEALTH PSYCHOLOGY			English	Article						concussion; drawings; illness perception; post-concussion symptoms; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURY; 1ST YEAR; HEALTH; IMPACT; OUTCOMES	Characteristics of patient's drawings have been linked to short-term health-related outcomes across a range of health conditions. This study examined associations between brain drawings at 1 month and illness perceptions and post-concussion symptoms at 4 years in 92 adults following mild traumatic brain injury. Greater damage depicted at 1 month was correlated with perceived greater impact on life, duration of injury, symptoms of brain injury, emotional consequences and late-onset post-concussion symptoms. Results indicate that brain drawings shortly after traumatic brain injury offer a simple and insightful tool that may help to identify those who need additional support to improve long-term outcomes.	[Jones, Kelly M.; Theadom, Alice; Barker-Collo, Suzanne; Broadbent, Elizabeth; Feigin, Valery L.; McPherson, K.; Jones, A.; Te Ao, B.] Auckland Univ Technol, Auckland, New Zealand; [Barker-Collo, Suzanne; Kydd, R.; Barber, P. Alan; Parag, V.; Ameratunga, S.] Univ Auckland, Auckland, New Zealand; [Starkey, N.] Waikato Univ, Hamilton, New Zealand; [Dowell, A.] Univ Otago, Dunedin, New Zealand; [Kahan, M.; Christey, G.] Waikato Dist Hlth Board, Hamilton, New Zealand; [Hardakar, N.] Accid Compensat Corp, Wellington, New Zealand; [Brown, P.] Univ Calif, Davis, CA USA		Jones, KM (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, AUT North Shore Campus,AA254,90 Akoranga Dr, Auckland 1142, New Zealand.; Jones, KM (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Studies, Sch Publ Hlth & Psychosocial Studies, AUT North Shore Campus,AA254,90 Akoranga Dr, Auckland 1142, New Zealand.	kejones@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; McPherson, Kath/0000-0003-0487-8497; Broadbent, Elizabeth/0000-0003-3626-9100; Te Ao, Braden/0000-0002-1050-200X	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 09/063A, 13/408]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Health Research Council of New Zealand under Grants HRC 09/063A and 13/408.	Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BROADBENT EA, 2004, J PSYCHOSOM RES, V60, P631; Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chong J, 2013, HEALTH PSYCHOL, V32, P710, DOI 10.1037/a0027353; Clarke AL, 2016, CLIN KIDNEY J, V9, P494, DOI 10.1093/ckj/sfw014; Daleboudt GMN, 2011, LUPUS, V20, P290, DOI 10.1177/0961203310385552; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Hagger MS, 2011, J PSYCHOL HLTH, V18, P141; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones KM, 2016, PSYCHOL HEALTH, V31, P1182, DOI 10.1080/08870446.2016.1193178; Kaptein AA, 2007, CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, P268; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; O'Donovan CE, 2016, CARDIOL YOUNG, V26, P100, DOI 10.1017/S1047951114002728; Petrie KJ, 2012, CURR DIR PSYCHOL SCI, V21, P60, DOI 10.1177/0963721411429456; Princip M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01801; Ramondt S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154348; Reynolds L, 2007, J PSYCHOSOM RES, V63, P525, DOI 10.1016/j.jpsychores.2007.03.007; Scharloo M, 2005, HEAD NECK-J SCI SPEC, V27, P857, DOI 10.1002/hed.20251; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sherwin LB, 2016, J PSYCHOSOC NURS MEN, V54, P44, DOI 10.3928/02793695-20160803-01; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Tiemensma J, 2012, J CLIN ENDOCR METAB, V97, P3123, DOI 10.1210/jc.2012-1235; Var FA, 2012, INDIAN J PSYCHOL MED, V34, P223, DOI 10.4103/0253-7176.106014; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organization, 2004, ICD 10 INT STAT CLAS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	1	1	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1359-1053	1461-7277		J HEALTH PSYCHOL	J. Health Psychol.	SEP	2019	24	10					1448	1458		10.1177/1359105317695430			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	IP7YA	WOS:000480262900013	31394985				2022-02-06	
J	Jorge, RE; Li, RS; Liu, XY; McGavin, JK; Shorter, DI; Acion, L; Arndt, S				Jorge, Ricardo E.; Li, Ruosha; Liu, Xiangyu; McGavin, Jill K.; Shorter, Daryl, I; Acion, Laura; Arndt, Stephan			Treating Alcohol Use Disorder in US Veterans: The Role of Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							ABUSE TREATMENT; DRUG-ADDICTION; GLUTAMATE; DRINKING; STRESS; PHARMACOTHERAPY; EPIDEMIOLOGY; MAINTENANCE; RELIABILITY; NALTREXONE	Objective: The authors examined the efficacy of valproate to reduce relapse to heavy drinking among veterans with alcohol use disorder (AUD) and neuropsychiatric comorbidities and whether antecedent traumatic brain injury (TBI) or posttraumatic stress disorder (PTSD) affected treatment response. Methods: Participants were male veterans 18-60 years old with an AUD and no other substance use besides nicotine or cannabis. Sixty-two patients were randomly assigned to receive either valproate or naltrexone. Participants were evaluated at baseline and followed weekly for 24 weeks. All participants received standardized psychosocial interventions as well as treatment for coexistent psychiatric conditions. Results: During the follow-up period, nine study subjects in the naltrexone group and 14 in the valproate group relapsed to heavy drinking, but the difference did not reach statistical significance. Participants with a history of moderate to severe TBI were more likely to relapse to heavy drinking compared with those with no TBI (hazard ratio=4.834, 95% CI=1.103-21.194, p=0.033). PTSD status did not significantly affect outcome. Conclusions: Intensive outpatient programs are efficacious alternatives to treat AUD in veterans, although the role of pharmacological treatment is not completely elucidated. Glutamatergic agents appear to be less effective than opiate antagonists to prevent relapse to heavy drinking and to increase cumulative abstinence. Future studies should examine novel pharmacological and nonpharmacological options.	[Jorge, Ricardo E.; McGavin, Jill K.; Shorter, Daryl, I; Acion, Laura] Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX 77030 USA; [Jorge, Ricardo E.; McGavin, Jill K.; Shorter, Daryl, I; Acion, Laura] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Li, Ruosha; Liu, Xiangyu] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Acion, Laura; Arndt, Stephan] Univ Iowa, Iowa Consortium Subst Abuse Res & Evaluat, Iowa City, IA USA; [Arndt, Stephan] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA		Jorge, RE (corresponding author), Michael E DeBakey VA Med Ctr, Mental Hlth Care Line, Houston, TX 77030 USA.; Jorge, RE (corresponding author), Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	Ricardo.Jorge@va.gov	Arndt, Stephan/A-6976-2013	Arndt, Stephan/0000-0003-0783-8204	VA Office of Research and Development Merit Research Award [IOIRX00324]	Supported by a VA Office of Research and Development Merit Research Award (IOIRX00324).	Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Beresford TP, 2005, BRAIN INJURY, V19, P309, DOI 10.1080/02699050410001720121; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; D'Souza MS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00404; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; HILLBOM M, 1989, ALCOHOL, V6, P223, DOI 10.1016/0741-8329(89)90022-0; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jonas DE, 2014, JAMA-J AM MED ASSOC, V311, P1889, DOI 10.1001/jama.2014.3628; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Knackstedt LA, 2009, CURR OPIN PHARMACOL, V9, P59, DOI 10.1016/j.coph.2008.12.003; Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Krystal JH, 2008, ALCOHOL CLIN EXP RES, V32, P85, DOI 10.1111/j.1530-0277.2007.00555.x; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Lan CW, 2016, AM J ADDICTION, V25, P7, DOI 10.1111/ajad.12319; Longo LP, 2002, J ADDICT DIS, V21, P55, DOI 10.1300/J069v21n02_05; Mann K, 2018, NEUROPSYCHOPHARMACOL, V43, P891, DOI 10.1038/npp.2017.282; Maremmani I, 2010, CNS SPECTRUMS, V15, P95, DOI 10.1017/S1092852900027346; McCarty D, 2014, PSYCHIAT SERV, V65, P718, DOI 10.1176/appi.ps.201300249; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Miguel-Hidalgo JJ, 2003, J PSYCHIATR RES, V37, P411, DOI 10.1016/S0022-3956(03)00049-9; Pfefferbaum A, 1998, ARCH GEN PSYCHIAT, V55, P905, DOI 10.1001/archpsyc.55.10.905; RAWSON RA, 1995, J SUBST ABUSE TREAT, V12, P117, DOI 10.1016/0740-5472(94)00080-B; Salloum IM, 2005, ARCH GEN PSYCHIAT, V62, P37, DOI 10.1001/archpsyc.62.1.37; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scofield MD, 2016, PHARMACOL REV, V68, P816, DOI 10.1124/pr.116.012484; Scofield MD, 2015, BIOL PSYCHIAT, V78, P441, DOI 10.1016/j.biopsych.2015.02.016; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; Spencer S, 2016, J PSYCHOPHARMACOL, V30, P1095, DOI 10.1177/0269881116655248; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2016, NEW ENGL J MED, V374, P363, DOI 10.1056/NEJMra1511480; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50	50	1	1	0	5	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2019	31	4					319	327		10.1176/appi.neuropsych.18110250			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JD7SI	WOS:000490181300005	31117905	Green Published, Bronze			2022-02-06	
J	Lowe, LM; Gokun, Y; Williams, DK; Yates, C				Lowe, Leah M.; Gokun, Yevgeniya; Williams, David K.; Yates, Charlotte			SPATIOTEMPORAL PARAMETERS OF ADOLESCENT GAIT WHEN PERFORMING A VISUOSPATIAL MEMORY TASK	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						adolescent; concussion; dual-task; gait; movement system	BALANCE CONTROL; CONCUSSION; STABILITY; CHILDREN; INJURY; MOTOR; EPIDEMIOLOGY; COMPLEXITY; COLLEGIATE; ATTENTION	Background: Accurate assessment of recovery following mild traumatic brain injury in adolescents can be difficult. When compared to single-task models, dual-task models that combine cognitive and motor demands may more accurately identify residual deficits that manifest during daily life and athletic play in adolescents with concussion. Previous studies have examined gait changes during a concurrent auditory task, or cognitive task. Purpose: The purpose of this study was to collect and present data from a sample of healthy 14-18 year old male and female athletes on spatiotemporal parameters of gait for walking with and without a concurrent visuospatial memory task presented on a hand-held tablet. Study Design: A two-way repeated measures study of spatiotemporal gait parameters in a cross-sectional convenience sample of adolescent subjects participating in high school athletics. Methods: Subjects comprised a total of 178 adolescent athletes (128 males; 50 females) ages 14-18 years old at six area high schools. Subjects were instructed to walk "how you normally do" on the GAITRite (R) portable gait analysis walkway for three undivided and three divided attention trials performing a visuospatial memory task on a hand-held tablet. Results: Significant differences (p< 0.0001) were present between males and females during typical gait in each of the measured parameters except step length (p = 0.0715). Female participants walked with a significantly faster gait velocity (by 0.21 m/s) than male participants (p< 0.0001). The females spent a significantly smaller (-2.27%) percent of the gait cycle in double limb support (p< 0.0001) and a significantly greater (+1.10%) percent of the gait cycle in single limb support (p< 0.0001) than did the males. Both groups experienced a similar, dual-task cost during the divided attention trials (p< 0.0001) for each of the four gait parameters. Previous studies have shown that adults decrease their gait velocity by approximately 33% when performing a task on a hand-held device. The current study revealed that adolescents decreased their gait velocity by 8-9% by shortening their step length by 7.4 centimeters (p< 0.0001), increased the percent of the gait cycle spent in double limb support (2.73%, p< 0.0001) and decreased the percent of the gait cycle spent in single limb support (1.38%, p< 0.0001) during the dual-task. Conclusion: These data provide preliminary reference values specific to the adolescent population for the dual-task cost during a visuospatial memory task. More research is needed to determine the dual-task cost during a visuospatial memory task for adolescents with concussion.	[Lowe, Leah M.; Yates, Charlotte] Univ Cent Arkansas, Dept Phys Therapy, Conway, AR 72035 USA; [Gokun, Yevgeniya; Williams, David K.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Williams, David K.; Yates, Charlotte] Univ Arkansas Med Sci, Ctr Translat Neurosci, Little Rock, AR 72205 USA		Lowe, LM (corresponding author), Univ Cent Arkansas, Phys Therapy Ctr, Dept Phys Therapy, Suite 300,201 Donaghey Ave, Conway, AR 72035 USA.	llowe@uca.edu			NIGMS IDeA Program through the Center for Translational Neuroscience at the University of Arkansas for Medical Sciences [P30 GM110702]	This study was supported by NIGMS IDeA Program award P30 GM110702 through the Center for Translational Neuroscience at the University of Arkansas for Medical Sciences.	Abbruzzese LD, 2014, GAIT POSTURE, V40, P658, DOI 10.1016/j.gaitpost.2014.07.017; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Fabri TL, 2017, GAIT POSTURE, V54, P154, DOI 10.1016/j.gaitpost.2017.03.002; Faul M, TRAUMATIC BRAIN INJU; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grants L, 2017, INT J SPORTS PHYS TH, V12, P1011, DOI 10.26603/ijspt20171011; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hof A.L., 1996, GAIT POSTURE, V4, P222; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Jeon S, 2016, WORK, V53, P241, DOI 10.3233/WOR-152115; Lamberg EM, 2012, GAIT POSTURE, V35, P688, DOI 10.1016/j.gaitpost.2011.12.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKay MJ, 2017, GAIT POSTURE, V58, P78, DOI 10.1016/j.gaitpost.2017.07.004; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Weerdesteyn V, 2003, J MOTOR BEHAV, V35, P53, DOI 10.1080/00222890309602121	35	1	1	1	5	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	SEP	2019	14	5					753	760		10.26603/ijspt20190753			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	JS7LU	WOS:000500486300008	31598413				2022-02-06	
J	Ludin, SM; Rashid, NA; Awang, MS; Nor, MBM				Ludin, Salizar M.; Rashid, Nor'ain A.; Awang, Mohamed S.; Nor, Mohd B. M.			Functional Outcomes 6 Months After Severe Traumatic Brain Injury Following Admission Into Intensive Care Unit: A Cohort Study in Two Tertiary Hospitals	CLINICAL NURSING RESEARCH			English	Article						traumatic brain injury survivors; functional outcomes; Glasgow Outcome Scale-Extended	QUALITY-OF-LIFE; MODERATE; DEPRESSION; GUIDELINES; RECOVERY; SCORE	Severe traumatic brain injury (TBI) survivors show physical and functional improvements but continue to have cognitive and psychosocial problems throughout recovery. However, the functional outcome of severe TBI in Malaysia is unknown. The objective of this study is to measure the functional outcomes of severe TBI within 6 months post-injury. A cohort study was done on 33 severe TBI survivors. The Glasgow Outcome Scale-Extended (GOSE) was used in this study. The mean age of the participants was 31.79 years (range: 16-73 years). The logistic regression model was statistically significant, chi(2)(5, N = 33) = 29.09, p < .001. The length of stay (LOS) in incentive care unit (p = .049, odds ratio = 6.062) and duration on ventilator (p = .048, odds ratio = 0.083) were good predictors of the functional outcomes. Future research should focus on larger sample size of severe TBI in Malaysia.	[Ludin, Salizar M.; Rashid, Nor'ain A.] Int Islamic Univ Malaysia, Dept Crit Care Nursing, Kulliyyah Fac Nursing, Level 2,Annex Bldg,Jalan Hosp Campus, Kuantan 25710, Pahang, Malaysia; [Awang, Mohamed S.] Int Islamic Univ Malaysia, Dept Surg, Kulliyyah Fac Med, Kuantan, Malaysia; [Nor, Mohd B. M.] Int Islamic Univ Malaysia, Dept Anaesthesiol, Kulliyyah Fac Med, Kuantan, Malaysia		Rashid, NA (corresponding author), Int Islamic Univ Malaysia, Dept Crit Care Nursing, Kulliyyah Fac Nursing, Level 2,Annex Bldg,Jalan Hosp Campus, Kuantan 25710, Pahang, Malaysia.	norainabdulrashid@iium.edu.my	Nor, Mohd Basri Mat/O-7334-2018; Ludin, Salizar Mohamed/ABE-3406-2021	Nor, Mohd Basri Mat/0000-0002-5433-6357; Ludin, Salizar Mohamed/0000-0001-7155-798X	Ministry of Education [FRGS 15-221-0462]; Ministry of Health [NMRR-16-121-28870]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank the Ministry of Education for providing a grant for this research (FRGS 15-221-0462; principal investigator: Salizar M. Ludin), as well as the Ministry of Health for allowing this research to be conducted (NMRR-16-121-28870 [IIR]).	Abdullah J M, 2011, Med J Malaysia, V66, P83; Adamu A. S., 2014, J ANESTHESIOLOGY, V2, P18, DOI [10.11648/j.ja.20140202.12, DOI 10.11648/J.JA.20140202.12]; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dubendorfer C, 2013, EUR J TRAUMA EMERG S, V39, P25, DOI 10.1007/s00068-012-0212-z; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Geok J. T. M., 2016, MALAYSIAN REGISTRY I, P1; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Harshini V., 2013, INDIAN J PHARM BIOL, V1, P39; Lefaivre C., 2015, TRAUMATIC BRAIN INJU; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Namendys-Silva SA, 2009, AM J HOSP PALLIAT ME, V26, P341, DOI 10.1177/1049909109333041; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Palys T., 2008, SAGE ENCY QUALITATIV, V2, P697; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ramtinfar S, 2016, INDIAN J CRIT CARE M, V20, P575, DOI 10.4103/0972-5229.192042; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Sandhaug M, 2015, BRAIN INJURY, V29, P915, DOI 10.3109/02699052.2015.1022880; Sarani R., 2011, MOTORCYCLE, V1; Sim S K, 2011, Med J Malaysia, V66, P138; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; Tobi KU, 2016, SOUTH AFR J ANAESTH, V22, P135, DOI 10.1080/22201181.2016.1206293; Watson MJ, 2007, PHYS THER REV, V12, P21, DOI 10.1179/108331907X174952; Weber KT, 2016, ARQ NEURO-PSIQUIAT, V74, P409, DOI 10.1590/0004-282X20160053; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS	30	1	1	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1054-7738	1552-3799		CLIN NURS RES	Clin. Nurs. Res.	SEP	2019	28	7					830	851		10.1177/1054773818767551			22	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	IP7VL	WOS:000480256000004	29618232	Green Accepted			2022-02-06	
J	Ludin, SM; Rashid, NA				Ludin, Salizar Mohamed; Rashid, Nor'ain Abdul			Health-related quality of life after 6 months post-injury on severe traumatic brain injury: A cohort study in two Malaysian hospitals	ENFERMERIA CLINICA			English	Article						Brain injury; Quality of life; Head injury; Health-related quality of life; Survivor	INTENSIVE-CARE; FOLLOW-UP; QOLIBRI; OUTCOMES; TERM	Objective: Severe traumatic brain injury (TBI) survivors show physical and functional improvement but remain with the cognitive and psycho-social problem through our recovery. This study aims to measure the health-related quality of life of TBI survivors within 6 months post-injury. Method: A cohort study was conducted where 33 severe TBI survivors recruited at two tertiary hospitals. The health-related quality of life was measured using the Quality of Life after Brain Injury (QOLIBRI) toot. Results: Participants mean age was 31.79 years old. The impaired range of health related quality of life on 6 months post-injury seen, but an improvement occurs within 3-6 months post-injury. Conclusions: Age and ventilation duration showed a moderate negative correlation in all domains and length of hospital stay showed a moderate negative correlation to social, daily life and self-domains. Nevertheless, small sample size and time constraint were the limitations of this study. (C) 2019 Published by Elsevier Espana, S.L.U.	[Ludin, Salizar Mohamed; Rashid, Nor'ain Abdul] Int Islamic Univ Malaysia, Kulliyyah Nursing Fac, Crit Care Nursing Dept, Pahang, Malaysia		Ludin, SM (corresponding author), Int Islamic Univ Malaysia, Kulliyyah Nursing Fac, Crit Care Nursing Dept, Pahang, Malaysia.	msalizar@iium.edu.my	Ludin, Salizar Mohamed/ABE-3406-2021	Ludin, Salizar Mohamed/0000-0001-7155-798X	Ministry of Education MalaysiaMinistry of Education, Malaysia [FRGS 15-221-0462]	The authors thank all participants for their contribution in this study. We thank the IIUM, and most importantly the Ministry of Education Malaysia for granting this Fundamental Research Grant (FRGS 15-221-0462) for the conduct of this project.	Abdullah J M, 2011, Med J Malaysia, V66, P83; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cohen J., 2013, STAT POWER ANAL BEHA; Database NT, 2011, NAT TRAUM DAT JAN DE; Douglas SL, 2002, CRIT CARE MED, V30, P2655, DOI 10.1097/00003246-200212000-00008; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Klemenc-Ketis Z, 2011, ULUS TRAVMA ACIL CER, V17, P509, DOI 10.5505/tjtes.2011.35336; Lefaivre C., 2015, TRAUMATIC BRAIN INJU; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Sim S K, 2011, Med J Malaysia, V66, P138; Sinha S, 2013, NEUROL INDIA, V61, P501, DOI 10.4103/0028-3886.121920; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Watson MJ, 2007, PHYS THER REV, V12, P21, DOI 10.1179/108331907X174952; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287	22	1	1	0	1	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-8621	1579-2013		ENFERM CLIN	Enferm. Clin.	SEP	2019	29			2			674	680		10.1016/j.enfcli.2019.04.103			7	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	JC2GN	WOS:000489095200122	31311746				2022-02-06	
J	Mascarenhas, L				Mascarenhas, Lino			Descriptive epidemiology of intracranial hemorrhage patterns and the main complaints motivating brain computed tomography scans in Northern Portugal	REVISTA MEXICANA DE NEUROCIENCIA			English	Article						Incidence; Head injury; Intracerebral hemorrhage; Spontaneous subarachnoid hemorrhage; Portugal		Background/Aims: This study aimed at documenting the patterns of intracranial hemorrhage encountered by means of brain computed tomography (CT) scan and characterizing the chief complaint that led to the diagnosis. Methods: All the brain CT scans performed in a hospital serving 334,081 inhabitants in a 1-year period were reviewed. Categories of clinical situations and imaging findings were correlated among themselves and with population data to obtain incidence rates. Results: A total of 8516 patients (M/F ratio 0.83; mean age 63.31) underwent brain CT scans and hemorrhage was present in 448 (5.26%). Head injury was the most frequent complaint motivating brain CT scan (30.11%) and acute subdural hemorrhage the most frequent pattern encountered (37.05%). An incidence rate of intracranial hemorrhage of 134.10, a global incidence rate of head injury of 767.48, and an incidence rate of hemorrhage of 76.33/100,000/year in the context of trauma were found. Incidence rates of hemorrhagic patterns more likely to be associated with a spontaneous origin add up to 45.2/100,000/year. Conclusion: Traumatic patterns of hemorrhage are more frequent than those of spontaneous nature and head injury the most frequent indication for brain CT scan study. Although within the ranges reported in literature, incidence rates of hemorrhage in the studied population rank low for trauma and spontaneous subarachnoid and high for intracerebral. This indicator serves to characterize the health status of the community.	[Mascarenhas, Lino] CHVNG E, Neurosurg Serv, Vila Nova De Gaia, Portugal		Mascarenhas, L (corresponding author), CHVNGE, Neurocirugia, Rua Conceicao Fernandes S-N, P-4434502 Vila Nova De Gaia, Portugal.	linomasc@gmail.com					Brown RD, 2008, J NEUROSURG, V108, P1132, DOI 10.3171/JNS/2008/108/6/1132; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Instituto Nacional de Estatistica, 2011, CENS; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0	7	1	1	0	0	ACAD MEXICANA NEUROLOGIA	MEXICO	SAN FRANCISCO, 1384 TORRE B 7O PISO, COL VALLE, MEXICO, DF 03100, MEXICO	1665-5044			REV MEX NEUROCIENC	Rev. Mex. Neurocienc.	SEP-OCT	2019	20	5					237	243		10.24875/RMN.M19000070			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	JJ0ZL	WOS:000493890000006		gold			2022-02-06	
J	Monterey, M; Kerr, K; Dannenbaum, M; Chen, PR; Blackburn, S				Monterey, Michael; Kerr, Keith; Dannenbaum, Mark; Chen, Peng Roc; Blackburn, Spiros			Open Surgery for Extraction of an Embolized Pellet in the Middle Cerebral Artery From a Shotgun Injury	OPERATIVE NEUROSURGERY			English	Article						Neurotrauma; Bullet embolization; Missile injury; Bullet; Embolization; Extraction; Missile; MCA; Pellet; Surgery	EMBOLUS; EMBOLECTOMY	BACKGROUND AND IMPORTANCE: Embolization of shotgun pellet from the peripheral vasculature to the cerebral vessels has been a known phenomenon that has been reported previously in the literature. However, there is no consensus on clinical indications for intervention, best modality of intervention or management upon leaving the hospital. We describe a case of a shotgun pellet in the neck that embolized to the middle cerebral artery that was treated with open surgery. Discussed is the initial management on presentation, timing of intervention from surgery and detailed surgical technique. CLINICAL PRESENTATION: A 20-yr-old man presented after being shot at close range with a shotgun. He was neurologically intact on exam. Initial screening computed tomography (CT) of the brain noted a shotgun pellet in the region of the sylvian fissure without intracranial hemorrhage. Computed tomography angiography again displayed pellet in the vicinity of the left middle cerebral artery. He was emergently taken for an awake cerebral angiogram and subsequent surgical extraction of the shotgun pellet. CONCLUSION: Missile embolization of a bullet fragment to the intracranial vasculature is rare and requires difficult decisions regarding management. Critical factors that are to be considered prior to treatment include neurological clinical presentation, timing of the trauma, and anatomic location of injury. Patients who are without neurological deficit that display compromised blood flow require immediate cerebral angiogram followed by surgical intervention depending on location.	[Monterey, Michael; Kerr, Keith; Dannenbaum, Mark; Chen, Peng Roc; Blackburn, Spiros] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA		Blackburn, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Med Sch, Vivian L Smith Dept Neurosurg, 6400 Fannin 42800, Houston, TX 77030 USA.	Spiros.Blackburn@uth.tmc.edu		BLACKBURN, SPIROS/0000-0003-2902-5079			ANDA T, 1992, Neurological Surgery, V20, P457; Bahnini A, 1986, Ann Vasc Surg, V1, P139, DOI 10.1016/S0890-5096(06)60716-4; CEBALLOS R, 1971, Alabama Journal of Medical Sciences, V8, P410; David W, 2003, J TRAUMA, V54, P417, DOI 10.1097/01.TA.0000032247.03438.78; GAGLIARDI R, 1983, NEUROSURGERY, V12, P636, DOI 10.1227/00006123-198306000-00007; GARRIDO E, 1976, J NEUROSURG, V44, P517, DOI 10.3171/jns.1976.44.4.0517; Haninec P, 1996, BRIT J NEUROSURG, V10, P311, DOI 10.1080/02688699650040214; KASE CS, 1981, NEUROLOGY, V31, P458; Kerr K, 2016, CLIN NEUROL NEUROSUR, V140, P85, DOI 10.1016/j.clineuro.2015.11.012; Khodadad G, 1973, STROKE, V4, P446, DOI 10.1161/01.STR.4.3.446; McCague Andrew, 2013, Am Surg, V79, pE322; MEYER FB, 1985, J NEUROSURG, V62, P639, DOI 10.3171/jns.1985.62.5.0639; Nolan Timothy, 2012, Semin Intervent Radiol, V29, P192, DOI 10.1055/s-0032-1326928; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Schroeder ME, 2011, J VASC SURG, V53, P1113, DOI 10.1016/j.jvs.2010.11.046; STEIN M, 1995, J TRAUMA, V39, P1006, DOI 10.1097/00005373-199511000-00034; VANGILDER JC, 1970, J NEUROSURG, V32, P711, DOI 10.3171/jns.1970.32.6.0711; Vaquero-Puerta C, 2012, J VASC SURG, V55, P535, DOI 10.1016/j.jvs.2011.07.091; VASCIK JM, 1982, NEUROSURGERY, V11, P532; WELCH K, 1956, J NEUROSURG, V13, P73, DOI 10.3171/jns.1956.13.1.0073	20	1	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	SEP	2019	17	3					E119	E123		10.1093/ons/opy312			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JI6JK	WOS:000493573400015	30423149				2022-02-06	
J	Oagaz, H; Schoun, B; Pooji, M; Choi, MH				Oagaz, Hawkar; Schoun, Breawn; Pooji, Manpreet; Choi, Min-Hyung			Neurocognitive Assessment in Virtual Reality Through Behavioral Response Analysis	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Behavioral analysis; motor skills; neurocognitive assessment; virtual reality; visual cognition	TRAUMATIC BRAIN-INJURY; COGNITIVE ASSESSMENT; LIMB APRAXIA; REHABILITATION; IMPAIRMENTS; PERFORMANCE; DYSFUNCTION; PREVALENCE; VALIDATION; DISORDER	The ability to detect and diagnose neurocognitive disorders at the earliest possible moment is key to a better prognosis for the patient. Two of the earliest indicators of potential neurocognitive problems are motor and visual dysfunction. Motor disorders and problems in visual cognition can be seen in many neurocognitive disorders, resulting in abnormal physical reactions to visual stimuli. Analyzing physical behaviors when presented with such stimuli can provide insights into the visual perception and motor abilities of an individual, yet there is currently no unbiased, objective, general-purpose tool that analyzes attention and motor behavior to assess neurocognitive function. We propose a novel method of neurocognitive function assessment that tests the patient's cognition using virtual reality with eye tracking and motion analysis. By placing the patient in a controlled virtual environment and analyzing their movements, we can evoke certain physical responses from subjects for neurocognitive assessment. We have developed a prototype system that places the subject in a virtual baseball field and captures their full body motion as they try to catch baseballs. This scenario tests the subject's ability to determine the landing time and position of the ball, as well as the test subject's balance, motor skills, attention, and memory. Preliminary tests with 20 healthy normal individuals demonstrate the ability of this tool to assess the test subject's balance, memory, attention, and reaction to visual stimuli. This platform has a twofold contribution: it is used to assess several neurocognitive constructs that affect visual and motor capability neutrally and objectively based on controlled stimuli, and it enables objective comparison between different neurocognitive disorders research in this field.	[Oagaz, Hawkar; Schoun, Breawn; Choi, Min-Hyung] Univ Colorado, Dept Comp Sci, Denver, CO 80204 USA; [Oagaz, Hawkar; Schoun, Breawn; Choi, Min-Hyung] Univ Colorado, Comcast Media & Technol Ctr, Denver, CO 80204 USA; [Pooji, Manpreet] Univ Colorado, Dept 3D Graph & Animat, Denver, CO 80204 USA		Choi, MH (corresponding author), Univ Colorado, Dept Comp Sci, Denver, CO 80204 USA.; Choi, MH (corresponding author), Univ Colorado, Comcast Media & Technol Ctr, Denver, CO 80204 USA.	hawkar.oagaz@ucdenver.edu; breawn.schoun@ucdenver.edu; manpreet.pooji@ucdenver.edu; min.choi@ucdenver.edu		Schoun, Breawn/0000-0001-7540-3398	Comcast Media and Technology Center under, CU Denver ORS grant; Department of Education GAANN FellowshipUS Department of Education [P200A150283]	This work was supported in part by the Comcast Media and Technology Center under, CU Denver ORS grant, and in part by the Department of Education GAANN Fellowship P200A150283.	[Anonymous], SEV TBI; Aubin G, 2018, NEUROPSYCHOL REHABIL, V28, P689, DOI 10.1080/09602011.2015.1074083; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brookmeyer R, 2018, ALZHEIMERS DEMENT, V14, P121, DOI 10.1016/j.jalz.2017.10.009; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; CONTINI R, 1963, HUM FACTORS, V5, P493, DOI 10.1177/001872086300500508; Freeman D, 2017, PSYCHOL MED, V47, P2393, DOI 10.1017/S003329171700040X; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Gonzalez A, 2012, IEEE INT C INT ROBOT, P1023, DOI 10.1109/IROS.2012.6385665; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Kamm CP, 2012, ARCH PHYS MED REHAB, V93, P1081, DOI 10.1016/j.apmr.2012.01.008; Kampmann IL, 2016, BEHAV RES THER, V77, P147, DOI 10.1016/j.brat.2015.12.016; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Kavcic V, 2003, BRAIN, V126, P1173, DOI 10.1093/brain/awg105; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lange BS, 2010, PHYS MED REH CLIN N, V21, P339, DOI 10.1016/j.pmr.2009.12.007; Levy CE, 2015, AM J PHYS MED REHAB, V94, pE31, DOI 10.1097/PHM.0000000000000248; Liu ZJ., 2016, DESIGNING PEOPLE, P75, DOI [10.1007/978-3-319-29498-8_8, DOI 10.1007/978-3-319-29498-8_8]; LOWES LP, 2013, PLOS CURR, V5; McKenna Cristin, 2013, Front Biosci (Schol Ed), V5, P732; MENDEZ MF, 1990, J CLIN NEURO-OPHTHAL, V10, P62; Mine M, 2016, BIORESEARCH OPEN ACC, V5, P228, DOI 10.1089/biores.2016.0023; Morina N, 2015, BEHAV RES THER, V74, P18, DOI 10.1016/j.brat.2015.08.010; Nakamura T, 1996, GERONTOLOGY, V42, P108, DOI 10.1159/000213780; Niiler T., 2012, SMITH S PENNS STAT U; Oliveira J, 2018, APPL NEUROPSYCH-ADUL, V25, P555, DOI 10.1080/23279095.2017.1349661; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Quencer K, 2007, NEUROLOGY, V68, P150, DOI 10.1212/01.wnl.0000250331.35912.a5; Rizzo A., 1997, VIRTUAL REALITY NEUR; Rizzo AA, 1997, ST HEAL T, V44, P123; Rizzo A, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1414560; Rizzo M, 2000, NEUROLOGY, V54, P1954, DOI 10.1212/WNL.54.10.1954; Rus-Calafell M, 2018, PSYCHOL MED, V48, P362, DOI 10.1017/S0033291717001945; Schenkman ML, 2001, PHYS THER, V81, P1400, DOI 10.1093/ptj/81.8.1400; Sears FW, 1987, U PHYS; Sessoms PH, 2015, MIL MED, V180, P143, DOI 10.7205/MILMED-D-14-00385; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Tippett WJ, 2006, BRAIN RES, V1102, P92, DOI 10.1016/j.brainres.2006.04.049; Tong T., 2014, P INT S HUM FACT ERG, V3, P28; Vanbellingen T, 2010, EUR J NEUROL, V17, P59, DOI 10.1111/j.1468-1331.2009.02741.x; Ward Mirela, 2015, Dement. neuropsychol., V9, P71, DOI 10.1590/S1980-57642015DN91000011; Webster D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-108; Wheaton LA, 2007, J NEUROL SCI, V260, P1, DOI 10.1016/j.jns.2007.04.014; Woodford HJ, 2007, QJM-INT J MED, V100, P469, DOI 10.1093/qjmed/hcm051; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Yu Z., 2017, VIRTUAL REALITY ASSE; Zanier ER, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00345; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24; ZHU MQ, 2017, SENSORS BASEL, V17, DOI DOI 10.3390/S17102398; Zygouris S, 2017, J ALZHEIMERS DIS, V56, P619, DOI 10.3233/JAD-160518	56	1	1	0	14	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194	2168-2208		IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	SEP	2019	23	5					1899	1910		10.1109/JBHI.2018.2881455			12	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Mathematical & Computational Biology; Medical Informatics	JD1IW	WOS:000489729400010	30442624				2022-02-06	
J	Ochs, CP; Kay, MC; Register-Mihalik, JK				Ochs, Corey P.; Kay, Melissa C.; Register-Mihalik, Johna K.			The Effect of Concussive Injury on Individual Game Performance in Professional Collision-Sport Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						brain concussion; physical performance; recovery; return to play	HOCKEY	Clinical Scenario: Collision sports are often at higher risk of concussion due to the physical nature and style of play. Typically, initial clinical recovery occurs within 7 to 10 days; however, even this time frame may result in significant time lost from play. Little has been done in previous research to analyze how individual game performance may be affected upon return to play postconcussion. Focused Clinical Question: Upon return-to-play clearance, how does sport-related concussion affect game performance of professional athletes in collision sports? Summary of Key Findings: All 3 studies included found no significant change in individual performance of professional collision-sport athletes upon returning to play from concussive injury. One of the studies indicated that there was no difference in performance for NFL athletes who did not miss a single game (returned within 7 d) and those who missed at least 1 game. One study indicated that although there was no change in performance of NFL players upon returning to play from sustained concussion, there was a decline in performance in the 2 weeks before the diagnosed injury and appearing on the injury report. The final study indicated that there was no difference in performance or style of play of NHL athletes who missed time due to concussive injury when compared with athletes who missed games for a noninjury factor. Clinical Bottom Line: There was no change in performance upon return from concussive injury suggesting that players appear to be acutely recovered from the respective concussion before returning to play. This suggests that current policies and management properly evaluate and treat concussed athletes of these professional sports. Strength of Recommendation: Grade C evidence exists that there is no change in individual game performance in professional collision-sport athletes before and after suffering a concussion.	[Ochs, Corey P.; Kay, Melissa C.; Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Kay, MC (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.	mkay@email.unc.edu					Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Associated Press, 2011, ASS PRESS       1226; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609	10	1	1	1	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2019	28	7					769	773		10.1123/jsr.2018-0168			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	IW7SN	WOS:000485194400018	30222485	Bronze			2022-02-06	
J	Osborne-Crowley, K; Wilson, E; De Blasio, F; Wearne, T; Rushby, J; McDonald, S				Osborne-Crowley, Katherine; Wilson, Emily; De Blasio, Frances; Wearne, Travis; Rushby, Jacqueline; McDonald, Skye			Preserved Rapid Conceptual Processing of Emotional Expressions Despite Reduced Neuropsychological Performance Following Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						emotional empathy; Emostroop; emotion recognition; traumatic brain injury	HOSPITAL ANXIETY; EMPATHY; PERCEPTION; DEFICITS; MIMICRY; TRAIL; FEEL; TASK	Objective: Emotional empathy is critical to successful social interactions and is often compromised after traumatic brain injury (FBI). Using the Emostroop task, we investigated whether adults with moderate to severe TBI (N = 26) have problems with rapid conceptual processing of emotional stimuli compared with controls (N = 30). Further, we investigated whether rapid conceptual processing of emotions relates to emotion recognition and emotional empathy. Method: In the Emostroop task, participants categorize emotional words (e.g., joyous, furious, and woeful) into three emotion categories: happy. sad, and angry. Each word is superimposed onto an image of a face, which expresses an emotion that is congruent to the word (congruent condition), incongruent to the word (incongruent condition), or is neutral (neutral condition). Slowed responding in the incongruent condition (interference) and speeded responding in the congruent condition (facilitation) indicates rapid conceptual processing of the faces. Participants also completed an emotion perception task, an empathy questionnaire (the BEES) and neuropsychological tests measuring processing speed. working memory. and executive function. Results: Contrary to our hypotheses, we found that rapid conceptual processing of emotional faces was preserved in people with TBI, despite diminished neuropsychological performance, emotion recognition, emotional empathy, and slowed responding. Further, the Emostroop effect was not correlated with self-reported emotional empathy or with emotion recognition. Conclusions: We conclude that in people with TBI, reduced empathy may be explained by processes downstream of the initial rapid conceptual processing of emotional information, such as flexibly attending and responding to this information in a goal-directed manner in complex environments.	[Osborne-Crowley, Katherine; Wilson, Emily; De Blasio, Frances; Wearne, Travis; Rushby, Jacqueline; McDonald, Skye] Univ New South Wales, Sch Psychol, London, England		Osborne-Crowley, K (corresponding author), UCL Inst Neurol, Huntingtons Dis Ctr, Level 2,Russell Sq House, London WC1B 5EH, England.	k.osborne-crowley@ucl.ac.uk	De Blasio, Frances M./D-9158-2019	De Blasio, Frances M./0000-0003-1442-9820; Wilson, Emily/0000-0002-1949-7657; Wearne, Travis/0000-0002-7565-9163			Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess PW, 1997, HAYLING BRIXTON TEST, P2; Davis, 2018, EMPATHY SOCIAL PSYCH, DOI [10.4324/9780429493898, DOI 10.4324/9780429493898]; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hofelich AJ, 2012, COGNITION EMOTION, V26, P119, DOI 10.1080/02699931.2011.559192; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Preston SD, 2008, COGN AFFECT BEHAV NE, V8, P54, DOI 10.3758/CABN.8.1.54; Preston SD, 2007, EMPATHY IN MENTAL ILLNESS, P428, DOI 10.1017/CBO9780511543753.024; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Shipley W. C., 2009, SHIPLEY 2; Snaith R., 1994, HOSP ANXIETY DEPRESS; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Wechsler D., 2008, WECHSLER ADULT INTEL; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	1	1	1	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2019	33	6					872	882		10.1037/neu0000545			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IT0XB	WOS:000482569400010	31021106	Green Submitted			2022-02-06	
J	Pham, TT; Lester, E; Grigorian, A; Roditi, RE; Nahmias, JT				Pham, Tiffany T.; Lester, Ellen; Grigorian, Areg; Roditi, Rachel E.; Nahmias, Jeffry T.			National Analysis of Risk Factors for Nasal Fractures and Associated Injuries in Trauma	CRANIOMAXILLOFACIAL TRAUMA & RECONSTRUCTION			English	Article						nasal fractures; facial fractures; risk factors; trauma; National Trauma Data Bank; epidemiology	PEDIATRIC FACIAL FRACTURES; MOTOR-VEHICLE COLLISIONS; CLOSED-HEAD INJURIES; UNITED-STATES; PATTERNS; MANAGEMENT; IMPACT; SEVERITY; CARE	Nasal fractures account for up to 58% of facial fractures. However, the literature characterizing associated injuries and risk factors for nasal fractures is sparse and is mostly composed of single-center experiences. This study sought to provide a large descriptive analysis and identify associated injuries and risk factors for nasal fractures in trauma using a national database. A retrospective analysis of the National Trauma Data Bank (NTDB) from 2007 to 2015 was performed. Patients >= 18 years of age with nasal fractures were included. A multivariable logistic regression model was used to identify predictors for nasal fracture in trauma. Of 5,494,609 trauma patients in the NTDB, 255,533 (4.6%) had a nasal fracture. Most were male (74.8%) with a mean age of 45.6 years. Blunt trauma accounted for 90.5% of fractures, with motor vehicle accident being the most common mechanism (27.5%). Closed fractures occurred in 93.0% of patients. Concomitant injuries included traumatic brain injury (TBI; 56.9%), malar/maxillary fracture (27.9%), and open wound of the face (38.6%) and nose (9.5%). Of all patients, 10.1% underwent closed or open reductions at index hospitalization. The strongest associated injuries with nasal fracture included open wound of the nose (odds ratio [OR]: 8.71, 95% confidence interval [CI]: 8.49-8.94, p < 0.001), epistaxis (OR: 5.26, 95% CI: 4.59-6.02, p < 0.001), malar/maxillary fracture (OR: 4.38, 95% CI: 4.30-4.45, p < 0.001), and orbital fracture (OR: 3.99, 95% CI: 3.91-4.06, p < 0.001). Nasal fractures are common traumatic injuries with more than 90% occurring by blunt mechanism and over half suffering from a concomitant TBI. The strongest associated injury with nasal fracture is an open wound of the nose.	[Pham, Tiffany T.; Lester, Ellen; Grigorian, Areg; Nahmias, Jeffry T.] Univ Calif Irvine, Sch Med, Div Trauma Burn & Crit Care, Dept Surg, 333 City Blvd West,Ste 1600, Orange, CA 92868 USA; [Roditi, Rachel E.] Harvard Med Sch, Brigham & Womens Hosp, Div Otolaryngol Head & Neck Surg, Dept Surg, Boston, MA 02115 USA		Nahmias, JT (corresponding author), Univ Calif Irvine, Sch Med, Div Trauma Burn & Crit Care, Dept Surg, 333 City Blvd West,Ste 1600, Orange, CA 92868 USA.	jnahmias@uci.edu	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X			Allred LJ, 2015, J CRANIOFAC SURG, V26, P2368, DOI 10.1097/SCS.0000000000002087; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Atisha DM, 2016, PLAST RECONSTR SURG, V137, P587, DOI 10.1097/01.prs.0000475791.31361.9a; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bartkiw T P, 1995, Int J Trauma Nurs, V1, P11, DOI 10.1016/S1079-2104(05)80405-6; Chan KH, 2016, LARYNGOSCOPE, V126, P485, DOI 10.1002/lary.25457; Chang MC., 2016, NATL TRAUMA DATA BAN; Chou C, 2015, ASIAN J SURG, V38, P191, DOI 10.1016/j.asjsur.2014.09.002; Cormier Joseph, 2010, Ann Adv Automot Med, V54, P3; Daniel M, 2005, EMERG MED J, V22, P778, DOI 10.1136/emj.2004.018994; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Erdmann D, 2008, ANN PLAS SURG, V60, P398, DOI 10.1097/SAP.0b013e318133a87b; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Greathouse ST, 2015, J CRANIOFAC SURG, V26, P1529, DOI 10.1097/SCS.0000000000001805; Hansen Luke, 2014, J Emerg Trauma Shock, V7, P256, DOI 10.4103/0974-2700.142612; Hitosugi M, 2011, J ORAL MAXIL SURG, V69, P1146, DOI 10.1016/j.joms.2010.05.030; Hwang K, 2017, J CRANIOFAC SURG, V28, P3, DOI 10.1097/SCS.0000000000003013; Hwang K, 2015, J CRANIOFAC SURG, V26, P525, DOI 10.1097/SCS.0000000000002030; Hyman DA, 2016, JAMA FACIAL PLAST SU, V18, P455, DOI 10.1001/jamafacial.2016.0733; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Kelley BP., 2010, SEMIN PLAST SURG, V24, P339, DOI [10.1055/s-0030-1269763, DOI 10.1055/S-0030-1269763]; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kraft A, 2012, CRANIOMAX TRAUM REC, V5, P41, DOI 10.1055/s-0031-1293520; Lanigan A, 2017, OTOLARYNG HEAD NECK, V156, P1041, DOI 10.1177/0194599816688179; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; McMullin BT, 2009, ARCH FACIAL PLAST S, V11, P165, DOI 10.1001/archfacial.2009.11; Mouzakes J, 2001, ARCH OTOLARYNGOL, V127, P1189, DOI 10.1001/archotol.127.10.1189; Murphy RX, 2000, PLAST RECONSTR SURG, V105, P516, DOI 10.1097/00006534-200002000-00005; Perez-Guisado Joaquin, 2012, Eplasty, V12, pe3; Reilly MJ, 2007, ARCH FACIAL PLAST S, V9, P82, DOI 10.1001/archfaci.9.2.82; Ridder Gerd Jurgen, 2002, Ear Nose Throat J, V81, P49; Rohrich RJ, 2000, PLAST RECONSTR SURG, V106, P266, DOI 10.1097/00006534-200008000-00003; Shere JL, 2004, OTOLARYNG HEAD NECK, V130, P164, DOI 10.1016/j.otohns.2003.09.018; Smith HL, 2013, DENT TRAUMATOL, V29, P313, DOI 10.1111/edt.12006; Stewart MG, 1997, OTOLARYNG HEAD NECK, V117, P72, DOI 10.1016/S0194-5998(97)70210-9; Stone ME, 2014, J TRAUMA ACUTE CARE, V76, P185, DOI 10.1097/TA.0b013e3182aafcd5; Wu G, 2018, WORLD NEUROSURG, V111, pE47, DOI 10.1016/j.wneu.2017.11.166; Zelken JA, 2014, J ORAL MAXIL SURG, V72, P352, DOI 10.1016/j.joms.2013.08.015	38	1	1	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1943-3875	1943-3883		CRANIOMAX TRAUM REC	Craniomaxillofacial Trauma Reconstr.	SEP	2019	12	3					221	227		10.1055/s-0039-1677724			7	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	IU8KY	WOS:000483831700009	31428247	Green Published			2022-02-06	
J	Pucci, AM; Anderson, MW; Fetzick, A				Pucci, Ava M.; Anderson, Maighdlin W.; Fetzick, Anita			The Transition Trajectory for the Patient with a Traumatic Brain Injury	NURSING CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Acute care; Discharge status; Complications; Outcome	MORTALITY; PHENYTOIN; ANTICOAGULATION; LEVETIRACETAM; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; DISCHARGE; SCALE	The trajectory status of patients with mild, moderate, and severe traumatic brain injury from emergency room evaluation, through acute care (intensive care if severe) and discharge is discussed. Additional considerations for elderly population and common complications associated with severe traumatic brain injury are also covered.	[Pucci, Ava M.; Fetzick, Anita] Univ Pittsburgh, Dept Neurol Surg, Neurotrauma Clin Trials Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA; [Anderson, Maighdlin W.] Univ Pittsburgh, Sch Nursing, 324 Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA		Pucci, AM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Neurotrauma Clin Trials Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	puccioam@upmc.edu					Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bouadma L, 2015, CRIT CARE MED, V43, P1798, DOI 10.1097/CCM.0000000000001091; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Catapano JS, 2017, AM J SURG, V213, P1104, DOI 10.1016/j.amjsurg.2016.07.010; Chartrain AG, 2017, CURR PHARM DESIGN, V23, P6428, DOI 10.2174/1381612823666171031100139; Chen H, 2017, METAB BRAIN DIS, V32, P1427, DOI 10.1007/s11011-017-0008-2; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cosano G, 2016, BRAIN INJURY, V30, P353, DOI 10.3109/02699052.2015.1118767; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gooden JR, 2017, AUST OCCUP THER J, V64, P33, DOI 10.1111/1440-1630.12306; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; JENNETT B, 1975, LANCET, V1, P480; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Mehta V, 2018, J CLIN NEUROSCI, V50, P7, DOI 10.1016/j.jocn.2018.01.050; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Rogers S, 2015, ARCH PHYS MED REHAB, V96, P276, DOI 10.1016/j.apmr.2014.09.018; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Soleman J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14398; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Surgeons ACo, ACS TQIP GER TRAUM M; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; The ATLS Subcommittee American College of Surgeons' Committee on Trauma and the International ATLS Working Group, 2012, ATLS STUD MAN; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zarshenas S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016694	40	1	1	3	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0029-6465	1558-1357		NURS CLIN N AM	Nurs. Clin. North Am.	SEP	2019	54	3					409	+		10.1016/j.cnur.2019.04.009			16	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	IU3CF	WOS:000483455600011	31331627				2022-02-06	
J	Querzola, G; Lovati, C; Mariani, C; Pantoni, L				Querzola, Giacomo; Lovati, Carlo; Mariani, Claudio; Pantoni, Leonardo			A semi-quantitative sport-specific assessment of recurrent traumatic brain injury: the TraQ questionnaire and its application in American football	NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; TBI; American football; Trauma questionnaire; TraQ; Chronic traumatic encephalopathy; CTE	COGNITIVE IMPAIRMENT; ENCEPHALOPATHY; PERFUSION	Chronic traumatic encephalopathy (CTE) is very frequent and studied among contact sport players, above all American Football. Now, the defined diagnosis is only post-mortem and, consequently, more detailed diagnostic in-vivo instruments are needed to facilitate diagnosis and to allow a follow up. This clinical questionnaire (Trauma Questionnaire-TraQ) has been designed to investigate in parallel the traumatic load and clinical and cognitive subjective symptoms. It evaluates 4 anamnestic fields (specific sport activity, all previous pathological events, clinical manifestations compatible with TBI (traumatic brain injury) or CTE and subjective perception of personal memory efficacy with PRMQ questionnaire). The aim of TraQ questionnaire is to allow a standardized follow-up of active players and to identify subclinical disturbances that may become warnings. A pilot comparative study with TraQ on 105 subjects (75 AF players and 30 comparable people without a history of contact-sports activity) revealed that AF players have an increased amount of severe head trauma, an amplified level of subjective aggressiveness, more olfactory deficits but also more speech subjective problems, previously never related with CTE. In view of the obtained results, the TraQ seems to be useful (1) to obtain a better quantification of the traumatic load; (2) to differentiate the risk of long-term neurological consequences, allowing better management of different athletes right from the pre-symptomatic phases; (3) to manage prevention strategies if regularly applied to periodic visits to sports fitness; and (4) to identify the predisposing factors for the development of CTE and other neurological consequences of TBI with follow-up studies.	[Querzola, Giacomo] Univ Milan, Neurol Unit, Luigi Sacco Hosp, Via GB Grassi 74, I-20157 Milan, MI, Italy; [Lovati, Carlo] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Ctr Cefalee, Via GB Grassi 74, I-20157 Milan, MI, Italy; [Mariani, Claudio; Pantoni, Leonardo] Univ Milan, Luigi Sacco Dept Biomed & Clin Sci, Via GB Grassi 74, I-20157 Milan, MI, Italy		Querzola, G (corresponding author), Univ Milan, Neurol Unit, Luigi Sacco Hosp, Via GB Grassi 74, I-20157 Milan, MI, Italy.	giacomo.querzola@unimi.it; carlo.lovati@asst-fbf-sacco.it; leonardo.pantoni@unimi.it	Lovati, Carlo/AAJ-6572-2020				Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bricolo F, CANNABIS MATURAZIONE; Cambier J, 2013, NEUROLOGIA DODICESIM; De Giorgi F, 2002, MANAGEMENT PROTOCOL; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kim J, 2009, J NEUROTRAUM, V27, P1399; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Omalu B, 2008, PLAY HARD DIE YOUNG; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; TEASDALE G, 1974, LANCET, V2, P81; Tom F, 2016, YOUTH FOOTBALL PARTI; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839	25	1	1	1	6	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	SEP	2019	40	9					1909	1915		10.1007/s10072-019-03853-z			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT6BE	WOS:000482954000017	31104170				2022-02-06	
J	Molinares, NQ; Daugherty, JC; Villarreal, RM; Hidalgo-Ruzzante, N; Aragon, CJD				Quiroz Molinares, Nathalia; Daugherty, Julia C.; Mejia Villarreal, Rafael; Hidalgo-Ruzzante, Natalia; De los Reyes Aragon, Carlos Jose			Intimate Partner Violence-Related Injuries Among Colombian Women	VIOLENCE AND GENDER			English	Article						intimate partner violence; Colombian women; injuries; review of reports	TRAUMATIC BRAIN-INJURY; DOMESTIC VIOLENCE; STRANGULATION; VICTIMS; STRESS; HEAD	Previous studies have reported that the majority of women who suffer physical injuries related to intimate partner violence (IPV) have been injured in the head, neck, and/or face. No studies have provided detailed information on injuries suffered by Colombian abused women, and therefore the types of injuries, where on the body they have been inflicted and the associated symptoms experienced by women who are victims of IPV remain unknown in the Colombian context. This study aims to describe the patterns of injuries among female victims of IPV in Colombia, as well as the related demographic and nondemographic factors. We used reports gathered from the "Centro de Atencion a Victimas de la Fiscalia [Center for Victim Services at the District Attorney's Office]" in the city of Barranquilla, Colombia, between January 2016 and January 2017. We found that most cases involved injuries to the head and face. The implications of this type of injury were discussed.	[Quiroz Molinares, Nathalia; Mejia Villarreal, Rafael; De los Reyes Aragon, Carlos Jose] Univ Norte, Dept Psychol, Barranquilla 080002, Colombia; [Quiroz Molinares, Nathalia] Univ Costa, Dept Social Sci, Barranquilla, Colombia; [Daugherty, Julia C.; Hidalgo-Ruzzante, Natalia] CIMCYC, Granada, Spain; [Hidalgo-Ruzzante, Natalia] Univ Granada, Dept Evolutionary Psychol & Educ, Granada, Spain		Molinares, NQ (corresponding author), Univ Norte, Dept Psychol, Barranquilla 080002, Colombia.	nathaliaq@uninorte.edu.co	Daugherty, Julia C./Q-8716-2017; Hidalgo-Ruzzante, Natalia/F-1108-2016	Daugherty, Julia C./0000-0002-1221-4394; Hidalgo-Ruzzante, Natalia/0000-0002-9952-9478			Ballan MS, 2012, VIOLENCE AGAINST WOM, V18, P1083, DOI 10.1177/1077801212461430; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Government Delegation for Gender Violence, 2015, INH DEN VICT GEND VI; Gracia E, 2004, J EPIDEMIOL COMMUN H, V58, P536, DOI 10.1136/jech.2003.019604; Hawley DA, 2001, J EMERG MED, V21, P317, DOI 10.1016/S0736-4679(01)00401-2; IVANY A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI DOI 10.1097/FCH.0000000000000094; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Meyer S, 2016, THEOR CRIMINOL, V20, P75, DOI 10.1177/1362480615585399; Meyer S, 2012, AUST NZ J CRIMINOL, V45, P179, DOI 10.1177/0004865812443677; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; Munevar DI, 2018, REV BRASILEIRA SOCIO, V5, P46; National Institute for Legal Medicine and Forensic Science, 2017, EV NEUR DET SAMPL WO; Ochs HA, 1996, J AM DENT ASSOC, V127, P757, DOI 10.14219/jada.archive.1996.0311; Restrepo-Bernal D, 2014, CASES SERIES 5 XERTE, V25, P179; Rincon BR, 2015, THESIS; Shields LBE, 2010, AM J FOREN MED PATH, V31, P320, DOI 10.1097/PAF.0b013e3181d3dc02; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Stein MB, 2002, BIOL PSYCHIAT, V52, P10; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Tiwari A, 2016, CAN J NURS RES, V33, P63; Tocci N, 2009, FACULTY JURIDICAL PO, V59, P615; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Wong JYH, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-6; World Health Organization, 2013, VIOLENCE AGAINST WOM; Zilkens RR, 2016, J FORENSIC LEG MED, V43, P1, DOI 10.1016/j.jflm.2016.06.005	32	1	1	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2326-7836	2326-7852		VIOLENCE GEND	Violence Gend.	SEP 1	2019	6	3					196	199		10.1089/vio.2018.0034			4	Criminology & Penology	Emerging Sources Citation Index (ESCI)	Criminology & Penology	IX8JK	WOS:000485932800008		Bronze, Green Submitted			2022-02-06	
J	Ridwan, S; Greschus, S; Bostrom, J; Barrera, J; Esche, J; Zur, B; Klingmuller, D; Bostrom, A				Ridwan, Sami; Greschus, Susanne; Bostrom, Jan; Barrera, Julio; Esche, Jonas; Zur, Bernd; Klingmueller, Dietrich; Bostroem, Azize			Spontaneous Aneurysmal Subarachnoid Hemorrhage and Related Cortisol and Immunologic Alterations: Impact on Patients' Health-related Quality of Life	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						health-related quality of life; subarachnoid hemorrhage; neurosurgery; vascular	BECK DEPRESSION INVENTORY; TRAUMATIC BRAIN-INJURY; INTERLEUKIN-6 LEVELS; ISCHEMIC-STROKE; POPULATION; HYPOPITUITARISM; DYSFUNCTION; VALIDATION; CORRELATE; SEVERITY	Objective To highlight the impact of aneurysmal subarachnoid hemorrhage (SAH) on surviving patients' health-related quality of life (HRQoL) with respect to cortisol and interleukin (IL)-6 alterations and also to identify possible clinical predictors for a better HRQoL. Methods Fifty surviving patients treated in our hospital for aneurysmal SAH in a 2-year period with sufficient HRQoL data were enrolled. A good clinical outcome was represented by the modified Rankin Scale (mRS) 0 to 2. The patient's HRQoL was assessed using the Short Form health survey questionnaire, the Beck Depression Inventory, and the Daily Fatigue Impact Scale at 6 and 12 months. The results were analyzed regarding possible correlation to 24-hour urinary free cortisol, serum, and cerebrospinal fluid IL-6 levels. Results A reduction of HRQoL in up to 35% of survivors was observed at 6 months and in a high proportion of patients (47.2%) with an assumable good outcome (mRS 0-2). Reduced HRQoL in survivors was found in terms of SF-36 (34.9%), depression (26.8%), and fatigue (14%) at 6 months and 18.4%, 39.4%, and 18.9% at 12 months, respectively. Improvement was recorded at 12 months, mainly in SF-36. Early elevated 24-hour urinary free cortisol and IL-6 levels showed a significant positive impact on HRQoL. Conclusions Early cortisol and IL-6 levels may predict patients' HRQoL after SAH. Twelve months after SAH, a considerable percentage of patients with a presumably good outcome (mRS 0-2) had a lower HRQoL compared with the general population. Implementing corresponding tests at discharge and 12-month follow-up is recommended.	[Ridwan, Sami; Bostrom, Jan; Barrera, Julio; Bostroem, Azize] Univ Klinikum Bonn, Dept Neurosurg, Bonn, Nordrhein Westf, Germany; [Greschus, Susanne] Univ Klinikum Bonn, Dept Radiol, Bonn, Nordrhein Westf, Germany; [Ridwan, Sami] Evangel Klinikum Bethel, Dept Neurosurg, Bielefeld, Germany; [Esche, Jonas] Univ Bonn, Dept Nutr & Food Sci, Bonn, Germany; [Zur, Bernd] Univ Klinikum Bonn, Dept Clin Chem & Pharmacol, Bonn, Nordrhein Westf, Germany; [Klingmueller, Dietrich] Univ Klinikum Bonn, Dept Med 1, Div Endocrinol & Diabet, Bonn, Nordrhein Westf, Germany		Ridwan, S (corresponding author), Evangel Klinikum Bethel, Dept Neurosurg, Bielefeld, Germany.	sami.ridwan@yahoo.de	Ridwan, Sami/U-9749-2019	Ridwan, Sami/0000-0001-5103-9560			Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bullinger M, 1998, FRAGEBOGEN ZUM GESUN; BURN JPS, 1992, STROKE, V23, P438, DOI 10.1161/str.23.3.438b; Ceccato F, 2014, EUR J ENDOCRINOL, V171, P1, DOI 10.1530/EJE-14-0061; Chaudhry SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122580; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dodel R, 2010, STROKE, V41, P2918, DOI 10.1161/STROKEAHA.110.586826; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Fisk JD, 2002, QUAL LIFE RES, V11, P263, DOI 10.1023/A:1015295106602; Gatti R, 2009, CLIN BIOCHEM, V42, P1205, DOI 10.1016/j.clinbiochem.2009.04.011; Heijink R, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0694-9; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hoh BL, 2010, STROKE, V41, P337, DOI 10.1161/STROKEAHA.109.569269; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Izzo G, 2016, INT J SURG, V28, pS103, DOI 10.1016/j.ijsu.2015.05.056; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; JENNETT B, 1975, LANCET, V1, P480; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Konig HH, 2009, MED CARE, V47, P255, DOI 10.1097/MLR.0b013e318184759e; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Meyer B, 2010, CEREBROVASC DIS, V30, P423, DOI 10.1159/000317078; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Naess H, 2006, STROKE, V37, P1232, DOI 10.1161/01.STR.0000217652.42273.02; Niwa A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0675-7; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Richter P, 1997, PSYCHOPATHOLOGY, V30, P234, DOI 10.1159/000285052; Ridwan S, 2017, WORLD NEUROSURG, V97, P495, DOI 10.1016/j.wneu.2016.09.123; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021	43	1	2	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315	2193-6323		J NEUROL SURG PART A	J. Neurol. Surg. Part A	SEP	2019	80	5					371	380		10.1055/s-0039-1677827			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	IU8QP	WOS:000483846800007	31272120				2022-02-06	
J	Shibaike, Y; Gotoh, M; Ogawa, C; Nakajima, S; Yoshikawa, K; Kobayashi, T; Murakami-Murofushi, K				Shibaike, Yuki; Gotoh, Mari; Ogawa, Chinatsu; Nakajima, Shingo; Yoshikawa, Keisuke; Kobayashi, Tetsuyuki; Murakami-Murofushi, Kimiko			2-Carba cyclic phosphatidic acid inhibits lipopolysaccharide-induced prostaglandin E2 production in a human macrophage cell line	BIOCHEMISTRY AND BIOPHYSICS REPORTS			English	Article						2ccPA; Prostaglandin E2; Anti-inflammatory; THP-1 monocytes		Cyclic phosphatidic acid (cPA) is a naturally occurring phospholipid mediator that contains a unique cyclic phosphate ring at the sn-2 and sn-3 positions of its glycerol backbone. Using mouse models for multiple sclerosis (cuprizone-induced demyelination and experimental autoimmune encephalomyelitis) and traumatic brain injury, we revealed that cPA and its metabolically stabilized cPA derivative, 2-carba-cPA (2ccPA), have potential to protect against neuroinflammation. In this study, we investigated whether 2ccPA has anti-inflammatory effect on peripheral immune function or not using inflammation-induced macrophages-like cell line, THP-1 monocytes differentiated by phorbol 12-myristate 13-acetate (PMA). Lipopolysaccharide (LPS)-stimulated THP-1 cells were found to have higher expression of the mRNAs of several inflammation-related cytokines and of the enzyme cyclooxygenase-2 (Cox-2); however, when THP-1 cells were stimulated by LPS in the presence of 2ccPA, the increase in the expression of pro-inflammatory cytokine and Cox-2 mRNA was attenuated. 2ccPA treatment also decreased the amount of prostaglandin E2 (PGE2) produced by LPS-stimulated THP-1 cells and decreased expression of the mRNA of prostaglandin E receptor 2 (EP2, PTGER2), a PGE2 receptor that mediates inflammation. These results indicate that 2ccPA has anti-inflammatory properties.	[Shibaike, Yuki; Gotoh, Mari; Nakajima, Shingo; Murakami-Murofushi, Kimiko] Ochanomizu Univ, Endowed Res Div Beauty & Sci, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan; [Shibaike, Yuki] Ochanomizu Univ, Res Org Promot Global Womens Leadership, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan; [Gotoh, Mari; Kobayashi, Tetsuyuki] Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan; [Ogawa, Chinatsu; Kobayashi, Tetsuyuki] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan; [Nakajima, Shingo] Natl Ctr Neurol & Psychiat NCNP, Natl Inst Neurosci, Dept Mental Disorder Res, 4-1-1 Ogawa Higashi, Kodaira, Tokyo, Japan; [Yoshikawa, Keisuke] Saitama Med Univ, Fac Med, Dept Pharmacol, 38 Moro Hongo, Saitama 3500495, Japan		Murakami-Murofushi, K (corresponding author), Ochanomizu Univ, Bunkyo Ku, 2-1-1 Ohtsuka, Tokyo 1128610, Japan.	murofushi.kimiko@ocha.ac.jp	Yoshikawa, Keisuke/AAA-4185-2019	Yoshikawa, Keisuke/0000-0002-6348-6138; GOTOH, Mari/0000-0002-8052-4247	Japan Agency for Medical Research and Development (AMED)Japan Agency for Medical Research and Development (AMED)	This study was supported by Japan Agency for Medical Research and Development (AMED). The authors gratefully acknowledge the work of past and present members of Murofushi and Kobayashi laboratory in Ochanomizu University. M.G. thanks timely assistance from the Research Organization for the Promotion of Global Women's Leadership, Ochanomizu University, with respect to academic support for woman researchers with young children.	Baek YS, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-18; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Cala MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190958; Cheon H, 2006, J IMMUNOL, V177, P1092, DOI 10.4049/jimmunol.177.2.1092; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Figueiredo JF, 2009, MICROBES INFECT, V11, P850, DOI 10.1016/j.micinf.2009.05.003; Fukasawa K, 2018, J CHROMATOGR A, V1567, P177, DOI 10.1016/j.chroma.2018.07.010; Gotoh M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-52; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Hashimoto K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27990-1; Johansson JU, 2013, J NEUROSCI, V33, P16016, DOI 10.1523/JNEUROSCI.2203-13.2013; Kakiuchi Y, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-33; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; MURAKAMIMUROFUSHI K, 1992, J BIOL CHEM, V267, P21512; Nozaki E, 2011, BBA-MOL CELL BIOL L, V1811, P271, DOI 10.1016/j.bbalip.2011.01.003; Palumbo S, 2012, J NEUROCHEM, V121, P418, DOI 10.1111/j.1471-4159.2011.07363.x; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rupp J, 2003, EUR RESPIR J, V22, P274, DOI 10.1183/09031936.03.00007303; Shan L, 2008, J CHROMATOGR B, V862, P161, DOI 10.1016/j.jchromb.2007.12.003; Shimizu Y, 2018, J CHROMATOGR B, V1076, P15, DOI 10.1016/j.jchromb.2018.01.002; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Wood PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193424; Yamamoto S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0923-5; Yamamoto S, 2014, EUR J PHARMACOL, V741, P17, DOI 10.1016/j.ejphar.2014.07.040; Yukiura H, 2015, J CELL SCI, V128, P3871, DOI 10.1242/jcs.172098	28	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2405-5808			BIOCHEM BIOPHYS REP	Biochem. Biophys. Rep.	SEP	2019	19								100668	10.1016/j.bbrep.2019.100668			5	Biochemistry & Molecular Biology	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology	VJ9JI	WOS:000646685000019	31367683	Green Published, gold			2022-02-06	
J	Shvets, AV; Kikh, AY; Lukianchuk, IA				Shvets, A. V.; Kikh, A. Yu.; Lukianchuk, I. A.			Features of postconcussion symptoms recovery after traumatic brain injury among military personnel	ZAPOROZHYE MEDICAL JOURNAL			Russian	Article						postconcussion syndrome; traumatic brain injury; cognitive disorders; electroencephalography		Traumatic brain injuries due to hostilities in Eastern Ukraine in 2017 accounted for 30.8% of all mechanical combat damage and injuries and are an important problem because of postconcussion syndrome manifestation in the long-term period. Purpose - to study the features of postconcussion symptoms recovery among combatants during their rehabilitation in hospital conditions based on electroencephalography and the dynamics of psychophysiological characteristics assessment. Materials and methods. 42 combatants aged 35-45 years who suffered a closed craniocerebral injury during 2017-2018 (more than 3 months after head injury) and 76 healthy men the same age, constituted group II (control), were involved in the study. The study evaluated and analyzed the results of electroencephalography (EEG), manifestations of postconcussion symptoms using K. Cicerone modified special questionnaire as well as the characteristics of attentiveness and short-term memory using a special computer program. Results. Among individuals with postconcussion syndrome, the functioning of non-specific brain systems was found to be impaired making dysregulation changes in the electrical activity of the brain stable and long-lasting. It was shown that the applied rehabilitation programs had a positive effect on the balance and improvement of the brain bioelectrical activity rhythms and, accordingly, the functional activity of these structures (theta and delta characteristics of EEG spectrum improved after rehabilitation (P < 0.05), which may indicate the inclusion of neuro-emotional stress coping mechanisms during rehabilitation in inpatient conditions). Somatic manifestations which very often occur and impair performance, as well as definite complaints from the cognitive sphere, reliably decreased (P < 0.05), but complaints due to sensory functions impairment remained almost unchanged in 17 % of people after the rehabilitation course. The characteristics of attentiveness and short-term memory had a positive (P < 0.001) dynamics after the rehabilitation course and did not exceed the calculated standard indicators. Conclusions. The features of postconcussion symptoms recovery among combatants during their rehabilitation in hospital conditions in terms of theta and delta characteristics of the EEG spectrum have been revealed. The presence of significant (P < 0.001) differences in objective characteristics of cognitive functions in patients before rehabilitation compared with the control group (below standard values), as well as significant (P < 0.001) positive dynamics of attentiveness and short-term memory after rehabilitation of military personnel with postconcussion symptomatology and approximation of these characteristics to standard values have been found. It has been noted that the diagnosis of cognitive disorders associated with traumatic brain injury should be essentially based on the results of neuropsychological objective testing of attentiveness and short-term memory, since they are more dynamic (P < 0.001) indicators compared with complaints relating to cognitive function changes.	[Shvets, A. V.; Lukianchuk, I. A.] Ukrainian Mil Med Acad, Res Dept Special Med & Psychophysiol, Res Inst Mil Med, Kiev, Ukraine; [Kikh, A. Yu.] UAF Ukraine, Mil Med Clin Ctr Occupat Pathol Mil Personnel, Irpin, Ukraine		Shvets, AV (corresponding author), Ukrainian Mil Med Acad, Res Dept Special Med & Psychophysiol, Res Inst Mil Med, Kiev, Ukraine.	shvetsandro@gmail.com	Shvets, Andrii/AAD-9322-2021	Shvets, Andrii/0000-0002-9461-7129			Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Kalnysh V. V., 2008, UKRAINSKYI ZH PROBLE, V16, P49; Kich A., 2017, KIBERNETIKA VYCHISLI, V3, P79, DOI [10.15407/kvt188.02.075, DOI 10.15407/KVT188.02.075]; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; O'Neil ME, 2017, J CLIN EXP NEUROPSYC, V39, P449, DOI 10.1080/13803395.2016.1232699; Shvets A. V., 2008, SVIDOTSTVO PROREIEST; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Zhirmunskaya E. A., 1972, RUKOVODSTVO FIZIOLOG	16	1	1	0	0	ZAPORIZHZHYA STATE MEDICAL UNIV	ZAPORIZHZHYA	PR-KT MAYAKOVSKOGO, 26, ZAPORIZHZHYA, 69035, UKRAINE	2306-4145	2310-1210		ZAPOROZHYE MED J	ZAPOROZHYE MED. J.	SEP-OCT	2019	21	5					618	624		10.14739/2310-1210.2019.5.179424			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JF0IH	WOS:000491070600008		gold			2022-02-06	
J	Thean, D; Lam, A; Honeybul, S				Thean, David; Lam, Alex; Honeybul, Stephen			Isolated medial rectus palsy following closed head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Medial rectus palsy; Trauma; Closed head injury	INTER-NUCLEAR OPHTHALMOPLEGIA; OCULOMOTOR NERVE	Isolated traumatic medial rectus palsies associated with closed head injury is rarely reported in literature. We report the case of a 48 year-old male with an isolated right medial rectus palsy following a mechanical fall with occipital headstrike. Bifrontal and bitemporal haemorrhagic contusions were seen on computed tomography (CT). Magnetic resonance imaging (MRI) revealed a T2 hyperintense lesion at the right paramedian dorsal midbrain, with changes on diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC), suggestive of ischaemic changes in the oculomotor nucleus. He was followed up at two and six-weeks. (C) 2019 Elsevier Ltd. All rights reserved.	[Thean, David; Lam, Alex; Honeybul, Stephen] Royal Perth Hosp, Dept Neurosurg, 197 Wellington St, Perth, WA 6000, Australia		Thean, D (corresponding author), Royal Perth Hosp, Dept Neurosurg, 197 Wellington St, Perth, WA 6000, Australia.	david.thean@health.wa.gov.au					BAKER RS, 1979, J NEUROSURG, V51, P552, DOI 10.3171/jns.1979.51.4.0552; BECK RW, 1981, ANN OPHTHALMOL, V13, P671; Chen CC, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.016311; ELSTON JS, 1984, BRIT J OPHTHALMOL, V68, P538, DOI 10.1136/bjo.68.8.538; Erenler Ali Kemal, 2015, Asian J Neurosurg, V10, P265, DOI 10.4103/1793-5482.161169; Kaido T, 2006, J CLIN NEUROSCI, V13, P852, DOI 10.1016/j.jocn.2005.08.020; Kook DB, 2015, ARCH PLAST SURG-APS, V42, P250, DOI 10.5999/aps.2015.42.2.250; MEMON MY, 1971, J NEUROSURG, V35, P461, DOI 10.3171/jns.1971.35.4.0461; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Tiffin PAC, 1996, EYE, V10, P377, DOI 10.1038/eye.1996.77	11	1	1	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2019	67						263	265		10.1016/j.jocn.2019.06.029			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU2MD	WOS:000483413600050	31248785				2022-02-06	
